>LONDMIMF_00001 hypothetical protein
MYKDLGQVQRTFDITIGSFWAFKSVDLDSIFIDKTQSLKLEKNLETLQSIRKTEIFMSPK
YAFLVIYRNKKDTLYMDENLRKGYYKNAHIEIEDKKGLLKIELEKLSPVFFDGKSN
>LONDMIMF_00002 hypothetical protein
MANQIKDPIQLQVKQEEMVKIIFDGWEVGMKKIPFVKLLNERASLSLTDAKKLKDRLVDD
NEIVEIKVINENLAKEILNEAQKLKVKGKILFD
>LONDMIMF_00003 Chaperone protein DnaJ
MKRIVEHRKLLGVDKTVTLKELKTIYRNTMKDSHPDKFVDDEAGRLEAEEKSKSVIEAYH
FLVSINPETQERYREEYEETTSKSNIHDFYYEKQILVIQHLDGNSYEYIGVPRNTYIKMV
NAESPSRFARRHIYGSFIYRKAGVMAED
>LONDMIMF_00004 UDP-N-acetylglucosamine 4-epimerase
MRMLVTGAAGFIGSHLAERLQGLGHETIGFDNFSSYYAPELKELNAGILQDKGIVVHTLD
LRNSDTLADMEPDFDYIFHLAAQPGISTDCTFEDYLSNNFVATKNVIDFALCCKNLKLFV
NIATSSIYGLQASFDEEKVPEPVSFYGVTKLAAEELVLAASREHKIKACSLRLYSVYGPR
ERPEKLYTKLIAAAFSGEVFPLYEGSGSHLRSFTYVQDIIDGIVSVIGKESQVDSQIINI
GTEEEHTTQQGIDAIEKITGKKIRIESVAPRPGDQIRTHAVIDKARKLLGYNPVTSFEDG
LRAQVEWYTTYFACEETP
>LONDMIMF_00005 Dodecaprenyl-phosphate galacturonate synthase
MDFELTIIIPVYNEEDNLLRVQQELSGFMLHARKKAKVLFVNDGSKDNSQKIIEEICSDT
DAFEFISFDKNYGLSAAIKAGFDTANTSWVGYIDADLQTDPMDFNILLEYADSYELVTGV
RANRKDSFVKNLSSKIANGIRRAFTHDGMDDTGCPLKIIRTDVAKKIPMFNGLHRFLPAM
VLLQGGRIRQVPVKHFPRIAGVSKFHLWNRLIGPLQDCFAYLWMKKKYLNYTINRKG
>LONDMIMF_00006 hypothetical protein
MNSWLIYAIGFTAQILFSSRLILQWIISEKHKRILTPILFWQISLLAAFLLFVYGYLRDD
FSIMLGQAITYYIYIRNLQLQGEWKKLHKAFRFFILLFPVLLIGYGYNNNSYDLDRLLKN
ENIPIWLLWLGIISQILFTFRFVYQWLYSEKRRESSLPLGFWTISFFGSLLILTYAVIRK
DPVLFAGHLLGIVIYSRSILIILKNEKTATS
>LONDMIMF_00007 Undecaprenyl phosphate-alpha-4-amino-4-deoxy-L-arabinose arabinosyl transferase
MKKLLPHKYPLLLLAVSLTLLLPHLDIIYVNIMEARNFITAREMVSNDNWLLTTINNLPR
YEKPPLPTWLTALAGILFGFDSLFGLRLPVVFATVFLVLMSYKFSKNLGLTQKQSFHNGL
LLITSFYIFFGGRDNQWDMYTHSFMMASLYFLWKLLQEDSAKAKNAILSGLFFGFSFLSK
GPISLYALFLPFLIAYGFTYGFKLRSRWHYGILVLGLGIAMGLSWPLYVRFADPESFLET
TTREASRWASYNTRPFFYYWSFFTQSGIWTIPSLIALLYPYMKTRVTNLKAYRFTLFWTL
ASVILLSLIPEKKSRYLLPVLIPMALNTGFYIEYLFEKFKTLTKNEKRMAYFAFGLIGII
AVALPFILPFILKTLNGFWLWYVLVAIASLVCGIIIIRSLLKNNFSKVFYSIIAFQICII
VFGLPLIGAFLGNPDYYSPQKLHVVKAKERIKIYDLQNYCPEMIWEYGEPIPLIINNGKI
KIPKENRFGLLVNIDDTTRLRETFKDYKIEKMLTVDMNPVPKSKKSHKKRLERDFYIVSR
>LONDMIMF_00008 Sensor kinase CusS
MSLSFRNRIAVYNLISAAALIAVVFGIVYSVVRLSVNYDINHDLETEIHYHQEFVESQPI
NHLMLVEPSEWEESEHNEINVNPVFVQIFDSKGRFYEKSRNLKDETLELKLGEEEPYTVD
TFLADIPIRQVQAPLISHGHTVGYVIIAMSMEQELRLLDNLSNVLLIAFFAVLMALFFIT
RFIAGKSIRPAVDIINTASKITNNNLGQRIELPKNKDELFELATSINQLLDRIEDAVARE
RKFTSDASHELRTPLAVIQGTLEVLIRKPRNSSEYEEKIQYCISEVNRLNDLADQLLLLA
RFENQKAAVQIENIELDEIILQVLERYSSRIAAKNIALSFEFSDHYKIRSDAYLVSVIIE
NLISNAVKYTKEKGRIVITLQESEGKIACLIADSGVGIAPEDLQKIYNEFFRAESQRQAI
KGTGLGLSIVKRLCILLNAELNIQSDLGKGTTATVLFDAADYRETI
>LONDMIMF_00009 Response regulator MprA
MNILVAEDEIGISNFLKQGLEEENYTVTVASDGEKALRLALSQPFDLLLLDWMLPKLSGI
EVCKSFRKTGRTAPILFLTAKDTVQETIEGLKAGANDYIKKPFSFEELLERIKVQFRSAV
AENSYVLGPIHLDKEKHQVFIHNEEVYLTQKEFSLLEYLIKNKGTVCSRSQIIKEVWNIH
FDYESGVIDVFINSIRKKLGLRKEEDYIKTVRGIGYIANEI
>LONDMIMF_00010 Diacylglycerol kinase
MTYIHFIVNPISGKGKHSITKEFLGHYFPETDFRLEIDYSNYKKHAIDLTKKAISQKPDI
IVACGGDGTISEIASQLVNTNIKLGIIPVGSGNGLASNLDIPKNITQAIEIIKKQKSVAI
DSGRVNQHCFFSNMGLGIDAMIIKKYESTKKRTLSAYVNASLKASSQYKPQKAILRYNGK
EHFVDPFLLFISNSNEMGYNMSLTPKASLSDGYLDMLYVPRIGFLEKMFFGGLVVAKQCE
KFKKAEHAMIQSLSAELPDRIFTDVQIDGEYHRLETNKVQVDILPKSLNVLVA
>LONDMIMF_00011 Lipoteichoic acid synthase 2
MEAPKSKFRLAFSSSRFSLLWNFFKGFLLLSLLLRIVFMLWQMNEVSWSPIAVIRTLATG
MFFDIGVVGFVALPGILYLLLFPNRYVGSRLDRFLIYFFFSLTVLLLVFVFFAEITFWEE
FRTRFNFIAVDYLIYTHEVVSNIQESYPLPYLISGVALITFLIVFLFQKKGIFAWTFAAK
ASIKEKLSVFAVTAVLLTFYIGFIKNTQAEWSSNRYNNEISKAGIYSFFAEFRNNQMEYT
RFYTSIDAKKAFEIARDQIKQSDSRFLKEGASIRRDITDVQPSGAKPNVVFILMESMSGS
FMKEFGNEKGITPYMDKLAQESIFFSNLYATGTRTVRGMEAVTLCIPPTPGQSIVKRPDN
QGLYTVSNVFKAKGYENSFFYGGDGYFDNMNSYFGGNGFTIYDRGRGSVLSDKIKTQRYN
IDDNEVTFENAWGICDENIYDKMLKVADEHYAAQKPFFNFVMTTSNHRPYTYPENKIDIP
SGTNRDGAVKYADFALGQMLEKAKSKPWFKNTVFVIIADHCASSAGKDEIDVANYHIPAF
IYNLPGQTPEKIQQQCSQIDLFPTLFSKLHWNYRSNFFGKNVYDREYAERAYVGTYRKLV
YMKKEKAMILSDQKKQAFYDWNKETNELKPIPMDKKFLEETIAGYQAADYLFTNKLLKE
>LONDMIMF_00012 hypothetical protein
MKSLTFLPVFSILFSCSGTSQEIPTNTKKLPLKEASAVAVSKVSDLIWVAEDSGNKNNIY
GLTPEGKIAHAVTLENAKNIDWEDLTADEEGNLYVGDFGNNDNIRKDLCIYKINAGDLKN
ETAVSPSKVEFYYPEQSQFPPKKSELFYDAESFFIYKGNFYIFTKNRSKGFDGTVMLYKV
PNQTGRHKAQLLGKFKACNNYHKCAITSADISPDGKKVALLSSSKVWILSDFKSDNFLNG
KTEMFELNDVTQKEGICFKDNETLLIVDEKSKKTGGNLYEIKLSDLKSKS
>LONDMIMF_00013 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MKLFWLNVTRKRNITPFKYICLIIFLQSCATNHSQFGSKEPVTIKDNFDNPKTISHTFYL
VGDAGNADELKAKQILKLFEERLKKADTNSTLLFLGDNIYPLGMPPKDSPDRKTAEEKLN
IQLALSKNFKGKTIFIPGNHDWYNGVEGLKEQERLVNEYLKEKKSFLPRKNCGIDHLNIN
DNVALIVIDSQWYLEDWDKHPTINTDCDIKSREQFFDELESRLNDNQKKTTILAIHHPLM
SNGTHGGEFSLKKHLFPIEKKIPMPVIGTIVNLLRKTSGISPQDLQNKKYNAFVKRVKTL
IQNRNNVVVVSGHDHNLQYIDKDNIKQIISGAGSKEEAARAINENDFSFGHNGYAVLEVL
GNGASKVSYYGADSKGKEGLLYKQQPTFPRPKPNLREYPNNFPTSKDTSVYTTKMTTKGG
AYRFLWGKHYRKIYSTPIKARSVSLDTLYGGLTPTISGGGHQSKSLRLVDKDGKEYVMRA
LKKSATRFLQSVAFKDQSVEKDFRDTYAEDFIMDFYTTAHPYTPFIVSELADRVGISHSN
PKLFYVPKQNRLALFNEEYGDELYMIEERPMSAFKDLKSFGKPDKIISTDDVLANIRADE
KYEVDEPSYIRARIFDMLIGDWDRHADQWRWGEYKENGKVIYRPIPRDRDQAFSRYDGTL
LSILMNFPALRHMRSFDDKLDNVKWFNREAYALDLAFITKSDEKVWSQQAKYITDNLSNS
EIDKAFEKLPKEVKDASIEKIKSDLKARKKHLEKYAHQYYKVLQKTVLIVGTDKKDRFVI
TRDGDVTKVEVYRIKKDREELIRQKTYHSPETRELWVYGLDDDDIFEVKGEGRRKLKIRL
LGGQDHDTYDVESSRKIRIYDSSTKDNTVVNTGKGEKMLSDSYLINTYDYEKPKYNVMAG
YPLLGFNPDDGVKIGARVNYTVNGFNRFPYSQRHVVGGNYYFATSGYELFYKGVFPHQIG
KWNFVIDALYTSPNFSVNYFGIGNETENPDDDINMDYNRVKIRRLKATPSLQWTGEMGGS
AIVQASFERISVDRTAGRFVSQPGVLNPDVFDYKNFVDLSAKYTFENYDNPSNATLGMVF
SLLGGYTININETDRKFPYAEGSLGFTYKISTSGNWVLATLLKGKALFDDDFEFYQAATV
GGDTDLRGFRNQRFSGKQSFYQSTDLRWNLGKIDNGVAPLRYGVFGGFDYGRVWVPNEES
DKWHQAYGGGIWINGVNLVTGKLSLFNSADGLRVSAGLGFGF
>LONDMIMF_00014 hypothetical protein
MNILQKAENFIFQLFKDNLSSDYIYHNFNHTLRVVDSVRQLIKGEKVSEEDAEILEIAAW
FHDAGYINGGERHEEKGAQIAEDFLKENGFPDDKISKVKALIIATEIKRTPENHLEMIIR
DADCSHFGHKEYSNFAELLRQEWKIVAQKKFSNLEWAKENRTVFLKYHRFYTDFAKANWQ
PQKDLNLSELQDKITDWEKGKKEKPKDTLNKKKLERLETPERGIDTMFRVTLNNHTKLSQ
IADSKANILLSVNAIIISIALSTLIPKLDSPTNAHLIVPTFVMLMFSVISIIFAILSTRP
KVTSGLFTRKDIEEKKVNLLFFGNFHKMPLDEYQWAMNVLMKDREYLYNSMIKDLYYLGL
VLNRKYKLLRITYTVFMFGIITSVIAFVWAFKTV
>LONDMIMF_00015 hypothetical protein
MNLQNMNHIHDNLSPFKVKISFAKVIEVLEEIADSDVDYRAAYAKGLLKEIEPYPELRDG
IESYQQIEKHYLRIKYLLSDLFPTALTHNEIKAVTIPFDNYIFNTTERLNKIISEAGEDF
EIIIRDFDEHQFYVMNCLIILNYYYGSKIDFSTPIFYDIPNADGIIKHYRILYNADFLEV
FPTEKSIALTQEDINLLIDNYDDLALWKEKFPPGSWILKGFGIMTLYDNSVESAISNLKS
NLLSNDKGNELKRETIETIFRSIYKIPDLRTGFAAFSSDGTRLKKADFEEEMHSFLLTGM
EEECRNALGECSLETLVGQKKYFIISDVKEFLIANPEEKGFAEHLLSQNVQSCIFAPVIK
DEKFLGIVELVSSEPKQLNSVNANKLDLVMPFLVDTIDRYFSDMQNQIDAIIQKEYTAIH
PSVYWKFREEASLHTTDKNARDLPFKEIVFKEVYPLYGQIDIKGSSVARNEAIEKDLTVQ
IERLLRLLRFVSDNLKLPVIYQNIFELEDLEKQLKETLKADTESLIQSYVLNEVHPMLHH
FKDSNEVVRAKVDTYFKSLDPKIMMVYDARKDFDQTLSLINKKMAFLLDKKQEEAQSFFP
HYYERFKTDGVEHNLYIGASIAPQLSFSHVYLSNLRLWQLQVLCEMENEYYHMRPSLPYD
LDVTSLILVFSTPISIRFRMDEKRFDVDGTYNARYEVVKKRIDKSNIKGTDERITQKGKI
TIVYSQHQEEVEYRRYISLLQHKNKLGAIETFEVEDLQGVTGLKALRVEILYSQPEDSEN
GYTYQDLVKELSVKN
>LONDMIMF_00016 Toluene efflux pump periplasmic linker protein TtgD
MKIKHLVYAILLLGIGGMIAYRIINNKKSESENGKGQGNKKPSTVSGVVVKPQNFADVLS
LSGSIEANEQIDVRSEVSGIVESINFNEGTMVSKGQVLFKVNDIELRAQLAQAKTAQGLA
SENERRAKLLLQKEAISQEEYDIASADFKSAKAQSQLISAQIAKTTVRAPFSGKIGLRSI
SEGTYVTPTTMIAKLVNTSRLKITFSIPEKYASQMKVNGEFTFTTAGSPEKFKAKIYAIE
PEIEVATRTLRLRAIAENPDGKLYPGTFANVILPLDNIPDALLVPTQALIPIQNGKKLFI
SQNGKAKEIIVKTGARTEKDILITSGIKAGDTVLTTGVMTLKDGMSVKVQIKN
>LONDMIMF_00017 Efflux pump membrane transporter BepE
MSLSTTSIKRPVLTIVLNLMLILFGIIGYTYLGVREFPSIDPAQISVRTSYTGANADIIE
SQITEPLEKAINSIDGIRNITSSSNQGSSNITIEFNLDKNLEEAANDVRDKVSQAVRSLP
QDIDAPPVVSKADADSEPIITMTVQSDNKNVLELSDYADNVIAQRLQTIPGVSSVQIWGQ
RKYAMRLWMDPIKMASYGVTVSDVRSALASQNVELPSGKLTGANTELTVKTVGNLSTEEE
FNNIIILAQGEKIVRFSDIGNAALEAENLETKLSDSGQEMVGMAIIPQPGTNYLDIAKAF
YIQYDQLKRDLPKDFKLNIAIDNTVFVKKAVVEVAETLLIAIVLVVLIIYLFFRNWAIAF
RPLIDIPVSLIATFFIMWLFGFSVNVLTLLAIVLATGLVVDDGIVVTENIFKKVEEGMTP
IEAAIKGSNEIFFAVISISITLAAVFLPVIFLEGFVGRLFREFGVVIGAAVLISAFVSLT
LTPMLNAYLMKGGEQKRSKFYEWSEPYFLKMNSGYADALGRFMKRKWLSFPILIICIGLI
ALFFSTLQKETAPYDDRSFIGVNVTAPEGASYDYMDRFMTELSDLINDSIPEKKVSLIIT
SPGFGSASVNSGRARIALVEPGERERSQKEIAEDLTKWTKKYAEAKVSVSEQPTISVNRR
GGLPIQYIIQAQNFEKLREKIPQFMDEAAQDPTFSITDVNLKFNKPEIYVTIDREKAQSL
GVSVIDIAQTLQLSLSGQRFGYYMMNGKQYQVMGQFDKKDREAPIDLTSIFVKNAAGELI
QLDNLVTIEEESSPPQLYHNNRYMSATVSAGLAPGKSISDGIDAMERIKEKVLDETFTTD
LGGESRDFVESNSNTAFAFGLALLLIYLILAAQFESFIDPFIIILTVPMAVAGALFSLWL
FGQTWNIFSQIGTIMLIGLVTKNGILIVEFANQLREQGKNKMEAIMEAAESRLRPILMTS
LAIALGALPIALSLGAASTSRIGMGVVIVGGTLFSLILTLFVIPAIYFMWSREKKHRPEF
DNIKEYEKE
>LONDMIMF_00018 hypothetical protein
MTSKLFFQIVFFFAISLAARAQEILTVEDAVKIALENNYEIKIASNELKIDQQNVSLANA
GVLPQLNANVTDNNSIQNTTQTQSDGSERKLNNARNMNLNYGVALNWTIFDGMGMFARYD
RLKELEKLGDAELKLAIFTKVSDVITTYYDLVQQQQQLKALDTAIVISNLRVTTADNRYK
IGKASKLEVLNAQVDLNTDTTALLRQKELYANTKIFLNEILGRDVKTEFVVADEIAIDGT
LLLPELMALAEKQNPQLQAQIINKRISELQLKQVKASRYPTVNITSGYNFSRTEASLGFI
TQSSGQGFTYGFNASMNIFNGGLQNRNEKAAKLQVENSKIVIEQQLQTLRSQLSSAYQTY
LTNLELTKLEAKNEEIAKENLDITLAKFKIGTIAPLEFREAQLNYVNAKVRNSNAQYAAK
VSEINLKELAGNLSLSQN
>LONDMIMF_00019 hypothetical protein
MEVNFLALLVAALSTLVVGFIWYNPKVFGTAWMNSAGLTEEKLKGANMAKIFGLSIVFAF
LMAFILQFLVIHQWGALAATGGDPDQAGPAYQAFMAEHGTKFRTFKHGALHGFMTGLFFT
FPLIAINAMFERKSWKFIFINSGYWIVNLTIMGGIICAWM
>LONDMIMF_00020 hypothetical protein
METTLSFKLFTATSELPENWDSLTTANIFLSKSYLKILETAAPDNMSCHFIGLFREEKLV
GIALSQFLDLSRVNSYGERDNCAKTSIRKFIFKNFSSKVLIIGNNMLTGQNAYEFDSGLP
YSDGLVLLKKAAIEIEKKLRKKGTNTHITVFKDFKKEDLHYFRLREFDEFYQFSTQPNMV
FTIRDNWKNEADYINALNKKYRDQYKRARKKSEGLTKKKLSLEEIQKQEKTIYDLYYCVA
KNAPFNTFYLPENHFSSFKTHLKDNFLFYGYFEGEKMIGFNTLIKNGGAVDTYFLGYDDN
CQKEKMLYLNMLYDMICYSINKGFRQIIFARTALEIKSSVGAVPEKMYGFIKHHNSFINL
FISRIFGYLEPELAWKERNPFK
>LONDMIMF_00021 putative lipid kinase YegS
MSTQKNYILVVNPISGDIDKAEIIGEAKEYAAKQDIHLVVYETTGKNDESEIQKLQEKNK
AERIIIAGGDGTIKMVAEAVENHDVILGILPAGSANGLSVDLNLPDSLEENLEIAFNNNY
MEMDMISINGKKSLHLSDIGINAELIKNYENSSIRGKLGYALQAFNTLAGLKPPFHAVIE
THLGRVETEARMVVVANSQKYGTGVAINPNGVMNDGKFEIVILKNLDLIVFSKILSGNMP
VENDDVEIISTDKAVVTTNSPVSFQIDGEYCDEVTRLEVEILPNQMWVAVP
>LONDMIMF_00022 hypothetical protein
MKPILKLYRGYANDQELIVMGHIFRPTTKEDYDFQKKNFKNAKSVIRMFRIKTQKNASIY
LEHQGMKIHTKSLDDGYFKFCIPLSRDLAYGWNEYKVSTYHNSKEISSKGSYIRPHEGNW
GFISDIDDTFLVSHTRNPFKKLYILLFRNVNDRKIFEDVVPHYQALSSAGRNSDAEKNAF
FYVSSSEWNLYRFITQFTELHGLPKAVLLLKDIKTSLTDFFLTGRGNHDHKFEKIKHILE
FYPHLKYVLLGDDSQHDPFLYEDICKIFPVTVKAVYIRQTGKNKKSKAIEAMANMESMGV
DTCYFRNSKEAIEHSERIGITSQDFHEKL
>LONDMIMF_00023 putative ABC transporter ATP-binding protein YheS
MLNIHNLSVSFGGTYLFEEITFRLGAGDRVGLVGKNGAGKSTMLKILARDIAPDTGSIAT
EKEVKIGFLRQDIDFEQGRTVLEEAYEAFTEIKIVEKKLEEINKQLVERTDYESEEYSQI
IEDLSDYTHRFDLLGGYNYVGDTEKILLGLGFKREDFNNQTETFSGGWRMRIELAKLLLQ
SNDILLLDEPTNHLDIESIIWLESFLRNFPGVVVIVSHDKMFLDNVTNRTIEISLGKAYD
FNKPYTQYLQLRQEIREKQLATQKNQAKKIEETEKLIEKFRAKASKASMAQSLIKKLDKV
ERIEVDEDDNSVMNISFPVSVTPGKVVVEAENVTKKYGDKTILKDISLLVERGSKIAFVG
QNGQGKSTFIKAIVNEIDYTGTIKLGHNVQLGYFAQNQAEYLDGEITLLQTMQDAANDTN
RSKVRDMLGSFLFRGDDVEKKVKVLSGGERNRLALCKLLLQPINVLVMDEPTNHLDIKSK
NVLKAALQQYEGTLLLVSHDRDFLQGMSNIVYEFKNQKIKEYLGDINFFLEQRNLENMRE
VEKKDVVKKETPKEKSLSYDEQKKNKALQNKLSKVESQIKQLEIDIQKDDKLLESEYDKH
IEDASFFIAYNKKKKDLDNLLEEWEAIQMEIENA
>LONDMIMF_00024 hypothetical protein
MLKKGSKLYSILTGTCPKCQKENMYVDRNPYNLPAVFKMHEKCSHCGQKYKIEPSFFYGA
MYVSYAVGIAFGVAAFVISYLFLGTNLKVAFVAIIATLIIFMPIIMRVSRNIWINMFVDY
DKDWDKK
>LONDMIMF_00025 Glycine oxidase
MVDYLIVGCGLAGIAFGETASQHNKSILFFENNSQRSSKVAGGLYNPVILKRFSGVWRAQ
EQLDLLQVFYGNLEKKLNTRFNFTTPVYRKFFSVEEQNDWFLATDKVGLTPFLSSELVSK
KYKAIDSPFNFGEVLQSGYVDTDILLSSYRNYLKENNLLREDTFDYSAIAFNEGYIQYKD
IVAKNIVFAEGYGMTANPYFGHLPLKGTKGELLIIKAKNLDLDAIIKASVFVLPLGNDLY
KVGATYNWADKTNEPTVEAKKQLLENSKEILQCDFEIVEHLAGIRPTVSDRRPLVGTHPK
YPNLHLLNGLGTRGVMIGPDMAKQLFESIEFGKPIDNSADILRFKKVKW
>LONDMIMF_00026 hypothetical protein
MNWRNFSLVVALSLVSGVSFAQSNLLNAKTPQEIGKKTEAQLKSDNDKPLPYGYVHDRDV
LMGKMVWEFIDLDERINFPMYFPVEGNLGPDRKSLYAVLVENMKSGKIAEVYDDSYFTAK
KSLKDIETSLSKIDTTDAGREQFNAGEKITEDNIVRTDITPADVMGYKIKGYWYFDKRQG
ELKYRLQGICPVVPDVYTMGTEQEDPIELFWVYFPAVRDVLHEAKAFNDKNSALPITFDH
LLNSRRFNGVIYQEENVMGDRKIEEYMKDNAQMQLLESERVKDKIRNFEQDMWNY
>LONDMIMF_00027 hypothetical protein
MAGGKLTPRQKMINLMYLVFIAMLALNMSKEVLSAFGLMNEKFEAANESAKLTNEQMMQA
LDTKAAEAKGEFAVAAQTAHKVQAATKKFYDFIGTLKAETLKGVEQENGKLPYESMDKGD
NLDNSWFIGDGYTKRGNEVMSAIETYKAEMKNALGNEKKYAAILNQVNKSFDVSDVTTKD
GLKDKFLNYHFKGFPAIASLAKLSAWQSDVKKAESDVISAALGKAAVQAASYSNYEAIVV
LDKNAYFQGEKVTGKVVLGRYDENTKPESVTGAVLDNATGQAKINLTAGGIGEQNIGGSF
NFIEDGKKINLPFKGTYVVVPRPNEATISADKMNVVYRGVVNPMTISFAGVSDNNVTASA
PGLTKAGRAGAYNMSPGAGREVVINVNGKLPDGTSVNSKKTFRIKSIPAPTGALRGRETG
TIKGPKSNLEVQTVNAILEDFDFEVNLSVVGFNIKVPGQPTIVVSGNKMDARAKAAIQRA
GRGDVVIISEIKTKLEGSSMMLSKTAPVAYEITQ
>LONDMIMF_00028 hypothetical protein
MAILSKKAMNFAYGMGAAVVIVGALFKIIHFEIGPLTGNVMLTIGLVTEAIIFALSAFEP
VDNEIDWTLVYPELAGGEAKKKEAKKENPTEAQGLLSQKLDNLLKEAKIDGELMASLGNS
IKNFESAAKGISPAADGIAATKKYSEELSMAAAQMESLNSLYKVQLESASRNAEANKEIA
DNAAKLKEQMQSMTANIASLNNVYGGMLSAMSNKG
>LONDMIMF_00029 Serine/threonine-protein kinase pkn1
MKKFIALAALASVLTSCGSSDKGELVGVKGRKWHPEKPYGMTLVPGGAFIMGKSDDDLAN
VQDAPTKTVTVRSFYMDETEITNSEYKQFVNWVKDSTIRMRLAILAEEVGQTKGTGGIGE
FAFDDTDPATMSPYDKYMYENYYSVGTGDDPYAGRKLNKKVKLITDPQKYPDEYYVEVMD
SMYLPAAESYNGLRTIDVSKLKFRYSEANLNDAVKKKGRKDFYKKTEPIEIYPDTTVWIK
DFAYSYNEPMHNDYFWHQAYDDYPVVGVTWKQAKAFCAWRTLYKNAYIKAKKKGRNQINS
FRLPTEAEWEYAARGGLESGTFPWGGPYAKNDRGCFLANFKPNRGDYAADGALYTVEAKS
YEPNDYNLYNMSGNVAEWTNSSYDASSYEYVSTMNPNVPDAKNERKVTRGGSWKDVAYFL
QVSTRDFEYADSARSFIGFRTVQDYMGVQNTGNTPK
>LONDMIMF_00030 Formimidoylglutamase
MEFDFLTPLDEEILEFINGLSSQNLGSKVVLHTREDFPDLNKIRLAIVGVKENRGAHIEI
ENTKLSHIRKELYGLFPGNWEASIADLGNILAGNDIEDTYFALKKVTAYLLKNKIIPIVI
GGSQDLTYPLYRAFDELEQMVNVASIDSKFDFGAADRPLSANSYLTKMIVEEPNNLFNYS
NLGYQTYYNSQEEIDLIEKLFFDAYRLGEVSNNISIAEPVFRDADIVSVDLTCVKSSDSG
NFITFTPNGFNGKEICSLSRYAGISDKVSIFGIFNHNNSKQEAVLIAQIVWYFIEGYHYR
SNEYPFGSRDNYLKYIVPLEDEELVFFKSHKTERWWIEIPFISNVNNKLKRNTLLPCTYE
DYLGACANEIPERWWKAQRKNIV
>LONDMIMF_00031 DNA topoisomerase 1
MAKNLVIVESPAKAKTIEKFLGSEYQVESSYGHIADLPSKEIGVDVENGFLPKYEVSPDK
KALVKKLKDLSKKADTVWLASDEDREGEAISWHLSEELKLEPSKTKRIVFHEITKTAIQK
AIENPRGINYDLVNAQQARRVLDRLVGYELSPVLWRKVKGGLSAGRVQSVSVRLIVERER
EIQNFKAVASYSIVAEFSNEAGKTFKAKLPKNFNTKKEAEDFLNKNIGSTYKVSDLETKP
TKKSPAAPFTTSTLQQEAARKLYLPVGVTMQLAQRLYEAGLITYMRTDSVNLSNEAISAA
EAEIIKSYGKEFSKPRTFANKSKGAQEAHEAIRPTDMSRHTVNIDRDQARLYDLIWKRTL
ASQMSDAELERTNVKIEANNHPEVFAATGEVLLFEGFLKVYLEGHDDEDEEQEGMLPALK
VNEKLQNNYITATERYSRPPARYTEASLVKKLEELGIGRPSTYAPTISTIINRNYVEKGN
LDGQERKYTQLTLQSGKVDEKLLKENTGSDKGKLVPTDIGVIVTDFLVKNFERILDYNFT
AKVEQDFDEIAEGNVNWAKMMQEFYDQFHPNVKDVEANAERESGERILGTDPKTGKPVSV
RLGKFGPMAQIGDAEDDEKQFASLMADQNIGNITLEEALNLFLLPKKLGDYKGEEVEVNN
GRFGPYVRFGKMFISLPKGEDPLDVTFDRAKELIAEKEQADAPIGTYKNEPVQKGVGRFG
PFIKWNGMFINVSKKYNFDNLSQSDITELIEDKLQKEIDKVIHDWKEDGIRVEKARWGRS
VITKGKVKIELSKDVDASKLTLDEVKDMIEKKAPAKKTAAKKTTATKKPAAKKTTVKKK
>LONDMIMF_00032 hypothetical protein
MISVLKKYLEQNRHGNLNEEFKDIYLSHPNYPSLFSVTDTLEVLRIENMAANVPKNQLEN
LPEHFIAAIEVKDALNFVFVSKNQDTIIYETENNEKHTVTLEEFRELWNGLILAIEKNEK
PSDIKKSEHKIAITLALLTTVYLVSNFAYGFEIYGFLFRTLSFIGLLAGIFILLEKNENG
NELVSKICSFNSHTSCDSVIKSKDSRITQWLDFTDLPILFFSINFIAGSLAGSAFGIIGL
LSLLSLPVCLYSVYLQQTKLKKWCMLCLVVSSLVLAQSLLYVSYFDNFKINLTAAIHYTI
ITVICSALWFPLKKIISERKNLADKNKELSRFKRNFNLFEFLSSDVRELSELTELKPILF
GNPQASLTLRLFLSPSCGHCHTAYQKGKDFMEKYPEKIRLAVYFNLNIDNLGNPYVSVAT
NLQQIYFSNGNIRQAIEDWHVQNLNIEDWLKKWKQQTISEEVATELNRQYQWCIKNEFNY
TPVKIVDHKLLPKEYELEEIKYFLSELEDLKAAIV
>LONDMIMF_00033 Lactococcin-G-processing and transport ATP-binding protein LagD
MQKFPFFKQADQKDCGPTSLKIIAKYHGKNINIQKLRSLSETTREGSNLLSLSEAAEKIG
FRTLGVRLSLEKLEEAPLPCILHWNNNHYVVLYKIKKGVYYVSDPAFGLLQYNKEDFLKS
WIGNNATEATQEGIALLFDTTPKFYENEFEKENKSVFGFGLLSRYVFRYKSFIIQLAIGL
LASSILQLIFPFLTQSIVDIGIQNQNIHFIYLVLFAQLFLFAGKTALELIRSWISLHLSA
RINISLISDFFIKLMNLPISFFDVRMTGDIMQRINDHNRIERLLTTSSLDVLFSIINMII
MGGVLAYYNLKIFLVFFAGSLLYFLWIILFLKRREALDYKRFSEISQEQSKVIELINGMQ
EIKLHNAEKQKRWSWEYIQARLFKVSMKGLVLEQTQNIGSSTINQLKNIFIIFLSAKLVI
DGEITLGMMMAITSIVGSLDGPITQLIQFIREVQDAKISLSRLSEIHEKEDESQQEENQI
HEFPVDSDIVLKDVSFRYTGTDTPVLENLNLVIPANKITAIVGTSGSGKTTLMKLLLKFY
DCDKGEIMVGNTLLKNIAQKAWRANIGAVMQEGYIFNDTIANNIAIGVDIINKERLAYAS
DVANIKGYISGLPLGYNTKIGMEGIGMSTGQKQRLLIARAVYKNPEMLFFDEATSALDAN
NEKEIMEKLDVFFKNKTVVVIAHRLSTVMNADQIVVLDNGKIIEQGNHEALVKLKGSYYQ
LVKNQLQLGT
>LONDMIMF_00034 Hemolysin secretion protein D, chromosomal
MPDDKHIELRSEEVQEILTKVPHWMIRWGNVVILTVLLSLLVMSWVVKYPDIVTSEITIT
TQIPPQRLITKSSGRIEKIFIKNGETVSANTALAVIENTARYQDVFLLKSIIDTLKIDKS
FIRFPFESLPSMQLGEIEGPFAVFEKDFIAYSLNRKLQPYKVEGAAQNYEVIEIKERLNL
LQQQKQISETEIQLKKKELDRYKKLYDKGIISTQEWETKNLDYLQTEKNLRGLSSSISQM
KSSLNDLNKNSKSTKINETKDDVSLFRNAIQSYNQLKKAIADWELAYVLRSSISGEVSFM
QVWTENQTITAGDNVFSIIPKESDNYIGKIKAKAQNSGKIKIGQNVNIRLANYPDREFGV
IRGKIQSISLTPDKEGNILIDVSLPNKLETSYHKKIAFRQEMSGTADIITQDLRLMERLL
YQFRDLFRRT
>LONDMIMF_00035 tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase
MEKIIEENKQGESLVLEHKTGNTKKLFIESYGCAMNFSDSEVVASILSENGFNTTQILEE
ADLVLVNTCSIRDKAEQTVRKRLEKYNAVKRSVNPKMKVGVLGCMAERLKSQFLEEEKIV
DLVVGPDAYKDLPNLLQEVEAGNDAINVILSKDETYGDISPVRLHSNGVTAFVSITRGCD
NMCTFCVVPFTRGRERSREPQSIMEEIADLSNRGFKEITLLGQNVDSYLWYGGGLKKDFV
KATEFQKATAVDFAQLLEMVATGFPKMRIRFSTSNPQDMHESVLHVIAKYPNVCKHIHLP
VQSGSDRILAAMNRLHTREEYIQLIDKINRIIPGCGITQDMISGFPTETEEDHQDTLSLM
EHVKYGFGYMYAYSERPGTLAGRKMEDDVPEETKLRRLQEIVDLQRKHSAFRTQEFLGQT
VEVLIEKTSKKSEEQFSGRNSQSITVVFPRENYKIGDFVNVKINSCTSGTLIGEAVGYSD
MN
>LONDMIMF_00036 C4-dicarboxylate transport transcriptional regulatory protein DctD
MESVQAIKQRFEIIGNDPKLNRAIEKAIQVAPTDISVLVAGESGVGKESIPKIIHSLSHR
KHGKYIAVNCGAIPEGTIDSELFGHEKGAFTGATSTREGYFEVADGGTIFLDEVGELPLT
TQVRLLRVLENGEFIKVGSSQVQKTDVRIVAATNVNMFDAIEKGKFREDLYYRLSTVDIT
LPPLRERKDDIHLLFRKFAADFAHKYKMPPIKLDDNAVHFLLQFRWSGNIRQLRNVAEQI
SVLETNRDISAATLQSYLPSEGSQLPSVIKDKKSESDFSNEREILYKVLFDMKSDLNDLK
KLTLELMQNGNTKVQENNKNLIQKIYGSNPSDSEIAFEEQPSVALITKPKAEEHFEENDD
NFTFAETVEEEEILKLEEKEIELIKKSLEKNKGKRKAAADELGISERTLYRKIKQFDL
>LONDMIMF_00037 hypothetical protein
MKYIKYIILPVLFLAFNGCSVYNFTGAKPINAKTFQVNYFQNNADLIEPGIERKFTQDLQ
NLIQNQTNLSLTNSGGELVYEGEIVDYRVSPMTATADQRAAQNRLTISVNVRFTNKNKEE
DDFEKRFSFFYDFPGTSQLVGSQLTTALDVIFERITQDIFNESLAKW
>LONDMIMF_00038 hypothetical protein
MNLNLTEFTTLLSHPNAVSERQVSALEKIVEEFPYFQSARALRLKGLYNQDSFKYNGELK
VTAAHTTDRSVLFEYITSENFMAINKAFFAEKEARINAIKVNEIEILNPEKKEEPVKIDP
LEQSILTSIREASASKPQQVEEEKAIEIPQQETKPEISEESIEEKLEIGKPLEFSSGEKH
SFQEWLQLSTFKPIQREETPIESEKTANTEEISEIDSEKKKKLEIIDRFIEANPKISPVK
NTTPISLISERNSQDNSYLMTETLAKVYLEQKKYQKAIQAYEILILKYPEKSHFFADRIL
DIKTLQQNNNN
>LONDMIMF_00039 hypothetical protein
MSTFTIFLVLITIVCFLLVVVIMVQNPKGGGLSSTLGGGGQMGGVQKTTDFLDKSTWTLA
GLLIVLILLSSLSFTGTFGGNTLKTIDPKAAPAPKTAAAPAKTNAAETPATAQPAATAQD
TAK
>LONDMIMF_00040 10 kDa chaperonin
MALNIKPLADRVLVEPAAAETKTASGIFIPDTAKEKPQKGTVVAVGNGTKDHNMTVKVGD
SVLYGKYAGTELKLEGKDYLIMREDDILAII
>LONDMIMF_00041 60 kDa chaperonin
MAKEIKFDIEARDGLRRGVDALANAVKVTLGPKGRNVIIGKSFGGPTVTKDGVSVAKEIE
LQDTLENMGAQMVKEVASKTNDLAGDGTTTATVLAQAIVKEGLKNVAAGANPMDLKRGID
KAVEAIVADLAKQATEVGTNTDKIKQVASISANNDDVIGELIATAFGKVGKEGVITVEEA
KGTDTYVDVVEGMQFDRGYLSPYFVTNSEKMEAELENPYILLYDKKVSSLKELLPILEPV
AQSGKPLLIIAEDVDGEALSTLVVNKLRGALRIAAVKAPGFGDRRKALLEDIAILTGGTV
IAEEQGYTLENATLEMLGTAKRATINKDNTTLVSGAGEIEMIKNRVNQIKSQMETTTSDY
DREKLQERLAKLAGGVAVLYVGAASEVEMKEKKDRVDDALHATRAAVEEGIVAGGGVALL
RAKSVLKDIKADNADEATGIQIVSRAIESPLRTIVENAGLEGSVVVAKVAEGSGDFGYNA
KTDEYVDMLKAGIIDPKKVTRVALENAASVSGMILTTECALVEIKEENAGASPMGGGMPG
MM
>LONDMIMF_00042 hypothetical protein
MQSIFRLHVVFIFFAATFSCYSQETDSQKNFISKTIEDYFFLERENIHLQLDKSVFISDE
DVWFKGYVYHRKEEVPFFTTTNVYASLYDENGNRIKDKLLFSSMGSFSGKFELGDAFKSG
NYYIQVFTNWMNNFKEDESSVFKFSVINKNDRTASIKSSPDYSKINIEFFPEGGSIIQGT
QNTVGIKVSDCHGNPLPSIEGEIIGPEGKSIQKVSLNRFGLGKFQIFGDGKISKASFQVN
GKKVEENLPFASPNGLALEINNFALKDKTIVKIRTNEKNIASFKSKKHYLVVHQDNKSTI
FDIDFKNTLEQNITFTKDNLSEGVNTVRIIDSDMKQLAERFIFKYPEESLKLDIKLLKKG
KDSIHFFGNLNYANTSISISAVPEQSIAINQDYSIRASFLLNPYLSKNQSNTNYYFEEVS
KAKEFELDLLLLTQSTGKYKWENIVTTPPKDNNTFDFGLTIKGTINQTLADRKKFKVKLF
SLQSSISESTGINDKNEFYFNNMVLADSTWVNFTLTDDKNKPIVLKLYPQILNGRRTFNK
PFKTEKKECASIEEKTEYETPSFVNGTIMLEDVEIAVEKKKKLKYSNSLGNGNLRGYKVA
ENDQTDVLNFIRNNGFEVPTINGFSNTVEIYSRSVTTINGARSTPILFIDGLQQMSFDLL
LNMRMNEVDEIYINAHAIVPSVNNNIGIIKIYMKKGGSGLPQKNNAIPFEIKNAFSKIEP
FKNKLYTSTENRGFQNFGLIHWIPAIYTHDSKEFKFQIPNMGQKKVKLLIEGFSAEGQLI
SETRTISLE
>LONDMIMF_00043 hypothetical protein
MKSLKYSLAFCGLSVLFLSQKTIAQEQQPAPEKPKHEFWHDKKLYLNEDGSNYLKFAMLS
QVWIRNQEYNPGTTIFDSPKTAGTDIGIRRFRIQMYGQVADRVFIYGQIGQNNFNNVSDR
KQGFFIHDALGEYAIDKEKLSLGAGLSSWTGLSRFSASSVGSIMGIDIPLFLESTNDVTD
QFVRKLSFYAKGKLGKLDYRMAFAQPLAIQKSSGYVAAISERSNFSPKPPQMQFNGYFQY
QFKEQESNLTPYATGSYLGKKKVFNIGAGIVYQQDAMWHRNAVNDTIYTDMLHLAADVFY
DAPIGSRGEAISFYGNFTHYDFGTNYIRNAAPMNPANGSSDSTVLNGSGNGFPAYGTGNV
LYAQLGYKLKDNLIGATTLMPYVAIQHAHYERLNKDMSFYDIGVNWLLNGQTSKFTVSYQ
NRPIYNTSGNLTDHKGAFIAQYQVSI
>LONDMIMF_00044 hypothetical protein
MKKLMIVLFVSLIGFAVQAQEKKNKNAKHTVEVKGNCEMCKKRIEKAAFSVAGVKSASWD
IGDKQLHLILNEEKTSEEEVQKAIAKVGHDTEKVKATDEDYAKLHTCCAYERN
>LONDMIMF_00045 TonB-dependent receptor SusC
MQKQFILLLCLIVSAASFSQELKGKITEGTATGQPIIGASIQWLNTQIGTTTDVNGDFSI
SYKPEFTKLVISYVGFSTDTITVNSPNFIHHSLVQNNELEEVTINKERKSLQKSYMKTAN
VTTMSSKELLKAACCNLAESFETNPSIDVNFSDALTGTKQIKMLGLTSPYLMITEENLPS
VRGASQAYGLSFTPGTWVESIQITKGAGSVVNGFESISGQINTELIKPVNDIPFFLNAYG
STDSRFELNTHFNKKVSDKWSTSLFLHGNARLGKNDMNDDGFLDNPLSKQINVLNRWQYT
DMEKGWVSFLNFRYMNDAKQTGEVDFDKDRDKFTTNYWGSEIKTQRYDVSAKLGYVFPDM
PYQSIGFQTSFNGHDQESYFGLNRYDINQKSFYSNLIFNSIISNTLNKFATGLNFTYDKY
DEFVGVPNIARDFNRIDNSVGAFFEYTYDNTTNFSLVAGARVDNHNRLGTFITPRIHARY
NPWDRAVLRASAGRGKRSANIFAENQQLFASSRVFDILNTGGKIYGLDAEIAWNYGVSFM
QGFTLFNRPAEVTFDFYRTDFQNQAVVDLYASPQQALFYNLDGKSFANSLQLDFNYELAT
HFNLRTAYKFYEIETDYLSGSAQRPLQAKHRFFGNLEYETHITDKGQQWKFDFTYNWLGK
QQLPNTASNPASDRLPDYSPSFSLMNAQITRTFSSTFEVYVGGENIGNYKQDKAILGSDN
PFGPNFDSSIIYAPIFGQMYYAGLRFKIK
>LONDMIMF_00046 hypothetical protein
MLAILIVLHQTIYKLMNLRKSTSLILALFLLVSNMGFAFNVHFCGGKVSSISAAYKTSEV
CALPKKETTEKKCCAKKAEEGKKCCSDKKVELKKKSEQVVVKTFSFHSGPAVIFQDWKPE
VFGKPLQAPKQENIEYYCDANAPPLFKLYSQYIFYA
>LONDMIMF_00047 hypothetical protein
MQKLLNYKKEIALSLMLVFLLALIRMFEEHFYDPFLAYFRSDYMEKPFPQYDSFKLFFSL
FLRYALNSLISIAIIQVLFKDLGLSKFAGILYLVFFILLIAVFFSILNFSDQENNLLLFY
VRRFLIQPLFLLLFVPAFFYQNKISKKNNNS
>LONDMIMF_00048 hypothetical protein
MFAYQLYLNSFDAEKFETDSFTELVASQTNDVLHLFGQDTSIAPHDSQPSVKLFLNGKFI
ARVVEGCNAMSVMILFVAFVVAFKGRMKQTIVFVLISILVIHILNILRIALLAIALYHYP
EYEHILHGVVFPLFIYGVVFGLWVLWVQKFSLHAKAS
>LONDMIMF_00049 Free methionine-R-sulfoxide reductase
MTFEELKPKVEDILHHKDILREDKLMQICHLLRDNIDYYDWVGFYFRNGDKEELILGPYA
GEPTDHTVIPFGKGICGQVAVSNQNFVVPDVKAQDNYIACSFTVKSEIVIPLFVEGKNIG
QIDIDSNVLDPFTEMDERFLEFVNAEVAKLF
>LONDMIMF_00050 30S ribosomal protein S15
MYLTKEVKEQIFAKHGGSAKNTGSAEGQIALFTHRIGHLTEHLKKNRHDYNTERSLVLLV
GKRRSLLDYLKKKDINRYREIIKELNIRK
>LONDMIMF_00051 Polyribonucleotide nucleotidyltransferase
MIPKVSKEIIDLGDGRSISIETGKLAKQADGSVVVRMGDSMLLATVVSAKKATPGVDFLP
LTVDYREKFAAAGRFPGGFFKREARPSDSEILTMRLVDRVLRPLFPDDYHAETQVMIQLM
SHDETVMPDALAGLAASAALAVSDVPFSTLISEVRVARIDGKLVINPSRAQLELSDIDMM
IGASKDSIAMVEGEMKEISEKEMVEAIKFAHEAIKIQIEAQERLQNLVGKKEVRTYEEER
NDEAIYEKVRELAYDRCFAIAQEGTAKHERSEKFAEVKEDVKAAFTEEELLENGDLISKY
YSKVNKEAVREVILQLGLRLDGRKTTEIRPIWCEIDYLPSVHGSSLFTRGETQALATVTL
GTSRESNQIDTPSEQGEEKFYLHYNFPPFSTGEAKPLRGTSRREVGHGNLAQRALKNMIP
ADCPYTVRVVSEVLESNGSSSMATVCAGTLALMDAGIQMTKPVSGIAMGLISDDKTGRWA
VLSDILGDEDHLGDMDFKVTGTADGITACQMDIKIEGLAYDIMEKALEQARDGRLHILGK
LTEVIATPKAEVKKHAPKIVTRIIPGNFIGALIGPGGKVIQELQKATGTTIVINEVDEQG
VVEILGTDPDGMAAVLAKIDSIVFKPEVGETYEVKVIKMLDFGAVVEYTAAPGNEVLLHV
SELAWERTENVADVVKMGDVFQVKYLGVDPKTRKEKVSKKALLPRPPRDETKRPPREEDK
K
>LONDMIMF_00052 RNA polymerase sigma factor SigA
MRQLKITKQVTNRETASLDKYLQEIGKVDLITADEEVELAQKIKAGDQRALEKLTKANLR
FVVSVAKQYQNQGLTLPDLINEGNLGLIKAAQRFDETRGFKFISYAVWWIRQSILQALAE
QSRIVRLPLNKIGSINKINKMYALLEQSNERPPSAEEIAKELDMTVNDVKESMKNSGRHL
SMDAPLVEGEDSNLYDVLRSGESPNPDRELIHESLRTEIERSLETLTPREADVVRLYFGL
GDQHPMTLEEIGETFDLTRERVRQIKEKAIRRLKHTSRSKILKTYLG
>LONDMIMF_00053 Ribulose-phosphate 3-epimerase
MKNTLIAPSVLAADFGNLQRDLEMINNSDADWFHVDIMDGVFVPNISFGMPVLETIQKHA
KKTIDVHLMIVDPDRYIKTFASLGANVLSVHYEACTHLHRTLQAIKAEGMKTGVALNPHT
SVTVLEDIINDIDVVCIMSVNPGFGGQSFIESTYKKVRQLKEIISRNKAETLIEVDGGVT
DKNAKQLAEAGADVLVAGNYVFKSANPTETISHLKKTASL
>LONDMIMF_00054 hypothetical protein
MSEAIFTVLTFLLAAIVILLVVAGFIRLFVEPAYVLIFNKPLYIHWYPVPKKIIPFQRQI
LEREFSFYRKLSDKRKVYFEHRVKSFLMNYQFHGKDISVTEEMKVMIAGTYVMLTFGMRF
YLTLLFRKIIIYPGQYTSVITQQNHKGEFNLRLKAVVFSWEDFLSGHNTTNDNVNLGLHE
FAHVLHFHSKKTNGDPNASIFYDEFNEIVKYYDDAALSLELVQRGYFREYAYENKFEFLA
VLLEHFFESPQVFRKEHPELYERVKKMINFKEEYLN
>LONDMIMF_00056 hypothetical protein
MSLQDKINEEIKTAMRAKDTVSLESLRAVKSALLLLQTDSGAKEITQDDEIKLLQRLVKQ
RKDSANIFTEQGRPDLAEPELQQAAVIEKFLPAQLSEEEVEAVVAKIIAETGASGMASMG
KVMGQASAELAGKADGKTISTIVKKLLS
>LONDMIMF_00057 Cell division protein FtsZ
MMSNSDFGSISFDLPKNQSNVIKVIGVGGGGSNAINHMFQQGIKGVDFIVCNTDSQALQN
SAVPNKIQLGVNLTEGLGAGANPEVGQQSAIESIADIEKMLDSNTKMVFITAGMGGGTGT
GAAPVIAQLAKERDILTVGIVTIPFQFEGKVRSEQALVGVERLRKQVDSLIVINNNKLRE
VYGNLGFKAGFSKADEVLATASRGIAEVITHHYTQNIDLKDAKTVLSNSGTAIMGSATAI
GENRAKEAIIAALDSPLLNDNKITGAKNVLLLIVSGTNEITIDEIGEINDHIQTEAGFNA
NIIMGVGEDEALGDSIAVTIIATGFNVEQQNEIVNTEPKKIIHALEDEQKMGRDLSQKQV
VPSFNFSPAPVEEKKETEEKIVFALEDFEVADAKVEEPEIVSDLIKTTEFIKNIDVEFQI
VSPISEHEFYITTPEVREMEVREPEFVAYKEEEQITFSFDLPIKKAEEPKEDRILFELSN
ETKDIKVNQPVQVVPVTELNEKGIVKYSLEEYMEVENELIQSKPVAKVEEPVDKELDLKM
KVEEPKFNNTAFEEISPLEMTIEQTLKKRADERRLKMKEFNYKFHNNPSRVDEFEKEPAY
KRMGIDLNHTQADNSKSRMSLGTDSNDDLQLRSNNSFLHDNVD
>LONDMIMF_00058 Cell division protein FtsA
MEKESIAVGLDIGTTKIVAMIGKKNEYGKLEILGVGKSKSLGVARGVVNNITQTIQSIQQ
AVHEAEVDSGYKIKDVVVGIAGQHIRSIQHSDYISRSNPEEVISENDIDLLINQVHKLAM
LPGEEIIHVLPQEFKIDGQAEIKEPIGMYGGRLESSFHVVVGQASSIRNVGRCIKSSGLD
LSGLTLEPLASADAVLSQEEKEAGVALIDIGGGTTDLAIFKDGIIRHTAVIPFGGNVITD
DIKEGCSIIEKQAELLKVKFGSAWPGENKDNEIVSIPGLRGREPKEISLKNLSKIIHARV
VEIIDQVFTEIKSYGHEDPRKKLIAGIVLTGGGAQLKHIKQLVEYITGMDTRIGYPNEHL
AGNSDEEISSPLYATAVGLVMNSIRNNTRSAVPLNQVEVEKAPAVQVHKEVVVETSNHYE
EEVIEEQPKKVEQAKSVSTEGRMKKSFFDKYIDKIKEFLDNAE
>LONDMIMF_00059 hypothetical protein
MKKFNWTNIKLVLMFVLVIFLYSFTSKRNEQRKLKKSVVEFVNENSPFITQEAVNKLLIE
NNAAPTSIQKDALDLNKLEKNLNNHNMIEKCDVFVSVDGVLKAVVKQKTPVARVFDDNGS
FYIDYEGHEMPLSDNFTARVPMVTGGISSKNKEELNKVFRYIYDDEFLHKNIIAIQVLPN
GSLKMMNRNFDYVIDFGRTINVDRKFKNYKAFFQKAIQDSLINKYKTVNLKFTQQVVCTK
N
>LONDMIMF_00060 UDP-N-acetylmuramate--L-alanine ligase
MNLNQIHNVYFIGIGGIGMSALARYFKAIGKNVSGYDKTETELTKELEALGIEIHFEDSI
SLIPKDYYAENTLVIITPAVPKTHSEWNYFLEREYQVKKRAEVLGIITKDTFCFAVAGTH
GKTTTSSILGHILYESGADVTAFLGGIVENYNSNLIGSGKTVTVVEADEFDRSFLHLYPD
IACVTSMDADHLDIYGDTASIEASFVEFADKVKDKKKLFVAKGLPLEGITVAVNDEADYK
AFNIRIENSTYVFDVQTPSEVIKDIRFNLPGKHNLTNALIALAMAYTYGTPTEAIAKALF
SFQGVKRRFSYQIKEKNRVYIDDYAHHPTEINAVHQAVSELYPQDKVLAVFQPHLFSRTK
DFIDGFASSLSAFDEVILLDIYPARELPVEGVNSAWLLGKIDNPNKKLVSKDSLISEILK
SDARVVVTIGAGDIGELVKPIKQALHEKV
>LONDMIMF_00061 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MQKLKFILSGGGTGGHIYPAIAIANELKSRFPDCEILFVGAKDKMEMQKVPQAGYPIKGL
WIAGIQRRLTLDNMMFPFKLMDSLLKSRKIIKQFKPNVAIGTGGFASGPLLKAAGSAGIP
TVIQEQNSYPGITNKWLSGNASKICVAYENLERFFPKDKIVFTGNPVRQDLIDIKGKKKE
SRDYFKLDPDKKVLLVLGGSLGSRRINQLIAKELVNFISQDVQVIWQCGKFYIEEYKHFD
EKENVQVKAFIDRMDLAYAAADVILSRAGASSVSELCLVGKPVIFIPSPNVAEDHQTKNA
KAIVDKKGALMMKENELDTQFTSTFNKLLEDKALQESLGENIKKMAMPNATKDIVDEIIK
LIESQR
>LONDMIMF_00062 putative peptidoglycan glycosyltransferase FtsW
MKEFINNLKGDKVIWAFIALLALISFMPVYSASSNLAYSANGSGNTMSFLIKHFAHVGIG
FLIVYMVHKIPYHYFKAISMIALPIVGLLLLYTLLQGKTIGGANASRWIQIPFVGISFQT
STLASMVLMIYVARYLAKKREVEDTFKKSVIELWLPVFAIIMLILPANFSTAALIFSMVV
MLVFVGKYPLKYLGLVIGAGIVGLTLFILLAKNFPDAFPNRVDTWVSRIENFTSDKPDED
NYQIEKAKIAIATGGIYGVGPGKSIQKNFLPQSSSDFIYAIIVEENGLLGALTVMFLYIM
LFIRFLIASHKANTLFGKLLVVGLGFPIVFQALINMAVAVELLPVTGQTLPLISSGGSSI
WMTCVSLGIILSVTKKDEEIAQENLERAQREEALQRLIEREMNGENNPDEDTAVENKEPQ
YAIEDVSDNPMKAVMGK
>LONDMIMF_00063 UDP-N-acetylmuramoylalanine--D-glutamate ligase
MEKRLVILGGGESGVGTAILGKKKEYDVFVSDFGKIKNNYKEVLGLHGIKWEEEKHTEDL
ILNADVVMKSPGIPEKSPIVRKLVERGIPVISEIEFAAQYTKAITVGITGSNGKTTTTML
TYHLLKQGGLNVGLAGNVGKSFAWQVAEGKHDIYVLELSSFQLDGIIDYKPHIAIITNIS
PDHLDRYDYDYGKYIAAKFRITENQTEEDYLIYDADDEAIHNWLKMNKTKAQLLPFSMTK
TIENGAFAKEDTINININNEEFVMPQDKLALEGKHNVKNAMAAATVAQLLRIRKSTIRES
LSDFQGVEHRLEKVLKIQNVQYVNDSKATNVNAAFYALDSMNTPTVWIVGGVDKGNDYSE
LMPLVREKVKAIICLGIDNKKIIDAFGDVVDELIEAQNMKDAVKYAQRMAEKGDTVLLSP
ACASFDLFENYEDRGRQFKQAVQNL
>LONDMIMF_00064 Phospho-N-acetylmuramoyl-pentapeptide-transferase
MLYYLFDYLDQMDIPGTGVFQYITFRSGLAIILSLLISTVFGKKIINFLRRQQVGETVRE
LGLAGQNEKAGTPTMGGLIIIVATLVPVVLLAKLNNIYILLLIVTTLWMGTIGFIDDYIK
IFKKDKEGLKGRFKVIGQVGLGLIVGTVLYFHPSVTVRTDTGNTNIFATNQTTVSAVPLE
EKSTATTIPFFKDNEFDYAELLSWAGDNYKDYAWLIFIPVVIFIITAVSNGANLTDGIDG
LAAGTSAISVIALGIFTFVSGNIIFSNYLNIMYIPNSGEMTVYIASFVGALVGFLWYNTY
PATVFMGDTGSLTIGGIIAVLAIAVRKELMIPVLCGIFLAENLSVVLQVSYFKYTKKRFG
EGRRIFLMSPLHHHYQKKGYHESKIVTRFWIVGILLAILSIVTLKLR
>LONDMIMF_00065 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase
MIILKDILYKVAIEAVKGSTEIAINAINFDSRKIENNDVFIAIRGTVADGHEYIETAISK
GAIAIICDTFPENIVSGVTYVQVKDTNRALAFIASNYYGNPSANLKLVGITGTNGKTTIA
SLLYQLFKKAGYKVGLLSTVKNVVDDVEYKSMLTTSDSITINKFLKEMNDVGVEYCFMEV
SSHGIAQKRTEGLQFAGGVFTNLSHDHLDYHKTFAEYRDVKKTFFDQLPKGAFALVNIDD
KNGPVMLQNTNAKKLTYALKSYADYRAQILENQLSGLLLKINEQEVWVRLIGNFNAYNLL
AIYGTAVELGLDTMEVLRLLSELESVSGRFQYIVSKGNITAVVDYAHTPDALENVLKTID
DIRTKNEQLITIVGCGGDRDKTKRPIMANIASTLSDKAILTSDNPRTEDPEAIILEMEKG
VEPQNYKKTLAIVDRKQAIKTACQLAQPNDIILIAGKGHETYQEINGVRYDFDDMKIVTE
LLEQLNK
>LONDMIMF_00066 Stage V sporulation protein D
MAVEEKNISYRIYLVAFAIVVMATGIIVKLTNIQWVEGDYYRKLAKDRTVKNFVIPANKG
NVYSADGSLLATSIPNYTIRFDAVAPKKEDFNKNIEALSDSLSVLLGKPSSHYLNEFRKA
KANKNRYMLLARGLSYTEYMRVKTFPLFNLGANKGGLIAEQKTVREHPIGMIAQRTIGYE
REYVDGGVDGKGIEWAFKDYINGKDGKVLKQKIAKGQWKPISDNNQVEPQDGYDIISTID
VYIQDIAHHALLKQLEYYEAEHGCVVVMETKTGEVKAISNLGRTEDGSYSETLNYAVAES
HEPGSTFKLIDLIALLDDKKVDTSQIYDSRGGDITYHNRHVRDSKKGGYGKVSLARGFEL
SSNTVMVQAVYENYKDNPMEFVGRINKMGLNKPLGLPFKGEGVPFIPQPKTKRWNGTSLP
WMAFGYGVSMTPLQSLTVYNAVANNGEMVKPIFVKEIKEWNKTIKKFDKEVINPKICSDE
TLKKVRKVLENTVKKGTGSKLYSKDFSMAGKTGTAQVDYAKGKHTDAMYYASSFAGYFPA
DNPKYSCIVIIHKPSKSKGFYGGDVSGPVFKRIAQKIFTDVPSTNEIKNLNRKSINQEKN
YAKYSDLVSKETIPNVQGMAGMDAVALFENMKMKVKVIGIGKVKKQSIPPGEAIVKNRTI
ILELS
>LONDMIMF_00067 hypothetical protein
MKGGIYSILKAKFLINDDAAKNWQFIIFLIVLALIMIANSHNYEQKTYRITELDKEVKEL
RSEFVDRRSELMKLKMESTISQKMEVKGIFPSSVPPKKIKVLKEKEKGFFEKLWQ
>LONDMIMF_00068 Ribosomal RNA small subunit methyltransferase H
MEYHNPVLLKETVDGLDIKPDGVYVDVTFGGGGHSKEILRRLGPEGKLFAFDQDEDALAN
ALDDDRFTLINENFRFIKRFLRFHNVKSVDGILADLGVSSHQFDVAERGFSTRFDAELDM
RMSQKNDLSAYTVVNGYDEANLRRVFYDYGELKNAPAIARVILEAREHGDIRNTEQLKIV
LSRFLPAHKSNKILAQMYQAIRIEVNQEMDVLKEFLEQSLEILKPGGRLSVISYHSLEDR
LVKRYIKNGMFEGEPERDFFGNFSVPFKTIGKLIVPDEEEIRVNNRARSAKLRIAEKI
>LONDMIMF_00069 Transcriptional regulator MraZ
MNTIIGTYECKIDAKGRVLLPAPLKKQLTDSLNDGFVLKRSVFQPCLELYPMAEWNLMMQ
KINKLNRFVKKNNDFIRRFTAGVKVVEIDNLGRLLIPKDLTAFGNISKDLVLSSAVNIVE
IWDKDLYEKSISGDDVDFADLAEDVMGNINDDNNGIS
>LONDMIMF_00070 4,5:9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate hydrolase
MEEHLIKEGKYKYFETGEGTPIVILHGLMGGLSNFDGVAEYFPKQGYKVVIPELPIYTQS
ILKTNVKAFAKYVKDFITYKGFERVILLGNSLGGHIALYHTKMYPEKMLGLVITGSSGLY
ESAMGDSYPRRGDYEYIQKKAGDVFYDPKIATKEIVDEVYAMANDRIKLIKTLTIAKSAI
RHNMAKDLPKMHVPTCIIWGKNDKVTPPEVAEEFHQLLPNSSLYWIDKCGHAPMMEHPDE
FNRLMHDWLQKTHL
>LONDMIMF_00071 putative GTP-binding protein EngB
MKINSAEFIISNSEVSKCPQERLPEYAFIGRSNVGKSSLINMLTNHKNLAKTSGRPGKTQ
LINHFKINSNWFLVDLPGYGYARVSKKTKEVFQKFITDYFEKREQLVCAFVLIDIRLEAQ
AIDLEFITYLGEIEVPFCIIFTKADKISKTKIDSHVAAYRKKLLASNWEEMPPYFITSSA
DGTGKEKLLTYIEEINTEVFKDLNNF
>LONDMIMF_00072 hypothetical protein
MSKKITSEIKITVELDENRVPEKLFWAAQDGGVVQEESKAMMLSFWDSNVQETMRIDLWT
KDMPVDEMKKFFHQSLVAMADTFQRATDDEKMSDTMRDFCDYFAEKMDLKAK
>LONDMIMF_00073 hypothetical protein
MRKLAFLLMFTLFFISCDKKDKVEKAIEEVPVELTVERFDKVFYESDPNELSKIKHQFPY
FFPAGNEDTVWTNKMKNPLLKQVHDEVQKKFGNFQKERGDLEELFRHIKYYFPETGLPKV
VTLISEVDTDNKVIYTDSLLILSLDVYLGKDHEFYTGFPEYQRKTFEKSQLLSDVVSSFA
IRKIVPPTDRTLLSQMIYFGKELYMKDLLIPQISDADKIGYTPEQIVWSQENEGYIWRYF
VDEKLLYDSDPKLPGRFINPAPFSKFYLEIDNESPGQIGRWIGWQIVRSYMKNNDVSLQQ
LLQTDAKEIFDKSKYKPKK
>LONDMIMF_00074 NH(3)-dependent NAD(+) synthetase
MQKNNTLQADKVTSHIVNWLKDYATNAKVNGFVVGISGGVDSAVTSTLCAATGMPTLCVE
MPIHQAPSQVSRGKEHIEQLKKKYSNVESVETNLTTVFEMFKSVVPASDDEKKLHLSLAN
TRARLRMTTLYYHAGIHGRLVAGTGNKVEDFGVGFYTKYGDGGVDVSPIADLMKSEVYQL
AEYMGVPESILIAAPTDGLFGDDRSDEDQLGASYDELEWAMKAVEQGKEATDFTGRKAEV
FSIYKRLNYVNQHKMIPIPVCEIPKHLK
>LONDMIMF_00075 Putative transcriptional regulator
MIKICLADNHPIVHYGIKSYFKDNSEISIVGHAEDFTTLEDILNKKSVDIVILDLDLEGL
SSINLIKGMVKDYPSTKIVIFTNLSEQMYAPNALKAGVSAYIHKTSKLENLASALIKVYG
GAVVFSETVKKNLALIGKRNKSERLYRKLSTREIEVLRYLSDGKKNKEIAKILDLNEKTV
STYKLRLLTKLNVTNLVDLVNKAKTLEIV
>LONDMIMF_00076 DNA primase
MIAKTTIDTVFETARVEEVIGDFVQLKRAGSNFKGLSPFSDERSPSFMVSPVKQIWKDFS
SGKGGNVVAFLMEHEHFTYPEAIRYLAKKYNIEIEETEQSQEEKAEANEKESMYLVSEFA
KRYFHDILLNNEEGQAIGYSYFKERGFTNETIRKFELGYSPDTWDALTKEALGKGYKLEY
LEKTGLTIVKEDKQFDRFKGRVMFPIQSMSGRTLGFGGRILGNDKKAAKYMNSPESDIYH
KSKVLYGIFYAKQSIAKLDNCYLVEGYTDVIQFHQAGIENVVASSGTALTSDQIRLINRL
TKNITVLFDGDAAGLRASIRGIDLILEEGMNVKVCTFPQGEDPDSFARKNSYEELVRYLD
TNAKDFIQFKASLLMDESQNDPVKKAGLIRDMVTSISKIPDRIQREIYLQETARIMDISE
QVLVNTLAQLIQKDVVETGKKQKQEQKAFEVVKNENPAQAQRIDVLYELERKIIEILLLY
GNKTEEFEDVILRANEEGEIEEVTEKKEYKVYQRIYLSLQEDEVELANPLFREIYNDMVN
YFHQNESFNTEHYLMHLAPELAQEVTDILMHEEREVLHNWEGQNIIVKQKDQTIEQYVSE
TILTLRWYLVDRIIEELKGSITSGPDSDNTETLSMAMDYYKLINSFSSKLGRVMSRYS
>LONDMIMF_00077 hypothetical protein
MQKIIFYAMIMLCFLVSKAIAQETFEQRAKAIALRIETITKEEKDALKEEVEAVNKLLEK
GEIDLEEADKRKMELADVRAKNIETRVGAEEAKLTDLVREKVDGKLPSEGRRTAFSIYWE
KDSPKRDSIRNNRGELRTTSQFVFAIGLNNALTKGDLGSLEGSDYRMWGSHFYEWGIAFN
TRLAKNHNLLHAKYGLSLMYNNLRPTDNRSFVVNGDQTNLERNPIHLKDSRFRNVYLVVP
LHLELDFTKKRVTEKRTYFRSHESFRLGVGGYAGVNVKSKQILRYEIDDHNVKERTKGDF
NVNDFIYGLSAYVGYGQTSLYVKYDLNTIFRDNEIDQNNVSLGIRFDFN
>LONDMIMF_00078 hypothetical protein
MELNKLEQDFKKKLNERTIQPSEMSWDRLDAMLSVAEKKSKPKKRTWLYIAASFLGFLLV
GTIFFKQPEVEIQTAKEKGVVVQEKTTEKQGEAITVDEYKTKSSNQITTAAAGAIASRLP
EQKKVQKIKSSAVSQEDKTSQVMPEKTEAIATVEQKETVKANKYIESEKLLAEAENKIQS
QSVKKYVAKSSVKVDSKGLLSDVEGELNESFRNRVIKSIGRNYESVKTSLANRNNE
>LONDMIMF_00079 ECF RNA polymerase sigma factor SigE
MKVIALHQEEKDIIAQAVANNRHAQHKIYAGHAPKMLSVCRQYIKDLHQAEDVMITAFMK
VFANLKNFEHKGSFEGWIRRIMINECISFIRVQKKVKYIEDETYFEETYNNTDSQFNVED
IQFLIDSLPDGYRMVFNLYAIEGFKHQEIAKMLGINEGTSKSQLSHARKMLQEQINKLKN
FQNGTE
>LONDMIMF_00080 hypothetical protein
MRLLYFSFFLITLQVCAQKPKEVLNWINTAPSENRNFYFEIPFTYRNDEIVIQVRIGNHT
CDYIFDTGGYNNITDAIQEKNNFPILTRQTVGSSNKIKKEINIVKLDSLHIGPLTFHDLA
ALQMNFDESPTIKCTIDGGLIGASIIKNYIWQIDYPRKKIIVTDQIGKIANLQKAIKVPV
TFNSRLMPYIEVRINGKKEKMMFDLGSSTLFSMTEKAAKKHDKENVYEIIGGGTEGGNGT
IKESIYVMNSGKLEIKNLYYSNKPILYTSSNNESLIGNPIIKDYIVTLNFKDDEMYFLPV
ETADEGWMTYGFTLKYDNGKTKIATLLKGSEAEKAGLMIDDVVEGINGKKIDCQDFCICK
KTYNILLEGKNEIVISLNKDGKTQQIRLEKQKIF
>LONDMIMF_00081 All-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific)
MKITEQIKQPILAEMELFEKKFHEAMSSKVALLNRITYYIVNRKGKQMRPMFVFLTAKMV
SGGTVNERTYRGASVIELIHTATLVHDDVVDDSNRRRGFFSINALWKNKIAVLVGDYLLS
KGLLLSIDNGDFDLLKIISVAVREMSEGELLQIEKARRLDITEDIYYEIIRQKTATLIAA
CCSLGACSVAPENDEVIERMRKFGELIGMAFQIKDDLFDYTDDAIGKPTGIDIKEQKMTL
PLIYVLNHCTPKEKSWIINSIKNHNKDKKRVKEVISFVKENNGLAYAEQKMTEFQKEALQ
LIQDFPNSPYKDALTLMVNYVIERKK
>LONDMIMF_00082 Dual-specificity RNA methyltransferase RlmN
MQIEKKDIRALSKDQLREFFVSNGDKAFRGNQVYEWLWNKGAHNFDDMTNVAKATRQMLE
ENFVINHIRVDQMQKSEDGTVKNAVRLHDGLVVESVLIPTETRTTACVSSQVGCSLDCNF
CATARLKRMRNLNPDEIYDQVVAIDNESRLYHNRPLSNIVFMGMGEPLMNYNNVMKAIDK
IVSPEGLGMSPKRITVSTSGVPKMIKKLADDEVKFKLAVSLHSAIDEIRSQIMPFSKSFP
LADLREALEYWYSHTKSRVTYEYVVWKGINDNKASVDALVKFCKYVPCKVNLIEYNPIDD
GEFQQASEESINEYIKALERNDIVVKVRRSRGKDIDAACGQLANKEA
>LONDMIMF_00083 Putative O-methyltransferase
MHFISPELELYVEKHSENEPALLAALHRETFQKIMQPRMLSGHFQGRVLSMISKLVNPEN
ILEIGTYTGYATLCLAEGMKENGSIDTIDINEELLSIQKKYFDLSPWKNQITQHLGNALE
IIPTLGKKFDLVFIDADKDNYLNYFDMIVPIMNKGGIILSDNVLWSGKVLETPNPKDIST
NVLLEYNKKLKDDPRIETVLLPIRDGLTVSRVL
>LONDMIMF_00084 hypothetical protein
METLLELDRNLFIYLNSLGSETFDGFWLFITKQINWIPIFAIILYLVFKNLGWRHALMII
VVMALLITLTDQTTNLFKNGFQRLRPGSDPDLAGLIRAVQTRKSFSFISGHASNSMAAAF
FLYKVLKPYLKYMGFIFLWPLIFAYSRIYLGLHYPGDILCGYVWGILMAMLMLRLYAYLR
DKYFPQKEYVDNPTNDEPIRN
>LONDMIMF_00085 Sec-independent protein translocase protein TatA
MFGIGGSELVFIIFIAIMLFGADKIPEVARTLGKGMQQLKNATDDIKTEIHKTASENGLD
TQSLTGGFSEEISKVKENFNKIIENSNDNSFGLDKITQDINSEITKVKEDIETMEGPIKR
QDR
>LONDMIMF_00086 hypothetical protein
MKKIIFLFAMLPAVFFAQETKNTEKKREPGKYDTNKFSQMYDLMATPNMFRTASGAPGPA
YYQQQADYKMNIELDDRNARLYGTETITYHNNSPDNLEYLWVQLDQNQKAKDSESPLVDN
QKMDKAMTPAGFSKKFLEEKPERGFVIEYVKDAKGNPMKYTINHTMIRIDLPKPLKSKEK
ISFSIKWWFNINNYRVEGGRSGYEHFDKDGNNLYVLAQFYPRMAVYNDVEGWQNMQFWGS
GEFALPFGNFEVNITVPADHILEATGDLLNRKEVFTAEQFKRYQLAEKTYDKPVVVVTQE
EAEAASKGFSDKKKTWKFSAKYVRDFGISTSRKFIYDAMAVKLSEKSVMAISLYPPEANP
LWGEYSTKTVAHTLKSYSSHTFDYPYPKAISISAEDQGMEYPMICWNYGRPDENGFVSER
IKYGMQSVIIHEVGHNFFPMIVNSDERQWTWMDEGLNTFLQYLAEQELSPSYPSQRGPAA
KIVPYMSGPQNFLEPIMSNSETIHQFGANAYAKPATGLNILRETIMGKELFDYAFKTYAN
RWKFKHPTPEDFFRTMEDASAVDLDWFWRGWFYSTDYVDIGIQNVKEYYVTAEAPKETKD
VNIRKGRFNKEEGPFVYMVSSDSEGFNKKNIKPLDVNDIKVLSDFMREKYTQEERSKLKS
PKYFYEVAFDKPGGMLMPILVQLVYEDGTTEDFNFPVQIWRKGNQVVSRVFATDKKVAKI
KLDPKLQTADIDLENNSWPREKAKSKFDELED
>LONDMIMF_00087 hypothetical protein
MKKAFKIVFLLLLFTGLTSASLHKFYVSVNQLDYVPEKKAIEITSRLFIDDMDLALEKRF
GKKIYLGTSKEIKESKELLQKYFQEKFAVKVNEQEKEIRFLGKEVEDNVLICYFTIKNVE
KISSIEIKDTVLMELYDQQHIFHTHVLGKKQSLLLTSDKIRGQLNY
>LONDMIMF_00088 hypothetical protein
MKSNKILLLTFLVSYVALSQEKMIKGRVVANGNNVEGINLVNLVNEKSAVTDSNGDFSIL
AKVDDLLVFSAVNMHYKRKIVEADDFQKDIIIIEMEPKINQLDEVEITKYVNITAYDLGI
IKFKPKVYTVAERRMIARVGSRAERKARLEGEKKLMLIERIGILYSDEYFIRVLKIDPDY
VMAFKYYCSEQPDFMKIVNSRVKDKIKLAIIELARKYNELQNEEIVKE
>LONDMIMF_00089 hypothetical protein
MKTSFLFAFLFVVHFTFSQEKIIRGKVTGSGNNVEGINVVNLVNEKSAVTNAAGEFRILA
KEDDLLVLSALNFEYKRKIIDADDLKSEVVIIEMIPKANQLDEVEITKYNNINAVSLGIL
SKPAKVYTPAERKLRTATTGLLDPLINLMSGRTKRLKQNISVEKKQILLEKVNDLFDDEF
YTQTLKINPDYIMAFKYFCIEDFKFASAVRGKNKTLATFWINELAVEYNKLQSGEKQ
>LONDMIMF_00090 hypothetical protein
MADGNYVGGINVVNLVNEKSAVTDEKGEFFISAKEDDLLVFPAINFEYKRKIISKEDILA
GAITVNVIPKTTSLDEVEITKYKDLDAFELGILETPAKRYTPAERRLRTAGDFKPVHLVG
LLFGQFPLDPVLNAINGKTKRLKKEVEIEQQEFLLKKVEDMFQDDYFLGHLKIPENYIQG
FKLYSIGDENFVRLLEDKNKIKSEFELARLSKEYLKLISNEN
>LONDMIMF_00091 hypothetical protein
MKNNYFLILLILLSQIAFSQSKENKKIYGKITAGQVPVDDIEVVNFSNATQTRTNAKGEF
YIYARTGDVLILSGANLEHKRKTITKDEFNSGNVEIVMKPEVTELQEVVVEKSDEFSVVQ
GVKKYTPAERKLRTASKPVELIQGLGISNDAILNFLSGRTKTLKKGVQVEREIARLEKLD
NFFDEAYYTESLDIPKDYVNGFKYYIVGDEEFSKALDQNNKTALEVAIIKLAEKYRGLLA
DEKK
>LONDMIMF_00092 hypothetical protein
MLKKIFLCSFFIAVSPSVLSQVSERKNLKGKVMASASNLDGIYVLNLSSEKETVTKEGGY
FSIQAKEGDSLMFSSIQFKGKIVEVSQADFEKELFFVKLETMVNQLDEVTVVQYKNINAY
DLGIIPKPAKVYTPAERKLRTATGVDPKVGLNNSFTLDPLLNLMSGRTSMLKKELEVEKR
EKWISQLEDLFEEEYYTKKLKIPAENVKGFLYYAVENERLVKNLNSKNKAMATFLLGEIA
KTYIQTITNEK
>LONDMIMF_00093 Peptidase E
MKNLIIASTSTLHNGGYLEYLLPELSIHFKNVSELVFIPYARPSGISHDEYTEKVRQAFS
KINIKVKGLHEFEDLKEALKQAEGIFTGGGNTFLLVTQLYRHDLMTLLSETLKKGTPYLG
TSAGSNITGLTMQTTNDMPIIYPPSFQTLGIIPFNLNPHYLDPDSNSTHMGETRETRIKE
FHQFNTLPVLGLREGSWLEVRNETITLKGSLKARLFRQNQQPEELESGSDLSFLN
>LONDMIMF_00095 Ribosomal-protein-alanine acetyltransferase
METIKEISALDTFSVRHPVLRPGKPIETCHFEGDNSESTKHFGLFSNEKLAGIASLFIHP
TPFLEEKLQFQLRGMAILPEFQKKGFGEALVKHAENDAQARGGKIIWFNAREIAVGFYKK
LGYEIIGEPFDIADIGKHYVMYKKLDTV
>LONDMIMF_00096 hypothetical protein
MLLLVSCKEKEIAYTPPLNKDTGDVTKHEPRSYDIDSAYVASFENDSLTSFYRMNDFKTV
WNTSKNRQLIIEELLRVDKEGLEPKDYNSYELERQEKSLSLLTEKEIVSYDVQMTLAIQK
YLLHQTRGKLNPKELYEDWDLIPNQAKINQLLTNASNGDSLQTIIEKAKPNHIVYKKLKE
ALVLIDKFPTDTLKKIEVAGKLKVNDTSQSIINIKKRLMYWRDMTPQDSLTNLYDPETEK
GIKRFQSRHGLAADGVIGPSTVMALNIPKNVRKEQIIANLERWRWFPKNMGEHYIIINIP
DYRLYTVFKNDTTRTHNVIVGTSKRKTPILSSKLSYAVFNPTWTVPPTILKEDIIPATTK
NRNYLTKKNITVYDKNGKEVSLTSWNPEKALNYRYVQSPGTYNSLGMVKIMFPNNFTVYL
HDTNHREYFDKTNRSLSSGCVRVQNPLELTEYLLDDKKNWSLEKITETLKREKTQNAKIK
KEIAIHQLYWTAWSNGNSLQFRPDIYTLDSSLYLKLRD
>LONDMIMF_00097 hypothetical protein
MIYKFLPVFMYFFASFTTNVSKPTEPEKLIAATAEASFSMKAEKLYHTLHSNNLSLPNLE
SFSKALQGFYQLKEKGLVSKNILTIIDFSLSSNSKRLWIIDMSTNTVLYNSLVAHGRNTG
EEYAKEFSNASSSNKSSLGFYATGEVYQGKHGLSLRLDGLEKGINDNARNRAVVVHGADY
VAESFIKTHGRLGRSQGCPALPVGITKEVINVIKDKSCLFIYHPSANYKAATKLIS
>LONDMIMF_00098 hypothetical protein
MGKPFSLILLFFAIISTFDSYGQRKNLQAKSISENISIDGKLNEAIWNTAPVATDFLMLE
PDNGRPISPNKKTDVRILYNNDAIYVAAILYDDEPQKILKELTQRDNFGTADHFGIFING
FNDGQQDFRFFVSSSGVQMDCLATEGGEDYSWDAIWDSEVSITEYGWVVEMKIPYAALRF
SNDEKQTWGLNFYREIKRDRQKYTWNLIDMKIGAALPQTGQLEGIENIKPPTRLFFIPYS
SFYVENNKEGTDNKFKAGMDIKYGINDSFTLDAILVPDFGQTKYDNVVLNLGPFEQQFNE
NRPFFTEGTDLFNKGNLLYSRRIGGSPSTYLYSSDENVIASNPSTVNLINAIKISGRTSS
GLGIGVLNAVTEKTYGTLRNTQTNETNRVVVEPLTNYNILVLDQRFNQNSSVALVNTNVT
RNGEFRDANVSALVYDLNTKNNKFNLTGDFKYSYINEYGDNDNLNGINTAIQIGKKGGKW
RYNTGATYVSKEYDANDLGITFINNFHSGYVNLGYRILNPNSVFNTFKINTNYYAEFQNT
TGRLQKGEINIDFTSTSIKNDYYAISVYISPLETYDFYEARVNERFVNLPKNVYSSFYFS
SNYNRKFALDFNPYFTVTSEKNRVSYGLKIAPRYRFSDKLLMNYMIEAYNQNSDRGWVAF
DGDAIIFAERDRRTLTNELGLKYSMNPKMTLNLAARHYWSYAENNQYLTLQNDGSLTSNS
TFTVNKNSNFSTWNFDLSYSWWFAPGSQISVLYRNNATDSRTEIDRRLGNNFKNLFNNNL
NNILSISVRYFIDYNSIKNKF
>LONDMIMF_00099 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MNKKVILMILDGWGKSPDPKVSAIDNANTPFIDSLYTKYANAQLRTDGLNVGLPEGQMGN
SEVGHMNLGAGRIIYQDLAKINLAVQHKTLQQEKALIDAFHYAKQNNKKVHLLGLVSDGG
VHSHIDHVKGLIDATQDFGLENVYVHAFTDGRDVDPKSGIFFISALEKHMENTSAKLASI
VGRYYAMDRDKRWERVKKAYDLLVNGVGIHSQNAVSSLHDSYEKNITDEFIEPIVMVDEN
NNPIATLQNDDVVIFFNFRTDRGRQLTEVLTQFDCHEQNMHKLNLYYVTMTNYDDSFVGI
HVIYDKENITETLGEILEKNHKKQIRIAETEKYPHVTFFFSGGRELPFVGETRILKNSPK
VATYDLKPEMSAYELADALVPELEKEEVDFVCLNFANGDMVGHTGVMEAAIKACEAVDKC
AEKVITTALAHNYTTIVIADHGNCETMINPDGSPNTAHTTNPVPIILVDKDLKHINNGIL
GDIAPTILDLMGIQKPEVMTQHSLL
>LONDMIMF_00100 hypothetical protein
MAYSQGGAPSCAELQANFERYQSCATSIPFTNSTNNTSGETFTTTCIRQNFRGPTWFFMK
IKTSGDIFLQISQVNNAGASTDVDFVLWGPFSEMRDICSQLNISKEVDCSWLPDGIENVA
IPNANAGEIYILLVDNYSNSRGQITITQTGGAGSSDCSFLSSVKIKDNTGNDITQLNYCK
PDTKDLVATIDVTDFPGNTSDLRFNYKWYKDGILLTTIANSLSNTNTLTVSDSGLYKVET
TAYDSTDPTVNQNDLQVSDAEIDLKFFTAPNMTLQNTNTQCLASNPVLQTIDNNTIVQTY
TYEWFRGGISIPGATGSTFTPTLPGNYFVRISNPGCAPFDSNIIAIYESPLITITDNQTI
CENDTYQITSAIANAANLTNVTYQWYKDGSLIPGATSSSYIVSLAGQNAGTTSSYVVEAT
EQGLCTTTSNSVSITLNAKPLLSTPVTLQQCDYISPNNDGFATINLTQAYNALTNGDSAL
VLSYFLDAGLTQQITTPNSFTNTVAFSQNIYVTAINPSHIPICTSNVAIINLSVNPTSVA
TYTDMTPVCPELNANYGFVDFNSKRAAIKASSFPTTTVDIAFYINETDASVEENALTNTS
QIPVGISTIYTRIETNNNCAGIGTFKVQVYAGPAQNAITPINACQTETIILANKDSEILA
SQTPTVSVSYFNTFDNARTNTAAINKNTALPLTVGTKAIFVRQFDMATQCISVVSFDINV
FANPTITTPDPITICGSNTADFNLDSRIPQITSGNTNYRVFFYETPADLAADTPITATNP
YNSVSKTISVKVVDPTGNNCFSTTTLRLNVVGSPGSTTNPDIIQACDDSGFYPFNLTQRQ
SQMAGTTPLNTIQFRYYIREQDALSNSNNAIPAPENFTNTVADYQKIYVRLNSTVNIGSE
NGEACFRILELELFVRPFPANNIQEYPYRICKDIYNNVVTPAFIDTQLSETDYDFEWYTG
HDAVASNRISSETGSTFTTSVQGDYSVKIINTTNTALCARIINFTAKNSLIPFSITGDPS
EQITFESDSKVTAIVTPQSPDFQYMIDDNGWQDSNVFHNIKEGIHLLKVRNRYGCGEIST
RIVIVDYPRYFTPNGDGFNDTWNIGGRTSLDISNVYIFDRYGKILTDLRQNGFGWDGTFN
GRPMPSDDYWFKIIYQKDGVKKEFKSHFTLKR
>LONDMIMF_00101 Methionine aminopeptidase 1
MIIQKTREEIELMRESALLVSKTLGMIAKEIKPGVTTLHLDKLAEEFIRDHDAVPGFLGL
YGCPSSILTSVNDQVVHGLPTNRPIEEGDVVSVDCGVLKNEFYGDHAYTFEIGEVAPETK
KLLQVTKESLYVGIREFKIGNRVEDVGNAIQKYTEAHGYGVVRELVGHGLGRKMHEDPEM
PNYGKRGRGKLFVEGMVVAIEPMINLGTKNIKQLKDGWTIVTADRKPSAHFEHDVALIDG
KPELLSTFAYIYDALGIKSDEENEFRRQPLVIS
>LONDMIMF_00102 Demethylrebeccamycin-D-glucose O-methyltransferase
MKKIFRFVLNTIPRPVLIRLSYVIRPVLAFALKGKKYTDPIDGKSFRKFLPYGYGTQRNN
VLSPSTLSLERHRLLWLYLKNETDFFTAPKKVLHFAPEQAFYKIFRNQKNLDYTTTDLLS
PLADVKADICNLPFEDNSYDVIFCNHVLEHIPDDTKAMQELFRVLKPGGMGIFQIPQDLK
RATTFEDDSITDQKERARIFGQYDHVRVYGRDYFDKLRSIGFTVNEEDYTKKTGPELVEK
YCLAPGEIIPVCYK
>LONDMIMF_00103 putative zinc protease
MKHYSKLFVLLLAFPVSIFAQELKGDGPIPFDPSVKTGKLENGLTYYIKRNAKPENKVDL
RLVINAGSILENDDQQGLAHFMEHMCFNGTKRFPKNKLVDYLQSIGVKFGQHLNAYTSFD
ETVYFLPIPSDDPEKLEKGFQILEDWAFNAVLTPEEIDKERGVVLEEYRIGLGAGKRMMG
RYMPKMMYKSHYAERLPIGKKEILENFKYDKLINFYKDWYRPNLMSVIVVGDIDVAAMEK
KIKDHFAAYKNPKNEKPRKIFDVPNHKETFVAVESDKEASAAQVQLIYKDYENAKPVVTV
NDFRKSLVEGLYSTMINNRLNELTNSPTPPFTYGYSYHGGTWARTKEAYQSFAMSQEDKQ
VDALKVLVTENERVKKFGFTQGELERAKSEILANIESDYNDRDKTESRRFVGEYQSHFLQ
KEPVPGIEWTYNATKKLLPAIELKDVNSLIKDYVKEDNRVVILTGPEKDGLKKPTEQEVL
GALKVNTAEITPYADSEVASSLLRKELKPGTIVKKEKNDKIGTTTLFLSNGAKVTYKKTD
FKNDEVLMDAVSFGGTNLYSVDELKKTQFANGGLTQAGFSGLKENDINKFMSGKVANVNP
YIGNTTEGLRGSSTPKDLEYLFQMTVAYITDLNYDKDAFEGYKQKQSAFFKNMASQPGFY
FQQELYGYLLKDNPRFFGMIPDEKAWETTDYQLAYNKYKERFANAADFEFFFVGNIDDKK
IEEYSAKYLAALPSNDKKEKAVDVGYRMLKGEHKKIVNKGTDPKSTVNIMFYGDAVYSPK
EALAMQALGEVLSIKLVEELRENESGVYGISARGSMSKVPNGSYNFSINFPCGPDNAEKL
TASALRELQKIIDNGPLPADVTKFKEAELLDYKKDIKENRYWLSNFNRSYVNGTNPEDIL
KVEEKVNAITAKDIQDVAKKYLTKDKVVGILMPEKS
>LONDMIMF_00104 hypothetical protein
MKKNYFIILLACLFSGLVTAQVQNEIDPPFNIKTVSFVQNGQNVIPIFNLQEGFQLQFDD
LYGNEANYYYEIVHCNYDWTPSQLVKSEYIQGFDNQRIQDYENSFNTLQLYSHYRLPFPN
KFTQFRVSGNYIIKILNEDRDVVFSRKFILYEDQVSVPLQIKRARDVRDINYMHNLDFAI
KSASITFINPLQSVKVMLLQNGQFKEAIYNIKPQYTIGNDLIYKYDKETQFWAGNEFLYF
DNKEIRAVVNNINYVRAKDLYEPHLYINRARANQVYTYYPDVNGNFVVRNFNTQNNEIEA
DYAWVYFTLDAPNYFGKSDIYINGMFNNYALNDENRMDFNQKTGMYEKAIVIKQGFTNYQ
YVIADKKGKIDHANAVDGNFYQTENNYQVIVYYRGINERYDKVIGRGTANSENIVN
>LONDMIMF_00105 Protein ApaG
MVTQITRGIKISVLTSFEGTYFKNYKIHFAFSYEITIENHSKDSVQLMSRHWEIFDSLNN
KDFVDGEGVIGKKPVLKPGESHTYSSGCLLSSPFGAMKGYFNMINFTSTKSFRVIVPTFR
LSAPFALN
>LONDMIMF_00106 1-pyrroline-5-carboxylate dehydrogenase
MPKGIYNVPKAVNEVVKSYAPGSPEREQILKTYKELYNSTVDVPLFIGEEEIKTGDTKRL
FPPFDHQHTLGQYHQADKALVEKAIASALEARKKWATMPWEHRAAIFLKAAELLAGPYRA
KINAATMIAQGKTVHQAEIDSACEFIDFLRFNVQYMTEIYAQQPVSSEGIWNRLEHRPLE
GFVYAITPFNFTAISGNLPSCVALMGNVVVWKPSATQIYSANVIMEVFQKAGLPKGVINM
ITGDSGMITDTILDSPDFAGIHFTGSTGVFNSMWAKIGQNISKYKTYPRIVGETGGKDFV
WAHPSSNPIEVATALTRGAFEYQGQKCSAASRAYIPVSIWNAVKDRLVADVKSFKMGSPE
DTSNFVSAVISESSFDKLAKAIDEAKASSEAEVIVGGGYDKSKGWFIEPTVIVTTNPKYD
TMETELFGPVLTVYVYEDAKWEESLKLVDETSIYALTGAIFSQDRYAIDVATKALVNAAG
NFYINDKPTGAVVGQQPFGGARASGTNDKAGSILNLLRWVSPRTIKETFIPATDYRYPFL
G
>LONDMIMF_00107 Ribosomal RNA small subunit methyltransferase G
MFTFVKILKMEEILKYFPNLSDIQKQQFEKLEELYHDWNAKINVISRKDIDELYTKHILH
SLAIAKIQEFEPGTSILDVGTGGGFPGIPLAILFPETQFYLIDVIGKKIKVVQAVAEALK
LENVKAEQIRAENVKGDFDFIVSRAVTNMPDFVSWVRLKIKKQQKHELKNGILYLKGGDL
TEELKDFPKATEYNISAFFDNEFFETKKVVHLPLKYKG
>LONDMIMF_00108 NADPH-dependent stearoyl-CoA 9-desaturase
MNTTIPTFSKNDSLKFFRTLNTRVNNYFKENNIKKTGNWKLHLKAIIMFSLFLTPYFLIL
ALDMPFWLMLLLSIVMGIGMAGVGMNVMHDGNHGSYSNKSWLNKIMGGSIYILAGNVYNW
QVQHNVLHHTYTNIHGHDEDLDAGKIIRFTQDAKWHRFHKFQHYYSVFLYGLLTFNWAIT
TDFRQMKNYLRRKLSYGEPQSPVKLWTVLVITKIIYISIWLALPMILGISWWKVLLGFLV
MHYTAGLILSIIFQLAHVVEETANPVPNDEGEIENTWAIHQLYTTANFAPKNKIVNWFTG
GLNHQIEHHIFPHISHVHYGKIAEIVKQTAKECNLPYHEFKTMRGAVAAHFRHLKELGQN
PAMA
>LONDMIMF_00109 Aspartate aminotransferase
MNHLSDRINRLSTSQTLAMAALARELKAQGKDIISLSLGEPDFNTPDFIKEAAKKAIDEN
YSTYTPVDGYAELKEAICRKFKRDNNLNYTPANIVVSTGAKQSLYNVAQVMLNDGDEVIL
PAPYWVSYYEIIKMSGGIPVEVPTTVESDFKITPEQLEKAITPKTKMIWYSSPCNPSGSV
YSREELTTLAKVLEKHPDIFVVADEIYEHINFSGTFCSIASIPGMFDRTVTVNGVAKAFA
MTGWRIGYIGAPEFIAKACTKMQGQVTSGANSIAQRATITAVDADPSVLNDMVAAFKNRR
NLVVGLIKEIPGLKLNVPEGAFYVFPDVSSFFGKTLRGTEIKNADDFSMYLLAEANVATV
TGDAFGNPNCIRLSYATSEELLTEALRRIKEVLA
>LONDMIMF_00110 Formate-dependent phosphoribosylglycinamide formyltransferase
MSKILLLGSGELGKEFTIAAQRIGQTVIAVDSYENAPAMQVAHGFEVINMLDGEALDRIV
AKHQPDFIVPEIEAIRTERFYDYEKQGYTVVPSAKAANFTMNRKAIRDLAAKELGLKTAN
YRYATSSEQLHKAVEEIGIPCVVKPLMSSSGKGQSTIKSPEDIEKAWNYAVEGSRGDVVE
VIVEAFVKFNSEITLLTITQNNNPTLFCAPIGHRQERGDYQESWQPARISDKDLFEAQDM
AEKVTEALGGAGLFGVEFFLADDGVYFSELSPRPHDTGMVTLAGTQNFNEFELHLRAILS
LPIFEIKLEKAGASAVILASENSSNPTYEGIEKIAGLAKTDFRIFGKPTTRPYRRMAVAL
TNDSLDTPIEEVIERAKNAAQLVTVK
>LONDMIMF_00111 hypothetical protein
MKNIIAIAFLFLSFTVSAQNSGAKQANPKKTAPKSQIVEASCGQCQFGMKGHGCDLAVRI
DGKPYFVDGSGIDDHGDAHASDGFCSKIRKAEVTGEVKNNRFVATSFKLLPEKK
>LONDMIMF_00112 hypothetical protein
MKKTILIFILLLIGFFLFYNILPVINYGFVGLPLLLLFLIFLAIIIFSKVEVTAKARKLN
VFSRTNKILFFLSFGLMLYLLVVPLLTSLPMFRSSAYQKLIGKVENGDDLKNHIAPISLD
KIRVVDEELAMLLGEKIIGSQPSLGSQAEIGEFTIQKVNDELYWVAPLLHTGFFKWYNNS
EGTPGYVMVSATNERDVKLIQNINGKPLKIKFQPSAYFGSRIDRHVYFNGYATTGLEDFN
FEIDDAGNPYWIVTKYKKTIGFAGNDATGVLTVDAQTGEIKEYNIDNTPLWVDRIQPISF
VEEQLNDWGEYVHGYWNFSNENKLQTTEGLTLVYGENHKSYWYTGLSSVGKEESTVGFVL
VDTRTKETTYYKQSGATEYAAQSSAEGKVQEKGYHASLPIPYVINNIPTYVMTLKDDGGL
VKMFAMVSISDYTIVGVGNTMRETLMSYKNVYNMADNGINPESITSKKSIKSVVTRISSD
VKNGNSFYYFTVKDYPNIFVGSSQLSNELPVTVVGDSITISFDVDLEEVIDVSSFENKNI
GKKK
>LONDMIMF_00113 hypothetical protein
MEDKKEYSNGEVTVVWQAEKCIHSANCVKNNPQVFQPKMRPWINIEGSSSDKIIETVKKC
PSGALSFYQNNQS
>LONDMIMF_00114 Transcriptional regulatory protein CusR
MKLLIVEDEPNLLSIIRKGLSEKNNEVSVALDGTTALEMIQNHNFDVIVMDIMLPDINGI
EICRRLRASKNFVPILLLTALGTTENIVTGLNAGADDYLAKPFKFSELEARIGALARRSN
QDHKPNDKIQIDDLEIDSRSKTVKRNGEIIQLTAKEFKLLYYLAKNTEIILSREKILDNV
WDINFDMNTNVVDVYINYLRNKIDKPYQNKLIHTIKGLGYVIKSQS
>LONDMIMF_00115 Signal transduction histidine-protein kinase ArlS
MQIRKKITATYIALSCFSTLLLSVLVFFLFKQNNEYYFLKRLQDRAKIASSIYYQNDLRK
TRYFQEFKKEGLEELVEEKDFVLKVNGENTFEYNTDLHLPPEFYANVMKTGSSWIEENYS
YYYGQIFKESGQKYMVIVTAKDRRGYTSAIYMIQILVLGGAGFLVLAFFFGRLLARRVID
PMARITKEVKRISASNLHNRLADAEGNDEISDLAKTFNDMLDRLETSFEIQANFINNASH
ELKTPITTIIAETEIMLLKEREVEEYVGSLENINRQATKLGNLTESLLKLTQTGYDGTKQ
VLDIARIDELLLEAKASIDTLFPDNRVNIKLNAIPEDESLLTIPCNRPLLELALNNIISN
GVKYSDNDEVFVTLSADKSKIKIAITDIGIGIPPEDIPYLYEPFFRGKIASKYNGYGLGL
PLAMKIIRMHNGELHIQSETGKGTVVNITFHKTNIRNSNLKS
>LONDMIMF_00116 hypothetical protein
MKNLLIPSTLEKDTINAIKVAIQQSKGKSCTIYLALVSEIPDTYSSAAFLRNIKSDMSVS
QKSILHSCRELVAASQNCSLKIHNQYGISAPVMKNLMEHLNIELTILTPSYKNTERRIHN
QFLQILANCKCPILHLSPNFEEQDLSKALYLEQTKSKLHVEDLQELVQNHFDFRIVSQAT
IFNDQKPEEIQPLLTEAITKNNINVLIETRKPKKIKLKNKNFSINESFGLPVLSLYEEIV
>LONDMIMF_00117 hypothetical protein
MLLKKKIPMKYVLGKIKIELFLVILYVISFEIFLYYYGTNAINIPIAIPTIIGTIISLLL
AFKSNQAYDRWWEARIIWGAIVNDSRTLIRQVIAFYKDPDFSVEANDFKENFAKRQAAWC
YSLSQSLRGKDPLKAVKQILSDEDFKYIKKHKHVPNAILLLHSKDLKKANEQGKINTYQQ
VEIDNTLTRLCDSMGKCERIKNTIFPTTYSMYIRFTLCLFIILLPFGLTDLLGWLQIPLV
TTIGAAFFLIEKMAIHLQDPFENRPTDTPMTAISSTIEKNLVQMVNEFRDEFETPAKKPE
VELHHIQPVKNSYFVL
>LONDMIMF_00118 hypothetical protein
MKTNTFRSIAGKAFLILGFLSFTFFVSCSNDSNPEAVAEKFLNHINKGEFKEAKEYCDEQ
TASLIGMMESMAGAKKDELKKNDAKVEIISSEVKDDKATVKYKTVGGKAEAAAEQTLNLV
KVDGKWKVTIDKENANKEGAKAPGADMEATDSLAAPADEPVVPADSTETAE
>LONDMIMF_00119 hypothetical protein
MKKFIFYTAMLFVLGIIAYKLFFYFDKKSEQKAILKNEAITRLSEDELSKIEEGDFILRR
GFGFFSDYISKELNSGPIDVTHAGIIIKKNDSLYVVHSLSSDVTDVDGLQLQPLKEFLKY
SFPNKIIVTRAKNCDKKMGAQISQLAQKYLAMHIPFDHKGDFDDDTKFFCTEMIWKILEK
DLHSVTLPTEAAARKKFFFSMTPMYDTQYFDIKINQYDIKNK
>LONDMIMF_00120 Malonyl CoA-acyl carrier protein transacylase
MKAYVFPGQGAQFTGMGKDLYEQSELAKELFERANAILGFRITDIMFEGTAEQLKETKVT
QPAVFLHSVILAKTLGNDFKPEMVAGHSLGEFSALVANGTLSFEDGLKLVSQRAMAMQKA
CEITPSTMAAVLGLEDHIVEEVCASIDGIVVAANYNCPGQLVISGETTAVEKACEAMKAA
GAKRALILPVGGAFHSPMMEPAREELAAAIENTVFSQPICPVYQNVPASAVSDPIEIKKN
LITQLTAPVKWTQSVQQMIKDGATSFTEVGPGKVLIGLVNKIDKEAATFSA
>LONDMIMF_00121 UDP-glucose 4-epimerase
MKKILVTGGLGFIGSHTVVELQNEGFEVVIIDNLSNAEEKVLHGIEAITGQKPIFENLDL
REKEAVKAFFKKYNDIAGVIHFAASKAVGESIENPLLYYENNISALVYILQELQLKTETS
FIFSSSCTVYGQAEKMPITENASVQPATSPYGNTKQIGEEIIQDVAKISSIKAILLRYFN
PIGAHPSAEIGELPIGVPQNLVPFITQTGIGMRKELSVFGSNYPTPDGTCIRDYIHVVDL
AKAHVVALKRLIDKKNEDAVEVFNVGTGKGSSVLEVIRSFERVSGQKLPYKLVGRREGDI
IEAYADTQKANSVLGWKAQSTLDEAIESAWKWEKKIRS
>LONDMIMF_00122 UDP-2-acetamido-2-deoxy-3-oxo-D-glucuronate aminotransferase
MKKIQMVDLKGQYENIKETVNNSIQEVLDTNTYINGPEVHKFQKNLEEYLGAKHVIPCAN
GTDALQIAMMALDLKPGDEVITADFTFAATVEVIALLQLTPVLVDVEIDTFNISVEAIKK
AITPKTKAIVPVHLFGQAANMEAIMQLAKEHNLYVIEDNAQAIGANYKYFDGKKEKVGVI
GHVASTSFFPSKNLGCYGDGGAIFTNDDDLAHKLRGIVNHGMYVRYHHDVVGVNSRLDSI
QAAVLNAKLPLLDEYNAARQLAAQKYSQALANHDKIVTPYIAGERDSHVFHQYTLRILDA
DRNALMQHLLDKGIPCAIYYPIPLHSQKAYLDPRYKEEDFPITNQLVQEVISLPMHTELD
DEQIKFITDSILEFLA
>LONDMIMF_00123 hypothetical protein
MEIKDNTFSRQFEAHSDGKLIAVEYSFQEKKIFLTKILTPEQFENDDFINDFLKEIMSIA
EQRKLKVVPIHPKIAAFFRKNPAYKELLPPGIRI
>LONDMIMF_00124 hypothetical protein
MMGKIPVYFMPGMAASSTIFERIHLPEDQFETHLLEWTIPLEGESLAGYAERMAKEIKHE
NPVLIGVSFGGVLVQEMARFVKARKVIIISSVKCNAEFPRRMKVAKSIRAYKFFPTGLMQ
NVEAFAKFSFGNDKMNKKLKLYEKFLSMRDKKYLDWALEQIILWDRAIPDEQVVHIHGDA
DEVFPPKYIKGFIPVKGGTHIMIINKFKWLNEHLPKIILGT
>LONDMIMF_00125 Membrane-bound lytic murein transglycosylase D
MKLMKKTGLIASVVLVSGILIHAVSDEKIGDKAPVEKGYFFPAEIDFAGEKTPLNIVDVK
ERFDRELLVNANLDASTLLIIKRANRFFPVIEPILKKNGVPDDFKYLAVAESALMNATSS
AGAKGFWQFMADTAKERGMEVNDVVDERYHLEKSTEAACKYLLDAYKKFGSWTLAAASYN
GGFGGVNKQITIQGVTNYYDLLLTDETARYVFRILALKQIMQNPVQYGFNVAPAELYQAI
PTRKLEIDSSITDLASFAKSQGINYKILKIHNPWLRDRKLTNPAKKKYVIEIPTEGY
>LONDMIMF_00126 hypothetical protein
MFHRNIKLILAGLIIATGIWQFTENNIGNGIFLILLSLVFILLYFKNEFILLAFLKLRKQ
DFAGAQKWLAYIKNPETALVRKQQGYYNYLHGLMLSQTNLMQAEKHFKKAVELGLSMDMD
LAVAKLNLAGVAMSRRRKIEATNLLNEVKRLDKQNMLKDQVKMMKEQLKKI
>LONDMIMF_00127 50S ribosomal protein L34
MSKRTFQPSKRKRRNKHGFMERMATANGRKVLARRRAKGRHKLTVSSEPRHKK
>LONDMIMF_00128 Carbamoyl-phosphate synthase large chain
MSALPGLTTTTHNNMPKDNSIKSVLIIGSGPIVIGQACEFDYAGSQSARSIREEGIEVIL
INSNPATIMTDPSMADHVYLKPLTTKSIIEILKEHPQIDAVLPTMGGQTALNLCLEADEK
GIWADFGVKLIGVDINAINITEDREQFKQLLQKIDIPAAPAKTATSFLQGKEIAQEFGFP
LVIRPSFTLGGTGAAFVHKKEDFDDLLTKGLEASPIHEVLIDKALFGWKEYELELLRDKN
DNVVIICSIENMDPMGIHTGDSITVAPAMTLSDATFQKMRDMAIKMMRSIGNFAGGCNVQ
FAVSPDEREDIVAIEINPRVSRSSALASKATGYPIAKIASKLALGYHLDELQNQITKSTS
ALFEPTLDYVIVKIPRWNFDKFEGADRTLGLQMKSVGEVMGIGRSFQEALHKATQSLEIK
RNGLGADGKGYTNYEQIIEKLTFASWDRVFVIYDAIQMGIPLSRIHEITKIDMWFLKQYE
ELYTLEKEISNFKIDTLPKELLLEAKQKGFADRQIAHMMGCLESQVHKLREEMNINRVYK
LVDTCAAEFKAKTPYYYSTFEAEIETADGKRYVHNESAVTDRKKVVVLGSGPNRIGQGIE
FDYSCVHGVLAAKECGYETIMINCNPETVSTDFDTADKLYFEPVFWEHIYDIIQHEKPEG
VIVQLGGQTALKLAEKLSKYGIKIIGTSFDALDLAEDRGRFSELLTELNIPFPKFGIAET
ADEASALADKLDFPLLVRPSYVLGGQGMKIVINKKELEEHVIDLLRSIPGNKLLLDHYLD
GAIEAEADAICDGENVYIIGIMEHIEPCGVHSGDSNATLPPFNLGEFVMQQIKDHTKKIA
LALKTVGLINIQFAIKDDMVYIIEANPRASRTVPFIAKAYGEPYVNYATKVMLGHNKVTD
FDFNPHLKGFAIKQPVFSFSKFSGVNKALGPEMKSTGESILFIDDLKDDQFYELYSRRKM
YLSK
>LONDMIMF_00129 hypothetical protein
MKKIVFIAILLSFTALYSQEIQKTITVSGKVIEKKTAVALEFATVTFTNSPGGESVAGSI
TDDKGNFSLKIVPGKYHIKAEFIGLESSIIENIDLQADQVLPTFLLDEIPTQLETVEIQT
EKTTIEHKLDKKVFNVGSDLVSKGGNATDILNNVPSVSVNYNGTVSLRGNTGVRILINGK
PSVLTANNGLEQIPAENIEKIEVITNPSSKYDSEGTAGIINIVLKKNKSKGFGSSVQVTT
GIPDNHALGYNVNYKNKKINIFSDLRYRYIYFPGNESTSRTIYDGNVIDSYLDGTVDRER
TNRTFTAYMGGDYYFNDKNMITLSYFYRNNTSRRTVDYAFNYLDENRNPERNVNAKEAYR
EPQTANQIELNYIKTFAKEGQKFTINLQYDFWNDDENESIAEQEFFPVALPVRALKSRNI
ESSKDFLFQSDYSLPINEKSKIEFGIKGEIRRINSDYQAYDNNVAIDSLNNLLHYDERII
GAYVQYGSSIKKFSYLLGLRIEDSKTGSNDRINLFNIDKKYTDFFPTAHFTYEINDVFNV
QLSYSRRISRPGFWQLNPFGGIADRRNIRIGNPDLDPVYTNSYELGTLIKWGKVTINPSI
YHQYSKNIFEDIRFTNSDGFLVEQAINSGTESRIGAEISFTYSPLKWLTLTGEANYYTFE
QKGMFHVSDKNFLSKQSTRIKFSTWNFQTNLNYLGATSSGQYSSKSQYWFDLGMGKDIWN
ERATITLKADNIFDSRISKGSARGDDYALNYSYRSPGPRVYATFTYRLNRKKSDRERLPD
>LONDMIMF_00130 Sensor histidine kinase YehU
MDNFKKISEYIRTHRLAQHLLFWFIIVITYIPVGLLDESHDPLGVILLFNFCIHIPQMLA
AYFLAYYLLPKFILKKKYFVSVILFLLSFYLFSALARILTVHVGEELVRTRPFEQESVYE
ILTDIHSLVVKYFPAVFSISFQFLFVKYFVNNEQKKNEARQLEQKKTESELKMLKAQLNP
HFLFNTLNNIYSLSLDNSPKTASAIGKLSDILDHVLYKCNGQFVSLSNEIELIKNYIELE
KLRYDDRLEITFDTAIENNIEIPPLLLLSLVENAFKHGAGEDSGSPKIGISITQKGNHFS
FEISNTVSSDYVSKDREKIGLNNIKKQLDLIYSGNYSLDIKQASNLFSVVLQINQNNSI
>LONDMIMF_00131 Sensory transduction protein LytR
MKIKCLVVDDEPLAIRLIEKHIAKIDNLEVVATCNTALKAFEILNLQKIDLMFLDIKMPN
ITGIEFLKNLKNPPKTILTTAYRDYALEGYDLGVVDYLLKPITFERFFKAVDKFLSTNST
SIEVKSKELVPDEFILVKSGIKNYKINTNDIIYIESLKDYIKINTTGDKNITSKYKIGDI
QQELNQDNFLRIHRSFIINTSKITAFTLNEIEVGGIEIPIGASYKDDVLLYLETLKNSK
>LONDMIMF_00132 hypothetical protein
MKKTTFLLFLFFLSTTVFSQKDIFNVARTGTVDEVKTLMKHSPDCINDLSPEGYTPLILA
CYRGNSSVADFLIHHVKDINAVSGMGTALMAASVKGNVAIVKKLLEKKANPNIPDSNGTT
ALIYASIFKNYEIAAFLIKAEADPYAKDNRGNSALDYAILSNDDKLIQILKTK
>LONDMIMF_00133 hypothetical protein
MRKTTLAFFTTLLSGFGLSAQTYSTGTVTLTSGFTAAIEVNSSLVTLTLVGPSTDWLGLS
FNATSMNDNGSDVVIFDGTAMTDRTFAGIGATPPLDASQNWTVTSNVINAGVRTVTATRA
RDTGDSNDYTFSTSAQPLNLAWAHRPGSLAMGYHGPGNSGATVANFTLGTENFTAESFKM
YPNPAKGFTTLELPDFVSGGEIKVYDNLGRVVRVQAISESQVTINTSDLTTGSYMVVVRT
DYGNATKTLIVE
>LONDMIMF_00134 hypothetical protein
MKKKLPLIILAFSAFFAQAQDNCQSALTITAGRYRVDQINGSANTYGICAGNGTAPNSEW
YKYTPTTSTSVTVTTDLLVNIGGDTRFHIYRGTCGALTCAGGDDDSGNLGNGYLSAHTFN
VTAGTTYYIVFDNKWQSTGFDFVLAEGPYTPEQPEVPGQIVRFNAQSITLIGSYKNCVVD
MNGDYLDDIVGISNTNLNILYQNAAGGFTSATVPTTNATFMPSWSVTAGDFDKNGYNDLL
FGAGNGVTFLKANSTGTAYTAISGPQSIFSQRSNFVDINNDGHLDAFVCHDVNPNVYYLN
DGNGNLIFHQGGMGDYPNGGNYGSIFVDYDNDGDQDLFIAKCRGGNPAASTDELHRNNGN
GTFTNVAAEAGLADPDQSWSSAFGDFDNDGYMDVLIGSNAGGTAQKLMRNNKNGTFTNVT
AGSGFDTYNNMGREYIARDFNNDGFIDVYGPGGIIMINNGDWTFTKSGGAPPNGSIGDLN
NDGFLDVQSENTIYLNQGNDNNWITINLKGVQSNGNGIGARVELYGAWGKQIRDVRSGEG
FEFANTLNTHFGIGTATAIEKVIIKWPSGLVDQIMNPTKNTRLLVTEGSTLGVSEANSAM
FVIYPNPASNQIRIQLNEMKYDITDAKIYDYNGRMVSDVKIKDNTIDIQSLSVGNYMMVL
QNSNGEKFSQKFIKK
>LONDMIMF_00135 hypothetical protein
MKQNYFLKKSLLLLLFFAFLSCGSDNDYVPLPEPTSPVVVDLAAVPYSKLSDYKFFEGTM
KNQVPSLDVLPYEPASQLFTDYAHKKRFVWMPKNKKAVYDGDGKTLVFPVGTALIKTFYY
DNVQPNNTTRIIETRVMIRKEEGWIFANYVWNAEQTEATLDPNGSFTEITWREGATIKTA
NYRIPSSAGGECLTCHKSVDKAIPIGPKPQNLNFAINYGSGSKNQLEKWAEVGYLDNNYP
RNIVSTVRWNDTSQPLEKRVRSYIDINCAHCHQEGSHCSYRDMRFAFSETSDISNMGVCM
VPVDNVGSGLSHIVAPGSPGRSVMSFRLESVNESTRMPLLGRTIVHEEAVEMINQWISSL
DTRCN
>LONDMIMF_00136 putative acyl-CoA thioester hydrolase
MGKIYKTPKSSRITISELMLPSHSNFSGKIHGGYILSLMDQIAFACASKFSGTYCVTASV
DTVDFLNPIEIGELVTLKASVNYVGNSSMVIGIRVTAENIQTRKVKHCNSSYFTMVAKDD
SGKNVSVPRLTLTTAEEVRRFCDSLRRIRSKKEHREQEVLFDHTSLDMLQEIQNMDIKIH
L
>LONDMIMF_00137 hypothetical protein
MNDTIITIIAFIIALAIGLFIGKALFSANAKSEKASLEERVNGLMSQMEQLRQQHQHEIR
NTENQLQQTAMERENLRAEKEALAIQLSKKEVDFENLWERNKEQKQEVEQLQEKFTKEFE
NLANKILEEKSSKFTEQNKENLKNILSPLQDKIQLFEKKVEDTHKESIDYHAALRQQILG
LREMNEQMSKETLNLTKALKGDSKMQGNWGELILERVLEKSGLEKGREYEVQQSFITEDG
TRVFPDVVINLPDGKKMVVDSKVSLISYEKYINEEDDILKASFLKEHLNSIRRHVEQLGA
KNYHDLYQIESPDFVLLFIPMEPAFAIALNEDATLYNKAFEKNIVIVTPSTLLATLRTID
SMWTNQKQQENAFEIARQAGALYDKFEGFVSDLVKIGKKMDEAKTEYQGAMNKLFDGKGN
LINSVERLKKMGAKAKKSLPENILRRAETDETEN
>LONDMIMF_00138 hypothetical protein
MKKTTLLSGVRQDFTQIKGLFFGAFLLASITAQSQSYCTPEEGDCTDGDEIVNVTFAGIN
NSSACSEFGYGDYTAGTAASVVAGQSYNISVTIPQHLGTQYVAAWLDFNDDGVFDASEFF
AIGTSPAAGSVVTASIAIPVSAPAGNIRMRVKAQYAQAITATSSCAEPYLGYGEYEDYAV
NVVAATACTGTPAVGAATSTQTSVCGQTSFVLSASGVTPAAGYSYQWQSSPTGTDQWTNL
GAAQNSLSYTRTGQTQATFYRVVITCSGSGLSGTSTAVSVGQNAVDACYCINTINFNCTD
GDVITNVTVGTINNTTTCGNATTGYTNYSGSVTPPVFNIGATIPVSVSVGPSGDGWLYES
VGVWIDYNKNGVFDEAEYNYIGTGLNQAVTGSITIPATAVVGNTRMRVVVAASAADSFGH
QFACGPVAANNNYGEMEDYTVTIAPSLSTPAFENASVSVYPNPTNGLVNVQFATQTAVDA
INVYSVSGQLVYSKQFNTASDSYTVDLQKAATGVYIMKLEGENGTIVKRLVKN
>LONDMIMF_00139 hypothetical protein
MKPQNLTLEKVTDSPINYEFVANVATRIIKIFFRTDKTIRLIYSNYSNKHFFGDKFIILD
YRFRNALWYKVGDKITEKRHFLLEKPEMPQKIVLTVYGFFRKKMYLLDFSAAEYIDSSTF
CVELKKSSRQDFENPVLG
>LONDMIMF_00140 hypothetical protein
MKTQSYSNHIRYYAPHHFVLYPLLLILLGTAIYFIFSREAERAIWIFISIGLFLIFWLAF
MLRQHYALTLQDRIVRLELRYRYFALTGERLELFENQLSQSQLFALRFAPDDELPGLLKR
ALKENLSGDAIKKSIINWKPDYHRV
>LONDMIMF_00141 Protein YceI
MNFTTHWFIDPDHSNIEFRIRHLLISHISGAFKIFNGKMTTKNDDFETAEIALSIDVYSF
DTNNIERDEHIKSKDFLDADQFPEINFSSTNLKKIEGDHYKLTGNITIKSVTREIVLDAV
FGGQAKDGFGKMKAGFEISGKLDRKDFGILADDVTESGHLIIGEELKIHANIEFDKEED
>LONDMIMF_00142 hypothetical protein
MATSGKDIGNKKWNGEQEKQKGEINEGFSGKNLPENYNPSKGKLKTEIEKDADGNTDTVQ
RARPGKDLKTDKDLKNKKNPENRDKNSDIDPNRYPSSHPENKRNRGNMK
>LONDMIMF_00143 Ribosomal large subunit pseudouridine synthase E
MSAHKHFLLHKPYGYLSQFIYELKRKKKLLGELYDFPEGTMAIGRLDEDSEGLLLLTTDG
LMSELVRSKKVTKEYYAQVDGLITEEAIEQLKKGVEIGFDGIRYVTNPCDAFKIEDPGFE
PRSKKIRDERHGPTSWISITLNEGKFRQVRKMTSAVGFPTLRLVRIRVGNVYLDNLKSGE
VKEVNQFSL
>LONDMIMF_00144 tRNA (cytidine(34)-2'-O)-methyltransferase
MLNIVLVEPEIPNNTGNIGRLCVGTGSRLHLIHPFGFQITDKNLKRSGLDYWVHLDWKEY
QSVEEWMQQIPDMSRVFLFSSHSEKSYLKESFQDGDWLVFGKESVGLSKEVLDKFENHLT
IPISPLVRSYNLANSVAFAIGEAKRQISI
>LONDMIMF_00145 hypothetical protein
MIDKSYLRSSIFRHLDGLAVAPVAIALKNKGVLEYILENRQANLTELKTRFKANEGYLNV
GLRVLCSQGFLDYHIDNATDGIHFTVNDKTPTAFSMVPLYQDAVDLLQFSTQFHPRIFED
APFERLDQIFEKFKLNYGIDFSDDVLENEVQKQILKHIEGYLIGPTIVRLAMSGMFHKYF
METSFRPEEFHKNPESFKKILNFFTYLDWFREKNGNYQFTETGLFFAKRASAYGVTVSYL
PTFAKIEELIFGDPNILRMIGDGENEIHVDREMNVWGSGGAHDTYFKIVDEIIIQLFNRP
IEEQPKGILDMGCGNGAFLQHIFEVIDRQTLRGKMLDEYPLFLVGADYNQAALKVTRANL
IKADIWAKVIWGDIGRPDLLSQDLMENYAIDLKDLLNVRTFLDHNRIWEEPKYISKDRVS
SSTGAFAFRGTRIPNNKVEDNLLEHLQKWSPYVKKFGLLLIELHTINPALAAKNIGKTAA
TAYDATHGFSDQYIVEIDVFNKIAAEAGLFPDKAVFRKFPDSDIATVSINLLKGN
>LONDMIMF_00146 hypothetical protein
MKFCLSILFLFTSIITNSQVRLELTPKGFEPNPLRGKLPAMTNEKFIEGTQLWIQEFSRG
EADISEVTENSLTIDAFRDNAFFYRSLGDTFFQKVKYRIKVAKEGNEYVLSFQITEIYSK
KTLLKSGITDYLTSDGKTKDGFQDVKPSIEKTVGIILDSYFRYMNYFART
>LONDMIMF_00147 Fe(3+) dicitrate transport ATP-binding protein FecE
MDKGKTILKAEELSIGYISKKEKKTIASHIELDLKAGKLISLIGANGIGKSTLLRTITGI
QKALSGHVILNEKDIRNYSPSALAQQLSIVLTESLPPSNLTVFELVALGRQPYTNWIGKL
TAYDREKIREAMELTQVSHLAHKKHYEISDGQLQKVLVARALAQGTPLIILDEPTTHLDL
LHKVSLLKLLKKLAVETQKCILFSTHDLDLALQLSDEMIVMIPEKTLQGTPEFLIRTGIL
NSLFKDENIIFDTEKAKFILKNL
>LONDMIMF_00148 Hemin transport system permease protein HmuU
MQQDNRNRILFTALLICLAVCFLLNISLGSVHIPVGDIASSLSGGQAGKNSWEIIIWNYR
LPKAITAILVGMGLSISGLLMQTLFRNPLAGPYVLGLSSGASLGVAFIILGSGLLPSFLS
VFFLSSYGIVLASCLGSLMVLLAVLVVSQRLRDTMAILIVGLMFGSFTSAIIGVLSYFST
AEELQKFTFWSLGSLGNLSWTNILILSVCCLIGLLLSALCIKPLNALLLGERYAKSLGIN
FKKTRLIIIIATSLLAGSITAFTGPIAFIGLAVPHISKMVFQTSSHYILFWGTLLFGAII
LLVCDTVSQMPGNDFTLPINAITSIVGAPIVVWLLVRKRKFMI
>LONDMIMF_00149 hypothetical protein
MKSFLSKYSLFLLLLFAVACKKNEPDSSGISEAKTQNSIRYAKGFEIYKYENFSIVKVSN
PWPEANKTFTYVLHKKGVSLPDSLKNYTSLQVPVKSIVVTSTTHIPSLEMLGVENTLLGF
PDTNLISSEKTRKLIDTGKVTEIGANQSLNTERLIDLDPDVLVGYSSGSDTKTYDNLQKS
GLKVFFNGDWMEESPLGKAEWIKFFGALYGMDEKADLLFTEVETAYKEATELAKKAKTKP
TVLSGAIYKEQWYMPRGNSWAASFLKDANAAYLWADSEGTGSLALSFETVMEKAENVDFW
IGPAQFTTFKEMVESNPNYAHFKAFKDKNIYSFSSKKGKTGGILYYELASNRPDLILKDL
IRILHPELLPDYELYIFEKLK
>LONDMIMF_00150 Vitamin B12 transporter BtuB
MDGKVNSKTQARRPAFLLNNYQTFGKKVSKIMIFRKLYLFLFFCICQSALAQYDSIHNLK
VVEISDLQLKDYSDSQSVLKLTDSIINKNQSSLTSLLNYNSVIYFKENGLGMVSSPSFRG
TTAQQTAVVWNGININSQLNGQTDFNTITTRDFNSIAVRAGGGSSIYGSSAIGGSIHLNN
TINFEEHFSNTLRLNYGSFNTYGGNYKIDASDGKFSVQVSLSRNSSDNDYDYVDADGKNL
NGQYYNTSLNAAIGYKINDANFLKLYSQVFEGERHFSLIFPSEIRTKYQDLNTRNLLEWD
SFFGQFVSKVKFAALSEKYKYFGNINSNAYTFGQVRTYIGKYDLAFDAGNAIKLNAVVDF
TQNKGEGSDIKNEQRNIGSASLLFKHKLTQKILYELSVRKELTNNYKSPFLFSLGTKWAA
SDFYTLKLNGSKNFRVPTFNDLYWQPGGNENLKPESSYQAEIGNEFRFAGFQLTLTGYYI
DIKDMLRWIPNGSVWSPQNTDKVRTYGGEALLTWSKNFGNHHLLFNGTYAYTVSEDMEKK
KQLIYVPYHKATSSLSYSWKKLAVDYQCLYNGEVFTRSDNNSRYNIDAYFVSNASVSYDF
GNKNSRIVGFQVLNLLNENYASVESRFLPGRNFNMYLTLNF
>LONDMIMF_00151 hypothetical protein
MLFASSLFLASCSSDDNSPNVSLGQYDNGVFVVNEGNSTITTSSITFISNSGAVEQDVFR
NVNPGAAELGTYLQPMFFDNTRAFIISGSANKITVVNRYTFEYIATISTNLQNPRFGAVA
NGKAYVTNAADWMTGTDDYLTVINLSDYSTSTKTLGVWSERIIEENNKLYITNGYAYGDA
TSVTVFNPATNNVEATIQLGFNPNSFEEEDGILYVLGSEKLAKINLATNMVVGTPITVAA
STSAGAKNLNVEDNKIYYTVDTAVYAMALNATVAPSAPLLTYESQSEYGRMYGFAVNDGK
IYIADGGDFSSDSKAYIYSTTGSLLSTITVGVGPNSFYFN
>LONDMIMF_00152 hypothetical protein
MKQLYGFLAASLLSFTALPVFGQSFNDGVFILNEGGAGSNNASVSFLSNTGNLQNNIYAT
VNPTVGALGDTAQNMAIHGDYAYIVLNISNTIKIVNSQTFQYVATINTGLNNPRYMAFSN
GKAYVTNWGSGGSTTDDYVAVINLSTNTIETNIALAEGVERILEINGKIYVAHQGGYGYG
NTVSVIDPTSNTLERTIQVGDVPNSMVEKDGILYVLCGGKPSWAGTETFGALVKINTETQ
TVIGQVDFPQKHPSNLKIDGSNVYYSINADVFKASIADTAVPATPFFTLPPQNQYGIYGM
EVINNKIYVGDAVNYVSDGKVYVYTTTDGTLSNTYTVGKLPNGFVKAVDSNLGTGEHTKQ
NIVLYPNPATDYLYVNTDKQATVKMYDMAGRLIKNQSYTTSGVGISELNPGMYVVEITID
NATSVQKIIKR
>LONDMIMF_00153 hypothetical protein
MKRILSLMSIMILSPVLGQSYAPEAGLAGSTAMEPNSPLFVAWATGVTVERGYVNKANPG
LVVSGSNRASAGVPQNALGPANGSVVCLGDEGSAILTFELPIINGPGFDFAVFENGGPSF
LELGFVEVSSDGIHFFRFPAHSQTQTATQIGTFGTPSAPYLNNLAGKYGSKGVPFDLTDI
PDNELLDKNKITHIKVIDVVGSIDPLYATYDSYGNAVNDSFPTPFNSGGFDLDAVGVIHQ
VTLGIGDTAKKKMMLYPNPASEKFYIQNLKETARITIYDLSGRIVFENNIQEAEAIPVSE
LNSGIYIVEIGTGTKKVNERLVVK
>LONDMIMF_00154 hypothetical protein
MKKTFIFTILLFIGISSFFACQDDLDDIEVPKELKINDFIWKGLNLYYYWQADVTDLSDS
RFANQGELNAYLNGFSSPEDLFYSLLNNYPNTDRFSVIFSDYTVLEGVLSGNTANNGVDY
QLLRKAEGSDEVFGWVRYIIPNSDASSKDIRRGDIFYAVNGTPLNVNNYRELLAGQNYTL
NLADYDSGNITPNSRSVALTKTELAENPILINKVLTYDTHKIGYLMYNGFYGEYDNNLNT
VFGQFRAEGVTDLVLDLRYNSGGAVKSATYLASMITGQFNGQVFAKQQWNAKIEDYFNDN
DPEQLINRFSNSIGGNAINSLNLTKVYILTSKSTASSSELVINGLKPYIEVVQIGDVTVG
KNVGSVTLYDSPSFGKQGRSNRHKYAMQPICFKIVNSAGFGEYQNGISPPTPQPENLGDL
GVLGEPTEPLLSMAISQITSVGRRRMQQPDKTFEPFKDRKSMQRFGTEMYIDKVPDGIKD
FFKF
>LONDMIMF_00155 ECF RNA polymerase sigma factor SigE
MNQSEFVKIITPFKDKVFRLAKRLLVSTEEAEDATQEVLVKLWDKKNGLDKYNSVEAFAM
TITKNYCLDQLKSKRAGNLQIVHNNYTDGQAGMQKQLEDRDSLGWVEKIIDGLPEQQRMI
VQFRDVEQYEFEEIAKMMDMNETAVRVALSRARKTIREFMTKTHNYGIG
>LONDMIMF_00156 hypothetical protein
MELDRIEILLEKYFEGETSIAEENELKAYFSSADVAQHLEHYKAMFGYFSSAKEQKFEQQ
IPLKSKKLQVAWLSVAASVVILLGMFTFYNRNISQSEDLGTYNDPEKAFEETQKALNLLS
KNVNVGVESMQYVNEYQQSKNLIFKN
>LONDMIMF_00157 hypothetical protein
MARFIITLALALVPTLFFGQSVFDKFDGQDDITSVVINKKAFEMLGEIKTDVKEKEVAKY
MKMANNIDNFRLFSTSSIKKAAEMKSTFDSYRKKEGLEELVRVNDDGKNVLIYMKSGKSS
SKVKELLMFIDAGDKKGDETVLISLIGDIDLASLDGLSK
>LONDMIMF_00158 hypothetical protein
MKKFLITAILAIMPLSFFAQSAFDKYDGLEGVTAVIVNKKMFEMMGNVKSNDKEAQQYMN
LVKKLDNLRVFVTSSPKVTSDMKLTSDKYLKSAALEELMRVNDGGKNIKIYVKSGGSSTR
VKELLMFIEGGGKDETVLMSLKGDFDLNDVSALTDNLPGGDALKKGLKGPKGPKGPKGPK
>LONDMIMF_00159 hypothetical protein
MKKLAIVAALCLMLWSCNSEPTLQQYFVKNSESKDFIALDLTTDILRLNKSEISAEENAA
LETLKKMNILAYQADAKNPAKFEAERAKIKNILKNEKYQELIKVNSGKEGGAVYFVGEED
KIDEFVLFANKNDAGFAIVRVLGKNMSPNSIMTMLSVLNKANLDIEQLKPLQKMIPN
>LONDMIMF_00160 hypothetical protein
MWLHLIVFVLTFCIMEFMAWFSHKYIMHGFLWKLHADHHKKDHDSWFERNDAFFIIYAVI
SIIFFLLWQNDILEIGLAIGLGIFVYGCAYFLVHDIFIHQRFKLFRNTDNPYARAVRRAH
KMHHKHIGKEDGECFGMLLVPFKYFRQEFRKK
>LONDMIMF_00161 15-cis-phytoene synthase
MKAIFDQISFDSSKCVTKAYSTSFSSAVKMLSPTIRQDIYNIYGFVRFADEIVDSFHDYD
KEKLFDSFEQDFYRALQDGISLNPILNSFQHTVRKYDIPVDLVKTFLESMRWDLTKTGCD
NKEEYHNYIYGSADVVGLMCLKVFVKGDASKYEELKQSAMRLGSAFQKVNFLRDLKDDFE
NLNRTYFPNANLEKLDEASKKQIIEEIEADFKDGYEGIIKLPIEAKLGVYTAYVYYKKLL
HKLKKTPSAKIRTTRIRVPDYEKLSLFARCYFNYKLNIL
>LONDMIMF_00162 Dehydrosqualene desaturase
MSKNIKIIGSGFSALAASCYLAKQGHSVTIYEKNATTGGRARQLIKDGFTFDMGPTWYWM
PDVFERFFADFGKKPLDYYELSKLSPAYKVYFGEKDSITIADNLDEIAATFENTEKGSSQ
KLKEFISEAQSNYDIAIKNLVYRPGVSPLEMITPETMMKVGQFFGNISKDVRKRFKNRKL
VQILEFPVLFLGAKPSDTPSFYSFMNFADFGLGTWHPKNGMYAVVEAMQKLAEELGVIIK
TDAVIDEIIVKDGIAEGLIVNGTKIEADIIVSGADYHHTETLLPQKYRVYTEEYWNKKTF
APSSLLFYVGFDKKIANVEHHTLFFDVNFDKHAEAIYDDPKWPEEPLFYASFPSKTDKNA
APDGKEAGIFLIPLAPGITDTEELRNVYFNKIMERFERITGQSIQNNVIFKESFCINDFV
KEYNSFKGNAYGLANTLLQTAFLRPKLKSKKVNNLYFTGQLTVPGPGVPPALISGKLVSE
LIQKNKS
>LONDMIMF_00163 HTH-type transcriptional repressor CarH
MNSSKSTFSIKDLENLSGIKAHTIRIWEKRYNILKPMRTVSNIRLYDTENLQKLLNITLL
HSHGYKISKISKFPPEKIPQLVSEIISDKNINSQVISSFKMAMMDFDQRLFNTTYENLLV
TKSFGEIFKELFIPLLNEIGMLWQTGTITPAHEHFISYLIRQKLLSNTEQLQLPDPSKNE
KIFVLYLPQNEIQELGLMYLNYEILSRGYQTIYLGQSIAIENLKGLATHFDTIVFLSYWT
TFPEADTIPEYLEKIQHEILSSGHSEFWVLGKMAHYIPTENLNQKISVFTTLQHALNKL
>LONDMIMF_00164 hypothetical protein
MKKTYILLILISASLLQTGCSSDFLDEPKPTNNVTPDVIFSNRAGVDAFIAGILRLNRGQ
FLNNEAAGLQSIYFARSVRGESLIQKQIWFGDDYDFQNREATYTRPNFTWRFSYRIIDQL
NNLIKGIESSSQLSEQDKRETKSQALALRGFYYFQLALEFGDAYQSPKNLQFPPIYTEPT
SEGKGMSTKAEFFGQILSDLETAVAGLSEERIDKSYINKQVAQAFLAQVYQYTGDWNNAK
ATAHEAYGGNTSAVLDAASYSKGFNDFNAREWLWALPQTADQSAYYMSHPHAMMDHVAVA
YHGTFINDDFVNLFSGTDVRNLFSNLYNAPVGDWQEFVTSKFKFTFDADIPVIRYPELIL
IEAEAEYHLGNESRARELLDAIRLNRDNQAQASTASGNALFELILTERRKEFYGENGIEW
FDAKRLLRGITRTGNHRTHINLTADDKRFELKIPQEEIDANLNITNSVNSNR
>LONDMIMF_00165 TonB-dependent receptor SusC
MKSKLSKILFGFLLLNALIAAAQEKEISGYVTDANSLSLPGVTIAVKNTTLGTQTDFDGK
FTIKATPEDILVFTFLGYKTREIKVGSQSHLTVQLLDESVGLDEIVIVAYGTQKQRAVVG
AIGKVSSEVLEKQQATSVISALQGSVPGVSVINSSGQPGESPTIRVRGIGSINASASPLI
IVDGVPFNGNINSISSDQIESMNVLKDAASTALYGSRGANGVIVIKTKSGKRNSLPQVSF
RVSSGISGDAVKTHEVLGTNDYVKYLWEARKNTYQYVQGQTPENAASNAASGLVSALGYN
PYNVSNIIDSNGQLNPNAQLNWETNWKDELFRNQSFRNEYNFNVSGGSENTTYFLSGNYL
NQDGLVKTSKFERSTFRLNVDTKVNDWLEVGSNVAYSASRQNFPVQSGTSFTSAMSWIYA
MPSVYPVYRRNPDGSLVSGNIFDYGNTTQLVNGVRPLMSGDNAVGSLYNDQNRNNRSNVN
LNGYAKFSLTDRLSFKTNLAYEDYNYDAKEYMNSVYGQASSVNGRVSREKTSTKTINFIN
ALRYDNNFGDHSVGVDVIYEAYQSKNDLFAASSTGFLPGVTVIGGGTTPESVDGYVLEDR
LNSFLGRVSYDFANKYFLEASYRRDGSSRFSQEVRWGNFYSVGASWIISDENFLKDSNVV
NLLKLRGSYGELGNNQTSSYFPYIQSFETGFSQLENPGVLLGDRVDKNLTWEKTASFNIG
LDFSLFNSRLEGSVDYYNKSSIDLLYNVPIPSSTGNTSVLTNAGSLRNYGLEVSLTSHNI
KTDNFSWDTNLNFSLDRNKITELTQDSFITGLNRWEVGRSLYDFYLRDYAGVDPNDGYAM
WYKDVVDANGNVTGKETTKNYDEATRYYNKSALPAIIGGITNSVQFKRFDVSALFNFSLG
SYVYDSDYAALMGGISRGRQSSPDIENRWTKPGDITNIPVLLNSTNNFAAASTRFLYKND
YVRLKALTLGYSLPIESIHKLKINQARIYLQADNLLTFQSHKGIDPEQSINGTTNFRSPL
SRTVTLGFNLNF
>LONDMIMF_00166 Leucine-responsive regulatory protein
MITLDATDRKLLLELQKDAKQSIKQLAEKVNLSITPVHERIKKLESAGVIQNYAAVIDPK
ALGKKLLVYCQVTLVRHQESLFEEFESYVLGLDEVLEASYIAGTYDFLLKLLLDDMEDYQ
NFAVHKISKLEIISNIKSAFVIRSIKESSVINCL
>LONDMIMF_00167 Arsenical resistance operon repressor
MMDNKKIEKISKALSDVSRIAILQQFKKKHDGVYCAEFNDMLDLTQPSVSHHLKQLVDAD
LLIPEKEGRNLKYSLNQKVLDEYIASLNNLKG
>LONDMIMF_00168 Purine efflux pump PbuE
MNKSIYIMALGAFGIITTEFGVIGILPTLAKEFQVSIDTAGWLLSAFALTVAVAGPFTTM
LTAKINRKTIMCAVLAVFVISNLLSVISPNFTMLMIARIVPAFLHPVFWAVSMSAAAKQA
GPKDAPKAISVVMAGLSVATVLGVPITTYMADLFDWRASFALAGIINLIAFIALALFVPS
MPVEEKLPTENQVKVLDKPQVWFKLFTSLIIVAGMFATYGYLAEYMDKISHMNGTEISIM
LLVFGVTGIVGNWLMGIALSKNVMLTNRLFLLSLIGIHLLAYQFGGTFVPMVIILSIWGF
IHTGGFLAANIHIINGVPEQALESVNGLMPSFFNAGITLGTLLGGFVIAQYGVHEVIWLS
VPLLLLAFGFTFITLEKKHKEVEQELEAEPVKVVSCE
>LONDMIMF_00169 hypothetical protein
MTSFSWAQRDSTYIRPYEHNFSVRTYLAVNFLSMEQQTGTEEYKKFMPNNPPNIGLGFSM
NNTIVNVSYGQGFNFMRDKEKGRTKALDLQIHNYGKKFTFDIFIQRYRGFYAEDESGNVL
ALYPDLKIRQYGAYGQYIFNNKKFSYRAAFNQNEKQLKSAGSFLIGGGVYFSKIESDSSF
VHKKRNSLHNFQFGVSGGYAYLWAINKKWFASISTTVGVNIGSEKFNTFGKEKIEVYPTL
FPRVALGYDTENWSAGLSFVSNTVFSAFSDNEHSNVSLFSGNFKLSYIRRFDSFDFLKKK
KKQID
>LONDMIMF_00170 hypothetical protein
MKALKKILLGISALIALSLIGGYFYFEKKFSPPQNYLTVSGLSEGIPMVWQGNDENPYGA
ILLPVRIDGIDKLFYMQLDLGSPVTIFYKNSLQSVKARFPDRIPEETEKAKIALDFSLRD
MKVSSKFFEVLDYGTKADFENPDAQNIIGTLGTDLLEKRIVTLDFKNSRCSFSKKREGSG
FERFEFKKRRILIPAVIGNENLKLMYDSGTSGYELIMNKDKWEKFRKGGEVKIDKGNSWG
KILTVMTASSHQKIRFGSKTLQLSEVTYIEGTSKAQNFLMKFSGMQGMIGNKLFLNRKMI
LDCRNQMYKIE
>LONDMIMF_00171 hypothetical protein
MFELDFFRYKPLNSILLMDQLKTRIKKFNEIIDRTFDDDEGESEYRIEQAETSSKEELKE
LSAFFDAEIPQELLAFYLQIGGIRNHAFDVYGLNIPPAYGLLKQLKAERRYEKRQSMGLI
DGIKHSWSNDRPEFSHIPESQINYINANYKCIGLHHYDWQFEEAFYIYFDKNHQFGLLRY
HQDKFDTLWQEHLTPLLTESQANQTLEQLLIQVLDRLEEGILNDFNGN
>LONDMIMF_00172 hypothetical protein
MEKQFLLLFLTAIIFFVSLLGRFFFLKMRTYLINKNPNKKTYRIKEHDKRNR
>LONDMIMF_00173 hypothetical protein
MNTKVINNYSRLKIPVFLLPFFLLILIVLFLYGQNALCINEYAEIQKNSFLFINRKLAPY
PNLLHNFTQFGDALVFLSLLGLFVLYAPKIWEAIISGSLVSLVFCSLLKNIFAVPRPAAV
FDNEGFTIIGKRLSGCTSLPSGHSITVFTVLTVLMFALMPKRLWYKMGWIFFLIIIGFGL
AFTRVGVGAHYPIDVIVGSIVGYICGLLGIFISRKYKILSWIGNKKYYHVILLLFLVSAI
LLITKIINENLIVFYLAFLSLVVSLYKIFTVYVKDKK
>LONDMIMF_00174 Phosphoethanolamine transferase EptA
MLKIKNNLKLAHFALLMSLLNFVFFHFPFYGYVFNNVDYKSGNGILLIVSLVVLMLVANA
FAFYLILYLSRPVGKFLLVLFFIISAVAVYFVNTYSVIIDESMIGNVLNTNYEESSSFFS
FKLVLYVIFLGIIPAVFIVKTKIASVPLKKFLTTLSLTLLFIVGMAFANASNWLWIDKNS
KQLGGLAMPWSYTVNTSLFYIHKYQKNKKEILLPDATIKDTEKSVVVLVIGESARKQNFS
LYGYARNTNPLLSKVENLSHFEATSCATYTTAGVKCILEHADTGKLYEILPNYLYRNRAE
VIWRTTNWGEPPVHIKNYQKRDALLPDCQGEGCGYDEVLLSGLKEQILASKKDKVLVVLH
TSTSHGPTYSKKYPSRFENFKPVCNSVELGNCSKDELINAYDNTIVYTDYILNGVIENLK
QLKEYKSSMIFVSDHGESLGEKNLYMHGMPMSIAPKEQYEIPFLVWVSDGSKQLKPNKSL
TQHHVFHSVLNFLGIQSPVYNEEMNIFQ
>LONDMIMF_00175 hypothetical protein
MNLLSDWIGSNQKSVKNEVCNKLKYSGDQKPLKKRGVTEKPYE
>LONDMIMF_00176 hypothetical protein
MKKRVFTLAVGALLCSTLFTSCYTYTTVVGKGAKGEQKVSKWNHYVIYGLAPVGVSDAKA
MAEGATDYTVTTKHSFINGLIAGLTFGIYTPTTTTVQK
>LONDMIMF_00177 hypothetical protein
MRKILFFLLLIIGLILTYKIGRIFICDYNRLTDYGLGYLTGLVIILLLIISITIWLGVKI
YRKRS
>LONDMIMF_00178 hypothetical protein
MEKNKASSFIFGIIAIILGSVLFKQFDFKTLKFEHTGLAVIYSITFLFSVYVLVRNYKNN
QKRQ
>LONDMIMF_00179 hypothetical protein
MNFTVMQSYRCTRQIHVQNIKITYYHNEKKNSTTSIINFFHL
>LONDMIMF_00180 hypothetical protein
MKRKILPLLLLTFSTFSYAQNCDCESNFNWVKKTFEENDAGFEYIISKKGRDAYELHSQM
YLEKAKQLPNDKECAIVIDKWVRFFRDGHIGIKYLKEPVQETNFTVENIPVNEKDFKKYL
SKKKTQDKYEGIWSFGSYVIAIKRRNNEYIGTILSSTNKNWKVGDVKTVFTENDGTLYLG
NKSPQKISKITTIGNTYLKLNTTILQKKYPDIKENATISKEIQWLDTAKPLFEKLNENTA
YLRIPDFEISEKKHIDSIIEKNKDIILATKNLIIDVRNNPGGSDASYSSLIPFLYTNPIR
TVGTLFYSTPLNNQRMLELSQNPDFDKESQEGFKKYYETLNASPGKFVDIFNKDVFIQTR
KEITRYPENIGIVINEKNGSTTEQFLLTAKQSKKVKLYGKTTRGMLDISNVNIIESPCKD
FELYYGLSRSYRIPDFAIDDIGLQPDYFIDGSVSEYNWIKFVDETLNSK
>LONDMIMF_00181 hypothetical protein
MDNEILFTERQRFRQWWLWFILLGINGLFLFGVIKQVVGGEPYGDKPMSNTGLIITMALT
VFLTFLFVSFRLETIIRKDGIYVRFFPFHLKFRHYAWETLTKCYVRQYAPIAEYGGWGLR
YGFMGKGKALNVSGNKGLQLEFTDNKKLLIGTNKPNELTEILKKLGQLKQ
>LONDMIMF_00182 Virulence protein
MIKFAYTILYVQDVTKAIEFYEDAFGFSRKFVSPENDYGELLVGETTLSFASTVLAKSNL
TDGFIESNLATRPFGIEIGFTTENIEETILKAVNAGATVVENPKTKPWGQIVAYIRDLDG
FLIEICTPMS
>LONDMIMF_00183 hypothetical protein
MNTHQHTAKPIVRITSEPQIIAADEPAFFVISVTENYKNIPLEEVHTMKMHLLLVNEELT
WFDHIHPEEQVDGTYYVSETFPSSGKYLLFMDYKPIDHPAAIAKHTIEVAGKYLYKRSES
DTKLASVIDGYTVILVNGKELKTNTGQSLQFSIEKDSILLEEKDMQPYLGANAHIVMIGK
ADKDFLHIHPMSDNRFPIYAETYIEKAGLYRMWVQFKIDGKIHTTDFTVEVSEGDETEGN
HNSHGAHH
>LONDMIMF_00184 Regulatory protein SdiA
MQNTYTKLNPTEQAYVKAYLEISKAFDRLTYKNIYIFDCIQRKIEYISNHRFFLHNHTPE
EIIGMGEKFFHTFIKMEDQPIVSQANKAGFAFYAELPESERKSYTLAYNFHLVDENQNTL
LVNHRLTPLLITNEGKIWKTLGMISLATNNSSGNITLTKDGDNSILKYDMEADQWIGHSK
IVLSEREIQILRFYAQGLTINGIASVLNLSADTIKFHRRNLLQKMEVNNINKALAYATAR
KLI
>LONDMIMF_00185 hypothetical protein
MKKIILSLSFLAGLVLVSCESADQPQDQNADNDNSLMRRQRQSSMFNYIQSTRIESDANC
ENNILIFPSWRHYWETIDRLDQMVDRDCEAFDSTVPNNISEERYDILADASGFDEDNVLR
RFETDLGFCSLRSKIESLETAWLDRQGDREWDANSDPDNHFIDDQAERTLLSPNAEVIVG
DDRRGYVYYKFLDDEGSRIEVLNNDRDAISQVSRGRIPTGNPNVVVVRPDKESDYNKCKN
KVTQIAYEVSGADRFKRKSKVRRAWGTNCLNNPCTSIFPSKVIAITKGYKKKNGKWRSRR
MLIAAGINGLGQNIPGLTYVDCIEERSIRLFEEKKKRKIRVVAKSTTNIAPIGTPRRYNF
SLQDNKLFSYHKRGNLIVNKDYYDMPGN
>LONDMIMF_00186 hypothetical protein
MKKIILSLSILVGLMAVSCERADLPQEQNADNDNSLMRRQRQSSMFNYIQSTRIDNGVNC
ENNILIFPSWNHYWETVDRLDQMVERDCDVFDSNLPNNISEDRYNTLADAAGFDEDNVLR
RFEEDLAFCSLRSKIESLERVWLSRQGDRGWDANADPDNHFIQDQAERALLSSNGEVIVN
DEKRGYVYYKFLNDKGNRIEVINNDLKAISQVSQGKIPTENPNVIVVTPGTTRASYGCRT
MLYEGSYEFSGLYAIKRNSRVEHPHWFSPSKIISKTRGYKKINGVWRPRRLLIAVGINGQ
SSNTSGTAYVNCNQERTLHLFKEKRRRVLSVKTTNPLFSLQYFGIRDNKLYSYHRLYNIT
VNKDFYDM
>LONDMIMF_00187 hypothetical protein
MKKVLFLFLVSSLTFLSCDSSDSSIEEKAISNEKEDSKLERRVLSTMTAGQLHNAYLDEM
YAYLRGRGNISASNIHVYSREFFSTFEYYNLALKRYRYTINTPNVRYDFSRQLNLEIENL
NRRLDNSDFRNLDEFKNFVSSYRPLYIRERNDLIAWQNYTDVFSYSVIYWSTNLERWTIL
INRNAIGLSERRCSEGKFFRRAWCKIKEYAKTDAAAYQEEKQKNPSASFEATVLAGAAAS
AAAFIKDLIPPSQS
>LONDMIMF_00188 putative MFS-type transporter EfpA
MTSTYTFAYTINCFQPTNYFRQLTINRQIKILTKINMETSTATAQSTPYSKRWAALFLLC
TAEFLVIMDTSIIGVALPAIKEDLGYSQTGLQWIFNAYVILFGGFLLLGGRLSDLFGARK
IFMWGFVILTAASLLAGMAWSESALNTGRALQGLGSAFIAPAALTLVISKFTDPKELNKA
LGFWGASAAAGGSAGVFLGGAITEWLSWHWIFLINIPIGIIVLLRSRSLLFTGDTRKGKV
DMAGAILATAALILMVYAIVASETSGWDSVQTIGLLIVSLALLFAFYLTQKHKSEPLVSM
SIFKVPNLSAGNIVMGLLAAAWIPLWFFLNLYLQQTLHYSAFNSGLALLPMTLAIMFLMV
GVTGKLVAKFGFKSNMIVGLLVLAASLFLFSIAPTNGNFVTHVLPASLLGAIGMSLTYIP
GTIASMSGAKPEETGLASGLVNTSYQVGSALGLAIIVTISAAKTNALKMAGEVETTALNS
GFQTAFFSAGVVCIVAALIAMAYIRTPKQ
>LONDMIMF_00189 hypothetical protein
MNRKLILFLVGSIAFLSCDSPDLLQEQDVKNGVSLTRKQRQSSMFSYIESIKIDNSIDCE
SNILIFPSWEKLWETADKLDEMIDDECNVFDATVPDSLTDEEYDILAYTAGFDEDNVLVK
FENDLGFCSLRKKVEVLENRWLELQGDGDWNINEDPDNHFIYDETERALFSINNEVIIGE
KKTGYVYYKLIDNFKWIEVHNWDLEAIIQVRRGFVPTNNPNIIVRKIKVNKDLQSSAECK
THIKKTQYYQNGTNRIKIKSKVINNDSWGAKKISALTVGYKKKNGKWKRARTRIAAGVTG
SDIANNSVLYQNCGVAFEKHKVKEKRRRRVKAKIRGQRFDGASLIIGIKPQKAYSYHKQG
SINLRLDYYDMY
>LONDMIMF_00190 hypothetical protein
MICTRIISVLIFILCIPTKIYSQTAEKLFGENLSKISLVLQPSLLKGYEVGAGYEGNSPG
ISFNKNFSAQFGFFYNFYQKNNFNFKAGVIVKTFKPTFNIKISNEDLNAGYNYSEYLSGF
EIANQFIFSQTVKTEYLIPMSNNLNFAVGLGMSLDIRTGGGGDDELSAVVFDYSKQKERI
FFNVNSTEQQVTGSLDVSLGVNYKTNIGLFQIEFFNNSQLLSYPKTGVYEFYLDKNQTKT
GVYTIKGNYNSLALIFTPRKGWLKRN
>LONDMIMF_00191 hypothetical protein
MAITILVTLVLFIAYSFYDLNKEKTFTKRQKVNWSFVLAILPLTGSMVYFICKTFIRNNR
HNFESRDCNLVR
>LONDMIMF_00192 hypothetical protein
MKNNVYGILAICLITVSCQQEDTTLENMQHKKIPTDSFFEKVIAENVTTQKEDNAFYIDY
LWDKENKTIEIIKVVEKELDFFPISERLLSKENPTNPDLIAPGKKYKITCTKGGKDIWTK
ECDGKFSCGSLIYDCLEDDGCSTICKNSMIYMPENNEFILIEL
>LONDMIMF_00193 hypothetical protein
MNNDRYKKAHLSPRSCPHPTARVIKMKLETKFRLTLYDYKYFTMKKASHILIITLLLFIG
SSPLFAQKKELSLQEALSMAKQGNKTLQVQVLEEKHAIEQTRESRGRLLPDISAGVAYSR
YFDRQNIFLPGSFAGTNKAVQEVAVGGRNAFNGFVSLYQPVLDIASYRLTKASKINEKIQ
TEKTEDLKSQVALWVSTRYLDILMMKRQLILLQQSHERNVRALKDSRALLAQGKGLKSDT
LRSFIAVENLKSSVSYLKNSIEVSGMELKRLIGMEDAQELELTDELESDIQANQTEFLTV
SKALEIAETNRNDLNVQELTLELQQQKLSAAKAALLPKLSLIGQYQIQAQADDLKLNDYV
WPRTSFLGLQVSIPILNGGQNKSRIGQARILAQQEQIRLKDLKEEVKTTLASIISKWKEA
TSQLEIQITTVQSAELNHQMTEDRFKNGLGSRLELTDAELALTQAKINYLQAIYNLRRLH
TELQYALGLLEL
>LONDMIMF_00194 Efflux pump membrane transporter BepE
MAGVFSLLIVILGIVGWKQLGIREFPLTEPPVISVITFYPGASPDVIASKLTRPMEESIA
EASGIRTISSESREQVSVISIEFNREIDIEDALNDVRDKVSKARKQLPADVDPPIVQKAS
SADNLVAFLEVESDTKDIKEVSHIASTVIKDRVQSIPGINNVAIVGEHKYAMRLRFDPVK
LAAYKLTPEDIRQALLRENIDLPSGRIDGNSSELSIRTLGRLTTVNDFEEMLIKQTGNTV
IRLKDVGSAELGEMNERTAIINETGNLNRVGVGVAIQIQRGANAIEVVDEFYKRLEQLRK
DIPSDYRLIVGFDFTQSVRESIKEVEETLFIAFGLVVIIIFLFLRDWRSTIIPVIAIPVS
ILSAFFIMYIAGFSINVLTLLGLVLAIGLVVDDAIVVLENIYKKIEEGMPPVQAAFKGSK
EIYFAVISTTITLPAVFLPIVFMGGISGQLFKEFAIVVSGSVLVSAFVALTLTPMLSAYF
LKKKQGPGWFHRVTEPFFVRMNNGYARLLTTFMRFRWMAWVFLLITSGLIYFVGQKLPSE
LAPVEDRSNMSLIAVAPEGVSFDYMKKHMMEVGKYVNDSTDGLYQTYSMVAISFIPAPAP
VNVAVQSIYLKDPKERKASIQDLYNQYGAASANFRGFLLFPYLPPTIGTRYGGGMPVQFV
LQSQNLDTLTAALPKFLNAVRQSKKLMFADADLKINKPEIKINIDRQKAALMGVSMEEVA
RTLQLALSGQRYGYFLRNDRQYEVIGQMEREYRNDITDLNSIYVRSSTGQLIPLNNLIAT
EEAVSPAAIYRYDQYTSATISAAPAPGVSLAEGIEEIERIKTEVLGDNFKTSLAGQSRDY
RESQGNILFTLILALVIIYMILAAQFESLRDPLTIMLTVPMAVTGAILSLHWFGQSLNVF
SQIGIITLVGLITKNGILIVEFANHLKDTGLSKYEAAIQAAEQRFRPILMTSLAMIFGAL
PIALTANSRQSLGIVIAGGLVFSGILTLFIIPAVYSYLSSNKRRKEVMEMDESEIATNHE
>LONDMIMF_00195 Multidrug resistance protein MdtA
MYRNHTHKLGILIPLVSILLTACQNKPKEAAAPAVANKLPVDIIVAQEKALDQREIFVGT
IMPLREVAIVSETAQKITKVAFQDGSYVSQGAVLYTLNDADIKSKLRQVQAELQLARLNK
DRMANLLKTETVKQSEYDEALMRFTSLEAQQDYLQTELAKTVIRAPFSGKIGISQVHLGA
YVSPGTPLVNLQDQSNIKINFTLPERYLPLLTNGTPIKFSTGLSEEYYNATVTATEPGLD
AQGRSLQVQATTSNNNGKLRAGQSVKVYFSTEQKGATGVMIPTEALMPGEKGYNAFVIKG
GMAKPVPVTISNRTETEAIITSGIKSGDSIIVSNMLRIGDGTPVQAVVKK
>LONDMIMF_00196 Melibiose operon regulatory protein
MLLLIKGMVCNRCVYVLEQEFNNLGFMEPDIQLGRVVLKTSGIQTSDLTIIRSMLIKNGF
DLLYSRNQIIVEKIKVLVENGINIQLTTNTALKFSAYISDKLNKNYDTLSAIFSSIEGNT
LEKHIILQKIEKVKELLVYTDQSLSDIAFALGYSSPSHLSNQLKKYTGFTSSYYKQIRQD
KIIIQKQASKN
>LONDMIMF_00197 hypothetical protein
MKKFLKIIKFTFIGILSICLLLLSCFFISNKLFLGSKNEDNISYLEKNKTQITDSINDEL
FDDDFYKSQVFLLGEIHGYADNQKLDKELLFFLNKKAGVKYYIAEMDSLTAKKLNSFLKD
SSKNQAKLKEVVVDIKQRIPQQSSQELFDKWNEIYDYNQKLADSLKITIIGIDKNFDDDS
KVSRDAAMVVNFKNSIKKMKLENEKFYGLFGYFHVLQSKTENGKETFASGLKKSGIKTAS
FVSYTIDSEMYLPENPQFPTPEDEKIDWVNADGPLQLVKGIKDLKELSKPNTITLFKIDS
PNSPYFKSQHLINVKSRIFGENIVPEEGTFTTDYFQYVFLLRNSRALTKLK
>LONDMIMF_00198 hypothetical protein
MKKLLLLLLLISSSVFSQEKYLELKNNETGKVRKITENKKVKIITNDNSYYIGRVQIVDS
ATVKIKENYIKLEDIDVISRKSVGKTIVGNSLVVLGWVALTGSAVAIIALEPVLAIVAFS
TGLTVGITGKILLSNTNKNYHREKWTYKIIYL
>LONDMIMF_00199 CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase
MKNQIPKILIFSRLVIGFLIVIVSYINIQNYKPIAVSLLTIGLLTDIFDGIIARKLNIST
QLLRRLDSTIDQIFFICVALATYIQCPEFFENNILLVSILIGTEILTYAVSFFKFKKEIA
THSLGAKFWTLLLFGTLIQVIVECQSVYLFQMCFWVGMITRIEIIGIILTLKEWTNDVPS
LYHAVQLRKGRAIKRRKLFNG
>LONDMIMF_00200 HTH-type transcriptional regulator ChbR
MTKIKRITPTDFRGQYMTEMSADFAILRTPIQIHDIAKTSGFIKVPTPLHRPEFNFIVHI
TKGTAKQQVDADLVSIKENEILFVRQGNVTSLMEVSQDAAGHMVLFEDQTLNQLLSKQEL
IKLFSVNVVIGLPEKSSTWLTSLFELLSIEIYQPNPNLGICYSLFQAGLQKIFTSSKELN
KNINRSAEITFNFKELVYKYYLDHKPISFYAAELSVSENYLHRCIKETIGDSPKEWINKV
SILQSHLLLQDLTKSISEVAFDLNYGDPSYFGRLFKKITGVTPSEYRIAFMQDLSE
>LONDMIMF_00201 hypothetical protein
MKTLIVTKNSDRSTTLSIISPCKYKVMDKGPCLYVFAFLSLFFSNKSHGQIIQDISGIAI
TSHTKATFKDQPSESLNPKNKFQLNTYDAWLPVPPIKIGKTTIFSNLNYRLMDFNYENNT
DDPNRIEKIQEIKSTIIIRRPISGKWSVLAIALPTLAAEKKISFDDVILDGIFGVSKKFG
AESNLEIGLGVHAMYSFGETLITPAVSFDYRSTNNKWLARFYWPRLNVLYNASENTQIGL
AGSIDWTRFNLKNYRGYNGKEVDYAQFSTIHAGLQLHQHLIGGVWLQVQGGMGLLNRYEL
FDTNQKSVNDFSVSGMAYGKATLTYRIGRR
>LONDMIMF_00202 hypothetical protein
MKTTILTTLVLCASFFAKAQQVKLNINITNIQPGKGIVIMNVYDKKEDFLKTAFLTKALK
ADSSNLTFVVDLPKEGPYAVTVFQDIDNNKKLKQDWFGIPQEPVGYGNNFKPSAKPRFNE
CAITIDADQITQTIKLY
>LONDMIMF_00203 hypothetical protein
MNAMKNTNHLPSAFSLRSLVLAAIPSYVFPALMSFLSGYFLQKTELMAASYTTIGLSSLL
STILSFMMLWQFELKQILVQNKWVRTLLVILLMVSLGVFCTSIFNLPSECFNITFSAFLG
AAIITIRQKVKNYKDEKN
>LONDMIMF_00204 NAD(P)H azoreductase
MKKIKPTIVVFGCTGTVGTEVMRQLNGRDCIARGVLRNPERPYPVQIGNDSSNITYVSAD
LNSMEQLKKACAGADALFLLTATSPQQVQHEINIIDAAKQSGIKRIVKLSAPIVQAAAHV
EVSQWHSKIDDYLIQNMEEFCCLRPHSFMQNWERNTFTIQYFGKIYGALGNVGRNYIDCR
DVATVAVNYLLATEEVKLRSVILAGPEAITNAEMAEKLSRITDRKIEYVDITPGELFSQL
TKKAKLPKWLANHIVELDNLAIKVPEPETDTVTNLILRKPYIMEEYLQEHRHLFKRKPLW
KLLF
>LONDMIMF_00207 Shikimate kinase
MIKIVLLGYMGSGKSTIAHLLSEKTQIEAFDLDGIIEERAGLSIKNIFEQKGEVFFRKLE
NQIFKELISSEKEMILSLGGGTPCYANNHELLNGDGVVSFYLKASIETLYGRLLSVRDNR
PLIAEQEGEEMKEYIAKHLFDRSYYYNQATHIVSVDGKSPEEVSAEIKRILA
>LONDMIMF_00208 Bifunctional protein pyrR
MSKNIILNNQEIEHKILRIAYQIYETFVDEEEIVIAGIAKNGYVFAEKIAQKVTQISPLK
VALCEVFIDKQNPHNEVTTSLGKNQYENKGLVLVDDVLNSGTTLAYGVKHFLDVPLKKFK
TAVLVDRNHKKYPVKADFKGISLSTSLQEHVQVVFEAQEDYAYLS
>LONDMIMF_00209 hypothetical protein
MVTEACKKNHITVNGQVAKPSKEVFATDKITFRKDQITHTITVLDIPQNRVGAKLVDIYR
KDETPIEAFQHLELLKLSKEHYRKHGEGRPTKKDRRDIDDFNLDFENDEDETDY
>LONDMIMF_00210 Peptidyl-prolyl cis-trans isomerase Mip
MTRIKLFLIAIVSSTVLFSCKKDDDSSKVAPPRDRATQYASDIQDIETYLKTHYLTVTMD
ANNNPVPTIIQIPEGGTQVSIWDQQDYPLKTKMVRNDGRTYTNADPIVGKPINDPVEYKL
YYIKLREGVGQSPTRVDSTLVTYRGNALDGTQFDYRPNPVWFSQESVVSGWRNIMTEFKS
GNAVDDPSNPGGTLLTDYGVGIVFVPSGLGYFNGAPAGSGLSSYSPLVFTINLHMVKYAD
NDGDGILSYLEDLNGNGDYYDDDTDGDGIPNFLDVDDDGDRTKTRTEIKDAFGNIYPFDL
IPNCSGTTGGLKKHLDPSCH
>LONDMIMF_00211 1-deoxy-D-xylulose-5-phosphate synthase
MKKYINTGNKDTRSGFGAGLTELGQKNENVVALCADLIGSLKMDDFKKNHPERFFQVGIA
EANMIGIAAGMTIGGKIPFTGTFANFSTGRVYDQIRQSVAYSDKNVKICASHAGLTLGED
GATHQILEDIGLMKMLPGMTVINTCDYNQTKAATIAIAEHHGPVYLRFGRPSVPNFTPEN
GTFEIGKAVLLNEGTDVTIVATGHLVWEALVAAEALEAKGISAEVINIHTIKPLDEEAIL
KSLAKTKCVVTAEEHNILGGLGESVARVLALNNPAPQEFVAVNDSFGESGTPDQLMQKYK
LNNQAIVEAAERAIKRK
>LONDMIMF_00212 Transketolase
MKPNTQQLNNLTIQVRRDILRMVHAVNSGHPGGSLGCAEFLVALYQNLMDRKPGFDMDGK
NEDIFFLSNGHISPVFYSVLARSGYFPVSELATFRHINSRLQGHPTTHEGLPGIRMASGS
LGQGMSVAIGAALTKKLNKDSHLVYSLHGDGELQEGQNWEAMMYASAYKVDNYIAAIDLN
GKQIDGPTDEVLNMGSIRAKFEAFGWDVLDIEKGNDIEAIIAGMTDAKSRTGKGKPVCVL
LHTEMGNGVDYMMYSHAWHGKAPNDEQLANALAQNYCEGESDY
>LONDMIMF_00213 Photosystem I assembly protein Ycf3
MKTQLMAELLAIFLISRPFLTVFHELGHAIPVILMTGERATIFLGSYGDTDKSFRLAIGK
LEIWIKYNLFKWRGGLCVPHASNISINKKIIYTLTGPLASLFIALISCYIAFTFRLKDFL
SFLFLIFLLLSIFDFLKNIIPSNQSITLHDGKIGHNDGTSLVRLFRHKKYPKQYFDAIDL
YNNKQYTEAATVFDTILSNGLKDQDTYRWAIYCHLLIKNYRKAKSYFDEFRKRFQMNSED
YSNLGLIYTHYENHEKAMKLYGISLKLNPMNSYSLNNKGYTLNILEKYEEAITFFDKALE
IDKSFAYSYNNRGFSKIKLGRMEEGLHDLNQSYELDPYNPYYFRNLGIYYQERGDYQKAL
ELFLESKSLDNYTYNIDALIIETRKYVNQKAY
>LONDMIMF_00214 Queuine tRNA-ribosyltransferase
MPPKVWDKEKRMKFELLQNDPNSKARAGKITTDHGVIETPIFMPVGTVASVKGVHQRELK
NDINPDIILGNTYHLYLRPQTDILEKAGGLHKFMNWDRNILTDSGGYQVYSLSSNRKIKE
EGVKFKSHIDGSYHVFTPENVMEIQRTIGADIIMAFDECTPYPCDYRYAQRSMHMTHRWL
DRCISHLDKVPYKYGYEQTFFPIVQGSTYKDLRQQSAEYIANAGAEGNAIGGLSVGEPAE
EMYAMTEVVTEILPKDKPRYLMGVGTPINILENIALGIDMFDCVMPTRNARNGMLFTAHG
TINIKNKKWESDFSPLDEMGHTFVDTEYTKAYLRHLFAANEYLGKQIATIHNLGFYMWLV
REARKHILAGDFRVWKEMMVKQMDQRL
>LONDMIMF_00215 Lipopolysaccharide export system permease protein LptG
MKIIDKYILKRYLATFFVMLFLFIPIGIVIDVSEKVNKIIQNKVPFGKVALYYVDFTVYF
ANLLFPIFLFLSVIWFTSKLANNTEIIAILSSGISFQRFLRPYLIGATIVSVFALLMGFF
IVPKASQGFNDFRYTYLKGNNKTRETTNVYREISPGEFIYVSNFNINSKTAFDFSLKKFN
DNKLNFAINASRIRFNPEDSTYTMYNYTKRKVGELDDRLETAVKKDTVFKFDLEDLTPVI
YIAETLTLGELNDFIDKERERGSSNINTYLVVLYKKYSLPVSAFILTIIAVAVSSMKRRG
GMGMNLAIGIGLAFTFIFFDKIFGTLAEKSSIPPFIAVWLPNFVFGILAIYLLRNAKR
>LONDMIMF_00216 hypothetical protein
MQKDNNLKSYLNLHLIVFIWGFTAILGELITIKEAPVVWYRMLLAGIFMLIYVLVTKKPW
RIPGKSFFHLISVGLIIALHWIFFFKAINVSNVSITLAVFSTGAFFASIMEPIFFNRKML
WYEVFFGLIIIGGLLMIMQVETHYVLGMVYALISVFLGVTFTLFNGKLIQKYDPSVITLY
EFFAGVFFVSLYLLYDGQFTAEFFSVSQHDWILLLVLSSVCTAYAFTASVNVMKKLTPYT
VMLTTNMEPVYGIMLAYIILGDKEKMSPAFYIGAVIILATVILNGILKNYTAKKSLLADK
QSNS
>LONDMIMF_00217 Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha
MEYLDFELPIKELEDQLDKCQVIGQESDVDVSNTCKQIEKKLEETKKNIYKNLTAWQRVQ
LSRHPNRPYTMDHVHALCGDTFLELFGDRSFKDDKAMIGGLGKIGGQSFMIVGQQKGYNT
KTRQYRNFGMANPEGYRKALRLMKMAEKFGIPVITLVDTPGAYPGLEAEERGQGEAIARN
ILEMIRLKVPIITVIVGEGASGGALGIGVGDKVYMLENTWYSVISPESCSSILWRSWEFK
EQAAEALKLTSFDMKKQKLIDDIIPEPLGGAHYDRETTFKSVEKYILKGYNELKDLSTAE
LVAQRMDKYSKMGEFKE
>LONDMIMF_00218 Replicative DNA helicase
MENLRNINPVRVDKTTIINLEKGKLPPQAVELEEAVLGAMMIDKKGVDEVIDILQPDAFY
KEAHKYIFEAIVQLFNDSQPIDLLTVSAQLKKNAKLDLSGGDFYLIQLTQKISSSAHIEF
HSRIILQKFIQRSLIKISSEIIEESYDETTDVFDLLDKAESKLYEVTQGNIKRSSETAQS
LVIQAKKRIEEIANKEGLSGVATGFEKLDKVTSGWQPSDLIIIAARPGMGKTAFVLSMAR
NIAIDFNHAVAVFSLEMSSVQLITRLISSETGLSSEKLRTGKLEKHEWEQLSIKVKNLEK
APLYIDDTPSLSIFDLRAKARRLASQYGIKLIIIDYLQLMTAGGGGKGGGNREQEISTIS
RNLKALAKELNVPVIALSQLSRAVETRGSSKRPLLSDLRESGAIEQDADIVSFIYRPEYY
KIDEWDDDEHSPTEGQAEFIIAKHRNGSLENVRLKFIGSLGKFDNLDEFGGGFDDLPSKM
NMQDAPFLTKNLPSANEAFGSNMNNVDDDSDVPF
>LONDMIMF_00219 hypothetical protein
MLKKTAFLFLFFLLSVPSWASFILLPMDETTQKNHLKAYGITYWSLDKQYKVSWLLNYRG
GSFLLPDAPEIRKECQIRGVSFELLSDSQANQILDEISSPSQNMETVVLEKAPKIAVYTP
KGKQPWDDAVTLVLTYAEIPFTPVYDEEVLADGLLLYDWLHLHHEDFTGQYGKFYGAYRN
APWYIEQKKEAEALAKKLGYSKVSDEKLAVAKKIRDFVIGGGFMFAMCSATDSFDIALAA
DGVDICEPMFDGDESEANYQAKIKYENSFAFKDYILERNPIIYEFSDIDMTMKRNVLPEK
DYFTLMEYSAKWDPIPSMLCQNHTQLVKGFMGQTTSFDSNRIKSSVLVMGENKVNNEARY
IHGTKGKGMFTYFGGHDPEDYQHRVGDAPTVLDLHPNSPGYRLILNNVLFPAARKKKLKT
>LONDMIMF_00220 Thermolabile glutaminase
MNYQKILQEVYIEAKSLPQIGNVAQTIPQLSKVNPDKFGIHLTTIKGQDFGIGDSNEKFS
IQSVSKALTVALAFSFMGEEIWKRVGVEPSGTAFNSLVQLEFEKGIPRNPFINAGALVIA
DMLVSHLKHPKEDFLAFIRTISGTQEIDFNLKVAQSEKETGYRNAALANFLKSFGNIEND
VETVLDFYFHQCSIEMTCKELAHSFYFFANEGKTMDGKQILSKSNVKRLNALMQTCGFYD
ESGEFTYKVGLPGKSGIGGGIAALFPKHFTIVTWSPRLNEKGNSELGMNALELFTTKTGM
SVF
>LONDMIMF_00221 hypothetical protein
MNKTTLLFFLLSFSIYAQDSDWSWAKGYENLNAGTITGSFMDNQKNIYQIGSFSSTSVTI
GETVIANSSEAPVNPNVKYMDAYISKHDSEGNLLFVKHFTGSKFENLTSIAYDNNNSFYV
TGHYNGNITIGNSTYEATDNMTKSFLAKLDLNGNVIWSKPLNFSGSTLLKFKDNNLYMAG
IHSGDTYSIDNLTTPSVGYTAVVNNMDKIFVAKLDLSGNAIWLKSSTYTGTASISDFHRL
GTQIKGLAIDNLGNVYVAGVIFSRSSTFGSITITKTVTNNNSNLFITKYDNAGNVAWANT
APTNSSANSVVSDLATDSNNNIYLLGYIYSSATNFGGVSLNFPSNYGSFLVKYATNGSVL
WAKSGKLATDAQPSTGLGYNFFDRMYIDSTNNVYVTGVFANYINFGNNITFQTNNWTPNL
FSIKYDSSGNASDYYKITEAIISRYPIILDITGDVFYYSGQVSDSNFVLGNTTISNPTTN
PFTFIAKRDKRLSIEEHSGNNFTIYPNPSQEQIYVSGLDSAENKIFSVFDITGKKIKSLE
FTNNDTIAIDVKDLASGTYVLKIENGTIQKNIKFVKN
>LONDMIMF_00222 Cyanophycin synthetase
MKILKIQALRGPNIWSVRRKKLIQMRLDLEEMEQYPTNKIDGFKERIEAMFPTMYEHRCS
EGVPGGFFMRIERGTWMGHVIEHIALEIQTLAGMETGFGRTRETKTPGVYNVVFSYTEEN
VGLFAAESAVAIAESLIAGTDYDLEADIQKMREIRERDRLGPSTGSIVEEAVARDIPWIR
LGTNSLVQLGYGINQMRFQATITCKTSSIAVDIACNKEETKRMLDNASIPVAKGSICVDE
EDLQNTIDKIGYPIVIKPLDGNHGKGASINVTNYEDAKAGLAYAQKYSRRVIVEKFITGF
DFRVLVIDNKVVAAAQRVPAHVKGNGTNTIEQLIEIENQDPRRGYGHENVLTEITVDRDT
TDLLEKMNYTLETVPRKGEIVYLKSTANLSTGGTSVDVTDMMHPENIFLSERISRVIGLD
ICGIDIMAENLTQPLNENGGVILEVNAAPGFRMHLAPSEGLPRNVASPVIDMLYPPGKPS
RIPIIAVTGTNGKTTTTRLLAHIVKNNGYKVGFTTSDGIYIQNHMLEKGDTTGPISTEYI
LKDPTVEFAVLETARGGILRSGLGFSRCDIGIITNISADHLGLSDIDTLSDLARVKKVVV
RSVKKDGWAILNADDEECVKIASELECNVAYFSMDEENPLIKKLGKEGRIVAVYENGYIT
IKKGDWKIRVEKAAHIPLTLGGKAKFMIANVLAATLASYLWGFKTEDISLSLQTFIPSVA
QTPGRMNIFEFKKFKVMIDFAHNPSGYMAIEDLLNNIEASRKIGIIAGVGDRRDEDIKEC
GMIAGRMFDHIIIRQEKHLRGRTEEEIINLILEGIEESGRDITYEIIPKETEAIKHAINS
ADEGTFITALSDVVTNAIEIVQQYLDKENEDGLI
>LONDMIMF_00223 Cyanophycinase
MIIGGAVDKGSFTEASFDANPANNLNFFETGILKRLLTESKHKEKSRIEVITTASKIPRE
VGPEYVKALQYLNATNVDVLHIEKREQATDPEILKRLRDADVVMFTGGDQLRLTSILGGT
EFHDILLDKYKNEDFVYAGTSAGAAAASNNMIYQGSSSEALLKGEVKITSGLGLIDDVII
DTHFVQRGRIGRLFQAVVGNPKVLGVGLGEDTGLLIIDDKMEAIGSGLVILVDGHQIKDT
NLTQVELGQPISINNLIVHVMSKYDTYDLKTNKMHIQSSQYV
>LONDMIMF_00224 Isoaspartyl peptidase/L-asparaginase
MKIIIHGGFFSESSTSQETKVAKQNALLRIVKDSYEFLKTHSALETVVYAVSLLEDDELF
NAGIGSQIQSDGKIRMSASLMDGSTHKMSGVINIEEVKNPIRVARILQNYDDKVLGGSGA
TNFARKHGFEVFSTEIPQRRTEYEAKVKATGTGTVGCVALDGEGKIAVATSTGGKGFEMP
GRISDSATVAGNYANEFCGVSLTGVGEDIVSGAVAAKIVTRVTDGFSLKQAFEKTFKELK
PFDGFAGAIAIDKDGTICHQDSHPSMVFASYDGTTEEVFQ
>LONDMIMF_00225 ATP-dependent dethiobiotin synthetase BioD
MGRFINPFTDFGFKFLFGREVEKELLIDFLNDLLVGEHVITDIQFLNSEQQPEVKTERGL
IYDIYCVTDTGERIIVEMQNREQPYFKDRALFYLSRAITQQAKRGVWNFQLDAVYGVFFM
NFVMDKDMPSKIRTDIVLSDRDTGKLFSNKFRQIFIELPNFDKEEDECSNDFERWIYVLK
HMDTLDRMPFKARKAVFEKLEEIADVASMSPKERELYDNSVKVYRDYLVTMDAAEKEGIT
IELEKIKEPKTKNSLVIEGAGGVFVPLNEKDTVIDLIQKDYKVVVVSRHYLGSINHTLLT
IAALRDKKLDIAGIVFNGNENKATEEIILSKTGLKCIGRIEDEPYFDKNVIREYADLFAN
NLKAL
>LONDMIMF_00226 Adenosylmethionine-8-amino-7-oxononanoate aminotransferase
MTLSERDQQHNWHPYTQHKLAKPAIAITRGEGALLWDENGKEYIDAIASWWVNPYGHSNR
FIADAIHKQLTSLEHVLFGGFTHEPAVLLSEKLMEILPDNQKKIFYSDNGSTAVEVALKV
ALQYFYNKGEKRTKIIAFENAFHGDTFAAMAASGISFFTEAFRGSLIEVVRIPVPVKGKE
QESFKALEKLVKTNEYAAFIFEPLVQGAAGMVMYETFALDKLMAICRENSVFTIADEVMT
GFGKTGQNFACNYLENAPDMMCLSKALTGGTIPMAITTFTQELFDGFYNDDVNKALFHGH
TFTANPTGCAAALASLELLQSKEMQDNIRRVHQKHTEFQKKISSHLRVKETRTLGVIFAL
EIKTETSESYYGDFRNKLYDFFINQGIVLRPVGNIVYILPPYIISDKQLEKVYAVVEEAL
EIV
>LONDMIMF_00227 3-oxoacyl-[acyl-carrier-protein] synthase 2
MSQKIAITSLSSISPLGNSPEQIWQNYLNGATSISEYPIGNTKALAAMLPGYLKNEIAKL
RDSESKYKNLDESVLYAILASRKAIENAGWKQGDDFGINIGSSRGATQLFEKHFQEFLET
GKTHTLASPTTTLGNISSWIAHDLNSKGPEISHSITCSTALHAVLNGIAWLRSGMADKFL
VGGSEAPLTPFTIAQMNALKIYSKSQDEFPCRAFDREKNQNSMVLGEGASVACLETGERQ
NALAYIEGVGYATEILEHSISISAEAQCFQKSMAMALGTTAIKDVDVIVMHAPGTIKGDS
SELKAIELLFGDHLPMLTTNKWKIGHTFGASGMLSIEMALLMMQHQKFIAVPFAENQKEK
KAIRKVLVNAVGFGGNAVSILLAKP
>LONDMIMF_00228 hypothetical protein
MKKLFLLFVFLLPLFGFSQTTLVRWDGANKTASPYIIASNISAGNITGSNVDFMVDNWNN
NGNAFNTAQWPSGTTPDYSKYVQVSISANSGNKIDLNQFNFEYQNYDSNGPSRMQVYYSK
DASFPSNGTVLTTNNSLVTTNTNFNAVSVPLTGITVQSGETVYIRITFYGRTNGWSGPRI
RIRHGYNDSAPSSHNASGPTITGTVTTACTPQGNPSVSPNGLWNGYVYSYSGTPAATTYL
GYVTENETFDRNVGSGAVAGQTTVLCQQPTDNFYTVYKMTKTFPAGTYTFTVGGDDGYRL
KINGESGYSISDWTDHGYTSGSTTKTFATSTTVNFVLEYYEKNGDSQVSFSYTCGNSPTA
PTTLTSNATNNTICAGNSVTLTAGGGSVNTSTYEWGTGTTVGSNVISGTGASITVSPSTT
TTYWVRRKGAAPCNFTTTGLTLQITVAAPTATAPTSITGVTTLCAGGSTTLTANGGSGST
YEWGTGTVIGSNVISGSGASITVSPAATTTYWVRRINSTPCSTPTSGVTVAVNVTTPSGD
PTAFGNNAWNVYGYNVGSMTPALANYAGYYTQNTLGLNTQDMANNGWNNETSPSYSAGWT
GCPVRVDDFTMVHKRKGFPCGKYQLSMDNWDDETRVYVNGTVVFYNSGWSGSNPTPTVVG
TYALDSNSTIEVVTREVGGYANVKLSLTAINATYNGTSWSTSPEGASIVIDGDLQLNSNL
NVCSCKVNPNKTLKVNPGVNLLVQNEVVVAPTANFIVENNASLIQVNDNASNSGKVTVRR
NTTPVTRYDFTYWSSPVAAADWTLRDLSPNTLADKYLSYNAAGNGWVTEMNGAAAMQTGK
GYIVRAPQQYSLTAPVIFETKFIGAPNNGVKKIEAKVGTTLKSNLIGNPYPSAISADKFY
EANKGTIKGTFYFWTHNIAVSSTPDANGVYNYNPASYISYNATGATGNGDTSNCTTCGNN
PSNKFKGNIASGQGFFVEAKNSGDIVFNNAMRVTETTGNGQFYRSNPNAIQSSENGNGEE
ETVIEKNRLWLNITNAAGAYNEILVGYVTGATNSMDDDYDGITYASGTALYSLLDANKLV
IQGRSLPFSTADVVPLGYMAATAGDYSIGIESVDGLFENQKVFLVDRLTGTVHNIKNDRY
YFSTTAGTFNSRFEIRYVNEALGIDTPKVNANDIIVYKKGDQIAIKADNFTIDTVQVLDL
TGKEIFFKKGVNNNEFTTTGINVGTQVVVAKITLDDNQTVSKKVIMN
>LONDMIMF_00229 Regulatory protein RecX
MRQKPEQKNYTPEEITKKAEIYCAYQERCHEEILQKLRTLTSSQSIIDTVIVHLIENNYL
NEERFACSFARGKHRIKHWGRLRIINELKARNISKYNIETALKEIADEYLDTFHSSTEKF
WDTILEKNSLKKRKKFCDFFLRKGFESNLIYEKAIELEKLN
>LONDMIMF_00230 hypothetical protein
MKHFYFLFFPFLCMAQAPVIEWQKSLGGTGNDYANSVHQTADGGYIVAGYTSSNDGDVSG
NHGGDDIWVVKLTATGALAWSKTFGGSGNDIANYVQQTADLGYVIAGTTYSNDGDITRNQ
GNSDAWVIKLDNAGIIQWQKTFGGAHIDAATSIRQMADGSYIVGCYTLSENTGDVLGNRG
GADYWIVKLTSSGNIEWSRCLGGQSSEYMRAVQPTVDGGYIMGGYTSSIDGDVSGNHGNV
DYWVVKLDNIQEIQWKKTYGGTGTDILTSLVQTTDGGYIVAGHVYSQDGDIAGSGFHGPL
YDDYWVVKLSSTGAIQWKKALGGYGNDLAQSVQQTADGGYIVFGYVTSNDGDVSGNNGYM
NYWIVKLSSQGVIQWQKALGGSNQEGFNPIPYATDGAHSIQQTTDLGYILAGYSKSNDGD
VSGNHGGFDYWVVKLANPLATDDFLSESISVYPNPASERIFVHTGASSQLSQLSLYDLLG
QHIRTTKENSISVSGLSQGVYLLQIKTDKGEVTKKMVVE
>LONDMIMF_00231 hypothetical protein
MRPTAKILFVCLFFVIVTSCDPPHYIDFVNNTKSNAKVKLNIDNKTESHGLRSIATGDSI
VFNLKPKDTASIHFGIGTWSTDEIDAVANSIKNIKIETENITTIYKTKSSIKNILENNKD
GFFTHLRIEIQIK
>LONDMIMF_00232 hypothetical protein
MPLHLTEIERVKTISKEDFYTNYVKKQKPLVIEKLTEDWPAYEKWKLNYIKEIAGDKTVP
LYDDRPVTHKDGFNEAHAKMKMADYIDLLQTKPTNYRIFLYNLMKEVPSLKSDFKWPDIG
LKLVKQLPMLFFGGENSKVFIHYDIDYSNILHFHFHGKKQCILFAPDQTPYLYKVPHALI
SREDIDFDNPDLEKWPALKKAKGLICNLEHGEMLYMPEGYWHYMKYVTPGFSMSLRAFPR
KISNLGKAVYNIFIMRNFDNLMRKWKGQAWIDYKNEQAIVRTHKNLKISN
>LONDMIMF_00233 Ycf48-like protein
MKKITIALLLLLSYASQAQISYEASTNFGKLEDLTYDATVPNKIYGRTQGNHIIVSVDNG
ATWSVKYSFPNPTAQLRDIKPYGQTGLSFSIINSGTQDGVYLFDLATNAITHFYAIPNPQ
DNAQVVSYSFYDTAGTDLIIHTSYLEGLIARTKVFHTKSSGALWNLIYFSPDHDDVHIDN
VAFSPVNSSKIYMGRSLGPNGINGGLLISENNGTTWTEKLPGFTFSAIAFNPLNSNDMLI
GTSIGFGIHPERIYRSTDAGETWTIIPITWTDQTLNNITKIVFHPTNPNHIIALEENEIA
KTNDGGLTWTNIPYPEGSTSYYYGLNASYNPSNPNQIAIATDLFPQFSNDGGTTLTQIKA
PFYNVVSISHAKYQSEKHLYYGSQGGRLRKNLTTGVTSIHDIEPPTSFNPKRNYMVADPV
VAGRVFTYASMGFFGSTLNMSTDYGASTTVLMDAFADDMQELIVDPNNSNIIYVSLRTGE
GGNLYKINFTNPEEIITDEITTPETSEFGYGVVTGISVSATNPNEIFIAKSSKVFKSTDG
GLTWVEKINGLTIDHEADLIWDMARNPLDANHFTAITSSGIYSTSDAGENWTAILDGVNA
KRIKYSPVNNGVMVASVHSALNIDAAIYYTTDGGANWTYVSPQQLNYIQSGAMDYDFDGT
TINAYIATTDLGVMKYQILNLQLGIHNPETASNPVFIYPNPANDILNVGVSGNQFEIKNT
AIYSITGQKVMESTSNTINISKLSSGVYIVNSTTQNDKQFSQKLIKN
>LONDMIMF_00234 hypothetical protein
MHKKARYVKSVCLSFLLCLLFTSKLQAQATAHCDSLIVSGIDYMWKKDHVKSLELLTQAK
NQAEKNRWYRQLFLATNNIGANYYTMLDYGEALNHYLESYTIAVKHLDPKSEMVVLNNIA
ILYSKEKNYEKANEYFKKAYNIAQENKDTLKVGLYAMNLGNVANETNELKKARAYFNESL
PLLGSQPQLQILAKMAIAENENLQGNSKQARTIAQELYRTTKDLEYNDIGISLLTIISKS
YLNENNLDLASDYANKVFERKPNLETKINIFRLLSDINFKKEKYALALNYRDSIIKTESE
LNEIKNGKVFENSRVKFEIENYKKEIANNESKIAEERKLFYSIIAVIFIVVVFLVWTLRN
ISIKHKQKKLIAERNEQIVLLELEKEKSDNLLLEKMFKEKETSALLEQEKLKNEIELKNR
KLSAKALYLSGRNELIEETLQSLSKLPEISKDPALVNHIQNLKGHLKTDDEWDSFITHFE
EVNQTFLNSLKEKHPKLNSNDIRFITYIYMNLSTKEISSMLNITADACRKRKERIAARME
LPHDINLYDYLSTL
>LONDMIMF_00235 Biotin synthase
MSIIRHNWTKEEIIAVYNKPMMDLLYEAASIHRMNHDPNVVQVSTLLSIKTGGCPEDCGY
CPQAARYHTGVEGNDLMSVQQVKAQALRAKSSGSSRVCMGAAWRNVKDGPEFDQVLEMVR
TINKLDMEVCCTLGMLTENQAQRLAEAGLYAYNHNLDTSEEYYKEVISTRGYEDRLQTIE
NVRKTNVTVCSGGIIGMGESIEDRAGMLVALASLSPQPESVPINALVAVEGTPLEEEKPV
EIWEMIRMVATTRIVMPHTQVRLSAGRTNMSREGQALCFFAGANSIFAGDKLLTTPNPDV
NEDMKMFEMLGLNPQKPFTKVSQPKTVEAVDSQFESLGEKPRWSRPEHKIERNLVASGKK
A
>LONDMIMF_00236 hypothetical protein
MKVSRLVTNGVIIFIGLGLYFLLIEALDLKDHIYLRLVNFIFVIYGVNKTIKSNYHDGIN
GYLTNLLSGFITAMVGLILGLIAFMIYVEYRGGNTYLESFADSYIFGGGDPSLYQFCFGL
FIEGSAASMIVSFAMMQYWKDKVEKINKVD
>LONDMIMF_00237 hypothetical protein
MKKLFLPIDNSPLIIFRIFFGFLLAAETFGAILTGWVKENFIKPQFTFSHIGMEWLQPLP
GYGMYFYFATMGVLGILVMLGWKYKWSLSAFTVLWTLTYWMQKTSYNNHYYMLVLVCLIM
IFLPANRYASLDAKQNPEIKSLTMPQWCSLVMILQVAIVYFFATVSKFYPDWLDGTFTKN
LLANKSSYPFIRNIFNQKWFYLFIAYSGILFDMLIVPMLLWKKTRTLAFIASLLFHLFNA
ITLQIGIFPFFALSFAVFFYPPEKIRALFFKKKPKPEGNEPIYQNKSILFYFFIPYFLIQ
IALPVRHWFIKGDVLWTEEGHRLSWRMMLRSRTGYSTYKVIDKKTGERLPYSLYSSLTDK
QIAMVADKPDAIWQMAQRIKKVFAKQGKDVSVFVDCHVSINGKPYKQLIDPTVDLAAAKW
DYFGHNDWILLYDENNKPVKSASLN
>LONDMIMF_00238 Riboflavin biosynthesis protein RibF
MNIFHNIKDFKPNRNTVATLGTFDGVHLGHKKIIERLTQEAEKSNTESLVLTFFPHPRMV
LQGNSVIQLLNTIQEKAELLESIGLQNLIIHPFDESFSQLSAEEFVKTILVDQFQIKKII
IGHDHRFGKNRSADINDLIAYGKIYDFEVEQISAQEIDEVSISSTKIRKALLSGDIQLAN
EYLGYNYFITGTVVKGRQLGRTIGFPTANLKIEEEYKLIPLNGVYIVKSYWNGKEIFGMM
NIGTNPTVDGKERTIETNFLDLEEDLYGKEMRIYFLQRIRSEEKFDSIDTLKAAIENDKI
ITQSFIKSLK
>LONDMIMF_00239 Calcium-dependent protease
MKKLLPLIVFVLMFSAGYSQSLPLWTKTSAEKLSVLEKADRSSMPQKFQIYHLDFSGLKS
QLQMAPSREAGEVSNVIIAFPNAEGKLENYRIYESSVMAPELAKAHPEIQSYIGQGIDDP
TAKIHLTTTIFGLHTMTLSGRGTFYIDPYTKDVKNYIVYDKSDLTAPRNFECHVQDSATN
SEEFIGTPPPASDGRFRTYRLAMACTIEYAAFHVNAAVTAGTLSPTATTAQKKAAVLAAM
NVTMARVNSVYERDMSLRMQLVANNESIIFIDSDNFNNNNAGQLINQSQTQITNIIGNAN
FDIGHTVSTGGGGLAGLGVVCLTGQKAAGITGSDAPVGDPYDIDYVAHEMGHQFGAEHTF
NGVGGSCTTVNGSDPGTRAPGQAVEPGSGSTIMGYAGICGAVNVQSNSDDYFHAVSIAQM
VAHITGSGNCVPGVANGNTPPVIAALTNYTIPKGTAFVLKGNGTDANGDALTYCWEQTNP
GASTASPSSTTTTSNPNFRSVRPSTSPNRYMPSLSNVLNGNLTSAWEMIPSVARTMNFAL
TVRDNRAPNGGQTARQNMTVTFDGNSGPFAVTSQNTDGISWTQGQTQTVNWNVAGTTAAP
INTSNVNILLSTDGGLTYPITLAANTPNDGSEAITVPNVAAPFCRIMVEAVGNIYYAINS
KSFAIGYTVTNTCNTYTTNTAFAIPDNNQNFTVRATSIPTTANISDVNVAVNISHTYLAD
LQVVLVNPAQTLVPLFLNACDGVTTSLNATFDDQGTNVTCGAVITGNILPAEPLSVYNGT
NPQGNWLFAVRDLAAQDTGTVNSFSITICSQTAVLSAENFGLADFKIYPNPNNGTFNIQF
NSDSSNEIKVGVHDIRGREIFNQSYQNTGLFSQSLQLSNAQSGIYLVTVQDGDKKEVKKI
VIQ
>LONDMIMF_00240 hypothetical protein
MKKYILLPLIGLVIACCSTKTSKTMANNSKKTKIESPCPEEGICSFEILQNKSMNVKTDG
IDKVYYELEENPDKVVFLYKYQKKIADKTLQDAGYSEEIVFEMDKNYTDFSFSDKGIQST
KMLFGVFCYCKGKAGYYRVTKGNLVKKGSELQIDMPPIVDNQLITHIKINL
>LONDMIMF_00241 Peptidyl-tRNA hydrolase
MKNWIFNIFSKKQKTTDSDPMKKFLIVGLGNIGAEYVNTRHNIGFKVVDHLARKESLDFQ
TVKLGAMAEYKLKGRTLFLLKPNTYMNLSGKAVKYWMDKENIPASNILVITDDLNLSFGT
IRIKPKGSDGGHNGLKSIQQTLNSSDYPRFRFGISDDFKKGRQVDYVLGEWNEEETAKLP
ERLDVAAEIIRSFALSGLDITMNTFNGK
>LONDMIMF_00242 General stress protein CTC
MFCTIKGSERESVGKSATKALRNAGMVPCVLYGGDQPVHFSAEEKAFKNLIYTPNAHTVV
IELEGGKTFNAVLQDTQVHPVSDKILHLDFFQLHDDKEITMEVPVRVTGVSPGVLLGGVL
RLNQRRLKVKALPKNLPDFVDADISGLEMGNKLYVTKLVADNYKLLHPDNTVVAQVRISR
AAMKAAQEAAKAAKAPAKGKKK
>LONDMIMF_00243 Ribose-phosphate pyrophosphokinase
MSHQEPEAKIFACSQSVYLAEQIAKSYGVELGKVTFSKYSDGEFQPSFEESIRGLRVFLV
CSTFPSADNLMELLLMIDAAKRASARHITAVIPYFGWARQDRKDKPRVPIGAKLVAKLLE
AAGATRIMTMDLHADQIQGFFEKPVDHLFASTIFLPYVKSLNLENLTIASPDMGGSKRAY
AYSKFLESDVVICYKQRKAANVIESMELIGEVKGRNIILVDDMIDTGGTLAKAADLMIEK
GALSVRAICTHAILSGNAYEKIENSQLSELIVTDSIPLKKESKKIRVVSCAPLFAEVMQM
VQHNNSISGKFLM
>LONDMIMF_00245 LexA repressor
MPLDRKHKAQKLTFFKPDLQSELKISYVSQGVSAGFPSPALDFLETTIDLNKALIEDPET
TFYIKAEGHSMIDAGINDKDILIVDRSLEPADKKIAICFIDGEFTVKRLKLEKDGLYLMP
ENQAYKPIKISEENNFMIWGIVTYVIKKI
>LONDMIMF_00246 DNA polymerase IV 1
MYALVDCNNFYASCERVFQPQYNGKPVVVLSNNDGCIISRSDEAKALGVPMGAPEFKVRE
MLRQHNVKVFSSNYALYGDMSRRAMNILNRFTPYVEIYSIDEAFLNFEGMSIPDYDNYGK
QIKDTLLKGLSLPVCIGFAPTKALSKVANKIARKYPERTNGVYVIDTEEKRIKALRWTKI
EDVWGIGYRMKKKMKAKNILTAYDFTEPFHESWVKKEMGVTGLRLRKELLGESVLGIEEP
ANKKSIAITRSFPKQLTEFDALRERVSTFASVCAEKLRAQDSCCHTVVVMLATMEHKTPA
TKQYYHNAVTLPFGTDSTLTINQAAIRILEKLYEEHKGERFQKAGVIVTQLINTNEKQLH
LFEEENPKHHLLMKAIDKINTKIGDRKVKLGSQDSKTWNMKQNMLSPKYTTRWDQILVAK
CH
>LONDMIMF_00247 NADH-quinone oxidoreductase subunit N
MYTLIAIAVLGVLCLLAEIFNVRKAIVPVTIIGLLAILGLTVTGLNDSADTYNNMIVSDN
FSTPFSCLFIVLTVFLIALTPSFHEKQIHKISDFVSIKLFLLTGAVAMVAFGNLAMFFLG
IEILSISLYVLAASNRLSLKSNEAGMKYFLMGAFASGFILFGIALIYGAIGSFDMAVIQE
AGTSADVEDWFYIGAILLSIGMLFKIAAVPFHFWAPDVYEGSPALTTALMSTLAKVVAMA
AFFKLVSAMNVNLPDSSQTALMLISILSMTIGNIMALRQNNVKRMLAYSGISHAGFMLMT
LLAVSTSAGILLYYASAYALAGIAAFSVLLYVTKDKDNEDIFNFNGLGKTNPLLAAVLTG
ALLSMAGIPIFSGFFAKVFLFGQMLNAGHVILVIVAVVNSIISVGYYFKLILAMYTKDAT
EAAKPVPFVYSAVATVAILLNIAIGLYPSFLLDLLV
>LONDMIMF_00248 NADH-quinone oxidoreductase subunit M
MDVSLLLIILLVGAIATFLSGDKWASKIALLFSLAAFGASIYLLNLYNAGQDINFIKPWI
TIPKIYIALGADGLSMALIVLTTALTPLIIFSSFGNTYAKSKNFYALILFMVFAMVGTFL
SADGFLYYIFWELSLIPIYFIALIWGNGNPQSRKKAVVKFFIYTFAGSLFMLVSFIYLYQ
KAGSFMLSDLIKAQLSTQEQFWIFLGFFLAYAIKIPLIPFHTWQAKVYQKAPAVGTMLLS
GIMLKMALYSIIRWQLPIAPQAAKEYLFYLVGLSVAGVIYGSIVALKQKDIKKLLAYSSL
AHVGLIAAGCYTMTLDGLRGATLQMIAHGFGVVGLFFAAEIISRRYATGKISQMGGIRIQ
APKFTSMFMILVLASVALPGTFNFVGEFELLYSLAQRSVTVCIIGGTTIILGAFYMLRMF
QKVMLGDKNEKFFADINFNEGVVMVIIIGVLVFFGLYPKPIIDLITPSLEEVVKIINRI
>LONDMIMF_00249 NADH-quinone oxidoreductase subunit L
METSLLLFLLLAPFAGFLFNVFFGKKVSRNVSGTIGTIAVAVSFGIALNFFFQINSTKQP
ILIDLFHWMTLGNFDVSFSFLLDQLSVLWLLFVTGIGTLIHIYSISYMHDDENLHKFFAY
LNLFIFFMITLVTGSNLLIMFIGWEGVGLCSYLLIGFWYKNQDYNDAAKKAFIMNRIGDL
GFLIGIFTLGYLFSSVDFTTIKAIVASGRTVDLGWLAFGTLCLFIGASGKSAQIPLYTWL
PDAMAGPTPVSALIHAATMVTAGIFMITRLNFIFDLTPTIQMVIAIIGAITSLVAAFIAL
VQNDIKKVLAYSTVSQLGLMFLALGLGAYEIAVFHVITHAFFKACLFLGSGSVIHAMHGE
QDMRKMGGLRKYMKVTYITFLIATLAISGIPIFAGFFSKDEILMVAFHENKALWVIASLA
SIMTAFYMFRLLYLTFFKEFRGTEEQKHHLHESPGLITFPLIVLAILSTVGGFISFPGHS
WLNEYLKPIFIGAREEHHLDSTTFILMGVAVVGALIGIGIAYSNYIKKSQVPAEDNEITG
FSKVLYNKFYVDEIYMAVIVKPIYAIASFSKNFIETALSGFIFGLGKVTNMVGTQGRVLQ
NGSVGFYLFVFVIGTASIIAYLFLAQ
>LONDMIMF_00250 NADH-quinone oxidoreductase subunit 11
MQNVLQEIGINNYIYLSTILFCIGIFGVLFRRNAIVMFMSIEIMLNAVNLLLVVFSTYHQ
DAAGQVFVFFSMAVAAAEVAVGLAILVGIYRNIHSIDIDKLKNLKG
>LONDMIMF_00251 NADH-quinone oxidoreductase subunit J
MLTTVFYILSAITLATAFLTIFSRNPIHSAIYLVICFFSIAGHYLLFNAQFLAVVHIIVY
SGAIMILLLFTIMLMNLNKEDEKHKSGLTILAAVASFCLVAFVLLAAFIKSMPIIEEYYV
SGEDYQSIKVLGQVLLDEKNGFMIPFEFASVLLLVSMIGAVLLSKKEEKISL
>LONDMIMF_00252 NADH-quinone oxidoreductase subunit 9
MSIETISLSGRKKEVSNKKMNFWESLYLVAIVKGLLITIKHLFTRKVTIKYPEQVRPMSP
VYRGQHMLMRDEEGRERCTACGLCALSCPAEAITMKAEERKPDEKHLYREEKYASIYEIN
MLRCIFCGLCEEACPKQAIYLTTSKKIVKANYERDEFIYGKDKLVMPLEQALNNTKLKTA
N
>LONDMIMF_00253 NADH-quinone oxidoreductase subunit H
MDSTIIIEKGVFIVIIFAITMLMAMYSTLAERKIAAWLQDRIGPNRAGKGGVLQPLADGL
KLFSKEEFLPNTPNKFLFVVGPAISMSVALMTSAVIPWGDKLHLFGRDIVLQATDIDVAI
LYVFGVLSVGVYGIMIGGWASNNKFSLMSAMRAASQMISYEIAMGLSIIALLMMEGTLSL
REISANQSGMHWNVFYQPLGFIIFLVCSFAETNRTPFDLAECEAELIGGYHTEYSSMRMG
FYLFAEYASMFISSTILAVLYFGGYNYPGMEWAVENWGVNPANIIGIVVLFIKICFFIFF
FMWVRWTIPRFRYDQLMRLGWKALIPLAIANIIVTAVVMLLVQ
>LONDMIMF_00254 NADH-quinone oxidoreductase chain 3
MKVTIDGQTIEVEPGTTILQAARMIGGESVPPTMCYYSKLKGSGGKCRACLVEVSKGSDA
NPTPMPKLVASCVTGVMDGMEVNSIKSERVTDARKAVTEFLLINHPLDCPVCDQAGECDL
QNLSFKHGKSQTRYIEEKRTFEPEDIGPNIQLHMNRCILCYRCVMVADQLTDNRVHGVVD
RGDHSNISTCISKAIDNEFSGNMIDVCPVGALTDKTFRFKSRVWFNKPFNAHRNCDKCCG
KTTVWMFGNEIQRVTGRKDEFHEVEEFICNECRFDHKNVEDWVIEGPRKFEKDSVINQNN
YTRKLDTVVIETEKGILKGREQDRRKISMAAVPLRKEEEQEFKEGNI
>LONDMIMF_00255 NADH-quinone oxidoreductase subunit 1
MSKKILLEKASIPGIKTYEVYRQNGGYASVEKALKSMTPDEVVEEVKASGLRGRGGAGFP
TGLKWSFIDKKSGKPRHLVCNADESEPGTFKDRFLMEYIPHLLIEGMITSSYALEANLSY
IYIRGEYMWVYKILERAIKEAYAAGWLGKNILGTGYNLDLYVHCGGGAYICGEETALIES
LEGKRGNPRIKPPFPAVSGLWSNPTVVNNVESIAAVPWIVNNTGAEYAKIGIGRSTGTKL
ISASGHIKNPGVYEIELGLSVDEFMNSDEYLGGMIDDRPLKAFVPGGSSVPVLPANLIYK
TANGEDRLMTYESLSDGGFATGSMLGSGGFIVYNDTACIVRNTWNFSRFYHHESCGQCSP
CREGTGWLEKVLHRIENGHGREEDIDLLWSIQSKIEGNTICPLGDAAAWPVAAAIRHFRD
EFEYHVRFPEKIKNRDHFVNEPFEKVRHLVGKQTV
>LONDMIMF_00256 NADH-quinone oxidoreductase subunit 2
MERLHIKQEINITEALMERINELLSHYPADKKKSALLPVLHDVQDAHDNWLSVELMDKVA
EILEIKPIEVYEVVSFYTMFNQRPVGKYMFEFCQTSPCCLRGVENLMDYTCDKLGVKVGE
PTADGMFEVRGVECLGACGYAPMMQLGDFFQENLTKDKIDQLIADCRDNKVILHDK
>LONDMIMF_00257 NADH-quinone oxidoreductase subunit 4
MSDLLLPPELRYADIIKQRQNEDGSELSILNLGPTHPATHGIFQNILLMDGERIVEGEGT
VGYIHRAFEKIAENRPFYQITPLTDRMNYCSSPINNMGWWMTLEKALNIEVPKRVQYLRV
IIMELARIADHIICNSVLGVDTGALTGFLYVFQFREKIYEIYEEICGARLTTNMGRIGGF
EREWSPAAFRKINEFLEEFPPVWEQFEKLLTRNRIFMDRTINVGPISAERAMSYGFTGPN
LRATGVDYDIRVMQPYSSYEDFEFNVPVGKSGDTYDRFCVRNAEVWESISIIKQALAKMP
EGPYHADVPDYYLPPKEDVYTTMEALIYHFKIVMGEIPVPVTEVYHPVEGGNGELGFYLI
TDGSRTPYRLHFRRPCFIYYQAFNEMVKGQMLSDAIATLSSLNVIAGELDA
>LONDMIMF_00258 NADH-quinone oxidoreductase subunit C
MALETSDIQNKLVDNFELIVRDFSQQHDIFSFEVDSTSILEVMQFLRDDKTLRFNFLTDV
CGIHYPDAEADRQFAVVYHMHNWVDNVRIRIKCFLNGENPEIDSVTSLFLGANWQERETY
DFFGIIFKGHPQLKRILNMDEMVSFPMRKEFPLEDGGRTDKDDRFFGRTTDNC
>LONDMIMF_00259 NADH-quinone oxidoreductase subunit B
MSDSKINMVETPEGYEGTGFFATKLDTVVGLARANSLWPLPFATSCCGIEFMATMGSHYD
VARFGSERMSFSPRQADMLLVMGTIAKKMAPILRQVYEQMAEPKWVIAVGACASSGGIFD
TYSVLQGIDKVIPVDVYVPGCPPRPEQILDGVMRLQDLVKSESVRRRSSPEYQELLASYN
IS
>LONDMIMF_00260 NAD(P)H-quinone oxidoreductase subunit 3
MSTDQTSYFPILMQFLLATGFVVMTIIGSSFLGPRRKSVNKDKNFECGIESVGNARIPFS
VKYFLVAILFVLFDVEVIFMYPWAVNFKEMGWAGLAKMAIFMFLLVVGFYYVMKKKGLEW
E
>LONDMIMF_00261 Cold shock protein CspV
MRTGTVKFFNESKGYGFIVDEETGKDIFVHASGIKAEELREGDRVSYEEEEGRKGKVAAQ
VAVLQN
>LONDMIMF_00262 hypothetical protein
MIRSVLWVAFLFFATASSASVNGSDPEFNAIFKEMQKELKKINAYYAPKIREKELRIQDI
SAKIYDTKETASKIDFLIQKDLLKEEILSLKKEEMQDLSKIRYLKGLQIIRLLYEKVLSL
DHHFASVRTFSEINKISNPNQYPEYEKLKEIVKSRKDRKAGFDLTSILGTNTIVSVVQTF
SNLMVSSLSKDEKDKEIANIECILDFTLRMQNELNTIYFETAFLQKSNEKIRTDIETLFK
EYTKPIGYANTLESCRTSDDWESVKQKTNDYLANLKTQQGPQLYSSQVNIIFPIDRLLQF
ITQYNSFIDQGGKFYEKFKIILNSYENEKQCETKLPLEYKKLKDDIDVAISKFNMAYRPV
EVNGSKMKEILYGINEFE
>LONDMIMF_00263 hypothetical protein
MKKILYLPALLFSGISLAQSGSSPGISIDDNGLGKQFPDCLLSGSICKLFPTNQDPKSSN
ANAYKTGESSFCIGIKKTAMTEDKQVALLGKALKNVNPGDAITFRIPASYTVEHDFLKAI
NLSTAKDIVATGSYPVEINSEYVLIKLTLSGN
>LONDMIMF_00264 hypothetical protein
MKLPNNIPLFFIIVINIVNLFFIIELSNYDEMISYVKNEGEKITSTKKTTTIFLFTALIN
LLFVSIVFMRSLIFSHKTKSR
>LONDMIMF_00265 hypothetical protein
MKNLFFSLMAIAMFSFNANANEIKENTIAISGVENSTNSEDLTSARARLTLEIDFGRRSR
DCNGFGVCRMVLTLEINFFAVTTNDRGNLVLEANSRGLEVVRSFFGSNTITVEEDYVVPA
EITKPLGLAPGYTIRAGKYTLAADRSGNFVTTM
>LONDMIMF_00266 hypothetical protein
MFSISANANEIKENTIATTAIDKIENTTDLENLTQPKATTSIKITWGRKSKGCRGFGICR
IVITIDVQFKASVNDRGNFVLEANSEGLESVRSHFGSNTITVEEDYPLEAEVARQLGLQG
DYTIRAGRYTLQPNGDGNFVTTM
>LONDMIMF_00267 hypothetical protein
MKKLLSLSLFLSLSFLSCSTDEDIEMNGTQTGTSAINHKKENPHNWSPQNTANSYDHAGV
LYRQILEQYYANASTNITPSQIIFDIESIANNFSEFDPMKNNNYSPIAYNNINWILSTDE
SYHTAISTNSSLSVTAKNQLEDLASTLKQMIDNEATAKNIHDYIVGFETLISSNTVLTAN
DKKTILTSSSIARHANYLRKKGRRWDIHHGITGSIYGCNENMAKAITTAASINVIGNTVN
E
>LONDMIMF_00268 hypothetical protein
MENKFGIFLILFLMLSIPVFSQQKGFSLPDSLKNKSYDYLNNRIDLYEEDTLKALFYLDS
YLSKAKKENNLNEIVNAYSNTIFFVSDSLKPIYADSIVASAKMTNNAPIIGSAYISKGNF
YYSIKDYVQALNFYLKASDYISRSNDDYLKYELKYHIAGIKIHLGFNDEALALLKECVDF
FKKSNEYDYQRGYLNSLHSLGLVYNRLGKYDLSTETNEFALKEAKRLNVELTQNYIIHSE
GINQYFKKNYPKAIHDIQQVLPAIIKNNDFANEAVGYFYIGKCYWDQGQQEKALPYFKKV
DRAFAEKNYIRPDLRENYELLVGYYKEKGDVKNQLYYINRLMKADSVLNANFKYMSGKIH
KEYDTKALRQAKQEIEKQLAGKEKTTLLLYFSLAVFFFLTLYFFYRYYSNQKLYRQKFEE
LMGAEKEESQAIAVEKEEAEKKGLDINPDVVAGIVKELEKFESRKKFLEKDLTLVNLASA
FNTNANYLSKVINHYRNKNYNTYLNDLRIDYIVELLKSQPRYRNYTIKALADEAGFSTPQ
HFSKAFFASTGIYPSYFLNELNKDLNN
>LONDMIMF_00269 Aspartate--tRNA ligase
MYRSHNCGELNASHINTEVTLAGWVQKTRDKGFMIWVDLRDRYGITQLIFDSERTDAAVF
EMAKTLGREFVIQVKGTVIERESKNKNMSTGDIEILVSELSLLNAALTPPFTIEDETDGG
EDIRMKYRYLDIRRNPVKNSLLFRHKVTMEVRKYLSDLDFCEVETPYLIKSTPEGARDFV
VPSRMNEGQFYALPQSPQTFKQLLMVGGMDKYFQIVKCFRDEDLRADRQPEFTQIDCEMA
FVEQEDILNVFEGLTRHLLKEIKGIEVDKFPRITYDYAMKTYGNDKPDIRFGMEFGELNE
VAQHKEFAVFNNAELVVGIAAPGCASYTRKEIDNLIDWVKRPQIGATGMVYAKYELDGSI
KSSVDKFYDQDDLQNWAKATGAKPGDLILVLSGPANKTRTQLSALRMELATRLGLRNPEV
FAPLWVVDFPLLEFDEESGRYHAMHHPFTSPKPEDIALLETEPGNVRANAYDMVLNGNEI
GGGSIRIHDKATQQLMFKYLGFTEEEARNQFGFLMDAFQFGAPPHGGLAFGLDRLVAILG
GQETIRDFIAFPKNNSGRDVMIDAPSAIDDKQLEELHIRLK
>LONDMIMF_00270 hypothetical protein
MKKCLIMAVMLVSGVVFAQKADHKYEVVDNMVKATYFYDNGKVMQEGFYKDGKVHGKWIS
YDEAGNKKSLGEYNNGAKTGKWFFWTDNNLSEVDYSDSRVAAVKNWKQDALANRN
>LONDMIMF_00271 hypothetical protein
MKKIMALSLFVLMLSCTSDKTETVTVKNKYSVELPSFLSEAKGLHDMASLQYQNAFKEFY
IVIIDEPKEEFANAAKVTTEFTPDFNGYYQILRGSLEASIKNGVFTDTKDTQINGLKAKT
FTLTGKVDEIPVFYDIAYVEGNDRFYQIVIWTIESSKEKFKEPMDKIIASFKEIGSGKSS
DRSLK
>LONDMIMF_00272 Multidrug resistance protein MdtC
MKIAEISIKRPTLVIVLFIILTLGGLFSYSQLSYELIPKFEINVVTISTVYPGASPGEVE
NTVTKKIEDAVSSLENVKKVESKSIESLSIVMVTLEPEADADYSLNDAQRKINAIEKDLP
EDVDPPSLTKFSLSDLPVITIGATAKMDEVAFYDLLDKKIQPILSRVKGVAQVNLVGGEE
REIQVSLDQNKLKGYGISVPQVQQMILSSNLDFPTGNIQTRETTMLVRLAGKYKNVEEMR
NLVISSKNGIQIRLGDVADVQDSQKEVEKIARVNSNNAIVLQVIKQTDANAVTVSEEIYA
AIAKIEKDYEKQELKLKVANDTSEFTLAAADSVIHDLFLAVFLVAFVMLFFLHSIRNAFI
VMVSIPASLIATFIGIYMMGYTLNLMSLLGLSLVVGILVDDAIVVLENIYRHMEMGKNKV
RAAFDGTAEIGFTVTAITLVIVVVFLPIAMSTGLVANIITQFCVTVIIATLLSLLSSFTI
VPWLSSRYGKLEHITDRTFFGRIILAFERGLDKFTHKVTDILKWSLKYKKTTLGIVAAVF
LLSTFGLLGGGFIGGEFFPKIDRGQFLVQIELPKDASIEQSNFIAQKAEDYLRHKKEIEE
IVTTVGQTSEGFGATQATVYKAEIDVKLIDKSLREDGTYIYAAKMKRELEKILVGAKIKT
VPVSIMGGADEAPIFLTVTGPDLESATAFAKKAEAQLMKIKGATEIKLSVEEGSPEIAVQ
VDRDKMAALGLTLQTVGTTMQTAFNGNTDAKFRAGEYEYDINIRFNEYDRSNINNVSDLV
FINDMGQQIKLSQFASVKESSGPSLLERRDKATAVSIKAQTIGRPSGDVAAEWKEQFSKL
ERPTGVSYVWGGDMENQEEGFGTLGIALLAAIILVYLVMVALYNSFVYPFVVLFSIPLSF
IGALMALALTNNSLNIFTILGVIMLIGLVCKNAILLVDFANHRKAEGETTYMALIQANHA
RLRPILMTTIAMVFGMVPIALASGAAAEMNNGLAWVIIGGLISSLFLTLIIVPVVYAIFD
SLIARFNKGKEPVKYEELMVADYEHKELSDDGFTAKHS
>LONDMIMF_00273 Multidrug resistance protein MexA
MKKLIYIGIGIGVLGLFGFILMNNKKKNEAETAIVSEKNTTVAVRTATVKTEAINSDFVA
NGNFIPSQELKFSAENSGRVIKVLVEEGSQVRIGQTLAIIKGDQLSIDVQNANAAYQNAL
TDSKRYENAFKTGGVTQQQLDQAKLALVNAKAKLDQAKITYGDATIKSSINGIVNKKSIE
PGSVVAPRTELFELVNVSKLKLKVAVSENQIPELKVGSVVKVKASVFPDKEFSGKITFIA
PKADESLNFPVEIEIANNPDNEIKAGMYGTAEFTSKATQQKPLKVIPRNAFVGSVSSNQV
FVVENNVAKLKKIVAGRVFGEKVEVLDGLNDGEIVVISGQINLTDGTKVNPIK
>LONDMIMF_00274 Outer membrane protein TolC
MKSMNRLAILLIGFIFSQGIQAQTRKLTLKDAIQYALENKADAKKAKLKVENSEYQIQEV
RSRALPQISAHGNVTYNPILQLNALPGDFFGQPGTTILAPLGQKWSSVGGVSLTQNIFDQ
AVFTGLKAARTTREFYQINQQLTEEQVIERVANNYYQVFVQRQKLTVIDSNYVNTSKVKE
IIKGQYDNGLAKKIDLDRITVKLHNINTQRQQLINEVQLQENSLKFYMGMPIETQIEIPQ
TEFEVTPHALSEQPDSTQRTEYALLKKQEQLLDYQKKSIVAEYYPTLAISGSYNYIGQGP
KLPLGAKSSEGVYWSDYSIIGLDLKIPIFTGFGTRARVRQADIELKQVKEDMQETKLSLD
LAYENSKTQINNSIITINNQKENVRLAEEVLSDTKNNYYNGLASLTDLLDAENSLVEAQN
NYNSALLDYKLAEVQLIKAKGELKTLIN
>LONDMIMF_00275 hypothetical protein
MYIKNKDEATEELIKKTAKKLFFGEGKFNATTQEIADAAGVNRTLINYYFRSRDKLFEIV
FADAQEKEQQRTESIVFSELPFKAKIEEFIDDSFVMAKEYPYMEIYLVTQFNQGCYFKDE
EGMERMLKKFYEELVVEMENGTIEKMEPIQFIINMVSLISFPISMRPLFQKTMRLTDEEY
EKILDDRKEIIMNTLFKEQSKSINNK
>LONDMIMF_00276 (2E,6E)-farnesyl diphosphate synthase
MHSISEYQDGFIDYLESRKIVGEPKSLYEPIQYILSLGGKRIRPVLTLMVAEIFDLEYKK
ALPAAFAVEVFHNFSLVHDDIIDDAPLRRGKETVHEKWNINTGILSGDAMLILAYQYFEQ
YEPVIFQALAKIFSKTALEVCEGQQWDVDFENRDDVTIPEYLKMIEYKTAVLVGAAMKMG
AIIAETSIENCEAIYNFGLNLGIAFQLQDDYLDAFGDPETFGKQVGGDIIENKKTYLYLK
TLQFATPEVKEQLLHLYSIQPTDNSEKINSVKEIFNHTGASQATQEAIKEYTFKAFETLE
KLNIAQDKKALLRAFGENLMGRKV
>LONDMIMF_00277 hypothetical protein
MNFIAPINTDDLLSEAEKENLYLKLLEQVNKDFNFANEPIDFPLSTKPLELKIQLHEKVY
RLIQHKFAEYLNLLYIIDVPEVEVKKLDGSDLVELSEQITFLILKREWQKVWFRNRL
>LONDMIMF_00278 hypothetical protein
MKILNLNHITKTLMAVIFLAVSSNATAQQNTNNDFQSRIRFGGGLGLGFGSGYTNLSVAP
SAIYDFNPYFSAGLALQVSYVRDKDFYESYIYGPSLILLTNPIPEIQLSAELEQLRVNLD
YDDKVGGGSDNFWSTALFLGAGYRMDNITVGARYNVLHDSDKNVYNDALMPFVRVYF
>LONDMIMF_00279 2-oxoglutarate dehydrogenase E1 component
MDRFSFLNAAHTEFFAQLYDEYLENPDSVEPSWRSFFQGFDFGMQTYNEEYEAPAQQLAN
YATSGNVDVSQISEKLQKEFNVLKLIDAYRTRGHLFTKTNPVRERRIFSPNLDLENFGLS
QSDLNTVFDAAKAIKIAPCSLLEIIGHLDKIYCQHIGVEYMYIRKPEVIQWIQDRIGYND
NHPRFSDDQKKNILNKLNEAVSFENFLHTKYVGQKRFSLEGGETLIPALDALIEAAAEKG
VEQFVMGMAHRGRLNVLANVFGKNTQDIFSEFDGKDYDDDALFDGDVKYHLGLTADKKTN
SGKNININLAPNPSHLETVGAVIEGITRAKQDRYFPDDFSKVLPIALHGDAAVAGQGIVY
EIVQMAQLDGYKTGGTIHLVINNQVGFTTNYLDARSSTYCTDIAKVTLSPVLHVNADDAE
AVVHAMLFALDYRMQFGSDVFIDLLGYRKYGHNEGDEPRFTQPKLYKIIAKHQNPRDIYA
ERLMAEGVIDDKYVGKLEKEYKAMLDENLEASRKKDLTIITPFMQNEWNGFVQADEKEML
QKVDTTFSKEKLGEIAQTITTLPSDKKFISKIQKLINDRKVMFETDKLDWAMAELLAYGS
LMTEGYDVRISGQDVERGTFSHRHAVVKVEDSEEEVILLQHLKDQKGKFHIYNSLLSEYG
VVGFDYGYALASPKTLTIWEAQFGDFSNGAQIMIDQYISAAEDKWNNQNGLVMLLPHGYE
GQGAEHSSARMERYLQLCANHNMFVADCTTPANFFHLLRRQMKTSYRKPLIVFTPKSLLR
HPAVVSSVDEFANGSFQEVLDDPNANAKDIKTLVFCTGKFYYDLVAEREANGRKDVAFVR
IEQLFPLPVEQLKAIIEKYPNVDDYVWAQEEPKNMGAYGYMLMNFDLVKFRVASLKAYSA
PAAGSYARSKKRHAAAIAMVFDKNLFS
>LONDMIMF_00280 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex
MILEMKVPSPGESITEVEIATWLVKDGDYVEKDQAIAEVDSDKATLELPAEASGIITLKA
EEGDAVAVGQVVCLIDTSAAKPEGSAPAKEEKKEEAPKAEVKKEEPKAEAKPVPAAEKTY
ATGTPSPAARKILDEKNIEASSVTGTGKGGRITKDDAVNAKASMGTPTGGNRGSERTKLS
MLRRKVAERLVAAKNETAMLTTFNEVNMTPINVVRNEYKDAFKAKHGGLGLGYMSFFTKA
VTRALQLYPDVNSMIDGQEKISYDFCDISVAVSGPKGLMVPVVRNAENLSFRGIESEIKR
LAIRARDGQITVDDMTGGTFTISNGGVFGSMLSTPIINPPQSGILGMHNIIERPIAVNGK
VEIHPMMYVALSYDHRIIDGRESVGFLVAVKEGLENPVELLMDNNPKKALEL
>LONDMIMF_00281 hypothetical protein
MDTIFDALKKKGYKKIKLKISKTNHLVIKAKINGVSGSFILDTGASNSCVGFGDIEHFNL
FAEESSTKAAGAGAVGMETQMSTNNTLQLGRWKTDDFSLVIFNMSHVNLALEQYKAKPVH
GIIGADILMKGKGIIDYNGEYFYLKQ
>LONDMIMF_00282 putative metal-dependent hydrolase YcfH
MILVDTHSHIYSEEFQQDREEMMQRAFDAGVQKIFVPSIDSGYTQKMYDLEKQYPENVFL
MMGLHPTYVKENYEEELDFVESQLSKRKFYAVGEIGIDLFWDKTRLEEQKIAFKRQIQLA
KQYSLPINIHCRDAFDEVFEVLESEKDDKLFGIFHCFTGDYNQAQQAISYNMKLGIGGVA
TFKNGKIDQFLNQIDLKHIVLETDSPYLAPVPFRGKRNESSYTKLVAEKLALIYGVSVDE
IAKITTENAKEVFGI
>LONDMIMF_00283 hypothetical protein
MSKFDKIRPFYDSEVNEALCKVADHPMMKAMMSFTYPDVEEKDWIEQLKRTHSIRDFQCN
FIYHAVMKVLEKSSDGLTTSGFEKLEKHTPYLFISNHRDIILDTSLLNTCLFDHGLVMTA
SAIGDNLVRKSFLHTLSKLNRNFLVQRSLSPRELLQSSKLMSEYICQLILRENRSVWIAQ
REGRTKDGNDATHPGVLKMLSMGSDEENLMDYFKKLKIVPVSISYEYDPTDALKMPQLMA
EANDEVYIKEKNEDFMTLLSGIMGQKKRIHIHVGDVLESELDEIASKFDNSNRQIQALAQ
AIDDSVLANYKLWPTNYIAYDLLNNTDKYSHLYTEKEKSLFERRLEIRIDENNPLELQGF
LAMYANPVVNKSKYENAV
>LONDMIMF_00284 L-asparaginase 1
MKMLSKAKILLIYTGGTIGMVKDFETGALKAFNFSKLLQRIPELKQLDCEIETVSFDTPI
DSSNMNPDKWVRIATIIEENYIAFDGFVVLHGSDTMSYSASALSFMLENLSKPVVFTGSQ
LPIGDLRTDAKENLITAIQIASLQHKNKPVINEVCLYFEYKLYRGNRTTKINAEHFNAFM
SPNYPPLAESGVHLKVNNDLLIPKSGNKKFQVHKELDNNVAVVKMFPGISENVLDAIFSI
PNLKGVVLETYGAGNAPTDEWFIALLKKAIKNGLHVINVTQCTAGSVSMGHYETSTSLKK
IGVISGKDITTESAITKLMYLIGQKVSPNVFKTIYETALRGELS
>LONDMIMF_00286 hypothetical protein
MRKITTLFNLSEGEDNREKTLESIKKNISFKGANLWILACAIIIASVGLNVNSTAVIIGA
MLISPLMGPIVGAGFALGIYDFGLLKRSLKNLLIATVVSLTVSTLYFFLSPFKDVQSELL
ARTAPNIYDILIAFFGGLVGVIAVTRVEKGNPIPGVAIATALMPPLCTAGYGIATGQWSF
FLGAFYLYCINCVFIGLATFLIIKYLNYPAVKQVNEKQQRQVKYIISFLIAIMIIPSSYL
AYTLYREQQFKKNADLFIENKFTSNGYTVIYKKTEYSSRRKQLELAFLSKRFDKAELKEL
QREFVKNKYLQGGRLVIRQDSTDRLSALKGDILNQIRSSENEVDGKDAKIMKLEKELADM
RFDNVQILKETKALFPSVTSIGVYKNNIAIQKDSIIPITAVVYETSVKLDKKDKERFRQW
LKERLSVNNMTLYNKDDD
>LONDMIMF_00287 hypothetical protein
MKKYFSIFIFFIFLSAFAQDPVKEKQIKQAQEREEQERIKEVLSNDKTTDIRKVEEDKKK
KDSISATVTVIDSLYREDQFYIGLTYDLLQNRPDGVSQNSFSSGVHIGFLRDFPLNKRRN
VAIAVGLGYSMNDYRQNIKITEVDGKPFYEVVNENDVNFDKNKFALHYLDLPIEFRWRTS
TIQSHRFWRIYTGFKLSYLVLNKSKYVQGNEKVRIFGNDDFNKLQYGAYISFGYNTWNFH
AYYGLNSLFKSEAKIDGKSIDMNTFNIGLMFYIL
>LONDMIMF_00288 hypothetical protein
MFISVYAVLLYFFLTERYHPYQEVFLVTIQVIILTILIPISIFYFLMTLGRANSFMLSEI
SQRKIPLAVNVLLLYILIRESIRIELIPELYYFFFGALVSTVLALLFVFINLKASIHMIA
ISSITVFAIGFSLHTQTNHIYLIAFLLLLNGIVATSRLSMKAHDTKELIVGFLSGVIPQI
GLLYFWL
>LONDMIMF_00289 RNA polymerase sigma-54 factor
MLKQFLQLKLSQKLSPQQIQLMKLIQLPTQAFEQRLKEEMVENPALEAGKEEDEYERDEF
ENDDYDEYDEFDNDRIDAEDINIDEYLSNDETPDYKLQANNYSDDDEDRSMPFAAPVSFH
QDLINQLNTFILNDEEREIAEFLVGSIDDMGYIRRSVPDIVDDMAFTQGIYTDEKNVERI
LHIIHELEPSGVGARDLQECLLLQLKHKTPTESVELAIDILENQFESFTKKHYDKLLQKY
GVSQDQLKKAIDEIEKLNPKPGGAFTGNNKMIEHIVPDFTIRIVDGELELTLNGRNAPEL
HVSKDYQEMMQTYKASRDKSSQQKEAVQFIKQKLDSAKWFIDAIRQRQETLFVTMNAIMH
YQQEYFLDGDETKLKPMILKDIADMIGLDISTVSRVANSKYVETPYGTKLIKEFFSEAMK
NDQGEDVSTLEIKKILQNVIEEEDKQKPLPDDQLAEILKEKGYPIARRTIAKYREQLDIP
VARMRKKI
>LONDMIMF_00290 hypothetical protein
MHMNKMEIIKQRALLVINFILIGLFLSCSSKQERNNSSKNDDYMIVTKIFETSKRNSKSK
TIHLQKSNNNEYVIKVLKSERAKSSLKNPEQIDDDFITTNHNEESLKRIFNYKEYEFLVS
QSVNSTWDADFIEQITGSNKTDYSSLKEITISKPVYTSNHKYALVSITEKTRMGIQIMEK
TNGKWIEKEIIAPLIFQPKATLFKN
>LONDMIMF_00291 hypothetical protein
MKLFKHFLKVSILLLLAISCTKDDTSEPTENIQKEYELIKTNFAELSKKEEFIRTLPLLS
RYHSANSGFLKKSPLEDANGFIIDSTQINKISAKGYTSYTFAVLRDKFDENSFENLLVEI
IDGEKEPRVSVIKYKYNKDTDGLAVVETYFVDYKTGARMGLGDCYVLTFVTEKQCPCAGH
WPGQSCSCQSGPSSSTSHMFICRSSGSGGGGGGGGGYINYPSNPIPIRGPAPGTSVPNTV
PVHGDNVNVGRRLFLASLSPEQRTWLAGKRPEAVYRSIFNFLISNNFSTPSSLFAKEAID
AMMRGGEVDFEKRIIDNITMPCQKQIIKDILAISSPFTNVIQQTFNSSDKVNIRLQNRVF
NEGNATTDPPTMNEVNSGSYIVDILYDNSYLENATDLSIVAVTLHELVHAYLIALYFKGD
LICENTNYGNLLTAFINFYQHSDQVTFNEYDNQQHNAMADFMNKMANSIYNYAQSKNISV
TADYCYKLACGTNTGTASFSSIYTQAQQFEYNNIYAHEQNGDNQAKGTPCN
>LONDMIMF_00292 Asparagine--tRNA ligase
MKHTKVKELLNSAQTLQEVYVKGWVRTFRNNQFIALNDGSTINNIQCVVDFENTPAETLK
RITTGAAVALKGSLTESKGAGQKYEIQVTSLEILGDSDPEKFPMQPKKHTLEFLRANAHL
RVRTNAFGAIMRVRSVLSFAVHQYFQEKGFVYVNTPVITGADAEGAGEMFQVTSLPLDNL
PRTEEGHIDYKKDFFGKHTNLTVSGQLEGETFAMALGQIYTFGPTFRAENSNTSRHLAEF
WMIEPEVAFNDLDDNMDLAEDFIQYVIKYTMDKCADDLKFLEGRLLEEEKSKPQAERSEM
TLLEKLNFVLENNFKRVSYTEAIDILKNSTPNKKKKFQYIIEEWGADLQSEHERFLVEKH
FKCPVILYDYPANIKAFYMRLNEDGKTVRAMDILFPGIGEIVGGSQREERYDVLVEKMKT
LGIDEEELWWYLDTRRFGTAVHSGFGLGFERLVLFVTGMTNIRDVIPFPRTPGNAEF
>LONDMIMF_00293 hypothetical protein
MKTNILVSDTLYGIGIVFIIILVILVFFLIYKLKKAKAQRREFEEKYNTLEVKVNGLKLE
TLESKLNPHLFKNILNSIQSHAYQTYHALDKLANVLDYILYESQKKFVSPREEIEFALNL
IEINKIKVSPLFELKVKTKIKEAELLYEQPILAPMISIDLIENAFKHADLKSPDAFISIV
FEFRDSCFYLTVSNKISDHRTLKKEYSGLGSNTLDQRLKIIYNNNYKLDKFIEDDVYIAH
LKIDLLEYKAQMLAAGR
>LONDMIMF_00294 Transcriptional regulatory protein NatR
MNTKLKCLLLDDELPGLTYLKMLCEQIPELEVVKAFDNPEKMLAEMANLDFDLCITDIEM
PGIDGLSVANLLKDKMVIFTTAYKEYAADAFDIEAIDYITKPVKKERLQKAVVKALEKNN
KKATNKKFVQLNTDKGKALLFFDQILYIQPSETDSRDKEVLMKDGNIILLKNITFAKLLS
HLPKADFCRINKKEIIAMKTVKFFAHDEITATIMDKNGKNLVLFLSDIYRSDFLCKVNI
>LONDMIMF_00295 Na(+)/H(+)-K(+) antiporter GerN
MQKHKNSIFYVLLIAVFSAIMYWFLDKGKHLEHGRTIIEKTSDKTQWEEFILSMQHSLQH
PLAILLAQILTIILVARFFGWICRKIGQPSVVGEIIAGIVLGPSLLGLYFPEFKETIFPV
ASLGNLQFLSQIGLIFFMFVIGMELDLKVLRNKAHDAVVISHASIIFPFTLGIGLAYFMY
ESFAPEGIEFLSFALFCGIAMSITAFPVLARIVQERGIHKTKLGSIVITCAAADDITAWC
ILAAVIAIVKAGSFVSSLYIIALAVAYVFLMIMVVKPFLKRVGDLYSSRKTLSKPVVAIF
FLTLIISAYVTEVIGIHALFGAFMAGVIMPESAKFRSIFIEKVEDVALIVLLPLFFVFTG
LRTEIGLLDDPYLWKVTGLIIAVAVAGKFLGSTLAAKFVGQNWRDSLYIGALMNTRGLME
LIVLNIGYELGVLSPMIFTMMVIMALVTTFMTGPALDLINFIFKTKNSIIPETISNKIKY
KILLSFAIPDRGISLLKVANSLVRKQNGNAIVTAMHLSSSNELHGFDASHYEQEVFKPIV
NEAENLEQKIITLFKASVDIDSDITEIANQGEFDLLLIGLGQSIFEGTLLGRVLGYTTRI
INPDRLIDKFTGKEGLFENSPFDERTRHIIAYSKMPVGILVDKNLDEIDQVFMPLFSAED
RFLIEYAQKLIHNNGSQVTVLDPTGEIKNNSEIKESIRAIEQIAPNHIAMSGEKTMKKEF
LEKQDLMIISLDSWKKLVDSQSVWLNNTPSVLIIKP
>LONDMIMF_00296 hypothetical protein
MKHLTFLFFLLSVSVQAQFQVSGIVRDENTKKPLPFATITGTSFSTVTDVDGKFLLQNEN
QINSFTISYIGYAPKTIAVTGNKKYYDLLLVPKAEHLDEIQLTSSENPANGIISKAIKNK
KKNDPQQKLLSFQFKSYNKLIVSANPDSIDGSIDSVFVERYTGREFKNVDSTNYKFKKII
DRQHLFQTEKVSQFQFNGKKLKETILGTKMAGFRNPIYEIIAFNLQSFSVYDSKYELFET
KYNSPIAPDAFKDYRFKILDTVKLDNRDTYMIYFKPKKKRKSSGLEGIVYIDKENYAIAK
AIMRIRGVLDISATHEFEYLEGMDIWFPTQKEFKIVKGKNDDDIRILGGTIKFEGDLDNN
NTHRKKDASDFTYLLSKSYNFGKELNTPVKIRHDAIAIEIKDDAVKKDEAFWNSFRKDSL
DSRSERTYFALDSIAQKERLEKKLRLGRKILNGYVPIGPVDMDLRYLLSYNNYEGFRVGL
GGITNEKFSNKYRLDGYTAYGTKDGDFKYSIGGAVRVGIFSNSWIGGGYTDDVREIASTS
FAIDKRVFKIYDPRPINLSTFYNHKTWRGYIETKILPKTESIWQLTHSRIEPKFNYIYMV
DGKSYTNYDMTTAMVSLQWNPFSDYMQTPTGKLEIEKRYPKFTFQFTQSLPKVFENDFAF
SKIDVRAEYEKRYLNGQRTALLMEAGYALGDVPISHLYNTSPNSLTKEKLIERITIAGKN
SFETMYFNEFFSSKYVMIQLKHGFKRVTVFKGIKPSLVLVSRMAWGDMDKPEQHIGLNYK
TLRDGYFESGIELNQIYKAFGLSGFYRYGPNQLAKFEDNLSIKLTVILNLGL
>LONDMIMF_00297 Ribosome-recycling factor
MTEEIDFILDSAEESMSGSIAHLEKEFLNIRAGKASPAMLGSVFVDYYGASTPLSQVSNI
NVPDARTITIQPYEKSMLQPIEKAIQIANIGFNPMNNGDVIIISVPPLTEERRRDLVKQA
KSEAEDAKIGIRNVRKDANTDIKKLEKEGTSEDICKSAEEEVQNLTNSFIKKIDELLAAK
EAEIMKV
>LONDMIMF_00298 Uridylate kinase
MTIFAQLKRKQSQRMKYKRILLKLSGEALMGDRQYGIDPKRLAEYADEIKEIHDKGVEIA
IVIGGGNIFRGVAGASNGMDRVQGDYMGMLATVINGMALQGALEDKGMLTRLQTALKIEA
IAEPYIKRRAVRHLEKGRIVIFGAGTGNPYFTTDTAAVLRGVEVNADVILKGTRVDGVYT
ADPEKNPDAIKFDAISFDDVLKKGLNVMDTTAFTLSQENALPIVVFDMNKKGNLLKICEG
ENVGTVVNV
>LONDMIMF_00299 hypothetical protein
MEEIIKNSLEKSSTYLEYRKIVADKLLEGKSTGSVQSDDLLHYSKLNETRMNRLEKTIVV
SAEIEERLKLLKKQYIWLVISEGWCGDAAQLLPVMHKMEVLTDHIDFKIVFRDENEALMN
KFLTNGGKSIPKLIVLDKETLDVLADWGPRPKEAFDLVKNYKEKHGVIDETIKTELQMWY
LHDKGISTQNELLEMMRLIEIQE
>LONDMIMF_00300 hypothetical protein
MAGYEEQGYLYLKNFFSEAEIIAIENILNKFHIKWLEDNAVYYEKGLLNSHSLTSGNYLN
EEEKTLLFKFITQNKLQTILKTVFSETPIFLNTQLFFDPKNSEQKNYWHRDIQYTGMSVE
EQKKAIHNQNVVHFRIPMKKESGIELIPKTHREWDLPEEFDVRNSLNGAFPSNDLQRGKV
VGLNRGDLLVFSANMIHRGLYGHNRFSLDVLFCDNIPEMRNFIDRNNYPSKEILENLGNK
EMFDF
>LONDMIMF_00301 hypothetical protein
MIMKKTILLLLFFFSCFSYAQINPSDLKTGDFIFQDMDCGPLCDAIEAVTEGYKGNDFSH
MGLVYKKNDTIYIIEAAGTKVRLNTLEKFSKNTSKPMYIGRVKKKYTQLIPEAISFSLEQ
IGVPYDDDYVYDNGKYYCSELIYDAFKKANKDKPFFQLFPMTYKEPGTNEFFPAWVEYYK
QIGSEIPEGKPGCNPGGMSTSNKISILGTLK
>LONDMIMF_00302 tRNA pseudouridine synthase B
MTAQDFQDGQVLQIDKPLNWTSFQAVNKLKWALKSKLGLKKIKIGHAGTLDPLATGLLLV
CTGKFTKRIAELQGQEKEYTGTITVGATTPSYDLETEINETFPTEHITEELIHETVKQFL
GEIDQRPPIFSALKKDGVRLYEHARNGEEVEIPTRKTVIHEFEITRIVLPEIDFRVVCSK
GTYIRSLAFDFGKALHSGGHLTALRRTKIGNYDVKDGYGLEAFVDSLSEKTE
>LONDMIMF_00303 Undecaprenyl-diphosphatase
MDLIEAILIAIVEGLTEYLPVSSTGHMIFTSSYFGIQEDDFTKLFQVSIQFGAILAVVVL
YWRKFFNFSKLNFYIKLALAVVPALILGYLFDDYIDEILGNPIPIAIVLIVGGFILLFID
NYFKNPVVAEEEDISIKKAVTIGFWQCLAMMPGTSRSAASIIGGMQQGLTRQVAAEFSFF
LAVPTMLAVTCYSVFLKTYKVSGLKGYELLTQSGDNMKLFVIGNIIAFIVAIIAIKFFIG
VIKKYGFKPWGYYRIVAGTLLLIYFIYIK
>LONDMIMF_00304 hypothetical protein
MSTKETNTQKNEFLFDKVNYKFLLIGIGVIALGFILMSGGGSDDPAVFSDKIFDFRRIRL
APTTVLIGFGITIYAILKNPKK
>LONDMIMF_00305 Cell division protein FtsX
MASSFEKFQKRRLISSYFSVVLSVFLVLFLLGILGLFVINSKKLSDDFKEEIAMSVYFKN
EANDSIINAFDTQLKTSKFVKSYEFVTKEKAAKQHTDIIGEDFMAFLGENPLENSFDIHL
KADYIVADSIKKFESTIVTNPMVSDIVYDKVLVNLVNDNIQRISFWILIASGFLALVAVL
LINSSMRLSIYSNRFIIKTMQMVGATKSFIRKPFIWRSIKLGIIGSLLAIFALIGVLYYV
DTNFPNLKIMEDQLMVGLVLVGVLIVGILITWFSTFFATQRFLNLRTDDLY
>LONDMIMF_00306 Leucine--tRNA ligase
MKYNPNEIEARWQKYWAENGTFHAENNSEKPKYYVLDMFPYPSGAGLHVGHPLGYIASDI
YARFKRHQGFNVLHPQGYDSFGLPAEQYAIQTGQHPDKTTKENIARYREQLDKIGFSFDW
SREVRTSSPEYYKWTQWIFIQLFNSWYDKDADEARDIRTLVLEFEENGNEKVNAVADDAI
PTFSAKEWKSYSKEEQERILLKYRLTFLAETEVNWCPALGTVLANDEIVNGVSERGGHPV
IRKKMTQWSMRISAYAERLLSGLETIDWTESLKESQRNWIGKSVGASVTFKVKDSQFERN
AVDYILSGDETNNHVIEVFTTRPDTIFGVTFMTLAPEHDLVAKITTPEQKKAVEAYIEAT
SKRSERDRMADVKTISGVFTGAYAEHPFTKEAIPVWIGDYVLAGYGTGAVMAVPCGDERD
YAFAKHFNIPIKNIFGGVDISEEAYASKDNVVIDNSDFLNGLDYKQATKKAIEALEELGQ
GKGKVNYRLRDAVFSRQRYWGEPFPVYYVNGLPQMIETQHLPVRLPEVEKYLPTEDGQPP
LGNASEWAWDTKNATVVSNELIDDVTVFPLELNTMPGWAGSSWYWLRYMDAHNEEEFVSE
EAQNYWQNVDLYIGGSEHATGHLLYSRFWNKFLKDRGFVNQEEPFKKLINQGMILGMSAL
VYRISGTNTYVSKNIKNNYETEGLHIDVNLVNASDEIDIEKLRHWQPQFNDAEFVTENGR
FFVGREVEKMSKRWYNVVNPDDICNEYGADTLRLYEMFLGPLEQAKPWNTAGITGVFGFL
KKLWKLYFDDSGLIVNSNPASPEALKTLHKTIKKVQEDIENFSFNTSVSSFMIAVNELTA
MNCHERSILEPLAVLISPYAPHIAEELWERLGHKESISAVPFPRFNPEYLIENNKEYPVS
FNGKMRFTINLPLDLTVKEIENIVMADERTIKQLDGKTPNKIIIVPGKIINLVG
>LONDMIMF_00307 hypothetical protein
MIGYYILIGVIALVSWAVSARLQSKFEFYSKVHLRNGMSGAEIAEKMLQDHGITGVRVIS
TPGRLTDHYNPSDKTVNLSEAVYNQRNAAAAAVAAHEVGHAVQHAKAYEWLKMRSRLVPV
VSVASGMSQWLVIGGLILGAATGFVGGFYIAVAGLVMMALATLFSFITLPVEYDASNRAL
AWFKNKNMLTQQEYAGAEDSLKWAARTYLVAAIGALASLLYWALQVFGGRRD
>LONDMIMF_00308 hypothetical protein
MNFDGSDTGILNDETKMLNWISANISKTSFKDLDEASIRWKNIKSKQSIIIRDNFDFFKA
LDDSKSGDLLNVMDPYTPPVANSGPCENKCINDAVDCDRTAKAVYEGGMRAAGRLISVDP
PLAALTATYVSLKYSEAQRTCVKNLNTCIDKCE
>LONDMIMF_00309 hypothetical protein
MISEKDFIPSEYTRSIEKGNFKWSAPSNIALVKYWGKKDNQIPANPSISFTLNNCKTITS
LAFEKREPDGDFSFDLLFEGKPKEDFKPKIRKFFEKIESYLPFLKEYHFTINTENTFPHS
SGIASSASGMAALAVNLMSIEKELNPEMTEDYFNQKASFLARLGSGSACRSVKGSIVIWG
NHEETEGSSDLFGVEFSRNIHPIFKNYQDTILLVDKGEKQVSSTVGHDLMHNHPYAEKRF
EQAHINLSKIKTLLESGDLQEFIRIVESEALTLHAMMLTSMPYYILMKPNTLEIINRIWK
FRNETNIPVCFTLDAGANVHILYPENVREEVLELIKNELVGFCQNSQYICDEIGFGAKKL
>LONDMIMF_00310 hypothetical protein
MKGPLFYSKILLFGEHAINKGSRGLSIPYNFFNGGLKVDNNLSDEAQKSNASLKRFVAYL
ETMQQENPELVTFNIELLKRNVEAGMYFDSSIPQGYGIGSSGALVAAVYDQYAENKITVL
ENLTREKLLKLKQIFSKMESFFHGTSSGLDPLNSYLSIPILINSHDNIEATGIPTQSLEG
KGAVFLLDSGMVKETAPMVSIFMESLKDKGFRAMVKNQFVKYTDASIDDFLHGDIKSLLS
NTKKLSKVVLNNFKPMIPEQFHGIWQKGLDSNDYYLKLCGSGGGGYILGFTHDYEKAKEA
LKDYKLEVVYQF
>LONDMIMF_00311 Protoheme IX farnesyltransferase
MLSRKNKLLVMKIISLFSVVRGYNIPVIVLAQYLSAIFILAPENTRALDVILDFNLFILV
LVSSFCIASGYIINNFYDAQKDLINRPNKSMLDRLVSQKTKLYVYFGLNFLAVFLAYFVS
WRVSIFYSSYIFLIWFYSHKLKKYPIIGNLTASLLAIFPFFGILLYFFKGQYQEYDWQKI
GIIFSHASFLFLLILIREMVKDLENMKGDFVSDYKTIPVVYGESVSKKAITVLTLLTIIP
VYILVDVYEVGYMVIYFYLCLMALIFFLLKLWKSNTRNEFLKLHNLLKFIIVAGVFCIVL
IEPAVLWHGKKILLAINFR
>LONDMIMF_00312 23S rRNA pseudouridine(2604) synthase
MNKNEGGNRRNASNRPGGKSSFGKSNPPLPKRAQGPKKNKPASFKAADSASEKTDKKPNQ
APKRQKASDEMRLNKYISNSGVCSRRDADIYIKSGNVKVNGVTVTEMGYLVKATDVVNFD
GALLTPEKKEYILLNKPKNFTTSLDEGFEHRNVSELVRGATKSVLSPVGRMDKNTTGLLL
FTNDTDMIRKFTIPNQKSSKIYQVSLDKNLKFEDLEKIGKGMMIENHRVNVEEISYIDDE
PKSEIGLKLRTANVKVVRHIFEHLGYDVLRIDRVVFAGLTKKNLPRGNWRFLTEQEIINL
KNI
>LONDMIMF_00313 hypothetical protein
MTPEILQSIAFKWFDAFNSHQLEKLLDLYDDEAKHFSPKLKIRKPETNGYVTGKQALREW
WKDAFERLPSLHYKVTSLTANHDRVFMEYIRTVDGEDDMLVAEVLEVKNEKIIASRVYHG
>LONDMIMF_00314 Dipeptidyl carboxypeptidase
MRKKSFFILLAIGNMLTIEAQENKQNMNPFFQPYSTPYEVPPFDKIKNEHFKPAILEGIK
RHEAEINAIANNTAAPTFENTILAMENAGELLANVNIVFSNLNGANTNEEMQKIAKEVSP
NLAAHSDNIYLNEKLFARVKAIWDKKESLGLNPEQAKILENLHKAFVRSGANLATADKEK
LRKINAELSMTSLKYGQNILAETNKYELVITDKKDLAGLPQELINTAADDAKAKGKEGKW
VFTLSNSSVMPFLQYSSNRKLRQEIWNAYQTRGNHDDALDNKENAVKLANLRGEKARLLG
YKSHAAYVLEESMAKNPENVAKLLNDLWKPALAIAKTEASDIQKMMDKDGVKDKVKPYDW
RYYTEKIRKQRFDLDEQELKPYFSLDNTRNGIFQVTEKLYGLKFKQLNDVPKYHDEVTVW
EVTEANGTHVGILYMDFFPRASKRGGAWMTSYRSQKTVDGQRKAPVISIVCNFTKPTGDT
PALLTFDEVTTFFHEFGHALHGLLSNVTYKSLAGTSVPRDFVELPSQIMENWAAEPEVLK
MYAKHYKTGEVIPDALIQKLQKSGTFDQGFATVEYLAASFLDMDYHTQTAAIQLDANSFE
KNSMKKIGLIDAIIPRYRSTYFSHIFSGGYSSGYYSYIWSGVLDTDAFEAFKTTNLFNPE
KAKLFRKNVLEKGGTEDPMVLYKRFRGAEPSVEPLLRKRGLDKKEEPAKKIRG
>LONDMIMF_00316 N-formyl-4-amino-5-aminomethyl-2-methylpyrimidine deformylase
MDTLKDYVQKNKERFLNELIDLLKIPSVSADSAYSQDVIDTANAVKASLEKAGCDFVEIC
DTPGYPIVYGEKIIDKNLPTVLVYGHYDVQPPDPLDLWTSPPFEPVIKKTELHPEGAIFA
RGACDDKGQMYMHVKALEYMVQTNNLPCNVKFMIEGEEEVGSASLSWFVERNQEKLKNDV
ILISDTGMISNTQPSITTGLRGLSYVEVEVTGPNRDLHSGLYGGAVANPINVLAKMIASL
HDENNHITIPGFYDKVEELSDAERAEMAKAPFSLEDYKKALDLNDIYGEKGYTTNERNSI
RPTLDVNGIWGGYTGEGAKTVIASKAYAKISMRLVPNQDWHEITELFTKHFESIAPSGVK
VKVKPHHGGQGYVTPIDSIGYQAAAKAYNESFGVQPIPVRSGGSIPIVALFEKELKSKTI
LMGFGLDSDAIHSPNEHFGVFNYLKGIETIPLFYKYFVELSK
>LONDMIMF_00317 hypothetical protein
MFKRFLFSIVLSMTFSMVCIAQETETAQNPTSVAENAVAVFPKFQGGDHKLSLSKYAKKH
YVMPNDFQGKGVLIVDFTIDTKGKVKNIRVINDLGYGSAESAIKLLKKMPRWTPAYNAKG
EPIEFINQLKITMSNLSQPVQH
>LONDMIMF_00318 hypothetical protein
MRIIKITPSISALLFILMLSGCKTNRIRNNERVGRWVEYDTIDGKIYKSVGRFRDGIGKG
THRQFSDKKLVREEKYKNDICHTIYYYDNGKITTEGNTKMVVTDEEIHWFYNGDWKFYDE
NGQLLGIRTYENGNVINEIEIQQ
>LONDMIMF_00319 Methicillin resistance regulatory protein MecI
MQLSNSEEQLMQHLWKLEKGFMKDLLECYPDPKPATTTIATLLKRMADKNFIAYNEIGNS
REYYPLVEKSDYFSKHVNGLIKNFFNNSASQFASFFTKETNLTQKELEELQKIIDKEIQK
KKK
>LONDMIMF_00320 hypothetical protein
MIGFLIKSSLCLAILLGVYILFLEKEKMNVFNRVYLLASLAVSFAIPFIQFEPIHEELQQ
NLIPYAVQTIQAQAISIEQQSDYSVWVLWILYGTITSLFLFRFIKNLLSITKKIQSNPKK
KFEISTLVLVKEKIVPHTFLNYIFINKEDYENRNVEEELYTHELTHVRQKHTIDVLVIEI
LKTLFWFNPILIFYKKAIQLNHEFLADAKVVKSYNNVPFYQNLLLEKASWNSNSYLASNL
NFLVTKKRLIMMTKTTSKSRALLTKLSVLPILAGLISFSCFETDNQKEVTEVVAKKQIIK
AEEPTMGEQETQKVYEASPGKSDDGLSVPKFPGGLQAFSKYVKKEYKIPSGFKGKGNLIA
SFIVETDGSLSDIKIVKDLGKGTAEEFLRLLKTSPKWQPGTLNGKAVRVKYNVPIHLNEV
>LONDMIMF_00321 hypothetical protein
MEVYLLKSTASLIVLLGIYHLFLEKEKMHTFNRFYLLFSLLLSFTIPFITIEIAVESLPK
PLLLSQSDPIPVLAQDKSIDVGVATVQKSGKNYIPIILWSLYALTTLFLVIRFGKNIYDL
ILKAKKNRKIVFNCSTLVLSKEEQLPHTFLQYIFINEDDFNSQNIQQELYTHELTHVRQK
HTYDVLFIEILKTLFWFNPILVFYKKAIQLNHEFLADENVVESHKNVSFYQNLLVEKASW
NSNLYLASNLNFSVTKKRLIMMTKTTSKSRAFLKKIALVPVLAGLVFASCIEKTAAKDKE
PEVWINGERVKESEMNQPISNWKKEQPNENNQTNEAAYFAGVRFIIYKTGTWTKDRVQGK
DIILDKTYEELTAEEKDRFKPYLRIPKGHVKKSPTAAELEDYKDSKKYAIWIDDVNVKNT
ELNKYSPSDIAYVLGSSVMKNARTQKHPQPFQFHFYTHNYFDKKQMGKAPEKYPLDKVEI
FDKIIKN
>LONDMIMF_00322 hypothetical protein
MLKHFFIVCAGVDKKIIESCSNGEQNKYAGIGATVFFTAVMAFIASSYALYTVFDNVYAA
VFFGFVWGLLIFNLDRFIVSTIRKRDSFSNEFIQATPRIALAIIIAIVISKPLEIKIFEK
EIDTVLLKEKNAMALNNKKEVANYFKSDLEKNKAKIDSLKSEITKKEKEVNTLYETYIAE
AEGTAGTKKLGKGPVFKEKIAKHDLAKSELDTLRKNNLAKIAETEKLSKKLEADQDKKVT
ETQPIIDGFDGLMARINALNKLPWLPSFFIMLLFLAIETSPIIAKLLSPKGEYDFKLEDI
ETALKATISQDKYQRELLVKTSAQMHDKVYEDIATDKGLFDLQHKKAKELLELQAHNFVE
KQKRTL
>LONDMIMF_00323 3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ
MSKDIENLIPHRAPFLFVDEIISVDKEQIIGVKKFDDTNFILKGNFPEFNYVPGTILLES
MAQCGGAGVRLLGVTNGIFALAYIETAEFLKGVLFGEQVKFIIRNLRLSEKIIKQSGKAY
VGDDIVMEGSWMSIRIEEAI
>LONDMIMF_00324 hypothetical protein
MKEQIKKFLNEEQDPKAIEKITSKLTDLLMKNEEIGYIGVQKKPAITVFPDSIVLTNKRI
IICKPKNLGLSMDFTDYTWDDIAGTFVKENILGSEFSFTTKTDLTISIDYIPKTQARKIY
TFAKEQLDVLKNGPVASAFAEEPKVEEFEEKEIAAETFAEVEEPEVIEEMETEEVTDFAE
IIPVSQSGYRDEKQYPDEKPEVAKEKTLGELSQDELFEKLQNYKKLLDNGLIMQGEYDAL
KKEILSHM
>LONDMIMF_00325 hypothetical protein
MNIQAYFEYCLSKKGVTEHFPFDEDTLVFKVGGKMFALSSLSGWEKGTPSINLKCDPERA
EELRAEFDDIKPGYHMSKVHWNTVSLHGDVTDKMVRELIDHSYDLVFKSLTKKIQTEIIE
LKN
>LONDMIMF_00326 hypothetical protein
MIRISTDKDKLDISFIHKFLTNTYWAKGRTMEEVKTTIENSYCFGIYSNGKQIGFARVVT
DYVVFAYIMDVFIAEEQQGKGYSSLLMDRLLSEPAFSKVKTWRLATADAHFLYEKFGFGA
LANPEKQMEKIIR
>LONDMIMF_00327 Kynurenine formamidase
MIATIQHNNQNFEVDFSKPIDISITLTNTDENPIAWYIEKPVIEPVRFGHWVGKVSEGSS
STNFNNIFFNPHGHGTHTECLGHITKEFYSINRHLKTFFFTAELVSVEPELRGEDRVITK
NQIEKALEGKFPEAIVIRTLPNPEEKLSRKYSDTNPPYLDEKAAVFIRERGIKHLLIDLP
SVDKERDQGKLVAHKAFWNVKNTHDLNDDARFDATITELIFVPDHVEDGSYLLNLQIASF
ENDASPSKPVLYKI
>LONDMIMF_00328 Oxygen-independent coproporphyrinogen-III oxidase-like protein YqeR
MSGIYIHIPFCKQACHYCDFHFSTSMKKKEEMVQALVKEMQMRKSEFENEIVETIYFGGG
TPSVLSDEELAFLIDAVYANFKVAENPEITLEANPDDLSDERIVELAGSRINRLSIGIQS
FFENDLKMMNRTHNAEEAKKSLETATRYFDNISIDLIYGIPGMTNEMWKQNIETALSFGI
PHISSYALTVEPKTALKKLIQTGKVSEPKDEVAQEHFMILVEMLQQHGFIHYELSNFGKP
DYFSKNNSAYWLGKKYIGIGPSAHSYDGISRSWNIANNPIYLKEIEAGKLPGEVEILTAN
DRYNEYIMTGLRTIWGVSLNRIQKEFGEEVLQYLQKQSEKFIADGLLAVEKNILKTTPKG
KFLADGIASDLFLINLDD
>LONDMIMF_00329 Crossover junction endodeoxyribonuclease RuvC
MANERIILGIDPGTTIMGFGLIRVINKKMEFLQLNELILSKYDDHYTKLKVIFERTIELI
ETHHPDEIAIEAPFFGKNVQSMLKLGRAQGVAMAAGLSRQIPITEYEPKKIKMAITGNGN
ASKEQVAKMLQQLLALKELPKNLDSTDGLAAAVCHFFNSGKSTGTKSYSGWDAFVKQNEE
RVRK
>LONDMIMF_00330 hypothetical protein
MIVIPHKAKQFLVFLVKLLIVGGAFYFIWNQLAHNEQLDWQKFLDLLDRKKSFWGIIFLL
SFSFFNRYFEILKWQNLAQVVEKISIGSATEQVLGALTASIFTPNGIGEYGAKTLYFKKK
EAKRIVFLNLICNGIQMILTIIFGTVGLLYFNYKFPIVSNKSLLLVCGIVLLIVVLLFGL
KKITVKGYSLHLLFEKINEIPKQIHQKNILLAVGRYLIFSHQYYFLFLAFDVKLPYVLLM
ATITSVYFLASSLPTFQFLDFAVKGSVAVFFFGLLGVNEWIVVFISTLMWFLNVVLPVVI
GSYYVFNFKSKWKS
>LONDMIMF_00331 Poly-beta-1,6-N-acetyl-D-glucosamine synthase
MEIIAFLFFGIVGIYSVFIIGLAYGFRKVTVFKNNSSEPKSTFSIIVPFRNEAQHLPQLL
YSFSQMDYPRSKFEVIFVNDGSTDDSVSIIQNFRALSFDYRIIDSVRKSASPKKDAIVTA
INLLENEWVITTDADCFVSPDWLKTIDSYIQNHNPVMIAGAVSFSADESFLQQFQQLDMI
SLQGATIGSFGLQKAFMCNGANLAYKKDLFFELGGFEGNDDLASGDDVFVLQKAVAKYPE
KVHYLKSECNIVLTEPLDSWKAVFHQRVRWASKTASYQNAFGKILALIVFGGNLAIVVGL
LLTLLGLFSFWNWYLLFAIKIFADFLLLNPTGKFLKPEQVRFFLISNLFYPFFSTTVALY
SLFGKYEWKGRKF
>LONDMIMF_00332 hypothetical protein
MPANHHMRKLTAILFLGLLCSCQNLQNQKISEEELLKQELQKVNWNQVDEFPSVATCDSI
KDETTRKQCFFDFLTVTIQQKLDLDTLSILYPQIDTIQVKVTVYPDSRIEFEPQFPSDSL
AYDKVKIDSILHSRLTDFPKINPALKRGIPVKTQFILPVILNVE
>LONDMIMF_00333 hypothetical protein
MEYFLLVAGFLCVIGGIIGSFLPVLPDAPLSWIGLLLLYFCDGIETEYWVLGITLFIAIV
SGILDYIIPAKGTKHFGGSSYGIWGTNIGLVVGLIAPIPFGFVIGPFLGAFIGEMLYDSK
DHSRALKAATGSFIGFLASTFIKFVVCMGFLGLFLYKVWEFRGVWF
>LONDMIMF_00335 hypothetical protein
MKIESQIEKISSFQHLELLANQVVEGFISGMHKSPFHGFSAEFAEHKVYNSGESTKHIDW
KLFAKTDRLYTKRFEEETNLRCHLIIDNSSSMHYPKLQDGQQFFESKIGFAVLASAVLMN
LLKKQRDAVGLSIYSDSYEYYAPEKGSERHHRMLLNKLEQLLAEPKQSKNTDTVTFLHQI
AEKMHRRSMIILFTDMFQPGNEEALLNALQHLKHNKHKVVLFHVIDNKTELSFDFDNTPR
KFIDVESGEEVNLFADNIKEEYEKRAESYFKRLSLTCAQNRIKYVPVSAGKNFEKILTTY
LVEKQMFG
>LONDMIMF_00336 hypothetical protein
MKTIKILSGALLAILAISCSSDDSKPAPSYPVENPLESYYTQTGFTTSSNFINSGSYEFG
LAFSPNVKGVMKAITVKLPDANPALRVTIWDYTTKEVIKTETVNVASANTLVSHPISDLA
LEKDKKYMITMNSNDWYKRNKADNTNATYPVTAGNINFLEYRWLSGTAQTFPTTVSANYN
AGDLSFDFKRTE
>LONDMIMF_00337 Transcriptional regulatory protein YpdB
MEKLKCIIVDDDEIDRLTVLSFAKRFENLSILGVFDNADEALAFMENNKPDILFLDIDMP
GMNGVELRKKALEVSACIFITSHPEFAVESFELDTLDFIVKPLKFDRFAQTMRRIEEFME
IKHKASLFESSIGGDVIYIKEGHDQTKVKLHDILYLEALKDYTLIITSKKRHCVLSSIGV
LLKESHFQSFIRIHRSFAVQKQFIEKINTQEILLSNGAMIPVGRSFKENINILLS
>LONDMIMF_00338 Sensor histidine kinase RcsC
MKKAFLFLVFCLFSTALSAQKQGQMLIDSLETALKNTKDKKTIVIIKNKLSQEYSRVDPE
KGKQLAKSAIEMAETIDFKNGLAEGYRCLGINTTDSTAINFYRKGLAFAKETKDKQVLSV
LYRNIAVYYIYRNDYKNGLDYSFKSLKLSEELGKNEEIAGTYINIGFIYNDLKDRKKALE
YFKKALDINKKFNNPTMKAVILENIGVLYNNEGKNELAVSYLNQALEINRKNNNLNFVAT
NLGTLGSAYLELKKYDLAESHIKEALKISKELKIRRVMSYNLQNLSMIYMDKYADPKNNS
FYKSRPVADTSLLMLKEAVIYDQESNDIKSLSTDFKQIASLYEELGDSKNALLYFKKFNT
YKDSIYQTDTKETVKNLEDQRTIELKNKEIQFNKLKIESKEKQKWYFILGLILLGIIGIL
LFYQSRNRKRSNEKLQQLNNELDLANKTKSRFFSILNHDLRSPVSSLIHFLHLQKESPEL
LDAESKKRMEDKTINSAENLLNSMEDLLLWSKGQMENFKPQPKTISVGSLFEDTRKHFSG
QEKIDILFEDPQGLVLNTDENYLKTIIRNLTGNAIKALEKTNNAKIIWKAWQENGIKHLS
ITDNGPGGTQEQFKALYDDKEVVGIKTGLGLHLIRDLAKAIDCKIDIQTQPNQGTAFILT
LK
>LONDMIMF_00339 Thioredoxin 1
MAQAITDATFEEIVLKSDKPVLVDFWAAWCGPCRMVGPIIDQISTEYDGKAVVGKVDVDA
NQEFAAKYGVRNIPTVLVFQNGEVVGRQVGVAPKQSYTDAIDALL
>LONDMIMF_00340 DNA polymerase III subunit alpha
MYLIFDTETTGLPKRWDAPITDTNNWPRCIQIAWQLHDEMGNLIESQDYLVKPEGFNIPY
DAERIHGISTELAAERGIGLSEVLEKFNIALSKSKFIVGQNVGFDVNIMGCEFYRFGVTS
KMAEMPVLDTCTEYTAELLKLPGGRGGKFKLPTLTELHQFLFNQPFAEAHNATADVEATT
RCFLELIRREAFTKEQLDVPADYFRRFNENNPKEIQLIGLKHINLKQASDEVRARLQKAT
DEAQKKQTAENTISLTDVDFVHLHNHTQFSVLQSTISIGDLVKAAAKHKMPAVAMTDHAN
LMGAFHFVRDVLNHNKAAKAKNQSLIDNGEEPTEVLMKPIVGCEFFVCEDHLDRTRKDNG
YQVVLLAKNKNGYHNLAKMSSIAYTKGFYYVPRIDKEVIKQYKEDIIVLSGNLYGEIPSK
ILNIGEHQAEEALLWWKQEFGEDCYIELMRHNQEDENRVNTTLISLARKHDLKLVATNNI
FYIDKEDANAHDILLCVRDGEKQSTPVGRGRGYRYGMPNKEYYFKSGEEMKALFADLPEA
IYNIQEIVGKIEIFDLAREVLLPKFDIPEQFIVPEDEIDGGKRGENLYLKHLTYEGAKRR
YKEITPEIRERLDFELQTIEKTGYPGYFLIVQDFIAEARKLDVSVGPGRGSAAGSVVAYC
LGITNIDPMLYDLLFERFLNPDRVSMPDIDIDFDDEGRGRVMDYVINKYGSNQVAQIITY
GTMAAKSSIRDTARVLDLPLFEADKIAKLIPMNLNLAKIFTFDNEQLKKALRAEEFDKVQ
ELIALANAGDLGGEAITQAKLLEGNLRNTGIHACGVIITPDDITNFVPVSTAKDSDLYVT
QFDNSVVESAGLLKMDFLGLKTLTLIKDTVKLVKYRTGIELDPDAFPIDDVKTYELFQRG
ETVGIFQYESVGMQKYMKDLKPTVFGDLIAMNALYRPGPLEYIPSFVRRKNGEEEIVYDL
EACEEYLKDTYGITVYQEQVMLLSQKLANFSKGDADVLRKAMGKKQKDVLDKMKSKFIDQ
AVANGHPADKLEKIWKDWEAFAQYAFNKSHSTCYAWIAYQTAYLKAHYPAEYMAAVLSNN
MNDIKQVSFFMEECKRMGLQVLGPDVNESFYKFTVNENYAVRFGMGAIKGVGMGAVQTIV
ENRKEGKYKSIFDLAKRIDLRAANKKAFENLALAGGFDCFTAHRAQYFHDEGDGITFLEK
AMRYGSKFQENENSSQVSLFGETSDVQIPEPVIPPCEDWSTMEKLAKEKEVVGIYISGHP
LDDYRFEMKYFCNAKLDALKNLEAHVNKNLTVGGIITDVQHRVAKNGKGWASFVLEGYDE
SAEFRIFGEEYLKFRHFLIQNNFTYMKILVREGWANAETGKKGEPRIQFIGIQYLQDVLT
TFAKKLIIQMNIRELHSEMITKLSHIFQANRGENNVTFEVMETEKITKEVPVTVETNADE
VEAIPDMENAEEMELNVPAVVEETKVITYLSMPSRKLKVNICGELLRELEKLQVNFKLN
>LONDMIMF_00341 hypothetical protein
MKKILSLLMLVAVFISCEDDATFNNPSVQGKKDNVRWRASSSYATITGGVLTVYGNTPFE
TLTLTTASIAPGTYTLGVSSANKATYTYEADGVTSVYTTGTGVGDGQIKIEQSPEGTVTG
TFYFNAPSTTADPIGAPVVNYQEGHFYRVPIQTAP
>LONDMIMF_00342 30S ribosomal protein S16
MSVKIRLQRHGKKGKPFYWVVAADARSKRDGKFLEKIGTYNPTTNPATIDLNLDSAVKWL
HNGAQPTDTARAILSYKGALLKHHLDGGVRKGALTQEQADEKLAKWLDEKAGKVNAKKDN
LSTSKADAKAKALAAEKKVNEDRIAAAKQAELEAAKAEEEAAVVEEEVTEVEASTEETPA
AEENNEETQA
>LONDMIMF_00343 Ribosome maturation factor RimM
MRKEECFYLGKIAKKFSFKGEVLVYLDTDEPELYENLESVFVECGKHLVPFFIENSSLHK
NDLLRVRFEDINTEDAADELIGNAIYLPLEMLPKLEGNKFYFHEVIGFEIEDKRLGVVGK
IQSINDSTAQPLFEVLDGDKEILIPMIDHFLVSIDRDNKKVIMDLPEGLIEMYL
>LONDMIMF_00344 tRNA1(Val) (adenine(37)-N6)-methyltransferase
MPFQFKQFSVEQDRCAMKIGTDGVLLGAWAPIEHNPYNVLDIGTGTGIISLMIAQRSHAE
QIDAFDIDEDAYEQAVDNFENSSWNDRLFCFHAALDEFMEETGDQYDLVVSNPPFYTEDY
SSGNEQRDLARFADALPFEDLAQAGGFLLSQNGIFAVILPYKEEEKFIALVRDFDLFPVK
ITRVKGTPTSEIKRSLLAFSRHYSENFPIDELVIEISRHNYTPEYIHLTKDFYLKM
>LONDMIMF_00345 hypothetical protein
MLENILKLEGVHKLSNGEQKTIKGNGAIRGGGNDIIACVCPGTGNIVVGHADSCEVLTKL
LCPQDS
>LONDMIMF_00346 hypothetical protein
MLESVAVIFKKASDNCVFDKKCDINLKESIRVKLFFATFILQIYFEHAENEYLKIKDIKP
KCL
>LONDMIMF_00347 Acyl-CoA dehydrogenase
MRPDLFQAPDYYLLDELLSDEHKMVRDAAREWVKREVSPIIEEYAQKAEFPNQIINGLAE
IGAFGPYIPEEYGGAGLDQISYGLIMQEIERGDSGVRSTASVQSSLVMYPIWKYGNEEQR
MKYLPKLASGEFIGCFGLTEPDFGSNPGGMVTNFKDKGDHYLLNGAKMWISNAPFADIAV
VWAKDEAGRIHGLIVERGMEGFTTPETHNKWSLRASATGELIFDNVKVPKENLLPNKSGL
GAPLGCLDSARYGIAWGAIGAAMDCYDTALRYAKERIQFDKPIAGTQLQQKKLAEMITEI
TKAQLLTWRLGVLRNEGKATSAQISMAKRNNVDMAINIAREARQILGGMGITGEYSIMRH
MMNLESVITYEGTHDIHLLITGMDITGIPAFK
>LONDMIMF_00348 hypothetical protein
MNIDTINARIQPQKDILLNHPLYKKIQNLEDLRRFLECHVYAVWDFMSLLKALQSKLTST
TTPWLPVGNPEIRYLINEIVLAEETDLTLDGKRQSHYEMYIDAMKDCGANITEIQSFLEN
VITTRNIFVSIKKSELHPKIKNFLDFTFRVIDEGKPHEIAAAFTFGREDLIPSMFTEILR
NFQENFPNADLQKLIYYFERHIELDADEHGPMAMQMIEELCNNDELRWQEVEEVSVQALE
KRIGLWDAIEEQISMKAELA
>LONDMIMF_00349 hypothetical protein
MKKITHFLCLGLIGFSAFAQNTPHVFGRKVQSVNPTTGIIKCVTTEYESFLQEKESKRAT
TQEFEEWLAPKAEAAKSKLLARRGTEGTNAVITIPVVVHVIHNGQNISNNGMNITDARIL
SQITVLNQDFRKMIGTPGYNTNPIGADVEIQFCMAQVDPNGNPTTGIHRVNLGVSQWDED
SVETILKPQTIWDSSKYYNIWVCQFGFDLDGVLGYAQFPGSSGLQGLQGPYTADTDGVII
DWRAFGSSDFSGAGGTYFPSINKGRTTTHETGHFLGLRHIWGDGGRRDLGRIVCGATDYC
NDTPEAGWENYDCDQVYDSCPSSPGNDMTENYMDYSNDTCMNIFTLDQKARMMAVMQNSP
RRRSLTTSTACQPPLSNPSFELLQGIKLYPNPANDVLNIAVSDSSKTPDSYTIYNSLGQV
IKLAI
>LONDMIMF_00350 hypothetical protein
MNKFICGIICFLLSYVGFAQQQKEIKINQCGTDELINQTLKKNPQLQEVMEMNEKMVREV
KADKISQRSGSQSLITIPVIVYVVHDGTSTTNISDDQVQSQISALNNYFNPYAMKFCLAT
KTVTSSSVPMPSGAVQTTPGIIHVSNSTLSNHAMTVTSQMQLENATSGIFNSGISSDTFL
RIWVVKSIDGTSSNILGYGTFPGMPMGIDGIVVRYDAFGDANTCSNCNLLPGYDQGKVLV
HEVGHHFGLYHTFENGCSGNTPATCETSGDRVCDTPQVAVPNSGCPVTVNSCLGESPTEL
PDLINNHMDYTNDICRNEFTQGQKERMFAMLSIHRNSLYTAENLINSGVTCTPSLISANF
TASSYTACIGSANAITFTAVNAPGVSYSWNFGDSGSPSNTANTQIATHTFSSTANSPYTV
TLTVTRIFDGITTSSTAQIFVENCSPILNSDSNWYTSWSNMLKFHTGTPSFDLSFPETAP
TSYALTTQSDNSGNLLFYAGKDYVWNANYQQLNTQSMAPDSNGARVNSVISLPNPGSASK
YTIFTNNSNSYNDQGFRYHIVNATSTALATLGPIRQPVTIPSNQGFLTSPIDGALIGGEG
VTAIKKCSGDDYWIITGLKKNNGYFLVVYSFTNTPINGGLTYVSQFQINPYNLDYNSIEA
SPNGDKLFLFLNGGSTKSFIYDFNKISGTISNEKEITVRSSVVGAAFSPDSKLLYIIDYQ
RVINQYNLSSPNINNTKIDVYRLPSEKFFHSMQSGPDGKIYMNIYPSKQLAVIHSPNTRS
TSGNPNACNFSTNGPLRPGGNYASLGGGLPNMIDAKHATVYPGTPASISSYITACNTYKF
FPDFCGTSFSWDFGDPASGSNNTSTEANPTHVFSAGSLPLYTYTVKLKNSSNVVIAQTTI
TIQNDPIQISGSTEACVATSPVTNNYTTLQEGDNAIWSITQGTGTFTGPNNLSNFNVNWT
SLPGTITLTITNSAGCIKTITQNIASSCIGEGTDKVVFTTKLQSDNKIIMGGNFTSYNGI
PINRIARLNTNMSLDTTFQVGTGANDVVYCSAIQTDGKIVIGGEFTNYNGNLRNGLVRLN
NDGSIDTSFTIGTGINNPSPGLNSIKAMAIQSDGKIIIGGLFTSYNGTARVNLARLNANG
TLDNTFVSNFISDGNTVECIEIQNDGKIIVGGYFTSYGSDQRSGIIRLNSNGTIDTTFNP
GTGIDWGGIHTVKALPDGKIIAGGDFGSYNGNLKPYLVKLNSNGSIDTSFSPSSIGIRPG
GIGVMTIGIQTDGKIIIGGGFSIVDNQIKPRIARLNSSGSLDLTFNPGSGFGPVDGNRVI
GAKLYSLSIQPDGKIVCGGYFKSYNSIEVNNITRIDLVTNIIGRTMNQNVVKQNETDTVE
KIYTTHLHEITLYPNPTNGILNIGVSDSSKTPDSYTIYNSLGQAVKQIKNVTEESLKIDT
SNYATGIYVIRFTKGNETKTLQFVKN
>LONDMIMF_00351 Rhodocoxin
MDVTIKITDREGTLHEVQAPTDMNMNIMELVRAYELAPEGTIGVCGGMAMCASCQCYVLN
DVSLPEMGDDEEAMLSEAFFVKSNSRLGCQIHITEELDGLEIELAPEY
>LONDMIMF_00352 Ferredoxin--NADP reductase
MIETDILIIGAGPTGLFTVFEAGLLKLKCHIIDALPQPGGQLAELYPKKPIFDIPGYPSV
LAGDLVTNLMEQIKQFQPGFTLNEKAETIQKQEDGTFIVTTDKGTAHHCKAVAIAGGLGS
FEPRKPLIEDIEFYEDKGVEYFVKDPELFRDKRIVIAGGGDSALDWSIFLANVASEVTLI
HRRNEFRGALDSVEKVQELKHAGKIRLITPAEVTGLNGAEHLESIDIDENGAHRNIKTDY
FIPLFGLSPKLGAIANWGLEIEKNAIKVDNSLDYQTNIEGIYAIGDVNTYPGKLKLILCG
FHEATLMCQSVYNKLNPGKKYVLKYTTVSGVDGFDGTRKEAEKAVVKSID
>LONDMIMF_00353 Fe/S biogenesis protein NfuA
MTTEEIKLNVEKALDEIRPFLESDGGNISLIEIEDDKHVKVRLEGACVGCSVNQMTLKAG
VETTIKKYAPQIETVVNVA
>LONDMIMF_00354 Iron-sulfur cluster carrier protein
MKIDRKEVLKALETITIAGEGKNMVESGAVQNVLTFGDEVVVELTLATPALHIKKRAEAD
IIKTIHEKVSTEAKVKVNIKVETPEKPEIKGKSIPGIKNIIAVASGKGGVGKSTVTANLA
VTLAKMGFNVGVLDADIYGPSMPIMFDVESEKPISVTVDGKSKMKPIESYEVKILSIGFF
TAPSQAVIWRGPMASKALNQMIFDADWGELDFMLIDLPPGTGDIHLSIVQSLPITGAVVV
STPQAVALADAKKGVAMFQSDSINVPVLGIIENMAYFTPEELPENKYYIFGKEGAKNLAQ
DLEVPFLGEVPIVQSIREAGDYGRPAALQTASPLEKVFEDIARNVVQETVYRNENLPPSE
AVKITTMAGCSAVKK
>LONDMIMF_00355 hypothetical protein
MNKKLILSLLLITSGIFVNGQENSWSLQKCFDTASQNNIDIKIKQLEINRAKKLYTHPLL
ELFPTVNLVGNHSYNFGSTIDPSTNNRVSSDIQYDNMSLAANVNLLNFGNLATSQRDKIN
IELARADKEVIEYEYKLQLLEKYFDALFSQELVKIQKEQIQNTTFNLERIKKEVEIGNKP
ESDLYDIQLSFSQDEKGLLEAVQLFEIQKLQLFQLMTFAVENLKAVTFEVYLAEETEPVD
KSVFKNPKIEYAELSYKRSKKEISILRSDNLPSISGYYSLSTFYSSPINQPNENMPSFKS
QFDDNKNHEVGLRLNIPVFNGFKRSRQITASKIEAEKVKLVSEQEKIRIQQQVELETTRK
KQYMQLASNLQNTLKYAKESFRTTQAKFTSGKVDAVIYTSVKNQLLSSEYDFLKNNLLVQ
YASLKINLIQKNEL
>LONDMIMF_00356 Macrolide export ATP-binding/permease protein MacB
MLKNWLKIFLYQIKDNKIFTTLNILGLSMGIAGLIFAILYWNDEHSYNEWNPDKERIFLS
ISDLGEDMLWATNVAGFEPYLKNYKELESYCYFNTDYEEDMVSYKGKKETLKITDAQKTF
FEFFPFEFIKGSPQNALADNNSTALSEEAAQKLFRNEDPIGKEVTYSEKKYVVRAIYKVP
GKSSMAPDVIISTIDRRLEGDRTQWGNFNYGLMLKLKNPQQTGPVKLKLERLLYENRELK
WAREQGITPEQWREKNREGHLSKIILEPLTAARLHAITESYGEGRGNYQFLLIMMGLSLL
ILTLSIANYVNLATANAIKRAKEVGVRKIIGATRGNIVKQFIFETMLMAGFAILISLVIV
ELSLPYYNEFLNKNLIIHSGQFYLQILLIFGLVVLLAGIFPAVYVSNFETLKVLKGNFGR
SKNGIWLRNGMLILQFAIASFFIVGSYIVYEQVSFMNSKDLGFKGDQVVQVNYRNPYDFK
EKGYLEKIVLRYETIRQELLKIKGVRQVSIGSFDFGGGAQASSGYEYNRKPIQGSNMAID
FDFLDMMNIKLAKGRNLSPSLSTDTIENILVNETALRMMNEKDPIGKEINWNDKKLKIVG
IAKDFHVSGPQDQIPPMTIFHYKTIPWMIQNAHQIFVKIDAEHMESAMKEIENFWIKKVD
TEYPFKYDFVNKSYARSYQAYVNQRNLFSLLNFIVIFIALSGLFALASYSIQRRMKEIAI
RKTLGAETKTLLQELSKQYVVFCIAGFLIALFPVYFLLNKWLENFAYRIDISIVPFVVGF
VALLLLMLIVVLSRAYQATRVNVLKYLKYE
>LONDMIMF_00357 Macrolide export ATP-binding/permease protein MacB
MLSNWLKIFLYQIRNNKLFTILNILGLSIGVAGLVFSILYWNDEQSYNAWNPEKENVFQV
VNDQPRSGFLAYNVVPLGARLKEVTPEVEEYCNFYPAYNRALVEYADKKELVSKVLKSEG
SFFSFFPFEFIRSNARMALKEKNNAAISEETAQKLFGDEDPIGKSIKVGEINCVVGGVYK
ISGKSSVEPAIVIREEFEEFIKKNIDNWNAHTVFLVVKLKNLANKEMVEKQIHQIYVDKQ
ARKAAKEKGITAEAYVKNYGLDIPHLEQLKTARLHSKVNNGYQEGSGNYQFLMIMLGLSV
LILILSIVNYINLATANAIKRAKEVGVRKIIGAAKKQIVWQFLFETVITTSFSILFALVI
VELLLPYYNEFLSKNMVLNSGLFYLQLIAVFVVTVIASGVFPALYISNFDVLKVLKGNYS
RSKRGIWLRNGMLIFQFAIASFFIIGSYIVYQQVNFMMDKDLGFNGKQVIDIPFNEAKNP
ADYEMIRNELLKIKGVEGVSAGNFSFGSGGYFTTVFEYKGKDIEVENMSMEFGLFDLMGI
QMAEGRKLSEKFASDTINSVIINKTTAALMGEKDPIGKEFDFEDDGDKPGIRRLKVIGVV
EDFNSYGPQREIPPMLFYHLKTVSESSYLSRLYVKISPENMEQTIADIEKFWTTKLDTRY
PLRYDFVDKSFARTYSGYISQRNLFSLLNLVVILIALFGLFALASYSIQNRMKEIAIRKV
LGAETKTLLATLSKQYVVFCIIGFVIALVPAYLLLDKWLENFAYRIAISSVPFLIGFVLL
MVLTLGIVISKAYQATRMNVLKYLKYE
>LONDMIMF_00358 putative ABC transporter ATP-binding protein YknY
MIKIQNLSKVFRTEEVETKALNEISLEVKQGEFVTIMGASGCGKSTLLNIVGLLDDVTSG
SYQLLGKEIRGLKESEKSKIRKQNIGFVFQNFNLIDELSVYDNIELPLIYNNVSASERKK
KVEAMAERLAISHRLKHFPQQLSGGQQQRVAVARALINDPKIILADEPTGNLDSKNGNEV
MELLTDLHANGATILMVTHSDYDASFSQKTILMKDGIILSEKLNSRNVNVLV
>LONDMIMF_00359 hypothetical protein
MQKFLLLVAFLILNFFQLFAQEKGTNNHIKAEGTHFTEPVKDKKWANENGNTYTKARYSE
YEGETFVKITASKDANTLLKYDIKVKKGTLEMRVVNSQNEVLFQKSFSKDEKGETEVLFQ
ENQEYKIKFLGQQTAGSYFCQWIEK
>LONDMIMF_00360 hypothetical protein
MDTIVPRKSRKNKYLLIGLPLFLLAAYIVFSSVTKKRGLDVKKGEITIKTVENAYFEDFI
VFQAKVEPLNSMLLNVIEGGSIQEIFVGNGDFVQKGQPLARLYNPNTELGYMTQETSMIE
QINNLNKVKLDLRNQELNLAKDLVAIEHDYLDAKSLYELNEKLFKEQILSKNEWEKTQEN
FRFQKERKNIIQQSIQKEKQTNQIQIAQINQSQAIIQKSLSILRNNKKNFLVAAPLSGRL
SSFEPVLGKNYLAGESIGKIDVMKGYKLLADVDEFYLEKVSEGQKGEIEYKGEMVQVTVS
KVIPEVKNGRFQVELNFMSTEKLDLRQGLSFGVRLLLSGKSKSTVLSKGSFYEDTSGKWI
FVVEGDKAVRKEISLGRENPLYYEVLGGLKAGDKVVTSSYKDYKEIEILNFK
>LONDMIMF_00361 Transcriptional regulatory protein ZraR
MSDNEHYLSKNEQSMKKTQATILVIDDQEDILFASRMVLKKHFETIYTLNNPKNILDTLS
QNQIDVILLDMNYRIGFEDGREGIYLLKEIKTFSPQTTVILMTAFGKVETAVEGLKAGAF
DYILKPWDNEKLLGVVKAAVEENRKEKKKTAKAPKQDTFFIGSSSGIQKAYSLAEKVAKT
DANVLILGENGTGKYVLANHIHQNSNRNNHPFVHVDLGSLNDNIFESELFGYAKGAFTDA
KNDTPGRFELAQKGTIFLDEIGNVPLQLQAKLLQVIQNKSVTRLGEAKPRQLDVRIITAT
NMDLKQEVTQKNFREDLYYRINTMEITLPPLREQKDDIVPLANFLLARIIEKYDRSEIIF
DNNALAQMERHSWNGNIREMENRIERAVILCENNTITVSDLDLDVISKTESNDDVQLSDV
EKSAIEKVLQKNNFNISKSAEELGLSRASLYRRMEKYKIDNPNGSE
>LONDMIMF_00362 C4-dicarboxylate transport sensor protein DctB
MAPNRNTALLLRFCAILAGITICFFLFQKGLFYTSIFLLLVVLILILELFSAIRNIFLFY
DKTIQAILNNDFSADFSKHASFENYKTLFKLYDNLKVKQNEQVSKDLVYRSILNNIETGV
LILEKEHEDWSIFLMNDYFSNHFQVPKVSKWHYLKNQLPSLCTIIEERSFQEIKTSLQIS
ISKQASQTFILQASKTKTFDREYYIILLDSIQKVIEKKEKEAWINLMKVISHELMNSITP
IRSLTQNLNELMQQESLSKEDLEDIRQSVTTIIHRSDHLQNFVESYRKLAMLPTPDKEVV
ELKPLLENTLEVMAPLFKKGNIIVKNTIESNRRIKADKLQIEQVLINLLTNSIYAVEDKE
KKEIEIVSEEKNGRTFITICDSGTGVDPAIEEKIFLPFFTTRKEGAGIGLTLSKNIIEAH
GGYLSHSNDNGRTSFTICLL
>LONDMIMF_00363 Aquaporin Z
MRKLFAEFFGTFWLVFGGCGSALYAAGIPNLGIGFAGVALAFGLTVLTMAYAVGHISGGH
FNPAVSFGLWAGGRFSGKELVPYILSQVAGGIAAAAVLYLIASGKEGFSIDATKAGAFAA
NGFGSLSPEGYSLEAAFIAELLLTFFFLIIILGATDRFANGKFAGVAIGLGLTLIHLISI
PITNTSVNPARSTSQALFAGGEYISQLWLFWAAPILGAILAGFAYKFLLQNNDES
>LONDMIMF_00364 DNA base-flipping protein
MKEENFFQRVYEVAKQIPYGRVTSYGAIAKYLASSGSARMVGWAMNASHNNEDIPAHRVV
NRVGLLSGKHHFDGTNLMQQLLENEGIEVVDNQVVDFEKHFWDPAIELR
>LONDMIMF_00365 hypothetical protein
MAIAMALLWGILLSAVGIALPGLINMTAAKISVRDGRTRAVYFAVGATVVVFFQTYIAVA
FAKFINSRPDIIYLLQEIGLVLFALLTIYFFFIAKKPKLKEEDSKIRTKTGRFFLGMLLS
ALNFFPIPYYVFVSITLANNGYLQFTPTLIWMFVLGVVVGSFSIFYIYIVFFKKIEHKTN
WMMENMNYFLGSVTGLVAIINLIKIFRN
>LONDMIMF_00366 tRNA (guanine-N(7)-)-methyltransferase
MGSKNKLKRFKENATFGNVFQPTREEVVGGEFPLKGKWNTSFFKNDNPLVLELGCGKGEY
SVGLAEKYPNKNFIGIDIKGARFWRGAKTAVEDGMQNVAFVRTQIELIDHIFGENEVDEI
WITFPDPQIKYKRTKHRMTNSQFLQLYKKILKPDGVVNLKTDSEFMHGYTLGLLHGEGHE
VLYSNHNVYKNEGSPEVVTSIQTFYEKQYLEINKAITYIRFKIK
>LONDMIMF_00367 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MSSKKILVAPLNWGLGHATRCIPIIEALENNGYTPIIASDGVALQMLQKEFPHLQSLELP
SYHIEYAKNGAFFKWKMIKNSPKMIEAILQEKKTIRQWIDEYDIAGIISDNRLGVYSKKI
PSVFITHQLNVLTGNTTWISSKVHQHIIKKFNQCWIPDVETKPNLSGKLGHLENPEENIK
YIGPLSRLHRKPTDKKYDLMVILSGPEPQRGMLEAQLTQEMGQFKGKVVFIKGKIEPEQK
IEQAGNVTYYNFMNTEELENTFNESEIVLCRSGYTTIMDLAQLGKKAFFIPTPGQYEQEY
LAKKLKKEGLVPFARQEDFKIENLLEIDLFKGLKNFGTAITWNKLFCLFEGK
>LONDMIMF_00368 Alkaline phosphatase synthesis sensor protein PhoR
MSVSFKRTYRFAVKSSLYITFFATGMVGILTSVFFTFSWKFCLIFALGIAIFSFFVLQYR
VERFIYRRVKKIYDDVSLLESTNFRSQPITTDMATLTKQVKKFATDKKLEIETLKVREEY
RREFIGNVSHELKTPLFTVQGYLSTLLDGGMKDKTIRKKYLQRAEKGVERLIYIVQDLDM
ITKLEAGELNLVNTRFDILEVIQNVFDLLEMKASEKNILLMFDLKYVKPIYVYGDKEKIQ
QVVTNLVVNSIKYGKEDGTTEVSVEDLVNNKVIVRIMDNGDGIEKQHIPRLFERFYRIDK
SGARSEGGSGLGLSIVKHIIEAHDEKIYVESQVGKGSEFSFTLEKTK
>LONDMIMF_00369 Alkaline phosphatase synthesis transcriptional regulatory protein PhoP
MKKKDIKILLVDDEQDILEIVGYNLSQEGYQIVTASNGKEAILKAKKELPHLIIMDVMMP
EMDGMEACENIRKLPELSNVIITFLTARSEDYSQVAGLDAGADDYIAKPIKPKLLVSKVK
SLLRRLKEEEQNSETLNVGGIEINREEYKIIQDGKEIILPRKEFELFYLLASKPGKVFKR
EEILDKVWGNEVIVGGRTIDVHIRKLREKIGEELFKTIKGVGYKLEV
>LONDMIMF_00370 TonB-dependent receptor SusC
MKIKLLFITLLLSTLGFAQSKSTISGVITDKDLNNETLPFATVTVKGTTTAAQTDLDGKY
TLTVKPGTHVLVFAFLGYESQEETVTIKAGETKTINKALSSGSVTLEDVVIESVQSREKE
TALLLEQQKAVNITQSIGAQELARKGVSNAAAAVTKVTGISKQEGSSGIFVRGLGDRYNS
TTLNGLPLPSNEPTNKNVALDLFSTDVIQSVGVSKTYYTDSYGDVGGANINIVSKEHNGK
GKLNVEIGSGLNSNAANSIFKVADGIKKTGFYDVKKPNNINTYQFQNRWVPNTESHPVDI
NFGINGGTSFDIGEEGRLNIFATASFENGYNLKKGSQKNIGNTNDNIIEDFYNVNKYEYV
TKTTGMANLAYKINSDHSLKLNSVFVNSSKSDVNEYDFFNENGTNSFTRQTITEQNKLFV
NQLLGKNALNERLELNWGGSYGIVNSDMPDRITSTLLEGTNGFTFNTNSQSTNNRYFQSL
KENEVAAKAVFSYKLFKGEGEDYKGKLSFGYNGKMKTRDFEATQFNFRINGSVATTESTI
DDFLNATNQSNATNIDNTFKILTSRNAGSLKPFTYSADLDVHSGLVNFEYSPSEKLTYTV
GVRAEKVLQEMKWDTNISLPNVNFNDAKIDELYILPVATLKYSLNDKQNLRAAVSKTYTL
PQFIEKAPFRFEVVGESTVGNAFLNPSDNYNVDIKWEMFPNKEELISITGFGKYIIDPIS
KARLNSALNDNTFVNAGDNAFVVGAEFEIRKNIWNVEDKQNLSAGFNFTYMYSEQKLDSE
KVASETNNTISVSFNDTKDGLQGASPLLVNADITYRIESGTFKPTISLVGNYFHDRIYSL
GNIQTGGNVMEKGIPTLNLISSAAIGDRLNISFNVKNLLDSKIERYQENAQGDATTYSFK
TGLDFSLGIKYNLF
>LONDMIMF_00371 hypothetical protein
MKKLVFSLAILGTLFTSCSSDDSNNGPTVPETGILSGNITQDMTLNAGTLYTLRGSTYVK
PGVTLTIPAGTKIEADADFEEVAFLAIEKGAKIIAQGTAANPIVFTSNSSNPAPQDWGGL
VICGNAITNLGTNVTAEVTGLTYGGTNPADNSGILSHIIVKYSGNLINEDAEFNGVTFYA
VGSGTTVNNILVYQGSDDGFEWFGGSVNATNLAAIGCQDDSFDWTEGWNGTVSNLYSDQS
SATGLSADSRGVEADNNQTNPLLTPISNPTLSNITLIGRGLANVPKEGGIWLRRGTHATI
TNAYVANFKSTASGSGFGINFDGTDSQNFFTANPLSNITIVGVTTPSNMAAGFNATTTAT
GAGAGAAKPSWMNWMGL
>LONDMIMF_00372 hypothetical protein
MPFILKGIFFGIIIEICFIYLQYQIHAMAKKYFYIIFFFLFLFSARVLAQESRPAANGKT
QETTIEGLSFYPNPVSNGKIYITSKSTLDKEIAIYDVLGKKVLQSVVTSKELNVSSLSPG
VYIIKIKEGEATATRKLIVK
>LONDMIMF_00373 hypothetical protein
MKKLYISLFIIALGFNATAQNLVNNPTFNNGLTGWTAGFVNTYTLPTLVAGDGSDGSNSA
QYIATATTGFYQDVAITGGHTLKISFWYKSAAGADARARIWSNYKDAGGTVIYQAAVGDD
PLRTNNLFLPAATTWTKHEITVVAPATATVFTFAVRAYNGGTVNFDQFSVEDMSLGVKEN
NIAGLKVYPNPVTNGKLFITSDANVEKTVAIYDVLGKQVVNTTATESVNVSNLKGGVYIV
KITEEGKTATRKLVIK
>LONDMIMF_00374 hypothetical protein
MRKFYILLLAVSFGNGYSQTVIFSENMGTPPTNPAQTPIASHTFQNSNPIIFSGDAVMVL
PNNPDIAMPSSGYEGASGGGCTAIFATDKTFMIEGINTSNYSNITLSFGQLKGNSQNSNT
ITIETSPDGAVWTPLTYTGVVGSLTTWSLITTTGTIPATENLRIRFKNPPSTVSAFRIDD
IKLTGTTLGVKENNISGLKVYPNPVTNGKLFITSDANIEKTVAIYDVLGKQVINTTATDL
VNVSNLKGGVYIVKIIEEGKTDTRKLVIK
>LONDMIMF_00375 hypothetical protein
MKTKQLFLTVSLVASFFTAKAQNVQSDSLATSGGLNAGITTTAPGGNTFYGYYAGSVSSG
NRNTYIGERTGFYSAGNDNVHLGWRAGTVTGSRNVLIGNNSGNEEKGHMGSGNVFIGYNS
GFSESESNNKLVIGNDETVQLIWGDFAQNLLKFNGKVGIGYGFGNFPTTAGSVNVAAYNL
FVKGGILTEEVRVNLQSDWADYVFDKNYNLKPLEEVETFIKENGHLENVPSAKQVKEEGI
ELGEITKIQQEKIEELTLYLIELNKENKMLQKKLLELEEKINSSNTKN
>LONDMIMF_00376 hypothetical protein
MKLTNFLSVGVLLCTITAFSQNVASTATLTSGGLNAGTSGTRNTFYGYQAGKLTTTGSNN
TFIGESGLGNKVGSDNVFIGNSSGNVNNGNQNVFIGAESGSVENDGNENTFLGFGAGRES
NGNKNIFIGAHAGHGVSGNNQLYIDVQETYNPLIWGDFAQDQLKFNGKVGIGNGFGNFPT
TAGSVNVSNYNLFVKGGILTEEVRVNLQSAWADYVFDENYKLKSLKEVETFIKENGHLEN
VPSAKQVKDEGLELGEMVKIQQEKIEELTLYIIEQNKINERQNKELQELKEILKSIIK
>LONDMIMF_00377 hypothetical protein
MKNLYKILFMLLIGINCFGQKIEDRPTCATDELLNQLIKNNPEVKERLNQLDNVANEESK
NLNRSTSFPTVTIPVVVYVIHENGPENISDAQVTSQITALNNYFNPYGIKFCLATKAGNN
VLSGGIQTSPGILHNANSDLTNHNALTEQGALSNMAINLSSDNFLRIFVVKNISNTGASS
PTLGYSVMPGTSITFDGIVVRYDVFGDNTCNGCNFNLLPNYNQGKTLVHEIGHYLGLYHT
FHEGCSGMNSGNCNLQGDRVCDTPPVATPNFGCVTGTNSCHESSPDLPDSIHNYMDYGND
SCLNEFSPGQIQRMLNVLTNYKSTLTSSDNQIYTGTCGYQNLLSATFTANNFAPCVNTPV
TFDPLSTGSGISYLWDFGDPSSGANNTSTLANPSHLFTSTSNSPYLVTLTVMRGTESVIS
KSYITVTNCQPINNADKNWLLSSSNILDFSTGTPIANGSLPNGNSFAEACAFQNDANGNL
LFYTDNLNVWNNLHARINTTTPLFGDQSSKSGSLIIPNPANTNQYYIFTKESQERLKGFR
YSLVNVNNGVATMSSTINQPINFPSNLGYLAGDNGALYGGEGLAAIEKCNGYWIITSLKK
STGYSLIVYSLTTNGLAYQSEFQITSTSQNNQIASVKISPDGNKLAYTSYNNAILLFDFN
KFEGTISNQRQVSNYGVYGICFSPDSNLLYVADQGNEIHQYNLNSNNIQNSRIKVAKEPN
QLGDIQQGPDNKLYVSIMFTKRLGVIHSPNNLITESNPNACFYTRNGPSVEKDLSFSLPN
IVTKFSSVYNNTITATPTDCFTYKFAPNVCGNNFSWNFGDPGSGSNNTSSQSNPTHIFSG
YGTYTITLNAGTTTITYNLNISAINPMILGSTTACLATSRVTNNSVVLAPGQKALWSVSG
GVISGLNNQSDLTVNWSSLPGTITLTVTNATGCSSTVTKTITSQCGGQPTCDANLTFNNT
QTATAQHQASQTITTNTNYIVNNGINIDLKAGQTVVISPNAHIKNGSVFLAHIGPCTQSK
AQKQSDTKPVVNTIDQVLIYPNPTPDFVNIELSDSLMTEITVNSIEGRLIHYKKTSNVNY
YSLDLSPYEKGVYLLNLKTSTGKSVTKKIVKQ
>LONDMIMF_00378 hypothetical protein
MNLTKTLCAGFLLGGIFSANSQNVASTNLLTSGGLDAGTVEKENAFYGYQAGRFTENAYN
SFFGHLAGAKNVSGDSNSFFGHQAGINNGEGSSNTFIGASAGSYNYDGRHNVYVGYASGA
SNQGNTNTFIGAYSGAKATGEGNVLIGSYAGYGETDSNKLHINNAYNVTPLIWGDFSKYL
IKLNGKVGIGNDFGAFPIFAGGLDISHYRLIVKGGILTEEVRINLQADWADYVFSDSYKL
KSLEEVEKYIEDNGHLPNVPSAKQVKEEGIELGEITKIQQEKIEELTLYLIQQNKEIQEL
KEMVKNLKQ
>LONDMIMF_00379 hypothetical protein
MKNLYRKPKTGLLILFCFLAGSLHSELYSQEQIIWDNVPVNTTGITATYSGGTLNVMATG
TGLNMVFYSIPANPTVFQTTGAWNNAPSKDLTFTFPEKVIITRFRVYDINYGTWNDSFSF
SNITFGGVTASAGCCATTSGVTVSAGTSPNTDVHWLCSNAVDNFTINYANTNGTTHAYLF
YTMEILRLPSIGTLCYNSIPPTLPTTLGNNIQGSWSPATIDTSVAGTTQYVFTPNGGQTI
QCPIAIDVTVLPPGQQNCCVPDITLTSPTDDVASGNQDNRETSNTITAQNTINSGAVGVY
HAKRTITLKKGFYSANGSRFRGYIQGCTGTFVGRESPTAETTDLKKLITDTPVTEKLLLY
PNPATQKATIEYQQPIRNIRVTSIDGKTMLSKELDANSYEIDLANYKNGMYIVTVQTGDG
RTITSKLFKK
>LONDMIMF_00380 hypothetical protein
MIAASDIFSISNNKQFEKIALKVFRFQYDNNSVYREFCQFLNVEKQQVKSLQQIPFLPIQ
FFKSHEVLSSTEKIQETFTSSGTTGMSTSRHFVTDITLYEESYQKGFAQFYGNIENHAVL
ALLPSYLEREGSSLIYMVDDLIKLSNHPESGFYLNNYDDLIQKLLQLDEAGENIILIGVT
YALLDLIEKQQFHLKNTIIMETGGMKGKRKEMIREELHELLCKGFGVNAIHSEYGMTELL
SQAYSLGNGIFECPNWMQVLIRDTEDALSYVENGKTGGINVIDLANINSCSFIATQDLGK
KQPNNSFEVLGRFDNSDIRGCNLMVL
>LONDMIMF_00381 Putative malate transporter YflS
MKEIKLSRLAITVLFGAAIWLSPVPEGVKPEAWHLLAIFLATILGIILKAASMGTMCMMA
VAAVALSGVLAPGNPSKSISLALRSFGDKVIWLIGISFFIARGFIKTGLGNRIAYLFVRI
FGKSSLGLAYGLGLADLALAPAIPSNTARGGGIIYPIMKSMSISFDSVPDKPETHRKLGS
FLTLNSYNMNLIASSMFLTGTASNPMCQKFAADLGIHITWMSWAIAGIVPGLVAFFVIPM
VLYKVYPPELKKTGDAPALAKQKLAEMGPVTKNEWLMLLAFTVLLFLWITGDLFGIDATT
TAFLGLVLLLLTSVLTWEDVKAEKGAWDTIVWFAVLVMMASSLNELGFIGWFSELIKTKI
GDLSWQIAFPVIMIVYFLSHYLFASATAHVAAMYAALLGVGVSIGIPGLLLAFMLGFCGS
FYGTLTHYGHGPAPVFFGSGFVDIKNWWTKGLITGVIMLVIYMVIGGLWMKVIGYY
>LONDMIMF_00382 hypothetical protein
MDIFRYFQNTVLKISFLICLLSSDGVFSQTSQADENEKKEATTYPKFSVKGLFQGQYVAS
LNTNVDINGLHHSDGEEVSNTFLVKRGRLQVKAIISDRTDVTMSVNLADFKSDPKNKVLE
NAYISYKLTDKISLTAGQFRPFFGLENTYPIDIVKSIDFSNQYYEFGNNGWESFQIGASV
SVRDSIGRMPVQYGLTVFNGNGRNQNNDKDNGKQYAGRVLFRLSEKNNVNLGLNGGLGQV
FHKDVYAAGFDITSNFSLSEKFLLELQLEAKQGTNHNLFFNLQPEERIYNLNRYQTRGFY
FLPNLRYDIQYRRLSSIEFSCRYEYLDSSYRVNSNLRQTWLPMLSLEFLKSYNARIQLAM
QIDDYKRNVPDTPKYDNKLFILQVQSRF
>LONDMIMF_00383 Tyrosine--tRNA ligase 1
MKNLVEELKWRGLYHDSMPGTEEQLLKEATTAYIGFDPTADSLHIGSMVQIILLVHLKNF
GHQPIALVGGATGMIGDPSGKSDERNLLNEETLAKNVAGIKSVLSRFLDFGTEGKNAPFM
VNNYDWMKEFSFIDFAREVGKRITVNYMMAKDSVKKRFSGEGEGMSFTEFTYQLIQGYDF
YHLYKNYNCLLQMGGSDQWGNITTGTELVRRMGGENAKAYALTTPLITKADGSKFGKSEG
GNIWLDADKTSVYKFYQFWVNTTDVDAEKYIKIFTFLDKDTIEALIEEHRQAPHLRILQK
KLAEEITVFVHSREELEKAIQASNILFGNATSEDLKQLDGATFLEVFDGVPQAEVEKGDV
ENGIDIVSLLNEKTGFLKSNGEARRALSENSISVNREKVTEESQVSSKDLINGQFILLQR
GKKNYFVVRAV
>LONDMIMF_00384 dTDP-4-oxo-6-deoxy-D-allose reductase
MVLVTGATGLVGSHLLLLLLENGEEVRALYRNEKNIQQTKALFEWKGRLDIFTKINWVQG
CLTDIPSLEKAFENIDYVYHCAAFISFDPGDEEQMRKTNIEGTANIVNMCLSYNVKKLCH
VSSIAALGDLQEHETIITEETEWNPEISRSDYAISKFGAEMEVWRGQEEGLPVVIVNPGI
ILGPGFWNSGSSEIFQRVKKGLKYYTEGATGFVTVEDVTRSMYQLMKSNIQKERFILVTE
SITYHRLADLIATSLGKPKPSVYLKPWVTGLAWRIDWLISTFFFKKRQLSKATAASLHTQ
SEFDNSKIKNALNFEFEDIPNYISKVSATV
>LONDMIMF_00385 hypothetical protein
MKKYFLLFVLLSVVACQEKAVEKPANLIPKDKMKNIIYDLAILQAMKGVNQAALDSNGID
PATYVYKKYKVDSLQFAKSDQYYAIENVKEYEKMYNEISELAGKEKMRIDSELKKEADTT
KILERKFEVKQKKDNVKQ
>LONDMIMF_00386 Allantoinase
MKSVLIKNAKIVNEGTIFEGDVLIENEFIVEIAETISAKSSSTKIINAEGNYLIPGAIDD
QVHFREPGLTHKGDIASESRAAVAGGITSFIEMPNTNPQATTIELLEDKFKIASEKSIAN
YSFMFGGTNDNLEEILKVNPKTVAGLKLFLGSSTGNMLVDNDEVLEKIFASTPLLIAVHC
EDETTIKNNLAKYKEEYGDDIPMKFHHLIRSEEACYLSSSKAIELAKKTGARLHVFHLST
AKEMKLFTNKIPLEEKKITAEACIHHLWFTNEDYDKKGSLIKWNPAVKTQADKDALWEAL
LDDRIDVIATDHAPHTLEEKKNPYTSAPSGGPLVQHAVVAMFEAFHQGKISVEKIVEKMA
HNPAKIFKINKRGFIKEGYYADLAIVNAGLPWSVKKENILYKCGWSPFEGYTFKSRITHT
FVNGELVYNNFKVKDVHPGMRLEFDR
>LONDMIMF_00387 Polyprenol monophosphomannose synthase
MNDGIVIIPTYNEIENIESIIRTVFSLQKPFHVLIIDDNSPDHTAQKVIALQEEYPGRLF
LEQRSKKSGLGTAYVHGFKWALEREYEYIFEMDADFSHNPHDLEKLYDSCRFGIYDVAIG
SRYVTGVNVVNWPLSRVLLSYFASVYVRMITGMEIRDTTAGFVCYKKNVLKSINLDKIKF
IGYAFQIEMKYRAYAKKFKIVEVPIIFTDRTKGQSKMSNSIIKEAIFGVIVLRVKKMFNN
L
>LONDMIMF_00388 hypothetical protein
MLEIVLQPRILESKDWATVLFVLCFILIAATRGVFEGRFSDFSRLAYSDKYIKIYRDSGN
LMNWFTISLFIVQVISFAFFIQIILSYFGYTSKTDWVTYIQIVTLLSIFILSKYLIEKII
ATSFNIEEFSEQFNLQKVSYRTYIGLCILPLNVILFYNDTPIDLLIYFLIAIILLINILT
YLLSLKIYQNLIIGKLFYFILYLCALEIAPYYFMYYWFTKR
>LONDMIMF_00389 hypothetical protein
MKVKTILVSQPEPKVENSPYFELQQKHKVKIDFRPFIHVEGVSAKDVRQQKIDLNNFTAI
ILTSKNSIDHFFRVAEEMRYKIPEDLKYFCQSEAIAFYLQKYVIYRKRKIYVGQKDFADL
SPLIKKYKDEKFLLPASDQLNADAPQTLNNLKVNWTQATFYKTVMSDLSDLADVYYDVLA
FFSPTGIKSLFMNFPDFEQNNTRIAVFGSTTQKEALDHGLRVDIMAPSPEAPSMTMALEK
YIAKANKEDKGK
>LONDMIMF_00390 Phosphoenolpyruvate carboxykinase (ATP)
MDNYTQFTKTISLEKYGIKNVEEVIYNPSYEMLYAEELNPNLKGFEKGQLTELGAVNVMT
GDFTGRSPKDKYIVQDDVTKDTIWWTSDKAVNDNKPISPQTWEALKKTTVDQLSGKKLYV
VDAFCGANENTRLKVRFIVEVAWQAHFVKNMFIRPTEEELENYGEPDFVVMNASKTEFSD
YKAHGLNSEVYIAFNLTEKVQIIGGTWYGGEMKKGLFAMMNYYLPLQGIASMHCSANKGK
DGDVAVFFGLSGTGKTTLSTDPKRELIGDDEHGWDNDGVFNFEGGCYAKTIDLSKENEPD
IYNAIKKDALLENVTVDANGKIDFKDGSVTQNTRVSYPIYHIDNIVKPVSKAGHASKVIF
LTADAFGVMPPVAKLSPEQTKYHFLSGFTAKLAGTERGVTKPEPTFSACFGKAFLSLHPT
QYGQELVKKMEEHKATAYLVNTGWNGTGKRISIKNTRAIIDRILDGSLEKAETTTLPIFN
FEIPTALEGVDSDILDPRKTYADPSEWETKATDLGKLFVKNFAQYATNEEGQNLVKAGPQ
VD
>LONDMIMF_00391 hypothetical protein
MDRKIIAAAAILGFVAIILGAFGAHALKKVLDVEQLVSFETGVRYQMYHALFLLFLGTTK
LVSDKTKSTIYYLVISGVLFFSGSIYLLATRNITNIDFSVIGFITPIGGLLMIIAWALLF
LNILKQKA
>LONDMIMF_00392 Shikimate dehydrogenase (NADP(+))
MRHILIIGAGRSASSLIQYLLNKSEEENLHLTIGDLSLELAQRKTKNHKNATAIAFDIFN
ESQRKEEIQKADIVISMLPAHMHIEVAKDCITYKKHMVTASYISEAMQNLDAQAKENNLV
FMNEIGLDPGIDHMSAMKVIDEIRDKGGKIILFESFCGGLVAPESDNNLWNYKFTWNPRN
VVLAGQGGAAKFIQEGTYKYIPYHKLFRRTEFMEVEGYGRFEGYANRDSLKYRSVYGLDD
ALTLYRGTIRRVGFSKAWNMFVQLGMTDDSYVMENSETMTYREFTNSFLPYHPTDSVEIK
LRLILKIDQDDIKWDKLLELDLFNNKKIVGLKNATPAQILEKILSESWSLEEHDKDMIVM
YHKFGYVLNGKEKQIDSTMVCIGDDQTYTAMAKTVGLPVAIATLQILNGNIKTPGVQLPI
HKEVYLPILKELENYGVTFNEKEVPYMGYNPMHVAG
>LONDMIMF_00393 Regulatory protein AsnC
MKINSLQIEIDGIDKEILRNLMEDARKPILQIANKIGISGAAIHQRLRKLEQAGVISGSK
FVVNTKVLGYSTMAFVGIYLDKAARNPEAVRELRKIPEVLECHYTTGNWSILIKMICRDN
EHLMQLLNTKIQVIEGVSRTETFISLDQQIERQIQL
>LONDMIMF_00394 RNA-splicing ligase RtcB
MGNKLSGKDLIKLGFPKNNSINIALGQINRYRKREKKESILAEAKEVLLHPEKFNGHGTW
GKVAEGLVNPVQVRMHQLKTTRAPFTIFGENEIDEQAKFQLYDSLKLPISIAGALMPDAH
SGYGLPIGGVLATDNAVIPYGVGVDIGCRMSLSVFDLPASFLKGKDDQLQAILKDHTKFG
MYETHAIKADHEVFYRKEFQDIPLLKRLLDKAYKQLGTSGGGNHFVEFGIVKIDNPLREW
KIEAGEYFAVLSHSGSRGLGANIAKHYTYLATKQCPLPRNVQHLAWLDLNTHDGQEYWLA
MNLAGDYAKACHDDIHRRIAKILGKRVVVTIENHHNFAWKEMVDGKECIVHRKGATPAAE
GQLGIIPGSMTAPGYIVRGKGNAASLNSASHGAGRLFSRAKCKSTFTQSEINKVLKTNNV
TLIGGNIDEAPMAYKDITKVMENQSDLVEVLGTFTPKIVRMDR
>LONDMIMF_00395 Peptide chain release factor RF2
MEKIIQITAGRGPAECTWVVAQVLKKVLAEAQELQLEAVLLQRQAGSENGTVETATVSVK
GKDVSMFVASWVGTIQWIGQSQFRKMHKRKNWFIGIFEIENQKSQTISENEIQYQAMRSS
GAGGQHVNKVSSAIRATHLPTGITAVAMDSRSQHQNKKLATERLFKKLESENLQQLKEQV
GKQWENQLNIQRGNPIRIFAGTDFKKNKIEKSYKGTRRKLKTDLRNENN
>LONDMIMF_00396 hypothetical protein
MKTIDKYVFQALDSYPYSLEETIESLDYAFSYDAKNTMVLCLYGRIQAEQLLNYEAAKNY
FEEAFTINIHALEVYPYYIQTLILNEDYEEAMRLIDFALTIKGISKADIFVKKAILFEVQ
HKFKKAMKEIRNAKLYSIHYDSESVIRDVEKRIKSKMELIKKKAKKKSN
>LONDMIMF_00397 hypothetical protein
MRALKIISDLLPIPSYTVILICFFFPFITIKCGTTELVSVTGFDYVVGTDMKEKMKDNEF
SKKLEKQLGKDLFGAAGANLDSLDVDEDGNPIKADSLPLPEETPDEKSSRIVMMIMMGIP
FFMAIAGLILSFVKARRKGLLHIIFSSIGFIVLLIFGIIIKSSDELNAVSSMADGMGGGM
ISIGMGTAYYMATILFLLVIMFFGMLKYLKNLYKEEQAIREEALDEFLTKE
>LONDMIMF_00398 hypothetical protein
MNPTVFLITPPFTQLNTPYPATAYIKGFLNTKNISSFQADLGIEVILELFSRKGLTDLFS
EAEKATDKSDNAKRILALREEYIKTIDSVMLFLQGKNPTLSHLICQEDFLPEASRFLQLE
ELDWAFGTMGTQDKAKHLATLYLEDISDFIVECVDENFGFSRYAERMGRSANSFDALYDM
LHREPTYIDRLLLGNLDRKMKELQPKLVCFSVPFPGNLYSAFKSAQFIKKQYPDTKIAMG
GGFPNTELRSLSDIRVMDFFDYITLDDGEAPIEELILNIENPEYDSWKRTFLLVDGKIAY
KNNSSKKDYKQSEVGTPDYSDLLLDSYISVIEIVNPMHRMWSDGRWNKLTMAHGCYWGKC
TFCDISLDYIKVYEPVAARLLCDRMEELIAQTGQNGFHFVDEAAPPALMRALALEILRRK
LAVTWWTNIRFEKSFTRDLCLLLKASGCIAVSGGLEVASDRLLELIQKGVTVAQVARVTR
NFTEAGIMVHAYLMYGFPTQTAQETIDSLEMVRQLFEMGVLQSGFWHQFAMTAHSPVGMY
PEKFGVLKETEVLGSFANNDIVHVDKTGTDHDAFSYGLKKSLFNYMHGICFDFPLQDWFD
FKVPRTKIPGDYIYNAIHEDENSFAKPTAKVIWLGNKPVISTYTKSKKGNSWEMASLAFH
TKKEAFAISVGKEQGIWLGAILEKITVSNLKTYTYQEIKTDYENSGFEDFELFWYSKPIN
SLREQGLLVL
>LONDMIMF_00399 hypothetical protein
MKTGLFFIAIFFLMLCPDTASAQYYNDFGGGVDRSIGSEVRQNKPKKNSKEKVDMGENWA
TYLDKEIKLDGLQFAAVKAIINDNKNSIEEISKSNLHVQEKKDKMREIMDKIDVEILKLL
SKDQAAKYLKMKEDSEKKAMTN
>LONDMIMF_00400 hypothetical protein
MEINWITIAIVVLIGLILIVFLMKRNLKDQKEVEKFFNEEYKAKPENESEVNDNDR
>LONDMIMF_00401 Putative ribosomal N-acetyltransferase YdaF
MYYPLFPENSDIFLITFILSIIYYFNMTFFTIETERLHLRKIDLEAYQYIYEHFSEKELS
EFLGINTPEKLQKEKEKFKKGITTYNKSMLLFQLLDKKNNKVIGGCGYHTWYLDHARAEI
GYALTDDNFKRMGLMSEALPPVLDYGFDKMQLHRVEAFISPTNNASIQLVKKFGFVKEGV
MRQHYQKEGQFENSEIYSLLKEEHQKR
>LONDMIMF_00402 hypothetical protein
MEIKIGTKLILQVLHVLSWIIFLGLCFEAGALIVNAIMTLTLDATEIKHLWMLIDLSDLY
KYGSHHYVVIMSQIIIVAVLKALMFYLIVKILYENKLDMAQPFNQAMGRFISLISYLALG
IGFFSAWGEKYTKGLIMEGVSMPGLDDMHFDGSDVWLFMGIILLIIAQIFKRGIEIQTEN
DLTI
>LONDMIMF_00403 hypothetical protein
MPIIVNLDVMMAKRKMSLNELSEKVDITLSNLSILKTGKAKAVRFSTLEAICKALDCQPA
DILEYQPDTK
>LONDMIMF_00404 hypothetical protein
MTSNKYTVVSYIEGFRTYDHKKILSCLAEDIVWDMPGFFHLIGKEAFDKEIEKNHFIENP
EIEIISLTEENDTVVVEGKIKCNFRSGDLLNAAFCDVFQMENGKIKKLTSYQMTR
>LONDMIMF_00405 hypothetical protein
MKTVIISLLFVVGFTARAQTEEEIVEKRIDEAQKLFHFSQDYQAEMDKIVKDYPRSAYAW
QQKAMPLFKQGKYEYAMPFLDKAVALNPKLYMDYRAFMKCIFGKRYVEAIEDFEAAKKLS
GNSYVMDHTYDFYIALSYLQLGRFAEAEQILEADREAHLATSSVEPHFLDVFYMGIAKYE
LGKYEEAIAQFDISIGTYREFSDAEYYKALCLIKLGRNNEAEKLMQKAITDYRNGFTINE
DNVVYERYPYQVYFLK
>LONDMIMF_00406 Ribosomal protein S12 methylthiotransferase RimO
MRTKSLKKNKINVITLGCSKNVYDSEVLMGQLRASGKDVTHEAPAHEEGNIIVINTCGFI
DNAKEESVNMILNYVDKKEQGLVDKVFVTGCLSERYKPDLIKEIPNVDQYFGTTELPGLL
KALGADYRHELLGERLTTTPKNYAYLKIAEGCDRPCSFCAIPLMRGKHVSQPIEKLVNEA
KGLAKNGVKELILIAQDLTYYGLDLYKKRNLAELLENLAAVEGIEWIRLHYAFPTGFPMD
VLELMKREPKICNYLDIPLQHISDNILKSMRRGTTQAKTTKLIEDFRNTVPGMTIRTTLI
VGYPGETEEDFQILKNWVEEMRFERLGCFAYSHEENTHAYLLEDDVPAEVKQQRANEIME
LQSQISWELNQEKIGQVFRCIIDRKEGNHFVGRTEFDSPDVDNEVLIDASKAYLKTGEFV
NVRITDAAEFDLYGEAVL
>LONDMIMF_00407 Murein DD-endopeptidase MepM
MFFLLLAPLMLLAQQRDVKVYREFIEGKTVVFADNNEFCPVSVLIRTELLNMKSSLKAPY
VLVPAKAKRFLLMEISVINLKKEFNFKYQSSFFLGDINLRKYDIDFPYSLPYKEGEEYSI
GQGYNGKISHQGEFALDFIMPVGTEITAARDGIVVDVQDSNTETCMSKDCAEFNNYIVIY
HEDGTMAEYTHIDTKGSLVKKGDVVKRGDKIGLSGNIGWSSGPHLHFFSFVSDIEKGRRS
IRTKFRTEGNKLEFLQEKKSYKKDYEF
>LONDMIMF_00408 hypothetical protein
MKKYFLFMIAGFALSAQAQEVSDAMRYAQDNLTGTARFRGMSGAFGALGGDFSAIGVNPA
GSAVFTTNQIAITLSNYSISNKSRYFGTTTKERDNSFDLNQLGAIWVFENEDASSNWKKF
TVAANYENVSNFDNQFHAAGFNPTNSVSQYFSSHANGIPLGDITNLPFEALTYREQQAYF
GYYGYLINPATNTDNNTVYTPNAPVGGNYFQENFIETSGYNGKLSFNGGVQYTDRFYFGL
SLNSHFTDYTRVTNFYEDYLDTPGNNPNSGPQALRFRNELYTYGNGFSFQVGAIAKVTPE
FRIGLAYESPTWFRLNEELRQNLVVDCPDCGTRNPVIVDPNVTMIYPSYRLQTPGKYTGS
LAYVFGKYGLISVDYAMKDYSNIRFRPSNDYRQTNAQLESLLDVTSEVRIGAEAKAKQWS
FRGGYRFEQSPYKNGKTVGDLQGFSAGLGYNFGGTRLDAAYSYAKRDIQQTFFSQGLVDP
TTVKTVSNNVTLTLLMDL
>LONDMIMF_00409 hypothetical protein
MKTYYISPKLASLYSLIGLLAILMTSCGSYQNSSYYDSDGVYNNNERRSNTTANNESSNG
YREYFRSLQDDPEIFTDSNNYASPAYNDTTYVATAASYPAWGSNSDNVTVNIYDNSWGWN
NWYGPGWGWGLGWGGWYGGWGWNSWYGPSWGLGWGWGWNNWYYPYYGGWNHWHGGHYYNN
YAYANGRRSYYANNSFGRNNYYRSNSATRSYRSNNAYNTSRRGEGTYYSNRNSTRYNTTG
TRSSSTTNSRDYNSSSRDYNTTRNSYNTTRNNSNNYSTPSRSNSTRSQNVAPSRPSYSSP
SSSGGGRSSGGGSYGGGGRSGGGGGGRRG
>LONDMIMF_00410 Proline--tRNA ligase
MSKNLTKRSEDYSKWYNELVVKADLAENSGVRGCMVIKPYGYAIWEKMQAELDRMFKETG
HQNAYFPLFVPKSMFEAEEKNAEGFAKECAIVTHYRLKNDPDKPGKLMVDPNARLEEELI
VRPTSEAIIWSTYKGWVQSYRDLPLLINQWANVVRWEMRTRLFLRTAEFLWQEGHTAHAT
QSEAIAESEQMMNVYADFVQNFMAIPVIKGVKTETERFAGAVETYCIEALMQDGKALQAG
TSHFLGQNFAKAFDVKFANAEGKQEHVWGTSWGVSTRLMGALVMTHSDDNGLVLPPNLAP
IQVVIVPIYKTDEEFAAITEAANTLVSQLRKLRISVKFDDRTTQKPGFKFAEWELKGVPV
RVAVGPKDLENGTFEVARRDTLSKEVVLKDNIVNHINSLLEEIQDSLFSKALEYRDTHVT
EVNSFDEFKDVLENKGGFIAAHWDGTPETEEKIKDLTKATIRCIALDRVEESGSCVFTGK
PSVGRVLFAKAY
>LONDMIMF_00413 30S ribosomal protein S20
MANHKSALKRIRSNEKKRVLNRYQHKTTRNAIKALRLATDKSDAAAKLSGVISMIDKLAK
KNIIHNNKAANLKSKLTKHVSAL
>LONDMIMF_00414 Chemotaxis protein CheY
MLHKILCVDDDPITLMLYKMVIAKASFTEEIITAKNGQEAMDYYEKLKANNETLCPELIF
LDLNMPVMGGWEFLDNFTKKEYQEFNTKTKVIVLSSTIDPTDIEKSKTYPIVIDFLSKPI
TKEMLEDLKDKL
>LONDMIMF_00415 Phytochrome-like protein cph1
MTFQKEGIHFLIIEDNQGDLVLIKDYIREEFRHPVFYEARNLKEARNILNTEEKIDIIFL
DLILPDGEGERLLNEIIPISRDIPIIILTGFSDKEFSIKSLSYGVSDYLQKEDLNASLLF
KTILYNIERKKIAQKLSDSEKKYKDIFQYSPLPKLVYDIETLHVLDANDAAIRKYGYTRE
EFLNLKASTLVAKDDTEKAMALVKSLRENGKFVEMSFKHTTKNSETIDVITQGNEINFNG
KRARLVLVTDVTERLKTEKENELNEQRFKALVQDGSELISILDTDGVFTYISPNVQTNYG
INPDDYIGLNAFDQLHPDEKEIFKQEFSRLKTEKRIATRPFRYIGINDNWRWLEANVIDM
RDNAAVNGIVLNARDVTERIENELKIKESNLRYEAIAKATSDAIYEFDAETKKIYIAGSN
YKKLFGFDFKDLQYLDLDFWVSRLHPDEREEVREKIAAIKEDSSDSHHEIEYRFRKQDDT
YAHVLDRFDLIWEDGKQVKKIGALQDITTRKFQETILAFEKDTYRLNAEPNKSLKDVLEK
VIQNIETLMPDALCSIIEIKNHKIKHFVGNSLPKSYVDSINDIDSKKSIFKNESAFISDI
EKEPLCKNFAPAAIANGLKSCWSIPIRKTDGSSLASFVTYYKTNREPNPNEIYLLDRIAN
LVGVVIENRRAGEELKEAIDRYDIVAKATSDTIWDWKIQEDDFQWNKGIRSVFGYKKEDV
GDTSKWWFDRIHPEDSLRVSVKLYNFLEKKVEKWQDEYRFKCIDGTYKHVFDRGFLIKNS
NGKPIRMIGSMQDVTKQKEEEQRLKLLETVITQAKDAVIITDNDTSETSIPKIIFANQAF
AEMSGYKASEVIGKSPLLFRGKNSDESELKKLVTAIKNEEETQIETISYKKNGEEYWVSF
SMIPITNKEGQLSHWISIQRDITLLKRQEKEREQLIRELTQNNKDLKQFSYITSHNLRAP
LSNLTGLLNLIEDIPIENDDLKLILNGFTKSTHLLNETINDLVKVVIIKDNPSIQKEEVL
FSEVFETVFDQLSYLINLHQPILKINLENDSLSNMNKAYLESIMLNLLTNAIKYRNPAKK
LKITITTKEKVDKTILTFEDNGIGIDIERNKDKIFGLYQRFHNYPDSKGLGLYLVKSQVE
TMGGTIDVQSQVNKGTKFTLTFKKE
>LONDMIMF_00416 Response regulator rcp1
MESIVILLIEDNEGDILLTREALGYGSIRKEISIVKDGWEAIQFLEKKGAYKNAIMPDLI
LLDINLPKLNGHEVLARIKSNPQIQHIPVIMLTTSSSESDILKSYQNHVNCFITKPIEAD
NFLETVAAIEEFWLSMVQLPKK
>LONDMIMF_00417 Phytochrome-like protein cph1
MYKPSNKIISIYLVIGILWILVSDRSFAYFGFNGDSILFQTLKGIGFIVASGALFWVMLR
RYENKNQKYLNRLKNITEELTLSNNRYTVVTKATNNIIWDWDFKKGRVIWGESLTRIFGY
PELENHSTWWTNKIHPEDKERVAKRFDKFIETSNKEKWSDEYRIITESGDIRHIYDRGYI
LFNKKGKPLRMIGSLEDITERKINEEQLKQLNLQLNKRMEELAVSNAELEQFAYIASHDL
QEPLRMITRFLSEIQRKYNDKLDDKGKEYIHYAVDGSHRMRNLILDLLEYSRVGKFDQTI
ETIDLNTLIEEVVNYHETFIKESKAVIKWSHLPTIQNRKTPIQLVFQNLISNALKYHSES
EPPLIEITYQDLDNRWLFLVKDNGIGIDPMFSEKIFVIFQRLHAKHEYSGTGIGLAICKK
IIEAQGGKIWVESEEGQGSTFYFTVSK
>LONDMIMF_00418 GTP-binding protein TypA/BipA
MESIRNIAIIAHVDHGKTTLVDKIMYHCQLFRENENTGDLILDNNDLERERGITITSKNV
SVVYKGTKINIIDTPGHADFGGEVERVLNMADGVCLLVDAFEGPMPQTRFVLQKAIDLGL
KPCVVINKVDKENCTPEEVHEKVFDLMFELGATEEQLDFPTVYGSAKNNWMSEDWKQQTQ
NIEPLLDMVIQHVPAPKVSEGTPQMLITSLDFSSFTGRIAIGRLERGILKEGMPISLVKR
DGKVIKSRIKELHTFEGLGRKKVEQVVAGDICAIVGVEGFEIGDTIADFENPEALQTIAI
DEPTMSMLFTINDSPFFGKEGKFVTSRHIRERLTKELEKNLAMRVGETDSADKFMVFGRG
VLHLSVLIETMRREGYELQIGQPQVIIKEVDGVKCEPIEELTIDLPENLSGRAVEFVSVR
KGEMLSMEGKGDRMVVKFNIPSRGIIGLRNQLLTATAGEAIMAHRFIGYEPYKGEIPGRN
NGSLISMENGKAIPYSIDKLQDRGKFFVDPNEDIYEGQVIGENTRSDDMTVNVTKTKKLS
NVRSSGADEKTRIVPAIKFSLEEALEYIQKDEYVEVTPKSLRLRKIYLNENDRKRFKF
>LONDMIMF_00419 hypothetical protein
MKRITTIATALLLATLFSCEQKQKTAIPIENSEKTVEKPQEIAVNLQPTLDSLKKIIGNK
WVKQNPVLEPTQPSFFTKENENSYFICPLQISGLDIPFVWDDNFALVDFLLAQNSNTTLK
KGIKADKDYKGTKIIWNQTIDGLIWLDNKTYKSAITDWYVIEDTDCPGTISFPSVSFQKI
NTVTESSLVNPNGLAIIPYKENSRIKSSEAEIKDKNGKTIQGTGYDINGDSIPDIFTYIE
TVEEMAVYKRLYINVSGQWKCKWVHLDEECI
>LONDMIMF_00420 Dihydrofolate reductase
MKKVILDLAVTLDGFIEGPNGEIDWCIMDEDMDFDGFLDSIDTIFYGRASYDAWGNYQPE
EGAGIAEQKLWQGVHSKNKFVFSGQKRQDPNATFISSDIVEKVAEIKQQDGKDIWLYGGA
GLIKTFIQSELIDIYRISVHPVALGSGKPLFEDLKQRVELKLLKTNTFQSGVVQLIYEPV
R
>LONDMIMF_00421 hypothetical protein
MHIKIKTIIFCLLAVSSLYAQKAKIEHLPDLPYDKYEIQNKKDTLTFYLSVTASKEKLPL
VVYVQGSGKNSLFAMRNGKVIPTNGHSSWYTVAQEKFKVLIIEKPGVKYLQDGSKNFDKK
FSLENWSNAITNAINYVLKKENIDNRKMLIAGHSEGGIVVSRVASLMKDTVSHVAILAGE
GPSQLYSLYKFAEDGTFFNTEEHNMPLPEQRIEYVKTIWNDILSDPNNTSKNFWGFSYLR
WSSMLKTSVIDELEKYNGKILLLQGTADKAVYPESATIAYTALLSKGKNIRLELINNADH
SFNISDQPQTDGWRMVIEKTLQWFNQ
>LONDMIMF_00422 hypothetical protein
MKTRKIWANLGVEDLERTTEFYTQIGFQPNGVSKELTSFLVGDDNFIIHFFLKEILKSNT
KIELSDPKQGNEIIFTLSAESKEEVNQWQEAVKSAGGTIISEAEEFGKGYYGFVFSDPDG
HKFNVFYM
>LONDMIMF_00423 Thiosulfate sulfurtransferase PspE
MKRIIIIVGLLLLIYIGYRIYRIYTLDKGLDKLLSEGAIILDVRTENEYKMGHIEGSLNI
SLGEIRNRYTELDTAKTYITVCSHGLRSVKAENILKEKGFKKAYNGGAWNDLQESVFFRH
>LONDMIMF_00424 hypothetical protein
MYQTLNFLHSTLRWLVLISLIVALYKAYRGYFQKTAFTKTDNAIRHWTATIAHLQLMIGM
TLYFQSPIIKYFLKNFSAAKENFDLLFFGLIHSTLMLIAVIIITIGSAMAKRKTLDNEKF
KTMLIWYGLALFLIFIAIPWPFSPFANRPYFR
>LONDMIMF_00425 Transcriptional regulator AcuR
MKKAAITRLNILQKAFELIYEKGYLTTSIDEILATTAVTKGAFYYHFKNKDEMGIAIINE
LLKPSFKATFLTPLQSGGDTIQTIYDMMREILMDNEILKVEYGCPASNLTQEMAPWNAEF
TKALNELSLGWKDAIISCIENGKKEGNIRPEVKAEQVAIFIMSGYWGIRNIGKLSNSKSV
YLVYLQQLKDYLETLR
>LONDMIMF_00426 hypothetical protein
MKHLLYIFLFIAVSCKDQTPIKSNSLPEDKTKDTIIYTSWSDTITTTTAELKKVSDNFST
STIAINPDQAYYCDDNLGSFNSEVGKDQYYILYAHLLQKRNGIEKYDDLRTKLTDIYQNI
NSLFGDLQHGGTYFGHQNSRIFGYVEYSIYLYSRSKDNFEKNYNIEKQKQIYIASLRQLI
DDELSIDTNTFGEEKAKRRKKLNQTVDSLEKLISDIFYLRRAQQFQSEYYQYY
>LONDMIMF_00427 hypothetical protein
MRKLLFSILLVINLTNTFGQNLNEEKYRFAKEVFNSNQYRKDNYPSFQENIQLVADNSYQ
FGEKIITVSIENKSYEILFKKGIFNPDVIFGKETVKKSKSQLDSLTSDQKIIYNFIRNDS
LSICCFEELEELNPNSQTKRFKFWLIQIGVINPTEYYIEFHNKKATKKTSIDEFIENAKM
TFYHKGTVII
>LONDMIMF_00428 hypothetical protein
MKKITEILNQENEEEIILQIGEIIWHKLDYNYENISNLSEVEKTFVFVDILEGQVNNGGF
DQFFFNSSGDYTYEVLKAYENIGAYKTAKLIYEAIRIFPQNPISKDTQTRREIMKSLNEG
ISEKWDQLDDKFYEYEDNIIKLLVEYFKENNKQF
>LONDMIMF_00429 hypothetical protein
MKTSSNYSHTIAGIFWFDLPLGIILSFIFHNIVRNNLFDNLPVPLRLRVSTFKQFDWNKY
FKGNWLIVIISILIGAFSHIFWDGFTHQHAYFVEKIPSLQNTIRLFEMQIPYWKVLQHLS
TFIGALIILFAIFRLPKDTKAFKPLNRRYWIVSMCLTLAIVFIRLFCGLDYKLYGHLIVT
IISAWLISLILTPILIRKHNSPNI
>LONDMIMF_00430 hypothetical protein
MPFTFSHPAIVLPMTFLNRKWFSLTGLVIGSMAPDFEYF
>LONDMIMF_00431 hypothetical protein
MKLQKLSSSLIVVIITIFISSCDGYKNVSGIIVDKQTREPIEKVMLREIGKYDTIYTDAK
GFFEIHYMSGFVFSSNNAELIVQKKGYRTDTIKIENGKNKTIELILN
>LONDMIMF_00432 hypothetical protein
MSIGLTTTLSYSQTKKKKYKDESEKLDCAKNTKINLQQRLANYPYNETSQIKLIAYQNKR
EGIIGEEIQEYLNSCIGKEAVAIESQFDEIKALNFNQIEKLTDIIYNYGYKAKTSLGVAS
KCYEPRNAILFYDNTSRLIAFIEVCFGCRNYRTNDSKITFGRFIQKLNMIKGLFDENG
>LONDMIMF_00433 Spermidine/spermine N(1)-acetyltransferase
MEDIQLKKVTLNDIDQLQKIGRQTFFETFAESNTEENMKEYLENSFSTEKLHSELSNTNS
EFYFAVEKETVIGYLKLNFGASQTELKDDKALEIERIYVLKEFHGKKVGQLLYEKAIQIA
KETKSDYVWLGVWEENHRALAFYKKNGFVEFDKHIFRLGNDEQTDIMMKLQLKR
>LONDMIMF_00434 hypothetical protein
MKKIITLLLVLATSTSPVFAQQPVEFKLSCSEPYAIYDFITKISDNYPDNELKSVFSNSK
YNTEAFKKQIADFEQLPIDYTYAFTQYPSPLKTGLMSRDMLERNLAISQTIADFRNKSLG
LIPNEYLSVFSETLENFLPIYRELVFEPNKTAFEVQKNNLQNYIKNNQFSDFFQTGLTFY
NTNWDKNIPFELNLLPSLDKGNLGARAFINVAVCEAPLDLKDHVSFFSVAMHEIYHIVYD
NQSLQMKENIQKWFNDTKSPNSQYALLLMNEVLATALGNGYVIEQINKKADDGEWYANKY
VSEMAKAIYPVLKKYIEDKKPMDEAFVKAYVNTYDTQFPQWNNELSHLFAYRYIVADTPS
DWSYFRRNFRKYSNNRMGAPVSATEVEKTMAMPITKVVVISQNHEQKLNLLKDYFDILKN
KKLNPKAEFIEIFNLPDNTKLFIINRHKSTVEDMMNKRFPNKLIK
>LONDMIMF_00435 hypothetical protein
MGKKISCVCIRLLLICGFLSCKQRQAPEIHKIPESKTEKQAENGTAEIENFDAFFERFSK
DSVFQKERTKYPLKIAYYEDIDEDLSVRYAKETESAYTDFTADTLAMNKKTDRFTFKIEK
TDTKIIYKRVGYDNGIYISYIFSLFGNSWFLSEIRDEST
>LONDMIMF_00436 hypothetical protein
MKKTIFQALILMLYSIKAFSQTDNVELQKMADDDQNSRMKSDINWMILNKEDSLRRVRVF
ELLKENKVQTAKDYFNSGIVFQHGNDTIASGMAVKTFKKALELDPSLNRWWYAAAVDRDL
MRKGEPQIYGTQFTKNKSTNGKWVRYKIDPTKVTDEERQYYAVETLAQQIEKERKMNLKT
ISSYYNSGNLADKTIKLIKQEFKKGTKSEYDISEEAVNEFGYNLLNQNKNEEALKVFKLN
TELYPNGYNTYDSYGECLMKLGQKEKAIKAYKKSLALNPDNGNAKQIINENK
>LONDMIMF_00437 hypothetical protein
MILKKFLLALLFFFTVTQAFSQNDCTDAIVVCGNTGFQGLSATGIGIQELGFGNNCSSEE
NNSIWLKLSIDTGGTLGFILTPENSNINVDFDFFIFGPNVSCGSLGQAIRCSTTNPQAAN
ATDNLTGLKDDEVDTTEGPGALGNSFVQSLTVNNGESYFLVIDRPVGSSNFSLTWTGTAT
FNQPPTFQVPTGVALDMENCDNDGTIDNSTSFNLDLNTSTIIGTQTSVAVTYHTSLNDVL
TGESPITPSNDFRNTVNPQPIFARITNTVTGCFSTSEFSVEVINSVVIPNNQFAICDDNL
DGDDQNGQATFIMNDVTNGIIANSNPVGTTVDYYSSFANAMANTGAYGPTYYNMIPNEEP
VFIKVTNPNGCFRIEEIKLIVNPLPAKVSGNLVQCDTGLTPDGLTLFNLNEAIPSLTGND
ANLGVTFFRTGTTTPLPTAYNNISNPETLDVKITNLTTGCFSWGTLDLNVNVINRTVTIA
PQCDLSETGIMPFDLGTTDLVLSPTETAHFYPNLNDALLEQNEITNTGNYPNATPYNATI
YVRIEDANSCSGISPIQLVVNRLPQIEVQDTDYVCTNLPNRYTTLDAGLLQGSVTDYTYE
WSTTPIQTTSSIRVNEAGTYTVKVTNANGCSKTRTIEVLPSNNATIADIVIVDLTQNNTV
TVILDPTSIGGYQYSLDLPNGPFQDSNYFENVAPGVHTVYVYDTHGCGIVSKKISVLKIP
AFFTPNADGTNDTWDIIGISPNFFANSKIYIFDRFGKLLADVDPKGTGWDGNFNGHPLPA
NDYWYLVKLETGRTIRGHFSLLR
>LONDMIMF_00438 hypothetical protein
MRSKLLVLFLFLSISCFPQGEASNWFFGNRAGIRFNSDNTITTLSTFPNPIRIVTDEGCS
SFSDLNGNLLLYTDGRTVWDRNHVIMPNGDYAAGTGLFGDPSSTQSGIIIPNPANPNLYY
IFTVDEPHHQNAAAYPNQFSGVYEAGGGTIPDGDDGFNNGLNYSVVDMSLIGANGSIGNV
TTRNVHLVTYNPDPAGEEIKYKCSEKITAVQIRNGGGYWVITHFIDKFYAFKIDPSGVST
TPVISQLNPVVPISGYRRNAIGQIKVSPNGKKIAVAHVQITETHVGPQTGGALYLYDFDN
STGIVSNGQAIVTDASCYGVEFSAETKKLYLSAENGVMQFNLEAASIPNSGQFISRKSFS
ALQLGPDKKIYKANINTGFEDAFLDVINNPEEDGIACNYQNAAISLDQGISRFGLPPFIT
SVFSTNILAKNLCAGQATEFEVSANGFVQSVVWDFGDGSAFSTVSEPSHVFPGPGNYTVW
ATAVVEGRTIRSSKNIQINPLPTAFPSSLTQCSPTAADTNILFKLSEASQNITGGNTNLS
VSFFLSSQAANDNANPLPNSYPNISNPQRVFARVTDNTTGCFVTTTLDLTVNAVINAPLL
LEKCDELNGEDGISDFTLTDVLIPGISPTATTSYYASIDDALLEQNALPTAYRNTVRDRQ
TIYARIEENNECDGLFPIHLVVNPLPQLRTEDTDYVCTNLPNRYITLNPGLLQGPISDYT
YEWSTTPIQTTPTIRVNQVGTYTVKVTTAKGCSKTRTITVLPSNNATIADVVIVDLVQNN
TVTVLLSPESIGSYQYSLDLPNGPFQDSNHFENVSPGFHTVYVYDTRGCGIVKKDISVLY
IPNYFTPNGDGYNDTWNIIGINSVFYSNAKIYIFDRFGKLLADVDPKGAGWDGNYNNHPA
LSTDYWYLVLLNPERTVRGHFSLKR
>LONDMIMF_00439 hypothetical protein
MKMTKAHIFFLLAICVPFLARAQYITVNDTYTKEQLVRDVLINNTCASVSNISVLGGNFA
SGEQSYGYFNAGTSSFPFANGIILSTGRAVAAQGPNSSLLDDGRGMDWPGDSDLETALEI
NNSVNATVLEFDFIPLGNKISFDYILSSEEYHDNAPCRYSDGFAFLLKEVGGTGEYKNLA
VIPGTTIPVKVTSVHPAIGGNGGCDAQNEEYFGGFNGYEHPTNFNGQTTIMTAQSDVTPG
VRYHIKLVVADEGNYRYDSAIFLGGGSFKIETDLGNDRLLANGNPLCKDETLTLNATNAN
AIRYEWYKNSILQPETTPTYQVIEAGTYSVRVELAGGCFSNGEIKIEYSPVPTVSNAVLV
QCDEDNDGLALFNLNQANAQIVAADPTLTDPVYFRTNAEAASDSNPITNVTNFENTQPIV
YARVENQYGCYAIAEVTLNVSNNNIADPQDLKKCDTDANPSDGLSVFNLRDREADILINL
PAGNVNYYTSYADALSGLNPIPAPETFPNTVPFTQRIYAKLSSGIDCYGIAEFNVRVNYF
GNSLDDVEVTICSGSSVLLNAGSGFSSYSWNTPNHETTQTIRVNAAGTYTVTVTNADGCE
GTKKFIVTASSIATVETIRIRDFQGGNNTATVVLTSNSIGTYQYSLDGITFQDSPTFTNL
APGRYNVIIKEADCGTITYEFYIMDYPKFFTPNNDGTNDYWRIPYLQYQPNATVAIFDRY
GKLIYFFKGGQPGWDGKLNGHDLPANDYWFKIILQDNREIRGHFSLLR
>LONDMIMF_00440 hypothetical protein
MTPGQNIQPMKRLLSIELQKIWQNKASRVLTLTYFILLSFIALIASINFSFLGINFRIAD
QGIFNFPYIWHFNTYIAAILKFFLAVVIVSMMANEYTYGTLKQNLIDGLSKKEFIQSKLI
TVALFALGSTIFIFIMSMILGLCFSSYDEAAIIFSDLEYFLAYFIKLVAFFSFCLFLGVL
VKRSAFALGFLLVWFFAEKIFYGLLRWLVFTSTEQVDKVAAFLPLESMSNLIKEPFTRFK
AYKAIENQVSGGVAAKDYSVHWYEIVIVVIWTVIFMLMSYKILQKRDL
>LONDMIMF_00441 putative ABC transporter ATP-binding protein YxlF
MLPGSSYYKTKPLSILETILKIENLYKNFGLVKAVKNVSLEIKKGNVYGILGPNGSGKST
TLGIVLNVVNKTSGTYSWFGGEMETHEALKKVGAIIERPNFYPYMTAEQNLKLVCKIKGT
DYSKINEKLEIVGLLDRKDSKFRTFSLGMKQRLAIASALLNDPEILILDEPTNGLDPQGI
RQIRDIIKVIAAQGTTILLASHLLDEVEKVCSHVLVLRKGEILYSGTVDGMNSHDGFFEL
LSDNLQELKTALAQHPSIEKVEEEEGRIIAYPKNQLSAAELNKFLFERNITLSHLVKRKH
SLEEQFLQLTNNK
>LONDMIMF_00442 hypothetical protein
MNPNIARHNVLFEKAFCRFFGHKFKTTRKITDHFKEFECKVCHRCATNDILGNKIHLSEE
MKDINKALNQLYERRQIAL
>LONDMIMF_00443 hypothetical protein
MINLFNTHIETLSVHRVGNKSRNEAFFLSESPYGLNDEIMPLLKEFFFKSFREKEENYFQ
FAHDVDLEYNEMYNFASEIFANPGSVHEVSKKITKHLFEQSNHPHIKNGEVYVAYLTNLS
IDNNQVDAVGVFKSELQSDFLQFEENGSNLEMILQHGINLNKLDKGCLIFNHKKEEGYKI
LTVDSNRYDARYWLEHFLSVDAFQDENFITKKYLKFCQDFAKDVVLPAEDKKEEVMFMNR
SVNYFAKNDDFVEQNFLNEVIDNPDLMSEFKNYKVDKGEKYSIEDVTTFPIANAAVSDAR
KKIKNVINLDTNIQIKLDFINPESAEKFVEKGWDEEKQMYYYLVYFNKEQKS
>LONDMIMF_00444 hypothetical protein
MNTFRNLLIWQKSMALVTEIYNATKSFPKEEAFGLTSQIRKCAISIPSNIAEGFGRDSNK
DYLRFLNISISSLFELQTQLEIAKNISYFTTEQFNKQYEDSREVERMLIAFINKIKERQ
>LONDMIMF_00445 hypothetical protein
MVYKFRVILDAEEDVFRDIAIQDNDTLEDLHNAIVNAFGFDGMEVASFYTSDDQWNQDEE
IPMFDTGDVPGEQKVMSDFELSEVLDEERTKIIYVYDFINMWTFFVELAAIEEHVPGQVY
PDVLFSHGIVPLEAPDKDFSDSAVNEFDYDEDEFDEDDLDMFDGGDNFEDYGFEENWN
>LONDMIMF_00446 hypothetical protein
MLKINKVHHIAIICSDYEVSKHFYTKILGFEIIAEAYRSERDSYKLDLALNGNYSIELFS
FPNPPGRVSRPEACGLRHLAFEVDDIQKTRHYLVENNLNPEPLRTDEFTNKRFTFIADPD
NLPIEFYEA
>LONDMIMF_00447 hypothetical protein
MKIPQQYLPVMPYLILNKASDFLEFSKTVLGAKEQLIVPGKNNSVMHGEIRIQDAVVMFA
QANDTWHQKTCGMFLFIEKIDDVFNLAIQKGSKILKNPGQEEYGYTAGFEDPFGNQWWIT
EPLRE
>LONDMIMF_00448 TonB-dependent receptor SusC
MKNIFTLLFLMLSVANFAQQTISGKVTDEKGRPVTGANVFIEGTYDGDSSDEEGNFSFQT
TVTGKQNLVVTFLTFETYNQEIVVEDFKNRTVKLKESVNTLDAVVITAGTFESGDKARTS
VLKPLDIVTTAGAAGDIVGALLTLPGAQTVGEDGRLFVRGGEADETQTYVDGLRVSQPYG
ATTNNLPTRGRFSPFLFSGIAFSTGGYSAEYGEALSSVLLLNTIEDPDQEKTEISLMTVG
LGLGNTQKWEKSSLSVNASYANLAPYQAAVPQAVDWNRAYQSISGELVYRYHFNNGTLKT
YMAFDAADFDLNQEDINRPEKIRVDVRNNNFYLNSSYKGYFGSNYQLTTGISYGYSQNKI
GIALDDVKNAEHATHMKIKIGKNITERIKLTAGADYFTTKFDEDYAQNAGSTFSSGYDNN
IAAAYAETNVFFSKRFAAKAGFRFSYTDLLQESNLSPRFSLGYKVSDNGQLSFAYGDFVQ
SPRQEYLKYSNQFESEKTAHYILNYEYSKTGRIFRAEAYFKQYRDLVKYDTQTVQFDSQF
NNNGKGFAKGIDLYWRDNTTFKNLEYWFSYSYIDTERDFKNYPKEVTPSFVADHSFSVVT
KYWINSLRSQIGLTHSFNSGRPYNNPNETSFMNGKTKSYNNLSLSWAYLVSQQKILYFSV
SNVLGTDNVFGYQYANNPDASGQFQRRAIGQPADRFIFVGFFWTISDNKKDNQLKNL
>LONDMIMF_00449 hypothetical protein
MTKCIITLVFFVTSLVGAQTQYEQGMQKAFALWGEGKTTEASAMFERIASAEKNNWLPNY
YVSMVNTTAAFQTKDKDKVAALLGKAQEALNIELDKNPENPELLVLQAMINTAWIVSDPM
TNGMKLSAKTIEIYNKALAIAPENPRALFSKAEFEIGGARYFGNDTKPMCAEIDKAIELF
AKFKPETPFHPSWGLDRALEAQKECNKKK
>LONDMIMF_00450 Sensor histidine kinase YpdA
MQKAIKYFFKTIVTGFVVSCAIIAIMFVLEALFGRSFKIDASLFKEMGYYFLYGIILTAI
NSTYFDFMNNRIEWKKYKRYRFTLSILGSVVLTVIGIFIIRLFIALVLEQRSYSEFIANE
NHRFYVVCLMITMVVTLAFHLIYFYKKSQENKVKEQKIIAGTASAKFETLKNQIDPHFLF
NSLNVLTSLIEENQDNAQKFTTSLSKIYRYVLEQKDKELVSVEEELSFAKTYMNLLKMRF
ENSVFYELPESVKNPDAKVVPLSLQLLLENTVKHNIASETKPLHIRIYEKGDYLIIENDY
QKKEVLQDRKGVGLQNIVDRYSIITNRKVRIEQTEKHFRVELPMLTKQIAIMETDYNTQE
STYRKAQKKVEDIKGFYGNLTSYIVVNIGLAALNLITSPSHLWFLYPAIGWGIGVAVHGM
TVFNYMPFLGSDWEEKKIRELMEKDKQDKWQ
>LONDMIMF_00451 hypothetical protein
MVMENFNSEKMAYERAKKRAKEIRGFYYNLTMYCIIIPILIIINLVFTPEFQWFWFSMLG
WGTGLLCHGMAAFGYNPFLGKNWEEKKIKEIIEKEKRKQDYYQQNIK
>LONDMIMF_00452 hypothetical protein
MENLTEQEQRRLERAQKRVKSILGFYKHLIAYVLVNLFLISRHYFDLKPGEEFFKFSTFS
VAFFWGFGLAVHAASVFGKNIFLGGDWEEKKINEIMEREKNSKWE
>LONDMIMF_00453 Sensory transduction protein LytR
MTTLIIEDEKPSARLLQRKLQKLDIETSTMLHSVEEAINWFQDNPHPDLIFLDIQLSDGL
SFEIFDAIDIKSAIIFTTAYDEYALRAFKLNSIDYLLKPIDEDDLEAAINKFKSRQPKTE
SMSLDLEMIKKMLVSPDTKNYKKRFTIKTGQHLKMINIDEVECFYSENKGTYLHTTDNRD
YLLEGTLEQLETELDPKDFFRVSRKFIVPMKTIKDIVVYSNSRLKLILPTYKEDEVIVSR
ERVNDFKNWIG
>LONDMIMF_00454 hypothetical protein
MKQPFLLICSCLLVTTMALGQNKKSISDKDLITICKTWGLLKYYEPVLSSGKIDADSLLV
TALDLKLPAEKTIADWIDFLKTKTVIKKAETVICKEQDNRNLSTAWIQKDKNLNAAQKKY
LSGLVSSNQIPGGYYCQKPDFIRYSGGNEKTYTEKALQENYRILNLFRAWNVIEYFYPYK
YGISKKWDNVLAEFIPLVKNATDTLSYKKTMMLFSGSIEDTHSRIEPVNYKEIFGNYGAP
FTYQIAENKIVVTKPVDVEICKALGIEYGDVIETVNGESIDRIIQRNSKYISASNTSVKI
RDSYNYMFYGEKGNFTIKGYDKNKKPFEKKIDRIDRTGGLWFENGIPDNSLVRYDETAKK
VIYSAINKDNIGYIDFSFFETSEVDSIMKAMKNTKGIVFDLRGYSTNGGVVKTFNYLFPE
PKWFGILTRPDFGKPGRFCWQDYIIREDYKYIGKENPDYYKGHVVILINENTQSLFEMWS
MIFKTAPHITVIGSQTAGADGNETTIPLVNGEKMIFSGVGIFYPDRKETQRIGIVPDIKV
KTTISDLQNKRDPLIEKGFEVILKK
>LONDMIMF_00455 Heme A synthase
MKKYFSSITKTALILVYLVIIAGALVRMTGSGMGCPDWPKCFGYYIPPTDISELTWSPER
EFKKGQVIIRGEKLLVAQEDFKSGSEFEENHWQVYTKHDYASFNPTHTWVEYINRLVGAL
AGLACFVMAVFSFSLWKQNKKITLLSWLVVFLMGFQAWLGATVVYSVLNPVKITIHMVMA
LLIVCIILYILNLAKPKPATPLKFDKVFDSVLIISLILTLTQIILGTQVRQFVDEQVKIY
GYDAMHKILEDPIIGFYFHRTFSFVVLLINVILITRNNKLQLGFKKINWVMWLLGIEILS
GIVMYWYDFPFGSQTIHLVIASLLFGTQFYLILESKNREIK
>LONDMIMF_00456 Multifunctional CCA protein
MKDKTSYKEAVNSKIFHVIAQASKELNIDSYVIGGFVRDLLLKRKFKKDIDIVAVGSGIE
LALKVSEMLPKKPKVQVFKTYGTAMLRFEDTEIEFVGARKESYHFESRNPVVENGTLEDD
QNRRDFTINALAISLNEANFGELVDPFNGLSDLELKIIKTPLNPDITFSDDPLRMMRAIR
FATQLNFDIEEESLKAIERNRERIKIISGERIVDELNKILMTDKPSIGFLLLHQTKLLHI
ILPELTALEGVDESEGQTHKDNFYHTLEVVDNIAPNTDDVWLRWAALLHDIGKAPTKRHH
KKNGWSFHGHEFVGGKMVKKLFERLHMPLNHKMKYVSKMVMMSSRPIVLSQDIVTDSAVR
RLVFDAGEDIEDLMVLCEADITTKNPNKFKKYHNNFKIVRQKIVEVEERDHIRKFQPPIS
GEEIMETFGLKPGREIGILKEAIKEAILEGEIPNEYQPAYDFMLKRAEKLGLQKTAS
>LONDMIMF_00457 Threonylcarbamoyl-AMP synthase
MNEEVHKAYEVIKEGGIILYPTETVWGIGCDATNPDAVAKIYALKRREESKSMIVLMNGE
RMVYNVFKDIPEVAWQILDLSEKPTTLILDNPRNIAKNLIAPDNTLGMRIVKEPFCYKLL
ERMKKPLVSTSANISGEPTPINYKEISPEILKGVDYVVNLQQEKMTGKPSAIIKLTSDSQ
VKIIRK
>LONDMIMF_00458 UDP-N-acetylbacillosamine N-acetyltransferase
MIIIGAKGHAKEVFDVLTIDAPDSFYFFDNVSADLEDSLFSYPILKTTEQARSQLKKNPD
FILGLGNPFSRNKVYNLFLEYNGMPVSAIAKNAVVSKSAVLGKGLNIMPFAFVSSDTFIG
NGVLINAYASIHHDCKIGEFAEISPGAKVLGNCEIGAFTTIGANATILPKLKIGKNVTIG
AGAVITKDIEDNAVVVGVPGKTIKYNVPKI
>LONDMIMF_00459 dTDP-4-amino-4,6-dideoxy-D-glucose transaminase
MINVTQTFLPPQSEYNNLVKRAWDSLWLTNRGQLTLELENKLKEWLNTDSILITNNGTVP
LQIALKLLGKGGEIITTPFSYVATTSAIVWEHCEPVFVDINPEYLTIDETKIEAAITPKP
TAILATHVFGNPCQVEAIEAIAKKHNLKVIYDAAHSFGVEYKNQSLFNFGDVSTCSFHAT
KLFHTGEGGALFCKDKELFHKLYYSHNFGHNGPLDFHGLGINAKISELQSAMGLAVLPYI
DTILAERKKVVDFYNANLNFSNLQGLKIRENTKWNYSYYPIILDSEETLLRVQKALNENQ
IFPRRYFYPSLNTVNFIKNTEMPVSESVSKRVMCLPLYVGLKTEDLEKITSIINQNI
>LONDMIMF_00460 hypothetical protein
MSIKKDFHKFQHQLKSFFLQGHHKSFKKKYFKEHYSDTKKLILFFVPSGTDRINGGILSI
CTIYNIVRKLKDIHGCDVVASFLPGKSETDYKYRKFSNEMIIFTFKEIERYFDHLDFAEI
HIPDVMIAAFNKGNKRMVPFFRWTENIKDIKINLLNQNDLFMPPIEKIDNVKKMFPNTTM
TMAHKRYATLEKRNYYGVPLHLFSAWLSPTPYNRKVFSEKENLVIYSPDKIQWVPNSSTL
TKEGILANLKAKLPHYTFVEITNMKYDTYKDYASRAKFVITFGEGLDGYLIETIFSGGIS
FAVYNEIFFTEDFKNLPTLYSSFDEMNEKIADDIKHYDNPETFKEYQDKLDIIVNKLYSF
NMLENNIKQYYLHNFDFK
>LONDMIMF_00461 hypothetical protein
MKIALISFDNWGLNEGIAKVLKQDGHTVHHIDFHNFIYKYPSFYYKIYNAFLKVFFRKNI
KNIYYGKEIIKRLEQIGERQDLIVTIKGDFIDKSYLKQLKKYTRKSIGFFNDSATRCPKI
KRVASAFDQAFSFEKEDCQKLGLKFAPNWIYEENKNSSKGPFDFQVFNICSKDKRLPVLS
KIISELKSKQIKHKIIVLSRDKECPKSEIEFFFERITLEEVSKFIEKSRALLDIKRDGQF
GLTFRIFESIGLEKKLITTNPDIVNYDFYNPNNILVIDEKNPVIPTSFFESDYEKLPEEI
YHKYTIRGWIQNVLFHK
>LONDMIMF_00462 hypothetical protein
MFKHYLITRFNLRNPDWNVTKNNETLLTDEWMEDRMWLFENFCFPSVVAQTNTDFNWLLF
FDTTTPEKYKSAITNLISDKTNIKAFYIDGMPEFYPAIQQFISEDAQNVPYLITSRIDND
DCIHKNFINEVQHKFQSQEYQAVDVIKGYSLQVKPRYILGKKEHIFNPFISLIEKNENPK
TVWFNDHTLWKKETRITQITDKRLWMSIIHEKNKVNEFDGYDNVKWAHINKDFIVSEKMN
SLIEKELIPYKNWMFLSLKNRLYVKLVLLSKKIKKALGVYKIK
>LONDMIMF_00463 hypothetical protein
MHEVYNPKFLHQKEAIRDCIANFEAKGILFVDGKRNKIRLFELDEITLNVKSFKIPNFIN
QVAYKFFRRSKARRSFEFANILLEKGIGTPQPIAYFENFKNVLYDSYYISEQLNADLTFR
ELTTDLNYPDHETILRQFVRFSFNLHENGIEFLDHTPGNTLIKKNGEGNYNFFLVDLNRM
QFHKSMTLKQRIVNLSKLTPKRELVEVMSDEYAKLYGRPYEEVLQMMIVETESFRNRFHR
KKRLKKKLFFWK
>LONDMIMF_00464 Chondroitin synthase
MKASVIMSTYNSEEWLEKVIWGFSVQTELNFEIIIADDGSKPKTKELLDTLRPQLSMPLI
HVWQEDNGFQKSQILNKAIVASNTDYLIFTDGDCIPRKDFVETHLHYRERGYFLSGGYFM
LPMNISQAITKNHILHQNCFDVKWLVGRGLKKSFKNTKLSATGLWAKFLNFITPTKATWN
GHNASGWKDDLVAINGFNQEMQYGGQDRELGERLFNKGLKSKQIRYSAIVVHLDHARGYV
NEATWKKNFAIRENTRKNKVIRTPIGIDSN
>LONDMIMF_00465 ADP-heptose--LPS heptosyltransferase 2
MKKILVIQQKMIGDVLASSILCNNLRTIYPDAQIDYLIYPFTKPVVENNPNIDNLVLFKE
EFRKSKKMLLRFLVSIRKEKYDIVVDAYGKLESNLVVGMSGAKKKIGFHKSYTNFLYTDT
FKELSKPKTSAGLAIENRMLLLQPFSSGIPLDNRPKIFLTEEEIKNGKDILIQNNIDFSK
KIYMIGVLGSGHNKTYPFPYMAKLLDAIVAKTNATLLFNYMPSQAEQAKKIFGLCQPETQ
KNIKINIVPGSIREFLSITYHCNALIGNEGGAVNMAKALFKPTFTIFSTWIKKEAWNSFE
DGIHYASVHLKDFKPELYGKKSAKEMKNQAMKLYESFTPELILPELNSYLEKN
>LONDMIMF_00466 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase
MSTLQTIIEQAWENRALLQEEKTTTAIREVIELLDSGKLRVAEPIAGGWQVNEWVKKAVV
MYFPIQKMETLEAGIFEYHDKMPLKKGYAEKGIRVVPNAVARHGAYISSGVILMPSYVNI
GAYVDEGTMVDTWATVGSCAQIGKNVHLSGGVGIGGVLEPLQAAPVIIEDGAFIGSRCIV
VEGVRVETEAVLGANVCLTASTKIIDVTGDEPVEMKGVVPARSVVIPGSYTKKFAAGEFQ
VPCALIIGKRKPSTDLKTSLNNALREYDVAV
>LONDMIMF_00467 putative methyltransferase
MKDNFSNQASEYSKFRPSYPPELIEHIVSFTESREMALDVATGNGQIAQKLSEYFQTVYA
TDISENQLQHAKQLLNVIYKKLPAERTDFLDKQFDLITVAQAIHWFDFDQFYAEVYRILK
PNGIFAVVGYGLFSTNEESDKILSDFYYNIVGTFWDAERKYLDENYQTIPFPFEELETLR
FQNKFTWTFEQLVGYLETWSAVEHYKAHNNENPIDLIRKELELTWNRSDKTVVFPMLLRL
GKLKM
>LONDMIMF_00468 Putative pre-16S rRNA nuclease
MPRILAIDYGLKRTGIAVTDEMQIIASGLTTIPSETAITFLKDYFAKEKVERVLIGEPKQ
MDYTPSESAKLIEAFVEKFKNNFPDLPFERVDERFTSKMAFQTMIDSGLKKKQRQNKALI
DEISATIMLQDYLSRKKF
>LONDMIMF_00469 Malate:quinone oxidoreductase
MATTTLRTETDVVLIGAGIMSATLGLLLKELNPNIKIEIYERLDMAAAESSDAWNNAGTG
HSAFCELNYTPELAGGEIDTKKAVKIAESFEVSKQFWAYLVEKNLISNPENFIKSIPHMS
FVWGEENVDFLKKRYDALQQYSLFKGMEYSEDKDKIRSWMPLVMEGRNPKSVIAATSMKI
GTDVNFGELTRSIFNYLKTLEGVSMKFHHEVKSLKKGEDGRWQIKVKNLETGDKTKIITR
FVFIGAGGGSLPLLEKAGIPEGDGFGGFPVSGQWLKCVNEDIIAKHNAKVYGKASVGAPP
MSVPHIDTRMIDGKKALLFGPYAGFSTKFLKNGSYLDLPLSIKPNNLIPMLSAGFHNLPL
TKYLIDQVRQSPEDRLEALKEYLPDARMEDWVLETAGQRVQVIKKGENGGGVLEFGTEVV
TAGDGSLAVLLGASPGASTAVSIMLDLIQRCFSEHEKTTEWQKKLKEMVPSYGISLNDNE
SLLQQVREHSAKVLKLDTL
>LONDMIMF_00470 Inner membrane protein YccS
MIQKVRNFTDSTNFSNALKVTLAAAIPVLLFSYTGNFEIGFNIALGAFLTYPSDIPSNRK
HRINGILVAALIVAGNNLVVNLLYPQPWILYPAMAAMIFFFSMISVYGQRATQVSFSALL
SICLAFGHIHDGWEMLQYSGLMFVGGLFYLLISLTFNYIRPHRYIELQVAECLRLTSKYM
KLRGDLWKIDSPREKIIEKQLYLQVELNTIHENLREILIRNRSHSNGTSDQTRKMTLVFI
SLLEILELALSTSFDHNKLHQKFADHPKVLATYQHLAYNLASTLKAIFKSLENRKKYVPK
HSLLKDLEALEKVISDYEQELGKEKASEGVWMLSNMLHYAEKQIEKIKIVERAFMPNFNT
NDYKGRDKNLDKLLTPQYYPWSTFRENLSFSSTIFRHSLRLTATIMLAFLLGSLFPFQNV
YWILLTIVVIMRPGYGLTKERSFHRIIGTVVGGLIAFALLLFIHNHIIIGALAITSMILG
FTFTSINYKVGATFVTIYVVFVYGIITPNINDVIQYRILDTVVGAGLAFLANYFFWPSWE
FMSQPIYIKKSIEANRDYLNEISIFYNNKGEVTTSYRIARKNAFIEVGNLMASFQRMTQE
PKSKQKQVQQVYKLAVLNHTLLSSLASLGTYIQTHKTSTASEAFNVVVQTVIKNLNYAIT
FADLEVSGTLAQTETNEDLAMRFTELKNMRAKELKEAHLSEDEEFQLKMQEAQLVIEQLV
WLTNLSESIVKAAKLLHQTK
>LONDMIMF_00471 Peptide deformylase
MILPIIGYGDPVLRKVGEEVPQDYPNLKQAIADMYETMYNAYGVGLAAPQVGLSLRLFVI
DTEPFSDDEDLEEKEREELKNFKRTFINPKMLKEEGEEWGFNEGCLSIPEVREDVYRNER
ITIEYFDEDFNKKTEEFDGLIARVIQHEYDHIEGILFTDKISSLKKQLIKKKLQNIMDGK
TRPDYKMKFVAKKGR
>LONDMIMF_00472 hypothetical protein
MNLDKILAISGKPGLYALKLQTRTGFVAESLLDGKKITVGLRSNVSLLSEISIYTNEQEK
PLVEVMRAIAVKEDNGPALSHKEDNAKLAAYFLEILPDYDQDRVYPSDIKKVLNWYNMLQ
AKGLVSKEAPAPKVKEEVTEENSN
>LONDMIMF_00473 hypothetical protein
MKQQKIRGLHRDLGYFYIGLIISFAFSGILMNHRDSWHPEKYTVETKNIEVKLPPEELIS
EKYAESLGKEHGIDDKIRRHSIKKGTLKISFENHDVEIDMKTGKGEIVAFKKTPIISHAM
KLHKNTSEWWIYYSDIFGISLIVIAVTGALMIPYGKFTFKKRGWKLAIAGIVFPLLFLFL
LS
>LONDMIMF_00474 hypothetical protein
MAQVNPYLTFNGNCEAAFLFYKFVFGGEFTYIGKFKDMPSEQPLPAGTEDLIMHVSLPIS
KETILMGSDTSEAFGQQPVTAGTNFSVSINTESEDEAKKLFDGLSNGGKVTMPLEKTFWG
ALFGMFVDKFGILWMVNYDYEQK
>LONDMIMF_00475 hypothetical protein
MKKTIYALAVLATLGITSCKEAHDSKLPPVEATPKTYAEIKKADWFLGRWENNSKEGNLS
EIWTKENDSTFHGESYFVIGKDTVFGEIVKLWQKENQLIYEVSLRNQNDEKPVEFALTSS
SDKQLIFENPKHDYPNKITYNQITKDSIVAEISGMKDGKTKSEQFAMKKVQ
>LONDMIMF_00476 HTH-type transcriptional activator RhaR
MNYHVFSPNDRLSKYIRCYWSLDNLDDLEPHSRERIFPDGCIELIFNHGDLFVTYTKNGA
ETQPKNFIHGQLKKFIEVQGIGKVGIFSIRFQPAGLQPFIDFPVSNLTGFFVELSKIWED
SSSLEEQMGCCQNNEERIRVIENFLENHLKNTTDTDTIESCVNEIIQSEGMISIEKLTAN
LKTGQRHLERKFLSNVGLSLKLFSRIIRFNHALQLIENKDFRNFTNVAYDGGFYDQAHFI
KDFTYFTGLNPKKYFSENLEMAKYFNLE
>LONDMIMF_00477 hypothetical protein
MENFDWTKFTRKIAIKSSLSTLYNAWATSSEIERWFLSNASYFDPNGKQLDSKTAVEKDA
TYEWRWFLYDDVEKGKITEANGTDYLQFTFAGNCLVDILLTQEDGYVLVELTQKNIPTDE
NSKRNIRLGCHTGWSFYLVNLKSVYEGGLDLRNKNENTYPMVNN
>LONDMIMF_00478 Peptide chain release factor 1
MLDRLQIVKQRFDEISDLIIQPDVIADQKRYIQLNKEYKDLKALVEKRDEYVNIMGNIDE
ANEIIADGSDPEMTEMAKMQLDEAKQRLPELEEEIKFLLIPKDPEDAKNVMVEIRAGTGG
DEASIFAGDLFRMYTKYCESKGWRTSVVDMNEGTSGGFKEIIFEVTGEDVYGTLKFEAGV
HRVQRVPQTETQGRVHTSAATVMVLPEAEEFDVQIDMNDVRIDFFCSSGPGGQSVNTTKS
AVRLTHIPTGLVAQCQDEKSQHKNKDKAFTVLRSRLYEQELAKKQEEDAQKRSSQVSSGD
RSAKIRTYNYAQGRVTDHRIGLTLYDLGNIMNGDIHKIVDELQLVSNTEKLKEASEVF
>LONDMIMF_00479 Orotidine 5'-phosphate decarboxylase
MTTQQLTEQIHQKKSFLCIGLDVDLNKIPQHLLNTEDPIFEFNKAIIDATHDVAVAYKPN
TAFYEAYGIKGWISLEKTIRYINEKHPEIFTIADAKRGDIGNTSSMYAKAFLEDMAFDSV
TVAPYMGKDSVEPFLAVKDKFTILLALTSNEGAFDFQTKSVEGKELYKQVIETSKQWKNS
ENLMYVVGATKAEYFTEIRKIIPTSFLLVPGVGAQGGSLSEVCKYGMSENVGLLINSSRG
IIYASQQQDFSEKAREEALKMQQEMEQILK
>LONDMIMF_00480 hypothetical protein
MDRTFILRFAVAFILIMHSVPGMLNNGIHEFGTLYLNTVGFAPYGVLLAWLIKLSHVVVA
VLLLLNKYVKIASIVTIFVLIMGIIMVHYPEGWFVVGGGRNGVEFNFLLIFVLLAIMFPE
GINSKLSKK
>LONDMIMF_00481 Vitamin B12-binding protein
MKTYSDQLGNSHTFESVPKRIISLVPSQTELLFDLGLEENLVGITKFCIHPYHLKSTKKI
IGGTKKVHYEKIKLLQPDIIIANKEENTEEIVEELRKICPVWVTNILTIEDSLQMISDFG
QLFNKRTEAQKWIDKIQFALTDFQNFIKDKEEQKVAYFIWANPYMVAGGDNFINEMLKLN
KFVNIYDNHPKYEGRYPEIVIQKMRIQGDPDLILLSSEPFPFKDEHAFELGRFTHHAKTV
FVDGEMFSWYGSRMAKAFDYFKKLHSNL
>LONDMIMF_00482 hypothetical protein
MIIFESKNFTLMKRLLLVAFLVPATCFAQLDGFIKKATEKVQSKTEKTQTKTSSKKTGSL
LGSTDISAGLKEALQKGISEQVTKLTAVDGFYKNEAVKILFPEELQKVDKTLRSMGLSSL
ADEGIKVLNRAAEDAVKEATPIFVSAIKNMKFADAKNILLGNEDAATTYLQGATSTELYT
KFNPVVKTSLSNVGADKVWEGIIKKYNTIPLVAKVNPDLNDYVTDKAMEGVFKMISVEEK
KIRTDIGARTSPLLKKVFAMQD
>LONDMIMF_00483 hypothetical protein
MVVFTFGIAVIPTRYITFQCPCRFFIRLVNNNIVKTVWEIIWSAASVSINTHLSVSLIIV
SSKRTSVYRNLLIIGTQSVTMRIRIGKQSSLQHLIWRISYSIHDVRRSKSGLFYILKIVF
GIFVKFDNTNVN
>LONDMIMF_00484 Transcription termination/antitermination protein NusA
MENIALIESFSEFKDDKLIDRVTLMAILEDVFRNALKKKYGSDDNFDIIINPDKGDMEIW
RRRVIVADEDLDFENEEITLTEARKIEPDFEIGEEVSEEVKLIDLGRRAILALRQNLISK
IHEHDNTNLYKQFKDLIGDIYTAEVHHVRPRAVILVDDEGNEIVLPKEKQIPSDFFRKGD
NVRGIIENVELKGNKPQIVMSRTSEKFLEKLFEQEIPEVFDGLITIKGVVRIPGEKAKVA
VDSYDDRIDPVGACVGMKGSRIHGIVRELGNENIDVINYTTNTQLFITRALSPAKVSSIK
INEETKRADVFLKLEEVSKAIGRGGHNIKLAGLLTGYELDVIREGNIAEEEDDVELTEFS
DEIDAWVIEEFAKIGLDTARSILKQDVNDLVRRTDLEEETILDVIRILKEEFED
>LONDMIMF_00485 Ribosome maturation factor RimP
MRGQIVPSFYKNMTFKEKVSELLKAGLEEKPSIFLIDLTITDAFKIIVTLDGDNGVTLQD
CIDISRAIEHNLDREEQDFSLEVASGGVSAPLKLVRQYKKNIGRTLQVKTATDIITAELA
DANEEFITLVWTAREPKKIGKGKETVEKRQEIPYTDIKEAIVTITF
>LONDMIMF_00486 Stress response protein NhaX
MKKILVPTDFSDHAEYALKVAAQIAKKNNGEIVLLHMLELPGQGSDAIGSGSDIPEIMFF
KNKAIEKLESLMDISYLEGIPVSEIIQFEKTFEGIINISKKNNVDLIVMGSHGASGFQEM
FIGSNTEKVVRSSDIPVLVIKKEEGEFSVEKFVFASDFTDEIKGSFAKVVEFAKKFNAHL
NLVMINTPNSFKSTEVSNKIMQDFVSNFDISDYTFHIYNDTNVEKGVLNFAKSINADLIG
MSTHGRKGLSHFFNGSISEDLVNHAQRPVVTFKI
>LONDMIMF_00488 hypothetical protein
MVSFNFKKWNTILGWTAFAIALVTYSLTVEPTLSFWDCGEYISTAAKLEVGHPPGAPLYQ
MMGAFFAMFATDASKMALMVNMMSVFSSAFTILFMFWSLTLLLKKLVSRFSEIDKNTSIA
ILGSAFVGSMAYTFSDSFWFNAVEAEVYAMASLLIAVLFWLGLRWEQDMDTPRGNRWLLL
ISLIVGLSFGVHFMALLTIPSIGFLYYFKHYKTVTVKNFIIANIVVVSILLFIFKLLLPL
TMGFFGKTEVFMVNSLGMPFDSGTIFVALLLVVLFYFGLKYTKQKGYIQYNTMILCVLFI
LIGFSTWMMLPIRANANTVINENKPSDAREVLAYYNREQYGVNPLFYGPQFSDTYAGLDK
DNPYLDKAPNYERDYKTGKYVIVNNYKNAEQNTDDNHKAFLPRMWSPEHAENYMTFTHVL
NFRMNPNYEYEEELPRYGINPNDLSEEELAHYTSQLRAEMEKNVDEFRKAYASGQIDTEG
YHKFLKSYGDYLIIDKPTTADNFKFMFEYQFGYMYWRYLMWNFTGRQNDNQGKYDNLDGN
WISGINFIDEARLGSQQNLPSDVLNNKGRNLYYFLPFILGIIGLIYHANKDLKSFYVLLA
LFLFTGLALKIYLNERPFEPRERDYALVGSFYVFAIWIGFGVYAIFDFIKKWLNPKIAGP
VVIATTLLAAPVLMASQNWDDHDRSGKYTAIAMAKAYLNSCEPNAILFTIGDNDTFPLWY
AQEIENIRTDVRIVNTSLFMTDWYIDQMKAKAYSSEPLPITFKHEQYVGDKLDYSIHRPQ
TDKRWNINDFMNFLSLNDPRALYELPNGQKIHYFPTNKIRIPINKEEIIANKVVSPKYYD
SIVPYIDIDIKDRALYKNRLMMLNVVANNNWKRPIYFTGGSFGDDDYLWMKDYLQLDGMV
YKLVPVKTALSKAPSPMDMGQIDSDKMYDIVMKWDWGNGGSTKIYHDPETRKNSISYRTN
LARLMEQLINEGKPKKAKDIIDLAMKQMPIDQYGYYAFVEPFAGGYYEVGEKEKAREILK
KLMKKYQESLTYFKTFSATEQNDYYVDIVTDIERYRGLLEVMKDRGDKEFYEANKKDFNS
YNAMFKRFERDNE
>LONDMIMF_00489 Peptidoglycan-N-acetylglucosamine deacetylase
MGFPMCQFEFQIGTSTLKRLEMGLWVKTNRLIKWAFPKYTWDIPNNANTIYLTFDDGPIP
EITEWVLDVLKEHGIKATFFCIGDNIKKHPDIFHRVIREDHAIGNHTFNHLKGWSTPKKD
YIENSMLCEKAIQQHVKGDGQGTKLFRPPYGKISPSQSRLLRRLGYKIVMWDVISMDFDK
NTTPEKCLENVMKNTASGSVIVFHDSIKAFGNLQFVLPEAIRRLKEKGFVFDKIS
>LONDMIMF_00490 Thioredoxin-like protein
MSKFGELINASVPVLIDFYTDWNEQSVSMHPVIRDVAAALGDKAKVIKIDVDKNQELADA
LRIKGLPTLMIYKEGQMVWRQSGELDANTIIGLVQEQL
>LONDMIMF_00491 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MLRWIFFIAFVVLVELYAFQAFKTITRAKWILIPYQLISLAIIIFVIYSFTQFDRTVGQN
RQSLITIGLVLLTFLPKLVLTFILFGEDIYRVFSGIITHFLGNNDRGHFLPDRRKFISQV
ALGIAAVPFVSLLYGMTVGKYNFKVIRQTLFFPDLPDSFDGTTITQISDVHSGSFDNPEK
IQYAVDLINEQQSDLVLFTGDIVNTHATEMHPWIDTFKKIHNPKLGKYSVLGNHDYGEYV
EWPSDKAKSENFEAIKDLHRQIDFKLLLNQNVKISNGTDEIALIGVENWGHNFKKAGDLT
KASEGLTDSDFKILMSHDPSHWEYEIKNHQTKYHLTLSGHTHGLQFGIEIPGFFKWSPVQ
YIYKQWAGLYENVGRYIYVNRGFGFHAYPGRVGIWPEITVITLKKGENVA
>LONDMIMF_00492 hypothetical protein
MVFRNPQIMKKIYLVVTTIFTCSLLQGQIFQEVTNQTFQGVFYGDAAIGDFDSNGRTDFI
ISGARPGYTGYSGLYKNNNGAFTENLNAAISQIMYSSIAVGDLNGDNKPDFIITGTKTGE
NASVVFEIYYNNGDGTFTKNTTSGIPGVNFGSVAIADLTNDGVADIVVNGNLGTEYITKV
FQQNSDGTFSDLNAGLMGTYFSAIKVFDANADGYPDILVTGFSTNYIPETKLYTNSGSGS
FTEKPITIPGIYFSSIDALDINNDGHLDLLISGTDYTPTPSLTIYTNDGFGNFILQENNF
TGTYNGNSKFVDYNNDGLIDIFSIGSNAAGTNTVVLYKQNLDGSYTLDTENSAPIFGVNM
SKGLWLDFDNDGDLDLLTIGFEGGNVAQTRLYKNKTINQETCGEPGNNTGDLGCVTFTYE
GTSVTYTTVRGSDGNIWLQQNLGSVSVATAQNDEASYGDLFQWGRWDDGHQKRNSVTGTV
PTPNNPSGLAAGSETYYTGWWTPNALSDKWEAATPSAATEVNGCDPCKALGNGWKLPTEA
EWTAIKESQNIQNPATAFQSVLKLPASGYRAASGSFSFVGTRGYFWSSTTSSSGAKYMYV
GSTIANPSAGGPRAQAAAIRCMKYPQTTSTYCTVSVDYDVEPITMVNFSDINNLTSEAVN
TTPAYEDFTSIVGNVVRGNTYQLTVKGNTVGQFEHDIRAFFDWNKDGLFDMQTEYYHAVL
MPSTGVDAIEATVSITIPATAVIGDTRMRIIKDQWNIYEEGEFDACLNPYYGQVEDYTIN
IQESLGTIDFNKNDFIVYPNPTNGIVNIQTKEAIKNISLYNHLGQLIVTQKQEQLNLTNL
ASGIYMVRVDFENGQTANKKIIKK
>LONDMIMF_00493 hypothetical protein
MYSQIFQAVTNQTFQGVFYGDSAVADFDNDGKTDFIISGAKPGYTGYSGLYKNNNGIFAE
NTNTALSPIMYSAIAVGDLNGDNNQDFIVTGTKTGENSPIVFEIYYNNGDGSFTKNTTSG
IPGVKYGSVAIADLTNDGLPDIVVNGNLGSQYITKVFRQNQDGTFSDLNAGLLGTYFSAI
KVFDANADGNPDILITGLSTNYRPETKLYINSGSGTFTEKTTTLPGIYISSIDAMDINGD
GYPDLLISGTNYSRIPTLTIYTNDGSGNFTIQENGFTGIYNGNSKFIDYNNDGLIDIFSI
GRNANNENTVLLYKKNSNGTYTLDTENSAPIIAVYMSKGQWLDYDNDGDMDLLTIGFESE
SVAQTRLYENKTINDGNLNTVTFNKNDFKLYPNPTNGIVNLLTDLEIKEVKIYNQLGQLV
SIQKTSQISLSDVANGIYIFHIDFINGQTAKQKVIKK
>LONDMIMF_00494 DNA polymerase I
MSQQKRLFLLDAYALIFRGYYAFIKNPRINSKGMDTSAIMGFMNSLLDLIKREKPDHLAV
AFDKEGSHVRSEMFADYKANRDATPEAIQIAIPYIHELLKAMHIPIIEYAGCEADDLIGT
IAKQAEKQNYKVFMVTPDKDFAQLVSENIFMYRPARMGNGIEIWGVPEVLAKFEIERPEQ
VIDFLGMMGDAVDNIPGLPGVGEVTAKKLLKEFGTMENLLENTHLLKGKMKENIEANKEK
GILSKKLATIITDCDVTFNETDYELTRPDIEKTEAIFQELEFRRMAEQFDAIFRPGSSLP
AANNQPDAKLYKKPQAKNEEQFDLFATTTDETTGEVKTSFYKTLKDTEHFYQLVEGDMAV
KFLMQNLLKQTSVCFDTETTGIDPLTAELVGMSFSWEKGKGFYVPFPENQTEAQTLVNKF
IPFFEAEGIEKIGQNLKYDLKVLANYNIEVKGKIFDTMIAHYLINPDMRHNMDILSETYL
QYSPQSIEELIGKKGKNQKNMREVPVEDVKEYAVEDADVTLQLKDIFSKELDSTNTKKLF
EEIEVPLVPVLADMEREGVNLDVEFLHNLSKELKDDIQKLENQIYENAGEKFNLASPKQL
GEILFDKLKIGGTKQKKTKTGQYATGEEVLSYLALSSPFVQDILDWRQLVKLLNTYVDAL
PLQVCQKTGRVHTDYMQTVAATGRLSSNNPNLQNIPIRTERGRLIRKAFIARDENYTLVS
ADYSQIELRIIAALSGDPEMVKSFQNGEDIHASTAAKVFNVPLEEVTREQRSHAKTVNFG
IVYGVSAFGLSNQTSLSRSESKDLIDAYYLTYPRLKAYIQEQIEYARQHGYVQTILGRRR
YLKDINSQNAVVRGAAERNAVNAPIQGSAADIIKIAMINIHKRLNEENWKSKMLLQVHDE
LVFDVHNSELEKIQPMIKQEMENAFKLDVPLIVDLGKGHNWLEAH
>LONDMIMF_00495 hypothetical protein
MKKTALFLCLLLCLNSFGQEQINKTISIPFTLLGSGHILVKAKINNVEGNFIFDTGAGLN
LLTKKFADNVKDLKKTDGFYTGHRATGEEIVADLWDTKSLEIGNQKLNAEKFTVIDLDFP
VDGLISLLPFRNIPITIDYKNKVLVLETEKSVKELAKKGISIPIQISDDLGKTLGIATYV
QLNDKLVVQMNLDSGAGFNVFRFNSRYMQSLGIDPSKTEMKHQKSDFKPTEGNNYYYTNL
SKINTESSNKISATNFKATFIDGLIYEAIGSINWLGDKITIDIRNKNMIINN
>LONDMIMF_00496 D-alanyl-D-alanine carboxypeptidase
MKKIFLFLSISLSLNAFGQSETRFDKIDSLLNYLSSNNKFMGSVAIRNNDEIIFENTYGY
ADVKNKIKADNQTRYKIGSITKTFTSVVILQLIEEKKLTLDTKLSRFFPTIQNSEHITID
NLLSHSSGIYSFTNDLDYPTYAKLPKTRSELMKKIKAGKPVFEPGEKAEYSNSNYVILGW
IIEDLTKKSYADNINTRIIQKLGLKNTGFATGAKNEALSYEWDGKNWKDASKEDMSIPGG
AGAILSSASDLTAFINALFSGKLLKQPSLDTMITIEKGYGKGIFAMPFAERRFYGHSGGI
ESFTSSLIHYPKEKLSIALLDNGQGYDTDGIMIGILSIYYKMPYRFPNLKTATVDVAILK
KYVGIYSDPNFPLKISIKEENGVLICQATGQESFPLNPLSDTKFNFDPAGLELVFSPNAM
TILQGGHEFKLTKEK
>LONDMIMF_00497 HTH-type transcriptional repressor CytR
MKPKATLKQIAKELNVSVSTVSKALSNSPEISEPTKIKIQEFAKLKNYKPNNIAINLKNR
STKTIGVIIPNILNPFFAKVFSGIEKKANEKGYNVITCITNESLKKEIHTMDMLSNGTID
GFILSIAEETQKQQEFKHFKDAISDGIPIVMFDRISDEVNCDKVIVDDFDSSVNAVNHMI
QLGCKDIALLTAIDNLSVAKLRAQGYAKALTDNDIAINKNLIIRTDNPDEFDFRLNELIN
TQKIDGIFALDEHASTMAMKMAIKKGIKIPDELCVIGFADGVWSRRLTPSLSTISQHGIE
IGEEAAKMLIEKLESKEEEYAYRTTVIKTELRQRDSTRKLS
>LONDMIMF_00498 hypothetical protein
MKNVVTVKEQLTSGTNRRSFLKISGLTMAATGLLLTGCNNDDDSMNNGPYAPGVRNGKFD
LGSGDLGVLTYAYALEQLEADFYTRVVNLNNFGALFNSEEQQILSDLYAHEVIHREFFKV
ALTGALPNPSTQLLPALQFDFSTVNFSSRSSILSTAKALEDTGVAAYNGAGKLITSTDYL
LLAGKIVSVEARHASAIRSLINPNSNDFAGDDVVNASNGLDAAKNPSQILPIAGSFITTE
FTATYLP
>LONDMIMF_00499 hypothetical protein
MNLLKFIESFTDDHLMNSKGSRRDSFGQFGQLGKNLALASIPLGLAAFTNKAFASDIGPT
PSTPIGALQLALTLEYLEDEFYRLGLESGVIPTGGRDEKVFMQIAKHEASHVEFLIAGLG
ASAVAKPTFDFTVGGAFDPFNTTGIGATAAYQQFLVLAQAFEDTGVRAYKGQAGNLISTP
DLLTAALQIHSVEARHASEVRRLRGLKGWITGNQRGAGMPSATQAVYDGEENVTQAGFNT
STVNNGSLGPAIPGLAGSESYDEPLTTQQSVNIANLFIV
>LONDMIMF_00500 50S ribosomal protein L13
MNTLSYKTISANKATVKKEWIVVDAEGHNLGRLASKVAMILRGKYKPSYTPHVDCGDNVI
VINAEKINLTGNKLDDKIYMRHTGYPGGQRTLTAKVLQTKNPASLVEKAVKGMLPKNKLG
AQLFRNLNVVVGSEHSHEAQKPKTVNLNDLK
>LONDMIMF_00501 30S ribosomal protein S9
MATIHKIGRRKTAVARVYVTEGTGNITVNKKEFTTYFPTATLQYKVLQPLSMTENASSFD
VKVNVYGGGSTGQAEAVRMAIARAMCEVNAENRAILKPEGLLTRDPRMVERKKFGQKKAR
KRFQFSKR
>LONDMIMF_00502 30S ribosomal protein S2
MANKVEVKELLEAGVHFGHMTRKWDPNMAPYIYMERNGIHIINLYKTAAKIEEANEALKK
IAASGRKILFVATKKQAKDIVAEKAAAANMPYITERWPGGMLTNFVTIRKAVKKMASIDR
MKKDGTFMTLSKKERLQVDRLRAKLEKNLGSIADMSRLPAALFVVDIKAEHIAIKEAQKL
NIPVFAMVDTNSDPREVDYVIPANDDASKSIEKILSLVTAAVIEGLSDRNTTSDKEVEQP
VDEATDAPNETVEASTEE
>LONDMIMF_00503 Elongation factor Ts
MATITAADVNKLRTLTGAGMMDCKKALVEADGNFELAIENLRKKGQKVAANRSDRESTEG
AAIAVVNADKTSGVVISLNCETDFVGKNEGFVKLATDLANLALNFQTKEEFLAADFNGIT
VADKLIEQTGVIGEKIEIGAFERLEGAFVGSYIHAGNKIATLVSLSANVPGAEEAARNVA
MQAAAMNPIALDEAGVDASIIEKEVEIAKDQLRQEGKPEAMLDNIAKGKIQRFYKDNTLV
NQDYIKDGAVSVSGYVKSVDPSLTVTGFKRAALG
>LONDMIMF_00504 DNA-3-methyladenine glycosylase 1
MEKIRCRWCVGDSLYEKYHDEEWGVPVYDDQKLFEFLTLETFQAGLSWITILRKRENFKK
AFDNFDYKKVAQYTEEKIQELLQDTGIIRNQLKIRAAVTNARAFMETQKEFGSFSDYIWK
FTGGKPIINNPKTLADVPATTPLSDEISKDLKKRGFKFVGSTVIYAHMQATGMVNDHVGE
CWTKK
>LONDMIMF_00505 Lysostaphin
MRKNTIIIGLLLSVLYACNSVKLPDVKVNAYPLGYSQKIEGDSLIITLDNRLECPVRIVL
NDSSLNKRFENKGIVVLEPKEKRRTGVFLERKEYTAGANYMLGNAISYPKDNKLSLPFQK
GKLYKIVQGHNGNFSHKEGLSKLALDFDLKVGDTVCAAANGYVVGLVDKYKYYGKNSSWK
DYANFITLYHPETGVFTEYVHLKENGAKVAVGDFVKAGQPIALCGMTGWTTTPHLHFVAY
FRNTDWKSEPIEIDFAENYKSGSLKPGDVVKK
>LONDMIMF_00506 Leucyl/phenylalanyl-tRNA--protein transferase
MRLYFLSKELFFPPVEEANPDGTLAIGGDLSPERLVLAYRSGIFPWFDDDEPILWWSPPE
RMVLFPDEFKVSKSMRNILNRGIFRVTFNQNFRDVISNCSTISRDGQQGTWISEQMIEAY
VKLHEMGIAKSVEVWQDEVLVGGLYGIDLGHVFCGESMFSKVSNASKVAFVSLVRKLKEE
NYKLLDCQVHNSHLESLGAREISREDFMAILKKEY
>LONDMIMF_00507 hypothetical protein
MEVTGRVKVINAEQQISASFKKRELVVTTDEQYPQHIMIEFTQDKCDLLNNYTPGEPVKV
SINLRGREWVNPQGETKYFNSIQGWRIEKLQPEAPSAQQAPPMPAREAFEPANDYKEEEH
DDLPF
>LONDMIMF_00508 hypothetical protein
MISIIPKEIPTAKLQGYLQGSVGPRPIAFASTMDHNGKPNLSPFSFFNLFSANPPILIFS
PSRRVRDNTIKHTLINAEATREVVINVVTYDMVQQASLASTEYGDGVNEFLKAGFTAIPS
DLVKPYRVKESPVQFECKIQEIISLGTEGGAGNLIICEIVKMHIDEKILDENGSVDQHKI
DLVSRLGGNWYSRSNMGLFEVEKPLTTLGIGVDQIPDFIKESPVFDGNDLGKLGNVEALP
TSEEVAIFVDQNFAVKGVLSSDDQEKVHLKAKEYLDNNEVMAAWKVLLSEKI
>LONDMIMF_00509 Sporulation kinase D
MQFSEKRNVTRWIIIIISFIIISLILWNTYTFFQIFKNEEHVKMQIWATSLKTINNADLE
NDDIELPRQIVDKNTTIPIVWTDQNGNIRGMRNIDDEIANDSIKAKAFFENFKNENEPIA
LELPGETQYVYYGNSSLLNNLKYYPIALFLILVLFGLLIFNFYRASRMATQNKLWAGMAK
ETAHQIGTPLSSLLGWIEIMKADNVDETTVTEVEKDIVRLQTIADRFSKIGSEPVLEEKD
IIAETEQSYDYLKSRFSNQINFSFKAPNHPIMTSINPILHSWTIENLVKNAIDAMKGRGD
LSIVIEEDSRFVKIKVSDSGKGIPKKEFKQIFEPGFTTKKRGWGLGLSLTKRIVEEYHDG
RIKVFSSELGKGTCMLVSLRKL
>LONDMIMF_00510 putative HIT-like protein
MSSIFTKIVNGEIPAYKITEDADYLAFLDVNPNAKGHTLCIPKKEIDKIFDMDEDHYLGL
MKFSRKVAKALEKTVACKRIGMAVIGLEVPHTHVHLIPLNEMDEMRFQNKVKLTKEEFEA
LAKEIQANL
>LONDMIMF_00511 Transcription elongation factor GreA
MKRNPVVMGFFLFYINDEIMSNVSYYTAEGLKKLKEELEQLKSIERPKASQAIAEARDKG
DLSENAEYDAAKEAQGLLEMRISKLEEVYANARLIDESQLDVSKVLVLSNVKIKNQSNGM
EMKYTLVAESEADLKSGKISVTSPIGKGLLGKSVGEIAEITVPNGILKFEILEITRD
>LONDMIMF_00512 hypothetical protein
MKKIIVLLLIGIAISACSDSKINNRNPYIPNYSFSVDINLNLPLYSDLQYTGNGKLITLN
GAGANGIIVFNAGAGNFKAYDASCPNQYASTCSRLVVEGINAVCPCDDVMYSLFTGLPNA
DVEYPLKPYRIQVTGNVIRVYN
>LONDMIMF_00513 hypothetical protein
MPRICLKTAITAPLDVVFDLSRSIDLHTISTEQTQEKAVSGKTSGLIGLNDTVTWRAKHL
GFTKYLTSKITDYNRPSFFADEMIKGAFKKFRHEHHFEVVGNQTLMTDIFEYESPLGILG
KLADFIFLENYLRSFLAQRNKVIKEFAESGEWKNILK
>LONDMIMF_00514 Vitamin B12 transporter BtuB
MKTLFKKNELGPKKKKSLSLPESFLDAKTMAGIAIFASASLFAQEKTVSDTTKTRNLDEV
LVSAVRVTAQTPVTFSNISKKELESRNLGQDIPALLNYLPSVVVTSDAGNGIGYSAISVR
GSDSRRVNVTLNGIPYNDSESQGTFWVNMPDFTSSVQNIQLQRGVGTSTNGAGAFGASLN
LLTDSYATEANGEISNSFGSFNSRKHTLKFSSGLIKDHFELAGRVSNIKSDGYIDRASSD
LKSYFFQGTYVGNSTLIKALVFGGKEKTYQAWNGLEDPEKLKNDRTYNTAGEYVDDNGVT
RFYDNETDNYDQDHYQLHWNERFSDNWSTNLAFHYTKGKGYYENYKKKQDLSEYGIEPQI
IDGVEIKKSDLIRRKWLDNDFYGTTFSANYKKEKIDFILGGGWNKYEGSHFGNVLWTRSV
ILPEYDFKYYDDFSTKTDFNVFAKINYRLNENWSLFGDLQYRNVGYKANGADTGLVDDNF
NFFNPKAGITYLVNDENNIYFSYARANREPNRSDYESGNPKPEKLNDFELGWRYSSPKTK
INVNGYYMRYKDQLVLTGALNDVGAPIRQNSGESYRLGLEIDATLFVAEKWIFRPNLTIS
TNKNEDFVFQRDGVLEKLGNTDIAFSPNVIFGNAITFLPVKNMQVSLLTKFVGDQYMGNI
DSKASKLKSYAVNDLNISYEIKTNTVFKSIIFSGLVNNIFDYEYESNGYFYTYDDDYSNP
GTIKTIEGAGYFPQAGINFLAGMTLKF
>LONDMIMF_00515 Peptidyl-tRNA hydrolase ArfB
MDTEKIISELKFKAVRSSGAGGQNVNKVSSKIVLSFDLGNSKALSVEEIAILEEKLAPRL
TNDKILILNSDEDRSQLKNKEIAIKRLLHLLQQNLIVPKERKATKVPKAVIKKRIQNKRK
LSEKKESRRKPDF
>LONDMIMF_00516 Trifunctional NAD biosynthesis/regulator protein NadR
MEENLKQQPTDKIRIALYGPESTGKTTLAKQLAEHFQSVWIPEFARDYLQEKWNRSKEIC
QPEDLLPIAIGQMQLENKALSESGKYLFADTNLMCTKVFSEIYYSFCDSALDKAARKHKY
DLFFLTDIDVPFEKDDLRDKPDEREMLIRKFEEALIENKKPYILLSGNKEERLQKAIAIL
EDLEKSKALGFDSCDFVQIYNQGIKIDTVANYLKVFNTGIPKAVLERAASLTDGIMPLSE
EEAVYYANLFESKKDRLKIQKFVPASGAASRMFKFLNEFVNEYKLGNETINAYINRKRCG
AMPVFLIGIEKFPFHKTVLEYTQVKYPEYKQWDKDTRFFYFVKSLLSSNHFDFASKPKAV
LPFHQYGDYIATPIEEHLNESGSYAFSSGISGLHFTISEEHQDSFDKIINDVKPKVEANT
NVQIHVDYSYQHKTTDTLAVDLQNNPFRLDDGSLFFRPGGHGALIQNLNQLFADVIFIKN
IDNVIQNHIHIISLYKKALAGILLEFQDRIFTFLKVLSTENIQKETIDEIVEFVKSKLQM
VINADFQKYTRENKVSHLQEILNRPIRVCGMVKNEGEPGGGPFWVRDAKGNVSLQIVESS
QVDMQNPAQAKILSSATHFNPVDLICGTKDYRGEKFDLREFIDNESGFIVEKNKNGKPIK
AYELPGLWNGAMAKWITIFVEVPLITFNPVKTVNDLLKPAHQPQ
>LONDMIMF_00517 Nicotinamide riboside transporter PnuC
MIDFFLNAYKNTPVVDIILEAIVFITGILSVYFAKKENIWVYPTGIIATVITVYLLYKAG
YFADMTLNIYFSVMSIYGWINWSRKKEDDYVVKISRTNTKQKIIGVLLFFLTIVVTYLVY
HLFGKEIKPENYIDIFTSGLFFTGMWYMAMKKIENWTLWIIADIIAVPLYAYRGLGMLSL
QYVIFTILAILAYIEWRKILNSSPQIKSE
>LONDMIMF_00518 Geranylgeranylglyceryl phosphate synthase
MQNIYNEILQSKKEKKKLLAILLDPDKISKDSLQSIIPKINQSSATHIFIGGSLVITNTI
DGIIRELKQKTALPVLLFPGNPSQISSEAHGILFLTLLSGRNPDFLIEHQVKAAPILKKT
NLEIISTGYILIDGGNQTAVASVSKTIPLPRHNSDIAVATALAGEFLGNKLVYLEAGSGA
KLSVPLETISLVSKNIEIPLIVGGGIKDIQGIEDAYAAGADLVVIGTAFENDSNFFINSN
LMLHD
>LONDMIMF_00519 4'-phosphopantetheinyl transferase sfp
MPLYKVIHFSPSIKVLIWKITEPFDELFSQVLLKEKTLGRLQSMKSEVHQRAFLSVRKLL
QEAGHNDLQLHYDEFGKPHLENETHISITHSFDFSAIILSDENVGIDIELRREKVMLIAE
KFVDESEFRFLDKEKKDDYVSRLTVIWGVKEAIFKIRNEKGISFKDHIFVAPFEMTEKKA
KALLTFGNLNIEFDICFEEIENYTLVYAFQKGNQ
>LONDMIMF_00520 Adenosylhomocysteinase
MSTTTLPFVAYKVKDISLAAWGRKEIELAEAEMPGLMALRREYKDEQPLKGARIAGCLHM
TIQTAVLIETLVALGAEVTWSSCNIFSTQDQAAAAIAAAGIQVYAWKGLNEEEFDWCIEQ
TLFFGEDRKPLNMILDDGGDLTNMVIDRYPELVAGIKGLSEETTTGVHRLYERMKNGTLP
MPAINVNDSVTKSKFDNKYGCKESAVDAIRRATDLMLAGKRVVVCGYGDVGKGTAASFRG
AGSIVTVTEIDPICALQAAMDGYEVKKLDTVIANADIIITTTGNKDIVVGKHFEKMKDKT
VVCNIGHFDNEIDMAWLNKNHGASKIEIKPQVDKYTINGKDIIILAEGRLVNLGCATGHP
SFVMSNSFTNQTLAQIELWKNSAAYKNEVYMLPKHLDEKVAALHLAKLGVELETLNEEQA
AYIGVEVQGPFKPEYYRY
>LONDMIMF_00521 hypothetical protein
MRKIVPILVFIATLSCSKSISQVSTVKKISESAKVNLPYGDKDVLHEFPADWSRGDALQD
SLYNKMSFFLFQDKDNPARSTIAINYPEAKTFIAKDFIPSNEIKNGKSKIEIKSAQVFDG
KNFKIVSVLYEGKIDCKTCEYPESQTQNVLLSIKDGKVIDKLPVSYLNGSDLGQSARYFY
IDSDRIIHLKDFKSDEEGVTFAEYLKYKITPDGKFAKL
>LONDMIMF_00522 hypothetical protein
MPITIDDTGQTVTLNPPYSPVTPDDSLQKITRVYFAKKTVTREGANVAFTRIDSLHAQQE
GGQNLLYDSVLGKTVYLVIETENMATLSIDAVIRPGDNTLTGNTETLNLMWFNPATQNFE
VRRKMTAVVGNFDALNNKGTTENPSGSHDHYTNLADHENKAIIKLQLRPSLRTDFNTWAA
NIAAAATHTANLEVVVERTDNEACAYGPDSTEEVKEAGIFLNSDAQGRFRVGNRNFYEIY
ARVLSGRTNNRNTYTDGTYNFLPMNGTVRRKISKLENPSSTQVTYYHYDIYGNEVFIATC
DKTSVMGRNNGQQLGAVPPGALRTENAPAGGAAQTNHIFANAIVTTGTHRNDRNARAFPG
ALRIVRYTASGTNVPLVRMPDTLNVTVNGRVIAYGFSNTQRRFCNPDCFAAFVGVLSQYG
LAGVNSTGMCFGDATSYPSLAHPNGDSVDTSYLANRQNEQDLLNAFVDWNFAQVIAGTTQ
QAWLRNAHRYAGDHNDHLHSGDFDSNSIHNIYQ
>LONDMIMF_00523 hypothetical protein
MRNITDTVEGIKELDISLYLEEHLQFYKFSMMEITTENGNVLKSEVNKTIHSTILKKDFE
TYLIQLEVFDIEYKNRTVSLTEKDFLGRIAEVNDDIILETDEHLNINKLVNQHQIQKRLE
EKIERLAKSNVGPKVEEMFQYLREFYSNDRRILLDIKNYRQHGLLLNPFYDRYTPLSVKK
RSVRYLNFVENAVVNIGEEARVKKIKLKERELEVGVKGKMIAPFYNDMIFKSIKKKEISF
DSEKDKPSLDKYEGSFIFNMNTGTVKKASIEIEFSLGNNYRKTISYQLNELNDADNN
>LONDMIMF_00524 hypothetical protein
MRKKITTSLLITCMILLSCKAQNHNVTEKNTLVADSTLAYENNKVIGKISQPTTYNCKAC
YTINKIGDIKIKVPVSNKVVNNQSVLEQDFAIDKVIKNGNTTVIKYSSTSSSKAYELEVN
KDYIVRMLTYSYGSKDIKIGENDYASFQANSICQNEKKIKIKDTITLNDGYVFATKDCFD
CPVKYTIEECIANRKKGVKMNWE
>LONDMIMF_00525 hypothetical protein
MAQSEEQNNESYSANPNQKVYDTPHVVDHLVDVIAIYFAEKKKKFKWTPKEETYTVNKGG
KIADVKKKYTDTFKAEKKTIQNLATDPDHTAALKPNDQIKVTWEEQEEDGFEMVKIPKAT
IGKKVYIVANCHGDKAKLTVQINENKLANPEAVYDAPVKFLIGDQEKDKVEFSITKDKSE
YEQEITLRPKTDADLKKLVEKFDKRTGKNAFVYLKGEVTETSDEIKFPDETHEFLNKEQE
RFEVLGTPCYCNRDITVDEMINLIYHLRDKQNYVSKRDHFFNNGSEKITEISISTGKISD
NRDKIQLFVNEMNAMFKKFNINTCKRKIHFIGQMYLETISFTYTYESRTSVPDNYKGGVD
FQGRGMKQITHDYNYLAYYDYINTTTFYDTYIATRSGYESVGDCVAKRPAATTAGLDTAF
YDGLKTFAKKISQELFHAFNSAGWFSTVYKPTTLTEMDKGLEDENIRLVTVAINGGENNL
AERKNYTKWTREFFKYDTECVRR
>LONDMIMF_00526 hypothetical protein
MNYQSIIENLKAKVLLRLLLLVAFLPNEVVSQVVKVDSISISKEWKDCNGMNKLTVNVNA
LCNPDEPPFDGHKTMIDVSLKNKKHSLNVQFDDPDYQMEMIAFSEKNIWFYNLKKARVVF
IPFSYCSNSDSEKKLSYIILYNDKKYLYHIPFKCTEEDDCVLNADLNKSMSDLNPKIRTE
LIKKIKSHYKKGSDFN
>LONDMIMF_00527 hypothetical protein
MATEQHKAQLEKKRAERKEKDSGDSPSEKREVVMHGAKLKCEYAQQLGELKVTSNELRLQ
DQLWATQGDGNNMINLQFKGTCGHPKWPARNMQPPPCMSVIKLSPWENLGTTEVQNQKVL
VKESTITCNPEFNTAVASPIPNVESIAIKPSPLIINAYFAKFELKTEKNVTTFNLTKVDE
RGLSYGVALVIETVGLAGKKLKVKIKSGVRKVLSDVDTAISFIDLKDIDAITKPENYKNV
KAKDEFEVEIGKLASDATLSNKDTFKDKGILKLMLNQKPDDLSFDLAKLIAADAGKEALV
YVEINCSEPNVEYMGVDSGSGTKNAFLKEEGKYFKIKNKEQAWLTTARKEMEKGVTEATH
CNTIINDYHQVNREHKPSGCATITNAWCASFVGWCLTQNSFSAQCDPGAYSYGHTNTRYR
NKKVVKDGKTVTLPDHFDDPVWAKTTNGGKLALGSICVVNNKKHVTFAVAKNKEGTHLFG
LGGNQGDAVKVSAYSVRNSSVYPIEYTINEEDYELPIYYRELKGESVT
>LONDMIMF_00528 Actin cross-linking toxin VgrG1
MSISTQIQIQIGGENLTRFSKLVINQKVHSHHHFSILQPLPKEFVSQAIDKAQKYVGQSV
TINIKPSNMMTNSPLIFNGIITEAQMIRTSGASGGIIINGYSPTILLEGPPNTRSFNDET
LSGIVKEILKDYSGDSLKPTVEISKDTALPYTVQYAESDFSFLCRIAQKKGQWFFFNGEE
LQFGKPKSKNFTLDYGRSLHSFNIEMRAKSLGFEYLGYDPSNGDTQKASSAEVDYQPQDG
YSKAIFESSKKLFTNTSTMLYSHSLEEGNSRTHLIDRVTTQLQSRTADMVTAKGESDETG
LRIGDVVSIKEPAFSLTGNILDGLQEQNFGNYIITDIMHVCDESGTYHNTFDAVPESVVA
PPYGNVHSFPTAESQPATVISNADPAGLGRVKVAFAWQKDAGKSTPWIRMVNSHSGGGKG
FYFVPEVGEEVLVAFEGGNAEKPFVLGAMYNGSASSGYSTSGNDKKVIQTRSGTKIIMDD
AAGSVFIEDPSGNTWLMDGQGNIDVNAPNNMKITVGKNLDINVGENMATTIGANENISVG
SNKTETIGKNYIQSSENKNVTVKNNKTDNVGESYRQITGNSDIQTSKGDLKLRGTTLTVI
QGGKDVKVSKG
>LONDMIMF_00529 hypothetical protein
MQLKLKNKIITTVILSFSTLLLSFCVSKMTSENYTIAWVQQITVENGEKTTDNFYGIFPK
NNDTIFIYKAAEDDPKRIEKQYRYTFKKTPKNTNALDFYYKEDTQPEETIRVRFEKNKVF
VNDDSYTVNESYYKFLMQKVLQENSVLELAALTKDGLGDYQPLFEPLSKNWGQTKSEKGF
KLLEIATKNKNNQTDSQFFQQKVTFSYGKQGDFLKAEGENYKKTKAKANQKYLKYDISET
NERSSSEIELYQNKKTLSDSVSVRWEQFSTAKEYSFIKYQSKLQKKIISQKPKPDSDFTK
FF
>LONDMIMF_00530 hypothetical protein
MEDVKENNKKEIAEKREEREKEDKVSEDLKLVIDMAKIQCTLCTNPQGILKVNFDTPTTQ
DKLTATVVEKDMRSLIFMGTCIKSPNSAAPCASVMQLGDWKDVGTLKVQDQFPLLKKSTI
PCNYGGSTIEITDSGQRSAPAEVAAVAAPVPQEEEVLVNGHFYNTDGTFEGKADKKEYKG
SVNDVYVCSGKETKNDSKGKPVEVFKNAELLKENGTNITHSDFCYVAYIVSHEAGEEDLK
ELKCIAYASFNRAKNTKTTWKKLLSTGYSSVPNKTELSQTKKDNKSKLTRQALFYVLQGK
DDLTKGAEFWDGTDFLAWGNSETNPYNKLGQNKFDEYKFVEIPKDVYDEFLKANGTSARY
KDKENHDAKTDKGTHEHTKKKVKKPVIGKDGKQEKGKDGKPLFQEVEVADRIKYAIPASD
FTDTNNWTSGNFYYDTGVKTTNGISGTIAAGKSVFWKLTPTRLTNATEVKK
>LONDMIMF_00531 hypothetical protein
MISIVHGLREYHLEPKVGARYSYRFETIVDDFSNKRSPVHKSYIREVQIMPIGKEGYLDV
YQIFTARISIKSNVAVADEYLIKQIGYAFDEIEAGVDYTGKIVRIFNKEELSSRWDKTKE
RLEVEYEGKFIQNYFSQISKILNDETRLIEFLSTYKMFGLYFHGLFGNYLLWEMPIVRKK
IVDDFKNCEAEEKIHPEKKEWVRYQIEGRSENINKYEGELLYKDYQLQEALIEIEDDTQS
VKYATLFLG
>LONDMIMF_00532 hypothetical protein
MGKSFVYNTGESKGPEEELEMTFGVFIDGTLNNKTNTELRRKYRNGGVENLTDEQIAESV
KRDEAAYKRLMKKGVPANPTEYEQYLIGSHRTYMDKMGTDNSYSNDYTNVARMWKYCDKE
YRIYVEGMGTDDKQKDSQDGFAFGAGLTGVRAKVRKACEIMANKINEEKRKGNNRNKVLT
KITVDAFGFSRGAASARNFVHEVNVKKAYEPKPFNMPDGYYPIDPYSEGMPVRKYRRTIG
DADGLEVNSEVLVEGKLPRMGHLGYSILKNTDITAEELEDITLVVRFIGIYDTVSSYGEG
GGRLGEYDVNGELKDDSFFKKAAKEVFSTHFDDDVEELQLNNLGYFQKMVHFTAKDEHRK
NFSLTRIRQIKDRAIEKNLPGVHCDIGGAYENETEYKDEIETSNHKPLWQLEKYRQELIA
GGWYHDDQIEINNKFWNFLTSGIVYRKLSGTRYVRKEYSYLPLHFMEEFGKDMMKTQAKS
NALIDDLTIQYSVEGNQILKQAKTYLEGYMKDEIPEWDFVSDEELARRKQERINRENLEK
LLEELEKSKVYEEQNATGFDGQKQYWPTMPPGLGQEPEPDPDPNVINIEEVVVTAYHPQT
LLRKLRNQYFHWSASRDWFGMEPAKNRIRGEY
>LONDMIMF_00533 hypothetical protein
MKIAKSYFFFLLLLLAFSSSCKENNTNKNDKEKALKDNSTKTMNVEKFYWEENINSPLGY
PVEVYRGGLEAKDGSYVSLSLGPDAGNWGELGSGMSSGEKPVPNRLNVTWISYAENIFYD
IDTEIDHDKMVKLFKEGYEENNKKWGRRKENYRTIIVGFAPGGVAVIWLAGAGKQVEIGR
YQGEKITIPQEEIDKLDSHDKLLFDEANVKRIMSKESFVPLEVQKANQNKPIPFGLWDTY
RKQYDWKIDFVVDNSGKVADFSYTLFNGERDEIFPENLPEKTYSKRAIPKQLSLGWHDQQ
GQLYGGSLDFNEKEIFNAFAAIYEKDPNAKATLVLTVNKTNTYLTVTLKTDDKTIALKEN
NINIFKSRKK
>LONDMIMF_00534 Actin cross-linking toxin VgrG1
MPISTQIKIEIAGETLTRFSKLVIDQKVHSHHRFSLLQPLPKEFVSQAIDKAQGYIGQAI
KITINPSNMMTASPLTFNGIITEAQMVRTAGASGGIIINGFSPTILLEGTPNTKSYTDKS
LADIVQEVTGNYSADSLKPAVSVQKDASLPYTVQYSESDFSFLCRIAQKKGQWFYFNGEE
LVFGKPKSKNFTLEYGRSLHSFNIEMRAKSLGFEYVGYDPSNGETQRASSSEANYQPEGY
SKSVFESSKKLFPNSSTMLYFHSLEEGNSKTHLTDRVTTQLQSRAADLVTAKGDSDETGL
RIGDVINIKEPAFSLTGNLLDGLQEQNFGSYIITDIMHICDESGNYHNTFDAVPDTVVSP
PYGNVHSFPVAESQPATVISNDDPAGLGRIQVAFAWQKDSGANTPWIRMTNPHSGGGKGF
YFIPEVGEEVLVGFEGGNAEKPFVLGAMYNGSALSEYHTSGNDKKVIQTRSGTKVIMNDA
EGSIFIEDPSGNTWLMDGKGNINVNAPKNMTFTIGENFNISVGKDMITNIGENRTTNVTL
KDKLQAQEAFETIDQNKTVKVSGDLKESTGTTTHKAEQGDIFFQSAGVAKVLGAIDAKVN
KG
>LONDMIMF_00535 Beta-barrel assembly-enhancing protease
MKIGKKYILLFFFLAMQLHGQEKKYAVSDLDNAYLQEMKAENAELSARIKTFPQEIQDIN
KKVSQAIRENNAPKALELAVEMDKKYPKNADIKNFIGKLKTKEAKYDEAVLLFDEALAIN
PGNKWFYINKATALAENNKIEEALKTIEKLNSAYPNWSIGYNFKASLFRELNQQNEALKA
YEQALNAAPPSAQILTNRGDFYLELSREEQAIADYKKALEIQPDYARAKEKLKSIPKTVS
DKK
>LONDMIMF_00536 hypothetical protein
MMLLAALFFSCSKKVYVRNDYHLFEENFTLAPDALLRTDGVYVLESIWNKDTGERKADEH
IFYKFYNTGQANLTVDLDSKIKTEEDYLESIKEHIASTNKAGFKTHLEGYYRLQGNKIVI
ERITIPRDVAVYSYGYVENGKLVIVTETIDGKGKFSDKHFTDNYKATYVFVPLEKSGLSN
LKPGW
>LONDMIMF_00537 hypothetical protein
MDELNTKFFIGLSWHFGGGPKSYFSGTAGVGVSRRFGPVDPGVNIAINAYNGGMGALSGS
NAMNFDVVMTGKLTVGGGRTNPMSVYPLHMDSGTGMEDTYKYSGTLGTSMVLNNNDRNQQ
VGFVQLRAGNFGFQFYNDFGGFKKIGIADGHDRWWTGGGKVILGNNRSNYQMIIASDVFT
ADTDSESVTDSEAAKRSLADFEQRHIGSSGFEKFKDKAFNYTPTTATEVGQDFLNFKRDG
VAWNPNAHSFDLNQGRTSFHARTPQGSIGINGIGQGHMYSQDMIHRFINFHLIPSERPNY
WEVQTGPNINTGF
>LONDMIMF_00538 hypothetical protein
MSFLAKLEIDGEVLNVLEFQCTLGQDTDKSGKPSADPAGGKIRIVVESTKSTMLFDWMVS
NSQTKNGKLTFYRRDAISKMRELQFKEAYCIRYDEAFVAYNTMSMRIEIVISAKEINMNG
SQFVRNWPLKF
>LONDMIMF_00539 hypothetical protein
MSFKSKLKVGGKELNILNASYDLHQEVDASGRPSSVTRGGTINLTVESTGDSFFFEWMTN
NFERKDGSIQYVKRDTDAKLKEMNFKEGYLVKYRESFDAQDGNPLTETFTISAKEISMGG
GEHINEWV
>LONDMIMF_00540 hypothetical protein
MANQENTKATNTTLANQERSTRTLEQNVESFIQYGGFDLLEGAIEGVQNLNPERKARKNI
FLSESSKKAERQALKTVLKLWAESLKTTDNLLDLVSESAKKSDIAEQTLKKNLAIAVAES
KELEENYRTLSLFYKNTEESKVKNVSIMNAELDQLKDLDNSRFIDNIQEELVNGFDRLDL
RQNYSLLVIPGYLGSNKVIEKWAKIAYDNKVMLITDFQHLDEPDDVMEMFESANLTGGDT
YRSNVMMACNWLVGRGKHDEIEEDDHLFIPPSTALAGKVYNTLMSQVTAGKKYGGINEVD
GVKFDLKKSEIANLENLGLIPMVNEYGKVMAFSGKTLFNGDNLGLQTYSVVRVFDYVTKV
LMDFLNRRAFENFNAKTRKEILNQIVKFLDNVAGPDKLIEDFEIKRFEQDPNQKDRIFLD
IRLKPYFPAKNFLIKMDGQKGDDGNDWDTEYAESK
>LONDMIMF_00541 hypothetical protein
MANSFSNSYGIGGNEVRQEGQESILEIPQNKTLIAQKLTPNTPVRPEIVTGLKNMDEVFE
HFDPKINVAFEDEDGKVTREELGFKNIGDFSINGLIAQSPFLTDLKTKNEQYQKMIKQLK
TNKVLKLALQDPDARQSIIDTIEALIKEIEQSDK
>LONDMIMF_00542 hypothetical protein
MNKSNQIKTHFDGKIILFFFIIFVMSCGLLAFKINNKAICTVKEFKIDAPTFKAGELITF
SDITPNSYEWRWYFGDGSKISYRSKVAHSFSKPGKYTIKLLVNNSCTIEKTITILPKNDV
IDESLLPKFFAPTVVYEGEQVRFRDSTAHAKSWEWRFGDGIKIDAIDQNPTYVYRIPGEK
IVSLVVNGDIKYVKQKKITVLPAKKETKDVVSERLARRSSSRADIVDEYFKQLPEAPKRS
AEIAGINEEKFKAILMGICEDKLSFDNVKRYFCEDDLPLVKLRNGKTISLKELDDAIRDR
NINIKKIELQRDQDGCVTVINLNYRYKTIF
>LONDMIMF_00543 Murein DD-endopeptidase MepS/Murein LD-carboxypeptidase
MFKKFIFLSLMSVCFVSCLPKKDFVITDDFVKSQAGNNKKNSNAKYSYSTTLSDDDRKYF
AKKLEVSETEIINEKLYIFIKSWEGTKYIYGGETRAGIDCSALMQELYSHVYKKKLPRTA
SEMSMDNRIELFKSDEKLREGDLVFFRITDEKIISHVGIYLKNNKFFSANLVGGVEISSL
KKAYWKKNFVAAGRFKQ
>LONDMIMF_00544 hypothetical protein
MTKNRFFIENHRNLTPFDLKAELLFDALLKNKTDDLDIVLKANGVFYRKFSKDTMSITTD
VNDSDILHINTSRDGFYDILPESITHNYRNRDQRHDPSQEFKIRKKEEKEARHFYNPLEN
ELFRFRHQIERHESNFFSKLSTNGIADIIRMILGIEKNIPDILTVKMFYALMKLKGNSGQ
NISDISKMLEKILGEEVSYTSKNIQLENGHDIEENSGEMIMGITTTLQSNQEIFLKKYNF
IVGPLKNPDNLPDYFDDHVLENFLTTFFNLFLPFQMQYSFEIQLNSEDELFAMDDTIYKS
RLGISTVI
>LONDMIMF_00545 hypothetical protein
MRKYLNHIGGTETLVYIFLAIAVAMIISMFIGMKTPKFRQEKKSYFIYILCQGLMLLIFG
AILFNLKDTTVNIRFISFQVYLLIAGAIHLTFFHLYFKQFDAKEIYKEIFIAIVSGIFME
AFVIMLVGHFQELPYMYYYLGAMLFFLIPTLCFCLFRTAISIPAKLHKRWFYPVNSKYPA
PHISEMRNIIIVNLVFTKKANDSTIINFKVKAPRAFDFGKLFYYFINDYNEKNPNSQVRY
LDDKNQPYGWYFYTKPKWFSSSDYIDPELAIDTNNIKDGATIICQRI
>LONDMIMF_00546 hypothetical protein
MAENIKHFPVNWIDGMKINKNHFITLQDNIEDLVRDARNLGVNELNYGLLSTHLSRPFQY
SISIDAHNELSVSIKLLKAVTPGGGRIEITDYTGEFNEKIELKDFDLKENNYFLLLNVDP
FQRIPTGEQNMEEVPPRFPNAMSRYFLTSVIESEVNQNNIGALQFPLAKFKTSANNYEIL
TDFIPPSLTINSHPTLITLFENYESFFKQLEFNSVQISQKIRFRNSTEDENLIANMVFEA
CEKILSYVAQNITRSKWVNFSMKPMEVLENTVSLARIIKNSFDSFSGDGKEMLFNYFSEW
TEISSGDYERLFSETINTKYKAYDIEPTVNQVNTFISKIDYLFTILNQLDYIGKKRDTGI
FVNENIVRNEKPSFFGNSDKDNNSPNSSPTFLAE
>LONDMIMF_00547 hypothetical protein
MDILNRKERTSAFLLFLLMFIITTGVLFFAIFFNYKLPLKENEVLKSENDKIMTEFNFQK
QFSDRLEHIGVLIDSLDKAPESFQFIEQNISFELVDLKEKIPADSDQGLKLYDNVILTIN
DLVKTKKLLLQVNDSKKEIDLLNKQLKEYEEENKELLRDLRLTQQLNRRTN
>LONDMIMF_00548 Chaperone protein ClpB
MVTEDILQAIHIAKQYAKDNFNQKYAPAHLLKALLNPQFNFMRELDAKGIDVFYLDEWAD
IRISEYPKSSKPSDDPAPDSGMNAVLTEAEDIAKKTGDETSFVPILKALVTPGVGFSHDQ
LKSLPLTPADLSSMFDSGTAKPQNNSEKTKIAPTGSSTLDKYCTDKIKHLKSKQSIPMIG
RDEELKTITEILNRKLKPHVIVIGESGVGKSTLIEGFCHKIGDKSILAAFNNASVFEINI
GPLFAGASYKGEVEDRLQKIFNEVKGYEKPILFIDDIHELFDSNQGNGIGSIIKSELSKG
DITFIGATTTEKFRKSLGKDDALSRRFETLEIHEPNQELALRMIKNVISHYQTHHDFSID
EEGLKESIRLSKRYLKEKSLPDSALDLIDRTMSSLKVAKETIKKELPELKKQLSAINDSI
EEIEKEEKMLWLHSDIQNKTGKLFSEDEDNFSSVASDKKIAHLESLLESLERLNEEENIV
SPSHLSHVVSGITGIPAGKVKSDERERLLDIENTLKKRVIGQDHAVKVVSDAILESRSGL
TKPGQPIGSFFFLGPTGTGKTELAKSLADFLFGDENAIIRLDMSEFKEEHSAALLYGAPP
GYVGYEEGGLLVNKIRQKPYSIVLFDEIEKAHKSVFDVFLQILDEGKLHDRLGKEGDFSN
SVILFTSNIGSDFIVKSFEKDIIPKSNDLIQLMTGYFRPEFLGRLTEIIPFAPISRKSVS
RIFDIHLKKELLQLLEKLDITLHIDEKDKEQIALMGFTPEYGARPIKGTIRNQLKRPLSR
MIISNEIKKGDSLKVTLNEEGAIKFTIEHERPILQDSN
>LONDMIMF_00549 hypothetical protein
MKDLYYKIPIDFKRLSSGEDIRKVTIEESLAQYISLIITTIFGEYKYDDDFGTIIWETDF
NLLSNANQLKDMIKESVHEKVKKYEKRLTVTDVTLGVSEDTVSYETNIRVKKRLDIVVYG
VIKKTNQPYYYKSSYFLAPFSFK
>LONDMIMF_00550 hypothetical protein
MNSLSKDQIKDRLLKRAAKQWGYSDVELENVFDPIVNLLFDVCAKELEKISNEIYSSRRR
ITERLVDILTPTASAKATPARAIVRAYPVENEVILNDHHQFYFQKKEANPYNPTENIIKN
YFFGPTKPVKLNRNKLNYVILPSGVQQIVKEQFRETVSSNNYIKPAPHGTIWLGLKHQGD
GIIKDLMFYFYLKNIHNRNTFFHFLPRAKWYLNDHLLQTVQGYNNDENYSNNYGELIQEE
FYHIERTQEHANDYFRKNFITIKDIINIDNNYSLPSELSSFIPAEELKVLADEKLIWIRI
EFPNVIGKDILSEIFCANNCFPVINKKLNEVQGNIKNLLNIYPLNLNNEFFLELFSVTDD
KNNEFDVIKNDDEKGDNDYAYLRFGGIARFDERNATEEINYLIDLIRDEAAAFSRLGHDF
TDNNLKEINQIISRFRNKMSQVGMQNINNPYLILNTTSNSNKGTLFAKYWTTNGESANKI
NTFSRLVAHKGSDFERDNIMFLSTTQGGKDELSNSEKIYAYRENLVSNQRVVTRQDIIIL
CKNHFGDAITRVEVKNGIQTSLDSNVGYTPTIDIYLERKDKDYYNEEEWYFLSEDLKLMI
ENRAINIVPFRIIYS
>LONDMIMF_00551 hypothetical protein
MKKVIFTMAIGGMFLATSCKKEETVTTTTEDGKTTVTTTTTKNGLNLELSEKAKANLDEA
EKKLAEAKAKGDKEAERLAQIAVDKAKSAWEATKDGIKETSEDIKEGAQKAKEDMKEGYN
ETLEKAKIK
>LONDMIMF_00552 50S ribosomal protein L27
MAHKKGVGSSKNGRESESKRLGVKIYGGQAAIAGNIIVRQRGSKHNPGENVYMGKDHTLH
AKVDGVVKFQKKSDNKSFVSVVPFEA
>LONDMIMF_00553 50S ribosomal protein L21
MYAIVEIAGQQFKVSKDLKVYVHRLANKEGDAVSFAKVLLLDDNGTITLGAPAVEGASVE
AKVLQHLKGDKVIVFKKKRRKGYKKKNGHRQYLTQIQISGITVSGAKKAAAKKEAAPATE
EAVEAPKKKVAKAKKEDTQE
>LONDMIMF_00554 putative zinc protease
MALGSVLMLGSVASAQKVAFEEYTLENGLHVILHQDKSAPVVITSVMYHVGAKDENPERT
GFAHFFEHLLFEGTKNIGRGEWFKIVSGNGGTNNANTSDDRTYYYEIFPSNSLELGLWME
SERLMHPVINQIGVDTQNEVVKEEKRLRVDNQPYGNLITAVKQNMFKKHPYRWAPIGSME
HLDAATLEEFQAFNKKFYVPNNAVLVVAGDIEYDKTIKWVKQYFGSIPKGKTDLTKQTFT
EDPITQTIKATYEDPNIQIPMLVTAYRTPSMKTRDAKVLDMISSILSDGKSSRLYKKIVD
QKKMALEIGAFNYSQEDYGVYFIYGLPMGDTSLDALTKEIDEEVTKLQTELISEKDFQKL
QNKFENQYVNSNASVEGIAENLATYYMLYGDINLINTEIEIYRSITREEIRDIAKKYLNP
NQRLILDYVPAKDKAQN
>LONDMIMF_00555 hypothetical protein
MQAQDRPQPKPGPAPVINIGKPETFELKNGLKVMVVENHKLPRVSYNLTLDNAPYAEGDK
KGVAEITSALIGSGTKKMSKDAFNEEIDFLGANIGFSANGAYASGLSKYSDRILELMADG
ALNSVFTQEELDKEKTKLIEGLKTQEKSVQAVASRVEDVLVFGKNHPNGEYLTEESINKV
TLNDAIMNYTTYFVPANAYLVITGDVKFKDVKKAVEKYFGSWKKATAPVITYPDPKDVQY
TQINFVDMPNAVQSEISLVNVSNLKMTDKDYFAVLLANQIIGGDFNSYLNMNLREAHGWT
YGARSNIRGDKYVGKFKSNTQVRNAVTDSAVVEFFKELKRIRTEKVAPDMLKNVKAGYIG
NFVMQIQKPGTVARYALLTKTQNLPADFYENYIKNINAVTADDIMRVANKYFLADNTRVI
ITGKGSDVLPGLEKLGIPMFYFDKFGNQVDKPVAKKAVPAGVTAKTVFDNYIKAIGGDKN
AKSVKTVFSTLNGKVQGIDVTMTRKSSAAGKKVDEVKGMGQTLSKEVFDGTKGYESAQGQ
KEDYSADKIANAKFYSLPFPELTLATKPGITLSGIESIDGKEAYAIKDGKKTLYYDVTTG
LKLAEANTEEMQGQQMTQVVSFSDYKDVKGVKVPFKTTLNVGIEIELTASDVKINEGVSD
ADFK
>LONDMIMF_00556 putative inner membrane transporter YedA
MKAVQSKWIFLFFLSLIWGSSFILIKKGLVGLTPFQLGSLRMIFAAVFLLAIGFKSLKNI
KQHQWKYIALTAMMGTFFPAFLFSIAQTQIDSSISAVLNSLTPLAALVLGALVFGLNFQR
RQIFGVTIGLFGSVLLILSGAVNHPGQNYWFAILAVCGAICYAVNVNLIKKYLSDVNPLS
ITVGNFAVLLVPALIILFTTNFHEVAHLPNVKTSMLFISVLAVFGTCVANVLYFKLIQIS
SPIFASSVTYMLPIVACFWGILDGESLTLVQALGAFIVLIGIYLSAKK
>LONDMIMF_00557 putative copper-transporting ATPase PacS
MNFSKSLLILALSGMLFVSCKNEPKATETGEPTETATDTTATKPTAENLQTASFQIDGMS
CAVGCAKTIEKKLASLDGVQEAKVDFEKKTATVAYDAAKQTPETLVETVEAVAGGTTYKV
SNVKSSADKAMLYKEKEKEKEKKKKDDKKASCHDDKAKDAKAGGCCSGKKSCGTDEKKAK
SA
>LONDMIMF_00558 hypothetical protein
MFRKSIGLFISGCILASVWGCQNDTVPKPAGQLRLEYPKAQYVHFENNCPYTFDINEDAI
ISQKGDCDFTISYPKMKATIYLTYKPVKNDIEAHLRDAQNLTYKHTIKADDIVEQPFVNE
KSKVYGMFYRVGGNAATNAQFYATDSLKHFVTGSVYFYAKPNFDSIMPASSYVKNDMQVL
METLKWK
>LONDMIMF_00559 Single-stranded DNA-binding protein
MNGTLNKVILIGHLGDDVKMHYFEGGNCIGRFPLATNEIYINKQTNEKIASTEWHNLVVR
NKAAEICEKYLSKGDKIYVEGRIKSRQWQTEEGVTKYTTEIQVTEFTFLTTKKDIEAGKQ
GSSVDVKSANFDSNSPEEDLY
>LONDMIMF_00560 Adenine DNA glycosylase
MEFSNLLIQWYLQNKRDLPWRNTVNPYHIWLSEIMLQQTRVAQGLPYFLSFTSSFPTVLD
LANADEEQVLKLWQGLGYYSRARNLHNTAKLVAFERGGVFPDNYKELLQLKGVGEYTAAA
IASFSYNEVVPVVDGNVFRVLSRYFDIETDIASGGAKKEFSELAKELIPHNNPALFNQAI
MEFGALQCVPKNPDCGTCVLNSGCLALQKNKVNELPVKLKKTKVRNRYFNYLVFSDDNQN
HIVRKRTEKGIWHNLYEFPLIETAAEVDFDTISKLIFEEYGSKFEIFSIKPLKNDVILHK
LSHQHLHIRFFRVSVQGEMENAMSYESMISLPFPIVIYNFIEKDLP
>LONDMIMF_00561 putative sugar kinase YdjH
MNKLLIVGTVAFDAIETPFGKTDKILGGAGTYIGLSASFFNLKSAIVSVVGDDFPQEYLD
LLTARNIDISGLEIVKGGKTFFWSGRYHNDLNSRDTLDTQLNTLADFQPKVPQDFKDADV
VMLGNLHPLVQASVLDQMEKKPKLVVLDTMNFWMDCALPELLEIMKRVDVITINDEEARQ
LTGEYSLVKAAAKIHTMGPEYVVIKKGEHGALLFHGKEIFFAPALPLEEVFDPTGAGDTF
AGGFAGYITQSENISFKNMKNAIIYGSNLASFCVEKFGTQRMENLSKTEVQERLQQFKAL
TQFDIVLEE
>LONDMIMF_00562 Amidophosphoribosyltransferase
MSDALKHECGIALLRLKKPLEFYKEKYGSAFYGVQKMYLLMEKQHNRGQDGAGFASIKFD
VEPGERYISRVRSNDPQPIQDVFAQINARINDELSNHPEYAESVALQKKNIPYIGELFLG
HVRYGTFGKNSIESVHPFLRQNNWMHRNLIVAGNFNMTNVKELFDSLVELGQHPKEMADT
VTVMEKIGHFLDDEVTGLYQDCKNEGYSKRDASPIIAERLDVAKILRRASKGWDGGYAMA
GLFGHGDAFVFRDPAGIRPAYFYEDDEITVVASERPVIQTVFNVSFDKVQELDPGHALII
KKNGKVSKEEIIAPVEKKACSFERIYFSRGSDAEIYQERKDLGKLILPAVLEAIDQDTDN
TVFSYIPNTAETSFYGMVEAAQDFLNQRKNNYILENRNTLTKETLQQLLAVKIRTEKVAI
KDAKLRTFITEDSSRDDLVAHVYDVTYGVIKPEDNLVIIDDSIVRGTTLKKSILKMMDRL
NPKKIVIVSSAPQIRYPDCYGIDMAKLEGLVAFQAALELLKERNLYHIVDEVYAKCKAQE
NFKDTDVINYVNEIYAPFQPEEISDKIAQMLSSEGIKAEVKIIFQSVENLHVACPKNLGD
WYFTGNYPTPGGNRVVNRAFMNFYEGKDSRAY
>LONDMIMF_00563 Superoxide dismutase [Mn]
MAFELPKLPYAYDALEPHIDARTMEIHHTKHHNAYTTNLNAAIQGTDLDGLTIENILINL
DKKNAAVRNNGGGYYNHNLFWKVMSPNGGGLPKGDLLDAIEKDFGTFEEFKAKFSKAGAT
QFGSGWAWLCVHKGGKLEVCGTPNQDNPLMPDVGCGGTPILGMDVWEHAYYLNYQNRRPD
YIEAFFNVINWEEVARRYAMEK
>LONDMIMF_00564 hypothetical protein
MFINIQDMKISHFFSILFLVSFSVYGQYTYDKSKISNKVLKIVKKIEKINVVKEEGDGVG
RISEQYENYEKLIKIATPKELAVLTSYPNGTVRCYAFIGLTSDEKLKETVDIFKIVKDHI
QDNEFVESQSGCIISSESVADFFIRTVEQKDYKLNFYTYQLNSQQQKEIDSLLIVGKNDS
YARQKAIQSLQINAQNYPLLRKLVVEEKNDTALPKLAEYKKEEDLQLILGFHKIKTEINE
DERLYATYLAIQEFPHPAFFPFLKERQSETFGKEYFSNEWESLYNAIARYKNREAFELLQ
LPFAKIVYTNVRKYHLGFVYDAIENSPCPLYDDLLWKLWEEENIYTLKALKHLLDLDPKR
AYKNIRKEFEITSEIKNPNLDLDRKKFSEIENREELMLNLVIANEKEIALEVISNKIRQA
NVHDFPLYTKYALKLKNPIFVVPLFERLRIESNPYTYLEIVKTLFDYNEDTINVEVVNTL
AVNKNLSQGWGGAQLKGMLLEKKLIKE
>LONDMIMF_00565 ATP-dependent helicase/nuclease subunit A
MQKTAFTLYDASAGSGKTFTLVKEYLKILLTSPKNDAYRNILAITFTNKAVGEMKSRIVS
SLSEFAKDEPAPKAVELMEVIQQETALNAIDIKIKARQIIKNIIHNYASFDISTIDKFTH
KVIRAFAHDLGLPITFDVSLETDNLLTEAVDAIIAQAGEDETLTRLLVDFTMEKTDDDKS
WDVTREILDTGKLLLNENNRNEIVHFQDKTISEFVEIKKKIQQVVTDLEAECAVLAQEAI
AVITAAGVDEKSFSGGYFPKHLQSIKEGRFNAKNKTYHEAEDIKINKTAKDKEIIEGIIP
ELLSLLKRIYKNQEKMAFYMAFLKNITPLSLLNTVSQELSKIQKEQNILSISEFNAIIYK
EIQNQPAPFIYERLGEKYKHFFIDEFQDTSEMQWQNLIPLIDNALSSEDLQGERGSLMIV
GDPKQSIYRWRGGKAEQFIELSKEHNPFNNPDKKIEHLDRNFRSYSEIIQFNNGFFKMIS
EQFTNPDYKNLYENHSHQEHNSKIGGYINISFLPKIEKTEGDDEETPDKTRQYVQATLVA
IKKSLAQGFEYKDIAILTRRGDQGIAVAGYLTEQGIPILSSETLMIENATEVIFILNVLR
YLNNSSNLEAKAYLLQYIGEYVQKQLPVHDFIFQGMENRNEKEFENWLMSFDISLSFQEL
RRKSLYEAVESIISKFINLKQNNAYIQYFLDLVLERDIKNQAGITDFLSYWEKNGHKFSI
PSPEGKNAVRILTIHKSKGLEFPVVIFPFAEEDYSRRPKDKLWLDSEDNISELPRVLIDN
SSAVEGFGEEASLVYQQKKQEDLLDNVNVLYVALTRAEEQLYIISSMNLSAKGELPKNNM
ALFFINYLEKFVGFDIQKHEYEIGSPERISHKSPIGEEARKIPFVREVLDPKNIKIAQRE
SLMWGTHQQKAIEYGNIVHEILSYIGTASDVGLALTKAIENGLIVESQQEEVAKTISLIL
GHPELMDYFAEGNNVMNEQTIIRKEGTPIKPDRMVMAQDNKVYLLDYKTGSHNQKYLQQL
EAYEQAIEKMGYQVAKKALVYIGEEVNVVNL
>LONDMIMF_00566 2-amino-3-ketobutyrate coenzyme A ligase
MYGKIQQYLQEELQTIEDNGIFKKERIITSPQGAEITISTGEKVLNFCANNYLGLSSHPE
VVQAAKDALDTHGFGMSSVRFICGTQDIHKTLEKKIADFYGTEDTILYAAAFDANGGVFE
PLFGENDAIISDSLNHASIIDGVRLCKAARYRYENSNMEDLEQQLIKANEAGHRFKIIVT
DGVFSMDGLVAPLDKICDLADKYDALVMVDECHAAGFIGATGKGTLEAKGVMGRVDIVTG
TLGKALGGAMGGYTTAKKEIIELLRQRSRPYLFSNSLAPSIVGASIKVFELLEKDTTLRD
KLEWNTNYFKKGMKEAGFDIIDGDSAIVPVMLYDAKLSQNMANELLKEGIYVIGFFFPVV
PRDKARIRVQLSAAHTKEHLDAAIQAFTTVGKRLNVI
>LONDMIMF_00567 Outer membrane porin F
MKHLNKIFAAMLLAVGLNANAQDSDNPWAISFGANAVDTRFSAAQKFEDQFSNFFNAKDN
WNILPSVSYLNVSRYIGSGFSFGVTGSVNRIDKFVNKVPGTYTTFETTNPGDLMYYAVDG
VIKYSFMDLINSKVIDPFAHVGGGYTFFGDASYGTVNGGLGLTLWFTETVGLTLQSTYKH
SFDENLRRPNGDVPTHIQHFAGLTFKFGGKDTDGDGIYDKDDACPDQAGLKQFQGCPDTD
GDGIPDKDDACPEVAGLAAFQGCPDTDGDGIPDKDDACPNEAGTKAMNGCPDRDGDGVAD
NVDKCPDVKGPKENGGCPWPDRDGDGVFDKDDRCPDVKGTVANHGCPEITEEQVNKLNAY
AKTILFNSGKSTFKPETMPVLEAINAILKEYPTSRFSIEGHTDSDGSNALNQTLSENRAA
AVKNYLIENGIESSRLRSTGFGETKPIDTNKTAKGKANNRRVEVKLIKD
>LONDMIMF_00568 hypothetical protein
MAETTFLDKIASIIVDGSTNTLSDLVVVLPNKRAKVFLIEALRNKTENTIFAPKIISIED
FIQDIAGIRSIDSIELIFEFYEVYLGITDKEKQQPFELFANWAKTLLQDFNEIDRYLLEP
NHVLSYLKDIEDIKHWSVDAEKRTPMIDNYLQFWSLLPKYYEELYSHLLNKGIGYQGLIY
RESVKNLNHFTNAIGRKEFLFAGFNALNASEEKIVQHLLATEKARIFWDADETFLNDPFH
DAGLFLRRFKENWKHYKSHPFEWIADDFKQHKNIQIIGTPKTIGQAKIAGKIVEEHAGKE
ITLNKTAVVLGEENLLVPLLYSLPSSVTAMNITMGYSGKNNPAQILIAKLFKLHSNALSR
NPNSYVFYYKDVLDVLTHPLIEPYSKTSDLVNTINQNNYTFITYNKLFELNQSQSDLFLL
LFQKWDKGSMPVLETISGLLLQIKSNLSNDDEGEKITKAFVYSIFKVINKLMNYYSKHRH
IDTIETLFAVYKQIIDLAEVSFEGEPLNGLQVMGVLESRVLDFETVIVTSMNEGKFPAGK
SQNSFIPYDVKRELGLPTFKEKDAIYTYHFYHLLQRAKNIYLLYNTESEGLDGGEKSRFI
TQLEVEKQKNHNITHEIYNAALPDVAYRPIVIPKSESVMLRLKEIAEKGFSPSALTSYIR
NPIQFYTQKILRISEVEEVEENIALNTLGTIIHETLRVLYEPYIGKFLSAEDIKNCIKKI
DEEVLKQFKIVYKEGEIKKGRNLLAFEVAKRNVLNFLKLELQEIEKSDDNAVKIVALEHT
YERLLEHPDLPYPVLIKGNVDRIEQRNGKIRIIDYKTGKVEGKEVALKQWDKLTEEIKND
KIIQVLAYAFMYEPHLEGQEIEVGIISFKNLKSGFLPFQFKIDKTEISIVNEEISGNYIE
QLVLLLNEILDKNIPFREKL
>LONDMIMF_00569 3-oxoadipate enol-lactonase 2
MQNKLSALKQIIYKNTTISYTDSGKGTAIVLLHGFLENSSMWTHFIPEFSKKYRIICIDL
LGHGATEPMGYVHSMEDNADAVHAVLSELKIRKAAFVGHSMGGYVALAFAELYPDAVKGI
VLLNSTSRADSDERKANRDRAIKAVKQNYTNFVRLSIANLFSENNRERLADEIENVKEEA
LKTPLQGIVASLEGMKIRKDREVILHFAPYPILLVLGKSDPVLNYDENIDQIENTSAKLL
SFPDGHMSPIENREQLKKELPDFFKSI
>LONDMIMF_00570 Xaa-Pro aminopeptidase
MKYHQIDRQLFIKNRQKFTAHMKPNSVAVFNSNDIYPVSADSTLPFAQHRDIFYLSGIDQ
EESILLLFPDAPYEHLKEILFLKETNEHIAIWEGEKLTKERAFEVSGIKTVIWLQDFHKT
LKEIMAYADTIYINTNEHYRATIETETREARFVKWWKENYPAHKVEKSNPILQRLRSVKE
SEEIDLIQQACNITEKGFRRLLSFVKPNVTEYEIEAELIHEFIRNRSKGFAYTPIIASGN
NANVLHYIENNQQCKAGDLILLDVAAEYANYSSDLSRTIPVSGRYTERQKAVYNAVLRVK
NEATKMLVPGTLWKQYHVEVGKLMTSELLGLGLIDKADVQNENPDWPAYKKYFMHGTSHH
MGLDTHDYGLLHEPMQANMVFTVEPGIYIPAEGFGIRLEDNVVVQQSGEPFNLMRNIPIE
IEEIESLMNQ
>LONDMIMF_00571 hypothetical protein
MKTAPSIFLDYLTVFSNTDDDSFPELLEKSKNAFTYLPLKKNDFFVKEGEICQHFCYIES
GILQHAIMVDGEEKTTYLALRNSVTSSLNSFLFGKPSRKSIKAISDCGLWIVDLPTFKNL
IENNEAFHQFYYNLIEKQLCLIDDYRIDLLTLSPEERYRKLLSTEPKLLQEVPLHYLASF
LGISSRHMSRIRKNIK
>LONDMIMF_00572 hypothetical protein
MKYFFHILALAVSFNLVAQDKLPYQLYDKNGKKTTYKKMLKEAGDAEVVLFGEHHDNSVV
HWLQLEFTKDLAEKKSLVLGAEMIEADNQKQLNQYLKGEINQKAFDTLARLWNNHKTDYK
PLVDFAKSKNLTFVAANIPRRYASLVYKQGFEALDKLSAEEKTWIAPLPIAYDKNLPGYV
KMLSMMGDHAHENMPKAQAVKDATMAYFISKNLKPNTVFVHYNGTYHSDNFEGINWYLKR
QNPNLKIMTIATVSQKDISKIEKENLKLADFIIVTDEDVTKTF
>LONDMIMF_00573 hypothetical protein
MAKSAILKSSLAKKYWMALTGLFLCLFLVGHLAGNLQLIFSDALHFNQYALFMTTNPVVK
LLSYLTYISILFHAVDGILLTVQNRKARPIRYAMENPSANSTWASRNMAVLGTLILVFIV
THMVNFWAVMHFDKNMPLQSVANGDSQVYVMVDGSYIPQEFVTSGDVKIEHRTEFFDSKS
GLKIGEGYKDLHKITFEFFKDSEYGLIATILYVIAMFVLSFHLWHGFASAFQSLGANNPK
YNGLIKGFGKAFSVIVPLLFAIIPVYIHFFAK
>LONDMIMF_00574 Fumarate reductase flavoprotein subunit
MSLDSKIPEGHISEKWTNHKNHLKLVAPNNRPKIDVIVVGTGLAGASAAASLGEMGYNVK
AFCFQDSPRRAHSIAAQGGINAAKNYQNDGDSIYRLFYDTIKGGDYRAREANVHRLAEVS
GNIIDQCVAQGVPFARDYGGLLDNRSFGGTQVQRTFYAAGQTGQQLLLGAYSALSRQIGL
GRVEMYNRHEMLDLVKVDGKARGIIARNLITGEIERHSAHAVIIASGGYGNVYFLSTNAM
GSNVTAAWKIHKQGAYFANPCYVQIHPTCIPVHGTNQSKLTLMSESLRNSGRIWVPKKKE
DAEAIRAGKLKPTQIAEEDRDYYLERRYPAFGNLVPRDVASRAAKERCDAGFGIEANDTN
EGVYLDFASEIKSKGRQAAYAQGNHHPTDEEIIKLGKQWVEEKYGNLFQMYEKITDENPY
ETPMKIYPAVHYTMGGVWVDYNLQSTIPGCFVAGEANFSDHGANRLGASALMQGLADGYF
VLPYTVSNYLADEIRTGKIPTNSPEFDEAEKRVKDSINFFLNNNGTKSVDHFHKALGNIM
WNKVGMGRNEKGLSEAVAEIDALRKEFYKEVYVPGSADELNPELEKALRVADFMELGQLM
AMDALQRKESCGGHFREEYQDAEGETLRDDENFKFVGAWEYQGSDINKEVLHKEELNYEF
IKIAARNYK
>LONDMIMF_00575 Fumarate reductase iron-sulfur subunit
MASSKFININLKIWRQKNAKEKGKIETYKLDNVSTDSSFLEMLDQLNEQLVSERQEPVAF
DHDCREGICGMCSLFINGRAHGPDTGITTCQLHMRMFKNNDTIYVEPWRSKAFPVIKDLV
VDRSAFDRIQQAGGFVSVNTSGNTIDANSTPVPKHDADRAFEAAACIGCGACVATCKNGS
AMLFVGAKVSQYALLPQGKVEATQRVLNMVRQMDEEGFGNCTNTGACEVECPKGISLENI
ARMNREYLAASLK
>LONDMIMF_00576 hypothetical protein
MVFNREINPVKNSFVEIFLYLKDKTNTMKYFSFLLLISTLSFAQNYQQYVNPMIGTGGHG
HTFPGATVPFGMVQLSPDTRIDGSWDGCSGYHYSDNVIYGFSHTHLNGTGVSDFGDIMLM
PTMGEPSLDNKIYSSKFSHSNEKAAAGFYAVKLDDDDIDVALTASTRVGFHEYTFNNSGQ
ANIILDLNHRDHLIMGEVRIIDNKTIEVLRRSEAWARDQYVFSRIEFNQPMVITKVNNNA
FAPAKVTDRFFAGSLLAISFSKQVKKGEKLLVKVSLSPTSYEGAKLNMSEINHWNFKKVR
TEAEKLWNKELSKIEVSSSDKNKMAIFYTALYHTMMQPNIAQDVDGKYRGRDNQIHTAKG
FDYYSVFSLWDTFRAAHPLYTLIDKKRTADFINTFLKQYEQGGRLPVWELASNETDCMIG
YHSVSVMADAMAKGIKGFDYEKAFEAAKHSAMLDHLGLDAYKKNGFISIDDEHESVSKTV
EYAYDDWCIAQMAKMLNRQEDYQYFIKRSQNWKNIFDWKTGFMRPKKNVGWDKPFDPREV
NNNFTEGNSWQYSFFVLQDIPGMIEAYGGKEKFEAKLDEMFNSESKTTGREQVDVTGLIG
QYAHGNEPSHHMAYLYNFIGKPEKTKEKVRYILDEFYKNTPDGLIGNEDCGQMSAWYVLS
SMGMYAVTPGNAEWTFTEPYFDTVKIHFENNEVLTITKKAHKGYLKEVMAKAQKEIFPEI
TPVPVIEADSKSFKDKMKIEIVSQNPNDVLYWMIEDPSKPRSGKPIWNKYTKPFEVAETT
AIRAYAERNGKNSSIVTANFIKKPNDYTITIQSQYNPQYHAGGDSGLIDGIFGNENWRKG
DWQGYQGQDFEAIIDLKNSKKVTSLSARFLQDSRAWILMPTKVEFYTSEDNHNFTLVKTI
ENKIDAKNTEVQIAAFESSIPETKARYVKIKAYKYGKLPEWHQGFGGDAFIFIDEITIK
>LONDMIMF_00577 (R)-stereoselective amidase
MKTALIQIPLIWENPKANRDYIEEKINSIKGADLIVLPEMFTTGFTMSPQNVAETMQGET
LLWLKHLAKNKNTAITGSLIIVENGNYYNRLVFVFPSGEVQYYDKRHLFSLAGEQKIYTS
GQQKLIVEYKGWKICPLICYDLRFPVFSRNTENYDLLIYVANWPKPRINAWDILLKARSV
ENMCYTVGVNRVGCDDSNHEYIGHSQALDFLGNPVLEPQESEGVFIVDFDKNQMLEVRQK
LAFLDDRDSFEIL
>LONDMIMF_00578 hypothetical protein
MFRIRFAFLYIILALSVISCAKRGSITGGLKDTLPPVMRSSVPKNFSTNFNVQEIRITFD
EYVKIKDVNKQLIISPPMKYPPIVSPTNASKYISIKIKDTLQPNTTYSFNFGSSIQDNNE
GNPYQQFKYVFSTGDAIDSLSISGFIKDAYSKNVDNFVSVMLYEVNETFTDSIIYKENPR
YVTNTLDSLKTFKLENLKEGKYLLVALKDQNNNFKFNPNTDKIAFHKEFVTIPNDTLYEM
ELFKEILPFKATKPYQASGNKIVIPYVGDGKNATVTLKNNTENLPVRVTKFPKKDSLQVW
FNPVKTDSLLLKIDKEKFSKEFTVKIKNQKKDTLSFQASQTSTLHFRDRFTITSSMPLAT
IDKSKITLVNKDTIAVPFTTEYDDFNQEVKIDFEKQPLETYRITALPGAFIDYMQKANDT
LSYRLKTQNISEYGNLRIRLQNVKHYPVIVEITNSKGDLIASEYSEGNDIIDFMALQPNL
FTLRVIYDENKNKIWDTGNYLEKRQAEEVVYYPTAIDVRANWDVDQTVNLGN
>LONDMIMF_00579 hypothetical protein
MFKSLFNLFFPQVCLGCGTFMQLNETVICTSCRHELPLTNHHSETENEIIKKFYGRIPIE
FGAAMFYFHKKGIVQQLIHNLKYQNHQEIGTMLGKWYGEELKFLEIVKNTDFIIPVPLHK
KRLKKRGYNQVEKFGLALSSLLKVPYNDSILYRNIYSDTQTQKSFFGRTTIKKDLFDVVF
SEIHQGKHFLLIDDVITSGTTIEACAKALLKIPDAKISIVAMAYTHS
>LONDMIMF_00580 hypothetical protein
MIIQKTFVQPDGFTFGRLFFVDNSRSVNFTKIFQKTMSFKPVFSLINITAIVSILTVTAL
AVKLYSIKTEKDNLAHTIELDRKLHNNEISEILIRYDAALQQNEQLTKELEELKNKTVQT
DDSVKSNFSLLKENISVLTKEKYTKSTQLETLNNILRLKQLDFESNKKEIEKLHNKISQL
ESEILASSETKAEKRKLRALNVSAVGARTVSEKVLETKKTKNTEQIKVCFTLEDSMGIEK
GIKEIFIQIINPKANIVSKNKASIEIKNQTLFYSAKTSVNYDKGDVDVCVFVDANKQNLI
KGNYIVNIFSGAHLIGNTSLNLL
>LONDMIMF_00581 Glycine--tRNA ligase
MAKQDDLFKNIVSHAKEYGYIFPSSEIYDGLSAVYDYAQNGVELKKNIREYWWKAMVQMH
DNIVGIDAAILMHPTTWKASGHVDAFNDPLIDNKDSKKRYRADVLIEDYAEKINQKAQKE
IEKARARFGEAFNEQEFITTNARVVEYLAKKKVILERMARSLETENLADVKALIEELEIA
DPETGSKNWTDVKQFNLMFGTKLGASAENAMDLYLRPETAQGIFVNFLNVQKSGRMKVPF
GIAQTGKAFRNEIVARQFIFRMREFEQMEMQFFVKPGEEMKWYEYWKTTRLNWHLSLGLG
KENYRFHDHEKLAHYANAAADIEFNFPFGFKELEGIHSRTDFDLKAHEEHSGRKLQYFDP
ETNQNYVPYVVETSVGLDRMFLAVFSNSLKEETLEDGSVRTVLRLPAVLAPTKAAVLPLV
KKDGLPELAQEIIEDLKWDFNVAYDEKDAVGRRYRRQDALGTPFCITVDHQSLEDKTVTI
RHRDSMKQDRVKISELKDIINKEVSMRTWLQKI
>LONDMIMF_00582 hypothetical protein
MKKKLILASLLFAVFASSCSDSSSDEFNNGNAGAAQKYLKTLTVTPTDGSESPNNFVVNY
DSSGRVSSITDGVQSNFFVYQNNNLANITGEGEPFRISELYQAPYQAYEIGEVLNYDSKG
NPTDLRLFQENEYDGEIEEFTAKITYDTAPNTFFYTLKAAGIIDVLDNVELNLNMQSLPP
EIVKAKLLLPVNNPVKVVIKNTSGTVVSTTQTDYVYASDKYPTSATITETSEEGVSIFAV
TYTYKQ
>LONDMIMF_00583 hypothetical protein
MDVLCHKMMKMIPLWERMPIKIVKIAPKTTIPASLKFIYGLNHDALTK
>LONDMIMF_00584 Transcriptional regulatory protein YehT
MSYSYVIINDNQENVLNIQGLADGFQNFCLVASANNYDDGLNCILEHQPQLVFLEIDPKD
KSSKLSLSLINELYRYLKEIPKIVVTAKNGNLALEAIKHEVFDYLVAPFELNDFRKTILK
FEKSTPSTTVSSPREPEQKPFFVDNDHPVKKDPEQLTICIKSYGDYRFIDAKDIQYFQAD
NNSTDIHLNNGEMITAFKTLKHFENVLPSQFYRIHNSYIVNIHYISRIHTGNAVCYIKNT
TTKLPFSKSYKGNIDQIIAVISSSGYLEI
>LONDMIMF_00585 hypothetical protein
MKDIMKKAILTFGLFSLVVLTSFTTTETKTQNIVAETGDTGDTGVGGASDRLGSGSSAGN
KKLDGIVKNEEISNSASNYQNSSSFSIEARKKLDI
>LONDMIMF_00586 hypothetical protein
MSCLFLAVFINHLIEFELYVLLIYQMLYFCVNRFTIFGNKLLDY
>LONDMIMF_00587 Oxygen sensor histidine kinase NreB
MKKYYLLFFVIGLLLLGCSKKKIKFSEKSISDTLATYLALANEDTIPYENRLSYNKKAFA
ILINQDNDSLNRVNLFKVANRYFNMNNFDEYQKTARIIIEKAKSGKDTLSIAKGYSYLGD
YYMNSPRRDSAYSYYSKAEKLYQKLNDKIGLGGIYINIATVQGYENDFLGSELSAIKALN
VLRDTKEKYKVYEAYNLLGIISNELKDYEKAIEYHTKALNLAKDNDINGFFERESSLNNI
GNVYQSNNKYELAIKNFQEALQNKNLIIGRPNLYALILDNLAYSKLKIKDYSQLPDLFYE
SLKISDSLKLRNSIIYSKIHLSEFYLIKRDTLTAKKFGSEALMLSRNIRNYNAILSSLKQ
LGTIEPEKSSVYSAEYIKINDSLQNEERKSKDKFARIQFETDEIIQQKDKLAEQNRNILF
FFGLVVMIGILLFVIKNQRSKTKELMLKQAQQKANEDIYNLMLYQQNKIEEGRANEKVRI
AQELHDGILGRLFGARLNLDSLNKRQDEDAIVSRNNYLVELKNIEQDIREISHDLNREKH
ALNNNFIGIVNNLIEQQETVSQAKVSFVVDMEIEWEKIENYIKINLYRILQEALLNINKY
AQAENVRIEIIKQEKTLKLTVTDDGVGFSVSKKSKGIGLQNMLSRANACEATFDIKSKIG
KGTTITVAFPLETNQK
>LONDMIMF_00588 Transcriptional regulatory protein RcsB
MAKKLNILIVDDHPFIIEAYKNTIAGYHPAEFEFNITQANDCKSAYEILTNPAIVPYDVA
FFDISMPPYQEKNILSGEDLAKLMKTVLPSCRVILLTMHTESLKINNIIKTINPNGLIIK
NDLTFDELLIAFDKILKNENYYSQTVVKFVSQQSSDSNLIDEYDRQILYHLSRGVKTKNI
PLHTPLSLSAVEKRKLNLKDLFKIKGGNDEDLINEARLRGFI
>LONDMIMF_00589 hypothetical protein
MKIKSIIIIATLTALLCCKSETNVKKNSRQNVARRESKDSSKQPKITVVKNNEYFLLNDR
KID
>LONDMIMF_00590 Thiamine-monophosphate kinase
MIEDKNQQRTSLSELGEFGLIKHLTKNFEINQPSTFKGIGDDAAVLDFKDKKAVISTDLL
IEGVHFDLAYMPLKHLGYKSVVVNLSDIYAMNAKPTQITVSVAVSNRFPLEALEELFDGI
ALAAKEYNVDVIGGDTTSSQKGLIISITAIGEAEESELVYRNGAKSNDLLVVTGDIGSAY
MGLQVLEREKQVFQVNPNNQPDLDAYTYIIERQLKPEARKDIRTLLHALEVKPTSMIDIS
DGLSSEIIHICKQSEVGCNLYEDKLPLDPQLINVCEEFNIDSTTVAINGGEDYELLFTIS
MDDYDKIKGNPNFTVIGHMTPESEGIHLVTRANIKIPLKARGWNALNG
>LONDMIMF_00591 putative ABC transporter ATP-binding protein YxlF
MKLKINNLSKTYKNGVKALDSLNLEIGSGMFGLLGPNGAGKSSLMRTIATLQKPDSGTIE
FDGINVLEDNIALRKILGYLPQEFGVYPNMSAEKLLDYFARLKGISSKSERKELVKKVLE
VTNLYEQRNKSVSGYSGGMKQRFGIAQLLLNNPKLIIVDEPTAGLDPAERHRFLNVLREI
GTNHTVIFSTHIVDDVKELCHEMAILNGGKILAQGTPEQAEERLKGQIWTKVIVREDLDV
YERDFNVISSKYNQDNTLNIKVYSNEKPDETFVEAAPQLEDVYFVALKSDQ
>LONDMIMF_00592 hypothetical protein
MFSTIFNFELKRWFRNPSFYIFAALFFGMSFLFAAANFGVFDDLTAARSSNAYANSPTAL
NGFINGMNVLIYFLLPIIVGSSVYRDFRFNMHTILFSYPFTKLDYIAGKFLSSLFVVILI
TLTIILGIVAASVLPWVNHDLLLPFNPVAYAQIYLIYVIPNLFFFGVLIFALVTISRNIS
VGFIGVILILLLQIMLSSFTSDIDNRYVVALWEPFGMEAASYYTKYWTIAEQNENLLPFE
GVIIYNRLIWMGISLVILGLLYYYFSFSQTALTIGKSKKSERAVKNNFGGITRIELPVVK
FDFSNWQNLKTAWSLSNVDFRFILRNWAFIVISIIGLLLLVAIAFSAGNIFGTDTYPVTW
QMLEVSGGFFMLFINILTFLFAGILIHRADTTRMSHLVDVTPIPNWVLLFSKFIAIVKMQ
IALLILILIAGVLVQLYHGYYNFEFGHYLFELYGIKIFHFMAWAFMAVFIQTIFKNYLLG
FFILMLLSIGIQFLSQIGIEQDIFRFNSDTRYAYSDMNGYGHSLNSYYLYKLYWNLLGIV
LFCIALLFWKRGIPMSIKERFANARKRFSPKLAIPMIVALVGFLAIGSAIYYEDNVRNPY
YSQKENEKQAVEWEKKYKKYEHYAQPRITDINVNMDIYPKSRDFKAKGYYFMKNKSKETI
DSIFLNYNGFESKFKFNRETELVSRDTLFHFNIYRLKTPLAPGDSIKLEFEVYNKPNTFI
TSHSPVLENGTFINNSYFPSIGYSESGELWDDETRAKYGLKPKERMAKPTDSIARQNTYI
SNDADWVNFETTVSTSDDQIAIAPGYLEKQWKENGRNYFHYKMDQKMLNFYAYQSARYEV
KKDKWKDVNIEIYYQKGHEYNIDRMIKGIKKSLEYYTENFGPYQHKQARIIEFPRTGGGF
AQSFANTIPYSEAVGFIAHVKDEDENAVDYPFSITSHEMAHQWWAHQVIGANVQGATLMS
ESLSEYSSLKVLEHEYGKSQMRMFLKDALDSYLMGRTFESKKEQPLMYNENQQYIHYNKG
SLVLYALSDYIGEKNMNNALKKYRDKVAYQEAPYTNSIEFVSYLNEATPDSLKYMIKDMF
ETITLYDNRIKNFSSKKLPNGKYEVTIDALVSKYRSDEKGKRSFKDESGKTLTYKGKGDK
HAIESYPLNDYVEVGVFGEQTVKGKVKEKELYLKKHKITQIDNKFVIIVDEKPVEVGIDP
YNKLIDTNSNDNRRKN
>LONDMIMF_00593 hypothetical protein
MNATAQAPQIISKDNLLRHWQGHRALTRRVIEAFPEKEFFEFSIGGMRTFAQLTSELLAI
ASPALKGIVERDEKPYVENMDNGTTKADYLRKWDEATEEINKNWNLLDVADFNQKFNLFG
QYEFPIIDNILYFIDNEIHHRGQGYVYLRALNIEPPFFWER
>LONDMIMF_00594 Bifunctional ligase/repressor BirA
MMDESPKRFDRIVAILIQLQSKKIIRAQELADRFEVSLRTIYRDIRTLEASGVPIYSEAG
VGYSLLDGYRLPPVMFTREEASSFIAAEKLMEKFTDKELHNHYTSAAFKLKAVLKSSDKD
WISTIESSVLMQPARKLFNEKAPNALALLFKSIAEKTQVVLTYLAIEAEVPTERLIEPVG
VFHENENWYTLGFCHLRNDYRQFRADRIHQIKPTDKPFSLEHPDLETYLQDDMQKYSTTK
VRIVVPKKISKYIAMQKKHYGFVSQKEINDGNVEMTFMSRDIEEGFSRWYMSYGDYGTIL
EPERLKERVLELLSKTRSRL
>LONDMIMF_00595 Elongation factor 4
MKHIRNFCIIAHIDHGKSTLADRLLSATRTVSAREEKAQLLDNMDLERERGITIKSHAIQ
MEYHYKGEDYILNLIDTPGHVDFSYEVSRSIAACEGALLIVDAAQSIQAQTISNLYLALE
NDLEIIPVLNKVDLPSANPEEVSDDIVDLLGCKLEEIIHASGKTGFGVENILAAIIERVP
PPKGDPEEPLQALIFDSVYNPFRGIEVIFRIINGQIKKGQKIKFMATGNEYFADEIGTLK
LNQVPKPMISAGDVGYLISGIKEAKEVKVGDTLTDAKTPTTNMITGFEDVKPMVFAGIYP
VDTEDYEDLRASMEKLQLNDASLVFTPESSAALGFGFRCGFLGMLHMEIIQERLEREFNM
TVITTVPNVSYLAYTKKEPEKGIVVNNPSDLPEPSKLDRVEEPYIKATIITKSDFVGNVM
SLCIEKRGVITNQTYLTTDRVELSFDMPLAEIVFDFYDRLKTISKGYASFDYSPIGMRTS
KLVKLDVLLNAQGVDALSALIHEDNAYNIGKKMTEKLRELIPRQQFDIPIQAAIGAKIIA
RETIKALRKDVTAKCYGGDISRKRKLLEKQKKGKKRMRQVGNVEIPQEAFMAVLKLND
>LONDMIMF_00596 hypothetical protein
MKKIIPILLLCCISIILVASCKKKDKDLSGVDVHEEENVIPFDSTQIAGFFTKYPDFKAF
QPEIKELYKKHDYHYIWYDRGGLIEFAEALYDKVNQIKSEGVQSQLPYKQQINDIFYEAK
EKGGPDLTSELLISSMYFFYAKNVLEGLDPKESKETGWYLPREKVSYVTYLDTLMKDPNL
LKKHDSELLPLYYDLKKGLQKYTEIEEKGGWGTIEMEAGVKSLKPGDSSKTIAEVRKRLF
ISGDLSKDSGNSQYDDELLQALMSYKKRNSREMDNLITPDLIKHLNVPVQERIKAIVVNM
ERCRWISTDLTKGGEYIAVNIPSYRMRYFKDNKMRLESNVVVGKEMNKTIVFSGQMSYLV
FSPYWNIPKSIIEKEIKPGMAKDKKYLANHNMEWNNGRVRQKPGNKNSLGLVKFMFPNSN
NIYLHDSPAKSLFNKENRAFSHGCVRVQKARDLAVAILEDDKNWTPQKIDKAMHAGKENS
YTLKKKIPVYIAYFTAFADENGMIGFFDDVYNRDARLASLLYKS
>LONDMIMF_00597 Response regulator rcp1
MKKQNLAIALLDDDQEEHLLFKEVADDFSEIKSVLSFAKGKEMLDYLGGKDKNVIPDILF
LDLNMPILSGLDCLIEIRKKEEYKNLPIVIYSTSSSEKDKEVTYRNGANLYVNKPIEFSD
MKKIFMEVLKINWKERSGAFNFQNFFLSV
>LONDMIMF_00598 putative tRNA-dihydrouridine synthase
MKKMVKIGKIELPDFPLLLAPMEDVSDPPFRRLCKLHGADLMYSEFISSEGLIRDAIKSR
QKLDIFDYERPVGIQIFGGDEEAMALSAKIVETVRPDLVDINFGCPVKKVVCKGAGAGVL
KDVDLMVRLTKAVIKSTSLPVTVKTRLGWDENSINIDEVAERLQDVGVQALTVHARTRAQ
MYKGHSDWTHIERIKNNPRITMPIFGNGDIDSPEKALEYKNRFGLDGMMIGRAAIGYPWI
FNEIKHYFKTGEKLPQPTMEDRVEAARNHLTWSMDWKGERVGIVEMRRHYTNYFKGIAGF
KEYKQRLVTTDDADGLFKTLDEIQEVFGGYQFV
>LONDMIMF_00599 Antitoxin PezA
MFGKNIKKIRSVHGLSQLQFAEMFDLKRATLGAYEEGRSNPKMDTVIKIANHFSIDIEDL
LTKELTVNRLLKFNETITTSPAVPKKVKTEGIPCVMEGMKSDYLLALTNRKEINLPQLTI
PTVSPENKTAFVLTDNSMAGISGLFLSKDIIVGEKITIQQPLADGSLVVVATKEEILFRK
IYFSNGRIILKANNSEFKDIEVSTEDVLLTWKVLHIFQHTLPQENTLEQRVAILESALAL
LNKNN
>LONDMIMF_00600 hypothetical protein
MKDYFNVIKGYLTELELEIKHENSADSIFIVSSEQEGVVNLIICVAYPIVIFEQFLFEIK
TDSPLVYKALLQKNRDIIHGAFVLDHTGQKVIFRDSLQLENLDLNEFGATLNSLSLLLSE
YSEQIINFSKR
>LONDMIMF_00601 Phage shock protein A 
MKFLRRLLKIGQAEVHHAIDNMEDPIKMTEQGIRDMKEDLDKALEALAQVKAMSIRAKKE
VDEYEDKAEDYNEKAMLILKKAQTGGIEPGEADRLATEALVKKEEAVGLKNQAIADKEKF
DQNVLQMEANVQTIKQNISKWENELKILRSRVKVADATKSLNKQMAKIDSNGTIALLERM
KEKVHQEEALAEAYGEIANSSKSIDEEINRVVDVKKSKAYNELEKLKEQLGISDPKD
>LONDMIMF_00602 hypothetical protein
MKELIEISFSPVNAFFSIMSIIMVVYWLLVIIAGIDPDLFSIDFDSADIESNFDHDVSGS
EHAHEGNGFMKVLEYFNFDELPLMFILTIIFFSMWLVGVNVTYYFGIESTLIGFLLLIPN
FILSLFVVKIFSKPLGYVYKQLNHKGEPEIDFLGRRCSVTSTVTEQKTGQIELIVNGDPM
KLYARSNTDEKLVAGDQAVIVGESNDKKYYLIEKFDY
>LONDMIMF_00603 Inner membrane protein YqiK
MLGNSLLITMIAIIIVVIGLLVWVISMYKKIIQGKVIVRTGAGGTKVFYNAGLVVPVLHK
MEIMDISVKKLDVERTGVNGLICKDNIRADIKVTFFIKINKSTADIINVAQTIGCERASE
IDVLRNLFDAKFSEALKTVGKKFDFVELYEARSEFREEIIAIIGTDLNGYVLDDCAIDDL
EQTPLSQLKADNILDSEGIKKITELTAAQNIKANLIRRDEEKTIRKQDVEAKEAILALDR
QLAEKEEQQKREIANIKAREEAEIVKVSEEERLKAETARINTTEKVMVAEENKDRLIIVA
AKNKQRTEAVETERVEKDRALEQTERERIVTLAQIEKEKAVEVERKNIQNVIRDRVVLEK
GVVQEQENMKDIEAFKEADRQKKVAVTLAEKESEELYIKRLKAAEAEKEAAKQKAEEINI
EAAARMAASEKEAEARKILAEAKAKEDATLGLSEAQVMHAKADANERQGIVDAVVIEKKA
LAEAAGIKAKAEAEKQLGVSEAEVIKEKALAEASGIEEKAEAMKKLDGVGKDHEEFKLRL
NKELQVDLAHIHIQKDIADAQANVLAEALRSAKIDIVGGETMFFDQIVGQITKAKGFDRL
VNGSENITEIKEAILGNDSEGGENLLERIKGFADKYGITSEDIKNLTVAGLLVELQKRSN
DEGEKGLFSNLMDMAKNLGLSGKKLG
>LONDMIMF_00604 hypothetical protein
MSTLEGGTYEIIRGRLETQKDDLSARLNKLNEARKEIFGSTETKLLANNRIITENNCIPN
DIVSIHDTCIFGYNVHFGLRTDIKTEDVFSIYKYEDGEFKQQGMDIISDSVFLDDFLNLY
KYYRDTEFKKFFITGNYLHMIFQLSDRISDIKTFKWLIKDGTLIYQDNRSDSEYRLPRQH
DFIWQQTSRDMQRYGKHPHVSILDKVFVETVGGTLTIKVEDNTSSGKGVYDEDVLYPDQT
LDDGNYQYADLGNLIALQIKPFQEEARFFIYNHKLQEVKKIDSLSTSAILLPDQHGLIFS
NGYYLQTGEYKIFENSLRNLLFQEKIASPNGEDFMYVFYEELTGQYVLMSYNIITHEVMT
PIICNGFTILENGELCYFRAEEEHTKNHLVQIWQTPFVKGDVMPTQYKDSFLYKIGNKDI
VKAMADCHSIITLLNKNDDYEGLYADLTRQSQNILDTYYWINSKETFELHIPLTEIKNTA
NTAIDEFEKVVQLRLNAAKITQEIKDKAEALFIKIKSSPLDDIDVFVADLAGLRTLRGEV
ISLREIRYVEENFINELEAEIIAQTEHISQNCLQFLMDDKALVPYHNRVEEKQKGLDKIT
TVTEGKKLEDEVNAITADLEMLIEIVSNLKIDDTSKSTHIINTISLIFSTLNRLKADIKN
KVAALGSKEARADFAAQMKLIDQSMVNSLDRAVNPDKADELLNKISVQLEDVEARFADYD
EFTGAILEKREEIYAAFEAKKNSLVEARNKKAVAIQKAAERILKNIDVKALALNSVEEIN
GYFASDLMVAKLRDLAAQLIEMDDTGKAETIETQLKASREDALRKLKDKQDLYENGENIL
RLGKHRFAVNKQPLDLTIVYKEGKLNYHLTGTDFYQELSGSALDSLQKYWSQDLISENDT
IYRGAYLAYKIFKTYGAARLYSLTEEELETIVKDETLKNYTEGYIKGVHDADAFKIVKVL
ITKHNDLKMLRYSPTVRAFAQFVWNSLPEDDRNAMNVKIKASGNVLAIFPESTEFDYIIN
ELRQKAEGFLETTAVSKNSGAEIAEIASYLFDELKDGDVFSVSHRATQIAENFIKTLEAK
SALMSFRHAVEAAADNETSLLLAVQWVSSYLAQNAEKQNAEYLYEVVALLLYSQKSDEKV
SGITPEETIIGLVGAHPSITDGVFQFHYHKFIKLLKEYFDKDVPAFEQFREERHKLTQQL
KVDLRLHEFTPKVLTSFVRNKLIDQVYLSLFGDNLAKQLGSAGENKRTDRSGMLLLVSPP
GYGKTTLMEYLANRLGLIFMKINGPAIGHEITSVDPTSASNSAAREELKKLNLALEMGNN
VMLYLDDIQHCSPEFLQKFISLADGTRKIEGVYNGQPKTYDMKSKKFCVVMAGNPYTETG
EKFRIPDMLANRADIYNLGDVIGNSAELFELSLIENAMTSNPMLAQLASRNMEDLYPFIK
MAQTGQRDGLELKGNHTKQDIEVYVSVLDKVLKIRDVVLQVNAAYIASAAMEDAYRTEPP
FKLQGSYRDMNKLVAKIEPVMNDAEVAALLLSHYQNETQTLTNAAEANLLKYKELTSTLN
DTEKERWASIKEIFQKNNKLKGFGNKNEMAQVLQQMMEFTSHIEGIKQILGKRLEE
>LONDMIMF_00605 putative FMN/FAD exporter YeeO
MTQTEQKQSFLSRLFITIKQSLKGEADFDYTSGSIRKAVILLAIPMVLEMMMESVFALVD
LYFVGHLENSSFAIQTVGLTESVLTVIYSLAIGLSMAATAVVARRIGEKDPIAASKAGMQ
AVIIAVAVNTVISILGLLYATEILMLMGASPEAALHGTNFMRIMMGGSISIVLLFLINGI
FRGAGNAAIAMKSLWLANICNIIFCPILINGLGPIPAFGLTGAAIATTAGRTIGVLYQLY
HLFNGKGILKIAASYFLPDWKLIQNTIKVAAPGVLQFVIASCSWIFLANLVAVTGGDHGS
AGYQTALRIMMFFILPAWGLSNAAATLVGQNLGAKQIERAEKSVMQTAKYNVIFMATIMA
ITLLGAEYIAGFFTNDLVVKEIAVEAIRIMSLGYIFYGIGMVLINTFNGAGDTWTPTWIN
FFGFWLFQIPLAYVLAKKLGMGPTGVFMAIPIAETAITIAGYVLFKRGKWKRIEV
>LONDMIMF_00606 Lipoprotein-releasing system transmembrane protein LolE
MTGIEFKFKPGADESAISEELQNIFNHKLTIKNRAQLNDSLYKMLNTEQTALYLIFTLVI
VLTLFTLAGAIIMLIIDKKSNLTTLYNLGVEVKNLRKIFLFQGSILTVTGGLIGLILGII
IVLLQQNYQLVMVTPSMPYPVIFNIENLIIVLATIFSLGFISSLIASSRVTKKLLD
>LONDMIMF_00608 hypothetical protein
MKKTYIRYDINRACQTILQEQLEELGIGYEVEDLGEIIIQKNVPAPLFLTLRNNLQRYGI
DLLNDQKGQLIQRIKNTIIEMVGRDKLPMSKISCYLAERLQMNYNYISAVFSEYTHTSIE
NYIILQKIERAKKLLLQELSLTEISYLLSYSSVAHLSGQFKKVTGLSPSAFKKIISERKK
IAYTN
>LONDMIMF_00609 Chemotaxis protein CheY 
MEKEEKMHIALADDDLEDRELFRDAIEELGLDVELTLFSKGDELLDYLHDSHEKKLPHIL
FLDLNMLCTKYDDCLSEIRRHSKFKDLSIAIYSTSGAEKDIHKTFVGGANIYIKKPNDFE
VLKQSLHEVLKINWQFHTSGLDKGTFLFRI
>LONDMIMF_00610 hypothetical protein
MKKFLRNNSLTLVFLLLFMGSLVGQVFCGYEEHNKELLQDGAIPITLWTYLHSGHFIQST
FENWESEFLQMALFVVLTIFLQQKGSSESKDFDKAEAVDREPSKNRKDAPWPVKTGGWML
ELYKHSLTIVLFLLFLASFALHFYGSLKDENEQLLLKGLPLEKPLEYLSDTRFWFESFQN
WQSEFLSVMAIIVLSIFLRQKGSSQSKPVDAPNQETGEG
>LONDMIMF_00611 Sensor histidine kinase YehU
MYRITKSALFLLLLFTFSVSYSQDRVIDSIKTLISNPKLHDTTKLRAISEAMDYHYMEQD
KNYYVLNNMLGKIALENYKKSNTPELKKKYTLWLASYYSTVGTEYSFTKEREKGLVYHDK
SIALFKSVKAYDEMYANMLTKAALYVRMNQDDKAIPLIFDAIKYFEKDKEYYVDDLAYAY
SGLGQIYIGQKQHQKAISYNQKAIRFYDDSYAQEPNDHTSYLKSLAYANIAYSYASLKKY
EESVAYCNKALQISRKIKNYTITGLVLSRLGNAKVQLGKLDEAEKIFNEIFSIKELAAAT
NDAALTAAYHGLANLYIKKGDLNKAALYAEKGFTLSKKTGSIDLQDQGAKLIYDISKATK
NFERALEMYQFHEKIVDSSQIQASKNALEQQLLKYDFEKKELNYKLTAQKKAEVKNNWLI
GLSGALLVLLIGGYFYYRNTKQKQEIAKLEKNQIKQKLLITQMNPHFIFNSISNIQGLIR
EKKEEESIRYLSKFSILTRQILENSNENYISLEEEVGMMENYLSIQQLLYNNKFSFTLVV
DEDIDQESLFLPPMLTQPFIENAIKHGLADKDQNGKIDYFKSVKFETKRE
>LONDMIMF_00612 hypothetical protein
MQPVKISIQGDFMDCQIYRGRLYLWTFDGKLKVYRWYDLINSLPNSERDALPLKFCFLDG
NYLYKSDLVDLFHDEDFRKILLDKFSRLSNQHYELTEKEADRFLYGQQDTPSNLLATDTE
IYSNSLYYINEQGLFSTSAHRDNKKYPVSSKPVKLWDCNLLSIKANKYPQLALSGGDEGL
FEYDLSKDYRSRWNLKDPVQVSNKHSSFANYTYWSIYNTSLVESSYMALFDLNEVELDEE
NLNIYDFGRRKFKREFKEEISERRIFDNQGNRNFLSWGVDDKIYRATDGGFEIVKFKNNP
NFEKGEEQFTRLQNLNLHAWKGKVIGGGTSYYGTILECENALVVLLSNGQSETIEGPITR
WRVYPRSMNYQNHLHVIKDDRIEIYSFNQDYFLDQDEKLIGLEHKAPRKWSNS
>LONDMIMF_00613 hypothetical protein
MPYELDRDIDLTPQTTAKYYVSSAHRRIQRHKSRWTVTIDKEVECFIDSQTKSWIDATAS
WGIIQEGNNLLVLGLNSQNEELKIAKFIAKNNDGVWHGYPADFNRKIQDRPAMSILQSWR
THGHIEKHHITKIRQGKECNL
>LONDMIMF_00614 hypothetical protein
MSKEICEELKSLTKLEFEKIINHLPSDPIVRFILFTESLRVLDLNSILFRNSTDVSRVPS
NDILKMGWNLLASILFEGHFSSGFPIMKSTEETFAVARGVLHHCGCITMVNRTVDMIYSG
VLTVEKENNKYVFKKTENANSQFLDDLEISQFQNLENELKNNIGGYYNDWNVVEKNNLEK
AFNSYGNFVSSITADFSSLFSDNIEELLNNQVYPWDSGHGVMTGYGSTPEIDMHFLGKAF
SLIHEWREIAGLHPKTKIGNITGADVTSAVLYMTSFHLKHISCCLLASKKHSEISLEQSL
TIWGPLDAVIDDIVEFSGMEKAIVAEAFESITLKPNDVNLLRTHTSRFMPLLIDIGNGIV
LRPISSIERNPFLTINQILEYRNPNFRNDLSYHREEWLRNNLYAIFSGSRYSTIPGNITL
KSGNIVETDIDAAILDITTGDLALFQIKWQDFFFNDAQKLRSRASNLTKSLDDWTQKVDS
WIGLNGRTKLLQTLRLPDDKSTGNIYLFAISKNAARMQGYGYTVKSENLAISNWHQFMRT
RHEVGPSKKVFKDLFDILKSEENKTVETAPLHAEFILSDKIFEYKDLWSTHGS
>LONDMIMF_00616 Putative zinc metalloprotease
MEIVIKLSQFLLSLSLLIVLHELGHFIPAKLFKTRVEKFYLFFDVKFSLVKKKIGETVYG
IGWLPLGGYVKIAGMIDESMDKEQMALPPQPWEFRSKPAWQRLIIMLGGVTVNFILAIII
YIGMAYVYGNTYISNSELKDGIWVSSPLGEKIGFKTGDKIIAVDGKKVEKFDDVQYNVNF
AKTATIERNGTVEEIKLPVDLLSKIVEEDRRYLKLRIPFTVGTISEDSPNINTLKKGDII
LSIDGKKMKYADEILAFNEANAGKTFDAVVFRDEKEEPIKVTVNKEGKLGVIQGGLKPEN
LEKLGYYKISRETFSLAESFPAGIQRSKDELGRYFTQLKAIVNPDTGAYKGVGGFYAIFN
VFPSVWSWEYFWTITAFLSIMLGVMNLLPIPALDGGHVMFLLFEIITRKKPSEKFLERAQ
VVGFFILIALVLFANGNDIYKAIVK
>LONDMIMF_00617 General stress protein 69
MEKRQLGNTDLHIYPVAFGGNVFGWTLDEKKSFEILNGFTEAGFNFVDTADVYSRWAPGN
TGGESERIIGKWLKEKKNRHNIVLTTKVGSDMGDGRKGLKKQYILKAVEDSLQRLGTDYL
DLYQTHFDDVETPVEETLEAYAQLQKDGKIRWIGTSNMSPERILASLEASVAKGLPRYET
LQPHYNLYAREKYETQYESLALENGLGVITYFSLESGFLTGKYRTKDDLGKSPRGGDMDK
YFDERGLKILAALDEISNQYKATPAAVSLAWLIQRPSVTAPIVSATSKSQLESIILAPEL
NLDADAIRLLDKASAWQQ
>LONDMIMF_00618 Inner membrane protein YbjJ
MEFRFINAFNTRPKLKGYKHAKESYLKRIRWAVSLFYFGMGLCFATWASRIPDIKASLHL
SESDLGSILFALPFGQLMIMPFSGKLVTKYGSHKILLIALALYAIALTNLGLAEKPWQLS
LGLFLFGIFGNLSNIAVNTQGVYTEGLFKRTIMSSFHGAWSTAGFSGALIGIAMLALKLS
PFQHFVIAALIVFVLMAANYKYLIRAKEKKSSEKKKFFAKPDGVLLWLGIIGFCCMASEG
VMFDWSGVYFKEIVKAPGPLVILGYTSFMIMMASGRFLGDRLIHTYGRKKVLQISGLLIS
TGLFTSVFLPYLIPSTLAFMLVGLGVSTIVPTVYSIAGKNAAVAPGEALTIVSSVSFLGF
LMGPPVIGFIAEAAGLQFSFAFIGIFGVLIAFMASRIKAIQ
>LONDMIMF_00619 Aminopeptidase N
MKKIYLLLALSLSGIGFAQSSSSQNHQIAEAERKSAVKKINFRNNPNTENYDVTYHRLRF
EVNPSNYYVKGNVTTYYRAKTNMSTVTFDLADELTVSSVKQRNTSLSFTQNGTNELVINL
PAVQNTNVLDSLTIVYEGAPPAQSDGFNTYTHAGNPGLYTLSEPFGARDWWPCKQDLNDK
IENLDVFIKTGSQYVSVANGVQISSVNNGDGTKTTHFRHGYPIPAYLVAIAVTNYTIFTQ
QAGTAPHTFPIVNYIYPESQAVVQNDLAVTVPIMNLFEQLFETYPFANEKYGHAQCSLPG
GMEHTTVSFMGSFGRDLIAHELAHQWFGDKITCGSWKDIWLNEGFASYLAGLVIEDMDGA
TNFNSWKSGLINNITSQPGGAVYLTDSEALDAGRIFSSRLSYDKGAMVVHMLRFKLGDTN
FFQGIKNYLADPTLAYGYAVTENLKTHLEAASGMDLDEFFNDWVYGQGYPRYTITVRNFS
PGVARFTVSQTQSHSSVSFFEMPVPVRVTGTGGQSLDLILDNTTNNQTIDKNVPFAITGI
TFNPKSDIIARNSTATLGNEAFVLDENVKLYPNPASHSLQLELPDNVVLEKAIFYNALGQ
IIKETASQTSWDVSALPVGVNFVKIITDAGTKQMKFIKA
>LONDMIMF_00620 Serine--tRNA ligase
MLQIAFIRENQEKVLKALAKRNMDAKSIVELAVQLDEKRRATQAEMDNILSESNKLSKDI
GELMKSGEKAKAELLKTKTTSLKEKSKELAEKLDVYTNELTEQLYLLPNLPADIVPEGKT
PEDNVTILQEGDIPDLHGEALPHWELVKKYDIIDFELGNKITGAGFPVYKGKGAKLQRAL
ITYFLDKNTEAGYQEFQVPHFVNEASAYGTGQLPDKEGQMYHDATDDLYLIPTAEVPVTN
LFRDVLLQENELPILATAYTPCFRREAGSYGAHVRGLNRLHQFDKVEIVRVEHPEKSYEA
LEGMVEHVRTILNELKLPYRILRLCGGDMGFASAMTYDFEVFSTAQDRWLEISSVSNFET
FQSNRLKLRYKDKDGKNHLAHTLNGSSLALPRVLAGILENYQTPEGIVIPEVLRPYTGFD
IIN
>LONDMIMF_00621 hypothetical protein
MKKIFLFLSLFTSLFVFAQNEQLAINYFDKGEFEKAIISFDELLKNQQGNSFYFQKIIES
YQQLQQYDQADKRLQERYAKYKQPSLLVEIGYNYQLQKDAGKAKKFYEQAISKINENPSN
VYAVANTFEKKVLLEYALESYNLAIKLEPKFKFNYQMAVIYGQLGKMDLMIDTFLEEAYS
NQNNTIMIQNQLSRFMTEEAEETFNTALRKALLVRAQKNQDIFWNQFLSWFFVQQKDYAK
AFIQEKAIYRRDPESFSNIVNLAELAMEENEEETAKEIFAFVLENTQDLDLQIRAHYFLM
ESKIQKAPEKEYPAIKSELDLLVKKYGISPYTLSLQILQAHFATFNLKNPEEGKTILKRA
LELPLNKYQTADVKMELADILLYEEKFNQALIYYSQIEEDLKNDAVGHEASLKAAKTSYF
KTDFEWALKQFKELKSASTQLIANDALELFLLINDNTVADSTQVGLKKFARGDYLLYQNK
NKEALEQFQSILKEYKGQEIEDETLLRIGETYEKLGDYNAALAQYQGIIDNHKDGIYIDE
ALYFSAEIYNKKLKDTDKAKALYEQILFNHEDSIYFVEARKKFRQLRGDTNL
>LONDMIMF_00622 hypothetical protein
MIIYNVTINIHESVHDEWLHWMQHKHIPEILGTGKFSSARLVKVLVEEEMGGVTYSVQYW
ADSRENLDSYYKEYAPGFREEGQRLFGDKMLAFRTELEFISDHKSV
>LONDMIMF_00623 Ribosomal RNA small subunit methyltransferase A
MDKVKAKKHLGQHFLTDENIAKKIADTLHFEGYDNVLEIGPGMGVLTKYLLEKPVNTYVI
EIDTESVDYLNANYPKLQGHILSQDFLKYDINKTFEGKQFAIIGNFPYNISSQIVFRALE
LRNQVAEFSGMFQKEVAERICEKKGTKTYGILSVLAQAFYDAEYLFTVHENVFNPPPKVK
SGVLRLKRKENFALPCNEKLFFTVVKTAFQQRRKTLRNSLKSLNLSENLREDTIFDLRPE
QLDVQQFIAITQKIEADAI
>LONDMIMF_00624 Magnesium transporter MgtE
MQFKISKELILQIEELILSKKDQQLEALLNDMHHADIAEILDELDFDEATYIFKILDSEK
TAEILLELEDDLRENILSRLSPKEIAEELDELDTDDAADIIAELSTDIKNEVISELIDVE
HAKDIVDLLRYDEDTAGGLMGKELVKVNENWNVLTCVKEMRIQAENVSRVHSIYVVDDEN
RLKGRLSLKDLLTTSTKTPISEVYIPKVDYVRVDTEDVEVARIMQKYDLEAIPVVDELGR
LVGRITIDDIVDVIKDEADKDYQLAAGISQDVEADDSILELTKARLPWLVLALLGGFISV
RVLGLFEGAMTEHGNLFFFTPLIAAMAGNVGVQSSAIIVQGLANNTLSGSLFSRLIKEIS
LSLLNGVILASILFIGSHFLLNVEFIIGVIVTSALISVIIIASLIGTFVPLLLNKFGIDP
ALATGPFITTSNDICGILIYFSIAKLILGF
>LONDMIMF_00625 Hydroxypyruvate reductase
MVPEEIKILHIDSNHPLLLSQLQEAGFTNHEDFKSSKEEIEAKIHDYNGIVIRSRFKIDK
TFLDKATKLQFIARVGAGLESIDCDYALSKKISLIAAPEGNRNAVGEHALGMLLSLFNKL
NQADREIRSGHWNREKNRGHELDGKMVGIIGYGNMGKSFAKKLRGFDVEVLCYDILENVG
DANAKQVSLEELQQKSDVLSLHIPWTPETDKLVNADYINTFAKPFWLINTSRGKNVVTAD
LVQALETGKILGAGLDVLEYEKLSFETLFEEDKIPEAFQYLLESDKVLMSPHIAGWTFES
HEKLAQTIVDKIKELYFGKNAEVKTPNRVTGIGGFFFKSEDPKALRDWYKKHLGLNTDDY
GCTFWWKDKEGYDCATQWSPFISDTNYFSPSEKQFMQNFRVENLEELLVTLKQEGVQIIG
EMENYDYGKFGWILDIEGNKIELWEPVDKVFL
>LONDMIMF_00626 hypothetical protein
MELERPENYGVIPEFRVDPIVVLLLGFITCGLYLIYWNIKVAQVLNAVAGKEVISQPIAI
FSGCCMPVNLYFYYLAGKEGLPKVYERTGEREKDQSTLLLILGFLFPMVAAMIVQGDINK
LYK
>LONDMIMF_00627 hypothetical protein
MLHNHDHHLETDQSLCPFKMLTGFPCPGCGITKSLVYLYEGDLQKSLSYHLFGPFAFVFC
IVVIIVLTLELKTQKEYFNSVFYSKKIAYFLGAVLIVYHIVRLVYFVRENTFDDILRQSI
WK
>LONDMIMF_00628 hypothetical protein
MGLVTAKEVAKAINTDKYGVLGTFSGWLLMKILKISTLNKIYDRNKHLQNVEFLNAILDE
FQIKFEIPEEDLKRLPKDGAYITISNHPLGGIDGILLLKLMLEREPNFKIIANFLLHRID
PMKPYIMPVNPFENHKDAKSSVIGIKETLRHLSDGKPLGMFPAGEVSTYKDGKLVVDKPW
EEGAIKLIKKAKVPVIPIYFHAKNSKLFYFLSKLDDTLRTAKLPSELLTQKDRVIKVRIG
KPISVNEQNEYDKIEEYSEFLRKKTYMLANPFEKETKLLDTSNLKIPRSPKQIAMPANHE
QIVNEVNALRQTDCRLLQSKNYEVFFTEANHIPNILHELGRLREITFREVGEGTNQSLDL
DQFDQYYHHMFLWDDDTKEIAGAYRMGLGAEIFPKYGIDGFYLQELFRFEPELYDMMSKS
IEMGRAFITKEYQQKPMPLFLLWKGIVHTTLRYPEHKFLIGGVSISNQFSDFTKSLMIEF
MKSHYYDPYIAQYVHPKKEFKVKLKDADKDFIFDEAEADLVKFDKLIDELEPGNLRLPVL
IKKYIKQNAKVVAFNVDPLFNNAVDGLMYIRIADIPESTMKPVMEEFQAELERKLAEKGE
KL
>LONDMIMF_00629 Exodeoxyribonuclease
MRIISYNVNGIRAAITKGFLEWLQHANPDIICLQEIKATPDQIPLDEFEKAGYPYNYWFP
AQKKGYSGVAVLCKTKPNNVVFGTGIEHMDAEGRNLRVDYDDFSVMSLYLPSGTNILRLD
HKFMYMDDFQNYINELKKEIPNLLICGDYNICHEAIDIHDPIRNAKVSGFLPEERSWLDL
FMKSGFIDSFRHFNKDPHHYTWWSYRANARNNNKGWRIDYILASRPIENRLKRAVILPDA
KHSDHCPVLVEID
>LONDMIMF_00630 putative lipoprotein YiaD
MIKKVSLGVLALALTTSCVSSKVYKELEDKYANLKKENRSLSDENQNLTKAKNQLDLESK
DLKSQLEKLKAERDKLAADYAAASANLNTLKSSYAALEKNSGDALDTNMKKNRELLAQLE
AKEKALAAEQERLNKLQAELKERSSRVDELEGMIAAKEESMRKLKETLSKALNSFEGKGL
TVEQKNGKVYVSMENKLLFGSGSWSVGAEGRRAVVEVGKVLGVNPDISVLIEGHTDNVPY
GGTGQITDNWDLSTKRATAIVNILAENKAIDKKNLTAAGRGEYAPLASNETAEGKAKNRR
IEIILTPKLDEISKMLNEL
>LONDMIMF_00631 General stress protein 69
MNYNTLPNTNLKVSELCLGTMTFGQQNTEAEGHAQIDFALDKGINFIDTAEMYPVPAREK
TTGETERIIGSWLRKSGKRNDIILASKIAGPNRGMQYIREDLAYNKETIKTSVEKSLKRL
QTDYIDLYQLHWPERKSNMFGQRGFKIQEDAWEDNMKAILEVFQELIQEGKIRAIGVSNE
TPWGVMRFLEESKKHNLPRIATIQNPYSLLNRTFEVGLSETAYRENVGLLAYSPLAFGVL
SGKFLTGEKHPDARLNLFPNFTRYNSQQTKEATALYEETATRFGLTLTEMSLAFIRQQQF
VTATIIGATNLKQLEENINSRHTVLSEEVLKAIDEIQSIRPNPAP
>LONDMIMF_00632 Aldose sugar dehydrogenase YliI
MNNFKFYFINLLPNPNCYKMKTTLRLLVLLFSTFAFSQTIGIVPFATGFNNPIEIANAGD
TRLFIVEQSGVIKVLNSNGTTNATPFLNITSLVSCCGERGLLGLAFHPNYASNGFFYVNY
TNTAGNTVIARYSVSSNPDVANTTGTILMTINQPFSNHNGGTIKFGPDGYLYIGMGDGGS
GNDPGNRAQNINELLGKMLRIDVNSGSPYGIPPTNPYAGATPGADEIWAIGLRNPWKFSF
NRLNGDLWIADVGQDQIEEINKVSSTAAGLNYGWRCYEGNATNITTGCPSMSTMTFPVAQ
YTHASTGGCSITGGYVYTGSTYPAMQNKYFFADYCVNRIGMVDTSGNITYSANFSGTNSF
TSFGENSSGELFVTGTAQDIVYRVIDTALSNDDFTKNGFSMYPNPADSELFLSNSNGTVL
QKVSIVDLSGKLLIDQKLENTPVNTINISSLQTGIYVVTIEDTSGNTFTSKLGKK
>LONDMIMF_00633 hypothetical protein
MKKFLILFLFFQATLYAQKPVFTTAKVKAATVYFNAAEISQTASVNLPAGTHEIVVKNVA
NWVNENSIQIGTSPTLTVLSVQFTDNYISEYEVDTNSPSVKKVKDSILIVQKEIAKLANS
RISEGKTIELLDKNQQVSGQNSGLNVTELMKMVEYYKTKRAELSNNINALAEKEQKLAEV
LKKLNDRLEVNNKNEEKISSGKLILQVMNEVAGNVPLEISYLTNSATWAPFYDLRANSIA
SPIDMMYKAQVTQSTGIDWKNVKLTLSSGLPNQNNQAPLLQAWFLRYGYVPDYSRNDDKS
NELQEVVVQGITTKKDKVMIRGSVSNFTAITENQLNISFDIDIPYDILSNGKKHSVALKE
IKLPATYKYYAAPTADKEAFLLAEISDYSKYNLLKGEANIIFEGMYVGKTFVDPNQTSDT
LNLSMGRDKKISIKREKVVDKSGTKFLSANKVQTFTFETTVRNNKKEAIQLTLKDQYPLS
TDKEIEIELKQSDNAKVNAETGILTWDLNLKPNETRKIRISYTVKYPKNKIIDNL
>LONDMIMF_00634 hypothetical protein
MKKLITILITLTIHQFLQAQSIDKASLDNSLSLKSDGIYVVNGVPYGQNDSIKLDSVLQS
YPKEYIVDIIKLRHDGGIVRCKNNDVAIILFAYQQDKKEIMKKVKILKTKFTDTYFGYSQ
HILTNSKNPILYIDNQLVYPTEATNAIKKLKSDKIYYIDIKDEPQNTELYGQNAKNGLVR
IWTKNKLIKNPNNIKGADN
>LONDMIMF_00635 hypothetical protein
MKTKIIFASLLLGTTFCFGSCDFFKKEPKENPNPENNPGPELALNTTTADDNTKIQVALL
LDTSNSMDGLIDQAKSRLWNIVNTLTTLKYEGKNPKIEIALYEYGNDGLSATSNYIRQVA
PLTTDLDLISEKLFSLQTNGGSEYCGAVIQDATKQLSWGKDKTNMKLLYIAGNEPFNQGS
INYKEAISDALKNDIYVNTIFCGSAMEGIDTFWKDGADKGQGKYFNINSDEKVRYIVTPY
DERISKCNERLNSTYMGYGAQGYEKKAMQAAQDKNAESVSSSNYAERAVSKSKAVYKNES
WDLVDRVKEDKSALQKIKKEELPKELQNKSPQEIKAIVDQKTQEREAIQKEMAQLAKQRQ
DYIDTENKKGKKQDDLGNAIASSILGFAKIKGYTAEK
>LONDMIMF_00636 hypothetical protein
MKTRIISAAVFLAACCVSVGIINNRSILQDNEVSKGKDLASLPKEKIEEEEEKPCVFMTV
MGEQPSEGFAAAKRDAKIDDKIMQGELWLIKAQNKDGGWGAGSHARQNVMDPHAVSSDPA
TTAMTAMALYRCGYNLESGKYSDVLKKSLNYLLAEIEKTKNNPNFITEVRGTQIQSKLGE
NIDAVLTLQFLNQVYPMLKDASLKTKVKEAIQICVNKIEKSYDETGKVKGAGWAGVLQSS
FASSSLETAAKNKDIKVNKEKLQKSREYQKSNYNAESESVKAEDGAGIVLYAVSSSVRGS
AKESQEAKAIMNQAKREGKLDKNAVLNKENLKKAGVSEEQAEVYDVADKVYNSAKVKAMN
KEVISGFGNNGGEEFLSFLQTGESMIVNQDEEWKKWYDDVSGRIMSIQNNDGSWNGHHCI
TSPVFCTATCLMILTVENDIKKLQ
>LONDMIMF_00637 Sensor histidine kinase YpdA
MMKTKWTFFFFLLLFGMKTAMAQDTIKKKSKYSPKEYNLNQAATELKKSLSEDENDLQTA
QKYEALAKQLSAKGQYAKAEEYLKKARDIYAKRNKKKEAAITNRGIAKVQESQNKTQDAI
VSYEMASQAATDKVAEKINYNDAERLKNSAPEQKKDYIFSNIQILEKEGEKEEAADAYQQ
MAKANIDRNDAKAAVENYKKALENVKHKPEEAIKIKNEIAKVYASENEFDKAIEINKKLI
NEAKEKNDSETQIMQMQELAAIYFKQQEAEKGISVLKKAYELAIQNGKTILAKNSLDQLI
SEYNAKGNGEKSIELYENFFENFESLIKSDNSLVDSKVFQVTEDRIKHLEKERALKDELI
SKKNTFNYFLLGSVVLMVLLFVFIVKALYSIKTKNKKIALQSLRREMNPHFIFNSLNSVN
QFISENKELEANKYLTSYSNLMRNMMENSNKDFVTLNNEVEQLKKYLDLEHLRFNEKFDY
EIIIDDALDGDAVLVPNMLLQPHLENAIWHGLRYKEGKGFLKLDFKLKNNIVKVIVDDNG
IGLTKSKELKTTNQKVHESRGMTNTRERISLLNELYKKNISLKISEKENPETGTRIEISF
PLIDRI
>LONDMIMF_00638 Transcriptional regulatory protein YehT
MMMLQKIRSVIVEDETAAREVLKNYVQKYCPQIEIIGEAQNFKEAVPLLHELKPQLVFLD
VEMPFGNAFDVLEACKDLQFETIFVTAFSEYSLKALNQSAAYYLLKPISIEELITAVNKV
QQHLLNHEIFNRNRIIVENFRETKPEKQQVILPTLEGFEVVKMEEIVRLRGNGNFTDLYL
ADGQKKMVCRFLKHFTEILPFPFVRVHKSHIINVNSVKSYHKGAGGYVTLTDGSEIEISP
SYKEEFLKVFK
>LONDMIMF_00639 Biosynthetic peptidoglycan transglycosylase
MRSRKQKAILAAKIVGVLFVLSIGTFFIFRNSILQKAIAKVSDKMEHDYDSNFSIKKASF
QGFSGISLENVLLVPKHADTLLNVESIQTNINFWKLLTGDVQLGTLHVKNGFVKLVKDEN
GRNFDAFLKRKSNEDTTNIETNYAKRAYRLLNQALNLVPTDMNLENVSLRMDDMGRKVNL
DLKKLRLEDKQLETSIGVTADNFQQHWKIKGFADPRRKKTDLRFFNLDTGKIRIPYIDER
FNMKAGFDSIRLNVSNIEMDGGELHIDGFTSIVNFTVNHPKIANKDVVIKQAKFDYNLLF
GEDFVAVDSTSSVTLNKMKFSPYVFYQKTKEDKNQIYALKVKIPKMKAQDFIVSLPEGLF
TNFEGMEAEGNFSYDLDFLYNKNKPGELVFDSKLNKENLKITKYGEANLSKLNGNFAYRA
IINGVRQRQIEVGMSNPNYTPLDQISPYIRKAVLTSEDPSFFSHRGFINEAFKQSIIKNI
KTKRFSRGASTISMQLIKNVFLTREKTLSRKLEEILLVYILENNRIASKERMLEVYFNII
EWGPNVYGIGEAAYFYFGKHPSQLNLNESLFLASIVPRPRGFMWQFDNQGKLKSFAEKRN
EYMTNLMIRRGLLTQDDTLQKHFPVEITGPARSFLRIKAPDSTAVDTIAIDEEFDF
>LONDMIMF_00640 hypothetical protein
MGYTLQAFITKKSNHKNLIDFYTNATMVDIGQELCLIPFTKELFDEINKLTKSKPIGKFD
YLTENIEVELLKQVGDIKIAYIEADYFGGEGGQIALIWEEQKRIYLSEWGDWEINKVLKD
FGVIRKDGKDEFDTVGLGENRSTEEWLNDSE
>LONDMIMF_00641 hypothetical protein
MKELLDKVLKNPKNYTLIKFLKLKIEDNLIQSFKTWADSYSVYNEGGCILFEDYGAFIPE
ENKFTLSGYSLMLNTNTAEIFAINIGRFSIFFKCNFIKSGIEDTPDLKKGYTFDCITDIS
ELGDNWCFMDEFDNPKDELKWSFELTKE
>LONDMIMF_00642 hypothetical protein
MLFLCLKSFSQTEDFQYRRTLENVSETWHKIILPEESFDKFNSDFSDVRIFGNNKTETPY
ILKTASDRISETAIQFKTINVSNKNADYFYTFELLQAKEINQIKLGFEQENFDWKLDLEA
SNNQTEWFLIQKDYRILSIKNSQTDYKFTQVDFPDSKYKFYRIKIKASEQPKLTEAKIRE
QQKEEGSFKTATIKTLKKTIDAKKKTSVIEVELAHKVPVSSIKINIGTTFDYYRPVTIEI
LRDSVKIEDKWHYNYDILTQGTLSSLEKKGFSTDNTLAKKLRITIENNNNQPLDIQGVEV
KNAIYFLIARFTEKGNYSLFYGNKKAEKPQYDIENFEENIPKNPSVITVSKEEQNPQFKT
ETKSPLFENKIWLWVLMGIIIIALAFYSLKMLRE
>LONDMIMF_00643 hypothetical protein
MSDNQDRINLLHQKLDFLIKRQDSFQKEISDLKKEIELLQPETFSAPKVERVSYTEEKPI
PEKPRVQQDIRVVPKPIAARPEPKIKKPSNWEKFIGENLINKIGVLVLIIGVGIGAKYAI
DNELISPLTRIILGYLMGLGLLGFALKLKKKFESFSAVLLSGSMAIMYFITFLAYSLYGL
MPQSLAFIVMVIFTIFTVFAALKYDQQVIAIIGLVGAYSVPFLLSDGSGKVLILFSYMTL
INIGILIIAFKKYWRLLNLTSFFATWLIFASWYFSSFYVSLHFNIGLTFLFIFFAIFYTA
FLSYKLIKKEIYEAKDIFSVLSNSFVFYGIGIAILNEHPVATNYLGVFTLLNAIIHFGVS
ILIYKKKLGDKSLFYLILGLVLTFITIAVPIQLNGQWVTLAWAFQATLLFWLGRSKKVPL
YEKLSYVVMVLAFFSLVEDWWNYRNATPVFNADFLNSLLFVVAFGFIFYFQRKFKEEENT
KLKFDVLLMNYFVPGVFLFVLYKAIQMEISNYWELQYLTSKADTSGNGYAERYTLYNEKF
MDYKTVWVLNFTLLYLSAIFFAIEKKIRNTALEITALVISGLTLFLFISTGLFAQASLIH
SYMNPADYASTGFFGVIAHYISLLVLAIFVYRIYIYFINRQEKNRMLFDIFFSILVIWIL
SAEMLIWLNAFNIYENNKLGLSILWGSYSLILISYGIWKSKKHLRILAIVLFGITLLKLF
FYDIVHLNTIRKTIVFVSLGILLLIISFLYNKYKHLILDDDKK
>LONDMIMF_00644 DNA repair protein RadA
MSKIKTTFFCQNCGAQYSKWQGQCNSCKEWNTIAEEIIQKEDKKDWRSAVSPDSKRVSKP
LLIHEIDSAEEIRLDTRDGELNRVLGGGIVPGSLILLGGEPGIGKSTLLLQISLKLPYKT
LYVSGEESQKQIKMRAERINPLNDNCYILTETKTQNIFKQIEAIEPEIVIIDSIQTLHTD
YIESSAGSISQIRETTAELIKFAKESNVPVILIGHITKDGNIAGPKILEHMVDTVLQFEG
DRNHIYRILRSLKNRFGSTAELGIYEMQGTGLREVSNPSEILISHKEEELSGTAIATTLE
GMRPLMIEIQALVSTAVYGTPQRSTTGYNAKRLNMILAVLEKRAGFRLGAKDVFLNVTGG
ISVDDPAIDLAVVASILSSNEDIPVGKDFCFAGEVGLSGEIRPVNRVDQRIQEAEKLGFS
TIFVSKYNKITLKNTFIKIRLVSKIEDVVSELFG
>LONDMIMF_00645 hypothetical protein
MKNFITTAFCIFSFSLFAQKSIEEVKSEKLNGTRQITISLPPAYEKEPDRKFPLVILLDG
EYLFDAFNGTLSYSNYWDDLPPVIMVGISQNKKGERFVDSQFDKESGLPEEGGSRFYEFI
GSELIPALEKKYRIAPFRVIAGHDTTAGFLNFYLYKDQPLFNAYISLSPEFAPEMETRIA
ERLAIFKQPIFYYLATADGDLKKMQKRIKDLDENIKKVGNPNLNYRFDEFKNATHYSLVP
YAIPNALYQIFSAYQPISTTEFQEKIATLPGGYVDYLANKYEIIEKSLGIKMPIRVNDFK
AIEAAILKNKTYAEFEKLSGLAKKSYPKSMLADYELGMMYEHTGDFKKAFKSYQNAYTKN
EIGDLTKDMMLEKADEMKSK
>LONDMIMF_00646 hypothetical protein
MRKKISKTLSILLPILLGVFLTIYTYNSFTPEQLEEMKSYFRNADYTYIFIALIFGFISH
AARAYRWKFMLEHMGYHSPFKNNFMAVWVAYFMNMTIPRSGEVSRALVLKKYEDIPFDKA
FGSIIAERVIDFIILLLFIATAVLLQFDILKTFLLNTIPVEKLLVYGIVAFVVFLSAILL
FIYSKSKWILMIKGKISGLTEGLFSVWKMEKKWPFLFYTAIIWLAYVLTFYTAIFALEET
SGISFGVVVTAFVIGSLAISFSNGGFGVFPVLIAGILALYGVPKEAGTAFGWIIWTSQTV
QIIILGGLSFLLLPILNRKK
>LONDMIMF_00647 Aspartate 1-decarboxylase
MQIQVVKSKIHRVMVTGADLNYIGSITIDEALMEASNIIEGEKVSIVNINNGARLETYAI
KGNRNSGEITLNGPAARMVQKGDIIIIISYGILDFEEAKTFKPTLVFPNEKDNSLT
>LONDMIMF_00648 Pantothenate synthetase
MLIFNRQEDLKKHLRSVTKENTTIGFVPTMGALHQGHLSLIEKSLTENQVTVVSIFVNPT
QFNNPEDLEKYPRTLEKDTQKIETVSKDVIIFAPSVEDIYEGNTTAKAFDFDGLENQMEG
KHRPGHFDGVGTIVKRLFEIVNPTNAYFGEKDFQQLQIVKKMVEKHQMPVNVIGCPIYRE
SNGLAMSSRNERLTSQQKEDSSLIYKTLKTAKEKFGTESAKEITDWVESVFEKNPEFRLE
YFQIADEEQLLPIGKKDNAKKYRAFIAVFINSIRLIDNISLN
>LONDMIMF_00649 Glycogen synthase
MEDKRILYVSSEVVPYLAENEVSIMSYDVPKMINDQGGQIRIFMPRYGNINERRHQLHEV
IRLSGMNLVVNDLDMPLIIKVASIPKERIQVYFIDNDEYFKRKATFTDEEGVLYPDNDER
AIFFAKGVVETVKKLNWVPDIIHVHGWLAGMLPIYMKHYYKDEALFSETKIVTSVYSQGF
EGNLDMEMMKKVAFDGIPNESIEYLAEPNYENVLKASIMHSDAVIIASEDLSSSLTKFIE
SSGKPFLPFATKDKFAEAYTNFYRNQVL
>LONDMIMF_00650 hypothetical protein
MLNNSTYKKLLFLIVGTGFLISCDSEYNSIGADIVDDNDHFGFIKNDGASIVAFNQKTNA
VQSNNLPVNPLGVFNNGIFGKTTANFVTQVELKSENPTFREVPSVDKIKSVVLNVPYFAT
YLETGTDGSNKYELDSIYGNFENKLKLKVYENGYYLRDFDPNGGFVDAQKFYSDQNAVFN
NAKGQQLNDSELVEQNDLFAFSPAEHVTQQEGGKVLREAPSMRLDLNKQFFYNKLIAGSS
NLVNNNVFKNHFRGLYFQVEEINGSAMSMLDFSKGTITMTYEDKKIKIVNGEEVDDGVQE
KTIVLNLKGNTVSLLDYTPTAASQTYDNVVANPVSGDQKLYLKGGNGSVAMIDLFGGGNS
AELEALRAQAISGNWLINEANLVFYVDRPVMLNNFEPNRIYVYNAKDNRPLTDYLFDVTI
NGAKPKYAKRIFGGIAKLTGKAGDNDRRTIQYKVRITEHIKNVLFKDSTNVRLGVAVTED
ISKSTSMSLRTPQTAFTKVPLSSVMNPLGTVLYGTAPVPSNEDKRLKLEIYYTKPN
>LONDMIMF_00651 Glutamine--fructose-6-phosphate aminotransferase [isomerizing]
MCGIVGYIGHRDAYPIIIKGLKRLEYRGYDSAGIMLYDGESMKVAKTKGKVSDLEEKAKE
ISINGNIGIGHTRWATHGVPNDVNSHPHLSNSGDLVIIHNGIIENYEPLKKELINRGYVF
KSDTDTEVLVNLIEDVQKKDNLKLGKAVQIALNQVVGAYAIAVFDVKKPDEIVVARLGSP
LAVGIGEDEYFIASDASPFIEYTSNAIYLEDEEMAIVRKNKSIKVRKIKDDSLVDPYIQE
LQMNLEQIEKGGYEHFMLKEIYEQPSVIKDTYRGRLLANKGIVQMAGVEDNIEKFLNAER
IIIVACGTSWHAGLVAEYIFEEFARIPVEVEYASEFRYRNPIINPKDVVIAISQSGETAD
TLAAIKLAKEKGAFVFGVCNVVGSSISRETHAGAYTHAGPEIGVASTKAFTTQITILTLI
SLRLAKAKGTMSNSDFHRYLQELEAIPEKVAEALATNDIAKTIASIYKDAPNCLYLGRGY
NFPVALEGALKLKEISYIHAEGYPAAEMKHGPIALIDEKMPVIIVAPKQGHYDKVVSNIQ
EIKSRSGKIIAVVTKGDTQVKELADHVIEIPDTAEALTPLLTTIPLQLLSYHIAVMRGCN
VDQPRNLAKSVTVE
>LONDMIMF_00652 TonB-dependent receptor SusC
MRVYLIILSLLFCGVAFAQNSISGVVTDETNQPLPGVSVKVVGESTASITDVEGKFLLKP
TKQPPYMVEISSVGYATQTIEVKTSGQKLEVQLLSQDINLDEIVVSASRTPERILESPVT
IERMGIKDVKNTSSATFYDGLENLKEVHFNTSSLSFKSINTRGFATVANTRFMQLVDGMD
NSSPALNFVLGNLIGLSELDVQSVELLPGASSALYGANAFNGILFMNSKSPFDYEGISVY
ARYGKTNQKLAGTNDYYDFGIRAAHKFSDYFAAKANFTYLKATEWIAGDERSMTNGGLGH
GINQNYDGLNIYGDEVTTFIPNVGQVSRTGYYEEDINDNSIESVKADFSLHVKPMKDDFE
IILQHKVGIGSTIYQGANRYRLEDFIMQQSKLEVKNRNFFVRAYMTTEDAGNSYDMRFAA
WNVNRAWKTDQEWFTNYATAYQLSSAVMGASTTQAAGIARQYADYNQLPAALVGLPQFAT
QPTGGPRYMPGSPEFNNALATVIQNPDLTKGAKFIDQSQLYHVDGNYNFKEIIQFAEIQV
GGSFRSYKLDSQGTIFTDFDGPIRYDEYGIYTQVQKKFMDDRLKFTGSIRYDKSQNFDGQ
YSPRVSFVYSAGERKNHNFRVSFQTGFRNPTTQDQYIGLDLGPFALVGSAPDNLGRFVET
LNVSPAGQALGQPATVNFSGGRAYNSDVYSVPSVQAFALSQNPADLEVVNIKLVKPEQVK
AFEVGYKSVTNDGIAVDLNAYYNIYNDFMSTSRVIVPYYGVVTANPAPNSDVLLALSNGD
RRVYQVYTNTSENVTSFGFGVGLSKKIYKDFEFGINYNHAQFDFDQAKDPSFIAGFNTPR
HRVKASLGNQNLFKNFGFNLNARWSDEYLWQSSFADGMIPAVTVFDAQMNYAVPSMKSVF
KISASNLFGNDYLQVIGAGRIGQQYLVSWIINP
>LONDMIMF_00653 hypothetical protein
MIKNFKWLLLVSLSLSIACSDDDSDSTGEVPVSPGSADFSKYIALGDSFAAGYSDNALFK
KGQENAYTTILAQQFQLVGGGAFAVPYMNDNIGGLLFGGTPNPSFGPRIYLRGFLNASTP
NVQPVAGPPTTEVFSHLTGPFNNLGVPGAKSFHLITPGYGNPGGLATTPPTSNPYFVRFA
STPGTSVIADALAQSPTFFSLWIGGNDVLGYASSGGAGVNQTGNPNPATYGANDITDPAV
FENVYNNLVNALTANGAKGVVANLPYINTLPYFTTVPYNPVPALPPASAAQLNQIFAVIN
QIAGSNAPRFSVLTADDGNPATVEATNPLLIIDETLPNLAPQITAALTPVFGAQTAGFVG
NLYGRARHAKKVVPTPQNPDVVPFVDYVLLPTRALIGTTQAGVPAPFNTVGVTYPLQDGA
VLTNAEVKDVRDATDAYNATIASVAAAKGLALVDTKAIMTQLLNGGIRFGNYHMTASYIT
GGTFSLDGIHPSARGYAYIANEFLKAIGVTYGSSIPAVSPGNYQIQYPESLN
>LONDMIMF_00654 ATP synthase subunit beta
MSKVIGKVAQIIGPVVDVVFNGKDVELPKIYDSLEITKKDGTLLVLEVQSHIGENTVRTI
SMDSTDGLSRGYEVVGTGNPIKMPVGPDVYGRLFNVIGDAIDGLGDLPKDGDNGLSIHRQ
APKFEDLSTSSEVLFTGIKVIDLIEPYAKGGKIGLFGGAGVGKTVLIQELINNIAKGHGG
LSVFAGVGERTREGNDLLREMLESGIIKYGEEFMHSMENGGWDLSKVDKVGMRESKATFV
FGQMNEPPGARARVALSGLSIAEYFRDGAGSDQGKDVLFFVDNIFRFTQAGSEVSALLGR
MPSAVGYQPTLATEMGAMQERITSTNKGSITSVQAVYVPADDLTDPAPATTFAHLDATTV
LSRKIAELGIYPAVDPLDSTSRILTPHILGDEHYNCAQRVKEILQKYKQLQDIIAILGME
ELSEEDKLAVSRARRVQRFLSQPFHVAEQFTGIPGVLVDIKDTIKGFNMIIDGELDHLPE
AAFNLKGTIEDVIEAGQKMLAEA
>LONDMIMF_00655 ATP synthase epsilon chain
MYLEIISPEAKLFSGTVTSVTVPGVDGEFQMLNHHAAIISILTKGDIKIAADSFEFSKEA
EGKFFLGDDKKYHLSIESGTLEMNDNKINILVE
>LONDMIMF_00656 8-amino-7-oxononanoate synthase 2
MLTFAPMKRFPKSLQQKIEQRKQGNSFRVLPEPNNLIDFASNDYLGFSKSEAIFHQTHQY
LSHQGIIQNGATGSRLLSGSHVLYKELEEHIARFHDTEMALVFNSGYDANLGFFSSVPQR
NDFILYDEYSHASIRDGIRLSNARAFKFEHNNLDELEALILKYKSENSAIYIVTESVFSM
DGDSPDLERLTIISEQHGCFLVIDEAHALGVFGESGQGLVQDLGVQDKIFSRIVTFGKGL
GAHGAAILGSKQLKDFLVNFARSFIYTTAIPPHSVAGILIAYKNLETQKAAIEKLRNNIL
HFNQEKQRLGLKPVFVRNKSAIQSAIIPGNDKVKAIAGKLQQHGFDVKAILSPTVPENQE
RLRFCLHSFNSGEEITKVLETLANYLF
>LONDMIMF_00657 AI-2 transport protein TqsA
MPIAKVPSYMKAVYISLLIIIIIFFMIMAKAILVPLLVSGYIAMLMTSFCNRLEGWKIPR
SLSAFIALLLIILLALGLIFFIVSQLQSFTNDVEMNMEESLNNFAIKINTSIENFIGYDI
GMGDGFKIKKVMELIQSGNTNISELLFTTIGTLSNIILLPVFIFFLLIYRDHLAVFVTKV
FDKQRNKVLMEHMVSMRKIVHAYIVGAGKVMIILGIVNTAVLFALGIKHAIFFGMIAGLL
NIIPYVGPFMGALMPFAYALITKDSLFYPFAVIVSFTLIQFMEGSFLTPKITGANVNLNA
FITFLGLLIGGAIWGVVGMILIIPTIAILKKLFELSPDTEPYAYLFGEEDAQWFKRRKPK
TDS
>LONDMIMF_00658 hypothetical protein
MEHKIHQGRNVKRFREMLGIKQEALAFDIGGDWNQKKVSLLEQKEVIDDALLQQIAEVLK
IPVEAIQNFDEEQAINIISSTFNDNAIGVIVNNNNPVDKIIQLHEEKIALYERMLKEKDE
MMARLEKLIDKK
>LONDMIMF_00659 5-methylcytosine-specific restriction enzyme B
MTETLEDKIIKISEEILNILLDYKKQNPDFTFSLRQRDSAQSKDKRLEKGFWFQGSNYIY
VPLFRKGDNARKIKTIGFVIGFEGDNIRNYIEISFKSGSNETEKAFYKELAAFINLKLNK
ENFGKHQFPNNNYIKNLEFYLSDFRNKALELLDNYSLKSQFLISESEFNRTLNKINDIKD
KLSKVPREINGKKYNSNPQNSDMKTPLNQILYGPPGTGKTYKLLNDYYSHFEVHNKTVSK
KEYEFDVVSKLNWWQVFALVLLETPNLAVPDIKKHRFVDYKLQVSNTKSLSQTVWGQLSA
HTIINSNTVKYDRRTEPLIFDKSSNSIWKIVDSEKEQIEDLIEIYNEIKEYKEVKKTSSN
HRFITFHQSFSYEDFIEGIKPVIDKESNNETSDVSYTIEKGVFYECCNEAAKLAGFLGLK
DAIENYTQEQRDQMFKTAPPYGLFIDEINRGNISQIFGELITLIEDNKRLGKSEIIVELP
YSKDKFGVPPNLHIIGTMNTADRSIEALDTALRRRFCFEEMLPKTELLSPSAMYCRLLWD
YENVEWEDSEFVGKENNLFLLLGVSQDFKDKRKDKWEQMREDRVKEKNDYFNEFDYSGIN
LELLLKTINKRIEILLNRDHTIGHSYFMSVNSFADLQNTFKNNIIPLLQEYFYGDYEKIG
MILGAGFFDDAEKYDNKLFAKFPTQNYPEGGSFLRLKTINENFNIIGAIETLLGNN
>LONDMIMF_00660 hypothetical protein
MSRIQVFEHSFLGIGEIGFEQRHYVGLSKLNALHKYRYFDLKHNGVVFKQFVGVIQVDGL
TIEILPKIDRYESEDNNNKTKWQKVLIEMLKVTRKLKIQEVGQADVSKQSIHLLDIYFEW
FLNEVRTLIHQGLIKQYYKKEGNVKALKGKLEFAKHINKNLVHKERFYTSHQVYEKDHLI
HQVLGQALDIIAHLSKGTYLYSKCKTIQLDFPEVKVIKANENAFTKIPKSRKTAPYDTAL
SIARLIILNYAPNISSGSEKMLALLFDMNSLWEEYVLVRLKQACHDTNIKVYGQNSKKFW
NNITIRPDIVLEKNSDNNEKEILIIDTKWKNIDQSQPSTHDLRQMYVYNEFWNSSRSLLL
YPSQNTDVKSESFIFFDDKEHSCSLGKITVINDSGNLDNNIAKEILGLLEVRKYN
>LONDMIMF_00661 hypothetical protein
MSNRLSDNKQVGIVASFSELVNTHFQESTNALCWHRNLDGDFEEIVSKLQLKENITEVST
DELLTLQLSEKGIAAREIILNDLQLLTDFGASPSLNLLKCYERDEEFDFISTDVYSWHVD
RSPVGTDTFLCTYYGAASDIIPNDEVLQKILIPEIREKLKELHDGPEAEFEDFLKENYFD
LHYQAKPIAQPVNLGLGHLWRLAVDHPEQKVLPCVHRAPVEKGECRLLLIC
>LONDMIMF_00662 putative oxidoreductase
MKKAIIIGATSGIGKELAKILSNNGYKVGLTGRRKQLLEAIQTGNPQAFEILQLDITEID
TLSNKLDELVHKLGGMDLLVISSGTGDFNPMLDFDIEKKTIDTNVTGFTFVADWTYQYFE
KQQSGHLVGITSLAGIRGNRIAPSYNASKSYQINYLEGLRQKAGKAKHDITVTDIRPGFV
ATDMAKGDGQFWVATPEKAAKQIYAAIRNKKRTAYITKRWGLIAFLLKILPKRMYEKM
>LONDMIMF_00663 hypothetical protein
MNNCNNIKLKSIMFYYIININVYTLKYLLLKLIILKIPVNLLLKRLNR
>LONDMIMF_00664 hypothetical protein
MKTLTGQNDLDFIRVFLTTGMSGTQKLETNKRHLITFYQL
>LONDMIMF_00665 D-inositol-3-phosphate glycosyltransferase
MRKLHSTYLLAFLLFGYTHSFAKKHLSSNNDVATVLAKKSVLYSLIDNMPDDSSVFYKKD
AHNTTNNSSSYKNPVGKNYLQNTNAATGVTETVSIPEANTVAPENFITVWDMSKPHGPLG
TSSALRFGITTLPNTPVNYSWTASGGNSGNGTIPANSTQALITGLPANQLITLTIAPDFT
AFNQIEPRRLVDISQWGSVAWKTMENAFLGCTYLKVTATDIPDLTGVSSMKGMFYGCSEL
DTIPNIESWNTENITDMSTVFRQAFAFNGNIGSWNTEKVTTMEGLFYDAKAFNQNIGNWN
TEKVTNMRAMFYQAETFNQDISRWNTISVKNMDFMFGYTYVFNQNISSWNTANVINMGYM
FQNAKAFNQNISNWNTTSVTDMREMFFRATKFNQNIGSWQLNTYANMGNMLDESGLDCTN
YSATLYGWANNPNTPPGRRLGALGIQYGNNITASRTLLTNNKGWVIIGDSPSGQNCGRSQ
TITATEMVKNYGDLPFVPTATASSGLEVSYVSADNSIAEPFQDRADGNKWKLKIKKAGQV
RVTAKQAGNEIFVQAPDVFFYLTILKAPLTITADAKSKEFGAADPVLTFTANGLVNGDTQ
AVISGTLRRAFGETIGTYPITQGGLTAANYIISYTGADFTITNATGDFITVWDMTKANHT
IISSVNITTLPSPNNRVRYFWTAPDGSSGSGTVTNSTPSGFQIFIPPNKPTITLHIKPEN
LASVVIFNEPRIIDVAQWGTAEWRSMQNAFLQCSNLNVTATDIPDLSRVTTMRTMFAECT
SLTGPANIGSWDTSNVTNMIQVFSRATRFNQDISNWDTRNVTTMAYMFRGASAFNQNIGN
WNTSNVTDMEAMFQFAQAFNQDIGSWNTANVTNMSNMFSYTMVFNQDIGSWNTANVTNMG
AMFQNTQAFNQDISNWNTANVTNMGAMFAYARAFNQDISNWNTANVTNMSYMFQQNPIFN
QDISNWNTANVTNMSYMFQQNPIFNQDIGNWNTANVTDMSYMFERNGAFNQDISNWNTAN
VTDMSSMFQYAYAFNQDIGDWQLNPVVKMTDMLRQSYLDCASYSATLRGWAANSNTPSGR
NLGALYRQYGTSALAARTSLTTSKGWTITGDSPSGTICGRPFVTVWDMGIPDGNQSTPTS
LRFGITTYQNAPVSYTWTSSGGSSGSGTLTTNTSAQITGLPAGEIITLSIASEIKAINIM
ANSNNNIRRLIDITQWGDVAWSTMENAFSDCVNLNVTATDIPNLSAVRSMRKMFNNCQSM
TGPANIGSWNTTTVNNMESLFTANIVFNQDISSWNTANVTNMGYMFSGARAFNQDLSNWN
TSNVTNMEGMFQESRASNLNISNWNTQNVTNMQGMFAFSPVFNADISNWNTSNVTNMSSM
FGGATAFNQNISSWDTAAVTDMNGMFANAKAFNQPIGNWNTSAVTNMRVMFAGAKNFNQN
IGNWNTSAVTNMSGMFDSATAFNKPIDSWNITAVTDMHGMFNYASSFNQDLSHWDISSVL
RLGYMFVNATAFNQNIGNWQLNPNAVMTNMLDLSGMDCQNYSLTLNGWANNPNIPSGRNF
GASYKKYGTNAETARNFLINTKGWTIRDGGPSGQNCGLDQTITATDMVKIYGDAPFVPTA
TASSGLEVSYVSTDNTIAEAFQDMADGNKWKLKIKKAGTTSIRAQQAGNETYNAATDVIF
RLTIHKAPLTITADALSKEYGTTDPALTYTLTGLVNGDDQTVVTGALTRIAGEAVGTYAI
TQGTLDTENYIITYTAADFTITTAMGDFVTVWDMSKYNDYWDPGNDIMFNSTITPGKSVD
YFWSASGGSTGRGTITEGGEVRISVPANEIITLNLKPSYLKGFSVHFYNYERIIDVSQWG
IAEWNEIRQAFNRCINMNVTATDIPDLSMVRDMSWMFSYCTSLIGTPSINSWNTEKVTNM
RGMFYDAEAFNQNIGNWNTENVTDMGYMFGDAKIFNQNISNWNTEKVTDMSGMFYNAEAF
NQDIGSWNTEKVTNMSFMFKNAKAFIHSGIEDFGIAPIEAQACGTPVIAYGIGGVLETVI
KGVTGLFYFEQNEENLKRTIEEFEKLTFDPVKIRQHALQFSKERFQDEIMEYINNILYEE
SINS
>LONDMIMF_00666 GDP-mannose-dependent monoacylated alpha-(1-6)-phosphatidylinositol monomannoside mannosyltransferase
MKKALIHDWYYVNGGAEKVINVLNQLWDDLDHFSLFDFLDDNDRKQILRGKSVKTTFIQK
LPFVRKKHKIYLQLFPYAIEQIDLNEYELIISSSSSVAKGVLTNSNQLHICYCHSPARYA
WDLYHEYMQDVSLRGIKGLYARYILHKFRNWDVLSSNRVDHFIANSHFIAKRIKKNYNRD
CVVIYPPVNTDYFTIKEEKQEYYFTASRLVSYKKIQLIVEVFNKRPDLKLIVAGDGSEFK
KIKNIANNNIEMLGSIDNELLKKYLQSAKAFVFTAKEDFGILPVEAQACGTPVIAYGYGG
LLETVIENKTGVFFKKQTIDSLHDAIYRFEKMVFIPKIIRQNALRFSRERFENEIKTFVE
KKYVEFLNKKD
>LONDMIMF_00667 UDP-glucose 4-epimerase
MKRILITGAAGFLGSHLCDRFIKEGYFVIAMDNLITGDLKNIEHLFKLETFEFYHHDVTK
FVHIPGKLDYILHFASPASPIDYLKIPIQTLKVGSLGTHNLLGLARVKKSRILIASTSEV
YGDPLVHPQTEEYYGNVNTIGPRGVYDEAKRFQESITMAYHTFHGVETRIVRIFNTYGPR
MRLNDGRVIPAFIGQALRGEDLTIFGDGMQTRSFCYIDDQVEGIYRLLHSDYIYPINIGN
PDEIRIKDFAEEIISLTGTNQKVVYHPLPINDPLQRQPDITKAKELLGWEPKVSRSEGMR
ITYEYFKSLSSEELLKEEHKDFSKYIF
>LONDMIMF_00668 UDP-glucose:undecaprenyl-phosphate glucose-1-phosphate transferase
MLDLIIINILANFLLPETLNLIGYHLFVSVSWLIIAWNIGFYEVYRYTKVIEIFSNILKQ
YFFFLLINFAFIGFYLKFSEPSKMIEFVSFSLILVSLAKFFVYFSLRRFRVVFGGNLRRV
IIIGNAKSAIQLRDFFNENPDYGYKLEKMFTLVPNKKEQVEECFTFAMDNKIDEIYCSLS
DLSNADINKFIDFTDNNLKILKFIPDNKEVLARNLIFDYYDYIPIISLRNIPLDEVANKI
IKRIFDIVFSLIIIIGILSWLIPILAILIRLESKGSVFFKQKRNGLNYKEFYCYKFRSMR
LNEIADLYQVSKNDPRITKVGKFIRKTSIDELPQFFNVLLGDMSVVGPRPHMVSHTEMYA
RRIDKFMVRHFIKPGITGLAQTKGFRGEVENDKDIIYRVKFDIFYLENWSLLLDIKIIFL
TVINAIKGEEKAY
>LONDMIMF_00669 Putative teichuronic acid biosynthesis glycosyltransferase TuaG
MKGHLVSIITPSFNSEKFISDTIQSVQNQTYQNWEMIIVDDGSTDETVSIIQEFLHDNRI
QLHQLDKNSGTGIARNTAISLAKGRYIAFLDSDDLWKPEKLQKQVEFMTSKNQPFTFSYY
ECIDEEGKPLGKIIQAPKILTNRQLFWSNWVGNLTGIYDVNFFGKIAISSARKRQDWMMW
LNILKKIKTAEPVPESLAIYRIRENSISASKTVLLRHNYKVYRDFHHKSIIGSVICMIGF
LFTHFFIKPKYVKKSRPE
>LONDMIMF_00670 Phenylacetate-coenzyme A ligase
MFKLFDFSLKISGFPIDEARLEFDNILEIPEASYESYILGKRKQIVDFHLKNNSFYRQLA
LGKTSEDWNALPVLTKKELQQPLDLRLSQGFTVKNVFVNKTSGSSGDPFIFAKDNYSHAM
TWASNMYRFGWYGIDFNSSYQARFYGIPLDFIGNKKERLKDFLGHRFRFPIFDLSDPVLE
KFLGHFKRKKFDYINGYTSSVVLFAKYLERKNLILKNICPTLKVCIVTSEMLFEKDKKLM
EKQFGVRVVNEYGASELDLIAFENQKGEWQVNAETLFVEILDDDGQPVPHGTQGRVVITS
LYNKAHPFIRYDIGDIGILDEKSTFKKPILKQLTGRTNDVAVLPSGKKAPGLTFYYITKS
IIEDDGNVKEFIIKQTSIDSFEVDYVSEVELTLEQIAKIEDAISLYLEPNLKFTFLRKSS
LARTNRGKLKQFQSLLRS
>LONDMIMF_00671 Phosphoribosylamine--glycine ligase
MTILLLGSGGREHALAWKILQSTKCSKLFVAPGNAGTETIAKNINISPTDFAAIKNFANQ
EKIDMVVVGPEDPLVAGIYDFFKNDESLKHIPVIGPSKVGAQLEGSKEFAKEFLVKNNIP
TAAYGSFTKETLEKGQRFLETLEPPYVLKADGLAAGKGVLIIQDLEEAKTELANMLVGEK
FGQASSKVVIEEFLDGIELSCFVLTDGKNYKILPTAKDYKRIGEGDTGLNTGGMGAVSPV
PFADTVLLEKIESRIVKPTIAGLQKDGIEYKGFIFIGLINVKNEPMVIEYNVRMGDPETE
VVIPRLKSDLIELFLAVANEKLDQATLEIDPRSATTIMVVSGGYPEDYEKGKVISGIESV
SDSIVFHAGTKMADGQIVTNGGRVLAVTSYGDNFKEAIQKSYQNIGKLDFDKMYFRKDIG
FDL
>LONDMIMF_00672 hypothetical protein
MKSFFEGIQYLFVDILFKPLDFFRELELKNWWAANTLNWIFMIICAVAIVYWIKQLKLHK
ANNDEFQDTTAHSFLE
>LONDMIMF_00673 hypothetical protein
MITSIFSKSRPLNYIIISTLLVVCYFLYLQKFPERIDSAEGVLSGIGLLLLLVGSLFIVN
FVTKKNGLSKDNSYTFLFFFSFLILFPTTLINVNLIISNFFILLALRRLISLQSLLTPKE
KIFDASLWIFIAAIFHFWSILFILIVFVSILFHVSRDYRNWILPFISFFAVGIITLMYAL
IFDRSLIETVVDSALIDFNFNYFTNNYQNFALSLYMISAAFFFITQALTLPNKPLNMQSS
YKKIIVAFCLGAVVFLISSNKNNSLLVYTFAPVAIMATNYIESMQINWLKETFIYVVVGC
SLLTFFSQL
>LONDMIMF_00674 Uracil phosphoribosyltransferase
MQIHYLSEANSVLNHFLGQIRNVNVQKDSMRFRRNIERIGEIMSYELSKNLHYKDVEIQT
PLGIKKTTEIQDDLVLCSILRAGLPLHLGFLNYFDSAENGFVSAYRHHYNNDDSFEIKVE
YQAVPSIENKNLLLIDPMLATGQSMVAVFNKLMEKGTPKEVHIAVVIAVPEGISYLQEHL
PDYCHLWVATLDERLNEKNYIVPGLGDAGDLAYGNKL
>LONDMIMF_00675 hypothetical protein
MFSKLAYSVFEQSIKDYHKHDNVDQPINNPYSNDTFEHLLYLKNWIDTVQWHLEDIIRDP
NIDPVAALKLKRRIDASNQERTDMVEYIDSYFLKKYSGVKVKDNAKINSESPAWAFDRLS
ILALKIYHMNEEATREDATQEHRNACQTKLNVLLEQRSDLSTAIDDLLTDIEKGDKFMKV
YKQMKMYNDDELNPVLYQNKK
>LONDMIMF_00676 hypothetical protein
MADKNFISSEPLFFKIVYGLTFLAFLYVLYEMLFLETEQQSQPLKLIVLALFGVFFIRKG
LSGMRQK
>LONDMIMF_00677 ADP-heptose--LPS heptosyltransferase 2
MSKIKHILVFRLSAMGDVAMTVPVLRAFAAQYSDVRLTVVSRPFFKPFFDGIPNLDFFAI
DLKERHKGFLGLVRLYKDLKKLGIDAVADLHNVLRSKIVRTLFALAGKKTAFVDKDRAGK
KALTRAENKVFKPLKPMTERHKEVFRKLGFEINLENPVFPEKANLSQEILNVTGIKNKKW
IGVAPFAQYESKVYPQDMIQEVIDKLSENQEYVVFLFGGGNKETEILKELAKGKENVITV
AGRLKLEEEIKLISNLDLMLSMDSGNSHIAAMLGIKVITLWGATHPYAGFLPFNQELSSA
LTSDREKYPLLPTSVYGNKKVEGYEDAMRSIPVEKVITTINDKLRG
>LONDMIMF_00678 hypothetical protein
MKKVIYLLLLSASFFSCKQNKGREAYSEEAAAETVSSQDASMVSSSAAVVDKNSTRKFIR
TADLRFKVKNVAKSTYAIENTVARFGGFVSSTELRSNIINTSTAKKSNDSLVETTRFVVE
NNMIIRVPNTLLDTTLKTIARQIDYLDYRIIKADDVSLKLLSNDLSQKRNQDNQKRVEDA
IANRGKKLGETLDAEDRLHESQTQSDEAKLSNLSLKDQVNFSTLSLSLYQREEFKKEVIA
NPDSEEYRTSIGVRIMDGLKTGWHILEEIIIFFVNIWTIIVLGIIIWILIRRRKKKANP
>LONDMIMF_00679 S-adenosylmethionine decarboxylase proenzyme
MAIQANPLGLHQLLTLLVEDHKKLVQIEQFIDFTEELLEKYNLEKVGIASHVFDNKSYTV
AFCLMESHICIHTWPENKNLALDIYLCNYSQDNTEKVRQLAKEYISFFGAEVLKQVEIDR
>LONDMIMF_00680 hypothetical protein
MHIACKKCGTTTSIESNFEARYFGCPYCRSLFEIKEELSLVKEFEHKPLNPILDIGRKGI
INGKEYEIVSMFVKKFHAIHYWREYTLKSKDDHYLYLSESEGHWILLEEIPDKFNVSRKY
KRLTYNEVSYDLYENTHCRVESAYGFFDEEIPQTEIQIIEYIKPPYIVSIEKLEKEQKAY
FGRHFSKREIKKAFGNPELPGKFGVGSVQPFLFNFYNVAIIFCCTAILILLTQLFMNNSR
GETEVFSKTFSFTEYNNKDFVSESFILEGASAPLTVLIHSEVDNSWANAQVTLVNENTNE
EESASQDIEYYHGYTDGENWSEGDRSEEFNICGVGQGKYHLVITPQKQPDDTLNDRITVK
AVWKSPSMWNFFISILVMGIVLGIIYFANKSFETTRWSSSDFSPFN
>LONDMIMF_00681 hypothetical protein
MEHILVKGIINSLIFSGVGIFVLIIGYLILEKMTPENTWKEIVNNKNVALAIVFGAFIIG
ISIIISAAIHG
>LONDMIMF_00682 Polyamine aminopropyltransferase
MYSGLSLLESQSLLALQFMAKNFLKFEYLLLFAVFIIATCGLIYELVAGTLASYLLGDSV
KQFSFIIGVYLFSMGVGSYFAKFVKKNQLNTFVEIEILVGVIGGLSSVILFILFEKVDYF
QFILYLLVFVTGCLVGLEIPLLMNILKEKVKFSDLVSNVFTFDYIGALLASVLFPLVLVP
KLGVMKTSLFFGMINVSVAIILCFLLSKDLKHSLLLKLKAISAFIILLLTFFFSDQILSY
SEQKLYGENIIFTKATPYQRIVLTHTKNDYKLYLNNNLQFSSADEYRYHEALVHPVMANA
KNIENVLVLGGGDGLAVREILKYKEVKKITLVDLDEGMTKLFASNTILTKFNDNSLTNPK
VEVVNKDAFLWVKEENNKFDVIIIDFPDPSNYSLGKLYSLNFYKSLKKIVAPEAAIVIQT
TSPYFAPKSFWCINNTVNEVFPNADAYHVYVPSFGEWGYTIASNNNTADFSKVNRKVSGL
KYYDYQYKKLNFFPKDMKAKDLEINRLDNQILVRYFDEEWGKL
>LONDMIMF_00683 hypothetical protein
MKNGENYNPKSRRSFLKSVSAGIILASVPSFLIACKEKAINFAIRLSGTNHILGHRLRTK
NFPKISKTIKIPHLIIGGGIAGLSAGRQLKKKGIEDFLILELETEAGGNSRNRENKYSKY
PLGAHYLPLPNIHDKELVRFLEESKIIVGYKDSFPVFDEEQLTFMPQERLFIKNTWQESL
VPKFGISKTSEEEFNSFFEIMSDFRNKKGEDGRFIFDIPLANISKDGHHDFLDKITMKEW
LIQNKFLSEELYQYVNYCCRDDFGLGIEFVSAWAGIHYFAARKHNATKEKTENVLTWPEG
NARLMNHLKEYSIDKIVTNHLVYEVGIKEENVIINAYDDLKKETVAIVASKVIFATPQFI
NGYLLASRQTVTKEFHYAPWLLATLTVKDLDDNNSYPLCWDNVIYGAKGLGYIFNQHESL
GQIQEKKVITYYYSFSTADLKKSRKELLTKPESYWKELIISDLKIPHPDIENSIEEIDIQ
RIGHGMISPVPGFLFGNSRVEASRAIENKIFFAHSDLSGISIFEEAFHQGINAVNKMLNE
TALDK
>LONDMIMF_00684 hypothetical protein
MKQPWINKPKTDISFILFPQFFVLGIVFFCQDFLKEAEEKHSFFTWLLLIVFIDVAHVYA
TLFKTYFVKEEFAKRKKLLLVLPLFCFLVGFLLFLFGAKTFWSVLAYVAVFHFIRQQYGF
MRLYSRYEIKTKWTVFLDNLFIYTATGYPMIFWFMNPSRKFTWFVEDEFFSYQNPLLLQF
FTWVYFLVLGFYVVRTMYFFIKTKYFNIPKNAIITGTILSWYFGIVYFNNDLVFTLLNVV
SHGIPYMALIYFNQRNNHHSFQIPKLSSFLGILVYIGILLLFAFTEEYLWEVLVWNEHFS
FNESIDSLVKWQILLVPLLTVPQFTHYILDGYIWKSRK
>LONDMIMF_00685 1,2-phenylacetyl-CoA epoxidase, subunit E
MHKIVRYYFLSFSYLKKLRECLFLHKIYRMSTFYKLTIKEVRRETKDAVSVLFNVPSELK
PNYNFIAGQYINLKLTLDGNEIRRAYSICSSPDSGELRIAIKAVSNGAFSQFSNKQLKAG
DTIEVGSPEGKFIFEPDANRIKNYAAFVAGSGITPVMSILKSVLEKEPQSTFVLVYGNKS
PEETIFHEELHNLQLQYTGRFFVYYVFSQAKAENALFGRIEKSAVNFILKNKHASVEFDK
FYLCGPEEMINTVNNVLKENNIKEKDIKFELFSASTKENKISESLEGHTKVTVLVDDEET
TFDMSQKMTLLDAALKQGIDAPYSCQGGICSSCIARIVSGSAEMKKNSILTDREIAEGLT
LTCQAHPTSAEIYIDFDDV
>LONDMIMF_00686 hypothetical protein
MKNSQLYKGSLTTIIMKLLGENGRMYGYEITQKVKEITKGELNITEGALYPALHKLEAEG
LLDVEIEKVDNRLRKYYKLTENGQTETVNRLAELEEFIKNMQSIVNPKLSY
>LONDMIMF_00687 hypothetical protein
MKLDKNQIHIIETVLEKLGVVYVDYKYEILDHIATEVEEKMILHTITFEEAFPEVLKKWQ
SKFKKSSSVLFGYFWEMPEILLNKCIKIYRKKLLLVFTGAMVLTSGFLLFSSFLRNHLAN
FFSIATILYSVAFLLSVIGYVKIRLSKRKTSYGFLYKQQFMASVLVTFQQLYFMNTGFER
NNFSPLFSYFMIFILSLYFLLSVYSFIFYKAHFQELKRMQYS
>LONDMIMF_00688 hypothetical protein
MKLNEQQINQLYLFTRRHFVEWYDLQSELVDHLANSIEDRWKENPKLTFEEALELEFKKF
GIFGFMDVVDERRRFLSKKYSRIIWKHYKEFFRLPKIILTVSSMYFLYFLSEKLQDSQYL
YLSILAVIGVVFTVESRKIHKAQKLKEKETGKKWFFEQTVDAFDVYPITLLPMQLINLSV
TIGEDVWHRGIAIFGAILLVLFALLQYVHWKIVYPKIVQEMGSVYPEYEMSK
>LONDMIMF_00689 hypothetical protein
MLEWKAFFRSASFRTNLALKILMIFGAIYFTLLFLFMGIGAFYLIKEELHLDPLVTVNQF
LIYYFLFDLIMRLFLQKIPVMNIRPLLTLPIKKSTIVNFALGKTVLSFFNFVHCFFFVPF
SIVLIMEGYDIVSVILWHIGLMALVYVNNFLNILLNNKDYLFLIFIGLVLVLGTMQYYDL
FDVTNYTSVFYQGLFDTRYIFLIPVFLLIALYAITFNFFKKNLHLDTGLSSKHSVAKTEQ
YTWLNQFGTIGTFLKNDIRLIKRNKRSKTTIFMSLLFLFYGLLFFASGIESYDNPMMHMF
AGIFVTGGFLFTFGQFVPSWDSAYYPLMMTQNIPYKGYLSSKWWLIVIATAISTVAASFY
LYFGLEVYLVIVVGAIYNIGVNSHLVLLGGAYTKTPVDLGSSKGAFGDKKAFNVKTMLIS
LPKLLLPMIIYALGYYLINPTTGLALVALTGILGFALKNKVFNLIERVYKTEKYKTLEAY
KQKA
>LONDMIMF_00690 ABC transporter ATP-binding protein NatA
MIQAKNLSKTYNGTTVLKIDHLEIQQGESFGLVGNNGAGKTTFFSLLLDLIQPTTGEIVN
NGFRVDQSESWKSLTASFLDESFLIGYLTPEEYFYFIGDLRGQNKADVDALLQKYEEFFN
GEILNSKKYIRDFSKGNQKKVGIIATLIGNPKVIILDEPFANLDPTTQFRLKKIIKELAD
NPEITVLVSSHDLLHTVEVSNRIVALQKGEIVKDIQTSSETLEELERFFAV
>LONDMIMF_00691 hypothetical protein
MKTNILKYVILFCLFAFLVACSTKKNNFVNRNMHALSTEYNILYNGDIALQAGINELKAQ
YKDNFWEILPVERMQPTQETMLPGDKKNPNFERAETKANKAIQKHSMYIEGGEKNPQIDE
AHLLLGKARYYDQRFVPALEAFNYILYKYPNSDKIYEAKIWREKTNMRMENDALAVKNLR
KLLQEIKFKDQIFADANATLAQAYLNIEEKDSAISRLKLAIEYTRENEEKARYHFILGQL
YDSEKKTDSAMAAYQSVIDMRRKAPRRYVIQAHAKQAQHFDFKSGDTLAFVKKYKDLLED
RENRPYLDVVNHQMGLFYDNLEKDNIAKKYYNKSLKANSQDNYQIASNYRNLAEIYFNDA
KYSVAGQYYDSTMVRMDNRTREYKAIKKKRENLVDVIKYEAIAKTNDSILHVVSLSDDGK
KSFFEDVIARLKKEDEEKAKKALVVNNGQPGTAVLMKDSEGNDEEAMKRSAKFGSKSREA
AVLADEMNMAPPGVGSSIASSNFYYYNPSTVAYGKNEFRKTWGNRALKDNWRLSQGKTKI
GFGDDVTDDSVASNEEGDTKKEDKIDVRYTVDYYLKQLPTDQKVIDSLAKERNFAYYQLG
LIYKDKFKRYELATGRLEKLLQNDPEERLILPSMYNLFKIYEVTDKQKAEAMRQRILSQY
PESRYATILQTSASDLTKANDTPDAAYNKLFKLYEAGQYQAVMKESEALIELYAGEDIIP
KIELLKANTTGKLKGLEEYKGALNYVALNYPNSKEGKEAESLLATNIPQMEAIAFDKEIP
ISWKILYKVGPNPDEKNTKVLQDKIKKFVSERTVDKLSMSFDVYTANESFVTIHGIKTEE
NAKDIASILKDYKDYKIPDNPIIISNENYKVVQIKKNLADYLTIKKP
>LONDMIMF_00692 hypothetical protein
MFDKNPKSYTDLLGKTNRIVEGTIIKGDIISQADFRLDGELIGNFQSKGKIVIGPAGKVI
GDIICRNADIEGKFDGKIEVMEILNVKAKAKIYGEVIVGKLSVEPGAEFSASCTMKANVK
NLNPGDGKQRPEEKIA
>LONDMIMF_00693 hypothetical protein
MENNDQKKKSLSKWAALMNIPFQMGIIIFAFTYLGMWLDEKYSNNSSTWTIVLSLLSVFI
ALYNVIRQVKNLNKK
>LONDMIMF_00694 hypothetical protein
MHRLFAFLKYFIPFSVILFIAQYFITEKLFPDMAFFYQVWSIYTFHIVATLLIYLFLLFV
NKNFFDKTGFAFLAGSVIKMMAAVVFLIPLIKADVNDPIIDVTAFFIPYFLFLFFETFFA
IRLINNR
>LONDMIMF_00695 ATP synthase subunit a
MVISNKPLQFILAAFLACIPLASFGSTTVDSIYVKTEAANPVHGSHKELNAHEEKEFNAS
ELINSHIGDSHDFHIADWNGHPISFSLPVILWTNNGLTIFSSKEFHHDNTGHHVVSANGQ
EFVRYNEVIFYADKFEKLTEEEKGAFNFEARPLDFSITKNVFSMIMSAIILFLLFSAVAR
SYKKNKMAPKGLAGFLEPLVTFVRDDIAIPNIGHKKYAKYMPYLLTIFFFIWINNLIGLI
PFFPFSSNLTGNIYFTFVMALITFIVTTLSGNKYYWKHILLPPVPKALYPIMVPIEIIGM
LTKPFALMIRLFANITAGHIIILSLVSLIFIFKTAAMSPVSGAFVLFMSVLELLVAALQA
YVFTLLSALFIGQAVEEHDHH
>LONDMIMF_00696 ATP synthase subunit c
MVLAGIGAGLAAIGAGIGIGKIGGSAMDAIARQPEATSKIQTAMIIAAALIEGVALFAVV
VALIAK
>LONDMIMF_00697 ATP synthase subunit b
MNPTAPESLVFWTTIIFIVFFILLRKFAWKPILGAVKGREESINNALASAEAARKEMQNL
TADNERILHEARMERDALLKEAREMRDKMIADSKHEAQIQGERMIEQAKTAIEAEKNAAM
AELKSQVSSLSLEIAEKLLKDELSNKEAQTKLVEKMLGDVKLN
>LONDMIMF_00698 ATP synthase subunit delta
MSGTRAAIRYAKAILDSALTNGAAQDVYNDMASIASTIEGNEELNTFILNPTIGVGVKEA
ALTEVFANVNGVTKSLFHLLFENKRFEILADVASQYKIQFDEMNGLEVAKVTTAIPMDSA
LEAKVSEKIKEFSDKKITIQNIVDPSIIGGFILRIGDKQYNASIANRLQVLKREFSN
>LONDMIMF_00699 ATP synthase subunit alpha
MAEIKPAEISAILKKQLSGFESGATLEEVGTVLQVGDGIARVYGLSNVQYGELVEFDNGM
EGIVLNLEEDNVGVVLLGPSTGIKEGSTAKRTQRIASLKVGEEMVGRVVNTLGQPIDGKG
PIGGTLYEMPLERKAPGVIFRQPVTEPLQTGVKAIDAMIPVGRGQRELVIGDRQTGKSTV
CIDTILNQKEFYDAGQPVFCIYVAIGQKASTVAGIAKTLEEKGAMAYTIIVAANASDPAP
MQVYAPFAGAAIGEYFRDSGRPALIVYDDLSKQAVAYREVSLLLRRPPGREAYPGDVFYL
HSRLLERACKVINNDDIAKNMNDLPDSLKPIVKGGGSLTALPIIETQAGDVSAYIPTNVI
SITDGQIFLESDLFNSGVRPAINVGISVSRVGGNAQIKSMKKVAGTLKLDQAQFRELEAF
AKFGSDLDAVTLNVIEKGKRNVEILKQGLNDPYTVEDQVAIIYAGSKNLLRNVPVDKVKE
FEKDFLEFMNNKHRDTLDALKAGKLDDKITDVIENVAKEVSAKYN
>LONDMIMF_00700 ATP synthase gamma chain
MANLKEIRNRITSVSSTMQITSAMKMVSAAKLKKAQDAITAMRPYAEKLTELLQNVSASL
DGESGGKYSDQRPVNKVLIVVITSNRGLCGAFNSNVVKETKNLLQNYVGKQVDFVTIGKK
GNDIVRKTNNVIMNNNGVFDNLTFHNVAEIAEELMKLYAEGSYDKIELVYNQFKNAATQV
IITEQFLPIVPVKAESKNQVDYLFEPSKEQIVEELIPRSLKTQLYKAVRDSFASEHGARM
TAMHKATDNATELRNQLKLTYNKARQAAITNEILEIVGGAEALNA
>LONDMIMF_00701 hypothetical protein
MKKITFLLALFGAGAYAQNFPNPYCDITVVEDVEEITSVNFAGASITNSDATTILLNHTS
TVANVTPGQSYTIQVQGNSHGDYDNEYIAYVDWNQNGLLTDTGEYYYIGKLTGTTGNDDA
IASTSIQVPSTATVGNTRIRVIKVWTDELEGIVLYPTPCAIAFDFPDFELVLDSYGQALD
FTVNVAALGTNSFDLNSLAVYPNPAKDVLNIKYKSDIQDIKIYNLLGQEVLSQKARQSDF
QLNTGKLSAGTYVVKLFAEGGQHNFKLVKE
>LONDMIMF_00702 Prolyl endopeptidase
MLFSKHQFSYQDDYSWMEKTDSKETKTWVNLENELTDSHLEAIKKNYSSLSKIKEYDFLS
TYSIPSKKGKYFFASYRIDKDKPAYLFYKKNLNDDPIELINPSKIFNNNNVSINGYYPSK
SSKLLAFSVSNDGSDMREVRFVNLDNRKNLDDKLTNVRYSNLAWNKDEGVFYKRNRNTDR
FAVDTTYQLYYHKIGALQENDKLVYDTSDTKSYFTFFTAEDKLFVIEQNEDETQVKYFYA
TLSDESLTFTRIFENTDDSFDFLNYVNGRVYFSTSKFGWGEVRSFDLNGNDEKVIVPQIY
ANLLVGTFFYKDYIITKYKTVGSNYMSIYDYEGKFIRKFEAPMGMDFRINYLEAETKNLY
VTFFSYTISNHNYKLNIETGKHNPYFNDFNQPKPSLFPFDYFETKAITYKSRDNKDVPIT
IIYKKGTKLDGKNPTLLEAYGGFGAVSGPHYDTGLLYFLEKGGVYAYAEIRGGGEKGIKW
HTEGKGLKKINTFNDFIDAAEYLIKENYTNPSKLAITGGSQGGLLVGVAMTKRPDLFKVA
IPKVGAFDMAKFDLYTVGKRHLDEYGNPNIEAEFNSLLSYSPYHNIKEDVNYPTTLIITS
ENDDRVPPLHSYKFAARLQNRSAQKNPIYLKTLSNSGHSGKSTYQGQIEEEASFYNFLLY
HLNN
>LONDMIMF_00703 hypothetical protein
MTKPILSLYKNLFKQTAIYGLATVVPRMFSFFLVPLYTELLPKAEYGQVNIIFAYLIFFN
VILAYGMETAFFRFYNTEDDKKTVVETSTVSIFWTSILFLVLALLFRTSVAEFIDIEVQY
VTYVIWILVLDALVIIPFSKLRARQKPMFYAAVKIGNVAVNLGLNLFFLIYLPKIAQQNP
ESFISSLYFEDFQVGYIFVSNIVASLLTLLVFLPNYMHVRWHFDFQLWKKMLRYGFPIMI
AGIAFAINDQFDKILLKYLLRPDIAEAEVGIYSACYKLGLFMVLFRTAYTLGIEPFFFSH
ASNENAKQTYATITKYFVIFGSLMTLAVIVFADVLKLVMIRDSSFWDAMGVVPLIILANF
FLGIYTNLSVWYKLTNQTHIGAYISIIGAIITLVLNYLLIPPFSYYGSAIATIAAYGSMM
FISYVWGNKFYPIPYDKKAIGGYLIISILFSFIYFYGYRENYWVGIPMLIAFMYFIYYNE
KETILRIIKRKA
>LONDMIMF_00704 Deoxyuridine 5'-triphosphate nucleotidohydrolase
MTIKIINKSQHPLPNYETLASAGMDLRANLSEPVTLGPLERAIVKTGLFIELPVGYEAQV
RPRSGLAAKKGITVLNSPGTVDADYRGEIGVILVNLSNEAFVIENGERIAQLIIAKHERA
VWMEAEELSETSRGEGGFGSTGVK
>LONDMIMF_00705 UTP--glucose-1-phosphate uridylyltransferase
MKIIVPMAGRGSRLRPHTLTVPKPLIPIAGKPIVHRLVEDIAGVINQDIEEIAFIIHRDF
GKQVEVELVEIAEKLGAKGTIYYQEQPLGTAHAIMSAKESMTGPIVVAYADTLFRADFTL
DTEADSVIWVKQVDDPSAFGVVQLNGQNQIVDFVEKPKEFVSDLAIIGIYYFKSGETLRN
ELQYLLDNNVVKGGEYQLTDGLENMKEKGLKFVPGKVDEWMDCGNKNVTVETNTRMLGFL
HNDGEHLVDYDVKTENSTIIPPCYIGKDVILINATVGPNVSLGKGCHVINSTIKNSLIQT
HSHIKNASLDNAMIGNHASFDGNFTSISIGDYSVLE
>LONDMIMF_00706 Beta-barrel assembly-enhancing protease
MKIKSYLLPLLFFGMLCVPAKTFAQAEPDDIALAEDGFQDSFYESLKQKGIENYDKAITA
LEKCLKLQPQNAVVYYELGKNYLSLKDYKKAYESFSQASLIDPKNKWFYVGMYDVCYQTK
DYTQAIVVVNKLIGLDIKYKEDLTSLYMYTDQYDKALALIKDLDDTVGETPQRNAYKQQI
LKDSKYRIGEKDQLLEAIKKNPKDESKYIALIYLYSESNQEEKAYEIAKKLEKEIPDSEF
AQVGLFKFHLNNNDGDKAVTAMNKVLESKKIDTEVKRKILKEFLVFVKNNPQFNTDLDKA
VGYFSSEDQALLTKEVGKVFYARKNWERAIHYLEIYSKNNPQEVESNIFLLQAYTENKQF
DVLAKKASDLIDFFPMQPDFYYYSGLANNQIKNYKKAKDFLEMGMDYLVDNRDLEINFNI
QLGEAFNGLGDAKKKEFYFQKADQLLKQKK
>LONDMIMF_00707 hypothetical protein
MKRYIFITFGALMLLSCNAKKAVIAEGTANEMVASSKVIENHYKLKRNFSTAYIKASAKY
KDDHMSQGVSAEIRIKKDEQILISVRFLGFTMAKALITPQEVKYYEKIGNKFFEGDYSTL
SKWLGTELDFQKVQNMLIGEAMDDLTKGKYTTIIDESLYKLQDASNKNTEKAFYFEAANY
LIKKQEVTQSKEDRRLQILYPGHKEYPEMVLPSQIIIDAVQNGKKVNINIDYNSVSFNEN
LTFPYSVPDGYERIYID
>LONDMIMF_00708 Murein hydrolase activator EnvC
MSKNIFTLFLLLATSIVWGQTDMQRKLEERKAQLQKEIREAENALQSEKKKEKSVVTQIS
QQTAKIKLQEKLIATTEKQAKLLSDDIYTNQLKINGLKKDLDELKKDYAKMIVKSYKSRS
EQSRAMFLLSSKNFLQAYKRAQYMKQYSNYRKNQGEEIKVKSDELAAYNEKLGIQKKEKQ
KLIVENEKEKQNLEKDKEEQEKIMKSIKKDVKKYTAEIKKKQQETREIDRKIDKLIREAI
AEANRKTAAANKKANPKATVAETKAIENSSKIVLTPEGKIISDNFKANKGKLSWPVAKGF
VSLRYGDQPHPLQKSLIVHSSGVEITTDSGASVRSVFAGEVTRVQLISPNNMVVFVQHGD
FYTVYQNLSSVSVSKGTKVTAMQNIGKVTTNAAGKTALKFVIMQNATTLNPQAWLANM
>LONDMIMF_00709 putative acyl-CoA thioester hydrolase
MQAKTPSESVAILTDLVLPGETNPLNNLFGGELLARMDRAASIAARRHSRRITVTASVNH
VAFNRAIPLGSVVTIEAKVSRTFKTSMEIYIDVWIEDRESGIKNKANEAIYTFVAVDETG
RPVEVPAILPETELEKQRYDAALRRKQLSLVLAGKMKPNEATELKALFIE
>LONDMIMF_00710 hypothetical protein
MKIEFYISQLLYRYQCVAVPGFGAFLTEIQPARLNESTMAFYPPRKVVSFNFHLKNNDGL
LANHISHAEKISYEDAVAQIETTVSGWKLALQLHKLLELKNIGQLSLNSENNIVFEPSDS
LNYLTSSFGLSTFVAPKIQREVYKEEVEALEEKAPIIFTPERRNSRPYLKYAAIFVLGLG
AAGFFGNDYYQKQIDSENLIVQKTVQKKVQDKIQEATFFIESPLPAVKLNIKEEKLAYHI
VAGAFRNEENAQKIFEKLSAKGYKARKIAKNKHGLHPVLYGSFSNYAEAQKAMSKIQKTE
NPEAWLLIQEL
>LONDMIMF_00711 DNA processing protein DprA
MNHEELFYLLALQKVESVGDILAKKLLAHFGNAKEIFQSKPSKLQSIEGIGSILIRNLKD
QTVFKKAEKELAFITSNAIDVFFYQSKNYPEKLKHCFDAPILLFASGNFDFNNRKIISIV
GTRQATPYGGECCRKLISDLAPLNPVIVSGFAYGIDIIAHQAAMEHNLQTIGIIAHGLNQ
IYPKAHKKYVSRMKENGGFMTDFWSSSNPDRENFIRRNRIVAGISEATIVMESAEKGGSL
ITANMANDYNRDVFAFPGKASDKYSQGCNNLIKSQKAQLLTSAADLIYMLNWDLETQKTS
VQKRLFVELDKEEQTVYNYLQAKDKELMDVIALECNLPVHKISSLLLNMELKGVVRPLPG
KLFEVI
>LONDMIMF_00712 Tryptophan--tRNA ligase
MSKILTGIQSTGTPHLGNLLGALLPAIELSNKPENETFLFIADLHSITQIKNGETLRHNT
YSTAATWLACGVDVNRVTFYRQSDVPQTTELAWYLSCFFPYQRLTLAHSFKDKADRLDDV
NAGLFTYPMLMAADILLYDAEFVPVGKDQLQHIEITRDVASRFNHQMGETFVIPDSYLQE
ETKYVPGTNGGKMSKSANNIINIFLDDKSLRKQVMSIETDSTPLEAPKDTENCKIFAIYK
LIANEEQLAAMTEKYKNVNRDFGWGHAKQALFELILERFKVEREKYNYYMNNLEEVDKAL
QQGAEKARAVADKVLERVRKKLGY
>LONDMIMF_00713 1-acyl-sn-glycerol-3-phosphate acyltransferase
MGLPIIIMLPFLLISISKEKWYPYFFVMARIWAKIILFGMGFHYKVEREQELEEGKSYML
VANHTSMTDIMLMLALVRNPFVFVGKKELVKIPLFGFFYKRTCILVDRSSSKSRMEVFNR
AQKRLAQGLSICIFPEGGVPDDESVLLDEFKDGAFRLALEHQIPIVPMTFADNKKRFSYT
FLSGSPGLMRAKIHRFVETKGHNADKKEIKQIKELVREIIYKQLLKFSNKKSA
>LONDMIMF_00714 hypothetical protein
MSEKKNIERLFQEKFKDFEAIPSPEVWDNIEAKLKEKKKRRVIPLWFKLSGVAAILLIGF
MIGDGIINSPIKTDTDNGVVDQNATDVDRSKDLTPMQSPIKSKEVITENENAVTETKNTD
LEKNNTTQQHKNSENPEQDQLNKSIISGKNKAKNTAIASQDNTDRERIKNTADKNLPVIT
NQKTKTESGLASQGPAQQHNRQENANQNKFNGKNQKDVFNKAGIADSGNKEKNQAKSIVN
QNSNKISIPENRNEGEKQLAVSDKKSNNLLQKNDKVSERNKQSDKEKNNNSRIAFDTKAF
EKQKKDSAAVATAEPNPLEELLQEKEKKQQAVTETKVNRWQITSNVAPIYFSSASKGSPI
NQQFADNSKSYEKNLSYGVGVNYAINKKWSIRGGVNKLTLGYNTNNIVYYAGLSDAVANG
EVFSPSNIQEQTAVRIFVKDNTPANTVSFDNVPGKKAGSLNQTMGYVEVPVELSYKILDD
KFGISLIGGMSTLFLNENSLSVVSPGMSTSIGKASNLNDVSFTSNIGIGFKYKFWKSFEA
NVEPKLKYQINTFSENAGGFKPYFIGLYSGISFNF
>LONDMIMF_00715 ECF RNA polymerase sigma-E factor
MVNNILQKYRGNSVFEIVNDTIPDEAEVEIDDENVSLEFLMKIIQELPDRYRLVFNLYVM
DGYSHKEIAEMLDITTGTTKSNLARAKMILKEKIEAQAGNGNYTAAK
>LONDMIMF_00716 hypothetical protein
MPYASVIIRKSENSSSIHQYTKTNKEGFYQIDLKESLDSIWVEVNALAFESQIKHLSSIQ
KNKQIIILNFNLENKPTELEEVVITKEMPIRIKNDTTTYNPESFKDGTERVVEDLLKKLP
GIKVEENGEIKFKGKSIKKFLLDGDDLFNSQYTTGSKNLSVDMVEKVQAIENFNENAMLK
GLVNAEDVAINILLKKGKTDLSGDAFFSYGIQDRYNVSMTGLFVNKKTKGFLTTAYNNIG
NNYSPYDFSSEITSLSQKSEKEEQTKTLIGQGGFYSQLENKYHRINSNFNLELNLLHKFS
SKITAKTNLGIYDDRLTRTNKSHTEYSINEEQFVINEIEDIIKKPRLYNANIQLSNKVND
CFIWEYIGKANYQEIDFDSNSLNNEVAQKNEVKTTNFFTKQDFNFTNRINENSAVTGVVL
YSNNRAPQDFLLTPGLNIEEGNTNAVISNNQYSRFDKETFKTKGEYYRNFNKAKLKLMAG
YLSVNNTLNSSLKANYSDGTVYTDRLYQNRMRYKYQLPNVALSLSYIKKQKYGFAILFNN
QYYDIALNDEIRNLNRKEEKFVFSPIMKFQYVLNTKSNLVATYSYNEIVPSEEHLFEGFV
LTGFRSFRNNSPNISFLNTHTYNLNYIYNDTFKVTRFSVSANHNNRSNNYFSRNTINLDN
TFTNSFLLEAGNRDYSLNLDFERYMHFMRTTLQINGSYALSFDKNIVNDSNLRDVESRLL
FINCVLRASFKSKFYIENNFSYSTIDFLLDNVIQNRFSSFNDTFKMTYKIRPDLKANLAT
NFVFPDLSKNNNYLFLDSELRYTPLNKRFQYALIMRNLTNNKKFETVSISDYSKTIASHN
LLERYILGSASFRF
>LONDMIMF_00717 hypothetical protein
MEITSRRHPYKFYFALLIINLAFLCFSIFFFISNEVNAHALGFIFIGMAAVLNYIFLKKS
PKIIVNDKGIQVGKKQYYWNDRLEIEITGKGMGYIHSDYEATKILFKNQDVVCIYDVYYA
NSPEIKSFINQVVIKKSEAFKFEKIRLEKKNLTFENLKTFKGHPIFSFRGIMMWGLILFV
IFVPSKNPKSLEFVPILVVSAFCLFWLLLNSWMAHYFQISNKYFIVKNHYFFWIKKVYLL
KDIREIVYDQQVRQPNALRIITKDFDNSRFLAGILRDKHWLEMMTVLRNKKIKVRNESI
>LONDMIMF_00718 hypothetical protein
MDHIVPYILPLFSVLIGYAIALFLKPKKKTNLKLLMAFSGSFLLSITVMHLLPEVYEASL
HAHHDHDHGHEHSNAIGIFIMLGILFQIILEFFSKGAEHGHVHGHEEMHKMPWLLFISLC
IHALLEGFPVSHHHDLALGIAIHHLPIAIILTSFFVNAHLNKTAILLFMVAFAIMTPLGT
VLSEYLPFLTAYYTEITAVVIGILFHISSTIIFESSEGHKFNLAKLSMIAIGIVAAYFI
>LONDMIMF_00719 putative S-adenosyl-L-methionine-dependent methyltransferase TehB
MQKEKNTWFASWFDTPYYHILYKDRDYEEAQVFMDNITNYLNLPEDAKILDLACGKGRHS
IYLNQLGYDVTGADLSENSIAEASKFSNSKLHFTVHDMRMPFDEKFDAIFNLFTSFGYFE
NDEDNLTTLKAIKESLSEYGFAVIDFMNVHHVISNLVPEETKIVEGIEFKIKRYVKDNHI
FKEIDFEDKAEKFHFVEKVQALTLQDFEEMMEEAGIFLLDTFGDYKLKKFYKNESERLIM
VFK
>LONDMIMF_00720 Ribosomal RNA large subunit methyltransferase L
MENFKMIAKTFFGFEEILAKELQVLGAQKVEQGVRMVSFVGDKGFMYKANLALRTALKIL
KPIYQFRATNEQSLYKGISAIDWSQHLNSNRTFVIDTTVHSDYFKHSQFVSQKSKDAIVD
QFRSKTGARPSIDKDYPDLRINIHIDRDQVSVALDTSGSSLHQRGYRIATNIAPINEVLA
AGMLLLSGWDGQGHFLDPMCGSGTILAEAAMIACNIPANLNRREFAFEKWNDWDNDLFDQ
IVDSLLKKVREFHYTIQGYDKAPSAVLKAKDNIRNANLDEYVSIAEKNFFDTEKTTQGPL
HMVFNPPYGERLDIEMERFYKNIGDTLKQNYPNTNAWFITANIEALKFVGLRPSRKIKLY
NGSLEARLVKYEMYEGSKRAKFAQPD
>LONDMIMF_00721 hypothetical protein
MMEKFVSIQPKNEIIRKYIAYYYFHSCTDAKFEKSFVFYPNYKNALTVYKNAEIVLSEEG
TAVSDSATKQLCVLYTTNLDKSIRVRFKGAFDKIGVVFTPLGLNHFVDKPLFQVLSERIG
YFDYFGFPFEKCVTAVFEENDESEKAKLLDAYFENRLVDFNVPVLEKAVSEIIKSGGLVK
VAALSEKLKTNRKTLLRLFQKHLLCSVEEYKKMVRFRQAINFSQEQNGANTLTEVALFSQ
YYDQADFIRQFKSITKESPKKVIPSISKLGNEETYWKLE
>LONDMIMF_00722 hypothetical protein
MVSRAVFVVCLFYLQFSFSQEKQEYLSVNKFDLNKLSEFPQSEMKIIGFGAYHGSAKTEE
AELLLLQAVLKNNDIRFYFPETDYSIAYYFNEYLQNGDEKLLKDLVQTYGTRVPQERSVE
AFMKWKKLKAINDNLPPNKKIKVLGADPIVTYKYTCRHLLLLADAEPNQWKKLSELKGMV
EKDTANYSPYKESYSKKMLREFVADYEADTQNYRRFIKNQKQFDYLIATIKTSFGEYSRE
ESIYNNYTALSKIYNYDEGLKFFRYGFAHLMKIREEEDFASFFTQLIENGVYKKEEIVSV
LGYLTKSRVFWDDVFDKQGNYKKSTTKGGFGIGDYSKEYFKGIDGLKKQQVSDLSLFRLN
QPHSPYRQKGCSDLIEVVTKPKPKHIIDYSKKSTADFIDYAVLLSHSKANTSLYKLSEE
>LONDMIMF_00723 hypothetical protein
MTLKTKAFLYQLLSFAVLFILFRFLVAAYTNLHGFWIPLTAFMIATLLSPQFQAVKTNDG
EKLFMKWIFMKGIRQIK
>LONDMIMF_00724 hypothetical protein
MKYTLKSIFNLALVLISLSAFAQDKKKDTVAPRTERYGLRLGTDLYKIARSIYDNDYKGF
EITGDYRLTEKIYIAGEVGNENKTTDEPQLNFTTKGTYFKAGFDYNIYKNWLDMENMITL
GMRYGVSSFTQELNSYSIYNPHPYFDESGVITVSRKYSGLSAHWVEFVAGVKAEVFDNFF
MGFTLRLNRLVSNKKPSDFDNLYIPGYNRTYDGDFGVGFNYTVSYFIPIYKKKNLPKAET
EGKKKE
>LONDMIMF_00725 hypothetical protein
MNKILNIITALFIAICFFGCEKDDICSGGTPTTPRLMIEFREKDNPSILKPVTNLTAVAT
GMTTGVVFNEGLSSTDPNRYLTSANKIGLPLKITGETTEYTLTQNSTSTNPAIRNEDKIV
FNYTTKEIYVSRACGYKTNFDLTGSPVQEPNTVDSNRWISNIVVETPNIVTENEIHIKIY
F
>LONDMIMF_00726 23S rRNA (uracil-C(5))-methyltransferase RlmCD
MGRKKTDKIVFENIKVLDAGAKGVSVAKAPDGKVIFIPNVVPGDVVDIQTFKKRKAYYEG
KAVAFHEFSEDRVEPVCQHFGACGGCKWQNMAYEKQLFYKNNEVFNHLKRIGKIELPEFE
PILGSEKQFFYRNKMEFSFSNARWLTEKEIESDEDLGNRNALGFHIPKMWDKILDITQCH
LQEDPSNAIRNSIRDYANEHGLAFFNPRNHEGFLRTLMIRTASTGEIMVLIQFFEENKEQ
REALLNFLLEKFPNIKSLQYVINSKPNDTIYDQNVILYKGRDYILEEMEGLKFSINAKSF
YQTNSDQAYELYKITRDFAGLTGNELVYDLYTGTGTIAQFVSKKAGKVIGVEAVPEAIAD
AKENAKRNEITNCEFFVGDMKVVFNEAFIAQHGKPDVIITDPPRDGMHKDVIEQILKIAP
KRIVYVSCNSATQARDLALMDEFYKVTKVRPVDMFPQTHHVENVVLLEKR
>LONDMIMF_00727 hypothetical protein
MKSYVALLRGINVSGQKLIKMETLRKVMEDFGFQNIKTYIQSGNILFDTTENITPETLEK
QIHDLIEAHFGFDVSVVVTDREMLQWISVNNPYLKEKEIDLKKLYITFLGSEPSKENIQV
LLNANFEPDEIILKGRIIFMKYNNPAGNSKLNNKLIENKLKVTATARNWNTTLKLLALFE
ERAVS
>LONDMIMF_00728 Peroxiredoxin OsmC
MKRNATAVWEGSLKEGNGKISTQSTVLSNVQYSFKTRFEHGNGTNPEELIAAAHAGCFTM
QLTAYLNEAGFRVASIETKCDVDFQDGSVVGSHLSVIGRVDAISTDQFQELVKKAETTCP
ISRLLNTKITSNATLVLP
>LONDMIMF_00729 Ornithine aminotransferase
MSVLEKNNASEAISLEDKFGAHNYHPLPVVLSRGEGVYVWDTEGKRYYDFLSAYSAVNQG
HCHPKIITALVNQAQTLTLTSRAFYNDKLGKYEEFVTRYFGFDKVLPMNTGAEAVETAIK
ICRKWAYEKNGIPENEAKIIVCDGNFHGRTTTIISFSNDENARKNFGPYTGGFININYDD
IEALENVLATQKNIAGFLVEPIQGEAGVYVPSEGYLAKAKTLCEKHNVLFIADEVQTGIA
RTGKLLAVHHENVQPDILILGKALSGGAYPVSAVLANDEIMNVIKPGQHGSTFGGNPIAA
AVAIAALEVVKDEKLAENADYLGTIFREKLGQYIKTSNIATLVRGKGLLNAIVINDTEES
DTAWNICLSLRDNGLLAKPTHGNIIRFAPPLVMNEEQLLDCVSIIIKTLKEFEK
>LONDMIMF_00730 hypothetical protein
MEKQKLPNALAVLILGILSILTCCCYGIIGLILAVVALILAAKDKKLYVENPELYSNYSN
LTTGKILAIIGIVLNVLMILLYVWLYAKLGLEGMQDQQQVEALMRDVMGG
>LONDMIMF_00731 hypothetical protein
MEEYMIPCMNKKIFGVDCLGCGTQRALALIFKGEFVGAFHMFPAIYTTILFFMVLGLNFI
DKARNYHKAIISLAIINAVIMVISYIYKITN
>LONDMIMF_00732 hypothetical protein
MALAGVFALYEQSKEKPNLYIMIFAIVIFMYGMMRLMAKVPSKNQNNSEDDVS
>LONDMIMF_00733 Endonuclease MutS2
MMLVKGDRVTVIDEAVNGVVLSVKNNEITIETDDGFQLTYFVNELIKIQKSSDLNFGIGS
HNLSQVLKEKEIPKPRSFVKEKKTRDERGVPEFDLHIEKLVPNKRGMSNYDILTLQTETA
KRHVEFAIKNRIPKIVFIHGVGEGVLKAELDFLLGRYDEIIFQDADYQKYGLGATEVYIK
QNPNR
>LONDMIMF_00734 hypothetical protein
MLLLQIIKKTIFALNSIEMKKYLGIMSCLFLLSACDDGDLTFDSFDFSNVTAADCENNNP
EVLNSVFKLNNNEALVIKFPTNVFPFRNIEGTSTLSISAQNKIIYRVFNGQVTPTYFCSV
IPPVTPVVIDEWSTADQSSGSIEIKTTPVNNTTEILDAKYDHTSIFKGITLSNSTGGTVT
YTEYIFGKYQTKSNIKFSFSSVPIQKCSESKLIKIFDSNVGNVENRQNLNEVIILDLPPS
VFQQAAGSETYYVDDSHQITYRLYGGDVIATALCSETGLPPLYEEWQAEDGVSNGANSTG
VIKIDTAVNGTTRTHTITLTKVQYRKTGPTNNTFVQEIQTFGDYITTN
>LONDMIMF_00735 hypothetical protein
MKLRFFQFLFFYSFSLCVQAQELLPFVENFTKSDYNGDNQVWNVTQGGDNAMYFANNHYF
LRYNGVIWEKYALPNKTVIRSIFIDDDKIYSGSYKEFGYWKRMNGKMEYFSLTRGKNIFQ
GGSDNEEIWKIFKYKDRLYFQTFNEVFIYDGKAIKKIEFPSQISYCYLIDNEIYVATVRE
GIYMMEGEKFIKRKNWKILEENVIHHIEKYQGKVYIFTKNNGVFVVIDGNLVPWSHPLNE
VIKKEVLVTAKFVDDNTLVIGSGLQGLYIINLKNGSYQNLNRQNALKNNAILSIGVDKEK
DLWLGLDNGICHVEINSPVQVFSDSSGILGSVYSLSTIDNGYLFVTNHGIFTSKNKILEV
LPNSQGQVWDIYKRGNEFIIGHNDGTFLYDGRTARLQKVSPINGGWKFLKGEFENVYFQG
NYAGIVVYEDINDLSKYKLLAGLKKPIKNLAQNKRGELWAADNYRSLYRILYDKNFNVKK
IENVSLQNGIKNDYGVKLFSYKNEILFLIDNNWYVYNSISGKLEKDKIFNASFKNTSDII
PINDENFIVLKNGLLYVVSQVKDRFIWELIPEKYYEGRIIMENIKVYQDGDHYLMNLDDG
FIAFKINNKKLKIRGVYAEAFYQDKLIDKDTRVKYNQSVEVNVITEYFGYNRPDLFYKLN
DSNDFVPIKKGKLILNNLSSGLQELEFYYNDGTKYTKVATYTFTVSKPWYFSFWMILFYI
LVISGSFFLYYRWNKIRYIEKIKLKEEELKHQKEILELELNAENKLKLQEYEKHILEIEV
QNKAYEVAGKSLSIAKQSEMIDSIQEILETEKDINQIKSKIRKSIKINALNKNEWESFEH
NLMQSHEEFVHKLSNKFPMLTSKDIKLCIYLKMNLSSKEIAPLMNISFRGVELHRYRLRK
KLGLTSDDNLSKFMINI
>LONDMIMF_00736 TonB-dependent receptor SusC
MKNFIFGVFVLLFFHGHLYAQDIKGKVLDENGLPLPGVNILSSTSSSVSDFDGNFSINAK
VDEPITFTFLGYVTLTINAAENMSVTMKMSSTDLTEVVVVGYGTQKRTDLTSAISTIKSD
QITKQPAFNALQSLQGKAAGVNIIANDAPGATPTIIIRGLGTAESGRSPMFVVDGVITGS
IANLNPNDIESFDVMKDAASAAIYGSNAANGVVFITTKKGKLGKTSIKINSFYGAKSILN
PVEMANSSQFVTYFNESRAAIGNPDRLALNQPYNTDWYDALAGTSFSQGNDVSFSGGSEN
VTYYFSFNNYKEDGLLEGHEVARNVLRSNNTFKAFDGKLKITQNASVAFTKSTPKPYSSF
TEAYKQAPIIPVYYPDGRYGMSYWNKTTGLPDYIIGAGQQGGRLNSIGNPVANVNFQNEK
NKMMELQGLLQADYTVTDWLTATTRFGATKSYSKTRIYNDIRGRYLAADPLRTLTDFQNA
QNGAPTSTEFANNSLSYKDVESFRYNWDTYLTVNKSFGKHNFNATVGVAKERRNDVYESF
IEGYGVPEQENYWNLDMASLNYNKVVKQFYQTPTNVLSYFGRLQYNFDEKYYISGTVRRD
GNSIFKKNADYWGTFPSVSVGWVLTNESFLSEVNNLDFLKLRAGYGEVGNANISRFNTTS
IITNPVSANTNYVFGPNQDLVFGGAVGSPAADLSWELTKEINIGADFELLDRRLSGSFDY
YNRLNTNAILNVKPIPNSPASENYFDHGGEVRNKGYEVALNWRDNITEDFSYSIGINYAH
NKNTLENVKPAYDGLTGGSLGDGQITKRLQEGQPLYSWWLLEADGVWQTQAEIDANPHIG
TPQPGQLRYKDQNGDGVIDDRDKKFYGSYIPKFSYGINVNLAYKNFDLSVDGFGAGGNKV
YNGLKGTRVDAGENIAAETFNNRWTGPGTSNTNPGANRDALSSSYYLEDGDYFRINNITL
GYTFKDMFNISRLRIYGTAQNPFLFTKYSGFTPELNNTGIPNETAGIELAAYPNIKTFIF
GVNLEF
>LONDMIMF_00737 SusD-like protein
MKINYKTIVCLSFALCVLVGCDDFLDVDARDKITEEDSGENLEPIAFVNGIYGMMTEWDY
AFSYLGITEIISDNADKGSSPGDPGGDKGLLDGLTFTSTAGSVEAMWTNWYKTIGRATYS
IGYTESYGLTDEAYKNRLIGEAKFLRAYHYFFLVRAFGDVPLQHIDLTVRVPKEQVYDFI
EQDLLDAIQVLPEKSQYASADLGRATKGAAQALLAKVYLYQKDWQNAYDYADDVITSGQY
GLEPDYAQIWRVNTENGVESIFEVQARGESIAHGVQQYSETQGARGPSGWGWGFNTPSQN
LLDAYNAEGDVIRRDATIIFRGETMYDGRVVSTAVENPMYNEKAYSSANAGAGDGDKNIR
VLRLAEIYLIRAEAANELGNSDVALSSLKEVRDRVNLGEVTTTDKTLLRNLIWKERRLEL
AFEHDRWFDLVRTGQAAQAMQANGKPFEVGKHELFPIPNAQLIQTPGMGQNPNW
>LONDMIMF_00738 hypothetical protein
MKYLFFIFLIFASCGSNESSPKGDDSSTPATPTPLTDEQLVDAVEKQTFKYFWDFAEPNS
KLARERYHPDGNYPENDSNIVTTGGSGFGLMSIIAATSRNYVSRSEAVSRLNTIADFLAS
ADRFHGAWPHWMDGTTGRVKPFGQKDNGGDLVETAFLCQGMICVREFFKDGTAEEKALAQ
KFDNLWKGVDWNWYRNNQNVLYWHWSPDYAWEMNFPLEGYNECLITYVLASASPTHGITP
EAYHKGWARNGGIVSSATKYGIPLLLKHNGAEQAGGPLFWAHYSYLGLDPRQLTDQYANY
WDVNVNHSKINYKYCVENPGNFAGYGPNYWGLTASYSRNPDGSIGYNAHMPSNDLGIVSP
TAAISSIVYTPTESLAAMRNFYENYSGQLWGPAGFYDAHSKHYGWTANRYLAIDQGPMVV
MLENYRSGLLWNLFMNAPEVRQGLVNLGFHSGQHGF
>LONDMIMF_00739 hypothetical protein
MKIKLALLGLLVSGISFAQKDITGAISVEITQKSKLNYALHIPKNTKGKKPLMVFLHGSG
ERGSDIEKVKIHGPFKYLKNNELDSYVLAPQCPDNEYWNAEVLYKLIQKIQKENNIDSNR
IYLTGLSMGAWGAWNLAFAHPEMFAALVPIAGFVDRVPMMENCKIKDIPTRIFHGLVDDV
VDMNYSIAIYKKLKTCSKDIHLTIFDDANHDSWSRVYDNKEIYDWMLEQQKQ
>LONDMIMF_00740 Beta-glucosidase BoGH3B
MKFKTVVLLLLAGSLTANAQKDKKKSAIKPKKEFVSELMAKMTIDEKIGQLVQFTADGTI
TGPAAGDNFIEQIKKGNVGSILNATTVKYTAELQKMNLDNSRLKIPLLFGYDVIHGYKTI
FPITLGESATWDLNAVELAAKISAAEAAAGGVHWTFSPMVDISRDPRWGRVSEGAGEDTY
LGSKLAMARVRGYQGNDLSAINTILACTKHFAAYGAAEAGRDYNTVDMSERMLREVYLPP
FKATVDAGVRTFMTSFNEISGVPATGNKFLVNGILKDEWKFDGFVVTDYTGMNEMIPHGY
AKDEKHAGELALNAGVDMDMVGGIYMKNLKKSLSEGKVTEAQINDACRRILEAKYDLGLF
EDPYRYNDAKREKEVTYKKEYLEAALDVANKSLVLLKNSNHTLPLKKEQKVAFVGPLISD
EYNIIGSWAASGDRHGFAVSVEEGVNKIITDKSKISFAKGVEILDKKRDMMQAAIDNAKK
ADVIVAVMGEFENMTGEAASRTNIDLPGIQKEFLAELKKLGKPIVLVLLNGRPLTLEWED
QNMDAILEAWWPGTRGGDAIAQTLYGISNPSGKLPMTFPRNVGQIPLYYNHKNTGRPYLG
KADNEQKYKSRYIDVDNSPLYEFGYGLSYTKFTYSNFKLSATKINFTQKLKATVEVANTG
NYDGEEVVQLYIRDKVGSVTRPVKELKGFQKILLKKGEKKTVEFEISSEDLKFYGIDMQF
AAEPGDFEIFVGGTSATDMKLEFELVK
>LONDMIMF_00741 Glucan 1,4-alpha-glucosidase SusB
MKNIFTLCLLVLTGFLNAQTVQSPSKEIAVTFKLTAEGRPSYSVNYKNKPVIKESLLGIA
LKETEALETGFEITNTQNKSVDESWKPVLGEQSVIRNTYNQAVFSLVQKATGRKLDIVFK
VYDEGVAFRYEFPKQDKLNYFIISDEKTEFNLAGNHKTFWIPGDYDSQEYVYNETKLSEI
DNDKLNLNNGIAVKSIGGRYVVQSPLMMKSAEGLYLNIFEAAVVNYPVMHLDVNTSNFKI
KSHLVPNAIGDKAYLQAPAVSPWRTIMVSDDARDIVGSKMILNLNEPSRIEDTSWIKPMK
YVGVWWEMHVGVSTWDLSGTQDASQKSVGKKPHGATTENTKRYIDFAAKHGFDGVLVEGW
NVGWEDWFGNWKEEVFDFVTPYLDFDIQQISDYAKSKNVKMIMHHETSGSVANYERRLDR
ALNVMKKYGYPAVKTGYVGKIIPRGEFHDGQSMVNHFNYVPQRAAEYKIMVNSHESSRPT
GVSRTWPNYIAAEAARGNEFNGWSNGNPPTHETILPFTRLLGGPMDYTPGVFEIKMSHYD
ASKTEQVHTTLAKQLALYVTMYSPLQMACDLPENYERYADAFQFIKDVAADWDESKYLEA
EPGDYLTISRKAKGSENWFVGAITDENPRNTTISLDFLTPGKKYKAIIYQDGKTAHWEKN
PINYEIKTIEVTSKSKLKLNLAAGGGTAISIFPVK
>LONDMIMF_00742 hypothetical protein
MIFFKRQNLKKVTKIVSLAGILLFSGQGFSQQKTYCNPINIDYGYCPIPNFVTQGKHRAT
ADPVITNFKGEYYLFSTNQWGYWHSSDMLNWKFISRKFLRPEHKVYDELCAPSLSFVNDT
LLVIGSTHTKDFPLWMSKNPKTDDWKELVHKSEAAAWDPQIFWDKEKDEVYMYYGSSNLY
PLYGVKLNRKTFQPEGERIPVLALNDDEHGWERFGEHNDNTFLQPFTEGAFMTKYKNRYY
LQYGAPGTEFSGYADGVYVGSNPLGPFEYQSHNPFSYKPGGFARGAGHGATYQDTNNDYW
HVSTIVISTKNNFERRIGIWPAGFDEDGILYSNTAYGDYPTFLPSQKKNHLQESFSGWML
LNYNKPVQVSSTLGGFQPNFSNDEDIKTYWSAKTGAKGEYLISDLGEKSTIHAIQINFAD
QDVELMGKPETTTGHKYIIYSSNDGKSWKIAVDKSKNTKDVPHDYMELEKPITARYLKVE
NIQMPTGKFAISGFRIFGKGTGQKPDAVQNFAPLRAEARKKGERRSVWFKWQQEPNADGY
VIYFGKSPEKLYGSIMVYGKNEYYFSGLDRSDAYYFQIEAFNSNGIGPKSEIKKSE
>LONDMIMF_00743 L-fucose-proton symporter
MSSETKTNYPALYTLITVFFFWGFIAAGNSIFIPFCKNYFSLDQFQSQLIDFAFYTAYYL
GALLLFIFGAVNGKDLVGKWGYKRSIVYGLLFSALGAGAMIVAVEANVYAGMLVGLFIVA
LGFSLQQTAANPFAVLLGDPKTGTSRQNLAGGINSFGTTIGPIVVGFALFGTAAAVSDEQ
IKGLGLDKVILLYVGVGILFLIAASVFFFSKKLPSGISDEPMEKANKAMTTLIVMTGLLA
IMFAPVFNSYNSPEAKKIVEIEKSIEPITKDIKKLSDNLVKIKKDKVLSEEEKNTASESI
KSEIKVLELSVEPQHKEIQEIRHPLEKYRMYWLSGALLVIVGGLLFANRSAQKKNEGWGA
MKYPQLVLGMLAIFTYVGVEVAVGSNLGELLKLPEFGSFQSSEIAPYISMYWGSLMIGRW
AGAISVFNLSASKRKLALIIVPLIAFSVIIGVNTLAQQDMTSLYYYVICVLLQVLVFFLS
KNKPARTLILFGLMGVTAMLIGLFSTGTVAIYAFLAGGLACSIMWPSIFTLSITGLGKYT
AQGSAFLVMMILGGGIIPPIQGKLSDIIGIHASYVIPVICFSYLTFFAIAVKGILKRQNI
DVDAIEAEGAH
>LONDMIMF_00744 hypothetical protein
MRLSKYYLAAITAFVIWGFFSLALKPLHLYPSLDILFYRVFLCVVLMMGINLLFRKKTLK
ETKENFRLMSATQKRNVVLLTLGGSLLLSANWFFFIYVMNHVSVKAASFAYLVCPILTTV
FAYFILKEKLNKWQWTAVGLSIFSCVLLSFNHFMDIFYSLIVAATYALYLVSQRKNTAID
KFLLLTLQLTTTAIILLPFYPFYSSEVPTAFNFYFYLVIIVVLFTIIPLFLNLYALKGVN
SSTVGILLYINPLINFFLAIFYYKEEITTFQIIAYSLILLSIIIFNSKHIFKPKTKEPQP
KDV
>LONDMIMF_00745 Cysteine desulfurase IscS
MKKVYLDNASTTALRPEVIQEITHVLQEEYGNPSSTHSFGRSAKNILESSRKLIAKQLNA
SAQEIIFTSGGTEANNWILRSAIKDLKVKRIITSKIEHHAVLNTVLALQAEYGVEVDFVN
LNSKGEADINHLVELLSQDKPTLVALMHVNNETGTVLDIEKVARLCKQYNALFHSDTVQS
VGKTEIDLQKTEVDFIVASAHKFHGPKGIGFAFIRKNPGINPMIFGGEQEKGLRAGTEGV
HNIAGMAKALEVSYENLEVERKYIQNLKDYFVGKLKIDFPNFKINGNPEGFYNIINVLFP
FSDEKTAMILFSLDMKGIAVSRGSACQSGSIKPSHVLKEMLSDEDLKKPSLRISFSHFNT
SEDIDLLIEALKAV
>LONDMIMF_00746 hypothetical protein
MKRRIISSIAIFGFIITSSAQNKGKIEIGFNAGLNSSNATTTYYSAERSISLNLGASADY
YLSDSWSLKLKLIYDRKGWDNDFIQVSGFDPIEFPAYERTNINLNYITVPLMANWHFGSK
KNWYLNFGPYIGFLMNAKETRLDTDIKKEFNTIDGGLSLGIGVKIPVSDKLKLFIEYEVQ
GGMADIYKNNEEGDKNMNIRSSFNFGINFLLD
>LONDMIMF_00747 hypothetical protein
MKQVLITLIAVFSCIAISFAQHKGKVEMGFNVGFNTTNISNNIEIYDLPDSRYGFNFGVS
ADYYFSDDWSIKAKYIFETKGWNNDLIQVSDESDPVVRYESTNIRLNYITIPLMITFHAY
GDDEDRINVYTNGGPYIGFLMDAKETRFNTIIKDSFDKIGGGISYGVGIKIPASNKFKFF
LEYESQLGLTEIFKYRDRYISVRHAMNFGINFLLY
>LONDMIMF_00748 hypothetical protein
MKRVLITSMAILGFIVTSSAQNKGKIEIGLNAGLNSSNASTGYDSADPSIGFNFGASADY
YFSNSWSLKAKLIYDRKGWDNDLIQVSDQFDPVVRYASTDINLDYLTVPLMASWHFGNRK
NWYLNFGPYIGFLMNAKETRFDSDIKESFNKVDGGLAFGLGVKIPVSDKFKVFIEYEGQG
GMAELFKYNDYDDTIMNARSSLNVGINFLLY
>LONDMIMF_00749 Dihydrolipoyl dehydrogenase
MKYDIIVLGSGPGGYVTAIRAAQLGFKVAIIEKENLGGICLNWGCIPTKALLKSAQVFDY
LKHASDYGLTVEKFDKDFNAVISRSRGVADGMSKGIQFLMKKNKIDVIEGTGKVKPGKKI
DVVGKDGKTTEYSADHIIIATGARSRELPNLPQDGKKVIGYRQAMSLSEQPKSMIVVGSG
AIGVEFAHFYNAMGTEVTIVEFMPNIVPVEDEDISKQFERSLKKAGIKIMTNASVEKVDT
SGNGVKATVKTSKGEEILEADIVLSAVGIKSNIENIGLEEVGIATDRDKIVVNPYYQTNI
PGYYAIGDVVPGQALAHVASAEGILCVEKIAGLHVEPIDYGNVPGCTYATPEIASVGLTE
KQAREKGYELKIGKFPFSASGKAKAAGTPDGFVKVIFDAKYGEWLGCHMIGSGVTDMIAE
AVVARKLETTGHEIIKSIHPHPTMSEAIMEAAADAYGEVIHL
>LONDMIMF_00750 hypothetical protein
MKLFFKLLFIVIILEIIIGISCTYIIQESSSRFLVNLSNLIIIFLSFPIYLIDKTYPFYA
VGSEGFGFMLVFINVTLQTLTLYAFIRIVTKKKN
>LONDMIMF_00751 Putative multidrug export ATP-binding/permease protein
MEYTKPYKTRYYWVIFFAVTLSVFAALRPFLLKRTVDSYIQPEDATGLLYFILLMGGALI
IEVVSQFYFVFLANWLGQDIIRDIRVKLFGHMMSFKMKYFDNEPVGKLVTRSVFDIESIS
KIFSQGLFMIISDLLKMVVVLLFMFYMNWKLTIIVMCAMPVLVYATRVFQKKMQVAFEEV
RTQIANLNTFVQERVTGMKIVQLFSREDIEYEKFKVINDKHKKAWIKNVWYNSIFFPIAD
IVSSISLGLVVWYGGMNIVAANGTTTFGDLFSYTMFIGMLYNPLRQIADKFNEMQMGMIA
ANRVFEVLDMEGHIQDKGKVTAPTFKGNIDFKNVHFSYTGKEEVLKGINIHVKEGETIAI
VGATGAGKSTIINLLNRFYEINGGEILIDGTNIKEFTLKSLRNQIAVVLQDVFLFADTIH
NNITLEHPDISREDVIRAAKEIGVHDFIMTLPHGYDYNVKERGVMLSSGQRQLIAFLRAF
VSNPSILILDEATSSIDSYSEELIQKATETITKGRTSIVIAHRLATIVNADKIIVMEKGK
VVEQGTHYELINKAEGYYKNLYYSQFAVES
>LONDMIMF_00752 tRNA pseudouridine synthase A
MRYFIEFAYNGKNYHGWQQQPNAPSVQETLGKAIAVLLRSDIEITGAGRTDTGVHAKQMF
AHFDTEISFEATIFKNRLNSYLPKDIAILKIHTVADDAHARFDAVKRTYEYHVTTVKNVF
EEPLSWYCHQALDMEKMNQAAKILFEFSDFQCFSKVNTDVKTFQCKIMEAYWKQDGHKLV
FTIAADRFLRNMVRAIVGTLVAVGMGKISLEDFRKIIESKNRNEAGASAPAQGLFLTKVE
YPYICGTQPIDKN
>LONDMIMF_00753 hypothetical protein
MKKILLLSDTHGHIDDTILKYVDQADEVWHAGDIGDLIVTDTLKKHKPLRAVFGNIDGDK
ARMEFPLNNRFMCEDVDVWITHIGGYPGKYSPAVKSEIALNPPKLFITGHSHILKVMFDK
KLNLLHMNPGACGISGFHQVRTMLRFVIDGDKIKDLEVIEIGKRP
>LONDMIMF_00754 Signal transduction histidine-protein kinase/phosphatase DegS
MTLKWTNFKLPFWTILLLFILFSGFATAQNKTTDSLSYYIENKDYLNGLKYSREKSKLYL
ENKDYKRYCDVSLKKADIYFMLNDNQKSFETLFKALKIAEDHNIVESRIKIMEDIGHRYA
SIRDYKKAKKYYEISLNLRKRNNLLSDDLFVYQRLYKALFYLDSDSVTFYMNKIMRSAKK
SGDFSRLSSSYNNYYTYYSNKQNYVLAKKYLDSCAFYAEKSKSTERIVTSLSNLGYHSLT
VEKNYKKGIEQYLKILEINPSDTISQNVSDTYLNLSYGYEMMGDYRNAIDYMNKYFHVNE
TIYEDNIKRAISDVETKYKIEKIENENKEKQRLLEEKQKNNQKIILIFIALFAFSTILFY
FFYQNLKLKQKNRFIELDRQIKQNIINATIDGQEIERKNIATILHDSISALLSSAGLHLS
AYAAKNPTENSEEIQKTRAILKEAHDNVRDLSHELIPPLLAKFGLFHALQDLCEKNSNSI
LQFEYSSYVPQGRRYNEEFEMRVYFITAELFNNIIKHSKASKAYITLEENNKQLLLTIED
DGKGFDTSKELLSDGFGLTQIKSRIKHLKGTISINSKINAGTLIYIKLQIPK
>LONDMIMF_00755 hypothetical protein
MSLFLKNYSIGKEDDTFRVAFQIPINCEYTTFVDPYDVNIIAVTLKPYEKDPSTEFVEYY
EYFSCIENVINVDFELPDGNSGGIGDGDPVTKKPRLRIDDLKMD
>LONDMIMF_00756 Transcriptional regulatory protein DegU
MDTKIRIYLADDHQVLIDGMLSMLKTNPKFEVAGYSLNGENLVEDVEKSKADVLVMDINM
PIKDGIEVLREFATKGFSCKVIILSSYDDVKIIKEVLKLGANGYLSKQSAGENIIEAINV
VANGEEYFSQSIRDRIFESFSKIPQQSYINEAMPLSSITERELEVLKLITMEYSGTQISE
ELNISTNTVETHRKNLIKKLNVKTTIGLVKYALKHNLIN
>LONDMIMF_00757 hypothetical protein
MIQRIQTIYLLIAFIIMGILPFVFPLETSSTGVKTFAADHLADMILFGLSAALSLIAIFL
FKNRQLQFVLGRLNIILNLILLGLFVYHSLSVSGEVATSEKGIGMFLPIFSIVFLVLANK
AIKKDEDLVKSVDRLR
>LONDMIMF_00758 Transcription termination factor Rho
MFDISVLKEMKLSELQDIAKATKKIKINGVKKEALIYQILDYQAANPEVIPAPAAETEAK
PKRARIIPEKKTKVAVENTNTLFSEPETTAVSEQPIQEKKKPVVKQPVNPAKTAETKSPD
AVAAPTQKDKKQRFNKNNFEKPQAAKEETAEKNTNEVVAPQPVEVESVSSQKGLEKTAKQ
QQPQQNQKQNPNQKQNQNQNGNGNQNPNQNQNQNNNPNANPNFKNNKKANFRDADFEFDG
IIESEGVLEMMPDGYGFLRSSDYNYLASPDDIYLSTSQIRLFGLKTGDTVKGVVRPPKEG
EKYFPLVRVLKINGHDPQVVRDRVSFEHLTPLFPDEKFNLAGKQSSISTRIIDLFSPIGK
GQRGMIVAQPKTGKTMLLKDIANTIAANHPEVYLIVLLIDERPEEVTDMQRSVRGEVIAS
TFDEPADRHVKVANIVLEKAKRLVECGHDVVILLDSITRLARAYNTVQPASGKVLSGGVD
ANALQKPKRFFGAARNIENGGSLSIIATALTETGSKMDEVIFEEFKGTGNMELQLDRKIA
NKRIFPAIDLTSSSTRRDDLLLDEGTIQRMWIMRKYLSDMNPVEAMDFINDRFKKTRNNE
EFLISMND
>LONDMIMF_00759 Ubiquinone biosynthesis O-methyltransferase
MEDNYLEINRETWNKKTEVHVDSEFYDQKGFLEGNNTLKPIELDLLGDISGKKILHLQCH
FGQDTMSLSRLGAKTTGVDLSDKAINKARETAQQLNLDTHFINCDVYSLPEHLNEEFDIV
FTSYGTIGWLPDLDKWAKVIQRFLKPGGKFIMADFHPVVWMFDDNFEGIGYNYFKDAPII
ETGNGTYADKEAPVSLKTVSWNHATSEILNSLIINGLELNSFNEYDYSPYDCFNKTEEFE
PGKYRIMHLGNKIPMVYSIVSTKK
>LONDMIMF_00760 Carboxylesterase
MNKSKTIVLIHGNFVNNQTWTAWKNYYEQKGYTVHTPVNPGHEGNPAELRKTEHPDLAKT
NFKAVVDNIVKLIDSLPEKPLVIGHSMAGMAVLKLTDLNKVAAAVSIDGAPPKNVFPPFQ
TLKTALPAFGFFSGKKNFMGSRKWYDYAFFNTLPEKEKEKMFDLYAVPESYAVSRQLVLD
SYSNINFKKAHTPLLFIGGGNDHIFPASLTTTIAGKYKDKNSRVDLKIYDGKSHFIAGEP
GWEKVADDILDWYEKL
>LONDMIMF_00761 hypothetical protein
MDKLKHLSFALKEFAGLTDEDFELSEPLWQEMSYKKWDFFNEYKNVCKYLGFVTEGVFRS
YIVDSKTGDEKNVFLYSGNQFVVSFKSFINQSPCDYHTQSMTDSQVLCIHINDLQGLYRQ
SHAWERFGRLLAQEAFNITIARTESFLFQTPEERYLDLIKHHPDIFNTVPLYQISSYLGI
QGPSLSRIRKRISGK
>LONDMIMF_00762 Extracellular ribonuclease
MPSLNYNLMKKFYTLAMVFSASFAFAQAGAPAPYYNGFDFSQTGMALKTALAQKITSTHT
RNLSYDGAEEAIKIIDLDPADATNTNVLLLYGFSNSICPSSQADDNDHRRRNKNSDGGGA
TCQWNREHTYAKSLGTPDLGTSGPGADAHHLRAADVQRNGDRGSEKFTAGSGNSRDITSS
TWYPGDEWKGDVARMMMYMYLRYGNRCLPKNVGVGTAVASDTNMIDLFLQWNAEDPVSQY
EDNRNTYLGNANNAYGQGNRNPFIDNPYLATLIWGGPAAENRWPSLSTQEFNPLSAVSVY
PNPASNGKINIASDIVLDEIQLININGQIVQEIKNPASQNNTYTLENLPSGFYFLKLGSQ
NQTATKKVIVN
>LONDMIMF_00763 Extracellular ribonuclease
MKKNYSFLLLLIATIGYAQAPAGYYNSATGTGYTLKTQLYNIIRNHNDRSYAGLYTTYQT
SDKKANGKVWDMYSNCDFTFGTVAEGGNQDNGTNAATECVFFNREHTVPQSYFGNGATPM
YSDAHFVLPTDKVVNARRDDYPFGVVQNATWTSQNGSKLGNNLNSGYSAGYSSTVFEPID
EYKGDFARLLFYFATRYENLLAGFYTSSSSTSKAMFDGSSDRAFSPTFLNILLTWNQQDP
VSAKEIARNNAIYARQNNRNPYIDNNAYVTMVWGTPLAVPVYESLAAVNVYPNPSTNHKI
NIDTELQLDEIQLININGQIMQQIKNPASQGKTYTLENLPSGFYFLKLTSDSQSATKKVI
VN
>LONDMIMF_00764 Ribosomal RNA small subunit methyltransferase B
MRLHRNLVYTTIDSLHAIFNEGEYADKVVARALKKDKRWGSNDRKFVAETIYDIVRWKRL
YMEIAEVREPFDRDNLWRIFAVWAVLRGYPIPDWRQLEGTPERKIKGRFAELSKIRKYKE
SIPDWMDELGIEELGEELWSKEIIAQNQPAKVILRVNTLKITKEKLRAILMDQDIETEFL
KDQPDALVLKERANVFLTDAFKEGFFEVQDASSQLVAPFLDVKPGMRVVDTCAGAGGKTL
HLASLMENKGQLIAMDLYESKLKQLKLRAKRNGAFNIEYRIIDTTKVIKKLHEKADRVLI
DAPCSGLGVLKRNPDAKWKLQPEFIDNIRKVQAEVLENYSKIVKPGGKLVYATCSILPSE
NQEQVKRFLTTETGKNFTFVKDVKILASESGFDGFYMALFERKDKKE
>LONDMIMF_00765 hypothetical protein
MKAKFITSALFAFLFATQIQAQDRTTVTANSSDISDNLDLRAVASIFGDSQDLADFERRL
NDPKTQISNLDLNGDNKVDYLRVIETVENNTHLIIIQSVLERDIYQDVATIEVERDSNNN
VQVQVVGDVYMYGTNYIYEPIYVTRPVIFNVFWTNYYRPYYSPWYWSYYPSYYYTWNPYP
IYRYHRHVHNHINVHNNYYYVNTRRSSRAVAMYNTRRSNGYERQHPDRSFAQRNNNVSNR
YELVQTRGGSTRNQSATTGSRNSNVTRSTTTGTRNSVTANRNSDPTITETRTTGIRTPDR
SFTSSTRNTTRSEGTTVRANSTRTTSSRIETPTRVENTRNTPTRSYETPNRASTPRVESS
TRSSAPSNANISRGNSAPRQSAPQQSRGNDGGGSRGNSGSRGGGSRG
>LONDMIMF_00766 Arabinose operon regulatory protein
MEMISVLDISQLKFGEGQKDFYVNRIPPHIAENHSKITRPHKHNSYLTILFTKGSGRHEI
DFNSYEIKPGSLFVLAPGKTHHWELSEDIDGYIFSHTANFYDLHYSHNRLHQFPFFYSIQ
NTPFLALDSENSKKTEYLFRKLLDEYESAKNFQQQLIISYIDIIYIELSRLYLIENAPKI
IKSGAYSEKFQQFEDLIEKNYISEKSPSQYADWMNISPKHLNRITKTIIGKTASEVITDR
IILEAKRRFLHTKNNFSAIAESLGYDDYAYFSKLFKKSSGLTPTGFLKLY
>LONDMIMF_00767 hypothetical protein
MSFLKNVIQNKCPHCGKGKVFKTNGNPFLFQMPEMHPECSECGHKFVKEPGFFFGAMYVS
YALAVGEMVATFFISRLFVTSLVHSLLFIVAAAFLLCTINFRYSRLLWIYMFDSKAKVN
>LONDMIMF_00768 hypothetical protein
MAKKKNKYGFKHWIGKIHLWLGMASGSVVLLLSVTGCIYVFSVEITEALRKDVMYVSKTE
SAPIPISKLWDDTQKKIGNNLKISRVKVSNNPEKTWVFGCYKKNENAITYFGAIDYYKSV
YVNPYSGEILAVYDEEMDFFNIVKFIHWSLLLEVGLGQQIVGWSTFIFVIMLITGIILWW
PKNKAARKQRFKFQWKETTNWRRKNYDIHNIFGFYIATIALIIAFTGMVWAFSWFQAAVY
VAASGTTERPEVVTKEADKNLPKISNAMEAILEKTKLAYPDADAFSLRKPADSLATMDVY
VQQNENTYYVSHEMRFDQKSGEILLNRNHSQKNFGEKLITANYDLHVGAILGIPGKIIAF
IASFICGMLPVTGFLIWYGRKFKKKTKRAN
>LONDMIMF_00769 hypothetical protein
MDNLYFNPYSGAFLKQESIEDDFFAIIEDLHMHLWLPPEIGKHVVGIATIIFIIMLISGI
ILWWPKKRKDLKNRIRIKWKAKWRRVNYDWHNVTGFYISLFVLVIALTGLTFSYEWMHKT
MYFVGNLGQEYPNDDFSPAIDSTLVPNTKANPMDIALSQAYKAKPNDEMFFVWYQGEKSA
IITGSYPDALDFDHQSNLYFHPKTGELLNTDLYENKSPGTQLQEMNYGLHTGQYFGLTGK
IIAFILSLLAAALPVTGFIIFWGRRNKKAKK
>LONDMIMF_00770 hypothetical protein
MAATFFATQAEFRKWLEKHHKNETELLVGFYKLDSGKPSMTWSESVDQALCFGWIDGVRR
SIDKESYSIRFTPRKKTSNWSAINIKKMEELTKAGLMTEAGQKAFAERIESRSKIYSYEN
EPVLLSAEYESQFRKNAAAWDFFMKQAPSYKKLTIHWIMDAKQEKTRQSRLEKAIRESEQ
QKKV
>LONDMIMF_00771 putative HTH-type transcriptional regulator YybR
MTKIKETSTNFENKKLLQDECLEVYASGIIGGQWTLAICCYLINGKLRFGELKKCMPTIT
ERMLTLQLRKLEKNKIITRTVYAEVPPRVEYELTAIGYQLHTIIGELEDWGRKHKELMKQ
>LONDMIMF_00772 General stress protein 14
MKTLVVVIHPNLQESVINKRWIEELEKYPDHYFIHRLYEAYSDEKIDVAKEQKLIESYDK
IVFQFPFYWFNCPPLFKKWLDEVLTHGWAYGSKSGYKMGGKKIAMVLSVGVDEEEYRADG
KYKYTLRELTAPFELTFEYIKADYRYFFAYYGIELNATDEWIEKSVPDYRKFLESL
>LONDMIMF_00773 Exoenzyme S synthesis regulatory protein ExsA
MHNSFYFCTTSPSQAIRLPMEYQAKYITDDIKLSCYEDKFFKSDIMFDHHMLVWFISGET
KIIQADATYYFKKGDIFLIPRNQLATIINYPKDGQPHKTVVMHLSTEKLRDFYTGLPIQP
KAVASQKIHSYSNHPLLESCLASLLPYFSMETLPEDIASLKIKEAISILRTIDKGIDDVL
ANFEEPGKIDLAGYMEKNFMFNLPLEKFGYLTGRSLTTFKRDFSKAFHTTPQRWLTQKRL
ELAHYQFIEKKKKPIDVCYEVGFENLSHFSHAFKKQFGYSPTELTKRQNA
>LONDMIMF_00774 Fatty acyl-CoA reductase
MRQNNYQGALQQPIGSGFGATSTASEVIKGIDLTGKIAIVTGGNTGIGLETAKVLAGAGA
TVIIPARDIEKAKRNLEGISNIELEAMDLMDATSIDAFAERFLASGRPLHLLIHNAGIMW
VPLRWDNRGYESQLATNYLAQFQLTARLWPALKKAHGARVVNVSSQGHQFGTFDFDDPNF
LNREYETLLSYGQSKTASNLFALELDERGKAFGIRAYSLHPGSINGTELAREAPLELFQK
LGYCDANGVLFPEVAAALKTIPQGAATTVWCATSPMLNTIGGVYCEDCDIADLVLEEGVT
KGVKPYSVDESSAKRLWTLSETMTGIPFNTAE
>LONDMIMF_00775 hypothetical protein
MFTEAQIKHAHSKVKSGADFPAYIQEIISLGVTSYDVYVADGHSEYHGANEYEITTTAKY
KNLFVADSCDTISFKAGLKSHQQGQTDYNAFIAMSAKCGIEKWVVDTQKMSCSYYDKTGN
EILVEQIPNNK
>LONDMIMF_00776 hypothetical protein
MNTSELITLFHNNHIELANYVNALPDDQFLYSKNGKWTAGQQVSHVYLCLLPISKALASK
EFLIQKFGKIERPLWDYDTVLANYKVALANGGKAPEKFLPEAVLPEAKKELTEELRQILD
SIQQQLSGYSEEELDTIVMPHPLLGIMTVREMFYLMAYHAIHHLKQTEQNLPA
>LONDMIMF_00777 hypothetical protein
MDKKKLSASQSETLTGILRTRFEKNANRHKGLKWSDIQAKLEANPEKLWSLDEMEETGGE
PDVVGFDKKTGEYIFYDCAPESPKGRRSICYDPQALESRKEHKPKDSAIAMAATMGIEIL
TEEQYRELQKLGEFDLKTSSWVKTPTEIRKRGGALFCDRRYDTVFLYHNGAESYYAARGF
RGCLKV
>LONDMIMF_00778 hypothetical protein
MEKRNKIIYWISTLWLALGMVSTGIVQLSGVKEETEMMAHLGYPAYFLTIIGVWKILGVI
AVLIPKFTILKEWAYAGFFFVMSGAIFSHLAAHDPVKDILPALLLLVLTLVSWYFRPANR
KTITVTS
>LONDMIMF_00779 hypothetical protein
MERKTKINAEEGKQELQIIREFDLPLELLFKAYEEADIVAQWMGTKVVKLENKKHGSYQF
ETSDAQGNVVFRSNGTIHEFIPNQKITRTFEMENTPFPVQLEYLEFEKLTDTTSKLTMHV
VYKSVAVRNQILQLPFAQGINMAHNRLQNVVSNLK
>LONDMIMF_00780 Transcriptional repressor SdpR
MNLRRDVFQAIADPTRRAILLLLSTQSMTAGAIASNFDTARPTVSKHLQILTECELLQQE
QNGREMYYHLNPNKLKEIADFIEPFQKMWDDRFNKLENIMKTYQSKK
>LONDMIMF_00781 hypothetical protein
MQLNYILQQKLYLIVAIILAIFCLTIDFNSLGLNKTVGMAYDMDSTAKIICLVSLLFSFI
GYSILSLLRYQTQKNLSLLYLSSILLAVVLNFIKQHEISIVFGILSIVVFSISIVRSLIH
KI
>LONDMIMF_00782 hypothetical protein
MKKILKPVIITIGILLICGFFLRGKISHKKFDSDKWKNSDLNSEENWSLRWDMMNSIRNN
HDLVGMQKNEIISLLGKPDDSISGKENQMYYYLGFSHQGINTGALYIDLNNKGIATKISV
IQG
>LONDMIMF_00783 hypothetical protein
MFKKAIGLIGVISLIMISCSSSLSKKNEANTFMGKWEGKWDDISVELVFQPRNKGFVTYT
NPLEKKYFNYKVKGDSITLNYPKLVRTYKFTVEQDKLYINSKDYKEESAEIIELIRYTRK
KE
>LONDMIMF_00784 hypothetical protein
MKIYSAIQIGDYHFNNCEDALYIGKFGRDKLICAVMDGCTTAIESQFASLLVCKILKKII
IEKGYKDMVDKSEATMSLEQHLKSILKDLFSELKIIKNQLLLDAKELLTTLIIMIVDKNS
DQGIVLTIGDGFVNINGKVTEYEQDNKPDYLGFHISEDFEKFYSLQNQKIVFDKISDISI
ATDGIFSFTKVQKSTEEMDVIDFLSQNKEGNETEDMLNLKLKILKNDFGLKPTDDFSMIR
ILNS
>LONDMIMF_00785 hypothetical protein
MEITTKFIIATEQGRSLLATLAKEIATEKFTSLIEPQQLEDYIEKKFNDKNLIAEMNSMS
NQWLVVYIRDTPVGYACITSNGRKPKNQEEARIMRIADFGILKKYNDTLIRQSLLEKCLA
IGKSYDGLWIHEYKENPLVAFFESEGFVMQDETCQHEELPLSSVFLVKNKHS
>LONDMIMF_00786 HTH-type transcriptional regulator NorG
MKSYKFEIFTSSLEKNIREGIYKPGHKLPSVRELKDKYRLSTNSVQNGYEHLIIQGLVES
VPKSGYYVNRQFGKSHEPVKTNRSPIIRDAFFENSLASITSLRKGRKLSEFNVAAPGDLL
IPQKLLLRTMQQVVREQGANLLRYYPSNGLPDLKDAIARRAAGYQTLLNPDELLVTDGAL
QALYIALASVCTAGDVVAVESPCVFSILEVIRVLHLKVIEIPIDRDNGFDVDFLRKACAK
NKVSAVLLTPNFHNPTGILLTDEKKKAVLSVAQDYEIAVIENDIYGDLNFNGIRPTTIKS
FDDSGLVMTYSSYAKTLAPGIRLGWLSPGKFIQKTEQIKFSLGSTVSPIYQETVNRLLSA
SSYERHLKAFRKQLSENAALTLDLLYDNFPEGTSITVPAGGYSIWIKMPEATNMDYFYTQ
CDKIGVRFTPGYTFSFSDTFSSYFRIVFADAYTPKRIEAIRQVGQLIR
>LONDMIMF_00787 hypothetical protein
MVAKEFDYIIRHLQIIKNMINKTLIIIVFLTFTNVWSQEKTENVDSLRTKSIELIRNIFW
NYPPRYQKWVNDYEDLYTFDQEAELTTLIDNFEKETSFEIAIVTIDTIIVTEDKFEDLSL
HIAKTWGVGKRFKDNGILIAISKGYRRIRIQNGNGTEKIFTNEETQLVIDNYFIPYFKKE
EYFYGTSLGIKEIMRILKSKM
>LONDMIMF_00788 hypothetical protein
MISNNYRKRQFQKTIHLYHFDYMKPLVLAFLTLLFYSCTTTKNTTNEPYSDLIDKVRNIE
DSISVGKMTIHNAFKSQLLAHSNGKFDSIMILKKVYQPNKYVFENCLSQIFGDEHGKKFK
PEGMLAWNRNLLTENETLIRQKLAVIDSVNINQLFTKHLRALQKITGQQGEGKWLIYFGP
KKFQIFGGCDNNAMVLDMSGSSWTSQSIDGLFAHELEHLLFNPILEKDTNGQTGLGITLD
EGLAVYFTSLYLKQTQEEALFGTDTQALLDREKEIYEKLEPYLYKTNEEGCPIFRHCSRN
SNCKSVIEGLPKAVENQLCYFLGFRIIQTYVKQNGKDSWKDIYKIPLKDFFEKSGYKDFI
SQKENW
>LONDMIMF_00789 Isopentenyl-diphosphate Delta-isomerase
MTEEKVILVNERDEQIGLMPKLEAHEKAELHRAFSIFILNSKNEVMLQQRASQKYHSPLL
WTNTCCSHQREGESNIQAGNRRLMEEMGFSTELKELFHFIYKAPFDNGLTEHELDHVMVG
YFDGEPVINPEEVEDWKWMDIDAIKEDMQVHPEKYTVWFKIIFDEFYHFLEEHKL
>LONDMIMF_00790 6-carboxy-5,6,7,8-tetrahydropterin synthase
MRVTVSRKAHFNAAHRLYRKDWSDEKNDSVFGKCNNPNFHGHNYELVVSVTGKINPDTGY
VIDIKDLADIILEEVERPFDHKNLNLDVPEFSDLNPTAENIAVIIWNKIRKRIDTDKDLE
VVLYETPRNFVSYKGE
>LONDMIMF_00791 Mannose-6-phosphate isomerase ManA
MEISVICFQKNMSLQLYPLVFEPILKERIWGGTKLKTVFNKPIQSDSTGESWELSTVAGD
ISRIAEGEYQGKLLSDLISQFPEEILGEAVHKKFGTEFPLLFKFIDAKEDLSIQVHPNDE
LAKKRHNSFGKTEMWYVMQADENARIVVGFKEKSSREEYLKNLEDKTLLSILQEVPVKKG
DVFFLETGTIHAIGSGIVIAEIQQTSDITYRVYDWDRVDAEGKSRELHIDLALDAINYNT
TDTERTYTQEKNKSNPVVTCPYFITNYFPLDGEVEIKKQHESFTVYMCMEGNFTIKYNGM
EWNYKKGNTVLLPAAMREYRLEGEAVLLEIYI
>LONDMIMF_00792 hypothetical protein
MANVRNLKKDINYVLGDIIEAVYIWEMSTTGKPTEASEALIDEAIVAFDSLIAKVNAKNV
ENKKAHFKQINAELEQTANQLVAKINAL
>LONDMIMF_00794 hypothetical protein
MRKIVFAFAALAMISCKEEKKEGNLHIKGNVEGLKQGTLYIQKIVDTALVAVDTIVIKGN
SNFESHLTIDSPEMLYLFLDRGETNSIDNNLMFFAEPGNMTIDTRLDSFFAAAKITGSEN
QKLFEEYRKIMSRYKNTQLSLTEEKLRALQFNRDVSSDFDKKNSDNLKRKYLMAINFALN
NKNHDIAPYIALADIYNANIKYLDTIDKSMSPKVAQSKYGKMLTKFVADRKQAEQKQ
>LONDMIMF_00795 hypothetical protein
MRKIIYSLAFAALLWSCKPSENVVSVTAKNEVQVEIDLNGIKDDKVMVTVLPPAIKSEKI
TYHIPKIIPGTYSEDDYGKFLENVKAYDAKGNSLVVAKIDDNSWTISDAKKLAKLTYWVN
DTYDVEGTHDIFSPAGSNIEAGKNIMLNTHAFVGYFKEFLDTPYQVNIAHPATLWGATSM
TDTDASDTKDTFTVSKYSELVENPIMYSKPDYTTFTVNGMEILIAVYSPNGIVTAESITP
EMKTMMTAQKNFLGKFNSTKKYSVLIYLSDTSRNDAKGFGALEHPTATTVVMPEAMPKEQ
LAEQFKDVVSHEFFHIVTPLTIHSKEIQFFDYNKPKMSEHLWMYEGVTEYFANLFQVNQN
LITEDEFYERMATKIANASTMDDTMPFTKMSSMVLQKPYKDQYQNVYEKGALIAMCLDIQ
IREDSNGQRGILDLMQKLSNEYGTKKAFDDSELFDKIESLTSPTVRKFLDTYVAGPTPIP
YDVYFAKMGVTKGKTTVAGNAFLKGMEPNFSINPATKEIFILPGSGNIDFYKSLGIKDGD
ILLEINGTKYNLDNVYDMIMGSLTWKENDPITAKVKRNGKEIQLKGVIKLPSEEIEGYQA
TDASKAKLREAWLKG
>LONDMIMF_00796 Esterase EstD
MIKKIIFLSFVLFSTMVTFSQESKFSTEEINVNALIPGTLYTPNTSKKTDLIILIAGSGP
TDRNGNQPGVSNNSLKFLAEGLAKNNYAVYNYDKRPVVEMRSGEIDESKLSFDILIQDVK
DIVSYFKAKKQFNKIVIAGHSEGSLIGMNAALPDANAFISLAGAGRPIDEILIEQIGSRA
PMLKEETVKGLESLKKGQTFELKNPMLASLFRASVQPYIISWLKHNPQEEIKKLQIPILI
VNGTKDIQISTQDAELLHKANPKSELVLIQNMNHIFKEIKGDDAENMATYTNPNVPVMPE
LIEKITTFLKKI
>LONDMIMF_00797 hypothetical protein
MKKLLLNPFEKNPETRLFIFGLAVTAIGSYLAYLFNGRYDGVIDLHFTKSVTVAQPFIDN
LINIVCLFATLFFVGKLINSKTRIIDIVNPILICRIPFYLLTFSNFRNYISDISVSLLEN
FNPKAMPSEMNLSPISMIVLGFFAIISILCLIWFVILLYNGFKIATNSKTGMHKLYFALA
ILVAEIISGILISFLNY
>LONDMIMF_00798 hypothetical protein
MTPKLPIHCPSCSDSLSVSQLKCGNCQTTVSGNYSLPFYLQLSEEEQNFILQFFLSSGSL
KEMAVQMGNSYPTVRNKLDDIIEKIKKLKSGNQ
>LONDMIMF_00799 hypothetical protein
MKKGKNIELTREENEKLVTLALEERNPFEIIKKELGLAEKDVIEIMKKRLTADKFELWKK
KAMASKPKPKPPKIDDFDEDLDGKYYIKNKFD
>LONDMIMF_00800 hypothetical protein
MNDIVNYFSTIPSLHRGLILVGGIAIFWMIENAFPLFRFNYKKWNHAGINIFFTLTTIIV
NFILAFILLLASEWALKNNFGVLEWLPELPLWLYTLIGLLLLDLIGAYLAHLVQHKTRWL
WHFHLIHHTDTWVDTTTANRHHPGESVVRFVFTAAAVLITGAPMWLAFLYQSLSVVFSQF
NHANISLPEKLDKYISYIIVSPNMHKVHHHYVLPYTDSNYGNIFSIWDRLFGTFLTLPKE
KIVYGVDTHMEASENNRLSNLVAIPFQKHRSPQVLPEEKI
>LONDMIMF_00801 Phytochrome-like protein cph1
MGKISLKTTIDITFIVIVASFAILAYSIHSRSQSVKQNRMIVNHTSNINSVLEKVLSSTI
DIETGARGYTITGDENYLEVYNHGHKNLEIWIDSLRSMNETDEYQNKKLDTLEKLIESKQ
KVSAMVIKTRREYGMEEAAALIKKGRGKEVMDSIRRSIRDYQKQAVLILSDNLAQTEENV
QARNNRFFLFIFVTFGILIFAYIKIRQNTKRLLLDKIIQENLMDELTIQNQQLNDFANIT
SHNLRSPASNITALIATIEKDSPIEEYKTIFEMLRKVAQNLNDSLNQLMEVLHIKKNKVE
KELLSFQQIYSKTIESLQGEILKSGAIIKADFKEVAEIAYSRIYLESIFHNLISNALKYR
ALERTPEITIRSERKNNIVYLYVIDNGLGIDLNKNGHKIFGMNQIFHNHPEAKGIGLFMT
KTQIESMKGKITVASEVNIGTTFTVMFGT
>LONDMIMF_00802 hypothetical protein
MPYLCPLFKNEKMLGNRVLKGVLLVGLGATSYGMLATFVKMAYGEGYTTAEVTSSQFLFG
IIGILLINAFQKSRKDNVVIKASKKNITHLMIAGTSTGLTSIFYYLAVRYIPVSIGIVLL
MQTVWMGVLLEMFLEKKLPSATKIVAVVIVLIGTALATNLINTEADLDWRGIAWGLMAAA
SFTTTMFTANRIAVGISSAQRSLYMLLGGGIIVLTFALITQNTPFDASIFLKWGIVLSLF
GTIIPPMLLNAGFPLTGIGLGSIVSSLELPVSVLMAFFLLNEEVVFLQWVGIVLIILAIV
IMNVKFRKQKS
>LONDMIMF_00803 hypothetical protein
MIQRTLLFVSLYLISCGEGPAAVKNNKKRDYATFHKEAKAFCKKEKFNEDYYFLVDLSVH
SGKNRFYIYDFKTGKISDEKLVTHGSCDAGQVNDTKWEKVKFSNKDNSHCSSKGKYKIGK
RDSSTWGIKIKYWLHGLEETNSNAVDRIIVLHSWSAISNTEIFPKYTPLSWGCPAVSDDF
MKVLDKKLQKTEKPVLLWIID
>LONDMIMF_00804 Chaperone protein HtpG
MTTGKINVSVENIFPLIKKFLYSDHEIFLRELVSNATDATLKLKHLANIGEAKVEYGNPI
IEVKVDKDGKKIHIIDQGLGMTAEEVEKYINQVAFSGAEEFLEKYKDSAKDSGIIGHFGL
GFYSAFMVAEKVEIITKSYKDEPAAHWTCDGSPEFTLEPSDKTSRGTEIILHIAEDSLEF
LEEGRISGLLQKYNKFMPVPIKFGTRTETLPKPENAPDDYVAETIEVDNIINNPNPAWTK
QPSDLTDEDYKNFYRELYPMQFEEPLFNIHLNVDYPFNLTGILYFPKMTGDLQIQKDKIQ
LYQNQVFVTDNVEGIVPEFLTMLKGVIDSPDIPLNVSRSYLQADGAVKKISNYITRKVAD
KLKSLFTENREDFEQKWNDIKIVLEYGMLSEPKFYEKAGAFALYPTVDGKYYTLEELKEK
TKETQTDKNGNLVILYASNTDAQHSYIAEAQAKGYEVLLLDSPIISHLIQKLEADNEKLT
FARVDADHINNLIKKEEETISKLSEEEKEKLKTELEGVISDKKYSIQLEALDSQSAPFVI
TQPEFLRRMKEMSQTGGGGMFGMGNMPEMYNLVVNTNHELASNILNSKDKSHQEALVKQA
LDLAKLSQNLLKGEELTAFVKRSFELIK
>LONDMIMF_00805 hypothetical protein
MKKLILFGVFALLFASCKTSSITNTKTDRSSQVAIKGNWVISSVSYPGSEYIKVNSFQLA
DSQCFVGSTWKFISNNNKGEMALTKMGCPAFSSPITWFVNKDGQFVLKVLDAGEKAKRVR
DGYVLGVANQSENSFQLIDKIDVGGKLTDVVYQFTKVN
>LONDMIMF_00806 putative lipoprotein YiaD
MKRIGIYSLACLFAIGTFFTGCESAKNMNNTQKGAGIGAAAGAVIGGILGNNIGKGGNTA
LGAVLGGVVGGTVGGVIGNKMDKQAREIDNALPGAEVERVGEGIKLTLNENAVRFDTNKS
TLTATAKANLDKLVTVFNSYPDTNIQIYGYTDSTGPADYNLKLSGERAASVKNYLVSKGI
NASRFNTTGLGIADPIATNDTPEGRSQNRRVEFAITANEKMVQDAQKEVKN
>LONDMIMF_00807 hypothetical protein
MATAKNSKSKKQLIDDDQLIEMYMNTVLEKNEAPKNVYLFCKENSVEEADFYSFFNSLDA
LKETIWVKFFENTINTLHKDTNYAGYENRNKLLSLYFTFFEILTLNRTYVYYALKDNKEG
LRNLKQLTSLRNHFKDYIVDILKSAETEKDSKIKKVTTPLFSEGAWLQFLFILKFWLDDR
SKGFEKTDIMIEKAVKATFDILDTTPLESLFDLGKFIWKERV
>LONDMIMF_00808 putative protein kinase UbiB
MKTLDKIPVNKIERAGQLVKTGIKVGGNYIAYYGEKIVNPSLTKEKLNENNAEDIYDGLK
NLKGSALKVAQMLSMDKNIMPRAYVEKFSLAQFSVPPLSAPLVRKTFKKYLGMFPEEIYD
SFTADSVNAASIGQVHKATKNGKNLAVKIQYPGVADSISSDLAIVKPFAIKMFNLQGKDS
ERYFKEVENKLLEETDYELELKQGVAIAEACSVIANLKFPKYYPELSSKKIITMDWMDGE
HLSEFVAHNENRAKGDSIGQALWDFYMFQMHQLRQVHADPHPGNFLIDKEGNLIAIDFGC
IKQVPEDFYIPYFELARPEIMDNQKLFLEKLYELEILRKDDTAEEVAYFSELFNRLLRLF
TKPYQTDAFDFSDEDFFSEMAQLSEEYSKDSKLRKMNGNRGSKHFLYINRTFFGLYSLLH
DLKARISTENYKKYMKD
>LONDMIMF_00809 hypothetical protein
MKNNYKNLSIDEFGSIPRAKILQLVLILFVFLTAYESFGQGASCATATAISVNTEYRALS
NITDTTLNDPTAGACNGQTILSDGWLRFVATSSEARIVVAANNRNPILYAYSGTCASLTQ
IGCVNATTSNGTQTEILNLTALVTGDTYFIRIGNAAANPTTNPMTITSLVVLTNNNCNIA
SPLTVNAGTTCSTSTVGTTIGATQSIAAITCGGFTGNADDDVWYSFVATGTTHIITATPA
ATSGIDDIVLELRTGACNGTNLTCTDNTTTGTETMTASGLTVGATYYVRLYSYNNAGSGQ
GGFTICVTTPIAPSITSLSATNGCVGSSLTITGTNLSGATGVTIGGTAATITNNTATSIT
VTVGTGTTGNVVVTTAGGTATSGTSFTVNALPATPTGLSSNSPQCSSPGVTFTRGTPPAG
VTWYWQTTATGTSTANSGVTYNVTTGGTYYIRAQNNTTGCWSTNSASLVATINTTPGTAT
GPSPANAATSVCYSGTGAVNTLTWTAVSGATSYDVYFGAGSLPGTITANVTTASYGTGTL
AASTTYYWRIVPRNSCGITTGTPTTWSFTTNATMCYCASTSTNNNEYISRVVSGGFSNTS
AQTGYRDYTNLGSIASVMQGTATSTIRVTTSNGHANDNLYLFADWNQDGDFADAGETVTG
PVSASGSGTYTLTVTVPAGATIGTTRIRIKLIRNTNATPCHTSFNNGEVEDYLITVIPLC
SHTVTATSGSSCGPGTVTLTATGGAGTTEYRWYEYISSGSPVAVTPTGSFVTPSLSVTKT
YYVTAYNGVCESPRFPVNAFVYPAPSSSVTPAAASLCDGVIELVATGSNSGTTDTLFYED
FEVSTSTLMMLQDYGSSANGYWYIEESPSQYISYETISSGSNFGAIDSAYDLNGFSNNAL
TMSAAISTYNYTSLALTFRHYYDYDNYQAPDQAIIEVNTDGDLDGVWTAIQTYTSDQGSP
TNFATVTINLSAYINQPNLRVRFRYYSGWNYGWNVDDIRITGTSVPSPVAWTPIAGLYTD
SALTIPYTGGNSATVYAYPDAAQTYTATVTNGSGCQATDTAVISGSSNIWNGTSWSSGTA
PVAGTEKIIFNGNYSSTGDISGCLLQVNSGNVVINADNTVTVANQVRINPAATFTLEDTA
SLLQTAGTTNTNIGIIRSKRRTQPVKRLDFTYWSSPVAGQTLYNLSPATMADKYYSWNPV
SQAWVTHMNGNVTMTDAKGYIVRAPQSFSTTSAVQYEAIFQGVPNNGDISIPVYGNTSTL
PADYKWNLIGNPYPSAVDLDEFLSYANNVAALDGTIYLWTHNSAPSNAVPGDQTYNYTAN
DYATYNLSGGVATSPATPDPLNPEISDNFNGAIPTKHLASGQAFFVRGLGNLPARFTNDM
RIQDENNRFFRNMNPVKRNAANSGIEKNRFWLNLRNNQGAFNQTLVGYIEGATNGLDRGF
DGSLFGGNHVTIYSINDSQKLAIQGRALPFDNSDVVNLGIKTTIAGAFTISLDMLDGLFV
NQDIYLKDNLQNAIHNLKSGPYSFTTGIGTFENRFQIVYRNEALGIPEFNPESIVIYKKD
KDVVVTSGTATIEGVKVFDIQGRLLFDGQKINASEKVIKSLPPTDQILIVQVVTTEGIRI
SRKILY
>LONDMIMF_00810 hypothetical protein
MKLLKIISTNVLLLAGMATYAQTTQSSGSFNEAGFGVKAGLNYSTVTKGDFDEGPDARTS
FYVGAIAEIPLIDDSFSIQPEVIYSRQGFERDYSFLGNNYTAEYQLDYINVPILAKLYIV
KGFSIEAGPQFGFKINEKIDLDNNDGNAGEELDEVNDFDMSLAAGLTFQFDGGLFINGRY
NHSFNEVIKDTDAKNSVFQVGLGFKF
>LONDMIMF_00811 Tyrosine recombinase XerD
MANWATYIKNFQSFLKIERGLSQNTIDNYTFDIEKIVFYLSENQINESPVSVSDETIQQF
IYEVSKTINPRSQARIISGLRSFFNYMIFEDYRNDNPMELVEIPKIGRKLPDTLSTDEID
KIIGAIELNTDQGERNRAMLETLYGCGLRVSELISLRISDLFFEEGFIKVKGKGDKQRFV
PIGNLTQKYIDIYKTTVRSHLDIQKGHEDTLFLNRRGKQLTRAMVFTIIKDLAVKINLKK
TISPHTFRHSFATHLLENGADLRSIQLMLGHESITTTEIYVHLDRRHLTDVMNAFHPRK
>LONDMIMF_00812 Sensor protein ZraS
MAFENYVNSNESYTSNQFYEKLLREIPDLIFQFKIEKDNTYSMPFVSHSAMEIYGFDKDF
LEHDAGPIITERILKEDVKGFLKSVLKSRDTLTRWNHEYRVQLPKKGVRWLKGSAKPEAM
KDGSVVFYGRITDITANKEQELRLVLSEKRFEFALEASMGGVWDWNLVNNTVFYSEQSMK
ILDLDEAEGINSFENCISKVHPDDQKEYLTDIDMHLKGITDVYENLHRVKGRKGTYKWIL
DRGKVIERDKSGKPLRIIGTHTDISSQKEREDELKKTLDIVSEQNSRLLNFAHIVSHNLR
SHAGNFTMLLDLVDDIQDSGEREETLQHLRTISNDLTQTIEHLNELVNIHTEIKIARENL
NLHEFFQRTLNVLSEKINKHDVKIISLIPDDVQINYNPAYLESILLNFTTNAIKYSHPDR
RLEITYQLTYEKGKKVLTISDNGLGIDLEKYKDSLFGMYKTFHQHPDSRGIGLFITKNQV
EAMGGKIEVKSKVGEGTAFKIYFNEKV
>LONDMIMF_00813 Chemotaxis protein CheY
MKKFNDVFVVDDDKVYHFILKNLLKRNNIEVNSRFFENGHDAIEGLKENSKNGTTLPDLI
LLDINMPVMDGWQFLEEFRKIKGSLNKETVIYMVSSSNSPFDLDKAKDFPNEIKDYFLKP
VCLEDICRIFLN
>LONDMIMF_00814 Ribonuclease Y
MDSTLVIIISGIVGIAIGFAVAKIMERSNVSNLIKNAKKEAASILKDAKAEAETNKQHKI
LQAKEKFIELKAEHEQVILARDKKIAEAEKRTRDKESQVSNELAKTKKATEDLEAKINDY
SNRIETLEKRQAEVDRLHKSQVEQLEVISGLSAEEAKNQLVESLRAEAKSGAMSYIQETL
EEAKLTAQQEAKKIIINTIQRVGTEEAVENCVSVFNIESDDVKGRIIGREGRNIRALEAA
TGVEIIVDDTPEAIILSCFDPVRREIARLALHKLVTDGRIHPARIEEVVAKTAKQIDDEI
IEVGKRTVIDLGIHGLHPELIKVVGRMKYRSSYGQNLLQHSREVSKLCGIMAAELGLNVK
LAKRAGLLHDIGKVPDTESDLPHALLGMQWAEKYGEKEEVCNAIGAHHDEIEMKSLLSPI
VQVCDAISGARPGARRQVLDSYIQRLKDLEDIAYGFQGVKSAYAIQAGRELRVIVESEKV
SDDNAANLSFDISQKIQTEMTYPGQVKITVIRETRAVNIAK
>LONDMIMF_00815 hypothetical protein
MDEKLKIKISIADRVYPLTVDMSQEEGLRSASKKIDMMIKQFEENYAVRDKQDVLAMCAL
QFASQLEQKQIDSSADNVEANERLKKINDLLASYLDK
>LONDMIMF_00816 hypothetical protein
MSEIAQIIDTLESRLEKLIAKIEGLEKTSRELQQELDRAAVVMQKQSKEIETLKTQQETL
RMANSLLGSEENKRDTKLKINSLIREIDYCIAQLSD
>LONDMIMF_00817 Murein DD-endopeptidase MepM
MRFSLLFLLFTISVFGQNDYPKDYFRSPLDIPLYLSGTFGELRGNHFHTGLDFKTQQKEG
LNVYAAADGYVSRIKISTWGYGKAIYITHPNGYTTVYGHLQKASPVIEAYIKKKQYEQKS
FEVEMFPAENELVVKKGDIIALSGNSGGSGGPHLHFEFRDSKTEKIINPMLFGFDIQIKD
TKPPVINSLVVYPIGDSSSVNQIQKPIEINLSQQKDGSYIAEKLMAKGKIGFGVNTYDLF
DNSYNKNGVFKVEGLCNGKPFFGYQFDTFAFDEGRYINALIDYPRYKRTGQRVQKLFMVE
PYLLSIITSNNTYGMIDVVPNLYQNFQVEVSDFNKNKSVINIPIEYSALPVKVAKEEKRS
GFLLKSRKDNSYTKDNVTVFIPAGTFYEDFYIDFDVKDSILYLHNETVPVHNNMTITFED
KVSSEADKSKMFIASKQGKRLGFNKTTRKGNVFTTYTKDLGQFVLAKDTIAPKISNPNFV
EGKWISKQPFLEIYISDNMSGIAEYNGYLNGKWILLEYDYKTRKLSYNFEDNISDEGRND
LKIVVSDNMGNSATFESHFFRSQQQ
>LONDMIMF_00818 hypothetical protein
MKTKNLAAVLFFFISVAAFAQTARIKGVILDENNQPVEDADISYKNTSATSNKNGFYILT
VPANQKITIIFSHLSNKSASLDIELKPNEDFEFNPVLSKKIEMIGVVEIYDNRKRIEGIT
NISPRDIKLIPGANAGVENLLKTLPGVNNNSDLSSGYNVRGGNYDENLVYVNEVEVYRPF
LIRSGQQEGLSFTNTDMIQNVDFSAGGFQAKYGDKLSSVLDITYRRPKSFGASLEASLLG
GSLMVETASKNQKWAAITGVRYRDNSLLVNSQETETNFRPTFADIQTNVTFNPNNKWEWS
FLGNISQNRYNYEPLTRQTNFGTIDDPKALLVFYEGQEKDRYETYFGALKTTYKASEDFT
LKFIASAYLTQEQEYFDIKADYSFGELDTNIGSGSLGNIVYTQEIGSQLNHARNDLDALI
VNAEVKGFHNIKENKIEWGFKYTREDIRDRIVEWEVIDSAGFSLNPPVIDLPIRDQPYTP
YTGPLVPYQNVRALNFTKIDRLSGYVQWSKKSLIGSHDVWYNFGVRAHNWQVSGDNLDGK
NQTTFSPRGQFAIKPDWDSDMVFRLSGGLYHQPPFYRELRGADGKVNPDVKAQQSIHVVL
SNDYSFQMWQRPFKLVTEAYYKSMSDVNTYTLDNVRIRYSANNDAKAYAAGFDARLNGEF
VPGTESWFSFGYMKTEENINNRGYIARPTDQRLKFGILFQDYVKNIPNLKLYLNLVYNTG
LPGGSPSYADPYVYQSRLRDYRRADVGFSYVFTEKNELRPDGHWLKRFKDLSLGFEIFNM
FNNQNAITNTWVRDVYTKVQYGIPNYMTTRVFNVKLTARL
>LONDMIMF_00819 hypothetical protein
MRKFQTYILVAAVACLASCKEKEETPKVIYDSKPEKVVTKPDSSQIKIADLPIHMEGTKY
LIHAIGDVRVYDGNSRTYGSSKTNSVSYAISNYNRFELTGYFENLKFQHIDSTALKPLTD
KKIQMQTVTFLNTISDKTKKQILVYSLVDMDTNKDGKLDANDIKCLYISEINGKHFQKLS
EDYQELIDWNIVEAQNRLYYRTIEDINKNGAFDKNDAVHYYYVELLSPDWKTEKYDPIGN
GNGA
>LONDMIMF_00820 hypothetical protein
MYQNNPNISLPENLDTVVWKYLDLSKFLDLLLSRKLFMSRSDKFEDQYEGTFSEPTFEEI
RKISENNPEFLDAYKTQRKNVIISSWHINEYESFAMWQIFTQNSEGLAIQSTIRRIQESL
HLEKQYVQHIGEVNYIDYKKEYIPFNDDFFPFLFKRKSFQYEREVRIISNLSSHNLTINE
GVKIDVDINKMIEKIYIHPKSENWYKNLVIQLVGQLGFDFTIEKSDLESDILI
>LONDMIMF_00821 Putative multidrug export ATP-binding/permease protein
MSNFKKIIPFVLPYKKYAYLNIFFNILYALFSTLSFISLIPMMQVLFDQTKRNTTKPEFE
SIFKITDYLESYMSYKITTLTDNHGVQTTLAFMVAIIISIFLLKNLFDYLAMFFITFLRN
GILKDIRNAMYKKTLELPLSFFSEKRKGDVISRISGDVYEVQTSFLSILELIVKEPLTIV
FTIVAMFTISTKLTIFVFVFIPISGYIISIIGKQLKKKSTRAQEEQGVFLSTVEETLGGL
KVVKGYNAEKYFNNVFQKSTSRFFNLSNNIGNRQNLASPVSEFMGITVIAVLLWYGGNMV
LIDKTLEGAAFIAYMGLAYNILTPAKAISKASYSIKRGNAAAERVMEILEQENTITDIPN
AVEKESFEEHIDIKNINFRYEEENVLKNFSLEVQKGQTVALVGQSGSGKSTIANLLTRFY
DVQEGEIKIDDTNIKDLKLNSLRGLMGLVTQDSILFNDTIKNNILLGKQDATDEEIITAL
KIANAYEFVKDLPNGINTNVGDSGNKLSGGQKQRLSIARAVLKNPPIMILDEATSALDTE
SERLVQVALENMMQNRTSIVIAHRLSTIQKADKIVVMQKGEIVEQGNHDELLARNGVYKK
LVMMQSFE
>LONDMIMF_00822 Phosphoglucomutase
MHIEQNILDKVNVWLSPIFDEKTHKEITEMMTSSPKELEESFYKNLEFGTGGMRGIMGVG
TNRINKYTLGKNTQGISDYMKKVFPNEQLKVAIAYDCRHNSDTLAKVVADVFSANGIKVY
LFSELRPTPELSFAVKHLKCHAGIVLTASHNPPEYNGYKVYWQDGGQLVPPQDAEIIQVI
EDLGYDQINFQANEKLIEYVDKKIDEAFIHSTIENASFNTPAEAKKNLNVVYTSLHGTSI
KLIPEVLSKAGYTNVNIVPEQAVPDGNFPTVKSPNPEEPEALTMALALADKLNADIVVGT
DPDSDRLGVAVRDNDGKMVLLNGNQTMVLMTAYLLQQWEKAGKITGKEFIGSTIVSTPMM
LELASAYNVECKVGLTGFKWIAKMIKDFPNQKFIGGGEESFGFMVGDAVRDKDAVAATLL
VCEIAAQAKANGSSLYKELLNLYVDFGFYKEYLISITKKGIEGAAEIQTMMFELRQNPLK
EINGQRVLMVEDYQNSTALNLFTGETEELKVPKSNVLIYYLEDGTKICARPSGTEPKIKF
YFSVNEPLDAVEHAKEVEKNLDQKIKNIVAEMQLQ
>LONDMIMF_00823 Dodecaprenyl-phosphate galacturonate synthase
MNLSIIIPLLNEEESLKELQQWIEKVMTANNFSYEVIFIDDGSTDNSWSIIEGLSQQNPN
IKGIRFLRNYGKSQALHAGFAKAQGDVIITMDADLQDSPDEIPELYSMIVNQKYDLVSGW
KKKRFDSVVSKNLPSKLFNWAARKTSGVQLNDFNCGLKAYKNVVVKNIEVSGEMHRYIPV
LAKNAGFAKIGEKIVVHQARKYGSTKFGMERFINGFLDLITIWFLSRFGKRPMHLFGAWG
VLMFIIGFLSAGYIGFMKLYRLYDKQTTILVTDNPWFYIALTTMIIGTQLFLAGFLGEII
LRTKNNEERYKVSKEINL
>LONDMIMF_00824 hypothetical protein
MSEITSPAKSAVQYGVFFGVIMVLEFVILYIIGIDTITNPTVGIVINLLNFFVLPILFIT
LACNNFKKNINNGVISFSQCLKAGVTTAFIAALIYAIFTVIFNLIFPEFTQEMLEKTRTM
MTETNPNMSQEQLDMALSWSEKFSSPFIVVPFTLAFYSFVGFIYSLIIGAILKNDRPQGY
>LONDMIMF_00825 50S ribosomal protein L31 type B
MKKGIHPENYRLVAFKDMSNDDVFITKSTAETKETIIHEGVEYPVVKMEISRTSHPFYTG
KSKLIDTAGRIDKFKTKYAKHAK
>LONDMIMF_00826 hypothetical protein
MNYILFDGTVRNALLPFTFTRPVADIRVGILTIREKWEKYLGYTTTSLTEEYLMEKFPMV
EMPENIMINASFLPNEVLAEMVKSLEQNQAIFKGEEVIAFFSEESQEEVDFENYEILEYN
DDCITIEHTWDIFQKNDAALREDFELLTEDRVSQPIPKSVNVIAPENIFIEEGAKLEFVT
LNASTGPIYIGKNSEIMEGSVIRGPFALCEGAQVKLAAKIYGATTVGPFSRVGGEVSNSV
LFAYSNKGHDGFLGNSVLGEWCNIGADSNNSNLKNNYEEVKLWSYETESFAKTGLQFCGL
MMGDHSKCGINTMFNTGTVVGVSTNIFGSGFPRNFVPSFSWGGAAGFTTYVTKKAFETAR
IVMSRRNVEFDEKEARILEHVFEETKKWRKD
>LONDMIMF_00827 hypothetical protein
MAVCLLKSPAYGQSATPNESLLVKAYELVRSNPDEAVKIGQYLLKNNPSDTQKTKFYLLL
AESYWAKGDYNNSVINVFEAGKFADGAKEEEKIKILLLKSQLFRAIYLDNQSKRCLEDAA
AKISELKSKEDQNFFEAKILMGNSGMYLDRQNYQKAFELLQKADKKYEPAFSKNALLRQE
FYITKARAFVGLAKIDSANYYLAKAQKLTKNQKNFDFLNEIALLNELSAVYFHEKQHTRA
IDTLLVSMKMATRLKNEALLKVINKQLGINYLALNDKKNYQLFDNKFLKAYDTVEESEQD
AVNSAYNLISQEQEADFQKAKTRYADYFYVAVGVLFFVLIAGFLLWLKNYLKKKRLKEII
SYLEIRTNNPVRLQPEKRETHKKIAIPAETEQVILAKLKRFENSTRFTNKEMSLAVLAGQ
FDTNTKYLSEIINKHYQDNFNTYINKLRITFIIGKLKEDPNYMHYKISYLAEKSGFSSHS
SFATVFKSITGIAPGTFIDLLKEETEALKQEKVNSHAV
>LONDMIMF_00828 hypothetical protein
MQYNRYFFSAFLGFVMLFGNASFAQSMKKADSIIRASGMEIYEKPEKAIEAGKYIIANAK
DDAQIKIRGLMLVADAYSVKRDYQKSLEYVIMANKLSNHIDDPILKIKIANKMGIQYQQM
KIYDEAIQYLNEAEKLCMAYPVKDSVMYHLGRNHIVRGFIYKEKLNCDIAINFFNKGIAE
LARVDNTMVKTNISIALYNKGNCYILLSDYESAKKSFFEAIEITKGIHASSLQAFAQKGL
AEVYTLEGRYRDAIKELEEALAVSNSVGDLVLNRGIYNGLLENYLAVNDWSNYEKFHARF
LETQLKVKESERKSINNLINEGYKTQNKNLKTEISKYNYYILTTLILIIVVVIFFYVLIK
KSEKNILKLNDIIENLQNNREKSN
>LONDMIMF_00829 hypothetical protein
MIRLPTLVLVAVPDPVGIPASAGCTTYSHELAKLATLSQETVTLVVVTLLKVNVAGGAQV
EKVNSKLKQTLASESNVVEITII
>LONDMIMF_00830 hypothetical protein
MTLKLAGFVSVVDIRTSTPNLGFGKKGLKAALYLNFKAFVPITLIAGEINQSS
>LONDMIMF_00831 Putative mutator protein MutT4
MPKGGIEKGEEIENTAIREVSEETGVSGLSITKKLQKTYHVFIRNGRYKLKITHWFEMKT
NFEGTPKPQEEEGIEKVAWLNPEQIQEALKNSYENIKLLFETEKLQK
>LONDMIMF_00832 hypothetical protein
MKYLLPIFLLSIMANAQNTDFLTPYENGNRNQTATYEETIAYFQLLDKNFETISMQEMGL
TDSGEPLHIITYNSDKEFDFEKIQKDKAVLLINNGIHPGEPDGIDATMMLFRDLALGKIK
IPKHLAVVAIPIYNIGGALNRNSFSRANQNGPESYGFRGNARNYDLNRDFVKSDTRNARS
FAQIFHLVNPDIFIDNHVSNGADYQYTFTYIATHYQKLGGNLGKFWNTDMLPSLLSDLKK
KKTESVPYVNIHDQKPDGGFDAMMDYPRYSTGFASMFNTIGSMPETHMLKDYASRVKVTY
DYMASTIEYTDKNHAKIKKLRKENLQNYLPGQKYTLLWTLDTDKVSSIPFLGYEGAYKPS
EISGKPRLFYDRSKPFSKNIPYHKEYKPSLEIIIPEAYIVPKSWWPIIELLKINNIEMSP
LEKAVELEVESYRIKDFKTSSSAYEGHYPHHSVSVIPTKKKVTFKKGDFLIHTQQPGVKY
LLETLEPQGNDSYFAWNFFDSLLQQKEYFSAYVFEDLAKQLLDKNPEMKAEFEKKKSEDS
KFSDSGEAQLDWIYRYSDYYEKTHMEYPVFRVMAPIKQ
>LONDMIMF_00833 ATP-dependent RNA helicase DbpA
MNNHHSNNLLLNLGIESLNEMQLAAQEAILENNSVLLLSPTGSGKTLAFLLPVFETLQPE
ILSVQCLIIVPSRELGLQIEQVWKKMGTGYKVNTCYGGHSMETEIKNLSNPPAVLIGTPG
RIADHIDRETFRTDKIRTVVLDEFDKSLQFGFHEEMSFILSRLPKVDKRILVSATSDIEI
PKYTRVVNPEILDFTSDNEGKSNLSIKTVISEEKDKINTLFRLICSLGSESALIFCNHRD
AAERISDLLNARGIYSTYYHGRMDQDERERALIQFRNGSVSYLVTTDLAARGLDIPEMKH
VIHYHLPMKEDEFTHRNGRTARMTASGTAYVIVHESEKKLDYIDYNQEVFDIANTVSLPE
PPVFQTLYISGGKKNKLNKIDIVGFFSQKGKLEKGDLGLIEVKDFVSFAAVKSKKIKELL
KNIKDEKMKGKKFKVEIARQVIK
>LONDMIMF_00834 hypothetical protein
MSLERDLMKRSGGKCELSGATENLKVYQILPTRKGGIEESILASATCIEQIENPEKTDPN
FWRCLNESMWSEHLPVQVVSWRMLSRLGKQDLLEQMYLEEEDLAWAKATGEGDDDDTKIV
HKDSNGVTLQTGDSVVLIKDLKVKGSSMVAKQGTAVRNIRLDHENAEYIEGKVDGQTIVI
ITQYVKKI
>LONDMIMF_00835 Phosphopantetheine adenylyltransferase
MEKIAVFPGSFDPITLGHYDIIKRSIPLFDKIIVAIGVNADKKYMFSLDERKRFIEECFE
NHPSVSVTTYEGLTIDFCKKVNAKFILRGLRNPADFEFEKAIAHTNRKLSKIETVFLLTA
ANTSYISSSIVRDVIRNGGEYELLVPDSVRVK
>LONDMIMF_00836 D-alanine--D-alanine ligase
MNIAVVMGGYSDESVISLRSGQLILNNLDKNKYKTFEVHILLDGWNVIIGEEKFPIDKSD
FTFTQNGIKTKFDAIVNTIHGTPGEDGHMQAYWELLEIPYSGCNFYQSALTFNKRDTLSV
LSKFNIPKAKSIYLSKGGAINAEEIKTELGLPFFVKPNQSGSSLGVSKVNDLSEFDKALD
FAFAEDSDILIESYLKGTEVSVGVLNYKGETKVLGLTEIVPHNDFFDYEAKYLGKSDEIT
PARLSAEVEQKVRETAAKVYEALGMSGFSRTDFIVMDGIPHFIEMNTNPGLSGQSIFPQQ
AAYAKIAFSDLLDNEIELALKRKLLWRK
>LONDMIMF_00837 hypothetical protein
MTLRQYLTSKSFFKQLLLAFGIVIVLVFLLLQWLSYATDHGNEITVPDLRKLTEQQVEEK
LDELNLEYVLLDTVDYNKDFPKYTVVQQDPLPGSKVKDGRKIYIKVNSADFGMVTMPDLI
EKTLRQTESSLMALGLEVGKKTYKPYLGKDMVLEMYADGKKLKVGDKVKKASKIDLVLGD
GKVGFEESETDTIKNTDTETAE
>LONDMIMF_00838 Ribosomal large subunit pseudouridine synthase D
MIDNPIADEALDDELFEHYRFEAAKGQSPLRVDKFLMNLVENATRNKIQQAATAGNIYVN
DVPVKSNYKVKAFDVVRVLLSHPPFENLILPENIPLDIVYEDEALIVINKPAGLVVHPGH
GNYTGTLVNALAYHFENLPLNSSERPGLVHRIDKDTSGLLVVAKTDQAMAFLAKQFEEKT
SEREYVALVWGNIAEDEGTVTGDIARHAKDRMQMAVVPDGEGKHAVTHYKVLERFGYVTL
VSCKLETGRTHQIRVHMKHIGHTLFNDERYGGNLILKGTTFTKYKQFIDNCFKILPRQAL
HAKTLGFMHPTTKEFMSFDTELPEDMKECIAKWRVYSNSHTVEED
>LONDMIMF_00839 hypothetical protein
METIKIKKLNKWANSHTSYPIDILRIALGVFLFLKGVTFIKESHRLIDLLAPLGNFDGGM
FIYHYVVAAHIMGGIMIVFGLLTRWSIWAQLPILIGAVLINFAGPMVVTNLIVSLITLIV
CVFFLMYGSGKHSLDYYFKMQK
>LONDMIMF_00840 hypothetical protein
METKITFGTEQRNLFQKPSFTEELISKKEELKKKMKDKNLQLRNLLKTNFELLKSNDINM
MLF
>LONDMIMF_00841 hypothetical protein
MKKTILINGLIAGFIVTAMMVISSALCYNDPNFKGSMVLGYLGMLLAFSFVFVGIKSYRD
KHNSGVITFGKAFKIGLLITLIASTAYVAVWLVEYYFFIPDFMEKYTAHILKQAAESGAT
VAEIQAQTNEMEMYKEWYKNPILVVILTYAEVLPIGLIVTLISALILKRNQKPENYTTA
>LONDMIMF_00842 Transcriptional regulatory protein LiaR
MQKFLQKYKSTMLYGVSLALLLFLMKWLEFRFMVINHTLEIYIGLIAIIFTALGIWLALK
LTKPKKETIIIEKEIYVSDAEFIQDRNQLEKLNLSKREMEVLELIAQGCSNQEIASQLFV
SLPTIKSHSSKLFEKLDVNRRTQAVEKAKRLKLIP
>LONDMIMF_00843 Peroxiredoxin OsmC
MLINQPKITHMKFTRNASANWQGTGMEGKGTISTQSTTLDKAQLSFKTRFADGVGTNPEE
LIGAAHAGCFTMKLSFVLSELGFTPENLDTVAKVTFEDGKITTITLDLTATVSNISEEQF
QEAAKNAKENCPVSQLLNAEIILNAKLT
>LONDMIMF_00844 hypothetical protein
MKNILYIGRHPEILGTVVRLINNNEDWFGAGAETDVDAMELFERIHFHIVLLGCGIEPES
EEKLRAFFKNTNPDCVIVQHYGGGSGLLTNEILMALENHNIA
>LONDMIMF_00845 Protein YceI
MATTKWSIDTAHSEIGFKVKHMMFTNVSGNFEKFDASIETDGDNFETAQFEFTGDIDSIS
TGNKDRDSHLLSADFFDASQFPKINFKSTSFKKLNEGEYKLTGDLTLHGITKPVTLDVEF
GGLAKDPWGNTKTGLSVSGKINRKDWGLNWNSALETGGVLVGEEVKLQIELQFIKQ
>LONDMIMF_00846 Quercetin 2,3-dioxygenase
MDRKDFIKKGLMGTGMFITSAAVGDVIKNDIDEIKELEPLGFNHLPNPESLIVENTVLHK
AATRGHANHGWLDSHHTFSFANYHNPDRMHFGVLRVLNDDRVDAGMGFGKHPHDNMEIIS
IPLEGDLEHQDSMGNTAVIKKGDIQVMSAGTGIYHSEFNKNKDRLTKFLQIWVYPNKRNV
TPRYDQISLDEKDRHNKLQQILSPNPDDAGVWIHQDAWFHLGKFDKGITTEYKLKKEGNG
IYAFVIKGDFNIGNISLNERDGLGIWSTSAIAIESLSQDAEILLMEVPMVL
>LONDMIMF_00847 hypothetical protein
MYTQINANISRYVSFSEEEFATFNSFLEYKKVPKKTIMLHEGEMCNFEAFVVKGCVRKYY
IDANGFEVILQFAIENAWVSDISFSIYETKPSQVYIETLEDCEFLMFTPESKEELFAKAP
RFERAFRILMQRNLAVTQNRLFHTISQTATEKYLEFLELYPTIPQRVPQHYIASYLGISP
EFLSKIRARIAKQ
>LONDMIMF_00848 hypothetical protein
MKIVISPAKSLDFETAVPTDRHTESVFLKESNTVHKVLKKLKPKKLSELMDISEKLADLN
WHRNQEWATPFTLENSRQAVYAFNGDVYIGLDAYSLPLEKLDDLQDKLRILSGLYGLLKP
LDLIQPYRLEMGTKLPVGKNKNLYEFWKKKITKSLNDELKKGELFVNLASNEYFDSVDVK
TLKVPVITPEFKDYKDGKLKMISFFAKKARGMMVRYIIDTNAETIDDLKGFNYEGYQFDA
NLSKGNKLVFTR
>LONDMIMF_00849 hypothetical protein
MGLFGKKEKKIFKEFSKKSVEYLTDINKDTDELLEELQESYSENRFAIPEFMNLIESIKA
KISFEESEKLEELSKKIVQIKKCAKKSVSAVAELSRNQRKTTREAIREFNEFVES
>LONDMIMF_00850 Multidrug export protein EmrB
MEATSGEDSLVEYGFRRVIITITAVLCALLEIVDTTIVNVALTDMRGSLGATLTDVAWVI
TAYAIANVIVIPMTSWLSQQFGRRNYFAVSIIIFTVSSFLCGNATNIWELVVFRFVQGLG
GGALLVTAQTIITESYPVAKRGMAQAIYGLGVIVGPTLGPPLGGYIVENYSWPYIFYINI
PLGVIATILTLSYIKSPKYGEKLKASQVDWWGILLLAMFIGSLQFVLEHGQQDDWFDDKM
ITTLSIVSVVGLILFIWRELTYKHPIVNLSVLKDGNLRIGTVMCFILGFGLYGSTLILPI
YTQSVLGWTALDAGLLLIPGSITTAFMMPIVGNLIQKGVPQGYMVGVGFLIFFFFTFWMH
NVITPDTGVEHMFWPLILRGIGLGLLFVPITTLALSTLKGKQIGEGAAFTGMMRQLGGSF
GIAIITTFITRFSQNHRVDLVSHLSADKLEVQNRVQQLQQGFMAKGFSASEALNKAYQVL
DVSVMKQATVLSYMDIFLYLGIMFLCCIPIILLIKKGKNKINPADAMH
>LONDMIMF_00851 Multidrug export protein EmrA
MEKKKTNKKFTYILIALVAIGATYGIYKYVHSLSHETTDDAQIEKNMNPIIPRVSGYVTK
VFVKDNDFVKKGDTLFVIDNKDYLVKVEEANAALIAAQGNLEASKADIGGALASISISEA
NISSAGGNIETAKIRLTRATNDFVRYQNLYKNRSITKQQFEQAEAAKLEAESELKILQQQ
QRASTYQKSVAASRSNVSSKQAEIAAANIKKAQAVLDAAKLNLNYTVVTASIDGQVSKIN
IQPGQFVQPGQSLFYIINNTEAWVIANFKETQLSKMVAGQKVSIHVDAYPDYEFKGTITS
FSPATGARFSLLPPDNATGNFVKTVQRLPVKITLDAENAPDKVKNLRPGMNVDVDVHLK
>LONDMIMF_00852 Outer membrane efflux protein BepC
MKTNPLLMGMLLILGFAEVAAQEKKPLTLNDAISLAVTQSNEAGLADTKAQTSKYELETV
KNNRYPSLKISGQYQRLTEANINSKISMGGSEPAEGGATSSPKVNQLILGQASLSMPLFS
GFKLKNSVKASENRYQAELLNAKNTKEQLAMNTIILYVNLYKAQQSVKLIQENLKSSQQR
VKDFTAMEENGLIARNDLLKSQLQSSNVELSLEDAKKNVTTINYQLVNLLKLPEGTQILP
DEAVFSKLGFSEATLNESDALSSRSDLGALQWMQKASEANIKAAEGNYYPSVSLLGGYVA
FDLKNVLEVNNAINFGVGVSYDLSSIFKNGKDVKLAKSQASETKQSADILTDRIKVEVHD
AQENYALSLKQYKVYQEAVVQASENFRIVKDKYDNGLSDTNDLLEADVQELQAKLNEAFS
KADIAQSYYELLNVSGKLTDSFNITKN
>LONDMIMF_00853 HTH-type transcriptional repressor KstR2
MTVDFNEKQLEILQVAEELFAEKGFDGTSIRDIAKKANINIAMISYYFGSKEKLLESLII
FRTSDLRLKLESLFSEDLTPIEKIEKLIELYINRLNKNRCLYQILHFEFSSKKRIMDFKV
FTDVKKQNLLSLQKIISEGQEKGVFRKNINSALLPPTIMGTFFHFHTNRPFYEELFDLKT
DEAYDHFIKTEIINHIKQTIKAFLVYEN
>LONDMIMF_00854 Aminodeoxychorismate synthase component 2
MKNILVVDNYDSFTYNLVHYLEALDCKVTVLRNDEIELEEVKNYDKILLSPGPGLPSEAG
LLNKIIKEYASSKSILGICLGQQAIGEVFGSTLKNLEKVYHGTATKAKILVDDESLFRNI
PTEFWVGRYHSWVVEKSDLSPDLEVTSVDENGEIMSLRHKFFDVRGVQFHPESILTPHGK
QILKNWISN
>LONDMIMF_00855 Protein YceI
MKNFKTIAIALLVAVGSFSATAQEKKVDVKASKINWVGKKVTGQHEGTIDLSSGVLIFKS
NKLVGGNFTVDMNSISTTDLKAGQGKEKLDGHLKADDFFGTEKYPTAKLVFKSIGKKSAN
VYTVTADLTIKDVTNPVKFEITVNKNNATAALKVDRTKYGIKYGSGSFFDGLGDKAIYDE
FELNVDLKF
>LONDMIMF_00856 Putative NAD(P)H nitroreductase YfkO
MSTIINNLNWRYATKKFDASKKISNEDLEKLKEAIRLSASSYGLQPYKVLIVENPELRAK
IQPAAWGQSQIVDASHLIIFANETNFGDAGIDSFADNIVATRGIPAESIQGYVDFMKSKI
STLPVETRNHWTSKQTYIALANLLSAAAELKIDATPMEGFEAEKVNEILGLDKLGLNTSL
IATLGYRHEEDATQHFKKVRKSNEELFINL
>LONDMIMF_00857 HTH-type transcriptional regulator MhqR
MKIEEIIKTTSPMAIGKRTVLNIMYTQNVLSERFNEILKAYDLSPEQFNVLRILKGQNGK
PTNMCVIQERMIAKTSNTTRLVDKLLLKELVTREICPDNRRKMEIAITEKGLELLAELNP
KVECHESALSQNLTTEELEQLNYLLEKFRTINQ
>LONDMIMF_00858 Thioredoxin
MKKIISLGIVFLLLSCKNDEKKEAVAVPKPLKTYTQDGISVDSYSFLGLEPYLKRNNDTT
YVVNFWATWCVPCVEELPHFEKLNADYKDKKVKVLLVSIDFPKMAETKLIPFIKTHNLKS
EVLLLNDPDANNWINKVDSTWSGAIPATLIYKGDKRRFYEKSFSFDELENEVKQF
>LONDMIMF_00859 Thiol-disulfide oxidoreductase ResA
MKTIKIFAFVLLAGLVSAFTYKNMDAAAGYKVGDIATDFSLKNIDNKKVSLKDFKDAKGY
IVIFTCNHCPYAQAYEDRIIALDKKYKKQGYPVIAINPNNPEKQKDDSFDLMKVRAKEKG
FTFPYLLDEGQKIYPQYGATKTPHVYILQKTSKGNQVKYIGAIDDNYGDEKAVKQKYVEN
AVDALLKNKEVAVKETKAIGCSIKA
>LONDMIMF_00860 Thiosulfate sulfurtransferase GlpE
MNITQEQWWSQAQEDENAVILDVRTEDECNRGMIPGAKNIDIYKGQGFIYEVEELDKTKN
YYVYCQAGMRSAKACSVMEQLGFTTTYNLVGGMSEWDGPVVLPE
>LONDMIMF_00861 putative adenylyltransferase/sulfurtransferase MoeZ
MKTLYSFLFVLISFVSCQSQNKSPELIAPEAFSKRIEKGNVQLVDVRTPKEYKQGHLKGA
KNVHLYDQDFTDRINKLDKTKPVYVYCKAGGRSAEAVEIMQAQGFKNIIELKGGTDSWTE
TGLPLEQ
>LONDMIMF_00862 hypothetical protein
MKNIKYIALLFLSVLCFSCEEVVDVDLKTAPPRLVIDASIDWVKGTDGATQKIKLTTTTG
YFQNVIPVVSNATVFVTNSSNTVFTFTETPGTGEYICSDFQAVIGETYVLTVVHNGQTYT
ATEKMTAVPDITRTEQNNEGGFSNDEIEVKFFYNDNGQEDNFYLSKFETSRLPYPDYDVL
DDKFFQGNEMFGLFTHEDFKPGDQLKISLLGISERYYNYMYILIGIAEGAGGGPFQTTPA
NVRGNIVNQTDKNNYALGYFRVSERTELIYTIQ
>LONDMIMF_00863 TonB-dependent receptor SusC
MNQKNQKTHVPLLILIFLIGSWAKAQDKVTISGTIVNSQNNETLIGVSIYIPELQSGTTT
NEYGFFSLSIPKGDYTLQVSYMGFQTSEEKISLQQNLRKNISLESSTQNLEEIVITERKN
IANIKKPEMSVNKLTIQEIKKMPAVMGETDILKSILQLPGVTNAGEGASGFNVRGGAADQ
NLILLDEALLYNSSHLFGFFSVFNSDAIKDLKLYKGGIPSRFGGRVSSVLDIYQKEGNSN
EFHMNGGIGVISSRLLAEGPLEKGKGSFLVAGRSSYAHLFLKLTDNKNSAYFYDLNTKLS
YKLNENNSLFLSGYFGRDVFDIGDQFNNVYGNAVLNLRWNHLYSEKLFSNLSMIYSDYYY
GLKLDVAGLNWDSGIKNYNIKYDFKHYISDRYKMTYGLNAVYYDFNPGTVSPTGASSGIN
REQLDKKYALEPALYVDAEHEITDKLSINYGFRYSMFYRMGQQDMNIYANNEAVTFNPEL
QIYEKGKPIGTEHFGSGKTIASFDNLEPRLAVSYQLDDNQSIKASYNRMSQYIHLVSNTA
SPTPLDVWAPSDNFIKPQLLDQVALGYFRNFHNDDYTLETEIYYKKVKNRIDYIDGADLI
ANKAIEQVILNGRSRSYGLEVLLRKNSGKLNGWISYTLSRSEQQTPGRTALETGINNGKW
YSTGYDKTHNLAVTASYKLTEKWSFGSTFALQSGQPVTYPNGQYEYGGVIVPSYGARNED
RLPAYHHLDVSATYIPKPDKKKGWQGEWVFSIYNLYNRMNSASMTFRQNEDTGRNEAVRL
SIFGFIPSVTYNFKF
>LONDMIMF_00864 Phytochrome-like protein cph1
MKLKELLTPNLVYRTAQGVSFILVISVAIVFHVQMKSLNQSVDLISTSNKKQFELEKIIS
EVIQRENEMRSYIITKDSAFYNNNLTTKRKIFKSLSLLKDNFSSKQDLKNIENIDDILQK
RLALFDETLAISSAQPIDSALLNAKLLEGNRQTKELQEKIYELIEQEVTKLKIHNINHRY
DIETSTITAFSLTILTLVILLFSLNKINIDFQKVRKLNEELKFVNQVSDNAEKVAGISHW
KINMHTGKFFYSDNFYRILGEEPNAFDSKVENVTPYIHPDDYEETMKQHEESMKNHTPTS
MIYRIIRKDGQIRYISSTGDFTYNTKGELVKIGVSNDITEEYTIKLALEEKNKTLIAINA
ELESFNQIVSHDLQEPLRKIQMFISRIEESEIETISEKGKDFFFKIKNSANRMQNLMMDL
VDYSKTIKDDKVFVKTSLNKLLADVLLELNVNIEEKNATVEIGNLPKINAIPFQIHQLFV
NLISNSLKYSKKDVPPVIKIKTEKIKVGEKINDIELFGKKYHKITITDNGIGFRQEFSEK
IFMLFKRLETDINYNGTGIGLAICKKIIENHKGYIKAEGNPEVGSTFTIYLP
>LONDMIMF_00865 Response regulator rcp1
MIKDQSINIMLADDDEDDRNFFNDAIKELKINNNLTVFKNGSELMDYLEQPDTLLPHILF
LDLNMPSKSGNECLREIRQNPKFKDMSIAIYSTSSSDKDIEETFVGGANIYIKKPNDFGN
LKKVLKEVVNINWQFHTSGLNKDTFFFSI
>LONDMIMF_00866 HTH-type transcriptional activator RhaR
MKLYIKYDINQACRIIMQEQLEKFGIQYQLLDLGEIEFKESIPEETYNELREALKKYGIE
LLDNQKSQLIQKIKDTIIEMVYEKDKLPTSTISSYLSDKLNLSYGYISNIFSEHTYTSIE
NYIIMQKIERAKKLIIEDGLTLTEVSYKLNYSSVAHLSGQFKKTTGLTPSMFKRIVDKRR
SMTKE
>LONDMIMF_00867 hypothetical protein
MKIVSLLLSIFVFGIAAYFFVTDFRNSFELNYIIYMLLLLILMSICVVGVMINIPLLIRE
KRKMNVFLYHSFSKKYAANSRRIRLKKHNYFKEEPNYQDTF
>LONDMIMF_00868 hypothetical protein
MMPHKGFDITIKLTYKLHTMKTKNVLLGIAAGVAAVAVARLILKRTGAWDSMCEKASDME
DRMFHKGYRKRERESLSTLPKGEEKTVSKKHYEASKLKNAVL
>LONDMIMF_00869 General stress protein 39
MKKPDSFPAQQQSPPGKEYKMFPEPEIIQKNYTGSNKLKGKTALITGGDSGIGRSVAVHF
AREGANIAIAYYSETKDAEDTKKMILKEGRECLLLKGDLKKESFCKSIVQKTISKFGSLN
ILVNNAAVQFPKEEIEEIDSKQILETFETNIYPFFYTTFEAIKHLKKGDCIINTTSVTAY
RGSPHLLDYSSTKGSIVSFTRSASGMLADKGIRVNGVAPGPIWTPLIPSTFDEKEVKKFG
KDTPMKRAGQPSEVAPAYVFLASQDASYITGQIIHINGGEIVGG
>LONDMIMF_00870 hypothetical protein
MEDNQNKDSHHLNLGSDNGTINLKSKLPDWLLGFFKPPMVCLTDSNEGLPEGYPDDDDF
>LONDMIMF_00871 hypothetical protein
MKSLASKLFLGTSVILLGFITSCKEKTTENNVDVDMVDTTTVEEPTAPAMPDTTTVPADT
TKTPMP
>LONDMIMF_00872 Outer membrane porin F
MKNIFLLLLCLSIASVNGQSKLKKANKLFKEFSYVDASKAYEEYLEKEKSPSTQALKNAG
DSFYYIDDKRNALKWYQKLYDIQGTSMPDEYLLRYVESLKGVLDYEKADKVTKEYLAGKG
DQKRIASYNRLKKQMDSLAKEKPLYTIRNLEINTDKSDFGTAFFGDKIVYSSSKDTTKFK
EKLYNWNKQPFLNLYVAERNTANGSLFNETLFLPNAMTKYHEATVAFAPDLKTVYYSTNI
VRKKKLVNDEEGTNNFKIVKGTISDGKLNAPQDIFFNSKKYSVGHPAISEDGKWLFFASD
MPGGYGGSDLYVCQIADDGTIGPPKNLGPEINTVGNDMFPSFTNGMLYFASDGHFGWGGL
DIYESRFKEDRTFSEPRNLGAPINSNNDDFAYIVDPKDTYGYFSSNRAQGKGDDDIYYFT
KEKAPCNQMITGKVINSKSKSVIGDASVKVSDLFGDKIAETTTAADGTYKLTVPCNMKVK
VSASKTGHSTEEKEIESKKVNGAEIKDVNFELTKYDDIVIVDGNKEKIDINPIFFDYDKS
DITPQAAAELDKVVFAMSKFPKIKIKIESHTDSRGKDAYNMKLSDARAKSTQTYILSKGI
DPSRIESAIGYGESRLTNKCKNGVKCTEAGHLANRRSDFIVIEK
>LONDMIMF_00873 hypothetical protein
MKITIYKISLVFLFILISIKANAQQDPGYTQYMYNPLTINPGYAGSTGTLEAVLLHRSQW
VGIDGAPSTQAFTLHSPLTNDKIGLGFTAVNDNLGPSNEIYLDGNFSYTLMFSYNTRLAL
GIKAGARVLNVDWSKGRFYDGSDVLLNSNINNKITPSIGAGAYLYSDNWYIGASVPSFIK
GDYYDDIQESIQIERLHYYLIGGYVFNFSDNFKFKPAVLAKGVSGAPISVDVSANFLIQE
KFTLGAGYRWDDSVSALLGFQISKDFFVGYSYDYTTTDLNKYNDGSHEIILRYQLSRKTS
QIKSQRFF
>LONDMIMF_00874 hypothetical protein
MKINFTFQRAYYFLYSPILILLLFYHNPLSAQSTRVYATVISGESNTDLSANAVDGNLAT
KANVRASSGLALGIGAYSGYIELEYPTPLPANTTSYIKIQTDENLLPALLGGSLGGLLSN
VLGAVLIGNQEFTVQAKDGNNVLLQGDSQDIGEFATERLRIVTDETGDYFVAITPAQSYN
RIRLRNRIGSLLGLFNTKQLGVFDAFYISDPDDCGYASYTSYSGQGISLDLLNLGGAGVT
NPKNVLDSDPNSFSRLSLGVLGVAASIEQTVYFDGLSQTTDEFDIRLKVDPSLLALGVAN
NIQIIAYNGPAIVDSRSLSSLLNLDLLTLLQGNQVATIPFAPNAPADRITVRYTSLLNLQ
LTQRLDLYDIVRVPKMPTITDPATLNAVVCSGSTASLIANTAAGNEIRWYNTPTGGPILA
TVASGAPFQTAQLSANTIFYVAAAKIGCTEESRRVAVPVKVISLPTAADINIQSTLTACQ
GNIVLTPTTTIGGALIRYYTDQNKTQEITTGFAGHAGATYVKNPATGALTITGLSEANSP
YSYFISLTSEGICENAVNNLKEVTVNVSSILNLQIQSAISGCGSVNLADAILNLNPTTTY
VFFDASNNPITAEAASNITTSGTYYIQAQGANNTCSSDILPVAVTVNPQPNLSITNTALV
TQIGNTVTLDAVSTGTITWYAPNGMALPSNVAGPFTAAGTYTFTAIATNGTCSVSGSVTI
TVLDPNECPPLSERKYANSQRWNTILTGGVVNAGSAVDGNIQTFSTITTGIGLLGIGTTS
QILEWSETIAAGTPVTLKLGSEYSGVTLAGGFSVVGTKRNGSGTPVDVGTLQPVSGSLLN
LLSGQNNFEYTFVPANNAGPQAYDGVRIEITSLLSVAQSAKVYEAYYKTPATQIACQSGD
AEDVLYGAIDLGVGAATSLVGVTTPRNAIDNSETSFATMISSVGVLAAAELTTVFRTPSV
VGDTLKIRISRPGSLLNLNLLAGITIQPMLNEAMAGPAIGNTSVLLNLQLLPDDQGAILT
VVPQHSFDRIRIRFGGVANVLDQLRIHTIERVANTKIEGGDENNAVEACQGETIRLEEDS
VACTSFIWYDAKVGGNVVSTGNSFTLPNNLSAGIHVYYVQPVRFGCEFLARGRVSVTVTQ
TAPADAIASVQINGGNSASFCTTTGNVVLNAVLNSTMTLSNPVYYWYKLDGTTQTLIPSE
TNSSLALTGLTPGTYTYFVGVSSDEYCQTALADRKQVTFTILPPSTAGDVVIDNKTVCLN
STVTLNPTSTLANPQFTYYLTNDTTQPITNGTIGGITYALGANGTLSITGLVTAGSPYTY
YIAITSDTTCLNTAGNLKAVTVTVGNPPAPTTNNATQNFCSTNNPTVADLQVNEANVVFY
SLPLGGVPLLVTTPLTAGIYYAAQIDGSCESDTRLAITVTIGNPPTPTTANPTQNFCELD
NPTIASIQVNETNVVFYDAAVNGNLLPSTTPLTPGIYFAAILDGTCESENRLAITVTITD
PGTPTTAATTQNFCQGDSPTVADLDVNETNVVFYSSPNGGTPLAPTEALVNGTYYASLVD
PTGCESVTRLAITVNITVVGTPTTNDNTQEFCLEDRPTIMSIQVNETNVVFYNAPTGGSQ
YAPTAPLTSGIYYASLVNGVCHSETRLAITVTVSNPNTPITKFPTQNFCQANNPTVADID
VNETNVVFYDAPTGGNLLAPTTPLVAGIYYAALQVGDCESATRLAITVTISNPATPTTND
DTQEFCSAQNPTVANLQVNEPNVVFYTLPTGGTPLAPTEALTNGTYYASLRDATGCESVT
RLQITVSITVVGIPTTNSTTQNFCLSNNPTVANIQVNEAGVVFYDAPTGGNVIATTSVLT
AGVYYASLFNGICESEARLAITVTIGNPSTPTTNNGTQSFCLSNNPTVSNIQVNGANVIF
YNAPNGGTALAPTAALTNGIYYASATDGVCESINRLAITVTINNPNTPTTANTTQRFCQA
DGPTIADLQVNETNVVFYNTPAGGTALATTTPLVAGIYYVALSDGTCQSATRLAITVQFL
TDGQAVITGGGNQACSSETVTYTTAAGMTDYVWDVTGGTITGGGQTSDNFATVTWNTVGT
GNISVTFTNTTGCSSDNFATRDIAVNVCSDITISKTASNLKPSIDENIIFTITVSNNGQS
QFTDLIINEPLQSGFQYVSSNASTGTYSNTSGVWTIPTLASGQTATLQITVKILSTGSYV
NTVTITSSTPIDSNTENNIASISIEPICLIVYNEFSPNNDGDNDLFRIDCIENYPNNTLQ
IHNRYGVEVYKTRGYHNTWDGTANVNSPINEDKKLPTGTYYYILDLGDGTGTKSGWIYLI
R
>LONDMIMF_00875 hypothetical protein
MNLILSSDKVTTHFANMQENKSQNAISVISRLKKALKIKTDIELSEFLNIKPNTISTWKK
RDSVDFDSIITICELYELDLNEIFLNKKKAGAYTNHTPLISREVQFQYAKGNDNASLLDI
LPKYSFPFISADESRVFQVVSNNMFPVIDENSFVVCEKIDIDRIENDSIIVFVSHEKGLF
INRVAKSTYDDNIFVLSNENDFYSSSKLNVSEISEAWVVRGVLSYDINNANRFKFINESI
KKINKFLDDAKVK
>LONDMIMF_00876 hypothetical protein
MGVVKLVCFLLLLICAKGLSQTFGKSPISIYPAPLSEKDMMYYKWYNHPEEENIYIINFE
RNIDGFTTAFKEVRRLLAENNLKFEETISNLSSFHPDLDSEHSYEELHSSVKDEKSKIFM
TWNSGKDFLTLFLKHDIYMLILGNKKAE
>LONDMIMF_00877 Response regulator rcp1
MYVFLVDDDQDDRELFEEVIKGIDDSIDLLMFKNALELMEYLNREDISLPQIIFLDLNMP
LISGTESLKQIRSNPRFMDISIAIYSTSSLEKDIEETFVNGANIYITKPNDFSILKKTIK
NVLNINWQYFGSGMDRKNFFYHV
>LONDMIMF_00878 hypothetical protein
MKIILSSAVFFVCTISLAQDVAFISSISKTDKGNARQASDKIASLTTLSYRFYKVMEQAS
DSTYTIIYAPAALSDADLESKSEWDECLYVDFKLENKEVSKTLKFQSIRGKYLDIFPAWK
KYFKQKAHIEYTITDPTTREIVDANHGYRFILKEGENARIPRWSIINKS
>LONDMIMF_00879 hypothetical protein
MPWTYLEKLWKRTMESNTGRTTDASSWDKEIEVLYRLGISMEDTLQFLYFEKPDFGSFKS
WIKANRKDSVISVEFEEVLSKQDLEFWDKNGYVILKEVISKEECKATENAIWEFLGMNPE
KKDTWYERHAEQKGLMVNFSNHQTLNRNRLSERIYKAYVQLYKTDKIYPTIDKVSFNPPE
TENFKFMGSPLHWDVSLKTPIPYGLQGLLYLTDCGPDDGAFHCVPGFHKEINSWLEKLQP
DEHPREKAPEALTAMPVTGNAGDFIIWQNTLPHCATANRGKTPRMVQYLTYFPNDYQSAL
EWI
>LONDMIMF_00880 hypothetical protein
MPGNNLMTYLFMAKIPQSALACIVLLFFAFSGCEEDKEIVTYSNLDVSHIKDFQYIPKDS
VICRLISQHHDFHTTQIESFESHYDVIGFDKEGNELTGYADVEKGERYGKGIIEDETGRE
IEIDVEWMGDGKLKAKDGQGNIWELTIEE
>LONDMIMF_00881 hypothetical protein
MIIKKEDLKERKDFSLEEHSPFMILDTKHFQYFSDIEKFGYAVEVLNVVNSITWINKMYR
DLKSDLHIETEIFYEIIDCILNSKRFSDQQLERYYLAQQKLEQFSSITHKLTDTDNNFDV
PFTVDFIILGANQEQYENLSDDRRNELHDEYAALFCQVRSGEIEIEDFLLQVKALIFSMD
ELELENSI
>LONDMIMF_00882 Ferrous-iron efflux pump FieF
MNTHTETAIKTTYFSILGNTALALIKGAAGYFGNSYALIADAIESTTDIFSSALVLFGLK
YSSRPADENHPYGHGRAEPLITFLVVGFLITSATIIAYESILNIGTPHALPKPYTLIVLG
AIIVWKEISFRLVMKKSKETNSSSLKADAWHHRSDAITSVAAFIGISIALFFGKGYESAD
DWAALLASGFILYNSYLIFRPALGEIMDEHLYDDLVEEIRKVSLTSAGIIGTEKCYVRKA
GMKYHVDLHAIVDANITVKEGHDLAHQLIDTLHREIPQLGHILIHIEPNS
>LONDMIMF_00883 Oxygen regulatory protein NreC
MATELKKILLADDHSVVRHGISLILKESFNGITVEHAESFTSVLNLLKISVPDLLFLDIN
LPGGNSTKMIEKIRLSYPDLKVLMFSAYDEEQYALRYIHAGANGFLNKHSSESEIINAVQ
SVMETGKYISATVKEKILENVLHKTPINPLESLSDREIEVAGLLARGEGNLEIANQLNIQ
MTTVSTYKNRIFEKLRINNVVSLVEILKIYEN
>LONDMIMF_00884 Sensor histidine kinase RcsC
MFAVFFSISTLFSQQENREYDIIWHSADDNSLPQNSVKSIIQDKYGFLWLSTENGLVRYD
GSKFKVFNIENLKGLGTNRISYFRGTVSTDSIYALSDFTDLILIKNNKPSVIPKHKIPES
FRLTNHLHKGKRVYVHKIYKTDNSYFSLENGTLAAYTKNNQKLWEIEYEYDPDNTEFFLL
NNTLYSHKNGKFVRFENGKIFFTAIEGLPATGFTVFPNTVAQQTFITFNNTVYLLEKNHD
KLILKVLLKDFNISKNNIISYYYDVPNDILYLGSSTDGLLIVKKKKFNSIVGNNKNGVYY
AQIPHGKDSFLSTTGEIFSTSGVQKKRFFTKENDNYILLKDRNGDIWTKQDNRIYRLNKS
TNFTTSDTWFFEDRVILLFETLKGEILAGTATNGAPAGKLFRLEDTGLSKPSFKLYMVVP
FHPTYMLQIEDNILWTGSHLGFHKIYFREKKVENIKKISNTYVRSIYIENPNEIWVTTYE
KGFFLYNPYTKKTTHFPIDKNRYLLSSHCIIEDQNGYLWISTNKGLFQASKKNLLNYSKG
KTDNVYYQYYDKSDGFYTNEFNGGCQPCGLKLGNNALSFPSMRGNILFFPEKIKLLLPDN
EIYFQEAEVDNRTQEINNDTLFLKNNFGRVRLFINSPYYGNPNNLNIEIRLQGPISQKWT
SLKGDEISYTSLPHGTYYLTARKLTGFDSNYKHKTLTIIIPPAFYQTIWFNILMVLCGLT
LIFYTIKMRIRYIRRKNVLLEKKIAEQTFQLRNTISTLRNTKEKLSEEIINHKKLIRTIT
HDIKSPLRFLALTGKHAYQNSNNIKLVEEDLKSIYTSSFQLYHFVDNLLEYTKVSKQENS
SEPYSLYTLAEEKTTIFLNIASSQKTEIINKIDTTLVLSTNKLLLSIIIHNLLDNAIKNT
FNGRIVLTSGKRDENIFIRIKDTGKGMSPELVDFYNTSKNSKTQEGIRKIGMGLPMVAEL
LIILNGSMNIESTVQLGTEITIWLQEEKSS
>LONDMIMF_00885 Aquaporin Z 2
MSLPTFASGHKKMFAKVQLASILAEFAGTFLLTFFVVAAILIPFFQDNFFNQLLLCLSIG
ILTFLATFFFYPISGSHYNPAISVGFFIANRIGFNRLIAYTCMHVAGGILATFLGFYLFS
QKGGTISGMFIKPTVLGYEEGLMLSTVCQSVLMFIILLLFLGLTYLKKSKLYVASIMAIT
VFMANFVNMSITNYPLNPAITAAELLFYGNHGSIETLSLWLSPFAGAGLAGIIYYITFIR
PIN
>LONDMIMF_00886 hypothetical protein
MCRLNTFEYTRPEIQLELAAFLTEISQAAINSVLFPCVQLASAATSVTDGVELLVSEPEG
KNSTFQIPACPAPTVTE
>LONDMIMF_00887 hypothetical protein
MKGKWTSAPNSCTLISPILVLAGSVFPAPSRPSQKTVLVPILQFPVMVLVGKAPSISILY
VPERLESKPM
>LONDMIMF_00888 Protein RecA
MSSEKEAKLKALQLTLDKLDKTYGKGTVMKLGDQAVEEVETIPSGSLGLDLALGVNGYPK
GRIIEIYGPESSGKTTLTLHAIAEAQKAGGIAAFIDAEHAFDRNYAEKLGVDIENLIISQ
PDNGEQALEIAENLIRSGAIDIVVIDSVAALTPKSEIEGEMGDSKMGLHARLMSQALRKL
TGTISKTNCTVFFINQLREKIGVMFGNPETTTGGNALKFYASVRLDIRRSSQIKEGENVI
GNRTKVKVVKNKVAPPFKTAEFDIMYGEGVSKTGEILDLAVEFEVVKKSGSWFSYGDTKL
GQGRDAVKSLIKDNPELAEELEQKIKSLIKENND
>LONDMIMF_00889 hypothetical protein
MRGIITIMEKLISYPISVVYYLIFGLILVIFHPIQWLCFNLFGYQAHKKSVDYLNLCLLR
ATHLLGTTYKVEGRELVPKGVPVIFVANHQSMYDIVAIIWFFRKSHPKFVSKKELGKGIP
SVSYNLRHGGSVLIDRKDPKQALPVIKGLGEYIEKHNRAAVIFPEGTRSKTGKPKEFAQT
GLKILCKNAPSAVVVPITINNSWKIVKYGFFPVGLGNRLTFTAHKPIAVAEVPFDELMKE
TEKAVVDGIKN
>LONDMIMF_00890 Putative acyl-[acyl-carrier-protein] desaturase DesA1
MSVKNIRLEVMQFLEKNIDAFVDQYLIPVEDIWQPSDLLPDSRSETFFEDVKELREIAKE
LPYDFWVVLVGDTITEEALPTYESWLMDVEGVNQVDEGGNGWSKWVRSWTGEENRHGDLL
NKYLYLSGRVNMREIEMTTQHLINDGFDIGTGRDPYKNFVYTSFQELATYVSHNRVSQIA
KKFGDKKLSKLCKLIAGDEMRHHHAYSEFVHRIFQVDPSEMMLAFQYMMKQKIVMPAHFL
RESGEKISTAFELFSDSAQRIGVYTATDYIDIMQKLIDKWDISKITGLTDEAEKARDFLM
KLPARMAKISERLVIPAESHIFKWVEPATLR
>LONDMIMF_00891 hypothetical protein
MDKILIEKTIAFVKEKLKDAEGGHDWFHIERVYNNAMNIAKDENCNITIVALGALLHDIA
DSKFHGGDETIGPKLAWEFLESQNVPEETIIHVVNIIENISFKGGNFERKFSSTELDVVQ
DADRLDAIGAIGIARAFNYGGFKNRALYDPTITPNMNMSKEEYKSAVSPTINHFYEKLLL
LKDRMNTKSGKAIAEERHTYMEKFLEQFFAECEGKR
>LONDMIMF_00892 hypothetical protein
MKKIVFTLLYIITLYSCENDTEIVGGTKKDYYFKITEFIISENSIDLNNDNVINSNMLLE
FSNYFNNTYDLQIKANNNSSLLSFYLPKQNIFFDYLCCPNGYVEFSKNGFTINMNRRQTI
LENQIIDNENKIILFSKLNDSSYKLILEKKYFDFNSNAFSAETFEIKYDIIK
>LONDMIMF_00893 hypothetical protein
MKNLLSSKLISFDAKAFVSKMKRESKKLAFVFSILALSSCSTEEDFTENKTVQELDKISP
KDEKSILKEKFAFSLMKSIKESPGLRDIIKDEALKMFNKDYEVLVYTIKDYTLENGMTLE
QTINQNADSNFQLSNLLRVEPTLTLLVPELPLESFSAKKWNTQSEIPAVAIRTNYTNQVP
LITPDLNLEMMPSDVIPGFPVIVVKNNERVVSNLENPNIRDLKTTTVFEKDGIIMKFWTD
SFNNEDKRKARLLIHPDRTLISAYTIYDEQSPNLDGWQRDFIYYKIQPSSSNGPFIYDFK
EHLRSFSMTGDPTNAYNRISDQTGDPTFRNNHRINTSHWTGGFYEFKVRTIINAKNGVGN
ELINGFTVSPDDLFFLEYETYTKGTLFWEKTYYRLKNISNKTVYVDVPLINWDLDEYASS
IKIEIEEVDLTITSVITDTRTVKFATNFGIDTALGVKTKIGLKFGASVETIQTQTVQKTF
TQGNNFLGEAIVNFADKVIIRKTNLRNMWITRDYITGSGYCEFSIEPKKVQ
>LONDMIMF_00894 hypothetical protein
MKKIIYITICLLVFQTNYSQKKDIEKSLFNFQTGVLGTWINNETKLTTNLALRSEIGLDA
GIFGGEINDNSGLFLTPVITLEPRFYYNINKRESKNKNTSNNGANFLTTSISYHPDWFVI
SSKNNINVYNQLSVIPKWGMRRNIANSNFNFEAGIGFGYRFYFLKQYGYLKNDGETALDL
HLRIGYTFKNSKK
>LONDMIMF_00895 hypothetical protein
MILFLIVDAEVLASGDGNLGKNKFFIKQF
>LONDMIMF_00896 hypothetical protein
MKSLFVSSKLELMRIGNHKNISFADIVILYNIDLYNDTD
>LONDMIMF_00897 hypothetical protein
MIGKVLNRIRFERFKNGFSQEYVANELKISQSFYSKVESGKNSLTLDLLLKLAALFRIPP
EELLK
>LONDMIMF_00898 Short-chain-enoyl-CoA hydratase
MNYENILAASENGIATITINRPTKLNALNKTTIEELHSAFDAFDKDHSIRVILLTGSGDK
AFVAGADISEFANFSVSEGAELAAKGQATLFDFVENLKTPVIAAVNGFALGGGLELAMSC
HFRIASDNAKMGLPEVSLGVIPGYGGTQRLPQLVGKGKAMELIMTAGMLTAEEAKTAGLV
NHVVPQSELLELANNIAQKIMKNSPVAIGKAIEAINANFKDGVDGYAVEIKNFGDAFGTE
DFKEGTGAFLEKRKPSFTGK
>LONDMIMF_00899 Sensor protein ZraS
MLKPIKIKRLSLRVRIFLSMIFLTLISSILMASLSVYQFKTAAKEYHEERLERRETAVKE
HINYILNTTTYPLTTENLPLIFKDEIYKLADIHSLAINIYSLDGKLLKSSKASFTVDTIL
PPIPNYILKLVQSSMDKRYVDVQSIEGKKFRSSYTQIKDTKFKPLGILNLPYIPDDGFYE
RELRNFLISLGQVYSIMLIIAFVLAYFLSSYITKFLKSITDKITETRFNQKNEKIELEES
SKEIALLVHAYNSMVEELEESASKLAQSEREQAWREMAKQVAHEIKNPLTPMRLTVQSFQ
RKFDPNDPEVKQKMSDYSNTLIQQIDTMSSVASAFSNFASMPAQQNETLNVVDVVQLTLD
IFNEDYIEFRSDEKEVITIMDRTQLIRIVTNLVKNAIQAIPEHQLKKSVIVSVKKEGEQV
LISVQDNGTGIETDNLNRIFEPKFTTKNSGMGLGLGIIKNIIENYNGTITFETASGKGTI
FNVYLPIIKM
>LONDMIMF_00900 hypothetical protein
MENYYEYLKSLHLIFVITWFAGLFYIVRLFVYQIEASQKESPEKEILQKQYKIMTYRLWY
IITWPSAVLASIFAFWMLFFTPQGNFWLQQSWMHVKLGFVFALYLYHLKCHQIFKQLQND
EVKHTSNFMRLWNEGATIILFAVVFLVILKNAVNWIYGVVGIFLFSILIMLGFKFYKRIR
ERNQS
>LONDMIMF_00901 Ferrochelatase
MKGVLLVNLGSPKSPEPKDVKPYLDEFLMDKYVIDVPYLLRALLVRGIILRKRPEESAHA
YKKIWWEEGSPLMVLSERMHKKVQAKATIPVALAMRYGEMTIEKGLQELHEQGVTEVLLF
PLYPQYAMASTLTILVLAEEIRKKKFPHMKFTDVPAFYNKPDYIKNLADLMKKHLEGFDY
DMLVFSYHGIPERHIRKTDVTKSHCKIDGSCCATPSAAHAFCYRHQCYETTKLVVEQLNI
PKEKYCLTFQSRLAGDKWLEPYTDIEINNMPAKGIKKIAVVTPAFVTDCLETLEEIAMRA
NEDFVENGGEEFLAIPCLNDDDNWVETVNNWIEDWASEKATI
>LONDMIMF_00902 Regulatory protein PchR
MSSAEEIKIEDDFIIIRIQNDSDETSHFEREVNVDLIQFHFGIKGRAKFIFNQGRYALDL
REDLSLFLYNPQKELPVHLEIAPHSWAISVLISIKKFHGLFSSEADYIPFLSEENKDKKY
YKDEPISPSMSIVLNQLFNFNLHPSIKNLYFKGKAYELLSLYFNRNEDPNAEQCPFLVDE
ENVLKIRKAKDIVIANMAEPPGLQELADQVGINLKKLKMGFKQIYGDSVYSFLFDYKMEF
ARKLLDSGSYNVNEVGLKIGYSTASHFIAAFKKKFGTTPKKYLMSIAVTN
>LONDMIMF_00903 Glutamyl-tRNA reductase
MNKNNLSKHHYFYAVGLSYKKADAEIRGKFSLGNQAKSDVLQQAKENGIGSLIVTSTCNR
TEIYGFSEHPFQLIKLLCDNSQGTVDEFQKVGFVYKNQEAIHHIFRVGTGLDSQILGDFE
IISQIKSSFSEAKSQGLANAFMERLVNSVIQASKKIKNETELSSGATSVSFASVQYIMNN
VPDIRNKNILLFGTGKIGRNTCENLVKHTKNDHITLINRTKDKAEKIAGKFNLIVKDYDL
LPLEIPKADVLVVATGASNPTVDQELLKLNKPLLILDLSIPKNVHDNVKSISGVTVVHLD
DLSKITDDTLENRKKHIPQAESIIETMMEEFTEWVNDRKFAPTIHALKEKLNSIKDTELN
FQRKKISNFDEEQAEIISKRIIQKITTHFANHLKDSDTMVDESIEWIEKVFQIEPSRK
>LONDMIMF_00904 Porphobilinogen deaminase
MNKIIRIGTRDSQLALWQAHTVEKKLNDLGYQTEIVAVKSTGDVILDIPLYEFGITGIFT
KTLDIAMIKGEVDIAVHSMKDVPTALPKGIVQTAVLKRANHEDILVHKGNLEFLHSNGTV
ATGSLRRQAQWLHRYPNHQVVDLRGNVNTRLQKLKDNDWNGAVFAKAGLERIEILPENHT
VLDWMIPAPAQGAMVIVAMESDDFCKEATAKLNHFESEICTHIERQFLRTLEGGCTAPIG
AFAEVLDGKIRFEGVLFSIDGKEKIEIEKTVEVTHYKNFGQEAASEILANGGQELMEVIR
RDLKK
>LONDMIMF_00905 hypothetical protein
MPEPIRILSTKKLLPNQRQFLLNAGFSVIEANFIQAVGKKFELGDEDGNLIFTSQNAVKS
FLENEKAQNLKNKKIFCVGTKTKALLEQNGYKVLASKEYASELAEVIVNDFKDESFLFFS
GSLRRDTLPEALQKANISLKEIEVYETILTPQKINGPVDGILFFSPSGVQSYLKENTIVN
QNCFCIGTTTAAPLEQLTDKIIIAKQQTVENVIIQTINYYSKKL
>LONDMIMF_00906 Uroporphyrinogen decarboxylase
MIKNDLFLRALNKETVERPPVWMMRQAGRYLPEFIALRDKYDFFTRCQTPELAAEITVQP
IRRIAPDAAILFSDILVVPQAMGIEVLMKESVGPFLPNPIRTIQDVEKVVVPDIQETLGY
VMDAIKLTKEMLNDEVPLIGFAGSPWTIFCYAVEGKGSKSFDTAKGFCFTHPEAAHVLLQ
KITDTTIAYLKEKVKAGVNAVQVFDSWGGMLSPTDYQEFSWKYINQIVEALAPETHVIVF
GKGCWFALNEMGRSKASALGVDWTCSPRNARYLSGGEITLQGNFDPSRLLSPIPTIKKMV
TEMINEFGKDKFIANLGHGILPNIPVDHAKAFVDAVKEYK
>LONDMIMF_00907 hypothetical protein
MLTKGLRDEENERINNILKQLISLVYVPENWNLDELEKHLNYLALILEKLLGFSSDDLIA
HLEKLHFDWANAEQFADFIVLLSDRKEEERTQLREKAVVIYEYIQKESKVFSFDIFNKIA
KAKA
>LONDMIMF_00908 Oxygen-dependent coproporphyrinogen-III oxidase
MKNKFYAYIQTLQDKITAELERVDGQATFRQDLWDRPEGGGGRTRVIENGAVFEKGGVNI
SAVHGSLPQAMQTYFKVGDVDFFACGLSLVIHPKNPMVPTVHANWRYFEMYDKEGNTVDQ
WFGGGQDLTPYYLFEEDARHFHQICKSACDKHHPDFYSKFKKQCDAYFWNAHRNEARGLG
GLFFDYCKASEDFTLDNWYDFVTEVGNSFLEAYVPIVEKRKNLEYTPENRNWQEIRRGRY
VEFNLVHDKGTLFGLKTNGRIESILMSLPPHVQWVYDHHPEAGSEEEKLINILQNPIDWI
>LONDMIMF_00909 Delta-aminolevulinic acid dehydratase
MFPLQRNRRLRTNDSIRSLVRETHLSPNDFMFPMFVAEGKDYKVEIPSMPGIYRRSLDLT
VKEVKELWDLGIKAVNIYVKVDDKLKDNTGKEAWNKNGLMQQTIRAIKDAVPGMIVMPDV
ALDPYSVYGHDGIIEKGQVINDATVDALTLMSLSHAEAGADFVAPSDMMDGRVLAIRKAL
EENGHHNVGIMSYSAKYASSFYGPFREALDSAPVDNMDVPKDKKTYQMDYANRIEAIKEA
LHDVEEGADIVMVKPGIAYLDIVREVKNAVNVPVSVYQVSGEYAMVKAAAERGWLDHDKI
MIEQLHCIKRAGADIISTYFAKEAAIILNK
>LONDMIMF_00910 hypothetical protein
MKNLFFILPALFLLSCQKETKKESLYPEKTLSAEEKQLELGREIFDGKGMCYSCHKPDQK
VIGPSITEIAKIYKEKNADIKLFLKEKSEPIVDPSQYSVMKTNFAITKTFSDEELKAVEA
YFYSHLKSEK
>LONDMIMF_00911 hypothetical protein
MKTLKLSFFALAGALLLSASSFAQTAAPAKAQPAAAKQAAKASGVTWTSDVHDFGDIQKG
KPASFDFTFKNTTKQTVLITNVKASCGCTATNYTKTPIKPGETASITATYNAASPGPFSK
SVTVTTNDTETPKILTIKGKVIEPQS
>LONDMIMF_00912 Alkaline phosphatase synthesis sensor protein PhoR
MKFNRLNIIIFIGLLAIVGVLFMQLLTLSQAYAFEKKEFSEKIHFALQDVVAKIHKDNKT
EVPVTSQIKKITDDYYIVNVDDVFEASVLEYYLKTEFQKVKLNIDYEYAIYDCSSDEMMY
GKYVSSSDKKAPRCEKCFTKKEGLVYYFAIRFPQLKYNYITSLQQYWIYTGVLVLVLVIY
VYSVLLLIKQKKYTELQTDFINNMTHEFKTPISSILIASNYAKNQEEITKNPKLSKYVQI
IIEQSNKLNQHIEKILHIAKSDSHMLELEKTRFNMFDVISLAKETILLKYGKEISIEIQS
DRTEYPIVADEFHFSNVVYNILDNAIKYNDSTPKILIVITENQKEVKLEFIDNGIGIETP
ELNAIFDKFYRISSAKRNEVGGFGLGLFYVKKICTLHRWKINVKNNPDNGITVTISIPK
>LONDMIMF_00913 Transcriptional regulatory protein WalR
MAKSKIFYVEDDATLAFLTVDYLEQFYDITHFSDGAEAVKNFHKDNYDLCILDVMLPKKD
GFEIAQEIRNANAEIPILFLSAKSLKEDRIKGLKLGADDFLVKPFSLEELSLKIEVFLKR
SSKAPIVTQKSYEIGSFLFFPNDYCLTRNAEKVNLTERESALLKLFLDNKNEILKRERIL
TALWGDDDYFMGRSLDVFISRLRKIFKEENSVRIENIPRIGFKLVME
>LONDMIMF_00914 Methylated-DNA--protein-cysteine methyltransferase
MLQAYINTPLGIAEISGDENGISSILALDKGSPVSTAIPPELQEAVLQLQDYFDGKRKDF
TFKMNPSGTEFQKKVWKGLLEIPFGKTLSYQEFSIRLGDVKAIRAVASANGRNPLWIAVP
CHRVIGSDGSLTGYAGGLWRKKWLLEHENPVKQQSLF
>LONDMIMF_00915 6-aminohexanoate-dimer hydrolase
MRFLKKFLLWFAIVLATFILLLYIFNLDYLIRAVRITYLNGEKTAFLEDYTEFPNREIKK
GTGQPWAISKEYNKQKPTDILEETHKKFETVAFLIIKNDSIWYESYYDGYDKDSKSNSFS
MAKSIVTAALGKAIMQGKIKSLDQKVTDFFPEYAGKYGDKMTVGDLSSMASGLDWDESYY
SPFSITTRAYFDDNLTDLMLGLKVVGEPGKEFKYLSGNTQLLSMVIEKATGQHLADYVSE
QFWKPLGAEHDALWQIDRPDGVEKAYCCIASNARDFARFGKLYKQHGKWNGKQILDSAFV
EKCVTPRFADAPMYGYGWWISDYRDKQIYYMQGHLGQYVIVIPKDDLIIVRLGRNRDERA
DGNFHRNDFYVYIDETYEMISHDRKN
>LONDMIMF_00916 hypothetical protein
MIEKINLENILFLDIETVPEEETFTALDEEKKELFDLKTQYQRKEQFTAEEFYDRAGIWA
EFGKIVCISVGYFTFKGDIRHFRVTSFFGDEKKILGDFTNLLENYFAQPQHILCGHNAKE
FDFPFIARRMIINQVKIPGKLNLFGKKPWEIPHLDTMELWKFGDFKHYTSLKLMAKILNI
PSPKDDISGSDVGHVYYVEKDIDRIITYCEKDVITVAQILLRFRREDLLIEDEIIHI
>LONDMIMF_00917 hypothetical protein
MKKITLLVASILFVGNIANAETTHYLGEKNFSANLDMDEPIAFVERGITFYVFPDGEFDF
NTEPTVANDVFYYKSGRRSSSANVNTTYGAPGVRNGQGVKIEHDSQGRIRRVGNVFVNYD
AYNRIKRIGTVYMSYNRYALSQIGGLQLIYNRRGEIVDMVGSVKANDYAVNNGNYYYGSG
NGYQYGNNNNNNYYYRTEKTPEKEK
>LONDMIMF_00918 Extracellular serine protease
MTKNSTSAFKVLTLLFLFSIPSIGFGQDKNDIQQITKDYDLKKLKELEEIYRKKAVSQKQ
QALKAAKLNNWPEFIKNENGTVDELIKLTPDGFPLYYSVNNKNAAKSTRANFLNTGGALG
LNLDGQGMVARVWDGGKVRASHREFGGRVTVNDAVAGSSGNNFHATHVTGTIAASGVDAN
AKGMAPMAQVRTFNWTNDQSEALSEIQSGMLLSNHSYGVPIVNNGQFAPSWYIGAYTTDA
RAWDEIAYNAPYYLMVASAGNNGEDENPNPFAAGFDKLTGNKTAKNNLVVANAQDAFIAA
NGNLISVSINSASSQGPTDDFRIKPDITGNGTSLYSTFETSDSAYGTLSGTSMASPNVTG
TLLLLQQYYKIKNKRFMKAATLKALACHTADDAGNPGPDAVFGWGLLNAKKAAETITANG
LGTVISEETLQQGQTFTMTVNSNGTEPLQATIAWMDVPGITNNGNLNDPTPALVNDLDIR
ITKGTSTYFPWKLTSNPNDNAVNNGDNNVDNVEKISIPSASGTYTITVTHKGTLVQGPQN
FSLIVTGVNSTFSLTPLSEDQTVCSNSNAIYNFQHTTTTSENTNFTILGLPAGTTGNLSA
SSSSINEALTMTITNLNTLPAGNYTIGIRGTRGTDVETKYVDLKVYSNTFQNSTLLSPAN
NISGVAPTVQLDWAPSANAESYIVQVATDSGFGTLMVNQEVTETTYFLNNLTPQYNYYWR
ILPKNRCATAISSTVYNFQTGALNCGQTFSATDFSEATIATTANAVGSVPVLVTGGMTIG
GLTATIDISHTYIEDMTIYLEGPEAIGSPYIKLFEEPCGDNDNIVATLSDAGIAFSCGAT
APSISGTVKPLEPLSNFNNLPADGIWTLYAIDKYNGDGGVINSFSLNFCNVTPSSLTVAD
SQLANISVYPNPSKGILNVSLPANSGNTTLYLNDIQGRRILTKETSNTNEVLNIDNFSDG
VYILTIQNGNLKTTKKIILNR
>LONDMIMF_00919 Glutathione import ATP-binding protein GsiA
MKKQPLLEVNALEISFKKDGGFKPIINSISYALQSNEILGIVGESGSGKSVSSLAVMGLL
PKNISKITKGEILFQGKDVSRFSKEELQNLRGKNISMIFQEPMSSLNPSLKCGFQVEEML
LQHTKLSKKEIRKETLDLFDRVKLPNPEKIYESYPHQISGGQKQRVMIAMAIACKPKILI
ADEPTTALDVTVQKEIIQLLKDIQQETGMSIMFISHDLALVSEIANRVLVMYKGEIVEQG
NASDVFHNPQHIYTKALVSSRPSLDVRLKRLPTIQDYLKNSVSDEIITTDERKKAHEKLY
SQTPILEVRNVEKEYFSSAGLFGKRIGFKAVNDVSFKIYEGETLGLVGESGCGKSTLGNA
ILQLDKATAGQIFYRGIDIMKLLKEDIRALRKEIQIIFQDPYSSLNPRIPVGKAIMEPMK
VHKLYKNDAERKAKTIEILERVGLGAEYFNRYPHEFSGGQRQRIGIARTIALQPKLIVCD
ESVSALDISVQAQVLNLLNELKENFGFTYIFISHDLAVVKYMSDQILVMNKGKIEEMADA
DALYDNPQKEYTKKLIAAIPKGN
>LONDMIMF_00920 hypothetical protein
MKYILIVLFLLCVSCTDKKEETAEVATSSEVEVIPTNESAFINKDSLLLDSKGISADKIV
ITEIKRSYDKDSIGTAFFEIGFFKNNKAIYTYPTKIVFGMDEGAEWNINQEFMSDSENEN
IDTRFIHCNYGIAACGYTHNHFLFFLDEKGVQLVTQWDSMWDGGYGVDQRFEPDFKTKPM
RSFFARTIDVSSDETVNDSIERVEVSYTDSVRYNFENGKWKKIQLTQKGKIYRKENFTFE
EYYKQ
>LONDMIMF_00921 hypothetical protein
MDYTILGFVADIKNDIIKEFLDETSNDLSVYSGKSGVLCFLIEYYVLTKDESILSQIDDL
INSDLKIYEDNKVSSYAFYTGNSGFAFLLIKLYAITKEEKYKEYSLLILKNSKSHFDFIN
RPLIELISGVSGILLALLHAANSGIEEEWLYEDITFYVELILESANISKEGIFWDVTQKN
IQGLTGFSHGTSGIGFVFFQIYKLTNIEAFKEIAYLSFEYEDSAFIEEKKNWRDFRHYPY
TELARKIFIQEAISENASFFTPVKTMNAWCHGAPGILLSRIETQFKEEFTREVFNSVLPS
IHEPDNHSICHSRIGNALCFIHVAEFLGIDIKDDIQKIGSELIDFYKKEGIFLDGYNNGK
KNHNLFMGTLGTLYFLLKAQAYINGIAIGSSIVFPKLENTGNNNHALERLKKYDATNAVK
IILSNKYKKTFELLDRRNISLNYSIPNFKNVFAQQIAGVKDEQLSAIYNFEHLLIENQAQ
SIPYNYNYFLIVKDAELLEKADKDGFLNMGIKLNTSFRLLDSKVLLDDFSDVVKLDSVLI
SNFPMPCFFRLEKFSLILVNFLREHSSVVIKDVVNSFLSNFSSEQDKNQAEVLLLENIKN
FILKGIIRIKHV
>LONDMIMF_00922 Lactococcin-G-processing and transport ATP-binding protein LagD
MFKIYRQKNAFDCGPICLKMIAKHYGREVDLDYIKKLCKTNSEGTTLLDLSTASEKIGFN
TLKAKVSKSDIDKIPLPFIAHWDNFHYIIVYKITRKHFYVADPAKGKIKYTREDFFNYWA
VNEGDEGYVLGLEPSAEFNKEKSLKISFIKEILVFLTPHKKIYFQVVFALLLGTIIQIIL
PVLSQLFIDRGVGERDTSLLFLIICGQFVLTIGGIFTNFIRSITSLHLGTIVNVSIVSDF
IKRILKMPISFFENKQVGDILQRINDNDRIEQFLTESLVNILFSILNLFIFTTILAIYSL
KIFVVFLIGSVLYMTWIILFQKRRKKIDRELFGLNSNNTSALLEIFEGVNDIKFFNIEKN
KRWEWEREQARIYKANRKMLIVNQIQSSGSITINTLKNFIILYIAATSVINGQISLGMLF
AIQFVLGQANAPIAGIMVFVRDLQFAKLSFERLNEINNEIQTVTSEGIEVVDPEPISDDI
SVSNVSFSYSQDNSDFSFENLSVTFPKNSITVVVGESGSGKSTILKLLLKYYVPSQGEIR
IGNSEIGSIDSQWWYKNTGAVLQNGYIFSDTIRNNVALGDETVDEKRMQEAIETVNLDKF
VQSLPDKYDTMLGKGGNELSQGQRQRILIARLVYKNPKYVFLDEATNFLDSENETIILNN
LKTFLKDKTTIIVDHKLSAIKSANKIIVVDSGKIVEEGTHESLMKLNSKYSNLIKQQKEL
NNTDFNK
>LONDMIMF_00923 hypothetical protein
MKEKLKLEDLKLESFVTELDNSFSFDIKGGKAATYGACDNTGKTLDCSGWLCDSTDVSQQ
SECETCGRECGVKTLDPRPRL
>LONDMIMF_00924 hypothetical protein
MLHQIIHPLSVEDFFSKYFEKQYLLIKRNDKDYFKDVLNVDSLDQLIFSSSNYYPTFKAV
SHSKGKLDPAKYCTNVNGGYVIDSSQFVKCYQEGYTLVLSDIQNKILSLRNLTNDVTKAL
GHRTGTNIYITPKDSQGFPAHYDTHDVFVLQISGTKKWRIYDVFEELPNGEMKFDNNFSD
TGNVLDEFLLEEGDMLYIPRGMVHDANCDDDSSIHITLGLFGKSWGEIISEYISESTQFH
KILRKYPKLYNSDFDNLNSEDISEIADLISNLIVNIKSDFKKLNNFEEHVRPANLGFFKQ
IYSLDSFNSSSFIYPSKMEKFNVIDKENGAISVHNSKIQLTLPAPCKEFIQEVFSLTEPK
QLSAIDCILDDDSKLQLVRQLINMGGIQFENN
>LONDMIMF_00925 hypothetical protein
MNSNESSNENLHCEEINELINYRSSWIIRNGIFAFLCLLVLLSFVIKIPQNKRVENFAII
DKNDPLYFVMPQKDKALRGKISDENLNYEFQGRGIIHISNQDEIKQGQEVTLKFENENKL
YKAIVANIQKEKDPKTNYILDINFKMDSSGDEKDFKAFKSNDHLTAKVIIKEQSLFTCLF
KDGKKLF
>LONDMIMF_00926 hypothetical protein
MEIYKYGIARQCNIPVNHNLLLPEKQSNNLLEKIYLSKKNILDKKAGIKLILEDLIGKSK
SINQTNVLINILRSIEGDKKIKEKDIHKLESEYDSLRGEIFGYVGLQEIYATSIHEFENY
YSELYTIKKSHLKEIATDEIFSNALLFSSYDLFNSSIKWDYTESNKKSKQIEVGLLKYAM
RSIFKPTPFSSFASIMLCDTEKTEKELIADSGSAIVSFMRINSKFFHEVRKFFLTHKKIY
YNLKIILNSTIQVDEEKNSYRLFINKNNYEFFNYIQVNPVIRLIKSFVEENEQITFGELV
EYCMNQISAPEDEISKYLYELLMSGFIELNLEVYGVDFLWPEKVVSILEKIEDSEEKETI
YTFLQNLIAIKEAFSLNFLNSEERSRLLVEANTIIADFYQKSNQLEGNPEDDEEIKKAIS
NIKNNVFFEDTRIDSQVSLDRPVLAANLEKLTKLFDVSLNYSLAKKEPLTNFFIDNYSAE
GDISLLKLYEDYYKYLKENKDDSPTAPFLNIELENFDINYNSELHTVFFDFKENYVRNTK
HNYSSCAVFQNFSENDTDGIVVNALSWGYGRPINRFLYMFNDEVLESQINLNRKLHKSNG
DVNVIYSEVTDSSLFNANLHEPVFDYECFMPGGNKSHGVKNPINVKFLKVKYVDQSLVLY
DTMNGNEIVIQDSCLQGTKGRSKLYSLLLNFSDRITPHYFSVINQINNLYYNEEQEGNIK
MYPRITFGESIVLQRKFWIINHLNFPKLDRLESDAVNFITINNWIEENNLPKRAFLTINF
LKSKEEEYRKDDYKPQFVDFQNSIFYNFLAKVFANNKSVELSECLPDKEQVGAKEDCKIR
EFVIQWYNGEAYV
>LONDMIMF_00927 hypothetical protein
MSDSNKIWISLYIFYQDLNFLLKEGIIPFVNHICETESIEKYFFIRYNQEGSHIRLRMYV
SENDKAQIEEKTNRFFSKFLKENASTRQFDHADFRPNNTFSYHEYIPEIYRYGGEKAILE
AEHHFFESSKAVLSLIDNQDSWDIGIAQAKAIQLYTIFFNAVELTDDAIKKMMHIMNNNH
WKRRAMEIAKTNDIDTIFSNLYARQKEIIERSVGLVKTILAEDEIEPEWLKLFHESLVKT
DGELDRIFSNGEIVFDSESNIFENNQSDAKARIYVSYLHMLNNRLGLNNHDESYMAFVLN
ELINSNLIRITS
>LONDMIMF_00928 hypothetical protein
MNSFPVHLKEKQLLKFETHIKDFNIAESTSLKAFKNLIENSEQYFLECSCKIINGVISGS
RFALLFKDHEHAYNIKKSFDFLNSLKDNGAKLNYELLDKVSFEDLDLSKVKALGLGIDLR
DDEAASRAKFWVAIENSNYRFFNSALDVFGYTDNMANLFNKNELLIGFDFYFNGKTKMKV
YPHFYEYELKNAVISKRLEATFSPLIMEMINQCYMLYVSFEGADNYRLLHFNPHNLKKLC
ELINNDDLNKLIERISYKYSNCIVTLIENEILENNIKTINVYY
>LONDMIMF_00929 putative succinyl-CoA:3-ketoacid coenzyme A transferase subunit B
MALTKEDIAKRIAKEVKDKYFVNLGIGIPTLVANYVREDISVEFQSENGVLGMGPFPFEG
EEDADIINAGKQTITTLPGASFFDSAFSFGMIRSQKVDLTILGAMEVAENGDIANWKIPG
KMVKGMGGAMDLVASAENIIVAMMHVNKAGESKILKRCTLPLTGVGCVKKVVTELAVLEV
TPKGFKLLERAPGVTVEHIIASTEADLIVEGDIKEMVID
>LONDMIMF_00930 Succinyl-CoA:3-ketoacid coenzyme A transferase subunit A
MINKKVASVSDALKDIQNGQTIMLGGFGLCGIPENSIAELVKLGVTDLTCISNNAGVDDF
GLGLLLQKRQIKKMISSYVGENAEFERQMLSGELEVELTPQGTLAEKCRAAQAGIPAFFT
PAGYGTEVAEGKEAREFNGKMHIMEEAFKADFSIVKAWKGDEAGNLIFKGTARNFNACMA
GAAKITIAEVEELVPAGVLDPNQIHIPGIMVQRIFQGEKFEKRIEQRTVRQKN
>LONDMIMF_00931 Penicillin-binding protein 1A
MATKKKNNTQQVKDVAYYNRLFWKIFLYGTGGVILFFLFASWGLFGSMPSFEDLENPESN
LATEIISSDGETIGKFYNENRTAIKYSDLPKHLVDALVATEDERFYEHSGIDARGTFRAI
VGFGSSGGASTITQQLAKQLFHGERSKNIIVALTQKVKEWIIATRLERQYTKSEIITMYF
NVYDFNNYAIGIRSAAKTYFSKEPKDLTVDESAMLVGMFKNSSLYNPVRNEKGVKNRRNV
VLSQMVKAKIITEAQKEKYSALPIKLDFQLQTHKEGTATYFREYLRDFMKNWAKNNPKKD
GKEYDIYRDGLKIYTTIDSRMQLYAEEAVSAHLANLQKEFFKQAKDNKNAPFIRLSEVET
EKLMMRARKNSERWRIMSNEGKSEDDILKSFKVKTKMRVFTWKGEKDTIMTPNDSIRYYK
HFLQTGVMAMEPQTGHVKVWVGGINYKHFQYDHVGQGARQVGSTFKPFVYAAAIEQQGYS
PCDSIIDAPYTIPKGRHNVTETWTPRNSNGTYKGMVTLKYALAQSINTVSAKLIDKVGPD
AVIDLVKKLGVKSNIPSQPSIALGAVEITVEDMVAAYSTFANQGVYIKPQVITRIEDKNG
VVLYEAVPESHDVLNKDIAYAVIKLLEGVTESGSGGRLRTDGGGFGYEMMTGYPYVLRNP
IAGKTGTTQNQSDGWFVGMVPNLATGVWVGNEDRSAHFKSITYGQGAVMALPIWGLFMKK
CYADKELKVSKEPFERPANLSIKVDCWKPAVKDTTNVDMEEQNTSEFDF
>LONDMIMF_00932 Gliding motility lipoprotein GldH
MSLKNSLLFVFAAILLVSCDKKRVFDQYKSVGKEWHKDSIATFTYNNQDTTKAYNLFINL
RSNNDYPFNNIFLIVAMEAPGGLTKVDTLEYQMANPDGTLLGEGFSDVKESKLYFKEKYK
FKSLGDYKIGIMQALRQTGKVNGVESLAGITEVGFRVEKLD
>LONDMIMF_00933 hypothetical protein
MACTSCSTSDGSAPKGCQNKGTCGTDSCNKLTVFDWLSNMSLPNGEAPFDCVEVRFKNGR
KEFYRNPEKLSLSMGDIVATESSPGHDVGIVTLTGELVKIQMKKKSVNPASNEILKIYRK
ATQKDIDIWSEARAKEEPMKVRAREIAIALKLEMKISDIEFQGDGSKATFYYTANDRVDF
RQLIKDFAREFNTRIEMKQVGFRQEAARLGGIGSCGRELCCSTWLTDFRSVNTSAARYQQ
LSLNPQKLAGQCGKLKCCLNYELDTYMDALQHFPDFDTKLITEKGDAICQKQDIFKGLMW
FAYTSNFANWHVLKVEQVNEIIAENKQKRKVSSLEDYVLEVTQEPEKDFNNAVGQESLTR
FDQPKKKKRPKKRKQAATADTPVVEKPAAKENKNPNANANPNKNNNNRNHNKNRPQKPAN
EKKPDNKNNNNNRPKNEPKK
>LONDMIMF_00934 putative adenylyltransferase/sulfurtransferase MoeZ
MQLYNTLSAEERAALIDEAGKQRLTLSFYAYAKIEDPKKFRDDLFIAWNELDALGRTYVA
KEGINAQMSVPAENLEAFRETLERYDFMKDIRLNVAVEQDDHSFLKLTVKVRDKIVADGL
DDDTFDVTDIGVHLKAKEFNQILEDPNTIVVDFRNHYESEIGHFKGAITPDVETFRESLP
IINEQLKDYKEDKNLVMYCTGGIRCEKASAYFKHQGFKNVFQLEGGIINYAKQIKEENLE
SKFIGKNFVFDHRLGERITDDIISQCHQCGKPCDNHTNCENEGCHLLFIQCDECKAIMEN
CCSTECREIIHMPLVEQVKLRRGVKNGNMIFRKGKSEKLKFKHSGELSDMPLAKAGNDIP
EAVKPKDIRQKIKIKKTLLGKAEHYFVKAGIGQFLIEKDELKINDKIIISGPSTGNQELQ
ISQMFVNGTEAAVAKPGDKVTLALPFRIRLSDKLYKVLD
>LONDMIMF_00935 hypothetical protein
MYPEEMVKPMRAELADAGFEELYSAGAVENAIAKPGTTLVVVNSVCGCAARNARPGAKMS
LDGSKKPDHLVTVFAGVDKEAVDAARGFMFPFPPSSPSMALFKDGELVHMLERHHIEGRP
AEMIAENLKDAYAEFC
>LONDMIMF_00936 hypothetical protein
MKKYDYIFAGAGLSALMTVYQMILSGKFKEKKILLLDADSKKNNDRTWCFWEKPDGDYEH
LVYRKWNTAIFSDANSTRDLNLSPYQYKMIQGMDFYQHAFEAISKEHNIEFLQQKIIRFK
EENNGILVETEHGKYFCDKLFNSILNPQEIIRQNKYPYLQQHFIGWKIKVKEPVFNPEKA
TFMDFSIAQKGNTRFMYVLPFSKTEALIEYTLFSKELLPENEYENEIQDYFKKLGITNYE
LIEKEQGAIPMTCYPFWKKNTKNLVNIGSAGGWTKASTGYTFKNATKKSKELVAFLATGN
DFRKFHKKTRFWFYDLLLLDILDRKNYLGSQIFSVMFQKGNPAIIFKFLDEETSFVEDIR
VISRCPKTPFLQALGKRIGI
>LONDMIMF_00937 hypothetical protein
MKKWFLILALVTAVPTFAQLKTHTFEEAEKLAAATSKPYVIFIHTDWCKFCKMMENTTLK
NKELITALNQNFYFISFDAEDKKEIFFNGTVFKFKPKGKNSGVHELATALAEKNGNTAYP
SIVILNSDYSIAAQLQSYINAKDLLQMLHKIR
>LONDMIMF_00938 Colicin I receptor
MKNIALLFLIFSFQNFYAQEKGAISGKITSEGIAVADADIKILGTNYGTSSDSLGNYKID
NIPAGNYKIQVAYVGSKTQRKAITIKKNETLEWDAELENDKNSLEEVVVSGTLKPVSRLE
SPVPVEVYKPSYFKKNPTANIFEAMQNVNGVRPQLNCNICNTGDIHINGLEGPYTLVLID
GMPIVSGLSTVYGLSGIPNSLLERIEIVKGPASSLYGSEAVGGLINIITKNPSNAPRFSI
DGFSNSWGEVNLDAGFKGNIGKNSSVLLGVNYFNYSNPIDNNHDNFTDVTLQHRISVFQK
WNLGRKSNKLFSLAGRYFYEDRWGGEMQWEKKYRGGDEVYGESIYTKRYELLGAYELPIE
EKMLFSFSYTDHDQNSVYGNTPYMAQQRIGFGQLTWDKKISNHDLLFGTAIRYQFYNDNT
PATSTADKTWIPSIFAQDEIRFNDKHSILLGARYDYNSDHGSIFTPRFAYKFKATDNDII
RLNAGTGFRVVNLFTEEHAALTGSREVVIAEELKPEKSYNANINYLKKIYTENGTYIGLE
TAAWYTYFTNSILPDYDTDPNKIIYKNLDGHAVTTGVSANLDIVFQNGLKFILGATYMDV
SKTENDTKTRQILTEKFSGTWAISYRIPKLFLDIDYTGNVYGPMRLPLLGELDPRKEYSP
TWSIQNIQFTYNKIKDVEIYMGIKNLLNWTPNKGNPFIIARANDPFDKNVQYDPQGNVLP
TPDNPYALTFDPSYVYGPNQGLRSFFGVRYTLK
>LONDMIMF_00939 Divalent metal cation transporter MntH
MSKSLEEVHGSVATQNKKSAFRKVLAFLGPAYLISVGYMDPGNWATDIAGGSQFGYTLLW
VLLMSNIMALLLQSLSARLGIVTQRDLAQASRETYSPFINYILYFLAEIAIAACDLAEVL
GMAIGINLLFDIPLIEGVLITVLDTFLLLFLINKGIRKMEAFIIALVAIIGFSFVFEMVF
AEPELDKVVLGLIPSIPNEAALYIAIGIIGATVMPHNLYLHSSLVQTRKFDRTDKGIKQA
LKYNLIDSTIALNLAFLVNAAILILAAATFYRNGMFHVAEIQDAHQFLQPLLGTKWAPIL
FAVALIAAGQSSTITGTLAGQIVMEGYLNLRIQPWVRRIITRLIAIVPAVIVIMIYGEQV
TGKLLIFSQVILSLQLGFAIIPLIHFVSDKRKMKGFHIGRITQIAAWIIASTIVSLNAKL
VYDEITGWIENAENPLVLWLTVVPLAIAFLVLLLYIVFKPFIARSKAKNYNHSPHNLTLK
FSEKATYTKKNIAISVDFSEADEVAINSAFELGGIEANYTLIHVVETVGAMMYGENIQDH
ETTIDEKLLNEYKEMLVQKGFRVETQLGFGKPGKVIPAIVNTGSFDILVMGTHGHTGFKD
LLFGTTVNKLRHQISIPLFIVKK
>LONDMIMF_00940 Iron-dependent repressor IdeR
MTFSEENYLKTIYHLTTASDAEVSTNAIAEKMETKASSVTDMLKKLAEKGLINYKKYQGV
SLTQDGKLAAKMIVRKHRLWEVFLVEKLGFSWDEVHDIAEQLEHIKSEKLINKLDDFLDN
PTEDPHGDPIPDREGRIIKIEKQLLSELSENQSGICVGVKDTSSEFLKYLDKQEIALGSK
IEFLSRESFDLSLRIKVNGKELTISNKIASNLFVKLL
>LONDMIMF_00941 Fe(2+) transporter FeoB
MALYLLGFSMAIFAAYILNKILKIKSKSYFVIEMPNYRLPLFKNVAINVIEKTKSFVVGA
GKIILAISIILWFLGSHGMSHEYANAETIVKERIQKQGLTRFNQNYIDNTLSEHYTALQD
SVAKNVYKINSQDIADSIAAKKIELFEKVENQEISSFKLEKSFIGVLGKGIEPVIKPLGY
DWKIGIAVITSFAAREVFIGTLASIYSVDSEEEATIKSRMEAEINPVTGDKIFNFATGIS
LLLFYAFAMQCISTLAITKKETNSWKWPVIQLVFMSSFAYGVSLIVYQILK
>LONDMIMF_00942 C4-dicarboxylate transport protein
MKNNNKLFIAIIIALVLGVGLGAFVHYQYPDGKAEFAKNIKLFGTIFIRLVQMIIAPLVF
STLVVGIAKMGDMKMVGRVGAKAMAWFITASLVSLSVGLVLVNWLKPGKGTSIKMDDLSS
ADDLLKNTNSFSLEQFVTHVVPKSVIEAMATNEILQIVIFAILFGIALSSMGKIGNPIMK
SLDIVSHVILKMVTYIMWTAPLGVFGAVAAAVANYGFEIFSLYARYLVDFALGIVVLWIL
LLLVGYMILGNRLWTLLKRIKSPLLIAFSTTSSEAVFPKLVEELERFGCKSKIVSFTLPL
GYSFNLDGSMMYMTFASIFIAQVYGVHMSLGEQLTMLLVLMLTSKGVAGVPRASLIVVVA
TCAMFGIPPEGIALILPIDHFCDMARSMTNVLGNALATTAVDKWESEPETVTQETA
>LONDMIMF_00943 putative membrane protein
MESFEWTQLLNPEFYINLKISGVPIGIYVVLFIVFAETGLFAGFFLPGDSLLFLSGIYST
ELTSTLFTINSDFVNLVVLSTMIATAGILGNTFGYWFGAKSGYYLYNKKDTFWFKKKYLI
ESRVFFEKHGGRAIIFARFVPIIRTFAPIVAGIVSMEKKKFMFYNIVSSFLWAFTLIFAG
HYLYDLFLTKFEIDLKAHIEFIVLGIVAITTVPLVVNYLKKRTAPKDGQEGA
>LONDMIMF_00944 hypothetical protein
MKANLSYWELKNWFSNIDFAVVGSGIVGLHAALRLREKFPESKILVLERGFLPQGASTKN
AGFACFGSISEIIDDLRNHSEEEVIQLIRKRWQGLQLLRNRLGDAAIDYKLYGGYELFLK
DSESHYNECLQKIPFINEVLKPLFKADVFAKQIDRFDFRGIHEYLVFNPFEGQIDTGNMM
EALLKQAIAANILILNRQNVVAYHETSEGVQISTDDFDFSAKKLLFATNGFAEKLTNGAV
KPARAQVLITEPIPNLDIKGTFHIDRGYYYFRNFGDRILFGGGRNLDFEGETTSAFGQTD
LIQNKLEEILKEVILPGHNFKIEHRWSGIMGMGSSKKPIVEKLSEHVYCGVRLGGMGVAI
GSLVGQELADLVTG
>LONDMIMF_00945 Biosynthetic peptidoglycan transglycosylase
MLRKIFRFLWKCALWFFGISVFFVILFKFVPVPFTPLMGIRALEQKQAGKEMTCSHDWVP
LEDISVNFQKAVIASEDGTFLSHNGFDFKALQKAYKNNSRGRKLKGGSTISQQTAKNVFL
WQGRSYLRKGLEAYFTVLIEMFWGKERIMEVYLNSIEMGDGVYGVQAASQYWYSKDASQV
SKREAAGIAAILPNPRKFKATNSSAYIERRKGRIMKHMNYVKLDY
>LONDMIMF_00946 hypothetical protein
MFLLLFFALPLMAQQRNGEIGIIIDNDLFTSTVNDQYYTNGIEIFYRYLNHNENPKVNKK
TTEFRVGQYIYNPHTVEAASISKHDRPFAGYLFGEAGFAKFYQNESVLKLGTQLGVIGPN
SQAEGFQKLFHKAFGYKDVEGWNYQIHNGIAVQGSLFYSKKIGPKQTDKIDYHIQGEANL
GTVFTGITVGPLARISLKKTLLPVYDSGLYGASLNADKAKYKEQSEFYFYINPNLNVQVY
DATIQGRLFNDNSPVTYNLVPLRFNGEAGFRYRKDHWNLHYLFVFRSKELRNDRMENYFY
GSIGATYLLY
>LONDMIMF_00947 hypothetical protein
MSAQYKYATVLEAIKQLRDAGFMVDFNIEGNFLTANSSNYHIDDFEIVEVYRYEGDSNPD
EESTVYGIESKDGVKGILVTSYGMYIDDISEELLQKLSLK
>LONDMIMF_00948 hypothetical protein
MNLKFLCSVVFMLCLNQNIKAQYVEKEEEEKITTLYPEVVFDSIQAKKALALGKGKITGV
AFTRPIFSQPRIYASNIKIVLFPVTPYFEAWYKLRKSKENLKKRRYVYMSDVAYKYRLEA
ITNSAGKFTFPDMKPGKYFLQGFMTWSSTGSYDQLTGTSYGSYGTQANHYEKKYYTVDHN
ERLEEFVEIKEDGEVVKVKLK
>LONDMIMF_00949 Prolyl endopeptidase
MKKVLLTMIAASALLSCKEETKEEAIVLKYPETKKVDTTNTYFGTEVKDPYRWLEDDKSA
ETAAWVKAENEVTFGYLEKIPFRKEMKDRLEKLWNYEKISAPTQEGDYTYYFKNNGLQNQ
SVMYRKDKSGKEELFLDPNTFSSDGTTSLSSVEFSKDGSLVAYSISEAGSDWNKIIIMDA
VSKKKLEAELVDVKFSGIAWIGNEGFYYSSYDKPKGSQLSAKTDQHKLYFHKLGTSQKED
KVIFGQNEKRRYVGASVTEDDKYLVISASNSTSGNELYFKDLSTPNSKIVNIIDNFDSDS
YIMDNVGTKLYIVTNLNAPNQKVVTVDASNPKPANWKDFIAETENVLSVSTGSGFIFANY
MKDAVSQVKQYDYDGKMVREIKLPGIGSAGGFGGKKEDKELYYSFTNYTTPGTIYSFEPK
GGVSAVYEKPKVDFNSADYESKQVFYNSKDGTKVPMIITYKKGIKLDGKNPTILYGYGGF
NVSLTPAFSITNAVWLEQGGVYAVPNLRGGGEYGKKWHDGGTQMKKQNVFDDFIAAAEYL
IAQKYTSSDFLAIRGGSNGGLLVGATMTQRPDLMKVALPAVGVLDMLRYHTFTAGAGWAY
DYGTAEDSKEMFEYLKKYSPVHNVKEGTSYPATLITTGDHDDRVVPAHSFKFAAELQAKQ
KGNNPVLIRIETNAGHGAGKPISKTIEEAADILSFTLYNMGIRELKK
>LONDMIMF_00950 hypothetical protein
MNSKFTSLVRILLGLVLLVFGLNKFYTLPFIPTPKLPEQAADFMGSLAATGYVLPIIGIL
EIFIALLLFTKNWIAFALILLVPISLNILLFHLFLDIPSIGGAILVAVLNGILIYKHWPQ
YRPLFN
>LONDMIMF_00951 hypothetical protein
MNVFKFLSMGLAAITLCASCSNDDSNPVNEEEVITTLTATLTGGGQTITLTSRDLDGAEG
PNAPVVTVSGNLATNTTYNGSLTLLNEAATPTESITEEILEEGHEHQFFFTVSNALATTA
YAVPNDVNGKPIGLNFTFTTNATTGNGLFTITLRHEPNKNAEGVSSGNITNAGGETDIQV
SFPITVVAP
>LONDMIMF_00952 putative TonB-dependent receptor
MLFFRTASFPKHVLIIILDFFKMRYILFFVFLLAGNQTRVYSQQVLSGTITNEKKQPLAG
SHIHAGTFFATTAVDGRYVINGIPQGNIPVTIEYLGYKTLDTIIAIQNDQVLDISLQPDV
SQLSEVVLKKTVSEKNASTQELKANVLENYSSESLGDALKEISGISSLKTGSTIVKPIIN
GLHSSRVLIINNNVRLEDQQWGTEHAPNMDVNTAGKISVIKGASGLQYGGDAIGGTVIVE
PAHIPVKDTIFGKTIINGATNGRGGSVSSSLSKGYENGWNWNLQGTFKYFGDFEAPDYVL
SNTGNREKNFSGNVGYKGENQGYSFFYSYFNADIGILRSSHISGMSDLIRAINSGQPQII
RDFTYDINAPRQELQHHLGKINYYTFFSDASKLSLQYSFQFNNRKEFDLRRGDDRNKAAV
DLDLMTHSFNADFETNSSEKVKYKAGISAAYQNNAANTGDTQVRALIPNYNKFDVGAYAV
ASYQTNENLVLEAGLRYDFSHIDAKKYYLKSRWTERGYDRDFSDIIIGEEGQQWYTNPVF
TYHNFSGSLGAKYQLNDKLTWFSNIGIASRNPNPAELFSDGLHHATGQIELGDLRLKREV
ALKMSTALHYAGDGFAFEINPYFNTISDFKILIPTTIILSNRGPFPVWEYRQVDARMLGI
DLTADYDFAKNLNWHSTAAFVYGEDVTNDRPLIDMPPLNLNNTISFNKENWNHLVLGIKN
ETVFTQHRYPNNDFYVDVTDSGEPVSTLVKISRPPKGYSLLHFNSEMSFDVLKKSKMTIG
FNIQNLLNTNYRDYLNRTRYYADELGRNFRIQVKLNY
>LONDMIMF_00953 hypothetical protein
MIAVLFSILFQSVHSYEHFLSGKAATVSQSDDNGHTKIQTLDHDHEKCFVCEFTLSSFIA
TETYIFDLFVPFKAVAYNFASVESSEFFAGSLYSHRGPPSNC
>LONDMIMF_00954 Aspartate-semialdehyde dehydrogenase
MRVAVVGATGMVGEVMLQVLAERNFPVTELIPVASEKSVGKEIEFKGKKYAVVGLKTAVS
MKPDIALFSAGGETSLAWAPKFAEAGTTVIDNSSAWRMHADKKLIVPEINASELTKEDKI
IANPNCSTIQMVLALAPLHKKYNIKRIIVSTYQSITGTGVKAVQQLENEYAGTKGDMAYK
YQIHRNAIPQCDVFEDNGYTKEEMKLVRETQKILSDKTIAVTATAVRVPIVGGHSEAVNV
EFSNDFDVNEVRRILHETPGVVVQDNTDTFTYPMPLYAQGKDDVFVGRIRRDESQPNTLN
MWIVADNLRKGAATNTIQIAEYLVANGLV
>LONDMIMF_00955 Large-conductance mechanosensitive channel
MGMVSEFKAFALKGNVVDLAIGVIIGAAFGKIVSSFIEDVITPLLLKPALEAANLSRIED
LVIFGSVKYGMFLSAVINFLIVAFVLFLVVKGINAARKKEAEAPAAPPAPTNEEKLLMEI
RDALKNRP
>LONDMIMF_00956 Alanine racemase 1
MSLRIQHIVPEIQARLSGNPDIEITNVSIDSRSLQNNSGTLFFALSGQNNDAHSYIPDLI
GKGVRNFVVNHIPKGLENKANFLEVNNTLQALQDFASYYRKSFHFPIIGITGSNGKTIVK
EWLNFLLSPDYNIIRSPKSYNSQVGVPLSVISINEKHNLGIFEAGISTVHEMEKLEKIIQ
PTIGILTNIGSAHDEGFQNQEEKIKEKLRLFEHSEVLIYQKNTLVDSLIRPDIKTFSWSL
DDKEASVHISQKSVAGKTQLTITYDKISFDAVIPFQDKASIENAINCLMAMLYLGYLPEI
IQERIQLLYSVEMRLKVKNGINNTEIIDDSYSSDYQSLRIALDFLEQQKQYKKKTIILSD
IFQSGLPTDDLYKRVSELIASNKIDRVIGVGEEIGTYSGSFKNIITYKNTDELIADFKNL
NFANETILIKGARIFQFEKIASLLEEKTHETVLEINLNAISHNLNFFRSKLKPETKLMVM
VKAFGYGSGGFEIAKLLEYHKVDYLGVAFADEGIALKSAGITLPIMVLNPENTSFGAIIE
HNLEPEIYSIKGLRAFLKIAEQRNLQQFPIHIKLDTGMHRLGFQENDLPELIETLRGTSY
IQVKSILSHMATSDDLEHHDFAKSQIALFEKLSSRLMQELSIEPIRHILNTSGISNYPEA
QYGMVRLGIGLYGISNDPSETKYLENVGTLKSIISQIRTIQSGESVGYGRRFMAQKETRI
ATIPIGYADGIPRSWGNQLGYVLIKNEKAPIVGSICMDMLMVDVSAIDCQEGDPVVIFGE
NPNVTYIAEKLGTIPYEILTGISHRVKRVFYRE
>LONDMIMF_00957 Thymidine kinase
MFLENTVNHKEQFGWIEVICGSMFSGKTEELIRRLKRAQFAKQKVEIFKPAIDTRYHDEM
VVSHDSNEIRSTPVPAAANIRILAQGCEVIGIDEAQFFDDEIVSVCNDLANSGIRVIVAG
LDMDFKGNPFGPMPALMATAEYVTKVHAVCTRTGNLANYSFRKANNDNLVMLGETEEYEP
LSRAAYFNAMKELQEKEEGFFAKKKENK
>LONDMIMF_00958 hypothetical protein
MKKKLEAELISIAHRILKLKNKSELIQLHQESQKLYEKLSVLLFVEENFTGSQPTIGRSE
AYEVLETAFDNDEVPGKIEMDVQEEIALEAEKTIEEAPKEEIQEEKAPEEEKNTAEEIKE
AEEEVANEPESEQEKVVVGEIELSDEEMEEEEPVEKEEEEEPAIEEPEEEEEEKASEEIR
EEAKEELAEPAFELAFDKKEDVEEVAKESGHQIIFEDFLGSDYKDLEFVKAEIEEKHRHD
HDEEPVAEETKEEVKEEIAEEVKAEEPQKIEEPVAETPKPAVEKVTKGITIGLNDRVGFV
NHLFGGSNEDFNRVLSQLNTFDTFQDAKNFIEDLVKPDYNEWKGKEDYAERFLEVVENKF
K
>LONDMIMF_00959 Ribosomal RNA small subunit methyltransferase I
MSKLYLVPTPIGNLEDMTFRAIKVLKEVDLILAEDTRNSGKLLKHFEIGTHMQSHHMHNE
HKTVENLIARLKSGETIALISDAGTPAISDPGFLLTRACVENNIEVECLPGATAFVPALV
NSGLPNDKFVFEGFLPDKKGRQTRFLALAEETRTMILYVSPHKLVKTLAEFIQYFGAERP
VSVSRELTKLHEETVRGTATEVLKHFEAKPPKGEIVVIVGGKSNK
>LONDMIMF_00960 hypothetical protein
MATHHVTTKWLGDMAFEATNPGGTIKMDSDPEYGGHDDGLRPKAMMLASLAGCTGIDIAS
LVKKMKVDIDTFTIEVEGDLTEEHPKFYHTVRVDYHFYGLNLDQTKLQKIVDLSVEKYCG
VMEMFRHFAKVEVRILYH
>LONDMIMF_00961 Single-stranded-DNA-specific exonuclease RecJ
MRWNLKPTPDSEKIKSLQDSLNIDELIATLLLQRGIETFEQARQFFRPKLEDLHDPYLMK
DMDKAVARIEKAIEKQENILVFGDYDVDGTTAVSLVSSYLKSFYPNVDTYIPDRYDEGYG
VSFKGIDYADDNGITLIIALDCGIKSIDHVAYAKEKNIDFIICDHHRPGDTLPDAVAVLD
PKREDCHYPYDELCGCGIGFKLLQALAKNRNQTIDDLRPYLDLVATAIGADIVPITGENR
VLAKFGLEVINSNPRPGFKAITQNLKKKNLTITDVVFILAPRINAAGRIKHGNYAVKLLT
EFGIEEAEAFAKELEVFNADRKELDKQITSEALLQIIENQEEDRYSTVVYKEDWHKGVIG
IVASRLIETYYRPTLVFTKSGDKLAASARSVKDFDVYNALEACSEYLLQFGGHMYAAGLT
LEEAQFENFKAQFEKVISETISEELRTPEILIDAVINLNDITEKFVRILNQFEPFGPMNM
MPVFMTENLRDTGYGKRIGSDENHLRLFVKQDDSEGYGAIGFGMGNKFELTQNQQPFDAV
YSLEENEFNGNVSLQLRLRDIKGKE
>LONDMIMF_00962 hypothetical protein
MKEIEQIYFNDFGVAFHWKKEQKVLKNKIQLVFKETGFYLSKEELNYFAETIDATCYEVN
ANCDACEFKRKCHKFLLKTPVQQIDLAVSVNELMQIKDLVEGTLFQIQLKDYLDEICQN
>LONDMIMF_00963 UDP-2,3-diacylglucosamine hydrolase
MADTKIYFASDQHFGAPTPELSFPREQKFVAWLDEIKKDATALFLLGDLFDFWFEYKTVV
PKGFVRVLGKLAEIRDSGIPVYFFVGNHDLWMSDYFEKELNIPVYHTTKEFTFNDKHFLI
GHGDGLGPGDKGYKRMKKVFTNPFSKWLFRWLHPDLGVKLAQHLSVKNKLISGAEDVRFL
GEDNEWLVQYSKRKLETKHYDYFVFGHRHLPMTIKVGENATYINLGDWIGYFTYGVFDGT
TFELKEYKS
>LONDMIMF_00964 hypothetical protein
MSEFWIYFNTGLRHVLDINAYDHVLFLIALTIPYAFKDWKRVLLLVTLFTVGHTMSLLLS
VYGFVQIKVNLVEFLIPITILITAVFHLFTAGKNSKKESISFIAIVTLFFGIIHGLGFSN
YFNTILPGNSSDKLLPLLEFALGIEAAQIIVVLIVLILSYIVQTVFRFSKRDWTLVMSSF
VIGVVIPMVIESEIWGR
>LONDMIMF_00965 hypothetical protein
MSISDLFDSGFKNRNKGHFASIVRVAMENGHLSEEERHFLDKLAMQLEISSEEYAEILAN
PMKYPINPPYLHTQRLERLYDLSRMVYADHVLGPKQKEILTRFALALGFTPGNVHYIVDK
ALSLLVLGVDLDTFLFEMTHMNK
>LONDMIMF_00966 Fructose-1,6-bisphosphatase class 1
MEERNKTLGEFIIEKQEDFQYSSGELSRLINSIRLAAKVVNYKVNKAGLVDIVGAAGEQN
IQGEDQQKLDVFANETFIQTLINREIVCGIASEESDDFITIKGKDECHNNKYVVLMDPLD
GSSNIDVNVSVGTIFSVYRRITPIGTPVTIEDFLQPGVNQVAAGYVIYGTSTMLVYTTGR
GVNGFTLNPAIGTFYLSHPNMKFPKDGKIYSINEGNYVHFPQGVKDYIKYCQLEEGDRPY
TSRYIGSLVSDIHRNMIKGGIYIYPTSSKAPSGKLRLLYECNPMAFLAEQAGGKASDGFG
RIMEIQPTELHQRVPFFCGSYNMVEKAEEFMKIASEK
>LONDMIMF_00967 Phosphinothricin N-acetyltransferase
MIIRRGTENDMKAVLALIQELAVFEKEPEAVVVTKEDLIRDGFGSNPLFHTFVAELDGEI
IGMALYYYRFSTWKGKTIHLEDLIVTEKSRGTGAGMALYSEIIKEGERENVRRIEWNVLN
WNTPAIEFYEKSGAKVLSDWRVVHMDEQGIDDFLKGQKSKVESRTSKV
>LONDMIMF_00968 Lysine-sensitive aspartokinase 3
MRVFKFGGASVKDANGIKNVYDVLQQVGYDDVLLVVSAMGKTTNALEVVIKNYFERSAEL
QSSLQDVKKYHNQILLDLFEDDKNAVFTAINQLFSDLEGFLKSNKSPNYNFVYDQIVSFG
EIISTTIISHYFNYRGLKNQWLDVRNFIKTDTTYRDAIVDWEQTQKLISKNVKKKVLNIT
QGFLGSDENNFTTTLGREGSDYTAAIFAYCLNAESVTIWKDVPGVMNADPRYFENATLLN
QISYREAIELAFYGATVIHPKTLQPLQRKEIPLFVKSFLNPSLPGTSVSKGADLEPHLPC
FIVKKEQLLISLSSIDFSFIMEENISEIFGLLHQYKMKVSLIQNSAISFSVCIEDKFGNF
NDLKNVLSKKFKVSYNENVSLYTIRHFNEKASEMVEKGKQVLLKQVSRETMQIVTKETTN
>LONDMIMF_00969 hypothetical protein
MLKKLLFLVLTGFVSGLSAQEVKSPYKNRKITASKDTIRIDSVSISSSFFKLQDREGNDI
DTTYYKVDFQKSILVFKNDFKSEDTLTLRYFSYPEYLTRKYSIYDDSRVVSNEAGKGNLY
KVSRDPISTFKPFDGLNTSGSITRGITIGNNQNSVVNSNLDLQITGKISDKVSLRASIQD
SNIPLQEGGYSQKLDEFDQIFIELFSDKWNIRAGDLFLENRQSRFLNFNKKVQGLSANFT
FGTPENKTNVFASAALVRGQYARSSFTGQEGNQGPYKLQGPNGELYILVISGSERVFVNG
ILLTRGENNDYTIDYNAGEIIFTSLFPITSEMRINVEYQYSDRNYTRFVTYAGAMHEQEK
WSLGGYLYSENDVKNQPLQQNLSAEQVEVLKEAGDNSAAMTAPSAYVDSYSENKILYRKT
TIDGVEVFEFSNNPTDELYNVRFSLVGANQGNYRLSNTATIGRVYEYVPPVNGIPQGNYE
PIIRLVAPTKIQIATILGKYKPSEKTLVDFELGVSNNDLNLFSSKDDNDNQGLAGKIYAK
QRLFSKKWQLDAFANYQFVQKQFRTIERLFTIEFDRDWNLTNPIGNQSLLISGLNFILPN
KGNARYQLEKLDFSESFSGTRHVVDGSFRFKNFTFQNNGSILKSDSNYSESKFIRNQTQV
RYHFGKNWVGGTFRLEDNEEKIKETGQFSALSQKFNEFGFFTGRGDSTKVYVELGYLQRS
NDSLVNGFVKKVNTSNSYYLKSRLMKTEKSDLSLFVNYRNLKFEDPTRKNETSLNSRLLY
NDRYFDQLIQVTTTYETTSGTIPQQEFTYLKVEPGRGVYTWIDYNNNGIQELEEFEIAKF
ADQAEYVRIFLPNQIFIKTHQNKFSQSVILNANQWQNEKGFRKFLSYFYNQTSFLVDRKI
VRDSDNFDLNPFSSGEKNLLGLNSSFRNSLFYNRGKQDHSLTYTYLRNRAKTLLSVGSQE
SNNRSHQIQYAHLVKKSWLLGFMGKTIESELYSENYVSKNFELKGYQLAPKISYLFSRNA
SWDLFYEYQDKDNKINDKEALQQHRVGTSFTYSSEKKFTMNGEFSLYKNDFSGDALSPVA
YQMLEGLQPGQNLTWRLLLQKNLTQFLDVNVNYEGRKSEESKAIHTGSVQLRAYF
>LONDMIMF_00970 hypothetical protein
MKTKIIAGSLLAVSLFMTSCKKELQPQESAEPTEAVAADGAATPAEGQSVSVQPQQMQAQ
PQVQPQVQPQPVATAPGMNPPHGQPGHRCDIQVGAPLNSPPGQKPAPTAVAQPQPVAQPT
ATPNKITPVNNADVVTAPGMNPPHGQPGHRCDIAVGQPLPKA
>LONDMIMF_00971 putative ABC transporter ATP-binding protein YbiT
MLILQNISYTHSNKEVLFSNINLTVNNHNKIAVTGSNGTGKSTLLKIIAGELQPVSGQRI
VDAKPYYIPQIFGQYNHLTIAQALQIETKLNALQEILSGNVTEENYSLLDDDWTIEDRCN
EALQHWQLTNLDLSQKMETLSGGQKTKVFLAGISIHQPELVLLDEPSNHLDISGRQLLYD
FIQSAKSTLIVVSHDRKLLNLSDTICELNKHGIKVYGGNYDFFTAQKEIENNALNQDIQS
KEKALRKAREKERETLERQQKLDSRGKGKQEKAGVAKIMMNTLRNNAENSTSKLKNVHAE
KIGGISKDLQELRSSLPDMDKMRFGFDNSSLHQGKILFTATNINFTYNTQPLWNENLSFQ
IISGERIALKGTNGSGKTTLIKLILGSLEPQTGTVYRADNKSVYIDQDYSLLDNKLKVYE
QAQQFNSSSLQEHEIKIRLNRFLFTREDWDKPCNALSGGERMRLLLCCLTISSQSPDIIL
LDEPTNNLDIKNVEILTAAINEYQGTLVVVSHDEYFLEEVKVNRVIEVVRD
>LONDMIMF_00972 hypothetical protein
MKTYNDYLTGYKRGFIGFTTLSVLAQSCLGAIAAMFILMGGTSIWHMIQLFFVTIFCMGF
NAAVLSQQKPKFVFAFLIVSVSFSILFSLLNIHYLFA
>LONDMIMF_00973 General stress protein 69
MEYRKLGNSDLELSAITYGAFAIGGTMWGGNEKQDSIKAVHASLDHGVTSLDTAPFYGMG
LSEELIGEAIKGKSRDKIQLLTKFGLVWDGSNNGKGDYFFDAESNGKTFPVYKYASKANI
VKELEESLKRLGTDYIDLLQIHWPDSTTPIDETMETLNLLIEQGKIRAAGVCNYDLAQLK
EAQKTIRLASNQVPFSMLNRAIENEIVPYVLENNIGIIAYSPMERGLLTGKYFKEAKLKA
DDHRNGYFGQFSAGNVKAFLDKIEPIAQSKNVSLSQLVLRWTTLQQGISVVLAGARNATQ
AIENAKSVDVSIHPTEMQFINDAISQI
>LONDMIMF_00974 Putative monooxygenase YcnE
MIYLTAIVKSKPEHNDAVKSLLMNMAVHSKKETACLQYDLHQNSTEPNIFVFHEIWNDEK
GLEAHNSQPYIQEFVKASETLLENNVIIYKTQKIG
>LONDMIMF_00975 Modulator of drug activity B
MKKIFIINGGQKFGHSGGRFNETIAQETFNFFKNNPNFEVRMTNINDNYNPAEEVEKFVW
ADVVIYHTPIWWFQLPHAFKQYIDVVFTEGHATGIYHSDGRSSTNPTVNYGTGGMLHGRK
YMLTTSWNAPKEAFTLPDEFFQQKNVDEGVMFGFHRMNAFTGMVPLEGIHFHDIEKNADV
ERDIALYNEHLNNIFLN
>LONDMIMF_00976 HTH-type transcriptional regulator MetR
MVNLEWYRTFKAVYKSGTLTGAAEVLFISQPGVSLHLSSLENYVGYKLFDRTGRKMVPTE
RGKVLYNFIIEALTKLEEAEKNFQRSTEKHTPTISVGMCFETFQITLEQYIATLPFNVII
QFGEYPEMVENLEKGILDIIITPQMVPKSGIDYQPFSSETIVLVGGNETDVQTFQALEEA
GDFEAVELWLKQQKWYGTTGDMEHLRRFWQLNFNKYPDFRPNYIVPNLNSIVRCLSSGQG
LAVIPDFLCKKDIDSGQIKMIWEGKVPLKNTLHFATRKKTIYADEIALIKEIFMKVMK
>LONDMIMF_00977 hypothetical protein
MKSKILPFAILLCVFAKAQEKEQLKENVKTAVTERFPSTRFLDFQYQQYLPTDFDSELFD
RAFEEGEIKNHYRFNANSNFVVFSKPRWSITTSLNYKYEAFELNDVENVAGDAIAPYDKK
IDFHYLSATLSFTYFARLFNKPFIYNASLTADGSEKDIERLKGFIGATIILKKTERTTIG
VGALVFIDPASPVPVAPTFMMEHRFQNSPWILDLILPQRLLFHRPVSENGKFSIGTELNG
DGFYVYNNNVPGFADVYDYRILELRSGLTYEHHINKTIIATFKTGLSTVFNSRLSERGEN
TNDYIFSTKQDGTGYFNIGISFMPDFKKKKN
>LONDMIMF_00978 Transcriptional regulatory protein YpdB
MNCIIVDDEPLAREGMLLLLQDIPELNVIGCFNGPKKAREFMLENTVDLIFLDIQMPGIN
GLEFAESIPEQTLIIFTTAYSQYALKSYEVDAIDYLVKPIIKTRLEKSIKKAFAYRELLS
GKEEKSTLESLETDFMLIKSERKFHKLLFRDILYIEGLKDYVVIYVNDSKIITAMNLKTI
SQHLPEMHFIRVSKSYMVNVQHIDSFDNHTIYIKTSEIPIGEVFRKKFLEQYLGKNISDR
L
>LONDMIMF_00979 Sensor histidine kinase YehU
MKDNCFQNNFIKFLIDPKYRVWRHLSIIIYIIAFSYDSGEIKEYSGDFHYYVKWLWIAYF
LAMVYINMYVLIPKLLFKGEYVTYLVCLVLLIVCSFILVKNGLNYFEQYRITPRKVFTSF
FREILATSNLLTILVFSSTSIKLFQQWARDTERIIELETNSLQLEIKELKNQINPHFLFN
MLNNVNVLVKKNPEKASTVIMKLSDFLRYQLYDNNQPSVLLLSEIQFLNDFMELEKIRRD
DFNFRLTIENEDSNSNLISQLVLPPNLFTTFIENAIKHSADLDHPSKIDITFKIYKKELV
FTCSNTKPAEPIDEQHKGGLGLANIKRRLDLLYAKDYKLDINDDDKQYTVTLTLPI
>LONDMIMF_00980 hypothetical protein
MKSVQAIERWITAIESSKQEACAKEQQIKAIVDLWKFADLYDQGTTITQKGELQLEDSDG
RIDKISVATSDLFLTPKENAISKILSEIETEFSELGDRYRALYNVEFRNPEANFDAAEIL
KLKSEIISGIKGEVILYKYVERIRKLPSSEFRIVNRDFRILECSYEDIQSAIDQNHLLQS
DQRQWLVIVLSAVDNNCRSFLIDETIKTAAFSSGFEKIFLFDFYTSEIIELNIKATAGTA
IKGVPLVASGVA
>LONDMIMF_00981 DNA-3-methyladenine glycosylase
MEFSQFTPSEFRSLCDSLAAKDQDIKNILDQYDYPPFWSRPNTFETLVHIILEQQVSITS
ALAALNKLRVYVGEITPERILSLSDEELRACYFSRQKTMYVRHLAQALLDKQIDLQLLET
QSDETIRTILSQLKGIGNWTIDIYLIFVLKRSDIFPIGDLAAVNALKQLKNMPKETSREI
LIEKAANWQPFRTVATMLLWHYYLSLRAKK
>LONDMIMF_00982 Sensor histidine kinase TodS
MAKFAFYFIIVFSIVFPQQMKSQNTADSLHTLIKKADGLRKSELNLELAKYFLPTNQDSC
LYYSQVAQKIGKKINNHAIVIRSFALIAESYQKQNKMKEAIATYQEGLKLAEKHNEKSLA
GNIYNGIGTCYFAMNDLKKAEYYLQQAAQAKKEANDYQYYSFIAANLAALQIINQSFGEA
IHTLKDAEKILLKNKQEKYLSTVYNSLGAAYQGTKSDSCVYYFEKGLEISQKNKDYLNMM
TTYQNLGDYYMDKKNNAKAVEYMKRAIAVNDLRPEDQYKPALYERIGILYESMGDFKNAY
HYKKLENETRQRLFSVAKQKEIEELEIKYQSEKKEKAIQLHKHEAEKAKNQQTALLYGSA
LLFLIGGFITYLIFQRRKIIQKFEKEKLRMFENILHEIKTPLTLIDGPIQIMKQRSDSSN
EEQLSLMERNSKKLMSLVTELLDASKLGRGSFQLHYTNGAVDDFIENTIDTFANEAKSKD
IQITHTKNNVEKHYSLPSNALEKILSNLIGNAVKYCPPKAKIQVASQIEGDRLNIRVSDT
GPGIPKGEQKKVFRRFFRGNQTSDTNGTGIGLSLVKELVELAQGTIHLQSDSSGTTLLVS
LPIQEVVNPTDAGVTNEGMPILLLAEDDPDTAAFSIAVLKENFQIIHAKNGQEALDLIRK
NLPDIVLSDVMMPEKDGIELLSTIRSEELTNHLPFVLFSAKASLESRLEGLQHGADAYIS
KPFSPDELKLTIKNLFNTVQRNKEAYKEAIHSEKVFEERVKSPNPYVNKVIGHILDNIDN
QNYSVNELSDNMSVSRSQLHRKLVALTGFSTTNFISMIRLEKAKDLLLNNEGNITEIAYK
CGFNSQSYFTKSFTEYFGKSPSQVLKNQ
>LONDMIMF_00983 hypothetical protein
MKQLLLFFILFWHVSSKANDECVNAIQLTPNANCVNVSGTFNGATLSGAAPTCATNSSQD
VWYRFTATEQTMSVNLSRVSTNSTMYLAMELYEDSCAGNLFKCVAWTTNVSTYFNNDFVI
GRTYYVRVLNASSDLSTLGFNICVRSFPKPANDSCAAAVQLTPGTSCVDTVGTFSGSLLN
GAVPSCANTSSQDVWYRFTATEQTMSVSVNRATANATMYFAMELYEDGCTGNRFKCIEPS
TNGVGYFNNDFVVGRTYYVRVLNPGVQLTTLAFNICVRSFPKPANDSCAAATQLTPNANC
VDTVGTFSGSMFDGAVPSCANTSSQDVWYRFTATEQTMSVSVNRATANATMYFAMEIYEE
GCTGNRFKCIEPSTNGVGYFNNDFVVGRTYYVRVLNPGVQLTTLAFNICVRSFPKPANDS
CAAATQLTPNANCVDTIGTFSGSMFDGPVSSCANTSSQDVWYRFTATEQTMSVSVNRATA
NATMYFAMEIYEDGCTGNRFKCIESSTNGVGYFNTDFVVGRTYYVRVLNPGTQLTTLAFN
ICVQSFPKPANDSCATAIELTPNNTCVNVSGTFRGALLDGAVPSCANTSSQDVWYKFTAT
GQTMTVTVSRATTNSTMYFAMEIYEESCTGNRLQCLPSGTNFTTFTNNNLVIGRTYYVRV
LNPNTAITTLPFTICLVGPPPVACTPAVTIDASQTSICHGTSVTFTATPVNGGTTPSYQW
KVNGNNVGTNSPTYTTTTLANGSTVSCVMVSNAACASPTNVTSNTITMNVTAPTVPAFTQ
IAPVCSGNTFTLPTVSNNGIGGVWSPAINNTATTTYTFTPTTGQCVTTATMTVVVNLVNT
ATTLQGSTITASATGATYQWINCANNQPINGATNASYTASGNGSYAVIVTQNGCSATSNC
VQITNLGVDTFIKDGLKIYPNPVTDRLFIQLNEATDVTIADMTGKTIQKETLKSGNNSID
VSSLASGMYFIRSESGATAKFVKK
>LONDMIMF_00984 hypothetical protein
MEKLDLTKKYKTYFASKTKPEIVEIEPAQFISLTGKGDPTEKSFSEKIQALYTTAYTIKF
MFKQQGKDFTVSKLEGLWWYDERKFAGITMDEAPKAIARSEWEYRLLIRMPEYVSENDVD
QAIQAAFAKKKMELVKEIEFFRMNEGKSVQMLHVGPFSKEIETLQEMRKVIEENGFQKNG
LHHEIYLSDFNKTEQSKLKTILREPVK
>LONDMIMF_00985 Magnesium-transporting ATPase, P-type 1
MMTSLKKKIKNPLHSVINSNGMNMGTVTKLQNASSQDDKFVYAMLETSEKGITDTTAEER
RLKFGINELQHQKAPKRLMQLLKAFANPFIYILLVIAVVSFVIDVWLPSVEDRDFKTVIV
VSVMILVSALLRFVQEYRSNSAAEKLKSMVKTTATVFRKFTGKKEIPISELVPGDIVYLS
AGDMIPADCRIIQSKDLFVSESMLTGEALPVEKSHFPIRNAEKKQPTELNNVCFMGTNVV
SGSATAIVVATGSYTFFGSISRSIVGERPETSFDKGINKVSFLLIRFMLVMVPLIFLING
LLKNDWAEALLFAIAIAVGLTPEMLPMIVTANLAKGAVTMSRHKVIVKRLNSIQNIGAMD
ILCTDKTGTLTLDKIVLEKHLNVYGIEDDEVLKWAYLNSYHQTGLKNLMDEAVLEHADLH
DYLKVEEQYIKVDEIPFDFQRRRMSVVLKTHNGKHLLITKGAVEEMLELCSSAFDPGDDR
SLHIENDSVVPMDDMMRKTVLNTSKKMNEEGLRVLLVAIREFDSSHPLTYSVQDENQLTL
TGFIGFLDPAKPSSKPAIEALQKLGVGIKVLTGDNEIVAKKICNDVGIPVQHVVNGIDLE
KMTDDELLQQIDTVSVFAKLNPLQKVRVVKALRGKGHTVGFMGDGINDAAALKESDVGIS
VDTAVDITKESADIILLEKDLMVLRKGVIYGRRTFGNIIKYIKMTASSNFGNMFSMLGAS
MFLPFLPMLPVHLLVQNLLYDISQISIPWDKMDEEFIRKPKKWDAGSVSRFMLFIGPISS
IFDFATFAVMFFVFKANIPEHQTLFQSGWFVEGLLSQTLIIHMIRTRKVPFIQSWAATPV
VALTSLIMVIGILIPFSPFAAALKMQPLPLSYFPWLIGILTCYCLLTQLVKNWFIKKFNS
WL
>LONDMIMF_00986 hypothetical protein
MTLLSFSTRLLFALVFGASIGIERQWRQKSAGLRTNTLVSLGSAAFILLSVSLTDVAGDP
SRIAAQIVTGIGFLGAGVIMKDGLSVQGLNTAATIWCSAAVGSLCGLGLFAQAGIVTAAI
MLTHMLLRPLGQKLSLLTFIKSNNIQTDYLFTIKCKTEVENQIRVLLMQMLGNEDKLLLK
SLTSNDTEDINQVTITAEIKSATPQDNLIEKTASRLTIEEKVIKVSWEITGTQSDL
>LONDMIMF_00987 Sensor kinase CusS
MKIRTRLTLLFTLITATILLVFAAVIYFTAKENREKEFYSLLKKEAITKANLFLNARVDK
KTLQEIYHSNRKILNEVEVAIYDPSFDLLYHDAVDIDYVKETRQMINEINQKGEISFYQQ
DWQVIGVRYEFQNSYYIVTATAYDQNGYIKLNNLFKTIVIVFIISVLFIYVAGRFFSKKA
FGPVKEMASKAANISATNLDLRLMSKGSKDELSELANTFNEMLDRLENSFEAQKHFVSNI
SHELRTPLAAIIAELELSTHKDRTINEYKDAITNALSDAQKLVRLSNSLLDLAKASYDPS
EIAFKPVRIDEILLDARLQVQQANPDYKIDIHFESDFENDDQISVNGNEYLLKVAFANLF
ENGCKFSNDKQSTVSFSYGDGKILLRFADKGIGISKKDIENIFTPFYRGENKKYADGNGI
GLSLTQKIITLHKGTISVKSENPGTVFTIELAHI
>LONDMIMF_00988 Response regulator MprA
MAILVIEDDQRVAELIQRGLEEQGFTVTLAYDGLSGKKLGLQNNYKLIITDIILPKMDGI
DVCRQIRETKPDIPIIMLTALGTTDDKVEGFDAGADDYLVKPFEMRELLVRVRALLKRNT
KTANSVGFIIRFADLEMNLHTKIVKRDGQEISLTPKEFKLLEYLMHNPERVLSRIEIAEK
VWDTHFDTGTNFIDVYINYLRKKIDRDFEKKLIHTKSGMGFILKAE
>LONDMIMF_00989 hypothetical protein
MKYKYSIPIIIILLIVSSIIQHKNREKEKKIYNLIFNEIKFSGTITGLQVSKNHDFGIIT
IKIKETNCKEFNPIINTKHILPYTIKDSAAEIYITVSSNLKKGDFVKVDSNNGKAIFSNT
SGILYQGQIHIISVESDIDFVKKNSTLNKKHLISILDSP
>LONDMIMF_00990 hypothetical protein
MKFNPIEIQRIDSAGNFKLNEYYILSDLYSDGWTERSLSANFYIDIYYNSKIEFNFSKWN
TVKEFLEKFEFQIEIETPIEIKTLILELVNQEELQLNYNYSDFFLEDSNKEHFVLNHGNQ
SHNVGIGILLNKPTPKNKSEEIFFNLYAEFKDWKETLYSDLLNSELL
>LONDMIMF_00991 hypothetical protein
MKIDTKNLVPNNKEDSNFIHNLKLKSISEIRDIIPQLLEWMQDMNWPQAPLIADYFSPHI
NEIQEELISILKSNDEIWKYWILHGLILHSEITPSQKILLEVKRVYLNASKQEKEEEVDV
IAMEILEKYHIPF
>LONDMIMF_00992 hypothetical protein
MKNYCHIILLLIPYYVLSQDKNLQIIDSCKTISDNKVLIFNKENLDFSLKFNDETSYINI
DFRNNDDDEIQLKRVRLSELNTINLKDKNYFLTYNFIYNVRYKEYSIYSISLKCDEKIPD
KLKYYENIMKNLKNGKLISPITAIEIAKKNGLNTIFSCVLDEDPRWKGLNFYEENEKKWK
VTWTIKTESNSDGGTDVIKLNARNGKVLYKYTEFPID
>LONDMIMF_00993 hypothetical protein
MIGTYVAIGKDYNYRLSLNADKTFDLKFTALDAKSGCEGKWDLKDSDLLVLSCNEPNDMV
ETLRCGYMSQRIQEVKIKSRDKLIYNNSVTLKRIP
>LONDMIMF_00994 Cobalt-zinc-cadmium resistance protein CzcA
MPSGNQIPLEQVADIQYEDGPMQISREDGRRRIVVGFNVRGKDVKRVVEEIQAKLDKQLK
LPDGYYTTYGGQFENLIDANKRLMVAVPIALGLIFILLYFTFKSVKQSLLIFTAIPLSAI
GGVFALWIRGMPFSISAGVGFIALFGVAVLNGIVLIAYFNQLKKEGMNDIYERIKEGTKV
RLRPVVLTASVASLGFLPMAISSSAGAEVQKPLATVVIGGLLTATILTLIVLPILYYYFE
KGFTRSKNTAIVSILVLALFSGTANAQEVPKNLGLKQAIELGLKNNTLIQSSELESKMQS
QLRGTAFDLPKTEITGTFGQLNTNAQDKNFSVSQSFSPFQYGARRKLLLENSNLSQLKAG
VTKQEVVFNIRQSWNAMLYYSELNKMLSRQNKLMQKFVRSASLRFDTGETNSLEKTTALA
KQQELEQKIKQNEAMIQVEKSKIRTFLNSKEEFTASDTSFVALPSLTVLDSALVRQNSNY
KLAKQQVAVAEAGRKVEKATMMPDISAGYFIQSFKGNQEVNGETVSYDGTPRFQGFTVGI
SLPIFAGSSVSKIQAAKTNIEAQQKNAAYMEMQLINQHEQQLQQLNTFQSLMDFYKGTAL
PNADLISKNAEKAYLNGDISYVEYVQGLETALEIRTNYINAVNNFNQTVINLQFLANQ
>LONDMIMF_00995 Cobalt-zinc-cadmium resistance protein CzcB
MNRKNIVYGSLAAIAIALILYFSLRHTENDGHNHDGEKTEKEPKEVATAKEVELNEAQYK
AAGVELGTFAMKNLSEVVNANGYTKLPPQNQADVSVHLTGIVKSINVIEGQAVKKGQVLA
TIESPEFAKLQEAYQTSKSNLEFLTLEYERQKTLSEENVNSKKVFQKTKADFETEKARLS
SLKQQLNLLNLSGSTNSGSIMPVVAPISGYITEINIKIGSNAEVGKPLLSIVDNSQLHVD
LLVYEKDLQKVKPGQNIRFVLTNQDNTEIKGKVFNVGKAFENETKSVAVHADIINKSQTL
IPGMYVNALIDVGARDVQALPLDAIVKAEGREFIFILEEGHEEEAHDSEEGHSHEDGHKH
EEAGKMYHFQRIEVKTGTSQLGYVQVSVLQKIDANAKIVLKGAYYIQSHLLKTEGGGGHQ
H
>LONDMIMF_00996 Zinc-transporting ATPase
MAHDHSEIGHSHSHDNQWKAYLPVIGSFLLLILGIGFEQSEMGFFKYPVDLIWYIVAYLL
VGLKVNYQALKEIRNGNIFSEFFLMSIATIGAFFIGEYSEGVAVMLFYAVGELFQDAAVQ
RAQRSIKALLDIRPDTVTVIRNGEPVVVNPSEVTIGEIIQMKPGEKVALDGELISQTASF
NTAALTGESKPDTKIKGEAVLAGMINLQTLIDVKVTALFRDSKLSRILEMVQEATARKSK
TQLFISRFAKIYTPIVVFLAIAIVSLPYLFVENYVFSDWLYRGLVFLVISCPCALVISIP
LGYFGGIGLASRNGILFKGSNYLDVMTKTDVVVMDKTGTLTKGIFEVQEVVSDIDQKELL
LLTAALESKSTHPIANAIVRYSGGSYKNAAVSEVEEIAGHGLEGIVEGKKVLAGNLKLLK
KYNVTYDKAIEARVETIVVVAIDEVYAGYFVIADELKEDAKEAISSLHALNVQTVMLSGD
KQSIVDKVAKELGIDTAFGNLLPENKVEKVQELKNQGKTIVFVGDGVNDAPVVALADAGM
AMGGLGSDATIETADVVIQNDQPGKIPASIKIGKVTRRIVMQNISLAFGVKVFVLILGAG
GLATLWEAVFADVGVALLAILNAVRIQRMKI
>LONDMIMF_00997 hypothetical protein
MFKKRFFAALVFASISGLSFGKSSSPVSTSKTNVSTAFNAALLANPIEGTGLFENPYRTL
ALNLFDCAGGSETFSNIGTAASAYATRTWTGDNGVAWSATDARTDQELTGKAIALRTSTL
KNTSTIANGIGTLSFKYKRVFSGNSTLKLFVNGVQYGGDIAVTSETAATFSYAVNVSGNA
VIEIRNSGNRTIVDDLTWNCYSAVAAPEIQLADASGATRECGNFSIDFGSRAVNQYHDAV
FTVKNPGTAALNVSALTLSNTTDFTIISPSVPFTVAPSGSGLVLVRFQGTTAGIKNSTLT
IASDDADEASCIVNLTGTALQECAAPVIAGADVAVSNIAHSSADVVVTSAAADAYLAVIS
TSGTLSAAPVNTTNYNVGDSLGGGTVAYKGTNATFSLSGLTESASYHIFVFPYNNANCTG
GPLYYTETSIDEAFTTPVAPCIGGNETFSNLGTASSTYTTRTWTGDNGVTWSATDSRNDQ
DLTGDAIALRTGILKNTAPVAGGIGTLTFNYKRVFSGDSTLKVFVNGVQYGGDITVSSDT
TAAFSQAIDVAGPVSIEIRNSGNRTVIDDLSWNCYTAPNGPELQLSDSDLILKECGNFTI
DFGAVLPNTNKNIIFTVENLGNQDLEVSALTLSDAVNYTIVSPAAPFTVVPLSAIEVEVQ
FNGATLGNKPATLTVVNNDANEGSCQIELKASVQENCVAPTETAVITSSNITDTSASVAV
SGVTASGYLAVITTGSGVVNAPVNGTVYQANDILGDGKVVYAGTNTTFNVTGLTANTNYS
IVIYPYNAECIGSPFYASLPAYDEILTAGAPCVGGTETFSNLGSSSSTYANRTWTGNNSI
TWSATDARTDQDLNGDAIALRTGTLTNTAPITTGIGTLTFNYQRVFTGDSVLKVFVNGVQ
YGGDIAVTSTANTVYSQAINISGNATIEIRNSVNRTIIDDVAWTCYSASPRAAATNNKKS
TAALDSEIKLYPNPNNGQFQLDFAGENADITVFDSLGKNILSKKVASQEVIDLGNAQKGI
YIIQIKSGNSTVSKKVAIK
>LONDMIMF_00998 Exoenzyme S synthesis regulatory protein ExsA
MDTLFIKNMVCNRCIMVVQNELDKLGLDVKSIKLGEVVLGKELSAEQRMKLQEAFSPLGF
EVIDDKKSRIIEKIKNTIIELVHHQENEAKTNLSDVLSSKLNHDYNYLSNLFSEVEGTTI
EKYFIAQKIEKVKELLVYDELSLSEIAFRMNYSSVAYLSNQFKKVTGLTPSHFKQIREEK
RKPLDKV
>LONDMIMF_00999 Copper-exporting P-type ATPase A
MATNSNKEIIYLPLEDVESEHCALIVEKGLAQVKGIETHKVELNNRRAAITVGNNQVVGE
AVKTIKELGYGVTTVKHTFPVLGMTCASCASSAESIVTFQEGVVNASVNFATGNLTVEYL
PNMTDASKLQKAVQSIGYDLLIENETKQQETLEALHAQKFQKLKNKTTWAIILSLPVVVI
GMFFMDIPYANQIMWLFSTPVVLWLGKDFFINAWKQAKHRSANMDTLVALSTGIAYLFSV
FNMVFEDFWHQRGLHAHVYFEAAAVIIAFILLGKLLEEKAKGNTSTAIKKLMGLQPKTVI
IIQPDGTEKQIAIEEVNAGDVILVKPGEKIAVDGMVVSGSSYVDESMLSGEPVPVLKKEN
EKVFAGTINQKGSFRFEAVKVGKETMLAQIIKMVQDAQGSKAPVQKLVDKIAGIFVPVVI
GIAILTFVLWLILGGDNGWVQGLLAAVTVLVIACPCALGLATPTAIMVGVGKGAENGILI
KDAESLELAKKVTAIVLDKTGTITEGRPQVTGIQWLNNDDTAQTILLSIEKQSEHPLAEA
VVKHLEDVSTVALSLFDSITGKGAKANYNNETYFVGNKKLLAENNIVIASPLQKQADEWG
SQSKTVIWFSDSKQALSVIAISDKIKETSVEAIKEIQEMGIELYMLTGDNEATAKAIAQQ
TGIGHYKAEVMPQHKADFIKELQQQGKVVAMVGDGINDSTALATADVSIAMGKGSDIAMD
VAKMTIISSDLTKIPQAIRLSKQTVATIKQNLFWAFIYNLIGIPIAAGILYPINGFLLNP
MIAGAAMALSSVSVVTNSLRLKWKK
>LONDMIMF_01000 hypothetical protein
MKQMIINIPDMQSAHCQARVNNAVKEIDGVQIQNVEAGKIAVSIASDNTKNEVVKAIEKA
GYSVSSESSNNDSDCATGCCNN
>LONDMIMF_01001 hypothetical protein
MENREFQFKTNINCGGCVASVKPHLDKAEGVNEWNVDTNNKDKILTVKTEGITKEEVLDI
IKKTGFKAEPV
>LONDMIMF_01002 putative peptidase
MNLYLSSFQFGNESDKLCELLQPGAKIGHITNATDWHGADEARKKADLENDMAFLQSLGF
KSEHLDLKDYFNRKEALDEKLAGLDGIWVSGGNTFILRQAMPLSGFDTIFGKLRQRTDFL
YGGYSAGICVLCDSLKYIEEVDDPTQFPYTQIKEPIYEGLGYFNYGILPHYKSDHFESAA
ISKEVEKCIENKWLFKALRDGEVIIIKE
>LONDMIMF_01003 hypothetical protein
MAVQSFERWRSYHYKRVIDCLKLYSKNEFLFLLCGSAPLREIIARKGAEPQDLYIRNH
>LONDMIMF_01004 HTH-type transcriptional activator RhaS
MQNDNIKCGQIEKSRGQYVDNILTDAYVWYEKNWRHDEYDHAHQRYQLTYVEDGYQYFHI
GQKTYLAPQNHVIWIPSAKEHRTTSDAKTVNLMIVLFKSVPEHEFFQNVHVFAAPSILKE
MLLYAEKWNQLPNEDEEQTLFLKAMLNSLPHFCNENEFLQIPVPADNRLLPVCNYINTHF
KYNFDIDTLASIANMSVRSLQRIFKQETGITMQKYMQLIRILKSIELIDTKQYTLSQIAL
MVGYKSLPAFTSSYYAIMKIKPRLKK
>LONDMIMF_01005 NAD(P)H dehydrogenase (quinone)
MKKTYSFLIGILVLFIINTAMAQEQKAKVLVLIYSDNGGTYELAKEIAKGIESGQKVQAT
IKQVKASENPKLKNIPVATVEELATYDGIAFGSPVYFGNISTGMSEFLSKTIGLWSSHAL
EGKPATVFMSAGSGAGKELALQSFWNSLAVHGMVLVPNGISGYENIDKNIPQGNSVLGTT
SLASLNSVERPSRSERYLAEVQGKNFAKVAYALRSDEKTKSVNKVGVAEKDVNHVLRDKN
IVLPSLPKPVGNYELYARSGNLIFINQVALKDGKIVNPGKIGVNVTEEQVKEATTVTMLN
VLAILKEAVGGDLNRVKKCVQLIGTFNTPETYTKHAELMNPASNLTVEIFGEKGKHTRNT
SGASSLPVGSSVSIQAIFEVE
>LONDMIMF_01006 putative transporter YycB
MKNKISLSLLSVIVIILIGGGLRSPITAVSPVLSEIIALLHLDNLQGSLLTSIPLIVFAS
CSVLVSKVAVKANIHYSIIYSLIFLIMGLYFRVYGNVPMLYIGSFLIGLGICIGNVTTPA
YIKNRFPEKIGIMTGVFSAAMNLMAAFASGFSIAIGKWTNLGWKGSLGIWIIWTLLALFA
VGAEAFSGKRASVKKPAAQTTKSEFNIFRSKQAWNISVFMGIQSLVYYCLVALLPIVLVD
YGMQKEETGLVLLVAQLSMLPVMFLSPVIATKMKDQKWMIFGVGILMFSGISLLALFKTQ
YVYLAAVLIGIASGWAFSLSILFFSLKSKTMAGTIKVSGKAQSVGYLIAAFGPPVFGMLH
DWDTSWKSSFYFLMLMIVIMVFFGRNAAKPRFVEEH
>LONDMIMF_01009 GTPase Era
MSHKAGFVNIIGNPNVGKSTLMNAFVGERLSIITSKAQTTRHRILGIVNGEDFQVVLSDT
PGIIKPAYELQSSMMDFVKSAFEDADVLIYMVEVGEKELKDEAFFNKIIHAKIPVLLLLN
KIDKSNQEQLEEQMALWKEKVPNAELYPISALENFNVKEVFARIIELLPESPPFYPKDAL
TDKPERFFVNEIIREKILMNYEKEIPYAVEIETEEFLEDEDIIRIRSVIMVERDTQKGII
IGHKGLALKKVGVQSREALEKFFGKQIHIELFVKVNKDWRSNAYQLRRFGYNNK
>LONDMIMF_01010 hypothetical protein
MELDKNIQLRPKFEQFSPKTIGEIKSTYEKIKTFASEDFKFQNAGNHIWLGVGMFRREFW
SPSLHIELDSYEDGRTYVKGIFGPDPILWFIFLAMHFIVGGLFIVFGIIAYSKWTLSQPN
SFDLFMMSVLSIIWLLLYFVARINRKKGAAQMRELFSLAHRIIA
>LONDMIMF_01011 GTPase Der
MNNIVAIVGRPNVGKSTLFNRLIQRREAIVDSVSGVTRDRNYGKSEWNGKEFSVIDTGGY
VRGSDDVFEGEIRKQVELAIDEADVIIFVVDVEEGITPMDEAVAKLLRKVTKPVLLAVNK
VDNAMREKDAVEFYNLGLGDYYTFASISGSGTGELLDALIEAFPEKPEPTKEELELPRFA
VVGRPNAGKSSFINALIGKERYIVTDIAGTTRDAIDTKFDRFGFEFNLVDTAGIRRKAKV
KEDLEFYSVMRSVRAIEHADVCILIIDATRGFEGQDQNIFWLAEKNRKGIVILVNKWDLV
EKDTMTTKEYEAKIRKELMPFTDVPIIFTSALTKQRLLKALEETVKVFENRKQRIATSKF
NDHMLKIIENYPPPALKGKYVKIKFCMQLPTPTPQFVFFANLPQYVKEPYKRFLENKIRE
NWDFSGVPIDIYIREK
>LONDMIMF_01012 hypothetical protein
MLRTILPVLFVLLSCAAFGQNSFTIKGKAVSKEVNLPLESATIYITAAKDSTVIDYTISN
KNGNFSISVKKLNQPFIVKVASLGYQTWEKEFPKLTSDIDMGEIFISDAVTTLGEVEIVS
EAPPIRIKNDTLEFNASSFKVRPDSNVEALLKKLPGVEIDKDGKIKVNGKEVNEILVNGK
SFFGKDGKVAIKNLPSEIVDKIQVSDTKTKEEKLSGDAASSDNKSINITIQEDKNKGLFG
KFTGGYGTDKRYESSGLVNYFKDKQKISILASSNNINSVGFSMDEIFDAMGGGRNFYSNS
NGSFGIDGMNFGGNEGITQSSMIGLNFADEWFKKLEPNGSYFYTNSKTDNDTRSRTENFL
TSENGTNSSFITESSGTTRRTSDGHNFNLELEYKINPSLTLSVRPTLVKNNTISKNFSEQ
SSTNDLGLVNESTNSSKSNNASSSFGNELYLHKKFKKKGRNFGVTFNNSNKSNDRDNITN
SETYFFQDPDRTEDIRRQRVYDVEKDNSYYTRIGYSEPITDSLSIMVRGSYEWKDYDNTK
STFNRNALSGQYSEFNSLLSYGLMSKTRTFNPNASINLRKKKYSGGVTLGTKVIRMENTS
QYDGTTAQVDKNYVYPSANAWLNFRLSKSKSLYMYYNFDVQLPTAEQILPVVDLTNPLFQ
VSGNPDLNPTKNHSLHLNYNNYDYASKSGFYLYTGFNYFEQQIVFSRVFNPVDLINRANY
QNINDTYNSYGGLNWRKTIKKEQHTFRFSAGGNANYNLNKGLTNNALYEARGLTLEPQVS
IGWDYGELLTIEPSYSYSWNTTSYENYSVNSSSNFTHNFKIQTTSHWPKHFVFGNDFGYT
YNSNISDGYKKDFYLLNTSLGYSFMEDKLTLKVKVYDVLNQNQSAVRYINPESIQDIQNT
VLKRYAMFSLTYKIEKFAGKKKEGNSFSF
>LONDMIMF_01013 hypothetical protein
MKKNVVSALLVMACFTGFAQDSKNKPFVASGKKIRVFTTAENTNLRLSSTSGSEFRPAKQ
PLENEVSVFVNPNKQFQTFMGIGGAITDASAEVFAKLSKQQQKEFLDAYYSKEKGIGYSL
IRTTIHSSDFSSESYTYVNENDKDLKSFSINHDKKYRIPLIKDAMKTAGKEMTLYASPWS
PPAFMKDTKTMLKGGKLAPEFYQSWANYYVKFIQAYEKEGIPIWGITVQNEPMATQTWES
CIFTAEEERDFLKKYLGPTMEKNGLENKKIVVWDHNRDLMVQRANTIYSDPEASKYAWGM
GFHWYETWNGGKPMFDNVKLVADSFPDKKLMFTEGCIEAFNPARYQFWANAERYGINMIN
DFNNGTVAWTDWNILLDEKGGPNHVSNFCFAPIHGDLTAGKLIYTPSYYYIGHFSKFIRP
EAKRISTAASRSQLLSTTFLNTNGEMVTVVMNQSDGEIKYKLFVGNSESELTIPAHAIQT
LVY
>LONDMIMF_01014 hypothetical protein
MKLFPTKNAFLLSFLLLLLVQTGYAQFNIPGKPNFQTSLYDYANILSSTDKTNLEEKLIR
YSDSTSTQIVVVTVPTINGEDIGLLAPKWAHAWGVGQKNEDNGVFVLLALKEKKIWIAPG
YGVEEKLTAGINGEIIRNIILPEFKAGNYYQGLNKGADAIFDVLKGKYKGSRKGNRGESN
SGGLVVFIIIFIVILFILSKNKNNRNGGNRGGGLDLSDIIILSSLGRGGGGFGGSSGGGF
GGGGGFGGGFGGGGFSGGGAGGSW
>LONDMIMF_01015 hypothetical protein
MSKVEDFLTREEENEIVQAISQAERNTSGEIRVHIEDHTEKPPLERAQEVFNFLGMQNTS
MRNGVLFYVGVSDHTFAIIGDEGIHKMVEEDFWDCTKDTVISHFKEKKYKDGLVSGILRA
GERLKQYFPFENDDTNELSNEISKG
>LONDMIMF_01016 hypothetical protein
MRKWLIPLGIIVVLVVIIGFWVVGIKNTALKHNQAVSKEWGNVETTYQRRNDLIGNLVNT
VKGAADFEKGTLTAVVEARAKATSMTIDPSNVTPEQMAQFQQAQSNVSSSLSRLLVSVEA
YPQLKANENFLKLQDELASTENQILTARTRFNEQVQIYNGYVLSFPNSLFLGGSYPEKPY
FKSVEGAEKPVEVKF
>LONDMIMF_01017 HTH-type transcriptional repressor BluR
MHLDLSPDKRYYSIGELAKAFDVNASLIRFWDKEFDILKPKKNAKGNRMFTPEDVKNLQL
IYHLVKERGFTLEGAKTHLKEGQKKTLDKFEIISKLEAIKAQLTNIKNEL
>LONDMIMF_01018 Murein DD-endopeptidase MepM
MKKVKYYYDTENLAYRKIKPKKGQKLGVIALFLLASALFGFLCFVILINTPFFETPKDRL
QAREIENMKINYAILNKKMDQIDEVLENVAERDNNLYRVYFNSSPIPEEQRKAGFGGVNR
YNALEGYNNSELVVSTTKRVDIISKELVIQSKSLDEILKLAKEKEKLLTAIPAIQPVKNE
QLKQMASGFGYRSDPFTKIRKFHAGMDFSAKTGTPVYATGDGVVERADNTASGYGNHIVI
RHGFGYETLYGHLSKYKVRAGQRVKRGDVIGYVGSTGRSEAPHLHYEVHKNGEVVNPLNY
YYGNISAAEFAAISKLANQENQSLD
>LONDMIMF_01019 Alanine--tRNA ligase
MKSQDIRKQFLQFFEERGHLIVPSAPIVLKDDPTLMFNNSGMAQFKEYFLGNATPKSKRI
ADTQKCLRVSGKHNDLEDVGFDTYHHTMFEMLGNWSFGDYFKKEAINWAWQLLTEVYKIP
KENLYVSVFEGNPAENVPFDQEAWDIWKTLVDEDRIILGNKKDNFWEMGEQGPCGPCSEI
HVDLRSEEEKAKVSGKSLVNNDHPQVVEIWNNVFMEFNRKADGSLEKLPAKHVDTGMGFE
RLCMALQGVQSNYDTDVFTPLIREVESITGKKYTSNEVKDISEEQNKTNIAIRVVVDHVR
AVAFAIADGQLPSNTGAGYVIRRILRRAIRYGFTFLNTKEPFIYKLVAVLANQMGEFFPE
IKTQQNLVTNVIKEEEASFLRTLDQGLQLLENVVKETKGNEVSGAKAFELYDTFGFPKDL
TALILKEKGMSYNEKEFDAELQKQKDRSRAASETSTDDWTVLVEGNIETFVGYDEVEKEV
RITRYRKVDSKKDGKLYQIVLDATPFYPEGGGQVGDKGTLFTPNQAIEIIDTKKENNLIL
HFAKELPENPQGKFMALVNTKLRSESASNHSATHLLHQALRHVLGTHVEQKGSLVAPNHL
RFDFSHFAKVTDEELKEVETFVNAKIQEQLPLIERRNIPFKQAIEEGAMALFGEKYGDTV
RAIKFGDSMELCGGIHVGNTADIWYFKIVSEGAVAAGIRRIEAITNEGAKEFFASQENAL
KEIKEALKNPQDSLKAVVSLQEENAKLKKQVEALLKEKAKNLKGELVSEIEEINGLKFLA
KQVDLNPEGAKDLAYELGNLGTNLFLVLATAEEGKPMLTCYISKELVAERNLNAGQVVRE
LGKYIHGGGGGQPFFATAGGKNADGIREALEKAKDFIK
>LONDMIMF_01020 hypothetical protein
MAKEFWINLPAKDLGKTRAFFKAIDFRENSQFSENPTMASFFVGDKNVVVNFFPETLFKS
FSGNEITDTAKGTETLFSIDAQSPNEVDELANKAVAAGAVLYAQPGEKDGWMYGCGFSDP
DGHRWNVLFMDFSKMPQQ
>LONDMIMF_01021 hypothetical protein
MNNSNQTITVETTVKAPISKVWQSFTEPQHTMNWSFASEDWHAPEAENDLRIGGKFRTKM
AAKDGSMAFDFEGEYTQVENHKKIEYVMGDGRRVSVSFEDSGDTVKVTETFDPENTHPIE
FQKAGWQAIMDNFKKYTETL
>LONDMIMF_01022 hypothetical protein
MFGLFSYLRTEKEKHSINPKFIIMENDKKLKKPFFANFLESQVPEKEMEQINGGTDVVTM
KFPSDGEDGPGQVITSRVKDLYQTMKYPSDSDEEGVEL
>LONDMIMF_01023 hypothetical protein
MILCLTHSNDLYTIDIVMKRLKELGKEAYRMNSDLFSSKLSFDYSLSNNKSTVQIQIDDR
VIDANAVEAVWYRKLWQAEAPDELDDDFKEIYLQEYYTMQNIFFESLRDVPWFNPMAKDH
EISNNKFGQLSVAAQNGIEIPKSLFTNNQEQVKAFFYEECNKQMIAKLHGTLSRSMLGNT
PFFPTTQITEPNLAGLATLIYCPMIFQEMIPKAYELRIIYVDGEFFAGKINAGQSERGKT
DWRIATDIYFKWEPYKLPDQVATSLSKMMQQMGLFFGAIDMIRHQDGRYIFLEVNPQGEW
GMLQRDLSYPIGETTAEKLVARLE
>LONDMIMF_01024 hypothetical protein
MKKVLIITHTHDNESIETVTQQLKKYNARAIRFNVDLYPLHYGLTSCFEDGQWKVYLDHN
GERESLHDIAALWYRRSHNLGSGLSSVLEGEYLSSVHGEIRTTLFGMLESMNCFHIGKFS
QYRRLDSKEEQMKIASSLGLKIPETCITNNPDEAKKFVLSHPKGAITKMQSSFAIDRGGV
EHVVFTNVITEDNLDAIDSLQYCPMQFQEKLEKQKELRITIVGDAVFSFAVDSQKLDNAK
IDWRREGVELLDQWEPYDLPEPIKQKLLKMMDIYQINYGAVDIIVTPENEHYFLEINSAG
EFFWLDRLIDGAISDQIAKVLSGEAPRRYIPVL
>LONDMIMF_01025 hypothetical protein
MQFATPVPIPKSSHSIDYASKVVSLGSCFAENMGNKLDYFKFQNTTNPFGILFHPLALHK
IIHKAVRQELFSEKDVFYHNERWHSFDVHSELSLADKITFLENLNSGIGNFHNALLESSH
VIITLGTSWVYRKIETDAIVANCHKVPQAAFKKELLSVVQIKESLLEIIGTISAFNPKTK
LIFTVSPVRHIKDGFVENQWSKANLISSLQEVVHATESTSYFPSYEIMMDELRDYRFYAE
DMIHPGSLAIDYIWKRFAETWISEDASSIMQEIDSIQKGLNHRSFNPQSEQHQKFLENLQ
NKILVLKSKYPFMEF
>LONDMIMF_01026 hypothetical protein
MKPTTLLSKMAIVFFFFLGTTAFSQNLVPAENLTPALLKQTFENAYIKVLETQDGFIKVQ
DTYDVFIDIDPSKRYVCFSSSYSLVAGTSPKDALELMNMLNTDIILVKSYYIEKNNSINY
IAYFWTERGFSPQSMVSAFKMYVSALTLSLQKDTKKIIK
>LONDMIMF_01027 hypothetical protein
MKTLKTLGAMCLLATILFSCSSDDGGGGSNSGGFSLTAKVDGANYSNSNYFDPMAVITNN
ILVIQSSDNGGNSIQIQVMNYNGVGSYISGNNNLMAGYINYLKVGATVGQFKTFTSVRGD
GLVEITEVTDTYVKGTFSATAPENVSNSTESVEITEGSFKAKIQTQ
>LONDMIMF_01028 hypothetical protein
MKFSVKLICSVLVLLTSIVSVAQDTPDYTYNLGGKIDFMKLTESGVLVVANGDGLAGIKP
GESKLHFDFNDYGKVKQEELEFIPMTPYVVISQGGMLSSKKSVLDFVSGKKLFATEDKGW
KMIYTCDVMMPQNKLVVSGQRTAKEKYAMAVGIYDLVSGNQDYLFNLQDPNKVSMGITTV
TGKPLMVGSGLIVPTSKALLHIDMNSGNITWTAKVDDITWMTADTSGKEIYAFEQTPGGD
TRIHKVSNTGQVLWADSHKVKGKISRFEILPQGLAIVSDVDNSGKSGLAKLASAASESRI
AFLSASDGQDLWEKAPKTKGYVQHFYIMDDGILFGIQEGGINKVSFDGKTLFKKPLKTGE
NIHTMALTPKGMIYITDMDADIINLSTGESIWNKPIKYKKAKAVASTYDKANKRYLISTG
EEMLAIQEESGEISTLANYKFQEKEAPSKLQVRNDGLLLTSEQNMVMLNFDGTPKFHEYY
KSPGTSTFGKILTGVMGAASMAVASSAAFTAGANKNAIGQYNDYGQNAKNVQDAFSGIAS
ASFSEMNKRFKATAATENAQFILTKLDDGVGLVKISKDSGKKEKEIVLKDKKPEYEVDEI
AGILYHKAGSNKINAYNLIQQ
>LONDMIMF_01029 Sensor histidine kinase LiaS
MHLKTKFILAVFLLFGVISGFSQANRTKIDSLKKQIYSKSSVSKVKSLILLSDELSSSNP
ENSLLYAREALRTSQEIKNDSLISVSYNSIALNFEVRSKLDSALFYHKKALDIRVKLNDR
IGMADTFNNIGICLDQQGKFQEALENYFKALKIYERKKDSEKIAMTYVNIGIVYKTQKEY
EKSLDYYKKANTIYARNKSEFGFAATSGNIGSVLIDFKKFRESIRYSELAKEGYQKLGYD
RYVAYPVSNIAIAYDSLKEYDKSEVFYLQAINLHKKFKNDYEIGNISNAYSRSLNKQSKF
KESIRISEEALGYIKKAKLFPLEVNALKNLANAYAGIGNYLKAYELSSAYSKGRDALFEE
EKTKAVFELETQYETEKKEREILIQRARIAENELKIERKNLMILAVVFLLLLSVLIGWQF
FNRQKLKNIQLQKENELKDALLKIETQNKLQEQRLRISRDLHDTIGAQLTFIISSIDNLK
YGFQIDDERLQNRLAGISEFTKETIYELRDTIWAMNMNQITFEDLKSRISNFIDNAKISS
IGIDFQFVYSDAGLCKRTFTSVEGMNIYRIIQETINNSIKHSGAGKIAVTIDGDEDNLVI
EVTDNGKGFSPGLNKEGNGLNNIRKRAKEIGGEIELNSKPGEGTAMKLFLPNNA
>LONDMIMF_01030 Response regulator protein VraR
MSIKIAIADDNYFLQKTILEKLSFFTELQCRFTALNGKELLEKLEANHNIDLILMDIEMP
EMDGIEATERVKSKYPHIKIIMLTVFDNDENIFNAIKVGADGYLLKEVNPKDLCQGILET
INGGAAMNPSIALKTLKLLRNPIEFERKCVEEVKLTSREIEVLEQLSKGLNYNVIADNLI
LSPGTVRKHIENIYGKLQVHNKIEAIEKAKNNKLI
>LONDMIMF_01031 hypothetical protein
MRRILIIAGIVVAVILAFRFCEFKKDDRSTIEYDTNLIQERIVNVGKLIVTEGHFAEVLT
YKDQEKYLMDLISFEKKALVIVNADVTVSYDLRQMKYDIDEKNKTITIKYIPKEEIKINP
DIKFYDINQSRMNPFTGDDYNKINKSVKANLAKKIEKSSLKTNAQNRLISELSKILITTN
SMGWTLRYDGQTVNEESIDKVLL
>LONDMIMF_01032 Phenylalanine-4-hydroxylase
MFLLKICNFTKTTTFENMNAPFESNPLIDRLPEHLKQFIKPQDYEDYTPINQAVWRYVMR
KNVDYLSKVAHNSYLDGLKKTGLEIENIPNMYGMNRILKEIGWAAVAVDGFIPPNAFMEF
QAYNVLVIASDIRQLEHIEYTPAPDIIHEGAGHAPIIANPEYAEYLRRFGEIGCKAISSS
RDYEMYEAIRLLSILKEAEGTPQDEIDAIEKKVDELQNDMGELSEMALIRNLHWWTVEYG
LIGDINNPKIYGAGLLSSIGESTWCMTDNVKKIPYDITAAFQSFDITKPQPQLFVTPDFA
HLSQVLEEFANTMALRTGGLSGVQKLIQSKALGTIELSTGIQISGVFTNVIESEGKPVYV
QTTGETALSYREKELVGHSTSYHSEGFGSPIGKLKGINLAIEDMSPRDLKAYGIYEGERV
TLEFQGDITVTGEIITGTRNIQGKIILISFKDCTVTHNDTVLFQPEWGIYDMAVGKKVIS
AFSGPADVRSFNLVNHVPSSKTIKAKKSTEREELESLYLNVRNMREGKTPFMTIEKTFEI
LKENHPKDWLLAVEIAELLDKNHQTDFLQEVLIYLEKLKQTRPEIAHLISGGLELIFENE
SV
>LONDMIMF_01033 hypothetical protein
MKTIKLLPLLFLFALVSCSSVQVATDYDKNVDFANYKSFAFFKSGIDKVEISDLDKRRIL
NAIDAELTAKGITKSENPDLLVNIFTKSRQQVDVNQFNAGWGYGWGWGWNPWMWGGRSTT
VSTTTEGTLYIDLIDARKKELIWQGEGVGVLTQNINKKDERIKEFVKKILEKYPPGKK
>LONDMIMF_01034 hypothetical protein
MKTLNSISLMFMSLGFFILGMLFENVRLKIVVLTAAAIVSIAAAIKSFQEKKKNK
>LONDMIMF_01035 Urocanate hydratase
MTFQEQIQQGIPSVLPQPKPYETDINHAPKRKEILSAEEKKLAVRNALRYFDAKHHEVLA
KEFRDELESYGRIYMYRLRPDYRMYARPISEYPGKSEQAKAIMLMIQNNLDYAVAQHPHE
LITYGGNGAVFQNWAQYLLTMKYLSEMTDEQTLVMYSGHPMGLFPSHKEAPRVVVTNGMV
IPNYSKPDDWEKFNALGVSQYGQMTAGSYMYIGPQGIVHGTTITVLNGFRKIKKSPGGHL
FVTSGLGGMSGAQPKAGNIAGCVTVCAEVNPKITHIRHSQGWINEIIENIDELVPRVKKA
LENKEVVSIAYLGNVVDVWERFDQENLHIDLGSDQTSLHNPWAGGYYPTGYTFDESNELM
ANDPEKFKAEVQKTLRRHAAAINKHTAKGTYFFDYGNAFLLEASRAGADVMAENGIDFKY
PSYVQDIMGPMCFDYGFGPFRWVCTSGKPEDLQKTDEIASKILEEMSKTAPVEIQQQMQD
NIQWIKGAQENKLVVGSQARILYADAEGRIRIAEAFNQAIAKGEIGYVVLGRDHHDVSGT
DSPYRETSNIYDGSRFTADMAIHNVIGDSFRGATWVSIHNGGGVGWGEVINGGFGMVLDG
SKEASRRLESMLFWDVNNGISRRSWARNDGAIFAIKRAMEVQPLLKVTLPNKVDESLLDF
>LONDMIMF_01036 hypothetical protein
MNEQNNENKLKEGEDFYYTPEGYKCFTEKHHLKRGYCCKSGCRHCPYGFDKKTGLNKK
>LONDMIMF_01037 hypothetical protein
MFLIVSRYLIPKGYRGITLFPFVILKNPLDRQNRVLVNHEKIHIRQQLEFLIIPFFLWYF
IEYGLRLIQYKNKNLAYRNISFEREAYFNEFNLDYIKNRKVWDFRKYL
>LONDMIMF_01038 D-cysteine desulfhydrase
MVEIKNQLILKTNKVDVFIKREDLIHPFVSGNKYRKLKYNLLKAKEDGYSVLLTFGGAFS
NHIAAVAFAGKENNFKTIGIIRGDELREKIEDNPTLKFAQENGMQFEFISRAQYSDKQSP
EFEEELRRRFGNFYLIPEGGTNELAVKGCEEILTVDDAQFDYICCAVGTGGTISGIINSA
LPHQKVLGFPALKGDFLKKEIRKFASNENWELIADYHFGGYGKVNLELIEFINNFYQDNN
VPLDPVYTGKLVFGVTDLIEKNYFPDKSKILIIHTGGLQGIQGMNTVLENKQLPKININV
>LONDMIMF_01039 Autolysin
MFKKIFFLLTIATLASCGSSKSKVATTKKAAYKPKREVAARKTHTGKTVSTTKSGAGSGR
TTEVIESTSKTIVYSDVVNSYVLQYKDIAKGNMKQYGIPASIILAQGILESGAGSGTLSK
TANNHFGIKCHTGWTGESVRHDDDAEQECFRKYNDPAESYRDHAEFLTGRSRYASLFKLE
KGDYQGWAKGLKAAGYATDPKYPDKLISYIERYNLHQYDAEVLGVEFTPIQKSQPVAMNT
RPNNTEGFYEVTKGDTLYSISKKFNTTVDDLKRLNNLSDNAISIGQFIKVK
>LONDMIMF_01040 Glutamate-1-semialdehyde 2,1-aminomutase
MLYQRSSQLFAQAEKVIPGGVNSPVRAFKAVGGTPIFVKSAKGAYLYDEDGNRLVDYINS
WGPMILGHAYDPVVNAVIERAKLGTSFGMPTALETEIAELAVSMVPNIDKIRFVNSGTEA
CMSAIRLARGYTKRDKIIKFSGCYHGHSDSFLIQAGSGAITFGAPNSPGVTQGTAKDTLL
ARYNDIQNVADLFNANKNEIAAIIIEPVAGNMGCIPPNEGFLKALRSLCDENGTLLIFDE
VMTGFRLAKGGAQELFDIKADIVTFGKVIGGGLPVGAFAARNEIMNYLAPVGPVYQAGTL
SGNPLAMAAGLEMLKALNADADIFKRLDEKTAYLEKGIREKLTVNGVAFTINRVGSMISV
HFDESPVTDLQSASKGDNEYFKKFFHGLLQEGVYIAPSAYETWFITDALTYEDLDFTINA
VDKVSKQF
>LONDMIMF_01041 hypothetical protein
MKKFIAILSVFFAFTIASFAQTSPADLAKKDIASLSEAVTLSEQNKATFLELFKKKHEAL
SKPGLTDDKKKVIYKSIDAKLRGTLSAEQMAKIDSNPELLKQLTQN
>LONDMIMF_01042 hypothetical protein
MKKMFVFAVLMIGMASFAQEKPVGKKMDRAKMERLTPEQRNEKHLKKLTTDLGLNESQQK
QMATLLSEQSANREAKKAEREKIMQAKRTERNEEMKAFDNKVKAILTPDQSKKWDEMKAE
KREKAKEKFQERRKRTEKK
>LONDMIMF_01043 hypothetical protein
MKKILAILAFFLAFSIGASAQESQKDAYASAQADFAALNAVIPISKKIEKDIKETLYDKH
KFLISRTDVTAEQKAQLSTEIETKLAEILSPEQFRKLKANQQLFKKLTQ
>LONDMIMF_01044 Lysine--tRNA ligase
MQLSEQEIIRREKLGRLRELGINPYPANLFPVTHTSKQVKDTFEEGKKVIVAGRVMSTRI
QGKASFASLQDSEGRIQIYVNRDELCPGEDKTLYNEVFKKLVDLGDFIGVEGTLFTTQVG
EKSILVTNFSLLSKTLRPLPLPKIDAEGNLHDGFTDPELRYRQRYVDLVVNPQVKEVFVK
RTKLFNAMRNFFNAAGYMEVETPILQSIPGGAAARPFITHHNSLDIPLYMRIANELYLKR
LIVGGFDGVYEFSKNFRNEGMDRTHNPEFTAMEIYVAYKDYNWMMEFTENLLEHCAVAVN
GTPEATFGEHKVSFKAPYARVTMTDAIKKYTGFDISGKSEKEIFEAARSMGIAVDETMGK
GKLIDEIFGEKCEGNFIQPTFITDYPKEMSPLCKEHRDNPELTERFELMVCGKEVANAYS
ELNDPIDQRERFEAQLKLSERGDDEATQFIDYDFLRALEYGMPPTSGLGIGMDRLIMFLT
NNASIQEVLFFPQMRPEKKTVEVELTAEEKGIIEILKTNENAMPLNLLKVKADLSGKKWD
ASMKSLAKHALTKVSIEGEDKIVHYIG
>LONDMIMF_01045 hypothetical protein
MRVRVAAVGAAAATDDQACDEDSEYGETEDYTVNIQPALGIDEIKNQNKLVVSNSNSLLN
INSSNSLIDSIELYDLTGKLIYHKANINNNSSSLDNSFFSNQILVLKILTSDQVVHIKKI
AN
>LONDMIMF_01046 hypothetical protein
MNWKTTFKNQKKQFTRIRFHNMKFIFGILFCSLGFQAHSQYCQPVLDCTDDDLILNVSIG
TLTNASTCGSNGYSNFTALAAPNLNMGSSYPISVTVGDG
>LONDMIMF_01047 Octanoyltransferase
MNKEIQLLDLGRKDYKDTWEYQESLFKDILDLKIKNRREGLELNTPNYFLFVEHPHVYTL
GKSGDFNNLLLSEKELESKGATFYKINRGGDITYHGPGQIVGYPILDLENFFTDIHKYLR
FLEEIFIRVLADYGLTATRSEGETGVWLGVGTPFARKICALGVRASRWVTMHGFALNVNA
DLGYFDNIIPCGIRGKSVTSLNVELGLEEVDVEEVKEKIKKHFTELFESQFVAFKAAMV
>LONDMIMF_01048 Ribonuclease HII
MLMLLNSYSNLNFECGTDEAGRGCLAGPVTAAALILPEDFLNELLNDSKQLSEKNRDFLR
PVIEENALCYSVTHIEPGIIDEINILNASIHAMQECIKKLNPIPNYIIVDGNRFKPIANI
PHSCIIKGDSKYLSIAAASILAKTYRDEYMNQIHEEFPMYNWKQNKGYPTKEHREAIKKY
GTTKYHRMSFRLLPEQLEIGF
>LONDMIMF_01049 TonB-dependent receptor SusC
MRSKFKWIFALLLAFSMQFSFAQEKTISGTITDGQGLPLPGVNVVVKGTARGTQTDFDGK
YSISASQGEVLQFSFVGYKTSTATIGASSVVNMAMQEGDEMLNEVIVTGYTSTKRPKSLA
AVNFVSVDEIEERSNASVIQNLQGMVAGLNIGTGSGQPGADSTILLRGVGSINGNIEPLF
IVDGMPVDEDGFRSINQNDIASIAVLKDAAATSIYGNRGANGVIVINTKNAKFGQSLEIK
YRGQYGITELQKFNLDVMSSRQILEFQRKYNDGRGAGMTDAEIADEARINTDWRDVFFRT
GVTQQHDISFASGSKNSRNFTSIGFMDQDGIFITTNFKRFNFRNNFNGKSDNEKFTYASN
INVNFSRSKGQDGAGSNATFFAPFTAAIRGLPYIDPLKELAYGDTAALTPENAPLVLLNS
ARMNENLSDELKILANFNADYKLTDNFTAGINLGVDYSSFNTLTILDPLSLLGPFQVSAA
AQFGGIHTEGNSRDFRFNSTTYLKYNKVFNEKHSLNVGLYTEYYKAHFNSFNFQKRGLDP
RLTGTGAAFIPGTTVESYQTLPPYIPTIGSTKVQEGLFSYFGQVDYDYAEKYGLSVNVRR
DASFRFIDDKRWGTFWSVAGRWNIDQESFMDGSVFNMLKLRGSYGVSGNQRILNAQYSAL
SLTRYLYGGGAGYNGTTSTALAQLGNPDLQWEEIAQTNIGLDFGLWQNKLNGSLDVYRKL
TTELFQSVPISPIHADDNISTNIGSLENKGIELTLNYNIFKNQDWDISVGGNGSYNKNKI
IELPPSANGLVFEGGSTALGTGQAIGSFYVVRYAGVNPANGNPLFRTVDGGLTETISDAN
RVFTDKSQYPVWQGGFNTSVSYKGFNLYTQWSFVADIYRNNLDLGTLENGTSGSLNNGGN
RSTTLLNAWQNPGDITSIPRIGQGYNEIDYINSTDRYLEDASYLRLRNIKLSYNFTSDQL
SRTFLKGLGFFIQAENIVTFSSWRGWDPESNFRSTDRGQYPTPKIFTFGTSINF
>LONDMIMF_01050 hypothetical protein
MKKSILLLPIFFLMLLSCSDAYDIVQDNELPEDEAYVTIGHLRSGLNGAYAAYGPDFGGD
AIAFNDLFTDNIRRGPNNNGQGAEEYNFLIQPNSDMPTAVWSNRYATINRVNRVLRAYDR
LFPTFNEVDQRNAKHVKGNLLALRALCHLDLFQYFTVDYKNLSAPSVIKMDFVPNSPFDV
YPRNTVGEILTFIKQDLTDAKTFLAAGLQLAPGETVLPSSLTAYNSPIYLREVAVDFIRC
RVAMLEGDYPTAESIATTILATPAFDLANRAAYLQMYGNADAPGECIFKLSRVLNNNSIL
NLFYFNTNSTGPIDPYLTASKQLYDLFPPVNSANNPDVRRVVLFGNVVDPANIAIDNYPI
RKYVGSADGPTINDVKLFRSSELKLIVAECKARNSDFLGAATAVKELRDKRITTTNVLPT
YTSLNAALTDILLERRKEFAFEGHRYLDLKRIGGEINVGINRLESDAFSFSAPTSLAAGD
YRFTLPIPTVELTANPTIVQNPNY
>LONDMIMF_01051 hypothetical protein
MKKLFILLISVASFISCSDVDGVTYNDSSTYLGFQASTYNLPVVVNSSSTVDIKFVASSK
SNVARTYNLSVITEETNADPLTYSVPATITIPANSYEGVATITGTDNGLLDFVVKKLVLE
VSGLNAKESTDTERITINMYEVCPLVMEDFVGVFSGNLYYWDNGDYDIIEGSAPNTLEIV
DFFPSTTNPNLVLTYDADNNVTFADQNTGYYDSNGGFLWLRMSAATVGTSKIDPCTNKIT
LKVKYYIPNLGAYPDGEDIFTKQ
>LONDMIMF_01052 Bacillopeptidase F
MKNYYVLISVFCTSILFSQSKEDLKEVVKNTNVSELMELNKIFQAEYIKRQERINDYLLK
NPQASRVIKDEFSKKEIYDVVNGDVSYYVTSNAGSSVTIRTNRLYSGGSLGLNVQGQGMK
AFVWDGGGARTTHVEFPNNKVNIIDGAALDDHATHVTGTIVAQGLTANLKGIAFDASVDS
YDWNNDYGEMAIEAASGMLVSNHSYWIGQNARWNFGAYDSRARAFDQIAFNAPFYLAVTA
AGNDRDRAADPLIGPYLNEKFGYNLVRGMQNGKNYLTVGAVSQVSNYTGPDSVVMSDFSS
WGPSDDGRIKPEIVAKGVSVRSTLVTSDTASGLKSGTSMASPAVTGAVVLMQQHYHNIFN
NYMRAATVKGLLLHTADEAGIYDGPDYEYGWGLLNAEKAANVITGKNVGSTIIDELTLNN
SQTYTRSITVNGTEPLMVSISWTDRPGTANNGTNDPTDLNLVNDLDVRVIKTDNTTYFPW
TLDPANTFNAPVRTQDNFRDNYEKVQVDNPGGTYNIVVTHKGTLTGGSQNFSLIVSGPQV
LSTNEVVKIDDAISIYPNPVANSLNFAVTNSIVLSDVSIYDVTGKQVISSKDLSSNSIDV
SRLQSGVYFAKFASEDKTVTKKFIKQ
>LONDMIMF_01053 hypothetical protein
MAKFFYVALFLLPLFVFAQTKDPQTKGNITAGKEKKVQLTEPAKNDTIATIDMYRIITLQ
HDTTYVDTSLTIQKEYKFNYLRKDNFGLLPFANEGQTFNTLDYGYNKTTAYPGFGFAGKH
FNYLEVDDIKYYNVATPMTDLYFKTVMEQGQMIDAFITLNTSERLNFSIGYRGLRSLGKY
VNQLSSNGNFKFMTSYNTSNERYFLKAHFTGQDLTNGENGGIVNLEDFEGGDSEFDNRAR
LDVYFLDATSILKGNRYFVDHHFRINANKSTNNLYVDHQFNYENKFFEYTQPTIVTSITT
PAQGTIRMSRFGSSYRSSNINDKTRYNRMYNKVGATYENNTLGQFQFFIEDFRYNYFYNR
IIIESPTYTIGNLLSDEFNVVGGQYTYQKNNWNGRFLFSSSISEQKMTTLDANLSYKFDE
KNNIHFQYQNLSKVPDHIYNLFQSSYIDYNWANNFENEKINSLNVNANTQWANASLQVSN
LKNHLYFFNQSTSQDTLTIKPAQYSKAINYLSLKVSKEFKFRKWALDNTVLYQKVAQDDD
IINVPQLVTRNTLYYSTHVFKKAMFLQTGITFSYFSKYYANDYNPVIGDFYIQTKREIGG
FPTFDFFVNAKIRNTRVYLKAEHFNSGFMDKNYYSAPNYPYRDFIVRFGLVWNFFS
>LONDMIMF_01054 Putative cystathionine beta-synthase
MKYANNILETIGNTPLVKLNKVTKEVDALVLAKVETFNPGNSVKDRMAVKMIEDAEADGR
LKPGGTIIEGTSGNTGMGLALGAIVKGYKLICVISDKQSKEKMDILRAVGARVVVCPTDV
EPTDPRSYYSVSKRLAEETPNSWYVNQYDNPSNSLAHYEQTGPEIWEQTDGKITHFVVGV
GTGGTISGVAKFLKEKNPNIKIWGVDTYGSVFKKYHETGIFDENEIYSYITEGIGEDILP
KNVDFSLIDGFTKVTDKDAAVYTRKIALEEGIFVGNSAGSAIKGVLQLKEHFKPEDVVVV
LFHDSGSRYVGKMFNDDWMRERGFLDEEITKAEDVIKDHIDKPLVVVRTEELVSHAIERM
RKYKISQIPVIDINGFVGSVDETDLFQSYVSDKNVADKPIKEVMGKPYPIVKSGTSIEEV
SKLFSKDNQAVLVDLGNGKHHIITKYDIIGSIK
>LONDMIMF_01055 hypothetical protein
MKHYFLIIFAFFTIASTAQKNNKAYKITYSRTSNGKTIEGQDPVLVFSDANESIITSENN
ITGKAEYPFEETFITQNSNIIQLARLSSSRKIFTVDSLSLAKQTFEIGNETRTILGYKCK
KAKTIINSNAIELWFTNDLNIKGAPSILGQKLGLVLEMNRNNNYIITATKIEKIKSIPTS
LLTLKSNFSAIDALTYRDLLWKSRFITIPVFENEVINFSDASKSNDSILRFANGTIILKK
IKFPEIKSGSQVFVDLKEQSNGDAYDRTGTVFAISSKEKFSFMEGLKNGAKTLPVYENGN
GKQYQGVIKTGEFSPLLELMRFFTPFGIKQYGHIQLKDKTWHESVPYRQDISELYSALSN
QEVYIGTFIGNYDKGGHKISLNITIHGEEKQSPKDSFVLPLFNTTNIMEMAGQEYATMFN
NEKGLVVDFVLEKDVKNAKLRYITTGHGGWENGDEFVPKKNTILLDGKEAFGFIPWRMDC
GSYRLFNPASGNFNNGLSSSDYSRSNWCPGTVTNPMLIELGDLKAGRHSIQVKIPQGPNE
GGGFSSWNVSGILIGD
>LONDMIMF_01056 hypothetical protein
MKEDFLHFLWQFKKFDLARLYTTQGEKLTIISSGLYLQKAGPDFFNAQIVIGAQKWAGNV
EIHRKSSDWYLHNHETDPNYDNVILHVVWEHDTEVFRKDNTELAVLELSKFVSGKMLENY
ESLMLDKTWLFCEKQIASVDSFVLDNWKERLFFERLEKKSRLIWNTFSETLNDWEALLFC
LLAKNFGLNNNGETFLKMALSIPFQKIRKESFEVRNLEALFYGRAGLLNNENEDVYFQDL
KGRWNYLRNKHLLKRIYVEPVQFFRLRPSNFPTIRLSQLANLYHSKPNLFSKIIESKSLA
EFYKIFDVSASDYWSDHYQFDKQSRRKEKKLTNAFIDLLLINTVVPLKFAYAAYVGNDIS
EEIVQLLSEIPAEKNIIIDKFRDFGIVANNAYETQALLQLKNEYCNKKRCLECGIGLELM
KN
>LONDMIMF_01057 hypothetical protein
MLTFELSNDMSFITNIRHFFEKHGFEVSSRLADRLGMRASSVRLFFIYISFFTVGLWFGV
YLTLAFLVRLKDLVYTKRSSVFDL
>LONDMIMF_01058 hypothetical protein
MPINKSFFRFDSKQRMGIFVLLMIILIIQLTAYFIDVTIKEDVSVEKQEWLSIQAEIDSL
KIAKTSRKPEMYPFNPNFITDYKGYKLGMSTIEIDRLLEFRKANKYVNSAQEFQTVTKIS
DSLLNVISPYFKFPDWVKNKKNDFSQEKQPAFKKEKIALIDINKATQEDLMKIYGIGPGL
SERILKQKDLLGGFVSMEQMSDIWGLSPEVIEKLNAQFYVGSLPEIKKIKINDASVKELS
QFPYFRYPVSKEIVTYRSMNNGVLTIEDLTKVKGFPVEKIKIIALYLEF
>LONDMIMF_01059 Acyl-CoA dehydrogenase
MNSTYFTEEHELFRKSLQDFLQKEVVPHIEKWEKTGAIERFIWKKFGEMGFFGINYPEAY
GGMNLDLFYTVVFLEELQKIKSSGFAAAMWAHAYLAMTHLNAEGDERIKQDYLATSISGD
KIGALCITEPFGGSDVAGMRTTAVKQGNKYVINGSKTFITNGVYADYYVVAAKTSPELGN
KGISMFLVDSNLKGIATTKLDKLGWRASDTAEIAFDNVEIPEENLMGEEGKGFPYIMQHF
ALERLIMAINAHARAEYAIEYTIGYMSEREAFGKTIDKFQALRHTIVEHATDVEHCKIFN
YATVARLNQKEYVVKEASMAKLKSTKVADETIYSCLQMLGGYGYMEEYPLARLLRDSRLG
PIGGGTSEILKEILSKIIIDKQNYKPAVK
>LONDMIMF_01060 30S ribosomal protein S21
MRGGVILMLIIPIKDGENIDRALKRYKRKFDKTGTVRQLRARQAFIKPSVVRRAQIQKAG
YIQSLRDQLEN
>LONDMIMF_01061 Tyrosine recombinase XerC
MLDNKESFKDYLQKEKKYSLHTVTAYSNDLSDFEAFLKQDFDQDSLEDVNYSQIRSWIVS
LVDAGISNTSVNRKISSLKSFYKFLLKIKRIQVSPLLKHKALKTSKKLQIPFSEKELDNV
LNYIVYPEGFEGMRDKLIIDLFYTTGIRRAELIGLKVANVDLSKGVLKVLGKRNKERILP
MLPVIQEQMRLYLSERAGLEEIKDGEFFFLTLKGVKLSDSLVYRLINMYFSNVSEKVKKS
PHVLRHTFATHMLNNGADLNSVKELLGHSSLASTQIYTHSSLAELKKVYGDAHPRNQK
>LONDMIMF_01062 Ribosome hibernation promoting factor
MKVNVHAVNFNVDGKLVAFIQARLDKLEKYYDRVVSSDVFLKVEKTSDKENKIVEIKIHV
PGDEFIVKKQCKTFEEGVELSSEALERLLVKRKEKIRTHI
>LONDMIMF_01066 Elongation factor Tu
MAKENFNRSKPHLNIGTIGHVDHGKTTLTAAITKVMAEAGFSKTAAKSFDQIDNAPEEKE
RGITINTSHVEYETANRHYAHVDCPGHADYVKNMVTGAAQMDGAILVVAATDGPMPQTRE
HILLGRQVGIPRIVVFMNKVDMVDDAELLELVEMEIRDLLSFYEYDGDNGPVIQGSALGG
LNGDATWVPKIMELMEAVDNWIEEPVRDVAKPFLMPVEDVFTITGRGTVATGRIETGVAN
TGDAVEIIGMGADKLTSTITGVEMFRKILDRGEAGDNVGLLLRGIDKADIKRGMVIIKPG
SVKPHAKFKAEVYILKKEEGGRHTPFHNNYRPQFYVRTTDVTGVIALPAGVEMVMPGDNL
TIEVSLLSPIAMNVGLRFAIREGGRTVGAGQVTEILD
>LONDMIMF_01068 Protein translocase subunit SecE
MTKVVNYITEAFGELKNNVTWPEWAEVQRLTIVVAVFSVIFALATWGVDVVFAKALAGFF
NLIKG
>LONDMIMF_01069 Transcription termination/antitermination protein NusG
MADNNVKKWYVVRAVSGQENKVKAYIETEINRLGMADYISQVLVPTEKVVQVRDGKKISK
DKVYFPGYVMIEANLVGEIPHIIKSITSVIGFLGEVKGGDPVPLRQSEVNRMLGKVDELA
VKTDNHAIPFTVGETIKVVDGPFNGFNGTVEKINEEKRKLEVMVKIFGRKTPLELSFMQV
EKV
>LONDMIMF_01070 50S ribosomal protein L11
MAKEISKVVKLQVKGGAANPSPPVGPALGAAGVNIMEFCKQFNARTQDKPGKVLPVQITV
YKDKSFDFVVKTPPAAIQLLEAAKLKSGSGEPNRKKVAKVTMDQIRAIAEDKMADLNAFT
IESAMSMIAGTARSMGITVTGDAPSN
>LONDMIMF_01071 50S ribosomal protein L1
MAKLTKKQKEAASKIEKNKLYSLKDASALIKTVASAKFDESVDIAVKLGVDPRKANQMVR
GVVTLPHGTGKDVRVLALVTPDKEAEAKAAGADHVGLDDYLQKIKDGWTDVDVIITMPAV
MGKLGPLGRILGPRGLMPNPKTGTVTMDVAKAVQEVKSGKIDFKVDKTGIVHAGIGRVSF
GAEQISENAHEIIQTLIKMKPTAAKGTYIKSIHISATMSPAIALDPKAV
>LONDMIMF_01072 50S ribosomal protein L10
MTREEKSIAIGDLTAQLAGTNIVYVADISGLNAETTSSLRRACFKAGIKLEVVKNTLLEK
AMEASENNYGELPGVLKGNTSIFIADVANAPAKIIKEFRKKSDKPVFKGAFINNEIYIGD
NLLDSLASLKSKEEVIGEIIGLLQSPAQRVISALKNQFANEEGAES
>LONDMIMF_01073 50S ribosomal protein L7/L12
MADLKQFAEQLVNLTVKEVNDLATILKEEYGIEPAAAAVVVSGGGDAGAAAEEQTEFTVV
LKDAGASKLAVVKAVKELTGLGLKEAKDLVDAAPANVKEGVSKDEAEGLKKSLEEAGAVV
ELK
>LONDMIMF_01074 DNA-directed RNA polymerase subunit beta
MITNQTERLNFASTKNIPQYPDFLDIQVKSFKDFFQLETKSDERGNEGLYNTFMENFPIT
DTRNQFVLEFLDYFVDPPRYTIQECIERGLTYSVPLKARLKLYCTDPEHEDFETIVQDVY
LGTIPYMTPSGTFVINGAERVVVSQLHRSPGVFFGQSFHANGTKLYSARVIPFKGSWIEF
ATDINSVMYAYIDRKKKLPVTTLFRAIGFERDKDILEIFDLAEEIKVSKTGLKKYIGRRL
AARVLNTWHEDFVDEDTGEVVSIERNEIILDRDTVIDKDNVEEIIDANVKTILLHKEDAN
QGDYAIIHNTLQKDPTNSEKEAVEHIYRQLRNAEPPDEETARGIIDKLFFSDQRYNLGEV
GRYRMNKKLDLDIPMDKQVLTKEDIITIVKYLIELINSKAEIDDIDHLSNRRVRTVGEQL
SAQFGVGLARMARTIRERMNVRDNEVFTPIDLINAKTLSSVINSFFGTNQLSQFMDQTNP
LAEITHKRRLSALGPGGLSRERAGFEVRDVHYTHYGRLCPIETPEGPNIGLISSLGVYAK
VNGMGFIETPYRKVTDGKVDLVSEPVYLSAEEEEGKMIAQANIEMNDDGQITADKVIARE
EGDFPVVEPNVVHYTDVAPNQIASISASLIPFLEHDDANRALMGSNMMRQAVPLLRPEAP
IVGTGLERQVASDSRVLINAEGDGTVEYVDANIITIKYDRTDEERMVSFDPDEKTYNLIK
FRKTNQSTSINLKPIVRKGDRVVKGQVLSEGYATQNGELALGRNLKVAFMPWKGYNFEDA
IVISEKVVRDDIFTSIHIDDYSLEVRDTKLGNEELTNDIPNVSEEATKDLDENGMIRIGA
EVKPGDILIGKITPKGESDPTPEEKLLRAIFGDKAGDVKDASLKASPSLHGVVLDKKLFA
RAVKDKRKRGKDKDDLAALEMEFETKFVELKDKLVDKLFNIVNGKTSQGVMNDLGEEVLP
KGKKYTQKMLNAVEDFAHLSKGQWVADDETNKMVNDLIHNYKIKLNDLQGALRREKFTIT
VGDELPAGILKLAKVYIAKKRKLKVGDKMAGRHGNKGIVARIVRHEDMPFLEDGTPVDIV
LNPLGVPSRMNIGQIYETVLGWAGQKLGRKFATPIFDGASLDEINKLTDEAGIPRFGHTY
LYDGGTGERFHQPATVGVIYMLKLGHMVDDKMHARSIGPYSLITQQPLGGKAQFGGQRFG
EMEVWALEAYGASSTLREILTVKSDDVIGRAKTYEAIVKGETMPEPGLPESFNVLMHELK
GLGLDIRLEE
>LONDMIMF_01075 DNA-directed RNA polymerase subunit beta'
MNRNKDKNQIKRFDKISIGLASPESILAESRGEVLKPETINYRTHKPERDGLFCERIFGP
VKDFECACGKYKRIRYKGIVCDRCGVEVTEKKVRRDRVGHINLVVPIAHIWYFRSLPNKI
GYILGLPSKKLDMIIYYERYVVIQPGIAKGPDGDSLHRLDFLTEEEYLNILDTLPMENQY
LDDNDPNKFIAKMGAECIMDLLARIDLDELSYELRHSANNETSKQRKTEALKRLQVVESF
RESNENRENRPEWMIMKVVPVIPPELRPLVPLDGGRFATSDLNDLYRRVIIRNNRLKRLM
EIKAPEVILRNEKRMLQESVDSLFDNTRKASAVKTESNRPLKSLSDSLKGKQGRFRQNLL
GKRVDYSARSVIVVGPELKLFECGLPKDMAAELYKPFVIRKLIERGIVKTVKSAKKIIDK
KEPVVWDILENVIKGHPVLLNRAPTLHRLGIQAFQPKLIEGKAIQLHPLVCTAFNADFDG
DQMAVHLPLGPEAILEAQLLMLASHNILNPANGAPITVPSQDMVLGLYYMTKERLSTPDH
KILGEGLTFYSAEEVNIALNEGRLELNARVKIRAKDFNENGELVYKIIQTTAGRVLFNEV
VPEAAGYINQVLTKKSLRDIIGGILSVTDVPTTAAFLDNMKDMGYRFAFRGGLSFSLGDI
KIPDQKQSLIDDANEQVEGISMNYNMGLITNNERYNQVIDVWTSTNALLTELAMKNIRED
QQGFNSVYMMLDSGARGSKEQIRQLTGMRGLMAKPKKSTAGGGEIIENPILSNFKEGLSI
LEYFISTHGARKGLADTALKTADAGYLTRRLHDVSQDVIVNTEDCGTLRGVEVGALKKNE
EIVETLGERILGRVALQDVINPLTSEVLVAAGEQITEAVVKLIDESPIEKVEVRSPLTCE
ADKGICAKCYGRNLATGKMTQKGEAVGVIAAQSIGEPGTQLTLRTFHVGGVAGGLSEESS
ITTKFSGRLEIEDLKTVKGEDLEGNTTDIVISRSTELKLIDVKTGIVLNTHNIPYGSSIF
VKDGDVVEKGTTICKWDPYNGVIISEFTGKVAYEDLEQGQSYQVEIDEQTGFQEKVISEG
RNKKLIPTLLIYGKDGELIRSYNLPVGAHLMVENGEKIKAGKVLVKIPRRSSKAGDITGG
LPRITELLEARNPSNPAVVSEIDGVVSFGKIKRGNREIVIESKFGEIKKYLVKLSSQILV
QENDFVKAGMPLSDGAITPDDILRIQGPSAVQQYLVNEIQEVYRLQGVKINDKHFEVVIR
QMMRKVQVQDPGDTLFLEDQLIHTKDFIYENDKLYGMKVVEDAGDSENLKPGQIVSPRQL
RDENSLLKRTDKNQVVARDVITATATPVLQGITRASLQTKSFISAASFQETTKVLNEAAV
AGKVDMLEGLKENVIVGHRIPAGTGMRDYDNVIVGSKEEYNELMAAKEEYNY
>LONDMIMF_01076 hypothetical protein
MSDSKQPQGQINIELDEKTAEGIYSNLAIINHSASEFVLDFVSIMPGIPKAKVKSRIVLT
PQHAKRLLKAIGENIHRYESAHGEIKDTEQPPIPLNFGPAGQA
>LONDMIMF_01077 hypothetical protein
MKNKIKFPLFIFISVVFFLVMNGKLTYQYSDLNNFKLYLKFLVSLLFGYILIYHLFIFKQ
E
>LONDMIMF_01078 hypothetical protein
MKSKNELNDTSSQHFRTSSSNFNTLKNRQSVEKLSRDFVNIENTILKIQKPAIEFIKSKG
VDISNIDNLIAFYESCEECNDKYRDAIIPLLKDLSRANDDKVLDILVKYSYNIDKLNLDE
VDKNNLKFMVNSMIVGTNNSLLINSGYENLPIIFRDNQYITFGFWDCLRQTGGKAIGRGL
ATGMITGCIGGAIAGGTVGTVTVPVLGTATGAVGGCIFGGAAGAVTGAVTGAIWAAVDCI
>LONDMIMF_01079 hypothetical protein
MNYYTLSSFRKTSKLRKGIGNLADPRPDSVSRGARPSWVSLFLIVILMAMNHSVWAQNSA
NYTFATSTTGSLALDMNGGAIDMSTGTTQLIGAGLDAAASAVTNIGFDFHLMGNRFTQFS
VQEDGILQLGSTAVGTNVYTINSGSATSPRLSAFNADLRTGLTTGKVHYKVSGTAPNRVL
VVEFLNMQLFYTSTTSVAASSTWQIRLYEKGNVEYVYGTMSAVDVGAGNKSPSIGFYTGS
ATGAFASVLYAGNTVSVTNPYAANPAVTAVGAIANLNSAADGSRRVYQFIPPGNPGNALA
TVIPPPTFLSFSNVGSASVTLNWAESSPNIDVVKYIILRSSDGGATYTQAGSVNVGTTTY
NATGLTPTTTYSWRVYAVSEGAKSNDLDGVQATNAVGTYTSVVTGNWNSASTWDAGMVPS
SYDSAIVSAGTTVTVDATGLSIANLSVEGTLAYGSTPANFTVGSNLTVASGGVVNVFNGT
TGKTLIVGGNIQNNGTIDLSVGSTTAGNLTLNGAAVQTVSGSGAFNNGVIRNLIFNNTAT
ATPNINWLINGVKVAYDLNLTGARINLGTNKMTYGSGAVGNSLTAPVGTGFLSGAKFSRW
WAATGTGTSVSAGSDPTGTGSRYPFINSAGASRAMYITRTNATGAVAGELAVVYNDAPAV
TSGLSVTDGAYTVNERYNGNWVVSNEGTPVSSSSYTVVLFAQNAFSGLANGNARVMFANT
AIGGAHQNGTTTPGAQRITVSQTDLLSAPLYVGVASSDIPFVSVANGNWTTPATWNKNAV
PGASDTVTIANNTTVALDGANTIAGLTVATGGTLNAATGSLNFTSLTNAGTVNISGASVT
AANTVANNSIMNVTGGSLNVTGASTTGITNGSSATLTVDGGTINLSAAGANNRTFANNGI
MTVTSGTVNVFGSMTHNGGSTFNQSGGNINIDGNDGGNTATSVASATHLLNITASAVSNL
NLTGGTITIVDPHANSSSSYALRVSQGGAYNSAGANHTFKFGDGISIDNGIASGNGFYMY
LYQGSYLYGLGNVTVDAGTIGTNRFVRTSSTTPIKGNLNIISGDYQMGNGHHLAGNLINN
GTLTAGSVLNMNDYNGSAVASTNPQTISGAGVFRNSGTTVTANLTSLTVNNSSTTGVTLD
VPLSISGTLTLTSGKVNTTNVNLLTLGTATAGGTLTGGSATAYVNGPLARTIISGNPNTT
YQHFPVGKVAYAPIWLAPATTAVSNFKAEAFDSNTGTSDATLLNLSATRRWEIPLMSGTI
TDMNVRLGDASIVSTSIPVQALTPAGVYTNAFGSIATYAAGTSGAPNTTQSNLPISAANF
TGYISFADSNVCSGTPNPGNTVASATTICAGASVALSLQNAVSGSGVTYQWKSSTDGTTY
NDIANANGPTLTVVPTVATYYECVVTCSAGPTIGTSTPVHIVFAHQVATNTPATRCGTGT
VQLAATPSAGATINWYAAAAGGAPVATGNTFTTPSISATTTYYVAAEVSTPPAANTLGAG
ATNSTTAGQSFFPGSWGGTKTQYIIRASELIAAGFSGTSNFTSLGFEPTTSGQAYQGFTV
QLANTTVTTAPTTTFINSGLVQVYAGTGTNGEFRPLANTVNTLAFGTGAGSSSVFNWDGS
SNILVTISWSSVPSATTSSNSSLKVDDVGFVASAYRQRDSVTPAAMLAETDVSGTTNFRP
KFIINGQSICSSPRVPVVATVTTPPALTLSGNPAAVCGGVATTAVTITAGASDYDMYVWS
PSTGVSGNAGSGWTFTSSATTAYTLTATNTTSGCSNTATVNVTVNTTPPAITVTPDAPSV
CAGSVQQLTVSGVPTSPTVVSGTGAATSGTNATNATLGPNPFQAYYGGTKQQWIYTAAEL
TALGFIPNTQISAIKLDLATANTTYALNNLVVKMKNSATASFATATAWEAGMTTVKAAAN
YTPVVGLNNFVLDAPFTWNGTDNLIIEMNYSNNNSGNSTTYNTAKHSPTTFVSTIFYRAD
NVTGTAIDAFVGTSSFTYSSRNDVTFEIIAPAITWTSTGTGDLFTDAAGTIPYVAGSAAG
RIYVKPVGNTTYTATATIGTCSSTDSTLVTVTPTVTPNFAEIGTICQSSTAPTLATTSPN
GITGTWSPATVNMSANGSYVFTPTAGQCATTQTLNVVITPQTVPNFAPIADICQGSTAPT
LATTSPNGVTGTWSPATISNTASGTYVFTPAVGQCATTQTLNVTVTVTPAPTATSPQDFP
AGATLASLTVNGTGIIWYDSSTLGNVLPATTPIVSGTTYYASQTVGGCESIQRVAIQAGT
ALKVDGFDNANFKYYPNPVNNILTVSYSEAITGLKLYNMVGQQLITKSVNANETQIDMSH
LPAGSYLLEVSSGNKSKMVKLLKNQ
>LONDMIMF_01080 hypothetical protein
MKKTLLFNCITRLFFLGVFLSFVTESSGQIIISQVYEGVSNNKWIEITNVGSTSIDLASP
IQYKVGMWNTGSDVGNATMSGTPTSTINLSGTLAPGAIYLIRNSSSSTTVPHNPMPTANN
SNTTVAGFNGNDALAIITGTSTIVDAFGVGINNKDISYHRNANVLTPNSTFTVSEWTSKT
LAEVASADNTLSEYIGVHIYGSPTSTTWNGTAWSNGTPTSSLDAIIAGNYSTGAAAPQGV
FTAKSLTVDSGIFTVASGTSVTVENAIVNNAASSNFIVENNANLIQTNAVANTGSIKVKR
NSNPLYRFDYTLWSSPLIGQNLKGFSSATLSNRFYTYNTATGTNGDYEAVFPTQSEGSYN
FESGKGYLIRTPDSHPAYVAGNPGTVINAEFTGVPYNQSVNVALSNANTGFNLVGNPYPS
AISIAQLFSSNSNAIDGTIWFWRKRNGASGSGYATSTGMGVTSAQPEAAALNPNGVINAG
QGFFVKVKLGATQNTLNFSNALRSATTGGAFFRNANTTEVERHRIWLNLSNGTEVVGQTL
LGYMTGATSGVDYGIEGSYFNDSATAFTSYIENKEFAIQGRSLPFTSDDVVPMSFKTDVA
GNYTIAIDHVDGLFAGSQEVFLKDNTTGQLHNLKSGAYSFASETGVFNNRFEIVYRAALG
VKVPAISSNNIVAYKQNGSLVINSGNYVMENIELYDMSGRLIYTKNNIDASSAVIANLPI
ANQVLVVKITTAENGTANKKIVY
>LONDMIMF_01081 hypothetical protein
MELLTKKLFTNIYPSDMKNSITTKISSLLLLLFLSTASFAQDPTEAPEDEDVTPAPINDY
IVPMLLAGVVLGYTFIKGKAKKA
>LONDMIMF_01082 Peptide chain release factor 3
MSFQKEIERRRTFGIISHPDAGKTTLTEKLLLFGGAIQEAGAVKNNKIKKGATSDFMEIE
RQRGISVSTSVLAFNYKDKKINILDTPGHKDFAEDTYRTLTAVDSVIVVIDVAKGVEEQT
EKLVAVCRMRNIPMIVFINKLDREGKDAFDLMDEVEQKLGLTVTPLSFPIGMGYDFQGIY
NLWEKNINLFSGDSRKNIEETIAFSDVQNPELEKIIGQKPADKLREELELIEEVYPSFNR
EAYLEGKLQPVFFGSALNNFGVRELLDCFIEIAPSPRPKESETRLVDPYESKMSGFVFKI
HANMDPKHRDRLAFVKIVSGTFERNKPYLHVRQNKTLKFSSPNAFFAEKKEIVDISYPGD
IVGLHDTGNFKIGDTLTEGELMSFKGIPSFSPEHFRYINNADPLKSKQLEKGIDQLMDEG
VAQLFTLEMNNRKVIGTVGALQYEVIQYRLEHEYGAKCSYENFPVHKACWVKPDDARNEE
FKEFKRIKQKFLAHDKYGQLVFLADSDFTIQMTQNKYPTVKLFFTSEFD
>LONDMIMF_01083 Chaperone SurA
MKLKQLFFGVLLSASFTSFAQNNNKEVLFTIDGKPYYTDEFARVYNKNIDLVKDESQKDL
NQYLDLFVGYKLKINKANKLGLQNGQAYQAELKSYRNQLSKNYLTDSKVTQELIEEAYQR
SQKEIKAAHILFMVDENASPEDTLKAYKKAVEVREKALKGENFGDLAVKYSEDPSAKENK
GELGYFSAFRMVYPFESAAYKTQKGHISKIVRTRFGYHIIKVEDIRDNRGELTVAHIMIL
KPNNQNPEEAEKAKATIQDIYKKLQQGENFESLAKQFSQDKSSASKGGVLNRFGSGQLSS
EEFEDAAFALKNPNDYSAPVESNFGWHIIKLIEKHPLKTAQEMQSELDGKIRKDERSRLI
TNSLTEKLKKKYSIKRNDKLFAAISKTVNDKFYTADWKLPENMKPFEGNLVTIDKKTISG
DEFFKYLVAQQRGENTIRPISKLVEKKYQEYVDAKVNELYNNNLENEFPDFAAVMEEYRD
GLLLFDLMEKEIWEKAKTDTIGLQNFYEARKNNYRWGNRVDALILSSTKMDMAKKAQKLL
KQGKSAEFIKEKFNQNGKVEVMSNAGIFEENSDALPKGLEKKDGVSGIIKDGEYYFVVKI
NKHLEAGPKTLEEAKGKVVNDYQQYLEEKWVSDLKQEFKVDVNQPAFEKVKKQIKS
>LONDMIMF_01084 hypothetical protein
MKKYAVIGLLSFFASCNTKPEAKSQAIARVNDSYLFKDEIKDLVPPGTSKEDSIVIVRNF
IDRWASQKLMMNAAELNLSADKQAEYNGLIRQYKIDLYTKGYLEELVKTTVDTTITEAEL
KEYYKQNKENFKTDGTLVKLRYIQLPKDHPKFQTIKSKFFDYRKSDRKFWDTYGMQFKSF
VLNDSVWVEMNQVYRKLPFITPDNRSQYIAVGKAIEKQDSLEVYLVKVTNVLDKNQVSPY
EYIKPTLEQVILNKRKLELIKKIEKDITDDAIKNEKYEIYN
>LONDMIMF_01085 Chaperone SurA
MMPLKMRSMKSIIKNACLIFGFAAFFNAVNAQEIIQNDTVKKVVPKPVSQKQKIDGVIGV
VGDYVILDSDIDIAYIEIANQGNPIKDITRCQLLGKLLEDKLYAHQAVQDSIVVTDAEIN
SMMQERIDAFVERAGSMEKLLKIYNRPNEEEFRTYFFDILKMGKLTSEMRNKIIENVEIT
PEEVRTFFRKFPKEELPQIGAEVEVSQIVINPEVTKEERQKVIDKLNEFRNDVMAGNGSF
FSKAVLYSKDEGTKSNGGFMRVNRKTNLVKEFKERAFSLEEGQISEPFQTEYGWHIILVE
KIRGQDVDLRHILLIPKISEEAMQEAKDKIIGIRNKIVNGEISFADAARNSSDEKETRAN
GGVLINPQTLDPRFDLTKMDPSLYVQISDLNEGQVSQPMVDEDRLGRKTFKLITVTKRYD
AHTADYAQDYLKIKDLALKEKQIKAISKWTDEKIKETYIKINGEYRDCVFVNNWLKK
>LONDMIMF_01086 ATPase RavA
MSDVAAIQNLVQKRIELKKEISKIIVGQEVVVDEILLSIFSGGHALLVGVPGLAKTLMVN
TISQALGLDFKRIQFTPDLMPSDILGSEILDESRQFKFIKGPIFSNIILADEINRTPPKT
QAALLEAMQERAVTIAGQHYKLSLPYFVLATQNPIEQEGTYPLPEAQLDRFMFAIKLDYP
SFSEEVQVVKSTTTDQTEKINPLFTAQEIIDFQHLIRRIPVADNVIEYAVTLVSKTRPDN
ALSNDYVKNYLDWGAGPRASQNLILAAKAHAAFNGKFSPDIEDVKAVATGILRHRIIKNY
KADAEGISEEMIIQKLM
>LONDMIMF_01087 hypothetical protein
MLKQELNNPQRIFGLDLMRAVAILMVLSSHCLWIYPENNSFIAQLLKLFGFLGVEIFFVL
SGFLIGRILLQSYLKDDFSFSQVRDFLKRRWFRTFPNYFLILLVNILIASVIGYKIESLW
KYFFFVQNFSGAMPAFFPESWSLSVEEWAYVVLPLLLLLITPFVTSKNKSKFFIILLVVL
LVFFLLAKIFCYQNTVHANLNDWNLSLKAVVIYRLDAIFYGVLASWIYCCHNNFWQKGKS
FFLIAGIFCFLFIFFGFGKIPFTEEGLNRFLYIVYLPVVSISIAFFLPFLSGWKSEKSKL
KNPIVFISLISYSVYLLHYSVILQLMKYFTDIENYPMLQKHIFTIVYLLLTIFFSYGLYV
WYEKPMMDLREKSKK
>LONDMIMF_01088 hypothetical protein
MQMLILRRADHALLAEPAISIALRKTGSFPVKLIAPDLYRSVDLQKDWGRLFEVEPKIPQ
AGLAIIGEIKGKEQLITKILEEYEKAINWYKSNQKDASELVVKTLPMLEVNGLADSIDYI
KFENINAQNSKKDLEFFFNVLLENDSKIIGGKLPDDSFYYK
>LONDMIMF_01089 ATP synthase subunit c
MKKIVLLVLAFAGFAFAADAAVANETLKAYSVVAAGIGLGLAALGGAIGMGNTAAATIAG
TARNPGLGGKLMTTMFIALAMIEAQVIYALVIAMIALYANPFLG
>LONDMIMF_01090 hypothetical protein
MAASCDSIPAAAVLTATDACGTATVTFAETRTDGACAGSYTLTRKWTATDLCGNTAEHTQ
VVTVTDTQAPTFVETVPADVTVSCGAVPAAVTLTATDNCSMATVTMLETIENGACAGDKI
ITRTWTAVDLCNNATSVTQIITVEDNTAPTLITPLQTTINVVCSEVPEVPVLEFTDSCSS
VESVIFDEQIENQTATGYTITRSWSATDSCGNSNVVTQTINVTIANPTQTIASELCVEDL
SIDLFTLLDNSIERTGTWIDTNNSRGLLGSIFNPANVTLGDYILSYVIADGDCPRTIQIN
MNVNDDCIVLAPCEVIVHNAMTPNGDGLNEFFQIDGLDCYPNNTVEIYNRWGVLVFDAQG
YDNTTKVFRGVSEGRATVKKSEELPDGTYYYVLKYVDAEGRSREKASYLYINR
>LONDMIMF_01091 hypothetical protein
MKTKFLFFALLLTGFAGFAQQDAQYTQYMYNTININPAYAGSRGVMSIFGLHRTQWVGLD
GAPVTNAVSLNTPINNSKLGIGLSFVNDRIGPTDENTISADISYTVQTSETYKLSFGIKG
TANLFSLDVNKLNPADAGDPHLQNFNNNFTPNFGAGVYFHSDKLYVGLSVPNFLQTTRYE
DNSVSVYKERMNFYFIGGYVFDLSPSIKFKPAFLMKTIQGAPLQLDVSGNFLFNDKFTIG
AAWRWDAAVSAMAGFQVTEGLFVGYGYDLETTKLSNYNSGSHEIFLRFELFNKFNKLTSP
RFF
>LONDMIMF_01092 Outer membrane porin F
MKIKFIYLAFLSTVCFSGYAQKSAVASADKKYEKYAYIDAIKTYERVAEKGYKSQDMLQK
LGNSYYFNADLENAAKWYGELFAMTQDVEPEYFYRYSQSLKGIGEYDKANEMLQKFNQKS
GTDSRGKLYEEKKNYLEEIRKNSGRYKIDNAGINSEYSDYGSAFFGDKVVFTSARDTGNF
SKRQHSWTNMYFTNMYVSDLSADGALSAPQKFAKSLNTKFHEATPAFSKDGKTMYFTRNN
YNDGKKGKSSDKVTLLKIYRATLEGDKWTNVTELPFNNNNYSVAHPALSPDGKTMYFASD
MPGTLGQSDIFKVSINADGSFGTPENLGPKINTPGRESFPFVSDENELYFASDGQLGLGG
FDIFVSKIGNDGSIKEVKNIGEPANSKKDDFAYIINSKTRIGFLSSNRDGGNGNDDIYKF
VETKRLEFECEQLLAGTITDLETGAILPNTKVTLFDEKFNKLKEVTSDASGKYSFEDVQC
GKSYYVRAEKQDYVTKESRITLPNESGETDLPIALEKTVKKVKVGDDLAKAFGIKIIYFD
LDKWNIRPDAATDLAKIVDVMKEYPTMKVDVRSHTDSRQTHKYNERLSDRRAKSTIAWMI
NDGIQASRLSGKGYGETQLVNKCSDGVPCSEEEHQLNRRSEFIITEL
>LONDMIMF_01093 hypothetical protein
MLRTLMPVAFLFTMLSCSSDSSDDSNLTNGNSTLVENYDYNPTELELMRIINEHRQSLNL
PALQPINHISYKSEEHNEYMIENNVVNHAYFEERSQNLIQVLGAVKVNENVAYNYNTPQA
ALHAWLESPSHRANIEGDFTHFGMSVRISPESGRKYYTNMFIKK
>LONDMIMF_01094 Pyridoxine/pyridoxamine 5'-phosphate oxidase
MKDLSDYRKSYEKSELIETAIPDNPFELFDLWFQEAEAIGGTEEVNAMTIATIGKDGFPK
SRIVLLKQLTPEGFIFFTNYESEKGKAIAENPNVCLSFFWPYAERQVIIKGTAEKTADGI
SDAYFQSRPFASQLGALASHQSEIIENRKLLEDKVKNLEEEFTGKVIARPAYWGGYLVKP
YEMEFWQGRPNRLHDRIRFQYRENTWKKDRLSS
>LONDMIMF_01095 Ribonuclease Z
MKLTILGCYAATPRTITNPTSQVLEIRDRMFLIDCGEGTQVQLRKNKIKFSKINHIFISH
LHGDHVYGLVGLVSTYMLLNRVNDLHIYGPKGIKEIITLQLKLSNSWTNYNLYFHELESD
VSETVFEDDKVIVKTIPLKHRIYTNGYLFLEKFSERKLNIDAVQEYEIDQVYYKKIKYGG
DITLEDGRVIPNAELTFDPDTPKSYAFCSDTVYNEDILPLIENVDVLYHESTFLESEALL
AEKTMHSTAKEAARIALKANAKNLVLGHYSTRYESIQKFKEEAETIFPNVFLGDDGESFS
F
>LONDMIMF_01096 hypothetical protein
MKVDQKGHTTVIKDTQGNVGSFLEKVTNEYGSFKNHNLVLDISSDKDVSLDQILSFLSLS
NKHRKAKKSFVIVVNDFDFNEVPDEMIVVPTLLEAHDIIEMEEIERDLGF
>LONDMIMF_01097 Aspartate carbamoyltransferase
MSELSVNHLLGIKYITKQDIDLIFETADHFKEVINRPIKKVPSLRDITIANIFFENSTRT
KLSFELAQKRLSADVISFSAAQSSVKKGETLIDTVNNILSMKVDMVVMRHSNPGAAYFLS
QNVNASIVNAGDGAHEHPTQGLLDSFTIREKLGEVAGKKVVIVGDILHSRVALSNIYALK
MQGAEVKVCGPKTLIPKYIESLGVGVESNLRKALEWCDVANMLRVQNERMDVNYFPSTRE
YTQQYGVDKAFLDSLNKEIVIMHPGPINRGVEISSDVADSQQSVILNQVENGVAVRMAVI
YLLASKIKQ
>LONDMIMF_01098 Bifunctional protein pyrR
MSQKILLTSKEVNIILHRLACQLIEKHLDFSDTILVGIQPRGTFLAERLKELLLKEYKVQ
DVALGYLDITFFRDDFRRTEKPLEANKTQINFLVENKKVIFIDDVLYTGRSIRSALTAIQ
SFGRPSEIELLVLIDRRFSRHLPIQPDYRGRQVDSINNEKVKVCWKEQEGEDVVYLVTN
>LONDMIMF_01099 hypothetical protein
MNKLLKINILLLILLTFSSCEVVEGIFNLGVGVGVFIVIAIIALVIFIISRFKK
>LONDMIMF_01100 putative ABC transporter ATP-binding protein YbiT
MLTVNNLSVQFGKRVLFDEVNTTFTDGNIYGVIGANGAGKSTFLKILSGDFEPTSGHVFL
EPGKRMSVLNQNHNMFDEHTVLETVMMGNKVLYAVKKEMDELYLDYTDENAERIGELQVQ
FEEMNGWNADSDAASLLSNLGINEDSHYTLMGDMEGKLKVRVLLAQALFGNPDVLIMDEP
TNDLDFETIAWLENFLANYENTVIVVSHDRHFLDAVCTHISDIDFGKINHYSGNYTFWYE
SSQLAAKQRAQQNKKAEEKKQELEEFIRRFSANVAKSKQATSRKKMISKLNIAEIKPSSR
RYPAIIFEQEREAGDQILNITNLSASIDGETLFTGVDLNMAKGDKIVLFSKDSRATTAFY
EILNGNKKADSGTFEWGITTTQAYLPVENHEFFDNDLNLVDWLRQWAKTEEERDEVYIRG
FLGKMIFSGEEALKISRVLSGGEKVRCMLSRMMMQRANVLMLDEPTNHLDLESITAFNNS
LKNYKGSVIFTTHDHEFAQTVGNRVIELTPKGAIDRYMTFDDYLDDEKVQELRKKMYS
>LONDMIMF_01101 hypothetical protein
MHNLKVFKIVSLSFLSMLSLCSCEKKFKSDNFTAYFGGEVSNPLNRYVLFLKDNKVIDTI
PLDRNNRFFKKFDSLAPGLYTFKHEPEYQYVYFDKNDSIMVRMNSNDFDESVVFCGRGEE
KNNFLMEMYLKNEEDRDKMFTVFDYDVNKFTKYIDSAYHSRKSYYNSKKELLKWSDDFDT
YALASLDFPYYTKKEIYPVIHEIRTGENISERLPKNFYEYRDEIDYNNKGLTNFSPFVKY
LTYMLNNMAMEKADDNASPEDKALEMNITKLNIADTLFKNPEIKNTILDNIAFAYLLEDQ
HILNNKKFLDRYNELSTDKGNQNEIIKIGNAIQMLKNDNALPNVDLIDLNGETVNSKNII
KGKTVIFFWTENAKSHFETAHRKAMELKAKHPGYNFIAINVDDNQSKWKNNLSKYKFDKI
EEFRVKDFEELKQKWVITKIHRAIITNADGTINNAFVNLFDVKFVDYLK
>LONDMIMF_01102 hypothetical protein
MRKLVTIVFFICFQSLMAQEAEIRQSIQTFFDGFHTRDSLKMKSVCYSNMILHSISESTI
TRKITTEKFSDFAKSIAAISKNMKFEERLLSYSFNVEGSLAHVWTPYEFYINGKLAHKGV
NSFQLLKDNGLWKIIHIADTRKRAN
>LONDMIMF_01103 Transaldolase
MKFFIDTANLAQIKEAQALGVLDGVTTNPSLMAKEGITGKNNILKHYVDICNLVDGDVSA
EVNALDFEGMVKEGEELAELHEQIVVKLPMTKEGVMAAKYFSDKGIKTNVTLVFSAGQAI
LAAKAGATYVSPFIGRLDDVSTDGLNLIQEIREIYDNYGFETEILAASVRHTMHIVNCAK
IGADVMTGPLSAITGLLKHPLTDIGLAQFVADFEKGNK
>LONDMIMF_01104 putative oxidoreductase
MKAVLPQMRSQKSGLIINVTSIAGYMGLPYRSVYSASKGALELITEALRMEVKNFGIKIT
NIAPGDFATNIASGRFHAPLIKGSAYEKPYGDTLKMMDEHVNSGSNPDMMAIAVAKIIET
PNPKIHYKVGVFMQKFSIVLKRVLPDKVYEKMLMNHYKL
>LONDMIMF_01105 Serine 3-dehydrogenase
MSKTILITGGSSGIGKSIGDYLTQKGYTVFGSSRNPERITDSKFPLVALDVRDAESIKNA
VSEVIQKAGRLDVVINNAGVGITGPLEEIPTSEIKNNFEFFRAN
>LONDMIMF_01106 hypothetical protein
MKKHKLLAFILLGTVLVSCGDKEIDKKNLFSIEQSGLKATYQPQESLSLVLNNDKNKTID
SIAYYINEKRVGGVKGNNKFDFPLADSKLGYQQIKAIVYYEGQNAETDARIEVVSNVKPK
LLSYTIVNTYPHDETSYTQGLEFYRDTLFEGTGQRGTSKLLKTDYKTGKAYQSVNLEGKY
FGEGITILNNKVYQLTWQENTGFIYNADNLKQIRTFNYFKNIEGWGLCNDGKQIYQSDGT
EKIWVLDPETMKETDYINVYSESSKIKAVNELEWVNGKIYGNVYQKDAVAVINPKTGAVE
GIIDLRELKTKVNMMDHDLGNDVLNGLAYNPKTKTLFVTGKRWNKMFEIKVSE
>LONDMIMF_01107 TonB-dependent receptor SusC
MSGKVNITIPKPCHENWHEMTVAEKGRFCNSCQKTVYDFTRFSDRQLIDKINSESNICGR
FLASQLNKDLRVPKGKSSIWIAGVSGILSFLNLGNQEIYAQENVKTEQTEEKNNVEKTID
NSSVPDIEITGFVFDESKLPLPGVSVTIEGKSISTKTDFDGKFSIKASKGDLLKFYYVGY
KETSVTVNSKKPIIIKLEDTHEMLGEVYIVRKTFFGRIFHSIGNLFR
>LONDMIMF_01108 hypothetical protein
MKKTLFLILILLSASLSYGQKKGAKKKAPAKPASTALAKADNLTAEIVKGNFYLFINNKA
KKDTIGIKTVDENSLPKNCAIKGFSAKGTPLYLLTWTEEQTTKTDLKTEVRSTLFSEVYD
VTTKTKLFSNQQTTTNITEKVFLDRLKNASETQEKVRREGFEFSLTPDGNIVQKNKTQQN
TFTFNAAEKKYVDGKTTSVAPASTPAKKKKA
>LONDMIMF_01109 hypothetical protein
MHSNLNDLIASYPVCCSKSKVASENGKRFEINSNEDFTRIRIDGCLIASQNVEKCDFGFV
RHSNDDFYFVELKGKEIEKAYNQILNTIDYFNSVIPKEKRFGFIVSSSVPKAGISTNNLK
QDFAKKYGRILEIKNKVLPYTPK
>LONDMIMF_01110 hypothetical protein
MEKLIVKNFGPIKEAEIKLTKYVVFIGDTSTGKSVLAKLISIFRDANFIFQNQGVKKFKE
LLVYYNIDFNFENSTFDYYFEDYRFKFLNNEFTLLIGDNIIEEKNKLYSDRDNDIVKIFS
SINSNIDSIKANADNKDLIQSIENFLLKIKSTPLKQTVYFPAERSLISVVGESISGLWAN
NVALPNYFKNFSANYEMARKYKLHKQYSDFGFEYKFENGEDKIVYAGQQIFLNQASSGMQ
SLVPLLLVFDFFLNAESYKLIKSILIEEPELNLFPKRQKVLVDYIVNGINKSEDSLVITT
HSPYILSVLDTLMLAKNTFNEHPDLIKEINSIVPESNWIDYNDISVYEVRNDGKVYSIKN
EEFKSIDTNAIDGASDIISEEFDKLTELRYAQ
>LONDMIMF_01111 Chaperone protein DnaK
MGKIIGIDLGTTNSCVAVMEGSEPVVIPNAEGKRTTPSVIAFVDGGEIKVGDPAKRQAVT
NPTKTIASIKRFMGNKFSESNKEAQNVAYKVVKGDNDTPRVDIDGRLYTPQELSAMTLQK
MKKTAEDYLGQSVTEAVITVPAYFNDAQRQATKEAGEIAGLKVMRIINEPTAAALAYGLD
KKGKDQKIAVYDLGGGTFDISILELGDGVFEVLSTNGDTHLGGDDFDQAVIDWLAEEFKA
EEGLDLRQDPMSLQRLKEAAEKAKIELSSSAQTEINLPYVTATATGPKHLVKTLTRAKFD
QLTDSLVKRSMAPVAKALKDAGLSISDIDEVILVGGSTRIPKIQEEVEKFFNKKPSKGVN
PDEVVAIGAAIQGGVLSGDVKDVLLLDVTPLSLGIETMGGVMTKLIESNTTIPTKKSQVF
STAADNQPSVEIHVLQGERALAADNKTIGRFHLDGIPPAGRGIPQIEVTFDIDANGIIKV
SATDKGTGKSHDIRIEASSGLTQEEIERMKKEAEANADSDKAAKEKIEKLNEADSMIFQT
ENQLKEFGEKLSEGNKAAIESALTDLKAAHGSQDLAAIQPALDKLNEAWKNASEEMYKQG
DAQGAPQDAQPQGDANGGDNVQDVDYEEVK
>LONDMIMF_01112 hypothetical protein
MKKLVLLAIVLAFLGCDKDNDATTPDIENRDFRQDMRNFVIGISQKAKSIKPGFAVIPQN
GIELVTVNGEADGSPSQDYLNAIDGNGQEDLFYGYDNDDQATPTSVSNYLKGFLNVSKSN
RKTILVTDYCTTPSKASNSYQVNAANGYISYAAPKRDLTAIPATTPNNSNDAVVANLSQA
KNFLYLINSENFTSKLAFINAVKATNYDVIIMDLFFNDEQFTAVEINQLRNKANGGKRMV
ICYMSIGESENYRYYWQPSWNTSKPVWMATENPDWPGNFKVKYWNDDWQKIIYKNDNSYL
NKIIDANFDGVYLDIIDAFEYFER
>LONDMIMF_01113 hypothetical protein
MKKLLFAFLLAFSLSGYAQLKSPADFLPEYGKQVSFYHEIETYFKYLKENSEYIKHESYG
FTSQGRSLNVYYISTPENLKNLEAIRDYHLYSIGMTDKKPAAETEKAIVWLSFNVHGNEI
GAAESSMKVAYELLNPQNTTTKQWLENTIVILDPCLNPDGFSRYGNWLRDISGKNLHPEL
TDREHIEPWPGGRQNHYAYDLNRDWAWQTQVETQQRMVLYNRWMPEVHVDVHEMGYNEPY
FFPPAAEPFHDFITKPQRDFHNVIGENTSKKFDAEGWNYYTRERFDLFYPSYGDTYPSFN
GAIGMTYEQGGIGAGRAVLMQNGNILTLEDRIDHHAVAVLTAVETASGRKEKLIADFKAY
FKDSRQNPKGKYKTYVIKNDGKAEQLAVMLKQNHIQFAYADETKKLSGYHYQSDKEKAFS
VESGDMIIQASQPKSVLTQVLFEPYQRLSDSLTYDITAWALPHAFGIESYALKNALVIKT
RESKISNTKVLPETAYAFYIPWNNRTSAKIAASLLKKNVKVRYSKKNSAFGDIKLNMGDL
IVLKSDNTKLPEFEKTMTGLLAEKNDYSVIKSGFSTGGTDLGGENFQLLKAPKILLLSGK
NVSPTDFGQVWFYMDQIIDYPISILDADYLGMINLTDYNTLILADGWYDLSDSQRKSIDD
FISKGGKTIAIQNALSLFENREGYNLSQFATNEEKDAAKKQSDEEALTSRFKEYQKTERR
SVSNGVPGAIIENVLDKTHPLSYGLGDKYYSLKTSDKYFKVLKNVWNVAYVPENYKSYGF
IGANLKKKLGNTVSFAVEPVGRGKMIYMVDNPLFRGFWENGNLLFSNALFLVD
>LONDMIMF_01114 L-serine dehydratase 1
MEECISVFDMLKIGVGPSSSHTLGPWRGAERFLNELREENILSKVIRIKVDLFGSLSLTG
KGHATDLAVMLGLTGADPEYIPIDSIDKTISEIRKNKQLHLAGERMIPFDMDTDIVFNKN
FLPFHSNGFTFTAYTPDGEYESTFYSIGGGFVVKEERTNASKKEIIKCAFPFPIQNAVEL
LDYTVKENKSISEIVYENEKSMRTEENIHNELMRVWNTMLECMYIGCHSEGILPGGLNVR
RRAFDMHQNLIGLANYSNPQEWLETIRKTEVKFRQILKWVSCFALAVNEVNASLGRVVTA
PTNGSAGVIPAVLMYYMVIENHQAGDKEIKQFLMVAGEIGSIFKKGATISAAMGGCQAEI
GVSSAMAAGALCELMGGSPAQVLMAAEIAMEHHLGMTCDPIGGLVQIPCIERNTMGAIKA
INAAELALETDPKNAKVPLDKVINTMWETAKDMNTKYKETSEGGLAISVNMADC
>LONDMIMF_01115 Regulatory protein LuxO
MARIIGLEGFEVIETGDCKSGLKKIEQHAFDVVLCDVKLPDGNGVDLTIAIKEKSPQTEV
ILLTAYGNIPDGVQAIKNGAFDYIVKGDDNNKIIPLLHRAIEKANLTKRIAQLEAKLEDK
LSFDGIIGDSKPLLQSINLAKKVAPTDTTVLLTGETGTGKEVFAAAIHQSSSRKHQNFVA
INCSAFSHDLLESEMFGHLAGSFTGATKDKKGLFEEANGGTIFLDEVGEMALDLQAKLLR
VIENGEFLKVGESKPTKVDVRIIAATNRDLPKEIESGHFRQDLFYRLSVFQIQLPALRER
VTDIEPLAKHFLNFFSLKTNKKIKALSDEFVQLLKLHTWPGNIRELKNVLERSVILETEA
ILTTDCLPMEIQQLKTANTSGESPVLSAFSLASAEKIHIQKVLNYTNHNKTETAKLLNIA
LTTLYRKLEEYKIS
>LONDMIMF_01116 hypothetical protein
MRKVIYALILPLVVVSGFVFANCEIKNETSKKTASKLLTAAEAKAERKKWEASPDGIKLK
EWEMSPEGKKVLASAAKIRSHISYSANMEAIITSLSLPPGSRLGFGVMAGINDDYYILSF
GLEKSNEFQQLRSLKANDKITIRSHFVSYAPKYDYPIVSVDYVEQDGKIIYKRAPRKDGC
>LONDMIMF_01117 Response regulator MprA
MSDCQNLFSGKRKYLFLLALLSFILVIFATFSMADKDDFNIARREVLLRKIGHELLLQSG
DSVSRVLPVKKIAENEYQISFEKEFSFQPDSLANTTRRLLANDPLTSDYVVNVINCGNSD
VAYGYAISKNRKEDNIPCIGRIQPKACYVINIKFKQKVIDKAKNGYLFAGLPFLALVGFL
FLTSGTTRKRKTLPDSKDTDTFTLGSVLFDAKNRKLITTEKTIDLTGTETRLLLIFALSP
NETIERSRLQKEIWEDEGVIVGRSLDMFISKLRKKLELDSNINIVVIRGKGYKLEISS
>LONDMIMF_01118 hypothetical protein
MRNFNDSLIKKMERLAEITISSLQLGKMARTKRCLALAEELLIKGNNEMKNAITNVYLFS
VSHYMEINRLETSRLLPIALHKEYVKQINASGV
>LONDMIMF_01119 Potassium-transporting ATPase potassium-binding subunit
MNTEITGIIAMFVLTLLLAIPLGKYISKVYSGQKTFLDPVFQPIEKLFYKISGIDSKKEM
NWKQHMVALVAINVVWFVLGMIVLLCQGWLPLNPDNNPNMTPDLAFNTIISFLVNCNLQH
YSGETGVSYLSQLFLMFLQFVSAGIGLAAAAVLFNALKERTTETLGNFYNYFIKSCTRIL
LPISVIVATILLFNGTPMTFEGKQAMTTLQGDSVEVSTGPAAAFTAIKHVGTNGGGFFGT
NSAHPLENPNYLTNIVEMIAQMIIPFAMVFALGFYLNRRKLSWMIFGVMTVGFLALTIPT
VITEMNGNPAITQMGIDTTSGATEGKEVRFGAAASGYWSIATTVISTGSVNSMHDSAMPL
SGMNQLLAMMINSFYGGCGVGILNFYIFIILAVFISGLMVGRTPEFLGKKIEAREMKIAM
IIALLHPFLILVGVALSTAFPEQGASTSTLNNPGFHGFSEILYEFTSSAANNGSGFEGLG
DNNPWWNITTGIVLLLSRFLPIIGPVAIAGILASKKHIPESAGTLKTDTSTFGLMVFAVI
FIIAALSFFPSLTLGPIAEYFTLY
>LONDMIMF_01120 Potassium-transporting ATPase ATP-binding subunit
MKTQNKSLFQKELLKEAFVQSFLKLNPATLFRNPIMFTVEIGTVVMLCVCLWILTGEESQ
GSFVYNLTVFIILLFTLLFANFAEAIAEARGKAQADSLRKTREETPAKKIFPVGEMYVDE
LQIVPSSSLVKGDIFICEAGDTIPTDGEIIEGLATIDESAITGESAPVIREAGGDKSSVT
GGTKVLSDKIKVRVTTEPGESFLDKMIALVEGASRQKTPNEIALTILLAGFTLVFIIVCT
TLKPFADYANITITIASFISLFVCLIPTTIGGLLSAIGIAGMDRALRANVITKSGKAVET
AGDIDVLLLDKTGTITIGNRKATQFYPTAGISEQEFIKASILSSLADETPEGKSIIELAG
KEATKNLSIEGATLIKFTAETRSSGVTLPDGTRIRKGAYDAIRKLSEKAGNTFPNDTSDR
VTEISSNGGTPLVVSENDKVLGVIELQDIIKPGIQERFERLRRMGVKTVMVTGDNPLTAK
FIAEKAGVDDFIAEAKPEDKMNYIKNEQIKGKLVAMMGDGTNDAPALAQADVGVAMNSGT
QAAKEAGNMVDLDNDPTKLIEIVEIGKQLLMTRGTLTTFSIANDVAKYFAIIPALFITAI
PALQGLNIMHLHSPESAILSAVIFNAVVIPFLIPLALKGVTYKPIGASALLRRNLLFYGL
GGIIVPFIGIKIIDMIVTIFI
>LONDMIMF_01121 Potassium-transporting ATPase KdpC subunit
MKNYLWIGVKLTLVTLVFFAGIYTLFILGIAQMAPNQGKGIMTESNGKKFYSNIGQSFTD
ARYFNSRPSAVNYNAAGSGGSNKGPGNPEYLAEVQKRIDTFLIQNPEIKANEIPADMVTA
SGSGLDPNISVQGAKVQIKRIAKARNIEEKKLEDLIAQNTEKPLLGLFGPEKINVLQLNL
ALDKLK
>LONDMIMF_01122 hypothetical protein
MKKLATAAFIAMVSLAQAQIDTIKTPESPLKISGYAEIYYLYDFGVPENNTRPGFVYSHN
RHNEVSLNLGFVKANYEKGNVRANLAIMAGTYGNANLATEEGIMKNIYEANAGVKLSKTK
NLWIDAGIFASHIGFESAISKDCWALTRSIQADNSPYYESGAKLSYTTDNGKWFVSGLLL
NGWQRIKRVDGNKTLAFGHQLTYKPNAAILLNSSSFIGNDKPDTDKRMRYFHNLYGVFQL
NEKWGLTAGFDLGAEQKEKGSNSYNSWYSPILIAKYKVSDKIHIAARGEYYADKNGVIIA
TETPNGFKTFGYSVNFDYNIYDNVVWRIEARNLNSRDEIFTENGNPTKQNFAAATSLAIS
F
>LONDMIMF_01123 Sensor protein KdpD
MESKREDSVQHFLNLIQKSRRGKFKIYIGMSAGVGKTFRMLQEAHSLLKNGIDVKIGFIE
THNRKETHDLLEGLPVIPRRYLFYKGKELEEMDVQAIISLRPEVVIVDELAHTNIEGSKN
EKRWQDVFEILEAGINVISAVNIQHIESLNEEIKHITGIEVKERIPDSVLAQADEVVNID
LTADELITRLKEGKIYKAEKIEMALKNFFKSEHILQLRELALKEVASQVERKVEIEVPKS
KNTRHEKFMACISSNEATAKKVIRKTARLANYYNSSKWYVLYVQLPHESADRIALDKQRH
LINNFKLATELGAEVIKIEHTRIAKAIIEQAESKGITTVCIGKPKMNLMKIILSTSAFKQ
LLNKLSSSEIDLIILS
>LONDMIMF_01124 hypothetical protein
MKNSIVKDKSFVFAVRIVRLYQHISENKKEFILSKQLVRSGTSIGANICEALQAPSKKDF
SNKMNISLKEAQETEYWLRLLFETNYLSEKEYQSVHSESIELIKILTSIVKTSRTNPD
>LONDMIMF_01125 Alginate biosynthesis sensor protein KinB
MRIKTKLRLGLGILFLLIILLTALAVRQVHAIAGDTENILVANYNSLDYSRNMMKELDKI
EGEKQSFENFNHFLELQGKNITEIGEKELTQNLKEDVKAWQSRPEEPSILLQIRKDLNDI
MKINMDAIQRKSIVAQKTTESAILWISITGLTCFLIALILLVNLPSDIANPIKDLTESIR
QIAAKNYSQRVNFETHDEFGNLARSFNTMAEKLQEYSDSNLARLMMEKKRVETLINNMQD
PVIGLDDKNLILFANEEALKISGLKAENIIGKAATEVAVSNDLVRSLLQHLMDENIEKSQ
QTLKIYADNKESYFEKQIVPILVLPTGEEEKKHIGSFIILRNVTAYKELDFAKTNFIAMV
SHEFKTPIASMKMSLQLLENSSVGNLNDEQKQLVSSIKDDAKRLLRTTGELLDITQVETG
KTQLKIENCNPDVIISDAVEATKILAEQKKISLNLTVPELLPEIKADQEKTTWVITNLIS
NAIRYSYENSTIFIAAEAKENALMITVKDNGIGISPQYKNKIFDKYFRIPGSEKEGTGLG
LAISKELIEAQGGTISVESNLGFGSEFVVTFKISND
>LONDMIMF_01126 hypothetical protein
MTIMRKLVLFVFFISLVSFVSFVSFQPLMGQEAEIRESIQTFFEGIHSRDSLKINSVSDE
DLMLQTVVQSPRRNKLVVTKAADFKRYVATVPKETKFEERLLSFTIKVDGGMAHAWIPFE
FYINGELTHKGVNSIQLIKKENLWKIIYYGDSKIKI
>LONDMIMF_01127 3-methyl-2-oxobutanoate hydroxymethyltransferase
MSVAKKDYKRITTKSLIEMKANGEKISMLTSYDFTMAKIVDTAGVDVILVGDSASNVMAG
HETTLPITLDQMIYHASSVVRAASRALIVVDLPFGSYQSDPKEALRSSIRIMKESGAHAV
KLEGGSEIKDSIKKILNAGIPVMGHLGLTPQSIYKFGTYTVRAKEDAEAEKLLEDAKLLE
KLGCFALVLEKIPAKLAEKVAQSITIPVIGIGAGGGVDGQVLVIHDMLGMNNEFSPRFLR
RYMNLYDDMTNAIGKYVTDVKSHDFPSEKEQY
>LONDMIMF_01128 putative RNA pseudouridine synthase
MKTISTKNNLQVLHEDNHIIVINKRVGDIVQGDKTGDKPLSDVVKEYIKEKYNKPGEVFL
GVVHRLDRPTTGIVVFARTSKALSRLNDLFKNRETQKTYWAVVKNKPAEASAKLVHYLKR
NEKNNTSKAHSKEVPDSKIASLDYTIIRELNNYYALEINLHTGRHHQIRAQLAAIGSPIK
GDLKYGADRSNVDGGIHLHARKLTLTHPVTKELLEITAPVPNDPIWKAI
>LONDMIMF_01129 hypothetical protein
MKLPILLCLLIGTSAFAQDHFSGITTSRRGGLLNASTNPAELANLKTKYEVGVFSLSFNL
SNNRLGFDDLVSGDDLEQKLFEGNKDVDLRFDGEVYGPAFAMKIEKWAFSFSTKAYGKVN
FTDVDPTIGDAVTNGALNSIFGASTIQSDKNQRANGTTWGEVAFGVARNVYETEEHKLSV
GVTLKLLFPGSYANLGLDKFSGTITNNLGNVNMTDASARMNISYSGDLADDFSDFGNYTS
SLFGKLNGFATDLGVNYQWKDDNDGYKINAGAAVRNIGSMTFKSDNNSNNNYELNIPAGQ
SLNLNQFESVSSFKEIEEILLSSGYLTATSNGSDFKVKLPTVFSAYADVKIIPDFYVTVF
GQQKFNKDNKDDQVTAQNVISVTPRYSRESFEVFAPLASNEISGFTAGLGFRAGGFFIGS
SSVVTALINDGEQADFYLGFRFGLQ
>LONDMIMF_01130 Aldehyde dehydrogenase
MNHQEINQRKEKLKKFSHVISLHENDIIEALHKDFGKPAFEAYLTEINVVQSDLKDTIKN
IHAWAKPKKVRASILNFPSSDYIYTEPYGKTLIISPWNYPFQLAICPLIAAYAAGNSIVL
KPSELTPHTSSLISKIIRETFDVKEVVAVLGDAEIAKSQLAKRWDYIFFTGSPAVGKEIA
KAAAGNLTPVTLELGGKNPCIIDKNANLQIAAKRIVWGKFINAGQTCIAPDYLLIHKGVK
TKFIRLLQQEIINAYGEDPKLSPDFTRIINKKHFFRLVGMIDEAKTITGGIHDEESLYIA
PTLIDEPSFDSAIMKDEIFGPLLPLISYENESDLEKIISKYEKPLSLYVFTDDKAFAERT
IRKFSFGGGCINDTVVHFSNKRLPFGGVGNSGMGAYHGKKSYDTFSHQKSIVKKATWLDI
PLRYAPYGNKLKVIRKLLKWL
>LONDMIMF_01131 hypothetical protein
MQKITTTKEKIEEIKQRGYPLEFGEILSQALNNYQKIVWIAGAGVLLLSIVFFAIIMGLA
AIFIGLSTFGRDIADFQIQNFSAAGIIVALVGGAIAVALIKPFYAGILRVAHHADAKEDF
DFSTLFYYYKSEYLKEIIIAGILIGFCSNGISTALELTGNTILGSVISYIIILLTLFTTP
LIIFGNLKAIEAIQASLMLVSRNFFMLLALMIVAVILAGLGVFAFCIGILFTIPLVFSVQ
YMIYTNVIGIDEKNELEEIGNSSSDY
>LONDMIMF_01132 Response regulator UvrY
MKTNRKNKVIIVDDHLLFSQSLKFLINSFSDFEVTHNFGNGKEFIQFLQEEENLDIEVDL
ILLDVNMPILDGLATMVWLKENRPDYKAIALSVNNEEDIIIQMIKNGAKGYLLKDTTPQI
FYDALKTVIEKGYFFTEMVSGILVNRIDNEDKKLEFKEKELDFIKRACSEKTYKEIADEM
CLSPKTIDGYRESIFAKLEIKTRIGLVLYAIKNKIVCV
>LONDMIMF_01133 Oxygen sensor histidine kinase NreB
MERKEIQLLVISLSIVFFTLLVLILVLFFYFHKKKTNFLIEKMEADLHFQSELVKSRIEM
KDQTLTEISRELHDNIGQILSVAIMQVNMYIQNQKAMTKEELDDLKNILGKSLDEIRTLS
RIINKDNLLESNFLEAIQLDLDRIRKLKRIDCNFSINGDFPEINVEHELIIYRIFQEAIL
NILKHSHSEIIDFQIDCLDHDNIKIKLIDHGIGFNSKKKSSGSGLNNIHVRAKLIGASVS
VTSDSSGTVVLFTYPKRINHENE
>LONDMIMF_01134 hypothetical protein
MLEDLRFYCIYLALLAGIVGLLFYNKLPGNKAKSLLGMIFFSVLTEFVGSNLTRWTGWIN
YGVYNFYMLVSLSYYLLLLKYLLVQRSHRRLVDVFLAVFILFYFANFIFIQKNISETFTY
SFTLGVLFVLLMSCLYLVEIFNSKKILNFSKSVFFWFILGVLLLHVPYLPFMLAIKWFLI
ESNESVYSLVLFILNVLMYGCFIIGFIWSEKKYNY
>LONDMIMF_01135 hypothetical protein
MKSSKTIFLAGLFCLTFFFQSCSEDRIYDKPTQLISNELATEMHMNYNSKAVRSKAEDSI
KEDANAVWYSVEELEKYINYIKTEGINKGYKVDGIRLYLGRYPDDPKYAEKAGMTTIFLS
PTGAKTDMQKSGMLNVSTMQEEPHYDITDLSVMNYGSMGNPPKMTYPFKK
>LONDMIMF_01136 hypothetical protein
MSQVTPLGYPHAGAGTVEILLEKEDGADFAVLFSPDPNNMLLRDNGLPMQFYYYPKYPRL
SKHPDGRFKFSMQVFKSEADGTTVIGAEGLEEEAGAYTTLTSTIDLPEALLKKAIDKLKI
KLDAEYKSQRTSKLFGLFSFLRGVDKDFNATNVRPIQLTENTIAMHVVGEKSQSNPFGGS
NPWSFNIQGEGSGTTFGLGDNALSILMGRNSASLVRSALENGTNNLVVENNIKYKAYMPT
TEIKVTVNAKKVHNYFSSKFSAGISWFRVNWEHEYEKIVTEGGITTEIITDNQFSDAERK
KVEEQLMTKARDFAFELLRKQILDPTDKNFGGETSESEKLLNIWNQGASMGFSLKSGQQV
REVNFTDSIRFSSIEVLSSKISGNLTPLTLKSGTEAKTELKKYISEIQLDEDFSKVQVIA
SLNGGLIKLDKDSDIVNDSPVSQVSIEVGYPDSKGKIIWKSSGRMIAPEGTPYVKTTSRA
GKEIDAIFPATWNDKSKEKNAFVFDFVKNNGASKVKVRQNIMYEKDKRVKLKDTVNEYEF
EGTKIFIPLLVQNMINYNLSTEELFESDTLEVTFKADKMATKKFKFTADNYEEMLPYKAW
YELDYNIKPTEYKVKYTCKGKIGKKAKKVTISTDYQKIDYLEGDILFEIPTGTDVQNADI
EKIRAPFME
>LONDMIMF_01137 hypothetical protein
MSLLFTKTQRFSKLEIMPDLKTFKLEGTKLVPTNRFNLEPAKPSNSFTTVVSPDAPFTVI
EHPIIHSINIDRPVIGILPINSYFPLIDGDTAIDESASFKDYSDSNITLLFPEIEIAPNN
NTLFYYENVLDKSGKNSGLMGRVTLKYTIKNKPLKANEKNIALNLKEVVLNLKIKDDSIK
INGIVTPEKNEIQFDLKDEAVKIAFLNLITQINNLKSSIDLFFEFKGYSKFRKNFLVARN
IGSIKNLKFFGNEPGTENIRTPKTSILSNPLVIKSNAPNTIISRRSILEIQKENHLNTDV
HAELVKSTFLLRINKTLNYPLSSDAATSLYKTIGGGFINNPFNLNEDFSQFRQIFVPGVH
FSKLSIYKSTLQPNTFLLISKTYGLSRDLDTMKPCISTIFHAYEDGTSTQEEISKISFQF
ALGPNLSEFDLAKLKIELLQNNYIDGDKTDYFEKVQFLFPNDIESDYEISGNYFLQQSDI
STDGKHFLFNLSTENLSEASILINALNNTISQFANINFRHKEIKDTSIIELNLEKTIGEM
IESVIDNTSKTIKISNKSISKCRLNSVLFVNNENAAYFNSTYFNKFPDLISSESKILDSI
TLNPNTKSSTVKNIFFDFESIEDISSEFSQIVSQSTSYNRYLQIEIKKQKAATSKITMEL
LVEQTGSRFTIEKLKAEFAIPVLFNFIVKNSISTNTLLSYKINYFDKNDNLVKSQNHVFD
YSTSSKITINQ
>LONDMIMF_01138 hypothetical protein
MKTIRLGTKSAEVNYLNELLQKLGYPLLVSNYFSPETEKAVRDFQLNHALVVDGIVGIKT
WSRLLEIANVGYASNNKLLSEQNLMDFASFHNLELAIVKAVNEVESGGKGFLVNGRPKIL
FEGHVFWRELDKRNINCSNYVNNDTQNILYQNYTKKYYVGGSGEYDRLEKAADLNPDTLF
REAAYSSASWGLYQIMGFNAPSLGYASIDEFVEKMYLNEGEHLKAFGLFLEQNNLIRLLK
NKNWAEFALRYNGKGYKTNRYDEKLMKAYARYSS
>LONDMIMF_01139 hypothetical protein
MNPSINQMIATLSNRVLRFEKANSDRDYSGGGWYEETKYALFLYPDFTVLYILESFSSVS
GGGLYLPNKNTQEYKGTWNVCEENQKICLHLTFEDNSSQKIETENLGYGIQKLGDQVWNR
YLIS
>LONDMIMF_01140 hypothetical protein
MIRFLKNIIFIIFLSVNYIYSQNKKIENMDVKNLNYSEGNKLIKDFNFKQIHYNPNDKEH
IYYISTDKRFLIYFNLHFIKF
>LONDMIMF_01141 hypothetical protein
MNALSEKKTIINFDSFHDKIEERIFFLNKFLGTNISSLDKLDNLNAFDKAIKDFGIEKID
FNTLFMNFFSYYYVVIRNELNYENFEIKLHDDDYEVFVFSDEKDKREILSNFQKMITDPD
EEINFHLRAKIIIKPFIISTRNRR
>LONDMIMF_01142 hypothetical protein
MDSVSKKWLQNMLRKVMDASLSPQGFYDDSDGITDPVDDYAYDDFGNMTADQNKNITEIL
YNQLNLPTKITFGSLKRKIDYLYTANGKKVRKNLNSRDLMEIGSIDYLDGFQYRDGWLQF
FPTSEGYVRATVVNGTTAYSYVYNYTDHLGNIRLSYAQDPASPTELKILEENHYYPYGLK
HTNYNSDLLVHREYRGALGIKDPGPIEPLVPVLPYNYKYNGKELQDEMGLNAYAYGWRDY
DPAIGRFHKIDRFAEKYYNLNPYQYGANNPIIYNDIKGDSIAIYSPEDNGFIKYENGNLY
SKNSKGKWEIYNGKNVKIDKNGSSSIGGFLGKVLEALDKIRNGNAGSELINVLQNASKYI
RIYEGENGASGIAGNVWWNPLNTTGGPNQLGNTFRPAYIGLTHELGHVFDGLDGVVNNMP
IGYIEKNVTASEYQAMHWENRVRGENGLPLRTHYGNDINGRAVGQALNLMALVIYILNN
>LONDMIMF_01143 hypothetical protein
MRYIVISFLAFIQYSAIIKLENYYCGEGVIFDKSIKYPFVEPDYKEGYTPTINDIKKTET
YLFNTYYEYETNVLDSFNLDKSKFKKKFKNPSIVKKKFFKYNRQYAGFIDKSNDTIIYIG
LLNFTNKKLANKYFEGWKENIFFGFDGFYDKNQKTYLYNLSKNKFVYKLDTSGYK
>LONDMIMF_01144 hypothetical protein
MKKLFYKIMISSIYTAQNNGFMSDIWKFASGFYFAFATSAYAIFVYLIINNYVLNGALDF
LIINFISDLRYNFILNIGVYCIIPIMSLHYQLFLRDDKYKILIKQFKKQYNKKTFGWYFM
IALVFMFASLFLKIEKP
>LONDMIMF_01145 hypothetical protein
MIKSKITGNAYFWSIFTIIPLFGSIVFAHRILKRPYLNISDILILLVFVFLFYIVINFLK
HIKHIIIQDTSLRYYSILRPFGKTIDLSACAGKIILQETGIQGSYNVVYLIDQKGITFFK
IMGLHYKNFEDLKNGINLKTIKFNPSVSQYLRLLFFERLNIKEHSDSLKKISINTFKPIK
YIVIIGIILFIFRFLIQNIS
>LONDMIMF_01146 NAD(P)H azoreductase
METKQILVLGANGKTGSRVVERLEKRNLPVRKGSRSAVPKFDWEYSENWKEVLEGISSVY
ITFQPDLAVEGSDDAIRLLSALAKEAGVEKLVLLSGRGEKEAEVCEKIIMGSGLKWTIVR
ASWFSQNFSESFFLEPILQGYVSLPVGDVKEPFIDADDIADVVVVSLTEEGHDGKLYEVT
GSRLLSFKEAIAEIAEAVGRPIVYEQPSTEEYVAQMTAYQIPKEYIDLSTYLFTEVLDGR
NASVSNGIEEALGRKPKDFSEYVKEIAASGLWNPED
>LONDMIMF_01147 hypothetical protein
MTQRDIAKFRMLAQQIAKPELKSAPEMVAYFGAIQGQEYAQTKWSLGLRMPHLTDVDIEK
DLNEGRILRTHLLRPTWHFVAPEDIRWMLMLTGPRVEAINAYMYRKMELDNATFNQCNTI
MQRALEGGKQMTREALSQEFLKNNIQADGTRLVCIMMKAELEGLICSGARKGNQFTYALL
EERVSPVSKKEQDEALAELSQRYFISHGPATAKDFSTWSGLSLTDCKKGIEMVKTHLAEE
KIESETYYFSPKLNLDTATFGQLQLLPVYDEMIMGYKNREALMQYRNAVQPGKRLRYDNT
LLFDGQVIGSWRRKIKPKVIDLEYEFLEQPGKKQESEFEKALLRFEKFYELPVNTINNSQ
>LONDMIMF_01148 Ferri-bacillibactin esterase BesA
MKSFLTLLFSFAITFSFAQKTSPKTEPFVLGRIEKINSKVLNETRTLNIYIPDSYNKNPK
TAYPVIYLLDGSANEDFIHVTGLVQFLTMIQKMPESIIVGIANVDRKRDFTFPTTNVQDK
KDFPTTGHSEKFLSFVEKELLPYVKKHYRTSTATIAGQSLGGLFVTETLLKKPELFDNYI
IISPSLWWDDESLLRKAPELLEKKRNKKIQVFVAVGSEGQQMEDDAFQLSEILAKSKDNL
VSSFAKMTEENHLTILHNSLYKALEAINKTQ
>LONDMIMF_01149 Protease synthase and sporulation protein PAI 2
MYTPPHYKNENIDEVREFIKANSFGILVSQTKGRLWGTHIPMELDFDEHGNTFLYSHISK
ANPQWESFADGEEVLAIFHGPHSYVSSSWYQKEDVPTWNYIAVHVYGKVEIIEGKELMDS
LKKLVDTYEHSSEHPVSVENLSEKTMRQVNGIVGFKIAVSEIQATYKLSQTRKETDFHTI
VNQLENSSDFMSKATAKAMKQSREKE
>LONDMIMF_01150 Bifunctional transcriptional activator/DNA repair enzyme Ada
MNEQEHINYIRIAEAIEYIRENFKDQPNLDDVAAKVHLSPFHFQRLFTEWAGVSPKKFLQ
YISVEHAKHMLKEKEATLFDAAYETGLSGTGRLHDLFIKIEGMTPGEFKNGGENLSINYS
YAESPFGNIIVASTPKGICYMAFSENEDQSFSDLKSHFPNAAIKQKLDLIQQNALYIFTH
DWDKLHQVKLHLKGTDFQLKVWETLLKIPMGDLSTYGKIAEKIQKPRASRAVGTAIGSNP
VAFLIPCHRVIQSSGNFGGYMWGNTRKTAIIGWEAAQSLSPKL
>LONDMIMF_01151 hypothetical protein
MENIHEKFTALDWAAFNDEMNEKGYAIIPKLITERQCDELVKNYDNPSGYRKTVVMERYR
FGLGEYKYFNYPLPDLIQGIRENLYPKLAPIANLWMKVLNINSRFPTDFHELQALCHANN
QLRPTVLILKYGKGGYNTLHQDLYGDIFFPMQTVLFLDNPDEDYTGGEFVLTQQTPRAQS
KAIVLKPKKGDALVFTTNFRPVKGSKGYYRVNMKHGVSELHSGKRHTLGIIFHDALS
>LONDMIMF_01152 hypothetical protein
MIAHEHITDALLRKIIRKEILLGGNKKLKIYGNLRCQSGKRMLRKNRVFFISEEEALQNG
YRPCGHCLSEKYKIWKTNNSNGFI
>LONDMIMF_01153 hypothetical protein
MDLFNTDITANLLPYDGTVIYYGKVMSHARAQFYLEKLLKDIEWKNDEAVIFGKLIITKR
KVAWYGDSDYLYTYSNTTKQALPWTKELLELKKLAEEISGTSFNSCLLNLYHDGNEGMAY
HSDDEKSLGKNTTIASLSFGAERKFSFKHKQTKDSVSVLLEHGSLLVMKDETQSHWLHRL
PPSKKVTRPRVNLTFRTIVL
>LONDMIMF_01154 DNA repair protein RecO
MLVKTKAIVISALKYQEKSLIVKCFTETDGLKSYFVHNAFSGKNNKQKIAYFQPLNLLEI
EAVHKNKGTLESFREIKLFAAYHTIHVDIVKSTIIIFLSEMLHHSIREEENNEDLFHFLE
TALLWLDSHDEIANFHLILLLEITKFLGFYPDASTNDYAFFEMTEGIFTPFQSLSCLSVQ
ETILFRKLLALRFDSNQQVFNGKERQQLLKIILDYYSFHLDGFKKPKSLEVLKEVFS
>LONDMIMF_01155 hypothetical protein
MKKQFLIFLFSFFIQIAFAQNNQLWKGYFSYNEVNDLTESATRITGATQKSLFSKNLATN
ELKTVTTINGLSGQDITAVYYSQAFNKTIIGHANGLMLILTESTGHILIVPGIRDQAGLT
PNRKRINHFYEHEGKLYISCDFGVVQYNLATLGFGDTYLLGPAGEEVKAYQSTVLNNFIY
VATAESGIRRADLSNPNLNDFNQWQTFDSGIWTGIVTHNNQIVGISANRVARHTGTAFAT
VTNLMQPGIDLRSYQNNLIATTLNHVYTYNENFSQTAHIVSSSIPEMTAAFNCATVIDGT
IYIGTKENGIISTEVTNTATFLVIKPDGPAKNNIFAIQTTPTGKLWAVYGGYNVFYVPDV
SSNGISKFSENGWLNIPYEDVLQAHSLSRITINPSNENQLYISSFHSGLLKVENDVVVAK
YDHTTQNGPESLFFGPDPNYKSVRINGAGFDRSGNLWFNNSRVENAIKVLKTNGSWQSYS
IDGFATGYLEQDYGRMAIDKNGTKWFVSSLNGVIGFNENAATKFRLAASQEDAGNPLIKN
AIAVAVDNRNQLWIGTMQGLRVLPSVDRFMGESDLETNPIIIIEDGLPQELLYEQFITDI
VVDGANNKWIGTADSGVFLVSSNGQQTIHRFTRENSPLPSNSINDIDINAVTGEVFFATT
AGLVSFQGTSTKGNDDLSQVYIYPNPVRPEFTGTVKISGLINDANIKITDIEGNLVYETT
SEGGTIEWDTKAFGKYRVASGVYMVFISSKDGSETKVKKVMIIR
>LONDMIMF_01156 NAD(P)-specific glutamate dehydrogenase
MIIKKKTSRIWRRCIFVLSNENVFIENVNNYLIIMSESINSFVEAVATRNPNEPEFLQAV
KEVAETVIPFIEENKKYQNKMLLERMVEAERVVMFRVVWMDDAGNTQVNRGYRIQMNSAI
GPYKGGIRFHPSVNLSILKFLAFEQTFKNSLTTLPMGGGKGGADFDPKGKSDNEIMKFCQ
AFMTELSKHIGDNTDVPAGDIGVGGREVGYMFGQYKRLRNEFTGVLTGKGISFGGSLIRP
EATGYGDVYFAQSMLQTKGQSFEGKTVVVSGSGNVAQYAAEKATQLGGKVVTLSDSAGYI
YDADGIDAEKLAYVMQLKNVDYARISEYTKKYPTAKYVAGKRPWEVKCDIALPCATQNEL
DGEEAKLLVANGCICVAEGANMPSTPEAVEVFQKAKILFAPGKASNAGGVATSGLEMSQN
SLRLSWTSEEVDERLKRIMLDIHTSCVKYGSDGTGYVDYVKGANIAGFVKVADAMLAQGV
V
>LONDMIMF_01157 hypothetical protein
MPRIYFLILALAFGGLNAAFAQFGFSHEIGVIVGPVALQSDYGERHDLSTNAGNTGIGVG
IIHYLNFSYKAECNCYARETFFNDHFKVRTELSYSKTNLQHFGKWVDDSKTSVTAQQLRN
MRGSTAITNIGMQLEYYPLSIRDFTASDGSWAPFISLGAQFSHYNPEAKSTTGPLTIINT
PVKYRDAFKNESGTVWSVVSSVGTRYKLNELSDLMVDLRFQYYFSDWVDGLRPDPARYSE
NKANDWLVWLNVGYIYYLN
>LONDMIMF_01158 Cystathionine beta-lyase
MKFNTKVIHGGQHHDPSTGAVMPPVYQTSTFVQSSPGQPVGDYEYSRAANPTRTALENAL
ASIENGTKGLAFSSGLAATDCVLRSFQAGDEVIAMDDLYGGTYRMFTRIYKNSGIKFHFV
DMNDLEKFKSLINENTKLVWVETPTNPLMKLADIEAIAKITKEHKLLFAVDNTFATPYLQ
KPLDLGADIVMHSATKYLGGHSDVIAGALVVKDEALAEQLHFQQFATGATLGPQDSFLVL
RGIKTLHLRVQRHCENGAKVTEFLSSHPKVKTVFYPGLESHPFHEIAKKQMKNGFGGMVS
FTFESGKKEDAVRFLEKLQVFTLAESLGGVESLANHPALMTHASIPEDKRKEIGISDDLV
RLSVGVEDIDDLIEDLKQALQ
>LONDMIMF_01159 hypothetical protein
MKRLLLFIAIPLAFASCQKDKKESSELKTVDFQSKTFEKKTTLPCKGDLCAEVKITVPEA
SAVPVVADSINKKIFNTVRGIVYFGEKPYNGKTYEDIMTSFINSYEELKKEFPDETLGWE
AKIDAKVDYTSDKVLNIKLHHYTYTGGAHGYEGNRSLLFNPETGKELTRKDFLKDEAGFK
ALAEKEFRKKYKIPAGAINATGLMFENEVFELPQSIFFTPKGLLLYYNTYEIASYADGPK
ELLLPYDQLKDHLLIK
>LONDMIMF_01160 hypothetical protein
MHEAYNITMQNRKVLQGYLQNYSLEELNKVPQGFNNNLIWNIGHIIVVQQLLVYKLSGLP
TMVSDEMISRYQKGTRPEADATQEEINEIKRLLYVTVEQTQTDFDNQIFKTYHEFTNNLG
FTIRSAEGAIAYNYYHEAMHLGMMMSIRKFV
>LONDMIMF_01161 hypothetical protein
MKIIIIFLFVVCAAFGQNTKDISSNNVIAVVSADKMNVVYRGIINPISIVVPGAKSFKAK
GLGLSETQIPGKYNLVPGAGLEVKITIEIIMPDDTVLVEEKIFRIKNIQRLNVVIDEESC
QNCILEFSKEELKDKEIKLGTKGFLFDIDLSKSYIKSFSVVFPNDKSMVVEGNKFDEKVL
KEIAKLKKGSIIKLTNIQCSNPLNACFTGVNPARIMIKNN
>LONDMIMF_01162 hypothetical protein
MYFYQNYQQIINMKSRIICGLLFGGIMAILFGCAKKDTIDLKLKLKAGEVERVYAATIVK
GGSMEFQSIVEMRFTTEAIKPDRNVIDVKVVRMSSSSDAFGEKESYDSNKDVNEMTQEER
STHQEFQQVLNQSFLVAVNNKGKVVEPFRSKNGDRRRLTEQIIDISNIYIPFPEEPVGVG
SEWEAEREESLTKIKTVSTYKITEINDKQIVVSIASKIKGMKGFVDNEAKGQYVLDRKTC
KMMTGDFSMSLEDKRKVFFKFRSVPD
>LONDMIMF_01163 Regulatory protein Spx
MNNKIYYLSSCDTCRKIIKSLPNTDRLEFHDIRQNPITEAELEEMHKLSGSYEALFSKKA
QLYKSLDLKNKNLQEADFKKYLLEHYTFLSRPVFIIDGKIYIGNSQKNILEVTKALS
>LONDMIMF_01164 putative inner membrane transporter YedA
MSTRNWALLGALMVSIIYGVTFTIAKDVMPEFVKPFGFIVLRVGGSALLFWLVALFLKTE
KIARNDFPRIIASAFFGVAFNMLTFFEGLSLTSPIMASVIIVTTPMIVLVLSAIIMKEKI
LKWKAFGIILGLAGTLLLILYGKSVGNAPNAMWGNFLVFVNAVSYGFYLIIVKKLMEKYS
AFSFVKWIYLFGFIMVLPFGWKQVQEIEWAVIPTPVYAKILFVVVISTFLTYLLNLLSMK
ELKPTIVAVFIYLQPFFATLFAIGLGKDQLSLIKAISAAMIFLGIYLVTQKKKTVPAN
>LONDMIMF_01165 hypothetical protein
MIQSMTGFGKATLQLPNKKITVEIKSLNSKSLDLNVRTPYVYREMELALRNQIAQKLERG
KVDFSLFIEITGEETSSKINVPIVKAYINQLRQVVDGDDTELLKMAVRMPDALKTEREEL
DENEWKTIQGVIDQGLENIQEFRTSEGIALEKEFLIRIGNILALMRETVALDGERIETVK
NRLKTAIEELNVNVDENRFEQELIFYLEKYDITEEKVRLENHLNYFMETLAGKEANGRKL
GFITQEIGREINTMGSKSNHAQMQKLVVQMKDELEKIKEQVLNVL
>LONDMIMF_01166 Guanylate kinase
MNNGKLIVFSAPSGSGKTTIVRYLLAQKELHLDFSISATSREKRGEEIDGRDYYFLSAEE
FQKKIEENAFVEYEEVYKDNYYGTLKSELERIWAAGKHVIFDIDVIGGLNIKKQYPKQTL
AVFVSPPSVEELERRLRFRQTETDEKIQMRLAKAEKEIAKAEEFDVILKNYDLEIAKNDA
YKLVYDYLKMI
>LONDMIMF_01167 putative nicotinate-nucleotide adenylyltransferase
MKIGLYFGTFNPIHVGHMIIANHMAEFSDLNQVWMVVTPHNPHKKKSTLLEDHHRLQMVF
LATEDYPKLKPSDIEFKLPQPNYTVNTLAYLQEKFPKYEFSLIMGEDNLNSFHKWKNYDV
ILQNHDIYVYPRISDEAISQEFTGHPKIHVIDAPIVEISSTKIRESIKNGKNARPMLPEK
VWDYIDHNLFYKK
>LONDMIMF_01168 hypothetical protein
MSQLLRQQIEKITPLTDGEFDYILSHFTPKKYKKHQFLVQEGEDVPNDFFVLEGCLKAYH
VSQDGKEHILQFALPDWWICDFNAYFNQTKATLNIDCIEDTEVLCLSLYNREKLCSEMHK
IEHFFRRKSNAGYIALQQRILSMLNNNPQERYEKLLQLYPSLFQKVPKKLIASYLGVSRE
TLSRFSS
>LONDMIMF_01169 Molecular chaperone Hsp31 and glyoxalase 3
MKKIIAPVLMAFTVFALFLNPDLSNAQTKKSKKMEKKKILFVVSSHDKKGNTGEPTGYYL
GEVTHAWEVLKDHYTIDFVSPKGGTPPVDGFDLNDPINKQFWEDAVYHNKISNSMKPSEV
NPKDYVAIYYAGGHGAMWDFPENAEIAKIATAIYENNGVVGAVCHGPAGLVNIKLSNGKY
LVDGKKVNAFTNEEEIAVKLEKVVPFALETKLIERGAKFEKSGLWQPHVTVDGRLVTGQN
PQSAKGVGEAVLKELESLGK
>LONDMIMF_01170 hypothetical protein
MNPLLLTDGYKVDHRRQYPEGTTLVYSNWTPRKSRIENVDEVVFFGLQYFIKKYIIEDFE
NSFFRQPKEEVVKKYARRINNYLGENQVGTKHIEDLHDLGYIPMVFKALPEGASVPVRVP
MFTMYNTKPEFFWLTNYFETLLSAVIWLPCNSATIARQYRKVLDRFAKETSSVPEFVNWQ
AHDFSMRGMGGVEAAVTSAAGHLLSFTGTDTIPAIDFFEEYYNANSDKELIGGSVAATEH
SVMCMGTTEGEFETFERLITKVYPKGIVSIVSDTWDLWKVLTDYLPRLKNNIVSREGKVV
VRPDSGDPIHILCGNPYGKTEEERKGVIELLWDVFGGTINDKGYKELVPQIGSIYGDSIT
IERATKICEKLKEKGFASTNVVLGIGSFTYQYNTRDTFGFAMKATYGEVNGEGRAIFKDP
ITDDGTKKSAKGLMKIELENGTYKLIDQVSWDEEKKGELKEVFRDGKLLIDYSLAGIRKT
INE
>LONDMIMF_01171 hypothetical protein
MKDIQYKKGDATNPIDNGNKVIVHICNDIGAWGKGFVMAISKKWKEPEKKYREWFKSKEN
FNLGEVQFVQVQEDLWVANLIGQHKINKDENGNAPIRYEAVEKGLVKVADFAHKIKASVH
MPRIGCGLAGGKWEMIEPIIEKTISKKDINTTVYDF
>LONDMIMF_01172 Bis(5'-nucleosyl)-tetraphosphatase, symmetrical
MRTLVIGDIHGGYKALVQVLERAKVTTDDTLIFLGDYVDGWSESAQVIDYLIELDKKHKC
IFIKGNHDLWCGRWLLLGASNPVWEENGGKATKESYLKTGLLTNSEHKSFFENLKNFYID
EEERLFIHAGYTSIHGVEKEEYESNYYFDRTLWEMALAMDKNMDEEVFAYPKRLRHYREI
YIGHTPTTNYNQDVPMNAMNVWNIDTGAGFKGKLSVLDIESKLFWQSDPLVELYPNEKGR
N
>LONDMIMF_01173 O-acetyl-ADP-ribose deacetylase
MKIEVIQADITEIQVDAIVNAANTSLLGGGGVDGAIHRKGGKQILEECIAIRNRQGGCDV
GQAVITKAGNLPSKFVIHTVGPVWNGDKEEKKKLLADCYKNSLELALENNIKTIAFPNIS
TGIYHFPKDKAAEIAIQAVKEFSRKEEFEKIIFVCFDEENHSLYKNLQDN
>LONDMIMF_01174 hypothetical protein
MKTQTLYRPVGLREMELIAESNYKKFPPRLEWQPVFYPVLNQQYAEQIANEWNTPDEFSG
FCGIVTAFNVDEDYLQKFEIQNVGDNSHNELWVPSEELEVFNQHIKGEIEIVNVFFGANY
KASINNDLNIKIEKFR
>LONDMIMF_01175 hypothetical protein
MNKNYRVEIANKTLEIIKNGFYEVNGKKVNIEKELRSSIENTITIAPEDWEPILRIPIDN
THNTEISIKNCSTIEAIFQEKEGKIGVLNFASAKNPGGGFLGGASAQEESLARSSSLYES
QIKDKKMYDFNRSQSSFLYSDYMIYSPDVLFWNDDNGNYFERPLIADVITSPAPNKGAML
QHNRKDEIEKIDGVFKRRMDEVLAIAAKNKIEILILGAWGCGVFRNEPKEVAQLFKEIIS
EKYSGAFHKIVFAVYDTSEKKSNFKFFEDFF
>LONDMIMF_01176 Ribose-phosphate pyrophosphokinase
MILNLDTHFNPFPGKREIQFQSFTFSGGEPHIKINPDFDVSEPVTITHRINSFNDFGLLL
LAIDALKRMDVKLINVFIPYFPAARQDRVMISGEPLSVKVYADILNSLKLNKVTVFDAHS
EVTPALLDNCEVIPNHAFIAEVLEKIGKEVKLISPDGGALKKIYKVSEYLGGVEVVECSK
SRDVKTGKLSGFKVYNDDLKGMDCLIVDDICDGGGTFVGLAEELKKKNAGKLYLAVSHGI
FNKGFDVFQKDFEKIFTTNSFREFDNEMVEVVKLKL
>LONDMIMF_01177 Bifunctional NMN adenylyltransferase/Nudix hydrolase
MSPVQNIRIAVDAIVFGYQNNKLYVLLIQQKFGSEKAYWALPGGLVKEDETLKEAVKREL
HEETNVAINYFEQLYTFGDDIYRDSRNRVISVAYFALVDSSKFDIKADSDAENVKWFEIK
AVPQLAFDHNLILDKAVERLKAKLTYQPVGFDLLPEEFMFSELENLYCTILEKEIDRRNF
RKKILSFGIIEETDKFSPIKSGRPAKLFKFNKQKYYDLEKEGFHFEIKFA
>LONDMIMF_01178 Alcohol dehydrogenase YqhD
MLNFELYNPTQLVFGKGQIAKISDLIPKEAKVLITYGGGSIFKNGVYDQVRKALHGYDIT
EFGGIEPNPRYETLMKAVEIIREKQLDFILAVGGGSVIDGTKFISAAVKFDGKPMDILKK
GIRILDNAVPFGTVLTLPATASEMNSGAVITINETQEKLSFGGPALFPKFSICDPEVVAS
LPKRQIQNGIIDAYTHVLEQYLTYPHDALLQDRISEGILQTLIEIGPKVVENPTDYKLAS
NYMWSCTMALNGLIQKGVPTDWATHMIGHELTALFEIDHARTLAIIGPNLYRVMFETKKD
KLAQYGKRVWNVADATIDEMAVEAIEKTVEFFHRMGMQTKLSEYTQDYEKTADFIARRFE
ERGWKGLGEKKNITPEKVKNIVELSY
>LONDMIMF_01179 Glycerol-3-phosphate dehydrogenase [NAD(P)+]
MNEHPKFAVIGGGSWATAIAKMLCVNLEEIAWYMRNESAIEHIKKFKHNPNYLSSVEFDT
KKLKLTSNINEAVKYADYIIFAIPSAFLSGELEHLTESLDGKIIFSAIKGIVPETSLIVG
EHFHEKYKIPYDNIGVITGPCHAEEVAMERLSYLTIACGDSQKAKIMAHNLSGNYIKAKI
SDDIIGTEYAAMLKNIYAIAAGMAHGLGYGDNFQALLMSNAIREMKKFIRKVHKMKRNIN
DSAYLGDLLVTGYSIFSRNRMFGNMIGKGYTVKSAMMEMSMVAEGYYATNSAYKLNEGLR
AKTPIIDAVYGILYEGKEPKKVFRKLTEKLN
>LONDMIMF_01180 Inner membrane protein alx
MQNNGVDHLVNHPGILTAFSVVIIIMLLLDLGVFNKKSHVVSNKEAAIWSIVWISLAMGF
SGVIYYLMGIEQFTQFQSAYWIEKALSVDNLFVFILVFGFFNVPKHLHHKVLFWGIIGAL
IFRAIFIFSGVELINMTYLPEMNIFGKLVSINVVLSVFGFFLVFAGFKSWFSKEDNDENK
DFTKSPGAKLVHRFFKVSENYDGDKFFTVENGVKMATPLLVVVAVIEFTDLIFAVDSIPA
IFAIAPNDPFILYTSNIFAILGLRALYFLLANFMYMFSRLKYGLAIILAFIGVKMLIQPF
YHISSPTSLTVVGSVLILSVMASLAFPVKEEK
>LONDMIMF_01181 hypothetical protein
MLEQLLNSGKFSEVLDHVANGEKLPKTLNEYSKSGIFDRLFQQKQFEIIRLFLENGVIET
DVYEFDSFDKSIFQSVVRGLQTDDESLDFFREFISKFDNINDEVGAKTLLGYFFEKGASL
ESIKILVETGCNVNFKNNAEENFLHQIIKTNLMKPELSLSYLEFLIQEGLDVNAQNIVQK
TPLITAIEFNRNEYLELLLQNGANPNHADKNGNTAFFYAVAHKLDVRLYDLLRNYDMPQF
DLLNSDQVTLLFEYMRMMYDTSEKSLELLRKLIDDGADIYQTSIYYGRDTMPADLIAEKK
PEVLQTIIETGAIDINRQDNSGNTLLHKVCAYNVNYDAEKAKEMYRKVKLLLENGADVTI
TNDKDQTALNLASDDNLKIKTVELLMKQS
>LONDMIMF_01182 Phosphocholine transferase AnkX
MSMSFIIACESGKRKIAELLLANKEVDVTYTDEKGRTALHYAAHHGYLDLVQILISEGAA
IDYEDHAGETPFYFACLQKQKQTALFLLEKGAKTDVKDFKGNSLLHLTAQTGQIEVLEKL
LEQGVNADIENNEAETPLLIAASWRNAAIVKKLLENGADVNTTNKQGNSPLLFAVKSKNQ
PMVELLLENGAAINHINHAGESALLLACYDSNRMLTKLLTEKGADIFVSSQNGLSPIWYA
CSNNQKEIVELFINNGVDVNYSKPVTGNETSMYSYLDWVETADSLSISSSFSLDTSYGYG
GESLLHVAAKSGHVSMVKLLLDKNANINIQDESGNTALHYAAANGKKDMVKLLLEKEADA
SVVNAKEQKAIDYSNIKGFNEITELLLKYSPSNTANPNSTKTEPAPASAPVDMASKKQAL
LDLKELLDAGILSQEEFDVEKAKILKG
>LONDMIMF_01183 hypothetical protein
MKKDIVIPKVENVFLAAVQEWNDDFMEKVWYVYLVNDSDFDLDSVMVVSKAFGTIDGEMK
KTSLLRHAFTQVPAVSVVKVEMVEKSVLALNNEFMVTYFIGNTLYDKKFIFRTNTINERA
TEEVPILFVNGVIVR
>LONDMIMF_01184 Phenylalanine--tRNA ligase alpha subunit
MIDKIKEYIGEVEAFQTQNKEELEAFRIKFLGSKGLIKDFFAEFKNVPNEQKKEFGQVIN
QLKTTAEDKLKSIQELFESKEETIGIYGDLTRPAEPVKIGSRHPISLVKNQIVDIFSNIG
FNVSEGPEIEDDWHNFTALNLPEYHPARDMQDTFFIQTNPDILLRTHTSSVQVRYMEENK
PPIRTISPGRVFRNEAVSSRSHCIFHQVEGLYIDKDVSFADLKQTLLYFTKEMFGKSKIR
LRPSYFPFTEPSAEIDIYWGLKTETDYRITKGTGWLEIGGCGMVDPNVLKNCGINADEFT
GFAFGMGVERIAMLLHQIGDIRMFYENDVRFLEQFKASI
>LONDMIMF_01185 hypothetical protein
MSRDIQLKQRWEKVVSLLSHQFAEGDEELDLDSIIYLIGVQELGKVHNKFKKDEKVNLMH
IAICRLLEPYGFYEFDYFDNDGWPHYKIKEELPPLKAGEQSVLMKEAIVNYFLEREFID
>LONDMIMF_01186 hypothetical protein
MAAYYFLMGFLDIILGIFLAYGLIRGLWNGLFVEFASLVSLLLGIYIAIKFSFITAEFLA
DVFSWNPKTIAIWAFVLTFIGVVIGISLLAKFFTSIANFASLGLLNKIAGGVFGVLKMCL
ILSFVLALFQKINSNNTFAEKKTLDDSLFYNPILKISEFVYPVFEEWFEELKK
>LONDMIMF_01187 hypothetical protein
MKNIVYILLLFTQIFWAQDNFEAGNKFYRQDKFEEAVKAYENVLKTKQHSAELYFNLGNA
YYKLNKTAPAIYYYEKALLLNPGYSDAKNNLQFAQNMTIDDIKPVQQVGFGKIIHDFTSS
YTYDGWAKIAIGFSILFLLFFIGYYFSAATWLKRVFFVGLFVALIALIVSVASAIAEKTS
YENDKPAIIFADTVGVKNEPKENADNAFVLHEGTKVQIIETLDNWRKIQLADEKEGWVNK
DVLKEIK
>LONDMIMF_01188 hypothetical protein
MLIAMRKYIAALILICFQGLSAQVQFEAKVSKQTLGLNERLRIDFIMNEDGDNFTPPSFE
GFRVVGGPSQQVSQTWINGRATFNKSYIYILLPQQRGTLTIKQATIEIKGQTYKTAPIKI
NVTAPIDESKDPSSPDYVPSGGIHLIAEISNTNPYLNQPITVVYKLYVSNNVSVRNWKEI
DSPKFNDFWSQNIDIKNLVVENGKYNGEDYRYVVLRKTVLYPQKSGKLTIEPLSLDIVVD
QPTNRRDIFGRVQFVTGNKTVSAGSKVINVKALPEAGKPQDFTGAVGKFNFVVKPSKTEL
RHGESLDLDISVSGNGNLKLFTLPKPIVPSALEMYDPVHSEQVTTPLSGMQGKIADKYTI
IPQYQGNYTIKGLTFSYFDLSTKTYKTITSNDIVIKVLDGPTSSDSSVAATPGATTNKQA
VKSTNQFRFIALKTQLHSTHKEDFFGSGLFYTLLFLPFLFIPIIILAKKKKEAIDSDVVG
NKRKMSNRLAKKYLSEAKKQINNKEPFYIALEKALHNFLKAKLHIETSEMSKDKIREILL
DRNARPETIDDFINLTENCEFARYAPYSSVAIQQDFDKAVTVISELEKQI
>LONDMIMF_01189 hypothetical protein
MRQLLIYTLLLFSFAAIAQEKDKDKNLPRGNKEFKEKNYVDAEAEYRISLSKSPTKAIAS
YNLGNTIYKQKQPSEAKLAYVNTIENAKTKAEKHKAFHNLGNIFMTEKKYSDAVEAYKNA
LRNNPADEQTRYNYALAKEYLKNNPEPPKDDKKKDKDKKEKDKDKKNEKDDKKEGDKGED
KKENKDKGEDKKDKQDGKNDEGKNDKDSDQKGQPKPQPGNSPSKQRIENLLDAVNNEEKK
IQEKVNAKKVKGKPVQTEKDW
>LONDMIMF_01190 hypothetical protein
MYDELDEKKYLYLLIVIPILVLIFLFNLYWKRKKQKEFGDLKLVKKLTPEKSVFKSTLKI
TVFLLALACLILGLVNPKLGTKVETVKREGIDIVFAIDVSKSMLAEDVAPNRLEKTKQIV
SQIINQLGSDRIGIVAYAGSAFPVLPITTDYSVAKMFLQSMNPGMVSSQGTSLDEAIHLS
SSFFSQDSKVSKLVIMISDGEDHSEGIEEATEEANKNGLKIITIGVGTEKGGPIPLKRNG
VVESFQRDQNGEVVVTKLNETTLKEIAKITKGGYVNGNNTKEVVDYVKHALENIEKSEFE
TKQFANYQSQFQWLLGIAFFLFFIDIFFLEKKTNWVKKMNLFNEKE
>LONDMIMF_01191 hypothetical protein
MKNVTFLNPEFFWLFVLIPIAIAWQIWKGKKQVSLKVSSLKGFKAKPSIWSKLKPLLFVF
RILALGFLIVAMARPQTVDISNKTNITNGIDIVMSIDVSGSMLTRDLKPNRLEALKRVAS
EFVEARPNDRIGLVVYAAESYTKTPVTSDKAVVLDALNSVKYDNLLQDGTGIGMGLATAV
NRLKDSKAKSKVIILLTDGVNNSGFIDPRMASEIAKEYGIKVYTIGIGTTGMAESPYAIA
PNGDFVYRMMQVEIDEQLMKEIARNTDGKYFRAKNNQSLKAIYDEINKLETTEIEEQKFY
NYDERFRPFAIAAGILLLLEVLLKNTVFRSFI
>LONDMIMF_01192 hypothetical protein
MKNNTLYILFFLFIGTFAFGQQKRVTTAVDSTKIKIGAQINLTLKTSVDTLSNVVFPEST
NFGQLEVLESYPTDTVKQKDRYLLTKRYGLTQFDSGKYMIPSLKVLINDKPYSTDSIFVK
VAGVKVDTLKQKMYDIKGIAEVKESMGNWWKYLLGLLLLGGIGYLIYYFSKKYKKKEKPE
EVVYATPIEKAVTLLKNLEQKGLWQKGEVKNYYSELTDITRTYIEEEIQVPAMESTTSEV
ITGLRNAAVRKKMKISQETVDNLERVLRQADLVKFAKSKPLDFEIAEDRAKIEKTIFTLH
KAIPEVEEEDEELLLLDAQKKELLLKKKRKRKIAIATFIGAFLVVGTLTYFITTRGLDAI
LGNPTKELYEGEWIKSDYGNPAVTIETPKVLKRTKLPGGNKDMGIKESQAFAYGNVFDEV
MVNISTTSFKDTLSRPLEKVVEKEIKSFEKQYKAKDVFVKQDQFDTKEGISGIKAYGTMV
VFKEDSDKGIKIGYEIMVFGQEGGLQEIIITYRDNDEYGSKISDRIVNSVELKKVN
>LONDMIMF_01193 hypothetical protein
MDTKELLKKVRKIEIKTRRLSDHIFSGEYHTSFKGRGMTFSEVRQYQFGDDVRAIDWNVT
ARYNEPYIKVFEEERELTMMLMVDVSGSESFGTQNGFKKDIVTEIAATMAFSATQNNDKI
GLILFSDEIELYIPPKKGRSHVLRIIRELIEFKPKSHKTNISQALRFLSGVMKKKAIVFV
ISDFMTDDNYEHTLKIAGKKHDLTGIRVYDVREEKMPNIGMVNMLDAETGETLLVNTGSK
AVRLEYEKYYQEKMKFFKETFSRCGSGTVNTRVDESYVTKLLGYFKSRG
>LONDMIMF_01194 ATPase RavA
MEENATALDIRAINEKIERESAFIDLLMMEMNKVIVGQKHMVERLLIGLLGQGHILLEGV
PGLAKTLAINTLSQAVQGSFSRIQFTPDLLPADVVGTMIYNIKDNAFSIKKGPIFANFVL
ADEINRAPAKVQSALLEAMQEKQVTIGDTTFKLDKPFLVLATQNPVEQEGTYPLPEAQVD
RFMLKTVIDYPKIDEERMVIRQNLKGSYEKVNPVVSTDQILRAQEAVREVYMDEKIEKYI
LDIIFATRYPEKYKLENLKPLISFGASPRGSINLANAAKCYAFIKRRGYVIPEDVRAVVH
DVLRHRIGITYEAEAENVTSVDIINKIVNEVEVP
>LONDMIMF_01195 hypothetical protein
MKLEYLKNLENIYASNKRISKIGVSEIDISVLEEKLNLGFPKAYKEFLFIAGNRDGILGD
WNRGFDNLEGIQEEAEESFNNVGLGLRNFFAFAEYGGDQFLFFFLNEGDNPPVYAYDEMK
IHKDEYGNPSYYKKTKPSFTDFIEKHIDEQISK
>LONDMIMF_01196 hypothetical protein
MSNVEKLNESSTSTASNLEETAASLEEMTSNLRSSTQNVEKMASIASSVTSRAKNGEKLL
ELYPNLEVKKPLNK
>LONDMIMF_01197 hypothetical protein
MKPTFRCGTRKAIDELSEELNIPHNSSMQDWSYTEGNPDDIEKYISHYYLTTDDDKKFVL
MEIIIQATEDQNTEELFIKYCETIKPILEANFKLHEFTIHYWACFDNENIDDCWKIATLM
RQLWTDKSKLKLLFVCTVNRMRSATAHKIYEDDKRFEVKSAGTDKSANTVISNEILSWAD
SIIVMEKHHRNFIRQKFPEIYKNKKIVCLYIPDDYDYMQAELIDILKNKVEDVYRRRLI
>LONDMIMF_01198 Internalin-A
MRNILTFLFGLFTALSTYGQDKKCCTTYVYEGYILTDQNKKLEINLNFLVLLDSTMVGSY
YYDANRGSLKLTGKLNPDFTFYLTERDITDNITGFFEGKLNTNYKLASGKWTNGKKEKVF
DFEIKQVIGKSYWDYIKKNRALYEYKKLKRAIRHKHKVLSIDVARQGLDKLPNKLSQLDK
IVSINLLGNQFETFPTVLSRLTTLDEISLSSNQLTNVGPEIGQLKNLRILIMNNNQLKEL
PREIGNLTNLLYLEIGNNELTNLPEEIKYLTNLQELHIERNNLSETERQRIKKLLPKCII
HF
>LONDMIMF_01199 hypothetical protein
MYNSLLIKEVRQTVIAKTLIVILKYQTTMSKLQLIAETISEVLYDNFKIRPDYIFEEKLK
WLTTHPQKELFQNSWQIIKEKYQSVTDNKFDLDVLEKDDLYRLKNENQYVDIWFSKPYNF
IVEFDEKQHFNQYRLATLTDYNSEWIIGDLNIYMENCRKKTLKPGISGFQKIKENLLFPH
FYPDSEKQDNRIRQRAFRDFLKDYLPIQFDLNPTLRIPYTVTNKKNKDFNHSDLEKLKLY
LIETKLCERLKIEKHHS
>LONDMIMF_01200 hypothetical protein
MLHYIDNLKDDRVNCYSVLLTSTIKDYLEFIEKVYQKKGGIEGQRSALKTKSAQRIRKRL
IDDLNRGTVIPPIVLGVKLENTAFEEFEKDIPNNSPKLLDTIDTEEQVSIIDGMQRTTAL
REAILIKGFDSNKLIRLELWIAKSTNSLIYRMLVLNSGQIPWNIRRQLEVVFKQLKKELE
TNVQGLELFETDEQISRKKAGQFQSSQFIELFMLFGTKRTSIDIQEELAEEFARLDIIET
SGNDYFIDIFFGVSQLLVNLDNAFSNLTENTSDIELSKFKTGKHIFSSQPARAGFIVAAA
QEIFGLPGVELPKEKQNEKYQKLKKGIDKFYELLVSKKNNQKELFEIIDLPTLDEQTNLK
TSKVGEFERNFFLKSFKTLFDLAKDDSLQSLTPCWRSSH
>LONDMIMF_01201 hypothetical protein
MSRNINNAIEIVFDIIKLNFDLSSTSVLPEDFYNKRYVNGNANDARWLSHSKIIKHVAFN
QAIKFAVLEFNAEFYFITIGLDDPDYLPTGIIEEKINAGLLTLIVSEFELPIKNSISNLY
LVENILSQSVIDPFYKGHDKADLEKIFPNIYAMKITTGFGGDPKNIYQLIAFLITLNSKF
IFLPFTNKTLDKIHELVACNSTILSYESITQALFSSHFKFAFLDLYRCIELLYQLIHLDE
AYTKLSLSIDKTDFLIAIENDLGWRPKERSSLIKIFNYTPNPFKLDLNKAIKDSVPGISN
YGNWLYDLRCNIVHLKSIQKKFELKDKDWEKIIYGISHMLCYWYNKYPDFN
>LONDMIMF_01202 hypothetical protein
MIYFKISTHNKMKPEKRYEILNSLPANGPMYVSVTDNGEPFYSEGFPVRFYKADGTEWLA
NFQPGWTDLKQVIEFEAIQDLLVIACGTCYLMNPEDTKPIEVFGVDYTAIFQASKGRLLL
KDQTQLTIIEPDGTHWNTERISWDGLAEIRVENNLVSGLAYDPMHDTDEWVAFKYDLDTK
TLTGGSYHSFENKKLW
>LONDMIMF_01203 hypothetical protein
MKKKHFKYINTLFVVIPMTLIMAFVGLIRNYGFGEDWFLKFLKAWSVMLPVAYASAFLII
PQARKFAERVTTKN
>LONDMIMF_01204 hypothetical protein
MPNFAYYVTVAMQEQFSRYIQEIITISDTELKTVMAYFKTLKVKKNEFLVNQGESSQRTF
FVGKGCLRIFFLTEDGQEATRYFAFENQFATALTSFITENPSAEFIQAVEATELLYISHD
DFYHLLEIIPEWEKFYRSYLEKAYVNNTNRLMSFITMDATERYRQLLNQDPIIVKRLPNK
MVASYLNISQETLSRLKSKV
>LONDMIMF_01205 Inner membrane protein YqjF
MKYIPLIGRFLFSIIFMYSSVAKFSDTFVYEAAAKGIPLSYILIPLVGVLEMAAGLSILF
GFMAKWGAWLIIIFLVPVTFIMHDFWTVSDPMLHQLVLMTFMKNMSIIGAALMLAYFGAG
PYSIDALRDEKKEA
>LONDMIMF_01206 HTH-type transcriptional activator RhaR
MTNFTTLKTIDLEKTGIRKLSISDILEILGDVPQSEGLHVYMGKGAITTIPFPYPYRSDN
FSVMLILSGTMKLQLDLISHTANPNDLIIISPRTINHILEIGGNLELIAVSFTLDFARQS
NRNKNEIDAFEFFASKAIPKLTFSEEECRNFIFLARLLMQENIEKNHEPYSDEVLHHTFS
LLMYIVASRYKKENSGLKPELSRQEELTLKFLKLLDTHFKQQRSVQFYADSLCVTSGHLT
KILKEVSGKTAGELIEEALLLEARILLSDPMLTIAQIADELRFSDQSSFGKSFKKNIGLS
PTEYRRKNSR
>LONDMIMF_01207 hypothetical protein
MRYNRLLLFLLLFLLCLNGMAQPSSQNTLIQKGWDALVKDHDDEAFRYFFLSYEKAKKDR
NETDMAESLLYLGICSFGSSYEKGLDYAFQSLNIYNRLEKTNPDVGQIGRSKCLQLISTI
YSRQKKYAQAKPISREVISILESREDKSGTLGLAYSSLGSLYEQQQLKDSAYYFYKLALK
DFEKSGNQAYLPNAYINIGESEMGRHNDQNGLDYFQKALEIANTTENKQAQASALLAIGR
WHLNHKHKTEALFYFQKAHVISEALSDKLFEIMTVEALIELNEKEKNYFEMSRLQKRLIF
LKDQLHSLEREKIVKSLEMQFEVAEKNRKLALVSKEKEVARLTNYLLAICIIVLLTALVT
GYLYLKSRNKRDRNLLKTKEALLEAKEKQRELEEIRFQNDLDHKESQLSAITLQMLQKNE
LLSDIKSAIEQQPQSEQQLIKMVNRHFEQNNNWDDFNLYFESINKNFYTRLKQLYPEISA
NDLKICALIKLNLSIKEMASILNISPDSVKTARYRLRKKLQLAADENLTNFILSV
>LONDMIMF_01208 hypothetical protein
MNRKKCIWFIGIILLIICGAYLYNGVLYKEARNIAEEKPAFRLSSLQLLSNYKANMSVSD
SSYLNKTLEISGKVTQISDSLLTLDSGISCSFAKNLAPDIHGKEITLKGRCIGFDELMEE
VKLDQCILIQ
>LONDMIMF_01209 hypothetical protein
MHPNTVIVSMRNIILQLTCLLLLGGSACAQEDLLSQLDSTQVQDTYATAAFKGLQVITLQ
STKMPTKKEFYFVVSHRFGTVKGGISEFFGFDDATTKIGGIYGLTDWLSVSGSRHTLSKV
YETSVKYRLARQSDLFPFEIVGYNTLDINSLLKKDDYPKIEFSDRLTYITQLIVSRKISE
RLSLELVPSYIHKNLYNPEIENDNQFALGYGGRMKISKRLSVNLEYAYNFNKPDFYKNPL
SVGLDVETGGHIFQLLFTNSQSMTESGYLTSATGDWGKGDFFFGFNLYRVF
>LONDMIMF_01210 hypothetical protein
MKKIYLLLALMLFFACDSNTYEDLEKPTTVDGPVTYQNTVKAIVDANCIRCHSPGGVSSF
RPLTTYQEVKDAVQNTNLLDRIQRQNGETGQMPQTGRMPQDKINLILQWRADGLPEN
>LONDMIMF_01211 Protein YceI
MKILKNKLPILLLFLLGTFSAQAQKYVTKNGNVKFEASVPSFEEVAAESKSTSAVLETST
GDFAALTLMKGFRFKVALMEEHFNENYVESDKYPKATFKGKIEDFDASQITTTEKTVTIT
GDLTLHGKTKRVSSTAKISKSGTGFKITGNFIVKPEDFGIEIPKIVSKKVADKVTVDYNF
LLNK
>LONDMIMF_01212 hypothetical protein
MKKLLAFLFLVTVSAIAQNKGPKDVFDTARYGTVEEIKALAAKNPDTINKVNAMGFTPLI
LACYRGNLTVAEYLTENVNNINYSSSSGTALAAVAVKGNIKLAEALLKKKADPNIADAAG
MTPLLYAIQFKNKELIELLLRYKADKTQKDKQGKAPFEYAVDTRNQEIINLFKN
>LONDMIMF_01213 hypothetical protein
MKKTLLTVTLGLLALVAQAQTKTTGTVNLLAGMTAKLDLNSTNSTATLTLTGPSDRWFAL
QFGSFSNGQGMEAGQDVVYYNGTTLIDAVHNGIGTPPTADTNNWTVTSNTVASGTRTIVA
TRAFDTASSSDYTFVYANTSIDFAFSRMSSASFSLAYHGANRGYQIDVPLAPALGVDDIE
AAKKFAIYPNPSSSQFSIRTDEDIKSVVIYDATGKLAARFSNRKEMLDISSLQSGLYFVE
IETTNNETSIEKLMKK
>LONDMIMF_01214 6-aminohexanoate-dimer hydrolase
MKQLYFYSRLFFCSCLLYGTSSKAQEKTVYPTAAESDPVKMGWMVGSPPPENRILRFEDG
SFFEFPGLRWSVAHMRQFMPTTNVSRGLGPSNPLQEALREDIGGVTFIPLGEKEPMTWEE
SLQKTYADGVIILHHGKIVYEKYFGALTPEGQHAAMSVTKSFTGTLGILLAKEGIIDERK
KVTDYIPELKKSAFGDATVRQVMDMTTALQFSEDYADPNAEIWQFSAAGNPLPKPKDYKG
PKSYYEYLPLVKKKGTHGKAFGYKTVNSDVLGWIIARATKKDVATVLSERIWKRLGVEQD
AYLSVDATGTPFAGGGFNLGLRDMARFGQLILDNGFANGYQIIPKVAIEDIKKGGNKNAF
AKAGYPLLKGWSYKNMWWITHNEHGAFCARGVHGQVIYVDPKADMVIVRFASHPVAANSA
NDAYSIPAYHAVAKFLMKK
>LONDMIMF_01215 hypothetical protein
MKVFRLAFLFLLISNSSLFAQVPVTDLDFAILRCEKAFESGTEEDIKTNFPLPEQQELLL
SLDKSKTKIVRKAGPSKILESDKKSALVLLTGTLLFGNSGNETLYSGHYSGIYRFKYSGG
KWTIAEKLPIDRKNLLMGHIINAAIDPGNSSLTVSDSMKILTQESYGFTVVLNHKAKITA
LQVDGKDADYVFNGGILWVRTKTNAEQQLALSYTLAVDKFEKDKNSGYFDDTYGHVRNQF
FWHPFFSFSSPNDRANFSVRVTIPSAYQLATSLPQEETVSENQRIVKAQSAGPTFALGLY
YDKKWKTYRYKKNDYQLEVFCDADFKPNPDILHKNFLEAYDLLAEKFGSPRGQYLAIVQD
RSNASNGWLNRSNDMIVAAKQGSDFLRDKPSPRAPFAHEVAHAWTTPIGPATNFLSEGWA
SYAERYFLEKQYGEAIFKDYLTSYKNIYFSEGFDTKVSLWDDVSNDGVSYYKGVWVFYML
EQLLGKEDFENGLKAFMQSGEPMTILFFMDKLTKTTGKKVQPFLEPWLKSKQVPHVRAVL
KDNALVISQEGDVLPFLLEVEFTLGDGTKTLSSFPIKDKQHRFKLSGAKFAGAKAIKLDP
SGKLLIKILE
>LONDMIMF_01216 hypothetical protein
MKSSLLVLLSILFVQASTSKRKEVYICNSPNGKRFHYTESCEGLQNCTYKIEKITLREAR
KAGKTRCGYER
>LONDMIMF_01217 hypothetical protein
MKENENNELEKLADKAMKSLPLETPSFDFTSRVMAQVAMAPEKTIPAYKPLLPKTFWIVL
ITIIIGLFGYAYFTDGSEQQIFNIDFDMAYANKLQNMANQLDSSKTTMYAAVALLLAMLV
QIPLIRNHFQGK
>LONDMIMF_01218 ECF RNA polymerase sigma factor SigW
MALPNDQFYIDRIMKGDTQAFTHLVERYKTLVYTLALRMIKNTEEAEEAAQDTFVKVFRS
MEKFKGESKFSTWIYRVAYNTCLDRIKKHKTVPLTVDIDNYGSRQLAAAENVLDAMDGEE
RHRAIQECLQQLPGEDAFLLTLYYFEEQSLEEIAKIIGIKANNVKIKLFRCRKKLGEIVR
ARLEPEIISEYERERK
>LONDMIMF_01219 hypothetical protein
MERIIIPVCLFATIFGVFYIYLSTRNRERLALIEKGADASLFKSSPQNVPVWKLLLLNLS
LLLIGIGIGLLIISILHAYTLLDSEAANTAIVFIMAGISLFTGFTLSKKLEK
>LONDMIMF_01220 hypothetical protein
MKTKIALAVLLLGLAIPALAQKKIAPGELPKPAQEFLKEHFSHTGIEKAKKDAEHGEKGY
EVKLQDGTEVEFWKDGSYREVDGGKNPIPTAFIPASIRDYVAANYPNEKITHIDYGHKDV
DVDLTNGIDLEFTKDGKFLKKD
>LONDMIMF_01221 hypothetical protein
MKKCYLLLALMGWQANSYSQTLNQSANWPNTAWTITGNYNEDSEAFESDPRIASSFAYND
RFSGNPHEDNIAAESPVINLSAAFANGETLLELTMPYGYRYKANDALRLEYWDAAISAWI
PWGENIPGNANTSFAVSNFCSLPKTLYISEMLNISGFTTAQLTGFRYRLFYDDDPAGAAW
NYGFCFDSPTLRSWSCAAPTRLTATGVGSSPITWDNVPGIAGYEYVLNTTSANPTGAGTP
TLSNIFLPSNLSLPPSTKHFFHVRSVCTASQSPWRTVSFTTSPVNDNCTAAIALTVNPTA
VCMVKTAGTLESATDSDEPHVGSGRPDDDVWYTFVATATSHRIELTNITGNGSEIIVHEV
LEGTCGGGLISVHLSDPDLNPTSSTPRALTIGNTYYIRVFTYASDANTQTDFDICITTPP
PPPANDNCSGAYTLTVNPNATCTAVTAGSLVSATDSNEGNPEIGTPNDDVWFKFTATQTA
HRVTLRNVSGMPRDLVVEILQGNCGNLTSMKISTSYANTIFGLTIGNTYYVRVFSESPDT
GATTTFNVCLSIPPTGAICEKPIVVSGLPYTTTDNTINYGDDYDFPQGGESGCEGTNNHY
LGGDETVYAYTPAANQTINIRIPGAPGWTAILVYTDCNAIGTGAIACANGDFEIGDREIN
ELAVTAGTTYYILLSTQPAPQSFAYTLNITEESLGTKPFDDSSFRAYPNPVKNMLNLSYK
EEMTAIKAFNILGQQVLSKNINATESEVDMSALHSGTYLVKAYAGEEVRTFKVIKQ
>LONDMIMF_01222 putative zinc protease
MTNKLFKIILSAGFYGAVCLMAVESATAQNLSEKLVTDPKTTTGVLKNGMKYYIRPNSKP
EKKVELRLLVNTGSIMEDDDQQGLAHFTEHMLFNGTKNFPKNKLVDNLQSMGVQFGADLN
AETGFDTTVYMLPIPTDNPKNLETAFQILQDWAQGALMTDKDIDEERKVVLEEARANLGA
ISRLRKKFLPPLLNSKYSERLPIGKEELLKTFKPDVLRRFYKDWYRPDLMAVVVVGDVTT
AQGEALVKKYFSSLVNPGNPRQRVEHGAGPYTKQEVMFLTDPEQTTTRLSLNFSPRKTEA
DKTVGDYRNTLVEQLAFSAINRRYRDLASEATPPFSAAQTSNSTYIRNYQALSLTVIPVA
DLTTALNAAVKELLSIEEYGFTKDELELVKKSLLSYAEKQYNERNTTNSAAYLGEYEENF
FIGQAAPGIEKELELYKTLLPGITPEEVTAAFKKLFSKEDKEKFFAYVLSSETKDALINN
DATLLAAIQKSFTQKAEKKAEVAISTTLLDKMPAKGKITKVEKDAKLEATTYTLSNGVKV
TVKPTTFKSDEILFTGVKKGGTNAYGVEDKATVSMLTSVIETMGYGKFTPTDLNKSLTGK
NISVRQSMGETTNEIGGRSDIKNIESLLQLNYLELTEPRLDPSLFNGYVSKMQMQLKFIK
SNPQAAFVDTLVNVMYNNNPLRPMVIPTEAQIKSINPQRAVEIYKNEFGKADGYHFFFVG
NIDENTLKPLLEQYLASLPTSGKEPKFVDNGLRLKPGNNKFMFNKGTEPQSLVVAQYFGE
MPYSEDMALKANMIGDILTIRVIEKLREEMGSIYSGGFQGSMDKEPYSNYSIQTQLPTGP
ESVEPILKQTEAEIAKLKKDGPEQKDLEKVKIAIIERRREEIKTNQYWIGKLQQLQFSGD
SVERFLNFEKELNKITVQDMKAAANKFFDGKNSFIGVLNPEK
>LONDMIMF_01223 hypothetical protein
MPLFVGIFGKRKFIGYKKIFSLFRSFKKLTALRFSVKIVSRKGAEPQRHN
>LONDMIMF_01224 hypothetical protein
MMAPNKQYYVYMRYSIINEYFKNALPKTVKDSIEQMVYELYDKQIVSNRVPLILKNKVN
>LONDMIMF_01225 hypothetical protein
MKKGFIAFCVLIIISCSSKNEKRDDLELEVLNDTLVAFPYDQSKDTVNVINYSIKNNSDR
TYYFKQGFGGDLLLKKVYKNGIYIILNEVGSNKEVSYTEKLPFEHYNRSVCDSCCNIIQS
KRLIKDTERLKEDGKLSYYGTKDKRHFFLIHPKEKLFFKQYVNLTDSMRYEDTRMNYAHL
KRNMEYYSKFFIPGDSVKYKEDLPEDILQTIKANNVKVYHGILESKNTVPVKVIE
>LONDMIMF_01226 hypothetical protein
MIAAGGLSSTIAGGKFVNGFRQGVITSGLNHVAHYVIQKIDYRKELRDRFNKDTDGNYIV
NPNGKPDLSFEGAMSLNKNVEGLEQAYNDGGKPNVRFDIKSDKYVGLTGFDDVNLNPSKI
TSNLKYAAVLFHEYRHAWQYFSGNYNYWAGKYGYAFVENYQERDAYWFQIKMGAGSFFEG
YSRYIDYRNLTPKITYKK
>LONDMIMF_01227 hypothetical protein
MKKIIFICFVLIGCAKYNRSEIRSDIDIRLTNTSVKDSTDLKITITNNTLKNYYLLYSSK
SVNDIMKEFNNGESLYTISVDIVDDKNSPISIELYDGSCPINIPVHTTEDILKLKPKQKV
KLSIPFRMKTNVSTYCYYQYVIDTIDLNKQYYVYVDYYIGNEYFKNALPKTVKDSIEQMG
YELYDKQIVSNRVPLVLKK
>LONDMIMF_01228 tRNA nuclease WapA
MRRFLTLCTFFLLVFNSVSAQQQQSIPLQFDVSGYSQDRNEAHRFDASSMDTIPSIKAEM
NVNEAGALTYLLPIEVLKGVNSFQPNLALAYNSQSGNGTAGWGWNIMGLSMITQGGKSKL
IDGVTIGVQYDGQDPFYLDGERLLKVSATTYVTEKYSKIKITKQSTGSEFGFIIQYTDGR
IAKYKELVPGQYYIATLIDALDNEVHYAYNITSNVPVLTTISYGGNSAANDKFFVEFIYN
DRTTITKSYRNGTGYFSSKILSEIRVKSTYLTANNGLYRKYKLFFDRIQSYTTERLIKIT
VENENGAALKPLKFNYNSATTGVIESSSSYINNWPFQTIGLGSVVVGDFYGTGVPSPIYE
TKESETNFKLYNPKTGTISSYSKSKDYFSGKVLRDNKISEADDLIALQTDYPGGTTNPST
LVDKLTFKTTSLSTGQAKTILMDLKGGLNEINGTRDDRPRNFVSGDFNNDGLVDLLIFER
LNLNRIQKVYFAEIGLLPGGTAVPATVACPALGIDDKTDFYIIEFDGDGVPEIMVVNRTT
NKYTILKFNSVTNTLTAIAGQTNIALTNFTEKTPIIFGDFNGDGLTDFITPQKIYNLEGS
TAARELSEMETETLLWWQYISTGQSFVKTPKDFTQQKLAYIATSQRNVMKKSSTWDKIWS
GKPDTYQYTEYATSTILAADFNNDGKTDLITVRKFGKAKYDLSGRLSLTNIQPLNSFENV
SPVNANRIFFHETRNLPDGSQTLHNLSTTIALDNVNISPLSLILNYSDYNYLNTYKTGIL
IHDPILRNDKKFIINNDNFIEGQLREVDNGSPVRQRIEYRAMAEKQSTYEDAAYSTESTQ
LNYPYYVHKNIGTNYLAYKVHTLFDDKIITKEYRYRNGIQHLGGKGFLGFQKTFVSDPYE
SIFENGKYRMKDIFKGHFWKTNTYDPLMEGALLSTAYGSLNMNSIFSLSTANSSRFDKGG
NRYLILTTSETNKDFLKNITIFKSYEYDTAGDLLLKKINTSYNSIGSSVEEYTYEPESSS
GQHYHFGRITTTTNTTWKGSDSFSTKEEQFFNANGTVYQTKKYGNATLPIVTDFTYYPFG
GTKSQTVSANGIAPVTTTYEYDVTNRYIRKTTDAEGMISTANVNALGKTLSEVSPLGHTT
SYRYDDWGNIKETTDYLGKKTTFAKNITPNEPLGYYSISVKKEGGAEIISIKDIFDRTIK
TKSETANGLWAITETEYDLFGKKIKESEPYFDGDPILWNTIEYDAIDRAVKHTSFTGKVM
TTCYEGLKVTVEDGHKKMIKVADAMGHIIKHQDGGGEIFYKYYPNGALKEANYDGVITKI
EIDGWGNKTKLIDPSAGTYRYEYDNFSRIKKEINPKGGYTEYTYDDFGKIISENTSSPSE
NTVIAKNYSYDSTTKLPTVVSGTYNGKSYTYTTFYNDPYHRITGKKEQTPDFTYLTTLTY
GDYGRVDMTEFKTTISNPNYTTTSQVSNKYDSRGILISQTDAETSAVIWELGTTNAQGAI
TNMSFGNGYGMSVTYNSNNLSLEKIRHNRRNGTLVNIDYNYDVQKGILLSRNNLVFGKNE
TYTYDDLDRLLSESVNGSVVQQYTYDKRGRMTSNSEVGSYNYNTQDYRLQSVDFNANGSN
LNTNRGFAEIQYNAFKNPNEIVLEGKDRISYDYSILKTRSASYYGSMDATAAARPNRKFY
SSDKSIEIVKENGTVKIITYITGDAYTANYMKVDQLFADGQVSSGKYFLHRDNQNTILAI
SGGYGNVIERRYFDAWGNLKEAKLGSSDTSVLPNALGWISGLLIDRGYTGHEHLKTVGLI
HMNGRLYDPALRRFLSPDNYVQDVYNTQNFNRYGYTLNNPLLYTDPSGEFIVEVLIGVAV
AVVLNGINNSINKIPFWYGSGKAGVVGGVSAAISLGIGEVMKGAFSSAFSTAVVQAGLHG
FTGGLLSMANGGDFLSGFAAGAVSSLISSGLQYLGNVDGFYLDDDYTKWTSTATRNPNLF
KGSMIAAGGLSGGLSSTIAGGKFVDGFRQGVITSGLNHVAHMIVNKIQEYKTINELLENA
GYDPNATALLDNAGAKDFASKVFPDMYSQANSPDFEFVEGLKSKSGQSSAGQAGIKVTQN
LETEVYTVKFTGLIKLNTYAKNTYHNLAATMGHELSHAIDAVSGNYTKWYNKHKSEGARA
ISEDRAYQWELNHGSLLYNPQEHQYWKNLMPR
>LONDMIMF_01229 hypothetical protein
MGGKKLFFAVFALLCGISAFSQIAITEIYYDTPYIERTDRAYHHLGEYIELYNYTTEDLS
LKGWSITDNASKYVFPDNVIIPSQSFIVVAYRDPFEPIGDYFTTFFPTTIGKESQIFYQG
NVMFRNKTENISLNVGFVRGTDLRGYAIQSASWHNDEFDRHFNPGYMNPSGVNFYLESLH
LSNEEYFYPGTPTPLTAAYVPPTQNLEDIASFQQASQDNYASLTWETYSNAILAITCPLT
INVVQQTAPYINPVLKKCFSHDASGNLVSTFLCDENNERTNDSGQAFEYGSSELEEIASK
IILYPNPTSTTVNVQWDGSINGKITQMQVFNTGGINISNTTILVSQSSTVIDLSYQPTGI
YIVRFLLDSGQFISKNVMKI
>LONDMIMF_01230 hypothetical protein
MKTNRRKFIGTSSMTLVGIAFTNTLLGQSVSSLIKIVEETIPQKLKRAADLRNNQVTSSP
VFRNRSGSNRNMEAALDIYNEVIVLDAKEVRAYDGIRKVLLQSKYKELEVLQVFSNYLVV
NTVSPIFKERVAKEYMRLALGNKKFANQLNSPNDLLLASNTLLNQARIAEPDNEQFEAQY
QKTVAKITQQTVVLDARDNPALKALKKINRQNHKKRFDHLTAAETKILLDKLLAKKPNTD
RNNHIREIHKVYINKLVKGGDIYNAVKELEGLIKFDNSDVHALKMARKICIQHYRYENLE
NIERENDKVKESFWSKTALFDILLKRYQKENTGSISELEDILSNAASKAKSFGQFFEVNT
RKIKVSMIQKIDPEAELGKLADSISGIKSAHAIDRFNVLCVKHYIEKNMRPQAVKVINIA
LRQNGLSLDDFLLQKVEEVNRHRIAEKPIHNERLNYLRTQLFD
>LONDMIMF_01231 Transcriptional activator protein Anr
MSKCEQCIVREFSSLKALNKEELLKIADCKSSYTIKKGEPVFEEGENVNGIFCVKDGVCK
LSKLSANGKDQIIKLVSKGELLGQRSMISDEPANLSAIALEDMEVCFIPKSEIMPLFNKN
NAFSMNVMRAICGDLKEADDHVVDMAQKTVRERLAETLLHLQETFGTHEDGSLKTQLTRE
EIGSMIGTATESCIRLLSDFNKNGLIELKGKKIFLKDIKGLKREAE
>LONDMIMF_01232 putative copper-transporting ATPase PacS
MDTHSCFHCGLEVIKKEEIVFDGKSFCCKGCQTVYEIFADNGLSSYYDFGKMPGASPQAV
NGRYDFLDNEKITSKLLEFQEEGTSIVSLYIPHIHCSSCIWILENLHRLHRGIGSSQVNF
SEKKVRIIFNPQETNLKDIVLMLCTIGYEPYISLENYEKGRTASDRSLIYKLGVAFFCFG
NIMLLSFPEYFETEEFWLDQYRGFFRWLIFGLSLPSFLYSASGYYVSAYKSIRNGMFNID
IPIALGIIVMFVRSTVDIVLGYGQGFFDSLTALVFFMLVGRLFQQKTYSFLSFERDFKSY
FPIAVTQIKAQEEVSVPVYDIQKGDRLLIRNQELIPVDGILISNDCQIDYSFVTGEADPI
HKKSGDKVFAGGRLLGQVIEMEVLNSVSQSYLTQLWSNDIFQKKNAVQRRSITDAISRYF
TPALLLIAFLGFSYWIFKDANTAFNVFTAVLIVACPCALALTAPFTLGNVLRIMGRQKLY
LKNAGVIEQLAKADMIVFDKTGTITTSKASDISFIGNPLSAIELSYIKNLLRGSNHPLSR
RLYDFLPVAELRIVHGFEEITGKGIEGIIDGNCIRLGAASYVGCENSSNTQTAVHIAINN
DYKGSYVFDNQYRKGLQQLFQSLKKNYDIKILSGDNDGERKQLEQLLPEGTELLFNQKPE
QKLEAIRKWQEKGHNVMMVGDGLNDAGALAQSNVGISISENVNVFSPACDGILDATEFSK
IAYFLKFSKKAITTIKMSFTLSLLYNVVGLGFAVSGKLSPLVAAIIMPLSTVTIISFVTL
ASNYYARKLKPKTGRA
>LONDMIMF_01233 hypothetical protein
MSVIYLLISISIVVAVGFFIAFVRAVRGGQYDDDYTPSVRVLFDDEVVSKKQEHPSKTRK
NCPETNP
>LONDMIMF_01234 Cbb3-type cytochrome c oxidase subunit CcoN1
MEVQQFYYDNKIVKKFLYATIIWGAVGMLVGLLIASMYLFPNLTENISWLSYGRLRPLHT
NAVIFAFVGNATFAGIYYSMQRLLKTRMFSDVLSKINFWAWQFIIVAAAITLPLGYTSSK
EYAELEWPIDIAIAVVWVVFGINMIGTILRRRERHLYVAIWFYIATFVTVAVLHIFNSLA
LPVGALKSYSVYAGVQDALVQWWYGHNAVAFFLTTPFLGLMYYFVPKAANRPVYSYRLSI
IHFWSLIFIYIWAGPHHLLYSSLPDWAQNLGVVFSIMLIAPSWGGMINGLLTLRGVWDKV
RTEPVLKFFVVAITGYGMATFEGPMLSLKNVNAIAHFTDWIVAHVHVGALAWNGFLTFGM
IYWLLPRMAKTSLYSKKLANFHFWIGTLGIILYTLPMYVAGFTQASMWKQFNPDGSLVYG
NFLETVKQIMPMYWMRAIGGTLFIIGLFVMIYNIVKTVKQGNAIEDELAEAPALQKITNK
RLKGEKFHPWLERRPIQLTILATIAILIGGIIQIVPTIMVKSNIPTIAAVKPYTPLELEG
RDLYIREGCVGCHSQMIRPFRSEVERYGEYSKSGEYVYDHPFLWGSKRTGPDLMRLGGKY
SDNWHFNHMWDPRSTSAGSIMPSYKWLFDNKPMDYSDIQKKMEVMVQLGVPYSKEEIANA
QAAIKEQALAIEKNLYSDPDFKKSYEESQKAAAAKGETFVPMHQREIVPMIAYLQRLGTD
IKVKEAKTNN
>LONDMIMF_01235 hypothetical protein
MLKFIKHNMETISGIEIYPIISLLIFFLFFVALYAWTYTYKKEKITEMSHIPFESENEID
NLKNDKP
>LONDMIMF_01236 Cbb3-type cytochrome c oxidase subunit CcoP2
MKKIFPVYLRVPIIFFAVFLAMEYFIDSGDRPAFLKYPMISVFLVVFLFLLIAIEVVVAA
VDNVTYHLLTDEQRKQLEEANEIKITDSKLFQKIKKWFVKESPIEQEADIMLNHDYDGIK
ELDNDLPPWWTKLFYACIVFAFIYLAKYHIFGHDNQAKEFETEMAEAKLAVEEYKKTAKD
LIDAETVTLLTDAGDIAAGKTIFETNCVACHRPDAGGAIGPNLTDDHWILGGGIKNVFHT
ITEGGRDGKGMVAWKGTLKPSEIQQVASYVLSLQGSNPKDPKPAEGEIWVEENAPKADTK
TEEAKTVAQN
>LONDMIMF_01237 Putative electron transport protein YccM
MPKMRDESFRDAIGTVDDKGKRVWVYPKIPTGKLYEKRKIVSYFLLLFLFAAPFIKINGN
QFLLFNVTERKFNIFGFPFWPQDFYLFVISMLVGVVFVALFTVAFGRIFCGWICPQTIFM
EMVFRRIEFWIDGDRGAQMRLDKQDWDAEKIRKRLLKWIIFFIISFLIANVFLAYLIGSD
ELIRLVQEPLANNLSTFIALLIFTGVFYFVYAWFREQVCIIACPYGRLQGVLLDNKSIIV
AYDHVRGEKEKGRAKIDKREDRTLSGKGDCIDCRQCVNVCPTGIDIRNGTQLECINCTAC
IDECDAIMEKVSLPKGLIRYASEDEITKHKTFEFTARMKGYASVLLILTGIFIGLLFLRN
DVEATILRLPGQLFEHKGENISNVYTYKIVNKTVHNLDDIHFELLSPKGTIKTVGKAWFT
IDKEGMAQGTLFVEIHPAFLEGDRTSIEIGVYQGGKLIETERTNFLGPRSFN
>LONDMIMF_01238 hypothetical protein
MKKINWGTGIFIAFALFMSFILFFVFLVQSDHKYDNELVIEDYYKYETGLQSQLDKENNA
EQLQEKVTVEVNKTGITVLFPHDFDYKNITGKVSLYRPSSQKLDFGIPIALSSSNLLIPK
SDLADGRWDILVEWNYNGTGYLNKEQLTLE
>LONDMIMF_01239 hypothetical protein
MLYSAFFFGLISSFHCVGMCGPIAMMLPLDRSSQAKKTAQLLLYHLGRLATYSTLGLIFG
LLGKGFYLAGMQQQLSIMVGVFMILIAIVPEKVFMKYNFSRPVYTIISKVKSGLGKQFRK
KNNSALFLIGLLNGFLPCGLVYAALFGALAMQNAPLGIAYMALYGLGTIPMLSAAAYAGS
FLSNGFRSKLQKVIPVVTVIIGTLFILRGMGLDIMYVSPGDMSLFVKSGADCR
>LONDMIMF_01240 Oxygen-independent coproporphyrinogen III oxidase
MPSNSLIQKYNVPGPRYTSYPTVPYWESGDFSYEAWMQSFKKSFRESNAAEGISIYIHLP
FCESLCTFCGCTKRITKNHNVEQPYLEAVLKEWQLYCHAMDEKPVIKEIHLGGGTPTFFA
VKHLEDLINGILKTGTKAKDFEFSFEGHPNNTTKEHLQKLYDLGFRRVSFGVQDYSETVQ
KAIHRIQPFSNVAKTTLWAKEIGYTSVGHDLVFGLPFQTIEDVVDTIEKTRSLRPDRLAF
YSYAHTPWIKGNGQRGYKDEDIPKDEEKRKLYEIGKALLHSNGYQEIGMDHFALETDSLY
KATEEGKLHRNFMGYSHSKTQLMIGLGVSSISDSWYGFAQNVKDLDDYYQLLEWNQIPVN
RGHILTREDLIIRQHILNLMCRFETEWNHADACFPELPAVLSELSEMENDGLLHIENNKL
VITEAGKPFLRNACMAFDLRLKRRIPETQLFSLIV
>LONDMIMF_01241 HTH-type transcriptional activator RhaS
MRHFKTISELHRSIGYPPPENPLISLVMCEKLSECSIGQSEFTTDFYMIAFKKIKSGYVL
YGRTKYDHDNGSMMFMKPRQVIEINNVELEEKGFIIWIHEDFLNGYHLHSEIKKYGYFDY
EANEALHLSAREEQIIWDLHSKIEGEYYNNQDEYSREIIIAHIDSILKYSQRFYKRQFIN
RTELSGKTVSKFNDLLASYLEKGKLQEKGLPTVKSLADLFNLSPRYLSDVLKQETGKTAI
ELIHIFLISEAKNLLQGSENSVSETAYALGFDNPPYFSRLFKKEVGMSPNEYRKNFVN
>LONDMIMF_01242 putative ABC transporter ATP-binding protein YxlF
MFDDFSADDFHRYCEELAIFSHGSIDMKKANSSFSDGMKMKLMLAGVMARKTDLLLLDEP
ASPLDPLMRDKLCQMIGEYIHEGNGKRSVFFSTHNISDMENITDYAIIMENGQIVEQGFV
EDLKEKYILIKGDAADTEAAGKVLYSMTKNPYGFEGICLAENIDKLAGLNVTKEIPTLYQ
ISVAVMKNNTKIVMR
>LONDMIMF_01243 hypothetical protein
MKKYLLFTLALLPITAYSQNKASLPDTIPLTINKQNTIYVKAVFNKTDTLNLNFDTGTTE
LVLTNDVMKNKLKSVPKLYDTFYDIKIGNQDYSTRVFDAQLTGHDTDGRFGWDLFKGKVV
ELNYDKNIMVVHPQLPISVLKEDAFSKLMITFFQGIFLVESQIFQDIVENSDFFLFDTGY
QRTVMLDNDLLKIGQFPTQNMKVIKKVIMRGAQGNEVPVITSSLQKLKIGKYEFKDVPVQ
LVTTNKPMHGQNIHILGNEVLKRFNMFLDFQNNFVYLKPNHLFNAEYIEKS
>LONDMIMF_01244 hypothetical protein
MKKLFALFVYVSLLLLSGGQYLNAATQPTSHSSHSFQKKHRVKFTNQDTSNTLLEEGDLD
LDEGQPGGDDLKDGIWNKLFIGNYSLSDNWYETIYCQPILDRYQKNFKTFAPFCGQSNPI
YITHRVLRI
>LONDMIMF_01245 Solvent efflux pump periplasmic linker SrpA
MKKIILTGITALLCLASCTTKKVEKEEADKFTVTSPVKIDTTFTKEYVSQIRSVRNIEIR
AQEKGFLQNIYVDEGQFVKAGQLLFKIMPKMYEAELLKAQAEQKSAEIELQNTKILADKN
VVSKNELAAAQAKLQAAKAEVSLAKLHLSFTEIRAPFDGTIDRIPLKLGSLIEEGELLTT
LSDNSQMFAYFNVSEPEYLQYQTNVKDRAETKVNLILADGQPFKFKGDVEVIESEFNNET
GNIAFRARFPNSTKLLRNGETGQVQMLVPLKNAIVIPQKATYEIQDKKYVFVVGKNNVLS
SKEITIGGEMPDLYVVNNGINENDKILLDGVQKVKDDDRIAYGYVAPKKVMSSLRLKAE
>LONDMIMF_01246 Efflux pump membrane transporter BepE
MFNKFIQRPVLSIVISLIIVFLGALSVLNLPVTQFPSISPPKVNITADYPGSNGELMIKS
VIIPLERALNGVPGMKYMTSDAGNDGEASIQVVFNLGTDPNLAAVNVQNRVASVVNKLPP
LVVREGVKITREESSMLMYVNLYSDDKNTDQKFLYNFADINILSELKRVNGVGVADILGT
REYAMRIWLKPDRMLAYKISADEVMEALSSQSLEASPGKTGESSGKRSQAFEYVLKYSGR
FTTKEQYGNVVLRSNPNGELLRLKDVADIELGSSMYDIYSNLNGKPSAAIVLKQSYGSNA
SQVIKDVKAKLEEIKKSSFPKGMNYEISYDVSKFLDASIEKVIHTLVEAFILVGIVVFIF
LGDWRSTVIPAIAVPVSLIGTFVFMQFFGITLNLITLFALVLAIGVVVDDAIVVIEAVHA
KMEEEHLSALKATKKAMHEIAGAIIAITFLMAAVFIPVAFMSGPVGIFYRQFSITMATAI
ILSGIVALTLTPALCAIMLKNHHGQPKKRTPVKIFIDGFNRTFNIASDKYQNVLGKIVNR
RTVTFAALLGFCAGTWFISSTVPSGFIPNEDQGMFYAIIQTPPGSSLERTNNVAERLQKM
AETVEGVQSVSALAGYEILTEGTGANSGTCLINLKDWSERKHSVQEVMEELEEKAKEIPG
ANIEFFQPPAVPGYGAAGGFELRLLDKTGSGDYKKMETVTQDFVKELNKRPELSSVFSFY
SASFPQFMLKVDNDLAQQKGVSIENAMNTLSTLVGSNYEISFIKYGFNYKVIVQAAPQYR
ALPDDILKLYVKNDKDEMVPYSAFMRMEKVYGLSEITRHNMYTSAEISGAAAAGYSSGTA
IKAIKEVAEKKLPRGYGIDWAGISADEVAQGNQAIWVFLICLGFVYLVLAAQYESFILPL
SVILSLPAGIFGAFLLLKIMGLENNIYAQVAMVMLIGLLGKNAVLIVEFAIQRHAAGKSV
LESAMEGAKARFRPILMTSFAFIAGLIPLVFATGPGKIGNRTIGTAAAGGMLLGTICGVF
VIPGLYYIFARIAEKHKLVKNEEENPLTEEIDNNHV
>LONDMIMF_01247 Outer membrane protein OprM
MFKSKIYQYSIVVALCLAVIGCKAPQTIAETPSKPVPESFGTSKDTTNMSTIKWNQFFKD
PNLVELIDTALKNNQELNITLQEIEIAKNDVRVKKGLLLPTVGLRAGAGLEKVGRYTSQG
AGDATTEIKPGVETPDPLPDYTIGAYANWEVDIWKKLRNSKKAAVNRYLATVEGKNFVIT
NLIAEVADSYYELLALDSQLDIVKQTIELQSNALEIVKIQKQAARATELAVQKFQAEVLT
SKSLEFEILQKIKETENKINFLLARYPQEIKRDKTNFTDLLPATVNSGIPSQLLSNRPDI
KKAELELVAAKLDVKVARAEFYPSLDISAAFGVRAFKPAYLFTFPESLLYSVAGDLAAPL
INRNAIKAEFKSANARQLQALYNYDRTVLNAYLEVSTQLSKIENLQKGYDLKSQQVDALN
RSIDISNDLFKSARVDYFEVLMTQRDALESKLELIETKKEQLNAVVHVYKDLGGGWK
>LONDMIMF_01248 hypothetical protein
MSLPLSHSLNIAPLSSTFNNTSATYKFYWLLAIIESLEEGKSEIGKKELFARMLTNSWYT
VNYFHISFGNQDLIQRAIKNISKNETIPINIKKHNLLHLLLNSPHKKTNNILKHFDKNVP
HRFLTPWIGRSKEENDTQYCKRIISESQQFSNQTLYALFPDRIYINPIWINYLTNNAKIL
KDYCYWNLSGFLQVRNPNVPNIQGKLIKPPMRSTLFNQRKNFWDIVFRELGTIDCIYTGV
PLSIQKYALDHFIPHAFVSHDLIWNLVPISVSFNSVKSDMLPEINLYFDKFYKIQKTAFE
IVSQNNPKSKLLEEYINLFGKEQHEFDFGYEKFKEIISPLISIARNNGFEYLER
>LONDMIMF_01249 Sensor histidine kinase YehU
MLNCKHLVSFLLLLFISLPVYSQNKTIDSIETILANRKISDTTRINTIIAGMDNTIMLSK
AHVAYYNQLLPVFTKGLAMPNVHPKVKQIYQFAAGVYYYNTAKKETSEGNKNAPIHFDEA
IKYWKASKDYKPMALALVGKGTYYRHIADWPNTFKYFFEALKFYESIHNESGISTVNMEI
GTACIAQQDWNKAIVHLKKALPYYDVPESELRKSDRHSLAVIHNNIGTSYTRLKNFTEAH
NNFLKAYSYIKKNKDLQAESIILVQLAQSSSELGKLAESEDYLKRALDLCNDDISRQGVY
GSAARINYKNKNYDKAAEYGELSYSLAKKNKNINSQSGLTSLLYKIYKESGQYEKALKMH
EANIVIKDSTNLEASKNELAQQELKYQFEKKELQQKILQQKKVTAVELEAQKKMALETSK
NKLARQQLVYDFEKKQLNQKLAQEKKVAAIKLISEKKTAVKNNWLIAVSSVFLLSLLGAY
FYYRNNKQKQAITVLEKNQIKQKLLITQMNPHFIFNSIQNIRSLINNRQNDDAVNYLGKF
SKLTRQILEHSNQNYISLAEEVEMLENYLAIQQLLYENKFTFNIRIEENIDTESIFLPPM
LAQPYIENAIKHGLSNTTENGKIDIHYYLKEEKLYFEVTDNGKGFGTDEKISNHKSLAMT
ITKERLVSYTKNKDFIVQTNNVIASDGTIEGAKVAFEVPYIYES
>LONDMIMF_01250 Sensor histidine kinase YehU
MFTIKSSLFLKRIFLLFFLASLSNGFSQNKAVDSLQTYTKKDTIRVKLLNAAALKIIESD
TDKALQLYKESEQLSEALQYKKGKAYSLLMSGRAYSKKGDYPTSITYFQNSLEVYEDLKI
KVSVANCHLNIGRSYYYLTDFPKALEHLKTATELSEQSGKLRVASNALMIIAMIYNTQGD
YDKSLEYYKKSIVIDEKLGDKKGLAVTYINLANLYKQQNQPTLALEHYNKSLEIYKQFND
EYGVASNLNNIGTLYQEMENNKAALPNYYKALAIFEKLKKDKEVMGCLSNIGIILMSEKN
PKALAIFKKGLRLSQEANEAFAVAFFNNNIGGYYFMTENYDASLPYYEKAVKTYKKIGAQ
RELSNSYLNISRIYFSRKEYDKALQYAKEGSDIANELKLLSLQTDYSLLFSKIYYALKEY
KLAYESGQEHKELNDSLYKKETFDKLAEIKYEYAYKDTLTTAKKSVNTLKKTVAVSELQK
KWLIGGFIGLLIVLGFLLALLKIRRVKMQNQQLLLEQKLLITQMNPHFIFNSIQNIRSLI
NNRQNDEAVNYLGKFSKLTRQILEHSNQNYISLAEELEMLENYLTIQQLLYENKFTFNIH
IEENMDTESIFLPPMLAQPYIENAIKHGLSNTTENGKIDVHYYLKEEKLYFEVTDNGKGF
GTDEKVSNHKSLAMTITKERLTFYTKNKDFVVQTNNVIASDGTIEGAKVAFEVPYIYES
>LONDMIMF_01251 hypothetical protein
MNILKIKDYIFPINTEKSFIKEYNQEDLEPVCTVWDIWVQSDEAPFIEGNHSGNIRCEQM
MATQGNLQSLVGKTISVKDSHDYVTDEHLFTFYMFRHNGVKDNEITFGKIENNKVDVHWK
GIIEELGFEGEYNTNVPFELSCVLEIKQMVDNKDYKSPSTEVLRLIATADDDFDNNQELL
EAIIDITDEYRLDDEAYTAIINLLSSESFLETFEEETDSLEDFISNFTHFSNDRTTPVPQ
NISRKALKKWRKIDLLAEIIGDDE
>LONDMIMF_01252 hypothetical protein
MNTKKLLEKKDWHYYVYEENNSITLSVPIPKPNPGFDILYTLNESEKEKYVSTGIKSLEN
RIEDMKTNFSNYEMNSWR
>LONDMIMF_01253 hypothetical protein
MKLLYLVSALLCLNLSTAQNIKTLNKGRVVQKNYNVSVPYQDINGLVIVEAVIKGKTYNF
IVDTGALSAISQELYNELGLESVNGLDVGDSSNLRQNMKLVTLPPVQVGDITFADVPAVV
TDSSFFLECLGIDGFIGSNMMRNSIVKFSSKDKTVSFTDKLKNFSIDKKKSAGLLKDQFQ
SNPYLKIDIKNKDAEATETLLFDSGMVGLYDLSLGVYENALSQKINLFSLLYQAKGAYSL
GIHGVESQKEHFMLSIPELNFAGVTLKNITTTTTSDTKSRIGSKILSYGDVVVDYPGRQL
YFNPYQDGAIDLAEKNWPVQPVLKDDKFVVGIVWDAALNDRINEGDEILKFGEFDFSDMN
PCESFKLNRKPQTDTAVMVLKDIKTGEVKNVELVKK
>LONDMIMF_01254 hypothetical protein
MMKRVFIILLILTSYHIKAQSFKEKELSFSEYIGYVKKYHPLVRQSGLMLSKSEAELLTA
RGGFDPKIEVDYDQKDFKDKNYYSLLKSTFKIPTWYGIEIKAAFDNSEGLYVNPQNTTPN
NGLTSIGISIPLGQGLFINKRMADVRMAKVQLQLSAAEQKMETTDVIYEASLAYFNWKRA
FDEAELYKTYLEYAQKRYDGILRLIETGDKPAIDSVEAGILVKTRELSLKDAQLKLTKSR
LELSNFLWIDNVPVELEENITPEENVRNSVDISLNTNLQVNPSAALDSHPKIQSLQSKLS
MLEIERRYKANMLLPEMNVSYNYLSEPAYFTDYRFQDYKIGLNFSFPLFLRKERGSLQLA
KLKIQDGQLDLELERVALKNKILTYSAEIESLNQQQLTAAELVKDYTVMLSSEEKLFSFG
ESSLFLINSRENNVVSSRLAEINTENRLLSSIANLYKVLSIP
>LONDMIMF_01255 hypothetical protein
MQHLSTIKQLSDRPHYKILKRIIIGLCLLGIVLLFLPWTQNVSGNGAVTTLKPNQRPQTI
HTAIAGRIEKWYVQEGDFVEKGDTILYISEIKEDYFDPNLVKNTKQQVDAKKSALQSYDG
KVKSLESQMSALSKEQNLKIQQATNKIRQAVLKVKSDSIDLEAVKTQLKIANTQFDRSVQ
LNKDGLKPLTDVEEKRLKLQDAQAKIITQENKLLTARNELINAKVEIGRITAEYNEKIAK
SSSDKFTALSSQYDTEAQVSKLENQYVNYSIRNGMYYIKAPQSGFVNRALQSGIGETIKE
GMPIVSIMPASYEIAVETYVKPIDLPLLKKGDRVRVWFDGWPTIVFSGWPGMSYGTFGGR
IVAIENFISPNGKYRVLIAPDKNEAPWPKQLSIGAGVQTITLLDTVPIWFEIWRTLNGFP
PNYYQHSQNQNSKEK
>LONDMIMF_01256 Leukotoxin export ATP-binding protein LtxB
MTPAKRFFSLLRLDSKDVSQIFFYALFAGFISLSLPLGIQAIINFIQSGRVSVSWIVLVI
FVIAGVALVGILSLMQLRITENLQQKIFVRSSFEFAYRLPKIRFGETHTNVYPPEIANRF
FDTMSIQKGVSKLLIDFSSALLQIGFGIILLSLYHPFFILFGILLIILLYLIFKFSYRPG
LETSLSESKYKYKAADWLQEIARNTSSFRTILNFNFALDKNNTLVEGYLKYREQHFNIIR
RQFIQLIIFKIIITAGLLLIGGFLVINQQMNIGQFVAAEIVILLVINSVEKIIIGLESFY
DVLTSVEKIGQVSDMDLDDEKYSDVLPEGTEMTIAAENVRFHYPDAKKDALKNVNLQILP
GEKILLQGNNGAGKTTLIRILSGLLQPTSGVLSINDDSLLKIDPASYRARIGYIIQGETP
FEGTIRENITFNNPSISMEDLRWALDAVQLTDFVKSLPDGLDTKIFPEGRHLSSSNAQKI
LLARSIVHRPSILFYEDPTDRMDNEATKAIIKFIFSDKNPWTVVVSSASLHWEEGATRRI
TMENGKIINDQYFTPC
>LONDMIMF_01257 hypothetical protein
MKSLLAHLKIQVNPKIYLKDPQTSELGRKIVQESIKLIDEVGFDNFTFKKLGERIGSNES
SLYRYFENKHKLLVYLSSWYWSWMEYRIVFATANISDPSEKLRQAITLVTEQIKDDASTD
YIDESVLNRIIIAEFTKTFLTKEVDEENKEGFFLIYKQVINRIVAMIIDLNPDFPYPKSL
ASSIVEGSLHQHFIKDHFKTITDCNEKVSPTDFYLYLITSLNK
>LONDMIMF_01258 hypothetical protein
MKILLTGATGYIAQRLLPVLMAQGHEVICLVRNSRRFDTGKFTGIIPPKVLEADLLMPES
LTSGIPKDIDAAYYLVHSMSASGEFTSLEEQAARNFTEAIGKTKAQQVIYLSGIINDSKL
SPHLASRKNVEDILASGHVPLTSLRAGIIVGSGSASFEIIRDLVEKLPVMVAPKWLHTRC
QPIAIRNVVEFLAGVLLQKQTFDRHYDIYGPDILTYKQMLMYFASERGLQRRIITVPVMT
PKLSSYWLYFVTSTSYPLAKNLVDSMKVDVVAVPNNLAGLLKIQLISYREAIALAFGKIE
QDMVLSTWKDALGSERQARLYSTVQVPEFGVFKDVKTMKATDPQQAANRIFAIGGTAGWY
YADWLWSFRGFLDKLFGGVGLKRGRRNASHISTGESLDFWRVLYADREEMRLLLYAEMRL
PGEAWLEFTIADGIVKQTATFRPLGLLGRLYWYFVLPFHYFIFNGMIKKIAS
>LONDMIMF_01259 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MENIANTYIVAGASSGIGLELATLLIHHGFEVFGLSRTPGPLNGHKLYRHYSHDFLSDEP
LPDITVKAAGLVYCPGSIMLKPLARISKEDVNKTITLNATAALLFVQQYLANIKNTKDPS
ILLFSSVAVRTGMPFHTATAMAKGAVEGLTLAMAAELAPDVRVNAIAPSLTDTPLAAGLL
NTEAKIQAAKARHPMNTFGTSAEIAKVAFHMLTEYRWVTGQVYNINGGLGTIIK
>LONDMIMF_01260 HTH-type transcriptional repressor CarH
MNNIKTVFSIGDLEGLSGVKAHTIRIWEKRYGLLSPERSENNLRYYGLDELRKLLNVVLL
TGYGVKISKVAKMRTEEIEMMVGEIRVGREDIKHTLHLFKLAMMTFDQPLFLDATDHLLA
KMPFERVFNEYYIPFLQEIGLMWQAGTIQPAHEHFISCLIRMVLIQQISLCSRRVRKGTL
PAYVLFLPFGEIHELGLMFLQYLITSYGHGCVYLGSSIPLDSLSEVTKLFRGVTFITYMT
VLPEEKPLDEYVEALLEKVRDNHSQLWIVGRRVAELTMGDRDSLTLFTTLQDIAAKLS
>LONDMIMF_01261 Immunogenic protein MPB70
MKRNFFRKGIAILTLAFIPVVSSCSDDDNEQMPQGNTIVDIASSNANLSLLVDALDRADL
AATLDGNGSFTVFAPTNQAFTAFLQQKGFANLDAVPVPVLKEILLNHVISGAVTSSSLTT
GYVKTMAKGSASSTNTLSMYINTANGVVINGGAANGGATVTTADVMASNGVVHIVGNVID
LPTVTSHAIANPDFSILVQALTRNDQPDFAGILSGTQNSPFTVFAPTNSAFASLLTELNL
TGLAQIPQATLENTLKYHVVAGQNILSASLMNNMSVTTFQGSNFTVNTQGGASIRDANGR
VSTITATDVQASNGVVHVINKVLLPPM
>LONDMIMF_01262 Fumarate reductase iron-sulfur subunit
MDLHLKIWRQKDRQSEGKLVNYDLTELNPHMSFLEMLDTLNEKLILEGDEPVEFDHDCRE
GICGQCGMMINGIAHGPLKQTTTCQLHLRSFKDGETILIEPFRAEAFPVKKDLKVDRSAF
DRIISSGGFVSINTGQAPDATAIAVTHQTAEEAFDAAACIGCGACVATCKNASAALFTSA
KITHMVSLPQGKEERSQRVLNMVRQMDAEHFGHCSNTEACEVECPQGISVLSIARMNYEY
NRALFFKKK
>LONDMIMF_01263 Fumarate reductase flavoprotein subunit
MVLDSKIPEGPLEKKWENYKKTAKLVNPANRKKLDVIVVGTGLAGSSIAASLGEMGYNVK
SFCFQDSPRRAHSVAAQGGVNAAKNYKNDGDSVYRMFVDTLKGGDFRAREANVYRMAECS
LNLIDQAVAQGVPFGREYGGYLNNRSFGGVQVSRTFYARGQTGQQLLLGAYQALMRQVGK
KSVQLFSRHEMLDLVVIDGKARGIIVRNLDTGAIERHAAHAVVLATGGYGKIYYLSTLAM
GCNGSAIWRAHKKGALMASPSWIQVHPTSLPQSGDYQSKLTLMSESLRNDGRIWVPSNKN
ETRKANDIPENERDYYLERRYPAFGNLAPRDISSRAAKERIDAGFGIGPLKNAVYLDFSK
AIKEQGKEKIQEKYGNLFDMYLKITGYDAYQEPMMISPSAHFSMGGLWVDYELMTTIPGL
FALGEANFADHGANRLGANSLLQASVDGYFIAPYTIANYLSNEIHTGKIATTTPEFEEAE
NHVKQQIENFISIKGTKTVDYFHKTLGKLLYDYCGLARNEEGLKYAINEIRKLKQEFYKD
VKVSGLGNAMNSELEKAGRVADYFEIGELMCYDALTRNESCGAHFREEFQTPDGEALRND
AEFQFISAWNWTGENKEPELVKEPLIFEEVKPTVRSYK
>LONDMIMF_01264 hypothetical protein
MCLTGLFLSFFLLIHFLGNLQLFLPQEQAHLQFNAYSHFLSGNILIKLVSYILYTSIILH
AIDGLVITLKNKKADGNYQVENRGRASKWYSRNMGVLGTLILIFLVIHFQNFWYVYKFGN
PPLDGNGNKDLYIIVVTVFREWWYVLMYAISMIALCYHLIHGIHSAARTLGLYHSKFVRW
FQRVGIAYSVIISIGFALMPVYIFFTYR
>LONDMIMF_01265 hypothetical protein
MDNHIHELLYHYNEDGYEGYDLREVQLLEKIDLERVEKLKLLLHNDDQYIAYQAMLILLA
WSIPDGFKQLDRFISEKWDEIKNFEPHRLYNQDNVYDVITDALSVATLKGKSEQELYPYI
KYFLNIYGDHFFESNLKEFLLKKNCRPLLQEIEQAMQSALKNKKYYQASQLFPIIVHYDK
YGYNKFIDIFNDLISQDDRISYNIEEAKKSLIDYRKKD
>LONDMIMF_01266 tRNA modification GTPase MnmE
MVSQDTIVALATPSGAGAIAIIRVSGKDALTIAASVFESVSGKDLLKQKTHTIHLGHIID
GTKVYDQVLLSIFKGPNSYTGENVVEISCHGSTYIQQQIIQLLLRKGCKMAEPGEFTLRA
FINGKLDLSQAEAVADLIASENEASHQIAMQQMRGGFSNEIAKLREELLNFASLIELELD
FAEEDVEFADRTQFYDLLERIEFVLKRLIDSFAVGNVIKNGIPVAIVGEPNVGKSTLLNA
LLNEERAIVSEIAGTTRDTIEDELVINGISFRFIDTAGIRETKDVVESIGIKKTFEKIEQ
AQVIVYLLDSSGILDFRFQTSDSSKLDNVKIEVEKIRNQFPLKPLIIIGNKADTLTESQI
QNLKSEIPEILLISAKENTNIEALKEQLLSFVNTGALRNNETIVTNTRHYDSLLKALEEI
QKVKFGLQSNISSDLMAIDIRQALYYFGEITGQVTNDELLGNIFANFCIGK
>LONDMIMF_01267 hypothetical protein
MKRILFPTDFSEIADNAFLYALKMADSLEAEIILLHTFDMPIIDGAEIPINFKEMYDTLE
IQQMSHFKDYIPHLKQIAEKNGMGHIQMSHLLKSGDLTYAMQDVVQEHNINLVVMGTSGV
SGWFDSLFGSQTGEAITSLTVPVLSIPVEAKYKKIKTIAFTNLYREKDFEALQRLVEIAL
KFGATIKSLYVKKSFTSLSDEDIKAWEERCSAWPVQFFVIPHDDVKETIHDFINNQHIDL
LTMLTEKRGFWEDLFTSSLTQKISYKIEIPMLALHENGL
>LONDMIMF_01268 Succinate-semialdehyde dehydrogenase [NADP(+)] 1
MAIKTINPYNNKEIKSFEEFSEEAVEKKIAQADKTYQKWKTIAIKQRAELLMNVASLFRK
RKEELAKLITLEMGKLIAQSEAEVEMCASVYEYYAKNAADFLEDKPIEIKDGKAFVRYTP
IGIILAVEPWNYPYNQVARVAAPNIMAGNVIMVKHASNVPQCAAAIEEIFREAGAEDGIY
TNLFLSSSRIAKLAEDPRIVGLSLTGSEKAGASLAEAAGKNLKKSVLELGGSDPFIILED
ADLEKAVKNAVKGRFGNMGQACTSSKRIIAVGKIADEFLEKFKEKVTGLKVGDPMERDTE
VGPLSSEEAAQKIEKQVNDTVKSGAKVVLGGKRIDREGAFYEPTILTDIKPGMVAYHEEI
FGPVASFYKVKDEKEAIALANDSTFGLGGSVFSENIDRAVEVASQIETGMVFINEHVASR
PDLPFGGTKRSGYGRELSELGIEEFVNKKLIRISNR
>LONDMIMF_01269 hypothetical protein
MARSIIKIVPFFALFLLLSCSDDDGRKLGENGFTFNGGFHVLNNAFVTDENIVDETPGPI
SIVLSNVNLNDSTAVSNISKIYFDFNGVNLEAGTITDIPNYSIQTGGAYVQNAEDDNYTY
VDGTFLLKSSEAGLNATEKTVTINSVSENKINLTFQFTRTDGQTFSGKYNGLFTDLSSNE
>LONDMIMF_01270 DNA polymerase III subunit beta
MKFIVSSSYLLKQLQVLGSVINSSNTLPILDNFLFELDNKQLTVSASDLETTMSATLEID
STSTGSVAVPAKLLLEILKTFPEQPLTFTVEENSTIEISSNSGKYALAYAPGEEFPKSVN
LDDPSSTIVPAGVLATAVSKTIFAAGNDDLRPVMSGVFFQFSPEGLTFVATDAHKLVKYA
RTDVKASQVADFIMPKKPLTILKNILGTSEAEVTIEYNDSNATFSFDNYVLTCRLIDGKY
PNYEAVIPKENPNKLMIDRSQFLSSVRRVAIFSNKTTHQIRLKIAGAELNISAEDIDYSN
KAEERLTCDYQGDDMQIGFNSRFLTEMLTNLQSDEIMLEMSLPNRAGILTPVDGLEDGET
VTMLVMPVMLNN
>LONDMIMF_01271 hypothetical protein
MKASKKQSLKQLSIVIILLIAANIAGNFFFKRFDLTKDKRYTLSKSTLDMIKKVDKPLYI
DVFLDGQFPPEFKRLEGETRQMLEEFRAYNSNIIFNFTDPLADESKAEQFVSELNGLGFT
PTNIQSNKNGKKSMIQVFPWAIANYGTKSVRVPLLVNNFGNNADENISKSVQLLEFAFAD
ALTKLAVTEKKKIAVMKGNGELNDKYLADFVLNLKEYYLIGEFNLDSLANDPNKTMQNLS
HFDAAIIAKPTEAFTDSEKYILDQYVMNGGKTLWLIDKVAADIDNLQNESQSAMALPLEL
NLDDMFFKYGIRINYNLVEDLLSTPITARSENGDFPIDWLYSPIVKSAENHPINKNVNLV
KLEFANQIDTLKNNIKKTVLLKSSPQSKVVGTPVEISLHQFMDELNEAQYSKGNQTLGVL
LEGKFTSAFKNRVKPFKANKGLDEGKANKMIVIADGDIINYTYVNKKPLMNGIDQWTQQV
YGNKDFLMNAVNYLLDDTGLINIRGKNVELALLDEKKVSENYTFTQFLTVGLPILILAIF
GLVFTYLRRRAYSK
>LONDMIMF_01272 hypothetical protein
MKSILLREIKSFFGSPIGYLVIAIFLLLNGLFLWVFEGDFNIPNSGFADLSPFFTLAPWI
LIFLIPAVTMRSFSDEKKQGTIELLFTKPLGIWEIINGKFFGAFLLIVIAIIPTLIYVLV
VSNLGNPEGNLDFGSTLGSYFGLLFLIASYTAIGIFTSTLSENQIVAFILSVLLCFVFYF
GFDGISTYAESFDLIVASIGMDYHFKSMSRGVLDTRDIIYFISITILFLSLTAFKLKSLK
S
>LONDMIMF_01273 hypothetical protein
MFVRIVKLSFHEENIPAFLENFELMKEKIRNAPGNRFLELYQDKNNKCVFFTYSYWETEE
DLENYRKSALFDDIWTFTKKLFNDKPEAWSVDKLVTLE
>LONDMIMF_01274 Adenosyl-chloride synthase
MSIITLTTDFGCKDHFVGSLKGKIYSEYPEARIVDISHEIDLFNVSEASYIVGASYSSFP
KGTVHIIGVDSELHPETQHIAMQWNDQYFICADNGILSLLIQKIIPQKIVSINIHDRLGI
NATAMDVFVTVACHLARGGLLNVIGKEITKIKEVTELQAVVSQDNNSIKGYAIYIDHFGN
VVTNISKQLFTKIGKGRKYEVSFKNYKLRTILPNYSSIVNFEQNSIKFYEGKELAIFNEA
GFLEIAIYRSNPNSVGGASSLLGLKYRDFVSINFI
>LONDMIMF_01275 PhoH-like protein
MNERTIELVDIAPKDFWGAQDSHLETIRKYYPKLKIVARGTTIKAFGEKEVLDEFENRFQ
RLMLHFSRYNNIDDNVIERVIEGGSQQVERMADHDKILVHGVGGKIIKAMTPNQQLLVDT
VNKNDMVFAVGPAGTGKTYTGVAMAVKALKEKQVKRIILTRPAVEAGENLGFLPGDMKEK
LDPYMQPLYDALRDMLPNEKLEDYITKGIIQIAPLAFMRGRTLDNAFVILDEAQNTTHSQ
MKMFLTRMGKNAKFMITGDPGQVDLPRRTISGLKEALLVLKDIDGIGIIYLDDKDIVRHR
LVKKVIEAYKKIENHD
>LONDMIMF_01276 hypothetical protein
MKKTTPLFFMLLFGVMTSYAQYSCANAVPITSGFTQSNIVTPGLGNGSPGNWVTSAPDCQ
GTGGYSSTLNFNTTCFDDVFMSQGDDYLFKYTSGSVAGEKVYFEILIKTRYMGLMAFSDC
NGTVISGCLSGAYSGSFNTATGTLSVTVDNLAANQTIYFGVGIWADPKVLNFDVVNFTVT
PPGLGIDELSDEKIKMFPNPVADMLNISGLKEGSNVAIYNMLGQEVVKQSKLEKEQLDVS
RLTSGTYLVKVNTDRATETYKIVKK
>LONDMIMF_01277 Phosphoribosylaminoimidazole-succinocarboxamide synthase
MNNTITTTNFNFPKQKSVYRGKVREVYNINDELLVMIATDRLSAFDVVLPKGIPYKGQIL
NQIATRFMEMTSHLVPNWLIASPDPNVAVGHLCEPFKVEMVIRGYLSGHAAREYAAGKRE
ICGVAMPDGMKENDKFPEPIITPTTKADNGEHDEDISRAAILEKGIVSEEDYEVLENYTR
VLYNKGTQIAADRGLILVDTKYEFGKTKDGKIVLIDEINTPDSSRYFYKEGYEERQERGE
SQKQLSKEFVRQWLIANGFQGKEGQQIPEMTEEYVESVSERYIELYENILGEQFFKADIS
NIHERIEKNVLEFLNK
>LONDMIMF_01278 hypothetical protein
MKKSIVYLGIALFAFGNVAIAANTNSLTENTVVVKAKNVSPLCQAIAKGDVETVKRMIEF
GTDVNATSNGMTPLMFAARYNKVEIVKLLLESGAKVNTKDEKGFTALKHAELSNATEAAE
LIKAHKKA
>LONDMIMF_01279 Putative aminopeptidase YsdC
MASKSILKKSSLDFLENYLNNASPTGYESGGQKIWMDYLKPYVDTFITDTYGTAVGVINP
EANYKVVIEGHADEISWYVNYITENGLIYVIRNGGSDHMIAPSKRVNIHTKNGIVKGVFG
WPAIHTRNRGKEEGARIDNIFIDCGCETKEEVEKLGVHVGCVITYPDDFMVLNENKFVCR
AIDNRIGGFMIAEVARLLHENKKKLPFGLYITNSVQEEVGLRGAEMITKTIRPNVAIVTD
VCHDSTTPMIDKKIEGDTQIGKGPVVTYAPAVQNNLRELILDTAEEKKIPFQRLASSRVT
GTDTDAFAYSNGGVASALISLPLRYMHTTVEMVHRDDVENVIKLIYESLLKIKNEETFTY
FGK
>LONDMIMF_01280 hypothetical protein
MKTINYFFLLFLLSNTLNAQVDKNDEYLNQPDTIKVVQLDEVLILKGEIDEESKKNFLIL
QRRVQRVYPYAKATAERLVALEKGMAKLKTEKEKKKYFKIVEKYLVNEFEGQLKKLSSRD
GQILVKLIHRQTGSTTFDLIKEQKSGWKAFWANKTARVFSINLKAQYNPYNVPEDFLIET
ILVRAFEEGRLPKQNPGININYQELAKSWNEKVAKSKT
>LONDMIMF_01281 hypothetical protein
MSMNVSSVFSRPSRSGCKGNTLFESRKPFRKKIFIFFLPEALPFLRTAKIWTFSVSRKLF
GIFFPESRYRISSMNVALIAGAKVKTFFETRKFIFGNFYSFFKPASCQYLPMNFAFIAGA
KVAPFSASASFIVTFFQTFLQGAGKQKSIDELFLDFSQAGSQKSEKTGMRNCKQGYF
>LONDMIMF_01283 Carbonic anhydrase 2
MELEKVFRNNEKWIAEKLQKDPDYFINLSKGQNPDILYIGCSDSRVTAEDLMGVSPGEVF
VHRNIANMVISIDLNVMSVLNYAVNYLHVNHVVVCGHYFCGGVKAAMQAEDLGVLNPWLR
NIRDVYRLHKNELNAIEDETAKYNRLVELNVQEQCVNLVKTAEVQKAYNERGLQIHGWVF
DIHSGKLIDLKLDIDRIMKNIMEIYNLGHD
>LONDMIMF_01284 Putative lipoprotein LppC
MKKLNFILVVSLLFSVTLFAQKTFTLSSKDLGGEATKIQEFGGFGCSGDNQSPQLSWKNA
PEGTKSFAITMYDPDAPTGSGFWHWVVFDIPASTKELVTNAGVQLNLVPKGAIQSITDYG
IKGFGGPCPPKGHGFHQYIITVYALKTDKLGLDENTNPAVVGFNLWNQTLAKASIVAYYK
R
>LONDMIMF_01285 Virulence regulon transcriptional activator VirF
MNSITIPDALLIDTSLPVQIFDYSSSRKISKQQIILNQNTFSFLLEGYKDVIFDNSSLSI
NNSKFVLMKSGHCLMTEQLSDRNNYRSLLLFFSDTALSKFIESIEFTNTDFQKNSSVHAF
EYDEFIRNFIQSLTVILKLSGKIRNNLLEVKFQEIMLYLTELHGTHFLNSLISNNNDSTR
KFIRTIESNQLNKLTLKELAFLCNMSISTFKREFEKQYAQSPVKWFQNKRLEYAHHLISK
EHKSATEIYFEVGYENLSSFIQAYKIKYGTTPGQHHKS
>LONDMIMF_01286 hypothetical protein
MEQKKNEQTPTPFEQTYFHGTKADLKIGDLIKVGYTSNYGQQKNAKYIFLSATLDAAIWG
AELAFGEGQERIYLVEPTGEIEDDPDLTDKKFPGNPTKSYRSTQPFKVVGEVTIWQGHPA
DQVKTMKDHLEKLKAQGVNSLND
>LONDMIMF_01287 Alkaline phosphatase 4
MIVHYLWASQRFYHMDRRKFFKNGSLFTIGTAVLNPFQGNANVLDFETINKNKKAKNIIL
LVSDGMSTGTLNMADLFLNRKYGKGSNWIQLYKDNRVSRALMDTASASSIVTDSAAASSS
WGGGFRVNNGSLNVGPDGKPHLPIWQKFKKTGKMAGCVTTVPITHATPAGFCVNSKSRNS
QDDIAEIYLELGFDIMMGGGKNYFSPQTRKDKKDMFAAFEAKGYQIAKTRSEMFNTSNDK
PVLGVFSDDALPYSVDRNSNDDLKKTVPTLAEMAQKAIDRMKGHKNGFVLQIEGGKVDWA
AHANDIAALINDQIAFDEAVKVAIDFAEKDKETLVIITTDHGNANPGVIYGKNANDNFDS
IQKYTQTNEWILNQISPNFSISQVKEVIEKANGHTPSDEEAKTILSYYDGLHKEEGLYNY
KKLPYKAYSEIQQKTNSVGWISMDHSGDYVELAMFGPGSELLKPFVKNTDLHYLMLQAAE
VENKF
>LONDMIMF_01288 Diaminopimelate decarboxylase
MQTKDLLQLLEEFGSPLYVYDAAKIQSQYTRLTDAFSKVGSLRINYAVKALSNISILKLL
KEMGSGLDTVSIQEVQLGLHAGFSPDKIIYTPNGVSFEEIEEAAHLGVQINIDNLSVLEH
FGAKYPSIPVCIRINPHVMAGGNANISVGHIDSKFGISVHQMPHLLRIVENTGMNINGIH
MHTGSDILDIEVFLYAAEILFDTAKHFSNLEFLDFGSGFKVPYKKDDIETNIEELGKKLS
KRFNAFCKEYGRDLTLAFEPGKFLVSEAGFFLAKVNVVKQTTSTVFAGIDSGFNHLIRPM
FYGSQHHIENISNPKGKERFYSVVGYICETDTFANNRRIAEIKEGDVLCFRNAGAYCFSM
SSNYNSRFKPAEVLWYEGKGHLIRERENFEDLIRNQVVMEFDKSYELVSKN
>LONDMIMF_01289 hypothetical protein
MILLSGNNDDDNTNDTSLQGTWKLIEVNGTIAGIRHQFEPGTIQWNFNTSNHTFTVVNNN
TDDSKQDVFESGNYGYFIESHDVSPGTCNKNIFLEGVNYGCYSTTAASLQINQGEADGLI
LKFIR
>LONDMIMF_01290 Succinate--CoA ligase [ADP-forming] subunit beta
MDIHEYQGKEILASYGVKVQRGYVANNPQEAVAVAKQLTAETGTGWHVIKAQVHAGGRGK
GGGVKLAKNLQQVEELAEQIIGMQLITPQTSAEGKKVHKVLVAEDVYYPGESETSEFYMS
VLLNRGKGRNMIMYSTEGGMDIEEVAEKTPHLIFTEEIDPTVGLQAFQARRIAFNLGLSG
NAFKEMVQFVDSLYKAYVGSDASMFEINPVLKTSDNKIIAVDAKVNLDDNALYRHPALAE
MRDIREENPIEVEAKAAGLNYVDLDGTVGCMVNGAGLAMATMDLIKYAGFEPANFLDVGG
TADAKRVELAFRIILKDPNVKAILINIFGGIVRCDRVAQGVIDAYKNMGDSINVPIIVRL
QGTNAELAKEMIDNSGMPILSAVQFQEAADQVKAALS
>LONDMIMF_01291 hypothetical protein
MIDFLTIEYLKSGNNRQREAYQTLMQHAVLEKLSEFSPVLVGTIPISIDISSSDLDIACC
WTNKNAFLNHIKDTFGNKAGFQISEIIINGHETIISSFILDNFEIEIFGQAIAIEKQYGY
RHMLIEYKILEQQGEEFRKKILELKERGYKTEPAFALLLDLQGNPYEALLQLE
>LONDMIMF_01292 hypothetical protein
MNNNDIFKKLRVALQLRDDQIVDILQLVDFRISKAELGAFFRAHDHPNYMECGDQVLRNF
LNGLIIHLRGTKENPTNAMDVINKNKAQLKSATKKVTPKETPKKLIVKSPAKNFKPKKVE
SKFNPVEKVKFNNGKNKKA
>LONDMIMF_01293 Carbohydrate acetyl esterase/feruloyl esterase
MSIPKIIPLRYLFTIFLSCLFLNLKAQESTASSQVSTFEIESPQLKTKKKIWVYLPKNYL
TSTKKYPVIYMHDAQNLFDAKTSFAGEWNVDETLDSLKAQVIVIGIEHGNEKRVDELTPF
PNKKHGGGKADDYLDFIVNTLKPYVDKNYRTKTNASNTVIFGSSLGGLVSYYAVLKYPEV
FGKAGVFSPSFWFSDEIYTLTEKSEKIKAKIYFLYGDSESDDMVIDAQKIKKLLDHNRCY
CLKLDKTVIVKGGQHGEKLWREGFAKAVLWLL
>LONDMIMF_01294 hypothetical protein
MNTYEQKLSLLAEMIAFAIVDGKLHDREYQFLSIVAQELKVKSEDFKNLFHEELKALPIK
SEQQRIQQFYRLALLMHCDGVLHEKEVIAIKQMGVNMGLNPFAIKRILKAMEESPNGMID
PEMLIEIFKEQLN
>LONDMIMF_01295 UvrABC system protein B
MKFQVVSDYKPTGDQPQAIEKLSKGIKDGERFQTLLGVTGSGKTFTMANVIQEVQRPTLV
LAHNKTLAAQLYSEFKQFFPNNAVEYFVSYYDYYQPEAFIPVTGTYIEKDLSINEELEKM
RLSTTSSLLSGRRDVLVVSSVSCLYGIGNPVEFQKNVVSLERNQVISRTKLLHKLVQALY
ARTEAEFNPGSFRIKGDTVEVFPSYGDEPFRIHFFGDEIEEIEAFDPKTSLVLEKYTNLN
IYPANMFVTSPEVLNGAIWEIQQDLVKQVDYFKEIGKHLEAKRLEERTNFDLEMIRELGY
CSGIENYSRYLDGRLPGTRPFCLLDYFPKDYLMVVDESHVTVSQVHAMYGGDRSRKENLV
EYGFRLPAAMDNRPLKFEEFEAMQNQVIYVSATPADYELEKSEGVYVEQIIRPTGLLDPI
IEVRPSLNQIDDLIEEIQQRVELDERVLVTTLTKRMAEEITKYPAKVAIRCRYIHSEVDT
LERVEIMQDLRKGLFDVLIGVNLLREGLDLPEVSLVAILDADKEGFLRNTRSLTQTVGRA
ARNINGKAIMYADKITASMQKTIDQTNYRREKQINYNKEHNLVPKALNKKIDSTLARNSV
STQYFEKQAMKAAEPESQYLTKPEIEKKIREARKAMEKAAKDLDFMQAAKYRDEIKALQE
KI
>LONDMIMF_01296 GDP-mannose pyrophosphatase NudK
MTNPAIKIKSSEILSDNWYILKKIVFDYQKKDGSWETQSREVYDRGNGATILLYNKTQKT
VILIRQFRMPTFVNGNETGMVIEACAGLLEEENPEECIKRETEEETGYSLTQVRKVFQAY
MSPGSVTEIIYFFVAEYSKDMKVSEGGGLSTEHENIDVLEIPFEKAMQMIETGEIKDAKT
IMLLQYAKINNLLE
>LONDMIMF_01297 Thiamine pyrophosphokinase
MSSHHIVRDDQEPALIIANGASCSSELMGQLLEWSPLVIVLDSAIERVLPLGIKVDVLLG
DFDNGLDIEYYKALQFPLEIVYAPDQEKTDLEKAFDYLVEKGHKAVNVIWATGRRADHTI
TNMTNIVRFQDKLKIVILDDHSKIFQLPKRYEKWYPKGFPISIIPVGTVHGITSTNLDYL
LHDETLTMGYRTGSSNHAAQDGIVTIEHKEGDLLLMECFD
>LONDMIMF_01298 Isocitrate dehydrogenase [NADP]
MSDKAKISYTITDEAPMLATHSFLPIVKAFTAPAGITVETKDISLAGRIIANLSDFLTPE
QKINDNLADLGKLATTPEANIIKLPNISASVPQLKEAIKELQAQGYNLPEFPENPQTEEE
KAIKAKYAKVLGSAVNPVLREGNSDRRAPKAVKNYAKKHPHSMGAWSADSKTHVASMSEG
DFYGSEKSVTIKDADTFKIEFVGNDGTTKLLKDTSPLKAGEIIDSSVMSMKALKSFISKE
IEDAKAKGVLFSVHLKATMMKVSDPIIFGAIVDVFFAPVFEKYKDLFAELGIDTKNGLGD
VYAKIAGHPKQAEIEAALNAVYENGPAIAMVNSDKGITNLHVPSDVIVDASMPAMIRTSG
QMWNKDGKGQDTKAIIPDRSYAGVYVATIDFCKKNGAFDPRTMGSVPNVGLMAQAAEEYG
SHDKTFQMTADGTVKVINSKGEILTEQKVEKGDIFRMCQVKDAPIQDWVKLAVNRARLSD
TPAIFWLDENRAHDRQLIEKVKLYLKDHDTNGLDIKIMNPVEATKLSLERIKDGKDTISV
TGNVLRDYLTDLFPILELGTSAKMLSIVPLMNGGGLFETGAGGSAPKHVEQFIEEGYLRW
DSLGEVLALGASLEHLGQTLNNSKALVLSETLDQATEKFLDNDKSPARKVGQIDNRGSHF
YIALYWAQALAAQNKDAELKATFTEIAKELTDNEAKINEELIGAQGKHQEIGGYYKPDFN
LTDKAMRPSETLNKALAKLA
>LONDMIMF_01299 hypothetical protein
MKKIALLFCLAILLSCSNDDSSQPHDTTADVLLKKTITQSNGTSYETLYKYDGKKLLEAR
SVRENKKFDYNGNNISKISWYTNPDTDNTLTQTVEFEYLPNGKLKKFVQESDNPLTVEFT
YVGQDTVNFVARAYRSSYFVGYFTMKDDEISEYVYLNGGRPRPSVRYTYDNKNHPLKNVT
GYNKLSLYHYFYNSVHFNGFTTNVGSSKNCISNSLIQDPSVVEVMNTYEYNENGFPKAIN
KDSNSAADYLFY
>LONDMIMF_01300 50S ribosomal protein L19
MADLMKFVKDEFVTKKDFPEFGAGDTITVYYEIKEGEKTRTQFFKGVVIQRRGSGTTETF
TIRKMSGSVGVERIFPVNMPALQKIEINKTGKVRRARIFYFRELTGKKAKIKDKRR
>LONDMIMF_01301 hypothetical protein
MKEGDGKYKFADSSFKFADYIISSIKKPFLSNPVVCVKVIL
>LONDMIMF_01302 Response regulator rcp1
MQVRKENLMVMSKNIYLADDDCDDVEFFKDALNEITFDFHLTISSNGQELLDKLHNSCLL
PDIIFIDLNMPIMDGFEALSLIKTDEVLNSIPTVIYSTSSNMNHITKAYELGASSYFKKP
SDFKSLKNELEKVLLIDWKNFIQSIE
>LONDMIMF_01303 tRNA (guanine-N(1)-)-methyltransferase
MRIDIITVLPELLRSPFEASIMKRAIDKGLVEVHFHNLRDYTTNKQKNVDDYQFGGGAGM
VMMIQPIDDCIAKLKSERNYDEIIYMTPDGETLNQGMANKMSSLENIIILCGHYKGVDQR
VRDHLITKEISIGDYVLSGGELGAIVLSDALIRLIPGVLSDETSALTDSFQDNLLSPPIY
TRPSDYKGWKVPDILLSGHFAKIDQWREDKAFEHTKNRRPDLLDR
>LONDMIMF_01304 hypothetical protein
MNSIFHPEGNKKLIERIETLTPITHNEWGTMNVSQMLVHCQMPIKVAFGELKIKVGFMGL
LFGKLAKKSVTSKNPIKRNLPTAKEFVVKGHPDFEQSKTELISLISKFANEGPKAIKNPK
HPFFGNLTTEEWDYMQWKHLDHHLKQFGA
>LONDMIMF_01305 putative peptidyl-prolyl cis-trans isomerase
MENGIYAKFNTPKGAILVKLTHDKTPGTVGNFVGLAEGNLENKSRPQGKPYYDGLKFHRV
IPDFMIQGGCPQGTGTGGPGYQFDDEFHPELKHDKPGVLSMANSGPGSNGSQFFITHVPT
SWLDNKHTVFGHVVEGQDVVDAIAQGDEIQSIEIIREGDEAKKWNAIEAFRVFEGSRAKR
EAQAREEAEAKMEKLAAGFDKTESGLRYKMIQKGNGKKAENGKVVSVHYTGQLEDGKVFD
SSYPRKKPIEFPLGKGHVIEGWDEGIALLQVGDKARFVIPSHLGYGSRGAGGVIPPNATL
VFDVELMDVK
>LONDMIMF_01306 hypothetical protein
MRFLFFILFLFSLSSKAQVAQHCGYDFTSYFVLNVHEAGKKENIPGLKITIINGLGLDLL
NINNLYSWTSAGKPLTFTANYKVDDKGNRITSDSKVSKERWFFPFAKDNYLLSVKNTFPG
DDFSLKVEDVDGEENGGHFKTQIVKLNSFNMYVLCSSKAREVQFGPKMNRPIDIVLEKK
>LONDMIMF_01307 Thiol-disulfide oxidoreductase ResA
MAKTPSNMLPLGTSAPQFRLKDTNSNFYYSFDDLKGKKGTLVMFICNHCPYVIHALPEIL
MVANDYRVQGIGIIAISSNDVEKYPQDGPEMMTEFAFKNSFDFPYLYDETQEVAKAFDAA
CTPDFYLFDSQDKLFYRGQLDDSRPSNGIPLSGSDLRNAIDALIYNRSLPEIQKPSLGCN
IKWK
>LONDMIMF_01308 putative chaperone CsaA
MNSELQNNLSWSEFERVEMRVGTIMEANDFPEARKPAYQLVIDFGAEIGIRKTSAQITKH
YEKADLVGRQIVSVVNFPKKQIGKFMSECLVLGAVGEEGSVILLSPDFKVENGLRIG
>LONDMIMF_01309 hypothetical protein
MKYLSVLFLFLSNCLLAQTKIAGTYDTKTQKFTPEDKNYNIQYFFKGYASVSDGKSSGII
DSTGTVIVPLIYDMTVSGFTENRAMVKKENLYGFANKSGKEVIPCIYDEAKGFSEGYAWV
RKGEKWGRIDASGKENIPFMYETAGFSSEGMTRVRKDGKFGALNQKGQEVVPCIYDEIGF
FKDGLAAATKGSKRGYVDKTGKTVVPFNYDIADDFKGGIAIVRNHNKCGLIDKTGKVVVP
LIYDGMGSFDSDQSGLARVQIGNKWGFINKKGKEIVPCIYIKANFFSEGLALIVTDKGES
GYVDATGKLIIPFTKYTRAENFRNGKAEVRKGNDVFYINKQGQTVN
>LONDMIMF_01310 hypothetical protein
MLEKEEIFSKVLRAGRRTYFFDVRATKADDYYITITESKKFTEEDGSFHFKKHKIYLYKE
DFAAFSEILEEMTSYVLNHKGEEVISERHQKDFKKEFYTEKATAETTATASFTDIDFDDI
>LONDMIMF_01311 putative multidrug resistance ABC transporter ATP-binding/permease protein YheI
MKELQYLNKYFTKYKYHFLLGIITTIAAQIFSLYTPKLIGNSINALTQKQFDSETTKNIL
LENIVWVLVTTIIAGVLTFLMRQTLIVMSRYVEFDLKNEVFRQYENLSQNFYKKNRTGDL
MNRISEDVSKVRMYVGPAVMYTINTFIRFAVVIVQMYIISPKLTLYTLLPLPILSYLIFK
LSNEINIRSGIFQQNLSQLSSYTQEVFSGIRVIKAYSLEDKSQGEFSELSEESREKSMKL
AKTNALFGPLMILLIGMSNLVVIYVGGMMYINGSIKSIGVIAEFILYVNMLTWPVASLGW
VSSMIQEAEASQKRINEFLKIQPEIKNKTLESSIIEGKITFNHVSFTYEDTNITALNKVS
FTIQKGETLAILGKTGSGKSTILNLISRLYDIKDGEITIDNHNIKDLNLHDVRNSIAFVP
QDAFLFSDTIMNNIKFGKENATEAEVIEAAKKAVVHNNIMGFNEQYQTVVGERGITLSGG
QKQRVSIARAIIKDSNILLLDDCLSAVDTETEEAILNNLLEICKDKTTILVSHRVSSAKN
ADKIIILDNGQIIQQGSHNQLVNQEGYYKDLYLKQLSEKEIL
>LONDMIMF_01312 Leucine dehydrogenase
MITEVAKASELHKIDPVFGQLSFDNHEQIVFCNDKDTGLKAIIGIHNTVLGPALGGTRMW
KYTNEWEALNDVLRLSRGMTFKSAISGLNLGGGKAVIIGDSKVDKTPEMMIKFGEFINSL
SGKYITAEDVGTTTPDMDLIRDVTPYVTGISQSRGGSGNPSPVTAYGVYMGMKAAAKYQF
GSDNLEGKKILVQGTGNVGETLIDHLTKEGALVQITDINEAKLKEISQKYGAQIFTGEDI
YSAPVDIYAPCALGATINDTTVNKIQAKVIAGAANNQLANEEIHGKILKDRGIAYAPDFL
INAGGIINVYAEIVGYDSAEALRRTENIYNTTLEIFNFAETNSITTHQAALSIAQKRIDD
RKKENAK
>LONDMIMF_01313 N utilization substance protein B 
MLNRRHIRVKVMQSVYAMHQNNSDNLEKEEKFLFYSIENIQDLYLIMLSSLVEIQKREED
FLDKSSKKHLATPDERNPNKKFINNQVLQLLLESNSLSMALENRKINDWHLNDDYIRILL
EEIKNSDLYKEYMSNRVNNFEEDKRFVVSVFTELIAPNEKLYEYLEDNKLTWIDDIPLVN
THISKQLKAIKSTDEDFSVPKVYKDSEDKEFTKNLFRKTVLNEPELSKEFIDKTPNWDSD
RIAEVDTIILKMAICELLKFPSIPVKVTINEYLEIAKEYSTPKSSIFINGILDNLVKDYQ
TANKLNKTGRGLM
>LONDMIMF_01314 hypothetical protein
MIRKTVGLLAIASLVLTVSCKDNASSKIEASNVQETAMREESAGKVPVMSFTEKEFDFGT
IKEGDKVEHVFTFTNTGNADLIIADAKGSCGCTVPEYKKEAIKPGETSTMKVTFDSTGKP
GKQQKSVNITANTASGNELLTIKAEVTPKAGGIGVTNH
>LONDMIMF_01315 hypothetical protein
MEQYANLLLFGGMFVVMYFFMIRPQQKRAKAEKEFEAGLKVGDKVITKSGLHGRISELAE
RTIVLETMSGKLKMERSAISLELSKMANEAK
>LONDMIMF_01316 hypothetical protein
MEEKHTWDKTNQWEEELDYLKSIIIRTELVEAIKWGAPVYTLNNKNVLAIGGFKNFFTIW
FYNGVFLKDTKKVLVNANEGVTKALRQWRFQSKEEIDEKLVLSYIREAIENEKAGLTSKP
SKKEAIVSEFLKNQFHSDSELKKAFELFTPFKQREFLEYIESAKQEKTKITRFEKIKPMI
FDGIGLNDKYR
>LONDMIMF_01317 Peptidase T
MQHIIDRFISYVTIDTESDPNSNTTPSTEKQWDLANKLVEELKAIGMEDVTIDENAYIMA
TLPSNVDYDVPTIGFVSHFDTTPDFTGANVKPQIVKNYDGGDIVLNKEQNIVLSPGYFKD
LLQYKGQTIITTDGTTLLGADDKAGITEIVTAMEFLIQNPEIKHGKIRVGFTPDEEIGRG
AHKFDVAKFNADWAYTMDGSQIGELEYENFNAAGAKITFKGKSVHPGYAKGKMINSMLIA
NKFLSKLPKDEVPERTKGYEGFFHVHHLNGTIEETVLELIIRDHDKKKFEKRKKLIHKIT
KKINKKFAEQFGGDIAVAEVKDQYYNMKEKVEPVMHIVDIAEKAMKELEIKPIIKPIRGG
TDGCQLSYMGLPCPNIFAGGHNFHGKYEYVPVESMQKAVEVIVKIAELTAAKK
>LONDMIMF_01318 hypothetical protein
MQKKLQQKFTNIFQKYATDSSLEKKFWQEIEKQYSSKKRHYHTLLHLENLFGELEPIKEK
LEDWDTIQFSVFYHDIIYKSFKSNNEEESASLAAERLREIGYPEEKIVKCKNQILATKAH
NFDDNDTNYFTDADLSVLGKDWATYAIYYQQIRKEYSLYPDFLYNNGRKKVLEHFLDMES
IFKTEYFRNKYENQARLNIEKEFQILDK
>LONDMIMF_01319 hypothetical protein
MTRPKLIGIAPQLIVPDVVQTAEYYRDVLGFEIIGYFLEPPVYAMVKRDEFQIHFGKADA
DFEINKNAYYKKGCTDLIIWVPEIDAFYEELRSRNAIIFQEITKRVYGSREFIIQDCNGY
LITVGD
>LONDMIMF_01320 hypothetical protein
MKFEELRPILRTEELDETIDFYTKILDFTCDERNDDWGWASLHRDAVVIMLAKPNAHEGF
AKPAFTGSFYISINDVDAFWEKLKDRANICYPIENFEWGMREFAIYDNNGYILQFGQDIP
DYN
>LONDMIMF_01321 Dihydroorotate dehydrogenase (quinone)
MYKSVIRPILFGFDPEKIHYFTFSTLRFLNKIPGAKSVFKSLYQVDDKRLEREVFGLKFK
NPVGLAAGFDKDAKLYKELSNLGFGFIEIGTLTPKGQEGNPKKRLFRLKEDSAIINRMGF
NNGGVFEAVERLKKNNGVLIGGNIGKNKLTPNEDAVSDYEICFDALYDYVDYFVVNVSSP
NTPNLRALQDKEPLTQLLQTLQQKNTTKPKQKPILLKIAPDLTDEQLLDIVDIVNDTKIA
GVIATNTTISREGLISENQKETGGLSGKPLTKRSTEVIRFLSEKSNKSFPIIGVGGIHSA
EDALEKLEAGASLVQLYTGFIYEGPALIKKINKKILSKK
>LONDMIMF_01322 Hydroxymethylglutaryl-CoA lyase YngG
MEQVKIIECPRDAMQGIKAFIPTEKKVDYIQSLLRVGFDTIDFGSFVSPKAIPQMADTAE
VLSKLDLSQTNSKLLAIIANTQGAEMASKHKEIQYLGYPFSISENFQMRNTHKTIAESLV
TLREILDIANATDKEVVAYLSMGFGNPYGDPWNVEIVGEWTEKLSNMGVKILSLSDTVGS
STPEVIDYLFSNLIPKYRHIEFGAHLHTTPDKWFEKVDAAYKSGCRRFDGAIQGFGGCPM
AKDDLTGNMPTEKMLSYFTAEKVATHTSPMSFESAYNEATKIFTVYH
>LONDMIMF_01323 Aerobic respiration control sensor protein ArcB
MPRTVISFLIVFIFLVLPQTKSYSFNLQKDSVSYYLAESKKIVYSDFKVAEKLLKKAETV
AKKSNDPILLADVAHNYGASYYMVGSYDVALKKFMEALLLYEENNHTLGIAKCLIGQGLI
QQGIGRNEEAIKLFRGANILISDLKDAVLESKVYFNIGISQIELKDYESSYKNFHKAMKL
AVRNKDANMEHLVFNRLGNIHYLKNDLDSSVYYYQKVITDSYQPNEWEKSFALTGLSEVY
IKEGNYKKAQEYGLKGFEAAKIVQAKWDIARAAEILSIAYKNENNYEMAFKYLAICKSYN
DSLFNDTKLKEINLLQLKRKEAENEKLIAKNEAAQHKLKNTRLFSVSVILFMLYLLTIIY
QYTKNSKIKEKLYNELEIKNRDIENQKVLITAQNHNLSELNQTKNRLFSILSHDLRSPIA
SIQQVLGLLKEGEISNEELKVLAEHLITQVDSTSIMLNTILHWSMTQLDGAKINKENIDL
ESAVRDSIAALELTAKAKEINIVHINSHEDVIIDADKGHVHIILNNLISNAIKFTPLAGT
IEIRYSEDDIFHNVHITDSGAGISQVKIEEILNFDKRMVSEKGTGFEEGTGLGLLLVKQF
LSDNNGKLDIVYHQNQGTEFIAALPKAKNF
>LONDMIMF_01324 Inosine-5'-monophosphate dehydrogenase
MKAHSTKVIGEGLTYDDVLLIPNYSEVLPREVSIQSKFSRNITLNVPIVSAAMDTVTESA
MAIAMAQEGGIGVLHKNMTIDQQAAEVRKVKRAESGMIIDPVTLPLTATVGDAKQVMREY
SIGGIPVVDENQILKGIVTNRDLRFEKNNSRSILEVMTTEKLVTAGEGTTLEVAEGILQK
NKIEKLPVVNADYKLVGLITFRDITKLTQKPIANKDRFGRLRVAAAIGVTADAVQRAGAL
VAAGVDAVIIDTAHGHTKGVVGVLKEVKKSFPELDVVVGNIATPEAAKYLVENGADGIKV
GIGPGSICTTRVVAGVGFPQFSAVLEVAAAVKGSGIPVIADGGIRYTGDIPKAIAAGADC
VMLGSLLAGTKESPGETIIFEGRKFKSYRGMGSVEAMQEGSKDRYFQDVEDDIKKLVPEG
IVGRVPYKGELLESMLQFVGGLRAGMGYCGSKDIQTLQETGRFVRITASGIGESHPHNVT
ITKEAPNYSR
>LONDMIMF_01325 Glutathione-regulated potassium-efflux system protein KefC
MENSFFLQAIIYLAAAVICVPIAKKIGLSSILGYLFSGIIIGPFVMGFIGSEGQDLMHFA
EFGVVMMLFLIGLELDPYKFWKMRRFILGMGSLQVGLTSLVLFTCSSIIFDWSWQTALTI
SLALSLSSTAIVLQTLKEKGMLQTSVGRSSFAVLLFQDIAVIPILALIPLLASSSHIIPE
EDLHHSLISNLDGWLQTLIVTGVIATIYFGGKYIIVPLLHIIAKTRLQELFTASALLLVL
GVSYLMQIVGLSPALGAFMAGVVLANSEFRHELEGDIAPFKGLFLGLFFIGVGASINFRL
IIDNPAFILIFGFILTMIKFFVFLGIGKLYNKKIDQNFIFSIGLSQAGEFGFVIMSFSMQ
LNIIPNMLANQIMAIIAISMIATPFLLLINERLIDPYFGVKEKDSNTYDEINENNKVIIA
GFGNFGSTIGRLLKTNKIPATILDLDSDRVDSLRKMGFKVYYGDATRLELLKAAGCENAE
LFIAAIDNPTVNLIVIEMLKKHFPHLKILARARNRNDAFEIIDMGIKNIYRENLYSAVHL
GIDALVYLGHRRYSATRQGQRFIKYDEDAIFRLAKKRHDKKAFMISAMEEIEMQEQLFKS
DLLNPMGPDDHAWDSENLKKDT
>LONDMIMF_01326 General stress protein 14
MSKNKILILFAHPLFEKSFANKILTEHIPDSHSITFHDLYETYPEFDIDVKHEQELLKQH
DIIIWQHPMYWYSCPPLLKQWIDMVLEYGWAYGKYGLALQDKVIFQAITTGANAENYSAE
GLHLFTIPELLRPFSQTAKVCRMEYLPPFVIHGTHKMDEQTCHEKAASYAQLLMYFTNNE
VDIRKIQEFPYMNDWMQSKNI
>LONDMIMF_01327 Adenylosuccinate lyase
MTTLTELNAISPIDGRYRSKTYSLSHYFSEEALIRYRVLVEIEYFISLCQIPLPQLKTVD
ASLFDSLRNIYKNFSADDAKAIKEIEKTTNHDVKAVEYFIKEAFDKLGLSEYKEFIHFGL
TSQDINNTAIPLSTKEAFQEVYLKSLIELTAKLKELSTEWADVPMLARTHGQPASPTRLG
KEIAVFVERLEEQMRLLFNVPFAAKFGGATGNFNAHHVAYRQIDWKQFGKDFVEGTLGLQ
HSFPTTQIEHYDHFAAFFDALKRINTILIDLDRDIWTYVSMDYFKQKIKAGEVGSSAMPH
KVNPIDFENSEGNLGIANAIFEHLSAKLPLSRLQRDLTDSTVLRNIGVPMGHTIIGFEAT
LKGLNKLLLNAAKFEEDLEKNWAVVAEAIQTILRREGYPNPYEALKGLTRTNEVMNKESI
HNFIKTLDISDAVKAELLVITPSNYLGI
>LONDMIMF_01328 NAD-dependent protein deacylase
MKKKLVVLTGAGISAESGIKTFRDSDGLWEGHDIMEVASPEGWKKNPVLVLDFYNKRRQQ
LKEVLPNAAHIILAELEQHFDVHIITQNVDDLHERAGSTKVLHLHGELLKARSTQNHRHI
IEWQDDLFLGNLDPNGYQLRPHIVWFGEVVPALDEAVRITHEADFFAVVGTSLQVYPAAG
LVDFAKPGTPLYYVDLNPARITNLSNELEIIPKTASEGMKILKEKLLRLA
>LONDMIMF_01329 putative HTH-type transcriptional regulator YybR
MKAKERATENKICPLEIAVNSISGKWKIPIVWQMNEGKKRPSEFLRGIAKVDRRVLNQQL
KEMEKDGILTKETFNELPPRVEYSLTELGEKLVLVLWQLNDWGKLLLEKEPLTTETQTI
>LONDMIMF_01330 hypothetical protein
MAEIKRKGARSAKDIPAAILEQLNSGRIETVNLTEWLAVDQRILLENLLEEKGRTSYLAP
VLETIEQLKKQTVNTINEAIGKGLYRVASQAGDSRFLEEIATHPSDLVRCWATYYIASDK
NHSVEEVLELIKPFAADNHFGVREISWLSVRKLISADISESIKILSEWTKSNDENVRRFA
SEATRPRGVWCEHIDVLKQQPELGLPILEALRSDKAKYVQDSVGNWLNDASKSQPKFVME
LCERWRKESPCRETDYIIKKALRTIENKT
>LONDMIMF_01331 hypothetical protein
MDKQEYIESGILELYVFGQLEEPEFSKITEMAKNDEDIRNEIISIEKAIINFSESVAPFL
SSENYEKIRASLMLKHRIAAEEKPKPGIALYLGWAASILLMIGVGYQYVQLEDKKDTIQT
IETEKSKLQQSVTDLNLQNKNTEAALSVIRDNSNTAVAMEGQEVSPLSYAKVYWNKTTKA
VHIDASGLPEPPEGMVYQVWALKLNPLTPTSIGLLDNFKDNTKRFFAIEKAEEAEAFGIT
LEPAGGSPSPTLGQLYTLGKV
>LONDMIMF_01332 ECF RNA polymerase sigma factor SigK
MSQEELLQQIYKKDDRAFTLLYDMYSKSLFSVIYNLIRDHEEAEDILQETFVKIWKNIES
YDESKGRFYTWILNISRNASIDRLRSKGFNNRQKNLSSDNFVHLLDESNKMNHKIDTIGI
REFVKKLKPKCIQILDLLFFKGYTQQEASEELQIPLGTIKTQNRNCINDLRNFLKV
>LONDMIMF_01333 tRNA (guanosine(18)-2'-O)-methyltransferase
MKEKVWELDYLSYLEGFLTESRKEKFLKILEQRTNHFTIALEDVYQLHNTSAVMRSCEVF
GIQNLHVVEEKYGKKIDKEIAMGAQKWVDVNRYNSNTECLKTLKEKGYQIIATTPHNDSC
LLHEFDITKRSALFFGTERGGLSEEVMEEADGFLKIPMVGFTESLNISVSAAIVIQDITS
RLRQSDVDWKLSEDEILSRRLAWAKNSIRDIKRIEQRYMEMNNISG
>LONDMIMF_01334 hypothetical protein
MRYFAVFFFFFVTSFAFAQDTKISATVINDNTLLPLADVSVINLNKVKGTTTNASGYFEL
VAEVNDTLHISTLGYKSIKVRVTNDWFKTKSTKIKMTEKAYALEEVVINQYNLTGYLEID
YKIIPIKENFRYSISGLSQGYEMGRYSPGAFSKVVGSIFNPADMLYNFFGKKPTELKRLK
EMKKDDAVKNLLASKFDRETLGALLGVTPNEIAEILERCNYSEAFIKTANDLQIMDAINE
CYEEYKILKGKK
>LONDMIMF_01335 ATP-dependent RNA helicase CshA
MNKFEQLGLSESLQRAILDLGFENPTEVQEKAIPLLLAQDTDMVALAQTGTGKTAAFGFP
LIQKIDADNRNTQALVLSPTRELCLQITNEIKNYSKYEKGINVVAIYGGASITEQAREIK
RGAQIVVATPGRMQDMINRGLVNISQISYCVLDEADEMLNMGFYDDIVNILSTSPDDKNT
WLFSATMPAEVARIARQFMSEPLEITVGTKNSGSATVSHEFYLVNARDRYEALKRLADAN
PDIFSVVFCRTKRDTQAVAEKLIEDGYSAAALHGDLSQAQRDGVMKSFRGRQIQMLVATD
VAARGIDVDNVTHVINYQLPDEVETYNHRSGRTGRAGKLGTSIVIVTKSELRKISAIEKI
IKQKFEEKPIPSGIEICEIQLLHLANKIKDTEVDHEIDNYLPAINNVFEALTKEELIKRM
VSVEFNRFINYYKKNRDISAQSAGERRPSGEGASREGGAVRYFVNIGSRDNFDWMSLKDF
LKETLELGRDDVFKVDVKEGFSFFNTDAEHADKVMDVLNGIEMDGRRINVEISKNDGGGR
NSSRRDHNGRGNRSGGGGGFRSDRNSAPRREGGFRSDRGGSSDRPGRRSEGFSSDRPKRE
GGFSERFPRRSENRSEFPKARRTRRD
>LONDMIMF_01336 Sensory transduction protein LytR
MQAHKALIIDDEVNNIALLKHFVTKYCPSIEVVGEALTISEGISEIREKEPDILFLDIKL
NEGNSFEILDQLDDLKAQVIFVTSYDEYALKAFKYNAVDYILKPIIIEDVILAVNKAIKN
IEQQDFFDFGKLTSFSGEPVSFSENKEYIAIPSLDKVDMVKSSQITYIEADNKYTVFHTI
EGKKYTSSKNLLSFEETLDKTRFFRIHHSFILNIEHLVTIIKKDGSYCEMSDGTLLPIAR
RKLEDFHRFLKIKN
>LONDMIMF_01337 Sensor histidine kinase YehU
MHLRITLFFLLFTVCVSGQDYALKEAQIRDGFNTYLFSSSAFVDNSRFVWYATNRDGDFY
RFDGKNKLRYQFYKDGNSHDDNFYISKNAWIQDHNNTIWAAELDKAYIITADKLQVDRIQ
YPTEKLSSRSFIAKDEMDNLWISNGSRYLIKITPDRKVTQVTHLLLKGKHEIEIIRVLNN
GRIIAKSGYNLFYIDSEGIHFFINIHTLDKEINPEFTLFENGKIVTENSSGYYKYNNVPY
KYIYLKGLNIQIFNYPYDETCYLGSCNWSSRALVVDSKLYLADDSNLFINQINKKTNEIT
TIDTLHFKKQISISNNKHYPNFIWISGYDELFKLLIIPNNFKRKLQFDDKQYSTRGIVSD
SKNNLFIATYEGLFKQEKDKKPEKFLIKGEKKGSYDIIVLDKNDSILWGSQEYHWIKKIN
LLTHTIKNIELPKGFKVEYMKEKLPDELWIGSNKGLYILNKKTEEINPYVEDGYYLGNIP
VLSLTEAKDGKKWIATRDGLFLKEKGKDFINFKNINPAFDYKSLLTLHEDEKGNLWIGTD
GRGIVFLDPKTNWFKNLTQSDGLSNNTICGILESKEALWFSTYYGLTRFDKQKGFFALYY
KEDGLADNEFNLRSAYKKNESAFYFGGLNGIVEFNPGKIELRGKHPHTIFLYSSTYFSSD
RNKNVTDYLSLNKKTINLPYNKNYFSAVFSINELFYIEKNTYLYKIEGLRNEWIDAGTSG
LVELPSLPPGNYVLRVKGKDAKGIETLNEIKINLHIEQIFYKTPLFIILMSLLALGSIIY
FFIRRNQRQKRFFEREKEIKELKSSALRAQMNPHFVFNILNNMQSVLILKGEAEANKYFG
AFSKLFRQTLDISRQELITLKSEIEYLNNYLLLNNLQLNDELKYSVNVQNSVGDTNTIFL
PGMLIQPFVENAILHGLSKKQDKKLTISFSMEEGYLVVVVEDNGIGRIMAAKNAVNKKES
HKSWATTIVNERINIMNYSNNNAKTVILKIDDLEKNGMPCGTRVTLKLQQP
>LONDMIMF_01338 Adaptive-response sensory-kinase SasA
MPKLFPSKNILFLALFLLCISYSHSQTQEIQKLQKSLPHVKDSISYVNKINRIGMLMHMK
NPDSSLIYAMNARTVAGRIRYKKGAVDAENVIGISLALKGLSNEAVKIFGQVLADYEKMG
DKQNTVQLYMNFASLQMQIGNQLRAVEYNRQALKIGKSIPTDSIMSRVYANYCMANPQLS
EDSVQYYLERSNKIGEKLNDQSLLIGNKQILGIFYMVRGARDKALPLLESSLQEAKAAKL
ERLQLQGLNAMAEFNANNPELALKYMEEQLAIIESNGYDELKAPVLFSMLRFAKMSGNIE
KERELSEKMIAAQLKRQASLEKFIGDYVHYYQIQENNKELERSQKASRQTIIILTVFSIV
CGILLLLLFRAYKKIRNDSKKKAALYEIIDKKNASLSEADAMKSNLVSILAHDFRSPLIS
TLYMVRLLERNTELTESEKESFYLTISNDISGTLENFDATLQWIKRQLGEFRINFETVDI
RSLLDEAISGYNAQLNEKGITVINNVPEGILATSDKEMLQFVNRNLLSNALKFSPKGKTI
AVDAFKTDSEIVISVKDEGPGLSHTQIEKLFSISSKGGSMHEGAGIALSFSKDFIVKLGG
RIWAENRNSAGSIFSYAVPSNPVDKESIQSKIVA
>LONDMIMF_01339 hypothetical protein
MAPEKAKTEREKKSVLNYSREGNRNLLYNIATNVVNDN
>LONDMIMF_01340 hypothetical protein
MNIFVGNLSFKTSEEQLFDLFASYGEVTSVKIITDKFSGNSRGFAFVEMPEQEEAQNAVD
NLNDSEFDSRTMAVKEAMPKENDTRSRKKHY
>LONDMIMF_01341 hypothetical protein
MADSFFKKENNKKKQKKQQDKISRREERKTNNNKGKELDDMIVYVDINGNFTSLPPHAQN
REEDAAKARQSKKAEMITEDTIFSGIVSYMSEKGYGFITEENSNENIFFHYGQLNEAVKK
YDVVHYKKEKTPKGYQATDIKSNK
>LONDMIMF_01342 Cold shock protein ScoF
MQEGTVKFFNESKGFGFISQDGSNEDIFVHSTGLLDKINENDKVVFDIEKGQKGLMAVNV
KRR
>LONDMIMF_01343 3-oxoacyl-[acyl-carrier-protein] synthase 3
MTSKIIGVGNYIPSQAITNLFFDKHHFLDQAGDALKQDNATIASKLKEITGIEERRYAHP
NQVASDLGFLAAQSAIEDSGIDPETLDYIIFAHNFGDVRTGTIQSDMVPSLASRVKHLLK
IKNNFCVAYDVLFGCPGWIEGMIQAHAFIKSGIAKRCLVIGAETLTRVVDAHDRDSMIYA
DGAGAAILETSNDESGIKSHLSGSFTLNEKDYLYFGKSYNNENCPNIRYLKMDGRKIYEF
ALLNVPSAMQKCLDDSGYSINDLSKIIIHQANEKMDEAIVNRFYKIYKTPVPENIMPMVI
HKLGNSSVATIPSLLTMILKNELPQHSIKENDIVLFASVGAGMNINAFVYRF
>LONDMIMF_01344 Response regulator rcp1
MKNLNEKMHIILVDDDAEDRMIFEEAFSQLNSGNQLLMFQNGLEVLNYLNENETVPDIIF
LDLNMPIMGGLETLREMRKNDRYRQLSVVIYSTSSAEKDIEDTLIAGANVYITKPNNFET
LRDTIAKVIHVNWQFLSSGLDRDTFVFVT
>LONDMIMF_01345 hypothetical protein
MLKINSKDMSSTSLFYIETLLLLGIHDRIPFELYNLGCNQAFEEEDTSVNIAVFQLIMKE
LRIETPEREKYLKAFLMGYLDGFKISFLSSKN
>LONDMIMF_01346 hypothetical protein
MSQLKTICLLLIFYSIVSCDRRKDGIESDIKNPPTSADTVLPATKPESDSIQNDATRLST
GKDSVKGEITPPNAKNQ
>LONDMIMF_01347 putative oxidoreductase
MKQRDIYTLALSDKVILVTGGTTGIGRATAHLLASLGARVFITGRHQEQLEETLRDGKTI
YPDAMLSGIASDLSSEEGIERVFQAMESEFGTIDILVNNAALSANSAAEGNYKEWSYILN
TNLLGYIACANAAIIRMKTKNGGQIVNVGSMSAEIRETGSSVYVATKSGIQGFTAALRKE
LNPDQIKVTLIEPGAVNTDMQPGSGEERQEKVDAMEMLDACDIAEAIAFCLSRPSHCDIV
SMQIRPLKQII
>LONDMIMF_01348 Small-conductance mechanosensitive channel
METLNQYFQKAVHTTTAFLPHLLSAIITLVVGFIIIRLFRKFMMRLIEKKRFDATLLKFV
MDVAVWTMRALLFVSIITKLGVETSAFVAAIGAAGLAIGLSLQGSLSNFAGGLLIILFKP
LRVGDYVEAQGEAGTVAAIFIFSTKIITGNNQSIYLPNGALSNGIIRNFSKEKLRRAEIT
LSVNHDSDISLVKALLFNVIRSDKRILQLPEPAVMIKDITADALLLSVLMWTTNEDYGWV
VSDFLETIKKSFKEQGISNPAPKREIIIEIKNYRDTKEK
>LONDMIMF_01349 hypothetical protein
MIAWYEIIARLLFAALLGGMIGFERERKDWAAGIRTHMIACMGSTLVMLVSCFGFSDILG
YPNVELDPSRVASSVVIGIGYLGAGIILILKRGNIKGLTTASGLWATAAVGLSIGGGMYI
TGLVATIITVLILYVVQKLQNKKSQVREHRMTVRLYKKEEGTLLLEKLISYHLNFSLLAM
EKKNKKYTVKARFVGAKTDVLHLTNELKLLPVVQKIRFK
>LONDMIMF_01350 hypothetical protein
MEKFREAIIILFASYEIKYSLEKGRSKDKTEHFIFVQSFLQEFEENLESFAQKYFKDNNF
SPEAIAEGKRYMEKIVEKLASKV
>LONDMIMF_01351 hypothetical protein
MENLINEEREEGKVAKAIEKQTSKLPSDLFLYAGLGAMGISATLKIMGMKHTSLFFGQWV
APFLLLGIYNKIVKVEGHDKADE
>LONDMIMF_01352 hypothetical protein
MDKKFTSWTAMAQSDIETAELIASTLQSGFNFELFNTGDSLWIVAVWPDKTRTAFRIAFA
LNGHFENVVVTDRKGLLQIRANTRLGKYNTEVSFPEKKGHLVRYTTTFEADFSFCIPFWP
RDIVPLTKTGSFENTSAKIHTSQIGTRSGLIYFSLTRPKTGSVFYFQNLSALSDYCEATQ
TSIGETVGGEWPEIGFQLPVSQENPLPAGKKVVLTDAFVLLSETVPVSEPEITQSFIENL
ANVYIHLPKPDTEYHDWLSLSQKAMDDLQHNKGCWTQAGGIPYLNAYLCDYKTPPEIMVQ
LSVLLPLKEFSDWKKIKPELYNELKCTLPEFYDDRIKSIVRWLPALSEELDNSEEQKKEM
VMDSWYLHHPLMNLARLALAGDKISKKLLLKSVDFAVKVARHFKYEWPVFYKMDTLEVIR
KETEPGRGGERDVAGSYAHLMLLVWKLTDNPLYFREAEKAARKLEGLGFDIFYQANNTAF
AATALLELFKLTGKQNYLESSFACLAGLFKNMRLAECNYGNTKHYPNFFTVFPLNEAPYS
AAYEEVEVYAALYDYVLSSEGITMPSGLLLLLSEFIKYSLSRMPYYYPPMLPRDILSDEV
RTGELQHSLWIPLEDLNDGWEKAGQVGQEVYGAGLPFAVVSRQYYRLEEEDLLFFVDYPV
KGFRKISNNLHFHTLGSSLMPCHVYIIGHREHKVSTHTDTVASKSIAPGLMQYAITGNSK
VKISW
>LONDMIMF_01353 hypothetical protein
MMVTYKNSSGQSGIKAYEIVPEGIAVQFMDGDIYLYTYASTGKEAVEKMKKLAVSGKKLA
TYISQNVQDKFEKRLR
>LONDMIMF_01354 hypothetical protein
MKTNKILKNLFFTGTIILFAFVFNSCKKDKNIDTKEIAQEENEEKFDNSKQDEKDSRYLV
EAAETDSKEIEIGKLAQEKSTDPDVKAFGKMMVDDHTQAAGDVKKLAARKNISLPDSMTE
EARKEYDDLNKKSGLDFDKKFAEMMVKGHEKAIDKMTEAAEEAADEEIRYWATNKIPTLT
EHLEHAKSLKEKIDNRKK
>LONDMIMF_01355 hypothetical protein
MMKNSDKYIFLLILIACMVMILSCRDNNTNRYESDGASQKETFTNEGTISSGTKDTMNKP
GTTVGPTQRDSAALEEGTRRSD
>LONDMIMF_01356 Phytochrome-like protein cph1
MKKKTDEGYMSHLENELRQRNAELEKNRELLQATLDSSLDMVQVFEAVRDEKGKIIDFIW
VLNNYTSETYYGDVIGQSLLKNNPGVVHTGIFNSFVEVTETGIPQQYEKHYVNEQFDGWF
YQSVVKLNDGVATSTSDITARKLADDRINALNKELSQKNRELESLNSELTTFNNIAANDY
RETLQSLYMYLEFIIKTDAPNISNAGKANIRKAQGAIQKLKLLTEDIVSFSRIPAMDSNL
TSVDLEELLNALLSDMAQKISEKEAIITRSGIFPAITGYPLLLSLLFYHLIDNALKFLPK
GKNPEIKISSSVCSEGACKGMYEICIEDNGIGFDQNQAENLFAIFFRLHDRSIYKGSGIG
LAVCKKIMDLHNGHIVAISDGNGAVFKCYFPV
>LONDMIMF_01357 Chemotaxis protein CheY 
MKTSDKLMQIILVDDDTDDRLLFEEAFNELDSGENLTIFKDGREILDYLYTTTEIPDIVF
LDLNMPILGGIDILREIRKDEKYQKLSVVIYSTSSAEKDIEDSLIAGANIYVKKPNDFET
LKETLRKVIKMNWQFQSAELNRETFVFVV
>LONDMIMF_01358 Sugar transporter SemiSWEET
METITIIGTLAAIFTTIANIPQAYKIIKDKTSKGVSAGTYLVLLIGTSLWTAYGILKSDW
PLIITNSISSLLSIVILILHQIPDRKIKKVNKALSNSGGKK
>LONDMIMF_01359 Formamidopyrimidine-DNA glycosylase
MPEGPSIVILKEEARQFEGQEIIFVSGNSKIDQNRLLGKKIISFRSWGKHFLICFKDFTV
RIHFLLFGTYRINETKDAPVRLNLTFPSGEINFYSSSVQILEGDVNLHYDWSADVMNESW
NPKQAREKLKNIPNKQICDALLEQDIFSGVGNIIKNEVLYRVRVHPESLVGKIPSKKRDE
IIKEARNYSFQFLEWKKKFELKKHWLAHTKKTCLRCDLPILKKYTGVKKRRSFFCENCQI
LYQ
>LONDMIMF_01360 hypothetical protein
MKKKNIYIGCSSYNTADWKGVFYPENLPKTKWFEYYCEHFTTYELNSTFYRFPTLKSLQS
WQDKTPENFLFSIKAPKQITHIHRFKECRQLIEDFYMVSSEGLAGKLGCVLFQLPPGFDY
SASGLELIVNSLNPEFKNVVEFRNQSWWIPEVFEVLKQRNITFCSVNYPKLPSDIMVTSD
IGYVRFHGNPKLFYSAYDREILEKAQNEILSTNKFKEVFVYFNNTASTAGVLNALEMKEL
LKSNRV
>LONDMIMF_01361 putative zinc-binding alcohol dehydrogenase
MKALVFHKPKDVRVDTVPDPIIEQSRDVVLRVTSTAICGSDLHIYNGFFPQPRNLVLGHE
FMGIVEEVGKSVRNLKKGDRVVVPFPISCGTCHFCNLNLPTHCENSNPEHYGPEGELLKG
KGGALFGYTDLYGGYSGGQAEFVRVPYADYGPRVVPENLTDEQALFLTDIFPTGWSAIDW
AALKGGETVAVFGCGPVGIMAMKSAWLRGAGRVIGIDTRQYRLDMAGKTANVETINAKDN
DAVEMIRDMTGGYGADVCVDAVGMEADQSFLSKAKNLIQGEVGTMKVLGFCMDAVRRGGT
VTVVGVYGSPYDNFPLHQWFDKGIKLRGGQAPVHNYIDHLIDLVATGKVVLEDIITHKVP
LSEASKMYDVFSKREDNCVKVVLKP
>LONDMIMF_01362 hypothetical protein
MDYLIKRKDSCKNKVKHRILHLFTAIFLLLLFSGIAHAQIQQKPELEVFKKPTRKKSRLK
VSQTFQLSHEIPEGSGLCVWKGMLWTHNDSGEPVLFSLDTATGKIIEKYLLPGVANNDWE
DLAQDEDYFYLGATGNNTEKKDTVEILRIGKQDLIRQKPSIEKIRFTWPETLTDGKRKKI
NFNCEAITVVGDSLYLFTKEQKRGRRTRIFTLSNRPGLSIAKYKSTLKTRILITGASYNS
GTKQLVLCGYNLLLRPFLLVFPETENNDFFGGNMKQIKLRIPFHQVEGVATSDGKRYYAI
NEKWHLYFFHTRQKLHVIELE
>LONDMIMF_01363 hypothetical protein
MKKRIHNQTSLFGPDYAYLVVLSPPDDIKADIALIKKELNAIADITEKNVHSIAHITLTD
RRTDDEALPEIIKELTSGSKPFPIRVQGWDYFDHKNSVTVYLKINNPEPIIELMISVKSK
ARTPHISLAKKIPYKTFEVLRPYLEKLEYSAEWTCKEVTVLKKLMSKKELGFKDRVSIPL
Q
>LONDMIMF_01364 hypothetical protein
MKKDNQKEQSKKEKPAANKTAAKATDDKDTARNQYSGSGDFGSDDNETTNTKDGQLNKGK
TIVDSQVPENGDSRYNNQKANSAHGPRSKTSPGGDTNDGQ
>LONDMIMF_01365 Gamma-glutamylputrescine oxidoreductase
MNNFSDALISSGDNVSFWIDTTPIISFKKPESPAKTEVLIIGGGIAGLTTAYLLSKAGKK
VIVVEDGFIGSGETGRTTAHLSNALDDRYYYLERVFGKEAAALAAESHTAAIDEIEKIIR
TEHIDCAFRRVNGYLFLHPSDKEENLDKELEASQRAGLSTTLLPKIPTMAGGSDQRCIVF
PNQAQFHILQYLSGLAKAIIRYGGIIYTEAHAESITKEGATVNGFAFRADHIVIATNSPV
NDVLTMHTKQHAYRSYVIAGKIRKGLLPYALWWDTGDTDSKWVSQPYHYARVAEYDSEND
LLIVGGEDHKTGQGDEESLSESARYDKLEAWTRERFPMLGDLSYRWSGQIIEPVDSLGFM
GKNPGDENIYIITGDSGNGMTHATLGGMIITDSIRGIPNRWQELYSPSRITLSTAIDFLK
EAGNMAAQYMDWIGSPDLQNIADLEPGQGGVLSHGIRKIAVYRDYDNKLSAFNAVCPHLG
CIVQWNNDEKSFDCPCHGSRFTHEGKVVNGPSIENLRKIRIT
>LONDMIMF_01366 CinA-like protein
MAIESILECSKLIAGKKLKIAFAESATAGWLASEFSFVPESGEIFLGGIVCYDVCVKEEL
FGIPKETIEKYTAESSEVTELLAERLVKFFRNDISVAITGLTSPGGSETPEKPVGTMFIH
IKMQDKKYIAHREVFTGSSKEIISQTINKVGLLLVELLKD
>LONDMIMF_01367 hypothetical protein
MESKNKKKKDFFETFASKVAHATGSTAAFLIAFAIVVTWGICGPVFNYSETWQLVINTGT
TIITFLMVFLIQKSQNKDSLAMQLKLNELLASSKLASNRLVDIEDLTEDEMLIINRYYSK
LNELAKKERALHESHSLDEAKEGHQYKIRLNKPKNSKRSVTKKSQNPKKT
>LONDMIMF_01368 hypothetical protein
MVKASGQNQTRKVLFLGNSYTYVNDLPYIISELAASVGDVLVYDSHLIGGYTLEDHFAST
VSLNKIRSQNWDYIILQEQSQRPAFIIPSGFMNGFNNLTTFIKANKPCAQVMSFMTWGYK
NGDTQNCSANPGVCTYDGMQTQLTNRYVSMSDLFESEITPVGVVWKHIRENYPSIELYQA
DGSHPSVAGSYLAACCFYATIFRKNPGQISNNYGLDANTASIIRNAAKTLVFDQMEQWYI
GRYVPVSDFDYVIGTGHNEIKINRNETTYRNSFIWDFGDGTTATDRMPTHSYSADGTYTI
RLTSYKCFLGQNIESVFERTVNFCAHTNTIYPNLLLCPDEIGTLWTQPADSYQWYDETSP
INGATNQSLQVEPGRAYRVLTTVNGCSEMSSPMLVDSYMNIEDCRLRLPENKAVEATIFP
NPVKDILTIRTNKTLQEISIYDMTGKRITVNQVSPYAYDVSGILNGMYFLRISLENGSYV
STKFIKE
>LONDMIMF_01369 Thiol-disulfide oxidoreductase ResA
MKKLITFALSLFLFSCAKETAPEYTIISGKMTNTEDGKFFIRGNSFQKEITVKEDGSFTD
TLQLGYNGTYEIGRQNIYLQKGKNLSFEANFEKLNDITFTGDLAAENNYFAKKGKLQEEI
IGADAKTLFSLEETDYLAKINELAKKRLTLLGGSTFTVSDFKDKEVQNLNYHRQYLLKIY
PDYHGVFTGNENFKVSENYPNPNETIDFDNAADFDFSTPYRQLVLTHFDDEIQKEAEKNG
NFHDVIITKIKSLKSQNIKNALAESFSYEVALSNQKMESFYNGLLSISTDENFKKELTEK
YNKLKKLTKGNPSPKFNYDNIKGGTTSLDDLKGKFVYIDVWATWCGPCMEELPFMKEVEK
KYHDKNIAFVSISVDEKKDADKWKKVVTQREMQGIQLHADKAFKSQFVTDYAIDGIPRFI
LIDPNGNIVSGDAPRPSEEQLIKLFTELGI
>LONDMIMF_01370 hypothetical protein
MNVAKALIFMVRFQRMYKLKNFPSTLKIIRPN
>LONDMIMF_01371 hypothetical protein
MSEEPSYHHYRLPVPQEFGDVFSHFYSAENNSTSILSKTLLPSFQTIMVFNFGARASLVS
KQGTAIEMDKCIVLGPIKQAFEYSLPPGAKILVANFKDDAFYRFFGKASLSGHLPVHPDE
AMEENCFTCLWHQLNSIDKVTERIDRILDFCRPYLRLQNTTSTLLVKLKSGPVNPIKSVA
EEMGQSERNIQLKHKKHFGYSAKEINRYQRFIKAIDFIEQAMASASEVDWFEIIGQCGYY
DQSQLIHDFQHFIGLSPKTFVKFQQDICQAI
>LONDMIMF_01372 Glutathione-regulated potassium-efflux system ancillary protein KefF
MKHLIIYAHPNGTSLNSLFRQTVEKTLKQQNHEVMVRDLYQLGFDPVLSLEDMEGQRKDM
VSEQVSREQEYITWADAITFIYPIWWTGMPAIMKGYIDRVFSYGFAYRYDQGIQKGLLTG
KLAYIINSHGKSAAEYGETGMDNALKLTSDKGIYIYCGLNIRQHFFFDRADRATAEMVSE
WTSKIIDAYA
>LONDMIMF_01373 hypothetical protein
MTQETKPIFNSAVYNPYLLMLYRSVKKIIKYGFYIVLLYFAFEAFMAWE
>LONDMIMF_01374 hypothetical protein
MKKIIFLLLTVGTFYCKAQNSVRFDYDNFESQVLAYNPNQNSNVSKKDFDYGMMILNETK
TATKNRPENFNLADYFNVFIAFLKLEESNENIKIAFEKFKNANGSCEYCITFENSLNKNP
KFDVVRAEYDKKMEECKLISTQKNFDAKEYSLKNNLDYNLVQQIYQIDSNDRKYRDTKDF
LTKQKELDNQNQKIINELHKKYKTYIGKSLVGEKFESVMWAVIQHSNIEMMEKYLPVVHI
AVKEKELSSTPLKMLIDRYYGLKYGYQVFGSQSSDFGFKMADEKKRKEIKLKYGIE
>LONDMIMF_01375 Purine efflux pump PbuE
MKKYAYIGCLGFIAVITTEFGVIGILPQIAEHYKISIDKAGYLLSAFALVIALTGPFMTL
LVSGFDRKKIMLTSIAIFLITGFVSSFSPPFWVLMLVRILPAFLQPVYIATALSVAVSKA
DDDKKNELMSIVFSGVTLAMVTTVPFATWLSSLWSWEYSFMIQTVVSFIALSVIYLMLPS
MPVSKKKSYGTQLKILTQPAFILSTAANFFMITAWFSTYSYFADYLNRAKGMDETMISYI
LFVFGIVGVFSTWLAGKMLNRNVTKTTAFFLSGTLVIPVLLYFSNGNLLLTIAVIAIWGF
MYSPSFLNASTYMISSVPDSLEFANSLATSFGNLGVTLGTTLGGWMIVSKGVAYNPWIGF
VFGSLAFLMMILRSFYEKSDRQIIAH
>LONDMIMF_01376 Carboxylesterase NlhH
MKKLIGILMIAGLISCKTINSNNKMNKIELTPELSKIVDNLQKIHVFDGKNPLDISRKGY
ETMAVQLGGKKEMVRMIEEFEIPQKNHKIPVRIYRPNGNESKSPAIVYLHGGWFVSGSFE
THDAIVRQLANATGAAIVFVDYRLAPENPFPAGFDDARSATEWIIANADYLNFDKNKIGI
IGDSAGGALAVGVSTQLARQLRFQVLIYPATDNKLNTKTWEVYENGPIINKQEGIRAWNW
YLSSPKDLHNPLAVPSLIKDFKNTPPTLVVLAEHDPLRDEGQQLAENMKASGVQVKILDY
KEMVHGFMHMGAVLKETGEAVQQIAAFTKENSK
>LONDMIMF_01377 putative HTH-type transcriptional regulator YybR
MGKRKENSTNSINEQYIITECDLTYAICKIGGRWKLLILCKLEHGKLRFSEIRNRITGIT
ERMLTLQLRELEKAGLVKRTVHAEVPPRVDYELTEIANELVPIWKQLSDWGNKHKKLIQE
EIPAGM
>LONDMIMF_01378 hypothetical protein
MFRHTGKGRTYLHNLRLASLLSAVAGIVNIVGVLGLNTLTTNVTGHFAFLSEEFVTKNYS
LVWVYLFYVVFFLAGAFVSSILIEIAARRNVIHSYALPISLEIIVLLAVSFTDTPMDNDQ
FPSKVFLSCLLLFAMGLQNSLVTKVSQSVVRTTHLTGLFTDLGIELSQLLFYRGLSERAI
LRKSILLKAAIIGCFFIGGLLGGFIFLQHGIRTLYIPVALLAAALWYDSILLRIYHIRRK
LRVHN
>LONDMIMF_01379 hypothetical protein
MQYVTLLGDFIENAKKTFKTGWVTTVSKRNIFLFIQLFVCNFCFSQSYSHLSISDTITIH
SKVFDVKRKVIITKPSPAKTEEKQSNYIVYMDADDQNINGLFLQSANNLIANKEIPQSYV
IGIIHENRNTELLEKDKLLNFLKEELIPLLEDKYGKANKITIAGHSFGGYFATYAFLMDN
DVFNSCIAISPAYWPNKNEVIELLLEKASLVYGSFYLAVGDKRWDEISLRKNVFKVQKML
RNQKDISFGFNDLTGFAHNATPVVGFGLGLSFVYDEWEWMNILEEQDNKLKQFPDFWGHL
EIKAEALFHLNRISEAKSFYQEALKNTAEDKHLSKSEMREVTKRLRTKIKKCQ
>LONDMIMF_01380 hypothetical protein
MTKIVQNGMFFVRFYIEVFDIHTAHSHLLVLQLFHGSSSININKNKTFDKFRCKE
>LONDMIMF_01381 Sensor kinase CusS
MFFAVCCKGQSTNEFSYQNIGDELYYLEDKSSAMSLTDVKKLADTEFTKGKDEILNFGNT
SSAWWIKISYTVKQDLPLYLIIDAPNIEYIDAYTTDSNDQTVLFKTGSLRTTQPNVIVRN
NFMLNLPVASKIENKTIYLRLKTNNILLAPIKLATAESVIQGQEFKQGIEYIYIGLLIGL
LLFNLFLFVSVRDITYLYYVLYVLTLSSYLLIYIRGYGFIFGDEIRIFFNQYPHVLLSFS
VIASLLFCNKFLHLRQRAPKMLGIFYGIGGLGLILFFVSALGFKHTATTIAQFLTVTVAV
VAWIAGVIAYRNGHRPAKYYIVAWFFIWVTVAMVTLSLGGLIPSSEFTIQLVPIGSTLEL
LLLSFALGDRYKVIIKTEQEVRDENLFLVRTQNQRLEEKVHERTLQLNSTIKELESSNAI
KNKLFSIIAHDLRSPLNSLLGILSLSDMQLLTPEELQELLEENKKTIKSVSYTMDNLLHW
AQSQMDGLITKKDSFELKAVFDELLVLYLPLIKQKGIQLEQLVEGDSIISADRNQVSLVL
RNLIDNAIKFTPLGGRIWFILQSIPEGVQFLAENEVADNPGIDIDNRIGNKMASATRGTG
NEQGVGLGLILCQEYVKNNGGTFQVHQKENRIRFSVVLPGER
>LONDMIMF_01382 hypothetical protein
MKNILILLFLLPSFLYSQDGTIDLDFNNPVHLNNPIYNGFSSSSSSGGAKIYTTKILHNG
KIAVYGDFDLYQGIPTNKLAILNPNGSLDTSFNVGLGPDYVNQYYGSSSMICEQPDGKLI
VVGSFTTFNGVSKKNIVRLNLDGTIDTSFNVGTSSNGYITCVKLQNDGKILCGGEFTEFN
GQAYASLVRLNTNGTIDNSFNIGLGFKNIINSFTEDGIIKTIDIQNDNKIIVGGKFLKFN
NSVKINLVRLNSNGTIDNSFNIGIGGGNNTTNGTNNGQIYRVIYDNSLNKIYITGIINNF
NGSPSYNLLRLNIDGTIDTTFNFTSVIGYNGLNSNGYIYDMNLQSNGKILLGGEGINLNN
CTGSYCSRIVQINQDGTLDTTFDCKLVGAYTTVYSIDSINDSIIVSGQFTSVNFEPIYKG
SIVKVLQNGLTDLSFNPNLGTDPYTPSFASSISLNDGNIIANPTYSINYVYPNGNTNGIY
NERITAGLIKINSDGSIHQNDYANFLTSNLYSYYLTKDNASNLISSNPFTTKIGENGLIN
NSFASTSSIIAPFNVNIFVYDHAVQNDGKIIIGGNFRYSSPGNNSYRQRLMRVNSNGTLD
TSFNIGKGINGASIAGTEGYSVNTIALVPNNKIVLGGVFTNYNDNIISNIVRLDSNGTFD
PTFNSGTAFNSNVYKIIYQQDIGKLIVVGKFTSYNSSNSNYIVRLNNDGTIDPTFTSPFA
IGSTDSRVMNMVIQPDNKYIISGKIDGVEFLKRLNSNGTIDTSFANSTYTAVQNTFGDYD
LIRNISLLPNNKILISGSFDHINSTRRDGIAVLNNSPFLSTNTFNKNSLHNIYIYPNPAT
NEFEFNSPIEEVSIYSLEGRFIKKFKDYETIFNINELKEGVYILKIKNQKSFAHLKLIKN
>LONDMIMF_01383 TCP pilus virulence regulatory protein
MIDLFTIIEETTDALLLKLEKFEKSKNAIKKEVSLTWLANHLNTNTRYLSEVIKKHKGKS
FNNYINGLRINYIIGLLYDNPKHREYKISHIAELCGFSSREVFTTVFKKETGISPSYFID
NLKSKQP
>LONDMIMF_01384 hypothetical protein
MERKSQILILFFVTVAAISLAGFFNSYIRFLPDDMDRFPLVIHVHFSAFACWFALLIVQP
ILIKQEKYSLHRKIGKLSYFIAPVLVVTILILVTGQTKKDIVISEERAAFTAFVGLLDAV
SFSAYYLIAMTNKRNLRWHVAFIIAATLIILNPGMSRLLNHIKPGLGLPAAVFLPFIISI
GIILIEKIKFRRPVLKSPYFLFFCCWTVEILLLVTIPKTEFWHLIVKKLLGIT
>LONDMIMF_01385 hypothetical protein
MEKYFKMVTAMFLMIVAVSCSKENDDTINEPEKTFDINNPVGYVIYAKFAGLEFYSTNLI
FLFDFLPAKRMVSYSAYAPRNESEYNTPNASTMIYRPYPSWANFNFTIENGKITNIKSLD
GSISEYSVIKKPATNQLAGKTFRGKYLKKDGTVLQDGFYTFLPDGKTVDVGVQFPTKTRT
ETYTNVGNIGALVNIVSGTNNDHEIMILVDGKLQVNYRDNVSSSPKIYHGIFEEVK
>LONDMIMF_01386 hypothetical protein
MKKLLYLSMLFLSLGLFASFESVKALKNDSFIQEKEYKKIAPEEVKKEALINIKAKYGDY
QIVEAGVAADGEYKLVLKKDNASITALFTANGELIKILQ
>LONDMIMF_01387 Ultraviolet N-glycosylase/AP lyase
MDLFNEQTDWATALKPLIAKYKNKQHPLEYKNLYQLLVMVVLSAQDSDAHINKIAPNLFQ
AFPNMKSLALADEKSLLPYIEEVRFHGNKIKWLLEIAESIKQDKNIPVTMKELTALKGIG
RKSANVIMREAGVPAEGIMADLHVVRVAPRLGIAKGKDADKIEKEMMEVLPKSMWSEVGM
AISFLGRETCRPSNPKHSECLMNSVCEFYKNKKSGN
>LONDMIMF_01388 Peptide methionine sulfoxide reductase MsrB
MKYPVNKTEEEWKNELGSERYKILRQKGTEFPHSGKYNLFFEKGTYCCGACGEPLFESSS
KFDSHCGWPSFDEALPGKIEYVKDTSHGMLRTEILCANCGGHLGHVFDDGPTETGQRYCV
NSLSVDFKEK
>LONDMIMF_01389 Peptide methionine sulfoxide reductase MsrB
MRHYIVLLVSIFAFVSCHSQEKKEISKKETPKQIQKTDAEWKKELTPEQYEVLRKKGTER
AFTGEYYNHFEKGNYVCAACGNVLFTSNAKFHSDCGWPSFDQAIKGSVIYKEDTSFGMVR
TEVMCAKCGGHLGHVFDDGPAQTTGKRFCTNSVSIKFVPAKK
>LONDMIMF_01390 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase
MSEKPKTHQQSLKIPKPILITAKITEAISPKLAMKFAAKLFTSPIKHKLPKREIGMDKNS
LQQNVFIQNLGKEIVVYNYGSSDKKILLVHGWSGRGTQLVKIADEMLKLGYSTLSFDAPA
HGKSSGKTSNMAEFIVSILELEKKFGPFEYAIGHSLGGMSILNAIKRGLNVKKAVIIGSG
DIVEDIMDDFIEKLGMNIAISKKMKASFEKKIKEPMDNFSAYRAAKEVTIPVLVIHDKED
EDVPVKAAYHIRENLKDGELVITEGLGHRKILGDTKVIKKIIEFLN
>LONDMIMF_01391 Beta-barrel assembly-enhancing protease
MKRRYLLIPIAIFGIVYSCATNPFTGKSTLALVPDSQILPSAFQQYSAFLKENKVVTGTA
DAQRVVTVGTKIKNAAEKYLNANGYKGYLKDYQWEYKLVESKEVNAWCMPGGKIVFYTGI
LPITKDETGMAVVMGHEVAHALLNHGQQRMSADVLQQLGSVGVGAAVGNQSESIQKIAMQ
AYGVGTQYGVTLPFSRSHESEADKVGLTLMAIAGYNPEQSVAFWERMAANSGGNAPPEFM
STHPSNTTRIANLKALIPQAKAEAAKYGVTFK
>LONDMIMF_01392 hypothetical protein
MRTTLPKGSKKLMNAWAFYDWANSVYPLVISSAIFPLYFGFLFPKETPDVQFLGYDFKAT
ALISFVTAFAFLVVAFISPFLSGIADFVGNKKRFLQFFCFLGASSCIGMYWFTVDNIYFG
ITCFFFGLIGFWGSLVFYNSYLPDIAFTEQQDGLSARGYSMGYIGSVILLLICLYLILSK
EGVEALEMMKVSFALTGVWWLLFSQYAFYYLPKGNKNADKITKDILLSGFRELKKVKNEL
LKHLSLSRYLAAFFVYSMAVQTVMLVATYFGEQEINWADTEEKTKGLIISILVIQLVAVL
GAIITARLSNKFGNIKTLIVINSIWVVICVCAYFVTEPIHFYVTACFVGLVMGGIQALSR
STYSKFLPKTEDTTSFFSFYDVAEKIGIVIGMCVYGLIDQITGSMRNSIVFLAVFFIVGV
LLLFRVPKSVAKE
>LONDMIMF_01393 hypothetical protein
MNKLKFLTAFVLIFTAFNFISCDNEPLDSAIDPNPQPSCVAPTSFQASNFIGGTNVNLSW
VASSEATSWEVQYGPTGFAIGEGTSVFSDVTNVTITGLVSTNTYHFYVRSNCSESEVSSW
IGPISVGTSTGGTTGGSFRVKIDGVDFVANNVVAVKQMPVDPITHAPIINPETGQPWITY
SISGNTNLKMVKIDVTELNRSSYDLPGNGAAISYHPNAMNPLGSYYSLTLDDDVVIGNVT
ITANDAVNKKISGTFNCKVYMIDANTGEPGGTPKQLTNGVFTNVPYTIE
>LONDMIMF_01394 Lon protease 2
MPNQKIITLDNLSLQEFDNDSELIPLLTPEDEEEMNNEQLPDDLPILPLRNTVLFPGVVI
PITAGRDKSIKLINDANAGGKVIGVVSQINEEDEDPSPEDINKIGTVARILRVLKMPDGN
VTVILQGKKRFEIDAVTSEQPYLKATIKEVPEKRPDNDDAEFATIIESVKDLAIQIIKES
PNIPTEATFAIKNIESKSFLINFVSSNMNLSVKEKQDLLIINDLKERALSTLRYMNVELQ
KLELKNDIQSKVRFDLDQQQREYFLHQQMKTIQEELGGVSQEEEIEEMRQKGLKKKWNEK
TKTHFEKELSKMQRMNPQSPDFGIQRNYLELYLELPWNEFSKDNFDLKRAQKILDRDHFG
LEDVKKRMIEHLAVLKLRNDMKSPILCLYGPPGVGKTSIGKSVAEALGREYVRISLGGLR
DEAEIRGHRKTYIGAMPGRIIQSLKKAKTANPVFVLDEIDKLSSGNNGDPSSALLEVLDP
EQNSDFYDNFLEMGFDLSRVMFIATSNNMSAIQPALRDRMEVINMTGYTIEEKVEIAKQH
LLPKQLKEHGLTTKDLSIGKKQLEKIVVGYTRESGVRGLEKQIAKMVRNTAKSIAMEEEY
NVKVTDEDIVKVLGAARMERDKYENNEVAGVVTGLAWTSVGGDILFIESILSKGKGSLTM
TGNLGTVMKESATIALEYIKSNAERLGIGPDVISNYNVHIHVPEGATPKDGPSAGVAMLT
SLVSSFVQRRVKKSLAMTGEITLRGRVLPVGGIKEKILAAKRANIKEIILCHENKRDIDE
IKPEYLEGLTFHYVKEMSEVLAIAITDQKAKNAKAL
>LONDMIMF_01395 hypothetical protein
MFKKLFIVFLLLFCAEGFSQIGGKYVYQFLNLMTSPRQAALGGKAVTIYDYDVNQGFFNP
ATINPEMDNHLSVNYGSYFGEVTYGTAAYAYTYDRHVQTFHAGVNYVNYGNFEGYDENGQ
KTADFTGSEIALSLGYAYNVPWTDIFIGANLKLISSTLESYNSFGAAMDLGALYVDDYND
INIGLAIRNVGVQIKPYQDTNEKLPMEIVAGISQELENVPIRWHLTFENLQQWNIAFSNP
NRAEGSLDGGSKEEKVGFLNNALRHVIVGAELFPEKSFSIRLGYNFRRAEELRIVEQRNF
SGLSAGFGLRFNKIRFDYSYSRYTAAASTSLFGLMINLQ
>LONDMIMF_01396 Cytidylate kinase
MDKKITIAIDGFSSTGKSTLAKQLAKYLGYIYVDTGAMYRAVTLYAMQHDFISDTHFDKK
ALIERLPKISLQFLFNPDLGYAEIFLNEKNVEAEIRTLEVSNFVSRIAEISEVRAKLVEQ
QQNMGKNKGIVMDGRDIGTVVFTDAELKLFMTASPETRARRRYEELLQKGQEVTYDEVLK
NVQERDYIDTHREDSPLTKADDAIEIDNSHLSIQEQFDKVLGLVNTVAKTL
>LONDMIMF_01397 Xanthosine permease
MSFLQFFVWGAWLITIGTYCFNAKGWTGAEFGAIFSTLGLSSLFMPALTGIIADKWLNAE
KLYGILHILYGLILLYVPEVNDPSILFYVIFGAMICYMPTISLSNSIAYTILKNNKYDVV
KVFPPIRVWGTIGFIVAMWITNIFSSPTPPNIFKDLGLSVGNAMSSVSGNPIYANQFYIA
AFVAILLGIYSFTLPKCPPQKSIAEDASFVEQLGLNAFKLFSSYKMALFFIFSMFLGGAL
QLTNMYGDAFLNDFAKIPEYKDSFVVEYSTIIMSISQVSETLFILAIPFFLKRFGIKQVM
LFSMIAWVLRFGLFAYGDPVQGLWMIILSCIVYGMAFDFFNISGSLFVETTTDSKIRASA
QGLFMMMTNGVGAYLGSVISGYAIDKYFTHGETKDWHSIWLSFALYALIISIAFAVMFKH
KHKPEDVENISH
>LONDMIMF_01398 30S ribosomal protein S1
MSEQTKAQAEFLENFNWHNFQEGIDAVDEKNLKEFEELVEKTFISTDQEEVVEGVVVRIT
DRDAIVDINAKSEGVISLNEFRYNPNLKVGDKVEVLIDVREDKTGQLVLSHRKARTIKAW
DRVIAANETGEIVNGFVKCRTKGGMIVDVFGIEAFLPGSQIDVKPIRDYDQYVNKMMEFK
VVKINHEFKNVVVSHKALIEADIEVQKKEIIGQLEKGQVLEGVVKNITSYGVFIDLGGVD
GLIHITDLSWSRINHPSEVLELDQKLNVVILDFDDEKTRIQLGLKQLNAHPWDALDANLK
VGDKVKGKVVVIADYGAFIEVAEGVEGLIHVSEMSWSTHLRSAQDFVKVGDEVEAVILTL
DREDRKMSLGIKQLTQDPWTDITAKYPVGSKHTGIVRNFTNFGVFVELEEGIDGLIYISD
LSWTKKIKHPSEFVSVGEKLDVVVLELDVEGRKLSLGHKQTTANPWDKYEDSFAVGTIHT
GEISEIVDKGATVEFGDDIVAFIPTRHLEKEDGKKLKKGETADFKVIEFNKEFKRVVASH
TAIFREEEEKNVKAASENTTMSSSNATASTLGDNNDILAELKAKMEKGGN
>LONDMIMF_01399 hypothetical protein
MKTNKNLAIILFALLLSVASFAQKNQKRANMNVVNPKFDATKNIIDNLTASQNYSSLAKV
FKAAEFEQMLREEGPYTILAPSNDVISRSSENLEFMTDPKNIHRTKDIAAYYMIPGKWYA
SDFGKLIRMSKGRGEIKTADGDILIITLENSIIYLTDAKGNKAKLVFTDAIQSNGIIHGI
DKTFSPN
>LONDMIMF_01400 Immunogenic protein MPB70
MKTTKFLSIAIALLFGTAVFAQKEKTVMVGGAPMYPSKNIIENAINSKDHTTLVAAVKAA
GLVETLQGKGPFTVFAPTNEAFAKLPKGTVETLLKPENKSKLQSILTYHVVAGKMSSADI
AKAIKKGNGKAVLATVQGGKLTAWMDGKTLYITDENGNKSKVTIADVNQSNGVIHVVDTV
VMPKA
>LONDMIMF_01401 Phenylalanine--tRNA ligase beta subunit
MRISYNWLKQFIKTDLKSDETASLLTDLGLEVEGIEKYQSVKGGLEGIVVGHVLTCVQHP
NADRLKVTTVDLGTGSPVQIVCGASNVAAGQKVPVATIGTTLYDKDGNSFQIKKGKIRDQ
ESHGMICAEDELGLGTSHDGIMILDDKYAPGTPASKVFSIENDEVFEIGLTPNRADAMSH
LGVARDLRAGMLQTNAHTELITPSVSNFRVDKRTLKMDIKVEDAKLAPRYCGVTISGIVV
KQSPEWLQNRLKAIGLTPKNNIVDVTNYVMHELGQPLHAFDAAKIKGNKVIVKTVAAGTK
FTTLDDVERTLHEEDLMICDENGPMCIAGVFGGKNSGVSENTTSIFLESAYFNPVCIRKS
AKRHGLNTDASFRFERGIDPTITEYALKRAALLIQEVAGGEITSDIIDIYPKKIEDFPVF
LNFAKATKIIGQEISKETIKKILVSLDIKVNSVSDAGLGLIIPSYRVDVQREIDVIEEIL
RVYGYNNINFTKKFNATVSNAARTEDYKVQNIIATQLNSQGFNEMMANSLTSPEYVKLSE
MLREEFNVLIMNPLSNDLSAMRQSLLFSGLEAVSYNINRKNSDLKLFEFGKSYHKLPSGY
TENKHLTLFTTGNRLGESWNTPQKPSDFFLFKGYVMGILSRLGIEKTNNKPVESDVFAEG
IAIAVGNDIIVELGTVKKSVLKHFDIKQEVLFADFNWNSILKLISNKIKFTDIPKYPEVR
RDLALLVDQNVAFDSIYTVARQTEKSLLKDINLFDVYEGKNLPEGKKSYAVSFIIQDSSK
TLTDAQIDKIMGKLKNNLETELGAVLR
>LONDMIMF_01402 Low affinity potassium transport system protein kup
MGKHIHKLSAAGLLVTLGIIFGDIGTSPLYVLNAIVGSDPINSRDIVGAISAIFWTLTLQ
TTVKYVIITLRADNKGEGGIFSLYTLIRKTKVKWLLFPAIIGGSTLLADGIITPPISVSS
AIEGLRVINPDIPTIPIVIAIITILFGLQQFGTKLIGKFFGPIMFTWFSMLGILGGIQLS
TNINVLSAFNPYHAYELLMNHKQGFLILGAVFLCTTGAEALYSDLGHCGKENIRVSWIFV
KSMLLLNYFGQGAWLISHEGKTLKEAGVTNPFYAIMPDWFLPFGIGIATLAAVVASQAMI
SGSFTLINEAIRLNFWPKVKIKYPTELKGQLYIPSLNWMLWIGCVLVVLYFKESSGMEAA
YGLAIVMTMLMTTSLLNYYLILKRYNKIFIAVLITTYAVIEISFLIANLHKFSDGGYITL
LIAMMLMATMFVWYFARKIRNRYLVFVKLSDYLPVLEDLSKDLSVPKYATNLVYLTSADH
RTEIESKIMYSILNKQPKRADIYWFVHVHVVDEPYTMEYRVNEFIHDDVIRIDFRLGFRV
APRISLMFKKVVEDMVKNKEVDVTSRYASLNKNNIIGDFRFILIEKFISYDNDLPFYEKW
ILDCYNILKKMGLSEEKAFGLDSSSVTIESFPLLITAPREICLTRVD
>LONDMIMF_01403 hypothetical protein
MISYNPKEWLSFIFYFHKGDTFRKLFWIMILIALYSAGIAYLELEYWKLSANSLVKNITV
MHNMLGFVISLLLVFRTNTAYDRWWEGRKMWGALVNNSRNLAIKLSVMLTDKEDKEFFKK
IIPAYASVLNLHLKMESISHELFDDKTLSQDHYKHKPNQIAKTMIQRINEMYKDGKITGD
QLIVLNAEIQSFTDICGACERIKNTPIPYSYSAFIKKFIFTYVLTLPFGYVFQLGYYVIP
VVVFIFYVLASLELIAEEIEDPFGNDPNDLPTQKISENIQKNVEELIY
>LONDMIMF_01404 ATP-dependent DNA helicase RecG
MQNNLLETPIEYLKGVGPARGELLRKELGIHKYGDLINLFPNRYIDRTRYYKINELQNTN
AEVQIIGKIIHIKTVEQKKGKRLVATFVDETGEMELVWFQGQKWIRENLKLNTVYVIFGK
CTSFNGQFNMAHPEMELLAEHEQNLRSAMQPVYPSTEKLTQRGISNRTINKIMQQLFIET
QAAFKEPLPDYLLEELKLIPKNAALFNIHFPKSPDLLAKAQFRLKFEELFFIQLQLITKN
LIRKNKIKGHPFEKVGVYFNDFYNNHLPFDLTNAQKRVLKEIRNDMGNPAQMNRLLQGDV
GSGKTIVALMSMLLALDNGFQACLMAPTEILANQHFNGLMELAKPLNINIKLLTGSTKTS
DRKIIHEELENGSLHILIGTHALLEDKVKFHNLGLAIIDEQHRFGVEQRSKLWKKNEIPP
HVLVMTATPIPRTLAMSLYGDLDISVIDELPPGRKPIQTVHRYDSSRLKVWKFIRDEIEK
GRQIYIVYPLIQESESMDYKDLMDGYESISRDFPLPKYSVSIVHGKMKPADKDSEMQRFS
QGKTNIMVATTVIEVGVNVPNASVMIIESAERFGLSQLHQLRGRVGRGAEQSYCILMTGH
KLSNDSKIRMETMTKTNDGFEIAEVDLKLRGPGDIMGTQQSGVLNLQIADLVKDREILQL
ARHCAVKLLKDDAPMVKPEHQNLRQAFIEMSKKKNIWNYIS
>LONDMIMF_01405 nebramycin 5' synthase
MAKPIYILGTGLSHNGSAVLLKDGRVCVGIEKERLSRKKHDGGNDTLAIQYCLDAEGIGL
DDLALVVQCANFDIPNRNYFKGERIFSGHEKIEIIDISHHLAHAYSAVGTSPFSECNVMV
IDGCGSPLEQFLKLHPEQEKYIAPEYLNELRMLCEKDSFYHFDGQKLVPLVKDFSVMSNQ
SGNFSLPTTQHSIGGFYASVSNYVFGDMDDVGKLMGLAPYGKSGIYDFEAFEFQSGNLFV
KEDWKKKIDNPSTGYEYFKEHFEYYANIARWAQEQVEKAVLQCIHNRLEKFPHSNLCYTG
GVALNAVANAKLQDSGIVREIYFEPAAGDNGLALGCAYYGWLEYLKMPKMPHDGSTCFGR
PYSEAEIDAAFQKEENKKYVPKRIPNEEELLDYCAAKLKEGKTIAWFQSGSEFGPRALGR
RSILAHSGIEKMKDHINLDIKFREDFRPFAPAVLKSKVGEYFESARYSPYMILVDRTREI
HYKELKNVTHEDGSARVQTVEESWNPRFAKLIEAFYKKTGIAVLLNTSLNKKGMPIVETP
EEALYLFGITDLDVLVMENTVVEK
>LONDMIMF_01406 L-proline cis-4-hydroxylase
MEKLVRSIKFPLFFDTERLKNDLSKIIDKNWTAHYNAKDYTGEWTSIALMSESGKSDQIY
ASPISEKLVPTEILNSCTYFQEILDSLLFEKTAVRLLRLAVSAEVKPHSDNCLGYEDGCF
RLHIPVITNSEVEFILDGNRLVMNEGECWYIDANFTHSVANRGKEDRIHLVIDGLRNAWT
DELFFKEAKPDRFIKPEATMSDEQKRLMIAELQRMNTPAALELLKTLE
>LONDMIMF_01407 hypothetical protein
MVDKNPDLQKTVRFLEGIGIPVTEKKLDDSTFLPGLALGPGVIYVDYEKLKYPGDLLHEA
GHLAVTTPAERNVAGTEQMAPEWPTQGEEIAAMLWSYAAVKHIELPVDFVFHPNGYKDNS
DWLISNFDNENYIGLPLLEWAGLAYGKERALKEGKEAFPVMTKWLRE
>LONDMIMF_01408 Aminopeptidase N
MRRLLYTFLLVPSCLFSQQFQKVDFKTLNATLALDPSHKKISGQVTYTFEVLSAIDTIRI
DARNMAFSNLKVNNAVSEFKNSGKELQLYKGFKKGKNTLTFEYEAIPKQTLYFIGEKEHL
QIWTQGQGKYTSHWLPSFDDVNEKVVFGLSISYDKDFEVLSNGKLKSVSDKGNEKQWEYQ
MEKPMSSYLVMLAIGKFAKQTETAASGTPLEMYLSKEDASKFEYTYKYNKAIFDFLEKEI
GVRYPWGIYRQVPVRDFLYGGMENTTATIFSEDYVVDEIGYNDRNYINVNAHELAHQWFG
DLITATSGKHHWLQEGFATYYALLAERELFGEDHFNWQLYEIAERLQQASKTDTIPLLNE
KASSLTFYQKGAWALHVLRENIGAKNFNKAVKKYLEKYAFKNVSTANFLAEINAVSNYDT
RKFQQVWLEQSGFEVAEALGILKKNKFIEQYLNVLSMAEKPLAEKQQVFAETIVSDVYYP
VKEEILFQLQSVDFSEKEPIIRQAMQSNNIKVRQAVAKTLNQFPESFRPDFETFLDDKSY
VTKEIALNVLWSQFPDDRAKYLDKSRNWIGMNDKNLRILWLTMALATKDFEPEHKPAYYD
ELLDYTSPDYESSIRQNAITNLLYINGNDTNVLKALVNPLTHHKWQFSKFARDKIRELAK
KERYRLYYLELLPSLQDNEKAILEKLLNP
>LONDMIMF_01409 hypothetical protein
MRALVISGGGSKGAFAGGVAQYLIKEKNINYDLFIGSSTGSLLIPHLALNKEDKIFKLYT
NVDMDKIFSVNPFIIKHKKNQEVITINHFNVIMQFMKGKRTFGESKSLKSYIEDNFSKEE
FDQLQSSSKEIIVAVTNITKNCVEYKSILDCCYEDFCEWIWISCNYIPFMSLVTKNRFEY
ADGGISNVIPIQEAINRGATEVDVIVLETEHNTAEKVIGKNPFSLTIDLFGTIIDQVERK
DIIIGRLAAAAKNVKLNFYYTPTKLTDNPLVFNKKIMLDWWHQGYEYAKNKSETMSQI
>LONDMIMF_01410 hypothetical protein
MDTTKIIELLSYTLPAVITGSVAFYFFKLHTKNEEGRRRYLIQRDAQKSALPIRLQAYER
MALFLERINPSNLLIRIAPNSSDKMDYQNLVVMHIENEFEHNLTQQIYLSDECWTIITTA
KNATIQMIRKAALNPEVDTANKLREAVLNELLEKQSPSNNALAYIKDEVGGLW
>LONDMIMF_01411 hypothetical protein
MKKNLLFLTFGLLMLSGIKVQAQNVLTVFDEILFYDGYAAVVNFPTPDGVIRHRNDLYAK
RINGGLQMPYGSSMTIEVTIKAACDNYDRIGNVNLVLAPKGLVSYNPDNVRRIELGRFIT
PFMNKNRQPDEVPYTFSANNLSQILNDPGLNASYDFWMELEVFGVPYAANTQVAGCSGRN
DVFFGTLKLISEGTSTNSLPAFLLPLNFKKNLNNYNENATDVVGQTVRTINFNLPNSITD
AKFYLITSNHGANSGGEEYNRRLHYITFDGTPVLTYRPGEPTCEPYRIYNTQGNGIYGAA
PKTPEQWQSFSNWCPGSVIPIREISVGNLNAGQHSFKIEVPDAVFVGGEGYFPVSLYLQG
TGQALDIKKFESNVYSLLPNPTRNVVAIETNQEVKGYAVFSLLGQEILKGTGKMIDLSQA
AQGTYLVRIEFMNNEIATQKIVKL
>LONDMIMF_01412 ATP-dependent DNA helicase PcrA
MQHYISQLNEAQQAPVLQKDGPMIIIAGAGSGKTRVLTIRIAYLMHQGVDAFNILALTFT
NKAAREMKKRIADIVGSSEAKNLWMGTFHSVFARILRSEADKLGYPSNFTIYDSQDSVRL
IGAIIKEMQLDKDVYKPKQVLGRISSYKNSLITVKAYFNNPELQEQDAMSKKPRLGEIYQ
NYVDRCFKAGAMDFDDLLLKTNELLTRFPDVLAKYQDRFRYILVDEYQDTNHSQYLIVRA
LSDRFQNICVVGDDAQSIYAFRGANINNILNFQKDYDGVKTYRLEQNYRSSKNIVEAANS
IIDKNKTKLDKVVWTANADGPRIKVHRSLTDGEEGRFVASEIFEKKMQLQMMNGQFAILY
RTNAQSRAMEDALRKRDIPYRIYGGLSFYQRKEIKDVLCYLRLVINPKDEEALVRVINYP
ARGIGDTTVEKLTIAANHYKRSIFEVMEHIDKIDLKLNSGTKSRIQDFVTMIKSFQVIDQ
NHDAFYLAEHVTKKTGLIQELKKDGTPEGIARLENIEELLNGIKDFIEGQKEVDGARGAL
SEFLEDVALATDLDKDTGDDDRVALMTIHLAKGLEFPYVFIVGMEEDLFPSAMSVSTRSE
LEEERRLFYVALTRAEHQAYLTYAQSRYRWGKLMDSEPSRFIDEITGEYLEYLTPTESNY
RYKPMIDMDIFGDVDKSKLRLSKPVNGTPPKRYDDDEPSPNLNIRKLKPVASNPPTSSGS
SASDTKLNVGNIVMHERFGKGQVLNIEGAGADKKAEIKFEVGGIKKLLLRFARLDILS
>LONDMIMF_01413 Threonylcarbamoyl-AMP synthase
MAQFIKIYPQNPNEKEIAKVVKVLRDGGLVIYPTDTVYGLGCDITNTKALERIAKIKGIK
LEKANFSFVCHDLSNLSDYVKQIDTSTFKLLKRALPGPYTFILPGNNNLPKEFKKKNTVG
IRVPDNSIALEIVKQLGNPIVSTSIHDDDDVIEYTTDPELIFEKWQNIVDVVIDGGYGDN
QASTIIDLSGSEPVVVREGKGSVDIL
>LONDMIMF_01414 Motility protein B
MKKVIFILSIAAFTLTSCGSKKKIAELEAKNKEIQDLLNTATVKLNTCLTERDALAHQID
FLKKNNSDLINNMGNLTTLSSKGAENLEKSLESLKEKDLKITRLQDALTKKDSVTLALVT
SLKSSVGISDPDIQVNVEKGVVFISIADKLLFKSGSYVVSDRAKEVLAKVAKVVNSKPDF
ECMVEGHTDNVPYKSNGVLLDNWDLSVKRSTSIIRVLQELNVNPKQLIAAGRSEYIPLVD
NNSAENRSINRRTRIVVLPKIDQFYDMIEKEMKNMTAKQ
>LONDMIMF_01415 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase
MKKTAIVILNWNGKKLLEEFLPSVVRFSSEATIYVADNASSDDSVTFIKKTFPSVKIIQN
TDNFGFAKGYNQALRFVEEEYYALVNSDIEVTENWLTPVIDLFDSEPETAIIQPKILDYK
NKQMFEYAGAGGGFIDKYGFPFCRGRIFQTLEKDRGQYNDTIDIFWASGACFFIRKEIYR
NLDGFDEDFFAHQEEIDLCWRAFNQNLKVKYCGKSTVYHVGGATLKDSNPHKTFLNFRNS
LWMMLKNLPKNKLFPVLFLRLAQDGLAGVKFMTEGKFSHLWAILKAHFHFYLKLFRFLNK
RESKQYDNYYKIKSITYHYFVKKGKVFENKF
>LONDMIMF_01416 hypothetical protein
MQQLNFNSYDFRFRNTEGRISIFDEIRKKFIILTPEEWVRQNVVQYLLQEKKYPKSYINV
EKVIKINGLVKRYDVVVFQPNGKLFLLVECKSTDIVINQTTFDQIARYNMVLESEYLMVT
NGLNHYFCQMDYQNEKYNFLKELPAFN
>LONDMIMF_01417 hypothetical protein
MSKKIVLLCIVCNAIATYAQQNATDSIPVLKPDSLKFNYKSLIIPGALIGYGVIGLESDW
LKGFNSEIKEEVNEDIDKKITIDDFTQYAPFVSVYGLNALGIKGKHNFKDRSIILGTSYL
LMSGTVLSLKGITKVERPDGSSNNSFPSGHTATAFAGAEFLWQEYKDVSIWYGITGYAIA
TGTGLFRIYNDRHWLTDVAAGAGIGILSTKVAYWLHPYIKRTFFGEKETKSTVMMAPFYN
GKQLGCGFVMNF
>LONDMIMF_01418 HTH-type transcriptional activator RhaS
MNYKQYPVHPALKNWIRYFWSYDVCTSATEALHIRSFADRYPRLVFQDICSFSPIKDAQG
TIKPICYLSGVDTQPTDAYWESHFSHFGVSFQPHALHFLFGINAAELTNQTPDIQLLDKT
EIPVLLLNAKNHLERVSILSEYFYKRISKAKGDVVIDHLFLGNWADRLDNEKNLATIASH
YQISERQLQRRFKQNVGVSARKFARVAKFEKSLPALSLTDYGSLTQLAYDLEYSDQSHFI
KDFKLFSGLSPYEFVKQSSLGSESASFIYIEELA
>LONDMIMF_01419 hypothetical protein
MKKRKKKITSLFILTMISFAFTACSKDDGGSENIPNASTHTLVLKAETSSGSTLSHLLYG
YDSNQTTVSGLGVATWTSLEIALPENASVVNFTANGVGIDAASTLKLQIFVDGVLKKEEV
GTGTILSVRTHHNLR
>LONDMIMF_01420 hypothetical protein
MDEVVKIVNDIKAGNIKPIYFLMGEEPYYIDKLTEYMEANLLSEDEKGFNQTVLYGRDVS
VDDIVSTAKRYPMMAERQVVIVREAQELSRSIDKLESYAENPMPTTVLVIAYKYKTLDKR
KKLTKFLDKTGLVYESKKLYENQVGDWLKRVLAGKKLNIEPKAAAMLVDFLGTDLSKIAN
ELDKLAIILPLGSTITPEVIEENIGFSKDFNVFELRKAIGERNVKKAYQIAQYFADNPKD
NPLVLTVGQTFGFFVQLLKYHGLKDRSPKSVASALGINPFFVKEYDVAIKNYPMKKVSHI
VASLRDIDVKSKGVGANGLPPGDLMKEMLANIFS
>LONDMIMF_01421 hypothetical protein
MKNFTQPHRKKFRTKQWLTLLYCMGMGIFLYAYSGPEMLQPQKTTATAGTLAYCTPAGTG
TSYFIKDFTTTGGFLNIINTNSGIGSGGYSNATTKIVRQSAGGSFDFSAVYSSGTYGLAI
WIDWNGNTTFEASERIFNTTSYGSSATGTITIPAGTANGSYRMRVLADFNKSNPDNPCGF
NSGNGEAEDYTLEVGDPPTCMPPTALGAGNVTFNSAQLSWMSEGFLFDVEYGPSGFALGS
GTLASSVANPYTPGELTANTMYQFYVRTDCGGVDKSIWSGPYSFYTGYCLPVATSTSYFI
KDFITTGGISNINNTNSGIGAGGYTNNSGNASMKVSYFEGGSVNFSAVYSGGSGFAIWVD
WNNNMSFDTDERVFNTTAYGSSSTGSITVPAGTPVGNYRMRIRMDYNNNNPSDACGFNSG
NGEAEDYTFEVIPTPSCLPPTDLGAGNVTFTSAQFSWLGDGTVFDVEYGPAGFTRGAGIM
ASSVGNPYDVTTLTPETSYEYYVRKSCGAENKSAWAGPFRFYTGYCVPAATSTSYLIKDF
TTTGGITNINNVNSGIGTGGYSNHTTMKVRHYETGVVNFSAAYSGSSGFAMWIDWNKNMA
FDADERVYNTTSYGSSSTGSFTIPAGTPVGEYRLRIRMDYNNSNPSNACSFNSGNGEAED
YTLEVVTPPTCMPPTELGAGNIVYTTAQFSWMSEGTVFDIEYGPAGFTQGTGTIVSSVAN
PYNATGLTPDTAYHYYVRRDCGAGDKSPWAGPFRFFTGPCKPVANTTSYFVKNFTTTGGF
ININNLNTGFGTGGYSNYTAMKVQQFTGGTVNFSAAYSSGSGFSIWIDWNNNMTFEASEK
VFNTTAYGSAATGTITVPTGTPLGNYRMRIMMDNNTSNPNNPCEFVEYEDWDWGDVYYSG
EAEDYTFEVTTPPSCMPPTELGAGNMTFTTAQLSWMGEGTVFDVEYGPTGFTQGTGTLMS
SVGNPYDATGLTSDTNYQYYVRRDCGSGDKSPWAGPFSFRTGYCLPAATSTSYFIRDFST
TEGYVNISNTGTAIGTGGYSNFSTLKVQQSEGRTINFSAAYSGGSGFAIWVDWNKNMAFD
ADERVFNTTAYGASSTGTITVPAGTPIGSYRMRIRMDYNNSSPSDACGFNSGNGEAEDYT
LEVIAVPSCIPPTNLNIASMTPTSALLAWTSEGTLFDVEYGPNGFTQGTGTTRTGVTSPY
SVTDLTADTAYQFYVRKDCGSGDKSLWAGPFRFTTAYCTPAATSTSYYISSFTTTGGATN
INNTGTTIGTGGYSNNTAMKVQQYEGASVDFSAAYIGSSGFAIWIDWNNNMTFESSERVF
NTTAYGSAATGTITVPALTPVGNYRMRIRMDYNNSNPTDACSFNSGNGEAEDYTFEVITP
PSCPAPTGGIAGSLTTATAQLSWTSSGTLFDIEYGPRGFTQGTGTMVSGVANSHTISGLS
ANTAYQFYVRRDCGSGDKSTWGGPFVFRTTCGTQTVPYLIDFEDATTPGLPACTSSQNAG
TGNNWKTDNITRGGFNSKVLNYSYNSSNPANAWFYTNGIQLEAGTNYTLKFQYANSGNTT
YVESVKVNIGTAADFNAMTRNLADYPSIVNDSQLESSTTFTVEASGIYYLGFNAYSITDR
AQIYIDNISVDVALSNPDFDATSFKAYPNPVKNILNLSYSKNITDVAVFNLIGQQVMTRT
INNDKGQIDMSGLPAGTYMVKVTADNAVKTIKIIKQD
>LONDMIMF_01422 Acetyl-coenzyme A synthetase
MNRQELVAPEWYNITDEFEKYAKDSTKNALIIYHEHSDVQFITYAHLLERANQAAHVFTK
SGLTKGDVILVMVPRSVEAYIVYIAALKAGLIIIPSSEMLRTKDIEYRIHHADAKAVVTF
DPYIEQFDQVGNLQNIQQFVIGNAHEPWQPLVDKMRKQPTTYISSTPTKSTDHAFLAYTS
GTTGNPKAAVHTHSWGYAHLRTTAPHWLGGQENGQLQHQDGKNGFGVRFSRF
>LONDMIMF_01423 NAD-specific glutamate dehydrogenase
MKDLLKKFENKEPEIIFNWKDSETEAEGWTVINSLRGGAAGGGTRMRKGLDVNEVLSLAK
TMEVKFSVSGPAIGGAKSGINFDPNDPRKKGVLQRWYKAVSPLLKSYYGTGGDLNVDEIH
EVIPMTEECGVWHPQEGVFNGHFKPSEADKINRIGQLRQGVVKVIENPIYSPDVNQKYTV
ADMITGFGVAEAVRHFYDIYGGNIKGKKAIVQGFGNVGSAAAYYLANSGAKIVGIIDRDG
GVINENGFTFEEIRNLFVNKNGNQLVADNMIPFAEINQKIWTIGAEIFTPCAASRLVTQE
QLDNMAAAGLEVISCGANVPFADKEIFFGPIMEAADKKISLIPDFISNCGMARVFAFFPA
NSIDSFVRSFSVPILIKRASAMATISSTSWLSSAMTGEAPNANRPLAWKLATT
>LONDMIMF_01424 Anhydro-N-acetylmuramic acid kinase
MAKENYNVIGVMSGTSLDGIDLAHIIFSRLENRWHYQIEETKAVPYTEDWVYRLKKAVDF
SPEELEKLNTDYTLLLGNVISDFIAANQLENLDGVCSHGHTILHQPQNGFTLQIGNLPEI
AKLTNQKVICDFRVQDVDYGGQGAPLVPIGDRFLFPEYDFCLNLGGFSNISFEQDGKRIA
FDISPVNTVLNFYADLLGYEYDDKGTIARSGTISELLLQKLNNIDFYAQAYPKSLGYEFV
KTIVLPMMERHNISIEDKLRTFTEHIAIQTLLAVPKKTGSLLVTGGGAYNEFLLERMAFH
LPEMKFEVPDDKTVQYKEALIFALLGILKLRNEVNVLASVTGAKHDHSSGKIFLP
>LONDMIMF_01425 Acyl-CoA dehydrogenase, short-chain specific
MDFKLTEEHLMIQQAARDFAQAELLPGVIERDEHSKFPTEQVKMMADLGFLGMMVDPKYG
GAGLDSVSYVLAMKEIAKVDASAAVVMSVNNSLVCAGIEKYCNEEQKQKYLVPLAKGEVI
GAFCLSEPEAGSDATSQKTTAIDKGDHYLLNGTKNWITNGATASTYIVIAQTDIEKGHKG
INAFLVEKGWAGFEIGPKEQKMGIRGSDTHSLMFTDVKVPKENRIGEEGFGFNFAMAVLN
GGRIGIASQALGIAAGAYELALKYSKERKAFGKEISKHQAIAFKLADMATQISAAEMLCL
KAACEKDAGQDISQSGAMAKLFASQTAMDTTIEAVQIHGGNGYVREYHVERMMRDAKITQ
IYEGTSEIQRIVISRSILNA
>LONDMIMF_01426 Autoinducer 2 sensor kinase/phosphatase LuxQ
MSQKPRSLKVKVIIGYLLLFVIAALSVWFIYSEILKIATPSNNANADSQKVIRVSNAIAS
LYASETVGRNSILTGSKADLNEYTKLLDSIKLEIEAIKSEADKTQLPKLDTIQYLLQRKK
NSINEIIEFRKYLDTRATYKRAERKVYYTKDSLVKKIKPVQFSGRQQYRSFLNEVLTKKQ
LDSLSKLPLSNDSLTMAIQGAIRKEASREIDKQYELVGKEQKMLDENRYISDQLRTVLSS
LEKQMLEKSYAKINESKRAIDNTIQTIAWVGAITFCLLIVFGYIIIRDLTINQNYRNQLE
ALNAEKEDLLRSKMMLLATVTHDIQTPLGSVIGFSDLLKNTDVNPKQLQYLDNIKHSSNY
ILKLVNDLVDFSKLENNRINIEKVSFNFKDLIESTCKPLEPNAENKGIELNWDVEEVLDD
NFISDPYRLKQILTNLISNAIKFTQEGSVEVHARVESATIVVSVIDTGIGIAKNKQKAVF
KEFTQAHAGIEKKFGGTGLGLTIAKRMLQLLDGDIVVDSEENKGSIFTITIPAIKSEAEA
VEVGVPNLDSETEFLKDKRILIVDDDAMQLSLMKEIFANYPVKVTTLVDAAKVRNLLEHE
QFDLVLSDIQMPNIDGFELVRIIRNNNNPEVAAIPVIALSGKRNLNPEDFTSKGFTAFHP
KPLRLEELLLLMKSIFNGKPVDVAVQVAEARKDEKLFDLSSLNKFTQNDPVSLKLIVDTF
ITSVSENTEALRQATCEMNLKRMSEVAHKMIPMLKQMEVYSISDLLEPIEDQSLEYDKEE
MEKYVAIIFQKLSVLISELEKKIS
>LONDMIMF_01427 Transcriptional regulatory protein ZraR
MSSKILVIDDDTSFCVMLKTFLQKKGYDVTNAFNAKEAEEAIRNQIFDVVLTDIRLPDSD
GIQILKYIKETSFKTQVVLMTGYTDIKTAVSAMKMGAYDYVGKPINPDEILHTIEQALKK
RLEKPEQPVTEKKEKKETSSSDFAFVKGGSLTSNQLHEYISLVSPTNMSVLIIGDSGTGK
EYIAHTIHTQSKRKDKPFIPVDCGAIPKELASSEFFGHIKGSFTGAINDKTGHFEAANGG
TLFLDEVGNLSYEVQIQLLRALQERKVKPVGSNHEVKVDIRVIAATNEDLSEAVKRGDFR
EDLYHRLNEFCIQAPKLSERKQDIMVFAHHFLALANDDLEKNIEGFDDEVIELFMNYDWP
GNLREMKNTIKRSVLLTKSNSVPIDVLPQEMRSAIEQENAIPYYSKENEESAIRSALEKA
GFNKTKAAKLLNIDRKTLYNKLKLYSIDL
>LONDMIMF_01428 hypothetical protein
MKKILVLAALILSFGVNAAASDKTINEISVTQEKQYKPIEPSAIPADVLKTISSKYGGYT
IKEAHVASDGEYKLVLSKDDKTVTAYFTATGEFIKEA
>LONDMIMF_01429 Glucose 1-dehydrogenase
MKNIIITGTSRGIGYELALLFANEGHQVLAISRKTPKALIENPNITCLSVDLANEADLAK
IENFLSSAWKQVDAIVHNAGALLLKPFSETSTQDFEQIYKVNVFGVASLTRISLPYLKPG
SHVVTISSMGGIQGSMKFAGLSAYSSSKGAVITLSELLSEEYKERGISFNVLALGSVQTE
MLAEAFPGYQAPLSAKEMADYIYDFTLKGNKFYNGKVLQVSSSTP
>LONDMIMF_01430 Vancomycin B-type resistance protein VanW
MKKLIPTAIKLKFRVIKRHITDLKFISKNRFAQKRPQENISGFSITIKQEIKKGTHFDNK
IHNLKLASKTINQVCIYPDELFSFWKIVGNPSERNGFKKGRNIVNQKISEETGGGLCQLS
GIIYHTALLANLEILERHNHSVDIYSEEERFTPLGADATVVYGYKDLRIKNNNPFPIQFK
IEIEGSGISCSLNSQKEIEEHHVTFNIIDKGRKIEVVTFIENKKAAISFYNKLRS
>LONDMIMF_01431 putative S-adenosylmethionine-dependent methyltransferase/MSMEI_2290
MIEEIKIYYDELASTYDQNRFGNSYGTYIDIQERAYLKKRLSHENFANILDLGCGTGRFL
DLASHGVDISPRMIDVAKYKFPEKNINLGSVSDIPHPDAFFDIIFSFHVIMHLDKVTVHE
FLKESHQKLKKDGKLIFDFPSQKRRKLFNYKKTGWHGANALSIKDIESLITPDWTIKYYR
GILFFPIHRFPSSARPLLQKIDAFFCKSFLKEYSSYLVIELEKAQPSEKTYPNRNKTKIQ
GN
>LONDMIMF_01432 Protein SprT
MSEVLSKYLPEHAVEPCFELIKANEVHLKIVNERVTRHGDYRKGPGGKHEITINSNLNKY
KFLMTLIHEIAHLVAFKKFGRNIKPHGNEWKYTFQQLMVPFIRPEIFPSQVLPLMARHFR
NPAASSDTDATLSLALKQFDKENDKSYIFEIPYGSFFRIHNGKIFKKGAQRIKRFECQEV
STGRIYLFSPNAEVELLPARC
>LONDMIMF_01433 Mannose-1-phosphate guanylyltransferase RfbM
MNKNYFAILMAGGVGSRFWPVSTSEFPKQFHDMLGTGETLIQKTFSRLSKLIPEENIFIL
TNESYNDLVLSQLPQVSQEQVLLEPAMRNTAPCILYASLKIKKINPDAVIVVAPSDHWIE
DERAFVSDLQTAFDFCEKDNALMTLGIQPTFPNTGFGYIEYDKSDANQVKKVSQFREKPD
YETAKEFLKSGNFLWNAGIFIWSAKSIIQAFETYQPKMYALFMLGYGAYNSDLEKVFIEE
NYAESENISIDYAVMEKAPNVFVLPATFDWNDLGTWGSLYEKLPKDNQLNAVVNASVVLE
NAFNNIIRTDAKKLIVIDGLNDYIIVDKEDVLLIYPKGKEQEIKRIREIVNK
>LONDMIMF_01434 hypothetical protein
MTEFEISLKQHFGVAGTEELKAITTLFEPELLKKGDFFLETGKKCDRLSFIQSGFLRIFL
ETKSKEITQWISTKGYFVTDLSSFIFDHPARWTIQALTDVEIYTIRKSEYAKIKTVLPKW
PELEKQFIVHCFTTLEDRVFSHLSMTAEERYCFFFENNKELFNQVPLQYIASMLGMTPET
FSRIRKKQFS
>LONDMIMF_01435 hypothetical protein
MKRLFLISAILLMSITVMAKEIKTEIVIQATPEKIWSILTDFENYPNWNPFVSSVKGAVD
IGNKIKVGIHPPGGKKMTFKPIVITKIKEKELSWRGKVLFRGLFDGEHKFELIDNQDGTV
TFIQSEKFKGLFVWMFNPKKTKEGFNRMNEKLKELAEKEID
>LONDMIMF_01436 Proline iminopeptidase
MQTNIIDNKADRLFTVIYSKSDKETIVLLHGGPGFPSDLTEVVNSLKDSFQVITFHQRGT
EKSPCASKDYSMEAYLCDLEAIRKFYQIDKFHLWGHSWGGLYAQIYAEKYADNLLSLFLC
SPGSGTNTQWKQTEKEVMQLNKSKTTGWQWTKMGMNSFFGMLGSDKAYKRLFKQVMKNYN
DGFLPTGTSDNSEDFNLLKAVPINKTRPEIIKYPLLKGLSNPDFKITILYGEQDVYKTSK
NFVIDRYPKAKVFIVLNSGHIPWLHNPKDHKDIMDNHYQ
>LONDMIMF_01437 putative ribonucleotide transport ATP-binding protein mkl
MIEVKDIKKSFGDAQILKGISTTFEAGKTNLIIGRSGSGKTVLLKTLLGIHTPDEGTISF
NGKIYSELSKDEKRELRTEIGMVFQGSALFDSMTVEENVGFPLKMFTNKKKNEIRDRVNQ
VLERVNLVDANNKYPSEISGGMQKRVAIARAIVNNPKYLFCDEPNSGLDPETSILIDVLI
QEITKEYNMTTVINTHDMNSVLQIGEKIVFLKNGIKEWEGTNEEILETKNKSIVEFVYSS
DLFKKVRESLLADIEDEDKEENK
>LONDMIMF_01438 putative phospholipid ABC transporter permease protein MlaE
MIIRYLTQIGRYFIMLKEIFNKPTKWSYMKQLILKEIDDLIIGSLGIVSFISFFIGGVVA
IQTALNLTNPLIPKTLIAFATRQSVILEFAPTFISIIMAGKVGSFITSSIGTMRVTEQID
ALEVMGVNSLNYLVFPKIIALMLYPFVIALSMFLGILGGYMASVYGNLTSSDEFIMGLQT
EFIPFHIVYAFIKTMVYALILATIPSFHGYYMKGGALEVGKASTVSFVWTSVVVILMNYI
LTQLLLSS
>LONDMIMF_01439 Poly-beta-1,6-N-acetyl-D-glucosamine synthase
MNYYIVIPAHNEEAFIALTLQSLADQTAVPAKVVVVDDNSTDNTSAIVQEFASKYPYIHL
VQKTSEAIHLPGSKVIQAFHKGYETLDSNYDIIVKLDADLILPENYFETIINIFKSDPKT
GMAGGFAYIEKNGDWILENLTDKDHIRGAFKAYRKECFLQIGTLKPAMGWDTVDELLCKF
YDWKVVTDQSLKVKHLKPTGANYNKTARYKQGEAFYTLGYGFFITAIASAKLAMLKKKPF
LFFDYIRGFFKAQSQKKPLLVTREQAKFIRNYRLKKMKEKLF
>LONDMIMF_01440 hypothetical protein
MYEKTFPEKRFKLTLDFLNKHINSSETILDLGVENPFSKIMKENGFQVINTTGEDLDKDQ
TALQSQQYTVTTAFEIFEHLLNPYTVLQNIKSDKLFISIPMRLWFSPAYRSKTDMWDRHY
HEFEDWQLDWLLEKTGWKILDRQKWTNPVKKFGIRPLLRRFTNRYYIVYAEKVHNS
>LONDMIMF_01441 3-oxoacyl-[acyl-carrier-protein] synthase 3
MNIKIIGSGSYIPEIRVANHDFDNHIFLDDNSEPLSHPTELIIEKFKDITGIEERRYADS
HLLASDIGFLASQKAIEDANIDAETIDYIIVAHNFGDVQYGKIQSDILPSLASRIKHKLQ
IKNPKCVAYDILFGCPGWIEGILQANAFIKSGMGKRCLVIGAETLSRVLDPHDRDSMIYA
DGAGATIVEGTDKNEGLLSYESATFAYEEANYLFFGKSYNKELNPDVRYIKMYGRKIYEF
ALSQVPMAMKSCLEKSGIDISEVKKVLIHQANEKMDEAIINRFYKLFKAVPPAGVMPMSI
HKLGNSSVATVPTLYDLLIKGKIENQELRKGDVIIFASVGAGMNVNAFTYRL
>LONDMIMF_01442 Group 3 truncated hemoglobin ctb
MKDLENREDLTLLMDNFYQKLLQNKAISYLFTEVAQIDLEHHLPVIVDFWNLSLFGKGNY
KNNVLKLHLDLNEKSKLSPQHFKIWLDTFYLTVDENFSGENSEKIKTKALSIANVMQIKL
HKSA
>LONDMIMF_01443 hypothetical protein
MKKSILLLMLLMTSSLIFAQSDKIFKHSGETVNGKVIRLDEYVVVFKYDGEDAENSIGKY
AIEKIVYGKSGRVEEVSEKIEVSSEKDWEKVVILEEKSYIAGLKKVDEVRGKTGLINFQT
GNTGDKKAEKKLKMEAAKLGCPFILLMADKATVGASSNALGGSQVIKKGVAYKY
>LONDMIMF_01444 Glycine dehydrogenase (decarboxylating)
MKTDAFALRHIGPRENDLQHMLKTIGVESIDRLIYETLPDDIRLKAPLNLEPAMTEYEYL
NHIQKLGNKNKVFKSYIGLGYHPAIVPAVIQRNIFENPGWYTAYTPYQAEIAQGRLEALL
NFQTTVIELTGMEIANASLLDEGTAAAEAMALLFDVRTRDQKKNNANKFFVSEEILPQTL
SVLETRSTPIGVELVVGNHEEFTFGNDFFGAILQYPGKYGQVYDYAAFIAQAKSNEIKVA
VAADIMSLVKLTSPGEMGADVVVGTTQRFGIPMGYGGPHAAYFATKEEYKRSMPGRIIGV
TIDTNGNRALRMALQTREQHIKREKATSNICTAQVLLAVMAGMYAVYHGPKGLDYIAGKI
HASAVTTANALSKLGIEQTNSSFFDTIVVKADAQKVKAIAEKNEFNFYYIDNNTVAISFN
ETTGLADINTIVSIFAEAAGKETIKVTELATQTQYSESLNRTSTFLTHEVFNKHHSETAL
MRYIKMLERKDLALNHSMISLGSCTMKLNAAAEMLPLSMANWNNIHPFAPIEQAEGYQTM
LKKLEQQLNVITGFAGTTLQPNSGAQGEYAGLMVIRAYHQSRGESHRNIALIPASAHGTN
PATATMAGMQVVVTKTSENGNIDVEDLRAKAIQYKDNLACLMVTYPSTHGVYEASIIEVT
KIIHENGGQVYMDGANMNAQVGLTNPATIGADVCHLNLHKTFAIPHGGGGPGVGPICVAP
HLVEFLPTNPVIPTGGNHAITAISAAPWGSALVCLISYGYITMLGAEGLTSSTQHAILNA
NYIKERLNGHYATLYSGEMGRAAHEMIIECRPFKEKGIEVTDIAKRLMDYGFHAPTVSFP
VAGTLMIEPTESENLEELDRFCDAMISIRKEIEKASADDKNNVLKNSPHTLAMLTADTWD
FPYTREEAAFPLEYIAENKFWPSVRRVDDAYGDRNLVCSCAPIEAYMES
>LONDMIMF_01445 hypothetical protein
MVFLGNFQRKLGVVNSFVIFAVCRLSDDYLIFILMAAYTLR
>LONDMIMF_01446 hypothetical protein
MQAIRRLFNFYINGSIHVAVAVLSLVLMTNHMFRNPFDLYMAGFAFFGTIFGYNFIKYED
FFRNKKPLRFELKGIAILSLIAFIAAAYFFFHLKFMSQITAFIFFGLTFLYTVPVFSSRK
NIRNWSGVKIYIVALCWSGVTTLLPLINAGTEVFSDVILKFSQRFLLVISLILIFEIIDL
KTDSPALGTVPQRIGVEKTKIVGLLLLVPLYFLEFLKSTIDTNQLFVNAILVIITSLFMI
FANENRSKYYTSFWVESIPVFWLGLVYLF
>LONDMIMF_01447 Epimerase family protein
MKKLIIAAGTGFLGQVLVNHFKDKFEEIIILTRGSSKIKGNIRHIKWNAKTFSGWEKELE
NADVLINLAGKSVDCRYTEENKKEILDSRLESTRILNLAVQQCKNPPKHWLNSSTATIYR
HSLDKEMDEENGEIGNDFSMNVAKSWEKVFFEIQTPHTKKTALRTSIVLGKNGGAYLPLK
NLTKVGFGGKQGKGNQFISWIHEKDFARAVAFIIEKELTGVLNIVSPQPIRNMLFMKTLR
KSLGVPTGIPISEKLLKFGAKMIGTETELVLKSRNVIPKRLTENGFTFEFGELKKALDDL
R
>LONDMIMF_01448 hypothetical protein
MKTLENQTLLYDEDCPLCQAYTTGFIKTGMLDKNGKKPFSNLTEEEHSFIDFKRASNEIA
LVDNKNKTVIYGIDSLLKVIGNSFPWIEKVGNVPPVKYLLKKLYSFISYNRKVIIPNQNT
NTTALQCVPSFNYKYRIIYILFTIVITALTLHNFSNLIPNLPRGNFGRELAIAFVQIVFQ
SLFLLKIEKRDLVNYTGNLMTVSLAGALLLTPILILNQFINIPQITILIWFALVVLFMFM
EHSRRIKILRLPTILSYTWVIYRVIVLLVILTF
>LONDMIMF_01449 hypothetical protein
MTLLQKINCFAIGLPFAIAALAVFEVGMLSFALLSTVITGFLQVSIALVLFINHYKNRHL
QAYLLLCILFFSLWFTMDWGWIWAMPPSLALYMTVILHYIVTEKPQ
>LONDMIMF_01450 hypothetical protein
MEFKEAKNKFIQTWGALGSQWGINKTMAQIHALLMVSPEPLSMEDIMEELLISRGNASMN
LRALMDWGIVYKEYKSGERKEFFIAEKDLDELAVKIAQERSKREIKPALRVLKDVSSIKA
NETGETKHFVEQTSKLYDFVLKADNMIDKVTEFKDNWIGRLVMKIMK
>LONDMIMF_01451 hypothetical protein
MWETVIFLTVFYIFGIILNDLLMKKLYLNFIFALIFSLNAISSYGQLPDFTLTVTGTDET
CNRNGTLSFTVSGTHPNAGIIYTIYKLPVLNSPYATVSTNSLSGLTGGTYRVIATQTLGT
ENNQQQKDFVINSTASFLEFNMTFSDIACSLNRNIIVNVTSGNPIGYEIISGPIIKPRQT
SNIFTNLVAGNYLIKVYDSCGNAVSRSYTLVTLEEIPNNLEVSVGITPHSELVNCNTIGA
SFTVDAIAGSTVSYPLTFVFTIFPPGGGAPITKTYIANGPQDSYTIELPFYNAPYSYSLV
VTDGCGKVFRQDVTPMNTLFSILLERQTLRCGIQSFTVTTSNFTYPITVEFLSVPAGFNP
SVYNSSHPTYFSNPTFGNTTNVLPEGSYVVKVTDACGRTATENVIIDHETDAKFVATGSC
GISGVIFGEILGSNIVSATINTAPSGFTFPTPHNVNAYIQSDGGLVISNILVPGLYSITL
VDECGNTYTKPVTVPAGGSGTPRINYLGGCEPGFGSVYIGGAPDVQIRSAEFVSVPSTYN
GPMNVSVNIRGSYFMMSSLPIGTYLIKIKDSCNSEYTLTLQIKEYIGNTTFEIAEACSSF
NIRFNHTNNNGSVINLGYWLQKFNPATGQWGHPNTNVAYTENSLPNINNSISVTNNNTWN
LNFPIGGKFRIVTASSIYNSVGTNNSCIFTIKEFETGMLPEIKGALNFSCSGTLSDVLLN
VVGEGNFTFRIIEKNGQPFVFSNGSSPLFTDLESAVYVFEIKDQCQNTSTYTHDVTTPFV
FSIATSLCDAQNSTLSVPNFPYLQYKWYKQGAENVTLGTSSTLTFAPLNVSTQSGMYHVA
ITYPAEPDSCLNQILNYQIDAGNPPNAGNDNDVDLCSIPPSINLFDYLLGNADQNGTWEQ
IPSTGALSSNVWNTEGVQQGSTYYFRYFVRGFCGVEDEAIVSIHFNNVIAAPIINPIGPL
CEGSPINISIQNPNLLYNYTWSGPNGFTATGINPVFPNATIAMSGTYTVTTNLVNCPSEP
LSFELVVTPQPEFHFTQENTRICFGQESIVKIVPDNFQESEASYIWRNENGQIIGGNSAE
IEINEPGLYSVLVNLNNCSFSKSIQIDENTDTFSVGAQAKCENDHYMLTAYAIDNSFNES
NATYAWTGPNGFNATTQSTDITGLESGVYTVVVTNEEGCTTTASIPVEKSYCKIPKGVSP
NGDNKNDTWNLAGLDILRVKIFNRYGTEVYEMNNYVNQWHGQCSDGKLLPTATYFYYIAF
RDGKEKTGWVYLNREVN
>LONDMIMF_01452 Oligopeptidase A
MSVLTKKFTTKYDTAPFSQIKNEDFLPAFKEAIASAKQEVDDIVNNPELPTFENTIEAMA
FSGATLDRISTIFFNLHSAETNDELQKIAQEVSPLLSEFGNDIRLNADLFKKVKAVYDKK
DSLSLTAEQATLLDKQYKSFSRNGANLSEDKKMELREIDKQLSKLSLEFGENVLSETHAF
QLHITDEKDLSGLPEGTIEAAKELAQSHEKEGWIFSLDYPSYIPFMTYADNRELRKKMAI
AFGAKGFQKNEHDNQEIVLQIARLRFERAKLLGYASHAHFVLEERMAESPQKVNTFLNDL
LAKARPAAEREFNQLTQFAKELDGIEQLEKWDGAYYSEKLKQQLFNLDDEKLKPYFKLEN
VLEGAFTVAARLYELTFVEINDIEKYHPDVKTYEVKDITGNLVSVFYADFFPRKGKRNGA
WMTSFKSQYVLGGSNERPHVSIVCNFTKPTETKPSLLTFNEVTTLFHEFGHALHGMLADT
TYPSLSGTSVYWDFVELPSQIFENWCYEPEALALFARHYQTGEIIPTEYIQKIKESASFH
EGMATLRQLSFGLLDMGWHGQDPTPIKDVKEFENVQFASTKLYPDVKENAMSTSFSHIFQ
GGYSSGYYSYKWAEVLDADAFEYFKEQGIFNSEVATKFKENILSKGGTEHPMILYKRFRG
SEPKPDALLKRAGLL
>LONDMIMF_01453 N5-carboxyaminoimidazole ribonucleotide mutase
MKIAIIMGSISDMPVMQEAIDILKEFGIETEVDIVSAHRTPEKLFDFSKNAHTRGIAAII
AGAGGAAHLPGMVASMSPLPVIGVPVKSSNSIDGWDSVLSILQMPGGVPVATVALNGAKN
AGILAAQIIGSNNKAVLDKIIAYKEGLKQAVLKASENLKK
>LONDMIMF_01454 N5-carboxyaminoimidazole ribonucleotide synthase
MLIFVANNNTTMNYFSSDFKLGILGGGQLGKMLLADTRKFDIQTYVLDPSEEAPSRIGCN
KFFQGNLMDFDTVYEFGKKADVLTFEIELVNLEALEKLESEGTKVYPSPKTLRNIQNKGR
QKDFYKTHNIPTAPFQRFQTLEELKTSLEKNNTALPFVWKSAEFGYDGNGVKIVRTATDL
ANLPDVECIAEEMIPFKNELAVIVVRNPKGEIKTYPVVEMEFHPEANQVEYVICPARIDD
KVAAKAREIALKVSEAFEHVGLLAVEMFQTENDDILVNEVAPRPHNSGHYSIEASYTSQF
ENHLRAILDLPLGNTESKVAGIMVNLVGEEGHSGQVVYKNIEQILAIDGVTPHIYGKRET
RPFRKMGHVTIVNEDITKARTTAEEVKKLIRVISNS
>LONDMIMF_01455 Response regulator UvrY
MEKITIGIIDDHKIVRQGLKELLQKISNFAVTAEFDNGTDFLASLPLENKPDLFILDYSM
PGMNGIEVLKALEEIDDEYKILLLTQHFDEQIIDAAYHHGARGFLHKNCTAHDLKFAIDN
IVKIGYNNVSEILKRMRNYETAPDKDAKSQIVLSERELEFLKLVCDERELTYDQMADSMG
LSVKSIESYRTALFERFGIKSKVGLVLFSYKYQITPPFI
>LONDMIMF_01456 Sensor histidine kinase ComP
MLNNVAFGIIIGLLFISLLILFCVVLVKLYIRKIKNYTEVIYQKDIDFQKTVNQTILETQ
EQVLQNISQDLHDDAGQQLTYINFQIENLKLDSPELNQTLQPLSESVGNLSQSIRNISHS
LNSQMLLQQDLIKAIESEIIRLQKGSIPIHFDLKGESKRIFSTNEKIVIYRIFQEIMNNC
FKHSKASLIEIRLKANPDFEMVISDNGKGFDYEKIKNSTATIGLQNIIGRAAIIDYSVTI
WSENGKGTKITLTENKLT
>LONDMIMF_01457 hypothetical protein
MSFFELLTPIRIYILFTFIMLAISYDKGKKAHVILFIILLLSVINESMSAILKYNNIPIR
LNASIFIVINNILWFFILYNVSSIKKSLLLIVILFFLSFTIYNLFLLNGIKEFNSYSFVI
GAFLYLILFIYNCSSELKKENLNYFLSNNFILMLSPVLFFIGFSLLFGFNNKNIHKIMIL
NRFKLYDFISYFVNITYYSLLNVYIYREKKLKHVE
>LONDMIMF_01458 hypothetical protein
MMGCNDKKKETVSEDKIQKIQRKDIAAGAPTDCENNPIMKSLRSMSHSEREKWLNKYGEA
ICMYDLYSCIENIHFIHDTVFTQLARQHSRNTTSIKLYELPWKDLESFIKKEGIKCYDAY
IAFDIDAINNKVSLRKTSFSTTEATYSIPLFEGIKKVHGNIQTIYVTDAVVGKKVISKER
IIFKVKDASGNFFHYDISDDPAIMNM
>LONDMIMF_01459 hypothetical protein
MKTITNLIIVLVCCCSYAQNKETPEEKAAKKELTALYQDFSYTKGLLELESKKLRDMNSA
GKPLADIEVQTKKERGIKKELDGLYKQYQTVKAYHLRKVSEKKLNQYFPPPANYKPLDGE
QVDESKSAEENETSSKDTVETEKAVYIMYGDKKIADESIFKNKEAETVFKEILSVKSETC
LGNFEIPGHKQKIQLYDVSYDAVANQFVCFKQVKFSIRDGNIYDIRVTVTNSEQTKEYYF
ENRVPISMLNYPREAKRNFLSHRSTLLMGDSLNGKDEVKNSYIRISDVLTYLPNPGNNFV
PDDVEYTFPTGLEKEVNEEKRRLYLLNQDTNLQNVMELRTYTDFLGLFDDTPNGIMQIEG
KADFFVVPFQVGRLHPMNFFKKVSPYVHYTRLDDDHKGLTLIDNPSLPGTQMIGRPLEII
EKSYLDMGAVLDVFSFSFIKESPFNINLYYALRYQIATIDRENEENLNFKTLGHAAGVRF
EFKRFNNFGFNFSPEFAYYNHMNKIDFMENPKNIWVFRNEAEIFYYPGESKKQSVFLRLR
TFMDVSDSEDSFFQLQFGYRFSIGLGSVKGKGL
>LONDMIMF_01460 hypothetical protein
MKKQTIKITAIRLVRLWLFFSCIVTAAQENTIQMKSDIYSENKTLTDIMRFEDIDYYTTK
FTGTALKNKEYYIVAKEIWNGKIKKTDTVFNSSTNSYIGKIEKDSMNLRVIAGKSSDKTL
KIKFMFDRFEVQKEYKSIRSDDYSLRDFGSHFPIITGKSFYAFAYILPYEDKQGNKFWCA
VESSGKDIESWGKEFGIKHYILFEMRFGE
>LONDMIMF_01461 Signal-transduction histidine kinase senX3
MKRKILLAFALMSVSVAGIAALQLFYSYTTYVSERRQFERDCNEALDEAVDSSFTRYRRI
VTGTFRSWLNDPSFIEITARWNPDVKETVFTIRERQPSSVGQSQISMSIGDLKERFDSIT
PGSKELLVNHMVSQVDAELKKGYVWFYTQKLGDSLTKIAYDTPIEKALLKKEYRVALEKR
GIMLPFVFNSKEDGKSYQTKKVNISLRRPHKKEMLQASVVNVDLFLLGQLKWVLTGAILL
LLITLFCFWYTLRLLLSQQKLNAIKDDFINNMTHEINTPLTSIAITADSLKKFSHDKEVQ
ENYIDIILHQSSKLMSLTDEILTSARLENSEMELHDMIAVDTMLQQIAVQIESPVQISVT
ANSNATLQGNKKHLDRAIANLIDNAVKYSTSTNSVIEIRSSIENGKLLIAIADNGPGIPD
EHKEAVFSPFYRIPLGNIHNVKGYGLGLSYVKKVITAHKGSILLKDNIPNGSLFLIKLPL
S
>LONDMIMF_01462 Transcriptional regulatory protein WalR
MSTTILLAEDEQFLGKVVKESLEKQGYIVMLAPDGKKAWELYKAHTFSLCILDVMMPYKD
GFTLASQIRNDNPEIPLMFLTAKSDIKDITAGYASGGNDYLKKPFSLDELFLRVKELLRR
TSSGKEKNDEERIGNYLFLSQRQELKINDKTIKLSHKETQLLELLLKHKNQVLDRKSTLL
LLWGDDNFFNTRTMDVYITKLRKKLEEDKNIEVINIRGFGYKLIC
>LONDMIMF_01463 hypothetical protein
MPTNIPASSLDFLKQLKENNNREWFNDNKDLYLKEYDAIEKFAESLLQELRNHDVIETVS
GKKSLHRIYRDTRFSKDKTPYKTNWSGGFKRATALRRGGYYFHIEPGNSFIAGGFWAPNT
EDIKRIREDISFDPEPLRKIINSKSFVKTFGSLQGEQLKKAPKGFDTTDEAIDLLRYKQF
LLIRKFADVEVLSPSFLKEADQTFKNMRPFFDYMSEVLTTDANGEQLPGLS
>LONDMIMF_01464 NADP-dependent alcohol dehydrogenase C 1
MIATKGYAAQDNKSPLAPWNFERREVGPHDVQFDIQYCGVCHSDLHQIKDDWFPGIFPMV
PGHEIVGRVVKVGDHVKKFKVGDIAGTGCMVDSCRECENCKKDLEQYCLKGNSQTYNGLE
QDGKTPTYGGYSNTIVVHEDFVLHVSDKLNLAAVAPLLCAGITTYSPLRHWKVGKGHKLA
VLGLGGLGHMAVKFGVSFGAEVTVLSTSPSKEQDARKLGAHNFVVTTDEAQLAAARNSFD
FILDTVSAEHDLNLYLSLLKTDGTHICVGVPSQPAPVAAFSLLGGRKSLAGSGIGGIAET
QEMLDYCAEHGIVSEIEMIDIKNIQDAYDRMLKGDVRYRFVIDMATL
>LONDMIMF_01465 hypothetical protein
MTVTDANNCQLTRTFTITEPAVLSATTSQTNLSCNGGTNGIAGVTVTGGTAPYTYSWAPS
GGTGATATGLAAGTYTVTITDANACQITRSFTITEPTALSATTSSTNVSCNGGSNGSATV
TVTGGTGAYTYLWAPSGGTAATASGLAAGNYTVTITDANMCQITRTVSVTQPSPIVIVPS
QSNVSCTGGSNGSATVAVSGGTGNYTFSWAPSGGTGATATGLAAGTYTVTVTDANSCTAT
QSFTITTTADTTPPTVVTTNITVPLTAGVATITAAQVNNGSTDNCGIASISVSPSTFNCS
NVGPNTVTLTVTDNSGNTATGTATVTITDPTNFCGLSVPEFGDIKMRLYPNPTNGIVTVE
FSRDITAEKIEVYSITGQLILSDTNTTTQSSRQFNMERFPSGVYLVKITTAHGTQVKRLM
RE
>LONDMIMF_01466 hypothetical protein
MKTFLFTLFATAIAPFAFAQEPDKALIRVRYAFSHVRDTTNRENYYRENMMLIAGKNASV
YLSYDKIIQDIEAKEAFEKQKRQQANVETPTFVSPPKKRQSNSMEIFYFANRHKFIIKEQ
LVAFYLTEEKVEKIDWKISTDTRIIEGLNCKKATGYFRGRNWTAWFAEELPFSTGPWKLV
GLPGLIVEAYDEDAEVSFIFLGLEKIDEKAKPVRNPSNDYTIRKIGSSNVLSETEIQLPP
DAIKATPEEIKKLKETRDKDPKKFLQTQMELVGLGSLKQVSPGKNTGIPAQMPVFNNPIE
RPKSLHPYP
>LONDMIMF_01467 hypothetical protein
MMIFGGMATMKTIVLLLLLFSCSNLAAQDLSNVLLYEQRFFDSDTCCWRKLANTKEYEKA
GNMIVLYLKNNKTHTNSQSLQWHAGQMFAKAQNDKQAIFYFKKTYNFSYRLFGGDEGKAW
YFYAKGTVAFIKRDKEKLQKMIQKWDKNLPKDRNYDALVQLYKNWDKKYLEATE
>LONDMIMF_01468 hypothetical protein
MKNTFLKQSILLFFMLFAVASFGQEGKKNQKAVIKTSIHCDHCKECETCGSKFQSNMLKI
KGVRMYELDEKNSTLTVYYNATKTDLQTIKTAISKLGYDADDIKADAVAYESLDNCCKKA
>LONDMIMF_01469 Trans-aconitate 2-methyltransferase
MDTKNKEHWEAVYQNKGPKEVSWTQEIPKTSLNFIHSFNLDKSAKIIDIGGGDSKLVDFL
LDEGFENISVLDISAKALEKAKLRLGNRSEKVNWIVSDILDFKPDTAFDVWHDRAAFHFL
TTKEQVEKYIEIAQSAVSGYLTIGTFSENGPKKCSGLDIKQYSEETLHAVLKNRFEKLHC
IYEDHKTPFNTTQNFLFCSFKRNRN
>LONDMIMF_01470 hypothetical protein
MTAKPDNIDEYIATFPHDVQKILEEVRSTIQKAAPEAIEAIKYAIPTFVLNGNLVHFAAF
KNHIGFYPAPEGMEEFDRELTAYKKGKGSVQFPFDQPIPLDLIARITAFRVKQNSEKKK
>LONDMIMF_01471 Mycothiol acetyltransferase
MQFQTLEKSSTEEILEVFNGSFSDYIVPFRLTLPQLEGKITNDSVRMELSVGAFEAGKLV
GFILHGYDKINGETVVYNAGTGIIPEKRGNGLTAQLYEYILPFLKAEKTDIVRLEVLTEN
IPALKTYEKTGFKIVRNLDCYKTSLQTEGQDKDYDIRELKSFDWQNMRLFWDWEPSWQNS
ITAVENLKETNHAVGIFDKEQLLGYLIYNPAAKRVQQFAVKKEFRRKGLAGQLFSYIASN
FGNEIALINIDGNSKETAAFLESLGFEKFISQYEMELKLDGLREVYTG
>LONDMIMF_01472 Phosphoribosylformylglycinamidine cyclo-ligase
MSSDTSKRYNLRGVSASKEDVHNAIKNIDKGLFPKAFCKIVPDYLTNDEDYCLIMHADGA
GTKSSLAYLYWKETGDLSVWKGISQDALIMNIDDLLCVGATDNILLSSTIGRNKNLIPAE
VISAIINGTEELIEELKSFGVTIHSTGGETADVGDLVRTIIVDSTVTARIRRDKVVDNSN
IKPGDVIVGLASFGQATYEKSYNGGMGSNGLTSARHDVFHNYLAQKYPESFDASVPADLV
YSGNVKLTDEVKGAPIDAGKLVLSPTRTYAPVIKKILDTYSPEQIHGMVHCSGGAQTKVL
HFVDNVHVIKDNLFPIPPLFRLIQEQSKTDWKEMYQVFNCGHRMEIYVPQEIANEIIAIS
ESFNIEAQIVGRVEASENKKLTIKSEFGTFEY
>LONDMIMF_01473 Photosystem I P700 chlorophyll a apoprotein A2
MKNTALYIFFLFFSLVAQAQEEFSVYFDSNKYELKKKENERLQNFINTNKEVKIVAINGY
TDEDGTTAFNDTLAQKRVDFIYGIINGKLKIRDDFKTRSFGERHRQSKIKSENRKVTIYF
LLAKDLPRENEILGIKEEPVVKKQREMPKYPQKMTLQNPNGTTSELVFDVAFMEKLTVAK
PGEKIKLENLNFQLNTFAITNDSRPKMYELLEVMKRNPQMKIQIQGHICCMQNDKQDLST
KRAKAIARFLEMNGIDKDRVTYKGFGVTEPLFAIPEKSEEERAANRRVEIEIIEN
>LONDMIMF_01474 hypothetical protein
MKQKFTTTFLLLFSVLLYAQEQQFQVFFDFDISETNTASTTKLQQWISDNPTAEVEKIYG
YCDSVGSLEYNDVLSVKRANYVLEKLKSSNIKISGKAEIKGFGKRLIQPGLASANRKAVV
YYTIPAKKEEPVAKENLSEETKNLKTGDKFTLKNLNFYNRSGVIVPSSEPILKELLSVMV
ERPDLKIEIQGHICCQLGTDLENIATIRARAIYNFLIENGISKDRLQYKGFGSSRPIHQI
PERNEQERNENRRVEIVILDSK
>LONDMIMF_01475 Protein TolB
MKNILIKSGFVLLLLLLSCSEEKVDGEDFGTVTGRVVVANTFEPLANAKVFSNPTSSIVF
TDEDGRFTVPKVVVGQYSFQAQKDGYLTKFEAANVVNNSTTEIVFELSVSTSGNRPPNAP
TLTLPADNAVNQNRQVVLTWTATDPEQDSLTYEVILRNDATDDVVVYSDISTPTFTLQNL
AFGTKYFWQVSASDGVNAPVMSAVRTFTTTSFPDTRFLFVKKLSENNVIYAGDNSGNQIQ
LTSSETNSWRPRKNNQSNKIAFIRSNGAQNHIYIMNPDGSGVFKVTNSVPVAGFNPEFIN
FSWNTSGSQIIYPSFDKLYRINSNGSGLTEIFHTPNGKFISECDWSYDGSKIALKVNDAS
GYNAEIYVITSEGSITDLVISGVNGAVGSLNFSITGQKLLFTRDISGFENPDYRQLDTRI
FQHTFSTNTTAEINTEKPAGTVDIDARYSPNEAEVIFVNTSNDFISARNIQKYLIGIVAS
RTTLFTNASMPDWE
>LONDMIMF_01476 Curli production assembly/transport component CsgG
MQIRYYFAIVLMLLLSGCGAYYNQPLKIEKASLGEITPATTLLRELPKPKEPVVVGIYKF
RDQTGQYKASDNGSTFSTAVTQGATSILIKALEDSKWFVPIERENIGNLLQERNLIRSTR
QEYSKNPNSTEQLTPLLYAGVLLEGGIVSYDTNIITGGFGARYFGVGGSTKYRQDRVTIY
LRMISTASGKILKSVYVSKTILSQAIDQSFFRYVKFKRLLEVETGYSTNEPVQMAVTEAI
EKAVQSLVLEGIQDKIWEADASKEEVDSLISKYEMEKEVADATGIYGRYKTERRSRFAME
LAGGATLIDGDYDKSLLRPMGRGALKYFFTPGFNLSGSTNVINLANKDRLDVGYLTFDLN
AELILLPKEQLSPYVFGGVGFGANRLFENTHAKVQYGAGLEYLASKTIGIKVYAEHNLNF
SDNIDYLERGVRDDYYFRFGLGLTYYFPRKNQKIYEKYIIEEAQNPLKQ
>LONDMIMF_01477 hypothetical protein
MKPLATAIIILLAYAANAQDLVYKPRNPNFGGDTFNYQWLLSSAEAQNKLKDNTVTTKTK
TELESFTENLNSQLLNLVSRSLFTQQFGNNGISEGSYTFGSLSVEIFPSENGLTVTILDT
NTGEQTQVIIPKS
>LONDMIMF_01478 hypothetical protein
MPKYLSYSFFILMLFSPAAYSQLTNSQVKAKIHLEEIEGNIKITGTAENLTDIVQSLSYK
LSVIRKNKINSNQSNNAQEGLFTLDPNETKKLSSTQINVNENDEVIVMLLFYDSEKKLVG
KDRIVIGEEKKDEGIVPVDGFELSGIVTDDTKTKAGKDFYDLYFFKYSDLKINSKKIVTI
TEELSFARNTKITISIDTNPIYEFLVNPDEEFLSLVAEDAVNVTSAYLKNLEKQSRYLTQ
Y
>LONDMIMF_01479 hypothetical protein
MKPLFFKLLLLVLFSQVALAQEEENPGFDQYSSSAFDSKEETLFVVSSMNPKQYANSLFQ
KGDILVQQIGDYNLFNANLKANEVNVSVLQNGDDNDISLSKQANTITQNIIQSGKNNGIQ
DFTYYTKYDVNTQMIQQGNNQNIQNYGTNSLSKDMKVTQSGNGSSVIIINQ
>LONDMIMF_01480 Minor curlin subunit
MKKVILSISVMLVSAVSFAQFNDSNVLQLGGSNNSAVNQKGSYQDSDVRQQGNNNVSNVT
QGINPNLSSASNHNKADVKQVGNSNNAFVSQNNLYNEAYQVQTGNSNQATIWQDQLNPVA
GNGHDWAKQVQTGNNNKATIDQGTSGNEMPSGAPFSAEALGFVSAVAVPFMPHGYNDALQ
TQNGDFNIAYTSQGGEMNDSKITQTSNAVAASGANKASHYQYGKENDALTTQNGFGHLDN
TLQIGNFNYSNVMQSGNNQTSMNVQKGNSNINNVTQSN
>LONDMIMF_01481 Glutamine synthetase
MSTFRFQALAQTAGRKPVKFEELEKKSAIFGSNVFNDKAMRQFLTQDAYQGVKDAIQHGK
KIDRKLADYIALGMKEWALSKGVTHYTHWFQPLTGTTAEKHDAFFETSFDGSDPVEKFGG
GQLVQQEPDASSFPNGGIRNTFEARGYTAWDPTSPAFIFGTTLCIPTVFISYTGEALDYK
TPLLRALHSIDEAAASVCRYFDKNVKKVTATLGWEQEYFLIDSALANSRPDILMTGRTLL
GHTSAKGQQLDDHYFGSIPTRVLSYMRELEYECMLLGIPVKTRHNEVAPNQFELAPIFEE
TNLAVDHNSLLMDVMQKVAERHNFKVLFHEKPFKGVNGSGKHNNWSLATDTGVNLLGPGK
TPMSNLQFLTFFINTIKAVQTYEELMRASIATASNDHRLGANEAPPAIISVFIGQQLTKV
LEELEGVSNGKLSPEEKTDLKLNVVGKIPDVLLDNTDRNRTSPFAFTGNKFEFRAVGSTA
NCANAMTTLNSIVAKQLIDFKKEVDALIEGKDMKKDDAIFNVLREYIKETKNILFEGDGY
SDAWQKEAAKRGLSNHKTTPEALKAKVSKKAIELFGELGVMNHVEVEARYEIEMEEYTKK
IQIEGRVLGDIARNHVVPTAIRYQNLLIENVRGLKDIFGKEYETIAKEQITLIKEISGHI
EAINTKVEEMTQERKKANNLSDTEKMAFAYCNKVKPYFEIIRKHCDKLELLVDDEIWTLT
KYRELLFTK
>LONDMIMF_01482 hypothetical protein
MNGKVYFCYGMFNIINKSLIYVYLFVGFFIFNEYYIVFRLSYKIWQVKYILQKGMKIFFL
CFACFLRGGYGIFLFLLFYTLKK
>LONDMIMF_01483 hypothetical protein
MSSKKLVIGIAAGVAALAIVGLIVAKKKSKKDKFSEKAKEARDNFKSKLNDLQRKAKREF
NDALEEGENLANKAKDRANEWANRITS
>LONDMIMF_01484 Mannosylfructose-phosphate synthase
MKNLPHSSTLTDLNPEAPAFPSRANTLTDEELLPEILFITSYPPRECGIATYSQDLMKAL
NNQYVSSFSLTVCALENDHERHHYSDEEVKYTLNTSDPSSFKAIAATINNDPTIKVVVIQ
HEFGLFRDHESFNLFLTEIKKPLAVVFHTVLPRPDEAFKQKVQQILDRADSIIVMTKNSE
AILLEDYTVVSEKISVIPHGTHLVPHNDKNALKAKYGVKGKKILSTFGLLSSGKSIETTL
EALPNIVDKSPDVLFLIIGKTHPGVVVNEGESYRDSLKEKIKELKLENHVQFVNKYLPLE
ELLDYLQLTDIYLFTSKDPNQAVSGTFSYAMSCGCAIVSTPIPHAKEMLQNGSGLTFDFG
NSKQLAEAVNQLIYDIGLRKNMILNGLHKIMHTAWENSAVAHAILFQKVSGGKIELHYRN
PKLNLDHIKKMTTEFGILQFSKLNRPDPNSGYTLDDNARALIALCQDYKLTRDIEDLKYI
SIYLNFISFCLSEDGKFKNYVDIDHNFTPQNNSVNLEDSSGRAIWALGYLISLAPILPSN
FTKKAETLFRKAMPQTEKMHSTRAMAFIIKGLYYFNRHIKDLDYKIYIEIFADRLVQMYK
HESSENWKWFESYLTYANSVLPEALLCAYAVTDNEEYREIAKDSFDFLLGNTFSENQIKV
ISNKTWHFKGQEKHSYGEQPIDVAYTILALRKFHDIFKDEEYLNKMEIAFNWFLGNNHLK
QIIYNPCTGGCFDGLEETNVNLNQGAESTLSYLMARLTIARYFGNPNTIYFRKKLKATKL
LLLKS
>LONDMIMF_01485 Copper resistance protein A
MNRLIHMFKRLLPAIFILFCAQSLFAQKVVRYELVLKDTLVNFAGKQKRAIAANGQIPMP
TLEFTEGDTAEIVVHNQLREGTALHWHGLFLPNKEDGIPYLTQKPIKPGTSFTYRFPIIQ
NGTHWYHSHEGLQEQIGMYGNFVMYKRADDKTFRKGIDDLPSVPIVLSEWTNLSPDNVHR
MLHSATDWFAIRKGATQSYAEAIRSGHFKTKIKNEWKRMLAMDVSDVYYEKVLMNGRNST
ELKSIDGKPLKAGDKVRLRIANGGASSYFWLRYAGGKMSVVASDGNDVTPVEVDRLIIAV
SETYDVVVTIPEDGKAFEFIATTEDRTQSSSYFIGNGEKQYAGALPRLKYFEGMKMMNDM
MKMNGDLDDMGMNMSLQQMDMNVVMYPEITGEEKKKDKSAKNKTVEADHSKHNMPDNENK
QNAGAGEHEMNTDENPDRYNANALSDIVTLNYSMLESPHSTELPENAPVKELKFTLTGNM
NRYVWSMDNRILAETDKILVKKGEILRITIYNNSMMRHPMHLHGFDFRIINGKGEKAPLK
NVLDIMPMETDTIEFMANEEGDWFFHCHILYHMMSGMNRVFAVDDYRNPYLPDKAKAYRK
LQRDHNMPHLMAENDFASNGNDGSAMLQNARWSLGSEWRLGYNDMHGYEIETHLGRYIGK
MQWLMPFIGFDWRYRKMGIDEHEKNIFGQVNKKDNRSAVSLGVMYTLPMLVNFQAEVYHD
GIVRLQLMREDIPIAKRLRAGFMVNSDLEFMGDLRYIFTKNLGIRTHYDSDMGFGVGLFL
NY
>LONDMIMF_01486 hypothetical protein
MKKVIKKILVIILFVFLVIQFFQPALNTDDGRVYTTDFTHTYKTPAEISTMLKASCYDCH
SNNTNYVWYDYVQPGRWLVEKHIRQAKNELNFNEWGNYSARKQERLLHSMAEQVETGQMP
LRSYTLLHKNAVLSKDQIEVLTKWLKEQP
>LONDMIMF_01487 hypothetical protein
MKHRILSILVFTTVVLIIFSCKQTPDKSNEKQEEKAPAAHGQETGEAGNNTTAPQNFSIE
TIVKDYLALKNALTIDDGKAAAEAGKQLFGSLNAVDMKTIPGDKLRDYTEIADNAKENAE
HISVSAEKIGHQREHFASLSKDVADLIELFGMKQKLYVDHCPMFNDGKGAIWISETKEIK
NPYYGSKMITCGSVKKRVLK
>LONDMIMF_01488 hypothetical protein
MKNFRIIIVLFFAILNVACAQNSKSQNVSTENRDHSHSDGKTNGVAYQKGDVVPHNEVCM
VNDAYMGKKQIEVEYEGKKYYGCCEMCEKRIPKEKEVRMAVDPVSKKQVDKAKAVIAITG
DNSEVSYFENNKNYKTFFKQK
>LONDMIMF_01489 hypothetical protein
MKKLMLVLVVLFFGFPAFAQNTANLLNNYMNVKNALVNGDSKAASEATASLYESIKKEDG
FNQKQELLQAAEKLNKAGNIEKQRAELNNVSVILWKLVENDKKLDQTVYYQYCPMKKTYW
LSKDKEIKNPYYGSSMLTCGKVTSTKQ
>LONDMIMF_01490 hypothetical protein
MMKEQSIQDKKGILMIPDISGFTDFVINSDMSVGKYITENLIKSIIKSNILCFEISEVEG
DAVLFYKYRNLPTFQETLIQIEQTYSEFQKELRRLSKKLALEIPLSLKTIVHYGEFTKYR
IGKFEKLYGTTVVEAHKMLKNRIAQYPPYALFSDTFVRANFDQPERSTVQYDACEDCKYL
PEIGYIHYL
>LONDMIMF_01491 hypothetical protein
MKKYILSLGMAAVLFYTNSISAQQWSIGARGGLSIPNLTAGSGSANNSLSKGYSSRLGAG
FGVFAEYQTSKLFSIQIMIEYSQQGGKKNGFQAFPVPAQMAPLFGSQATPYLYADFNSTA
KFDYLMLPVLAKFGWDLGPKKKWRIYAGVGPFAGLLLSGKQVTEGISQIYLDEARTTPVP
LNPANPSQGILTLSFDNTKNIKDRLRQFNFGLEGNVGIGYKIKRSTIFLEGGGNYGFIDI
QKGTANGKNKSGAATVMIGYAYSL
>LONDMIMF_01492 Riboflavin transporter RfnT
MKTTAKWSNVYLLFIAQALFQTASILVITLSGVVGLAMAPDKNLATLPIAMITVGTAMMM
IPASMLIRKAGQRNAFMVGTLIGVLAGLVSWYGIIQNSFWIFSIGNMLIGAYQGFSQYYR
FAAADAVPEKAKSKAISLVIAGGIVAAFSGPNLAKFTQHLGKVPYAYSYFSIVLLSILAF
GIVSLLKLDKTSLQKNDKNNTDKGRSLKKIIKNRDTILALLASSTAFAVMGMSMTVTPIA
MYGFGHSAESSATVIQWHVLGMFLPSFFTGLLIQKFGTYRIIISGLFIMFLYIIIALSGT
GTGNFVAALFVVGLGWNFLFIGGSSLLTKVYRLEEKEKTQAFHDFTVFAVISIASFFAGN
LFNHWGWKGVNIVLIPMLVITLIAALRITWYQGKSVR
>LONDMIMF_01493 Cadmium, cobalt and zinc/H(+)-K(+) antiporter
MGHDHEHNHSGSANKKTLIISLVIITAYMVIEVIGGLITNSLALLADAGHMLSDAISLFI
ALMAFTFSSKIADYSKTYGYKRFEILAAVINGATLILISVYIIYEAIERFQKPPEITSGG
MLIIAAIGLAVNVLVAWIMMRGADVKENLNMRGAYLHVISDMLGSVGAIIAALLIMFFDW
VWADAFASVIVSVLVLRSGYLVTKSSVHVLMEGTPDNVEVEKVTQKILETEGIIGIHDLH
IWTITSGLNALTCHAVVDEKMTIEAGEIMLRKIEHDLEHLKIHHVTIQLETPAHLHDASV
LCTTKAEVIAHDHNH
>LONDMIMF_01494 hypothetical protein
MKRILLLLAIVGMTALQGCSNDDDRVDNDTIAEVFEINQNTTFTQANGYTINYSLVPPIY
NSDMILIYRLSGQSGGRDLWEALPQTYFFSNGTEYLQYTFDFTTTNINIYIDSNFPAEQE
PAFSVNQVFRVVIIPGFLSNKPAKSSDKGIATPASIDYNDYYAVMRAYGLNDSNIKTLKP
SK
>LONDMIMF_01495 hypothetical protein
MKTICSWLFFLNLFFIADMAAQIAGCTDPLSKNYNPEATINDGSCQYKRAAIRSEFSKKL
DEKLHETSGLIFWNRKLWTHNDNKDTVIYGIDTISGNIQESYELKKVVNKDWEEISQDSS
YLYIGDFGNNVAGNRTDLHILRIEKKSLALNPVIDTISFHYSDQMNPIIPSKANQTDYDG
EAMVVSKDSIYIFTKQWTSKKTALYSLPKTPGNHVAQLKTVHDIRGLVTGAVFLEAESTI
VLCGYSKHLKPFLYLLYDFHGTDFFTGNKRRIKLRLPFHQIEGIATQDGFHYYLTNENFS
RKPFINKTQKLHQVDLSRFLRVYLEKKRKNNFNKE
>LONDMIMF_01496 hypothetical protein
MLKHLKTEHFYNSNNVICRKRNQQIVMVKKLKEEILLKDASIKKVQFDKYWFYDLKDVAD
YLNEDLSEVEYIHLPFVVDEVKINTKCATLEDIERARAAKGKTI
>LONDMIMF_01497 hypothetical protein
MKFLQALFILFAVNATAQSELGIGIATIKYTGNSVLNLYAAAYDKEPKQIIQFYQDEVTG
SPDIRDIESVEKWLKPEGFFLDYDQLVFRCKSEERFWIEVIVNNETGESYWIRKTKSVDL
DTWEGFLKNAFMISRNSFPQEIKAQPNDSARTIPFDGEDCFQVKSMKGDWIQIFTGSHCD
DDGNPIKSGWIRWKQENEILIDYFLTS
>LONDMIMF_01498 Endo-1,4-beta-xylanase Z
MKNLKLLWSAVFLFYGLASQAAKVDTLAIPSVAMNKTYNAAVVLPNSYAKSKTKYPVVYL
LHGAYGHFRDWLNATSKNSTVKNLADQYDIIIVMPEGETFSFYLDSPVNKGSQFETYITK
EVVQKIDQTYRTINEKKGRVITGLSMGGHGALYLSAKHPDIYAAAGSMSGAVDMGTMKNM
GIDTPERIDQLMEPVFGSQGAPQEVYAAHAVLNMIDKMKANGLPLIIDCGVDDFLIGPNR
ELHRRLVYSKVPHDYTERPGAHTWEYWENSLPYHMLFFSKIFKVNNATAQ
>LONDMIMF_01499 Aminoglycoside 6-adenylyltransferase
MDWAISNDDIRAVLLTSSLVNPYAPVDQFSDLDIEFVVSNLQQFLSDDSWVENFGKKIAM
IVENEEAFEGKHAMRMVFYEDYTKVDYKIYSVDKFLEEVNNEELQEDWDVGYKVLLDKDD
ITKNMKPPTYNAVMVKKPTEQEFTTLFNDFWWDMTYVAKCLWRDDLFYAKFMLEDNMRTQ
YFQKMIEWHIGLEHNWNVSTNKKGRLFKKYLSPEMWKKIEATFSGSDIQDNWRALFAYAD
IGTELGTAMSQKLGYAYPAELDSKIRNYLNHVKSMEDKDS
>LONDMIMF_01500 hypothetical protein
MEKVTIAQKLSLFNDYWNPRIVGELNGQHVKLVKFQGEFVWHKHDNEDEMFLVVKGQFNM
EFRDKTVELKENEFLIVPRGVEHRPVAPQEVSVLLFEPASTLNTGDAEKSDLTKRTLDTI
>LONDMIMF_01501 hypothetical protein
MKYQNKNFYILTGGPGVGKTSVLNELEKSGYTVMPEIARAIIKEQMATDGEALPWKNKEL
YMQLMVEASAESYREAISKNSLLPVFFDRGILDAVCYARMVGLDLSNEIQEIAEHYQYNT
KIFVFPPWQGIYEIDEERKQDWKEAEATFEAMKKTYQDYGYEIIEVPKDTVEKRKEFIIN
RIKQNTSDED
>LONDMIMF_01502 FAD-dependent urate hydroxylase
MVVKNKKIAIIGGGPGGLTLARLLQQNGVDVTVYERDAGRFVRVQGATLDLHDDSGLKAL
KEAGLMEAFKKYYRPGADKMRIADQYGNLVYDQHNEPDNMADFGHEHFRPEIDRGPLRDL
LLDSLRPETIVWDSHITALEKEKGIWKLVFQNGKTETADLVIGADGANSKIRPYLTTIRP
FYSGITVVEGSLYEAAEKAPRIYEMVKGGKVFAFGNQKSLIVSAKGDGSLSFYTGCKTQE
TWVRDSGIDFKDSQSVATWFRTEFSDWDEIWMELFVTEGTSFVPRPQYCMPLDQTWKARA
DSTLIGDAAHLMPPYAGEGVNMAMLDALELSNCLTGTDFLDIEEAIAHYEKQMRKRASEI
AKMTLEQTEALHSENAISHMLELFKE
>LONDMIMF_01503 hypothetical protein
MEGPFKYKIVKPDSSIAGYVESFWEIRTPSGEPKNIIVLPDGRIDIIFSYSDTEPFRAVL
LGLETEASQTLMQSGRTMFAVSLRLLAVEYLLEASVSSLLNGGRLLPEGFWNIAKEDLSD
FDAFCNKLTGKIQSLIKTVPDNRKLRLFDQIYTSNGTLTVKELSEKAGWSSRQMNRYFSH
QFGLPLKTYCNILRFRASFKHLKEGKLFPEQDFADQAHFIRDVKKFSGVLPKELSQNKND
RFIQFSTLNKK
>LONDMIMF_01504 hypothetical protein
METGKENFLLIGIQLDNKTTNKEGQAAIDCGGLWHQFETEKRYGQIEGKLGNEIYAVYFD
YDGDHTQPYSYFIGCKVAEGTAVPQGFKSLKIPAQTYTQKIAKGVMPACIAEAWREIWKE
DANLNRAYQYDFEIYDERCADWNNAEVDIFLSVKK
>LONDMIMF_01505 hypothetical protein
MAPDTSVHTFHIPVMGLSFTIDSPIRVAHYGISSVVSIVDDELIEKMNAFYSKKFCLPYQ
EITKKIHDYRAERIKSYLDMMDHVVKEKFQAFKRELSESRPALERFLGMLPNQSDFKRSL
QELLENSSELKHGIKNFLEKHFTPGAIDVNIMTKVDRENYDKKEALSIDFNDAHAALRGF
ANSKLQSSIVFSAGMNPRLYSYLESFNCFFPDTEGKLEKKITLKVSDYRSALIQGNFLAK
KGLWVSEYRIESGLNCGGHAFATEGFLLGPILEEFRTKRKELIQTSHELMAKALEQKGLP
VPSHQLPLKITAQGGVGTAEEHDFLLHHYRMDSVGWGSPFLLVPEATSVDNDTRLLLAKA
EEKDLYLSHISPLGVPFNTIRGTSNEQLKQHRIRTGRPGSSCPKKYLALDKELDKKGICT
ASLKYQSHKLEMLENRKSELTAMAYEQAKFNITEKACLCVGLANASYLENGITVKGEAQG
VVICPGPNMAYFNREVSLQDMLRHIYGYDSVMDFPNRPNLFVKEIRLYIDYLKKEIALHH
STATPAQFKKWTTFQKNLLSGIDYYEKLFLSVSLGTDTHPWNNLRKEIEAIETGQVSFEN
LQTS
>LONDMIMF_01506 hypothetical protein
MQNETHYITRSGWLRAAVLGANDGILSTTSLAIGIAAASETRSPIILAALAGVVAGALSM
AAGEYVSVSSQSDIEKSDLKREMKELEETPESELEELTQIYISRGLTPELAKEVALQLTS
HNALESHARDELGINEITQARPMQAALASALAFICGGILPLLVAIFAPLKYMVFLQYGFA
IIFLALSGTLAAKAGGSNKIKSVARICIWGTVAMVASALVGYAFGVQTS
>LONDMIMF_01507 Disulfide bond reductase DsbH
MKLFTFLFLLAFVPLKWETDFDTAQKDAKEKKQLILLNFSGSDWCAPCVATKRDYFENDS
FLSMAKDNLVLLNADFPRKKKNQLSPEQIKKNEALAEKYNKQGNFPFTLLLDSNGKVLKS
WVGKPEVSVEKWTKEIKNICDSHK
>LONDMIMF_01508 FAD:protein FMN transferase
MLEFSQSLRLMGNQFTITVVSPTKTEAESHINTAIEEIRRIERLLTTFDENSQTCLINNN
AGISPVEVDTEVVELIERSIGISKITQGAFDISYGSIDKTLWNFDRNMTQLPSREEALKM
IHLIDYRNILVDKENSTVFLKNKGMRIGFGGIGKGYAAEMAKRLLMQKGVGSGIINASGD
LSAWGHQPSGRPWRIGISNPDFPEDIFSYLDISGKAVATSGNYEKYVMINGKKYSHTIDP
KTGLPISGIKSVTIISSNAEFADAMATPIAVMGIKAGLYLVNQIPELHCIIIDDDNQLYT
SKNINLT
>LONDMIMF_01509 hypothetical protein
MKNLPVWIAACCIVMTAGCSSVKEYQKNKINDSEMALSNRKVEKTELSFQSYREGSSGAN
AGKSGGGCGCN
>LONDMIMF_01510 hypothetical protein
MKRVFITGFALLGLLKAYAQNEQADSTAYKPKKLKVDEINLVSSYYRQNGDNSAVTGGLG
TEKLTDISNAIDLRVVKYGKNNIKHNFDIEVGVDHYSSASSDKIDLNANSSASSSDIRVY
PSLNYIRENEEKGRTLGIGVSSSTEYDYQSFGGNVSFSQKTKDRNGEFGVKFQAYLDQVK
LLAPIELRGLPNVDDSGNASRNTFVGSLTYSQIINKNFQVMFQADLISQQGYLSLPFHRV
YFTDGSVHQEKLPDSRLKIPLAARASYFLGDNVIIRGYYRFYTDDWGIQSHTADIEIPVK
ITSFVSVSPFYRYYTQTAAKYFKGYEMHNLQSDFYTSNYDLSKFDSSFIGLGLRLTPVNG
IFGIKHLNMLEIRYGHYARSNNLNSDIVSINIRYK
>LONDMIMF_01511 hypothetical protein
MKSIAKLSILLLMILGTSIISCSDDGKDGVDGLNGMDGEPGTANVIYSDWLDRPVGTEAT
IDGTSGMLYTYSVPQITNEILNSGTVLVYMQFNGADIFALPYTSRAGNSINTIEAITTLG
NLKIFRYRHDGLTPTIAVGSGVKFRYIIIPGGTPAARSINLRDRSYDEVCELLAIPK
>LONDMIMF_01512 Fused isobutyryl-CoA mutase
MEQAKPYIPKNKVRIVTAAALFDGHDAAINIMRRIIQSTGVEVIHLGHDRSVEEVVNTAI
QEDANAIAMTSYQGGHNEYFKYMYDLLNQKGAGHIRIFGGGGGVILPDEIKELQEYGITR
IYAPDDGRELGLQGMINDLVQKSDFPIGDKLNGEAKHLEEKNPTAIARLISSAENFPEIA
KETLDAIHKQNETSKIPVLGITGTGGAGKSSLVDELVRRFLIDFPEKTIGLISVDPSKRK
TGGALLGDRIRMNAINNPRVYMRSLATRQSNLALSKYVAEAIQVLKAAKYDIIILETSGI
GQSDTEIMDHSDVSLYVMTPEFGAATQLEKIDMLDFADLVAINKFDKRGSLDALRDVKKQ
YQRNHNLWDASPDDLPVFGTIASQFNDPGMNTLYKAIMDKIVEKTEADLKSTFEITREMS
EKIFVIPPHRTRYLSEIAENNRKYDAVALTQQQVAQKLYGIFKTIESVSGKTPELTKSGI
NDDSVLPSAVEEHNENRIFLNLLLNQFDKVKMDLDPYNWEIIFTWDEKVNKYKNPVYTFK
VRDKEIKIATHTESLSHSQIPKVALPKYEAWGDILRWCLQENVPGEFPFTSGLYPFKREG
EDPSRMFAGEGGPERTNKRFHYVSAGLPAKRLSTAFDSVTLYGNDPHLRPDIYGKIGNAG
VSICCLDDAKKLYSGFNLAHPLTSVSMTINGPAPMLLGFFMNAAIDQQCEIYIKENNLED
EVEAIIAEIYKKKNIERPRYNGTLPEGNDGLGLMLLGVTGDQVLPKDVYEQIKVRTLSQV
RGTVQADILKEDQAQNTCIFSTEFALRLMGDVQEYFIAKNVRNFYSVSISGYHIAEAGAN
PITQLAFTLANGFTYVEYYLSRGMDINDFGPNLSFFFSNGIDPEYAVIGRVARKIWAKAL
KNKYGANERAQMLKYHIQTSGRSLHAQEIDFNDIRTTLQALYAIYDNCNSLHTNAYDEAI
TTPTEESVRRAMAIQLIINKELGLAKNENPIQGSFIIEELTDLVEEAVLQEFDRITERGG
VLGAMETMYQRSKIQEESMYYETLKHTGEFPIIGVNTFLSSKGSPTVIPAEVIRASEEEK
QFQIHTLENLHKAYGDKMKEQLAIIQDVAINNQNIFEQLMEATKVCSLGEITASLFEVGG
QYRRNM
>LONDMIMF_01513 hypothetical protein
MKNIFVLACSLAIFASCADKNKETEKTEETIQTPADSLPKTDSVAVAPVEATQTPEVDAK
TAAKGDEVIEVTPAKEIKVEYASFGDKILADKALSKEQMFQKYKSMKKGDTIAVKFKSKI
NSVCKKKGCWMKMELPGQAESFVRFKDYGFFVPLNADSQEAIVSGRAFVDEISVAELKHY
AKDGGKSQEEIDKITQPKITYAFQADGVLISK
>LONDMIMF_01514 hypothetical protein
MKKYLLISGIIMAFSSCNKKEEAQPVVKKEVPEKTTGAKEFEMYEMSEMAALMEQMYVDN
QRLKERIKNGDTIGKFPSHFLEIHKRAMTDEAENDAFFKEQAAVFIKAQEQIYEDPKNAK
AHFNKAVSACVTCHEVKCSGPIPRIKKLFIE
>LONDMIMF_01515 tRNA 5-methylaminomethyl-2-thiouridine biosynthesis bifunctional protein MnmC
MKREIIQTSDGSTSILLPEWNETYHSKHGAIQEAKHVFIQNGLSLFKGQSVSILEIGFGT
GLNAFITYLEAQKLQQKIEYTGIEAYPVAAEDVLKMNYVTELDAGSEKDIFLKMHESDWN
QREILSPDFSLEKQNIKFQEITDTNQYDLIYFDAFGFRVQPELWSLEIFQKMYAALKPNG
ILVTYACRGPIKNAMTEAGFLTEKLPGPPGKREMLRARK
>LONDMIMF_01516 hypothetical protein
MTRPMFAYTKSILERVSFDPLLFCKELEKAIRSLLPYEIEQLTEWLLSYTVEKPELKQCL
LIVNK
>LONDMIMF_01517 Hydrogen peroxide-inducible genes activator
MTITQLYYVLAVAENKNFTLAAEKCFVTQPTLSMQIQKLEDELGVLIFDRSKKPIQLTEI
GQKIVTQAKNIVNESDRIQDIVDQQKGFIGGEFKLGIIPTIMPTLLPMFLNNFIKKYPKI
KLIIEEHNTEEIITRLKNGHLDAAIAATPLEDEKIKEIVLYYEPFVAYFPESHHSFHKEE
IEVDDIDVDSLLLLQDGHCFRDGILNLCKNVNNSETSPFQIESGSFETLIKLADEGLGTT
LLPYLHTLDLKEKDKLKLRHFKEPKPAREVSLIFPKSELKIHIIDALRQVIAGVVKGAIV
FQNVQIISPLSKKN
>LONDMIMF_01518 DNA protection during starvation protein
MKTNILGLPVKETEEISNDLNILLSSFQVYYQNLRGIHWNIRGKRFFDLHVKFEELYNDA
QLKIDMIAERVLTIGGRPLHTFEDYMKNNKLKVGKNISVDEEAVHLIVTSLSDLLKIERD
LLSKSADANDEGTNSMMSDFIKEQEKTIWMMKAWLEEKI
>LONDMIMF_01519 hypothetical protein
MKLAVKIVLLMFMTFIVTPTIVGLIKKDVDTSMVYSMSEEEQHNHNSCKELKADFKVADY
LTFSHYTESSSSLIISQHSLKHDNAASTIFSPPPEQV
>LONDMIMF_01520 C4-dicarboxylic acid transporter DauA
MTKKINLFANLKSDFASGLVVFLVALPLCLGIALASGAPPLSGIIAGIVGGIVVGFLSRS
HISVSGPAAGLTAIVLTAITDLGAFNIFLTAGLIAGLLQLILGFIKAGSISNYFPTNVIE
GMLAGIGVIIILKQIPHAVGYDSDFEGDETFVEKGGGNALESLMDSLGHLQLGAILITLI
SLTILISWDKFSFLKKMKLVPGALVAVIVGVVLNEIFTASGSSLAISKEHLVSLPVPQSF
DDFKNIIVTPDFAGFMNPKVWVVGATIAIVASIETLLCIEASDRMDTQKRYTDTNVELKA
QGIGNMLSSFLGGLPMTSVVVRSSANANAGAKSKMSTIIHGVLLLISVLSIPVLLNKIPL
ATLAAVLLMVGYKLAKPTVLMHFWHKGKYQFVPFIITLLGVVFLDLLKGVALGIAISVVF
ILRGNLKRAYRFRKEKFEDGDVIRIDLAQEVSFLNKAAIKTTLAEIPENSKVVINASDTV
YIAHDVLDLIHEFATIRAADENIKVKLKGFKKAYELNDIDDKANHVFFENYEEARARKQA
KADYDRCMALVEKSKEN
>LONDMIMF_01521 Carbonic anhydrase 2
MSDFYKKIIDGNRKWVESKINQDPKYFEKLAEGQSPPLLWIGCSDSRVPANEVIGAQPGE
VFVHRNIANMVVHSDMNMLSVLDYAVNVLKVKHVIVCGHYGCGGVKAAMGNDSIGLIDNW
IRHIKDVYRHHHHYLDSILDEKERFDAFVELNVKEQVYDLAKTSIVQGAWRNGQDLCLHG
WVYRLNSGIVKDLEVNLCGNEDLDQVYQLKF
>LONDMIMF_01522 hypothetical protein
MINPSAHGWIDKFFAEQKYLQFPVADNPLEFYKNTRNTGFIYGHVVSFDTPQPIDTKGWI
SEEFSKVALLNTLYRVYGLVTHDTDPKNFIAKVIAFYKEMHPKGFNLLDKMLPESIPSHN
LEKIIAERIQTNEDIISKNFSHILTNALLFMDVLAFQQYLMNHSIPDNYLKKLEETIVSI
ISLALKTKLKKSKYDDLLIKLFEASVRYTKFSKVNVQDMEALGLDIFTKQLEKLYLIDMA
GMALWSDMEMESNEAYFLYELAKIMDVPDNFVAESIVSTDDFINKYKKQIPYFNYSNPVR
HFYDQATQNVKILITRNKTRLVKELSNNGDLMLLLTQSTHRSLDAKEKKKVKKQLLEICK
TIPSLTIFLLPGGSLLLPILIKFIPQLLPSTFNENLDEE
>LONDMIMF_01523 hypothetical protein
MICGAVPLREKITRKDAEAKNLQQSSIIFDFIIKNIALHQKFES
>LONDMIMF_01524 Gamma-glutamylputrescine oxidoreductase
MNLKSGMPFWLIKDGLPHTFPKLDKDIETDVIIIGAGISGALVRYYLINAGIQCVMIDAR
TIGLGSTSASTSLLQYEIDTPLHKLIDKIGKEKAERAYQLCNYAIDKLEKIAKELKLDEF
EKKKSLFYAAYKKDIPMLEKEFQARKEAGFGVSLLDEKQIYKQFGFKAPLAILSANAAQT
NAYAFTHKLLQVKKGSHLDIYDRSPIVKIDTQKNGAVLKTESGFTIKAKKVVYATGYEVV
EFIDKKIVDLKATYAVVSEQYNERKFWKDEVLIWNTANPYLYVRTTPDGRVLVGGRDEDF
YNPDKRNKLISKKTKQLTKDINTLFPQLDFKPEFSWTGTFGATKDGLPYIGVYDKLPNSY
FALGFGGNGITFSLIAAEIIRDLLLGKENKDASIFSFDRV
>LONDMIMF_01525 hypothetical protein
MKKPTIFGKAILSLGVLTLSLGTVSCKNEPKAEDPKEVAEDENEAKFDNTKEAEKDAEIL
VDAADFDLEQRELGKLAQSRGVSAAVKDLGKMMEKHHNEAFTQLSALAKEKQISIPTAIT
EDGQKEYDRLSKVDVKNFDKEYLDRVYKEHHDAIDDFTQDAQATKSVEIKAYLESMISTL
KNHHDEVEKLQSTLVKK
>LONDMIMF_01526 hypothetical protein
MGNLLYTIAVILVIVWAIGFLGGMVTSNLIHVLLVIAIIVVLLRVIQGRKPLE
>LONDMIMF_01527 hypothetical protein
MGNLLYTIAVILVIIWALGFFGILGEGIATNGLIHILLVIAVIIVLLRIIQGRKPL
>LONDMIMF_01528 putative acyl-CoA dehydrogenase
MADTIEKDVTRGGQFLVKETKCEDIFTPEDFSEEQLMMKQTVKEFVDKEIWPNKNRFENK
DYAFTEECMRKAGELGLLGVAVPEEYGGLGMGFVSTMLVCDYISGATGSFSTAFGAHTGI
GTMPITLYGTEEQKKKYVPKLASGEWFGAYCLTEPGAGSDANSGKTKAVLSDDGTHYKIT
GQKMWISNAGFCSLFIVFARIGDDKNITGFIVENDPSNGISMNEEEHKLGIRASSTRQVF
FNETKVPVENMLSERGNGFKIAMNALNVGRIKLGAACLDAQRRVTSGAIKYANERIQFNT
PISNFGAIRSKIAEMATSCYAGESASYRAAKSIEDRINARVAEGSSHQEAELKGVEEFAI
ECSILKVAISEDIQNCSDEGIQILGGMGFSEDTPMESAWRDARIARIYEGTNEINRMLSV
GMLVKKAMKGHVDLLGPAMKVAEELMGIPDFNTPDYSELFAEEKELIGKLKKAFLMVAGS
AVQKYGPDLDAHQQLLMAAADILIEIYMAESTILRTEKLAKSKGAENVKEQIAMAQLYLY
KAVDIINAKGKEGIASFAEGDEQRMMMMGLKRFTKYTNLPNVVALRETIASKLIQENQYC
F
>LONDMIMF_01529 hypothetical protein
MADFKRHNFKRLKIWQMAMDIAKMVLDLTDTFPESEKFGLKNQMDRCSVSLPSNIAEGSS
RSSKSFSHFLDISLGSSFELHTQLLLANHRKYITDEITTDLENRIEEFQKMTMGFQNSLQ
SQ
>LONDMIMF_01530 3-ketoacyl-CoA thiolase
MKTAYIVKAYRTAVGKAPKGVFRFKRPDELAAETIQYMMNELPDLDKKRIDDVMVGNAMP
EAEQGLNVARLISLMGLKIDDVPGVTVNRYCASGLETIGMATAKIQSGMADCIIAGGAES
MSFIPMGGYKPTPDYAVAKEGHEDYYWGMGLTAEAVAKQFKVSREDQDLFGYNSHQKALK
AQAEGKFDKQIVPITVDQTYIDENGKKATKSYTVTKDEGPRADTSLEALGKLKPVFAADG
SVTAGTSSQMSDGAAFVMVMSEELVKELNLQPIARLVSYAAAGVEPRIMGIGPVKAIPKA
LQQAGMSLNDIELIELNEAFASQSLAVIRELGINPDIVNVNGGAIALGHPLGCTGAKLSV
QLFDEMKRRGNKYGIVTMCVGTGQGAAGIYELL
>LONDMIMF_01531 putative 3-hydroxyacyl-CoA dehydrogenase
MKRLIKKVAVIGSGIMGSGIACHFANIGVEVLLLDIVPRELTEAEQKKGLTLESKVVRNR
IVNEHLANALKSKPSPIYNIKFADRITTGNTTDDLSKIAEADWIIEVVVERLDIKKQVFE
QIEKYRKPGTLITSNTSGIPIHFMSEGRSEDFQKHFCGTHFFNPARYLKLFEIIPGPKTS
TEVLDFLNNYGEQFLGKTSVIAKDTPAFIGNRIGIFGIMSLFHQVKELGLTIEEVDKLTG
PVIGRPKSATFRTVDVVGLDTLVHVANGLYEGVPNDEAHELFKLPEFISKMMENKWLGSK
TGQGFYKKVDKDILSLDLDTLEYRAPKKASFATLELTKTIDKPIDRFKVLVKGTDKAGEF
YRKNFAGMFAYVANRVPEITEDFYKIDDAMKAGFGWENGPFEIWDAIGVEKGIELMKAEG
HEPAAWVTEMLASGNKSFYTIKDGATYFYDRASKSQKKVPGQDAFILLNNIRESKKIWSN
SGAVIHDLGDGILNLEFQSKMNTIGGDVLQGINKAIDLAEKEYNGLVIGNQGANFSVGAN
IGMIFMMAVEQEYDELNMAIKLFQDTMMRVRYSGVPVVVAPHGMTLGGGCEMSMHADKVV
AAAETYIGLVEFGVGVIPGGGGSKEMALRASDLFRKNDVELNVLQEYFLTVAMAKVSTSA
YEAYDLGILQHGKDVVVVNKDRQIAEAKKHALIMAEAGYTQPVRRKDVKVLGKQALGMFL
VGTDSMEAGHYISEHDKKIANKLAYVMAGGDLSEPTLVTEQYLLDIEREAFLSLCTERKT
LERIQYMLTKGKPLRN
>LONDMIMF_01532 Organic hydroperoxide resistance transcriptional regulator
MKDKTIDYILRATWQAVSRMYNEEAAKYGATMATGFALLSLDKDKGSPSTTLGPKMGMEP
TSLTRTLKSMEEKGLITRKKNPVDGRGVLIHLTKFGKEKRELSKNTVLKFNEKIREHIPE
EKLLHFIEVAETINTLIADKNIFSDIPEEKQMQTTNK
>LONDMIMF_01533 Sodium, potassium, lithium and rubidium/H(+) antiporter
MLHEFPFYLAVILAIIFLVMLANKIKVAYPILLVLAGLAISFIPGIPLVKIDPELIFIIF
LPPLLYEAAWSTSWKELWRWRRIIGSFAFLIVFLTALVVAVVSNHFIPGFSLALGFLLGG
IVSPPDAVSVGAILKFVKVPKRLASMLEGESLLNDASSLIVFRFALIAIGTGQFVLQEAA
INFSWMVFGGVAIGVSIAFVFFKVHKLLPTDVNMDIVLTLVAPYIMYMLAEELHSSGVLS
VVSGGLFLSKRSHQFLSSSSRLRAVNFWESLVFVLNGLVFMFIGLELPEIVDGLGAIGLS
TAIGYGVLITGVLIVVRILCAYGAVIVTLIARNFIIVAETRNPGIKGPFVLGWAGMRGVV
SLAAALSIPVHLDNGMPFPQRHLILFITFVVILLTLVLQGLTLPFIIRKFNLPEYDHPLS
DEESYHQMYKKLTQQSLEHLKSNFSKELEEQAVLQQMARKWEDANYLPDDASMVVECKTV
YLSILDQQRQWLRDWNQDHHINEEVVRRHLRRLDIEEEKMSFQ
>LONDMIMF_01534 hypothetical protein
MGHNLLMNFTVDKENNKIRVEREFAATRDRVWAAWTKSELLDQWWAPKPWKAETKAMNFS
DGGFWLYAMVGPDGSKHWARADFEKIRELESFSTFDAFCDENGTVDTSFERSFWTNTFKE
QSGSTIVNIEIVYKSLEDLEKIIAMGFKEGFTAGLENLDALLAS
>LONDMIMF_01535 hypothetical protein
MQLQYFKPKSKLLSQYLEGYYFLEKERNEPTVEYFTFPNNFSIVSVLDDTRLVMDNNGAF
AKEKKGVPFISTLICHYKKPFKIHYEGKIREITFYFKPLGLNAFIPKQLKYYLENYSSSF
IPFEDYETTFKSILNESNMEEQRNQIEKYWLSKLIGFGNPLIQDVALELTQNAEAASIEQ
LAAKHHTSRQNIARQFHIHLGKTPSEFRKIQRFRETMAKNTGLANNDKNKGTLNYDSSFY
DQSHLIKDFKAFTGLAPKAFFKSVSLQENATINWLFL
>LONDMIMF_01536 hypothetical protein
MSQNKNALIRYKTIDKCLQNQYRKWTLEDLMEACSEALFEYEGKEGSVSKRTTQLDIQLM
RSEKLGYNAPIVVYDKKYYKYEDEEYTITDIPLTETDINVLTETVSMLKQFKDFSLFSDV
SDILQRLEDKIYAEKSHTQPVIYLDKNENLKGLHFLDILYQAIIKKVVVVLNYKSFKSRE
PQQFIFHPYILKEFNNRWFLVGKKKVSQPIVNLALDRIEAVDFDFGHPYAEENFNAENFY
KDVIGVTVNQGQRVRTIRLWIDADNAPYVITKPFHHSQKIEEHREDRSIVISLMLKINYE
FERLIMGFGEGIEVLAPESLRQRIRDKHKKALRKYDLPVK
>LONDMIMF_01537 hypothetical protein
MNINDFDNFFLPAKNLDEAKEFYKDKLGLEIKFDFSDKGMTAFKVGQNEPAIIVSTMQNA
KPAIWFTVDNVQEAYEILKQKGITFLSEPFEIMTGLAVEFNDPFGNKLGLTDYSKLNKKE
>LONDMIMF_01538 hypothetical protein
MDKTLDRKPAKKCYEHIGGKLGMLLLEQFIAKGWLAKEKPDDKNFYITDIGILEFTKLGV
DLSQIKS
>LONDMIMF_01539 RNA-splicing ligase RtcB
MISALYHQKMRNMKTPINGTDLLELGYPQGSVIGIALKVNKKRTGHTKEQMLELYKKVLE
TSEEYIDDALFGKLATALIEKLAEKPEDFIALNPNPKAFSSYGLDHIEAGAIDQMKTAMQ
LPVTVAGALMPDAHQGYGLPIGGVLATQNAIIPYGVGVDIGCRMALSVYDIPDAYYYENE
HTFKRELIAHSKFGAGHGFHGQYRADHAVLENPNFESNPFIKNLKDKAWSQLGSSGGGNH
FVEFGILEFESDDAVLGISKGKYVALLTHSGSRGFGATVAGHYTKLAKELCPLPEVARNL
AYLDMNSEIGQEYWIAMNLAGDYASACHEIIHNKMQQALGAEVLAKVENHHNFAWKEIWN
GEEVIVHRKGATPAGKDVMGIIPGSMTAPGFLVRGKGEENAINSASHGAGRQMSRGQAFR
TITKNEMQAILNHHGVTLIGAGLDEAPMAYKDINQVMASQQELVDVVAKFTPKMVRMADD
GSRED
>LONDMIMF_01540 hypothetical protein
MTTINYQLTTINYKEVFAFRRHNTDIAFPGLDSRFYKTQVYNHYRLIGQTYPVSMI
>LONDMIMF_01546 hypothetical protein
MRQDILKRFLTNTDETGRFLMKSRITGIIYFVEPIYNGKTPEWGDLDPATKKLTGNYGSK
YTGAVTKKESLITEENGFVNIGYFKGSPFGAIEQRDREHQKRLGLL
>LONDMIMF_01547 hypothetical protein
MIRKVRINAYQVGLVFENKKLVDVLEEGSCWLFGNKELMVFEKKQSFVAPVELNILLQNE
ALASLLEIVEVADNEIALYYANGIFKEVLLTGRYAFWKGYAKNEFVKVDLSKVYITEQIP
LALLDNVKLRTYVRRFNVASYEKGLLFVNGTFVKEVTAGAYYFWSNAVAVEIKTIDTRQQ
QLEISGQELLTKDKAGLRINFFVSYQIADIYKALINNKDFEKQLYVLMQLALRAFVGNLT
LDELLNRKDTIAKEILEHVEAKIKNLGLVVSDAGIRDVILPGDMKEIMNQVLVAEKKAQA
NSIMRREETASTRSLLNTAKLMEENEMLWKLKEMEYVEKIADRIGEITISGGGNVINQLK
DIFLK
>LONDMIMF_01548 hypothetical protein
MANFGYLKITILMITGLYETHIQVSNLTKAVQFYTETLGLQLAHYDETRPIAFLWIGEGK
KAMLGLWEQKESLQTRHFAFTCDIEFILQQSEGFLKNNQLQPYNFLKNGSSEPMVFAWMP
ALAIYFNDPDGNQLEFISLLEGNGQPELGVLSYDRWLQLKK
>LONDMIMF_01549 hypothetical protein
MKADVDSLVQYIEETHPNPYYRYPKKKFQKDIQQLKNGLNTNLNEVDFYLAFIKIISRLD
DGHTGIDIPLNSYLKTNPSLLLYEFTLSPQKPYIITGKPYTTIKNEIPKDSEIISINSIS
SEKIIKDIIALNTGERDEFKAEYGANSFFFYLDYLYNAKGIYNITYKLNGKKQKITVKGV
PYQDYEKQRNLKQENSGNEDTKDTENYTLKLIPEKSTAIISFQIFDWDGFSEFCKQAFTE
IKDKKIENLIIDIRNNLGGDSDVGDELFQFFMNQPYKQYDRVIGKNSRLIKERIRTHERN
GKILTSEDLATLKKAEGIYDTIVYEEIPIRENSLRFNGKMYLLTSAQAFSSAADFAQCFS
NYKRGKIIGEETGGLVVSYGDIVSHQLPNTQLPITISSKLYYNVGTKTDDWHGVIPDIKI
PAGKALDEALKIIQNQ
>LONDMIMF_01550 Long-chain-fatty-acid--CoA ligase FadD15
MNKITRLFDFPYHQQEKYSIPDSLVTKYDGEWVKTSTDEYISKANAISRALLRMGVQKDD
KIAVISSNNRTEWHIVDIGILQTGAQNVPIYPTISEEDYEYILNHSGSIYCIVSDEEVLK
KVNAIKNNVPNLKEVFCFNTISGCKNWTELLELGKDESNQSEVEARKETVTTEDLATIIY
TSGTTGKPKGVMLSHKNIVSNVLGSEKRIPFQAGKSKALSFLPICHIFERMVVYLYQYYG
VGIYFAESIDKLSDNLKETRPHVMTAVPRLLEKVYDKIYAKGAELTGIKKKLFFWAIELG
LKFEPYGKNGWWYEFQLGIARKLIFSKWKEGLGNNLELMVSGSAALQPRLARVFAAAQIP
VMEGYGLTETSPVIAVNDMRNHGFKIGTVGKVIDNVEVKIAEDGEILCKGPNVMMGYYKD
PEKTAEAVKDGYFYTGDIGLIDKDGFLKITDRKKEMFKTSGGKYIAPQLIENAMKQSRFI
GEIMVIGDGEKMPGAFIQPDFDFVKQWAAKKGLSIGSTNKEIVANEEVKKRFQEEVDDIN
KKFGHWEMIKRFELTPEVWSIDGGELTPTLKLKRKNVKEKYQDLYDKIYRDA
>LONDMIMF_01551 Long-chain-aldehyde dehydrogenase
MSDILKRPQFKERYDNYIGGKFVPPVHGKYFDNVSPIDGKVFAQAARSSKEDVELALDAA
HEAFKSWSKTSPTYRSNLLMKIAQVIEDNLEYLAIVETIDNGKAVRETLAADLPLVVDHF
RYFAGVIRGDEGTIAEHDENTVSIVLHEPIGVVGQIIPWNFPLLMATWKIAPALAAGCCT
VVKPAEQTPVSIMVLMELIGDILPPGVLNIVNGYGIEVGKPLATSSRISKVAFTGSTTSG
RLIMQYAAENIIPSTMELGGKSPNIFFKSVADADDEFFDKAIEGAVLFALNQGEVCTCPS
RMLIHEDIYDKFIAKVIERTKAIKTLHPLDKSCMMGAQTSNEQYQKIQSYLKIGKEEGAE
VLLGGEINRLEGDLEGGFYIEPTIFKGHNKMRIFQEEIFGPVVCVTTFKTVEEAIEIAND
TLYGLGAGVWTRDAHELYQVPRAIQAGRVWVNQYHSYPAHAPFGGYKKSGFGRENHKMML
DHYRSTKNMLISYDKKKLGFF
>LONDMIMF_01552 Sorbitol dehydrogenase
MANMKAARWHAAKDIRVEETTVPSPGKNQVQIEVQFAGICGSDLHEYTHGPMLIPFDKPY
PLNGHQGVTTLGHEFAGIVNEVGENVKNIKKGDRVVVEPIFKNPESPFIANGQYNLSEPL
GFVGLTSNGGFAKYTVVEDYMVHKIPDSMSFEQGALVEPAAVAVYAVLQSGLKIGQSCVI
FGAGPIGLLCVQAAIAAGATTVVVVDVAEKRLEKALSIGASYVINGKSENISQQVRDLTN
GGADIFLDAAGVQATFDAGLASLKNGGTAVCLENR
>LONDMIMF_01553 hypothetical protein
MFGKPVSHDAFTQVVREITIKGIIAYRNIFPEVINLIATGRMPVEKLVTSKIKLDNIVKD
GFEALVTNPSEVKILVDINN
>LONDMIMF_01554 hypothetical protein
MATKRVLATEKAKEVIARLKTEYGELIFHQSGGCCEGSYPHCFEKGGFLIGSNDVCIGEI
EGCKFYMAGDQFEYWKHTQLTLDAMEGRAASFSLESVLDVGFFIHSRLYTEEEAKDLEPV
ERFN
>LONDMIMF_01555 HTH-type transcriptional activator Btr
MVMALKNGIILNAPELSKENSLKTLVENRTIHTLNHCELNLFETYQEAQLVPLKFNDLVV
TSMLRGKKVMHLFDKEGFDYLPGETVIVPSNVEMKIDFPEASKQNPTQCLALALDHSKIS
EILNLLNEKYPKGQDEYWQLNANNYFFYNNIELAASIQKLIKVCLSNSVTKDIIADLTLQ
EMLIQIIQLQTQKGAQDNTLTDSNPTLSPIIAYIKANINNNINMKKLSDVACMSTTAFHR
FFKRELGITPIEFILQEKIKMAKALLSGQNIHVNEVSYELGFEDSNYFIRLFKKHEGITP
KQYQKLTVN
>LONDMIMF_01556 hypothetical protein
MKRQSRLLYFLLLSGTIVLGLLSRFIKTIPLFIGDILYAIMIYFLVRFLFPKARTKTTVL
ISLLVCYIIETLQLYQADWIVSIRATTLGRLILGQGFLWNDILAYTFGIGIVFMIENILK
SSRNRQQKR
>LONDMIMF_01557 hypothetical protein
MGMLFYLAMGWCGTKFPGWWRFPVPPHPDPEPWRDFSVLSVIGIIAGGAGGSLFHDAITQ
NALFAGQEMIASGMFAFAASGIVTGIGSVMMKGKR
>LONDMIMF_01558 Phosphoribosylformylglycinamidine synthase
MIHFFGNESNTVFAVQTQNELSAQDISKLNWLFGNTHKIEKSVLADFFVGPRAAMITPWS
TNAVEITQNMGIEGIIRIEEFKKVTTDFSDFDPMLSQKYSELGQEIYSINIQPEPILEIE
DIAGFNTKEGLALSKEEVDYLENLSKKLGRKLTDSEVFGFSQVNSEHCRHKIFNGTFIID
GEEKPSSLFKLIKKTSAENPNDIVSAYKDNVAFLKGPKVQQFAPKSADKPDFYETKDFDS
VISLKAETHNFPTTVEPFNGAATGSGGEIRDRLAGGQGSLPLAGTAVYMTSYSRLEENRP
WEKAMEERKWLYQTPMDILIKASNGASDFGNKFGQPLITGSVLTFEHEEENNPARVLNSG
RAEVEDNRKLGYDKVIMLAGGIGYGKQDQAIKQKPKTGDKIVILGGENYRIGMGGAAVSS
ADTGAFSSGIELNAIQRSNPEMQKRAANAIRGLVESDANPIVSIHDHGAGGHLNCLSELV
EETGGLIDLDKLPVGDPTLSAKEIIGNESQERMGLVIGQKDIDTLQRIADRERSPMYQVG
DVTGNHRFTFESKTTGAKPMDFALEDMFGSSPKMVMTDTTVNRNYTELEYTQENFKNYLN
QVLQLEAVACKDWLTNKVDRCVGGKVAKQQCAGPLQLPLNNVGVMALDYLGKEGIATTVG
HSPVASLIDPAAGSRTAIAEALSNIIWAPIKDGLKGVSLSANWMWACKNEGEDARLYEAV
QGCSDFAIELGINIPTGKDSLSMKQKYPNGDVIAPGTVIISAAGNCTDIRKVVEPVLKKD
GGNIYYINLSEDAFKLGGSSFAQVLNRIGNDVPTIKNAANFKTTFNVLQDLIKEGKIQAG
HDIGSGGLITTLLEMCFADVNLAADFDLSNLNENDTVKVLFSENIGIVFQADASVETVLT
QNNISFFNIGKIKDGNTVTIKNGSQNLSVDVAEARDTWYKTSYLLDKKQSGELKAKERFE
NYKKQPLQFKFPEHFTGKKPVIDASKPRPKAAIIREKGSNSEREMANAMYLAGFDVKDVH
MTDLISGRETLEDIQFIGAVGGFSNSDVLGSAKGWAGAFLYNEKAKTALDNFFRREDTLS
VGICNGAQLFMELELINPEHEVHGKLRHNDSHKHESAFTSVSVLENNSVMLSTLAGSTLG
VWISHGEGKFDLPYTEDKYNVVGKYGYENYPANPNGSFFNIAMLCDKTGRHLAMMPHIER
STFQWNWANYPEGRNDEVSPWHEAFVNARKWIENKI
>LONDMIMF_01559 hypothetical protein
MKTNYIYLGALLLCLTACKKEVKVETTTTVPKDSVPTETVKSEPMDSIAMQKAWQEYMTP
GEMHKKMAADVGTWDEEITFWMGPDDRLPHKSNTTANTKMILNGLYQESVHTGNMMGQPF
EGRSTLAYDNAAKQYVSTWIDNMGTGIMVMKGNYDEASKTIKMEGEVTDPMTKKTKKVRE
VITVVDPNTQKVEMYDMTPDGKEFKSMEIMLKRKK
>LONDMIMF_01560 hypothetical protein
MRNTFIFLFIIAVISLTSCRKDFDFEPSSGNLGFSKDTVFLDTVFTNIGSSTYTLKVYNR
SDKDISIPTIQLAKGMNSKYRMMVDGMQGTGGKIFNNVELLAKDSLFIFIETTIDYNDFA
NPDAEYLYTDQILFDNGTKQQKVQLVTLVKDAIFLYPNRDNEGNYEQIPIGVDEEGNPIT
GRGFYLDDTERHWTKDKPYVIYGYAGVPANETLTIDAGTRVHFHSGSALIAYNGSSIKIN
GSQSFTDQLENEVIFEGDRLEPAFSDSPGQWLAIWLTNGSTGHEFTNLTIKNATVGILVS
GNSGINNPTPDLKLKNVQIYNSSNAGILAQTGYVEGENVVINWGGSSSFVGNYGGKYDFK
HCTFNNNWSGSRKYAVALDNYIQGATPEVQPLEASFKNCIIFSSNQSGLLLNKKEGSDNF
NATFTKCQIKLSNSINTTNNIYSFVNDQSNIVRNGNPNFLDVNKNKLMIGEESAANGEGD
TGVATEVPTDIKGTARNLIKPDLGAYESITFEER
>LONDMIMF_01561 Putative esterase
MGLLHGGASVALAESVGSAASLMFINPETHEVRGIEISANHVKSKRAGMVYGTAKIIHKG
RMVHLWEIRITDENDMLISLCKITNIVLERTKK
>LONDMIMF_01562 hypothetical protein
MMSGLYQKAEEQFKNRLPFVLYSKPGETVAVGIFQKDASLHFTTDFKEEGFVLAPFHGEQ
FVLLPKEKSDVFTEAYTRIAIENNNTVFGAEVAAKENFEQLVQNGVDAICKGDFKKVVLS
RKETVSLENATPFELFKKLLSAYPTAFKYCFFHPEIGMWL
>LONDMIMF_01563 hypothetical protein
MKTITNITILLFSLLLLNLISCEEMLEVDVPENQIDKNNVFQDTQTANSALSALYSSLRD
NSLLAGDKMGLFLSNYTDDLTCYATTATNGIYEISQNQLISSNAAVYSLWSNTYQQIYFS
NSILEGLEKSSGISNTDKRRMKGEALLIRCILYFYLQQIYGDIPYLTTTDYTANNTSSKL
SSDDVLVRLENDLNECYILLADEYSNSERIFVNRKVAELMMAKVYFAEQRPADAEAKLKS
IAQSSLYTFETDIAKVFQKSGKHILWQLKPKNSGDATKEASLYYFTGAAPSSYALSTSLM
SSFASSDFRKSNWMAVITVGANTWYRADKYKNRSNNTTEYSIVFRLEEVYLLLSESLAKQ
NKLNEALLYLNATRQRAGLSAVTSGISQSDLITEIASENRREFFTEMGHRFFDLKRNNNL
NSLISSKPNWQTNHQLWPIPQKDLELNSNLNPQNPGY
>LONDMIMF_01564 TonB-dependent receptor SusC
MKKSYSKIGSIGIVFLLTALCSNAKAQTKTVTGTVTVGENQTPLSGVNVSQEGSDQVTQT
NSKGFYILQINGENPIIIFRHPEYAEKRITVNGKAVINLSLDQKVQGIEEVVVNAGYYKV
KEKESTGSIAKVSAKDIENQPVTNVLSSVQGRLAGVTITQNSGVPGGGYDIQIRGRNSLR
NKDNSTIDGNQPLYVIDGVPMGGEMTSLYSTVILPGRSLNPLNSINPNDIEKIEILKDAD
ATAIYGSRGANGVVLVTTKRGKSKRLNLNFNTSYGLSTVISNLNLINTSEYLSMRKKAFE
NDGISTYPATAYDINGTWNQDRYTNWPDKLVGNTAALSNTQLSLNGGGETTNFLLSLSNN
EQTTVFGEDFKYKSKNISSHISHRSADNKFQMNIANSFSIQKNNVIRTDITRQAYNLVPN
APELYNSEGGLNWQNNTFANPVAAYNSTYTNENKQFLNSITTQYEVYKNLLLKLNGGFNY
QTFEELSLQPNTIYNPAYAAGQSSATSTASKNNQDRFSFIIEPQINWNYQSEHHKIDALA
GGTFQRETNEQGSIVGVGFESNAFITNIGAARTKTVSDQITNEYRYAAFFGRLNYQYLNK
YIINLTGRRDGSSRFGPNKKFANFAAVGGAWLFKKEKFAENLEWLSFGKLRGSYGTAGSD
NIGDYQYLDTYTVSSSYIYNSVTGLIPSRLYNGNYSWEKTKKLEVALELGLFKDHINITT
AWYRNLSSNQLVGYQLPSITGFTSVLANLDATVENKGWEFELAAQPLKTGSLKWDTNFNI
SFPTNKLVSFPGLEGSTYANQFIIGQSTSIIKLYQLEGIDPKTGKYSFTDFNGDGKISSP
EDNKVAQDISVKFFGGWSNSFRYKNWDVSFLFQFVKQKNRNYNSIITVPGSMNNQPVEVL
DVWSTDNPTGTYMPYTSGVNTLHTFFQNSTASVSDASFIRLKNVQLGYQIPLKNSVFRNV
KIYIQGQNLLTVTKYFGVDPEFLALGYLPPLKTYSFGLQFNL
>LONDMIMF_01565 hypothetical protein
MDSKEVLRLFMLEFSENLKKIRATKYNSMDEVAQNSNFDSSNYNKFENGKGNPTIETMLK
MSSAFGITPKELFDFDFDINKYKIDE
>LONDMIMF_01566 hypothetical protein
MKAIKIYSIVATLVIVGLSVWVYSTKKELKETEEVLDQCSDRYYQEINK
>LONDMIMF_01567 hypothetical protein
MKTKLLFLLLIQIIFVSCQKKVTDFKLVSYDIKSNNELSISAYTTLDKDGVLNVYLDRER
DKVYYQYKLSQSELDEINSLSDKNLDKYVIKKALDANQGYAGSRNYLSFKVNGKEDKICF
ILPFMDSDFKKVIDSLEDKIYLQDESQRTEASPIDFKKVEKEIITQNQIDNYLPSKSLPP
PPMR
>LONDMIMF_01568 hypothetical protein
MDTQDYLQDQLKICEKNSQISDVVELNTVIALGRNFNPNIQINGLRHPRTKGLTGWYIWS
GEFSYADDFFQPSHAYHLLEDASFIIQYLGLPAGNRFLIDSNGYEDIWYDESLLDV
>LONDMIMF_01569 hypothetical protein
MKKIVDIETALKMFEEASIIQVESTENGNFKVGNKNYEKVMNAASFLKNQNSIESLFQFL
NHQHKGPRLWSACYILHLDEKKAVKVLKEIIKQSGIIGSTAEITLDEWKKGNLTFI
>LONDMIMF_01570 hypothetical protein
MEISRTEIEEKFLQHSVQHGVLYVNGDYKKANKLHKELHNLYNHAKEQREEELFSEMLDN
PDEYVKLWAAIFTLKSKPDIAENILKKLSTNSKVKMTASATLHLWKEGKLELLL
>LONDMIMF_01571 hypothetical protein
MEDKYITGIKQVVKTAQAFLNEFKEFAPFGLIFKNNEWIDLGAYDENLTSDQMKNFLIST
IIEDFNEGNTEFGAVCVDAKIKEIGDVIIIYNTSNGKDWFELVYKYYLEGKSVKIIEENI
EY
>LONDMIMF_01572 hypothetical protein
MKKLFYVFFLIIAVFLNAQVEKNVSNNPEKIYVNPVKLTKEERLRPYMDEVLKTRDTLTP
AEAERRRQNIEAGNPFKKYGFYPKIATLSKGKYLEAHDLDSIVSIGSVRYNARTNEIVEL
LDINIENADSQPYLDTAGRWFSPDPLSEEYRRWSPYNYAMNNPLRFIDPDGRSTEDAVEE
SEQCCLFGISGLVRFMPIFEGGSNVRPNPVVETMTKTSEATTKSQEHFNRGRQMEPEQIN
RMNEEGQNVTKNTKNFEATDSKTGKTGGTRPDGFTKEGNPVEIKNVKNQSLTRQLRFQDN
LVDGKRLILRINKDANLSNPLKDSGIEIQPYNLTGPAPAKTDNIRVNNNPAPKIKPVPVK
KDPCAGIPGCI
>LONDMIMF_01573 hypothetical protein
MQFALLVIVSMVITVKAQRNQFYEEAYAHIDNMLSGKEKYSFKKAVLSVEQSYYQGKIDT
IAINNELKFLKSFAEQIVKSRELTYQGNDKDKVSKYAALYSIICQPIPVIVKDSTIQYKP
FSYDFTDVFGHDDLPNLFVSKLLATKKGNCNSMPYLYKILAEELGVDANLALAPNHVYIK
HNVKSLGWFNTELTSGIFPEDGWLMASGYIHLDAIRNGMFMKALDNKESLALCLFDLAQA
YNRSFPSNDGEFLLKVLNKALEVYPNFAKARILKAETYKARFQKLMDRQDLKSGSSNNIK
LALENPKAKEIYDLMVQEYSTLYKLGYRQMPEGMYLDWLVSLKTERNKYENKKLKNNFK
>LONDMIMF_01574 hypothetical protein
MLKFIVKKQPFHFTTSLRKNNLKFLTMKKFALKTMALVLFVSTALTSCSNDDDSKSNNQT
TQKEFTTAVTGPTTGAKNQEITLTVTHVVDNNCGVFNRFVESTSGNTKTVEVEVKYTGTN
CGTTPSTKTQPYKFTVSQNGTYVFKFKKSATEFITHSVVIQ
>LONDMIMF_01575 hypothetical protein
MNIVLQNKELKATINTKGAELISLKRNAKEYIWEGNPNFWDKHSPILFPIVGTLKEGQYN
YENKSYQLSRHGFARDNVFYVEETFQNKAVFSFRSSEETAKYYPFDFELKIIYTLEENYL
TIKYEVTNNGNTKMPFSIGGHPAFALTDTFENYSLLFENDESLTCYSLENNLLSERTTVL
KLSDHKLPLTYSLFEEDALIIKKLESKKIQILENGKPYVEISLYDFPNLGIWTKNNAPFI
CLEPWHGYSDTLQSNGNLFEKEGIIILTPRKAFQTSFDIKAY
>LONDMIMF_01576 hypothetical protein
MATIRNIISLHLQKLISLKMKKYLSLLFLACAFISHGQTYVKFNGATALILVPNIGVETS
IGKKMTFQFDATASFWESIDGAPYKALILTPEVRYHFNEKNNGFYIGANVSGGTFKLQKY
GYQDTNNYQKGYNYLLGMTLGYQWKLSEKWALDLFVGGGHQEAFYKGYSIETGERYDTWI
HDYNKSGEWILYRGGLMIAYKIK
>LONDMIMF_01577 ABC transporter ATP-binding protein NatA
MTEFEKQFQEIKSFLDFEDYSLLTKRIIDLTLDTEDISFYQKTNELLDWLDQNENNIELK
KQRFALLLEELYQQLKNKPVPEKQILVTAENLKKTYGNASFSLGPIHLELSQGEILGLVG
ENGNGKTTLLRLLCGELFATSGKLGYNFDFNDTYDLRTQLVYIPQRTATWHGSMFENLQF
TASSYGYKPAENKLIVELIIARLNLRKYRNHSWKNLSSGYKMRFELARMLLRKPKILLID
EPLANLDILAQQTVLEDFRAIAKSPFRPIGIVLSSQQLYEVEKTSDQVIFLKNGEQKNLH
LKATPQETEKTEEQFLIIEFESEWSQNQLNEVLTGELISLKFNGGTYIATFSEKLDTYGF
LRIITEKHIPLQYFRNISKSTRRFFVS
>LONDMIMF_01578 hypothetical protein
MFANIQKKLLLTHPLLWNSKIALFSVLTLTFHLIFFLLGYSKGEIDFTDSNDFYDYGIDN
TIIVFVSVLISILMFIIWLVYYSRNNAFKSFYPKGKFSLYKEWLLILLFCILNSTYAASF
FYAQDLKARNYFSEEEVSRRLEIISLSSLFVEGPYRESNFITEYKDGKYIQVERDSFKYG
SRIYSLKSLINKKIQGFTYFNDEKDSLMELKGKRWLIENKKDSIQLLFREFFKISKEHGL
SSNITPEKWFELIYDYPEFTEYINVGKTSKEYSQNYSYYEGVNVDYDYAIEPEGVTHDTL
SKTIKVVGGQEYIYSKYYVPFDALTKSYGKISRAYENPVVNLEFIMSLIYLAIGLSLCVF
SFKITSGRNWLIAFVTLGLFGIISGIISVIIRYSMTFPIIYILLFLGLLFYFVIILKAKE
SKGITGITINQTLWLMPAIIPIAYAVLIDILKRTSGYYESYSYGADGMKREQFPRIEWLE
EHYVYMFILNIIFIFLFMLLFSIYIKKWKGIAEA
>LONDMIMF_01579 DNA-binding protein
MENKQANNPLHGITLQKMLEQLVDFYGFDTLGELIKIKCFNVDPSIKSSLTFLRKTDWAR
TKVEQLYIKTLPKFPK
>LONDMIMF_01580 hypothetical protein
MKNLCLILLFFLMQTVSGQNQATTTLYLIRHAEKADFSSNPELSDGGMKRAKSWAAYFEK
TPIDLFYTTMYKRTQQTCSAIAATKQKDIIFYKPEAMDLKKIIAENPGKTLLIVGHSNTI
PNYINKLLGTAKYADIPEPEFGNLYRITVTGEEIWDELIHL
>LONDMIMF_01581 Outer membrane protein W
MKKIIFAVMALTVFGTGLTNAQENNSVDFKKWQVRVRGVGVVPDESAKIGIIGGDAKISN
TFIPELDFTYFFTKNISAELILGTSKHDVSTVGSDISAVGGPTSADVNLGSVYLLPPTLT
VQYHFLPDQIFNPYVGAGVNYTIFYNEKAGNTVRGIEYDNSFGYAFQVGFDLMLNDKFFI
NADIKKIFLKTDVTVDASNLATGLSIPADVEINPLLLGFGVGMKF
>LONDMIMF_01582 SsrA-binding protein
MLKTINILNKRARFDYEIIEKYTAGIVLTGTEIKSIRLGKANIAESFCEFNNNELFAINM
YIEEYAFGNQFNHKARSERKLLLNKRELKTLSKSVQTKGLTIVPLRLFTNEKGLAKLDIA
LARGKKTYDKRESLKEQDTKRDLDRIKKSFR
>LONDMIMF_01583 Adenosine monophosphate-protein transferase and cysteine protease IbpA
MKTLLRNARELKNMKVREVSQQTGIDQALISKFETGTRKPTRDQLLKLAAVLEIDLETLM
VAWLKEKILYEIGDEEFALKAMKVAEEEIRYQAKTAKKVSGSLQKILAEIDTLKTKLDRF
REFDSYRITQALELEYTFESNRIEGNTLTLRETDLVINEGLTVSGKSMREHLEAINHQEA
IGYIKHLMEKNSLLNEREVLSIHNLILRGIHPEDAGRYRKVQVMIKGSTYMPPQPYMVSK
QMEDYFIWYEANKNSLHPVILAGEMHERLVTIHPFVDGNGRTSRLVMNLILLSHGYIIAN
IKGDYDTRMQYYQTLEKAQTTSDKEDFLLFIAQIEKESLERYLDIISQ
>LONDMIMF_01584 Protein-L-isoaspartate O-methyltransferase
MKDTAKHQGLRNQLVTVLQQKGITDKNVLEAIKKIPRHLFLNSSFEDYAYQDKAFPIGAG
QTISQPYTVAFQSQLLEVEKDHKILEIGTGSGYQTAVLCTMGAKVYSVERQNELFKTTSL
LLPKLGIRPKHLSFGDGYKGLPNYAPFDSIIVTAGAPIIPKPLMAQLKVGGRLVIPLGEE
HQIMTMLIRKNETQFEKHEFGEFRFVPLLENKN
>LONDMIMF_01585 Prolyl endopeptidase
MTTLRKIAMLTIGITFTTNSFGQTKPSKAPSVPATDDYYGIKIEDKYRNLEDLKNEQTLN
WMKGQADYTNSILGSIPGRQHIIDELTSINNRATESIGGLAILDDGTYIYLKSTPNDQIS
KLYKRNGLKGKESLIFDPETYQKNGKDVYSVSSFSANKSGKLIAINISKNGGEMSEMFLM
DLTDKKILPEKFDRLRFGGANWLKDGNSFIYIQSPTEDVHDMNAQMDIVTKIHIVGSDVS
QDKTLFTKAMYPELNIANEEIPFVSYDIDSNLLFFMPYTVDQNQKVYIAPGSDLNQKKIN
WKLLTDRKDEVKNFILSDKDIYMYTTLNAPKFKVIKTSIANPNVATATLVIPESSDSNLN
SPIVTKDGIFYTRTKNGVESKLYFTDFEGKKHREIATPKKAATISVTARAPKFSDVWIST
TGWTTKGERYRYDLKKNTFTREQLSTIIEYPEFENFDVEELMVKSYDGVEVPLSIIYKKG
IKKDKNNPVLFYGYGAYGASITPSFNTQLLLWVERGGILAVAHVRGGGELGEKWHLAGQK
TTKQNTWKDVIACTEYMINQGYTNPTKTAIYSRSAGGIFVGRAMTERPDLYAVAIPGVGM
MNTVRSENTPNGPANIAEFGSMKIEPEAKALIEMDSYVHLKDGVKYPATLTTAGFNDPRI
IAWMPAKFAARLLEANASNKPTLLKVDYEAGHFGGASKTKSYEEIADVLSFAFWQVGHPD
FQPKN
>LONDMIMF_01586 Sensor histidine kinase YpdA
MKLLKSGKYHLLNFLGWQVYTFSTLTFSKISYAKFADGLTTAQLNALYYTLWEGFLCALL
GFVLSYIILLFLETRFNLSNLRRKDWWNLFFVFSLAQIIYHFTLWPLLDIPVMYYFGSSN
IQHLTLLMKITNVPGFLAEFLVWLFIVLAIKIYEYINEVKFNRLKLESSLKESQLNSLKG
QINPHFMFNSLNNIRGLILENPLKSREMITRLSEMLRYSLTKNDINTIALEEEIEMVENF
IEISRIQLENRLKYTPKIDTGLLKMEIPPMIIQMLIENAVKHGIAKLKEGGEIILDIHNN
DKALKIVVSNTGVLSIGEDSTQLGIKNIEKRLHLIYGENANFKLQEIENQVVAEITIPF
>LONDMIMF_01587 Transcriptional regulatory protein YpdB
MKKIKAVIVEDSRLARNELKELIKNHPEIEIIGEAENVDSGFQLINSTHPDLLFLDINMP
EKDGFQLLEMLDRVPITIFTTAFDEYAIKSFEYNALDYLLKPINPKRFAKAIEKVSQNLV
EKEERNSKKLTLNNQIFLRDGEKCWLVKISDIYLFEVDGNYTKIFFQNEKAIISKSLNQI
EEKLPEDNFFRANRNQIINMEYIGKIDPWFSGNLLVHLPKDTKVEISRRQTNNFKEKLSL
>LONDMIMF_01588 scyllo-inositol 2-dehydrogenase (NAD(+))
MLKVGVLGAGHLGKIHLRLLQQSEKYELVGFYDPNQENAEKVAKEFGYQKFDTIAKLIHA
VDVVDIVTPTLSHYKCAKVAIKSGKHVFLEKPISNTVEEAEEIIALAKEYNIKGQVGHVE
RFNPAFKATKAMIENPMFIETHRLAEFNPRGTDVPVVLDLMIHDIDAILSVVKSKVKNIN
ASGVSVISDTPDIANARIEFENGCVANLTSSRISLKNMRKSRFFQKDAYISVDFLEKKCE
VVKMKDAPEVPGDFDMILQNAEGVKKQIYFDNPDVEANNAILDELETFADAINNNTTPIV
TLEDGTEALRVAYQIIDCFKK
>LONDMIMF_01589 putative 3-hydroxybutyryl-CoA dehydrogenase
MKNIAVIGAGTMGNGIAHTFAQSGFTVKLIDISEKSLDKGMATIAANLDRMVAKGTITED
DKLKTISNIITYTDIKDGVVGVDLVVEAATENVELKLNIFKQLNDACSHNTILATNTSSI
SITQIGAVVSHPERVIGMHFMNPVPIMKLVEIIRGYNTSDEVTKIIMDLSVKLGKVPVEV
NDYPGFVANRILMPMINESIETLYNGVAGVYEIDTVMKLGMAHPMGPLQLADFIGLDVCL
AILNVMYEGFKNPKYAPCPLLVNMVRAGKLGVKSGEGFYDYSESKKAEKVAKQFI
>LONDMIMF_01590 hypothetical protein
MIYDFREVSFINKFVYIQTKLSTIPYQLSTTINYPLSTIHYITLMAKIIPFKAVRPTRDK
VSLVTSRSYDEYSPAELASQLDFNPFSFLHVLNPAYVNQQKIGLEKRFKLVAQKYHDFKE
EDVLIKEEKPVFFLYEIQTKTQTFTGIIAGTSIEDYQNNVIKKHEDTLQYRVELFKDYLH
STGFNTEPVLITYPDDAELTNWILEKKQADSLYEFSTTKREKHILWKIETPEEISWLQEK
FAAIGNVYIADGHHRSASAELLYEEDKASGNENLNYFMSFLIAESNVKIYEYNRIIRDLN
GHSKEDFLALLSNEFWIKNKEQELWKPTKKFEFGMYLDNEFYSLILKDGHSFSSVLESLD
AQILYTKVLHPILGITDLRNDERIDYIPGKQSIVTIKEVIDEGEFELGFMLFPTDISEIK
ELADNNLIMPPKSTYIDPKFRSGLVVYEL
>LONDMIMF_01591 hypothetical protein
MNKIKYHSGSIILHSTLLVVVWIASIVLFLSTNKIGGHLFLILFSLLSLFSTLTFFPTFI
NYFKKEDAIIFEDSYFIYKTFNLAIKFDDIEKYYFYYSKGGTFLILKFKNFNSYSEVLSK
SLLGKIALLNFRTFGKSLVFINLRFIKTTIKEIEKNLGTNVNRKQSS
>LONDMIMF_01592 hypothetical protein
MSIENNLLEIKATLPDNVTLVAVSKTKPVSDLMEAYEAGQRVFGENKIQEMAEKFEQMPK
DIEWHMIGHVQTNKVKFMASFVSLVHGVDSLRLLEEINKQALKNNRVIDCLLQVHIAEEE
TKFGLSESELNELLQSESFSQLKNIKIKGLMGMATFTDNQNQIEKEFKHLKSVFDRLYQT
QKTDNYEMEILSMGMSGDYQLAIDCGSTMVRIGSSIFGTR
>LONDMIMF_01593 putative ATP-dependent helicase DinG 
MYAILDIETTGGQYNEEGITEIAIYKFDGHEVVDQFISLVNPEKAIQPFVVKLTGINNAM
LSSAPKFYEIAKRIIEITDDCIIVAHNAQFDYRILRTEFTRLGYDYQRKNLCTVELSKKL
IPDQVSYSLGKLVRALGIPMADRHRATGDAMATVKLFKMLLAKDLEKEIVKSFVKTEIEK
GLTPKLLDIVSKLPSTTGIYYIHKENGDLIYIGKSRNIKKRVNQHFTGSSSKSKKIQLEV
FDVTYEETGSELIALLKEAEEIKINKPKYNRSLKKTIFPWSLYQEKDLNGYIALRIQKTD
ARKKELASFSSPAEAQSALFKITDSYQLCQKINGLETVKSHCFPYELNQCNGACIQKESS
EEYNIRVESFFENNEYQKQNMIIIDRGRNIQERSAILIEDGIFKGYAFFDLNYQVNNIDI
LKNIIIPMKSNRDSKNIILSYLKKKKVLKTLSF
>LONDMIMF_01594 Cyclic nucleotide-gated potassium channel
MEITKTERLRNKLHEIIYEADTPFGKLFDLFLLLLIIVSIVAVMLESVVTIRLIYGQELA
VIEWIVTIFFTLEYIGRVIAVKKPLKYIFSFYGIIDLLATLPTYIDLLFPGLHFLVSLRA
VRLLRIFRILKLVHFVGASNQLVRALKKSRLKIAVFLFSVIVLCIILGTIMYMIEGPESG
FTSIPMSIYWTIVTLTTVGFGDITPITPLGQFVSMIIMILGYGIIAVPTGLVTAEFMSKD
KTVHQNTQVCPNCSADHHRDDAKYCYHCGHSL
>LONDMIMF_01595 tRNA dimethylallyltransferase
MKYLITIIGPTAIGKTALSIQLAKSFNCDIISCDSRQFFKEMAIGTAVPSKEELDAATHH
FIQNKSVFENYTVGDFERDAISLLDKLYETNDYAILVGGSGLYVDAILKGFDSFPEIDPS
IRKEIISNYEKSGISYLQQELEKLDKTYFDTLSKENPQTLQNPQRLMRFVEVSVGTGKPY
SSFLNLKKNTRNFTPIIIGLEAERAEMYERINLRVDLMMQAGLLKEAERLYPNKNLNALQ
TVGYRELFSYFDGDSTLDFAVEEIKKNTRHFAKRQMTWFKRTENVKWFHYKTETEKVIDY
IKKLLT
>LONDMIMF_01596 hypothetical protein
MKKLILLLATFPFLLATQCDPDDSPCGRFIEIHKDDLITIENRQTEYSLNDVLWLTASVD
RNQETSDSNIDLFELDHKLYYDVVLKKESAYIEYNYLTLSTRTTVIAQGESERNFFILIR
DGNSFKNRIGIRLLESGNYTLTINNIRSYKSYNGNCNFTTLSILTDFNEMDSSSFSFVVN
>LONDMIMF_01597 hypothetical protein
MPISSNFTSIYSRDWELNFTHCTPNGYLKYTDLCNLLQLTAGDHADIGGISFTDMQQHNQ
AWVLSRMKLEIESLPKWRDIVTVKTWIVSLENSRSVRALEMHVNDKKVIGCETYWAVFNT
KLRRPETLALPHEHFEKYPERLATEERVKKIDLPDSMKKIAERKVVLSDLDIVNHVNNVK
YLEWCLDLVNPKSILKQQLKSFDMNFMKELVLGDEVAIDEKTDADKSIFSITKNGKPCFA
LELNWK
>LONDMIMF_01598 Response regulator MprA
MENVNKKILLVEDDPNFGSILKDYLSLNDFEVTLAKNGMEGFEKFKKDTFDLCILDVMMP
YKDGYTLAKEIREKNKDIPLIFLTAKSMKEDVLKGYKVGADDYLNKPFDSEVLLMKIKAI
IQRKASDSKADNTKFEFQIGNFHLNSKLRFLTYKDEEPIKLSPKENELLKMLAVHENDLM
PRELALTKIWRDDNYFTSRSMDVYIAKLRKYLKADEDVEILNIHGEGFRLVVKNKVSE
>LONDMIMF_01599 Signal-transduction histidine kinase senX3
MNKTLFRLLVVLMSLSLIGIILVQLYLINTSFNNNEEQFKYHVQQVIGNVSEKLKQQETY
TIVNQYNILRDSIGKDPNPSQLLDFVLVQKNKVTNETIIYSNNIIAEDYNINLTFFDKKK
DSVKAQNFISKRRTEIYSGKPIDNSGIQKNTTPDITIEKSGNIEMLERAQFDMFYKDIAE
TKPLKDRVSKEKLQKMLQQELKQYEVKTPFEFGIYSDGLATKIRSDNFKFDKNSTFQTPI
LTDSDGKSKYQLLVSFPEKKKFLFTDLIGITILSITFTLIIIIAYASALNQLIKQRQISE
IKTDFINNMTHEFKTPIATINLALDAIKNPKIIEDKEKVHRYLQMIRDENKRMHAQVENV
LRISKLEKKELEITKDPIDVQTIVEDAVEHVNLIVEDRQGTIRTHFNATRTTTLVNDVHF
TNVMVNILDNAIKYSPEAPIIDIYTENVKDFILIKVKDQGQGMGKAAQKRIFEKFYREHT
GDLHNVKGHGLGLAYVKRIVDDHNGQIFVESEKGKGSTFIIKLPLIN
>LONDMIMF_01600 Dephospho-CoA kinase
MTKIIGLTGGIGSGKSSIAKHIESLGIPVYIADTEAKKILDTADVIAKVIALFGDDILEN
GKIDRKKIAALVFQDPEKLKKYNAIIHPEVYLHFQNWVKQHSNYPLVVKEAAILFESGSY
KDCDKIILVTAPKENRIQRVMKRDAVTREAVEQRMSHQWDDETKKSMSDFVIENIELEKA
KQSAENIITLLRNQ
>LONDMIMF_01601 Hyaluronan synthase
MKFSFIIPVYNRPDEIDELLQSLVLQKYDKPFEVVVIEDGSTIPCRYIIDTYQERLTISY
YFKENSGPGDSRNFGMRKARGDYFLILDSDCILPQDYLSEAEKALELNYVDCFGGPDKAL
DSFSDIQKAINFSMTSFLTTGGIRGGSEKIDKFQPRSFNMGLSKKAFEASQGFGNIHPGE
DPDLSIRLWKMNFETRLFPKAYVYHKRRIDWSKFYKQVNKFGKARPILDSWYPEYSKLTF
FFPTLFLLGFLASVVFSFFWTGIFLVLYGFYFLAIFIVSTFQNKSLKIGFFSLIAVVTQF
YGYGTGFLKSFWNIKVLKKKPQEVFSELFFKK
>LONDMIMF_01602 hypothetical protein
MEKNYFGPISQRAKAKLFLKFLLLLVSTSTFSQTTLINPTTDGGFENGNTLAANGWNAVN
ASVDSWNVGNVPVAGAGTNCAFVSSTGGATWQYSQTSSVIHLYKNITVPANEPKITLSFR
WKVGGEGTGTNDWDNMKAFLVPSSYNPVSGVPIPPNYQIGTLYKLSSTNWSTANISLAVV
PGNSYKLVFSWKSDILDVVNPPAAIDQVSMISNPPRTFTSVASGNWNLPATWDINAVPTS
ADNAIVSTGTTVTLNVNNLAINDLTINGTLNYATAAATFAVKGNLLVNTGGNLDAFAGTT
GKSLVVSRNLTNNGNIDLSKGTAVNNILTFDGIIPQTIGGTGTFTNNLIRNLTFNNSSTG
VITWNFNDLRVGGNITFTKGKVALESNTLILGTGVAAGTGNNAIGALVYTSGGFVSGTFS
RWWANTATGTALTAGSQPTAALGRYPFISSTGINRAAYVQRVTPTAGGQIACKYVDAATT
SASSISDSGYVLDSKYDGNWTFSTPGTVPVSATYNIALIGQNAYLASNGNSRIIRETAAV
EGTHLNGTNLPMGQRTGLTLAQLTQSPLYIGLAFADTPNASIASGNWNNAAIWSKGNVPN
CNEIVSIAPNHTVSINSAGNSCKGLTVSLGGKLSVSGGDLVVGCTDNNNTLNVLGVLEVT
AGTLNVNGNISTSFGSVFSQSGGNINVDGNSGNAATSVPNGTRIINIVPEDSESLNWTGG
ILTIVDPHASTTANDVLRIDGAFDGSVNVTSGHTIRFGDGVSVQSGGNATNGFRINCWAT
VTGLPLGNVIVEGPEGTNRYLTSTYPVPVNGDLTVNNGAECRISTVYLNGNAMVNTGGIL
TSTTGFFFANARFVNESTVAFGPSLNLQQLTNNGIIRNLAASPTANFTNMVFNNGSTAGV
TLNSPVSLSGTLTLNEGKVNTSNTNLLTVGTATVAGDIAGGSATAYINGPLARTFGNNRA
AVGTYSNVTIYPVGKDGSYLPFYIDPSTSGGALQIKGEAFVANSGTFPSNVSSLSNNRWE
ALLIAGNANLLNANVRIVDAGITANSKMLKSATANGEYAVFSPASIVAADNLYTYSSIRV
SDFSGYFSHGQMICSGTVAEPTGSPVQDFVTGQTLADFVVNGSDIIWYDADGNRLPLSTI
LVSGTTYYASQTINGCESSGRLAVTAGINLGTDDFEAIAFKYYPNPVSDRLNLVASENID
SVEIYNLLGQRVFSKKIDAMQEQLDFSQLPKGTYILKAAIGNVMKNVKIVKK
>LONDMIMF_01603 hypothetical protein
MVYTNCGDIGTAAVACASGSDIGNREINQFSVTAGTTYYIVLSTFPSPQSFAYTLNITEN
TCIAPAVTFSRTSNCAVSPGFFVNANITSLGTATSLTVTDNQSSPAQQVTAAGTVQFGPY
PNNTSVILTVANNQDANCVVTSPAQNQTACPPVNDNCANAVAITPTATFVPTDGTNVGAT
ASSTETVPVNCNGYSGGDVWFSVVVPPSGNLTIETGNSSTGASGLDTVVTVYSGACGSLV
QVGCDDDGGEGAYSLVVLSGQTPGSTLYLRVYEYSNDSTGSFGISAYDSSLKTTSFDNMS
FKVYPNPVKDRLHLSYTENMSDVAIFNLLGQQVLSKKINATESQIDMSALAGGTYLVKVN
VGNQVKTLKIVKE
>LONDMIMF_01604 hypothetical protein
MFFSFRKAIISSVVPVAIWFVNRHPTLERTILGLYKSLFGLAMITASSFAASAVRSIAPI
FPGFSGDSAIKINGFLPRFNSERERFFDFATAKMPSVVSR
>LONDMIMF_01605 hypothetical protein
MKLLKKLYINNFFFYALIGVGFLYCVAFIFPALYNAASYLLLILLGFLALDILILFSAKH
GIEGTRIAPEKLSNGDENPIGVTIRNYYTFPIGVKIIDEIPEQFQIRNFGIKRRIKASSQ
DDIQYYLRPTSRGEYVFGNLNIYVLSPLRLVSRRFTFNKNQMVPTYPSYIQLRKYDLMAF
SNNLFQYGVKKIRRIGHTMEFEQIKEYVQGDDIRTLNWKATAKKNALMVNQFQDEKSQSI
YMAIDKGRVMKMPFNGLSLLDYAINATLVLSNVILKKQDKAGMFTFSKKVENRVAAERRS
SQMHQILENLYNVKTDFFESDYSRLYVDIKKNINHRSLIILYTNFETLDSLHRQLPYLKG
IAKNHLLVVVFFQNTELNDIINSKAVTIQEVYDKVIAEKFAFEKRLIVNELKKYGIHSVL
TQPENLTLDTINKYLEIKARGIL
>LONDMIMF_01606 ATPase RavA
MEENTAHNPNVNPIENVNFQSRIDLSQLQESIEKIRAEISSVIVGQHKMIDQLLVAILSN
GHVLLEGVPGVAKTITAKLVAKTLNIGFSRIQFTPDLMPSDILGTSVYDLKKSEFEFKKG
PVFSNLVLIDEINRAPAKTQAALFEVMEERQITMDGITYDMEAPFLVIATQNPIEQEGTY
RLPEAQLDRFLFKINIDYPKLDEEILIIQKEHQLQNHGKLDNIQTVLSSEEIQKYQSLVK
QIIVEPQLLEYIAKLVINTRENAFLYLGASPRASIAILNAAKGYAAIRGRDFVTPEDIKE
AAIPVLQHRVIVTPEREMEGITSIEIIKQVIEAIEIPR
>LONDMIMF_01607 hypothetical protein
MNKTIKIYIVFLVLLLVGIVYIDVTRPKPINWTPTYDIKDKIPFGLYVFNEEAPALFGQK
VNRITETAYQYFEPKYDYDSLVNTYTIRGTILSVSDQYMIDDESTQELLYFAQHGNKIFI
SSKSFPQKLMDSLKFSYSSKFMGRDTIFTSLANPHLGKKKYDISVGAGNSYFEKIDTLNT
TVLGYHENTKEKLVDFIKVPYGKGEFYLHTQPVVFTNYHLLKDNHSEYAAKVLSYTDGEV
FWLLKNQSGEIVSGSPMRYILSQPALKAAWYIFLLGMIVFFIFNAKRKQRIVPIIKPLEN
TTVDFTKTIGNLYFQEGNHDNIIEKKIIYFLEKIRNDYLLDTTVLDENFEKKLQQKSGKK
IEDIQKVVYLINQRRKSYHQSIESDLIALNTAIEKILAKEKNSQET
>LONDMIMF_01608 hypothetical protein
MMKTTPPLVKLTLSEQILNKLLYIFLFFFCLNTFGQDSLSVAKTDSVTVASKFSEKDIII
DSTKIKERSFSNFKEKYSDSSFDYEPKSKEKSAWERFKEWLAYWYNKIFSLGNDEASMSA
IELILKILAVIVILFVIYLIVKAIMNDEGQWIFGKSSDKKVIHYDEIEKNLHLVDFEKLI
KEAVKSGENRLVIRYYYLWLLKELASKEIIEWDIEKTNSDYLYEIKNEKLRNDFAYLSYL
YNYIWYGEFELGEETFSQAIQSFEKTIKTL
>LONDMIMF_01609 hypothetical protein
MITLFKKRNFNDYLNDTFSFFKKDGKHFLKNYFVINGIFLLLLVVFIYFLSKIYFEAIFS
TFENTNTGYNPIDKLFNENLGLFITSLVGFILLSLFLSLLNFAYPIVYLDLYDKNSGSSF
DTRDIINGLKNKTGKILLFFIISLFVIIPAVVILFIVLLFLSFIIIGIPLMIIALPAISS
LITLAFFDYLNTENGYFTSLGNAISYLKKQFWPIVGVTMLMYMIIQIILTIFSMIPYVIA
MVLLFSSIEGGSTAPTQDAFSTFGILMTILFVIAILANYILNNLLIVNQGLIYYSRREHD
ENNSTFGEIDTIGTNFE
>LONDMIMF_01610 hypothetical protein
MREIAFIKQNKEKWLDFEQAIFGKAKKNPDEMASLYIHLVNDLSYAQTYYPKSKTVVYLN
YLAAQIYQKIYKTKRTETNRFVYFFSTEVPLLVYQYRRYVLYAFLLFFLTTAIGVVSAKY
DPDFVRLILGDNYVNKTLGNIKDGNPVAIYKDGSNWGMTIGITLNNLYVGLRCFLYGIFA
GLGTFYILIQNCIMLGAFQYFFYEQGVFWESVRGIWIHGSMEIFAIVIEAAAGFILGASI
LFPKTYSRMTSFKIGFKNSLKIFLGTMPFTIGAGILEGFVTRYSLEMPNWLNVFIILSTL
SLISFYFLIFPFIVNKKIQSAK
>LONDMIMF_01611 hypothetical protein
MTQLSINTTQNVNINFTAASIGDRILAYLLDFLAKTAYLIVIYSVFFYGLGINKLMDKMD
DWSRISILVLFYMPVAFYSLLLESLLEGQTLGKRLLKIKVVKIDGYQASFGDYLMRWLFR
IIDVSFSSGIVGLVSIIASEKSQRLGDMAGGTSVITLKNNININHTILEEIDVSYVPTYP
LVIKLSDNDARIIKETFNSARANKDYHMITRLKTKIEDVTGIRNQSGNDEDFIKTILKDY
NYYTQKM
>LONDMIMF_01612 hypothetical protein
MFYLLDIIGTMAFALSGALTAMNKRLDPFGVFIIAFVTAVGGGTLRDTLIGRTPVGWMRD
LNYVYFIIAGYFLAIIFRKKLDRLRTSLFLFDTIGLGVFTLIGLEKGLDTNLHPIICIAL
GTMTACFGGVTRDILCNEIPVIFRREIYATICIVGGILFFILKHWNLDNDILYVITSCVM
ISLRLLAVKFKWYLPALKQN
>LONDMIMF_01613 hypothetical protein
MNLKLQIRNFVVLFFFSCAAFAQDVALFRQFNGRYDFTIIGNTLNTSENNLNNFCTITTS
SSATLNMGVNDEIEKAYLYWAGSGTGDWNVVLNGVPITSERNFAYFQNDLDYFCAFTDVT
SQILSTGNGNYTLSDLDVSPFLDANHYCNNRTNFAGWAIVIVYKNESFPLNQINVYDGLQ
GVSRTQNHLTLTLNSLNVIDNAGSKIGFIAWEGDVNLPTAGFTESLKINGHILSNALNPA
NNAFNGTNSFTNSRTLYNMDLDVYEIQNYIQINDESVEIQLTSEQDFVMISTILTKLNNQ
LPDATISIDNVALECNSRRIMVDYTVYNLDSTNPLMAEVPIAIYADGNLIEQTLTVPPIP
IGGSYSDTIFLTIPDEIPNDFTLKFVVDDTGNGTGIVTELDETNNEFSVSISMLVSPEFN
LLDKILACNEGLKKGTFDFSHYEEIVKVDPDHIVHFFNSQEEAQANQNPIPNTNHYVASS
TPKEIFVRIEDENCYSITSFLLDTKNCPPTVYNAVTANDDGWNDFFFIRGLRDIFVNFKL
SIYNRWGTLVWTGNNNTENWYGQATKGIQIGGNNLPDGTYYYILDLNDPDYKTPLTGYVY
LTR
>LONDMIMF_01614 hypothetical protein
MRNYTVRKYQAGDYLNWNAFVANAKNATFLFHRDFMEYHSDRFRDYSLVVLDGENWIAVL
PANVVGDTVFSHQGLTYGGILCDVKLKQSMMLLIVKNIMQYLESAGIQKLHFKMMPSIYF
DYPSDELNYALFLADAKLTRRDALSVIDNSRPHKISRARRACVRRGQQLGLAIKEEPNFR
LFWDEILIPNISAKHDAKPVHTVEEIEKLHRLFPENIRHFNVYFEGKIVAGTTIFISKNV
AHPQYVSGQNEKNELGSLDFLYSHLILEVFKDKRFFDFGISNEENGRKLNEGLIFWKESF
GARTLTQDFYEIATSNYDKLENVLI
>LONDMIMF_01615 dTDP-3-amino-3,6-dideoxy-alpha-D-galactopyranose transaminase
MIKFLDLKKINQPYEQAFQDKMKTVMDKGWYILGDEIKAFETNFAHYCGTKYCIGVGNGL
DALVLILKAYIQLGKLHKGDEVIIPANTYIASILAVLQADLIPVLVEPDLETYNLDPNTV
EKAITSKTKAILPVHLYGQLAPMKEINTLAKKNNLLVIEDAAQSHGAVLYSQKSGNWGDA
AAFSFYPGKNLGALGDAGAITTNDDALAKMIFAIRNYGSEKKYVHDYIGINSRLDELQAA
FLSVKLPNLDTENAVRKKIAERYLAEIKNDKIKLPFFDGMQNHVFHLFVIRTANREELQE
YLSANTIQTLIHYPTPPHHQKALSYMGDLSFPITEKIHREVLSLPISPVMTDEEVSYVIE
IINKF
>LONDMIMF_01616 Lipid III flippase
MVSVKKIVGSSLFKVTSLNSISVIIKLLIGIVSSKVVAVFLGAPGMALVGNMRNFFSSIE
TITTLGFQNGIVKYTAENKDDEDRLKRVISTVFIALLVSSVLFALALFIFSDFWNNQVFG
ERNNYDFVISILAISIPFYVMNVFFTSILNGFGKFHKVIYIAIFGNIIGLLVSVILIWKL
NIAGALISIAATPALLLIVAYLYFRSLMNVREYIHFRYFDFDVIRNLSSFSLMAFVSGFF
GPLVYLNIRNNVIEKLGEEQAGYWSAMERISSNYLLFISTLLTVYFLPKLIMAVNNHETK
KVFYSYYKTILPLFIFVAAIIYILRDFIVKLLFTKEFLPVEDLFQWQLIGDTFKVASMIL
GYEFFAKKMTLAFIVTELMSLGVLYVSSILFIDFYGIEGIVKAHAFTYAFYFLVLGVYFK
IKMKPVGSVY
>LONDMIMF_01617 Poly-beta-1,6-N-acetyl-D-glucosamine synthase
MNQALFIIPFYNEGKRISFDSYREIIDASKEIDFLLINDGSSDDTLDILNRLSEELQNCT
VYSLSQNSGKAEAIRQGILHNPKEYEYIGYLDADFSTPVSEMIKLLDYAKKNRDIDIVLG
SRVKLLGNEVVRSQARHYFGRIFATIISKLILRVPVYDTQCGAKIIKGDIAKKLFDKPFL
TRWIFDVEMLLRYKMSYSDSLATVKEFPLEIWIEKGNTSIKLKEFLIFPFQILKIYFHYN
KKKG
>LONDMIMF_01618 hypothetical protein
MKTINSSYRLLFFLILAVYCLFTARYGFETWDTGYIPGYSWRIANGQDVYKDFVYKAPPS
TLYFQAIFIKILPEIGQFYFIKVTNYLLFALQVVLAVKSFTNFYPQQIKFNKWALMILGL
VISLLNFTAYPWPTTDGLFFSVIALYILSLSKKSSNLHLLAIALFCVLSSLTKQSFYLIP
FGFLFAITCLQGIKKGLFFFLYLVLFLLLFLSWVAYTSSLHEFLEQTTGQTHFKDLLYSG
FLDYIITYPRISVFIPLLIVSAFLLFYFPKQKPLTIPGYLKNLSIVLLVFSFSLCFFSDF
LIASRIAMLSTVLAVISKIIKDWKRFYYFIPILLVLLIAWSCSISMGYNYPIFFSTGIIL
SITVLFEEELDKVYNQKLFVFTGSIILVLAYSSNLRPYREKPFSELNYSLAEVSPKLKYL
ITNKDTGEKLLDLKSLVKKYGNNYIVAPSFPMAHYVFNTQSVLPADWLTNNEINRNPERI
LKIAAKKENFIFFEKSFLEGEEFMFENRDDFSVTAMYIYRNFKKTDETAHFIIFNTQERN
EIYPTIVRKSVH
>LONDMIMF_01619 hypothetical protein
MRILLVGEFSRLHNSLKEGLTALGHEAHIVGTGDDFKKYPVDFPISSTLVASNSLLRFCN
RITRKLFRLDLEAYERTYRFRKLLPILKGYDVVQLINSNAIETYPKLALRLYEKLFAQNS
KKFLLICGDETPIVDVLLKNNLKYSVLTPYFNDPAANKYYNYTLNYTNNQQRKLFDFVQT
NCDGLLVSDLDYKIPMEQTGFDFTFIPNPINTDKLEFIPMEIPSKIVIFHGVNKYSAVKK
GSSVFLEALSKIELKYGNKVEIRIVNSLPYDEYQKHIRSAHIILDQIYAFDQGYNALEAM
ALGKVVFTGAETEFQEYYQLTDSVAINALPDVESIVQQLSFLIENPEELTLIGKRARQFI
EKEHHFVKIAEIYTESWNTTNP
>LONDMIMF_01620 N-acetylgalactosamine-N,N'-diacetylbacillosaminyl-diphospho-undecaprenol 4-alpha-N-acetylgalactosaminyltransferase
MHQTKICLIGITLSNGGAQKIHAILSNFFSSKNIEVHNIVILDEMTYDFSGELLNLGKLK
DKGNGIWNNLKRFLLLKRYIKENKFDYIIDVRTRNNQIKEFLITKFAYKAQYIPMIHSYN
TDWYFPKNKFLAKNIFSNAYGIVCVSKEIEEKVRNKYGYKNLKTIYNPLEIDKIVSLSKE
RINLNFEYVFAAGRMVFDNNKQFDKLIRAYAASRLPSQNIRLVLLGDGPQKEYLQNVAQS
EKLGDKVVFLDFQNNPFQYMKSARFTILASKNEGLPNIITESLACGVPVVAFDCKSGPRE
LIENGKNGLLVEDQNFDALVKAMDEMNENEILRATCRENAFESIERFSVEKIGAEWLEYL
KIK
>LONDMIMF_01621 TDP-4-oxo-6-deoxy-alpha-D-glucose-3,4-oxoisomerase
MNIEIIEIPKIEDYRGNIAVIENEVVPFEIKRVYYLFDVPSSSYRGGHAHKTLMQLLIPL
SGSFDVMLSDGKEKQVVTLNKPDKGLLIKPTTWRELGNFSSGAVCLVIASEVYQEEDYIR
EFDQFIEYVNQS
>LONDMIMF_01622 UDP-Glc:alpha-D-GlcNAc-diphosphoundecaprenol beta-1,3-glucosyltransferase WfgD
MPFFSVIIPLYNKENSIRNTLSSLLAQTFSDFEVILVNDGSTDNSEARALEISDARIRLF
STENQGVSKARNYGITKASGTLVAFLDADDYWFPNHLEQLSNLYKMFPECGLYCTNYERF
FNADKVIKPKHIDIPSHPWQGIVKDFFKSSYIDRIAWTSAVAVPRTILNEIGGFKTTITL
GAGEDTDLWIRLALQYDVAFDNEISSRHVLDAENRISLEKTLKRSYARLDEFQEEEKQNP
SLKKYLDLHRVFFAIQHKLAGDMKTYNFYMQSVDKTNIPLKAKLVMAMPVFIARKFYAFK
KYLERKNILVSIYD
>LONDMIMF_01623 hypothetical protein
MFLSMQKKELHIVSFDNPFPPNYGGAIEVFYKIKALHEIGYAIYLHCFVNSVPEQSPELD
AIVSEVYFYKNSHNPFYFFSKTPFSVLSRNNRELLNNLKKNNAPILYEGLKTAYCFEDNL
LKNRVKVIRLHNLEQDYFKGIALSENNLIKKALYFLESKKYESYEKKLQHFDKVLALSRF
ENDYVNSRFHNSSYIPVFHGNEKVEIIEGFGKYAFYHGDLRTSDNRKVVKYLIEVFKNLD
YKLVIASGSKEKMVRRLIGNAPNIEFVFLKDFEMLKQLLGEAHINLILSFQRSGTKLKLL
NSLFRSRFCIINENIIDDEIVSDFCIKTDSKEKLISRINFLKSQPYLDGEKKKAVLEEYL
NDRTNAQILSGILESLNR
>LONDMIMF_01624 Cell division ATP-binding protein FtsE
MSQPVLFLRNVNIYQEKNLILSNVNIEVKHGEFLYIIGKTGSGKSSFMKTLYADLPLTEG
QGSIVDYDLATLKEKNIPYLRRKIGIVFQDFKLLPDRNVQENMIFVLKATGWTDKQEMQV
KIEEVLEKVGMKNFANKMPHQLSGGEQQRIAIARALLNDPEIILADEPTGNLDPQTSVEV
MDVLRKINANGKTIIMATHDYALLMKFPSKTLKCDSGSVFEVVQRTV
>LONDMIMF_01625 Lipopolysaccharide assembly protein B
MHRLSRLFLLFSFIGTAPVFAQQTAIYTNDLTEYNKAVSLYNDKQYQAAQIIFEKVKADN
SNKNSDIEADCAYYIANCAIRLNQANADQMMESFVEDYPTSTKQNQAYIEVAHYYFEQGK
YPQSLKWFDKVDEGSLSNNDRERYNFQKGYTFFTAGNKKEATNYFNQVLNSKEYGSQAKY
YLGFMAYESDDYTKATKLFDEVSGEEKYQEKMSYFQADMNFKLGKFDKAIELGKAAMAKS
NALEKSELNKIIGESYFNLKKYDQAIPYLNEYKGKKGKWNNTDFYQLGYAYYKQNDYENA
ISQFNKIIDGQDFVAQNAYYHLGESYLKTDRKQQALNAFKNASEMAFDAKIQEDAYLNYA
KLSYEIGNSYQSIPAVLNGFIEKYPNNPSRAEIETLLINSYITSKNYKEALTLLEKNKAS
NREAYQKVTFYRGLELYTDGNYQEALAMFKKSLGERSNTRFTARATFWKAETEYVLDSFK
EAVLTYKQFLGDAEAKNTPENKNIYYNLGYAYFKLKDYDQAATNFQSYISGPKDDKVRLN
DAYLRLGDSYYVSSKYWPAMEAYNKAIEIKGVDADYAAYQKAISYGFVARNEKKIEELNS
FIKNFPKSQLRDDALYELGNTYVAEKKTESAIQTYDKLIAEYRESSYTSKAILRQGLVYY
NAEKDDQALTKLKKVVAEFPNTPEALEAVSTARLIYLDKGKVDEYATWVKTLDFVEVSDA
ELDNDTYGAAEKQYLQNNIKPAIAALSGYIAKFPNGINSLKANFYLAQSYFADGLENNAI
PNYEFVIAKPRNEFTEQSLARLSQILLKKADYAKAVPVLKRLETEADYPQNITFAQSNLM
KSYYEQKDYANAVVYAEKVLANAKTDDRVKSDAQVIVARSAIKINDEVKAKAAYAKLQTI
AKGELAAEALFYDAYFKNKDGKFEASNTAVQKLAKDYSGYKYFGAKGLVVMAKNFYGLKD
SFQANYILESVLKNFKDYPDVIEEAQKELDIIKGEEAKRNSSIQN
>LONDMIMF_01626 hypothetical protein
MTHKTQYKIALLFLFAGLQGVFAQKKDENIGTEVVNVVKPYTPTISDAFKVKETPPLEDE
DNTKKEEIKYNIFSFPVASTFTPAKGRAASVDKAKQEKLYKNYATLGVGNYGTLNAELFV
TENLNRNEYVGGMLRHLSSQGGIDDLLLDDKFYNTSLDLTYGNQQKDFSWNVDAGYQHQV
YNWYGLRNDFANDLADPQDRQDLINSIDPQQTYQNIYLGGRISAKESIFKEASLKFNHFS
DAFGSSENRFYVKPTVGFEISGNKVNANFIVDYLGGSFEKDYFGTTAINYGFTNIGIQPS
FVYQQDDLTVNLGAGLFYSMDNENSDNKFFVYPQITATYRIVGDVMIAYAGAEGSLKQNS
YRDFTQENFFVSPTLAIAPTDQKYDIYVGLKGKIANNVSFNIRGSYKNEDGKAVFLSNPY
NNENPNQEGYAFGNSFSVLYDNVKTMSFFGELKADFSKNVSFGINGTFNSYKTDELAEAW
NLPELQVAANLDFNITEKWYAGASVFFVGERKDVFSYTSLLRNELETVTLDSYFDLNMHV
GYKYNDRLTAFLKGNNLTSQDYQKWLNYPVQGIQVLLGASYKFDF
>LONDMIMF_01627 hypothetical protein
MTLKEKTLNYYKQLVQDKIDAFQDMISNLTDDAQNDAKGSAGDKHETALSMMHLEQEKLN
HKLKEFLEQKGVLDKIDASKETKIITLGSVVKANGILLFMSAALPKIKIEEKNIIALSPQ
SPLGNKLLGQQVGYSFEINGTKYLIEEVQ
>LONDMIMF_01628 Asparagine synthetase B [glutamine-hydrolyzing]
MCGILAIIGKGKDEELVRQLSKRMSHRGPDESDLHVTENGHILSHERLSIIDLHSGRQPI
KGTRSAYMVHNGEIYNHQELRDTVLKHHTFRTKSDSEVIVHLYEEFGYDFLNMLDGDFAF
VIIDGDDFIAGRDAVGVKPLYYGLDERGRIYFASEMKPMADQCKTFATFPPGHYYTQKTG
FVKYYRPEYEDHEKATEALDLVKIRETLTEATRKRLMSDVPIGVLLSGGLDSSLTSSIAA
RLLKEKGKELRSFSIGLDAEAPDAKAARKVAEFLGTDHHEIYFTIEQGIEILDKLIWHLE
TYDVTSIRASTPMYFLSKAITDMGVKVVLSGEGADEIFGGYLYFRNAPSTEDFQKETIER
VQKLFTADLLRADKSTMAHGLEARVPFLDKAFLDLAISIRPEEKQPKTYDGVEKYILRKA
FDTPENPYLPQEVLWRQKEQFSDGVGYSWIDTLIEYCSSRVTDLQMEQAAERFTYNTPVT
KEAYFYRDIFHKHFPQLSAAQTVRKWIPKWQENLDPSGRANAAHIQADTAISKTGAVA
>LONDMIMF_01629 DNA gyrase subunit B
MWLIITPVFIYLFVKQKNTFLDRLYMSEEIKKSNYSADSIQALEGMEHVRMRPSMYIGDV
GVRGLHHLVYEVVDNSIDEAMGGHCDTISVTINEDNSVTVEDNGRGIPVDIHKKEGVSAL
EVVMTKIGAGGKFDKDSYKVSGGLHGVGVSVVNALSNHMKSTVFRDGKIYEQEYERGKAL
YPVKQIGETEKRGTRQTFYPDDTIFTQTTEFSYDTLSARMRELSFLNKGITITFTDRRVK
DEKGEFLSEVFHSDEGLKEYIRFLDGNREPIISHVISMESEKGEIPVEVALIYNTSYSEN
IFSYVNNINTHEGGTHLQGFRTGLTRSLKKYADASGLLEKLKFEITGDDFREGLTAIISV
KVSEPQFEGQTKTKLGNREVVSPVSQAVGDMIEAYLEENPNDARVIVQKVILAAQARHAA
KKAREMVQRKTVMGGGGLPGKLSDCSEQDPAKCEVFLVEGDSAGGTAKQGRDRNFQAILP
LRGKILNVEKAMHHKVFENEEIRNIFTALGVTIGTAEDSKALNIEKLRYHKVVIMCDADV
DGSHISTLILTFFFRFMKELIENGHVYIATPPLYMVKKGNKKEYAWNDAQRDEITERMGG
GSSVQRYKGLGEMNAEQLWETTLNPEFRTLRQVTIDSLAEADRIFSMLMGDEVPPRREFI
EKNAAYANIDA
>LONDMIMF_01630 Malate dehydrogenase
MKVTIVGAGNVGATCADVIAYRGIASEVVLLDIKEGFAEGKAMDIMQCATNTGFNTKVSG
VTNDYSKTANSDVVVITSGIPRKPGMTREELIGINAGIVKSVAENVLKYSPNTIVVVVSN
PMDTMTYLTLKATGLPKNRIIGMGGALDSSRFRYYLSKALDKPSNDVSAMVIGGHGDTTM
IPLTRLASYNGIPVSEFLSQEALDKVAADTMVGGATLTGLLGTSAWYAPGASVAYLVDSI
LNDQKKMIACSVFLEGEYGQNDICLGVPCIIGKNGVEEILSINLDEKEKALLAKSADAVR
NMNADLKSVLA
>LONDMIMF_01631 hypothetical protein
MQNRGLVKFFAILFALVSIYQLSFTFVANRVKSDAKAFANGDEKKEVKYLDSISKENVYN
LGFTKFTYKEVSDKQINKGLDLEGGINVILQISVKDVLKTLANHTKNPVFNKALENADKN
QQGNQDYIDAFFIAFDEESKGAVKLADPEVFAHRNLEEVNFNMSDAQVKTIIKRKVKESV
ESAFRVLTERIDKFGVVQPNIQMLGESGRILVELPGAKDVDRIKKLLQSTAQLEFWETYK
IEEMGNFLMATNEVLKKTEKEINTKETPKTANDTLGNLLTDASKDSTAVKGNNPLFDKMT
AYGQGPILGYYSPKDTAKINSYLKMPEVKSLLTGEQRYAKFVWSKPQSINVLKQQIVDPT
KTPNSKKVEVLELYALKGNRQNTPAMSGGVVTDASDKFDQMGKPSVEMIMNSKGAKDWEA
LTGKAYTEKGFIAIVLDDVVYSAPGVTSGAITGGISQITGNFDISETKDLANILRAGKLP
ASADIVQFDAVGPSLGQEAIDNGITSALVGLLLVSLWMVVYYGKSGWFANIALAVNLLFL
FGILASIGAILTLPGIAGIVLTMGTAVDANIIIYERAKEELRMGKTLEEAVKVSFSWRGA
MSSITDANVTHVLTGAVLFIFGTGPIKGFATTLLIGIFTSLFTSIFITRILLEWSISRKN
NLTFVTSMSKNWFTNFNYDFLGKKKITYIFSSCVVIVSVASFFINGLDEGVDFKGGRTFQ
IRFEKPVEASEVSDELTKVFDGVVQAKVLGDKEQLKIVTKYKIDDPSSDADVEVNKMLFD
NLKKYYGPDLTYEKFVNAYDGKTIGIVSSSKVGPAVAKDIKTNSFWAVLGAMGIVFLYLM
ISFRKWQYSLGAIAAVAHDVIFVLGIYSLCYKFMPFHMEMDQHFIAAILTVIGYSMNDTV
IVFDRIREYLAGKTKGSFNDIVNRSVNTTMSRTLNTSLTMILVLLIMFIFGGESIRGFIF
AMLVGIIVGTYSSLFIATPVLCDSISDAEHKRIEDMHNNVENK
>LONDMIMF_01632 Prolipoprotein diacylglyceryl transferase
MTTALNIVWNPSEGIDLGFFVIRYYSLMFVIAFVLGWYLMKKIYLREGESIEKLDTLFIY
TFFATLIGARLGHVIFYQSELFREDFWSVFLPFKTKPHFEFTGFSGLASHGAAIAIIITM
YFYSKNVIKRPLLWILDRIVIPVASGAIFVRLGNFFNSEIVGHKTTSPLGIKFLRDSIKP
DVAMIETKTNNVNDAYHQIATNPEYAAILQQVAPKHPAQLYEAVGYVIVFFILFFSYWKT
QAREKSGYLFGLFLVLLWTVRFLVEFVKESQGGIEESLGLFSTGQWLSIPFILAGLYFIF
TAEKKVNSL
>LONDMIMF_01633 Cysteine--tRNA ligase
MPLYQTQNLKIYNSLSGEKEVFVPLHEGNVGMYVCGPTVYSNVHLGNVRTFMSFDVVFRY
LLHLGYKVRYVRNITDVGHVVDDEDEGEDKIAKKARVEKLEPMEIVQRYTVDFHEILKEF
NFLPPSIEPTATGHIIEQIEIIKKIIENGIGYVSNGSVYFDVQKFNKTHNYGKLSGRNIE
DMIANTRELDGQSDKRNPQDFALWKRAEPEHIMRWPSPWSDGFPGWHLECTAMSTKYLGN
HFDIHGGGMDLKFPHHECEIAQNEACTGQAPVNYWMHANMLTLNGKKMAKSTGNNILPRE
IYAGGSPFLSKKYAPSVARFFMLQAHYRSNLDFTDDAIAASEKGFVRLMDAYDTINEIIP
SEKSSLDIQAWIDACYDAMNDDFNTPILIAQLFEAVRYINLLKENKETITSEDLKLFSKT
IENFLFDVLGLTNEKSLENNDKLDSVVNMLIGMRNEARANKDFALSDKIRDQLTNLGINL
KDGKEGTTFSIN
>LONDMIMF_01634 GTP cyclohydrolase 1
MTNNEDFLDEIGDNHIATNAKNPLRSDAFDITDDQKIELIKKDVENILLTLGMDLTDDSL
KGTPNRVAKMFVKEIFGGLNPAKKPNASTFINNYKYGEMLVEKNITVYSTCEHHLLPIIG
RAHVAYISNGKVVGLSKMNRIVEYFAKRPQVQERLTMQIVQELQKVLNTEDVACVIDAKH
LCVNSRGIKDIESSTVTSEFGGKFKNEATRREFLDYIKFDTQF
>LONDMIMF_01635 hypothetical protein
MGEIVNKVANSALEVFDLEDYYPKGERVELDISQWLLEGFLLREKDFREQLKQYDWSQYA
DKYVAVYCSTDAIIPGWAFILVTVYLTPFAKKVANGRLEDLENSLYEEILPTLDYTKYEG
KPVIIKGCSRKPVPTGAYLLAAQKLQPFARSIMYGEACSAVPLYKKK
>LONDMIMF_01636 hypothetical protein
MIKKFTLLMLCFFGMTKAKAQEPAAPADTTKTWQTKGNASLLFNQSTFDNWLAGGENNIS
GTLGVNYDFNYKKDDLTWDNKVIASYGIVKTRTSSFAKKTDDRLELNSLLGKKFKPDSRW
YYSAFLNFKTQFTKGYEYGKDANGVEIRSEITNFLSPAYLTFGPGVLWKRDDNLKFNFAP
ATSKITFVDKNFTLPNEAYFGVKEGKSLRYELGAYASAYYKLDIMANVTFENILSLYSNY
LEDPQNVDLDYQLNIVMKINKYLSTNLSFQTIYDDNAFQGFQIRQVFGVGANYGF
>LONDMIMF_01637 GTPase HflX
MLEKETIKFEKTVVVGIVTQHQNEEKLNEYLDELEFLTFTAGGEVVKRFSQKMERPNPKT
FLGTGKMDEIHHYVKEHNINTVIFDDELSPSQQKNITKILNCKVLDRTNLILDIFAQRAE
TSYARTQVELAQCQYLLPRLSGMWTHLERQKGGIGMRGPGETEIETDRRIVRDRIALLKD
KIKVIDKQMSVQRSNRGAMVRVALVGYTNVGKSTLMNVISKSEVFVENKLFATLDTTVRK
VVIKNLPFLLSDTVGFIRKLPTQLVESFKSTLDEVREADLLLHVVDISHPDFEDHIDSVN
QILADIKSADKPTIMVFNKIDSYKHLTIDADDLVTEKTTKHYTLEEWKDTWMSRMGKDRA
LFISALNKENFEEFREKVYEAVREIHITRFPYNKFLYPDYKEAPEDKND
>LONDMIMF_01638 hypothetical protein
MKKTLLFLILILYGIRMNAQCWKSISFCTGIKTDGTLWKWGPNHAGQIGNGTYISTNLPV
KIGTDINWKVASCTDYFTAAIKTDGTLWTWGENSEAQLGLGDSMIRRTIPTQVGTETNWK
TVSAGQDHCLAIKTDGTLWMWGLTGTTGGLILSPIQVGTDTDWEQISAGLSYSLAIKSNG
TLWSWGRNQEKLFLGLGSSAPDVVNSPTQIGSDTNWIAIATGNTNPTDGNVNFALKSNGT
LWGWGKNASHSPLGDGTATPRYIPVQIGSDNDWAKISLQSGIKNNGTLWAWGKGHIIGIG
NTSAVITPIQIGTDTDWKAINNNLINFLKIKGDGLLWNSGMNNDGELGSGSTSPTLSLVS
IQVLTTNCPPPIIANDDLGTALNGLANTAITNVLSNDTFNGNPATFSDVALSFTSSTHSG
ITLNTSTGAVNVSAAVPVGTYTLNYQICQATNLSNCDTATVTITVNPQTIDAVNDNFSGT
PIDYLTGGVTPSLLTNDIVNGAATNPAEVILTLTNNGGVAGASINANGGINIPVGTLMNT
YTLQYSICLISNPSICDTATVTVTVADRVITTPEIVFAIRANTTVFESQLQSTGKIIICG
PFTKYNNVDAKHLVRLNTDLTQDTTFPALGSLPHPPEDFKVLPNDKIIAVGTFTSINGTP
TPRGIARLNANGTVDTSFNAGGTGIDTNDRIISCAVQSDGKILLGGGYIHSYNGVPTRNM
IRLNNDGTLDTSFVYPYTYDPSTFSSIYKIVVQPDGKILVSGNRSFATDALGNYIGQPHL
FRLNTDGSLDLTFTKTVVEATDRDSSVCSTCIAPIQNIVLQPDGKIIIVGAFTSFHGVIR
KNNIVRLNSNGTLDATFQTNKASLTSDRVIKDAVVEPSGKIIIGGEFTTYNRASVNKLVR
LNANGTVDATFSPGDGPTHANNYPGIVFDLNRQADGKVIVSGSFSHYNNISATNITRIAP
EIPGSQAKGNSIQLWNTEKEIGNNVQTTIGEISIYPNPSSGIFSLDLTQSKEPYTTIMVY
NALGQKVYQKNSVPESVNEIDLSNLPDGYYYAQITGGKSSVQKVLIKK
>LONDMIMF_01639 hypothetical protein
MLKCITLYKNDCFLGETLKKSANNTLKRRKKIYVKHTIDLKTADIHKTI
>LONDMIMF_01640 hypothetical protein
MKKITLLLLTFFISLVAYGQGLTENFDGGTTNALPTGWDRFNVGGGANPRFWLVNNTQPN
FSASAPNSAFIQNYQIGQGNTSRDWLRTTLVTLPENAQLQFLTRGFLNDNQGTIYEVRVS
RTLTGDVNNPANYTLAEDWTEPELNPTGIYEDDGTTPRWDEKTVNLKALGYNAGEQVYIA
FVRVFTQPTPSLGGDRWYIDDVRVSKKCEMPINMAAPTINMTNAVLTWNVPAGGATDFEL
VIVRDTQTLDQGIIIPITGALTYTIPVGTLTAATNYKYYIRAVCSATNKSDWTAPYFFTT
AALGERCSDPIVMPGIPYSTNNNTSNSNDRTDVAQGTGCGAVPATTNYMTGNEVFYSFVA
PSTGDVRIEMTPTGPNSALFVYNSCANVGVSCITGVANTGSGTRIIPALAVTEGQTYIVV
ISSTSATQTVGYYLELQYVTCPEPTNLSAPVVNQTGVTLAWDNPNPAYATWEVAIQPAGA
SIPGPGVSGTRVTTNRDFTTTIDGTPIVASTAYQYWVRALCVEGGTTFSPWAGPFEFFTP
ICDATLPNAQCVHNFRLTGTNGWQGAVMHVRQNGITVKVLGPQFTSGTSLVVPVPLCNGI
PFELVWVSGGTAQASVGIVVQNSFGQLLYQKTAGTGAPGTTPLHTEMVDCEFPKCPPPIN
LGATAITASGATLTWTPASLPSGPTTEWEIYLAPQATAVAPGNDDPINTDNTTTDRPNPR
TGLISDTQYVFYIRTVCGTNRASTWVGPFTFRTAVSCGIPTTLGVRNPQTTSADLFWTQP
ALGGASAWQVVVQAPGAGAPTYDDARAVNLANGGTYGTGGAGSALTPATQYEYYVRAVCS
TSPLDVSRWVGPFLFNTACDPLPVPYSEGFNSTSTRELCWSVLSVLGTNTWNMNDTATPS
EGNEVATFTPNNGTNNDDWLISPTLDLRPNYRLRYKYKVASATAANTLQVVITNENNVGI
APSEFNTATPLWTGTLTNTTYQERIINLVGRGDLTTNGDLVNIAFRVPPTVNNANKIFID
DVVFEPIPACPDPMDLGIVTNSITSTSAQIFWTPGYQETQWQVAVQPIGTGVPAANFNGA
VTTNNVNFLANTNTVNGTPLQPGNQYEVYVRAICADPNVSQWVGPIVFRTLLCETADLCA
YTFTMTDTASNGWGTGVSMNIIQNGLVIATLTGPANGQASATQVVNFCPGVQFEVFWNPS
TASTANLAQVGLTITNFYNEVVYTKPAGTGRPNSRLYRGMPFCSTITCPYPTNLSVEQTS
PVSANLTWSPGGTEQAWEYVFQPAGGNYPGNLPGQRVNVPHANITGLAQATPYEYYVRAI
CGPDNVSYWAGPYEFTIYNSPGCIGVDIEGITMSVGEEKLLCPNDNCIDLTASYFQTQAT
NRYRVERIDYAPPFPYTAGPGSITVPVNVDDDWSPLIDLTLLSDSTGNSRPFNFCFFGDS
YSKLLVTDNGAITFSIAGPQGNGGMYTPGSDNAGWTMATNRQIPSIPPTNAPTQLPYRNS
ISGVLQDLDPRPGNSPADASINYTVLGTAPCRAFVLNIYKMASYGCNSQLQTSQIVLYEG
SNMIDVYVESRTPCNSHNQGLGVIGIQGDTNTEFAVPPGRNVGTWTASNEAWRFIPDGDL
SNVVFKWLKNGEFYSNDLSINVCADDVELMQAVALYDKCDGTTTERKAEVTLKVDQFPIN
EPNDLLACTGTTTSFNVTENTAVILDGVDNSDDYEISYYLTQPEAEDGSTPGITSVISTV
VAPIYVRIEKISTGCFVTREFNVDPTAPLPAFTVTGDTILCEGDSTTLTVEATNFNVADA
VFEWTLPDGTVSSQTGSTFNIAAATAADAGTYSVKVTAGCDETLEFTVQVNQIDTEFTYP
TPVCPSGTISPTAVTAATFTAGGSYTISPALPIDPATGTITLDGATAGDYTVTYTVTPAI
TNCTDDKTGQFTITIAGTTIVPVVTFNYTTPVCKSATTNPTPNLGAGFVTGGVFSSTDTN
VSVNPATGEINLANTQPGTYTINYLLDAIPAECKAGGTFDATIVITNSITPVTDFSYADD
SFCSGATLPGQLPTGAFEPGGQFTVEPSTGLNVNPTTGEFMAGTSTPGTYVIKYIIPADP
AICRSRSESSYTVTIESTFEINVTDECRNNEYVLIAEPSDPSYTFVWKDALGAPVGTNSN
IFNVSQYVANLSGEVQYPLNFTVTISTATGCLNVKPVVVESTFCDIQKGISPNNDGKNDY
FDLAGFNVKKLTIFNRYGTEVYTRTNYTNEWRGQSSKDKELPDGTYYYVIERSGVPSKTG
WIQINRQTK
>LONDMIMF_01641 hypothetical protein
MKKILFTALITLSVFVDVEAQQDPHYTQYMYNMNVINPAYAGSKENLSFGLLYRQQWEGI
EDAPRTFTFSGHSPAGKNVGLGLSVISDEIGPVKEQNVYGDFSYTLNLGGEHRLALGIKA
GATFQKIGLFSDINGSLPDPTDEAFSEDSNNTYFNIGTGFFYYTNNYYIALSVPNMLKSK
HLNVRRDGQERYYGEETQHYFLTGGYVFQLTDNIKFKPFAMVKSAFDAPTSFDVSTNFLF
NEKFEIGATYRLDDSFGGMVNYAITPNLRVGYAYDRIISDLKVTTPASHEVILLFDLNFP
KKVSRSPRYF
>LONDMIMF_01642 Outer membrane protein A
MKNLYITLSFVIASMTLSAQNKDTEKADKLFNRFEYVDASNEYLKLVDKGKADNYVYKQL
ADSYYNVFNTKEAIKWYAKATQEKQDAETYYRYAQMLKAEGKYEESNVQMQKFAGMAPND
QRAVAFKQDPNYLPKLKSQTKLYDEKSLDINSDQSDFGAVLTNDNTLYFASARNKSRKTY
GWNEEPFLDLYKATYNANGTFSEPVTVSEINTKFHDGPASITADGNTMYFASESFKEGDF
EKDKSKKLKFGQVYLFKATKEGDKWGNVKALPFNSKEYSVSNPSISKDGKTLYFSSNMPG
SLGGNDIWKVAVNADGSFGTPENLGTKVNTEGNESFPFITDDNKLFFASDGRKGFGGLDV
FLIDFNKKTDAINVGAPVNTSKDDFAFTFNTAKNIGFFSSNRTGNDNIYQATPVCGVEVV
TIVRDAKTGAILSDARVAILDDKKNVIETRTTAADGQVVYSVDCNRAYTLQVAKDGYESN
VFPVAKTNGGIVNVNADLQPIDVIVTPTEIVLKEIFFEFNKSNITQEGAFELDKLVQVMK
NNDQMVIMVKSHTDNRGSDAYNMNLSDRRAKSTVQYVISKGIDKSRISGKGYGESEPKVD
CKENCTEEDHAKNRRSEFLIIKR
>LONDMIMF_01643 hypothetical protein
MKSIIFKSIFVSMIAAGLISGCANDDNYNTPNLGCVDPGLTATKTVQQIIAMATGTPKLY
EDDDIIEGYVTSSDEKGTFFKTISMQTLPETGAPVGFSIALNVSSTFAEGFTPGTKVYIK
LKGLYYANVFNSLQIGALYQGNQIGRISENVWRQFIFPSCTRVNEDDMVRTVTLAQAYNN
ANLNTLIEINDVRFADASVGRKYYDIDSGGGATNHFITSASTGGASNIIRFSSFAPFSGN
RVPSGSGKIRGVMTKYNSDFQFIVRYESDIQLSGNRSFNFLGSFTENFESYVANQSNFPN
YFNKPFVGTKVWNIKTTASKYLEMSSFGTPNEDNKTMFFVPVDMTAANTMTFKYKVSFPV
TGHAPLKVYYTTNYTPGQDIRNAAIVDITSSFNIGTSQTFVNAGTFTIPANVTGNGFFIF
EYTGSGLTNPRLTTNFGIDDIVVN
>LONDMIMF_01644 hypothetical protein
MKMNKITTLLFASLTMGMMSSCVNDDDTSLPEYTPLIFGEDFSEGADNTLFEKEGWLNFA
ETGTVRWTNQVYSGNGYAEFTSYQSGQSSNIGWLITPSIDLDAQEGEKLVFQTAQAFVDN
AANTIEVLISTDFDGTNVTAATWQSLSATFPTTSATYYQFIKSGVIDLSRFTGTAHIAFR
VKGNGTTLDGTYQIDNIRVYN
>LONDMIMF_01645 hypothetical protein
MKKLVISILFVMQVVFAFAQQGSLVKGKVVDSKTQKPLQNVVATIRNTTLTALTNSDGVF
VFENAPHGSHLLEVSSTGYSRQILSIDVEGQPLDLGVVVLAEDITSEQQLSLITITENDL
GDDNSGSESTSGLLQATRDAFQQSAAFNWGQARFRIRGLDNEYGTTMINGIVMNKVYDGR
PQWSNWGGLNDATRNQEFTMGSAPSDYTFGSILGTQEINTRASFYRPGTRISFSGTNTNY
SWRMMGTHASGMNKDGIAYVISASRRWAQEGYFDGTDYSANSFFASIEKRFNDKHSLNFT
SIYAQNSRGKNSPNTAEVNRIAGEKYNSYWGWQDGEKRNSRDKDVEEPIFMLSHYWKITD
KTNLNTNVSYQFGKIGNSRLDFQNVNNPDPTYYRNLPSYYTSMYDGNTFVGNSEANILEA
SRARFLTNRQIDWNAMYAANSRTAAGNSVYALYEDRTDDKTWTANSILNTQLSDNIILNA
GATYRKLKSHNFQNMLDLLGGQYFNDIDNFYTGNFAQSDLNNPNRQVGVGDTYGYNYNLL
ADVADAFTQFKFNYSTFDFYLAQSFSRSQYQREGLYRNGLYANNSFGKSDKIVFENFGFK
GGMTYKMTGRQMFDVNAIYMTKAPSLRNTFPNARLNNIIVPDINSENIMSVDASYIIRAP
KLKARLTGFYSTIKNATETSFFFAEGVFEGDGSDANAFVAETVTNINKKNMGVELGIEYQ
IIPTLKFTATGTYGQYTYDNNPNVSINNDALAALVQEGSLASVGAPNTQVNFGQANLKNY
RLPGMPQQAYSVGLEYRDPHFWWIGANANYLASNYLDVSALLRTHNFFENSADPYGMDFP
FSDIDRENARKLLKQEKFDDFYLVNLTGGKSWRIGGKTVGFFASINNVFDQTYKTGGFEQ
ARNANYQELNRDVSSGTPSFGPKYFYGYGRTYFVNLYINF
>LONDMIMF_01646 hypothetical protein
MRIKKFIALFIVLSSINVAQAQDKKFRVQTIAFYNFENLFDTINNANVNDEEYTPTGTQN
WTAEKYKKKLANLSRVLNEIGTSDQQKESPVIIGGAEIENRGVLEDLVKQPLLINKDYGI
VHYDSPDKRGIDVALLYQKKHFKPTSSINIPLIIYDQTDKTKRIYTRDQLLVTGLLDGEE
MHFIVNHWPSRSGGEQKSSPNREAAGRLNRKIIDSLYNINPNAKIITMGDLNDGPYNKSV
KVELGAKAKKEETKERGMYNPMEEMSNKGIGTLAYRDAWDLFDQMILSEPLIRKDYSSYR
FWKAGVYNKPFLTQTTGQYKGYPLRNSNGQVGFSDHFPVYLYLIKEVK
>LONDMIMF_01647 3-hydroxyanthranilate 3,4-dioxygenase
MAISKPFNLNQWIEENRHLLKPPVGNKNIYVDSEDYIVMIVAGPNARKDYHYNETEELFY
QLEGSIKVIIQEDGKRKEMELHAGDMYLHPAKTPHSPVRSAGSIGLVIERKRAGKGYTDG
LLWFCENCNHKLYDVYFELNDIEKDFLPHFQHFYNSKTLRTCTKCGTIMEADKKYTLKR
>LONDMIMF_01648 Cobalt/magnesium transport protein CorA
MITFYKNDSGLIPAQNPNESCWINAVSPTREEIRYLLEDLKIPEAFYNDIEDIDERPRLE
TENGWNLIILRIPFKSNDEKLPFNTAPLGLIFNDDVFVSLCFQPNDMLEDFVLYTQRKKI
AIASHYDLVLKLLLSSSVWYQKYLKHINQRIKLAESNLEKSIKNEELQALLQIEKCLVFF
ITSLKGNDILFHRIKNLKNQKTTLNPDLVEDVEIELRQAEETTNVYSNILTGMMDAYASV
ISNNLNVIMKRLTSISIILMIPTLVASLYGMNVPNNLQASPLGFWIILLMSLFISILGVF
IFKKRNLF
>LONDMIMF_01649 NAD/NADP-dependent betaine aldehyde dehydrogenase
MATIANQFGMTEALQQLGLAAINEGTSTGNSWFSNGEIIESYSPVDGQLIGKVKTTTKED
YEKVMKSATEAFKTFRLMPAPQRGEIVRQFGQKLREKKEALGKLVSYEMGKSFQEGLGEV
QEMIDICDFAVGLSRQLHGLTMHSERPGHRMYEQYHSLGVVGIISAFNFPVAVWSWNTAL
AWIAGDVCVWKPSEKTPLCGIACQNIIAEVLKENNLPEGISCLINGDYKVGEWMTADVRV
PLVSATGSTRMGKIVAQAVAGRLGKSLLELGGNNAIIVTPDADIKMTVIGAVFGAVGTAG
QRCTSTRRLIIHESIYDKVKDAIVAAYGQLKIGNPLDQNNHVGPLIDTHAVEMYNKALEK
VVAEGGKIIVEGGVLSGEGYESGCYVKPAIAEADNSFEIVQHETFAPVLYLLKYSGEVEN
AIDLQNGVAQGLSSAIMTNNLREAERFLSVAGSDCGIANVNIGTSGAEIGGAFGGEKETG
GGRESGSDAWKVYMRRQTNTINYTTKLPLAQGIKFDL
>LONDMIMF_01650 hypothetical protein
MKKLVFYWVLFFASIAGKAQTGISGQVKADYVPFSNYIRPIDSVKTDSKSDFKRVQAALE
IPLSLKMVDENKPKLWSLYLQGSYAAMENKYYDEKLFPAELLNAQIGLKHIRPIGGKWSM
MATLSMGIYTDLEQITIDDVLLQGGVLFIKNFKPNLAFGFGPVLTNAFGVPMVLPGIYFN
WETQTALHFKIAFPEGAEIGYRFTPNFDLKAVVELDGMTAEVSRDGKSKLLGYQQIIAGI
RPQFKLGEHWTIDFTAGSTLTRSFQTNDRKLSDIFKEKDMANPKFSTTFYGAAALKWKF
>LONDMIMF_01651 Transcriptional regulatory protein YehT
MNMNADQSSKVMIHCLVIDDEPLARHSIIDFIEKIDFLEVIGSCASALEASEYVQKGLVD
LLFLDINMPYLSGLEFLDSLERPPMVIFTTAYSEHALEGYRLQIVDYLLKPITFQRFYQA
SLKAQQLFSLTASAKQQVPADPFLYIRQGEGFQKISWMDILYIEGMQNYAKLHFKNQVLI
IHQTMISLEETLPKEKFFRIHKSFLVNIDHIDSIAGGRLSINGQQLPISRTRREALLKEV
VYKNLLSR
>LONDMIMF_01652 Sensor histidine kinase YehU
MPLVENAFKHVSRLPHENGYVNLLCRQEGNDLMLKIKNSYTEQYKPSSNDHGLGLENVRK
RLDIQYPCRYDLSIEKTKDTYTIILNLALN
>LONDMIMF_01653 Sensor histidine kinase YpdA
MYIRKFNEARLSLPFLMKKNSQYKHWLFISVFWCALGFAIWSQMIQDFNFLHAAYQALLF
LVFSITIAHTLSDVLLPKALNKNRMGFFGAQFVFMVFLLAGCLALISVVFSSYEIRGIYP
QSKLPVLEHFWFRFYTAIPAALLVNGTACGLRFYQEHGIMEKKHALLKQNHLEAQIKILQ
DQINPHLMFNVLNHIHILMQRNVPLASELLIKFSDILRYQLYQSNREYVMLDAEIKYLKD
LVGIEQVRWGNELDVDCRWEIQNGSLQHAITVDAISRKCF
>LONDMIMF_01654 Histidine N-alpha-methyltransferase
MNTAQPIHYTAFAEDVLEGLTSKKKHLSSKYFYDDNGSQIFRQIMKMPEYYPTNCELEIL
SWQSDIILDKIAFKGKFNIVEFGSGDGTKTKQLLKTFLNKDADFTYIPIDISEEAILILE
EDLLSALPKLKMESKIGDYFDVLEDIAKDDTPNLFLFLGGNIGNYKKEDVFGLLQKFSSG
MKKGDKLLLGIDLQKDPRVIQAAYDDPHGITKAFNMNLLHRINKELDADIAIDQFDFYCH
YNPENGEVNSYLYSLIQQQFYSRVLNTSFSFEKNETIWTELSKKYSFAEIEDLANQLNFK
VVENFLDGKQYFTDSLWEK
>LONDMIMF_01655 Hercynine oxygenase
MTLSDRYNSIRKYTEHLCNALTTEDFVPQPADFVSPPKWHLAHTTWFFEQFVLNEHLPDY
KLFDDDFSFLFNSYYNFVGKRVFRADRGNITRPGVHEVFEYRSYVDMHMQILLQLKSEEL
KDLIELGLNHEQQHQELLITDIKYILGNNPIFPVYDENIDWEKQENEETGFVKLEEGIYE
IGFEGEGFSFDNEHGRHKVYLHDFEISKSLVTNAEYLKFISNGGYTNFDYWLDEGWSWIT
ENKIEAPLYWHKIDGEWHNYTLGGLEKLNPEAILTHISFYEAAAFATWKKMRLPTEFEWE
AAADKFNWGKRWEWTNSAYLPYPNFKKPEGAIGEYNGKFMVNQMVLRGASCATPPQHDRK
TYRNFFHAHERWQFNGIRLAK
>LONDMIMF_01656 hypothetical protein
MKKIITIGLLLSAFLGNAQAFSGKGDKKFQVGANFQDHATGIMATYDYGIGENMSIGGYT
TYLLGVDGDGSKFEDRFDLKARFNANIGNVMGLPENVDIYPGLDLGLRNFGAHLGGRYFF
SQGFGLFTEFSVPIAKYKSDVFGYDRLNNQFVFHIGASFNL
>LONDMIMF_01657 Bis(5'-nucleosyl)-tetraphosphatase PrpE [asymmetrical]
MNRTLIIGDIHGGLKALHQIFKRADVTTNDTLIFLGDYVDGWSESPEVIDFLIALKTTHN
CIFLRGNHDDLLLQWLEVKKDNPQWFNHGGRLTMEKYSILSQEKKQAHIDFLKTLENYHL
DEHNRLFVHAGFTNLNGVTYEYFPKMFYWERTLWENALSLDSSIEKDSPFYPKRFNLYTE
IFIGHTPVTRIGETVPVNKANIWNVDTGAAFKGPLTILDIQTKEYWQSDPVYLLYPEESG
RN
>LONDMIMF_01658 hypothetical protein
MQKIYPQLAFLFFIGQVLYAQNTIKGKIIDSETKEPLAFATVVINGDNRQGVSSDIEGTF
VYKSTSPISSVSCSYMGYENFSTPILKKDSEIVIAMVRSKFDLNEVVIESGENPANAIIR
KVIANKELNNPENINSFKYRCYNKLIYDYRSDSPDKKDSLLIRQKLKGSRLFMMESVTNR
KFIKPDISEEVVIGTKVSGFENPTFASLATDFQPFSFYKDNIRLFNINYLNPISKGSLKR
YKFRIEDTIYQQKDTVYILSFRPQANKNFDGLKGFLYINTNKYAVQNVIASPFEKGKIDI
RIQQQYAFIDNKYWFPQQLNYALIFNEFPTKTIGMILDGKSYIDQVEVDIPLNKKEFSLE
AVRMDSEAAKKDSFFWDNSRAEKLNNAEMTTYKVIDSIGKKANFDGFLTFMEKFAQGRIP
AGPIDIDLSKTFSYNKYEKLRLGTGFYTNEKLFKDLTLGGFFGYGMEDHDWKYGGEILYR
ISKENEMVVGAKYQQNLMETGNYGLNTYEPSLYNFRNYIGYQYDMIRQNNLNFSFRTLRY
LKFKVDFNHTKTTPRYEYLFNDGNRDFRNYTTTDLTFHLRFAYKEKFVNSMNQRYSMGTK
YPVFNLAYTKGIKNLIDSDFDYNRIEASVQQSFFTKNFGQTDYRLEAGFIDKPLPYGLLF
TGEGSYDSKSAIIMKNTFQTLRPYEFLSDSYVNLFLSHNFGGLLFKSGKFQPGVTWHNNF
GWGNLSDKSAHQVIAFKTKDKIFTETGLQIDNILKINYMNIANLGLGFGVYYRYGAYSHP
EFNDNLTFKFSMAMSIK
>LONDMIMF_01659 hypothetical protein
MINKRLLIKNLLAHNDESSFYDKKRQLNLHTREGKAKFLKHICALSNSNPANNSYIVVGI
EDHDNEIIGDDFFDDSRIQNLVNAFLENPPKIQYENVPFPNLPKDKVIGLVTIKPSKKVS
FFKKGIHTIPAKSIFIRIGSNSVPVDEIPNDSGRNYQNVETVISIENNSRNSIEHTLEGV
IDFMNNRHKDMSPKYKVFKELFVVCWAGHKKKVKDMTYLSRVDIELVNEQVKLFYSALDE
VSIEYDNHTFSITEYLPLGLNDKTSYYPLEKQTISFYDNGYYKIETQFLFEPPQYNRKML
FHIYNSNQSLLAKLDKGLTLSEREKKDLENLPSTFMICYLNGFEEAKQKLIDAKPLLKSF
ENPTVYVNFKEAMRILRKMKYDTSLD
>LONDMIMF_01660 NADP-dependent 3-hydroxy acid dehydrogenase YdfG
MKTVLITGATSGIGRATAIELAKHNFKLILCGRREDRLAELQLELEHRTKVHTLNFDVRK
KKAVQESIDSLPKEFAEIDILINNAGNAHGLDPIQNGDLEDWDAMVDINIKGLLYVSHAV
IPKMVERRNGHIINIGSTAAKEVYPNGNVYCATKHAVDAINQGMRMDLNQYGIRVGGIHP
GMVETEFSQVRFKGDAERASNVYKGFEPLKPEDIADIIRFVITRPYHVNIADLMVMSTAQ
ASSTIVNRIL
>LONDMIMF_01661 Oxidoreductase YdhF
MKTTLSPIIAGTMSWGVWDKNLTTSEMANLIHVCSENKITTFDHADIYGGYTTEAEFGKA
LSESKIDRRKIQLISKCGIQHVLGNRNNKIKHYDYSKDYIIWSVENSLKNLHTDYLDVFL
LHRPSPLMNANEIAEAVEKLKSEGKILDFGLSNFTPSQTDLILSKTEVSYNQVQFSATDF
KAMTDGSFDHMQVHNIRPMAWNPLGTVFREKTDQTRRLKTLLAELVGKYHVGSDTILLSW
VLQHPAKVIPIAGTVNVSRIQQLYKATEFKLENEEWFAIWTESMGNKVP
>LONDMIMF_01662 hypothetical protein
MREIINLSNNNDWFDDFDEESKNMMENIQFLNLSSDFQNRISNNFRGTPEQINKSRTPNL
NNPFGKDSIFYKAKEGSLRLFLEDRSLYQQAKNKFNDIDLENILINVADSDEIDDLPYFC
KKRNRIRVVQHTIGDSFEKYFENFIDIKTKKLETYFDNFIWFEEGNNSNVICFHFFVSNN
HIKEIICTMGSDIFDCLKSKSNINASGGFTVKNDEDEYVVNPALDKFKNDIVDRLKKFYY
NEEVFLNVKLPIRTEKVIEALDQEFKAEGDYQRTVDWIFEKMEITTTLKDFVNDLKDDSK
NIESYRFEESRYLPFHPNFDPVFNDSLLKAFGINPMVKIEDYFFEFEKEDIEKFKLVEKE
VNWVYGFNAFFCGLWNGIIDTVDGFILLIPELYEIFTDRARLKVFLNLIKELFEHITELM
GKIEEWELKNSSYSVYRYEYFQTYGLTIIMSLFLPVPKLAQSGKTSEAFKLFTQAGRTFV
ESEIVLTAYRFGLRVEKTSNEWRLYFYDILLSSGSKEKIANRIGNIMEVAAKNPNIVFKL
LSEWKLEKLVNVKKGKGIKGLPKESFVAVQKKLYNANIAQAEFKVYYNGKTIVKELKAYS
GSNIGELDGFGFSKSPNLRSNELKSNFSEVINGNITGRFLDTESKIFREFEDAHLKGIMK
ELGAKSTDQLRIKVSLQTILDPCNVCQGQMSKFQKLYNAKIKIFSSGAKDGYIFKKMYPK
LHVDKPLKK
>LONDMIMF_01663 hypothetical protein
MEILYLKKMEDFPKIGSYKNEGVSETEINNMEQSMNVKFPKAYREFLFLGGNYENLLSNW
NRNFYDLDSAQEYAREAFQGVGLNMKPFWCFAEYNNADSSLFFFLDEGEDPPVYNFVADK
VIVDDNGHEVFYKKTYQSFSAFIEKSITSALK
>LONDMIMF_01664 hypothetical protein
MEIEYLIKMKNTPKIKYIANRGLSEEKIEQVESKMGIKFPKAFKEFLYLGGDYEEIINDW
NRGFDNLELIQEEAEESFVRVGLGLTNFFAFAEYARDQFIFFFLDEGENPPVYMFAEEKF
HKNDQGEYVYYKKTDTSFSECIDSFISSALK
>LONDMIMF_01665 hypothetical protein
MGDSGRLFGRVTSIYLSPWYCGNFLTMSGIFLIFLYQKIRKRLWEIAFLGIIFFSFWIFV
IISGNRSALAILIIFYTIYMYSKIQLWKSVAISITIIILFIFVITPNVPFIETYIESLYS
NSNKVTGSSVNGRIEQLFGCYEEWSNAPLFGHGYNWSSYYRFSHNGNQHPTMLGFESIIF
IQVCNLGLYGCIMTYYMFYYLYNRINKKAKDAIYIMCGFLSYSLVTGIYGSYETFIVFYI
TSVQLLASRNLKYQSKKYVKKWITKLK
>LONDMIMF_01666 hypothetical protein
MDNKIKVIAYYLPQYHPFKENDEWWGKGFTEWTNVGKAKPLFKDHYQPKIPADLGYYDLR
YAPIREQQAELAREAGIEGFMYWHYWFGNGKQLMADIFDEVLASGKPDFPFCLGWANHSW
FAKNWNIDGTHGKDKLLIEQCYLGESDYRRHYEYCLKAFKDKRYIKINGAPFFLIFQPDN
LPIEFISLWQKWAKEDGFKNGIYFVATADMSKIYNNIADIDKYKKRLFSAIVVPRLSSPM
RYAPNKAKRFLLKINKTLKYITKKPVNCIKYEQAIKYFVTSQECREDSIPVIIPNFDHSP
RSGYGAQILDKVSPELFKKHLTKIKL
>LONDMIMF_01667 Hypoxanthine phosphoribosyltransferase
MIQLHDKHFVPFISGKEIDSAIAKMAQEVAEDLDEEIPLFVGVLNGAFMVVSDFMKHYPK
ACEVSFVKLASYEGTTTTHEVKKLIGLNQDLSGRTVVVIEDIVDTGNTLVELKAMFESQN
VKQLKFATLFLKPEAYKKDIKIDYIGIEIPNKFIVGYGLDYDGLGRNIPEIYQLKD
>LONDMIMF_01668 Adenylate kinase
MINIVLFGKPGAGKGTQAEFLKKKYNLTHLSTGDIFRFNIKNETELGKLAKTYMDKGDLV
PDEVTIQMLQSEVDKNPESKGFLFDGFPRTLSQAKALDNFLESKNEEITATVALEANDEI
LVKRLLERGKTSGRPDDQDEEKIRNRYQEYNEKTAPLMDYYKAQNKFHAVDGIGSIEEIT
HRLSTVIDSLN
>LONDMIMF_01669 Magnesium and cobalt efflux protein CorC
MEIAIIFFLILLNGVFSMSEIALISARKNRLETSAKKGNPSAKTALDLANSPNKFLSTVQ
IGITLIGILTGIYSGDNITGDVKIFLDQYEFLQPYSANLSVGIVVVILTFFSLVLGELLP
KRIGLNYPETIAKTVALPMKVISIITAPFIWLLTISTESLLKLFRIRPTADGKVTEEEIK
AIIKEGTEVGEVQEIEQDIVERVFHIGDRKVNSLMTHRKSVDYLSLEDDLPTLKQKVLDE
IHSVYPVCEESLDEVVGVVLLKDLFAKFESGDFNLRDIMKEPVYLIEHTSAYKALDIFKK
TKVHYAIVTDEYGITQGMITLNDILEALVGDASDFYHEEFQLVAREDGTWLVDGHYSLHD
FLTYFDLDELINDYEVTTVSGLIMTELSYIPKQGEKLIWNLFELEVIDMDGVKIDKVLVR
SLKE
>LONDMIMF_01670 GTPase Obg
MTEGNFVDYVKIYVSSGKGGKGSTHLHREKFIEKGGPDGGDGGRGGHVYLVGNKGLWTLF
HLKFAKHVKAGHGGDGGSARSTGADGEDKYIEVPLGTVVRDKETNEILFEITEHGEKKIV
VKGGKGGLGNWHFRSSTNQTPRYSQPGMPANELDIILELKVLADVGLVGFPNAGKSTLLS
VLTSAKPKIADYPFTTLKPNLGIVAYRDFQSFVMADIPGIIEGAAEGKGLGHYFLRHIER
NSVLLFLIPADADDIKKEYEILLDELRRYNPEILDKERFIVISKSDMLDEELKAEMKAQL
DKEFKGLKYHFISSIANQGLVELKDKLWQMLNAEENQ
>LONDMIMF_01671 Lipoteichoic acid synthase 1
MKINWKNDFTVMLLRLLVVYVAFMLGRFIFYFFNDHLIDPIHHKDIFSLLRGSLMFDTVS
ILYLNLPFIFLSLLPFRFREKENYQKRLFWVYMISNSLGLLVNFADVFYYPYKQSRLVLG
DLFLVKEDSFSLLILDFMVDYWYGFIFYFLVLAMLCVGYRRIGYGKSILSNNRDYYVVNS
AYLGVMVFLTVFLVRGASLSKASFPISMSDAFLYTSNASHTSLILSNPFCLFRTIGKSKK
VPKLEYFDKSTAEAYMPTTHMPSSSGKFKIDRNTNVFIIILESFGKAHIKSLSDQFKPKQ
ETHTPFLDSLFNEGYLFTNAHQNGYRSMDALPAIWASIPTFKEPFLSLPNSVADYHALPA
CMNEMGYHTAFMHGAVKESMGFVSFGKNLDIKEFQSREEYEEAKGDDDFDGKWGIWDHKF
WPFVHEKINVMPKPFFTTVFTLSSHHPFSIPAELKGKFAEGTLPIHRVIKYSDYALKTFF
EGIKKEPWYKNTLFVITADHASGADSPKFLKPPFDYSIPILFYHPGKNFKGTDDKIMQHI
DIMPTLLGMLDYDKPYFAFGKNHFNKEEQENHFAINFSNSAFNCTTDSYYYQFNEKDILV
KSDYRKDPLWKNNLLKCKIPQDEKNVLYFKAFIQQYYSHLNERNFLPQQKSRKAKEIAGR
DEDIILKGQETRSLKQKLKLR
>LONDMIMF_01672 Dipeptidyl-peptidase 7
MKKIILSLITAILLVPTTVKADEGMWFLMFIERLNHRDMQKMGLQLTSEEIYSINHSSIK
DAIVQFNGGCTAEIISNQGLVLTNHHCGYDAIAEVSTPKDNYLRDGFWAKDKKSEIKPNS
LYVRFFVRMDDVSKRILSKVNDGMSEAEREKVINQEIAKIQKENDEGGKYTVSVRSFFQG
NEYYYFVYQDYKDVRLVGTPPESIGKFGGDTDNWEWPRHTGDFSMFRVYADKDGNPAEYS
PDNVPLKPKHHLPISLKGVQENDFAMILGYPGRTNRWMPAGGIEQNVKFAYPAWVEGSKA
GMDAMKFHMDKSDQVRLNYASKYASVANYWKNRQGMIDALTKFKTAATKQKEEAEFNKWA
NKPENKQKYGDVVATINNYYKATNEKSRHDNYLISILRNSSLAGGPASLGNGIAAYAKEN
DAKKAEMLPRLQAAIEGVYEGFYLPLERDVLIAELNLYAKKAGYKLDPFIEGLAKENNND
FTKFVDQAIAESAFATKEKAEAFLKNPNVDALKNDKLYLLSSSILATYRSKPEDLAKLEN
DFQKSFRLLVEGLRESKLNKIKYPDANSTLRLTYGKVRALPADKRNDAKINNYTTLQGTI
KKYKPNDQEFDLPKRLIELNEKKDFGPYADKKGYMPVNFLTDNDITGGNSGSPVLNGKGE
LIGVAFDGNIEAMAGDVIFDSKLQRTINVDIRYVLFIIDKYAGAKHIIDEMTIAK
>LONDMIMF_01673 TonB-dependent receptor SusC
MKKIIGLLALFFSLSITAQKLDKSWNKVYEYEYDGKIKSASDELNKIYKKARKQNDQAEI
IRTFIYQSKFLMTLEEEAQYKIIKNLREELTTKDEVNKAIFNYIYGKLLSEYYSQNRYKL
KNQTATESVFNPDFRTWSASDFEKEITAAYENSIKNETILLKTPLSDYDKIIVFGKFETP
INRSLYDFLSEKYLEKKGFYKDESQEEKNFLSKNILSFYGEPKEFQEIDLKTYQSSPFYH
RLAIYQKLEKSYASQNNANALSNIILKRIQTVYKKRNMLEEYLTVLDRFIANTQNKYQSV
FLIEKARMYQDNASKNTHTDYNSKAVEICDLVILKGDEPFVYEAKNIKVSILAKSLTIQT
DKYIIPNQPNLALIKFACIDTIYGSLHKIPLKFAAKFESGNIEKDSIFIDFVNKNKPYKT
FKNRLPDTKGYFEYSTEIILPEMEAGVYLLTISTKKDNLSAEDIYSYATINATDLTLAYS
GSNNTERFQVLNRKTGKPIEDVVIKSSDFMTKTDKNGMARYERTKAAQNYSQNIQAIKAK
DTLSLFYNTTYFYEHARTKEEEKEEKENFRVKVNLFTDRSIYRPGQTVYFKGILLKRKDN
KNDIVPDMFVSVRAENVNGEDIYMARLKTNEFGSFIGEFIIPKNTLTGDFTIYAEEDEDY
ETDAHYNEKTDKHPFWDKINRFEHSEISFRVEEYKRTKFEVTFEPITESYIVNQNIKVKG
KAKAFAGAAISDATVSYTVKRNSYYNNWQYSNNHFSYDDKEIAAGTIETDEDGNFEIEFT
AIPAEDFSEEGQPVFNFSIEAEVTDVNGETRKNTTVAKAGYHDLVLFANISEMINAKTIQ
KITLDSQNLNGQFIPIIGELKIYKSKSPDRVLSSRRWEAPEIQIIPEDEFMRLFPTLPYR
NNKTTEKRDLIFSQKVDTKTTKEITLKDLKKWKSGAYQLFFTSKDISGKEIEVSSGFKLL
NDSDKVPGDYELFQYQILNEDPKKDGFMEVQYTSAAPLYIMTEAFYQSKVVFNKVIEVNG
KKIFRIPIEKDWKTDVKISMNFIWENKNFEKKHTQLFPIYQEKINIETGTFRNKIEPGGN
ESWSFFIKDQHEKDRKAEVLASMYDASLDQFYESAWNTSLDFSNDNYNNIEFKQFLGIGN
LTSLYFRNLFPYEKPVYYSRSQFNWFGFDFLHLEQKDSQYHQYLTDKLILSSGKTISGVI
TENGLPIPGVSVKISGTDRGTQTDFDGKYEIKALMNEILEVHSIGMKSRYIRVNNKTINI
EMTYSEEMLREVIVTAYASTKRAKSLAAVNFDTIEERSNASAIQNLQGMVFGMEITSGRD
EPGYDTTIFLRGNGSINSGKASLFIVDGVPVGEDEYRSIDLKDIISANFLKGNEATSLYG
SRASNGVVIITTKKSLEALTEVKARKNLSETAFFFPQLQTDGKGNLKFSFTSPEALTQWK
LRLFAHTKKTVSGYLENFIITQKDLMVLPNVPRFLRENDTIVITSKISNITSDPKSGIAM
LQLFDAVTMEPIDAKMLNSDNVKNFNIKANGNTTVSWKLFVPQGLQGVQYKILAKAGDFT
DGEENILPVLTNTMLVTESIPLWIPGNTKKEYVFENFKKNQSATLRNHLLTLEYTSNPAW
YAIKSLPYLMEYEHECAEQVFSRYYANTLANEIITGNPKIAAVFDAWKKAGNPISKLEQN
EELKSLILAETPWAKDTENEEQQKKNLALLFDLEKMKTDINDNFEKLDRKQSPSGGFPWF
SGGNDNEYITRHIVTGLGHLEKLKISNQNIEKFRRITAKAIPFIDEKFLARNKNAEINQK
KNKIWNYDIYSDLHYLYARSFYTNTYPVNDSLQKAILKHLDYAKKHWMEYGLYQKAMATL
VLNRFGEKETAKKIITSLKETAINNEENGMYWLNNKAGWYWYQAPVETQALLIEAFSEIG
DEKKSVEAMKVWLLKNRQTKSWNTTKATTEAIYALLLHGEDWLSVKDNTVIKLGDEKIVT
KKLAQNEKEAESGYIKMSWKADEITKDMSAISINNKSSIPGYGGFYWQYFEDLDKIKSSQ
DSPLSIEKELYIKGNTDKGKELQKITNKKALKVGDLVTVRLVIYAKDDMDFIHLKDMRAA
AFEPVDVLSEYKWQGGLGYYMSTKDAATHFFFDNISKGKYVLEYDIRVNNPGEFSNGITT
IQSMYAPEFSSHSKGIRVKIEE
>LONDMIMF_01674 Lipopolysaccharide assembly protein B
MKHFFLILFLFPLAVFSQSEFAKGAQFFDKGNYEKAKEIFTALYKKNPKDVSVIEYLGDI
EAHAKKWEEALVYYEKLKELKPSEANYYYKYGGALGMKAKESNKFKALGMIGDVEDSFKK
AIELNPKHIESRWALVELYLQLPAIIGGSERKAQKYADELMTLSAVDGYLSKGHIAEYFK
RYKEAEKNYKKAIEIGKSKTTYKKLADLYKNKMKQPEKAKAVLEEYAEISKT
>LONDMIMF_01675 UDP-N-acetylmuramate--L-alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptandioate ligase
MRTHFIAIGGSAMHNLAIALHEKGYQVTGSDDAVFEPSKTRLEKRGLLPEELGWFPEKIT
SDIDSVILGMHAKADNPELLKAQELGLKIFSYPEFLYEQSKNKTRVVIGGSHGKTTITSM
ILHVMHYHGINVDYMVGAQLEGFDTMVHLTEENDFIVLEGDEYLSSPMDRRPKFHLYQPN
IALISGIAWDHINVFPTYENYVEQFEIFIQKITNGGILVYNEDDAEVKRVAEAATNPIRK
IPYTTPNYTVENGITLLETPEGNMPIEVFGAHNLNNLAGAKWICQNMGVDEADFYEAISS
FKGASKRLEKIAENKNNVAYKDFAHSPSKVTATTKAVKEQYPDRKLIACLELHTYSSLNA
EFLKEYEGALDAADVAVVFYSPDAVKIKQLEEVTYDQIAKSFNREDLIIYTNPAAFKEYL
FHLKFDTEKIALLLMSSGNYGGLNFDEVKTLL
>LONDMIMF_01676 hypothetical protein
MKYFISFTCFLFITAIIEKSFPEKLSDAAITLTKDKVVYDPGYFSISYPNGDVPKGKGVC
TDVVIRAYRKLGIDLQKEVHEDMKKNFSKYPQKWGLKKTDPNIDHRRVPNLQVFFTRFGK
SLEVTDKASDYKTGDLVTWMINDKMPHIGIVTNRKSADGKRNLIVHNVGAGQVLEDCLFQ
YKITGHYQFKK
>LONDMIMF_01677 hypothetical protein
MQGKEAKKTKTFPIKDWAKDDKPREKLMHKGQEALSNAELIAILIRTGNHTESAVDLSKR
ILADAKSLNGIGKLSIEKLLTYHGIGEAKAITILAAVELGRRRRSEEAVPSRRIATSRVV
FETMQPVIGELAHEEFWILFLSNSNRIAHKWRLSKGGMTGTVVDARLVFKIAIEHNATAI
ILAHNHPSGVLYPSESDRIITKKLKAAGESLDIRVFDHVIITENDYYSFADNGIL
>LONDMIMF_01678 hypothetical protein
MKRHIGILLLLLSSVYGKAQTKLPEFNDKPAYFNATTNELIELEKSQYNTMAKAKGLFSA
EGGFYLNGIKSSVTIKNKSTLKFIVKVTPGTDPTSVFDLVKFEIRKDKRVLITTKAKATS
TSTSFDKINYTIEKVKDGYYYLVVKNLASGEYFFGSGDFMFAFSLE
>LONDMIMF_01679 hypothetical protein
MKQLFKYVFLFTLKISAQTNTETYQFSKDIAAKIEKDTLAWKYQMGATDYSINGYYKQAL
ETWDKNGRPARKISKEDSLYFTSFRQKNAKDYIINRSKDEKIIIINEAHHNNRHRVFTTS
LLQGLYDNGYRFFGLEALADTEINDRKFPVMESGFYVKEPQMANMLSEALKIGFVLFEYE
ASDGKNGKEREIEQAANIARLVKENPNSKFLIHCGFDHVIEGIPPSKSWERAMAGRLKDE
TNIDPFTIDQVYYTEKGDIKFTSPYVLMANPKKSVILINGAGKLFNGGETNDQTDCRIIH
PITEYENERPDWLLLDGKRKTYMVPKSKITEYPVLVLAYRKNEYEKNGVPADIIEILNKE
TKTNLILDKGIYKIIIKDKNYKIIHEFDVKIK
>LONDMIMF_01680 hypothetical protein
MKTIKTFFSILLIAITVSCSSDDGDGNPIPTPTPVKTAKFEITGNFTGHIFVVYNNNVTG
NTTETVTSLPWSKTIEYPDNVMGIGISGNAVMQNPGVAGQTASLKIYYDNNVVRQSNKIA
DVNGTFSFESLAFVFP
>LONDMIMF_01681 hypothetical protein
MKKLINLSVLLLTVSALAQSPLEKGKIQLNAGFGTSNWSTPIYVGADYTISNPITVGVEA
SYQSYTTYGIKSTIIGLQANGNYHFNELLKIPNEWDVYAGLNLNYYNWKFKDSETNTYLV
DDKPFGVGIQIGGRYFFNERFAVNLELRSGNVTTGGKIGITYLLN
>LONDMIMF_01682 Sensor histidine kinase ComP
MVITFVAYLYKMKRLHLFFLLFASSLAHAQSSSTLNDYEVTIDSLKNAISTSKSDSLSCI
MNYRLAYIYTKNVDKKELGKIHLKKANELVKNNSYLKDLSYYYNSLFFSLTKENLQKFRK
ADEALKKYNSREIYILRSKILFNIGLLYQRENEPLQTIEVLVKEAIPVAKKSKDSQELSN
LYKLIAVIFYNNEDIAKTKYYLDLSISTLEQGKSKKNRYNEDLIELYLFNVEVLSVQKKT
NEAFEYLQKAEDLLKSYPLKSLYIEYYFAKGSLNQEIKNYEQAISDYDNGVRLSQLNKDS
ALEQRFKLMKYEVFILQNKIESAKDLLLDVFKTGGMNIKDRAYYSYELSKIYRKLNDFEK
AYVYNEQYIQLKDSLSQMFEAEKIADIEAKYNKLENENKIKELTIEKQATLLNQRKNMLF
LLLLSFALICVLTVTYFIWKNLKNQKKITAQKEINHFQKLNNLKREKEIEIMQTMINVEE
AERKRVARDLHDSIGSKLSALKIIFANTQNKNDYNDSRINTILETSIAELRQISYNLVPE
SLLKLGLEKALGDLCFTLRSDTVSIEFHSYEIDNSMPLTTQTNIFRIVQELLNNALKHSK
ATQILVSCSQNGNRFYISIEDNGVGFNISEIEENQGLGIKNIKSRIELLHGSLDCESSSG
GTSYNIELDV
>LONDMIMF_01683 Transcriptional regulatory protein LiaR
MENKKLNIAILDDHPLIIEGLTTLFSNHTEFNLLGGFNQSEELYGFEAIDKIDVLLLDIF
FGNNNGIDICFDLKKKYPKMIILGISSQAERSIVLQMIKQGASGYLLKTAKNDEYIHCIK
EAAKGKIVFGKEVQAMLDKIQIADLKSIPRLTKREKEILALLIKGKSTQEISEELFLSFL
TIQTHRRNLLQKFDVKNSLELINFANENGLLNDPYFPPNFS
>LONDMIMF_01684 Lipoprotein-releasing system ATP-binding protein LolD
MQALAEMTLVMIQTKNLAFSYNGKANFNFPDISLNSGEVLLITGGSGKGKTTLLHLLGGL
LKAQSGSIRIGDVNIETLSNKNLDKFRGENIGLILQQSHFVEAFSVFENVVLSSWLATGR
KADEKAKLLLAELGLSDQIHKLTSRLSIGQQQRVSIARALVNEPQLLLADEPTSSLDDEN
AYKVADLLSQLSKEYGAALIIVTHDQRLKDRFSNQITLA
>LONDMIMF_01685 hypothetical protein
MIGRLAWKNIWFKPLNTILSIILLTASVAIISLLILLQEQFEKQFSSNIDGVDVVLGAQG
SPLQLILSSVYQVDAPTGNISYSEAKTWMKHPFVKSAIPLAFGDNYRGFKIVGTTPAYLD
KFGATVSQGKIFQSDFEVVIGAEIAKKLNIKVGDKFFGSHGDAAEGEVHEEFAYKVSGIA
SPTGKVIDNLILCNIPSVWAMHENHEHADENPEHGEEGHIHFEGDEHEHHNHEAEMPVSE
EGKEITAVLIKFRNKMGFVTWPRLIAQNTKMQAASPAIEINRLFSLFGIGLQALQYLAYG
IMLISGISIFIALYTTLKERKYEFALLRVGGASRLQLLNLVMFESILLCFVGFIFGTIVG
RIALFLISSSTDEEYKMTFDPFAFVWKKEGILFIVTIFVGVLAAAIPAIKAYRLNISKTL
ANA
>LONDMIMF_01686 hypothetical protein
MRKTYFFIALFLFLGAIYMNVKGRESDSFSVQQAGFLPKAGAFSKSEAKSLIVTDTLNWK
LLGAIKFVKKTTKDYPEGVMYPIINSTLKTKNKKRIAMSGFIVPIDNTTYALSKNVFAAC
FFCGQAGPETIMGIKFRGGTPKLKTDQYVTLEGNFRINENDVEDWIYHIEDAVIVKGK
>LONDMIMF_01687 Pyrimidine 5'-nucleotidase YjjG
METKISDVFFDLDHTLWDFEKNSALAFDTILKKHKVNVDIQEFISLYVPVNIKYWKLYQD
DKVTQQELRYGRLKDVFDHMKIEVDDEMIHFLAEEYISYLPQFNHLYEGAIELLEYLKPK
YRLHIITNGFHQIQNNKLVNSKIVHYFETITNSENAGVKKPHPEIFNYALDLAKCNKETS
VMIGDNLEADIEGALNVGLDAIFFNEHNLETHPNIKQVNHLLALKKYL
>LONDMIMF_01688 hypothetical protein
MKKNILILFLFVSLSALAQRSLNDYKYAIVPVKFDFLSEPNEYRLNTITKFNLTKMGFEA
FYSNEDLPLETAGERCSRIFVDVEKVSSLLSTKLVVVFRDCNNVEINRSDVGVSKTKEYK
IAYPEALNDAFKSLFTFGYNYNGTVYKPESAKKVETPKSSVEPEDTPNMLFAQPIPNGYQ
LVDKTPKVVFKIFKTSHPDYFTVQSDAINGALIRKNNEWVLEYYKDDKPVSEKLLIKF
>LONDMIMF_01689 Replication-associated recombination protein A
MEAPLAERIRPQQLEDYLGQPQLVGPNGSLTHQIAKGIIPSLIFWGPPGTGKTTLAQIIA
QESKRPFYILSAINSGVKEVRDVIEKAKQSGGLFTAKNPILFIDEIHRFSKSQQDSLLAA
VEKGWVTLIGATTENPSFEVIPALLSRCQVYILNAFSKSDLEALLERAMKTDVYLKEKNI
ELKETEALLRLSGGDGRKLLNIFDLVVNASNDEKIIITNDSVLKLVQQNTVLYDKTGEQH
YDIISAFIKSIRGSDPNGAVYWLARMIEGGEDVKFIARRMLILSSEDIGNANPTAFIMAN
NTFQAVSTIGYPESRIILSQCAIYLATSPKSNASYTAIGKAQQIVKQTGDLPIPLHLRNA
PTKLMKELGYGEDYKYAHDYQNNFAEQEFLPDEIKNTPIYVPGNNSREQSTREFLKNRWK
DKYGY
>LONDMIMF_01690 hypothetical protein
MDDKNLRFSPSVLAWPLFSVVLLWIIFWAEVRFKLNLTEFGIYPRTFSGLRGILFSPFLH
GDIQHLYNNSIPLFLLIAAMRFFYRNQTLAVLGYGILLSGFLTWVIGRESYHIGASGLIY
VLVSFIFFKGIQTRYYRLVALSLTIILLYGGMVWYIFPNVQQGISWEGHLSGLITGYVFS
LAIKTPEYQKPIVYDWERPDFNPEEDMFMRHFDENGNFQNLPKPDVDDETGNEDFFRSNY
NVFYTIVRDNSEGNPENNEDGAEENT
>LONDMIMF_01691 Putative TrmH family tRNA/rRNA methyltransferase
MEKGHQIFGIRAIIEAIQAGKEIDKVFIQKDAQGELMKDLMKVMKRAGVNFSYVPVEKLN
KLTPNNHQGAVATIAPVSFHNLETLIETVMESGKTPLFLILDQISDARNFGAIIRTAECT
GVDGIIIQKQGAAPVNGDTVKTSAGAVFNVPICKVEHIKDAIFHLQGSGIKTIAATEKTD
QNIYDLSLNEPIAIIMGSEDRGVNPSVLKIVDEKAKLPMFGTIASLNVSVACGAFLYETV
RQRS
>LONDMIMF_01692 hypothetical protein
MKNNKFKFAAIAIILALFSSCLVDDDVTDFGAGTNLVDFPSGSIDGTFDIGMDEAEFQVP
ARLVGGNGSAAPSDIVVTYEVDPAKTTAVEGTNFVILNNGTFTFPAGETQATFPIKILSS
SLDPELPVPLTIALKLTAATGSFPVGVSTKESTGTIIINLKPLCPITDDLSGTHTYTQTS
MQYGDGEGTGTGTGIAGTISGTVTWTETEPGKYSLDDASFGLYGAIYDDDPAVGPDGAFL
TWVCREFLFSGSDQYSDTFTYNIVSVTGPVMVFTWRNTWGDGGTVTLTREGGVDWPDIFQ
TN
>LONDMIMF_01693 hypothetical protein
MKNIFKKSSLLIASFFLLFSCSDYLDINEDPNNPTNVKPELLLASAQNSGARKLNVRMNH
VGNFMVYNWSNNIEEFIAYQDEMQYIVNSTFYDDTWDDLYLTLANFHKIEKTSLENYENY
QAIAKIMKAFYFQYLVDLYGDIPYTEALQRDLELTPAYDDAEAVYDDLIVQLDAAIELIK
NAPSSALDPANNDIMLHGDMDEWIKFANTVKMRILIRQSGMPSKQAYIADKFQDIIDEGS
GFITENVTNNPGYITSTGKMNPFFETYGTTLSGSPTSDNRAVKGTQYTIDYLNSTNDTRL
EKIYAPIPGGGFAGINQGAPDEQGTVVVPYSGLGNGVLKNFTQDAYILTAAESYFLQAEA
VARGYIAGSAQNLYESGIEASYETLGLTAAQANTYYSQATNLVGWNASAGNEIEAIITQK
WIALNSINGIESWIEYTRTGFPSGIPLSLIASRPQRPIRLMYPNSEYVANSANVPNQTTD
DAFTSPIFWDN
>LONDMIMF_01694 TonB-dependent receptor SusC
MKTKLNGLLTLVLALIMQISFAQERTISGTVSDQSGLPLPGVSVTIKGTTMGTQTDFDGK
FQIKASPPDILVFSFIGMTTKEVMATANDFNIVMEDDATQLETVVVTALGIKRNPKELSY
STQVVKSDELNQAKAVNAATALVGKVSGLQINTINSGVNPQTRVVLRGARSISGNNEALI
VIDGVPSALSTLSELNPNDIESTTILKGANAAALYGSAGSNGAIMITTKKGRNGKMTLQY
NSTITFEQVQFIPDRQTRFGQGWAGELDPVENTNWGAPLDGSLVQVGPELPDGSIREFSY
VARKNNIKDFFNVGTTKQNGFSISQGDENGNLFFSAQDVKTEGIIPGDLYHKNTFRLNTS
KNSGNWSVTGNVSYFTDKTDIAGSLTGSDDESSFFTDTESGRSLYSQLLQTPINIPLEVY
SQGDLQDYFTNYAYNPYWILKNSRRISSTERFQGSVDLGYKINDWFNVLYRGGVSMLSSD
FKHTNNGHVFTDGSGREDLNQGVSDGSNFERRINSDLMLNFDFNLTKDITAKIILGNNIR
DIRTKEIGIRGDNLVVEGLYNVSLRTGELRGVEFNSRLRSIGLYGSAELGFKDFLFLNVT
GRNDWSSALIKENNSYFYPSYGISFIPTSAFPELKGNVLNFAKLTASYTKVGNSTSAYAN
QNTYVRSVGFPYGDLTSFNLSNTVALAGLKPEFTTSKEFGLNLEFFNKRIWLDASYYISN
STDQIINAAASSSSGATRALLNAGELQTKGLELDLGFVPIQTEDFSWDFRVSYSAPKTEV
KSLLPGVNELSLGGFSTAGVYAVVGQEYPIIKGTAYERDDQGRVIIDQATGNPIQSSALK
NLGKTTPDYIVGLSTNFNYKGFRLSAVFDYRTGHVFYNEIGQMLDFTGSSVQSAQTGRLP
FVFPNSSYQTAPGVYTANTSIPTSSGGQPFWDSVYSNIAENYVIDATAFKCREIALSYSF
PKKVLDNSPFEGITIGANARNVFMILPKANRYTDPEFGFTTGNAVGVGTVNEVPPTRSYG
FNVTLTF
>LONDMIMF_01695 hypothetical protein
MSREPKKRNCFLENEIQENKKQDDSTFLFKFRLGQRTRFIHIYLGKDSELRKLGIVESPG
DTLKLPLGETESFLNTTLNSLERKGYSLARLQLINLKKQKNILLADLNLQTEKQRQVNDI
VINGYEKFPEGHKKEIRRRYRNKVFNQQNLKNIHEDFNQFQFVTQTKYPEILFMNDTTKV
YVYLEKSKPNRFDGFIGFGNDDKGDLKINGYLDLLLVNSLNVGERFNLYWKSDGNDQKTF
NANIELPYIFRSPLGIKAQLNIFKQDSTFQNTQTAIDLGYYFNYNTRLYVGYQSTESNDI
QNLNSSTLKDFDNAFITSNFEYTRFKNDDFLFPDKTLLNIKAGVGSRNSEASKNSQFFTN
VDLRHNLYLNDKNIIALRSQNFLLQSDSYITNELFRFGGINSIRGFNENSLQANLYSSIL
TEYRYVLAPTIYIHSIIDFGYYQDKTTDNDGNLLGLGFGFGLLTKNGLFNIVYANGSTGN
QQIKFSNSIVHISFKAKF
>LONDMIMF_01696 Outer membrane lipoprotein Omp16
MTNLQDFFKMRIMKKILYVLIVILNFHNGNAQDLKKANAYFERTFYSEAIPLYENIIKDN
HSFEVVSNLANAYYYTNDLKNAERWYSFLLKNYSADFGEDYYFRYMHSLKAVGKQEEANA
LARGRIEYYAKTDEVAAFDKQLAVLENIAALGNRFEIRNLEINTKNSDFGAVRKGSDLIY
ASPGKSKVYKWNNENYLDLYVIPIENVKKGDSIAKDFSNSINTKMHESNAVFTKDGKKMY
FTRNNFNNGKKGKDNKKVSHLQIFSAEFEDGEWKNIKSLPFNSDNYSTEHPALSPDEQTL
YFASDMPGSIGSFDIYYVAVNEDKFSTPVNLGTNINTIHKEQFPFISKDGKLYFSSDGHL
GFGSLDVFVSTGDNGEFSKPVNIGFPVNSEYDDFAFTIDSDTKEGYFSSNRIGGKGNDDI
YQINETKPLIVEDCKQLISGVITDEITNLPLEGALVVLQNSEKAEVQRKITAADGKFLFD
AACASAYTVLASKEKYTDNSRSLKLSKERNKNNDASMALKSLETIKQEQETALQQKKKEE
EAAKQKEKELEEAEAQSKAEGTHREYMRDSVTEEKKRIEKLLADEKDVVRDKDRLLIKTE
PIYFDYDLWYIRKESKPILNKVIALMKKYPDMVVEIGSHTDVRGNNKYNLDLSEKRAAST
REYFIEQGIPNSRIFSRGYGETVQIVKCVPEESCTEEQHELNRRSEFVIKGI
>LONDMIMF_01697 hypothetical protein
MKKILLLILFTGFLNRATAQQDPQYTHYMYNLSVVNPAYATATPEVLNLGGLYRTQWVGA
VGAPKTFTFFGHMPASKNVELGLSFISDDIGDGAKKENNIFGDFAYVLQLNSNHRLSLGL
KAGVTIFETNFNGFVLESGPNGTDPAFAQNINSVFPNLGAGAFYFTDNYYIGLSAPNLLN
TKHLEERQGINRFGSENVHVFFTGGYVFQINQDLKLKPSFMAKAVKGAPGVVDVSANVLL
YDKFELGASYRLDDAICGLVNIKVTPDLRIGYAYDYTTTNLGQFNSGTHEVFLLFDLNFM
KKGYDKSPRFF
>LONDMIMF_01698 hypothetical protein
MYLKITCLPLKAGFFQLLLFTFFLLSCNLTKAQCAGEDTSITICNIPDSTNQNINLFNLL
GGTPTPGGSWTDLQQSGGLNISTGILNVWSINESDTYVFVYTVNDASCADNVATVTVTIG
GYAGISNPNASACDDNNSVNLFQFLGNFPNPQQNGYWRDDSGSGALRGNFLDATVSGLGT
FSFTYTMPAIGSCPSVSATVDVTVHPAPEPGVTSDLILCDSDDMSIYTNLNLLDYIFGQD
PGGKWSEGGTSELSGPEDTFINVQNIYNTFGPGEYGFTYTVQPSHPVCNPKSSTIKIIIE
EQLDFTGSTLVIASDICEDEIGRATFVATLTQGLENIPNGNYNLQYQITGPISSGNTILV
RFENGVVTFPIPAISFPFVGAYTVSIVNIHETTGYNACDHIIGDISDILNVYPLPKINAG
TLTIENACQESDVEVRLSGNTNLADGNYRITYDLGGSNTASAQQVIMTVVGGVGTFILPS
SLLSNPGNMTIVITHIINLQTLCENTASLSQSFIILPKPDVSNVRVTINDVCESQPVIAN
FSGFGMLTSIQITYSLTGANTASGIVTIAAVNGTAVFTIPANQLLNTGTTTFTISEIVNN
ETSCGAGNLSITDSFTIYRLPETPVVNNMEFCQSENATVADLVPNGTSYIWYASESGSPL
SSDTVLTSGNYYVATVSPFGCVSQKAIVAVIITDLLPPVLETGGQNFCGLDSPAPTLANL
SANVNGTGTIVWFDALHNGNQLPDSQVLQDGMTYYGFDSSATTGCISENALAVTVSLSHC
GEDEYELMIPDGFSPNGDGINDTFNIPNIEFLFPDFTLEIYNRYGNVMYKGNRNTPDWDG
RSDQSTVIDGVAPNGVYFYIVNFNKGNKPAKQGRLYLNR
>LONDMIMF_01699 Glutathione transport system permease protein GsiD
MNKSTQSLTGIALRKFKKNFWGVFSFGFILLLMLLSIFAYVLAPDNSENANWGDLTIRSK
KPGFEVKILSIPLKEQAESGFWDFFLGHEQQFSKEPISDFKIEKDKIVYTLYNDDPKVII
QKETTLKDFPGYNSLEEAAKDHIKNQKFYLGTDKAGRDYLSRMLVGSRVSIAIGFVAVFI
SLVVGIFFGALGGYYGGKVDAFVMWLVNIIWSIPTLLLVIAITLSLGKGFWQVFVAVGLT
MWVEVARVVRGQIISVKEMQYVTAAKALGYTNWRIIIHHILPNIMAPVIVISAANFASAI
LVESGLSFLGLGAQPPVPSWGGMIKDYYGDIILDKPYLAMVPGTAIMLLTLAFMMMGNAL
RDALDVRN
>LONDMIMF_01700 Tail-specific protease
MNAIMEFMKRNYKIVLVVVALSAALWSFVPREVKNDPEKDRLLIELLTFVIERGHYDPAK
IDDTFSKGVYKDYLEAIDPSKRFFLQSDIDEFSKYETKLDDQILARDLTFFDLTYNRLLQ
RIEESKKYYKDILTKPFDYKKDETFNTDYAEHSYAKNSDELRDRWYKQIKLSTLASLTNK
LEIQEGKNVADNDDFSDLTTTEKAKKEEEQKKEKKEIEKKPFDVLEKETRESQLKSLNEY
FGFIKDLDRDDWFSVYINSIATRFDPHTSYFAPDDKERFDVSMSGKLEGIGARLQKKNDF
TEITELISGGPAWRGKQLEPGDVVLKVAQGDKEPVDVVGMRIDDVVKKIKGPKGTEVRLT
VKKTDGTIKIISIIRDEVEIEETYAKSSVVEKNGKKYGIIYLPKFYIDFENADSRDAGKD
IALEVERLKQAGVDGIVMDVRDNGGGSLKTVVDIAGLFIEKGPIVQIKSAGKKKEILYDK
DSRVQWDGPLVVMVNSFSASASEILAAAIQDYKRGVIIGSTQTYGKGTVQNVIDLNQFLR
SNSMGDLGALKTTTQKFYRINGGSTQLNGVSSDVALPDRYSYIKMGERDIDNAMPWDKID
AADYKVWDKQPNFDLAVENSKRRMEKSEQFKLIEENAKWLKQRQDEKEFSLNIDKFKQEQ
AQLEEKAKKYKAISNYKNNLKFTSLPYENEMVKNDNLLKEKRDRWHESLSKDIYVEEALN
VLDDLQPNASIKGTVNVKKKDKLVKS
>LONDMIMF_01701 5'-nucleotidase SurE
MKKKPLILVTNDDGISAPGIRALISVMKEIGEVVVVAPDSPQSGTGHAITINSTLYLNKI
SPGDVTPVEYSCSGTPVDCVKFAVNEVLGRKPDLCVSGINHGSNSSINVIYSGTMSAAVE
AGIEGIPAIGFSLLDYDWNADFEPVKKFVKKIAMEVLENGLPEGVILNVNFPKLSEKDIK
GIKVCRQAKAMWSEKFDKRTSPMGRDYYWLTGKFVNQDNGEDTDEWALKHGYISLVPVQF
DLTAHHAIQNLNSWKLNDNS
>LONDMIMF_01702 Lipid-A-disaccharide synthase
MKYYIIAGEASGDLHGSNLMKAIFKKDPQAEIRFWGGDLMQEAGGTLVKHYRDLAFMGFA
EVVMNLKTILNNIKFCKADIQKFKPDAIIFIDYPGFNMRIAKWAKEIGIPTHYYISPQIW
AWKENRIKAIKRDVDFMYVILPFEKDFYEKKHHFPVEFVGHPLIDAIHNREHIDEDSFRK
EFDLDDKPVIALLPGSRKQEISKMLSEMLAVVKDFPAYQFVIAGAPSQEYDFYKQFLKDQ
NVHFISNRTYDLLSIASAALVTSGTATLETALFKVPEVVCYKGNWISYQIAKRIITLKYI
SLVNLIMDKEVVTELIQGECNPKRIRKELHKILETSQREKLLQDYEILEKKLGGIGASEK
TARLIVDKLKK
>LONDMIMF_01703 Murein DD-endopeptidase MepS/Murein LD-carboxypeptidase
MSAKKIFLLFLPLFLLVSTSGHSQIITTKKEALKKGVYEKPVEKKTTVAADKPAPAPVAV
ADKAKATKNTKTVKNKKNVIVEQEDPELIASVAPTESYISLQLINNAMNFLGVRYRGGGT
TTAGMDCSGMVTAVFNLFDIKLPRSSHDMALIGEKVDTNDIKKGDLIFFRTNGRRVINHV
GVVIEKIGDEIKFIHSSTSKGVVVSSTSEPYYKRTFAQVNRIIQQ
>LONDMIMF_01704 ComE operon protein 3
MKILKFPLARITLWFVLGVLAAFYFEPIPLLSLILCGVSILLFGTAFYFSGKDFIQKSYF
GYATYFVFFCIGITTHAVHNERLSKYHYGHKLDGHTHFVEVVLLEKLRSNPYSHRYIAKV
TAIDSEIAEGKIVLQVKKENLPQDFPVGTRLLITGTIYEPQAPGNPHQFDYKKYLAFKSV
YGQMYADVSTIQISPKKEKNIWYYAADFRNTIIKNLKDSGFRNEELNVAVALILGQQQDI
SPELMKDYQFAGAVHILSVSGLHVGCLMLFIGFLLSPLPKTKTGNILRLAILLSFLWVFA
LIANFSPSVTRSVVMFSFVAVGKYARRKTNIYHTLLVSVFMILLFEPSFIFDVGFQLSYC
ALFFIVWLQPLFSSLWQPKNKIGKYFWDILTVSLAAQMGTFPLSLYYFHQFPGLFFITNL
LILPLLGIIMALGVFVMLWASFSSVPSYLVKCLEWSLYILNKIISKVASFESFVFQDIPF
NWQMLVTCYLLLFTAVFWLKKPNFKKLAFALASIILFQLAYLGNRYSSKNHEELIVFNVK
KNTIIARKKGEQLTVFSHQELSEQTINFILKPYLVGSFSRIASTEKIGNLMYFNQKKILI
IDSLGVFPKSQRPDIIILSQSPKINLERAIQDAKPKMVIADASNYRTDVERWKTTCLKEK
IPFHSTVEKGFYSLSE
>LONDMIMF_01705 Thiol:disulfide interchange protein DsbD
MKKLLLALFLAVGSMAAVQAQEIKWMTLDQALAAQKKKAKPIFMDVYTDWCGPCKMLDKN
TFQAKEVADYINANYYAVKFNAEGDSEVNYKGKKYTNPKYDATRKGRNAVHDFTMFLKVQ
GYPSMYIFDSKGEVKSPIVGYYTPEQLMPMIKI
>LONDMIMF_01706 Di-/tripeptide transporter
METTVKRSHPKGLWYLFGTEMWERFGYYLMLGIFSLYMLDGWNNGGMGFDPAKKSDIYGT
YLGLVYLTPFIGGLLADRVLGYRRSIIMGGLMMAAGYFLLSIHSITTFYVALFCIILGNG
FFKPNISTLVGNLYSGDDMKDKKDAGYNIFYMGINVGAFICNFVAAYMRINYGWGHAFAA
AGVGMLIGVVVFLIGTKHIKHVDVIKPVKEGDMSTGKILGLTVLPMFIFGIIGYMIPGNF
LGSDTNDAFIIGCIPVIGFFIYLAFKAEAKESRAIKALLAVFTCVILFFAIFHQNGDALT
VWAEDHTDRNMPTAVSNVADKLGMAQVVVNNDIVSADQATFDKTIEEMRAKEAAMPAVSK
EEIVAKGKYSSEIGQLEKSRKYFATLPGDQIPAKGTNLKLYSTELYQSINPFWVVVLTPL
VVGVFSWLRRRKKEPSTPTKIFIGLVITALSALVMVGAVFATNDLTMKASSWWLIASYGV
ITIGELCLSPMGLSLVSKLSPPRITALMMGGFFLAISVGNKLSGMLSSLWEEMPQKENFF
FLNFGLVLAAAIVLLLMLKWLNKVMKENNVA
>LONDMIMF_01707 Di-/tripeptide transporter
MSEITSNNNDFFKSKVLGHPSGLFVLFFTEMWERFSFYGMRVLLINFLTMAAIGTNPGWE
WSSENAGALFGTYAGLLYLTPIVGGIIADKFTGYRWAVVIGALIMTSGHASMAFETEFSM
YFGLGLLVIGTGFFKPNIVSIISEMYKDLPEKKDGAYTIFYMGVNAGAFFGMMLCGYLGE
KIGWSWGFGLAGIFMLLGSLQFWLAKPLFGTIGDVPKRDKVVEAISPDGQIDITEPKAEV
KPEDKRNPFTMLDKVLIVITSIIGLLYLIDDPASKIGNIHLLPQEFLVSKEVLPGALVIT
IIGLVLFLFLVISRISRYTKVVRDRMIAVIVFAFFTVFFWLSFEQGATSLILFARDFTDR
TLMGNQAIVFNIINTLLTIIPLALISWVLFLLFRQTAKKIATSNIILALSFLGVWGIVVW
MLNNDYNSKAYELKYQAIKTAQIDKKTKKQAVDENGDLVFDFNAVTETTVLKPTDVVVDQ
TVTISSQEVLKVNDKVALHSEIGNFVYLTKGLETKIRDDYKKATKDSQIIKAEVVQLKEN
QVEVTASWFSILNSFFIIAFASMFSKWWDSKYNPSAAVKYGLGLIIMGLGFAILAYGARV
IPSGAEAGAVRVSMIWLILAYLFHTWGELCLSPVGLSYVSKLVPSRMIAFMFGMWYLAIA
IGNKLAGSLGGMIEGITKEYDMSTFFLIFTIVPIVAGLIVVALNPMLKKLMHGVR
>LONDMIMF_01708 Dipeptide and tripeptide permease B
MNTTTPTLEEIQNFKGKYPKQLWYLFLVEMWERFTFYGMRALLALYISHLVLSADYKPLA
PAELEAKKTEFLEKNKEVLDKSHPRYYIETSQQKVKDDAESKSNKQYGLIQAFIYAMAFV
GGLFADKIFGFRKSVFWGGILMAIGTFIMAVPGAFPFYLGISILIVGNGFFKPNISTMVG
SLYRKDDSRRDAGFSLFYSGINIGALLSGLTIAYIGTSVSWSLGFALAGVCMICGLILFV
FTQKSLGPIGLPPEPEKLQEKKFGISKNLLVYIGSLLFIPFFFVLVYFPFDVDLTFMLGE
IVKADGTTAPNLVQFSDVFMITIAVLILLYLIKTLFDVTKEEFGKMAVAIILILFSVLFW
SFFEQGGGSLNFFANGNVDNKGFNMTQVNNSVNALWVVLIAPIIGMFWIFLSKKKAEPNT
VVKFGLGFVFLGLGFLVFFASKFFATPTGLTPLWMFVGAYLVITLGELCLSPIGLSMITK
LTPGRLHGVMMGTWFLASAYGQYGAGLIGSALAKVDTSIENPTNVDKLVQYTNGYASIGY
VAVGAGIVLLLISPLLKKLMADAKVA
>LONDMIMF_01709 Prolyl tripeptidyl peptidase
MNSRKIAALLFFIGMSVFGQQKITLEEIWGGAFRAEGMDELQSLKNTNQYTVLNFDRPSR
SMQIDLYDYATLKKVATLIDTKNHKDLPMIDSYIFNSQENKMLIACKSEQIFRHSFVADY
YLYDIQTKQLTKLFDFKIQEPTFSPDGNQIAYAKDNNLYVYNLQSKTTKQITTDGRKNAI
INGITDWVYEEEFSFVRAYDWNAASDKIAFIRFDETEVPEFSMDLYSGGLYPTQQVFKYP
KAGEKNALASLHVYDLKANASKQINLGNYNDFYIPRIKWTNEANVLSAQVINRHQNNLDL
LFVDGTTGATKVVLNEKDKAYVDITDNLTFLKDNSFIWTSEKDGYNHIYHYDKSGKLKNQ
ITKGAWEVTAYYGLDEKTGTIFYQSVENGSINRDIYSIKLNGKDKKRLSSATGTNSATFS
PNFQFYINTFSNVSTPAQYSLNDAKTGKEVQSIKKNEKLLSKLQGYNLPSKEFFELTTEK
GHKLNAWMIKPKDFDASKKYPVLMFQYSGPGSQEVKNSWLNTNDFWYMMLTQQGYIVACV
DGRGTGYKGADFKKVTYKELGKFEVEDQIDAAKVIGKYNYVDSSRIGIWGWSYGGFMSSN
CILKGNDVFKAAIAVAPVTNWRFYDSVYTERYMQTPQENASGYDENSPINHVGKLKGKYL
LVHGTADDNVHVQNTMLMIEALVQANKQFDWAIYPDKNHGIYGGKTRLQLYTKMTNFIKD
NL
>LONDMIMF_01710 hypothetical protein
MKNYLLYFLLISFTINAQNLKDCSKCSSEIIRESSIQNLNVPALKLLKNEMYARKGYTFS
NEEYARHFKQFSWYQPSANNNTIVFSDIEQKNIAILTQKINEISQPGSKNEPNSKYKTLT
QEKIDEIFTHEKKKELGINFSIWKVYDYQDKTGKYYLVLTEDKMNTSKEGNFNNAVKAFN
FKVENNVWTKTFETNDSKKDGEDSIWFWTKYIYVEDFDLDGIIEPILFYGTNGLNGYDDG
RIKILTYYKGKKIGIRIQNGVLDDERNFSIDADFYNLPKSIQDTVVAQMNKMVENGHSIL
PYGWHKKMAKKMTFIKE
>LONDMIMF_01711 3-hydroxy-3-methylglutaryl-coenzyme A reductase
MNKTISGFSKLSKEEKISWIAENYFSNPEEATAIIKNYWNSDTRLQKLHDDFIENTITNF
YLPLGIAPNFLINGKFYTVPMAIEESSVVAAAAKAAKFWSERGGFKATVINTEKIGQVHF
LYKGDASKLEKFFTEIKNRFFEETESITKNMQKRGGGVLDIVLKDKTDLLPDYFQLHATF
ETKDSMGANFINSCLEQFAKTLKNEAQSSGIFSEEEKNIQIVMSILSNYVPNCIVRAEVS
CKVEDLKEKNSNPGDFAEKFVRAVQIAEVEPYRAVTHNKGIMNGIDAVVLATGNDFRAIE
AGVHAYASKSGRYQSLSHAKIENGIFHFWLEVPLALGTVGGLTSLHPLVKLALEMLEKPS
AQELMQIVAVVGLAQNFAALRSLTTTGIQEGHMKMHLGNIINQLEATDEERIKIMNHFEH
HPVSHAAVVEYVNDLRKVKS
>LONDMIMF_01712 hypothetical protein
MKKTFYSNGKLLITGEYVVLDGARALALPTKFGQNLTIKNGKNNQMDWKSFDKDGSIWFE
DNITFESIIKKESFSSDKIKTTLIEILHEAYLLNPEFIEASEGYTITTELTFPKLWGLGT
SSTLINNIAQWLDIDAFELLRKSFGGSGYDIACAQKDTPILYWLQDDRPRIEETVFNPDF
TRNMYFVYLNRKQSSKAAIASYYNKQNNIAEVSRKIDHITEALLKAEDLKTFAYLIEKHE
MILSDVLEMQTIQETYFSDFKGVVKSLGAWGGDFVLALSKNDPTDYFKEKGFPTILTYDE
MILK
>LONDMIMF_01713 Foldase protein PrsA
MAVLSKIRQRSLLLIFVIGFCLLAFVVGDLINSGGFKQTSKYVGSINGEDISFEDFRSKV
DAVEKGGQGISSSQAANQVWEQEVSLALLTEQFEKLGIRVGESQILDVLKQSQDIGQNPQ
FQNAAGQFDYQKYKEFFQSNPELTTQLRERETQAAINAKYQIYSTMLKAGLITTEAEGKL
QYEMESDKVTFDYVAFPFSNIKDSEVPVSNDEIVAYMRKNEKKFKADETRELQFVVIDDK
PSKEDEEEVKKNITALLSPRVVFNETTGKNDTIKGFKDITNNQEFVDANSDVKYDSTYVT
KNNLPAQFADQLYNLPTGEVFGPYIYNGYYAISKSLGKKAGASAKASHILVSYAGSKIPN
PAITRTKEEAKAKADDLFKQIQANPSILESLVATNSDDQGSLQTRGEYDNIVPGQMVKPF
NDFVFNSPIGKVGLVETEFGFHIVKVIDKRDAVRLATIAQRIEPSEATSDDIFKKATKIE
MEAKDKDFATVVKSLGLTVASANVKALDENFGSFTNQRQVVRWAYNKETSEGDVKRFNVP
NGNLIVKLKKINEEGLMAISDAKPIVEPILKNQKKTEKIKQIMKGATLEEAAKAAKVSVA
NATDITLQNPNLLGFGAEPKVVGTAFATAPNKVSDLIEGRAGVFKLQTKSVVKAPAIKNY
DTYTARLKAMSGASLGRIIPALKDKAKIKDNRLDFGF
>LONDMIMF_01714 hypothetical protein
MVYLKYIQYFYLIAAILFAVDGFVQLNSAERSPWLSFFFAAIALFMFFFRRRFAKKYENQ
NKNK
>LONDMIMF_01715 Lipopolysaccharide export system protein LptC
MISKSKIVFPAVFVLLAGFLFSCESNFKGVQKINVSAFTPVGEADTINLKYTDSGKVKAI
LVSPKMLDFSNASFPYTEFPKGVDVTLYDNNGKKSYVSSDYAITYKGTDIIDLQGNVKIT
SEDGKILETTQLYYDQKREWFFTEKKCKLTLGPGNEFYTKGFDASRDFKDINGQVFFGEG
QADEF
>LONDMIMF_01716 Photosystem I assembly protein Ycf3
MNKKNLFGSRLAVLIFAVLGFNFAAKAQNPECKNKLIAFEEFIRENSYDQTIYNRWKELK
QQCPTESEAIYLLGEKILSQKVDQANTAEEKSPLITELLNLYDEHDKVFPNNKRGNRINK
ALLLYENKSGDSREIFTFLDKAFQLDNSGFTNPEVLNIYSELLVSQYEKKEIELTSDQLL
TKLDQIAEKVQVELKKSNQIKDNLTLKSQTAKLTAEEQNSLQQSKLSISELTIVAENVNA
GIDKQANCEVLLSFYQKNFDKNSENALWLERASDRLDAKKCKSDFFVKVTEKLYALSPTA
KSAYAMGMIARNARNTPQTIEYFTRSAELQTDVNKKAELYYLIATTYGYPEKEKAREFAK
KALEIKPNFGKSYIFISQLYSYSTRDCESNNAFESKALFWLAAETAKKAGTVDPSMKKTA
DQLAADFTKKAPSKQEISQAKRKAGEQISFKCWIGESVSIPKL
>LONDMIMF_01717 hypothetical protein
MIKKIIVSLGLLFSLASVAQEGSASPYSFYGIGDARFKGTTENRSMGGLSILPDSIHMNL
QNPATFASLKLTSFTAGGSFSVSNLKTREATAKAQRTTIDYLAVAFPAGKLGVGFGLMPY
TSVGYKINSFSDVEGVPDRSYSGKGGMNKVFLGAGYQITSKLSLGADFSYNFGSIETKSL
LSQDVQYGTREMNVSDLSGVSFNTGLVFTTKIKKLDFVSSVTYSPQANLKSENERKIATL
VGSSQSEIVVEEKEIEVADSDLKLPSKFAFGLGLGKKGEWFVGAEVTLQESSKFGNRYND
ITNVSYENATRYSLGGYFVPDYDSFTSYWNRVTYRAGFKYENTGLVVGDTSIKDYGMTMG
LGLPVGGTISNLNIGFEYGRKGTTHAGLVKETYANIFLSLSLNDRWFVKRKYE
>LONDMIMF_01718 Type III pantothenate kinase
MLLAIDVGNTRIKGAVFENDSLLGHFIFLKKDFKKNIEKILKDFPKTAFLVVASVGSLDK
NDFLDFGEKLKVHFISHEDSFPFVNLYETPKTLGMDRMVLAAGAVLQFPKQNRLVIDAGT
CITYDFVDENDNYLGGAISPGLRLRYEALHNFTARLPLLELDSPKSIIGNSTSQSIHSGV
VNGAVNEIDGFINDYKQHYSKFTIILTGGDAEFLAKRLKNTIFANSNFLLESLSHLFQYK
IKND
>LONDMIMF_01720 hypothetical protein
MKNFLLKSNLVFFLITLGCSSEPDSNESDITPTSKLNAREIGKITVSDLQKDPKKIGQIH
NEVMDNVYNELLLIKEGKLKPSEKTLEEFVNIHVAKSLETKIDFEGQEAAKFINLGIESP
NDDQRLVDFYKELEDLTNKNLITNEFNIEANRILGKYKNYRKDNLYLQSLAAIHSIAINS
NEYWAANADKWEDLAGAVALRRPPGSDGRIVRADIYGALRGGLAGAVGGALAGGIGALPG
GLLGAVSSACSSSAITGVREHLGYSSWIPW
>LONDMIMF_01721 hypothetical protein
MKKFFLNFKKARCKNCGQMQNYFRIPKNWRQFLWGGYSCGKCGAELDKFGEIIKMPKEFD
TME
>LONDMIMF_01722 hypothetical protein
MKKILLSLILFTGLLQISCSEDSVVDSSNVPTNNSVDVYVAGQKNSQACYWKNNQLVLLN
SGGINAPTANKIMVVNNDVYVLGIGVGTTTTETFPMFWKNGVLTNLKTSLSSADDEVVTV
TDFEVVGNDVYFVGYTKRRVITFEDYSLVYWKNGIKTTVHNYGGYVQNYSKIKVVNNTVY
ITGTNNRDSSINGYYVNTVFNEIPFSTLNGLAVNNNEVYTYGTANNGGYYKNITTGSETS
FPTVATVTSMLFDNNNLYLTDVASIYKNGAMFDAGQPQLGGIMDFKILNNNTYKIIQEGV
APGYISHLTINGVEAAQIPDSEGTFLSLFVVQN
>LONDMIMF_01723 ECF RNA polymerase sigma factor SigW
MNSINWHEIYTKTSPKLLGICRRYIKDIATAEDIVQDSFIVAIQKEETLKDKSALQGWLS
RIVINMAIHHLKEVKKINFSTQQDYEIVDSTTVMNTIAIDAKSLLLSADLERDDILEAID
RLPEHHKSVFNMYVIDRFSHSEIGKILHISTGTSKSHLSRARKAIQLFLLERIKEKPVDE
KKKRRIAFLIFLGFGNQMFANFCKKQFNDFEIEPMETFEPVSNKITFPNQFIGLAKINPV
PKFMTIAICFLGVLGVAFYAYFFEVKDIPQKHPKPDLESVDIIPENQLPVAVEDTAKGEE
PATEPKSIKTLFTHEKATVTNKNSQKTTEEVNSIVTKDSVKNEPQKVVIIKRQIVKKDTV
YVSE
>LONDMIMF_01724 hypothetical protein
MFQNKILLFFLAFTTYTFSQEKKVDTIYVYEEIIIHDTVFIEKPLKIDKAIFTETDKKDL
LELTQNGKKITVDTLIINSKKRIAKNEKSWFFGGRLHLGLASNSLFKEVNAPSPIGLGLG
IWTRKELFQSRFSLGIGIDAFYWMSPFSFNASKKDSHLNGYYFTQNNEPKLFQSLDSKHF
QLQIPVQLYYKINKFMPSVGGFVSTSIYKSQFLGSSGRLPRTLDETQTFRAEALQIGYLA
EVQYAISEHLSLALHFSSGKANNLLFTNKQDKSQSFKTGNEFSEKRFGLQLVYRW
>LONDMIMF_01725 hypothetical protein
MVWWKKTLIGIGILIVLALILNIGLNYWIRKQLPVIINENNNSPYQITYKTLEVALFDGN
AIAKEITVVPKSSLKKTDVKAGIYTTIQSIKIEGISAWSILFSKRIVAKKIVINKPEIIL
FKDNDRALNDPNSIRDKVVAPFKNTISVSDIYLLNSSLQIISTTDNKASLIVHNLSMQLD
GILLDDNTLKEKIPFTYKNFEIDCDSIYYRANEFYHLTAKKIHTDKSDLKIADFRMIPEY
DRGEFVRRIPKEKDIYTINAQEIKINNMNWGFKDSVFYFNSTNVFLEKVFANIYRPKMPP
DDLSKKHLYNKLLRDIKFPLHVDTLAIRESTLEYEEEKTFEKGAGLLSFNKFNMFVTDIN
SGYGHKKLPDVKITVNCRFMNVSPMKVNWRFNVMDVSDGFNIKGSISQFPANRLKPFTKP
YMNASVEGMLNEVYFNFSGNDVKSKGDFAIKYDDIKVTLYQKKNPKKKNKFLSAVGNLFV
KNDSDEKVVEAEVEVERIPEKSFYNFFWRNIGEGLKKTLL
>LONDMIMF_01726 hypothetical protein
MILSTFLKLSTSPLVSKDLKSIHEKNKTMSSPKKFPIPTYFKSTAIHSNKTTLKTTLENC
LRIFILFNKSNLLFE
>LONDMIMF_01727 UDP-N-acetyl-D-glucosamine 6-dehydrogenase
MGLEKIAVIGLGYVGLPLARLFATKYKVVGFDINQNRINSLRSGTDSTLEVADEVLQEVL
VDDFQNHQNGLLCSSSLDDIADCNYYVVTVPTPVDKNNRPDLTPLYKSSETVGKVLKKGD
IVIYESTVYPGVTEEECVPVLEKVSGLKFNTDFYAGYSPERINPGDKEHTVEKILKVTSG
STPEIGKKVDELYKSVITAGTHLAPTIKVAEAAKVIENSQRDINIAFVNELAKIFNLLGI
DTHAVLEAAGTKWNFLAFKPGLVGGHCIGVDPYYLAQKAQEVGYHPEIILAGRRLNDSMG
EYVASQVVKTMIKKNIKVNGAKVLLLGITFKENCPDVRNTKIVDVVKALEDYSVNVTIYD
PWANPEEVMHEYGFSTVNNIDNAMIKKNGFDAIVLGVAHKQFLDLDLTQFLEKENGVIYD
VKGILKNSTIKL
>LONDMIMF_01728 UDP-N-acetylglucosamine 4-epimerase
MSKILITGGAGFIGSNLCEYFLEKGNQVVCLDNFATGHRHNIEPFFSNPDFTLIEGDIRN
LDICNEAVQGVDYVLHQAALGSVPRSINDPITSNEVNVSGFLNMLVASRDANVKRFIYAA
SSSTYGDSEALPKVEDKIGKPLSPYAITKYVNELYADIFSKTYGLETIGLRYFNVFGRRQ
DPNGAYAAVIPLFVKQFMNYESPVINGTGDFSRDFTYIENVVQMNEKAMLATNNEAVNTV
YNTAVGDRTTLNELVGYLKEFLTVLDPKIASVEIKHGPNRKGDIPHSLASIDKARNLLGY
EPTHKIREGLKEAVDWYWENLK
>LONDMIMF_01729 Glucose-1-phosphate thymidylyltransferase
MKGIILAGGSGTRLYPLTRSISKQLMAIYDKPMIYYPLSVLMLAGIDEVLVISTPHDLPN
FRNLLGNGDDFGIKIEYAEQPSPDGLAQAFIIGEKFIGSDDVCLILGDNIFYGHGLTDLL
KTAVNNVVVDKKATVFGYYVQDPERYGVAEFDKTGNVISIEEKPKEPKSNYAVVGLYFYP
NSVVEIAKSIKPSDRGELEITTVNQEYLYSKNLKVELMGRGYAWLDTGTHESLLEASNFI
QTIEKRQGLKVACLEEIAYEMGYISKEKLIELATPLQKNEYGQYLLRLANKR
>LONDMIMF_01730 dTDP-4-dehydrorhamnose reductase
MKKILITGANGQLGSEIRVLSPLFSDFDFVFADRAEFSLESESETRSFLEKTKPDYLVNC
AAYTAVDKAETEVELADLVNHKAVALLAKWSFENNCKLIHISTDYVFDGTSEIPLKENDQ
TNPQNEYGRTKLLGEIACQKNNPDSIIIRTAWVYSEFGSNFVKTMLRLMNERDSISVVND
QIGSPTYAKDLAEAILKIIETENWYPGIYNFSNEGKISWFEFALAIKEISGSNCDVKGIP
SEAYPTPAKRPAYSLLDKTKIKEIYKIKISDYKSSLEKCLNNIGKNI
>LONDMIMF_01731 dTDP-4-dehydrorhamnose 3,5-epimerase
MKIENTPIEDLLVITPRVFEDERGYFFESYNEALFRENGIDIKFIQDNQSFSKYGVIRGL
HLQVPPFAQTKLVRVLQGEILDVAVDIRKDSKTYGQHFSILLSAENKKQLLIPQGFAHGF
SVLSPTAMVSYKVDQLYDKDSERGIRFDDPSLNIDWKLNHKESIVSAKDQILGELKDLE
>LONDMIMF_01732 dTDP-glucose 4,6-dehydratase
MKQILITGGAGFIGSHVVRRFVKKYPDCHIFNLDALTYAGNLENIADIENEPNYTFIKGD
IVDADFINDLFAKHQFEGVLHLAAESHVDRSITDPLAFVKTNVIGTMNLLNAFKEKWKGN
FEGKRFYHISTDEVYGSLGAEGLFTETTPYDPNSPYSASKASSDHFVRAYGETYGLPYVL
TNCSNNYGPNHFPEKLIPLFINNIINNKSLPVYGDGNYTRDWLFVEDHAVAIDLVFHEGK
NHETYNIGGFNEWKNIDLVRLLCKIMDSKLGREEGTSEKLITYVKDRPGHDLRYAIDASK
INKELGWKPSVTFEQGLERTIDWYLANEDWLKNVTSGEYSKYYEKQYN
>LONDMIMF_01733 UDP-glucose 6-dehydrogenase
MKITKICCIGAGYVGGPTMAVIAQKCPDINVTVVDLNEARIAAWNDEDTNNIPIYEPGLS
DVVAEARGRNLFFSTEVEKAIDEAEMIFISVNTPTKTYGSGKGMAADLKYIELCARQIAR
VSKSNKIVVEKSTLPVRTAEAIKNILDNTGNGVRFQILSNPEFLAEGTAVQDLLNPDRIL
IGGDTTEEGQRAINALVDVYANWVDRTRILTTNLWSSELSKLTANAFLAQRVSSINALSE
LCEKTGADVSEVAKAIGMDSRIGPKFLKASVGFGGSCFQKDILNLVYIAKAYGLNEVADY
WEQVIIMNDHQKRRFSHKIVTTLYNTVSGKKIAFLGWAFKKDTNDTRESAAIYVADDLIN
EQAELHVFDPKVAEGQILSDLNYLDSRTPEENRQQVTVAENPYEACKDAHAIAVLTEWDE
FRDYDWKKIYDNMMKPAFVFDGRNILDAKKLTEIGFVYKGIGS
>LONDMIMF_01734 hypothetical protein
MMKKVIFLLIPMGIFAQNKPFDAVKTQERITQYIFSKPDSARIYLDIMLKNNHLLHDTVV
AKNYNNFGVYYSLTAKHDSAKIFFNKAVSKYAKYPKNKAGSFINLSIAHRNTGDYKTSLE
YLDDALKIYESLDNERGKAIVYGEMASNYAYMIDNKSATRYLLKGIEILSKSDDKTDRKN
LVVQKQKLANIYFKLENFKFAIDLYEECLPAMKEVRDLKNYYLTLINYGDCLTYVKDNTK
AKKALMEAAKGLEDFHNAEFISLAYSKLGKIALHEKKYDLSGFYYKKAFDGIKNTDSFRF
MLIGAEYIQLLNQIGDFEKALGIIKLVENSPNRKTFNAEDQMFFYEVSAVTFKNTNIKDK
GIEALEKAIIIKDSLAKAHKESTTEELQAKFQTQTQQEKNLFLKQKNELLSQKVSAQRRN
YILIGSGIVVICALGFAISRAYWLKHKLEKAKLREAEIEKMNLLERNAYKKRITEDQQQI
IQLREQELTSMTLQLANLQDQISSIIENESSGADSKSNSVKSSLQQIIKQKDYWKEFSIK
FGQIHPNFNDKLQERFPILTKNDINFCSLLKLNLSNKEIATLLQISHESVITKKYRIKKK
INIQDDNEFQKIISEI
>LONDMIMF_01735 hypothetical protein
MVILCINYTYAQSPDDQIKVLQKCIDLKELQDYLPGKSTQPLYVMQHGVSFDKDIKVSKN
GKPLVFLSKQEIKSQQPQAYLLFWTFEINEKTARVSFVYNYDQNQSPKAVRADLELNKQG
AEWTVKTVAINKV
>LONDMIMF_01736 Pesticidal crystal protein Cry22Aa
MGNKNYFQKLSQAILLIVPVLMLLIPSFTEAQTRVINNNKLRVGNGSENSINNSGNMQQP
FYYNSIAAQWRKLTYSNYALDNAYAVGGDGTNEWNTYGTIVQNPALTNQTIDYSGFTFTT
APNGYGKVVSKGNINVGGSLLEVENTFTLLQSAGYIEVKVKVKNVSAAPISNVRIWVGTR
DDFVGLTDSNIKQKGNLVNGAFVLNTVASQPSAALKIYNNDEAILFYSNSPRGNTIVNSC
CDWNNVINQNPATSVVNSGTTDGSYGFYVRFNNLAVNASDDFTWYYAAGTIADIDDIIED
VAQASGAVNNITYTSAVFNSTSQNAVNGYYVVVPQGSPTPTEAQIQAGTTYGSVTPVAHG
SSAMPANVEVPFPISGLTPNTTYELYFVTRDAVPAYSTIYHTSFTTLAYTVPNVTTTTTA
SAITANSASSGGTVGSDGGQAVTERGICWSTTANPTIANSRTTDGSGLGTFTSAMAGLNA
GTTYYVRAYATNSVGTGYGPQVTFTTVANNNPTISTVANQSVCANAATTALAFTVADVET
PAASLTVTRSSSNTTLVPNANIVVAGTGANRTVTVTPAANQHGTATITLTVTDQLGATAT
TTFTVTVNQFPVISYASATYNLYQSQTITPIAAINTGGASTNWSITPALPAGLTFNTANG
TITGTPTGSQSTASYTVTANNNGCTATTSFSIYITPCNTFNASDVITNGNALLTGNEVRL
TESLGNLYGTVWGKARLDLNENFKISTQLYFGASDSGADGLAFVLQPLSSNQGVSGGGLG
YQGISPSLAVEFDTYYNPGADPISNDHIAIVKNGLAASISAHSEFAPYYNAGQIEDGNWH
DAVFEWIASSKTLKVTYEGTVIFNTVIDIPNTVLGNQYAYWGFTAATGGSVNEHRVRFNG
YCLTSIVSTPPTISTVANQSYCYNTAGSVNVTVADSESPVANISLQATGSTNTALLPLAN
ITVTGTGATRTVNFTPVSGQFGTSTVTLRATDGDGTTSTRTFTVTFDDTVNPTAVAQNLT
VYLGTNGQATTTAAAINNGSSDNCGIASITASPLTFNGTNLGANTVTLTVTDVKGNVGTA
TSTVTVIDNIAPTVITQNTTVSIAANGQVSITPAQVNNGSFDNVGITSLTVSPNTFNCSN
LGPNTVTLTAVDASGNTSSSTAVVTVQDTTNPTIITRNITVNVNAAGIYNLVPSEVDNGS
YDNCGISNLGITRALFTCADVGQSFTITLFGNDPSGNLGAATAVVTVADVMAPNVITQNI
TVQLNASGQATITPAQINNGSTDNCGIASYALSKTTFNCSETGANTVTLSVTDIHGNVGT
ATAVVTVQDTTNPTILTQNITVQLDANGQATIVPAQINNGSFDNCAITALALDITSFDCT
NIGANTVTLTGTDASGNSASNTAIVTVQDLIAPIVLTQNITVQLDANGQATITPAQINNA
STDNCAITTYALDVTSFDCTNVGANTVTLTVTDVNGNSASNTAVVTVEDVIAPTVLTQNI
TVQLDANGQATITPAQINNASTDNCTIATYTLDITAFDCTNVGANTVTLTVTDVNGNSAS
NTAVVTVEDNIAPIVLTQNITVQLDANGQATITPAQINNASTDNCTIATYVLDITAFDCT
NVGANTVTLTVTDVNGNSASNTAVVTVEDNIAPIVLTQNITVQLDANGQATITPAQINNA
STDNCAIATYVLDITAFDCTNVGTNTVTLTVTDVNGNVASNTAVVTVEDVLAPIVLTQNI
TVELDANGQATITPAQINNASTDNCAIATYTLDITSFNCANVGPNTVVLTVTDIHGNSAS
NTAVVTVEDNINPTVLTQNITVQLDANGQATITPAQINNGSFDNCTIATYVLDTTTFDCT
NVGTNTVTLTVTDVNGNSASNTAVVTVEDNILPTMIAQNVTVHLNINGEYTLTTADVDNG
SFDNCAIETMGISRTFFNCSDIGTTNAITLFGVDVNGNYASTTAIITVADMMAPTVRTQN
ITVELDANGQATITPAQINNGSTDNCGIATYALDITSFNCTNVGANTVTLTVTDNYGNAA
SNTATVTVIDTVNPIVNTQNITVQLDANGQATITPAQINNASTDNCGIATYTLDITDFNC
TNTGANTVTLTVTDVNGNSASNTAIVTVEDVIAPTVLTQNISVQLEANGQVTITPAQINN
GSTDNCTIATYTLDITEFNCTNIGANTVTLTATDASGNASSATAVVTVEDTIAPTVITQN
ITVQLDANGQASITAVQIDNGSADSCGIATYVLDITDFTCANVGANTVTLTVTDVNGNTA
SNTAVVTVVDSVAPTVITQNITVQLDINGQATITPAQINNGSTDNCGIAGYTLDKTNFSC
SNVGNNTVILSVTDVNGNIATQTATVTVQDAMAPFAITQDVTISLDADGMAYITVADINN
GSSDNCGIASITLSQTAFNCGETGTNFVTMTVTDIHGNVSSAEAAVTVINTFGDNDGDGI
PDNCDSDDDNDGIEDSVDNCPFTYNPDQTDTDNDGIGDACDDDYDNDGVPNDIDNCPYTY
NPGQEDIDKDGIGDVCDLTEINISQAFTPNNDGINDTWQIINITNYPNSVVKVFNRWGSE
VFSAKGYKNDWNGHYKGSSNPLPESSYYYQIDLGNGTPVYEGWIYLTR
>LONDMIMF_01737 hypothetical protein
MKTLNKLSTVLLFFFAAYAYGQQETSFTFYRNNMNIINPAYAGADGETIVSSSFKTQWAG
VKDAPETQAVSFGTPTGKKLGIGLSIINDKTFVEKQTSVFADFSYLVPLNETLDLYLGVK
AGGNFYDVNVNGLQTYNVESDPSLVNINRFNPNFGIGAYLKHKKFYVSLSTPKMLSTQRA
KNEDGVATVASDRPHIYLSGGYDIILNENFMLQPSTLLRYVNGAPVSMDLTGVVTYKQQF
GLGVAYRTDKAINGLATIKVNNWFDFGYAYEHSLRDEIASATSGTHEFYLRFNLSPKAN
>LONDMIMF_01738 hypothetical protein
MLILLDIDGVMVPANSWRKPEFLDDGFPVFSNGATKALQKLISETSANILLTTSHKSKYS
IDKWREIFLLRGISVQSIDVLPENTLGLNRREEIMKWIDIQKVHSHYIIIDDDKSLNALP
GFVKANLLQTSGSIGLTEYQVEEVLEKISDMA
>LONDMIMF_01739 hypothetical protein
MRDITKEEVEKFLNENNFEYVPNQGAVSFPKLQRIYTRLSQGKNLSSIKVADGKIMDGHH
RFICSKLLGVKIDIVPGAKNHTDVEYRWETMELHSIDYDTQDEIDNYVKEFDQE
>LONDMIMF_01740 hypothetical protein
MAEKIARQENDFNNQQWLYEITPKRKLISFNFEEIWRYRDLLMLFVKRDIVTYYKQTVLG
PLWFLIQPLLTSVIQFVIFNKIAQIESDGINYFLFALAGNTLWFYFSDCFKSTSDTFKTN
QNIFGKVYFPRVIMPISITISNLLKFGIQFLFFICMMAYFIMQGKAVMPNWEIVFTPILL
ILMALISLGFGMIISSMTTKYRDLTFLIGFGVQLYMYLTPVVYPTSLVVKKLKPYGYENL
VYLNPLTSIFEFFKYSYLGKGEFTTFGLVYSVVFSIVIFLLGLIVFNRTEKNFIDTV
>LONDMIMF_01741 Tyrosine-protein kinase YwqD
MLDPKDFSFFENQNNFDFKGFLIKILSYWKWFLASLIVCFVIAYQVNIRKEKIYGMESLI
AIREESNPFFTSNTSLVFNWGGTSDKVQTIITTLKSRSHNEIVVAKLEYYIKYFKQGKYN
LIDAYGEAPFKVVIDKSKGQLSGIPIKIKFLNASEYELSIAFENESVNIINYYNDSQSQI
AVAIGDYSKRFKVGEQVKLPYLNWKLELKPDASSYAGKEYFVRFDNFNSVVSQYQGISVD
SDTKGSSILKLAMQGTNKARMVDYLNTTVEVLRKNQLDSKNQFAINTIAFIDSTLIKMED
QLKGTEGQLKDFRRGKNVLELEDGGEKISEKLAGLDIEKDAINRKIAYYNTLRSYLNNSV
DYSKLPAPAVAGIDDPNIVGNVSRLIALSIQRSEKAYAVKNDRFFRDFDNEMESVKKVLL
ENIAAAKTVIQNDLALVNAKMGQAESTIKRLPDDQQDLLKITRKYDLAESIFNTFLAKRN
EANIVKAANLSDIHFIDSAKDTGGGLIGPKTSVNYVLALFLGLMIPLVVVFIITFMDNSI
HTVEDIAKLTKIPLLGVIGKKKMASNLAVFEKPKSALAESFRAVRSSLQFLYKKQNVSGA
KTLMLTSSISGEGKTFCSINIATVFALSEKKTVIVGLDLRKPKIFGDFDLDNSFGVVNYL
IGQKTADEIIQKTRISYLDVITSGPIPPNPAELILGESMKDLLDDLKRKYDYIILDTPPV
GLVSDALELAQFCDATLYVVRQNVTKKGMLALVNDKHKRGELTNISIVFNGYESKARYGY
GYGYGYGDYSNGYHDEGEPENRFKRLLNKWLKK
>LONDMIMF_01742 hypothetical protein
MKKSLPFLSIAIVIAIIFTSCVPSQDLIYLQNKNNSETASSVNPVVAKPYRVQTNDILSI
KIKALDAALVEMFNATDGNVNNLNEQNLYFNGYSVDDHGNIRIPVLGEVKVVGLTLEEIR
IKIEKQLLDEYFHKEANIFVNVKLTGLRYTVNGEIASPGTKVLFQEKVNVMEAIANSGDI
TMVGNRKEVAIIRQYPHGTEMHTLDLTDANVMKSPYYYIQPNDYIYVKPLKQKSWGTGTT
GIQSLATVITLISLVTTAIVLINR
>LONDMIMF_01743 Recombination protein RecR
MEFSSKLLEKAVYEMSQLPGIGKRTALRLVLHLLKQPKEQTGLLSQALLTMREEIKFCQS
CHNISDVAVCEICSNSNRDHQLICVVEDIRDVMAIENTGQFRGIYHVLGGKISPIDGIGP
SQLNIPTLVEKVKSGNIRELIFALSSTMEGDTTNFYIYKQIKDYDVITSTIARGISVGDE
LEYADEVTLGRSILHRVPFENSFKNT
>LONDMIMF_01744 hypothetical protein
MRKIVTAIALFLVSYAGFAQEDAVSEVKIDMNFNKSLFPMAEGNMYMSAEPVAFIMANMM
AQTYEDAKAEMQAISEDKDLTDVKKGELKEKGKDILYQTALIKNDEGQDLVMEIYVVKVD
KQNTIMVSGGYDLKAKETFKDEIKKAALSAKAVK
>LONDMIMF_01745 Sodium/glucose cotransporter
MKPLTILLIIIIYFGILILISNIVSKKDSGNDAFFKANKNSKWYLVAFGMIGTALSGVTF
ISVPGQVGSPDIQFKYFQFVLGNAIGFILIAKVLLPLYYRMNLTSIYSYIEQRLGHVAYK
TAATIFLISRTIGSAARLYLVVIVLQRYVFNAFGVPFWVTVLISLGLIFAYTYRGGLKTI
IITDTLQTLFLVSSVIFTIYFICSSLDYNLPEAFEAVKESSYSKIFFFEDWLKSNYFWKQ
ILGGIFVTLAMVGLDQDLMQKNLSCKNIGEAQKNMFTFTGIFVVINIFFLSVGALLYMYA
EKNGISVPLDAVTGKPRTDLLFPEIAFNYLTLVPAIVFLLGLTAATFATTDSALTALTTS
FCVDFLGMDKAENAMNPNMVRTRHLVHIGFSLLMFLVILVIYLLNSDAVVGLIFKVAAYT
YGPLLGLYSFGLFMKTKTVNDRFVPIICILAPGITFLISSYSTELFGNYQFAEELIILNG
GLTFLGLLLISKKATTQTRF
>LONDMIMF_01746 ATP-dependent RecD-like DNA helicase
MTLRETFSKYTLTSGQSSLIDELEKFFSDQTPCFLLKGYAGTGKTFLMKGLTDFLLQSKR
NFVIAAPTGRAAKVISQKTKHKACTIHKTIYSSKELKEFKTKDEDGTETFKFYFEVRISE
DPTNTVYIIDEASMISNVYSESEFFRFGSGFLLKDLIRYINFENNDHSKKIIFIGDNAQL
PPVNMNFSPALDGRYLQENCGLVSNEFELSEVVRQKADGGILHNATKIRQSLKENIFNKL
DIETGFKDINKTKYEELLPKYLQACNNKIDEETIIIAYSNSAVKGYNDFVRNHFFPNQKT
ITVGDKVILLSNNYNYPQMELLNGDIGFVVEVSPTTESRTIPLKRKNSKNIVEEINVPLT
FRNVTITFSDENFRKHDIECKIIENLLYSHHRDLSSDELKALYIDFKIRNKNLKIGTQPF
KDALRSDKYFNALRIKFGYAITCHKAQGGEWENTFLNCKTSMGYFNSSYFRWLYTGITRA
KENLFTLDEPHFSIVSNIQPPKIENIKPREDILALNTEIAEIELPFDFSNQTTFLKNIYL
TISEYLKDENINISDIRHTSYLEHYTFSQGTENAIFKIHYNGQNKITRIEKPTNSTEFIE
SVYSKLANLQNKTIIIAEPETTETEFEFEQAFQKEFYENLKAKLEPFNFQIAKIEHKQYH
EIYEIKKNGFTATYKFWYDGNFRFKKTELIPTRTTGLAEEINELLLEKAS
>LONDMIMF_01747 hypothetical protein
MDSKTVFELRKEAQNLSGIEKLNKLNNALNISRNLYLEDSSDEWIQKAFAWVLIDLCKYY
LAERNLIQAGVCYNELITIDFQGYDDDIIENQKNFLRPKIDTNYSEVQKAEELSKSGNNK
EALEIFKNLIAQNRLTELHHESYGWVIYRYIKAEESNLSSVEVRTFFRDYMNLKNERPSM
LHSMILNFALNYSKTHSDFKFYNFFLLWNPDNLRHEDLHDGYKDGKSIPSLISRICREFV
NSNTEINIEEFISKIDLSKETVLDFFRETIFWNIFNAHKENNFFELWNLFEQYNNNYSKH
GQSKWHSEILNLAERFMKENDEWHFLNFFKNWNPENLRNDDWKETKKDEHTYKPLATKAL
KKTFEILKTQTSEQDLSWLIKPYETAIKLFPDDEWLLREKALLHFKNNELELAIKIYKQL
VLELSNKHYVWQEFSDCIISDNSLKIGMLSKALSLEKNEDFLGDIHLDLAKALIDENLLE
NALVELEAYKKHREIKGWKLSSLFDELHENASSIKQSLKDNRELYKKYIPFAENFAYADF
DWTELVLVDKWKDDKGKDRLTFTDGKTIDFAIIKNRFDVLKQLELGQAFKFKLYKQEIKK
EVESKFAWMGKTIVSEFKHIPLIAEKSEKKHWEILEDTFAIVDYINKEKNIIHAITTQNK
EVFFSQIKPELQIGDFVTAKSYIKKGKDENRTELRQIQKIDKGSVISKFKTQIAIIDGVN
EQKQLFHFVISPKLQGIVKFTETNLRPSEGDFVKLSFATKTDKDKKLRMKILSIELTDEA
NPNLRKDITGIIEMKYKNYDEEVPDFAFIGDYYVPKYLLEKHNITDDCRVNARAIYAGDK
WKVTEIERV
>LONDMIMF_01748 hypothetical protein
MADNKLQSLTEIFNQKVFRIPDFQRGYSWEEDQLEDFWEDVINLKEEKVHYTGLLTVEPI
DKKSVQKIEKWQDDLWLLEKGLSAYYIVDGQQRLTTSIILINEILRNFKDDEGINFDTKE
FWVSKFLYKEFGADYKSYIFGYEKDNPSDEYFKTKILEQHSSSADKVPEQTLYTSNLKFA
RTFFDKKLKKLEKEEIENIFKKLVNRLKFNFYEIDEELDVYVTFETMNNRGKSLSNLELL
KNRLIYLSTLLPDDIATRTRLRKDINEVWKTIYEFLGKDKDNPLDDDYFLYNHWIMYFKY
DRSKSDAYAHFLLHEKFTAKAVIKGELDLQVIKEYIDSLSESVKAWFYLYNVSYSSYSEE
TKEWVQKLDRLGMGAFPPLFMAAMTKENDEKKLIYLFKAAEKFIFLVFRLSQRPSNTKNS
HFYRLAHMYYFDQDHWGQGPTDVEKVIGNINWHTEGHNSEDEYVGWFDLWKFESYIKELA
QKEEGYYSWNGLRYFLYEYELYLTDRAKGNTKVTWTDFNKRKKEDTIEHIYPQTPKDECW
KVAFKESDKKQKKALLNSLGNLLLLGQSKNSELQNKCFDFKKKHKNSKGDEVGFFNGSYS
EISVASYKDWTAKEIRERGLKMLDFLEERWSVDIADWEIEKIDLLNLNFEGKAE
>LONDMIMF_01749 Fumarate and nitrate reduction regulatory protein
MNERLLNNIQTKIKLTTKEIETLQTFWKQKRLAKNEYLVRNGEVCKYDSFVISGSFKAFY
IHPETGKEEILFFAIEDWWATDLDSFANQTPSIYDIQALEESLVQQISYPSFEKLLLTIP
KFERYFRIILQGYTASIQKRITLTNAHSAEERYHNFIEKYPKMVQKIPQYLIASYLGITP
EFLSKLRSKNLRSLLNID
>LONDMIMF_01750 FMN-dependent NADH-azoreductase 1
MRKVLVINSSTREQKSHSRALTKLFVETWSKKYPEDTYHYREVGLTPVPHITNEWIGASF
TKVENRTEENQKPLELSNILVKELKESDVYVIGVPMYNWSIPSGLKAYIDHIMRINETWK
FRSGEPDGDYVGLLENKKLFILSSRGDNGYAEGEHNAHMNFQTNYLRTIFNILGLQDVEI
ISLDNEEYGGELFAKSQQEIHNQILRIK
>LONDMIMF_01751 hypothetical protein
MKSFFQALTLGILAGMASLITFLSDLPTWILFLGWTSYFLFGQKTKSFFYVYTQQLIGVL
LAILIIYLGNFLSERLGSQWFHCSVFVILFSVFYVTKLKVFNDLTAYFLGMIIWFGLATD
PTLEKILIVAVTLFTGFLSGWINLNLNKRIETKLK
>LONDMIMF_01752 hypothetical protein
MNNQVFDRYKNLFEERCGKIRLLDLGEDSVRYDFFIALSEIENLNPCDIQLEYSIHKSAF
KERLNKNSKRKEKPQIDLVVETEKGKLNFEFGLFRQNSNE
>LONDMIMF_01753 hypothetical protein
MVRLAVDSHFTKRESYFICVADDKMLGHQLQSKILGKFPSDYEINKELIKKQKEKKTSDF
DDRFLAVFNELDLTIKSKIVFNQKVEAKLINRETKIIIWNVKTEQRQKGSH
>LONDMIMF_01754 hypothetical protein
MTITKTEIPKNSLLKTNNMTYDYTDSFQGNFDDKFQNIGITEVGKSFFSSGPKWVDKLFG
FRNKLVRLFGLKTSGKVTDRQKMLDNFKGEKGEQIGLFKVFDKTDNEIILGEDDKHLNFR
VSLFIKKQNETKTDKKLIISTTVKFNNWFGRLYFLPVRPFHKLIVPTMLKGILKDIEQQN
LK
>LONDMIMF_01755 hypothetical protein
MSRTNTVIGILAGAAIGAAVGILFAPDKGQKTRKKIKDGFDHQKDELQNKFNQLSDQVKS
KFSRAKVDLESGFDELVANAQDTKEDVIAALEKKLADLKAQATAASKK
>LONDMIMF_01756 hypothetical protein
MAFEKIKENTDELQDRAKEFLDANIAYYKLWGFKIAMKSTTLMLKLFLLSVMLVIVTLFF
SIALALAIGYGLDNFAYGFLIVGAIYLVLAILVYYIQDKIVEGPILRTFSRLFFKKY
>LONDMIMF_01757 hypothetical protein
MQVKSYSSYEEINRELQILKVEKDLAYEKMNKSFHETKDSFTAKNILGTVPGIALSIIGS
LSGPLKNVGIAYLTKKIFRL
>LONDMIMF_01758 Modulator of FtsH protease HflK
MDLNIPLYVFLFFALFIFFSSFFTVKQQTAAIIERFGKYQSIRHSGLQLKIPIVDKIAGK
INLKIQQLDVIIETKTKENVFVKMKVSVQFKVIQDKVYEAFYKLEYPHDQITSYVFDVVR
AEVPKLKLDDVFERKDDIAIAVKRELNEAMTTYGYDIINTLITDIDPDIQVKNAMNRINA
ADREKSAAEYEAEAGRIRIVAKAKAEAESKRLQGQGIADQRREIARGLVESVDVLNKVGI
NSQEASALIVVTQHYDTLQAIGADANSNLILLPNSPQAGSDMLNNMVASFTASNQVGEAM
KRAKAFDKTEKKSTPKPPTPPHLPESGDVEGYDSTK
>LONDMIMF_01759 Glutamate--tRNA ligase
MSRPIRVRFAPSPTGPLHIGGVRTALFNYLFAKKHGGVFYLRVEDTDQNRFVPGAEAYIL
EALEWLGIAPDETVGKNEKFGPYRQSERKHLYKEYADQLVQSGWAYYAFDTAEDLDQLRK
NEEEQGKTFIYNHGNREQLDNSLTNSAEKTAQRIANCEEYVIRFKTPVNEILHLNDMIRG
EVKFDTNLLDDKVLFKGDGMPTYHLANIVDDHLMETSHVIRGEEWLPSLPLHVLLYRAFN
WEAPEFAHLPLILKPVGNGKLSKRDGDKLGFPVFPLEWKDPSSGEISSGYREKGFLPEAV
INFLALLGWSSGTDQELFTLDELITAFDLERVHKAGAKFDPDKNKWFNHQYIQRADNNDL
AQQLSHVLLEKGINKPIEFLTEVVRLVKERATFASELWEVSEFFFLAPTSYDEKAAKNWK
PETAELMEKLISVLENTLDFSTENVENTVKTWMTENEIGMGKIMQPLRLSLVGSLKGPHL
FDIMSMIGKEETIARIRKAVDSLK
>LONDMIMF_01760 hypothetical protein
MENKTLIYDKLEAFIKKYYANELLKGLIFFIGLGLLYLLFTLFVEYFLWLKPTGRTILFW
AFIAVEVFLLFRFIMFPIFKLFKLQKGIDYEEASAIIGSHFSEVNDKLKNFLQLSNDNNQ
SELLLASIDQKAQTLNPIPFGNAINFKGNIKFLPWAIIPILFFAFFMISGNSDMITQSFN
RVVRYNERFSPPAPFAFEIINPSLQTEQGNDFVLQIKSQGKVVPENAMIYIDGESYFMES
TKPGFFEYKFTRPSKNIRFHIEANQVTTKDFELAVVAVPTIANFEMVLNFPSYLNKKSET
IQGSGNAIVPEGTKVTWKVATLATKSVEWSDLKTITPFSSNENTFQITKSIFQNTDYQIL
TSNAKVKHYEKLNYQISVIKDQFPTIAVNNAPDSLKLNQNVIVGQVSDDNGLSKLQIVFY
SKNKTNEAKKMALPVKKDVFDQFIFTFPGQLPVEEGVSYEYYFEVFDNDALHGFKSTKSS
VFSDRLATVEEKEEQNLQQQNDNINSLEKSIKNQDKQLSEIDKLQKLGKEKTNLEFKDQQ
KVNDFIQRQKQQEQMMKEFSKKMEDNLDKFKTDKKDEFKEELKERLEKAEKEIEKNEKLL
DELQKLSEKLREEELFEKIDKFKQSSKNQTKNLEQLVELTKKYYVEKKAEQLAEKLDKLS
EKQEALSNKDKENSVENQEDINKEFEKIQKELDQLEKDNEQLKKPIDLPKDEQTEKSIGE
DLKKASDELKKDQKAKAKPKQKSAAQKMKQMSGAMMESMGSGEMEQLEEDVKMLRQILDN
LLAYSFSQEDLMKNFKGLKKGSLSFNKNLKIQQDLKQQFKHVDDSLFAMSLRNPKLGENI
TTEIGNVHYNVDKALETLSDAQIQKGVSHQQYAVASSNKLADFLSEILNSMQMQMQMSGS
GAGKPKQGQGQGMQLPDIIEKQKGLGEKMKEGMKKGEKPGEGNEGKDGKPGKEGKGKNSK
SGNKEGEGGEDGEGNAGEILEIYKEQQRLREALQKALEKEGMGGSGQNALNQMKQIEKDL
LNKGFKNETLQKMLNLKHELLKLDNAIQQQGEEKKRQSQTNKKEYNNQTNAISPALKQYL
NSIEILNRQTLPLRPNFNQKVQEYFRKDD
>LONDMIMF_01761 Endoribonuclease YbeY
MISFNYETEFELPNENEIEKWLSEVIVSESKKEGDINYIFCDDEYLHEINVKYLDHDTLT
DIISFDYSIGNELHGDIFVSVERVADNAKDFNVSFDEELKRVLAHGILHFAGYKDKSEED
ELLMRSKEDEKIAMFHVKQ
>LONDMIMF_01762 tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG
MFQETYDVIVVGAGHAGSEAAAAAANLGSKTLLVTMSLQNIAQMSCNPAMGGIAKGQIVR
EIDALGGYSGIVSDKTAIQFKMLNKSKGPAMWSPRVQSDRMRFAEEWRLMLERTPNLDFY
QEMVKGLIIEDGKIKGIKTSLGIEIKAKSVVLTNGTFLNGLIHIGEKQFGGGRAGEGAAY
GITEDLVRAGFTSGRMKTGTPPRVDGRSLDYSKMEEQPGDVNPDKFSYSDETKPLVHQKS
CYMTYTSLQVHDLLREGFDRSPMFNGRIKSLGPRYCPSIEDKINRFADKERHQLFVEPEG
WNTVEVYVNGFSTSLPEEVQFKALRSVVGFENVKFFRPGYAIEYDYFPPTQLKHTLETKL
VEGLYFAGQINGTTGYEEAASQGLMAGINAHLKVHEKDPLILRRDEAYIGVLIDDLITKG
TEEPYRMFTSRAEYRTLLRQDNADFRLTPKSFEIGLASESRMRRMEKKLNESEAMVNFFK
ETSVTVAETNPILEEKGSALISQPDKMFKVFSRPQIDLEDILKFEKVAQYVQDNNLDKEV
LEQAEIQVKYSGYIEKEKNNADKLTRLEDVKIPESFDYDKIKSLSHEAREKFKKIRPVTL
SQASRISGVSPSDISVLLIHMGR
>LONDMIMF_01763 hypothetical protein
MFHVERSTQNRIIKGVVSILLIIFVLQSCIGTKQAFMIDDYYISENGKEVLGTKPLNAFI
FENNLKNLPFEQFLAIKYKLDNYLTREFWITIDGDKYKLIVYENSEFDKYFGFSNFAVQN
QENIANIVGGQPKFIAISMINEFNEDCLSNKSMFQNKVTAYLKNLKDEYIQFKQ
>LONDMIMF_01764 Demethylmenaquinone methyltransferase
MTSTNHKHYQTVKDNSVSKEVFELLHDEDLDMLITSPQPKGTELSKYYESDDYISHTDSK
RSIFEKAYHFIKNIALKNKLSLVNSLQKKGKLLDIGAGTGDFLLTAKNDGWNVIGVEPSE
KARSIAAKKGIELKPVADFDDHSFDIITMWHVLEHVPDLQNQIKELKRLLKPNGAIIIAV
PNFKSYDAKYYGKFWAAYDTPRHLWHFSKTAIKKLFQNENIELVKILPMKFDSFYVSLLS
EKYKTGKMNFIKAFFIGLKSNWKAKEKFEYSSHIYVLKNAKN
>LONDMIMF_01765 hypothetical protein
MKKSIVAIAIAISLFSCNKAEEKSTSEKTAYIDTVKLMEEYTESKDLQAKFEEKSKVMGR
ELELEIKKFQEEADNFRRNAQANGPEWAQRKGSELQKKEQQLTYAQQAMSQQLQKEAAVE
RDSVVSKVRKYIKDYGKKNGYSYIYGTGDAATVLYAKEGYDITDKIVKELNDNYKAPEKT
ETKDTAKTEEKK
>LONDMIMF_01766 RecBCD enzyme subunit RecD
MQPISEAASYTLKFINQTQRSLFLTGKAGTGKTTLLREIIQSTHKNTVVVAPTGIAALNA
GGVTIHSMFQLPFAGFIPEYNKTPHFSDTIKFETKDTLKRHFKMNGTKKSVILNMELLII
DEVSMLRADLLDAIDFTMRSIRRKELPFGGAQVLFIGDLLQLPPVVKNEEWEVLKNYYRG
KFFFHSHVMQQYPPLYIELSKIFRQTDDKFISILNNLRNNQVDAEDIKNLNQYVKPDFDL
KQNKGYITLTTHNAKADAINEQSLVDLQEKQLTFLPEIIGDFPEKIYPVDERLNLKVGAQ
IMFVKNDLSLEKNYFNGKMGIVKSLSEQEILVHFPDENKTIEVERYEWQNIRYSVDPNTK
EIVEDVLGTFTHYPIKLAWAITVHKSQGLTFDKAVLDVSQVFLPGQAYVALSRLRSLEGL
ILLSPLQMNGISNDYDVMQYSNNKASEELLQSSLEKETLNFIHNYLKNSFDWKELAQEWR
NHQYSYNEDAEKSEKSKHMQWAKRQAESIGALTEPATKFMRQLDKLFFDEAHDIQFVLER
IQAAHDYFLKPMDQLVYEILWKLEEVKRVKKAKTFFQELYALEELQTKAVLRLMKAKRLI
EIVASGQEICKENLDSQEIKSYKSKKLDAIREEFKNTHATLVDDDYDEERYMPKKKEKKL
PKKSTVEETHELWQQNNSIPEIAGLRKLTQQTIVTHFVKLIQSGQVALSDILPEGVIQDL
AEAFEGYNEESLNGLKEKYGNKFTWDELKLFRASQQ
>LONDMIMF_01767 hypothetical protein
MNNTASILILVFLAVTFLQSGYDKVIDWQGNVGWLKGHFEKTFIKNSVPQSLMLILVLEI
AAGILCVAGIIQMLMNKGTTFGFYGSVVSAVTLIFLLFGQRIAKDYDGARTIAIYFVPAI
LGVFFMQ
>LONDMIMF_01768 DNA polymerase III subunit gamma/tau
MLFSEILGQEHIKSHLTKSADAGRIPHAQLFVGPEGCGTLPMALAYAQYVLCRNSGGENQ
GENEACNLKFNNISHPDLHFIYPTVSTDDVKSKPKSLDFIADWRSFLMERPYGGLFDWYK
YLGVQNKQGLIRVEDAQEVLKSLSLKSYEGGYKIMIVWMADKMNIEASNKLLKILEEPPE
KTLFILISEDEESIIQTIRSRCQVLHFNGIHENIIADALVSRENIDPREARKIAHQAQGN
FSKALHLLHEDSEEQPFEQWFVLWVRAAFRAKGNASAINDLIAWSEQIAGLGREAQKKFL
HFCIEMFRQALLLNYQASSLVYMEPKVEKFKLENFAPFVNGNNINDIYKELSDAVYHIER
NGNAKIILTDLSIKLTRLIHKK
>LONDMIMF_01769 hypothetical protein
MKHSFLFDLDARYIVVFLFFAMLLAINVGYRFGVKKTKTDSDNSGILSSLLGLLALILAF
TFGMSGSRFETRKASLIDEANCIGTAILRADTYPDSLKNVFKKDFAVYLSSRIAYFESDR
NEEKINISLRESAEISQTLWNRATQYSRDKDLFLPSNMMIPALNSMFDAATTANEAYNAN
VPEPIVYLLLFFSIIISFYIGYSSGFKKKIDRFYILGFCLLTSVVIYITLDLDRPRRGSI
NMQNEMFLFNDLKGNL
>LONDMIMF_01770 Phosphoglycerate kinase
MKTLNDFNFKNRKALIRVDFNVPLDENFKVVDATRIEAAKPTIDKILADGGSVILMSHLG
RPKAKEPKYSLEHILEKTAEVLGKEVKFANDCIGPVAEEAAKNLKPGEILLLENLRYYPE
EEAGDVEFSKKLASLGDIYVNDAFGTAHRAHASTTIIAQFFPNDKCFGTLLAKEIESLNK
VLKHSEKPVTAVLGGSKVSSKITVIENILDKIDHMIIGGGMTFTFIKALGGKIGDSICED
DKMDLALEILKKAKEKNVEIHLPVDVVAANAFSNDAETKITDVKNIPDGWQGLDAGPKSL
EDFKKVILNSKTILWNGPLGVFEMEKFSHGTIALGEFIAEATQKGAFSLVGGGDSVAAVK
QFGLEPKMSYVSTGGGAMLEMLEGKSLPGIDAIIS
>LONDMIMF_01771 Membrane-bound lytic murein transglycosylase D
MNKTKIALFLVPFFSLNIFAQDAVSQEVAPQITAPKLSVLDSIKNTFVDHEVASCVDKEW
MDELTNQDLFKEMEFDIAHMNPDEKVDYDLSTDLLKARLKEMDAKSPFNIEYNQGLENII
KSFLKNRKKSYERLMAISEYYFPMFEAALAKYDVPLEIKYLAVVESALNPHARSRVGATG
LWQFMFATGKQYNLDVSSYIDERSDPLKATEAACQYLSNMFKIFGDWDLVLASYNAGPGN
VSKAIRRSGGQQNYWNIRKNLPKETQGYVPAFLATMYIYEYHKEHGIEPKRAAISYFATD
TVMIKREMSFKQISDLLDIPESQIKLLNPGYKLDVIPFVKGKNHYLRLPLPKIAVFTSNE
DKIYAYAQIEENKKEKPYFSRKATSPTGNTNETAIASSEARSPYIDYSEEPEIVKGSKIV
TKTKYHTVKKGDNIGEISQKYGVSVAEIKKWNRLKNNNVMLGAKLKIQTSERVATTVVKK
TPKPAAKTKDTTETALAAVEKQEAKTKEVATDDTENKEDDKSEFYVVQKGDNLNSIARKY
GVTVAEIKEWNNLEDANVLSGSKLKLIPNENAPVIETKAEKAQQQIASSAKVHQYLVQKG
DSLFSIAKKYPGVTVENIKKWNDIRSENIKPGMKLKIQG
>LONDMIMF_01772 hypothetical protein
MKKLLLLLYLAAFSFSCNQKEVKNSDKQSIGNTNSLAVFIDDKLWIGEIGDTIRKKFAAP
VDGLPQEEPLFTINQYPLHAFEGSLAKNRNILYIKKEARNDFNFSENQFGVPQNLIRISG
NSTASIIGHLEKNAAEIIARMQQTEIEVTQNQIKASLMDDKKFRNKFNISLLVPKTFKVV
LEKDKFLWLKQEIQTGNSSILIYQVPLHSIKKNDDAINNIVRARDSIGGLYIHGTTQNSQ
MITEDSYSPYLINTTIGGLKAYQTKGNWELRNDTMSGPFINYSIIDAKNNRILVIEGFCY
APSTPQRDLMHELESIIKSISFL
>LONDMIMF_01773 Acetyltransferase
MSLIWKIKPFKALSLDELYNLLELRTEVFIVEQNCVYQDIDGKDRKAIHLIGEFDGETVA
YCRLFNAGDYFDESSIGRVIVKEKYRDRKWGHDLIREAIKAIKENFDEEKITISAQLYLK
KFYESHGFSQTSEEYLEDGIPHIEMKRS
>LONDMIMF_01774 Photosystem I P700 chlorophyll a apoprotein A2
MLRILKILPLLIFGFVSAQEEVVHSVYFDTNKYNLTENQVEDVTKFIQSTDSVRIESISI
YGYCDDRGKDEYNFKLSSNRANAIKEKLVENGIRSKIIVTIEGRGRVLIEDDIDNISEVR
SKNRRVDVVMNFKEIPIEKLEIPGVYSEIHKNHVVGDRIYLEKLLFEKGSSKLTMKSKNE
LDRMARQLLKYKNLEFEIQGHVCCTPPYHKEAIDKDTKKRKLSVNRAEAVYKYLVFKKVP
KTRMTFKGYGNTQPLGKGSDLDRRVELVITKV
>LONDMIMF_01775 putative CtpA-like serine protease
MYAFLKKRYIIPVVAGGLLYVGASFRNDFFEIAKQIEIFTTMFKTVNMNYVDETNPGELM
DKAIKNMLMELDPYTVYFNEQDVVKFKINNTGEYTGIGAMITRKEGKLIIKEPYKNYPAD
KAGLKAGDEIVQIGDVNLSDFKDDASQLLKGSKNAKIDIKYLRQGKTNNTTLVLEEVELK
AVPFFSKIDDKTGYIVLSQFNAKASQETKQALEKLKAEGAEKIILDLRGNPGGLLGEAVN
ICNLFVPSGETIVTTKSHIEKHNNTYRTSRAPVDTEIPLVILVDGKSASASEIVAGALQD
LDRAVVVGARSFGKGLVQRPIDLTYGTQVKVTISRYYTPSGRCIQALDYAHKDKDGKAIR
TDEKNYNAFKTRKGRTVYDGGGIQPDVELSETKLSAITEALVKNDGIFNYVTRYYYKNPS
LGDKIPTITDADYADFKKFLKDQKFAFDTETEQAMKKTLEAAKKEKIDEDIKNEVQQLLT
ALQKSDETQLNKHQAEIKELILDEIIKRYQYKEGLYQYYTKNNSEIKKATALLNNPAEYN
KILLR
>LONDMIMF_01776 Ribonuclease P protein component
MNTYPKTEKLKSRTTIDSMFREGKSVSKFPLRLVYKKQAFDEGQKLKIGVSVSKKYFKKA
VDRNYFKRVLRETYRLNKNLLLDSLEESYAFMLLYQTKERLSYEDINHKTIQLFEKFRLQ
VKPEIEKDKD
>LONDMIMF_01777 hypothetical protein
MKALKMLAVLFFLLIGTQQTFAQKYRFKTSSYSVMEQNAKGQWGKWSDFKDTNLIIVLDG
DKNRIVINSAQTQLYYIDAYGKTIENETDKTVTFNCIDNSGNRCVIEIITRKKQGNRIQF
YINYPDLKIVYNIYP
>LONDMIMF_01778 hypothetical protein
MKKLILSAIMLTGVVAFAQETPKKATKEVVKNAASSIEAEKKAEAPKVTEVKQEAEVAKK
AETTTTKTTEAVQPAAPAVKTAKKQE
>LONDMIMF_01779 hypothetical protein
MSKKIKILSLDGGGIRGIITCVILKYIEEQLQKLDNPNAKIGDYFDLIAGTSTGGILASI
LLYPDSNKKAKYSVETALDLYAKHGESIFNVSFWQQLINPFGLFNERISQKALERQLENV
FGNLEIKDFIKPCLITSYDIFHRKAKFFTSHETGSDLENFYAKDICRATSAAPTYFEPAN
IKSLYGQEFTLIDGGVYANNPALCAYAEARKIEFSKVLNQPGKKDFPKISDMIIVSIGTG
QVLKPYTYRQFENAGKVKWVQPLIDILLSSNVETTDYHLKKMYETLGSRNRQNYHRLMPS
LKNASPEMDDVSSKNIYELIQAGLSYIDQNRKELNEIAKKLIKNS
>LONDMIMF_01780 hypothetical protein
MDIEKLLKQLKQELVTLLGDKYKEFKPEIQKDITAFLESSKEKLERWTSLLASSSITEEE
FSWLLKSQQDLIALKALQGAGLSKIKMNNIKNAIIQTVFKTVLLSI
>LONDMIMF_01781 hypothetical protein
MKTIGKNMMLFFFLSFAAISCESTRTAVFDQHSYQKTTELKVEASKLMDKATAPYAKHQQ
ETEAFFLQVEKLIEYEKNKPDNEITFAMWKLLTDEEKNLLSGFFKRWKEKESLSPVFLQE
SKKQVMEAMDMLIQYEIKKDKTSKDGLLSLINSNK
>LONDMIMF_01782 Peptidoglycan L-alanyl-D-glutamate endopeptidase CwlK
MDKYTKQRIEKLHPTVREEVTKVIEECDNALTGRAKIRVTQGLRTFEEQDALYAQGRTKP
GKKVTNAKAGQSIHNYGFAVDICLIIDGKDASWDTKKDWDNDKVADWYECVKIFAKHGWE
WGGNWKTFKDMPHFEKRNLSWRSLSKLKKDKNGYVILK
>LONDMIMF_01783 hypothetical protein
MRNKIIVSLEHRDKEQVLKKIIEFGKKNKFEIIPKEKTLSLGDMGLNKGIDNDNIYIEFS
ITDKDEFKTQHISNSSVINGKRYYFYIWVDHTKNVETYHSMNKFFNEILSDYPDMLVTDE
TCKNFYSFEQIKNKQVPEWLLV
>LONDMIMF_01784 hypothetical protein
MIREKQIVFDGQTWSWTNPKNTTLKWSGLSKEVIIKNIDNILIKGDPTAVFEASVAKKIL
ELVENTADEITDFSNKVLNKITSMHIGDIDCATKKYIIEAKTNLGSEKAIQKLNIQIQKY
LPQNIKSTEGFMNPMGKKVVVVYDDLGTFTLSHPILRELEGKGVIFIKGIDNLKKLY
>LONDMIMF_01785 hypothetical protein
MSRIKFIVSEKYVERMEILKEIENFGKQNNYNISKKNDIFNEEEIIMWREDVFQLEFLIK
NKANFKDDISNSSIIKNKRYYNLIIIDYYGDSLPYFNQFVKYFLALHPDMLVADEAYKDF
YSYEEIKNKQVPEWLLI
>LONDMIMF_01786 hypothetical protein
MIREKQIAFDGQTWSWTNPNNTKLRWSGLSKEIIIKNIDNALINAKENGKLFEAKVAKRI
SELVKNVADEITDFSNEVRDMISKLSNGDIDCATKKYIIEAKSELKNIDSIRKLYKQLQK
YLPQNINSSEMYMNPLNKKVVVVFENMGTYTLDHPILKELQNKGVIFIKGIDNLSKLY
>LONDMIMF_01787 hypothetical protein
MFTKEQAKAKMQDFIDFQNNLFIWNDGYNPEIVIYEDLTQEKDFGWIFYWQVKNVKEDYS
NVIVGNGPIIIEKKTLDMYEMGTGLDPEEYIKMYLKDKNQLAKLEKNDDGVWDIVNLD
>LONDMIMF_01788 hypothetical protein
MTIEYLKKLKENLKIGSEKSRGVSINEIEKVEKKFGIIFPTAYKEFLYLAGEYSGNLMIL
DTDDLETISSDWHQEIMWEELQDTGTKIDRPFWLFAESNGCEIFYFFYLDEEKSDPVVHM
VNYAQEDRKRNVRSLEISFSEFISEMIDLAYRYEKNGY
>LONDMIMF_01789 hypothetical protein
MINAFRVSLDDQKIKLEYPYGQLSVEKYYNSIEDLIISIKHTFPLT
>LONDMIMF_01790 hypothetical protein
MKYQFKKEITNPPRNSSARPLVEFGVKVFDKNIEALEQIEWHGWTPSEVQMIIDKSKALR
GNQVYNYQVSGSDLSIHIYPEEVYFFDWRTEREEEDFKWSFNEFIDFMEQFKKFIKENS
>LONDMIMF_01791 hypothetical protein
MRATEYGLLHYGNYSFTDIKSNIYAFNNEISIINDETDENQSSAYTEIIYVEVEPNDENS
NEFRLAKNGEILDYREGNYILNSNVIPATEVSGSATVFLQTLSIQARICKFGEKYFAFVT
KNMAGAVAWETFLGGVEIAATQMKKKKREKITLLNDILTEKQLSVVLFISKDGALLETAY
QSIDNLYGNEIVLFIETNDSMNLFGSVIRIKTGANVTSSSGIPYKKLSKVVDHFNTNVSS
SALLEIIKQHIADKSSGFFLVKRAFWGAVNRVVRFSSDLTLEGIGKISDGIGELVGKLKL
DDSQWQYYDDNGLPLKNANLFLPGLGGIKYLQEANKKSRPEETNAKAINKITELEKILKE
SKKTLGKADFFKKIINQLLYMLRKVKDFLRDPLGKALDFAETTFVIYNAFVVGIINSIVD
AIKGIFDIISILCNALAALQKKGRDIGQNPLSYLRLFFEIIENMVETLENLFSKENLKAL
IEFFTKSAAFILTLPTRAFVWLAENAAMPNLDKVAYYYGYIIGFIIQLILEILFTGGAKT
AADAFKKLADSLINIFKTMEKIVFKFSDELVIGFENLLAIFAYIREKSKNLRVLLEYLFR
WLNELFAGVKSKVVLSRGLTYSFVDPVTVFAQFFYNLVRKKWWAQLHEIGVAIAKNEEGL
YTFIYKNEEIANGLSKSEVENYLKELFSKTKKSVDETTEYLDNLTEIIKLRKAAYTKWVS
KFDKKFHAHFDGEFKIERVSNRDGSQIIKGTGGHNYSVVGKNIQIRRELTSPVIDNMPFD
TLIEVRYKNDQWIEKTAKSTMFPKNWSIQRVKEEIALVYEEMIKSEKFNELTIRKSPSYK
GLDSSGNFWIKIEFDEIGNLTNAHPLI
>LONDMIMF_01792 hypothetical protein
MSTQIKNTLFRFMTMRAPELTGDEKTKTHFAQLIDVSEHLASHFIVGIKQNTGISKKALL
QNLATNFESQSLKSKQEISDAVSDPVLKFSEWLTRNRNSLTEDNLLQNMPSDITSFDLNT
RVRIWDNLFYQIISQKSPYLRESLLSLLVTDLFLKNEKLPFEELKEVAKARIIIPKIFFE
NETEFVPPVKGEPRSIPVNSKALDKKLDLFLAEQKISRYQETIKELNAIQKSYNKSTQLA
RENAYKQYEQDVKDIYASAQTVEKKYTDKDLGIEKTLVEYVGVTVPPFEFDANSEIDFAL
SSPNISAFTESVILNLSNDFGTLTGIIGAIEGGIIDESNTLIQQNPGNQEIVNNGGILTP
INTNTIGLGNVFSFVGQNHLGKSTLTFLFNNAPQGADVIGASYNAKFQNGTTVSGTSFED
TWVDDKLQVTLFKEKLDYSVATNFTVDGELLLSNNTAIQFTGRGVLGGGGIISGIIQELK
VSGNGSYKIVDVYDENTPGQPDTTPVLEPVRTFGFRRLGITDYRKVEQEICCYVPGEVSH
IENIMAREFKEKTTRRSRKTEDTTTTSSEQEIEKLTDTSTTERHEMNQEVASVMAKDTSM
GVQAGVHWGSGQGFGGEVNASYANNTSSETSNSQAVMYAKEITERALDRVVQKVKEERTT
KIIEEFSEEDTHGFDNRKGDNHISGVYRWVDKIYKNKVVNYGKRLMYEFMIPEPSSFHNE
VTSGKKDKFTEVLVKPIDPRTATLLALKDSNVMIPNVYKHWAAIYNAEIEAYPDEEITVG
ESFTVLGHPNGAKIADTESNSGNGKIKVPEGYKTTRALGIFNASGANDFQGNILSLSIGN
LTSKNVQAFRQATLTIDGEMKDFEIEVPVSFTLGNHVAGDIVASVKCTLTEKAKQQWRLK
AFNAIIEAYEAKLAEYQEKLTEAKATGEAKAKTNPGFYRQVENTILRKNCIAYMLGHENM
GKNMLLGSNAKDLRVKNDAELDIYTSQVKFLEQAFEWDLMSYHFYPFYWANKEKWAELYN
PNEANDPIFRAFLQSGMARVILTVRPGFEEAVNWFMATGQVWNGGQVPAVDDPLFVSIIK
ELQTQEGEVEETWESRVPTSLTIIQAGSMGLNVVNALPCNSDCDDNTLFDSDGQPILDAE
GNPIKSFVKTDALIGDNSQTA
>LONDMIMF_01793 TonB-dependent receptor SusC
MKNLKFAISLLLLSVSLLSYAQERPQAKKVKITGKITEKSTSQPLGYATVTLQNSKRPDV
ITGGMTDENGVFTIEANAGTYDVKFEFISFKPIEMKQLAIEEDKNFGTVALEAEAEMLDA
VEIRAERSTVEIKLDKKVYNVGQDMIVKGGTISDVLDNVPSVSVDVDGNVSLRGNENVRI
LIDGKPSGLAGINIADALKMLPADAVDKVEVITNPSARYDAEGGAGILNIILKKGKNQGI
NGTVTATTGNPANHGFTGTVNYKTEQFNLFTTQGYSYRKGPGNSMTDTEYLDENGDVTGY
LKERRNNERLNKSYNGVLGLEWYLDKSITWTNTLSYRRSSGENPDNVFQYRYDPAMNLQS
ITNRFSLESDKDENVDFSSNFIKKFKKDGHQLTVDLSFSQSDDDEDADIPSRNVLDGTPI
SEQRTGNIQKQNRSLLQTDYVLPIGENSQFEAGYRGNFNDLLTDYSVENFNYGTGGWEND
PQFTNTLEYKEKVNAFYSQFGTKINRMSYLVGLRWEDSNIDINQLTQNIYKNKKYNNFFP
SAFLTYEFNENSSASLSYSRRISRPRSRSINPFSSLSSNINLFRGNPDLDPSMTDAFDFG
YLNKFGKLTFNTSMYFNRTKDAVQYVRNTEIINGTATLVTSPVNVGSEDRFGFEFTLSYN
PYRWWRLNSNFNLFRNQTKGNYTYTDLSNNSQTIDFSNTAYSWFARINSKINLPLGIDWQ
ANTTYNAPQTNAQGRSKGIISANLAFSKDVLKDKGTIALNVNDLFNSRKRITETNLATQN
AYSEMQWRERQITLSFTYRFNKKKNEREKQPKRMDSDNGGEDYMGG
>LONDMIMF_01794 Arsenate reductase
MIKIYHNPRCGKSREGLSLLEKSGKEFEVIQYLKEVPTAEELKSIIKLLGIPPIELVRQK
EEIWTQNFKGKTLTDEETIKIMAENPILIERPIVVNGKTATIGRPPEKILEIL
>LONDMIMF_01795 hypothetical protein
MFIAQGFKSKGNAFWKYIVGSVIVIAASTIGQFPLMIAIAVKSIEENKDFPTDQAAMLTF
LDSNLTLFLMLISFAFALLALFFVVKFLHRQKFIEVTTSRPKMDWKRFFFAFGLWTAITV
VITVAAYFVSPQDYEVNFQPVPFAILAIIGIALIPIQTSTEEYVFRGYLMQGFALLSKNK
WFPLLMTSVIFGLLHIFNPEVEKMGYIIMIYYIGTGLFLGVLALMDEGIELSLGFHAANN
LIGALLVTSDWTVFQTHSILKDHSEPAAGFDVLLPVFIIFPILLFIFSKKYQWKNWKEKL
TGTIPDNLTTDDTYHSNQFDKNDGEAHIL
>LONDMIMF_01796 2-succinylbenzoate--CoA ligase
MTLTTVINLIKTMEKPTYYDVHNRFKLNGFHLNKDDLCRVAYSFIKEGEAYERPVGIFIL
DWFDEKDYIEMTTSGTTGAPKKIQISKQAMVNSALATGDFFELAPGDKVLHCLPAKYVAG
KMMFVRAFILGLDMDFVEPTSTPLERNEETYDFAAMVPIQAQHSLEKLSQVKKLIIGGAK
VNSALAEELKKIPTAIYETYGMTETITHIAAKRVGEEAFDVLPGITVAEDERHCLVVNAP
AISEEVVVTNDVVKVLNDHQFIWLGRIDNVINSGGIKLFPEQIEEKLSHKIDRRFFIASQ
ENEELGEKLVLAVEGDPYVIDDAAFGELGKYEKPKVVLFIPKFLETPTGKVLRKESLASI
>LONDMIMF_01797 Aminopeptidase N
MKRFFPFFILLCGFQNSLAQEFTRKDSLRGGFSFERICYDVQRYDLNITINPEEKSIRGY
NDITFKTVKNTQKIQVDLFENMKIDSIIFDGRSLEYKREFDAVFITFPKPLAVDGTDKTI
RCYYSGNPQIAKYPPWDGGFVFKTDSKGKPWIGVAVQGTGASLWYPVKDSQSDEPDFGAT
IKVAVPDGLMNVSNGRFKGSENLKNGYTRWDWEVKSPINTYDITVNIADYVHIHDNHNGL
DLDYYVLPENEEKAKKHFEEVKPMLDCFEAKFGKYPFAEDGYKLVETSYLGMEHQSAVAY
GNKYRKGYMGSDISGTGIGLLFDYITIHESGHEWFGNSITSKDIADLWIHEGFTTYSESV
FVECLYGYEKAMEYINGQKKRVSNRSPIIGYYGVNDKGSTDMYYKGALLLNTLRHIVNDD
EKWWKILLKYSETYRHKIIDTQTVIAFFNTETGRNLTPVFEQYLRYKNIPELEVAVKNKE
VKFRWITDVPDFKMPIIIKQGSKEIRLEATNKWKSHSIKNNDPVKFDDYRFLIKITYN
>LONDMIMF_01798 27-O-demethylrifamycin SV methyltransferase
MGNLSEKELQELAGQLSHPNGESGIQTAYSMNIANDNMIRHTIEQIEIMPHSKILEIGPG
NGIHIKYLFEKEANLNYYGIDVSELMIEEALKLNSEFTATERAVFELTDGEKISYPDSFF
NSTFTANTIYFWKNPTEYINEIFRVLQSGGSFILAFIPKEVMEKIPFSKYGFELYDTEKA
KSLLENAGFRIENILSETEEVLSNTGEIKIRTFTIIKAQKP
>LONDMIMF_01799 putative propionyl-CoA carboxylase beta chain 5
MDINFNKNEDHNKLLLSDLKQRFAKVRLGGGEKRIEKLHAEGKMTARERIDYLLDPKKES
IEIGAFVGDGMYAEHGGCPSGGVVVKIGYIKGKQCVVVANDATVKAGAWFPITGKKNLRA
QEIAMENRLPIIYLVDSAGVYLPMQDEIFPDKEHFGRIFRNNAIMSSMGITQIAAVMGSC
VAGGAYLPIMSDEALIVDKTGSIFLAGSYLVKAAIGESIDNETLGGATTHCEISGVTDYK
AKDDKDALDKIKNIVDKIGDYEKAGFNRIQPEKPALSEKEIYGILPKLRTEQYDMMDIIK
RLVDNSEFEAYKEGYGQTIITGYARIDGWAVGIVANQRKVVKSKKGEMQFGGVIYSDSAD
KATRFIANCNQKKIPLVFLQDVTGFMVGSKSEHGGIIKDGAKMVNAVSNSVVPKFTVVVG
NSYGAGNYAMCGKAYDPRLIFAWPSAELAVMGGTQAAKVLMQIEASSLKAKGEVIDEAKE
QELFDKIKAKYDAQVSPYYAASRLWTDAVIDPLETRTWISMGIEAANHAPIEKQFNLGVI
QV
>LONDMIMF_01800 hypothetical protein
MSLNSIFQFLVPKDKKFFPLFEQASQNLILLAETLHEAVNAPKLERENYFRKIEELEAII
EEITHKTHLELSRNFITPFDREDIFALVKSMDDVADYMHGAASRMRLYQVEKITKSIRKL
TEINLEACQHIGIAIKELKDLKNLKAIADACKKINKLESKADNVFDKAVADIFENETDAK
NIIKYKEVLSALESASDKCKSVANVLESVVVKHS
>LONDMIMF_01801 Low-affinity inorganic phosphate transporter 1
MDFTILIVIIVLALIFDYINGFHDAANAIATIVATKVLTPFQAVVWAAFFNFLAYWVFGF
GVADTVAKTANTMEINLTVILAGIIAAICWNLLTWWLGIPSSSSHTLIGGFAGAAIAHAG
FDVVTWYKAASGGGMPSGVIIIIAFIVLAPLLGALASYLISIWLLNSSKKSIYPKLFTGA
LMIATVVFVAYQMIPYDKIKKPRFDSHFWSVVFEAHNIKWFLVAFIILSVSTFCLFFSRM
SHSKSESWLKKMQLLSSAAFSLGHGGNDSQKVMGIIAAAVAVYIHTNGLPQESMPEWLNV
VLPDETGDFHMPSWIPLACYSAIAAGTLSGGWKIVKTMGSKITKVTSFEGVAAETAGALT
LYFTEHLKIPVSTTHTITGSIIGVGLTKRISAVRWGVTVSLIWAWVLTIPISAILAALFY
YVLNMFL
>LONDMIMF_01802 hypothetical protein
MEGEKDLNKLLKSMKPILNEGEYVFCTIKEIGKIDLDSILLLFKEEEGLTVILEKNVADS
QSLDYSFIASWITLTVHSSLEAVGLTAAFSKALSDEKISCNVVAAFYHDHIFVDKDDSSR
AMTILEKFSN
>LONDMIMF_01803 hypothetical protein
MKTRNFIILSILVTNVAMAQLKKVDYKDNAQILSGFSAVPKKALANKPGVLILPAWKGVD
EHSKEIATKLADMGYYAFVTDIYGADKRPKDTKEAGEKSGYYKTNIKEYQNRISLALAEL
VKQGANADNVVVIGYCFGGTGALEAARVNMKVRGVVSFHGGLGKDASREISAIQPKVLVL
HGADDPYISEKEIKDFQNEMRTAKADWQMNYYADAVHAFTEKSAGNDNSKGAAYNELADK
RSWEAMKLFFNEVLK
>LONDMIMF_01804 Alginate biosynthesis sensor protein KinB
MIYKKSISFIPNNEALRLQKLYDYQVLDTHSEDTFDKIALLASQIFNTKNAFVTFVDEHR
VYFKANIGDFQATEVRREDSLCSLAILDEKITVFSDTRAIPDLSENRFVNSQNGIRFYAG
APLKTPEGYSVGTVCVIDSAPKEVTEHQMDMLRTLADIVINKLESRLRYNTIIKSQNELM
GIALHEIKNPLASISLANDILRLDTSKTQKMTDMIKYCVATIQNKLTDLLKLSEDGEKEQ
RLSIEEADLKEMLDRLVNNFELLANKKNQIIELTIEDTLPKINIDKTKISDVLHNLLSNA
IKYSYSNTTIKIIAKKIDDFVEIEFQDQGQGLNDEDADKLFKKFAKLSSKPTGKESSNGL
GLSICKSFVELHKGQIFAKSPGKELGTSFFISLPIIYKQEETEISHH
>LONDMIMF_01805 Peptide chain release factor 2
MLRSKKKWVEDYDKAVSLAEELQLAYEFYREGEMTAEELDEQYNLANTHIENIEFKNMLS
DEGDSLSAVLQITAGAGGTESCDWAQMLMRMYMMWGEKNGYKIKELNFQAGEVAGIKTVT
LEFEGDYSFGYLKGENGVHRLVRISPFDSNGKRHTSFASVYVYPLADDTIEIEINPADIS
WETMRSSGAGGQNVNKVETAVRLRHHPTGIIIENSETRSQLDNKTKAMQLLKSQLYEIEL
KKKQALRDEIEAKKMKIEWGSQIRNYVMHPYKLVKDVRTEQETSDVESVMNGEIDEFLKA
FLMMMGQKEEE
>LONDMIMF_01806 L-allo-threonine aldolase
MEINLVSDTVTKPTNEMLQQMFRSKVGDDVYKQDPTVNELEEMVASIFGMEAALFFPSGT
MANQTAIKLHTNPGEQIICDKWSHIFHYEGGGASFNSGVSCCLVDGKRGMITAEQVRESI
NPPEFYHSPLTSLVSIENTTNKGGGACYEIEELAKIKEVCKENNLKYHLDGARLWNALVA
KRQNPKHFGELFDTISVCLSKGLGAPVGSVLLGSKETMDRALRIRKMLGGGMRQAGYLAG
AGIYALKHNVSRLQEDHNKAKELAYILKQLPWVESVEPVETNILIFAVKPQYNEDVVIEK
LKQKNIFISSLGKGKLRIVTHLDYRDVMHTYVIETLQKLTF
>LONDMIMF_01807 Nucleoid-associated protein
MFGDLMGMMGKLKETQQKIEETKKRLDSVLIDEQSNDGLLKVTLTANRTVKSIEIDDSLL
EDKEQLEDYLVLVMNKAIQKATAVNEAELGAVAKDGMPNIPGMDMFK
>LONDMIMF_01808 Dipeptidyl aminopeptidase BI
MSITIPPPTAKKIPKTLEKHGDKRVDDYFWLNDRQDKEVIDYLNSENQYYEEMTAHTKGL
KNLLFEEMKGRIKEDDSSVPYFFNGYWYITRFETGKDYPIYARKKGSLTAKEEILFDCNE
MAKGHSYFQLGGVSISPDNKYASFGVDIIGRRIYTIQVKNLQTGKLFEDKIENTTGSSTW
ANDNKTLFYTQQDKQTLRSDKVFKHKLGGRQEQDVLVYDEVDDTFNVSVSKEKSKKYIVI
SSSSTLTTEFRTLLADDPDGEFKVFQPRVRGMEYSIAHYGDSFYILTNKDDATNFKLMKT
PEKATSMENWKDLIPHREDVLLEDIEIFKDYLVLGERSNGLNKIRIMPWNGKGEYYLPFD
SETYTANISTNPDFDTQILRYSYQSLGTPSSVIDFNMKTKEKEIKKEQQVLGGKFDKKNY
VEERVWATAEDGTKIPISMIYRKGMKKDGKNPLLLYAYGSYGATMDPYFSSTRLSLLDRG
FIYAIAHIRGGEDMGRLWYENGKLLHKKNTFTDFIDCSKFVIKEKYTSAEHLYAEGGSAG
GLLMGAVVNMAPELYHGVIAQVPFVDVVTTMLDDTIPLTTGEYDEWGNPNEKEYYDYMKS
YSPYDNVKAQNYPNMYVSTGLHDSQVQYWEPAKWVAKLRTLKTDTNLLFLDTNMDAGHGG
ASGRFEALKELAKEFSFLLDLEGIEN
>LONDMIMF_01809 Putative cystathionine beta-synthase
MINYFFMKEEIKAYNNVLELIGNTPLIKLNKVTENIEGNFYAKVEAFNPGHSTKDRIALY
IIEEAERQGILSPGDTIIETTSGNTGFSIAMVSIIKGYNCILAVSSKSSKDKIDMLRSMG
AKVYVCPAHVSADDERSYYNVAKRLHEETKGSVYINQYFNQLNIDAHYQTTGPEIWEQTN
GKITHLVACSGTGGTISGAAKFLKEKNPNIRILGVDAFGSVLKKYHETKEFDSNEIYPYR
IEGLGKNLIPTATDFDSIDKFIKVTDEESAHATREIAKKEGLFVGYTSGAVLQAIKQYAE
EGEFNKDSNVIAIFPDHGSRYMSKVFSDDWMNEQGFFDSVNAEEAQKIEFIK
>LONDMIMF_01810 hypothetical protein
MKKTQFLLLFGLFFIAVANSQTKTESRTVGNFSKVESRGSAKVVLVAGNSNTLTAEGDEK
TLQNLITEVEGNTLKIYIKSTKKLNLKGEVVVKVPIKQLDEVSLSGSGSIKSEISIKSNK
FVASVSGSGKIDLDNVNADAASIKIDGSGKVEMNLNANTADAKINGSGKIELDGRANVFS
AEISGSGSVDASDFTSSTTKAAIHGSGYVKTKTEKDLTADIQGSGVVKYTGNPSIKKNIS
GSGQVTKG
>LONDMIMF_01811 putative transcriptional regulatory protein
MGRAFEFRKNRKMKRWSAMAKAFTRIGKDIVMAVKEGGPNPESNSRLRAVIQNAKAVNMP
KDNVERAIKKATDKDTANYKEVLFEGYAPHGIAILIETATDNNNRTVANIRSYFNKCNGT
LGTQGSVEFMFDHTCNFRIPAEGIDIEEMELEFIDFGAEEIFADEDGILIYAPFESFGAI
QKELENRGIEILSSGFERIPQVTKKLTEDQIADVEKLLEKIEEDDDVQNVYHTMEE
>LONDMIMF_01812 hypothetical protein
MFWKASTLFPIITPLKKTRQSMKKTVLAIFALFAITLAKAQDFRTPVDYLNFIGKESAAI
SRNTWNYTKAVAHSKSARRIDASRKALLKSIQNASKKIAGLKNGYKGDTEYRDQLLSYLS
ISEKYINDEYEKIIDMQEVAEQSYDFMEAYIMARDLVNEKINDEVEKLNANQKLFGNKYN
IQITDDNSDLSKKMRASNAVFKYHTEMFLIFFKVNVTDINLMKSIEQKDLNAIQQHASSL
ELYANEGLEKLKTTVPFNKDASLIAATKKALEFYKKEAIELTPKVVSFLMLNQQVEDTKE
SLDKKPEKNRTKQEIDNFNNLVKSVNNEISEYNKLNSKFYQNKIAVNTEWEQAGEQFISK
HVPKD
>LONDMIMF_01813 Tail-specific protease
MNRILLFLLFIPFVSHSQDSGKSCDVLIKINKLIQHEHFNPKPVDDSLSVYVFETLMNEL
DTDKNIFLKTEYDYLSKYKFKFDDYIAGNDCSFFEDFSKTYKKALERSKTAIEKLQKEKL
DYNTNDTVRFTKKNFPFYVKAEDVSKVFAKRLRFDILEDIAKTSKNYDSLKQNFASLEKK
SREKIFETALCKITNRLDSKEGIEKNIRNSFYSIFCSYFDPHTSYFSYDTKSSFLSELST
DNFSLGMYVSLNENEELIVQEIVPGGPAARTEIIEKGDQVIKVSPKKGEDFLVSCSSLET
IGSIIFSDTHKEITLSMRKKNGTLYDVTLQKKIMKADDHAAYSYIVSKNNTRIGYINIPS
FYTDFDRNTVQGISDDVAKEILKLKKDNIEGLILDLQDDGGGSMEEAIKLSGMFIDAGPI
SVLVNNKKEQKIIKDFNRGVVYNGPIVVLVNGNSASASEFFASVMQDYNRAIIIGATTLG
KASMQQILPIENGNEQDFVKLTIEKFYRITGKSHQLTGVVPDVAIPTLYDGIISREKSSK
TALKNDVIITKAKFIPYSRSDFENLIAQSKKRVSNNAYFNEINAINTKINSIYNSPKDPI
LLNFESVFKDVHSIDAFFDSVKKIVETPIDFEIANTSYEKEILKFDEFQKSISEYRIKDL
KTNAYVLEGINIISDYYATKKN
>LONDMIMF_01814 Aminomethyltransferase
MKNTALTHVHESLGAKMVPFAGYNMPVQYEGVNIEHETVRNGVGVFDVSHMGEFLISGPN
ALALIQKVTTNDASTLTVGKAQYSCLPNENGGIVDDLIVYKMKEDQYLLVVNASNIEKDW
NWISTKNDVGAEMRNISDDYSLLAIQGPKAVEAMQSLTSVDLAAIKYYHFEVGDFAGVPD
VIISATGYTGSGGFEIYAKNENIEQIWNKVFEAGKSYGIKPIGLAARDTLRLEMGFCLYG
NDINDTTSPIEAGLGWITKFNKEFTNSENLLKQKEAGVLRKLVGFELTERGIPRHDYEIV
DKDGNIIGVVTSGTMAPSLNKGIGLGYVTTEFSGVDSEIFIRIRKNDIPAKVVKLPFYKK
>LONDMIMF_01815 hypothetical protein
MKFNIRTTVLFFSVFFSVQLYAQKQVAITIDDIPNTKRFQKDGFQSLLLKKLDSLQLPIA
IFINEGKIYETDSVSMNFRLLENWVKRSYITLGNHSFSHLRYSDAGLTVFANDIDKGEAI
TKELVKKYSKPLKHFRFPFNDLGKDTLQHKEIENYLTQKGYRITPYTVESEDWAYGTVYE
YYLAKNDIANAKSTGEKYVKKTIEFFEFFEMLGTQQYKRPVRHIYLCHDNLLNADYLPKI
VKLLKAKGYTFVSLDEALQDSVYQQQDNYYKKWGVSWLYRWMKSQKEATAIMRKEPGNNE
IERLYKEITKE
>LONDMIMF_01816 hypothetical protein
MKKLIVLGIALLFSGYMSAQETTAKKKAKAEVAQAKADSKKAVEKADAKAKKAEESAKKD
VAKAKEKAVESKTEAKADVAKTKANAKVETAKAKEKAVVTKTEAKADVAKAKADAKVETA
KAKVADKASGEYYNGKKVYTGPKGGKYYINKNGNKTYIDQK
>LONDMIMF_01817 D-alanyl-D-alanine dipeptidase
MRFLQLIVCLIVLSSCKNPQEVVYSDALLSSNREYIDENAAILEAAKANISDTAFVNLRD
YGKDFFYDMKYATEDNFLKTKVYDCAECYLRFKTVKALIKANQAFLKLGYKIKVYDCYRP
LDVQKKMWAIMPNPTYVADPAKGSIHNRGGAVDITLTDYSGNELDMGTGFDHFGPEAAHD
YKNISAEAATNRKILKEIMLKNGFRSFASEWWHYNLMSASTLPVSNFTWDCKN
>LONDMIMF_01818 hypothetical protein
MKRLLILTFLTLQMGVYAQKSCEYSSNFTDSIGSYKETVQKIVYEKNFAGTSSYIFFSLI
NANGTPLLNFQNIQKSKDFIKAYCFDKNSRVYLQLANGKIITMLISDEGSCGSMIRDEAQ
SSNIRISTGAFLFMKNTMEELEKSPITLIRIKYASETVDYIMKKELTSELNGEKSYPENF
FIDHLKCLN
>LONDMIMF_01819 hypothetical protein
MISDILKPEIQNFIEANIRKDISKLALQKNPFPEIDFAVLLNQIAAKGKSEQKLPTWFAA
KNIVYPPKLSIEQTSSEETASCKAAIVSGKSLIDLTGGFGVDSYYFSKKMESVVHCEMNA
ELSDIASHNFKILHASNIECFTGDSSEILQKLNRKFDWMYVDPSRRSDVKGKVFLLKDCL
PNVPELQKFYFEYSDNLLIKTAPILDIAAGLSELSNVKAIHIIAIENEVKELLWEISKDY
TGSITIITLNKTKEKTEKLDFVLGESENAFYGLPKKYLYEPNSSIMKSGFFESVSAKFKL
DKLHPHSHLYTGNELVDFPGRTFQIDEVIKYGKTEMKELLQNKKANITIRNFPETVENLR
KKWKINDGGNLYCFFTTNMNNDKIVLLCTKIKTEE
>LONDMIMF_01820 hypothetical protein
MVTSKTIANGILRALAVITGILLLLFLLYKIQSVILFLFIALIVSMIGNPIVKFLEKRLK
FNHIVAVIVTLVFFILLMAGFIMMFVPLIVSQGENLSLLDTARLEADLVDLTERLKSYFS
DHNIDIESMVKKSDLTSKLNLNFIPNFINSLVSILGNVGVAIGSVIFITFFFLKDQKLFI
VNAKKILPNEHEDKILNSFRKINHLLSRYFIGLIGQVTILFICYLIVLLIFGVENAFIIA
FITAILNIIPYIGPLIATVLVAILTMLGHMDPESQGEMLSTTIYVLIGYTVAQIIDNNIT
TPLIFSNSVNSHPLEIFVVILASGFIFGVLGMIVAVPLYTIVKVVAKEFFPQNPIVKILT
RNI
>LONDMIMF_01821 hypothetical protein
MKKIYFAFLLCFSLVAQSQEIALLKYNGGGDWYGNPTSLPNLIKFCNQNINTRITPKPAT
VEPGSPDLLSYPFVHMTGHGNVVFSDSEINNLRNYLTSGGFLHVDDNYGMDEYIRRELKR
IFPNNALVEIPANHPIFQKPFSFPAGIPKIHEHDNKRPQAFGIFIDNRLALLYTYETDLG
DGWEDPEVHNDPKEVREKALKMGANIIYYIFNN
>LONDMIMF_01822 Ribosomal RNA small subunit methyltransferase E
MQLFYNPTITTATETFFFDKEESKHIVKVLRKKEGDNLYVTNGLGYLFKTKIALASDSKC
LVKIIGSEKGEATGYKLHLAVAPTKMNDRFEWFLEKATEIGIGEITPIICEHSERKVVKT
DRFDKIILSAMKQSLHYYLPKLNEPVSFKDFIKQQQNEGLKLIAHCEETQKKSLKETVLP
NQDVTILIGPEGDFSEKEIKLAVENNYIPVTLGNTRLRTETAAVVACHSVVFINEK
>LONDMIMF_01823 tRNA N6-adenosine threonylcarbamoyltransferase
MGNNSLFILAIESSCDDTAAAILQDNKVLSNVVANQSIHGEYGGVVPELASRAHQQNIVP
VIEMAIRKANIDKKQLNAIAFTQGPGLMGSLLVGSSFAKSLSLALKVPLIAVNHMHAHIL
AHFIEEEGYDKPEFPFLALTISGGHTQIVKVNDFFDMEIIGETTDDAVGEAFDKSAKILG
LPYPGGPLVDKYAKLGNPKAFSFTKPKVPGLDFSFSGLKTAILYFIQKNVAQNPNFIEEN
LNDICASIQHTIIEILMDKLKLAAQQTGINQIAIGGGVSANSGIRQTLKEAETKYGWKTF
IPKFEYTTDNAAMIGIVGYHKYLASKFEDNSVVSKARIPF
>LONDMIMF_01824 hypothetical protein
MLLLGIALSLPFVQTKIAHYVTETLNEDYGTDINVDQVAISIFGGVKLKTVLIRDHHKDT
LIYANSIKTNILSFKKLKSGDLIFGDIYADRLFFNLKNYKGEEESNINVFVGLFDTGKKS
HKPFQLNADNIYLSKSHFKITNENAITKTSVDFTKMDASVRKFKIYGSDITTEIRKLAFQ
DHRGLYVKDLTGKFSYSKESILLKELTLLTKESNLKGNVVLTYKEGGLADFVNKVHFDVD
VDSASISTNDLNHFYGEFGKNKKFNFSTILAGTMNDFFTRNLKLIVDNHSQIIGDINFKN
LFNPDKDAFLIRGDFKKLSSDYANLKSILPRILGEKLPSSLEYLGDFDITGNAQITHSDV
KADIYLTTSIGELAADLQLYDIDNIDNASYKGNINFEKFNIGRFLRQKDFGPVTLDLEVA
GKGFTRKFLDTKVSGKIYSLNFKKYDYKNIEVDGTFKNPLFQGKVVVNDENLKMDFKGLL
DLSKSENRYDFHALIDYADLNKLNLVKRDSISLFKGDVTMQITGNSIDNMYGDIFISQTS
YQNQKDIYFFDDFTIQSRFDENRVRTIAINSPDIIKGQIVGKYEFRQVPKIIENAIGSLY
TNYKPNKVKPGQFLDFNLSVYNKLIEVFLPEVSIGTNTVVSGKMTSDSNQFKMNFDSPEI
KAYGNYFDKVSLEIDNQNPLYNAYIEMDSIKTKRYKISNFSTINVKLEDTLFFRTEFKGG
NESKDFYNLNVYHTIDEKNNNVVGIKKSEVNIKDYMWFLNENDANDNKIVFDKKFKNFSI
ENILMTHNNQKIELGGTIRDSTYKDLKLSFREVSLGKLLPEMDSLRIEGKLNGEIDFKQN
KAIYQPASTITVDSLNVNEIALGNLSVQIQGNENLNRFSVNSVLENDNVENFIITGDIGI
LNKQTLFDLDFKFNKFNLGALSPLGGNVISRIRGFATGNANFVGTFKDPQINGRLFLDEV
GLKVPYLNVDYEFDERSIVDLTENQFRFNDARMTDTKYKTKGYLTGSIKHQNFKKWVLDL
NIQSDRLLALDTKDSDDAMYFGTAFIAGRASIKGPTNGLLITVDAESKQGTSIKIPINSA
AGVGNNTFITFLSPKEKYNLEKGIVEKVINNSGLELQFDLKITPEAEIEIIIDRNTGHAL
KGNGDGTMRLEISTLGKFNMWGDFQVREGEYNFKYGGIIDKKFQVKKGSSISWDGDPLRA
RLNIDAIYKTQANPAVLQDNASFNRKVPVEVVIGLTGNLMNPDPDFTINFPTVSSVLKSE
LQVKLDDKDTRVNQALSLLGTGNFLSSENAGTAVYGSLFERASGLFNDLFQDEDGKFTVA
LDYQMADRTPTAETSSQFGIAITTQINERISIDGKVGVPVGGVNQSVIVGNVEVKYRVND
DGTLNLRVFNRENDINYIGEGIGYTQGLGVSYEVDFDTLKELWYKIFNIKTKEEKENTST
DHMPDSDLSPDFIQWTQDRRKKADTQKTEKQKTEQPKVPDMD
>LONDMIMF_01825 hypothetical protein
MATQIFVNLPVKNLNRSIEFFRKLGYTFNPQFTDENATCMIISDTIFVMLVVEPLFLNFT
KNELCDTRKYTESIICLSAESRDAVDEMVKKAIAAGATTPVDKQDHGWMYGHGFQDLDGH
LWEIAYMDISAMPQ
>LONDMIMF_01826 hypothetical protein
MATINTYLNFNGNTEEAFNFYKAAFGGEFAVVMRFGDTPGCEEMPATDKNKIMHIALPIG
GNMLMGTDVPETMEQVKNGTSVSISVNTDSEQQTRDLFEKLSAGGDVKMPLDNMFWGALY
GMFTDKFGIQWMLNYEYEK
>LONDMIMF_01827 hypothetical protein
MLSNSKAFSGFSVDDSQKAKKFYGEILGLDIEEDAEMEGILTLKPAGGNSIIIYTKENHK
PATFTILNFPVKDIEQAVDELTKRGIVFEQYGGNIKTDKKGIFRGGGPLIAWFKDPAGNI
LSVLQEE
>LONDMIMF_01828 hypothetical protein
MEITTTSNRMFSLLVLYDMQTLYFERALEKISDEDAHKRLDTKANHIAWLTGSLVQQRYE
IANLLGYSEKQKASELFQDGKGIQDGLKYPSLSQFRDDWKKISPVLKDLLVKITDQKLDE
KFEMMPGMSLTYYELITFIIYREANCIGQIALWRRLLGYEALRYDDM
>LONDMIMF_01829 HTH-type transcriptional regulator CdhR
MKLGILLTQEHRLLSVAAMLDVFETVNKFYAEEGKAPFFDITLLHMDEVSQTYSEYNLMR
PDSEKTYDILLIPAFKHDVVPKAVSLNMRWIQWLRQQYERGASVASFCTGAFLLASTGLL
DNKPATTHINAEYAFAQAFPAVNLKVDAVVTEEQRVYTSGGATNSFHLMLRLIENFCSRK
MAVKTAKVFSVDLDRNQQTYFGTFAPAEDHGDDLVKQTQEVIKKNFREANTIEEIITDVP
ASRRNLVRRFKQVTGITPIEYLQKTRIEAAKQMLEHSRQSVMEVMFESGYNDLKSFRSLF
KKNVGMTPTAYREKFNNLVA
>LONDMIMF_01830 Phytochrome-like protein cph1
MSVSKTSTIERIIALANEPMVLLDKDFAILYANASFHIKFNLPELAPKNRNFLEVIESSF
DTHPLKLLFWDVLKTKSIVKEYEINSKNSENNKISFNVEAIEADGETFLLLAFNTNKETE
QLQSFLQSVLNSTNYGIASYEAMYNNHGMINDFRITYTNPEVPRNFGLEPKDVIGKTCRE
VYPGIFKNGIFEKMVKCVETGLPDSYEIAAIHNNKTLWLNATIEKAGNAVAVTSKNITHE
KTAALEIEAINALLLNKNKELEQQLLKEFSESFYSYGNGEEFFSSLLLEIATKTKMDYVL
LGEVQLNELGEEIIKSISVIAFGEIADNFKYPIKDGPCDEVIKGHYACHPRDSQKLFPES
KTLSDLNVEGYIAYPLVGSSGKVIGLISVLHQSEIHDIAYIESLLRIAAKRSEIEFERLQ
NEKLLEMKNKELERQNVELASFAYISSHDLQEPLRKIQLFASRILFKEKANFSDSSLAYF
QSITNAANRMQNLIESLLNYSSMDASEIHFVPTDLNIAIDDIKNNMTDILEKKNARVEVG
KLPTLSVIPIQFQQLLTNLISNGLKYSKPDVPPVIKIDAELVTSEELVGKQFWKLDIADN
GIGFPQEYEQQIFELFKRLHGKSDYEGTGIGLAICKKIVQKHDGFIRAQGIPGVGSIFSI
YLPVV
>LONDMIMF_01831 Cobalt/magnesium transport protein CorA
MAIETCNFSDSAIVWTDITNPTKEELEKVSKTYNLSSYTLIDSLDPDHLPKYEEHNKTHF
FIVRILQHSHEHEQTVRELSSKIAVFYNSDFIITIHRTAQPIMQEIRKNCIRNGKLETTG
GMAIKIIWEMLHSYELPAIKLSDKIDYYESKVFLKKNIPADMIEGMYYLKRKAGLCKKLL
LLTNEVVNSVKVEEKDLPALQDVRDLHLKLLTLYGQVQDDANNLLNIYLSLSARKTNDVM
KILTIFSVFFMPLTFIAGIYGMNFKFMPELDEKWGYPLALLAMVIVSVIIFIWFRRKKWL
>LONDMIMF_01832 hypothetical protein
MENREKNRKDTTGEKYIHVSEIPVQKLDKDANFKDDKNNPVTNPGLKEVRQPKAENNETM
GIP
>LONDMIMF_01833 Penicillin-binding protein 4*
MKHFFLLVLSVIVFISCKNTPENNIKEIASSYNKKGAFNGALLVARNGKILYDTVLGYSN
FKTKEPLNSNTSFYIASLAKPFTALAIMQLKEQKKLAYDNPISLYIPNIPEFTQKVTIRQ
LLNHTSGIPDYEKEMPNVKNLTNEQVMQWLATKNSLNFSPGEKFEYSNTGYIILAAIIEK
ISGKSYAGFCKEAIFKPLNLNRTIVYDTTKPTITNRAIGYYKNKEPDDYSILTTGDGSIF
STTKDLFMWEQALYGQKLLSRKEMENAYKTATLNDGSISNYGFGWNIKEENGQKIVSHTG
GLNGYRACIWRNLNEKTVVIVLTNQGDAFPLQEFMEAIEKEL
>LONDMIMF_01834 hypothetical protein
MKSKLFLLLLLTCFYTFGQDYRSTIAQAEQLYNIKNYAKSTSKYKEAFTIEQKNSNDYYN
AACSAALSGKKDLAFEWLNQVLKNGWTNLEHMKSDTDLKTLHTDKKWDKLIAAIQQEIDK
GAVGIDKPLQAELIAIYNDDQTIRQHYMTALKEFGNQSKQADSIAKIMGYKDSINLIKVK
DILDKRGWVGPNKVGAQANMTLFLVIQHSDLETQQKYLPMMREAVKNKNAQSSALALLED
RVALGEGKKQIYGSQIGYDSKTTKNYVLPLEDPDNVDQRREEVGLGPISEYVKTWDIVWN
VEEYKLMLSEIEKQKKKTN
>LONDMIMF_01835 hypothetical protein
MKLKLLAVFFITCPLTTFGQDIVYKDITQQLLSIDESDQKYRNQIDETISRFGNNSKEAK
ELFKNMKTTDSLNLIQVEKILSKYGWLGADKIGSQANTTLFMVIQHADLPAQLKYLPVMR
TAVKQGNAKAASLALLEDRVALKQGKKQIYGSQVSWNMETNVSFVAPLEDPDNVDKRRAA
VGLPTLADYLLEMGLDWNVEQYKKELPALEKTFFKKK
>LONDMIMF_01836 hypothetical protein
MKKLLYLLPLLLSSAVQAQLYVSTNSYMYAKDQVLYVKQDINLQNNGNIYLRNESQLLQG
TTTASANKGLGKVSVFQEGTSDNFDYNYWCSPVGNASAATGNENFGISMIHRPTTSTAST
PATILPSSNSNGTANPLAISSRWIYKFLSSISYSQWIYVGGASTLAPGEGFSMKGTSGSD
PIIVEANGIQNNPGGTGAQRYDFRGKPNDGNISVTVATNNLTLTGNPYPSALNVNAFLLD
ATNNAATGIAYYWEQDKTVNSHNVGLYKGGYGAYSPISLGSNGVYVPATFNSYNSDGSLN
GVGTSSGLVIERKYAPVGQGFMIKGASNGTVTLKNSHRSYYKESGPLSQFERPNKPKISK
NSNETTNSGETNATESETTITEAQFKLNIILNNEFTRQIALVFLPEATDGVDIGIDALSI
APDELPNDAYFFLDNNKYVIQGTSFDVGKRIPVGVKATNNASIKFYVPEVTSFDPDQMIY
IYDAADGSYHDIKNSSYQVNLPTGIYNDRFFVTFVNSVLGVGEVTKSNFGITQNNTNQTL
ILQNPNLADIRSVVLFDITGKSIFKKNNLGINDKYSFSTSGLSKGVYIIDLVTSDNQKFS
QKIIINNHKE
>LONDMIMF_01837 hypothetical protein
MTTITKTIPMVLLLLLSMTGYSQIGIGTTTPEPTAALHVESTTQGFVTPRMTTAQRTAIT
TPANGMIVYDITLASFYFYDTPTTSWIKINNGKDGRLKYKLIRSTDVLATVLAAEKTAGS
NTKYLLDAATLYEINGTINVDLPIELNNAYIAGADSSEDKLVKATGDLFTGTTGGSMRVL
TLQATAGNVFNITGTGSIGGGTQTQSMIVRDCIISSSANVGKLENFALVFTSIVQYVNNT
TGIIYKDISRLLISNAGWFSNNSGTYETLQGTFGLVTKQGGFSEVTGTKIGLDVSANPTI
TGDAVMETVVFTGTLTTGKYINPYTVGSYTGFNFNNSWSVRCTGIPNEGDSQSSGTVYLD
RTGTAQSQTSVGTLATNVKLTIAAGLSSNLYRTTSAQTNRITYSGKKGRVFQVNCSISFG
NVSGVSNTEYAFFIMRIPAAGGTDPQVATETIIDTNAGYIQSFPVQGSVYLNTGDSVELW
IRRLNQGTGTTAQSFLVRSFNMSVK
>LONDMIMF_01838 hypothetical protein
MSALKDIYSPVFYDRLANILQQTVPSFEKKTFVAQIFDDSFSQKELKDRMRHTTKVLRNF
MPDDFGAASGILEKTIHLLRENQHGEDSLAYIFFPDYIETYGLDDYSNAVKSIEFVTQFI
SCEFAVRPFIVRYGNQMIEQMEKWSLHKSHKVRRLASEGSRPRLPWAMALPELKKDPTAI
LPILENLKNDPSEYVRRSVANNLNDIAKDHPHIILSIARQWKGHSKETDAIIKHGSRTLL
KQGHPEILSHYGLDSKGLEISGFHINTPQIRLPQSLEFEFTVNNTNKEPKHIRLEYAVYY
NKANGQLSKKVFKISERTYFAGQKETIKRKQSFKPITTRKFYSGLHKLSLIINGEESNLE
IFHLLD
>LONDMIMF_01839 hypothetical protein
MKKTTMATLTLIISTLMLALIAGLFYSYSCSVNPGLKQLDDSGYLAAMQSINRAILNPLF
FLSFMGTLVFFPVSLFFNFTTWDSPKFLLLLGAFVLYACGTFGVTIFGNVPLNEALDAFP
LKTATLEEISRARRDFEIPWNNLHSIRTVASVISLLLVIISITLPLKATELITP
>LONDMIMF_01840 Cbb3-type cytochrome c oxidase subunit FixP
MKTFLYIGLLIINIHQTKAQNNSAEGKSIFEHKCQRCHGSDGTKGLFGAKNLQLSRLENT
ELILVISKGRRGMPRWEKRLSQTEIESVATYIKSLRK
>LONDMIMF_01841 HTH-type transcriptional activator RhaS
MNFNSIAPTLQLSAFVKHIEVITSGASLQSESYLRFFADGCPGILFSQSNHGFFTDSCNE
KLSSFYLYGQTIKPINLFSFGQFTKIIFYLKPHVLGFLFRINASEITDTCLDISLLQPKE
TPILLEKLSEATSVENQIRLISDFLLTIASKDNSDLILQQATETIIRYNGEVILTDLHKK
FSLSERTFERRFENSIGISPRLFARVCRFRSALTQLHTYDYTKLSDIAYENGFSDQSHFI
RTFKEFTGVTPKLYLSEFENNFAAQPIVSV
>LONDMIMF_01842 NADP-dependent glyceraldehyde-3-phosphate dehydrogenase
MDNNKIPFEESLERLFVEESAIPEQFRIGEIHQKEYLSNGEMKKWSGEVHEVYSPVYIKT
ASGLQPKLIGSYPVGTPKEAQASLDAAVEAYNDGRGEWPTMSVSERIHHVEQFTGRMIAK
KEMVVRLIMWEIGKSYADSVKEFDRTVEYIYATIDSLKNLDRDSSRFEIAEGIAAQIRRS
PLGVVLCMGPFNYPLNETFTTLIPALIMGNTILFKPPKFGTLLHYPLQEAFQESFPKGVI
NVIYGRGSDIIPGLMHSGKINVLTLIGSSKVANELKKQHPKVNRLRAVLGLDAKNASIIT
SKADIGLAVKETITGSLSFNGQRCTALKIVWVHRSIADQFLNEFSKAVSNLKFGLPWEEG
VSLTPLPEPYKIDYLNDCIKDAEEHGAKVVNENGGVSKASFFYPAVVYPVNEKMKLYHEE
QFGPIIPVVPFDDVEEVIQYLIDAQYGQQVSIFSTDASEVGALIDPLVNQVSRVNINSQS
QRGPDIFPFTGRKDSAEGTLSIPDAIRSFSIRSLVAFKMNDANKELINEIVNSDKSNFLS
TKFIF
>LONDMIMF_01843 Putative cytochrome bd menaquinol oxidase subunit II
MLYVVLFFTLFSLFLYALLGGADFGAGILELFSSKDHQVSIKKRVYSVMGPVWEANHIWI
IILIVILWIAFPGFYNVIIIYLHIPLTLILLGITLRGVAFVFRHYDAVKDKSQLLYDRMF
EFSCLVTPIFLGMTYGALISGNIVLLENTPNADFASVYIKPWLQPFPILTGFFFSALCVF
LSATFLIGEATEYERRMYIRKAGIATWVVVVLGFVTLAVAYFEENKFVLDVLKNYYAIGA
VAVSGLLLVPLWKSIRKGKIVWCRFLAGLQVLLILSAAVGAHFPNLIITKTGQISLLDDM
APESTITILGISLIIGGLIILPGLFHLLKSFKMIKILENEEN
>LONDMIMF_01844 Putative cytochrome bd menaquinol oxidase subunit I
MDNLDAARMQMAFTLIFHIVFACIGMVMPFFMVLSHYKWLRTRKPVFLKLTKSWQKGVAI
FFVTGAVSGTALSFELGLLWPEFMKHAGPIIGMPFSLEGAAFFVEALALGFYLYGWNKLP
EKFHLLTGIIVGLSGVASGILVVSANSWMNAPSGFDYVDGQFLNIDPLKAFLNPAWFTQA
LHMTLAAFVATSFAVAGIHAWQIYKNRNVALHLEAFKIAIVFGAVAALLQPLSGDLSAKD
IAQRQPVKLAAMEAHYETEKGAPLYIGGIVDEETQTVSYKLEIPKALSFLSFGDFNAEVK
GLNDFPKEDHPPVAITHYAFQVMVGLGTLLMFSGLLYFVSLKKKKWQASKKYWLFYACLA
PVGFLALEAGWIVTEVGRQPWIIHNVMRTKDAVTPMPGMIYSFYLYVILYAVLSVAVTWL
MIRQIKVLNNSEN
>LONDMIMF_01845 Cysteine desulfurase SufS
MTTTEMSTELEQYFQQFRNNIIGIDQEFISPFGKKKIIYTDWTASGRLYRPIEEKLMNDF
GPFVANTHTETTVSGTAMTMAYHEARHIIKKHVNANEDDILIADGTGMTGVINKFQRILG
LKIPENLREFTAIPDEKRPVVFVSHMEHHSNQTSWLETIAKVEVIPACEKGLLCMDSFKA
LLEKYKDHTLKIASITSCSNVTGIRTPYYEVAKLMHQNNGVCFVDFACSAPYVDINMHPE
DKEAYLDAIFFSPHKFLGGPGTSGILIFNKKLYKNMIPDHPGGGTVSWTNPWGEHKYLDN
IEEREDGGTPGFLQAIKTALAIQLKEKMGVKNILKREHEIIDYVFSELGAIPNITILADQ
HKDRLGVISFYIDGLHFNLGVKLLNDKFGIQTRGGCSCAGTYGHYLLHVDEETSHDLTNS
ITAGDLIRKPGWIRMSIHPTTTNAEIQFVCESIKAVAQNHEEWGSEYEYHKNSNEFTHKN
ASNPEKELVKQWFSAI
>LONDMIMF_01846 Lipid A biosynthesis palmitoleoyltransferase
MQLLLFIILYPFLWLMSILPFRVLYFFSDCVYLLVYYVIGYRKKTVRENLDIALPHLSKQ
EKRIVEKKFYHHFCDNFVEMIKTMTISDSEIEKRFKFTNLEVYLEMEKRGKSIALFCSHY
GSYEWLISMNRKITFKGYAIYKTIRNKYFDKLVRNIRAKFHAHLIDTKETINVIHENQKN
GIKGVYGFASDQSPKASKAFHWGDFFGVRVPMHTGAEMIAKRMDLNVIFVDVVKTKRGYY
EATFAEMVDHPKEIPNYQISDMFLRMVEQQILKAPEYYLWTHKRWKFRDKSPK
>LONDMIMF_01847 Rhomboid protease GluP
MNIFLIVIIALNLIVSFKGFNDLSFFRKYEFHVGSIRAGEQIRMFSSGFLHVDIAHLAFN
MLTLYLFAPYVIAGLGSFTFLMIYAGSLILGNLLTMALHKNDYSYRAVGASGAVIGVVYA
AILVQPALEIYFMPGYIFGIIYLLYSIYGMKSKSDNIGHTAHFGGAIGGYIITLSRAPVI
ISENTFTVIILAVPIVILFIMAKTGKL
>LONDMIMF_01848 26 kDa periplasmic immunogenic protein
MKKTIFILMTIFATAAQAQEIKQVPQINVSGEGKIKVTPDYAIISIGVENTGADAAEVKK
KNDATVDAVIKYLKGFKLPASDYQTKQVYLHKSYDYNKKKNTFVASQQITVTLKDLSKYD
TLMMGLVDTGINNINGVEFKSTKVAQLESEARRAAVADAKTKAMDYASALNQKVGKAIMV
SDNSQTHYPVPVMYAMKAEAAGDAMSRETLAIGEIEITANVTISFSLE
>LONDMIMF_01849 putative N-acetyltransferase YafP
MQNHYTIRKGSLNDLAELQRLFVETITTVCTANYDEQQIKVWTSSVDNKKRWHEVMTKQF
VIVAQYGNKITGFATLDNGNYLDFLYVHKDHQRQGVAQLLLDTIEAEAKRLNQNIIRSDI
SKTAKPFFERNGFKTLKEQTNVRQGIEIINYKMTKQL
>LONDMIMF_01851 Thiol-disulfide oxidoreductase ResA
MKLKMKKILLLLSVTAFMVSCNKSGDGEYIITGTVTGVENGKTVILQKQDEEIMGKMIPV
DTVKVENGKFELKGTATEPSIHSLRIETKQGEIDFVLENGKINIAVDKDTLGKSKVTGTY
NNEELTKFKTDTQAIQKDIQKKAMAFQQMNMEKMTAAQQAKDTAVINQLMKEYGKIQEPL
IEKYYSYSEKNPKSFISALITQSLFNTPEPDFARIQKIYDGLTSELKNTKPGKAIKEKLE
NRLAVEIGKKAPDFSAKNPEGKTVSLKESLGKVTIIDFWASWCGPCRQENPNVVALYNEF
HDKGLNIIGVSLDREGEAESWKKAIEADKLTWTHVSNLKFWQDPIAKKYNITSIPATFIL
DASGKIVAKDLRGEELRAKVKELLGA
>LONDMIMF_01852 putative metallo-hydrolase
MKLEQIYTGCIAQAAYYLESNGEAAIFDPLREVQPYIDRATKDNAKIKYIFETHFHADFV
SGHLDLAKKSGGQIVYGPTAKPNFEAIIAEDGQEFKVGAYTIKAIHTPGHTMESTCYLLT
DENGKQHGIITGDTLFIGDVGRPDLAQKMSSDLTQEKLASHLYDSLRNKIMILPDDLIVY
PSHGAGSACGKNMSKETTDTLGNQKKTNYALRADMTREEFTAELLDGLGIPPAYFPQNVM
MNIQGYESLDNILEKSFKPLTPREFEAIANQSEALILDVRHEDDFVKSHIPGSIFIGIQG
GFAPWVGALIRDVKQPLLLITPEGREEETITRLSRVGFDNSLGYLKGGIAAWKEAGFETD
SIESISPEQFQSEVNEKSIIVDARKPGEFNAEHVENALNIPLDFVNEQLAEVPKDENFYL
HCAGGYRSVIMASILKARGYHNMINVEKGIAGIRKTGLPLTAFVCPSTNK
>LONDMIMF_01853 hypothetical protein
MDAFFGYLGALVIGLVLGLTGGGGSILTVPVLVYLLGINPVTATAYSLFIVGTTSAFGTI
QNYRKGFVDVKTGLKFALPSLTAIYLTRKLIVPKIPEILFSIGEIAITKNLFIMILFAIV
MLMAALSMIQNKKSKKSAIPPNPAITIIQIFMVGVVIGLVGAGGGFLIIPALVYLARLPM
KKAVGTSIFIIAINSLIGFTGDIGNIAIDWRFLFIFSFISILGIFAGIYLNKFINEKNLK
KGFGWFVLTMSILILTKELLF
>LONDMIMF_01854 Extracellular ribonuclease
MIKNYFSLLFLLFSTCFSYGQVVINELDSDTPGIDDKEFVELKSATPNFSLDGYVLVFFN
GNAESASTGNKSYLTISLNGLVTDANGLVVIGSNAVSPVPQKIIADNQIQNGADAVAVYL
GSAADFPDGTLATTTNLIDALAYDTSDPDATQLMGLLGLTIQINEDENGLGTTQSIQRKP
DGTYEVKTPTPGANNDGSGIIFNGISISVPSLLYTEGDSFPITFTTQTAVTSDLAFNYTL
ANGSFNASDFTANTNVLIPAGSSTFTTTIQLIDDAIDEGDEVMKIRFGTLPAGYVRLNDN
VEVRIIDNDFTVSPWGTPLNPTHGAVASTAPPGYYDSLEGKSGAALKQAVQDIIANPAVV
RAHNYGDITTILKTADQNPLNSNEVWLMYKEVSRSKYLFQDSGSGVGRWNREHIYPQSRG
GFTNGTSDTPDGINVWEPSNANMLNHGHADAHHLRAEDGPENSSRNNKDFGLTDYNGFAG
NAGSWKGDVARAVFYMCVRYNGLNVVNGNPPDSTVGQLGDLATLLQWNVNDPADDFEMNR
NNYIYTWQQNRNPFIDYPYLADYIWGSRAGETFSLSAPEFSELKVSIYPNPAKSHITIAG
VNNPATIELFSISGQKLLTKDFSGTSTLQINLASGLYIAKIFSEGKTAVRKIVIQ
>LONDMIMF_01855 Chemotaxis response regulator protein-glutamate methylesterase
MNQIICLIDDDPIYQTITKKIIHKSEAASKILSFPNGAEAIDGLTKLVQQPEEFPDIIML
DIEMPVMDGWNFMEHFQKIKTIFPKEVSVYIVSSSIACSDKERSKSYNGILGYFTKPVTL
QNVLEIAKS
>LONDMIMF_01856 putative diguanylate cyclase YegE
MKIENKWSKITGWFISRPRLSTFIVFLALLVLICPLVLQRYEIIKENREQEMSNILHVVQ
QNLNHSLKNCYTTTISLAMIVNDNGEPENFDALAKVLVESNPTIDAVQLVPNGIIKYTYP
NNPDLIDFDILNTKSVREEALETIQKGKIHFAGPLKLKQGGLGVIGRLPVYRKGKFWGFS
AVMVRLETLFKSSGINSIKDSRYYFQFSKENPKTGRTEFFLPNKENFADKYFQVLSIPDG
NWKVYLISKNKYGLISEIRPALVLTVLFCFIFSLFLTSLLKKPAELQLLVHDQKNKILND
EIKFKSIFDHAAVGIAHVDSRTGCLIEVNDQYSRMLGYTFEEMRNMSFRDITYKDDLEEN
LKQLERLKSGEIRELTIEKRYIHKNGNLIWVNIAYSPLWQEGEEPSSHISIVEDITSKRE
AEDAIRKSEIRFKSLFEDSPIALWEEDFSYLKNYLEEIGLIGKNREEVKAFFDANPEVVQ
KCITLVKIINVNNECLTLHHPKTKEDLIQRLGDVLNNDSMDSFKAQLVAITQGETRLTID
SKVKKTDGEYRDISLRWSVMPGYEETLERIIISTEDITARKISEEIVIQSQKKMESLINT
IDGIVWECDYNTYIFTYVNQKAEEITGYTREEWCSDGNFWANTIHPDDKTRAVNYCAIES
KKSQQYDFEYRMIAKNGSVLWIRDIVNVIYENGKPVSLKGIMIDITKSKEAEKDLSNSLE
LVTEQNKRLLNFSYIVSHNLRSHTSNIQSISTLIETAETEEERNELVKMLQNVSNTLNET
MLNLNEVINIQTNINLIIENLNIKDNIDRIINIVSEQIAFKKAVIKNNVSPEIFVKYNPA
YLESILLNFISNAIRYCHPERNPVIILNSYTENDKTVLEIADNGLGIDLTKYGDKLFGMY
KTFHENPDSKGIGLFITKNQIDAMGGTVTVESEPNIGTTFKIYFK
>LONDMIMF_01857 hypothetical protein
MQDKHLYEYAIIRIVPKVEREEFVNTGIIVFCKKEQYIKVLYKIDKAKLQLYSDELDYDQ
LEQNLQAFVKIAQGAKEGGPIAAFDVPSRFRWMTAVRSSVIQTSRPHPGMCNNLEEISER
LFSELVL
>LONDMIMF_01858 hypothetical protein
MDNPFSLRTVNVTRYIAPLREGGSLPALADADDGFKYVLKFKGAGHGVKALIAELIGGEI
ARALGLAVPELVFANLDEAFGRTEGDEEIQDLLQGSQGLNLALHFLSGAITFDPVVTETD
AALASKIVWLDAFITNVDRTFRNTNMLIWHKELWLIDHGACLYFHHSWNNWENSAKSPFA
LIKDHVLLPKASRLEETDKEFKSLLTEDKILSIVNLIPEEWLQWEGSEETPEQIRNTYAS
FLITRLAHSEIFIKAAQDARQTLI
>LONDMIMF_01859 hypothetical protein
MKKHKIIFWITTILIFLFEGVMPALTSQTEMAKEGIRHLGYPEYFGIILTVFKVLGALVL
IIPAAPKRLKEWAYAGFTFDFLGASASHAAVDGFGFEAVFPLIVLGVLLLSYMSYHKLNS
QD
>LONDMIMF_01860 hypothetical protein
MTNNFDTAALIAETNATYEGMEQLLLTIDSNLWDKNPAENSWSVGQVMEHILKANSGLKS
LFAENIGETNRPADEKVPVIKSVFLDFSTKLDAPGFIIPTEKTHDKQQQLDKMKALKDGT
LQLIGSSDLSKTCKGFELPVFGYLTRLEWILFTLFHAQRHTNQIKNIITVIDK
>LONDMIMF_01861 hypothetical protein
MGRRNEINRLEHKKKTDQKKKREQEAEKLRKNKLKEIIKKNNASNEAQTE
>LONDMIMF_01862 hypothetical protein
MLPTKPKQNKMDSKVYEELKKDVQEIIDLIAGKQNKEANNKLVEVSETLDELLDHAEEDE
ELVELGRYMVLLNQLHQKINAE
>LONDMIMF_01863 hypothetical protein
MLNNLNCPCGSGLLFAQCCEPFIKGNSTPPTAEKLMRSRYSAYVVQAADYLIATTHSSTR
RNHSKSAILEWSKSNQWLKLEVVEATENTVEFKAYFLDSRLKAQMHHEKSFFRKENERWF
YVDGEFFE
>LONDMIMF_01864 putative NTE family protein
MGAIIGGLYASGYSATQIDSIFKTTDYDALIQDYIPRSTKNFYEKRNDELYALTLPFKKM
KIGIPRALSKGLYNFNMLNKLTHNVRHIRDFNQLPIPFLCIATDIETGQQVLLNKGSLPQ
AMIASAALPSLYMPVEIDGKLLVDGGVTNNYPILEVKNLGADVIIGVDVQDDLKDRDALT
DATKILVQISNMQMIQKMDRKRKATDIYIKPDITAYSVISFSQGNEIIKTGEDAARKVID
QIQKVGNAEKPVKRMVPLQRDSLFVSEIKTNQLENYNRTYVIGKLGFKAGTKISYEDLDK
GINTLSATQNFSGIGYSFSKSASGNDVLSMTLVENPIKTYLKFGLHYDGLYKSAVLLNVT
QKKLLFKNDIVSLDIGLGDNFRYYLDYYIDNGFYWSFGLKSRYNTFNRNILTDFNNGELL
NLFGLSSINIDYSDFTNQAYFQTIFAQKFLIGAGAEFKHLKIKTKTFEATDPILENSDYV
SIIAYLKYDSFDKKYFPKNGFLFCGDFQSFVYSSDYTKEYQNFSILKGEMAFSKTFFNRF
TLNLQSEAGFTVGEQTVPFFDFVLGGYGYNMINNFRHFYGYDFVSLSGNSYIKGAVGVDY
EIFRKNHLNFTANYANIGNKIFDTSNWIDRPNFSGYAFGYGLETIIGPVEIKHSWSPETK
DHQTWFSIGFWF
>LONDMIMF_01865 putative amino acid permease YhdG
MSIWKRKSLPQLLAEASEDEKGLKKTLTAPGLVALGIGAIIGAGLFSITGLAASMNAGPA
ITISFLVAAFGCVFAGLCYAEFSSMIPVAGSAYTYSFATMGEFVAWIIGWDLVLEYAVGA
ATVSISWSRYLGKFLSSYGIHLDESYMLSPFEGGIINLPAVLIVMVMSLVLIRGTKESAF
VNGIIVLLKVSVVLIFIAVGWQYIRPENYTPYIPENTGTFGEFGFSGIIRAAAIVFFAYI
GFDAVSTAAQEAKNPKRDMPIGILLSLAICTVLYVLFAHVMTGVVNYQAFAGKDGIAPVA
IAVEAMGSAGADGMITPAYPWLNNAILLAILGGYASVILVMLMGQSRVFFSMSKDGLMPK
VFSEVHSKFRTPAKNNFLFMVIVSLFAAFVPARVVGEMTSIGTLFAFILVCIGVLIMRKK
MPDAPRAFRTPLVPFVPIAGVLVCLFMMVFLPLDTWIRLIVWMMIGFDLYLFYGMKHSIL
NKGNFNLDSFKVVAGSGLGMVVALVIVAIIHHRDPNIDDTFLYYFSLIFAAIHALIYAYS
YKKSR
>LONDMIMF_01866 Homogentisate 1,2-dioxygenase
MPLYHKLGNFPQKRHTQFEKPDGGLYYEQLFGTEGFHGHSSLLYHVHRPTQVKEIKASYS
VEPKIAIGKNIKSLLFKGFELKPQEDFLDSRKAMLVNKDCTIGLAAPQKSLRDYFYKNAD
ADEMIFIHRGKGTLRTMMGNIPFEYGDYLIIPRGIIYQIDFETSDNRLFYVESFAPFYTP
KRYKNQSGQHLEHSPFCERDFKLPSELETYDEKGDFLIKIKKEGMIHEVVYATHPFDVVG
WDGYNFPYGFSIHNFEPITGRVHLPPPIHQTFETSTFVVCSFCPRLYDYHPKSIPAPYNH
SNIDSDEVLYYVDGDFMSRNNIEQGHITLHPKGIPHGPAPGAMERSIGKTETEELAVMVD
TFRPLMVTEEAMGLDDGQYYKSWVE
>LONDMIMF_01867 4-hydroxyphenylpyruvate dioxygenase
MSKEVKSVEYGLEKIFEGAQDFLPLLGTDYVELYVGNAKQAAHYYKTAFGFQSLAYAGLE
TGVRDRASYVLKQDKIRLVLTTPLNGDSVLNDHLRKHGDGVKVAALWVEDARSAFEETTK
RGAKPFMEPTVEKDEFGEVVRAGIYTYGETVHMFVERKNYTGVFLPGYKEWKSDYNPEPT
GFKYIDHMVGNVGWGEMNTWVKWYEDVMGFVNFLSFDDKQINTEYSALMSKVMSNGNGRI
KFPINEPAEGKKKSQIEEYLEFYGGPGIQHIAIATDDIIKTVSQLKARGVEFLSAPPKAY
YEAVPERLGEHMKMMKEDLNEIEKLAIMVDADEEGYLLQIFTKPVQDRPTLFFEIIQRMG
ARGFGAGNFKALFESIEREQEKRGTL
>LONDMIMF_01868 hypothetical protein
MKKIIILLLFATANLQAQDNKAFDVGEWFKFRIHYGLINAGYATLEVKEATKNGKKVFHA
VGNGYTTGMTKFFFKVNDDYQSYFDKKTGQPYQFVRKINEGGYTKNQEGFFNQSANNVLV
KDYKKNSEKTISVPENVQDIVSSFYFLRNHPTIDKLKVGESIVIDMFFDDETTKFKLKFM
GREVLKTKFGKVNTMIFRPYVQAGRVFKEEESLTVWISDDENKIPLRIKASLAVGSLKAD
LDGYKGLIHPFKIIADK
>LONDMIMF_01869 Tryptophan 2,3-dioxygenase
MDITPNIKDQLDQLEEKFQAINQKTETHLEGLLWSKPITYWDYIQTDALLNLQIQRTTLP
DEMVFIMYHQVNELLFKMILWEMEQLCHTPKPETSYFTEKLMRISRYFDMLTTSFDIMGD
GMEIEQYMKFRNTLTPASGFQSAQYRLIEFCSTDLINLIDYRFRKTIDRNTPYEHALEHL
YWQAAGKDYHTGEKSYLLKEFERKYKSQFLSYMEEYNTINVWRKFKELPEQDQKNEELIK
AMRHYDHTVNITWVMQHLNTAKKYIDGSGKGDGEATGGSDWKKYMHPKYQRRIFFPELWS
PEELASWGEEKNV
>LONDMIMF_01870 Murein DD-endopeptidase MepM
MKYAVLTLLLLFTLVSCNKEEKSEKENNIKEVPVKEPIVVEFGFTLNDFLVVNDTVKSGD
TFGTLMDKHNLGKYKVHEITEKARDSFNFRDIRAGRPYTILKTKTAPNTVQVFIYQPDNI
HYNVIDLRDSIVAYRNKKPITIKRRTIATEIESSLSETLSKAGVDASLAQNLADIYAYSV
DFFKIQKGDKFAVTFNEKYISDTIYAGVESLEASFFEYKGKKIYAFPFKQDTTAKKVNYY
DEEGKVLKTMFLKAPLKFGFRISSKFSTRRFHPVQQRFKAHNGTDYAAPAGTPIITTATG
VVEKTGYTAGNGNFVKVKHNSTYSTQYLHMSKILVRKGQRVSQGDVIGKVGSTGLATGPH
VCYRFWKNGVQVDALKQKLPNSIPMDAKYKPRFMAEMAPLKKELDSIAAIKFKK
>LONDMIMF_01871 Glucose-6-phosphate isomerase
MALGRTNPSGTVAWQKLREHFAEMQYASMQEMFANDSSRAEKFNLQWNNFLVDYSKNIIT
EETISLLLSLAEEVNLKDAIAKYFNGDSINETENRAVLHTALRAPESAVITADGQNVMPE
VYRVKNKIKAFCDEVINGQRKGFTGKAFTDVVNIGIGGSDLGPAMVIEALQFYKNHLNVH
FISNVDGDHVQEKIKNLNPETTLFVVVSKTFTTQETLSNSETVRKWFLKSAKQEDVAKHF
VAVSTNIQKVTEFGINPDNVFPMWDWVGGRFSLWSAVGLSISLAVGFDNFNKLLKGANEM
DEHFKSAEFDQNIPVVLALLSIWYNNFFGAESEALIPYTQYLQKLAPYLQQGIMESNGKS
VGRDGNPVNYQTGTIIWGEPGTNSQHAFFQLIHQGTKLIPTDFIGFVKPLYGDEDHHNKL
MSNFFAQTEALLNGKTEDQVRAEFTKTNFSSGAAEFLTPFKIFQGNKPTNTLLIQQLSPE
ALGSLISLYEHKIFVQGVIWNIFSYDQWGVELGKQLANSILDEINSGVVKQHDSSTALLL
RYFLDKKKS
>LONDMIMF_01872 Ribosomal-protein-alanine acetyltransferase
MSKFRPIKIELKNGKVVQIRQAELDDAEKLLHCIKTYIPQSEYIPKLTHEIKLTINQEKD
WINSFLVNKNSLLLIAEYNNEIIGNIDLTGNQRKLMEHTAVIGMGMLKDWRDTRLGTALL
SNVIEWAKQNEILEVIWLQVYTENIAGLALYKKLGFSENGIIKNFFKHENEYFDNLTMSL
SVK
>LONDMIMF_01873 hypothetical protein
MSKSKNDLAWEKIFEKHKILEKILKDGHIEITATKINEFREARLMTKFDHKSQLPKLFAD
NKLSILPTSRGGYVIGEFETFCDFNTDDIEVSPIEFPTFLESLDYRDITSEATAINCAFV
SNILHDFTNEKNLLPTVSGRMSSSTFNFGINSSRGLFNVNVGNSQVEIDGGYEGDTSLNL
IEAKNYISDDFLVRQLYYPFKLWSGKIQKQVRPIFLTYSNGVFHLREYAFSNVNHYNSLV
LVKHRKYVVQEGNFNLEALAQIIDTTKTIKEPEIPFPQANSFERVINLCELLNQKEFISK
EDITQNYDFDRRQTDYYSNAGKYLGLIDTGRDPFTGQTGCFLTKKGKQVFNLNLIDRQKE
FVRLIVSHKAFKETLKLYLNNGEMPEKGIIVETMKQSKLYNVDSDSTYFRRASTIIGWTN
WIINQTEE
>LONDMIMF_01874 Modification methylase DpnIIA
MAKNNKLVAPFLKWVGGKRQLMPSIVEHLPENIKDYKYIEPFIGGGAVLFNLQPKNAIIN
DLNEELINVYQVIKNNLEELITNLKKHKNEAEYFYAIRGLDRNAEFKKLNAVERASRIIY
LNKTCFNGLYRVNNAGEFNSPFGRYKNPNIVNEPTLKAVNKFLNSNNIDIKCGDYSDVLK
QADKKCFVYLDPPYHPISESSNFTGYVQGGWNMYDQIDLKTACDELNKKGVKFLLSNSSA
EFIIDLYKDYKITIVKANRAINSNGADRGEVDEVLIRNYE
>LONDMIMF_01875 putative membrane protein
MDNFDWKQLINPEFYIAMELGGVSVGLYVVLFIVFAETGLFAGFFLPGDSLLFLAGIYSR
ELVENLVIIESDFGNVALLATLVAISGIIGNTVGYWFGAKSGWYLYKKEDSFWFKKKYLE
QSRVFFEKYGGKAIIIARFMPILRTFAPIIAGIVQMDKKRFIFYNILSSFLWAFSLIMAG
HYLYGLFLSKFDIDLKSHIEIIILIIVAATTIPLVVKFLKGNKETPENNTEE
>LONDMIMF_01876 Inner membrane protein YbaL
MNELENTAAASHHLYPLISDLGLILMTAGVAILLFKKIRQPLVLGYLIAGFLAGPYFTLF
PSVKDVQNVEVWAEIGVIILLFSLGLEFSFKKLMKVGGTASITALVQIFSMVFLGYWCGQ
LMGWSSMDSIFLGVILSISSTTIILRAFDELGVKGQKFAGIVFGALIVEDIVAILMMVLL
STIAVSQQFSGMELFESVLKLLFFLILWFVGGIFFIPTLLKKAKNLLSDETLLIVSLALC
LMMVILATMAGFSPALGAFIMGSIIAETTKAERIEHLVKPVKDLFGAVFFVSVGMLINPS
TLAEYAVPVIIITLLTVFGKTLSSTIGTLISGQPLKQSVQTGMSLAQIGEFSFIIATLGM
TLGVTSNFLYPIVVAVSAISTFTTPFMIKLSIPVSNMLERKLPKKWIKAIDSYSSSSQTI
KATSNWVLFLRSSIIQIIIYSVIIIAIILLSSRVVLPLVNGSQWANVAIAVLTLLCISPF
LWALSFRKVAPTAYEELKRERKFLGPIKIVNIIRILFTLFFIGLLLNSFFSNFIAFTALV
IFAVAYMVFPKKLQTLYDRIENRFMQNLNDRENTEASKSKRELSPWDAHMTTFEISAESN
IIGKPLHQLELREKIGINIAAIKRGNITINVPNRNEQIYPNDILYVIGTDRQIEKFKTYL
QQSFVAVPENNSETVLKNFELKNEDFIGKTIRESQLREKTDGLVVGIEREGRRMMNPESH
VVLERNDIIWIVGDKKKMNSITLNAS
>LONDMIMF_01877 hypothetical protein
MKKAVHITFLCLFFLLGMRCDAGNKKNLSLTFPETNCTPQLKTCQYGLSKKEFSVVRDTL
DKLHKKKKFSNPYRYSMARLSKCHGLTLLFGAVSSSKFVFHTYFALANPFEKHSLFGSFC
HKGKLLSIFYPFQAFW
>LONDMIMF_01878 hypothetical protein
MDTYKIILEAHSDIAYVALSTIGVATINSLIGLSAKNEFKPKDRRIALFGLIAAHLQFVF
GLILYFVSPKGIALFGQAGMKEIMGNSELRMMAVEHPFVNILAIVLITIGWSTHKRVDDS
NKKFKKIAIFYALGFLLLLSRIPWNVWFS
>LONDMIMF_01879 Endolytic peptidoglycan transglycosylase RlpA
MKYKTTILLLAFIALVFSSGFSIQDRNFQKTPPEKTQAFQDSVKKVAIEDSLKIAESKKY
KLHKKNAHASYYADKFTGRRTASGKIFDNKKYTAAHRKFPFGTKLRITNEANGKSVIVEV
TDRGPFTKGKEIDLTKKAFMDIASSRYGGHLKVTIEIVQ
>LONDMIMF_01880 Endolytic peptidoglycan transglycosylase RlpA
MKARIFLFIGVLGSLLASCSSAKSVSGKVYKKNVHASYYADKFNGRKTASGEKFHNSNYT
AAHKKLPFGTKVKVTNIANEKSVLVEINDRGPFVPGREIDLTKKAFMEIADNKNHGSLRV
NIEIIN
>LONDMIMF_01881 hypothetical protein
MLAFLLLKNGQLKININLSSFSSVITEPDLTLRQN
>LONDMIMF_01882 HTH-type transcriptional regulator MmpR5
MTDIAKEREGLVEMFGVHFEKYWNFSPLSGRILGCLIVWNDAKGLTFDDLVSTLGASKSS
VSTNLNLLLKIGKVEYYTFPGDRKKYYRPSSFGDRMQNHLQMVLDEKKMVERIIEYRKKT
VSDGDCANLELIKIYQEHILEFEKFLNKTIQKLEKVENK
>LONDMIMF_01883 Solvent efflux pump periplasmic linker SrpA
MKNKSLFSIVIAIITLYSCGKKEQQMPPQGPMPFPVQAVAKQDAVVYQEYTANLEGQQNV
EIRPKVNGFIQKIFVDEGQVVRKGQLLFKLETQTQNEDASAAKAAVQAAQVEVDRLKPLV
DRKIISNVQLETAKAKLAQAKASYGAIAANIGFATITSPVDGVIGGLPFREGSLVSSTSE
MPLTTVSDTRVIRAYFSMNEKQLLFFNKTFKGATTAEKLKSAPEVSLLLVDNTEYDQKGR
LATMNGLVNPQTGTTQFRAEFKNPEGILRSGSSGIIRLPIDEKNVMLVPQNAVFEVQGKQ
MVYVVGKDNKVKSRIIETKGTSGLNFIVSGGLEEGELIVVEGASKLKDDMEIVPQQGKPE
AAAPAENTAAKDAAKTTTPSAKK
>LONDMIMF_01884 Efflux pump membrane transporter BepE
MLKTFIERPVLSTVISILITILGILGLMSLPIEQYPEIAPPTVQVNATYTGANAETVLNS
VVTPLEEEINGVEGMTYMTSSAANDGSAKISVYFELGVDPDIAAVNVQNRVSRATSKLPQ
AVVQTGVTTLKSQTSALMFFALYSKNKQFDETYIQNYAKINLVPKLQRVKGVGQVNVFGA
KDYSMRIWIDPEKMATYGVLPKDIQAALQEQNVEAAPGKFGENADGVYEYVIKYKGRLSV
IEDYENIVIKSTGNGNFLHLKDVATVELGGFNYGTKNIAMGQEGVAVGVFQTSGSNAQDI
ITEVMSILEETKPDFPQGVDYVIPYNTKTFLDASISKVISTLVEAFILVFIVVFLFLQDF
RSTLIPAIAVPVAIIGTFFFLQLFGFSINMLTLFAMILAIGIVVDDAIVVVEAVHAKLDE
GAKSGKEATLSAMSEISGAIVSITLVMSAVFIPVSFLSGPSGVFYQQFAITLAISILISA
VNALTLSPALCALFLKPHKDSDHHKKNLKDRFFLAFNTGFNKMNEKYTGSLRFLVRKRWV
TGVALLVFCGITYFLFQSTPSGFIPNEDRGIIMADLTLPPGTTLEKTQKAVNELDSILAS
MDIVEARMSVVGFSLLNNVNGGSYAFTVIKLKDWAYRKEANQQVDAVVGELFGRTAHFKD
ARALFFTPPSVQGFGTADGFEFKIQDKGDDDWATVSKVSNEFLGELMKRPEIQYAMTNFN
PNFPQYQMDINVERAKDAGVSISDIFNTMQGYYGGLYTTDFNKFGKQYRVMIQAKPSDRA
TEESINNIYVRNANNQQVAISQFIDFKRIYGPEAVARFNMLKAVNVNGKAKPGYSSGDAI
KAIQEVAAQHLPKSYTYEFSGMTREEILAGSQAAGVFLLSLIFVYFLLSAQYESYLVPLS
VLLSLPVGIAGAIGFVKLAGLENNIYFQVALIMLIGLLAKNAILIVEFAIQRRRHGMDLM
QAAIEGAKARLRPILMTSLAFIFGLLPLALASGVGAVGNRSIGMGAVGGMLIGTVFGVFV
IPVLFVIFQSLQERISGKPFEEKESDVILLNEEYEE
>LONDMIMF_01885 Outer membrane protein OprM
MKNKIYKIGLLVFAAAVMQSCFVAKKYERPELKTEDLYRTEVVSADSTSLANVSWDKIFT
DPILQDYIKKGLQNNLDIRIAMQNIAAAEATMKQGKAGYFPTLSGNADWTHQQLSKNSQL
GAFLQDRSTDQYQLTGTLSWEADIWGKIRSNKRAANAAYLQSIAANQAVKTQLIASIAST
YYQLLSLDAQIKVAEESLINRNESIETIIALKDAGNVNEVGVKQTEAQKYATEIIIADLK
NNVIILENALNNLLGEGSKKIARGTFESQVMQPEITLGVPATLLRNRPDVIAAEYNLIST
FEQTNVARSNFYPTLKVTATGGFQSIDLQQWFSANSFFSNVVTGLTQPIFNQRQIRTRFE
VAKANQEKAYLQFEQSLLTAGKEVSDALAQYNNETAKITIREKQVDALKKAADYSDELLT
YGLVNYLEVLTAKDNALNTELNLIDNKYRQYNAIIQLYRALGGGWQ
>LONDMIMF_01886 hypothetical protein
MKPEKYKKLDNPVWYSLSESHRDFAINYNNIKFYHPDYCPFGGFQSPDDISESIDSYSHL
TDSFFVVGEKPLLSDKLLLKNELICAQMIVENKIDMEYKNTIVSLTSNNTKALFDLVNLV
QPGYFKEKTALLGNYYGIFEKGELIAVTGERMKMDDFVEISAVVTHPEHTGKGLAKQLVA
HTANAIIEQGKMPYLHVVESNEGAIKLYEKLDFITRRKISFWHIVKLR
>LONDMIMF_01887 hypothetical protein
MKENKIGKITIAIITIVLVLVTIRLSGHKHSLGIFVLALFGFYFVAFLIGALLKATEVIS
KSLFYVFLAVLLTSFSLFFVYHHSYDSHNETRSLLYGFNGE
>LONDMIMF_01888 Acetyl esterase
MITPITMKKILIAFLFLLSFHVGNAQKMTTLTYFQNDTIKLDLDLFLPAKTSGKKLPLLL
YVHGGGFSGGERQSGHSLCRYLAQNGYASATITYTLYAKGRKFSCDGILSEKIKAFQYAV
NDLWLATSFFIKNSEKYAIDTSKIFIAGSSAGAETVLHAAFWDFKTMNLYDNSLPAGFKY
AGLVSGAGAIMDLNLITEKNIIPMFFFHGNGDTTVPYATAPHHYCKTNASGWLMLFGSYS
IYNHIVSLDGSGALYTFCGGGHEYSGYLFEKEHHIVLNFLNDVSSGKKFQKHDIMPTGKK
NELSATYKFCD
>LONDMIMF_01889 Inorganic triphosphatase
MLEIERKFLVNSDQFKTLAFAKNHIAQGYLNSHPERTVRIRIKGESGFLTIKGKGNESGV
SRFEWETEIPLMEARHLIQLCEKGVIDKIRYEVRFGNHIFEVDEFFGDNEGLVIAEVELK
SEDEIFEKPDWLGSEVTNDERYYNAFLSQHPYKTWK
>LONDMIMF_01890 hypothetical protein
MKIRKSKPKISIASFMKHYFDESQLWTKANDEIELLVQLVSIIRPKKPKAVLVVDIQELL
EFLQQNDFIRLQFSFYVKKLLHNKKFNKFLSDAGILRDVDFIFEVRKRIFSKLLPYQPSK
DSLEYILNQVFYLATDTIWVNKIPVSQIEELYDLLLFNSIYDTVEEDSVLSEMLLSMNII
TQRISGRAMETDVIKMVPEYDNLESPFAALEKELHQIDDTVRNAESNHFISSTDLYYKQL
LILHKQCNDFVEKAFANSSKYGISLRVNQNLLRIRQQLYRLKVLIPLLVVDREENKKNNG
IQLALKLIKYNCYKNDIRGLVSESTQLLSYEVTQHTAKTGEKYITETRQEYFRMFRAALG
GGLIVGLLCIIKVMLGKVETSGFGHAFLYSMNYSIGFIAIYLCGFTLATKQPAMTASALV
RALEQGMKKQGNSSEKHQAFAVFFARVFRSQFIAFVGNVVMAFPVSLLGIWLIDYAFEYN
IAASKWTKLLTDISPVHSPAIFHAAIAGVFLFLSGIISGSIANRDKHHQVYYRIQEHPVL
KMTFGREKTKKIADMYEKKWAGIISNFWFGVFMGSTASIGLFFGLNLDIRHITFASGNMA
LGLYGADFMVTLSLVIWCVIGIGVIGLVNFLVSFALSLGLAFRSRNIPLREIRFVILSIW
KHFKSKPMSFFFPSERKIKTQTEEEYLALDTKNKK
>LONDMIMF_01891 hypothetical protein
MIIREYAGSDKNRILELLRLNTPEFFSPNEEKDLSYYLDNEADNYFVLVMEGKIVGCGGF
NLTEDGKTAKISWDIFDPGYQGKGLGSALTRFRIEKIKENKQVKTLSVRTSQLVYPFYEK
FGLRLREVVKDFWDEGFDLYQLDCDIESV
>LONDMIMF_01892 DNA polymerase IV
MEEQEQIQNRKIIHVDMDAFYASVEQMDNPELRGKPIAVGGGGNRGVVAAASYEARKFGV
RSAISGYQAKRNCPELIFVRPRFERYREISEQIRQIFYDYTDLVEPLSLDEAYLDVTVNK
KGNPSATLIAREIRKRIWDEVGLTASAGISINKFIAKVASDFNKPNGQKTVNPDEVLAFL
EELPIRKFYGVGKVTTEKMYQLGIFTGKDLKEKTIDFLIKHFGKSGAFYYSVVRGIHNSA
VKPERIAKSVGAEHTFHENLTSEIFMMERLESIAATLERRLKKYDISGKTVTLKIKYSDF
TLQTRSKTMPYFISDKSLILDVAKELLYQEKMKDSVRLLGISLGNLNTEVKKTVVVQLKF
DF
>LONDMIMF_01893 Blue-light-activated protein
MFDLNEYENAQKGYSATQNAIPVPLYSWDFFGEYLEQLKNSLSDLSKLNVLSKSNHWKLN
WDFKEELQKDHVIVVTDTSLNIVFASENIIGMTGYASEEVLGKSPKMFQGDETSKKELQQ
IREAIDARIPFEKTIINYKKNGETYSCHIKAFPIFNRKKQVVNFIAFEKAA
>LONDMIMF_01894 hypothetical protein
MNFKSNNPFLGNKNFSKPTVHSYSQDENSTLIDYGQEMTVSGTINKSFFMLLLLTATASL
TWWLAFNGFNPLPLAIGGAIVGFILVLISSFRPQYSSYLAPAYALVEGLFIGGISAVFEA
MYPGIVIQAVGATFVTFLVCFGLYKYQIVKVNEQFKSVVIAATLAVATYYLISWLLSMFT
SFVPVHHGNSLMSIGISVVVIIIAALNLFLDFDLIEKGAKNRQPKYMEWFGAMGLMITLV
WLYIEFLRLLSKLSSRN
>LONDMIMF_01895 Pyruvate kinase
MSTRKKTKIVATLGPACSTKDVLKDMIDAGVNVFRINFSHADYTDVKARIDMIRELNEEF
GYNTAILADLQGPKLRVGVMKEDVIVSKGDIITFQTAEDVPGTAERVYMNYKQFPADVKP
GERILLDDGKLIFEALESNGVSEVICRVVQGGPLKSKKGVNLPNTKVSLPALTQKDIKDA
LFAIENQVDWIALSFVRTSEDLQELQDLISKNSAHKIPIIAKIEKPEGVENIDKIVAFCD
GLMVARGDLGVEIPAQEVPLIQKKLVHRAKTARIPVIIATQMMETMITSLTPTRAEVNDV
ANSVMDGADAVMLSGETSVGNYPVQVIEKMTQIIEAVEDSPLIQVPQNTPQIRTKRFITK
SICHHAALMANVIKAKAICTLTNSGYTAFQISAWRPQSHILVFTSNKKILTQLNLLWGVN
SFYYDKFVSTDDTVTDVNEIAREKGYVDKGDFLINLAAMPVVDKGMVNTLRVSEME
>LONDMIMF_01896 hypothetical protein
MGIHKLHLDEFDEVDYELIAIHTSLEDFRLAYFINQQLPILLSRSNDEIGITTKDGEAAF
TKFSYDDVAKDILWSLVQNKNEIITYKKNNTQDLFLDENVEIATKVYLLPELKKVDYFLK
IENNCNTFEIEEILQKLNKIEWITTVYEVVPDNIKSKNNLIF
>LONDMIMF_01897 hypothetical protein
MKIGEKLRLLRKLKGYTQEIMAGKLHMERRSYANLENNVTKIDMERMTQIAEVYGIELEE
LLAFDENKIFEKCFNKNIESFFSVQEFKSTTSIEEREFFIQQIQQLLETIDKERKVFIET
IENLKAAITKQNNTD
>LONDMIMF_01898 hypothetical protein
MKNLITLLGIKEFIIENELTDSVMLVLHPKNFDELAMEYIVSNNMQIERPFEVLGICVIE
DTDGEVAYNEIDILEIAYDHHEEFEYEYLRAAV
>LONDMIMF_01899 hypothetical protein
MNRLTFAISTVGLLISGYALPGRFADNSSEMASLLLKGGFILLFICSFIVNGYCIISFFR
KKRSFGRRKHYGIRTVRQYYPQRSTR
>LONDMIMF_01900 Chaperone protein ClpB 1
MNFNNFTIKSQEAIQRAQQIAQNFGHQQIENEHIVKGIFEVDENVTPFLLKKLNVNLGLL
QQILDSTLQSFPKVSGGDIMLSREASSTLNNAANIAKKMNDEFVSIEHLLLAIFNSKSKI
AQILKDQGVTEKGLKAAIDELRKGDRVTSASAEETYNSLNKYAKNLNELASSGKLDPVIG
RDEEIRRVLQILTRRTKNNPMLVGEPGVGKTAIAEGLAHRIVDGDVPENLKDKIVYSLDM
GALIAGAKYKGEFEERLKSVVKEVTSAEGDIVLFIDEIHTLVGAGGGEGAMDAANILKPA
LARGELRAIGATTLDEYQKYFEKDKALERRFQKVMVDEPDTESAISILRGIKEKYETHHQ
VRIKDEAIIAAVELSQRYITNRFLPDKAIDLMDEAASKLRMEINSKPEELDVLDRKIMQL
EIEMEAIKRENDENKLKSLGLELANLKEERNEIFAKWKSEKDIVDNVQATKTEIENFKLE
AERAEREGDYGKVAELRYGKIKEAQERLDAFQKQLQENEGHSLIKEEVTREDIAEVVAKW
TGIPVMKMLQGEREKLLHLEEELHKRVVGQEEAIEAVSDAVRRSRAGLQDVKKPIGSFLF
LGTTGVGKTELAKALASYLFDDENAMTRIDMSEYQERHSVSRLVGAPPGYVGYDEGGQLT
EAVRRKPYSVVLLDEIEKAHPDTFNILLQVLDEGRLTDNKGRLADFKNTIIIMTSNMGSS
IIQEKFENLKGNVESAIEAAKVEVLALLKQTVRPEFINRIDDIVMFTPLNENNIKEIVGL
QLKSITKMLALQNITLDATPEAVDYLAKKGYDPQFGARPVKRVVQKEVLNELSKEILSGK
VTTDSIILLDSFDGKLVFRNQTELAN
>LONDMIMF_01901 hypothetical protein
MSFFDKIFGNTDKSDKSDNKDTNQNGFNWNDLTELKQLDSIIEESEEKPVVIFKHSTRCS
ISRMALKNFEREYKADDNEASLYFLDLLNYRDISNEIAQRFHVIHQSPQLLLIKNGKSVY
DVSHSAIDAEALEGKL
>LONDMIMF_01902 Argininosuccinate lyase
MKLWEKGIPTDQKIDLFTVGNDRELDLVLAKYDVLGSIAHAKMLGKINILTEKETTDLVL
ALEDILAQIKQGNFTIEAAFEDVHSKIEYLLTEKLGEAGKKIHTARSRNDQVLVDIHLYL
KEEITSVKKLVKELFDLLILLSKKHEDIILPGYTHLQIAMPSSFGMWFSAYAELLIDDMV
MLNAAQKIVDQNPLGSAAGYGSSFPIDRTFTTQELGLSILKYNSVAAQMSRGKAEKTVSF
AFSGLAATLSKLAMDVCLYMSQNFNFISLPNHLTTGSSIMPHKKNPDVFELIRAKCNKIQ
ALPYEITLLTNNLPSGYHRDFQLLKEGLFPAIQNLKSCLEIACFSLKDIQVNTTILQDKK
YDYLFTVDNLNELVQQGVPFRDAYKIIATQIENGEYEPSSKTTHTHEGSINNLCLEEIVL
KMESFLRD
>LONDMIMF_01903 Succinyl-diaminopimelate desuccinylase
MTHKSIEIVTNEAISLLKQLIETPSFSSEEAQTALLLENWFQNNSIPFQRENNNVWAVNL
HYDASKPTLLLNSHHDTVKPNEGYTLNPFEAIEKDGKLFGLGSNDAGGCLVSLLATFTYF
YAHENLPYNILFAGTAEEESSGPNGLNGLLKHLPEIECAIVGEPTQMQLAIAEKGLLVLD
IIIPGTASHAAHQNADNPIYNALATIEWFRTYEFEKISEILGPVKMTVTQINAGKQHNVV
PSECSLVVDIRVNDCYTNEEILKVVQQHIKGNVNPRSMHLNASSIDKNHPLVQAGISLGR
QTYGSPTLSDQSVLNCQSMKLGPGDSLRSHTANEFIFLEEIREGIHLYTKILSDFFNLNN
TIT
>LONDMIMF_01904 Acetylglutamate kinase
METKPGLSIVKIGGNIIDNEQLLSEFLTDFSELKGHKILVHGGGKKASEIAEKLGLKPCF
SNGRRITDEAMLDVAVMTYSGLLNKQIVAQLQQFGTNSIGFSGADGNLIQSEKRKNTEID
FGFVGDVIQVNNKLISALLVQNCIPVFSAITHDGKGQLLNTNADTIAAEIAISLSEEYEV
ELIYCFEKKGVLLNSEDDDSVIEVLDFEKYQTLKNEQTIHSGMLPKLENCFKSLKNGVHT
IVIGNQKTLKNKAAATQIKL
>LONDMIMF_01905 N-acetylornithine carbamoyltransferase
MKKFTTVDDINDLDELILTAKKIKSDPFGNSGLGKHKTLGLLFFNPSLRTRLSTQKAALN
LGMDCIVMNLNTEGWSLEFEDGTIMDGDKAEHIKEAAQVISQYCDIVGVRSFPTLTDKEK
DEAEQVIHAFTKYASVPVISLEGATEHPLQAVADALTIQEYKTKRKPKVVLTWAPHPKAL
PHAVPNSFVKIMKLSGYELVIAHPEGYELNPEITKGATITNNQDEAFKNADFIYAKNWSA
YNDYGKILSKDMNWTITQEKMELTANAKFLHCLPVRRNMIVSDEVLDGDNSIVIPQANNR
TYAAQAILTKILENGN
>LONDMIMF_01906 Acetylornithine aminotransferase
MSLFNVYPIYNITPVKALGAKVWDDKNQEYLDFYGGHGVISVGHSHPNYVKAIQSQIEKI
GFYSNSIQNPLQEAFAKKLGEMSAYPDYSVFLCNSGAEANENALKLASFHNKKSKVIAFH
KSFHGRTSAAVAVTDNPSIIAPINANHPVLFLPLNDIELVKKAVSENEISAIIIEGIQGV
GGLDEGTPKFFQELEELCNANDIILIVDEIQSGYGRSGQFFAHQYHGIKPDIITIAKGMG
NGFPIGGLLISPKFTASFGLLGTTFGGNHLACASALAVLEIIEEEAVLENVKKQSDYFIQ
AVSQIPQVKKIKGKGLMLGLEFDFDVAELRKKLVYEQFIFTGNASQKNLLRILPPLLITE
TEIDKFVAGLKNALQSLN
>LONDMIMF_01907 N-acetyl-gamma-glutamyl-phosphate reductase
MIKAGIIGGAGYTSGELLRILVNHPKVEIDFVFSTSQAGKPLTAAHPDLIGETGLVFTDK
INPDVNVVFLCLGHGKSKAFLENNKFALHTRIIDLSNDFRLENDADFNSDSFVYGLSELN
KNKIAAAKYIANPGCFATAIQLALLPLASENLLENDVHVNAVTGSTGAGVQLSETTHHSW
RNSNISHYKAFEHQHLAEIKQNLNSLQEDFENEILFIPNRGEFTRGIFATLYTKTSKSKK
ELIDLYQTYYKEHPFVWVTAEDISLKMAVQTNKCILSLEKKGDYLLVTSIIDNLLKGASG
QAVQNMNLMFGLEETTGLKLKPSGF
>LONDMIMF_01908 Argininosuccinate synthase
MKKVVLAYSGGLDTSFCLKYLKNEKQLEVHTILINTGGFDNEELDAIEKRAYELGSAQHI
NLDIIDHYYEKAIRFLVFGNVLKNNTYPLSVSAERVFQAIETVKYAKKIGASAIAHGSTG
AGNDQIRFDLIFQTIAPQLEIITPIRDLKLSRQEEVDYLQKNGVEYSWEKAQYSINKGIW
GTSVGGKETLTSNLSLPESAYPSQLQKTEPEKITLHFKKGEIIGLNDAFDKPTAIITQLE
KLAGAYAIGRDTHVGDTIIGIKGRVGFEAAAPLIILKAHHLLEKHTLGKWQQYWKEQLGN
WYGMLFHEGQFLDPVMRNIETFLEDTQKNVTGIVTVTLKPYYFSLDGIESEHDLMNSKFG
QYGEINNAWTADDAKGFIKILGNAQSIYSQVNSIDYD
>LONDMIMF_01909 hypothetical protein
MNVTICIAQKEHYKFAQEICDTMEASALLRGTGIAKRSPEYIQKKMENNDAIIALENGKF
AGFCYIESWEHGQFVANSGLIVHPDFRHLGLAKKIKKKVFEYSQEKYPGAKIFGITTGLA
VMKINSDLGYKPVPFSELTTDPTFWAGCKGCTNYDILERKEFKMCLCTGMLYDPENKKTE
EVKFNKKVLTRLKQIKQTFLKK
>LONDMIMF_01910 Sporulation-specific N-acetylmuramoyl-L-alanine amidase
MKKTAFIFGLLLCSLGINAQIVVLDPGHGYGTSTSDNPDGRTATEIETALAVAQKTKALI
DNSCTWTVHLTRTTNVNGWISVNQRATMSNNWNADRLLSIHCNAGGGTGTETFYCTADDT
NTAPDIAFAQKIQADMVTHGSWTNRRCVEDNSFLAYHLGVLRYSSATACLNEIGFVDTTS
DAAKLNSNTWRDSFALAYFNAFKSNLNLTCSAVAAPGTFSLTLTPECSGTSTQNRLNWTA
SSNATGYDIYRNGALYASNITGTQYINTLVTGGTTYTYYVIAKNSSGTRTNSNGTLSAST
LVCNATPGSFTISATATCSGTQSAINVTWTTSSNATSYDIYRNGNLYAPDVTGNSFLNTY
LITAGTSYSYYIKAKNANGSVNNSNGTISRTAISCGSGRAAASPIGKSELDVKIYPNPNN
GQFTITVDKASAGDVQYAIYDITGKVIESKSIESDGRLETAVDISRLPSGTYIINVTTDN
QEFTKKIIKN
>LONDMIMF_01911 Protein TolB
MLCSFLMSLSVYAQKIEDFERIEVDGFYTNPLFSPTGEYVLLTGEHLKGVYLLELKTKTV
KPISDKQGSGYAYVWDKSGDSFYFKEKSDKEYFSNAKVINYNIRDNYSKKVENIDPNYLP
SYRGASKKGDNQVVVYTNLANLKIEAKDLATSKQWVVTNDEGQFYNAMLSNDGKKVAVHN
GADIYIYDIDGKTKGRKIGTGIATAWSDDDSYLIGFLDESENGHTVSNSELYLFDVEKGK
TKKITNTEVIFEMFPTIHKDKVIFSDDKTGRLFIATLKMN
>LONDMIMF_01912 hypothetical protein
MKKITLLFLVFALASCGVKQTTNMLTSGDYDGAIDNAVNSLRSNKDKKGKQDYIYLLEEA
FAKAKERDLRDIQFLAKDANPRNLERIYTTYVLLNNRQEKIRPLLPLRLMKENRNAIFPF
DDYTDQIVNSKNALSKYLYDNARALLLTKDKMTSRRAYDDLLYLDQINPGFKDVRKLMDE
AQLKGTDFVNVYMRNETNMVIPIRLQNDLLDFSTNGLNDKWTVYHSSKQKGVNYDFEIVV
NFRQINISPEQVKEKQFIKEKQIKDGVKNLTDSRGNVVKDSLGNVIKVDKFKTIKVDIYE
FTQFKAAQVTAKVDYIDYKSGQLLQTFPLTSEFIFENIYSTYRGDRRAADESYYTYFNQK
AVPFPSNEQMIYDTGEDLKVKLKNIISRNSIRR
>LONDMIMF_01913 hypothetical protein
MPITANDPNRKSWLEVPQDSDFPIQNIPFGVFLTKDDVVTIGTRIGDYAIDLGALQQLNY
FEGIDLTDDMFMQDTLNDFISDGKKTWRLVRNRIADIFDATNSELRDNEKHRETVIFKIE
DVEMQLPVLIGDYTDFYSSREHATNVGKMFRDPENALLPNWLHIPVGYHGRSSTIVPSGI
PVHRPMGQTLPNGETTPVFGPSRLVDFELETAFITTDANIMGENIPVHEAEDYIFGMVLL
NDWSARDIQKWEYVPLGPFLAKNFASSISPWIVTMDALEPFRTKGPNQDPMPLPYLQEKG
KKTFDINLEVSLQPENAEPTVISKSNFKYMYWSMSQQLAHHTSNGCRVNSGDMMGSGTIS
GPTPDSFGSMLELTWGGKNPLTMSDGTERKFINDGDTVIMKGYCKKDNVRIGFGEVSSKL
LPPFFRK
>LONDMIMF_01914 Serine hydroxymethyltransferase
MLRDEQIFDLILEEQDRQIHGLELIASENFVSDQVLEAAGSILTNKYAEGYPGKRYYGGC
EVVDVIEQIAIDRAKALFGAEYANVQPHSGSQANASVYHACLKPGDKILGFDLSHGGHLT
HGSPVNFSGKLYHPVFYGVDQETGLLNYDKIQEVATKEQPKLIIAGASAYSRDMDFARFR
EIADSVGAILMADISHPAGLIAKGLMNDPIPHCHIVTTTTHKTLRGPRGGMILMGKDFEN
PFGIKTPKGEIRMMSSLLDAAVFPGNQGGPLEHIIAAKAVAFGEALSDEFFTYARQLQKN
AKAMAAAFVKRGYNIISGGTDNHMMLIDLRNKNISGKEAENALVKAEITVNKNMVPFDDK
SPFVTSGIRVGTAAITTRGLVEADMETIVDLMDRVIQDHTNEELLEQIADEVNEMMSERP
IFVY
>LONDMIMF_01915 Penicillin-binding protein 4*
MVKLITISAIFFLQVAVAQTKTEKLDSLFQSAVNDGSFNGNVLIAEKGKVIYQKSFGYSD
IKAKEKLTGKSVFELASVSKQFTAMGIVLLQKQGKLSYDDPISKFLPELSMYNDITIKNL
LVHIGGLPDYMELMSQEENHDGFATNQTIIDLFVKKKPPVVFKPGEKHEYSNTGYALLAS
IIEKASGKSYGDYLAENIFKPLKMNDTRVYRRWFKPEKVKDVTKGYIYSDSLKRLVTPDE
ISKDYFTIYLDGIVGDGMVNSTTTDLLLWDQALYTDKLVNKQDKELIFSSYPTQSGKATN
YGFGWKVSTSSLYGKIASHSGGWSGYVTYIARYLDRNCTIIILQNAMNQNTKIPQAEIRN
ILFEPIYKADKKKMEEIVGIYKTEKGNERELLFEKGKLYTKLNAEQKLELIPISENKFLA
DGYQPEVFYEFVAENNKISKYIVTQPELSVRSEAVKIK
>LONDMIMF_01916 Penicillinase repressor
MQAEPTKSELEILQVLWQFGPSTVRFVNDQLNEQKRAVQYTSTLKLMQIMTEKGMLVSDK
TQMKHVYSPAIEEKKTKGFLLEKFVDALYNGSSSSLVMQLLGNKKTTQEEIEEIRSLLDK
LDKKK
>LONDMIMF_01917 Regulatory protein BlaR1
MIMPNENILKAISWTLIHSVWQGLVLAILAGLVIVFTRKSKAAIRYNVLSGLFVMFLIAV
GFTFNYEYHQEIAIEPDAIMIAGTNPEFQNTFTGPSAIAPDYFEESISYLNQYATTIVVV
WFLIFALKCFGIFRNLTHVYRIRNYKVHNAPEFWSSKVADLSKKLGISKPIVLLESQLVK
VPSVTGFFKPIILVPVGLLSHLPQDQIEAILLHELAHIRRKDYFINLLQSFAEILFFFNP
GVLWISSLIKDERENCCDDIAVTITQSKSKFIHALVSFQEYNMKQNELALGFGKNKNQLL
ARAKRIIQDNNKSLNTVEKTFLSVCIIIMLTFSLACSNTKATTAKTAEKENKVEIAYLKG
LTRAKLSEGEEIRQAEIAAQEAHKAAEIAKVEAEAAKVKAETAKAEAQKAQQQGTLSDDE
AKQYEAEASQAQVEFEKAKKEHEIAMKEHGIAMEEHEKAMKKHGIAMKEHEKVQKEDKKV
WKEHEKAMKKHKKAMEEHEKAMIQAEKDRKSVGTTYQIVRPMTFEEAQKSGICVITDKIK
ADNALVKKLKENDELLVIKMKEKDKLLVEKMVQADALKEKRDLWLIDQKAKFRLKKAEMI
EVKKIKQLDLQKIKFSKDSLLKVYKENWGQKTGSTDVPNSINGQIIPVLTKERAIANLNN
PSYKLNSDNIIFYGEAVIGNTYTKPTKYLKPNSSAVYYNFDSANQNLKDAVKPLKS
>LONDMIMF_01918 hypothetical protein
MSMLRLKLPTDPRWVNIVETNIEEILTDHAWCEQKAASNAITIITINSEYPDLVTDMLAL
AKEEIEHFEMVHEIIKKRGLKLGRERKDEYVGELAQYMKRSNTGSRVSGFVERMLFSAMI
EARSCERFKVLSENINDEELSKFYRDLMESEAGHYTTFISYARKYGQGIDVEKRWKEWLE
FEATVIAKYGKKETIHG
>LONDMIMF_01919 hypothetical protein
MTDYIHDQNYANEVYTEDAFNLKEFEVCHFSNCNFTRCNFIGVTFTDCTFTNCDFSGARI
NHVAFRGVNFIDCQVLDVNFSMCDRLIFEIHFKDCILDFCKFYDLTMKGTTFSNCSMIAL
DFMNTDLTNVLFDHCNLHKTVFSNTTAIKADFTTSYNFSIDPEKNKIKKASFSLAGLKGL
LQKHELIIKE
>LONDMIMF_01920 hypothetical protein
METNKRKGFLFKKYEAPDLSPFDKLFEIFKELITHTSGDFDEAIDWLRELDKEYKLTDSS
YTIDDFIEDLKKKGYIREEIKDDGSGGLAITSKTERAIRQQALEQIFGNLKRSGSGNHKT
KYSGSGDEHTGEFREFHFGDSLERISLTESLKNAQVNNGIESFKLTEDDLVVEDAQFKAQ
MSTVLMIDISHSMILYGEDRITPAKKVAMALAELITTRYPKDTLDILVFGNDAWPIAIKD
LPYLKVGPYHTNTVAGLELAMDLLRRKRNTNKQIFMITDGKPSCIRERDGSYYMNSYGLD
DYIVDKCYAMAQQARKLHIPITTFMIANDPYLQQFVNYFTEANQGKAFYTGLKGLGEMIF
EDYETNRKKRIK
>LONDMIMF_01921 hypothetical protein
MKAETIKTLGELKKSGYQSQSIKDELRNNLREKISKGETVFQGVHGYEDSVIPELERAIL
SRHNINLLGLRGQAKTRLARLMVNLLDEWMPIVAGSEINDDPLQPISRYAKDLIAEQGDN
TPIEWIHRSERFFEKLATPDVTVADLIGDVDPIKAANLKLSYADDRVIHFGMIPRANRCI
FVINELPDLQARIQVALFNILQEGDIQIRGFKVRLALDMQFIFTANPEDYTNRGSIVTPL
KDRIGSQILTHYPESIEIARTITEQESNLDSRQSNLVHVPSLAKDLLEQISFEARESEYV
DAKSGVSARLSITAFENLLSTAERRALKTGAEKTTLRLSDFMGIIPAITGKVELVYEGEQ
EGAGAVAQHLIGDAIKTFFSLYFPKIEKLEKQEEKSPYKDTIDWFFNESGFELLDDATDA
EYKQQLDSIIPLRALIAKYQPDVAPEDIYFMKEFVLWGLVEYNKLSKDRIVKGYQFNDLY
GSYIRKL
>LONDMIMF_01922 Nisin biosynthesis protein NisC
METISKNIFLETAWEIGCQLMKNSIWHGNSCNWQGYSVEFVDGVYQPIMRTFGADLYSGT
SGIALFLTALYAERKDPILLKTIEGSIVQIQNTIDTVPELGFYAGKPGIASALIHIGKEL
DREDWIEYGLSLLDSIVPSSLQSHEVDVISGAAGTISMLIDAYKVFQKQELLDKAITHGH
LLCDRAVKNETVWSWATVPSPKNLTGFSHGSSGVALALLQLYEITREENFLKGAEGGFNY
ERQSFDISQQNWPDFRDGVSTTAAKVCGLAWCHGAPGIALSRLKANQAKADAVFVQEMNV
ALKTTASSIYHALTDNLNTTNYSLCHGIAGNAEILLDCGGVEYHQLAEAVGTAGIQKYQK
NRIPWPTGLNTGQYTPGLMMGIAGTGYFYLRLFNKNRHKTFLVPGLLD
>LONDMIMF_01923 hypothetical protein
MFKDSAIIKELTRLVNQLEITFSHIIFRGKQYAVTPDTLQESLTGILYSECYALKESYQS
DLLHKPNYSIENDANFMRLLSQNNHSKDRIEQGWQVKTNYSNGYAEIVRQTESHIVPLNA
LKETGGQNVTVFFPKEDQHRQPTFYYAFGNLNLDTSKNLVRVYWNITSEGAPVLIDSITK
KLNRYNIPFLFKCLNHPELYFRRDAAVLYIEDTLQHLLGQLLPELYEDIKEFLEEDVPLF
SHRYQKGMGMAENPSSQESFGMNRMAIVASVLANSAPKNPDAGTLLQEIATAFQQKGIHP
ETTFLNKGTKKAFN
>LONDMIMF_01924 hypothetical protein
MQLIPENVYHYLHKRQLIDEEAVVKGHFMVHPVKTRNTILKVIVEPHNSLFVKQTGNDAM
SKSLFLREINAYDLFKNSHTFSAVALVTSCLLDHDDENNVMVFELLHNAKNLTEYYMLTK
NFDLHLAREQASILALCHIRPKAETDGLQFPKLLPWVLQLDRHTADAFFANNEASATAIQ
LIKDNPLLLNALSQLGATWQYTHLIHGDIKWINFLAIENENGISQRLIDWELADIGDPMW
DVAGLLQSYVATWLLGFDNNNPFSNKLPEHMKFYDLKNMQPSAQAFIYQYIEEKTIPESD
HPTFFTRLMQFTAARILQTSIEGITFNTKIEANNMRCIQLAFNIMENPLAALEELFDIKL
YQYV
>LONDMIMF_01925 hypothetical protein
MAKIANVEKVEEGAVYTGYDHLTAMEWCTPSFLGCSACISASAVNGLVSITISLKTPFGN
VGKSFNFNSNVNYTWQPFSRFKISVSITNFNEAGGVFSFDLGLQPCVEVPSLGWKCFDYS
HHFIVPLALNGIENDIDDSQFASILALHSGNDFNASCGCDDKGSSLLQGDIYNNYLNSLA
GFPTIPVTQCLPIPTVQCIPTVTSCITGVSPICAAQQEANLGAGFPTIPVTQCFPIPTVQ
CIPTVTSCITGVSPICAAQQKAKLRAEFPTIPVTQCLPIPTVKCIPTVTSCITGVSPICA
AQQEANQGAGFPTIPVTQCFPIPTVQCIPTVTSCVTGISPICRAQEANQGAGFPTIPVTQ
CLPIPTVKCIPTVTSCVTGISPICRAQEGLVGAPATENIPTIVTPQCLPTLPQSCFATSP
VICRPLPTMPIMCPPTHMSVCFTNPVACHLTNQGGNDGLKAAAAPTLPVDQCIPTVGCIP
TISCIPTISCTGIPFIC
>LONDMIMF_01926 Transcriptional regulatory protein YpdB
MSKVSVLIIEDTPAESEALVKVLTQNNYAIAGVATTFSDALALFYKNTVDIVIIDVFLNG
SPEGITFAETINITPDIARPFVFLTSSNDRQIFERAKLTKPFSFLLKPFNELEILYAVEM
AVEKFYEQSNVFLSDDQDTVLSTDSLFIKKKNALKKVLIDDIVYIEVEERYCNIITEHEK
FVIMISLTKISELLEKNKFVKTHRNYIVNANKIEEIVLHDNLVILKGNHKVTLSEKHKDF
IKKLNILR
>LONDMIMF_01927 Sensor histidine kinase RcsC
MMSRIKLALILLFLFPAYSLFSQEQNNSLLNSEIRKKALENRDKTDFYKAQAFFLEKNWD
STLVYSMKQLAHTGNPEIADYCHYFRAFSFKNKRLLQEARKEFLQISKRFRFYYKVRLYL
GEIALEENNYEQAIRYFKEIENLPETGNYDFKRGVVYHNLGLCYLHLKKYEQADAYLSKG
SEVMQAEKDTLSLIGSYMNIANLYYEQYKDNLAIPYFEKAYSLSKKIKNVELKQNAALNM
AVVAENNKNFPLALTYRKEYESWRDSLNDQNKVWAIAELEKKFTVKQKEKEIDILEAENK
LKIAERNGFFYSSVLLLVLFGTGIYFYRQKIKSNRIILSQKNKLDELNAAKDQLFSIVSH
DLRSSVNALKTSNSKLAESLESKNFEALDKQLQSNSAIAHSSYNLLDNLLHWALLQTKQL
YFRKESVHLFSVVQQMEFNYKPLMQEKNIHFENLVPKALFACADLSSLKIILRNLMDNAI
KFSGENGRITIHGSASEDFCTLTVEDSGQGMSRETIQQLLEESALVSKKENPEKNGTGLG
MQLCFSMAQKNDGKLLIESEENKGTKISIQLLKAKKNE
>LONDMIMF_01928 hypothetical protein
MNASISSGKLTPISAQQISQINFETLNVIGVIDPSELLTPMVSAEIDLTDKGPVLNVRMV
ILIPKTLLGKAPVELFLDLDNAAQNELRLVLNYESAEKTPKDYLAWFVSYAHDIKDGEQE
IKSIRTFTQNTHFEDANPKTSRGTVTHVLQS
>LONDMIMF_01929 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MARNDLKGKVVLIAGGAKNLGGLLSRDFAAKGAKVAIHYNSSSTKADAEKTLAEIQNAGG
TAFLFQADLTKVDNIKKLFEETKAKFGGIDIAINTVGMVLKKPFLDTTEAEYDTMFDINS
KVAYFFIQEAGKKVNDNGKICTIVTSLLAAYTGLYSTYAGAKAPVEHFTRMASKEFGSRG
ISVTGVAPGPMDTPFFYGQESEDAVAYHKSASALGGLTNIKDIAPLVEFLVTDGWWITGQ
TIFANGGYTTR
>LONDMIMF_01930 hypothetical protein
MKSPYDPCPCGWRVPSAYSSVSAEANTTPWGKNATNTNTTFQNLYGNADFQGIKIYPGLG
FDFSGVSDRNFNQIPINGNYEYYPQAMSLKDGSTLNRDANKLFLNPTIGFQDQNSDGGLH
TSTFLSSIESNPANKPVTGTRGLLLISDAANVPNHSQVGWHYIAQNRYLEGNTYESRGVR
CIKDPNNAYMPAAFETEYVSTSPMAYTLETLKEWSKEPNSYIEYTNSAINTPNATDKDRV
IDIPLRKAYAMQKLYLSETNDFPVGNIKSSSVVWSTDQSLISKIEIIDGSIENAILRVTL
NENKTGNAVVAFHLGSNGTWTNGNNNDPVIWSWHIWAPQSLVQEYSTYTTETVANGGIKD
DQSGQFVNPTNSYYGVPLKTTLMDRDLGAQAPFLNQHYVAAGLTNFIYNPANPNSESSLR
VQAIKNSGGLHYQWGRKDPIPVFYYPGGYYEHSSGGSTRDNFRKYSVYRQTGVSGTNIVY
GTINEASYIANYSKDYSSYSSGISTNDSKYEKIKKVLKYSVANPSTFMYQNTSSNAKDWI
SDENGLYPERWGHATEKSPFDPCPNGWRIPDLPKSLNAQDGVNIYDGFLNYNTGNSPWFY
NARFSQNNKNIYGLVPSDINTYVNNEAYNINSLNYIGGYVRATGTGRTQTKYGFILNKLE
YNIGNFPNNGIRGYNGGNTLTASQTAVTPGVDDNFLYSGIWTATLTNDQAIGILFNANIS
QASSTQNNKLFFFTPSNSFRPQASMSCRCAKIEYDANGNEIGRYEPFAIAVPKNTTGKAT
NVFAQKQIEEIKKDEKKLSVFPNPVKSLLYINADDKEYFYQIYNASGQLVKEGKFENKKT
DLSSLAQGMYLVRINNAETVVKIIKE
>LONDMIMF_01931 hypothetical protein
MEILLSEILLKIRHQENIFSSHIMQTSDEAYQMTLFLNTMLHNIKADVLKSGFKNEQQEI
DFFKNIKPQILGKLIYYNKVFRLETTCPASKGKMYQSFYEKQLKILKTEYEENICNEDFY
RYYRANRTDRDHSYFTLGNINYHDGLKSGVFEIDLTFSTYYDHKIAHIIANELIYTYLLS
KINPEENPDALLQNLETNKDISWTNSQNALIELIYALYASNSVAYGKIGIRKLALIFQVL
FQTPLNDIHHSFHRMKTRAGSRTAFLDQLKLSLEEYMDKDL
>LONDMIMF_01932 hypothetical protein
MKIITIEEEAWLKLNNSINAIADYLKKLEDKSYDDLWLNNHEVSQYLRLSEKTLWRMRTK
GEIAYSKIYGQYFYTIGAIKDMLNANAIESSDEFLQELMAKGKSYIEKGRNLKLGKP
>LONDMIMF_01933 hypothetical protein
MNIDRMEFLAWMERLIGRLDMLGDNINELQKKRNSIDGEELLDNQDLLQMLKISNRSLQR
YRSNGKLPYYTISGKLYYKLSDVHQFIRESFNPPTK
>LONDMIMF_01934 hypothetical protein
MSEETANTQEMPEQLSDILLVLDKEKMKIQAVKSIDEKGKMETVDPTKKNENQFMRVDKG
GDFFSNFFSNFFSQLKNPTNFSFFKVPAPIAVEKAQEMQKQVNKPTPEGEKVMQEHEIKT
EIKQDNKQENQKDMATTQTAAETSEYRYKPEQIDWDTMNNLGLSKEFLEKRNLLEPLLKG
FKTNELVPIGVNLGGSILRTDARLSLQQAEDGKVVVGIHGIKKEPTLHFEFFGHKFTDED
KKNLLATGNMGRVVDLKNTKTGEMMPSIISIDRLTNDIIALRTDFIKIPDEIKGVKLNDA
QKQTLLEGKPLYLEGMISNKGTEFSATVQFNADKRYVEFLFDRSNTNKQTQSNGQNNQQS
NQQNQAQEAPKTFRGKELTDEQHKDFKNGQTIYIDGLVDKKGQPYQGYITFNKEDGKTNF
EFPNQYKERAKPTETHKTQTAVNSEGKTNEATKKINEPLKSGQQSPKNKQQQEQQEKPKT
PAKSKSRKM
>LONDMIMF_01935 DNA topoisomerase 3
MKTIIAEKPSVAREIARIVGATEKKDGYITGNGYFVTWAFGHLIGLGMPEDYGISGFDKT
ALPILPNPFLLTVRKVKKDKGYAVDTGALKQLKVIEQLFNKSERIIVATDAGREGELIFR
YIYEYLKCNKPFERLWISSLTEKAIKQGFENLKSGKEFDGLFQSAQGRSRADWLVGINAT
QALSIAAGNGIYSLGRVQTPTLALICKRYLENKNFTIKNYWQIQLLQNKSSIDFESISAE
KWEDKKVADDILKSIQRNGTVTIKSVEIRNVTEQPPLLFDLTGLQKEANKKLNLSADETL
NIAQSLYEKKFITYPRTGSKYIPEDMWAEIPNLVRALQDRENCKQAVSKMKWGRFNKRIV
NDLRVTDHHGLLVTDKIPSALNAKENAVYDMIAFRLLEALSQACIKEITDVDLQALHYDF
TAKGCKILEAGWRSIKGNFSDDDTEVLQDLPELNKNDELKIKEASVLEKKTKPPVLYTEA
GLLSAMESAGKEIENEDERKALQNIGIGTPATRASIIETLFTRNYIQREKKSLIPTEKGI
QVYELVKDRKIADVAMTAEWELALQKIENNEMNAETFQKEMENYASSITNELLQTSIAQN
NLPKLVCPKCKAQHLIIRDKIVKCPDEVCNWIQFRNVCGIQIAIADIENLINKKKTSLIK
GLKSKAGKKFDAYILLNEDFTTSFEFEQNKSPKNNRK
>LONDMIMF_01936 hypothetical protein
MDTPKKDLSYFSLRLKDLLNTSFPEKAHDQKFIEHRASLAANVYEGAFQSGNDVEKCNEI
ANYILFEGLHFSKFDTVFEVVCNEFDTVMADEELRLFALKMFPICKPIFDGYELTDDFAY
NTDFDLLYTELTGTIALWIEENGLQ
>LONDMIMF_01937 Modification methylase VspI
MGFSKKQHLQQNIDALRIAFTLDKEKRQATVGERLLMMQYSGFGGLKFVLNPIAKEIDIN
NWRKTEHDLFPIAQELHQLLKENSEDEKQYRKYVDSMKSSVLTAFYTPPQVIDAISTTLR
ESGLNIEKFLEPSAGIGSFIQSFSENQKASVTAYEKDLLTGMILKQLYSESNIRVSGFEE
IPEKEQNSYDVIASNIPFGDTSVFDLSYSRSKDTAKVQAARSIHNYFFLKGADMLREGGL
LVYITSQGILNSPKNEPIRRALMEDNNLVSVVRLPNNLFTEYAGTEVGSDLIILQKNTAK
EKLTEIEELFCQSKPTEFNTIGNAYFQDNSRIVYTNQKLDTDPYGKPALIYTHKDGFDGI
AKDLKQMLSEDFGKHLNLGLYRGERNNEPIIQIPIEPKITSPNIETVITQGSAQELKQLS
IFDLFENVNEPVTVIVPPKTTTPTKRQNAKKSSRTNGRQANLFSSVQQSYIPSVANSSEN
VITSNYSKKQEVIGDLFSSLDGNDQVTQPAVPENIPEPVIFSGELQSFHRNDCLVVDNGW
VGHLQDVDNSNGKAVFHPLRLPTLQNARAEAYIAVRDVYQELYNKEAKFHTEQKGERENL
NQLYDVFIKKYGNLNSADNIKLIKTDSSGKEIPYLERVVGGVVHKADIFSRPVSFSTITI
ATDNPEEALAASLNKYGSVDLNYMSEISGMADDALKEALHGRIFYNPLQKEYEISERWIA
GNVVEKAQEVKSYLERNPDDTEAKASLTVLEEARPRRIEFEELDFNLGERWMPTGIYARF
ASHLFDTDVVIHYSESSDDFSVKCNRGNLHIWEKYAVKSESRTFDGIALLKHALVNTTPD
ITKKITVEGQEVKVRDMEAIQMANTKIDEIRTAFSEWLHAQNDEFKNRLTDQYNDTFNCF
VRPNYDGSHQDFPGLDRKALGIEDLYSSQKDTVWMIKLNNGAICDHEVGAGKTLVMCTAA
QEIKRLGLAHKPMIIGLKSNVHEIAEAYRTAYPHAKILFPGKEDFTPQKRLRIFGDIKNN
DWDCVILTHDQFGMIPQSSEMQKEILQIELDSVERNLDALQSQGKEVTRGMLAGVIKRKE
NLEVKLKTLQHDIDNRKDDVVDFKMMGIDHLFVDESHQFKNLMFNTRHSRVAGLGNVDGS
QKAMNLLFAIRTIQERINADMGATFLSGTTISNSLTELYLLFKYLRPRAMEKQGIHSFDA
WAAIYARKTTDYEFSVANNIVAKERFRYFIKVPELAQFYSEITDYRTAKDIGIDRPDKNE
ILYTIPPTPDQSAFIQKLMDFAKTGNAELLGRPPLSQSEEKAKMLIATDYARKMSLDMRM
VSGKYEDHPDSKASHCAATIAKYYNQYNAQKGTQFVFSDLGTYKPGEWNVYSEIKRKLVE
DHGVSAHEIRFIQEAKNDKQRKELIKGMNEGKIRVLFGSTSMLGTGVNAQKRAVAVHHLD
TPWRPSDLAQRDGRAVRKGNEIAKFFANNKVDVIIYAVEKSLDSYKFNLLYNKQLFIDQL
KNNNLGKRTIDEGSMDEKSGMNFSEYVAILSGNTDLLDKAKLEKQIAGLESEKQAFNRSK
SSAKYKLQDYTVLLESAQSRFNRMNLDWGNLKQRIQKHSDGTIANPVQLDGLPLNADIKQ
IGIKLNQLADKSRTGGQYEEIGNLYGFTLLVKTEMSEKEGLDIRVNRFLVQGEGNIKYTY
NNGLIAKDEKLAAMNFLNALEKLPSYIDQEKKKIVEIQKDLPVLQEVINGTWAKEDRLSE
LKTELASVERKIQLSINPENKGEEKEKIEKQTLKTANPESALKNKSIHLSRGV
>LONDMIMF_01938 hypothetical protein
MTKFFNETLHKLETEITEIEAESCFQKVEAIINLIVNSLSELREYVLKNEFQDKEEEIRF
FKYQKPVIVAKLIFYNAIYKIETKRPYGAKLIKKYLNIELRKLKRFFESNLEFYKYYRTN
NTYIDEKIFVRGKYDIKLSLDTFYFQADHTFSTSHDYKVAKIIANDQLQIYIENQLHKAT
NEEKSTDLPTLNWTASKTALIELIYALHSQAVFEGGNIDLKVIAKTFGQTFNIDLGDFYH
TYIELKSRKINRTKFLDNLKESLLKKMDEQDEM
>LONDMIMF_01939 Multidrug resistance protein MdtG
MNKIIKPIIEPFKSLRNATFAKLYFAQIASLLGDAFTWLGLALLTYQMSPKNAAAILASA
LTLRVTAYILFSPFAGVVSERFQRKQILLVTQVARMTIVCALPFVNAEWQLYGLIFALNV
FAAFFTPTYRAIIPQIVEKEIYREANGLSMATFQLLSVFGPALAGIFAVWMGATQIFFIN
GATLFVAILIILTIPKGTLQKGVNNENTASKNTWNEVLKGIRLLFGNKIVRFALSIEFIS
AIAGAIILVNTIGLVKNSLKLDDQHYGWIMSIFGVGAAITAFLLGSLDKSKSRSVSLISG
AMLLGIAISFANFLPYNGVMFLWVLAGIGQTLADMPSETLIGENIEAKDHGKVYGAHFAF
SHLWWAIAYPIAGFLGTQFPGREFLYGGIATIILAIAAILLIRKPQVKQ
>LONDMIMF_01940 hypothetical protein
MLLNKKISISYFVKQVKWQIFFVVTFALTIGFLHLTPVLADIAIPFSILALLGTIVSILL
AFRTSQSYERWWEARIVWGAIVNDSRTLTRQLNQFLSTKEKEEIKIFAQRQIVWVYALGE
TLRKVGFSSKVEAYINFHKISAVNIPNAILDEHSKQMGFLAEQRKISEFQQLQLNETITK
LCDSMGKCERIKNTVFPRAYSLLLHTLIYVFTILVPFGLEHSQFTIQIILSILIPIMFIA
IEKTAIMMQDPFENTPVDTPMTSLALTIEINIKQMIGEDEIPQKKDNELYFEM
>LONDMIMF_01941 hypothetical protein
MSLFILQNIIHYTLHFFFPGLVAFVFFKKEWKTVWIILLSTMLVDIDHLFAEPIFDPNRC
SVGFHFLHSYYAIVLYVLLFLFGNKIIRIIALGLLLHMVADFQDCLW
>LONDMIMF_01942 Nickel and cobalt resistance protein CnrB
MNSSFKKYIPFLLIVVITVLSCKDQKETATEQAVTENKTDTASQVKQITFTPDQYKLSDI
QTGTIELRNLSNIIKLTGAIEAEPNSVATVSAPLGGYIKSAGLLPGQFVKKGQQLATLEN
PEFISIQQEYLESIGRLEYLSQEYKRQQDLRNEDINAAKTYQQVSSDFKVMKARISGLEQ
QMALIGISTASLKRSNKISRTAGIYAPISGYIKNSNTNIGKYASPTDILFEITGTNDLHL
ALNAFEKDLGKIQVGQTVRFSLSNENDYKHTGKVFLVGQAADDKKMIPVHCHFTKDVKLL
PGMYVKAWVETGTDEKNAVPNDALVQLEGVDYIIAQTNEGKNGYTFQLIQVAKGIEQEGY
TGIELPSTANPQQIKIVTKNAYTILSAIKNAEEEE
>LONDMIMF_01943 Cobalt-zinc-cadmium resistance protein CzcA
MLNNIIHFSIKNKLVIGLFTLALICWGSYSVTKLPIDATPDITDNQVMVITVSPTLAAQE
VEQLVTFPVEQTMVSIPGIKDMRSFSRFGLSIVTIVFEEKVDIYWGRQQVQERLTLAAKN
IPEGVGVPEMAPLTTGLGEIYQYVIHPKKGYEDKYDATELRTIQDWIIKRQLLGTPGVAE
VSGFGGFVKQYEIAIEPDRLASQNINISDIFTALEKNNQNTGGAYIDKGPNAFFIRSEGL
VKNIEEIKKIVVKNEGGIPVLLRDVADVRFGNGARYGAATRNAQGETVTGIVMMLKGANS
SEVITNVKAKIEEIQKSLPEGVEIEPFLDRKKLVDGAISTVSTNLVEGALIVIFVLILFL
GNLRGGLVVASVIPLAMLFAIAMMNLFGVSGNLMSLGAIDFGIIVDGTVIIVEAVLHRIT
TSKNRYGGVEKLTQEQMDEEVFQSSTKIRSAAAFGEIIILIVYLPLLALVGVEGKMFTPM
AQTVSFAIMGAFLLSFTYVPMMSALVLSKKTTHKDNFSDKMMRAIQRVYSPIIEGAMKRK
LLVISIAVAMFVITLFAFNRMGGEFIPQLDEGDFAVETRVPVGSSINQMIDVSQKAQDIL
LKNYPEVKQVVNKIGSGEIPTDPMPIEAGDMVVVLKPKKEWTSAADREELIDKMQQSLAV
IPNATFSFQQPIQMRFNELLTGAKQDVVLKIYGEDLDVLSDLASDVGKKIKSVEGVEDLY
VEEITGLPQISIQFDRDKIAQYGMNVEDVNSAIETGFAGKTAGLLYEGERRFDVVVRLDS
ASRADITDVQNLFVSTPTGQQIPLSEVANISYKPGPVQIQRDNAKRRITLGFNVRNRDVK
SIVNDIQDIVAAKVKMPAGYHITYGGQFKNLEEANARLAVALPVALLLILLLLYFTFRSV
KQGLLIFTAIPLSAIGGVFALLIRDMPFSISAGVGFIALFGVAVLNGIVLIAEFNRLAKE
GVTDIYERVRIGTKVRLRPVLMTAMVASLGFLPMAISSSSGAEVQRPLATVVIGGLITAT
ALTLLVLPVLYIYFTKSTFKMKKNKTLPTAILLLGFLCFSSTLKAQVSSGTNTRVLTLQQ
SIDEAVKNNNSIRIAEYNINVQKALKKGSVTIPKTELSYTQGVVSNPTINDNLINVTQRF
DFPTLYSNQSKLAQEKIISTEKYKAVSENELIENVKLAYLQYQYVLEKGKLIAALDSIYS
NLSKASDARYRTGESTNLEKMTSSVQLKQIQNELEKNNADVKIAKQQLQTLLNTTDDISI
AETNLTAKELLLTIENFSANNNPIIGYLQQEVNVSQQEMQVEKSKMLPEIILGYSAQTYK
GMQTINGIDRTYTGKDRFSFFQIGIGIPLFPGGYKSKINAAKINREIAATQVELNKTNLN
GQLKELEQQYAKLQNELNYYQQQALPQANLIISNSEKSFKSGEVSYAQHLQNLTLANNIR
TAYVESLYNFNKAIIAIETLSGNK
>LONDMIMF_01944 hypothetical protein
MSEIAHKVLDKKSIIKQVIIALIIGTTLLVSAVLPAEYGIDPLGIGKATGFSKLYVPEGS
TENLSSEPHKILKMENVGSPADVAKPDAANNPAPATQLAERTDDVSVVIPAGKGLEYKVN
MLKYGQLKYEWITDKGELYFDFHGEVKNNSNYFESYTIAYSNNMAGSFLAPFEGPQGWYF
KNNSNEDITVKIKMKGQYLLKQ
>LONDMIMF_01945 hypothetical protein
MQYVKIVLSIALLLLVSGSAYAHGVDEDTQTFLSGNSGVAFVPFLYIGAKHMLTGYDHLL
FLVGVIFFLYRPKEVLLYVSFFTIGHSITLLLGVLADMAINAYLIDAIIALSIVYKGFDN
LGGFQKFLGRQPNTKAAVLIFGLFHGFGLASKLQELSFDRTGLLTNLLGFNIGVEIGQFI
ALALVLFVITLWRKSPSFFKFSTVTNMLLMAAGFLLFGYQLVGYFNS
>LONDMIMF_01946 hypothetical protein
MKKSFIIAAFAALTLVACNTNEKKSSDNTDQVTPVETANQDSIDKAHGHSHDPSGNHTAP
AAKADSSTVAPLKQDSIDKAHGHKH
>LONDMIMF_01947 hypothetical protein
MVLKFFFLLSFVTNKTYLYIFVKMLRRYTAILFLIVAQIMILGHGIVSHHHHLEIVNDEH
HNGKNNGETPLEIAFSGFIHAGENISFTNSSETKIVISKDDVKSIKALPIHFTAPVEYIV
DYQKNTFPPDRHIIYLPPLHGAYSLRGPPSFIVA
>LONDMIMF_01948 hypothetical protein
MQGEDDLRGLAKIMAFMRAVSILLVLMHLYWFCYGFFLERGWTLEIINKILGNFDRTAGL
FSHNLYTKIFALVLLALSCLGTKGVKNEKITWSKIYVALSIGIILFFLNFPLLKLPLLTA
TFLYIFTTALGYIALMVAGVWMSRLLRTNLMEDVFNNENESFQQETKLMENEYSVNLPTK
FYYKGKWNNGWINIVNPFRATIVLGTPGSGKSYAIVNNYIKQQIEKGFSMYIYDFKFDDL
STIAYNHLLKHRDKYKVQPKFYVINFDDPRKSHRCNPLNPDFMTDISDAYEAAYTIMLNL
NRSWIQKQGDFFVESPIILLAAIIWYLKIYDDGKYCTFPHAIELLNKKYSDVFTILTSYP
DLENYLSPFMDAWQGGAQDQLQGQIASAKIPLSRMISPQLYWVMTGDDFSLDINNPEEPK
ILCVGNNPDRQNIYSAALGLYNSRIVKLINKKGQLKSSVIIDELPTIYFRGLDNLIATAR
SNKVAVCLGFQDFSQLTRDYGDKESKVIQNTVGNIFSGQVVGETAKSLSERFGKVLQKRQ
SLTINRSDKSTSISTQLDSLIPASKISTLTQGMFVGAVSDNFDERIEQKIFHAEIVVDNE
SVASETKAYQKIPQILSFVNQQGEDEMKKQIEGNYRQIKMDILNIVENELERIKNDPDLQ
HLLQQA
>LONDMIMF_01949 hypothetical protein
MIAKIGRSGNLYGALAYNQLKVENENGQILFTNKMIETANGHYSVSQLAQSFAPYLIANR
NTEKHTLHISLNPDPRDEVSDDKFREMAEEYMREMGYGEQPFVIFKHTDIDRSHIHIVSV
CVDEEGKKISDKFEKMRSMNVCRELERKHGLIAATDKEHKLNDKIFSPINYKAGDVKSQI
ASVIRHLPNYYQYQTLGEYNALLSLFNITTEKVEGELQGQLQKGLLYIPLNEKGEKAGHP
FKASLFGKSAGLPALELHFEQSKIALKNNPVQKTLKSAINIALQSTTDELSFKKQLTEQG
INVVVRRNDVGRIYGITFIDHNSKTIWNGSRLGKELSANTFNDYWNNNIKPEIKEPVQSQ
IKASKSNDAENLPVEKPHHFFDFLNTEKHEDGLVEALGGLLPEIQGEDYEEQDFANKMKK
KRKRHRGQQ
>LONDMIMF_01950 hypothetical protein
MNENNKRKQNKGGRKAKIDPSIHRHVFRLTDEENAKLLSLFETSGMPNKAKFIISLLFGN
EMKSVKIDKGTVDFYMRLTSFHSQFRSVGVNYNQIVKLLYKNFSEKKAAAFLYKLEKQTA
EMAMLCQKIIQISEEFETKYLKKQP
>LONDMIMF_01951 Iron-sulfur cluster carrier protein
MDTKKKPLFIAFSSQKGGVGKSTFTTLVASTMHYRLGYNVAVFDADFPQHSLMKMKTRDL
AMVMENETLKKLAYKQFTTINKKAYPIMQHKADSVLEAAQEFVNTSTTPVDVVFFDLPGT
VNTPGILNALAGMHHIFTPIAADRVVMESTLIFTQLLQDVIMKKGETSIETIHLFWNQVD
GRESTPLYAVYNQLIEQLGLSLMQSQIKNSTRFRKESEADSKTVFRSTVMPPDERLMKAC
QLNLFIEEFLKIIQL
>LONDMIMF_01952 hypothetical protein
MEKDNKRKATPDINEEMMMNLMVDGVKKDGIQLPPEPIEKMENEAVKQEEFSRNKPAQKE
KNRTKKILDGSYGDHFLKTHSMTKRGDKSIYIRQEYHERLSRIIQVIGKDEIPLYAYLDN
ILEHHFEVFEKAIIDDFNEKYKPIF
>LONDMIMF_01953 hypothetical protein
MEIVIVICLLIVIFLLVQDKIIINKKSKQKPTQEKINPNLPDIMGLPKPVRSLSMPNTAN
ERQIEEDEINPDNLDIEYDENENVGIQIPQEELDEVFRNIPDLDEEEEEWNRYGISDGDD
GFAQGVTFEELSSVGMLLQKEELEPAQKETAVDIVQRLQGTELFSLLESSIDGASRRIAE
LLDSTLTSETDAGSSTLRKSDVSDFDIGEFV
>LONDMIMF_01954 DNA primase TraC
MPLKINVPYSDKDSAKSKGAFWDVEQKTWFVPDHKDINDFQHWIDKSKVSVIIKSPVSIA
LNSSDCYKCANKTAVISLASNNFYYLNTDENEDEKWFRADGLSFFSMPVFIENEIAGKIK
RLFPNYKIAYSKTAESSYWANHCEHCGALQGDFFLHSEPGGAFFPLEIEEYEQLTFITVP
SKFDVEIDADYSWLSNADVIPKYAKSVSYEEFLEQQK
>LONDMIMF_01955 DNA helicase II
MFIWEKDSINKEQEDAILEDNSVLLIACPGSGKTRTLTFKIAYELSRLKSDKEFVIAITY
TNRASDEIKERVELLGVDTSQLWIGTIHSFCMEWILKPYHLYSERLKNGFKVINSFDSEK
ILTELCKPYKEEKITYYDCGILAKTDNFYLTCLDTKKHNSLQKILGEYFAILEKNRQIDF
EQILFYAYEILKSKPVVANILSKLFPFILIDEYQDTKEIQYHIISKILSVNKGNSKTLIV
GDPNQSIYDSLGGYPMPKDELEKLLGFELTPLSLDKNYRSSSAIINYFDYYKTFDTPIVA
FGNGKDYPSIITFNSVVSVDDLIEELAQLILYNVETAGISPNEICITAPQWVHIASITRK
LIIRLPDFSFDGPGMAPFSRDIDNFWFKVSRVALTEPSPFMYVRRLRWSKEILNELDSAG
VDVSNVSSKEFLRICNSFEINETDGLTYLKSFFNQICEKLKIVLPNFPLLDEHFNSFFAS
SESRIQRLIDEGNPYIGDIENFRKVFRQRDGITVSTIHGTKGEEYDAVIGFGLLDGYVPH
FNDNNGIENSKKLLYVLASRARKNLHLISEKYRNVHKFYAPDGKPPTSHLLEYTYDYSFQ
KFEGMD
>LONDMIMF_01956 hypothetical protein
MGAENINQVQRYLDAVRTNLLFAKGVILVEGDAEEILIPIIVKKVLGISLDELGISLINI
RSTGFENVAQLFHNDRIQRKCAILTDLDDAICDTTENAGDSDALKKYKKKVAGSKQKGLE
RKTKLDAFEAGNTWVKAFYAKHTFEVDFISEGNAWEVERIIKKVYIDPATRTQAKTDIES
ADVAIYGKRVLTMAKQEGKGWFAIMLGKHISYKTEIPAYILDAILFAKETYSSNIVADII
QYRMNKHFEADNALDFTSCKAELLKYRNGTNKLEDLAFDFDLVLPDDQILILIDKLK
>LONDMIMF_01957 hypothetical protein
MIILYHQNNAVTQVWNDTLKGDVPVRLASIADTLFEVAHAFPESLLFWCHESQRNYFNKD
SNSIAAIFHHKKIMAFYNPAKENYFPDTIGYVDESLFANPNKNEKFATWFASAAIGGIAS
EVLLRLEKEIVHDRDFDYFLHSLAKLWMPHGLLCYSEPRLLLHSNTDYKTSKATAKTVFK
FVRQHYKFRWLFLLRLNYVLHQKSGHSKAFYQSLFYSKRKTDGKALDTLVVQSSRKIINK
ATVDVVIPTIGREQYLHTFLSDLAVQTQLPQKVIIVEQNSVEGTQSNLDFLKNTSWPFAI
SHTFTHQAGACNARNIALAQIESEWVFFADDDIRIGEDFLETAFSQITKYGNEANTLSCL
QLNEKTVFDTVFQWKTFGSGCSIVKAETVKGLQFDLRFEFGFGEDADFGMQLRNKGYDVL
YFPFPQILHIKAPIGGFRTKPELVWKHEKLQPKPSPSVMLYRLLHQSKTQLQGYKTVSFF
KFYKHQSIRNPFRYYKNFKAKWAVSLFWANKIKNS
>LONDMIMF_01958 Alpha-maltose-1-phosphate synthase
MHIAFLTPEYPHEKVRHAAGIGTSIKNLVLALHKEGIKVSVFVYSQKTNEILEEDGIKIH
LIQHKKYKAFGWYFYRKHLQNYLNRYITKDKIDLVEAPDWTGITAFMNLNAPLVIRFHGS
DAYFCHLENRKQKRKNFWFEKLGLGKAKAYIAPTQFAGNLTKEIFKIKGKLIQTLHYGIQ
LFDFSNETPADFEPGLILYIGTIIRKKGVLELSAILEKVVAKNPEARLLLIGSDSYDLQT
QSTSTWQLLHSMLNETLKEKVSYLGRVPYNEIREHIQKANVCVFPTFAETLGMVTIECMA
MQKAVVNSNIGWAKELIIDGESGFLVHPKDHTVYAEKINELIADKNQMLQLGKNARTRVE
HVFDIRKTVLQNIEFYKQQL
>LONDMIMF_01959 hypothetical protein
MKRFLLHLLKVFVGFIAVIYLLDYAFTAGYVNSKPRNKIALAYTGKPQDYDVIFLGSSRA
NNHFVPQLFIDKGYSAYNFGMSGSRLEESALLLELLLAKGTKIKNLVVEVDLNINSNGFS
EGTRAYFYPYLKESVQIRDYYKNIEDFDQLYYLPFYRYLKYDAKIGSRELFFTIAERPSK
SLQRHGFYPLKGEGKNMKYDLSKYSPKRNTAYEKIKKICRENNIRLIAVTTPMCENVKNA
AYFEDVVKLYPEVHNFEAVVTSDDYFSSCGHMNERGATVFTQFLLDKFFQ
>LONDMIMF_01960 Peptidoglycan O-acetyltransferase
MFFNSLSFAVFLPVVFCLYWFVFKTSKKAQNALLIIASYYFYSCWDWRFLFLLIFSTGLD
YFTALKIENSQSKASRKTWFWISVGVNLGFLGVFKYYDFFAVSFSELLKGFGLQANPLLL
KLVLPVGISFYTFHGLSYIIDIYKERIRAERNFIDYALFVSYFPLLVAGPIERATHLLPQ
VKVKRNFDYQQAKEGLHQILWGLVKKIVIADSCAQYANAVFDNYENMNSLSLMLGAVYFA
FQIYGDFSGYSDIALGTSKLFGINLLKNFDYPYFSRDIAEFWRRWHISLSSWFRDYLYIP
LGGSKGGTWMKIRNTFIIFLVSGFWHGANWTYLVWGFLNALYFLPLLLSKKNRIHTGNIE
NVNPVQAFKLIPQIGLTFLLTCFAWIFFRAPTITDAFGYIQRMFTNLKFKSQYFSIERYN
YELLLMILLFVGFEWFNRYKVEPISGRYGYLKIALAIAVLLLFGVYSEYKSFIYFQF
>LONDMIMF_01961 hypothetical protein
MHNKKIFILLPDGIGLRNFAYSHFHELGQKEGFEPVFWNNTPFDLKTLGYEEVKIHRAKT
HPLTDIYKNARKHIELNLNIQKSGDSVYDAYRFPFSYKNLKSSLKSIATHVIIASKSSGK
GLEKVRKKIQQQERKTDFYRDSLATLQKEKPAMVFCTNQRPVLAIAPLLAARDLGIPTAS
FIFSWDNLPKATMVVETDYYFVWSDHMKKELLYYYDYIRPEQVFVTGTPQFESHANKATI
QSKQAFFEANGLDSAKKYICYSGDDITTSPDDQQYLADTAKAVRALNAKGYNLGILFRRC
PVDFSSRYDAVLEANKDLIVSLPPLWKKIGEGWNTILPTKEDVALQQNTIFHTEMVVNLG
SSMVFDYVSYDKPCCFVNYDTESTAGSNSSVKKIYNYVHFRSMPHKNAVIWLDKPEEIAD
RIEAGLQHPESNVVAAKEWFDVINEQPIENASARIWEAIRNIIR
>LONDMIMF_01962 UDP-N-acetylglucosamine 2-epimerase
MKKILFLTGTRADFGKIKSLIQILEKDQDFVPYIAVTGMHLQQEYGYTLIEIERCGFENI
HTFSNHTHETTMDLTLAKTIEGLSAYVKECQPDLIIVHGDRVETLAGAIVGSLNNILVAH
IEGGEISGTVDELIRHSVSKLCHIHFVSNEQAAKRLIQMGELSSSIFTIGSPDVDIMFSE
NLPDLETAKTYYDIGFDNFAIAMFHPVTTEAKYMMEYAANFIQALLNDNHNYVVIYPNND
LGSKAILDAYQQLKDNPRFRIFPSLRFEYFLTLLKNAQFIIGNSSAGIREAPYYGIPIIN
IGTRQQNRAVHSEIINADYSVEAINDALKTIDSHTVNAEKEDFGAGNSAGLFLNSLKNQD
IWQLNHQKQFRDIDAQ
>LONDMIMF_01963 N,N'-diacetyllegionaminic acid synthase
MNPYIEIAGRKIGIDYPPLVIAEIGINHEGSLAVAKEMVDAAHKAGAEVVKHQTHIVEDE
MSGAAKKVVPGNATVSIYEIMERCALNEAEELELKEYVESKGMIFISTPFSRAAAERLKK
FDIPAYKIGSGECNNYPLLEHIAGFGKPVILSTGMNTIESVRKAVAIFDRHNIPVALLHT
TNLYPTPIHLVRFGAMTELHQAFPDKVFGLSDHTLNNNACLGAVALGASILERHFTDHMN
RTGPDIVCSMDETACKELITGSNEIWQMRGGSKEPAKEEQVTIDFAFATVCSIKPIAAGE
VFTKENIWVKRPGTGKILAEHFNDILGKKATRAIGNDEQLVWNDIQ
>LONDMIMF_01964 CMP-N,N'-diacetyllegionaminic acid synthase
MKTIAIIPARGGSKRLPGKNLMTLGGLPLIAHSILYAKANSNVIDAVFVSTDDSEIKKIA
LEYGAEVIDRPAHLAGDHEPTVTALKHVLESIKTRPETVILLQPTNPLRPEKLLKQAIEI
YKNEKCESLFTVTRSHHKLGKINNNKFVPFNYKPGQRSQDLEPLYFENGLLYICKSDLIL
EDTIISENAYPLLVEHVFAQVDIDTADDFDYAEYIYQKNK
>LONDMIMF_01965 GDP-mannose-dependent monoacylated alpha-(1-6)-phosphatidylinositol monomannoside mannosyltransferase
MAKVILISQLPLPYPKIGSWTTLYQNYLNGDHAIDYIICEQPDEQFQNVEYGVVSQTLTL
KLKKKYQKNNYIGYIETLEKIVVSGEKYVIQIVDNFGIIKPLQEFLESKGKRTQCYIQFF
YHGFAPFYGNFESRSFYEFIDEMVLLTHDSYKAHKNYYTILPCRFSVLHNGIDENKFFKV
SKEQKQKLREKLGLTSKTVFIWCSQDRPKKGLDLILDVWNRIYEKHTDCTLLVIGAKRDK
TFAGVSFLGKIPNDELPQYYQAADAYLFPTLWHEGFGLSLIEALHCGCYSIASALGGVPE
VLQHGDLGRLVENPHFIAEWVDAIDEFLLEKKEYPSLAEELYSKTAWNKGMNERIAEAKK
SLGR
>LONDMIMF_01966 hypothetical protein
MSQNGNIRLFWWSEIQLAGKKKENYGDLVGHYLVEKISGRKAVWTHPKKRSFLDRFKTVY
FTAGSILTQVSGKCVVWGSGIISKEYKIKKAVFLAVRGPQTRKHLIAQGYDVPEIYGDPA
LLLPVFYNPEREVQYDLGIIPHYADFQIVTELYKDHKNVLIIDLMTNDVESVTNQILKCR
KILSSSLHGVIVAHAYQIPAVWVKFSENVFGDGIKYQDYFESVGIENYTPEFLAQAQDNN
QTELLFSQTDSLPKAEKIKELQNKLMDVCPFK
>LONDMIMF_01967 hypothetical protein
MITLLYPYRNREIQRIQRSMDSLAQQKVHNFNVVFIDYGSEDGIAAEAKAQVEKYDFASY
VYLYAKNQPWNKCKALNYAIKKLEEGYCFVADVDMIFHPEFTCVLEQCLDAYTATYFQVG
FLSESETKKNVAFESYQVNFKTNEEATGMTLFPVSCLKKINGFDEFFHFWGAEDTDIHNR
LKNAGCKVNFYDKKLLMLHQWHPNYRQRETKTLNKELQLSGIVEINQQHLFHNQKENIIQ
VNPKDWGNIMDKAEWEELQAFPVTLLSNEKQRIDYFLYQQLPNSMNGILAVEIKENPVQN
NFKYRLKKKMGKKVPQFYSLKEINDQILLHIVSFYHTKPYIYQVKEDLKTIIFKIKT
>LONDMIMF_01968 putative glycosyltransferase EpsJ
MKPQVSILIPVYNREHLIAETLESIRLQSFSDWECILVDDHSTDNSFEIVSAFINQDPRF
KLYKRSSDRLKGANACRNYGFEMAQGEFINWFDSDDIMHPEFIHKKVMALNTNSGLDGII
SKTMMFENSIENITGRENRTFLTETTLEDFLKLKISWYLPDIMWNGNFLKGKQLFDEELL
AGQDSDFYARMLIEQPKLEVIDEYLTYYRKHPQNITSHIDNRKNARLKISHLHSVIRLIA
LLEKKGKLSKDLKLHFFKAMMKYLPYVISSKQDLKALMKLLRKLSFFDFGIFKRWIKIFL
AYFSLKIIGKGEKLLK
>LONDMIMF_01969 GDP-mannose-dependent alpha-(1-6)-phosphatidylinositol monomannoside mannosyltransferase
MKSSSPNIAIVTPSQNAYSETFIQAHKNLLDGNVSYYYGTASNIKLEGKGEVLGGAKKLI
GKAIDAVSSKKLQSQKKALLNSWKKNRIDVLFFEYGTTAAQFIDVIKESGLPLIIHFHGY
DASAHATLKEFEKQYAAMFSYATYVIVVSEVMHKKLLEIGCPQEKIVKNIYGPNDIFFDL
EPAFSKSQFLSVGRFTGKKAPYYTLLAFNEVLKEFPEATLVLCGDGNLLETCENICRYYQ
IEKSVKFAGAVTPEQIKNYLKESLAFVQHSITAKNGDMEGTPLAVLESSAAGLPVIASKH
AGIPEVIIDGETGLLFEEHDVETMAKHMKSLLKDKQLAKEMGAKGRLNIRSSFSMKRHID
ILNGLILKASNS
>LONDMIMF_01970 Putative glycosyltransferase EpsE
MKISVCMITYNHENYIRDAIEGVLMQNIDCDMELIISNDCSSDTTDAVIKEIIQSHPKGS
LIKYFFHEQNLGMMPNFIFALKQCSGEYVALCEGDDYWTDENKLQKQIAFLDNNKEYAGC
FHNVLVINEMVPDFKPKPWREYDKHDFTQLDTFSKLALFHTCSFVFRQRFLEFPTWFEKV
KSGDMALFSIISAKGKLRLIDGIMAVYRKNERGVTSGQKIIDYHQNRIRLMRFFKAHFGV
YQTHLNEIIAYHRKEIIKTYKKKVLSIFKIK
>LONDMIMF_01971 Ubiquinone/menaquinone biosynthesis C-methyltransferase UbiE
MNILRKIKKKLTAPKGNFSCSVCGKDNVRLNPLPEKYLRTFAKEGFIHSIFLFETLNLFE
YSCANCAASDRSRLYALYLNDFFSKSKAVKVLDIAPTEHLKNYLNSKVLAQNYRSADLFM
KDVDDNVDIQAMDIYPDNSWDLVICSHVLEHVPDDIKALSEIYRVLKKGGVAILMAPINL
GLEKSFEAEKDKHYTVSERWKYFGQDDHERLYSKNDFIQRIKSVGFNLEELDKDYFGESV
FKKYGITSGSVLYIGKK
>LONDMIMF_01972 Teichoic acids export ATP-binding protein TagH
MDKEIILKAEGISKQYRLGKVGTGTLSHDLNRWWANVRGKEDPYLKVGDTNDRTSKGTSD
YVWALQDISFEVQKGEVLGIIGKNGAGKSTLLKILSRVTAPTTGVIKTKGRIASLLEVGT
GFHSEMTGRENIYLNGAILGMTKKEIRSKIDEIIEFSGCQRYIDTPVKRYSSGMTVRLAF
AVAAFLEPEILVVDEVLAVGDAEFQKKAIGKMQDISRGEGRTVLFVSHNMAAVKSLCTRA
VLIDNGRFVFSGSPESTIDEYLKAEKSSNVLEKVWPLEKAPGNNVCKLISVKAKTEEKSI
FISNDLEIEFVIENLGEAPKKLNISMVVYSSAEVPVFNVVSDSYNCEKGRYVISTIIPKN
LMNTDTYSVRVLLVEDSSKPLCNEYNVLNISYLEEKRDVAWYGKWIGAIRPQNLIDWDFK
KI
>LONDMIMF_01973 Tyrosine-protein phosphatase YwqE
MLFFSKNKPILRDLIENYTDIHSHLLPGIDDGSKNFETTLSLIQSLQKIGFEQFVTTPHI
IKNIWDNSRSGIETLCASTTEKLSKENVNLPFKAAAEYMMDDSFSKLMESEKLLTLKDNY
LLVEMSYINPPMQLYDIIFDIRIAGYQPVLAHPERYIFYHTNFEEYNKLKKAGCMFQMNL
LSTVGYYGSAVAKVAQKLLEKGMIDFMGSDLHHENHLKSFDKKLAFSDTAALKEAIRRND
FFRV
>LONDMIMF_01974 Tyrosine-protein kinase ptk
MNNNQELLQENHESDFNIREQIEKYLAHWKWFLFAVIIALTCAFIYLRYATPLYKASATI
LVKDDKKGGLASELSALSDLGMFGGSKSNVDNEVEVLRSRTLIYNTVEELKLNVYYINHG
RVKSIELYKSSPIIFLFSPKEKDSKKFKKITFQVESVTNNTYRLSYGDKELGVFKYNKLI
SSTFGNISVTKSNRNGSNPNAEFSIDCVVSSLSKETQSFKSRLNVNPLSKNTSVVELSIV
DAVPERGEDFLNTLVELYNQGAIEDKNLVAEKTSEFIGQRLEYITNELTDVEKDVEGFKS
QNKLTDIESETKLFLENASEYDKKRIETEIQLNVIGSMISFLNSSKPEDLIPTNILSAGT
DSEATGLISQYNSLVIERNRIAAGATLDNPVVKNADKRISALKSNIAQSLSRMQSSLTIK
KRDLDRQESQIGGRKAQVPRLEREFRIIDRQQKVKEALYLYLLEKREETALTLAATEQSA
KVIDAALSSEAPVSPKRSIIYLGAFIVGLIAPFGIIYTRDLLNTKIKTRQEIEKRLAIPF
LGDVPKSDSHEEMINTNSRSGSAEAIRIVRTNLEFMLTGTSTERGKVIFVTSTIPGEGKT
FISVNLAGTIALSGKKVLLVGMDIRNPKLAEYIPIRSEGVTNYLSKQDKDLSSYITKLDN
FEDFHVLSSGVIPPNPVELLMNDKINKMFAELKETYDYIIVDTAPVSVVTDTLLIAKNAD
AFIYVVRANYLDKRLLHVPEMFYNQKKLPNMSLVLNATEVMNKGYGYGYGYGYGADVEVK
PWYKTLFKK
>LONDMIMF_01975 hypothetical protein
MKQLNYFRPLIILLLSLFIFSCASRKNVAYYQNIDQLPDLENSSSYETKLQPDDLLMIVV
MAENPEVAAPFNLPSVIMQSNTEIEIQQMRMNSYLIDNNGFIQFPIIGAIKLGGLTRTEA
VAKMNQELSKYITKPSVNLRILNFKITVQGEVTQPGVHNITSERITLTEALSLSGDLTVY
GKRENILIIREKDGKKQATRVDITKADFLNSPYYYLSQNDVVYVEPNKTKVNASVVGPNT
AIVLSAVSLLVTIIALTVR
>LONDMIMF_01976 UDP-N-acetyl-alpha-D-glucosamine C6 dehydratase
MKELDKGNFTSDMRNVISGLKLSFSFKNLGYLPRWVVLLLDLGIVFAAGLITYLMLKGIK
LTYIPDGYLFYGAILYFSVNIFFFWVFRTYSGIIRHSSYIDAVKIFFAQFCALITLVFVN
FVFLLDHDYKIFLNTGIFINGVLSFCFLFFYRIVVKQTFEKYLSVSRKEGQTRALIYGFD
NNAIAVANALRSENPSRFKLLGFIDKFNQNSSKRILDLPILQLKRRVPVVMRSVGAEALI
IADKSLTKEERLAIVDECLEYNYKVYTISLITDWENQEEISKNIKSFEIQDLLERKQIVL
DMNSISSQLRDKTIMVTGAAGSIGSEIVRQVIGFNPKTIVILDQAETPLHNLSLEIANCN
PNIRIHNVLADVRNKQVLKQVFKLYQPQVVYHAAAYKHVPLMEENPSQAIFTNILGSKIL
ADLAHKYKVERFVMVSTDKAVNPSSVMGASKRIAEKYVQSLNYKYRNDAENNSTKFITTR
FGNVLGSNGSVVPLFKKQIEEGGPVTITHPDIIRYFMTIPEACQLVLEAGAMGNGGEIYI
FDMGDPVKIIDLARKMIKLAGFTPDKQIKIKIVGLRPGEKLYEELLNDTANTLPTHHEKI
MIAEETFDDYEAVTMAIQDLIDISEITSNEEIVAKMKMIVPEFKSMNSIFETLDSKHVSQ
T
>LONDMIMF_01977 Putative pyridoxal phosphate-dependent aminotransferase EpsN
MGNQKIWLSSPHMGGTEQNYVNEAFETNWVAPLGPNVTGFENDLEKYIGQDSYVGALSSG
TAALHLGLIILGVKAGDEVICQSMTFSASANPIMYQGATPVFVDSEKETWNICPIALEEA
IIDRIAKGNKPKAIIAVHLYGMPYKADEIHAIANKYRIPILEDSAEALGSHYKNQKCGTF
GEIGALSFNGNKIITTSGGGAIVAKSKEIKDKAVFLSTQARDNAPHYQHSEVGYNYRMSN
ICAGIGRGQMEVLDKHIALRRKMNEFYKDYFKNREGITVLTEPNEDYFSNHWLSAIVVNP
KKTQGKTREDLRLALEKGNIESRPLWKPMHLQPIYEKYPYYGKNIAEDLFENGLCLPSGS
NLTDDDRSRIVNVLDDFFKNNNLQ
>LONDMIMF_01978 Undecaprenyl phosphate N,N'-diacetylbacillosamine 1-phosphate transferase
MNKRIFDVILSFVLLLFFAIFIGLAWIGASVDTRSNGFFIQERIGQFGNPFAIYKLKTMD
KLKRISGFGYWLRKSKIDELPQLWNVLKGDMSFVGPRPDIPGYYDKLEGEERNILKLRPG
ITSDASLKYRNEEFLLAQQENPLRYNDEVIFPDKVKMNLEYYYNRSFLGDLRIIIKTFIR
I
>LONDMIMF_01979 hypothetical protein
MLNVYRLDSEEKSKDYEGLLSRFEEREPYFSSRYMNIFSGGFENLIYFLFESDETGATIL
MPGYLKPIVIGGERTSYFDFITPYGYTGPLFSPNISVSDIMEFWKCVDQWYVDNNVVTEF
VRFNLLGNEAHYSGNVFPTMLNIKGKILDEENQWRDFDYKVRKNVNKAKREGLTSRIYFR
EIKDEEILEFHRIYIQTMERTNANASFSYSFEQFKTFITQNNNVAICTVYFELTPISSEL
LLISKDSIFSFLGGTNEEYFYKRPNDFLKIEALNWARNNEKKYYVLGGGYGFEDGIFKYK
KSFFPNDVVNYFTGRKIVNNDTYNQLVEKANNFRIANGLEKLETNDTSFFPLYNKLN
>LONDMIMF_01980 GDP-perosamine synthase
MITKKAQNQNHLRREWNYTASARDAWSDIIEKYKVLHPNGRILLPSYIGWSANEGSGIFD
SVVKSGVNYDFYELGLHLEINFEDLKHKIAEQENQLVLLVHYFGFMDYQYGQITDWLLEN
NVFFVEDCAHAWLTDLIGGVCGRKGAFSFYSLHKLLPVSEGGIMVDNLPKEREVERMNPF
LDLGYDLLSIYTVRRANYSYLASLLKDVKGIEVIYKNLEEGICPQTLPVIVENYDRTTLY
HKMNESGFGMVSLYHTMIHELENSSSLAATVLAKKIINFPIHQDIDKNDIDEMVLELKKI
LNA
>LONDMIMF_01981 Spermidine/spermine N(1)-acetyltransferase
MTKENYNIRFAKKDDVAEIVKLVRASFNQNYLIPSIYRGKGIEKFVLQELDNPFSPYRYF
VLMDENEIAGYAEYKIFESASMAFLNMISVNNKYKNKGIGRKLFDYTRAFFLEMGLKAIQ
LDVYETNSIALSWYSGLGFRQSNAVSFFKIKPKEEINEIQHKFYIQNYPQYKELQNTFGF
YFLDLTLAGESIRLGVIEQDLIIRGSYTQALEERLGHFSKTLGFENAYFIGADIQSGTGE
FVDKIIRMELNIKL
>LONDMIMF_01982 putative sugar transferase EpsL
MYKSFFKRVIDFLAALVGLLILSPIFILVTIGLFFANQGKPFFFQVRPGKGEKEFKIVKF
KTMNDKKDKNGNLLPDAKRLTKIGSFVRKTSMDEIPQLINVLIGDMSLIGPRPLLMRYLP
FYTERERLRHTVRPGITGLAQINGRNTVKWDDRLAFDVAYVENMSFKQDLEILYKTVLKV
IVSENIVVDPESIMQNLDDERKL
>LONDMIMF_01983 Putative glycosyltransferase EpsD
MKKKFLIVTTISDSLPFFRGQVNVLKENFEIELVSSPGPHMNDMCAQHSVVGHPIKMNRE
ISVFADVVSLIKLIMLFIRTKPFLVHGNTPKAGLLSMIAAWITRVPKRIYYVHGLRYHGE
SGTKKKILMQMEKISCALATNVVAVSEGVKKVLIEDKVCKKGIQIIWNGSVNGLDMVYFD
PDPIDESHVKSDFSIEKDDFVFGFIGRLVGDKGINELVNAFKKINAENPKTKLLLVGNFE
TTLDPLKAETLLEIQNNKNIIHAGFQKDVRPFFKAMHVFTFPSYREGFGIVLMEAGAMNI
PSIASDIIGCNEIITNNENGFLIESRNESALYEKMKFCVGNPEILNNMTKNTRSYVLERF
EQQLLWKKSLEAYQHICEKK
>LONDMIMF_01984 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MDLTFVTECRFYKTPDGKYYADDMSYTNSLWERYLKEFDNINVIARVFETSEKFDESFLV
DNVNFCPIHPFDSIFSFAKNRSKVKKGLRKYLSKDTVTIIRGAGPLGYMATGICKQQKIN
FGIEIIGDPYEVYAPGVVTHPLRPVLRKLFTDFQKKAVRRASAVIYVTKYSLQKRYPALS
GVYTTFASDVFLNEKKIATQHKKISIENGKPNLISIGSLNQMYKSPDILIKAVKLLKDKG
IQAQLVWLGNGKFQPDMEELAKNLGLGDDVIFPGAVSSDEVTRFLDASDIFLLVSRTEGL
PRAVVEAMARGLPCIGTNVGGIPELLQKEVLVQPESAEEISDMIEYFLSNADFSNNQAAI
NLENSKDYSFEVLDSKRSDFYRFLKTNHK
>LONDMIMF_01985 Putative glycosyltransferase EpsF
MKKIVFFVNDLNSGGIENYLLRFLSHYEGNIVPVVVCKGGVFGDLEQEYRKISNIELVKL
KVGYLDFPAYKNLYQFFKKKNYDTVVDFTGNFAALPLLIAKYAGIKNRIVFYRGATNHFK
GNLLKNTYNSFLNFLIKNTATHILSNSKAALRFFFNKKEDPRFEVIYNGIDAEKFLDSSK
NLREELGIPGKGFVIAHVGRYTEAKNHQTIIETAVQLCQLNKKVYFILCGRDVDISLKER
VEKEKLSDRIKLLGYRKDVISVLNSSNAFYFPSLTEGQPNALLEALITGLPFVASDIDPI
KETIPEELHSYLVKATDVSGAINRLQQIFENEEIRKSLNLSVWAKENYEPGYLFNKFYSK
L
>LONDMIMF_01986 Serine acetyltransferase
MDKTIREDLYRYGGLKGARGFWKGMMIPGFRYMFFFRTGLKYSKNPLVSFFCRLMIRHYS
YKYGFQIYIPTEIGKGFYIGHHGTIVINPKVKIGNYCNIAHNVTIGETFRGELKGTPKIG
DKVWMGTGSVIVGGINIGSNVLIAPNSFVNFDVPDNSLVIGNPAKIIPKENPTEGYINDF
Y
>LONDMIMF_01987 hypothetical protein
MLLLILMFGLVSYMYVPNFEDDKARYFEIYENYRDGSFMEMFTYFFLSSQDFILQTLFYV
ASQIDLPAQLVFSTVTIITISFIFFIYYKIINSFENNLKLGLLSFILLICSISYLDLLSG
TRFMFATSFVLLSFYLGLVGKKKWPFLLLFVAIFIHFSTLIFIPVYFALKFLPDKNKIFR
LIFIISLIFLILPKSFAISLFEMLGLGGALQEKGKVYLDGNDFMEEGLGDSFGTIVIFYV
SILWIFMGYLYLFLTFKRENLFRNMVFLVGALINIFYATPTIFLRYAIVLKLLFVFMLIY
ELYRYKKSKAVNIFCIIFSMILTTQIIVTRNNIEKSFMNRDSLLLITIIDKEKMTPDDFI
Y
>LONDMIMF_01988 hypothetical protein
MENRDAFISEFRGETLGTVTSESSSDEIFQNQVLRPILKLQNDLFIDVFRNYISKYKNDF
YSYPVEKKLAYIENSIQKDIKFRNSLKGIVIGLFTIHEYDVYIKNSSSLNKRMMNMLIER
LKNQVQLFELQEE
>LONDMIMF_01989 hypothetical protein
MKKQSIIALAALSFLFINCKPKSAEKEVSGTDSLSVSKDSVAIKQTNDVFFKASGTEPFW
GIEIMKDSVRFTSPETEKNFILSYGKPNRAMDANVISYEAKSDSIHLKFTIQQGKCSDGM
SDNEYNYHVNASLKRGKDKDFKNLEGCGNYIVDKQLEGNWILEELEGKKINPDDFEKKLP
GIEINAKESKFTGFAGCNGMGGKLFYETEILRFTDVFTTELMCPNYDKEKLFVKALQSTT
TYQIKKDKLYLLNPDGTKAVLRKAK
>LONDMIMF_01990 hypothetical protein
MKAKFLSVICAIVLVGLQSCSCKKGAEAIAELSTGSWELEQTFGDPIDKGEFAKIPVLNF
DKTENRISGNSGCNSMSGSYTINEDNISFGPIAQTKMACQGTGEGKFMTLFNSVQKFKLQ
GNKLKLYDGNGTKVLSFIKK
>LONDMIMF_01991 hypothetical protein
MAEYKIRKDIRVQKNLENLYLDTKIGFRLTQL
>LONDMIMF_01992 hypothetical protein
MTTNTILLLLLSILIAGGLSFFQYFFRSKNKSKTQLLLAFLRFFSIFGILLLLINPKITT
STLEIVKTPLPVVVDNSSSITELKANETALEIHKKLVSDSRLQEKFDIQSYQFSNEFELS
DSFNFKGTQTNLDEVAKNLKSINKNTAFPTVILTDGNQTSGNDYVYSFNPNNRVFPVILG
DTTTFLDLKISQLNVNKYAFHKNKFPVEVFLQYSGNKSIAADFSISQGGAVLTKQSVSFT
PSKKTAVLNVLLPADKIGVQVFKASITSKEAEKNTYNNQKNFAVEVIDQKSEVALITAIN
HPDIGALKRSIETNLQRKVTIVNPNKINSLQDYNILILYQPNSEFKSVFEANKLAGLNTW
IITGTNTDFNFLNQQQNTLQFRMSGQKEDYLSDFNAQFNLFAIDNIGFENLPPLQNAFGT
ITPKENIEVLVSSRIRNVNTGAPLLAYSENQGKRNAFLLGENIWKWRLQNHIENQSYDKF
DVFIDKTIQFLASNNARKSLVVNHENFYNSGEAIEITAQYFNKNYEFDENARLTISITNK
KTKQTKNYDLLKGNNSYKVNLDGLSAGEYSFKVVEAKSKNTYNGFFEVLDFDIERQFVNP
DLNKLTQLASQTQGKLFHPNQVEELIKSLLQNDEYKATQKEIIKKTPLVDWIWLLILIVV
SLAAEWFIRKYNGLL
>LONDMIMF_01993 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKLLEGKTAIITGASRGIGRGIAEVFAKHGANVAFTYSSSAEAAKVLEDELIALGVKAKG
YQSNAADFNEAQKLVDDVIATFGTIDILINNAGITKDNLLMRISEEDFDKVIEVNLKSVF
NMTKAVQKIMLKNRAGSIINMSSVVGVKGNAGQTNYAASKAGVIGFTKSVALELGSRNIR
CNAIAPGFIETEMTGKLNEDVVQGWRDAIPLKRGGTPEDVANACLFLASDMSGYITGQVM
NVDGGMLT
>LONDMIMF_01994 Malate-2H(+)/Na(+)-lactate antiporter
MMKHLIKTKGSIVALLPFFVFIFTFLGAGILLNDFYALPSPIAVTFGIITSFLLFRESIE
AKVDTLIKGCGNNQIITMCLIYLLSGAFAVVTQAMGAVDAVVNLGISTIDTEYFPLGIFL
IASFLSTATGTSVGSIVALGPIAISLADKSGASMPLIAGSLLGGSMLGDNLSIISDTTIA
ATQSLGCEMRDKFKVNLFIALPASIITILLLFYLGINSEINPVTIEKESYELITIVPYIL
VIGLAVSGLNVFITLLIGILVAGIIGFFQNDFTVLSFLQKNYEGFLSMTDIFLLSMLTGG
LAALVEKAGGIDYVLQKIKSKIKSKKSAQMGIGTLVSVTNLAIANNTVSIVITGAIAKEI
SDEYELSPKKTAAILDIFCCIVQGILPYGAQVLLILNFAKERLDVIDLISNAWYVYILLI
FTLIAIYSKTWNKRIDKFLKV
>LONDMIMF_01995 Quercetin 2,3-dioxygenase
MSNIDLIIEERPRDIGDFLVGRLLPFRKKRMVGPFIFIDHMGPTKMGPDHYMDVGQHPHI
GLATLTFLLEGEVMHKDSIGTVQKIAPGSVNWMIAGNGVTHTERTPEELRHGKEYMMHGY
QIWVALPKDKEDMEPEFHHFDRNDLPRWKDETAEFTLVAGKGYGKESPVPVHSDLFMVEI
KTQDEYLLHTEGQLFGEIGICVVEGAVQACDNHVGKGNMLVSKLDNACSMTLKPDTHIIL
FGGQPLPEERFIYWNFVSSSNEKIEAAKERWRKKEFPKVKDDNSYVVMPEV
>LONDMIMF_01996 hypothetical protein
MKQAFPPLVNQNSKILILGTMPGEKSLELQEYYGNKVNSFWKLLFTLFNRPLPKEYIEKK
QLLEENNIALWDVLAYCERTGSLDSNIKNEKANDFESFYKQYPNIKHVFFSSKNASNFYD
KYVGRKKDLQYSILPSPSGANASKSFLQKLEEWEAILEALK
>LONDMIMF_01997 Succinate--CoA ligase [ADP-forming] subunit alpha
MSVLVNKDSKIIVQGFTGSEGTFHASQMIEYGTNVVGGVTPGKGGTTHLDRPVFNTVKDA
VDQAGADTTIIFVPPAFAADAIMEAADAGIKVIITITEGIPVADMVKAYAYIQNKDCRLV
GPNCPGVITPEEAKVGIMPGFVFKKGKVGIVSKSGTLTYEAADQVVKQGMGITTAIGIGG
DPIIGTTTKEAVELLMNDPETECIIMIGEIGGQLEADAAKWIKADGNRKPVIGFIAGETA
PKGRTMGHAGAIVGGADDTAEAKKRIMRENGIHVVDSPAEIGKKVKEVMG
>LONDMIMF_01998 hypothetical protein
MTPKEIVQNFYKSDALLDQKIMESSLHPEVVLDWNSSKGFLQMNRTEILALSAELQVAYT
RSKIRISHILEEENLVSVRYSHYVKTFENPREEMLLAHFMVIWEIKDGKLYRGFQMSQLS
>LONDMIMF_01999 UDP-3-O-acylglucosamine N-acyltransferase
MKFPKTQTLKEVADIIDSKYIGDPNFPVYGMNEIHVVEPGDIVFVDHPKYYDKALQSAAT
IILINKEVECPEGKALLVSDDPFRDFNKLTRHFRPFRATETAISLSAEIGEGTYIQPNCF
IGNHVRIGKNCIIHSNVSIYDHTVIGDNVIIHAGAILGADAFYYKKRPEGFDQLISGGRV
VIEDNVGIGALCTIDRGVTGDTTIGEGTKLDNQVHVGHDTVIGKKCLIAAQTGIAGCVKI
MDEVTIWGQVGIISSITIGERAVVMAQSGITKSIEGDKTYFGTPADEAREKLKQYANVKK
IPEILNKLK
>LONDMIMF_02000 Elongation factor P
MASTADIRNGLCIKFNHDIYKIVEFLHVKPGKGPAFVRTKLKSLTSGKVLDNTFSAGHKI
DVIRVETHTFQFLYAEGNEYHFMNAETFEQISLNKDVLDAPELLKEGTNVMIQINTETDL
PLSVDMPASIILEVTYAEPGVKGNTATNATKPATVETGATVNVPLFINEGDKIKIDTATG
AYMERVKE
>LONDMIMF_02001 Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase
MNQPLAYVHPGAKIAKNVVIEPFTTIHNNVVIGDGTWIGSNVTIMEGARIGKNCNIFPGA
VISAVPQDLKFGGEDSLAIIGDNSTIRECVTINRGTIASGQTVIGKNCLVMATAHIAHDC
HIGDNAIIVNGVALAGHVTVGNYAIIGGLAAVHQFISIGDHAMISGGSLVRKDVPPYTKA
AKEPLSYVGINSVGLRRRGFSTEKIREIQEIYRILYQKNYNTTQALSIIEAEMEATPERD
EIILFIRNSSRGVMKGYTGIY
>LONDMIMF_02002 UDP-3-O-acyl-N-acetylglucosamine deacetylase
MVKQKTIKNEISLTGVGLHTGKEVKMTFKPAPINNGFTFVRVDLEGQPIIEADANYVVNT
QRGTNLEKKGVKIQTSEHVLAAFIGCDIDNVIIELDASEPPIMDGSSKFFVEAIEKAGIE
EQDAERKVYVVKEVISYTDEATGSEILVMPSDDYQVTTMVDFGTKVLGTQNATMKSIADF
KTEIADARTFSFLHELEALLENGLIKGGDLNNAIVYVDKEISDSTMENLKVAFGKDKISV
KPNGVLDNLTLHYPNEAARHKLLDVVGDLALIGMKIKGKVIANKPGHFVNTQFAKKMSKI
IKIEQRNQVPVYDLNQEPLMDIHKIMSILPHRPPFLFIDRIIEMSDTHVVGLKNVTMNES
FFVGHFPGAPVMPGVIIVEAMAQTGGILILSSVPDPENYLTYFMKIDNVKFKQKVLPGDS
LIFKCDLMSPIRRGICQMQASAYANGRLVAEAELMAQISKTN
>LONDMIMF_02003 UDP-3-O-(3-hydroxymyristoyl)glucosamine N-acyltransferase
MKFTAEQIAGILDGEVVGNPHAEVYKLSKIEEGSEGSLTFLANPKYLNYIYTTQATITIV
NTTFTPESEITTTLIKVEDAYKSFSKLLEYYNQVKLMKSGIEQPSVISENVTYGDNLYLG
SFCYIGKNVKIGENVKIYPNSFVGDNVTIGDNTILFAGVRIYSETEIGRGCTIHSGAIIG
SDGFGFVPNEEGVYSKVPQIGNVIIEDNVDIGSCTTIDRATLGSTIIKKGVKLDNQIQIA
HNVVIGENTVIASQTGVAGSTKIGSNCIIGGQVGIVGHITIGNGVRIQAQSGVGKNLADG
ETVQGSPALGYSDFNKSYVHFKNLPKIVSDIEALKKQVTNENSINNG
>LONDMIMF_02004 hypothetical protein
MYSNLTTVSYTNKLKIFNDPIYGFITIPDTLLYDLIQHPYFQRLRRISQMGLSYLVYPGA
HHTRFHHALGCMHIMQKAVEVLRYKGVIISNEEEKALYIAILLHDIGHGPFSHAMEHSIV
ENVNHEAISLLFMNKLNEEFDGQLTLAIRVFKGEYHRKFMLQLISSQLDMDRMDYLRRDS
FYSGVAEGNINSDRLIQMMNVVDDVLVIEEKGIYSVEKFLMARRLMYWQAYLHKTSLVAE
NMLVRVLKRAKELSQKGIVLPCSEPLLYFMQHKVELNDFDDAVLERFSQLDDTDIIAALK
AWQNHNDFILSNLSKMIVNRDLLKIKLSSEKYTPEDVEDLKSKLTNFYRISQQEASYFIF
KGKIKNQAYNKDVEPIKILKKDRTIEDVVEASDQLNLKALSKPVTKYFICFPKVLAENS
>LONDMIMF_02005 hypothetical protein
MKKIFIAIAFFAGIGFGSAQIDKDDNPQADIQDRIQQEPPRPTQTQMERAARIDADKKKE
EEKLETEKKAADQQQSKNNTKVNPDKLSPVTKDSSKGVQPVKKPRNK
>LONDMIMF_02006 hypothetical protein
MKTNTKSVTSLLLLLVAFIAGCSNCDDGTSSDNSQEKQAVRIDSTYTK
>LONDMIMF_02007 hypothetical protein
METDRNKTIEEWDGEWFGGNQTLAYNNMQNLKYLESDEFNEKAKVMFEKSLEEDHVDYRP
HSFTRSSLRTPEARVITENTPDR
>LONDMIMF_02008 Transcriptional regulatory protein SrrA
MDKIKILWVDDEIDLLKPHILFLEKKNYEVTTCNNGRDAIDIFEEGNFDIVFLDENMPGM
SGLETLSEMKEKKTATPIIMITKSEEEYIMEEAIGSKIADYLIKPVNPNQILLSLKKNLD
NTRLVSEKTTLDYQKEFRKISMELAMVNSYEDWIELYQKLLYWELELENIDDQSMFEILE
SQKVEANSQFGKFIERNYEDWFQQNADRPTLSHTLFKELVLPELKKKDRPILFVVIDNLR
YDQWKAFESVVANHYKLEKETPFFSILPTATQYARNAIFSGLTPLEMEKKYPQYWKNDVE
DGGKNLYEAEFLTEQLKRLGMNIKQDYFKITNFAGGKKLVDNFKTLKNNDLVTVVYNFVD
MLSHAKTEMEVVKELASNDKAYRSLTLSWFKNSPLLEIIQQAQQLGFRLILTTDHGTINV
KNPSKVIGDRNTSLNLRYKTGRSLTYEEKDVFAIKDPKSIQLPAINMSSSYIFAKNDYFL
AYVNNYNHYVSYYRNTYQHGGISLEEMIIPFLVFNPK
>LONDMIMF_02009 tRNA threonylcarbamoyladenosine biosynthesis protein TsaE
MEIQFTLDEINQVAQKILVQKPHKVILFHGDMGAGKTTMIKALSKALGVSNATSSPTFSL
VNEYETDGGEIVYHFDVYRLNNESEAYDMGVDEYLYSGEWCFIEWAEKIPSLIPSEHSII
TIKVEKDGKRKLTLK
>LONDMIMF_02010 Alanine dehydrogenase
MSFTPFTKQQLIPQEEKLEVARKKSDLFIGIPKESSFQERRICLTPDAVNTLTSHGHRIL
IEAGAGESSSYSDQEYSNAGAEITQDTKKVFNCPMVLKVEPLTLPEIEMMNSNSLVISAL
QIKTRKKEYFEALARKKITALAFEFIKDDDGSYPAVKSLSEIAGTGSILIAAELMINNQF
GKGLLFGNITGVPPTEVVIIGAGTVAEFAARTAIGLGASVKVFDNSITKLRRLQNNLNQR
IFTSTIQPKSLLKALRRCDVAIGAMKGKDRCPVVVSETMVEHMKKGAVIVDVSIDTGGCF
ETSEVTTHEKPTFIKNDVIHYCVPNIPSRYSKTASLSISNIITPSLLQIAEDGGIESAIR
CNKGLKNGVYFYHGILTNKTIADWFDLPGSDINLIVF
>LONDMIMF_02011 hypothetical protein
MKFSQRLAYYLGGLLLGTIIVVYFLQAKAESRNVSFCYLPNCRVLQDLRKKPLHYSAESE
ATLKENWVTLQDVKNCMQYGDVDFSKSNEPFKGGKIYFIKGKNTKGEPITVSMVNYSDKV
LLNEIKKD
>LONDMIMF_02013 hypothetical protein
MKSEIKIILEEGSSNKAKGNCFESLIRNLLTLHQYDIRGNINYSGMEIDLVAEHKHNKES
LYVECKAKEKVSSDELSKFSFNVGFKKIDKGYFFRTQELESQAGALLSEIKARPEYKNLT
FFEPSEIIKILSDGKMIFEPTSELKNYLISKRTLAVTYFGDFFIYLINESNALPTKFIVV
NANDTKIQIGREILQNLKNSILEIQNLEFIDISSNKADYREKIDINIQIESISEVQESEN
WYDYLPASSSRNHFVGRDEIRRDVLSFFKEIEDKKTDKHIFYLNGKSGWGKSSLVLEIKG
RSQNKHYKNRFFTVAIDTRSANSDNFVALSFNKIIKEAYEQNFIHKSIFTKDLEFTSNVD
LLSSDSIKELLNLLEVEKKYLVLIFDQFEDVFRKKDFFKTFYKFLSDVTDLKPNLIIGFS
WKSDFLIQSDDSSYHIWQQAKEQAKEFTVSEFGEREIDGIIKQLEGSIGIVPKSIKDRIK
ESSQGLPWLTKKLCIHIYDQIQSGLKREELLESNLNILDLFKKDDERLQSDELRALKLIA
KRAYEGNSFEETEVGELIHGNIISSLLHKRLIIRSGAIYNIYWDIYRDYLVTGEIPIIGE
SYLLRQGVNLCLEVFLLFENDKIESISSLTEKHPKGISQDTLNNILIELRNIGLINKNEE
NYYAEKDIEISKEGFVEFISTKFSNYTPYIALRKIKKSKIDKEDIIIILKQIFKQEFQDN
TWDAYAKNLISWFNLSNLSIKEKLIEPKKGRGGISTLNFNESEKDTFLPRTSIKEIIEIL
PLFELDESVINSKFNKDLLFLEIIDNTKKLTDFGKELIQVKDPDETKSILRNKCLEYKKF
KTLKKILDSNPKIKAKELVKLLGTNFFDGKELSSKVIYATKATSWIK
>LONDMIMF_02014 hypothetical protein
MKKRFIDPFFPNRPVKDPSLFEGRTEQIDEIVDALYQTKNNNPKHFIITGDRGIGKSSLL
LQTKILSEGENSLADRYEIDLGVEKYDFLSSWTDVTEGQTLENLAKSLLVDLESTVKKIF
ASLKFSIDLGGFVQIEKNANGEKSVTDIVNEFVKSLKTIYENVSKKSKDGIIIFIDELDR
VSVSSGVSSFFKLVTEKLNRENINNVIFVASGITGAIQKLGSEHASIDRTFRDIPLPLFT
EQETKEILVNGFDKIGFTFDESIPSLSYSISSGFPEPIHILGSEMLSVSTDNHICEEDFK
NAKVKIVTDVRKNKLQDILTKAGYGKYQSILEAMAKYSDVNVPLEYISKEIKSKQNEFSS
NIGTLIDKNIIRRVDRSVYAFVDPLLKEYIKQFGIIKIDK
>LONDMIMF_02015 Proline dehydrogenase 1
MEKIFNNTQVAFALKSDTELDRAYFLFKMIASEPLVRIGTAVTNFALKAHLPVEGLIRAT
VFDHFCGGVNEEDCLTVVDKMFTKGVSSVLDYSVEGKEEEEQFDQALEMTLKTIEFAKER
QAIPFAVFKPTGLGRFELYEKLGEGKEFSKEEAEEWQRVVNRFDLVCKTAHAKDVALLID
AEESWMQDAADDLVLEMMRKYNKEKAIVFNTLQLYRWDRVDYLKKIHEIAKVEGFYIGMK
LVRGAYMEKENKRAEEKGYVSPICISKEATDVNYDTAVMYMVEHLEKMAIFAGTHNEDSS
YKLMKLMDGNNIEKGDTRVWFGQLYGMSDNISYNLASNGYNVAKYLPFGPVRDVMPYLIR
RAEENTSVAGQTSRELNLIKAERDRRKGK
>LONDMIMF_02016 3-dehydroquinate synthase
MKPIEANGYSIFFNENAYEALNSHLAENQYSSIFIFADSDTNEYCLPVFLPNLETDLNIE
IIEFEPGEINKNIETCVELWNVLTDLGADRKSLVINVGGGVVTDMGGFVASTFKRGIDFI
NVPTTLLAMVDASVGGKNGIDLGSLKNQIGVINVPKMVLIDTTYLETLPQNQMRSGLAEM
LKHGLIFDKKYWSLFLDLNNLNTGDLDTLIYQSVEIKNTIVTQDPKENGLRKSLNFGHTL
GHAIESYFLENENKTSLLHGEAIAAGMILESYISLRKDLISDLEFEEIKNGIDNIFERIV
FEEKDIQPILELLIHDKKNEYGTIQFALLDGIGGISTGQKADNELIIDAFLEYNS
>LONDMIMF_02017 Biosynthetic arginine decarboxylase
MNTKYFDLINQTYYFPQDEFKLNKDNLQFHNIDLMKLVEQYGTPLKFTYLPQISNNINRA
KAWFRKAMEKNKYEGKYYYCYCTKSSHFEFVMNEAFKNNIHIETSSAFDINIVENLLENG
KINKSTYVICNGFKRDQYITNIARLINNGHKNAIPIIDNYEELDLLQAEIKGKFKIGIRI
AAEEEPKFEFYTSRLGIGYKNIVNFYKKQIQENKNLELKMLHFFINTGINDNSYYWNELV
KCIKVYIALKKECPTLDGLNIGGGFPIKNSLAFEYDYQYMIDEIINQIKIACDEAEVDVP
NIFTEFGSFTVGESGGAIYQVLYQKQQNDREKWNMIDSSFITTLPDTWAINKRFIMLAVN
RWNDQYERVLLGGMTCDSDDYYNSEQNMNAIYLPKYNKEKPLYIGFFNTGAYQETIGGFG
GIHHCLIPQPKHILIDRDENGILATEVFSEQQSSEDILKILGYAKK
>LONDMIMF_02018 Deoxyhypusine synthase-like protein
MSKGPISQFIEKYYLHFNSATVVDAAKAYEQQLQNGSKMMVTLAGAMSTAEIGKIFAEMI
RKDKVQIISCTGANLEEDIMNLVAHSHYERVPNYRDLTPQQEWDLLERGLNRVTDTCIPE
HEAFRRLQKHIYKIWKDADDAGERYFPHEFMYKMLLSGVLEEYYEIDLKDSWMYAAAEKN
LPIIVPGWEDSTMGNIFASYVIKGELKASTMKSGIEYMTFLADWYTKNSDKGVGFFQIGG
GIAGDFPICVVPMLYQDMEMHDVPFWSYFCQISDSTTSYGSYSGAVPNEKITWGKLDINT
PKFVIESDATIVAPLIFAYLLDL
>LONDMIMF_02019 hypothetical protein
MKRIIVDYSKLTNEILTLLVEKFPDGYDDSNIIRFKNAKNELVEAVEVRTEDTIYLVKVS
TKLASRIENFDEDDDLEDVVVPMEAIKDLDMDDDADDDDDDEKEDKIELDDEDDDEDRDI
ADIADDEDDDED
>LONDMIMF_02020 hypothetical protein
MLFKSNRKQKHCQEWFDFKTLIALKIIFLLWGLSILGIYLRMFEITRGFKIAIPIAFGFF
ILSLFSRNKHRKEKGIVLFLFALVLFAIIQAIDIFAGTRYFSKL
>LONDMIMF_02021 hypothetical protein
MEILMPVETLLKITMKTDQLLPTEFAPYYSTYISRVDQEANLLEELEISVHEFIKFVQNI
PLDKYDYRYAEGKWTIKDIIQHLMDSERIFAYRALRIARNDKTPLPGFEENDYADTANAN
ERSIRDLLTELAIIRQSTIALFATFNEEILKRMGIASGYDVSVRALGFIIIGHQKHHQKI
FMERYL
>LONDMIMF_02022 Phosphoenolpyruvate carboxylase
MGNPAASLDPEWFEDELTRATVESIYAIQKIQEQNGEMGANRYIISNNQSALNVLETYAL
FRLCGWENPSVDIVPLFETVEDLENAQRVMQTLYTNPLYSEHLKSRNNKQTIMLGFSDGT
KDGGYLMANWSIYKAKEALTSISRNYGIEVIFFDGRGGPPARGGGKTHKFYASQGPDIEN
NEIQITIQGQTISSNFGTLDSCRYNLENLLSAGAANQFFNKGENKLSDAEKKTLESLSQI
SYKEYSDFKNHPKFIPYLERRSALKYYAMANIGSRPSKRSQSEKLDFNDLRAIPFVGAWS
QLKQNVPGFFGVGTALKHFEDNGKWQEVQELYDHSLFFKTLIENSMMSLAKSFFPLTSYM
KDDPEFGEFWEIIFNEFKETKRLVLKLSGFDALMENYPDGKASIQMREQIVLPLLTIQQY
ALTKINDLNLKGNPDEEMLKIYEKIVMRSLFGNINASRNSA
>LONDMIMF_02023 Sensor histidine kinase YehU
MVKKHKGLLYLGLTILLALLFSVIVYEISSVWLTKASSLYEFSHQKSYQYQLATVVGTLI
CILGPVMFLKFYREEKKKREEALLFNQMQLNSLKSQLNPHFLFNTFNTLYGISLEFPQRT
PDLIMKVSQLMRYQLESNAKQCVSLDEELSFINSYIQLEKERVGYRCEITYESRIDNENA
YKISPMLLIAFVENAFKHGTCAIENCYVHITMVVEKGKLYLKIRNSIPEKKVNVVSTGIG
IRNTTERLKLIYGNDYKLDINNSGKEYTVDLELPLKKIAE
>LONDMIMF_02024 Transcriptional regulatory protein YehT
MMKDPKKCIIVDDEPAAHYVLTNYIRQNPELELVHQCYNGIEAMNYIRENPVDLMFLDID
MPEITGLELLKILPSQPRTILTTAYSEFALESYDYGVIDYLLKPIYFPRFLKSIERFFSF
YAEKKAMVSNLFISIKADGGIVDLDVRKILFAQSYGNYVKIFTSGKTYLASMTTNELEAS
LPEGQFLRVHKSYIVAVDKIEENERDVLVVNSQKIPVGITYRRELERVLAR
>LONDMIMF_02025 hypothetical protein
MTLTSCRVTKTITMINAKSNAAETEVEFIKHKITSISFLPLSEEQEEIAISIWKKEKEQL
EKNRLKKNSEIARVIFQSENEFRSILTPEQLQEYKAEYNDSMITKYFLSNRAMNEIKRIY
KLEGEIR
>LONDMIMF_02026 hypothetical protein
MKRILLLAILLPTFSFAQEKQNDNTETPELKQRFWIYGNSTYSDPIQTGLTLEYKSKNLD
SGRNSSNILNLSYGMMNYDNDIIDVDGTGFVIELGSRTYIEKGKWDGFYAENFISYGNIK
FDETIGGLGKFDGTYSYWSIINPNVGYKFMIGKKFSIDPYVGANWKWEVKGKGDVDNKNV
DNFVFRAGLKVGFSF
>LONDMIMF_02027 hypothetical protein
MKKIEFSIEVDAPREKVWDILWGKDTYPQWTAPFSEGSRAETDWKEGSKVLFLNADNEGM
IARIAKNIPNEYMSIEHIGVMMDGIEHTENEKSNDWAGALENYTLKTVNGKTQLMVDMGV
TEEYKDFFNETWPKALNKIKELSEKK
>LONDMIMF_02028 Aconitate hydratase A
MTKDIYQIKKLLNTKNGAFTYYSLPEMEKHGFNIKKMPFSIRILLENALRNFDDFAITRE
NIETLLNWKPEASDKDIPFKPARVLMQDFTGVPAVVDIASLRAEIARKGKNPDEINPLIP
VDLVIDHSVQVDYFGTEYSYARNMDEEYKRNKERYQFLKWAQKSFSNFSVVPPGMGICHQ
VNLEYLSKGVIERNGEVFPDTLVGTDSHTPMVNGIGVIAWGVGGIEAEAAILGQPIYFIM
PEVIGLRLTGKIPLGSTATDMVLTIAELLRKYGVVGKFVEVFGPGLDNLTVPDRATIGNM
SPEFGCTVTYFPIDEKTLEYMRMTNHSENQVQLVEDYCKANLLWRTGNEEITYTHVLELD
LSTIEPTVAGPKRPQDKILLKNFPTTFIDVLNQSFGRKYIKPQEQLTRWFAEGGSSLPMQ
TETAMVPDTKIEEKIEDGMKIVTVTVGQEQFMLSDGAVVIAAITSCTNTSNPYVMIGAGL
VARKARERGLNVKPWVKTSLAPGSKVVTDYLIKADLLDDLQSMKFHIVGYGCTSCIGNSG
PLPAHIAKAIEEHDLVMASVLSGNRNFEARIHPQIKMNFLMSPMLVVAYAIAGRVDIDLL
NEPISYDPNQQPVYLKDIWPSNDEINSIMSSVLSPKQFANSYGTIFEGNEIWQNLEVPNE
KIYVWDNQSTYIKEAPFFKNLPDHPQPLKDIENASALLVLGDSITTDHISPAGSYGESSA
AGKYLLSRGVPKEEFNSYGSRRGHDEVMIRGTFANVRIKNKLADKEGGYTKYLPTGEEMT
VYDASVKYKEAQTPLIILAGKEYGSGSSRDWAAKGTFLLGVKAVLAESYERIHRSNLVGM
GVLPLQYLSGQNAESLGLTGTEQFSITGIANDIRPLKEVEVTAQRKNGEKIQFKAIARLD
SKIEIEYYRNEGILQYVLRQFLHKS
>LONDMIMF_02029 Purine efflux pump PbuE
MDKQQSLSFTGYQKFVIFILAITQFTVILDFMVMSPLGDMLMKSLDLKPSAFGVAVSAYA
FSAGVSGLLTAGFADKFDRKKLLLFFYIGFIIGTIFCGLAENYTMLVAARIFTGLFGGVI
GSISMAIITDIFALQQRGRVMGFIQMGFGASQVLGVPIGIYIATLWKWEAPFWMIAAFSV
LIAIAIAVYLKPLTAHLSLQHDKSAFVHLWHTVSKRDYRIAFTSTALLSIGGFMMMPFGS
AFAVNNLGVNYNQLTMLLMVSGISSLVVMPIIGKLSDKINKYTLFAGASVWMMIICVVYT
NLSVTPLPIVMVLNIMMMMGIMSRMIPSSALTSAVPDMADRGAFMSINSSLQQIAGGIAA
AVAGMIVTQESKGSPLVNYNIVGYVIVCISIISIILMWRVYKLTIKKTQYTQVTTSQDEA
PQNLNEVL
>LONDMIMF_02030 putative HTH-type transcriptional regulator
MRMRDADKISLVRQKAIELIATHGLEGFSMNKLAKACGISVATLYIYYKDRDDLILKIAV
EEGNIMGAAMIVGFDPEMSLEEGLRKQWENRCNYSMKNPKTSLFFEQLRSSSYQEEFLAS
FLKEFKSVVGKFMHNIIERGEIEKMPFEVYWSVAFAPLYNLIRFHNEGKSKGGRPFKLTD
EVLWLTFDFVIKALKK
>LONDMIMF_02031 hypothetical protein
MSVDFEIIIRFLLAILWGGLVGAEREYKGKPAGFRTTIMISFGACFFTIMSIAIGGDSSP
DRIASNIVTGLGFLCAGVIFKSDNHINGITTAATVWAVAAVGMGIGGGYYFASASGSILI
LFILLILPYFQKIIDKKNQLRVLTIEYRQNSGALELCENLMKQHRIRYQMVKQIREKENM
TAVWEIHGNQTHFISFNNRIMAEPSIDRVETLR
>LONDMIMF_02032 hypothetical protein
MRNKPLLICLLFFFCASAWPQATISNYKVFLATVSSGTKNLLIIRKFEQFGKTNYLTVDL
NTMDTQILRADKLITTTISWQKLYSDYANTPYIKALTYAKKQSFALQDAGIIHGWPVEKG
INLTVDLCPSHKPLDRTIFTSLISEFGKIEKPVPIALSITGRFMLDHTNDMEWLNSLEAK
GDIDITWINHTYNHYYEPKMPLTENFLLKPGTNIDFEVLQTEIALLERQLLPTVFFRFPG
LVSDNSVSSNIINYGLIPIGSDAWLAKGQKANSGSIVLIHGNGNEPVGVNDFIKLLQSEK
QKVLDKQWLLYDLKESISEEFKE
>LONDMIMF_02033 hypothetical protein
MKKIFFILALFALFGQTASAGAEEDSIYNPFRNYSLFFGEDCDACGCSANGGSMGFSSML
NNNFVGIRYFHQSYKSRDGVFNNSPWIDENFNTAQLWARIPLGKRIEVMGLIPYHFNNRE
KATGKEDINGLGDITVMGFYTLFGTRTDSATVFHKFQLGAGLKAPTGKYDSANNGSVNPS
FQLGTGSWDYMLATEYTVKRKNLGLNAILNYIFKTENEKKYQFGNQFNYAATLFYNAKIE
KLNVVPQLGLAGEKYENNKDHGEKVPLTAGDILFGKMGVEIGLQKWSLGLSTMLPINQNL
TGGRVEANYRWSLNLNYSL
>LONDMIMF_02034 Cytochrome c551 peroxidase
MKRIALFLILLSIFSCQDDDSNYTEIKQPLDFIVPANFPETAQDISRNFPTQKGFELGRK
LFYDGRLSRDGTVSCSFCHEQSSAFTHHGHDFSHGIDNLAGIRNAPAVQNMAFQSEYFYD
GASNSLEMLSIVPIHNPVEMDETLENIVSKLKQDAAYVKLFAQAFENKEVSSGNMLKALG
QFMTMMVSANSRYDKFVRNEPGGTLNNQELQGRALFQSNCASCHKTDLFTDNSFRNNGLP
PNPNLNDLGRETVTGFARDRYKFKVPSLRNVALTAPYMHDGRFGSLQSVLNFYSNGVQNT
ENLDPLLQQHPTLGIPLNQTEKEAIIAFLKTLTDEEFIQNPLFYFRT
>LONDMIMF_02035 hypothetical protein
MKSYLKNIAVCIAFTLFLTSCSSDDDSKPVEGTFGDVELFFDNGVSGDALTLGNSYTNSN
GETLKLQRFNYIVSNFVLIKEDGSQFTYPKDDSYFIISEEAGTFTVHLENVPVGDYKKIK
FGIGVDQQRYLQGETAQQSFWDLAAANNMTWTWSTGYRFINFEGTFTAAGGDGVSRNFMV
HQGSNTATDNYREVILNLPTTARVRTGEMPNIHLKSDANVILDGDNKIALRLNMNPAGTA
ASIMGGENLISIAENTKKMFTVDHVHNGAGTHH
>LONDMIMF_02036 hypothetical protein
MAPQVFCGEKREKSISRHFSEYQKLKNGRAEDRPAIQVTVQIGVEGVGTLVGQRAFYRNE
TEIKYFLKKQDMAFGSHKPFFFGLIAIVLRRFGKLLHQMTLTVTFHFGLVFVNTEHRCDV
IVINGIFDDWKHGLQEHKQCEYGCHFFHSANLRKHNQTV
>LONDMIMF_02037 hypothetical protein
MNKIIFSLIAFIFFSYHANAQAPANDDCASATILNVNTDLSCTLKVPGTLSGATRSNVVS
GINGFVPNNDVWYAFTATSPNHKISLQNIQGTNVRHYIEILVGNCGELVPITFSPDSSIP
LTGVAIGTTFYVRVFTFRPTSGSFEICVSTPPAITNDECTTAIDLTVNPDLNCTSMTSGH
LIGATNSGSFGNLAPSEDVWYSFTATRPNHRISLNNYSINEPPLGFQIFEGNCQTLTSKL
VAIAYPNAGSRDATNLTPGTTYYIRVFNTLPDPIATTFDICVSTFPIPNNDECANAVVLS
VNTDESCTLRTSGALGGATASNENSSVSGIANDVWYSFTATATSHKIELLNATGSTSESV
NFEVLEGFCGQLISISGSEPEFVTISSLTIGTIYHIRVFNNPQLDVRTSTFDICVGTPLP
TPANDNCVNAIPLAVNPDSSCTLKTAGTIANATNSLEGDNPMGTPDDDVWYSFVATSTSH
IVSLLDVVGTPVLISEVMQGSCGGQLFSLNTSNSTSNRVSGLNVGETYYIRVFSSYEGIN
VNTTFNICVSVPPTPPANDNCNNAVSLTVNPNASCTQTASGTITGATNSQVSNGINTPDD
DVWYTFIATSTSHKIKLLNIAGEQTDLVIEVLNGPCGSQMTPVGSSNQRENLVSNLIIGN
TYYIRIFSLAIGSTGTSSFDICITTEQRPQNDKCEDAIALTVNTDLSCTLKATGTLRNAI
DEVSNQFGIPDVWYTFTATATHHQVKINSSDFRCEVYSSGGDCLTDRAWVTVQTTPEGII
PNGLIIGNTYLIRVMSNTESPSETFEICVGTFPPAPVNDNCVDAITLNVAPSMEEGIINS
TTVGATDFYYYPSPTCADYNRGDVWFKAIVPANGQLNIQTGDPGNSTNSPFDSGLAVYYG
VCDGFLELMACNDNISPTEVHSKITLTNVAAGEEIFIRVWEIGNNQKPFTISAWSTSLSV
PEFDANNFTAYPNPVKDILNLSFDQIISTVKVYNLLGQIIASKEINDKNGNIDLSGLPTG
PYVIQINSNGISKSTTIIKQ
>LONDMIMF_02038 N-alpha-acetyltransferase RimI
MNTNKETETIRIVTYEPQYQEAFKSLNTEWISKYFEIEAADTIALDHPKEYILDKGGEIF
IALLNDEPVGVCAMIKMQEDFDYEMAKMAVSPKAQGKGIGLLLGRFVIDWAAKNKATTIY
LESNTQLEPAINLYYKLGFKEVKGKNSPYKRANIQMLLELENKV
>LONDMIMF_02039 2-aminoadipate transaminase
MAQLNHNFNSVKKRNHAEKPKETLYLKIAKIIEEQIQSDTLRLGDKLPSIRSAQKLYNVS
INTAKQAYLELESRSLIESRPKSGYYVSKTSQRKLALPTVAKISSTEKEKTPEDLIDKVF
GTIAKSDFTQFALGIPGKNFLPLAKLNKSLINTVRRRNDGGTAYEPVQGNEHLLREVAKW
ALVLEGKITEDDLVITSGAMNAIYNALMAVTKPGDSVAVESPVYFGFLQAIQLLGLKAVE
IPTHPIFGVDLDALKKVLPNIAACCFVTNFNNPLGFQMPDENKKELVRLITEYNVPLIED
DIYGNLFFGAERPKPCKFYDEAGLVLWSGSVSKTLAPGYRVGWIAPGKFKDKIIRQKLVQ
TVCNPSLYSDVIADFLEHGRYDHHLRTFRNKLYANYLQIQRAVEAYFPDNTKISQPKGGF
MLWLELDKRICTEDLYDVAGNQKINFAPGRMFSQYNQYNNCMRLNYALEWTNRVENDLEK
LGKLIKNSI
>LONDMIMF_02040 hypothetical protein
METPLTHQETLQFAEVYLSDIAPLKTIFFQAFPKNQDITPAFGVPFLIAKKENKTVAFAS
FVLNSKDEIDFNIYNSEPVMTDEEKLIFVSFVTDYIKKQDNGNYRNPEQLKNMINKILQW
LN
>LONDMIMF_02041 hypothetical protein
MRKTLPFLALLASTFSFAQVTIGSGTLTDSNAGLSTPISIYYSTSLAQMIYMASEIGTAG
TITSIDFKVNNTNSLVNTNGMIDVWIGHTTRSSYSPVVGTSGADWISIAGHSQVVANGTF
TQTGTTITFTFSTPFAYNGTDNLVITVDANKPGDDGNTTLFYQIPATTNITSLMIRTDTA
ADNADPFNPPLNYTGGTIATSVQAKRTRPIIVLNGLVLGVEEHGLESAISLYPNPATNGL
FVASQNKVASGEIYTMTGQLVRSVTIEENKIPIGDLSSGVYLLKLRMEDGQILDKKFVKQ
>LONDMIMF_02042 hypothetical protein
MLGLMLLLLSTFGLGYFYCKNTVDAIGLMPNRNRIVLFGGGFLFASILVLLNCLIESSIF
SAEWKLNDSVNFSLLGKAIQYFFISALTEELIFRGILLYILTDKTGIQKAALISAAAFGI
YHWFSYGMFGNEIIPMLYIFLITSLAGYVWGIAFVKSKTILLPLVLHFGWNLISSLVQKS
QPYGEIIFHQVSKAALSDLNKLFASLFMGIFPSILMYIALYLMFRKKKVL
>LONDMIMF_02043 hypothetical protein
MIWRPNDVSMFYDKSKIGESIKLQRIAKGWTQSQLSERSGIGLRSIQRIENGEVNARSYT
LAKLQEQLDIRFDETHTIAINQTTDFAKRSFTNWRTSKIALSYVTGFIIAIISGSFLVNS
ATFPETHFELFVFLCSLAIMYSILLLYIWRKSK
>LONDMIMF_02044 hypothetical protein
MKNKLLVFNDKGIYCAQADVYLDPWRPVKNAIITHGHSDHARFGHRYYITHHYNIPILKH
RLGDIVVTGKEWGETFTINGVTFSLHPAGHIIGSSQVRVEYKGEVWVFTGDYKTEDDGIS
TPYEAIRCHTLITENTFGLPAFRWLPQAEVMQDINTWWAQNKAEGRTSVLFGYTLGKAQR
LLKYLDSDIGPIYTHGAVENMTEVLRTIVDFPPTIRITQETKKEAFPGSIVLAPPSAHGT
VWIRKMTPYVTAAASGWMAFRGARRRRAIDKGFVLSDHCDWQGLLESVKATGAERIICTH
GYSDIFSAYLRELGYDAVTENTQYEGDEEEISVGNEKDAEKKEEL
>LONDMIMF_02045 DNA ligase B
MRNFAALIKTLDSSNKTSVKVEALTEYFLHASDPDKVWTIALLSHRRPPRPVNTTLLRLW
ASELANIPLWLFEESYHIVGDLAETIALIIPDSKEHSEKSLSEYVGEMIALKSKSEAEKR
LYLHENWQMLNYYERFVFTKLITGSFRIGLSQKLMTRALSKAVGIDEDVLAYKLMGDWNP
QKITFQKLILEEKSQDYLSKPYPFYLAYAIESEPENLGDVRDWSIEHKWDGIRSQTIIRY
GEVYLWSRGEELITDKYPEFQAFVNVLPDGTVIDGEILPYKDGRIGTFGDLQTRIGRKTV
TKALLQKTPVIIRAYDLLEWQGKDIRNHPYEERRQLLEELYDAVKDLGLPLQLSERFDME
SWEAVTKERMKARELNSEGLMLKRKKSPYLVGRKKGDWWKWKLEPLTIDAVLTYAMRGSG
RRANLFTDYTFALWQDKEDGSRELVTFAKAYSGLTDAEFRMVDDFIKKNTLERFGPVRSV
TPALVFEIGFEGIALSSRHKSGIATRFPRILRWRTDKKIEEANTIQELKNMIR
>LONDMIMF_02046 DEAD-box ATP-dependent RNA helicase CshB
MNREVLFDIAKTWFSGKGWTPHTFQLKTWTAFLQGKHGLLNAPTGSGKTYALWMPVVLDY
IKKNPEYKTRHVPGLKAIWVTPLRALSVEIKQAAERVADDLQTGLTVGIRTGDTSATEKS
RQKTKMPDLLVTTPESLHLMLATKGYEAVFKDCTAFIVDEWHELLGSKRGVQIELALSRL
KTVAPKLRIWGISATIGNLEQAMEVLLGPESEAFQNKELVRAHIEKKIKVISIIPDKMDS
YPWRGHMGLHLIDEVAKIIKNSRTTLIFTNVRSQCEIWFQALLEKYPEFAGEMAMHHGSI
SRETRQWVEQAIRDEQLKAVICTSSLDLGVDFAPVETVIQIGGPKSVARFLQRAGRSGHR
PGQESVIYFLATHAIELVEASALKRAVKETVVEDRIPYLNSWDVLVQYLVTLAVSDGFYP
SAIYKEVKSTFCYQAMTESQWAWILNFITKGSQSLEAYDEYKKVEIEEDGRFKVNSRSVA
LRHRMQMGTIVGDAVMSVKFMSGGYIGSIEESFVSKLYPGDVFIFAGRKLELYRTKNMEV
LVRKANPSAKAQHASWMGSRMTLSAQMGELIRTELYAANNEKASPELRALKPVFKQQQKE
SVVPAADEFLIETFKTREGHHILFYPFEGRFVHEALASLIAYRISLLTPITFSLAYNDYG
FELLSDKQIAIAELLDNNLFTPEYLHEDLQKSLNATEIARRKFRDIAVIAGLVFAGYPGR
IIKTKHLQSGSQLIFEVFRDYEPDNLLLQQAYRETFEHQLEEGRLIMALERIQNQQVVWK
QCEKPTPFSFPIITDRLRERLSTETLAERIKKMTASYMKSN
>LONDMIMF_02047 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MILEIEINNQEFVLHNSGALYWKGQEMLLVSDVHLGKISHFRKHGSALPTQPIFKNFSKL
DKLVDHFTPQKICFLGDLFHSSMNREWLLFEQWRNRTALPIVLVAGNHDIVDRKKYEELH
IPVVNEWLLDGFLLTHFPEEREGLYTISGHIHPSIVLAGEGRQFLKLPCFFQSPFQIILP
AFGEFTGTFAMELRQGDTAYVLTKEEVIAISKQ
>LONDMIMF_02048 hypothetical protein
MALFNDTELFFSGNRGKKIFDQPDTELLLIDNFFTKEESDFYYTTLLQQTKWREYEMEIY
DKVVTAPRMIAWYEDKENVGADVNGPDWTPELLAIRKRVESETQLNFNSVLLNLYRNGKD
GVSWHSDREGNSGKDPIIASVTFGATRMFRLRHKFRTDIPQVEIPLHHGSFLLMAGTTNS
FWQHQVSKTTKEVLPRINLTFRQVNRKT
>LONDMIMF_02049 hypothetical protein
MKGKNQTPVPKVSSKKKPEIDYDNQKPAEEHLESGHSKGISPSSKETSKDIKTTKEAQEK
REKNLERGHDSLDIPSGSEGKAKRKK
>LONDMIMF_02050 Ubiquinone biosynthesis O-methyltransferase
MAEFWETNFSEKREMWGLEPANSALLTKNLFVENAIKKILIPGIGYARNAQVFRENGIDV
TGIEISKTAIKLAKKHYGNDITIHHGSVTDMPFDANLYDGIYCHALIHLLDEQERKKLIQ
DCFQQLANNGYMVFTAISKKAHTYGSGKFISKDRYEIFEGVKMYFYDPESIQSEFGEAGL
IEIREITENYPFYLIVCKKR
>LONDMIMF_02051 Sensor histidine kinase WalK
MKKLSFFCLLLLTWNISFAQSSELKKIQASLPKISDSLQYVDRLNRMAMLLYEKNADSTF
YYARMAREIANRHNYEQGRADAMNNLGVFFDIKGNFQLALKYYNQGYTRYKKLGDATNCV
QSLMNIGMVYQEMGKDDRALRRYDLAFRQSEKLRNDSIRSLVIYNYLLSYPEHFSRDSTH
YYINVAQKIAAKYKDERTLVAIDQLIADDLIKHGNRAEGLALLKQTISTAIDKKLFYVSM
DMHIDMGQQLEATDPEQSIHYYKQALAIAENNDYLYYSEILVRKLFEIYNARKDYAAAAE
YSKKLIEIHDKESALSRESGIDYIDYAVKDEEIKSLESRYNYQLALSVLACIAFVLAISM
IISIRKHLRRTKRQNSQMKKALSALEQSQADNTRMIRIVAHDLRNPIGGIHAIASMMLEE
PDRSEEDRTMLELMKTSGQNSLDLVDNLLQLQFSSEQLKKEPVDIAEMLKYCVALLKSKA
DVKQQQLNLEIVTAIVNASREKLWRVISNLIANAIKFSPNGTRIKIKMTQKEQKIRILVK
DEGIGIPPEMGEKIFDLFTEAKRPGTAGEQPFGMGLAISKQIVEAHNGKIWFENNNSSGT
TFFVDLPFNSGN
>LONDMIMF_02052 hypothetical protein
MQNRFSDQNKTLSHFYDEVWVVCPACGKKAVAKASAENKSTRLYCSNCGYIKEASMETSI
AGQKAILRWAAHNYFDVELWLQYPFKNDVFFAYNGEHLNYLQQYISATIREHKDRTHFTL
LEKLPKFYHEAKNRKALLTIIKKLEKK
>LONDMIMF_02053 Small-conductance mechanosensitive channel
MLIDAQKIETFTDRIITILVDYSPKLVSAFLLLFAGLWGIRLLNRLATKIMISRNLEPTL
TTFLANILIWVLRVLLFVAFISQLGVETSSFVAILGAAGLAIGLSLQGSLSNFAGGVLII
LFKPFRVGDTIEAQGETAKVLEIQIFTTKLLTASNQIVYIPNGILSNNKIKNFSQNNNRR
ADLVVKINYEADIKQIKDTIMDIMKKHPQVLKNPAPAIIVSDLTDNGINLVARPWAKNEN
FGNMSSDVLEQILTELEKTEKNPFIKATT
>LONDMIMF_02054 hypothetical protein
MKKILFLSISLTALFSNFAEAQINAQQTVNDIVTNERRFADKNAVDKTAGSKYFNETFLP
AKIVGSNEIIMLRHNAYTDDMEVSVNDDIKIVPAETNMVINMVNGSISYEYVPYTNEKGV
KKEGYLKLVSNNPKVKIYKSEVVYLKPEVHPASGYDTYQPASYKKAKDEYFIKIGDSEIK
TLPLKKKAIVSIVPEKEKEIASFIKENKISFSEDADLNQLGKFINSLM
>LONDMIMF_02055 tRNA threonylcarbamoyladenosine biosynthesis protein TsaB
MSYILNIETATKNCSVSIAKEGKTLFCKEMSEQGFSHAEKLHVFIAESLEALMIDFSDLA
AIAVSQGPGSYTGLRIGVSAAKGLCYALNIPLIAIDTLEIVARQLTVSEGLIIPMIDARR
MEVYDAVFDSQHTKIRETKAEIITEDVFADFEGTIHLLGDGAMKCAEILNDSRFLYHPEI
IYPSAKEMSSLSFDKHKKSDIVDVAYFEPFYLKDFILHK
>LONDMIMF_02056 Macrolide export protein MacA
MKKKTVYYMLGGAILLIIVLLVLSKAGILGNKEKGKEIEVAQVDAMTIIETVSATGKIQP
EIEVKISSEVSGEIIDLPVKEGQVVKKGDLLVRINPDLYTSGLNRSVASLSGTKAGLSQA
DAQFKEAKANYERNKTLFEKGIISKSDWDKAVSSYEVAQATKQSAYYNVQSASATVNEAR
DNLGRTTIYSPADGTISSLGVELGERVLGTQQMTGTELLRVANLNNMEVEVDVNENDIVK
INVGDSAKVEVDAYLKKEFRGIVTSISNSASTALTADQVTNFKVKVRILKESYADLLEGK
PANFSPFRPGMTATVDIITKRKENVLSVPISSVVVKSDTSATAKPVVVKSKDDQNNNQKA
PKSDKKFECVFVKEGDKAKLRVIKTGIQDDTNIEVSSGLKKGDVVIVGPYATVTKDLNSG
DLVYVKKDDKAKKDKPKK
>LONDMIMF_02057 hypothetical protein
MKKTFVSKIILIFALFSGLASNAQAKKWTLQECVQYALDNNISIKQADLDSQVAEIDKKD
AFGNFLPSINGSAVHSWNIGLNQNITTGLLENQTVQFTSAGLNANIDIYRGLQNINRMKK
ARLSIIAAQYKLSKMKDDVSLNVANAFLQILFNKENLKVQKEQLQNNEKQKERTKALVDA
GSVPRGDLLDIDATVASSQQAVIVAENTLLISKLSLAQLLQIEDFQNFDIQDNDYEVRES
EVMLQSPSAIFEKAKQERAELKIAKANLDIAEKDVQIARGAYQPSLQGFYSFSTRASYSD
RIVDYNLNAQNPTRVIGVVEGTNQNVVTQNLSPILGKPAPIFDQFSDNKGHSFGFQLNIP
ILNGLSARNNVERSKVALERSRTLYSQQELDLERNVYTAFTDAKGALKSYESALVALEAR
TEAFNYAKEKFEVGLMNAFELNQAQTLYVNAQSEVLRTKFDYIFRVKVLEFYFGIPIQKQ
>LONDMIMF_02058 hypothetical protein
MGKYFSLSISLLTLVLVSSCATTKKIEALKPEPDDASPLVYENSTSFINLPVKIKLKDIE
SQTNKLLNDVIYEDKNIEDDDIQMKVWKLGDIKISEEKGKIKTVLPLKINIHYRYGIDRL
GIKLYDTREINMNGVITLISDVGLTNWKMNTDTSIKSLEWNESPTIVIAGKNVAITYLIN
PAIRLFKSKIENNLDEAIKKSMDFKPNVLDALEKICTPFQMSETYDSWLRIVPIELYATN
SKLQKDMVSFEMGLKCNMETIVGQQPKNKLDRDKIVLKPVTKMPDYISANIAAISTYQDA
SKLMTKNFQGQEFGSGKRKVTVKKVDIWQKNNKMIIALDLLGSVTGTIYLSGYPQYNDAT
KEIYFDQLDYVLDTKDKLIRTANWLASGMVLRKMQESCRYSIKPNLEEGKKNMMNYLKNY
SPMPGVFVNGNIEGIEFKKIQLTNKAIIAFITVNGKVDVSIDGLK
>LONDMIMF_02059 hypothetical protein
MRIKNCLNKTLSLKWVFPFLALFLLSLDANAQCAMCRAVLETEEGGIKAEAVNDGIVYLM
VIPYILVGILGFAIYRMKTKKKPE
>LONDMIMF_02060 hypothetical protein
MDNNLNAVELKYRKWIIVLSIAIPLVVAILFGVKLKDFGYDVKPLSFLPPIYAAINGITA
VLLVSAVMAVKNGKRKLHENLMKTAIACSVAFLGMYVAYHMTAESTPYGGEGISRYIYFF
ILLTHILLSIIIIPFVLITYVRALAERFDKHRKLARITYPMWLYVAVTGVIVYLMISPYY
AH
>LONDMIMF_02061 SCO1 protein 
MKNKSYIGISFIILVFGIYAIPKIIDRVKNNDVSVQDRLNVPAKEKKSEEAKNLVKIGNA
PQFSLTDQNGKTISNKDYEGKVYVVEFFFSTCPTICPVMNQNMRMIEDEFGKNENFGIAS
FTINPVNDTPEVLKEHAKQLGVTSPNWHFLTGDQEYIYKIANKGFNIYAGESKKEGDAGF
EHSGYFALVDKKGNIRSRKDKSGNPIIFYTGLNYKDKEGFQDDLQGKYKPGIHAIKEDIA
ILLEE
>LONDMIMF_02062 hypothetical protein
MKKNIVLFVLFILPIVAYLFFASGINSFAKLPTITEKIPDLKWKTADGQSITLDNKITIL
GFTGSKVLYNEGNFFNLNQKIYNKNKNFKDFQFVMIAPKGSEGEVKELMEKLKPIAEDKD
ISKWIFVFAAPEEIREYYSKLNLVGQLDENAGTANVYIVDKARNLRGRKGKNLEGKEEYK
EGYNTISAADLHNEMSDDVKIILYEYRAALKKNNPKTEMKRKI
>LONDMIMF_02063 hypothetical protein
MAHAHEHVSNTKRIWMVFGILSVVTIIEVAFGIYKPAILHDTLFLQMNLLNWLFIGLTIY
KAYYIVWAFMHLEGEKSNLRWSIVAPLVFLIIYLVFILLVEGNYVFDVFKSSQIKWNF
>LONDMIMF_02064 Quinol oxidase subunit 3
MGSTVTTANSEGKIWGGGNEPMGINYGKMMMWFFIVSDALTFSGFLAAYGFSRYKFIETW
PLADEVFNHFPFMHGVDAPMYYVALMTFILIFSSVTMVLAVDAGHQMKKQKVAIYMFLTI
IGGGIFLGSQAWEWKNFIKGEYGAVETKGGSILQFVDATTGKRVKLSDVAIPLHEEREQL
TRNKGFWFSKESTLPTYSVNEVVEGFKANPNILVRTEAIYHPSMAKNVGVHSELNKSTHK
HKTILTREESLKRLADVHYVVEGANLIRNEYGQKLFANFFFFITGFHGFHVFTGVLINVL
IFLNVVLGTYEKRRSYEMVEKVGLYWHFVDLVWVFVFTFFYLV
>LONDMIMF_02065 Cytochrome bo(3) ubiquinol oxidase subunit 3
MEMTIKGMTAKEHKERKARSYKLILWFAMISMTMMFAGLTSAYVVSASRPDWLKDFDLPS
AFYASTVVIVISSLTFHFAKKAIQKDNRSLTTSLLLVTLALGLLFVFLQFEGFNQMIAMG
LNPTGPTSTVTTSFIYVVVLVHFAHLFGGLISLLIIIYNHFKQKYNSGQTLGIELGAMFW
HFLDFLWLYLFLFLYFFK
>LONDMIMF_02066 Protoheme IX farnesyltransferase
MKAALSTTANNFSLKSLYIDFREITKARLAVSVVFSSIAGYLLGFDDAHPFKWLTLFMLA
VGGYCMVGASNAFNQIIEKDLDVLMDRTKNRPVPSGRMSVNTAFIIACVLTIIGLVILYN
INPKTAMFGAISIFLYTSVYTPLKTKTPLSVFVGAFPGAIPFMLGWVAATDDFGIEAGTL
FLIQFFWQFPHFWAIGWFLFDDYKKAGFFMLPTGKKDKTTATQIILYTVWVIVASLLPAF
FPVIGLVGSKLQLSPIAAVVVFLLGIWMLVYAVKLYKSREAKAARTLMLVSVSYITLLQI
VYIADKFLR
>LONDMIMF_02067 hypothetical protein
MKKLLKIAILLLSVHSWAQSNREREQFPVFPKCEGQQSENLEACFYNELQDFVFANFKVP
QETTDKNYKGRVIVLFEVDTAGVFKVQYVDAVDASLAEESKRVFGLLPKIKPATYNGNPT
YAKYTISINIPLEKQAAVVAEAEKEKTNAVIKDRSRELTEFDSIVYKKFDNPQLKSHLNI
PFSHSLYAQFDRALNQVGSNNHTASKPYTYAEVSRYYDLEQANKMIQKNKQGWWGRKLWN
ENLVAIQGDGYWFTMNPILDLRMGKSDPGKADYTYQNTRGVQVQGEIGKELSFTASIYES
QGRFADYYNRYAESIKPSGGNPAVIPGIGIAKRFKEDAYDFPMAEANISYTPSQFINLQL
GYGRNFLGDGYRSLLQGDGTSPYPFFKINTNFWKIKYTNTYMWLKDVRPEVTEDNTYATK
FMANHYLSWNVTKRWNLGFFESVVWANQNNRGFDASFINPIIFYRAVEFSSSSKSGNALL
GLTSKYKFSNQIQLYGQFLLDEFSIADMKAGDQSWKNKFGYQLGAKYFDAFNIDNLLLQL
EYNHVRPYVYAHSNPLTNYAHSNQSMGHQWGGNFKEFIAVARYFKGRWFADAKLTYGKRG
LDFDTEENSFNYGGNIYKNYGEGRPFDTGVKTGQGNETTILIADLQAGYLVNPATNLKFF
AGLIYRNFNPNVDTPTAFKEDTTWFSIGLRADLFNWYFDY
>LONDMIMF_02068 Deoxyribose-phosphate aldolase 1
MGFFYFYHMDIKQYLDSTYLKTPQQAGISEAENEKIVRSFVQEAIDEGFKLIMIRPDMVH
MAKQMILKAGSKVLVGTVIGFPEGNYSLEHKLEEAEKAIKDGADELDFVCDYEAFKRGDL
DLVKKEILKGTQLGLSNHKVVKWIIEVAALNSQQIMHLSCLVKNVVISNFAEDNYASVFV
KSSTGFYKTEDGLPNGATVPSIIMMLENASPLPVKAAGGVRTFEEAKEMIRLGVRRIGTS
SAKAIANGEAANNDY
>LONDMIMF_02069 hypothetical protein
MEPNKKRILFLALAVFWTISITIACLVSMSEVPVVNVDQADKIVHLCFYAVFSILWFLYL
RTKIRNTKKLFLVVFFLSVLFGILIEICQSLFTKSRQADLKDVIANTIGALLGLALMAVY
NKRFKN
>LONDMIMF_02070 Glycine cleavage system H protein
MNIPANLKYTKDHEWVSIDGDVATVGITDFAQKELGDIVYVEVETLDQTLDKDEVFGTVE
AVKTVSDLFLPLSGEIIEFNDTLESSPEKVNTDPYGEGWMVKVKIADASEVEGLLDSEAY
KNLIGA
>LONDMIMF_02071 hypothetical protein
MKTNYTKGIACNLKISFWLISIFFSVTIQAQEDEEVQDTTKTGYSVGRVELKNPPSIIEA
YTYDPITDRYIYTNTVNGFNINYPVVLTPQEYEELVLRESMRKYFKEKSDAIEGKKDGSD
AKKKDLLPRYYVNSSFFETIFGSNTIDIKPTGSVEMDLGIRHTKQDNPALSPRNRSTTTF
DFDQRISMSLMGKVGTRLNVNANYDTESTFAFQNLIKLEYTPTEDDIIQKIEVGNVSLPL
NSTLIRGAQSLFGVKAQFQFGKTTITGIFSEQKSQTKTVTAQGGGTVQEFELFALDYDAD
RHFFLSQYFRNQYDRSLRNYPLIDSRVQITRIEVWVTNRQNRVSTTDNNLRNIIAIQDLG
EAQLTGQDDNEVVSANPIPGGFFTAPANTPSKNSNNRYDPAKIGTTGVLNPSIREIATAS
SGFTGITVSEGTDYSKLENARKLSWPSDYSYHPQLGYISLTQRLTNDEVLAVAYQYTIGD
QVYQVGEFGTDGVDATQVSNGIPTTQSLILKMLKSNLTNVNKPVWNLMMKNVYALPGAYQ
LEQEDFKLNIMYTDPSPLNYITPAAPSAANPLPPDVEQTPLLRVFNMDRLNYTNDPQPNG
DGFFDFIPGLTVDKQNGRIIFTTVEPFGEHLFNKLRTSPTQDYDAPAAGNYNGNQNKYVY
RTMYRSTQAAALQDSDKNKFQLKGKFKSTSGDGIAIGAFNVPQGSVTVTAGGRVLVEGVD
YTVNYQLGRVNIMDASLQASGTPIEISLENNSVFGQQTRRFFGVNVEHKFNDKFIVGATL
LKMSERPFTQKSNYGQESVNNTIIGLNTNFSTEVPFLTRLVNKLPNIDTDVPSNISFRGE
VAYLKPDTPKADRFQGESTVYVDDFEGSQTTIDMRSPFAWSLSSVPEKPTVSDYNDFGGS
LTTLNYGYKRAKLAWYSIDPTFYVQRPGGVSEDDLKLYSTRRIYSRELFPVTDIAVGQQT
VINTLDLTYFPRERGPYNFNPLAQATNSFTPEQAVDNFGGIMRAINSTNFEQSNVEYIQF
WMLDPYYNDQRGSANAANTGKLYFNLGEISEDVLKDGRKQYENGLPGAGSTQPTFTTIWG
KIPISQSLIYAFDTNGGNRQFQDVGLDGLNDAEEAAQFPGFASQPDPAADNYQYFLSASG
DVIQRYKNYNGLQGNSPVDVGDTNRGATTLPDTEDINRDNTMNEINAYYEYGIDIRPNMV
VGSNPYITDIRETIASIPGQETTGARWIQFKIPVSQPQNTVGSISDFRSIRFMRMFVTGF
NDQITLRFGALELVRGEWRRYVKSLDPNEQDDDINNADDTALDVLAVNVQENGDRSPIKY
VTPPGVVREQLYNSNTIINQNEQSLSLRVTKANPSLPGLGGLEPGDSRAVFKNVSVDMRQ
FKKLKMFLHAEALPVPTDIQPLADDQMVAFIRFGNDFTQNFYQVEIPLKVTQQSAAVTAE
QVWPEANQIDLALSLLTKLKILAMDPTNALLVEDALGVKYVDDFVLDPSLAGRINPLRLG
IKGNPNFGLVRTLMVGLKNRHTDDIRGEVWFNELRLADMDNKGGMAAIASLDSNLADFAT
VSATGRMSTQGFGSLEQGPNERSREDIKQYDIVTNVNLGKLLPKKWGVNLPFNYAIGEEK
ITPEYDPFNQDIRLDQLLDNTADAAARNNIESRAVDYTKRKSINFIGVKKERGAEQKPHF
YDPENLTLSYSFNETEHHNYEIESLLDQQVKASVDYTFAFQPKAVEPFKNTKFMKKSQYW
KLLSDFNFNYLPSTISFSSNIMRQYNRQEYRDVDIQGIGLSPLYRRNYMFNYQYGFNYNL
TRALKINYTASTNNIVRNYLDEFGVPMEDFTIWDDFWNIGQANQHMQQLVVNYDLPLNKI
PALGFIKSTYSYTGDYSWQRATDALASVTTEDGTFSLGNTIQNNGSHRLNTSLNMDVLYK
YIGLGKKPKVATRPTTQAPPKPGEKITNANKPQTSGSNVFLDGLVGVLTSVKNVQINYTQ
NEGTVLPGFIPGVGFFGTTKPSLGFVLGSQADIRYEAAKRGWLTNYQDFNQNFTQTSSKV
LNMTANVDLFPDFKIDLTADRSYTENFSEQFDAADGIYHSRSPYNYGNFSISTVMIKTAF
GKSDENSSAAFDDFRSNRLTVADRLATSYYGTTEFPRTSDGFPVGFGKNSQSVLLPSFLA
AYTGADAGGVKLGPFRDVPIPNWNVKYNGLMRYKFFKDRFKRFSLQHGYRASYTINSFRS
NFEYDQNRDAVDASGNLLSKTIISNVNLVEQFNPLVRVDFEMKNSFKVLAEVKKDRTLSM
SFDNNLLTEVRGMEYIVGLGYRFKDVVITSRLADNPTNTIRSDINLKADFSLRKANTIVR
YLDYDNNQLAGGQNIWSVKLTADYAFSKNLTAIFYYDHSFSKAVISTSFPLTNIRTGFTL
RYNFGN
>LONDMIMF_02072 Holliday junction ATP-dependent DNA helicase RuvA
MIAHLQGKLVEKNPTEVVIDCNGVGYHINISLHTYSLIPDSENIKLFTYLQIKEDAHVLF
GFAEKSEREIFKLLLSVSGIGAGIARTMLSSLEPKQIIQSIASGDVATIQSIKGIGSKTA
QRAILDLKDKVLKVYDLDEVSISQDNTNKDEALSALEVLGFNRKLAEKTVERIVKENPNA
SIENIIKLALKTL
>LONDMIMF_02073 NADP-dependent malic enzyme
MDSGVAANPIQDWDKYREELMERLGSDNKMVRLLANRAKTDPKRVVFAEADHLDVLKAAQ
IVLEEKIGTPILLGNREIIQELKEELGFDADVLIIDPKTPEEDERRLRYANSFWEARRRK
GTSLLDAQKWMRERNYFAAMMVNEGEADALVSGYSRSYPSVVKPMMQLIDKAPGVSKIAT
TNMMMTKRGPIFLSDTAINPNPTADELAKIALMTAKTVRMFGMEPVIAMVSFSNFGSSND
EGARKVAEAVAYLHKYYPDLVVDGEIQADFALNSEMLQQKFPFSKLAGKKVNTLIFPNLE
SANINYKMLKELDKSVSIGPIMMGMDKPVHIFQLGASVEEMVNMAAVAVVDAQEKEKKQK
SIKVNF
>LONDMIMF_02074 NADP-dependent malic enzyme
MNKYSKRREALLYHAKPSPGKIEVVPTKAYATQRDLSLAYSPGVAEPCLEIAKDVNNVYK
YTAKGNLVAVISNGTAVLGLGDIGPEASKPVMEGKALLFKIFADIDVFDIEVDTKDVEKF
IETVKNIAPTFGGINLEDIKAPESFEIERRLVEELNIPVMHDDQHGTAIISSAALLNALE
LAGKKIEDVKVVVSGAGSAALACANLYVLLGINPENVIMFDRKGSLSKNRTDISEMQRKY
ANGEKSITLEEALVGADIFLGLSSGNVMSAEMLMQMAENPIVFAMANPIPEIDYHLAIAT
RKDIIMATGRSDFPNQVNNVLGFPYIFRGAIDVRASKINEEMKMPAVKALALLAKETVPE
QVNIAYGETKLVFGRDYIIPKPFDPRLISVVAPRQRWIPELRQIQFRIGINTEKN
>LONDMIMF_02075 hypothetical protein
MFYYFLYISLSSTMLHKFYKFIATMKKLLLMLCIITASLQSCQKEKGEVSKKEDGKLKTI
LENYYQERLKLFPLEATSAGDNRYNNLLPNDASDDYIAKIKAFFTKYKEELAKFDDSTLS
ENDKLSKAILSWECDANLEALTFRKDLMPINQFEGMPLMIGQYASGSSAQPFKTVEDYNN
WLERLNGFNDWVITAEAKMKEGVSKGYVLPKALTLKVIPQLKDLAKEDKTHIFYAPLNAF
PKTFTEDEKKTITDNYTKLIAEKLVPSLKNLYNYVNTDYLAKSRTTSGINAIPQGDAYYK
HLIKRYTTTDLTADEIHKLGLNEVARISAEMEKVKNQVGFKGNLKDFFNYVRDKKELMPF
TEPQQVIDNFNAIHEKMKPNLDKLFDLKPKTPFVVKRTEAFREKSASAEYNPGSVDGTRP
GIFYVPIPDVKKYNFYADEDLFLHEAIPGHHYQISLQQENTSLPEFRKTIWFNAYGEGWA
LYTESLGKELGLYQDPYQYFGMLSAEMHRAIRLVVDTGLHTKGWTREQAIQYSIENEAEP
AESIVAEIERYMAIPGQALSYKIGQLKIRELRTKAEKELGAKFSIKEFHNQVLESGCLPL
KILEDKINNWIQSKK
>LONDMIMF_02076 hypothetical protein
MSIGKFSPIKESVLKGLFFILDADYHGLITRIWEIYTT
>LONDMIMF_02077 Epoxyqueuosine reductase
MEEEAPRLEAWLKNNAHGQMGYMENHFDKRLNPTLLVDDSKSVISLLLNYYPEQTQIADS
YKISKYAYGQDYHFVIKEKLKEFLFSIQENIGEVSGRAFVDSAPVLDKAWAAKSGLGWIG
KNSNLLSKQVGSFFFIAELIVDLELEYDTAVTDHCGSCTKCIDACPTGAIIAPYVVDGSK
CISYFTIELKDNIPQEMKGKFDDWAFGCDVCQDVCPWNRFSKPHNEPLFNPNQELLSMTK
KDWEEITEETFRAVFKNSAVKRAKYDGLKRNIDFLK
>LONDMIMF_02078 hypothetical protein
MTSEELKARTEKFSLMVIDVVEKLPNTISGRAIANQIVRSGTSIGANYRAVCRARSDREF
ISKMSIVIEEADEKLFWMKFFKRKNGLITHN
>LONDMIMF_02079 Holliday junction ATP-dependent DNA helicase RuvB
MNANLDPTSNNYNSEELDFEKRLRPLSFDDFTGQDQVLENLKVFVQAANLRKEALDHTLF
HGPPGLGKTTLANILANELGAGIKITSGPVLDKPGDLAGLLTNLEERDVLFIDEIHRLSP
IVEEYLYSAMEDFKIDIMIESGPNARTVQLNLNPFTLVGATTRSGLLTAPMRARFGIQSR
LQYYTTELLTSIVERSSAILKMPITMEAAIEIAGRSRGTPRIANALLRRVRDFAQIKGNG
KIDIEIAKFSLKALHVDAHGLDEMDNKILTTIIDKFKGGPVGLSTLATAVSESGETIEEV
YEPFLIQEGFIIRTPRGREVTEKAYKHLGKIRTNIQGGLF
>LONDMIMF_02080 hypothetical protein
MSDKYADIPLVQNQDKRRFEMEVENHIAFIEYIINKDNIMYLTHTEVPKALEGKGVGGSM
VEKALNFVKDNGYTLAPLCPFVAAYLKRHPEWQSILAKGYNVG
>LONDMIMF_02081 Alkanal monooxygenase alpha chain
MKKIGFLSFGHWANHPAYKTRTASDTLLQSIDLAVAAEDIGIDGAYFRVHHFAAQLASPF
PLLSAIGAKTSKIEIGTGVIDMRYENPLYMVEDAGAADLISEGRLQLGISRGSPEQVIEG
WRYFGYEPKEGENDADMGRSKAMEFLERLDGVGFAQPNPTPMFPNPPGLLRLEPYSKGLR
ERIWWGAASNATAVWAAENRMYLQSSTLKFDESGKPFHVQQAEQIRLYKEAWKKAGHPGE
PRVSVSRSIFALVNDQDRLYFGQEANRVDQIGMIEPGRNAIFGRSYAAEPDKLIKELAED
EAIQEADTLLLTIPNTLGVDYNVHVLSSILEHVAPGLGWR
>LONDMIMF_02082 hypothetical protein
MKYLTLIVICVLALGCNNNSIQKTNETDQLLAKIKLLEEQNQKLKDSISRDQMDFLHSQI
LIGISDDEVLKVGKKNNIVILVHTYNRELPKYEIYTVVDNKEIKIGENNQTRFNFEFIPK
SVEDNSPEIFLKMQYKGETIKIPGKLLLKVEK
>LONDMIMF_02083 hypothetical protein
MIKYFTVIVFLFYNCTFAQEANHAIAANSIKANFSVKVLEAYEENSFSKLEDFYELLEIY
SAKNTPNTLKKQLEERINALYKENTLVSDFFTSDKISVDRLLEKVASKELKFEVKNIQKV
KTFGNYWTASYILTIQRDKETLQKNISQRIYFYPEAKTFGNKKKEVWSLFLGEME
>LONDMIMF_02084 hypothetical protein
MTELDFFQLLKQEVLLAYQKQYPYFQGNWKSFSSQDIQNLIELVEEKTRQGISEKWIYTH
LKAETNSKLPRKDMLDILSQFSGFSGWDEFVFKNREVAVEQKENHSQKNKKHFVVIGFLA
VIMVAILFFAYSGKKQTQKLQLKNEFTNDTIQAKEVKAYTIEDDKKIEIPIRNSEIEVAL
KDENAKVVIQSPYYKKQEIKVNKTSEKTEILLQPDDYAMMLKAFMKSDIKDWETRKIQLN
KILSDNLEVIVMLKNDLGAEYFNKNEFSEKLIIPTESVKRMQILEIKNNNEGKIEFIRIK
Q
>LONDMIMF_02085 hypothetical protein
MKLKFTIAGILFFGMAYAQHGANQVYNNQNNPYNYKNASLFQNAEKVNYTEDGINFRIAI
LNNVKPDSYVVTLGLNEEGLSVKDCNAKINKRLDGFKNALKKTGIREEEIFVDFISQTKI
YDYKSTSTSSQVNITQEDKGFEIKKNIIVKLKDVSLFDKLIDMASEYEIYNIIKVDYKKA
DTEKIYDEMLAEANEVLKSRSKIYDKYGKRDFESEPQLLINFYSIQPGKQYKNFTAFESS
DAVYNDYYNSNKVLVRKEQRKNKTFYYDGIDPDSFDKIMNSDSPAVGIQYVMEFSISYKT
KKKPKEETKKLYHIITPNGDVKTLDLKN
>LONDMIMF_02086 Acetyl-coenzyme A synthetase
MSYYQVKSLEQYFKHYNKSIREPRKFWDKIADENFTWYQKWDKVVEFDMQEADVKWFLNA
KVNITKNCIDRHLAKRGNKTAIIFEPNDPKEEAQHITYNELYDRVAKMANVLREQGIKKG
DRVCIYLPMIPELAIAVLACARIGAVHSVIFAGFSASAVTTRVNDSQCKMVITSDGAYRG
NKSIDLKGIIDEALEKCPSVEKVLVVKRTNAEINMKTGRDLWLQPLLEAAIPNNVAEIMD
AEDPLFILYTSGSTGKPKGMLHTTAGYMVFAAYTFKNIFNYEENDIYWCTADIGWITGHS
YILYGPLLNGATTVIFEGVPSYPDFGRFWEVIDKHKVTQFYTAPTAIRSLAKENSEWVEK
YDLSTLKVIGSVGEPINEEAWHWYNNHVGKKRCPIVDTWWQTETGGIMISPLPFITPTKP
TYATFPLPGIQAVLMDEKRNEIEENQIVGSLCIKFPWPGMARTIWGDHQRFKETYFTAFP
GKYFTGDGALRDEVGYYRITGRVDDVVIVSGHNLGTAPIEDAINEHPAVAESAIVGFPHD
IKGNALYGFIILKEYGESRDRANLANEINQHISGHIGPIAKLDKIQFVSGLPKTRSGKIM
RRILRKIAEGDFSNFGDTTTLLNPEIVEEIKNGRV
>LONDMIMF_02087 H(+)/Cl(-) exchange transporter ClcA
MNYLCINPEDKMQTRKKLLWLKWLKLALAAVLVGFLASFLAISLKHVTEHYEGVFYGKAE
KYNFLLLVLPFFGLSVIYFLRIYLFKNKENKGIKEVFESTKPGKSLPAYKIPSHFINGLI
TVAFGGSTGIEVSTVVASAAVGSIAHSKESFLKRYKTELICAGVSAGVAALFASPIAGLL
FAYEVISKKLSRSFLFTTVIAISVTWLFLFFMDVKPLFDVGISTWNYHAIPYFILLGIIA
GINSVYLTKCVLQIKAWFSKIKTPYYRVVLGALLVGVGLFLFPQLFGDGYNAVKENIANS
SSTPAISVLLTLAACIVLKPIITSVTLSSGGDGGVFAPSIFIGALLGLLLAFVSNRFFDA
GVIPLNFMVIGMAAMLSASISAPFTALFLVCGLVGSYVLFWPILVVSLVSKYVAERLCPY
TVYTYAAKTTA
>LONDMIMF_02088 hypothetical protein
MPIKKIHRTYRKTRYVLYKETLVDFREHFWAFIGSFVGMGLIAYLQYGSFNENDFVYLIG
SFGASCVLVYGVIQSPLAQPRNLIGGHVVSALIGVTVQKLVPDVLWIAAPLAVSLSIVLM
QITKTLHPPGGATALIAVTGGPQIKALGYGYVIFPVLSGALILLLIALIFNNLTPKRKYP
SAPILRKKKRKKHS
>LONDMIMF_02089 hypothetical protein
MKKLVAYCIVLLFAGIQTGQAQSVTGRWKTFDDETGAAKSIVEIYEKNDKIYGKVVEILE
KGKEDKTCEKCKGSKKDKPIKGLVIIEGLSKNDDTWEGGTILDPKNGKEYKCHINLENKD
KLKVRGYIGFSLLGRTQYWTRVEK
>LONDMIMF_02090 hypothetical protein
MKKASLIICTICFALIGTKSQAQEFYIRGGLGFVTESGKTEFNNADPNGLTMIQQSTDIT
VNPDGSMRIKSLNGTLGGGFKGNITAGYMFNNYIGAEIGFNYFSGYDKTIGKLTSPQLQS
EEVAYLRGLDIIPAIYITPGLSKLNPYARIGAIIPTAGKLFIETTANQTDGGGQGTDIHV
EAKSEVESKFSVGFVGALGVTYPVAPRLQVFGEVEFKNLSIKSKSAEITEYRTTAVANGN
AVLVPGQQLADLPVNEKKFVFSDSYTQGPADPDSPRRLPTQYVNASGIGVNIGIRYSFGK
>LONDMIMF_02091 Transcriptional regulatory protein YpdB
MTLQATHTVFNSRLKMRTVFTACLVLFVTVNVLIDYLSTLSQNSAFYLSESLLFSSYWIL
FLPLLTLFLQLTEKKDKIAIKIVLIGGAVVLHLLSYPALIWIVSKIFYSHTFSYWQTFNF
GISAYLIKTIIIYGFLLMAFSLSNQKIQTAPLSPSNEKKAYINSILISDSTNRKTVVAVN
DIFYFSANSPYVNIYQLSKKYLYSGTLKSLEVQLDNKQFVRIHKSYMVNVNKIISVRSRQ
NGDYDITLTDDTVLRLSRNYAKNFKLHFSAHQLSLK
>LONDMIMF_02092 Protocatechuate 3,4-dioxygenase beta chain
MKKRIFFKLIFLQLMFMSCNGQQVNEKLLPKNNSIIGGGCDGCELMYIGMPKELHATDTS
PGWNEKGQKLIVSGTVFQLDQKTPAPNVIIYYWQTDNAGYYSPTQKMDERVKRHGHIRGW
VKTDKNGKYTIKTIRPAPYPNDVLPAHIHLSIKEPDVANEYYTDEINFEDDKLLTAHFKK
YPQEKRGGSGIVKIKVKDGVQITTHNIVLGLNIPNYPKKFK
>LONDMIMF_02093 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase
MKTVFITGANGLLGTNLVNEMLALGWQVKALVRNPDSFKGGEHSHLELIKGDLQEDLCTH
MDACEVVIHIAAETRQHLLRYSDYQKINCNATISLFRSALVSGSVKKFVFVSSANTIGHS
DLFELGSEDKVVRYPFKDSYYAKSKLEAENFLLQNKDSMDVIIVNPTFMLGAYDTKPSSG
KIILMGWKKHILFYPPGGKNFVDVKDVARGIIAGIEKGKNGEKYLLANSNLSYKAFFELL
CEYSNQHPIMIPLPKWLLYLLGYGGNCARFFGLETSISLTNMRILCQNNFYSNKKSVQNL
GIKYRPIDYAIHDAVTYFKSENVLR
>LONDMIMF_02094 putative oxidoreductase
MLRKNDETVASGNETGYAVVTGASQGLGRAFAYELAKNNIPLILMSLPRQELAELSSEIS
EQYGVKVFFYETDLSVKKNVLDFAAWVNANFSVFMLINNAGTGGTQKFDEATAEYISKII
EVNVMATSLLTHQLLPNLKKKEKAYILNVSSMAAFCPIGYKTVYPASKAFVHSFSRGLYE
ELKHTSVFVSVVNPGAMKTSPEITRRIEKQGFLGKLTLLNPDAVARYCIRQLLKRDTVIM
VNRMSWLMLVMLPIWIKLPLLTRSIKRELNPEV
>LONDMIMF_02095 HTH-type transcriptional activator Btr
MIYIDRLIVIFLLGGFAMLTMLVIFNPLKVNRKANVWLGLFLFLWGTFWIDEAAEILGIA
SIGKPFLFVLNFLQFFTPLTFYYSAVHFTNPAFSFSLKELRHLPLAALFLALLSLSYFYD
KADKDILRAWLTVIMLVQSLFYALYSCEIINRHQRKIQQFSSDTYPISLNWLKYIAYTIL
ASGIIITVYNIIFIAERPGTYLNFAFLIAIYFIAYYSLKQQEVYPVGTQQPDTVFSFQEE
SKTNEGPKIKLLGNEETELIKQRLLGVMESEAPYLDGDLNLIKLAQLMEVTPHQLSYVIN
TGFNENFFQFINKYRIEKAKELLADNRNNNLSILGIAFESGFNSKTSFNITFKKFTDLTP
SEFRKKSSDL
>LONDMIMF_02096 hypothetical protein
MYKILSLDGGGSWSLLQLLTLKDRYPDKTGHAILKEFDMVIANSGGSIILAALVEDWPLD
KAIALFKDQKIREKIFSKNSFWERFFPVDYIKSIGPKYSSKRKGKAFRELFTESAKRQMN
ELPDFIGKPDLKLIVCTYDALNNRAKFFRSYGGGPYYDSVKLTQAIHGSSNAPIQYFDFP
ARFKAKNSEVFFELWDGALGGFNNPIAAGVIEAIKSGVPRDSITLVSLGTSNKSMSNDDK
KTFYDIKQTTIKQRRKKYKFWLWKPQLQFFKMSIVNQAKTILYEPPDWSNYVAFMFLFGE
DYKEGLDAAALKRFIRLSPMIHTDKNTLPEMEELLNTLYRMDMNLTKDEEIQKLEECYAG
WKEGKIPNQPIEYSITRENELLPTFGHIRYNDGINDWKT
>LONDMIMF_02097 Glycerophosphodiester phosphodiesterase
MKKYPAFLLVACLAATSCNIAHNTATTKLSHIEVQGHRGDRGHFPENSLEAFRSAIDKGA
DVIELDVVISGDKKVVVSHEPFMSSEYVSLPNGMPVTREKERSYNLYQMSYDSIRKFDIG
SKGNTHFPEQQKFKAYKPLFSELIDDMEAYTAKHRPGKPIRYNIEIKSGADQYDKSQPQP
DVFVAMVMEIVKKKEIQKRSNIQSFDPAILNALHKKYPDVTIAILAGDKGLAKNLSKLDF
KPQIYSPHYGQVNQALVDSVRKLNMRLIPWTVNDEKDIDKMIELKVDGIITDYPEKVIKR
L
>LONDMIMF_02098 Internalin-J
MKKLYYALLVFCFWQSMKGQGLYIPDANFKAKLLAADAGNEIARNRQGQYFRIDSNENGE
IEASEALAVSYINVSSSSIANLKGIEYFTAITTLLCNDNQLSSVPTSDLPSLTSLQCANN
KIVSLDLSACSKLYSLSCANNKLESLVLNNPELNFIDCRHNALISLNINNSPNLEYLYCS
YNSLTDLNLSVNSRLRDLECSFNRLSILNLTGLARLRDLECQNNQLAILQLAGNFIKKLY
CHNNRLAQLDLSAQTTLEELNCSNNVLTALDFTGLTKLKRLLLHNNRLVSLSNLVDYPEL
VSVIADNNKLLSMTVSGPAITELSLANNQLGYLKVYGCPELSIGRLNFRSNPLASLDLRG
FEGLDTLPCSNYGLSGALTVLADKELRSVSFDGNRLSSLDIAQCPGVEVLEFGSNPLLTS
LFIKNGKDNTAFFEHSLSTVPRLRYICADEEEIDMIEARLAALPGLECGVNSYCSFTPGG
NYNAVKGSTTFDDDMNGCDAEDTIVSFAGYKLIRGTTETVYFSDRSGQYNLPLLDGNTTI
IPLLTNPDYFDVSPPSMTYSFSDQPSGSLEQLFCLKSKGEYPDVEITLLPLNDAVPGNVA
NYAISYRNKGTRTQSGNIQLEFDATIIHPEITTSTTQNPGRLIWSFSNLKPFESRTIALR
FILNRPTDNPSLNSGDILNYKVTIITPSLDAVPEDNTIVLRQKVVNSFDPNDKTCLQGLS
VSSSIIGQYVHYIIRFENTGNFVAKDIVVKDLIDTERFDISTLSTIESSHNFSTKISNTN
KIEFVFKDINLPFYDHINDGYIAFKIKTKPSLAPGDSFSNAASIYFDFNLPVMTERVTTR
IESLSDKDYEFSNRFMIFPNPSSDFITITNKDEILIKSVTVYNIMGQPVRTFSSTFDTKV
LDISNLASGNYVIRIYSDEGTATAKFVKY
>LONDMIMF_02099 hypothetical protein
MVKKYALFFIVFYATICQAQIGDTVAVQKPEKRIETYDNHIKLRLGLSNSFNSFRVKDRT
NHLDFTLSPNQRLRSTLTLIYKFIEIDLGYTPEFLRFNKDDALRGHTKFYNFGTRLYFGS
WMQELQYVKTKGFYIDSKDIGIENNILFPHFQVQKIGGSTSYVFNPDFSFRAIFLQSEWQ
QKSAGSFVPSMSYYFTQIKNNEPGKDHIFDIAVGPGYYYNWIIRNKWLVSAGAYAGLGFN
STRTVYNDNKPDEVIDGLSFQTLFRLTLGYNTERFFAGAATSLNSFSYNSDAQIHVADQQ
QFLEFYVGYRFKAPKRINSLFGKE
>LONDMIMF_02100 hypothetical protein
MNNTRIYKMSFASVYPHYIQKVEKKGRTKEELDTVIFWLTGYDEKSLQQVIEQKTDFETF
FAKAPQINPNVSKITGVICGYRVEDIEDKLMQQIRYLDKLVDELAKGKAMEKILRQ
>LONDMIMF_02101 hypothetical protein
MLATELQKFIVILLFGSLVLQSFIVLANPMNVNKKANLFFGLFLFLWSSFWFFDVIALCG
LNTGFVLTQIIYILQIFTPLFLYFSVVFFINPNYVFKKADLVCLILPVIYIALMLDPPHN
IVYSMIPISHNLPYIAIVYFKIRRHQKRIETISSNTENSSLQWLIKITSLLFVTIIITEG
YELYNIFIEKRQEHLVMDLLFLIIVYLTSYYSLRQKEIYPLDEAQRKELLEIELKDEGQE
EKKKLLSDNELENLKLKLTELMETEKPYLDGELNLIKLAGLLGISAHQLSYLINKGFDEN
FFQFVNTYRVRHAQKLLSEKKNQFSLLGIAYESGFNSKTSFNTIFKKMTQQTPSEFRKDL
K
>LONDMIMF_02102 hypothetical protein
MNIQNACLTLLFIGLNSFAQQTGINTKNPQGVLHVDSAINNPTLGLPTVEQTDDFIITNS
GNVGIGTITPNTKLHINSTTSGALRIQDGTQAANRLFVSDINGTGTWITPAVTKTVTMGT
FPSPAQTITLTGTNNGGSTNPIYSGLYLDLEPGRWLVNAGITLENLPTGAIQGWGHAWLS
TNNSGAPVQNGFAHLGSAGNNTSFAGVLQGAFLTYTPSTPKTAFISGTSIIQVNGTSTLR
IFLMLERFSYTYRTNTSQNYFYAVPVN
>LONDMIMF_02103 hypothetical protein
MKTLNIYFCLLFIGLSLHSFSQTGINTTNPLAALHVDPARNTPATGTPTTQQTDDFIVYN
NTGNVGIGTVSPITKLHINNETANPSITITDGTQGVGKVLTSDANGVATWVTPPITMSAV
LGTFPTISLPVTPTGETDPPIFSTLRIALKPGKWIINVGLVFDSLGSATFIQNAYLSTSL
TGAITQTNFSHLGPGGSNTSYVGVLTGSATFTPDTADNRRSYVTGSSIIQVTGSPVSIIN
LRLQNQPIGYYRFDPYAPENYFYAIPIN
>LONDMIMF_02104 hypothetical protein
MSTRHIFLITLLTGFSLNNFAQQTGINTKNPQGTLHVDAAHNNTGTAPTSTEQADDFIVD
ETTGNVGIGTVSPTTKLHIVSSAPGALTIADGTHDGNHVLLSDASGNGKWVDHPVMRPNI
RGSATTTNVYSDGNAATPYLYTGFSITLTEGDWIVNAGLTFVELGRRGGGSINVTFWQKA
YLSSTNSSTSISQTSFSHLGPAGNNTCYGGPMYGLSSRSPYEIGYITGSSVIRVPASTKA
TIYLMIENKPVWYYRYNSTYWENYFYAIPITQ
>LONDMIMF_02105 hypothetical protein
MKLQFAILFLSISALSFAQKTITMKIKENTVPCEGVAPMDCMQVKEGKAKEWSNFYSTIE
GFDYQPGYEYKLKVIKTKRQGNIPADASAYTYRLKKLVYKKQVKAANETYLGKKMILSQI
NGKNINNGKVYLTIDKAKNAIFGKSGCNRFNAGYQLKGNQIQINLLMGTLMACDQESMQL
EQEFKTAMENKKFEIHTQGTTVHFKDPKTKKVALAFTIPTEEEIWAAIDGKKWKLIQMDN
VGKDYGKAGLQFDAKSKKITGNSGCNNFFGTFSTVKDQITFSALAGTKMACIDKDAAATE
TKMRHYLSETTLRFDVAEETLNFYKDNKLVLVFVKQ
>LONDMIMF_02106 L-allo-threonine aldolase
MKIDLRSDTLTLPTPQMQEAMNKAPLGDDVYGEDPSVNALEEKATKMFGMEAALFCPTGT
MTNQLAIKVHTRPGDEVICDKLSHIYLYEGGGIAMNAFSSVRPLEGDLGRITAKMVEENI
NNANDIHQPITRMVSLENTVNKGGGSIYDFNEIKKIKEVCHANGIILHLDGARLFNALIE
TDQTPLDYGKTFDSISICLSKGLGCPVGSLLLGKKSFIDQARRYRKAMGGGWRQAGALAA
AGIYALNNHIALLKDDHRRAKEIGKMLAGNSWVEKVYPVSTNIILAQLPQNITSTDFVEK
LKQNEVYCVSFGKHLVRFVTHIDFTDEQLEVLRTRLAF
>LONDMIMF_02107 hypothetical protein
MKTNQSFLLEKDLDLENENFIVKKGTLLHIVNLYDKSDKKSPTVVGVKFGNINGTYHLDE
TLLKNLMKSGNMSAVARRFNIGDCVVTPDGEGAVKSHFLDPLLSWMYGVNLKKGGAFIYR
ENELANCA
>LONDMIMF_02108 hypothetical protein
MKSVFKLVVISLLFTSCASRLKVVVKVADREQVLKMADASLKAEVLPSVIALENFIDSWN
EEALLEEIYASVEKKLGASLRDTTKIEYKEEFRKQFGPKIILIRGFIDETRRKYDANNVN
DAFTAINKAILEITSIQKLLKEYKEDKDLDPNRMLGVQEETVTMTAKTAIAGTERTRFPI
LGDPLTSQIAKKENEMIWKSVFNETVSWSFLGNSDIAFILRSNPPEKEIKSGDYNNNFTI
KGVRMDAADATNALITGLTQTMNFIANTQGISIPMPQQTANTDPVPVQNTLIMGLFADTM
AYETKKKKLEDYKKMLIEKIKMEGIETKQNEELNDAIKRIEDYWTSLKVELNKP
>LONDMIMF_02109 hypothetical protein
MKTQYLLSLILIGLLLTSCSNIREVHYFKDKITEKSDAPTKTIANYYKVEIRGYSFLSSS
RYLSGYFDQSAINLYFNEFTQPEDGKLFGNNPQGGLTDETGNELVLIFSTNAKAISDQIG
NISKNQVILNSAASLIQEDKIKEAQKLKMSLNELSLETNNFIFQSDSYLKGISTKTEAEK
KLAIRQFLQILQSN
>LONDMIMF_02110 Flavoredoxin
MEFNPDELDQKAIYKLISGAVIPRPIGWISTISEDGINNLAPFSFFNVVGDDPPHVMFAT
AHSNQQKKDTLANTLATGEFVVNLVTEDIVEAMNTTAQTVHADIDEFELGGLTPVPSVKV
SPPRVKESPISFECRLVHHYSLEGHKYGGATVIIGRVVMFHFDEKVLLDDYKINMENYKP
VARLAGSNYSKLGEIFAIKRQ
>LONDMIMF_02111 Putative cysteine ligase BshC
MPTDCISYQESGYFTSLINDYLNQKSDLQSLYHRFPSLENFEKQLLEKEKNFNSDIEKRK
TLVSVLEKQYSGLSVSDLTKWNILALENPKTFTVTTGHQLNLFTGPLYFLYKIVSTINLT
KQLKLKYPEYNFVPVYWMATEDHDFEEINYFNLHGKKVRWNTESGGPVGRLSTKGLEEVF
EVFSLELGIGKNAEYLKKLFEESYVRHNNLADATRFLANELFGKTGLLILDADSKELKKH
FAPYVKEELLNQTAHKKVLETSEKLKNYNIQVNPREINLFYIEDDFRERIILQNGFYYVN
NTELKFTEAEILELLKNHPEKFSPNVIMRPFYQEVILPNLCYIGGGGELAYWLELKSYFE
AANVTFPILLLRNSVLLATEKQVKKADKLNLSWKDLFSKQQELMNLKVKTFSEFSIDFTA
QKAFLRQQFDDLNKIAEQTDKSFTGAVKAQEVKQMKGLENLEKRLLKAEKKKHQEELERI
SDLQNELFPNQNLQERIVNFSEFYLGYGDVLLDKLFAELHPLEQEFKIVIL
>LONDMIMF_02112 Nucleoside diphosphate kinase
MATNRTFTMIKPDAVENGHIGGILNMITEGGFKIVSLKLTQLTVADAQQFYAVHSARPFF
GELVEFMTRGPIVAAILEKENAVEDFRTLIGATNPADAAEGTIRKKYAKSIGENAVHGSD
SDENAAIEGAFHFSGREQF
>LONDMIMF_02113 hypothetical protein
MAKRLNNENSVGDVLKHIIEANKLQPGIDRIAVKEAWISLMGNGVNSYTKDVVLRNNTLY
VELTSAVLRQELSYGKEKIIKMINEEFRRDIVKEIVFR
>LONDMIMF_02114 hypothetical protein
MKKGVLLLFAAVVTIACNQNVSKEDAKKLNGYWEIEKVILADGSEKDYKINTTYDFFEIG
NNYKGFRKKVSPQLDGKFLTDDTSEAVEIVEKNGKVYLDYKTDYAKWEEELKSVSENQMT
IVNPQKIEYQYKRATPINLLDGKEAK
>LONDMIMF_02115 hypothetical protein
MKKIGYSLLFILALISCSSESDSSSSNPPESTIYFPPLEENALWETKSLSSLGWNENAVT
PLLSYLEEKHTKGFIILVDGKIVMENYFNGHSATSNWYWASAGKTLTATMVGIAEQEGHL
NSNGRVSDYLGQGWTSLPVTKENLITNKHLLTMTSGLEDIDNGDCVEPDCLTYKADAGTR
WAYHNVYVKLQDVVASAVSTTYSNYFNTKLRNKIGMNGAWIQSGNNSVYWSTTRSMARFG
LLMLNKGKWNNEVIVNESYCTAATNTSQNINLGYGYLWWLNGKSSYHLPQTQIQFPGSII
PEGPNDMFMALGKNDQKIYVIPSRKMVIVRMGEAADNVNLALSDFDEVLWEKINALIN
>LONDMIMF_02116 hypothetical protein
MAFSIHNVKPLHLYILFVLLIFISTFFEGRVQIVYYVFVILGWASFFMAARNFIKQRKGK
ARKVTAKKK
>LONDMIMF_02117 hypothetical protein
MKLNHYLAFLSLIVPFCVSAQDKNGYLIDRNNHRTEVLFKDVDFTDNAAIRYRVSENETY
QAVDINDIIEYGIGDNFKFVKRTVKHDKLFTETATVKEPILEKETLFLNVIEEGDINLYA
YFDKGRMKFFYEIKDSSGGAVQFIYRKYSSDNRYVRENNYFRNQLNDILKCESLQVSDFI
NLKYKKEDFLKIFKQYNSCKRNEPSKIYDNKTNKKLKLKYSAIAGIYQNDFSVEFYKGET
EKISKTTFGLGGEVALVFPSETVEVFIGMEYNSSFSGESKFGKISGPYDLGHNFKFESAF
LNVNIGARYNFILNNKNKIFIDGAVLISNPLDDIEYTISYPEASGVENKTYAYPSQTNTS
LSFGIGYTFNNKISACLRVDTNKDVFKSGAPVEAKSNFSRAGLNLKYTFN
>LONDMIMF_02118 Signal recognition particle receptor FtsY
MSFFKKIFSSEKKESLDKGLEKTKTSFFSKLTKAVAGKSKVDDEVLDNLEEVLVSSDVGV
NTTLKIIERIEERVANDKYLGTDELNQILREEIAGLLSETNSGEATEFEVPKDKKPYVLM
VVGVNGVGKTTTIGKLAYQFNKAGYKVVLGAADTFRAAAIDQLQIWADRVGVPIVKQQMG
SDPASVAFDTLQSAVAQNADVVIIDTAGRLHNKVNLMNELTKVKRVMQKVVADAPHDVLL
VLDGSTGQNAFEQAKQFTAATEVSALAVTKLDGTAKGGVVIGISDQFQIPVKYIGVGEGI
EDLQVFNKIEFVDSFFK
>LONDMIMF_02119 hypothetical protein
MAKKTVATLQTASKRLTKAIKMVKSPKTGAYTFVESVMAPELVDDFLKKK
>LONDMIMF_02120 50S ribosomal protein L33
MAKKGNRIQVILECTEHKTSGQPGTSRYITTKNKKNTPDRLEIKKFNPILKRVTVHKEIK
>LONDMIMF_02121 50S ribosomal protein L28
MSRVCDLTGKRAMVGNNVSHAMNKTKRKFSVNLVKKRFYLPEEDRWITLRVAASTIKTIN
KNGIAAVLKEAKANGFIK
>LONDMIMF_02122 hypothetical protein
MRKLYFAIAATLTTAFAFAQAPTGNLTIFSEDGDRFFLVLNGELQNDIPQTNIRVEELNQ
PYYNAKILFEDKSLVEITKKNLAIADIDGEYMDVTYKIKRDKNNKNKLKLNFFSEIPVDR
QYRAPQNVHVVHYGAPQPVSTVSHTTTTTTVGNTGMGVGVNVGGVGVNINIKEPNGIYTE
TTTTTVTHGQPQVNYAPPLKGCNNKYPMGSTDFNSALTSVKKQGFDETKLKVAKQIVSAN
CLDVNQIKQIANTISFEENKLDFVKFAYDYCTEKKNYFRLNDIFSFSTNVDDLTEYIRNK
>LONDMIMF_02123 Nicotinamide-nucleotide amidohydrolase PncC
MKATVVTIGDEILIGQIIDTNSAFIAKSLDKIGIDIHEVISISDSREHILETLKRLQNQV
DLVILTGGLGPTKDDVTKKTLCEYFEDQLIVDEKVLAHVTELIEGFYKRPISQMNKDQAL
VPSKAEVLFNKVGTAPGMWLKKENTVFVSLPGVPYEMQHLIENGVVPKVIEEYKRPFIIH
KTILTYGQGESLVAERIENWENNLPEFIKLAYLPSPGRVRLRMSARGTNEQLLQKAIEAN
TDSLSKIIGDIIVGYDENETLEVILGRLLTKNKMTISTAESCTGGKIAQLMTSIPGSSSY
FKGSIVSYATEVKAEVLKVPQVLIDTYSVVSREVAIEMALGVQKLLKTDYAIATTGNAGP
EKGDSPAELGTVFIALATPYPAPDNIICEEFNFGQPREKVIDRAVNKAFGMLQNEILKIR
>LONDMIMF_02124 hypothetical protein
MAIHYNLAKVYEISDNDSEFVQDIINLFVTEVPADLKNVKKGIKEKDYKLAYGFAHKIKP
TLDLLGMTVAFEEILLVEDWTKREGKKKEIKDTYKSIADKVEKAVKEIKKDFNL
>LONDMIMF_02125 Fumarylpyruvate hydrolase
MKIICVGRNYAKHIEELQNERPAEPVIFLKPDTAILPKNFPFFIPEFSSDIHHEVEILVR
INRVGKYIEPKFAHKYYDEIGLGIDFTARDVQSALKEKGLPWEKAKAFDGSAVIGEFLPK
SQFNSLENLTFELTNNGKPAQTGNTNQMLWKIDELISYISQYFTLKIGDIIFTGTPEGVA
KVNPDDILEGYLEGHKLFRIQVK
>LONDMIMF_02126 putative ATP-dependent helicase DinG 
MELKLTKPICFFDLETTGIDICKDRIVEISIFKVYPNGNKESRTWLVNPEMPIPPQTTAV
HGITNEKVANEPVFKELAATIHNMIKDSDLAGFNSDRFDIPLLAEEMLRAGLDFDMKNRV
AVDIQTIFHKKEERTLSAAYKFYCGLSLENAHSAEADTLATYEILKAQLERYEDLPKDMK
SLSEYTTRKKSVDFAGFIALDKDNEEIFTFGKHKGAKVEKVLEAEPGYFGWIQNADFPLY
TKKVLTAIKLRKLNNKLN
>LONDMIMF_02127 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex
MAKFELKLPKMGESVAEATITNWLKKVGDPIEADEAVLEIATDKVDSEVPSEVSGVLSEI
LFNVDDVVKVGQTIAYIEVSGGVAVEAPKEEAPASVAEIEKTVETAQQTVAAPQDFSGSD
KFFSPLVKNIAKEEGVTVAELESIQGSGKDGRVTKDDILGYVANRKEPKAVSQQVPAQAP
VAQVSSPAPKATAAVPVSVNGGDEIVEMDRMRKLISGYMVASVQTSAHVQSFIEVDVTNI
VKWRDKVKNAFEKREGEKLTFTPIFMEAVAKALKDFPGMNISVDGEFIIKRKNINLGMAA
ALPNGNLIVPVIKNADQLNLVGMAKAVNDLGNRAKAGKLKPDDTQGGTYTVTNVGTFGSV
FGTPIINQPQVGILALGAIRKVPAVIETPEGDFIGIRQKMFLSHSYDHRVVDGALGGSFV
KRVADYLEAFDVNRDF
>LONDMIMF_02128 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase
MQLSVIILNYNVRYFLEQCLLSVREAIRGLDAEIIVVDNNSPDDSCRMVKERFSDVILIE
NKENVGFPKGNNIGVEKAKGKYVCILNPDTVVAEDTFTKILAFAQTQANLGIIGCRLIDG
TGNFLPESKRSIPTPWISFTKIFGLYKLAPTSNWLGRYYAGHLQENQTGKTDVLVGAFMV
LERALYNEVGGFDERYFMYGEDIDFSYTVLKNGRSNYYFPETSIIHYKGESTVKDGTYMK
RFQQGMELFYEKNLKASPFFSLFMKLGTLFFSFMKTFQGKPKQKSRPESYAFISDNPAVK
EKLQNKLKKNIQIQKFENQKAVFSQTFSGLGPVEMILDADYLTFKECISIMEMYKNKNLT
FKILPKSSNFIIGSNSNNERGEFILF
>LONDMIMF_02129 hypothetical protein
MKKIWFLLFVSLSMQAQKGYPTPKITDNHLFYIQHSKNHNTFVYEANFDDSKFDDTEPIK
IHRVAYTKGGVKEELTKIQRKLAYGVDVRKLKENHYEFTLVSYPDKKLYLELGPKDKPQV
KTVVNGKKMILIRMYLSMEESKSIKPKVEYIDFYGIDPETKKEIKERFFMK
>LONDMIMF_02130 hypothetical protein
MDIVNEIDNSYLKQPEPFRSCLLALKDIILSQDTDITSVLKYGMPFFCYKGKMLCYLWIH
KKQQQPYIGFMEGRYLDYQELVVENRSRIKILLFEPDQDLPVEKIENILKGALDLYKSGK
IALKK
>LONDMIMF_02131 Energy-dependent translational throttle protein EttA
MQKISTVNYLSVENISKSFGERTLFKDISFGINKDQKIAFIAKNGTGKTSIMRIINGDDE
PDTGQVIMRKDIKMAFLSQDHNLQDELTIEESIFASDNEVLDVIHQYEKALENPEDEEAY
QKAFDRMDQFNAWDFETQFKQILFKLKLENFKLKVKNLSGGQKKRLSLAIVLINRPDLLI
LDEPTNHLDLEMIEWLESYFAKENITLFMVTHDRFFLERVCNEIIELDNGKLYQYKGNYS
YYLAKKEERIASENSSIDKAQNLFKKELEWMRRQPKARTTKSKSRQDDFYVIKQKAESRR
KENQVELEINMERMGSKIIELHKVTKHFGDKIILDNFSFDFQRGERIGIIGKNGTGKSSF
LNVLTGTIPLDSGKVVVGDTIKIGYYTQSGINPKPGQRVIDVIKEFGEYIPLTKGKIISA
SQLLERFLFDNKKQYDYVEKLSGGELKRLYLCTVLIQNPNFLILDEPTNDLDIVTLNVLE
SFLLDYPGCLLVVSHDRYFMDKIVDHLFVFRGEGVIENFPGNYSDFRAYEDSVEPVKEET
VKEKNNWKQQNVSSGLSFNEQKEYQKIEREIKDLEIEKAKIEQLFSDGKVADADIEKKAN
ELQGIILKIEAKEERWFELSAKMEE
>LONDMIMF_02132 hypothetical protein
MHLLKSYLKFLWNSNNSHGVHSPFVFDLLRKCFYDKNEYTEYTLLKKYRESLLQNKNTIE
VTDFGAGSRVFKSNIRAINKIAQNAGISGKDARLLFRIVNYFEPKTILEIGTSLGLATSA
LALGNPKAKITSLEGCPETAKISRQQFDKFDLGIDSVVSKFESYLQNEKSDSYDFIYFDG
NHSKIATLQYFDSLLSTAHNETVWIFDDIHWSADMEEAWEIIKKHPKVTVTIDTFQWGLV
FFRREQEKEHFILRTSNSFFLNSILGLRKLWGLLP
>LONDMIMF_02133 hypothetical protein
MPNKSPGPQIKDKDQYEALRDKGYSKEKSARIANSKGAEKRGGHAKKYEDQSKKEIYAEA
KKVGIEGRSKMTKGELIKALRTN
>LONDMIMF_02134 hypothetical protein
MKRINLFLGSAIIAVAFASCKSENEKQAEKTVDAYEKYVDSVTNVAVADAKANWQSIEVS
YNQKTADAEAALAEMKDKANAEARLEKSKAKYAGLKSKLEAEAQAEKEAQAANPANRKQL
LRDAYFGAGKIGEDMDFSWVNKDNILRVYNDFYNEFDKNKDTYSREDFDEIKAMYEALDA
HKNKVEKEGLSSKDNLKIAELKFKFAPKFKWERMGAKAEENKKAKE
>LONDMIMF_02135 putative ABC transporter ATP-binding protein YknY
MNSLLQKFITFRAQIKAMSLIKITNIKRDFVLGNEIIHVLKGIDLNINKGEYVALMGPSG
SGKSTLMNILGCLDTPTSGQYILNGKDVSQMSDDNLAEIRNKEIGFVFQTFNLLPRTTAL
NNVALPMIYAGYSKSERSARAEEVLNQVGLKDRMDHEPNQLSGGQRQRVAVARALVNRPS
IILADEPTGNLDSKTSVEIMNLFNEIHANGNTVILVTHEEDIAAYAHRIIRLRDGIVESD
KPNK
>LONDMIMF_02136 Cob(I)yrinic acid a,c-diamide adenosyltransferase
MKVYTKTGDKGTTALFGGDRVPKHHIRIESYGTVDELNSYIGLIRDQEINSHYKDILIRI
QDRLFTVGAILATPPEKEILKNGKPRLNIPKITETDIELLENEIDDMESALPPMTHFVLP
GGHTTVSYCHIARCVCRRAERLSVHLNEQEPTDELVIKYLNRLSDYLFVLARKLSYDLKA
DEVKWIPEKQ
>LONDMIMF_02137 hypothetical protein
MYWTLELASYLSDAPWPATKDELIDYAIRAGAPLEVVENLQSIEDEGEIYESMEEIWPDY
PTDEDYLWNEDEY
>LONDMIMF_02138 Protein translocase subunit SecA
MSFINSILKAFVGDKSEKDVKAIMPIIAKIKAHEETLAALSHDELRAKTIYFKERIKEAR
AEKDAKIASYKLEVEKTQDIDAREDIYASIDTLEKEAYDISEKTLMEILPEAFAVVKETA
RRFKENTHVTVKATPKDLELSATKSYITIEGDNAIWANSWNAAGKEITWDMIHYDVQLIG
GAVLHQGKIAEMQTGEGKTLVATLPLYLNALTGNGVHLVTVNDYLAKRDSAWKAPLFEFH
GLTVECIDNYQPNSEGRRKAYNADITYGTNNEFGFDYLRDNMAHTPEELVQRKHNYAIVD
EVDSVLVDDARTPLIISGPVPQGDRHEFNELKPKVENLVNLQRQLANGFLAESKKQLKEG
NTKEAGFLLLRAYRSLPKNKALIKFLSEEGVKQLLQKTENHYMQDNNREMHKIDEALYFV
IEEKNNQVELTDNGIKFLSGDTDNDFFILPDIGTEIARIEKMNLDKDAEAEEKEKLFQDF
SVKSERIHTLTQLLKAYTLFEKDTEYVIIDNKVLIVDEQTGRIMDGRRYSDGLHQAIEAK
ENVKIEAATQTFATITLQNYFRMYSKLAGMTGTAVTEAGELWEIYKLDVVEIPTNKPIAR
KDKEDLIYRSTREKFNAVIEDVTQLSAAGRPVLIGTTSVEISELLSRMLKMRNIPHNVLN
AKMHKQEAQIVEEAGKAGVVTIATNMAGRGTDIKLSPEVKAAGGLAIVGTERHDSRRVDR
QLRGRAGRQGDVGSSQFYVSLEDNLMRLFGSERVAKVMDRLGLKEGEVIQHSMMTKSIER
AQKKVEENNFGVRKRLLEYDDVMNAQREVVYKRRRHALHGERLKVDIANMMYDTCEVIVE
ANKASNDFKNFEFELIRYFSITSPVNEADFAKISAQELTGKVYKSALEFYNEKTARSARE
AYPIIKNVFENESNQFERIVVPFTDGIKTLNVVTDLKKAYETEGAQLISDFEKNITLAIV
DEAWKKHLRKMDELKQSVQLAVHEQKDPLLIYKFEAFNLFKNMIDNVNKEVISFLFKGDL
PQQNNPEIHEAREVARPKENYKTSKDEIPNTDEAAAANREAGQTQRPQVTETIVRDMPKI
NRNDNVTVKHVMSGKTETMKYKKAESLLASGEWVIVNE
>LONDMIMF_02139 hypothetical protein
MDSTTKQETLHTIQNYLGALAQRDLEKLLTYFPENVDWLVPGNEEVAPWLGKKSTKKEVK
AFFELLWANTEPLGATIDHILAEDNHAVVTGEFSSRMTRTGKTYESLFSIHFTIENGLII
RYRLLEDSYGLVKALS
>LONDMIMF_02140 hypothetical protein
MIMKIKTHTLKDTNIAEIISDDEIIKTSDDGLDLLGNLYYQGFDKIIIYEKNITSAFFDL
KTGIAGEILQKFSTYRVRLVIVGDFSKYESKSLKDFIFESNKMGQIYFLSSLSEGLEKFS
K
>LONDMIMF_02141 hypothetical protein
MLIDTFWKLLLKTIGLWLLFSCISVVPQFFSMISSINGSIDFQNLLLLLVMSCTTIIILV
IIIRLFLFKTGWIIEKLKLKDNFKEERIDITIKSTTVLTISIIIIGALILIESLPNFCST
LITFLQQKELLKDYPQTGWLIYHFIKIIIGYLLLTNAKNFTKFIEKESHEN
>LONDMIMF_02142 hypothetical protein
MKIKTTSIRPFIGAQNFEISRSFYKDLGFEEVELFPNMSFFKTQEGLGFYLQDAYVKDWI
DNTMIFLEVKDVQDCWDNLLSLDLTSKYKNARLVPIRNHDWGRECFLHDPSGILWHFGEF
FKS
>LONDMIMF_02143 Transcriptional repressor SdpR
MRRDIFQAIADPTRRAIIAMIALQPMTPNALAEHFDTTRQAVSKHLKILAECELVKPEHQ
GREIYYQLEINKMKEIDKWLEQFKKIWESRFSQLDDLLDTIKEQ
>LONDMIMF_02144 hypothetical protein
MEGKEILKQHIAKTASLSEEEFEHFFSHFKAESFKKGEVVINEGDDVEKEYFVLSGCLKT
FFMNDNIKMHILQFTMPTWWTSDYAALYNKSKATITIDCISDAEVLSITNEAREKICREL
HQAEYFFRWRTNKGYVAAQKRLLSFMNNDAKTRYEELLALYPALYNMVPKHLIAAYLGVS
RETLSRLYNSSK
>LONDMIMF_02145 putative tautomerase
MPYVKIEVTREGVTREKKQQLIAGVTNLMSDILGKDPNLTHIVLQEIELDDWGFSGEQVS
VLREKSITAQKSNS
>LONDMIMF_02146 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKTKTAIITGASTGIGKSIAKLFLEKGYNVVINSANADNLKNAQKELGHEEHLVSVAGDI
SDISVGKQLIETAIKHFGSADVLINNAGVFQPKPFLEVEEKDLDRFLDINLKGTFFTSQA
AIRQMLTQNGGAIINIGTVLVDHAIDGFPATAPISSKGGIHALTKQLAAEFGRNNIRVNT
IAPGIIRSPLQSKIGVADADHLAGLHLLNRIGETQDVAELALYLAESNFVTGETINLDGG
HVAGHRIA
>LONDMIMF_02147 hypothetical protein
MRNINEDRKLITSVLEDYFNGIFVGDINLLRSVFHPMAFLSGDINGEPYFKTLEQYLDGV
KNRKSPNELGAKLGMEIISIEIINTIAVAKTHVPIFEYNYYDLLSLSLIDGKWVIVNKLL
THVKE
>LONDMIMF_02148 Nitronate monooxygenase
MWNKTKITELLGIQYPILQGPMGGGFSTAELLAAVSNAGGLGSFGAYTLSPEEIREAGKA
IKAKTNKPYNINLWVSDVDKSLTDYPKESLDNVKALFKPYFDELNIPLPELSTDIPSKFE
KQVEVLFEIRPAVFSFIFGIPSQEILAEARRLGIKTTGAATTLDEALALEEARVDAIVAS
GFEAGGHRPSFLKPAQDSQTGLFTLIQQLKAKTTTPIIAAGGITDAKGIAAALMLGADAV
QLGTAFMVTDESGATPLHKEVLLSGSPKHTVLSKSLTGRMGRMVSNKIADEVKFETEVLP
FPLQTRLIAPLRVAALAQGRTDMIIFWSGQNTAILKHHKADELMQALITETSNLFK
>LONDMIMF_02149 hypothetical protein
MRTAKTNIHFLDNYLLSPTNPIRVHVIGAGGTGSKFMTALMEINHSLLELEHPGLDVHLW
DDDIVTGSNIGRQRFAESEKNLYKSQAIINRLNRWAGTN
>LONDMIMF_02150 hypothetical protein
MEDITNSFGTYFDPICALVIYQGNSGYNESYVEYFDMENGVPVNPHPLSVMEGQRLSTAL
QVNEENLNLLKSDGILQSNLLSFDATSSTIVWFTKAGFRELFFDKHLGIKSGKAHIPPLV
WIADRQTLHLYALSTNRKPTLNTPLYYAPFFNIYENGSVCMGTVDIATTEIGTVNELMTL
WENYFFNSYFSHLMADHNPVNGNCVILWKNLVGTGKTFPNDKLVKTAKKLKNILL
>LONDMIMF_02151 hypothetical protein
MISVYAYIYQVLAVPYYRNEDSYLHSMYDMLENSYAEEDEEEEFNDESSLEFSDVERIGD
YIKELIADKKHLLSFQKLLTTFRPKNNFESDVHRIASSFYELYETYPNVRIDRKYFPLRY
REITDEYDRPVTMDNYVSFCASITGNLFETLCDFVNNDLQECSEVDEPTRFLPFDNRKIE
NNNFDFETKVFDSIDNLIRLWQEHNF
>LONDMIMF_02152 hypothetical protein
MLFDENLLIEIFVKADDVCKLIEKEFISKLIEEQAVEYSYKKPNCEMTESEMMTLLIFYH
YSGFKCFEYFYKQLVMNKLRSYFPKILSYNRFVEILSSVALPMFIFAKSLCSESQNTGIS
FIDSKKLVVCHNRRIHQHKVFSGRASRGKSSTGWFFGFKIHLVINEKGELLDFDLTPGNV
ADNNHGLLKRILKKITGLCFGDKGYVTTLWKDFYENGLKIVTKTKGKTKAKLMTLQERYM
LLKRPIIESVNDIFTSVFDLEHSRHRNPNNALTHMLSCVCAYCFYPEKPSVNFPNWLN
>LONDMIMF_02153 hypothetical protein
MNHAKNISANGKTSYSRKPVTTAPPVGRVREMDETSKRCRRTPQGQTAVRTTCDVTNAFL
KMQFYPRLQEPEIGEKQHSPTLEREFYQSLSMISKKLNISVQDCKSLPFPYNISESLSHF
KKQLKIHTNDWKEIRLVNDGTSTFFAREDRYNTGSTLY
>LONDMIMF_02154 hypothetical protein
MLVATTLQRVFILKEKEQEIRLDDPEPKWNLQAVLNFYSSNYPALTTAKISRPTIVDDVV
EYRFETVIGTKG
>LONDMIMF_02155 hypothetical protein
METANFFRQIAKMDINSKLTLSITKATESTILVSILIENDSCGDKAKNIIPPFNLKGSPE
ELDSGFFEHIKKPVQMADGLISNMQNFLKGLETAQANSVMEKQKSDKEKAKGKKYGEAVQ
KADALANAGKYKEAWSALPKVANYPEHKEEIRKKQDSYEKQFVPDLWSASEPKAEQPEQQ
EFNP
>LONDMIMF_02156 hypothetical protein
METLAKYKFADWLYNRFVENYKNQNIAEAFTFLDILSRYQMFAMEVRKLSDQRRHIKELY
CDIQKALKNGTANKLFLTGEEGAAEFKREMKTYENYLREQGFSESYITECVSDKAMNYYG
NS
>LONDMIMF_02157 hypothetical protein
MNSQTDTESQALHTVAEMLMQFGLLHVLNIRREDRKQLHMVRECLEKIIYDNGFRMNYDR
NIKNNLIKL
>LONDMIMF_02158 hypothetical protein
MTRSNLHITLSNGQQVICVADSSSAPEQGYIVEQLFIPLLSLNNSRSEIELLKKHCTMDE
RRANADYRYYINLVDKEVTMFEEHFNYTSEKFRKGKEITQRYTSYVENLNTKDHE
>LONDMIMF_02159 hypothetical protein
MLVKAFSEKGRNNHEVAIIPLWGDWLQKSVETTDLLELLNVESFSGYIARKDHGISFLLC
RTAKIPFYEQWLDGNEIAFLEAQASEIEQLCRHFDCIKSDSLRVHPSGMANYEAFEDMKF
RTVDFDLRLIQEILTSKN
>LONDMIMF_02160 hypothetical protein
MKNLQQMNNLDRAYLLANLFPDELKALTEFMKKEADLFTENREQVYAQWTEKNIDADLWF
RFIANFQNSYNGNATRLHRNKKTFRDQLFDGYDSLFTLHAILHYTEQKECSSELKYAIYM
LFGTRKLIEINLTTSP
>LONDMIMF_02161 hypothetical protein
MKALTEMNNTERAFAVARLFPNHLGTLTDFIKTEIAHLREKEQYIRKARPPNCVASADYG
YRLVENAEQTIEKFGVLLYRNPRIFADQFFYQDNSVFGIHCLIRLAGSQDLPPMLRLAIE
LYFGDDKVVTIDFKKKP
>LONDMIMF_02162 hypothetical protein
MGHNLNFNNRTGRYSFFSVKEKAWHGLGQIVQDYPTSAEAIRHAGLDYEVQKSPLYTKGS
GIVEISDGIVIQDTEIEVPNYFANIRTDNNTVLGVVGRDYHIVQNKDAFSFFDSIVGGGS
GILYETAGALGQGERIFITAKLPNYIRIGNSDDIIEKYIFLTTSHDGSGSITAAFTPIRI
VCQNTLNASLRNMSNVVRIKHTAGAKQRLNDAHKVMGLANNMTTQMDGIFNHWSTIKVKD
SEVRKLIQLALCPNKESYNLLKKGAEDELSTMFKNTVDDAFAYAMMNDTQQLETTKGTLF
GAYNAVTGYFQNVRNYKDGEAKLQSIVLGGTAQLKSQKAFDLCTSFEKIGTDIFQLN
>LONDMIMF_02163 Single-stranded DNA-binding protein
MNISGRLTQDATVSKTTTGKEVVNFSVAVIDGYKNRQGEWVDNTAFIECAYWRSAKPVSW
LKQGLYVELAGQISARAWTGKDGNLKAGLNFTTSNIKPAWGTASEKDSVQASIKQEPVNT
AKEDEKDDLPF
>LONDMIMF_02164 hypothetical protein
MKKLFLGLSLVTGTSSYVLANSIEIEKMILTKQKFLKSNALCR
>LONDMIMF_02165 hypothetical protein
MQVIVNYETPCGVYLYSSAIPKYNVNWRQGQAEGTTDTYCKVRT
>LONDMIMF_02166 hypothetical protein
MKKFILTVTVLGFAGLSYASSPIVKKVAAEKRLAGCFTQTVTQYEDLQGNYVSSSVGPRV
SVECAQGQLEGSTQTTYVHQISPLAVYWLGFP
>LONDMIMF_02167 hypothetical protein
MKKLILGLFLIAGSSSFALANTIEIEKDLDQDQCFKGNCYAQVIVNVENTCGQYLYSSAS
PKYTVNCRQGQAEGSTSTYYEVRTEGGWNPGSDPNQATSCP
>LONDMIMF_02168 hypothetical protein
MKRIILAATVLGLSGSTYAAPGVKKVNKKKLAGCFTQTITQYEDKQGNYVRSVAGPRVAA
PCASGQLEGSTTTTYVHTLDPYIDLWP
>LONDMIMF_02169 hypothetical protein
MALKNVLIFLLLTIFGYADAQHKIIVEYDYTFAHMSNLKSFVISDQKNSYFFFASDPSVS
YKKLIETDFTSINPYHVYDYDLSSENLYQRVYMVPKNEKQPLPRLASEKLKNLDWKISKE
SKDILGYKAFLATANFRGREYTVWFTKDLNVEVFPWKLKGLPGVILEFQDKDGFIRGTAK
TISLNSQDKFPPKILAIFEKKTTDPIMPFKKMIELENVILQDDMNKSIAALPAGTEYEVP
NIREMSMETHFEWEPDTKKP
>LONDMIMF_02170 hypothetical protein
MKYLCLLSFILILKISAQTKIAGTVLSDSKQPLLRASIILTDTHDNIIAFVFSNKDGSFS
LNTDQYGSFNLMVTVAGHEKKNIPISFIKKNSVIDLNAIELSRDKVKEIKEVVITRNTPV
RQKKDTTEYNVQSFSNGTERNVEELLKKLPGITVESDGKIKFRNREVERVMIENDDLFEK
GYQTLTQNMPSKPLEKVQVLENYSKNKLLKNIENTNRIALNLTLKEDAKGKWFGNLLLAS
TSYKEDMRQGKVNVMNFTKRRKVYFLLNANNLGLNEMKGVEYLIDPASENEVENVGTNVG
ILSVVNLHQKNSIFQDKRINFNNDKLGSLNYIYNFKNDWKIKFITVFNDIENRNYISSFY
RFNYAGQNFANVEDKTWKQNNTNLVGKLEISKEFRNNSNFQFYSKTSSLRENNDNIFVFN
EQLNNQIGTNRLLSTENKFVYTKKIDSSKAVVAVARYIFQDRPYDFTDDNDVFQKVTGNP
EARKSRQTISSKMNFGGVKVSYLKKYSEKESVEIQGGNEYRRNRLSSGLSLFDADNNKVN
YDDRSFSNDVSLEQNNLYAQGKYLRKSKKWRYGVTMLGQFIYSDLRDEHTAGFHLFPTVN
IGYENSRTGNISLSASRKFSTVSINDVYTGYIYQGNRNFNKSEVGFTVLPSYSFNLSYNI
GQISSQYLSFNGNFSKNDSYLSNNMIVNPTFTFSQAILVKNNSTFAANLELRKYLNFIKT
RISLLGSYSDSEYENRINSGPLIKSRFSNLKTGFEMKSGFLGFFNYELGYEIAFNKIVSD
VNSNNYRDQKAFANVYFKVNSMFRIESSMEYYKFGNTGQDPTHFWDIKLNYTWKKYNSDF
YLQGNNLLNSNSITKYSIDNISESLYTQKLIPFHIVFGINKNF
>LONDMIMF_02171 hypothetical protein
MSLLFNNVNGNIPQTHVFIIGVGGYPYIKGGTEEKKQTLDCAKKLGQLTSPPLSAKALYD
TIINLHNQDAWIKPLGSVELLISPVGADPFIIAGEEVGRADMENITDSFNSWLERCDSSA
DNVTLFFFCGHGVDKAEHILLTEDFGKNPVQPWSGSFAFDKTRLGFFRCQASTQLFFIDA
CRLFTADMLLTEVPLYTLIPQHFNATDCRFNLTQKAAAHNEGAYGEINDISFYTKALIKA
LEGGVLTKKQDEWTITLASLATKMDDLLEMVSEQIFTDQRCSNRTGKSTDILRFAEAPNI
DVVIDCSPEEAHNLAHLSYFSVESKEKNYRLPNVDPWKVHIKPGIYELNADFPNGQYENK
NIFESFMPPAGARTLKFEQ
>LONDMIMF_02172 hypothetical protein
MSDSVNNLGKLTLNVITGEEVARNFNEGSLPKNVQILSANLNTERSFWMLNETWSDFLTA
GFYIVKLKIASAKEVEKIVKVLPQEEISIEFDIRDKRVYREVFNFSADNPNYYRTFVYNL
KKKYRREIVMIDWIYEEGILKMYPNYRFFPKFLEMESTIISQRDRMHICELHVAFGKSVF
VCLPPEYELILARNSADIVTNLKITIGLPNKSAQTLLYLMNKGDSDKAESLYEIQQAEFL
LREKRRDSIAAAIGGYFLLSTGQLEFLHDWPNNLADWFPWLPDGPIIHAWQMIKSKNLNI
PRIQNRLLEAVQRGIPLFTEGLRLLYEGLSLLDDHLHSDNYEVWMALKKVKRYMESADLN
KEYTTLVGESDLLRNIANGYNYY
>LONDMIMF_02173 hypothetical protein
MIFNINLLPARYGDSLWIEYGDAENPSIVLIDGGTGGTKNEIRRLIDAMTGQKHIELLVV
THIDRDHIEGILSLLQADKLDFTIGTIWFNGWNHLPGNDLFEIFGAVHGEKLSAAIIKHG
INWNTHFGNTAVVHQTELQPPVFQLEKGLKITLLSPTPENLEALKPVWIKELRKANLDPG
FGLEILEEPEDLSADIEQFGEGVPDIEKLFREKFEEDRAAANGSSIAFLAEFQGKRVLFA
ADAFPSVILRALNQLSSDKIPLDLIKVSHHASANNTSPELLEKIDCKKFAISTNGSISHH
PAKVTVARVIKQSGEGTELLFNYRTKDNECWDDEILKMQYGYRTTYPEGEGLIIPLL
>LONDMIMF_02174 hypothetical protein
MKTKIAAVLDKVSEIKRRLAIIMGVTHTQDDYAIYIKNIGGEIEKFLKDAVYENNNNNWN
FYNLIKGLEPLGISAASTDKMHLLREFYNSLKHDPLYNTNILLAEERIDDLLSALHEIES
KAIGRINENYIQANSRILWLCAWDDYIGGMTELNLFLPNYDLDFPYSVEYFNISLEGWDT
LKDKFIPTGDLQLGKQFVSEKAYKVWSAGPDLIGVGRFTGDVKDLVKTLSSLVNKERESG
LLEVLKRKNDSTSNFTSTAYAIQDTLLNDSWKDFNDFKDEIRLRIDFDYGIAVDSKVLDL
YINKLNPEILSVDRNDLKNVNNLLWLSKDQYERESIRAIIMEKPYIALTTENKIIVKIT
>LONDMIMF_02175 5'-deoxyadenosine deaminase
MRINSTKPICLIGRVYDSITDQCSVKSLFIDNGTIIKIIEGKSDSDLLPDSFIIELEDNE
VIFPSFINLHTHIGYNVLPLWNSPHIWYNRHQWRNSPQYAAEIKDFTSFIKKEWASKPAL
LESFIADFIPATKIASLLYDESNSSYREFYMFRAITEVERIHAILSEIQAVCGGTGLLLQ
TLSLDEEDPEMKHFLIRNTGNSEDMGINKSLKVFPVVDFYNPKIRPDGTPVADTSNWSPE
KQGKLDNYINSVNQNNANYYSTIAHIGEGKSGNLYNATKDKYSLNECKQLFHELKQKVKS
QYLRESNLILVHANGIDYEDSDTISFLKDNNISIVWSPVSNLLLYNDTLPIEKLLDENIN
VCLGTDWTPSGSKHMLDEMKFARYYCDYFNIACSDKQIFDMSTTNAAKALGNLKYSVIQE
GAFADLFVYKTNNLENVLGDFLQSDDEKIKFSMINGRIIYGDTIVFENMKVDYQKFPDNE
GEFSKDKAISINANLNFNLENAIKKMDSLIKAYSTETLGQELFRTKFLSSDDQVYKDRIS
KLMQNL
>LONDMIMF_02176 RecBCD enzyme subunit RecD
MIKHLSIRVTWHDSKWNGTMCQNPSHNAFCLNLPRIYAEKDDEVEDELAGQHWADLEQHQ
LPPCKGEGGGFMSSRSYKRLFNHPYNKPNMRNIPHLALRPTNIDVPPYNSFAVPFWWMLR
KNQQEIREWYPDIPIDENPPFPSSWVYSSATQEALLNKFYGYIKENHSLVVFYAKGANPV
DENSRRIIVGIGSIWNKSNILKYESSADYTYPLWDRLIGHGIRANDLNSEGLLLPYHEYL
ALPDNFQINTKEGVKTKHDLLNEIKLTLQETASRQEVIDDFAYGTAHVNDSSILLILGKL
RSIIERIREHGIVKDVYEHHLTWIDRQIGKVKESMGPFPSFADALLALGFQFGYSLEEDL
RNNGHLGVKDNPWDAWEDVLFGKISMGQRLYVADLQYFRDIWLNESTERKELLMLLSRFE
LREKQIKNWFDSNQRQKLGCKITDAEILINPYRIAELDEGNQEYYPIAVETIDNGLYMDR
AIQGEFVPEKPQIVDSPLDQRRIRAIITDVLKRAAENGDTLLSVNEITETINMLNFQRAT
VLPANYIFANLAFINEQIPSVRSGDEIALQLKKYGEIESYFRKILLARAKRGLEGIAEEW
ESLIKTAIANNGITFDPLNSKHAAALADQVTALRQLTERKISVLHGHAGTGKTTVLGALF
GCKTLTSEGILLLAPTGKARVKLGKMAGGEAYTIAQFLSKQKRFDWDRMKPIFHSAQKYK
AEQNVIIDESSMLTEDDLYALLQALDLGHIKRIILVGDPYQLPPIGAGRPFADFCTFLDN
LTPESADGDAISALARLKEVVRNVDGANSDSLTLASWYSGIKPSKDADSVFQKLGDKSLL
NDLCITTWTDEQSLIESMNTQLIDKLGLTDERDFQTLNKFLGVQGTKIDTKKIEGFQLLS
PVKSPYWGAFNLNRVFQQQFRTGLKGAVSIGDYRIGLYDKVIQTVNEKKDGFPGGITCQI
SNGQLGLVNDITKGFANVVFAGQDNSLKFGYKSQGQAEGDYGNIELAYAITVHKSQGSDF
DYVFLVIPKTGRIISRELIYTALTRAKKQLILLIEGDSPHWIINLSKPQYSETAKRNTNL
FAYAVRDQHNTIPYAEGLIHKTKREGLLVRSKSEVIIANMLVEKGVEFEYEREFIGKNDQ
KRIPDFTFIDAAGDTIFLEHLGMMSLPSYKADWEKKLAFYESNGYKIGSNLFTTTESEKG
GIDSLAIADVIDKILELI
>LONDMIMF_02177 hypothetical protein
MYIFVDMQVFIDYGTPLSIFLIFKHKLMAVKTVLAALGMAAGKVIVKKATESLLGNLNQL
YTYGISNFTKIRNQDVRFSISYLIRIKIPGTSKFLLVRGHRIKNQLQPVGGVYKKVNGFS
EFREWGYKEDSSNKGIKTDDVSLNDLRFRVQGKYTLNVIKWFESAVGREYTFEREFEEEL
IETGILDAEIFRKKSLEKVSKVMKVFNYSTFHQCYEVLIYDIVEFHPTAEQQQALKQLLD
RARNEGDEYMLVDITEIERLLVMENEEQIARIGEHTKYLINEK
>LONDMIMF_02178 hypothetical protein
MKSNLHKYTEQEFKKDELLAIIASNLELDETRKNQMESAYKAVNDVLSRDENFFKGYTIS
VYAQGSLLIGTTIKPLCGKEFDLDIVLHIEDSYRNHSPSEIYDELYRVLSNHGTYRALLQ
KKNRCVRINYNIDFHMDVLPGCIIASNNTRLMIAENEYRKFWSRTDPKGYAEWFKEISER
NNGSFLLQERYGLLLEAKIETEDLPTNLYFKTPLQRTVQIVKRYRDLFYLNKDKFTNPAI
SSIVLTTLLAQCHQGNLSIQDSLRNAMVQMKKLADNYKYHGIKFTVYNPVDNHEDKSKRE
NFTDSWKDRHYSSFVNFVESFEKKLNAFINYSTTESNYTDLFGAGFYKENIQTVVQLEER
VSGNSRLAALLSGTAYTNSSGKINVSSGVKNGSHGFYAER
>LONDMIMF_02179 hypothetical protein
MDFMLSDSEKARKYWVGFLFKTKLACEAAFDWLTFELKGRVLEGRGTLEENGKTYHFTIL
YSPFFHSRFERVIVETKKLRKCADTHFNGDGSLCLYHPIMDLKGRAYLDLVEVIPWISEW
VYYYGKYVKYKTWLGPEYPHNI
>LONDMIMF_02180 hypothetical protein
MNNKFKLSEIVSIRSGMVVPKTVNNDEEKLTDAFVRMIGTSDYNDQGVLRPNLEPNVLFK
PSIEKNFLVKDEILFNSKGRRFFAALFSNEYSHTIASASFLVLTLQRDDVLPEFLVWYLS
HPETLKVFDSKMVTQTMPSITKQELGELEVIIPNLQTQNQIIALDSLKKQQIAIQKELIV
LKEDFINKVTYKKLKNEF
>LONDMIMF_02181 Type I restriction enzyme EcoKI M protein
MSSKVSQRDINNTVWNACDTFRGTIDPSQYKDYILTILFLKYVTDVYNEKKEEYAKKYEG
NEERIKRALQRERFIVPDESSFYFLYDNRNNPKIGEMINHALAELEDANREKLGGNDGSN
IFRSIDFNSSNLGDERGKVTRLRNLLNDFFKLNLSSSNLENSDVIGGAYEFLIANFASDS
GKKAGEFFTPSEVSTLLAKLTKSKPGSRIYDPTCGSGSLLIKAGREVGDNNFSLYGQEAN
GSTWALAVMNMYLHGYDSAIIRWGDTLRNPKHKEGDNLMLFDTVVANPPFSLDKWGAEEL
SSDVYNRFWRGLPPKSKGDWAFISHMLESLNISGKAGVVVPHGVLFRGAAEGKIRTKILE
EDLIEAVIGLPSNLFFGTSIPAAIIIFNKQKLNRKKVLFIDASKAFVPGKNQNVLGPDHI
AHVSDVFTRFHDELALTGVVEDKFAYVANLDEIKENDFNLNIPRYVDTFEEEEEIDIKSV
MKEIKTLEAKRAELDKEIEGYLQELGLTL
>LONDMIMF_02182 hypothetical protein
MQQGQSAPTESRELTAKEKKEGEFINALLIDNLDVWTEIFKENGWTYKAPKLVLFSGQVS
TACGGASSASGPFYCPGDQKIYMDMTFFDELKSKFGAKGGDFAVAYVVAHEIGHHVQTLL
GTSAKMRQMQQGLSEAEANKLSVALELQADFYAGVWTHYNEEMNQILEPGDIEEALSAAN
AVGDDAIQKKMQGQVVPDSFTHGTSEQRMYWFNKGFKTGDIKQGDTFAEIR
>LONDMIMF_02183 hypothetical protein
MKTILIWSIIQFIFLTGTTILFINGHQDLAGNFYDIFIAQFIFFAGHVLYFLLKKGKAQW
TDTGKK
>LONDMIMF_02184 hypothetical protein
MELTFRELKKAELITIKEINRSEIIHEIYKYVNGVLILKPEYCVVEAFDPKELEYIITSQ
NRILEEGGKVIGAFDNDTITGVASVENKKRGIRSEYCKMDILYVSADYRGKRIGHKLVEE
CKKIALNFGAKKLYISATPTKATIDFYRNEGAVITKEIDSDLFKLEPLDIHLEIDLT
>LONDMIMF_02185 Competence protein ComM
MLVKVYGSAVFGVEATTITIEVNIDKGIGYHLVGLPDNAIKESSYRIAAALKNNGYQLPG
KKITINMAPADLRKEGSAYDLTLAIGILVASGQLQSDVVDRYVIMGELSLDGSLQPIRGA
LPIAIKAKEEGFKGFFLPKQNLKEAAIVSDLEVYGVENVQQVIDFFEGKGNIVPAVFDTR
AEFYKTLEFPESDFSDVKGQESIKRCMEIAAAGGHNIILIGPPGAGKTMLAKRLPSILPP
MTLREALETTKIHSVAGKIKEAGLMSQRPFRSPHHTISNVALVGGGSYPQPGEISMAHNG
VLFLDELPEFKREVLEVMRQPLEDREVTISRAKFTITYPSSFMLVASMNPSPSGFFNNSE
SSISSSPHETSRYLNKISGPLLDRIDIHIEVTPVPFDKLSEERKAESSASIRERVIKARE
IQVTRFSDYEKVNYNAQMSTRLIREFCLLDENSKELLKSAMERLNLSARAYDRILKVART
IADLENAADISSDHIAEAIQYRSLDREGWLG
>LONDMIMF_02186 Phytochrome-like protein cph1
MIFPQIPHNEKERLDALLAYKILDSAPEKDFDDIVKLASEICHTPISTITLVDKDRQWFK
SKIGLEFSEGARDTSFCAHTLNNPREMMIVSDSLEDDRFYDNPNVIGHPNVRCYVGVPLV
DPNGHALGSLCVIDNQPRNLDNFQLLALEKLANQVINLLELRKKNFQLMENHNMLLSKYK
DLEQFASIVSHDIKSPLNNIMMLTRLLQESNHDQLDGDGMQMLGYIYKSSEELKKLVDAI
LEYYKYDNEQVIANENIRLNDFMQYLIDILDTKNEFQFILPDKNHKIRSNKMALGQIFYN
LISNSIKYNDKPKGIIHIDFSETEDFNIISIEDNGCGIDKANHHKIFNIFETLGKTDRFE
AKGTGIGLSTVQKMVQKLNGKIEIESELGKGTRFKVFLKK
>LONDMIMF_02187 Coenzyme A disulfide reductase
MKKQKLIIIGGDAAGMSAASKVRRENKEIEIIVFEKSEYTSYSACGIPYFISGKVSSSDE
LIIRTPEQFKKKYNIDARILHEVLEVDTDHNRVLVKNSLEKTQFWENYDKLLIATGGKAY
CPEVENRDADGVFGVSTLRSGIKINQYIENKKPKHAVIVGGGYIGLEMAEALLIKGLKVF
LINRSEEIMNTLDPDMGKTIRKAMENLGITIYLKEELRHFEVKDNTISAVVTNKQKLKAD
MVILGMGTSPNTAFLKNSKIALSEKGAVKVSRTQRTNIRNVWAAGDCAETYHLVSKKPFH
VALGTVANKTGVVAGKNILGQKATFPGIVGTAVCKICSYEVARTGLLEKEAKSLGIDYIT
ATIQSKTRAHYYPDAKDICVKLIAEKNTGKLLGGQIIGEEGAAKRIDVLTVALTNKLTLR
NIIDLDLSYAPPFSPVWDPVQIAARKLIGNQE
>LONDMIMF_02188 Thiol:disulfide interchange protein DsbD
MKKISLLLFFFFALVSSHAQILDPVKWTSKIEKLSDTEYEMTFDGVIEPEWHMYSQFTPE
GGVNPLEVLMNNGEGNFEATGKAEESKTRTEFNDIFKIDEIFFENTVQLKQKIKITNKDN
NLVQIELSYQVCKKVCIQQNKYFEFDLKNLTAQEVKTFSEPVTTKVEKKAETVTRQKPAK
ETEKGLLTIFLIAFFSGFAALLTPCVFPMIPMTVSFFTKQSKTKSQGIRNAILYGVSIIL
IYVILGSLVTAIFGADALNALSTNVWFNIIFFILLVFFAASFLGAFEIVLPNSWANKVDR
QADRGGFIGIFFMALALAIVSFSCTGPIVGSLLVEAASKGGIAPIVGMVGFSLALALPFM
LFALFPGWMNSLPKSGGWLNTVKVSLGFLELAFAFKFLSKADLVMQTHLLEREVFLAIWI
AVFGAWAFYLFGKITLPHDSPLTHISVGRFSLGLLVLSFTIYLIPGLWGAPLKIISGFPP
SITYSESPYGVGNSKGGGTSSGEALPEGAKLAVHDIVAFTDYDQGVAYAKKVNKPILLDF
TGFGCENCRKMEDFVWSDNNIQSILKNDVVLISLYVDEKQELAEAEKYVSKETGRKIKTK
GNKWSDFQITRYKANAQPYYIILDSEGNDLNEPVGYTPDKEEYEAWLKSGISKHKKGGL
>LONDMIMF_02189 tRNA(Ile)-lysidine synthase
MLLKFQKHLAENLPFLKEKKLLLALSGGLDSMVLAYLLKESDCIFTMAHCNFQLRGNESD
GDEKFIRDFALQNKIQLFVTHFDTESFATDNKLSIQVAARQLRYIWFYQLLEENKLDYIL
TAHHLDDNLETFLINLTRGTGLDGLTGIPAQNNRIVRPLLNFSREEIRNFAVENKIEWRE
DSSNASDKYLRNKLRHDIIPMLKSLNPSFLDSFQDTLNNLQQTKSLADDASVLVYKQVVS
EKENQKHFNISELKRLANYKAYLYEWLKPFGFRAWEDIYELTEAQSGKIILSENYRLLKD
REYLILEPIKEKDSGIYEIIGNEIKTPIPLKISETDQIIKASDTHRIYVDKETLKFPLHI
RKWREGDYFCPTGIDGKKKISKYFKDEKMSLSEKENTWLLISDNKIVWIIGKRSDRRFYV
SNTTQQILKIEILK
>LONDMIMF_02190 Aminodeoxychorismate synthase component 1
MSPNKAFLRTSIIIEVQNPKEFKQQLLGWSEQFREALFLDSNDYRQNYTSFDAVLAVDAF
TLIQTDEHNAFEDLKQYQQTTKDWLFGYLSYDLKNDTEALISANFDGLHFPDLFFFQPKK
LFFLKGNQLEICYLNMCDDEIEEDLEAINKQVTPVNAEQKLKIQQRISEQSYLQKISEMQ
EHIHRGDIYEANFCMEFFAENATINPIATYKSLNKISEPPFAVFFKNNKQYLLSASPERY
LRKERDKIISQPIKGTAKRHPDFQQDEAIKQRLLSNEKERSENIMIVDLVRNDLSRTAAK
NSVEVEELCGAYTFKQVHHLISTVVSKADKEKSAVEIIRTTFPMGSMTGAPKISAMKIIE
DLEETKRGLYSGAVGYFTPENDFDFNVVIRSILYNQQNGYVSFSVGSAITALSVAEKEYE
ECLLKAKAMREVLES
>LONDMIMF_02191 Dihydrolipoyl dehydrogenase
MSSFDVVVIGSGPGGYVAAIRAAQLGFNTAIIEKYSTLGGTCLNVGCIPSKALLDSSHHY
YDAVSHFKEHGIEITGEVKFSIEQMVARKGTVVDQNVSGIKYLMDKNKITVFQGVGSFED
ATHINVAKADGSSETLEAKYTIIATGSKPSTLPFIKIDKERIITSTEALNLKEVPKHLIV
IGGGVIGLELGQVYLRLGAQVSVVEYLDRIIPGMDAGLSKELTKVLKKQGMKFYTSHKVK
SVERNGDGVQVQAENAKGETITLDGDYSLVSVGRRPYTDGLNAEKAGVKITERGQIEVND
HLQTSVPNIYAIGDVIKGAMLAHKAEEEGVFVAETLAGQKPHIDYNLIPGVVYTWPEVAA
VGKTEEQLKEAGVEYKAGSFPFKALGRSRASGDTDGFVKILADAKTDEVLGIHMIGARTA
DLIAEAVTAMEFKASAEDIARMSHAHPTYAEAVKEAALAATDNRSIHM
>LONDMIMF_02192 hypothetical protein
MKTNILNIAGVAVLSKENLKAITGQGSVDLDTSIDLSLCGCSCSGAVTGPKYCIYYIACP
QVYTCDQSPI
>LONDMIMF_02193 Na(+)/H(+) antiporter NhaA
MQHQLQQTTVDKYIINPLKSFISNSVMGGVVLLGAAIIAMILANSPWSESFLGFWKNRIS
IGFNDTVFLDYDLHHWINDGLISIFFFVLGLELKREMVDGQLSGFRNAVLPIIVGISGMI
FPALIFFLFNGSDTQAINGWGIPMACDIAFVLGILYLLGDRVPVSVKIFFTAFGIVDDIG
AVLVIALVYTNEISIWSLGLGLLFFILLILANKIGVRSTLFYGIVGIIGVWIPFLLSGVH
ATIAAVLVAFTIPATTKISEKGFLSKIKSYSGELDKTESLSGVTLTKGQLNIIKKMKSMT
KHATPPLQRLEHSLHPVVSFIVMPIFALANAGVVFDIDFADLFSNNIFLGIVTGLIVGKF
LGIFGITFLLLKLKLVKLPKKMTVSHLLGISVLSGIGFTMCLFITTLAYDNPQHVTQAKI
AIFAASIIAGISGYILLNRKPKNETGSISAS
>LONDMIMF_02194 Leucine-responsive regulatory protein
MTLDTIDKKLLKLLQEDSKRTTKELSLKLDLSVTAVYERIKKLEREGIIKKYVALLDRNT
IQKGFVVFCHLKLMQHTKEFISQFEKEVVQLNEVLECFHVSGDYDYILKICVENMEEYRE
FMVTKLTSLQHIGSTHSMFMIGEVKNTTAFVF
>LONDMIMF_02195 L-methionine gamma-lyase
MIFYLFDCFFGFYFTINYHYIMKDFNPADNIQDLQYFGEFGGVNPSISDSSTYTFLSAKT
MFDTFEGNAEGCYLYSRHSSPSNLYLDKALAAMEGTESANVAASGMGAITPTLLQLCGNG
DHIVSSRTIYGGTYAFLKNFAPKFGIKTTFVDITKLDVVEASITPDTKVLYCETVSNPLL
EVADIAGLAKIANKHNIKLVVDNTFSPLSVAPAKLGADIVIHSLTKYINGSSDTVGGVVC
ASQEFVNSLKNVNNGASMLLGPTMDSLRSASVMKNLRTLHIRIKQHSYNALYLAEKFEKD
GLKTVYPGLKSHPSHELYKNMINPEYGFGGMMTIDVGTLDKANELMELMQQRNLGYLAVS
LGFYKTLFSAPGTSTSSEIPLEEQAAMGLTDGLIRFSIGLDNDIDRTYSMMRTCMEDLGI
LDKSMALA
>LONDMIMF_02196 Prolyl tripeptidyl peptidase
MKKISFLSAFLLAGIVAYAQKNLTIEEATFGQYRNFAVENLVAPKWRKDTKAITYLDNSY
SKLVSKSEEGNWTETIVLTKADLQTALKNKFSTDEFQLRMFPYSYTWIDKSTLEFEVDGK
NSKYLIQFDVDKKEVRNGIAFSSDGRNQIISSNGKYAAWLDNNNIKITTNSGQTTNVTSD
ENAGIVNGSDYTHRQEFGINRGMWWSPKNDKLAYYRKDETMVADYPLTDFSARIAANKNI
KYPMAGMKSEEVTLVVYDINTKKSVTLQTGEPKEQFLTCITWDPSGKFVYIGVLNREQNH
LKLNKYDASTGTLVKTLFEEKASTYVEPLHDLTFLPNSVTEFLYRSEKDGFEQLYLYNTE
GKQVRKLGYNDVVVTSLLDFDKEGKNVFYIGTSNNGLDRQFFKVDLKSGKTTQLTTTSGM
HAGSISSDGTLLFDQFTNVTTPNEVAIVNLKTNKSTNLIKASNPYLGKTNLPKMELVKIT
AADGKTPLNGRLIYPANFDATKKYPVMVYVYGGPHAQLVQNEWLGGAGLFDFFMAQNEFV
VFTVDNRGSDARGRDFEHVIHRNLGQNEMADQMKGIEFLKSKSFVDQDRIGVYGWSFGGF
MTTSLLLNHNDVFKVGVAGGPVCDWKYYEVMYGERYMDMPQENPEGYEKASVINKAKQLK
GHLLMIHGAQDPVVVQQNSMEFIQACIKEGKQVDYFLYPTHEHNVSGRDRIHLNQKIADY
FFLYLKK
>LONDMIMF_02197 putative amino acid permease YhdG
MSFSSLFRKKTVQDILKQVEKNEIDGHSSLGKHLTARDLTAFGIAAIVGAGIFSTIGKAS
ADGGPAVIFLFLFTALACSFAAFAYAEFASMVPVSGSAYTYSYVAFGELIAWIIGWALIM
EYAIGNITVAISWSDYFTGLLESGGLHLPQWIQMDYLTASNGYAEATALMQGGKSFANLD
AGLQDAYTAWTTSPVIGSFHLVTDIPALFIIVLITALVYRGMKESRNASNLMVVVKLCVI
LLVIAVGVFYVDTENWNPFAPNGVNGVLKGVSAVFFAYIGFDAISTTAEECKNPQRDLPR
GMMWAIIICTILYIAIALVLTGMVKYNSLNVGDPLAFVFEKLDLKWMSGIIAVSAVVAMA
SVLLVFQMGQPRIWMSMSRDGLLPQKFSRVHPKFKTPSFATIVTGFVVAIPALFLNLTMV
TDLCSIGTLFAFVLVCTGVLVLQNKPNIPRGKFKTPYINSKYIVPVLLLAGIVYSFTYNK
KNTMDFITNVPQINSPASIVTSLNKAETEEVYKFLVENHKERVFNKTTDLEQILSDFQEN
ETEYIAVVESLPIDKSLKYETGFALFKHKIPMWIFLTVLVGLAVWAFRQNLSLIPLLGLI
CCLYMMAELSVWNWIYFFIWLLVGLAIYFGYSRKHSKLNFIQEN
>LONDMIMF_02198 putative peroxiredoxin
MSLVGKKFPSIAVDAISEMGDNLKINIFEEAVNNNKKVLLFWYPKDFTFVCPTELHAFQA
ALPEFEKRNTIVIGASCDTNEVHFAWLNTPKSNGGIEGVTYPILADTNRNLANILGILDI
ESTSYSEETDSVIIEGSNVTYRATYLIDETGKIFHESVNDMPLGRNVAEYLRLVDAYTHV
QTKGEVCPANWEEGKEAMFATREGVASYLNN
>LONDMIMF_02199 Thioredoxin
MLIDLNEDTLQNLVNSNEKVVVQYSASWCGNCRIMKPKFKKLASENENITFVLVDAENSP
ESRKLANVSNLPTFATFVNGQLVNQTQTNKAEVLSELVNEIA
>LONDMIMF_02200 hypothetical protein
MKLPVIKHLTQFIEENDQDYIIETIEVLEALTEVPSLKDEELDVIGELISNMYGALEVNK
MIKDGTDKKEALNKFMQRVLGSIDK
>LONDMIMF_02201 hypothetical protein
MAKGKNLKAPTVDLKEKKQEKIKQKLEAKQNRKRK
>LONDMIMF_02202 Thiol peroxidase
MATVTLGGNPVKISGELPKVGSKAPDFKLVNKDLGVVSLSDFAGKKLVLNIFPSIDTATC
ATSVRSFNAKASSLENTTVLCISRDLPFAQKRFCGAEGLDNVICLSDFRDGSFGKTYGLE
IADSALQGLHSRVVIVLDENGTVLHTEQVSEIANEPDYESALAVL
>LONDMIMF_02203 Undecaprenol kinase
MKTDHSFVTGRLKSFKYAIRGAYKLISTEHSVMVQFFLGIAITIAGFYFNISKTEWLFQT
MAIGLVLSIEGLNTAVEKIADFIHPNFHDKIGFIKDVAAGAVFFAAVAAIAVGLIIYIPK
FQNL
>LONDMIMF_02204 DNA translocase SpoIIIE
MAKTTKKETPGKKDSQSSEKKTWKLTRQHKVIFGALLVLFSVALLLAFISFFLYGQYDQS
AVDALADRSVEVQNWLGKFGAYLANLFLYQGFGVASFLLVRLFFITGMYLILDLPVKKLK
NTWFWDLFAIIIISILFGFFADFLPELGGVIGFEMNLFMQDYLGKAGTLLLLVFGLLVYL
IFKMKVSPDAIKNYFEEKKRKAEERAVAESVAAPVAVQELTDEILEEDIIEEEDIIEEED
EEIEEPTLKPLSQFEINKEALKPTINNPSHITIEPIVKPPVAPVHSHEPEIIETNDDAFV
IEKFADEDTVIENLASKLVADFGEFDPTLDLSNYKFPTLDLLKEYSNGGITINQEELEEN
KNRIVETLRNYKIEIAQIKATVGPSVTLYEIVPEAGIRISKIKSLEDDIALSLSALGIRI
IAPIPGKGTIGIEVPNKNPTMVSMKSVIGAAKFQEAEMELPIALGKTISNETFVVDLAKM
PHLLMAGATGQGKSVGLNAVLTSLLYKKHPAEVKFVLVDPKKVELTLFNKIERHYLAKLP
DTEEAIITDNAKVINTLNSLCVEMDNRYSLLKDAMVRNIKEYNEKFKLRKLNPENGHRFL
PYIVLVVDEFADLIMTAGKEVETPIARLAQLARAIGIHLIIATQRPSVNVITGIIKANFP
ARIAFRVTSKIDSRTILDTQGADQLIGRGDLLYTNGNDVIRVQCAFVDTPEVEKITEFIG
AQKAYPNAYLLPEYIGEENGIKLDVDISERDSMFREAAEIIVTAQQGSASLLQRKLKLGY
NRAGRLIDQLEAAGIVGPFEGSKARTVNIPDLNSLDQFFNNEQNDF
>LONDMIMF_02205 Outer-membrane lipoprotein carrier protein
MIFKMKRFLPVIALFFISFTFQAQNSQKARNLLDEVSAKVKSYDNIAIDFKYSLTNPKEN
LNQESKGNVIMQGNKYVLNFMGVTKIYDGKKIYNIVPEDEEISISKFDENEEDAVTPSKM
LTFFNHGFKYSWDILQNVRGRKIQYVKLVPTSSKDERKEIYLGIDVQTKHIYNLMEIGKN
GSKTTITVNSFKTNQPLSKNQFTFAESKYPNYYINKLD
>LONDMIMF_02206 hypothetical protein
MKILDRYILTTFLKTLATVFVILFFIFILQAVWLFIAELAGKDLDVLLIVKFLLFYSPKM
IPLVLPLSILLASIMTFGNLAENYEFAAMKSSGISLQRAMKSLMVFIVFLSIIAFFFANN
IIPSAEYKFLNLRRDIVQTKPAMAIAEGQFSDVGDYNIKVNKKSGDKGEKLSGVTIHKKA
ANGIGNNIVIKAKNGLLVNQEESTMLQMILFDGNYYENIIPKKYEERNRVPFVKASFKKD
IINIDLSKLNTVEDESNITNTNAMLNVSELTYTLDSLHKNFNKDLVSFAENIYQRSGIIN
FRDPNAAAANSKPKKDTNITDPLSILSTADKSRALEIAISNLESAKFSIEGTKQEMELKQ
KNINNHWLALYEKFVIAFSCILMFFIGAPLGAIIRKGGLGLPIVFAVLIFITFHFINTFG
RKLAQENGIPPFLGSWMSSFILSPLAVLLTYRATNDIGLINMDIILSPIQKGFQKLFRIK
NNNTPK
>LONDMIMF_02207 Riboflavin biosynthesis protein RibBA
MSENKITKLNTIEEAIEDIRQGKIIIVVDDEDRENEGDFIAAAEKVTPEMINFMATHGRG
LICAPLTEARCKELDLNLMVTNNTVLHETQFTVSVDLIGHGCTTGISVHDRAKTIQFLVD
DNTKPEDLGRPGHIFPLRAKQGGVLRRTGHTEAAIDLARLAGLKPAGILVEILNEDGSMA
RLPQLFEVAKKFDLKIISIEDLVAYRMQHDSLIQKKEDFEIETRFGTFRLRAYVQTTNKQ
VHLALTKGSWNIGESILTRINSTQVNNDILGTLTNDPDQKLERMFQRINEEGKGAILFIN
QEIQPIELLNRITELKGLQEKGVFKAPQVKMDNKDFGIGAQILHDIDITNIRLLSNSEQT
KRVGMIGYGLEIMEYVEF
>LONDMIMF_02208 Fe(2+) transport protein A
MKTLAQLKIGQKAQILDVNIDTIPLKLLEMGCLPGNFVELLQIAPLGDPLYIDVNDSHVA
IRKETALAITVEVVNEAL
>LONDMIMF_02209 hypothetical protein
MKKLIYAAFIVIVFSACKDTASENAMLEQQREIDSMKVVMKEQEEALAKQRTIDSMNAVV
AAAEAKAARASANKAAPVTAEQKKKGWSNTAKGAVIGAGAGAITGAAVSKKKGEGAIIGG
LAGAAVGAGTGAIIDDSKKKKEKQ
>LONDMIMF_02210 SCO1 protein 
MLTFFKKYRIFFLVLFLLSATIITLFYFALKPKKTLKIYNPADVNPEMVDTTVQYVKKYH
TIDDFSFTNQNGKTITQKDYEGKIYVADFFFTTCPSICVPMGENMAWLQEQIKDNPKVML
LSHTVMPDIDTPEVLKAYAVKKGVIDSKWNLVTGDKKDIYYIARKSYLAVKTTDSSELYD
MVHTENFVLVDAKRRIRGFYDGTKLEEVKRLLEDINYLSNEKSE
>LONDMIMF_02211 Neutral endopeptidase
MKIISNKGMLSVTAMILTAISANAQEKSPHPGIEIQYMDLSVRPNDDFFKFVNGKWVKET
EIPADRTRWGSFDELRQRTDEDALAILKKAVSDKKLDPKSDQAKAVNLYKSIMDTVTRNK
QGITPLKPYLAKINAVKNVKDLQALMIEMEPVGGVGFTGAGVGTDAKNSNRNVVTVGLGS
LGLPDRDYYVSDEADSKEKREKYEQHVARMLQYLGEKPDEAKKNAAKIVALEIAMAKPRL
DRVERRDRRKTYNPMAIADLQKLTPSINWNTYLTGIGLPKLDSVIVSQPKYMTALEEIFK
QNKVEDWKEYMKWTLLNKSAGTLSTEIETANWEFYGKTLTGAVKQRPRDERALQTVNGMI
GEALGKLYVAEKFPPEAKAKAEKMIKNIFLAFENRINRLPWMTKATKASAIEKLHKSRIK
IGYPEMERLFCIDNRCS
>LONDMIMF_02212 Neutral endopeptidase
MTIVAPEKGGTYFENIKNAARWNYKEDIEKLNKPVDKDEWFMSPQTVNAYYNPSYNEIVF
PAAILQPPFYDYKADEAVNYGGIGAVIGHEISHGFDDSGSRYNADGNLVNWWSDDDLKQF
TGLGGALADQYSALQPLPGIYVDGKFTLGENIGDLGGVNAAYDGLQLYLKENGRPGLIDG
YTPEQRFFISWATIWRTKARDEAIKNQVKTDPHSPGMYRAYVPLQNVDAFYEAFKIKKGD
GMYVEPEKRVKIW
>LONDMIMF_02213 hypothetical protein
MKKALFLFLSSVMFLSCDDENGQINQLKDDFSVLGKRMSSDIVVAFEKDVKDSNIDLEIK
NWEKALNKQDFDKVETYQNSIVGILNSFYEKYKKESVEDYVKLLHEIEAKVLGTHDKDPC
TRNKNGTIYLDACTFWQKVSFFISFSCSGLPVDTKSQQESYMNCLQSTVCKKCK
>LONDMIMF_02214 hypothetical protein
MITKKRIGYIVLVLLIVYLAFAIPNAIKKYDATRLPPDEFFKKYK
>LONDMIMF_02215 hypothetical protein
MPMQQISILGCGWLGLPLAKALLEKGFSVNGSTTSENKLSILENSGIKPFLVAVSSEGIQ
GNSYDFLKGSDLLIIDIPPKLKGDTNENFVKKMQNLVLEIQKSSIKKVLFISSTSVYADT
ENTPVITEENTPNPDTESGRQLFESENLLLNNPKFSTTVLRFGGLIGEDRHPVKFLSGRE
NIENPDGPVNLIHQQDCIGIIEKIIEKDIWNETFNAAAPIHPGRKEYYTQKAESLGLEVP
RFNVEKKSVGKIIISNKLEAILNYNFEVMDRNF
>LONDMIMF_02216 hypothetical protein
MKKRYSSLISALLVAGIIYGIFFAMMPQNIAEEEIPLTEFSTKRALEQVASIAKSPHYVG
SENHKNVASLLEKELQKLGLETTTQAGYTLTEWGNLAKSKNILARIKGSNNSKALMLLSH
YDSAPHSSSLGAADDASGIATILESVRAFLAKKTANKNDIIILFSDAEELGLNGAALFVT
EHPWAKEVGLVLNLEARGSAGPSYMLMETNKGNAAMVKEFTKANPAFPVSNSLMYSIYKM
LPNDTDLTVFREEGKIQGFNFAFIDDHFNYHTQQDDIQHLSPTTLAHQGTYIVPLLKYFS
NTNLSTLNDGEDYVYFNTPFYFVSYPFSWNYILVTIAGVLFIFIVFIGIGKRALSIKEIG
RGFAPFFASLLVSGAAAFLGWKVLNEFYPQYKDILHGFTYNGHYYIGFFVFISLAISFAF
YKKYYFENQAMNFAIAPLFLWLLINIALAIYLPGAGFFIIPVFCALIMLAYFVITQKKSW
ILNLILSIPAFIIFIPFITTFPIGLGLKLLAGSAVLTVLVFTLLLPVFGYYSKKGIWATA
MLLIAIGFFIKAHLESGYEPGKAKPNSLLYVYDGDTGKALWVTYDQNLDSWTKGYLGEKP
SDAKQLEPYNLFSKYNSKFTYSNSAPAKELEEPTIQFLRDTVIGTQRHLKIKISPNRKVN
RYDIFAHENLTFHNLRANGVKHINQKGSAFKRKGRKLLSYYVTDNEPLELQFSIASKAVL
DMDLMESSFDLMSNKMFSIAKRENWMMPTPFVLNDAVVIKQKIKPNFRKEIIPEQLLDSL
QQQPTTLEINANAAN
>LONDMIMF_02217 hypothetical protein
MPKSCLECRERITGREDKKFCGDGCRNAYNNKINKDSNNLMRNINNKLRKNYRILSGINS
DGKIQVSRSRLLTKGFDFEFYTSTLPTENGNTYYFLYDQAYLPVKDDSFILVKKEYLTPP
K
>LONDMIMF_02218 (R)-stereoselective amidase
MQAEINKVELRNLQIEDYKQLKTSMLHAYDEFDEPYWEEKEIEKLLSVFPEGQLVILVDD
KVVGSALSILVNYKKASSNHTYQKITGNFSFSTHDPDGEVLYGIDVFIDPEYRGLRLGRR
LYDARKELCETLNLKSIIFAGRIPKYSQYSEEMTPKEYIDKVRLSELYDPVLSFQLSNDF
HVLKIMKNYLEGDISSQEYAVLLEWNNIYYEKSPKLINVKKSVIRLGLVQWQMRPLANLE
ALFEQSEFFIDVVSGYSSDFVLFPELFIAPLMADYNHLSEADAIREISHFCEPIRKKFQE
FAISYNINIITGSMPYTEDGNLYNVGFLCKRDGTYEMYTKIHITPNEVQYWGMKGGSEIR
TFDTDCGKIGIMICYDVEFPELSRLMADEGMEILFVPFLTDTQNAYTRVKFCAQARAIEN
ECYVAIAGCVGNLPKVNNMDIQYAQAAVFTPSDFAFPSNGIKAEATPNTEMTLIADVDLD
LLKKLHEQGSVRILKDRRDDLYKIKKLK
>LONDMIMF_02219 Single-stranded DNA-binding protein
MNTLRNRVQLIGHTGKDPDIKNFDGGKKLASVTIATNEVYTNDKGEKVTDTQWHSVAAWG
KTAEIIEKYVTKGDQIAIEGKLVHRSYDDKNGEKKYISEIVVNEIILLGK
>LONDMIMF_02220 Acetoin utilization protein AcuC
MLPIAFHPIYKHPLPEGHRFPMLKYELLPQQLLHEGIVSESDFFKPGIPDLQHILAVHDK
AYVDELVNLTLDARAARKIGFPLSTELVERELRIAQGTILGCEKALQYGIAFNIAGGTHH
AYSNRGEAFCLLNDQAIGAQYLLDKKLASKILIIDLDVHQGNGTAEIFQNNSNVFTFSVH
GKSNYPFKKETSDLDIALPDKTGDEEYLRIINDTVAKLIDREKPDFIFYLSGVDILDSDK
LGKLGCSINGCKKRDEIVLSLCRKFEIPVQCSMGGGYSPEIKTIIEAHTNTYRIAKNIFS
>LONDMIMF_02221 hypothetical protein
MKKIFLSLFTLCCINLSFAQTLLATHPLELKKATSNHQIVNAVNDQNQVFVFASDKEKLK
VLKYNNALFFKDSLSVNRPDKNYTAMAGFSFEDNGNPYLYWSSDDYTKIQSHYFDFNNRT
SVTASHQLSLKNESIISVFSENNSFYILSLTQKEDKLKFYCFNKGQLDEKIIDFSSYKFM
DEKGKSSTFSSLIKENGIEKIDTRSSNPLFQSVPKIKFYITGKHMMLTFDSSGRTQLFDI
DLTTFVVNEKTIPALTLKGSGGQSNSYFHDNKLYQIRANEEELAIAAVDIATEEELKRYT
AGSKDSISFRNSPLYSQTGNERGQELKNTKKFFNKLSNSSLGITVYKTPASLMVTAGGIR
DVSSGGGILLGITAGVAMAISGSYYVPEDIFDSQNMQTIYFESLFDDKFEHKKGPQQGLA
VDYISQFLHENNVSLVSVFPYKDYFIMGYYDSKKKEYAMRKFEDFNE
>LONDMIMF_02222 Chloramphenicol acetyltransferase 3
MKTKLDLNSWPRKEHFEFFSKFEEPFFGITATIDCTKAYETAKKKGTSFFLYYLHKTLAA
VNAVENFHYRISEGEVYRYDKIDASPTLTRDDNTFGFSLVEFFPDYELFEAKAKEEIERV
RNTPGLFTRSFEVDNLIHFSAIPWVDFTSLSHARSFSFPDSCPKISIGKMVVQDNGKRTM
AVSVHVHHGLMDGLHVGEFFNKFQEVMDS
>LONDMIMF_02223 hypothetical protein
MNIKVIAFDADDTLFVNEPYFQETEEKFCALMQDYLSHQGLSQELFRVEIQNLSLYGYGI
KGYILSMIEAAMKISNKTISVDVIEKIIEYGKELLQKPIELLDGVEETLEALHGKYKLVV
ATKGDLLDQRRKLHNSGLGHYFHHIEVMSDKQEKDYHDLLNRLEIKPQEFFMIGNSLKSD
VLPVLGIGGHAVHIPFHTTWAHEKIDHKVEHKNFKALDKITEVLPILL
>LONDMIMF_02224 Methionine--tRNA ligase
MIQDPKRYTITAALPYTNGPIHIGHLAGVYVPSDIYARFLRLQGRDVAFICGSDEHGVAI
SMKAKKEGITPQEVIDKYHTLIKKSFEDFGISFDNYSRTSAKIHHDTASQFFRTLYDKGD
FIEEVTEQLYDAKANQFLADRFVIGTCPKCGNEEAYGDQCERCGSSLNATDLINPKSTIT
GETPILKSTKHWFLPLDRYDAFLREWILVGHKNDWKPNVYGQVKSWLEDGLKPRAVTRDL
DWGIPVPVEGAEGKVLYVWFDAPIGYISSTKEWAQREGKDWEPYWKSDDTKLVHFIGKDN
IVFHCVIFPAMLKAEGSYILPDNVPANEFLNLEGNKLSTSKNWAVWLHEYLEDFPEKQDV
LRYALTSNAPETKDNDFTWKDFQARNNNELVAIFGNFINRVVVLTNKYYDGIIPQPNEFS
EIDEATLTELKAYPAVIASSVERYRFREALGELMNVARLGNKYLADEEPWKVIKDNPERV
KTQMYVALQIAGALSVLAEPFLPFTAQKLARILKTENKLSWNDISENSDLISAGHKIGEA
ELLFAKIEDEEIQKQVDKLEATKTANKAENKKAEPQKDLIQYEDFAKMDLRVGTILEAEK
MPKANKLLVLKIDTGIDIRTIVSGIAESFTPEEIIGKKVTVLANLAPRNLRGVESQGMIL
MTTNPEGKLVFVNPDAEASNGETIN
>LONDMIMF_02225 putative murein peptide carboxypeptidase
MQRPNQFKLLFTLLTLLHFLTFYAQNKLIMPEYLKKGDTVGILATARKIDLATIEPGIKL
LESWGLKVVIGKTIGKEQNQLAGADWQRATDFQEMLDNPTIKAIWAAKGGYGTVRIVDRI
NFTEFKKKPKWIIGFSDITVLHSHINNMDIGTLHAIMAISAKTATPEAIESFRKALFGEK
LEYHIPAHPFNKKGKAQGELVGGNLSVLYSIQGSKSAVDMKGKILFLEDLDEYLYHIDRM
MMNLKRNGSLDGLKGIVIGGMTSMNDNDIPWGKDALEIIEDVVKDLKIPIAYNFPAGHIK
DNRALILGKSVTLDVNDKETVLKFE
>LONDMIMF_02226 hypothetical protein
MAVHNELGKQGEALAVEYLRKEGYEILETNWVFQKAEVDIIALKGDVLAIVEVKTRSSLE
YGLPQEFVKPKKIQLLVKAVNEYVIVKNLDVNVRFDIISIHKNAENVTIKHLIDAFLHF
>LONDMIMF_02227 hypothetical protein
MKTISSVVEHYIKTKPFLLSALSQGIINLTSLSRNMLPDLKQELGKEVKQGAVVMALKRL
SEDLDFRLNHKILKVLKGIGEITVRSSLTDFTFAVSDKILDKQASLISEINTYSDIFYTS
SRGVSETNIVVSESVSHLVDKHFVGEKMLHKWENLASITVKLPKDNVSTPGVYYFIFQRL
AWEGIIVNEVISTSYEFTILVSEDEVDVAFKVIKDLKSL
>LONDMIMF_02228 Transcription-repair-coupling factor
MKPHILKTYAGNPKVRQISESLAVRENKIQLKGLIGSSLSFVVASLFEKSELPYLLILQD
KEEAAYYLNDLEQLVGEEDVLFYPGSYRRPYQIEETDNASVLLRAEVLNRINSRKKPAVI
VTYPEALFEKVVTRKELDKNTLKVAIGDQISIDFINEVLFEYEFKRVDFITEPGEFSVRG
GILDVFSFSNENPFRIEFFGNEVDSIRTFDVETQLSIEKQKKITIIPNVENKFFQENRES
FLNYINEKTVLFIQNTELLFSKLDQLYGKAKEIFGSMQSTVNHIAPEELFLNQEAFIKKA
LDFTIAEISPRAIFKTQKTFEFHILPQPSFNKQFDLLLNNLNDNHFNGYKNFIFCSNEQQ
TKRFHDIFESLDEANSENIRKQYHTIVFPLYQGFIDEENQIACYTDHQIFERYHKFSIKN
GYSKKQTITLKELNTLSVGDYVTHIDHGIGKFGGLQKIQVEGKTQEAIKLVYADNDIVYV
SIHSLHKISKFNGKDGTPPKIYKLGSNAWKVLKQKTKARVKHIAFNLIQLYAKRRLEKGF
QFAPDSYLQAELESSFIYEDTPDQVKATQEVKADMENERPMDRLVCGDVGFGKTEVAIRA
AFKAVDNGKQVAVLVPTTILAFQHYKTFSERLKDMPVSVGYLNRFRTAKQKTETLKQLAE
GKLDIIIGTHQLVNKNVVFKDLGLLIVDEEQKFGVNVKDKLKTIGTNIDTLTLTATPIPR
TLQFSLMAARDLSVITTPPPNRYPIETQVVRFGEELIRDAISYEIQRNGQVFFINNRIEN
IKEIAGMIQRLVPGARVGVGHGQMDGKKLEELMLAFMNGEFDVLVATTIIESGLDVPNAN
TIFINNANNFGLSDLHQMRGRVGRSNKKAFCYFITPPYSSMTDDARKRIQALEQFSELGS
GFNIAMKDLEIRGAGDLLGGEQSGFINEIGFETYQKIMNEAIEELKENEFKDLYEEDKGT
EKEYVKEIQIDSDFELLFPDEYINNVSERLNLYNELSNVKNEEELLAYERKLIDRFGTLP
KQAVALLNSIRIKWIATRLGIEKLVLKQGKMVAYFVSDQQSEYYTSNQFHKVLQFVQRNG
NLCKMKEKETKNGLRLLLTFENVKSVRKALELMEMI
>LONDMIMF_02229 hypothetical protein
MKIYSYILLVLFCFLVSCKDDEAARLQANAKDAKKNEQIFASIDKAWNFNLQPMNPTVAT
MIQNWSEWRLFMTELQQKPKSSIGAFQQKARTLSQKAMNLNNNIPAAFDKPEIKSRIMTL
ITKVRSLDLFINLNQIQEQKVIKLIPEINEELASLQSQMDEIVRKSQIRLEEGEAEMLRS
LAKDSLQKPQSESGNLPKPSNSTQQGGIVPTLNPKQKSQ
>LONDMIMF_02230 putative epimerase/dehydratase
MHAKILIIGACGQIGTELTKKLRSQYGKDAVIASDVRKGSPEFVNSGPFEVVNALDFNQV
ETVIEKYQIEDVYLMAALLSATAEKNPAFAWDLNMNSLFHVLNLAKAGKIKKIFWPSSIA
VFGPTTPKDNTPQYTVMEPSTVYGISKQSGERWCEYYHNIFGVDVRSIRYPGLISWSTPP
GGGTTDYAVDIYYKALSDGKYECFLSENTELPMMYMDDAIRATMSIMDAPKENIKIRSSY
NLAGISFTPKEIAAEIKKHIPDFSISYVPDFRQKIADSWPSSIDDSYARKDWGWKHEFDL
ESMTKVMLEHLSENV
>LONDMIMF_02231 hypothetical protein
MKKTALLLFLMATVTVYGQKKKADAVEKEKITKLLDEWHAAAARADFNEYFGKLTENSIF
IGTDATENWNKKQFEAFSKPYFDKGKAWNFKALERNIFLSDDGKLAWFDELLDTQMKICR
GSGVLEKINGKWMIRHYVLSTTVPNDVIDEVIKVKTPIEDKLIETLKKK
>LONDMIMF_02232 Very short patch repair protein
MRAIKSKDTKEERLLAKALWRRGHRYRKHDRTVFGTPDLSFKKYRIAIFVDGEFFHGKDW
ESIQQRLDTNKEFWLSKIERNRNRDKIVNEYLTSKGWLVLRFWSKDVKRKLYTTVRTIEK
EIENVHKKIYFQDTPHQ
>LONDMIMF_02233 hypothetical protein
MKKIYHFLLIFLTIHTVHSQELSIPTFTQYLADNPFVISPSYAGIGDNVKIRMNGLTQWV
GIKDAPDMQSLAADMRISDNSGIGLFLYNDKNGNTRQYGGKFSFAHHLILDKYYDQFLSF
GISYNLNQFRLEIENFNVPDMGVKDDRALINHNFDVSVLYRIQDFYFSFNASNILNKNLD
KFNINEPGKLRNYQFYTGYIFRENRNSAFEVEPSAYVQYFESDGRSSTDLNVKLRWKDNN
DDYYWAGLSYRFLNDQMMEPINIGPMAGLKKSNFYFAYSYQLTTNELMAYNSGTHMITLG
LDIFQGVSNCPCTF
>LONDMIMF_02234 hypothetical protein
MKDANGCEIAPQTFTINRGVDIRPTATVVPNCTNNVPGNTVTINVNPAVASQVQYSLDGI
NYVASNTFTNVAPGNHTAYVQHTNGCTKTVPFTINTLIPVTANANVTANVLCFGQSTGSI
QVTATGGTGVYQYAISPAYNYSSSNTFINLAAGTYSVKVKDQNGCEITLTNITVTQPAAA
LTAVVNGTPETCDGLDDGTITIIPSGGTAPYYTSLNSNNPANFTTTLTYTGLIGGRQYTV
FVKDANGCQITPAVFRVNDGLNLQPTAVVTTNCNGNTPGNTVTVSVNPAVVNDVQYSLDG
VNYVSSNVFNNLPVGTHTIYVRHTNGCTKTTTVRINPVTPITASATAVNATCNGLSNGRI
TVTASGGTGPLQYGISPDFNLTSSNVFQNLAAGNYIVRAVDSKGCYKEVTIAVTEPNVLQ
ATVVDVLQEICVDDDNGAIEIAVTGGTAPYSTSLSENGTYVRNEFLYENLNGGQTYTIYV
KDSKGCTTSVQVTLDAPVDIDARENIVYNCNGNTVTISVSPGVANNVTYSLDGGTPQTGN
IFTDLTNGRHTVEVLHASACTDTVSFFISNAVPVTVTLAETGLNKITATAFGGTGNYTYT
FNGYDNGRNNVYVFYQSGTYEVIVTDSNGCEARAAINVVFVDITIPNVTTPNEDGDNDTW
SPGNTQNYPNITTDIFDRYGRKLATLRQGQSWDGKYNGTEMPSGDYWYIIKLGNPNDNRE
FVGNFTIYR
>LONDMIMF_02235 hypothetical protein
MDKKTQEFYERLKTELDEANVWPAEYLFKFIVPTDKQKIDTVENAFNGMGAVINTTQSKT
GKFTSVSVNVRMESSQSIVDKYIEVSTVEGIISL
>LONDMIMF_02236 hypothetical protein
MYIKENPHDIVHHLEYNAERPHLIIPEYGRHLQKLIDQATVIEDRNERNKAAKYIIAVMG
SLNPHLRDVPDFQHKLWDQIFIMSDFKLDVDSPYPVPSREMLQQKPERLKYPQNFPKYRF
YGNNIKYMIDVANKWEEGELKSALIKVIANHMKKSYLSWNKDTVKDEVIFEHLYELSNGK
INLKTSSEELLNSTDLMRTNKKMSNKNQSTPQKAKSKNGGKQNNQNKNNRKPQG
>LONDMIMF_02237 UDP-N-acetylglucosamine 1-carboxyvinyltransferase
METFKIEGGVPLKGEITPQGAKNEALQILCAVLLTPEKVTINNIPDIIDVNKLITLLKNL
GVKVEKIGKGSYTFISDEVNMAYLESEAFKKEGSSLRGSIMIVGPLLARFGKGYIPKPGG
DKIGRRRLDTHFEGFINLGASFRYNREDHFYGVEATKLTGTTMLLDEASVTGTANIVMAA
VLAEGKTSIYNAACEPYLQQLCKMLNSMGAKITGVGSNLLEIEGVSSLGGCTHTILPDMI
EIGSWIGLAAMTRSEITIKNVSWENLGVIPGTFRKLGITLEKRGDDIYIPAHTDGYEIQN
YIDGSILTISDAPWPGFTPDLLSIVLVVATQARGSILVHQKMFESRLFFVDKLIDMGAKI
ILCDPHRAVVIGHDFKSQLKATTMSSPDIRAGISLLIAALSAKGVSKIQNIEQIHRGYEN
IEERLKALGAKITAE
>LONDMIMF_02238 hypothetical protein
MKQIITLILFTFSIAASAQIKGKITDQSGTTLPAVNVYIENTYNGTSSNEVGQYELNVKS
SGKYTVVFQYLGYKTQKIAINADRLPYVLDVTLLEENIAIPEIVIDSKENPANAIIRSAI
AARKQNSEMTAKFTADFYSRGIFRVKDMPKKILGQTMDEKGILDSTGTGIMYLSETVSHI
TYQKPDKLKERIIASKISGNDNGFSYNTARNTDYDFYQNYIEFNINMVSPIASNAFGYYK
FKMEGTFIDENNNTINKIKVTPKRDSDPVFEGYIYIVEDSWAIYAVDLDIKGYRMQEPIL
EVMNLTQNFSYNSNSKIWAKSLQTLDFSAGLFGIKFTGKFTHAFSNYEFKEEFEKKTFTK
EIVSIDKEANKKDDNFWDAARPVPLTDEESKDYIKKDSIQTIRKSQTYLDSVDRKKNRFK
PFDLIEGYTFRNSYKNWSVKYDGLIQVPAFNTVQGWNLNTGFSYTKTNPDERTYTSFGAK
MNYGIAEERLRAYGYFSTRLDNQTNAYLFASAGNQIVQFNSAAISDVVNSVSTLFFKDNY
MKLYDKTFGRISYQQEVVNGLTLFGNAEYSRRKSLFNNTDYVLIKNDKEYTSNNPLAPTA
NSLPIFETHRLAKASISARVNFGQEYISRPDGKMNIRNEKYPVLFATYEKAFAGSEKEYE
YDAIHARMTYDVTLGNKGELGVNLKAGKFFNADNISFADYKHFNGNQTHIGQTERYLNVF
NLLPYYSHSTNDAYIEFHAEHNFKGYIMNRIPLLNKLKSNLVVGYHAIAVPDVKPYSEFS
VGLDNLGFGKFRMLRVDYVRSYQNGFQGDGVIFGLKFLNILE
>LONDMIMF_02239 3-dehydroquinate dehydratase
MKIIIINGPNLNLLGKREPEIYGSQTFEEYFVSLQAEFPNVELVYFQSNIEGEIISKLQE
TGFTFDGIILNAAAYTHTSVGIGDAVKSITTPVIEVHISNTFSRESFRHQSYISPNAKGI
IIGFGLESYKLAIKAFL
>LONDMIMF_02240 hypothetical protein
MKKFIVAAILIIAGATNADAQLLKFGIKGGVNFANFNGGADGIDYSSRTGFHAGAVAEVK
LFQNFSLQPELLYTSQGADVKGLGDFNLDYVSVPVLAKFYLISEKLSLEVGPQFSFLIDE
AKNEFENKSFDFAAAGGLGLNITDNFFAQARYTIGLSEVSKEAEVKNAVFQLSLGYFF
>LONDMIMF_02241 hypothetical protein
MKKIILTVAAVFAFGFANAQDAKSTANGGQTAKGKWLIEANTGFGAAHSADTSFGLRSED
GETTWSIGAEGGYFVMDDLAIKAGLGYVDMGDDVSSFTYKIGAKYYIISQIPVQLDYSGA
SIKDADENPSYLGIQGGYAIFLGQNVSIEPGLRFNKSLNDDFYDDVFQVRIGFALHF
>LONDMIMF_02242 hypothetical protein
MKKIVLTVAAVFAFGFANAQEETSEGFKKGDAFISGAVSFGSTKTGDFKTSDFEIAPSAG
YFVTDNIALGLAFGYGSSKVDVGVADAKNSTLSVGAFGRYYFTPASKFSIFGQLGVNYMN
YDFEFNPETITPAESKGNGFGVAVAPGVSYFLAKNFAIEATFGILSYETLNPDEDGVDST
NGFNFGLDMRDIRLGLVYKF
>LONDMIMF_02243 Fe(3+) ions import ATP-binding protein FbpC 2
MLSVQNISFGYTEKQVIENISFTIQKGQNIAIIGESGCGKSTLLKLIYGLYDLDEGQIFY
GDTPILGPKYNLIPGEDYIKYLAQDFDLMPYTTVEENVGKYLSNVYKEEKAQRVADLLAM
VEMSDYAKTKAKYLSGGQQQRVALARVLALEPEVLLLDEPFSHIDNFRKNALRRNLFAYL
KKKGITCIVATHDSADALSFADETIVMQKGRMLEKAPSKELYFNPVNKYVASLFGEINEI
TVEDENGTMINLLLYPHQLKVAQTGFIQVLIKQSYFKGNRYLVKAVLEKQVIFFEHNGAL
ENETFVFLELNNKIS
>LONDMIMF_02244 Dipeptidyl aminopeptidase BIII
MLFLLVGLTGFSQEELTYQKPSKEILDLADYERAPSVSMDTKKEYMLLSYRNTYKTLDEL
NQEEMRLGGLRINPITNISSTVTYINNLKVRKIKDKNETQVTGLPQNPKISNISWSPDEK
KLAFTHTTATGVELWVLDIASAKATRLTEATVNANMGSPYSWYRDNQNLLVRMLPKNRPA
LIDSKKDLPKGPTVSTSDGSKSQNRTYQDLLKNKTDETNFETLVSSELYKIDLSGKASLY
KSADLYAGEGFSPDGNYIMITTIQKPFSYIVPLSRFPMKSVVYDLSGKEIKVVNEVPLSE
IMPKGFMATRKGKRSMGWRSDAPATLYFVEALDGGDPANKVDFRDEVFLWQAPFTSNPTS
LVKTVQRYGGIVWGNNTTAILYDQWYDTRNEKTYLFNPSNPGQAPKVIFDRNSQDIYSDP
GSFETIKNQYGRQVLALENDNAFLIGQGHTKNGQFPFIDEFNIKTFKTKRLYQSAYKDKK
ESIFSIEDFKKGDVLVQIQSKSEYPNYYFRNIKKKNELTQITNFKNPFESIKNVHKEVIK
YKRKDGVELSGTLYLPVGYDMKKKEKLPLLIWAYPEEYKDKNSAGQSSQNPNEFTFPNYG
SFVYWVAKGYVVLDDASFPIIGEGSTEPNDTFITQLVDNAAAAIDAVDKLGYINRKKVAV
GGHSYGAFMTANLLTHSDLFACGIARSGAYNRTLTPFGFQSEQRNYWEVPEVYNTMSPFM
TADKMKTPLLLVHGDADNNPGTFTLQSERYFQALKGLGAPVRLLLLPKESHGYAAKENIL
HLLWEQDQFLEKHLKN
>LONDMIMF_02245 3-oxoacyl-[acyl-carrier-protein] synthase 3
MYHSKIAGLGYYVPENIVTNDDLSKIIDTNDEWIQERTGIQERRHIVKGDGNTTTSMGVK
AAKIAIERSGVAKEDIDFIIFATLSPDYYFPGPGVLVQRDLGLNTVGALDIRNQCSGFVY
ALSIADQYIKTGMYKNILIIGSEVHSTGLDMTTRGRGVSVIFGDGAGAAIISREVDTNKG
ILSTHLHSEGQYAEELIVKAPGMGGRWVTDIIADNDPNDESYFPYMNGQFVFKNAVVRFS
EVIMEGLKASNLDVSDINMLIPHQANLRISQFIQQKFKLADDQVYNNIQKYGNTTAASIP
IALTEAWEQGKIKSGDLVVLAAFGSGFTWGSVVIRW
>LONDMIMF_02246 hypothetical protein
MNVYSGGILLKTYKIALGKNPIGHKEIEGDCKTPEGTYTIDGKNPESAFHKNLGVSYPNE
KDLEHAAALGKSAGGDIKIHGLRNGRGYRSKFHRWKDWTAGCIAVTDYEIDELYQSVKVG
AEIEIFP
>LONDMIMF_02247 hypothetical protein
MRLKLFFLCLIMPLLSMQAQNNLTITGKVVDKSGQPISYATVTIKEGTAVITGSITDDNG
DFEVKGLAPKNYDIEIQFIGYKPYNGKADLASGQKSLSLNRITLADEATQLEGVEVIAER
STIEQKIDRKVINVGRDLTTAGATASEIMNNIPTVNVDQDGKISLRGNQNVRVLVDGRPT
NIDPAQLLKQIPSTSIKKIELITNPSAKYNPEGMSGIINIVLHKNSNNGFNGSLNSGITF
AKDAKFNNSLDMNYRTGKVNFFGNAGSNFGKYYNDGFIQRFDNNSQQVLDIVNDNESYLY
KIGMDYYIDDNNTISFYTNQNSMNGKGNVDTDIRYLNGDLPNVLQLGRYKTDNNSGAYNL
AYKHKFAKEGHTLDFEGNYNDYEQTQNANFNTTTFNTPAEQVVYGDKIKDERKTTTLNLD
YVNPLSEKSTLELGAEARITRTTNDYTTGNLLVPIENRISNYTYDIDIYSAYATFGQKFE
KFSYQLGARFESYKVKANLNVNNSNVAFDDDYFTVYPSAYLTYNLTEKNMFQLSYSRRVD
RPSLEQTKPIREFATPLVTGLGNQELEPQFTNSVELNYTRILSKGSITGGIYYRLINDEI
NRVLYSDETTDNPNDLIMSWANFDNNSAYGFEVSANYKITKWWDVQPSVDFSNITQKGLV
SVLRPGTTDQFDFVRKEIDAAAFNARLNSNFKATKNLSFLLFGFFRSGVDGIQNDSKDMY
KIDMGGRYSLLNNKLNFSVRFNDVFNMMEYGFDSKHPYPSTGTFRWESQSLYFGINYMFG
GGKNRALQRKYREDNTKQGGGMF
>LONDMIMF_02248 hypothetical protein
MKNNLLILLALLPIVGYSQAITVDTSTRTVPELVTNVLVNSPCTEVTNISWRTGTNFGSS
NGIGYFQNTNPNFPIPSGVLLTTGDANRAPGPNNSTLNDGDNPAWIGDTDLENVLAAAGI
TMNSVNATVLEFDFVPISSNFSMDFLFASEEYGNSQCNFSDAFAFLLTNLNTGVTQNLAV
IPNTNTPISVLTIRDFLYNSSCPSANPEYFGRFNGGSEALGSAINFNGQTVLFQATSVLI
PNTPYHIKLVIADRSDYKSDSAIFLSSDSFNIGQDVLGPDLTIASQTAICQGATHTLTTG
LDPATYSFSWLKDGNPIGGDVDELVINEPGTYSVTYNNTLFPCEAPVTDTIVVEYYPELI
TPEPHTLYKCNTGQASYNYDLSYNTPIILSGIDPGVTLSYHASRADAESGANILPAIRPS
AGNETIYVRIRNTNGCITIKSFDLLLIAPPTATQPNDMTECAVALDATDADFSFAVQDSS
VLNGLSTDIYTISYYTSLPNAQAGSNPLPSTGYTTGGNQTIYVRIENKTDTDCYDTTSFQ
IFVKNLPPVDRLENVIVCDQHELTPLTNGNYFSGPNGTGTPLLPGDVITETQTVYVFNQT
GGSPNCTNQSSFRVTIIDPESLIPPDGRYCTSYTLPTLPFGNYYTQSGGNGTQIAAGTVI
RNTQTIFVYYQFPEEPFCIIDGSFDVEIIPFENLPEISSVFDCDSYVLPALPFGNYYTLP
GGTGTIVPAGTTITATQTLYAYVQNDICEDEKEFTVFIRIDTPPNAENCSSYTLPSLPIG
NYYTGPAGSGTQIPAGTVITTSQTIYIYVATTENPNCTDNVHFDVIISDPFDSIPEDIAV
CGSYTLPPITVGNYYTGSNGTGTMMLAGQTIYSTQRIYIYKPVLPGQNCTNEISYLVTIN
PIPQISSRSDIGPTCQPYTLTPLAVGNYYTEPNGQGRILNAGDVISQTQTIYIYAISTTE
PPCSAQNSFTITIVGIEADSPDPAISCDSYVLPPLAVGNYYTQSGGQGTLRHAGEVITAS
ETLYIYAEIDNRGEICSDDNIFPITIVTTPTVNPIPEGLKITCDNDDVNDGFTAFDLTPF
TDFALGSQLPADYIVEYFESENDALRRTNPVTSSTIQTIYVRVSSRISDSCYDIMPIRLT
VRRLPEPRPRGGTVCINSETNQLISSHTMQTGLSSSTHTFEWFDDNGPIAGATGSSYTAT
APGTYSVIATNNTTGCPSKLTSVEVVRSEKATVTYVVTNTFGDNQSIIVTATGIGGNYVY
QLDNGPFQSSNVFENVSSGEHTITVDDLNGCEKTTITAFVINYPRYFTPNGDGYNDYWNI
WDLAHQPEAVIYIFDRYGKLLKQIKPSQPGGWDGFYNNAPMPSTDYWFKVIYTENGVTKE
FRAHFAMKR
>LONDMIMF_02249 hypothetical protein
MILYINNLTDLFKTGKNIFLELKFCLPKFSQN
>LONDMIMF_02250 Arginine--tRNA ligase
MTLSQILTPQIEKAISALFGVTIDKIEFQATRREFEGDITMVIFPLLKLVKSNPVELGNK
IGTYLVENVAEVEKFNVVSGFLNIVISDSYYLDFFAKTRTEKNFGFVTPKENEKAILVEY
SSPNTNKPLHLGHVRNNLLGYSVAEIIKASGKKVYKTQIINDRGIHICKSMLAWEKFGNN
ETPETSGMKGDKLVGKYYVEFDKAYKDQINALMQQGKSEEEAKKQAPIILEAQEMLQKWE
AGDEQVMNLWRMMNQWVYTGFAETYTNLGVDFDSYYYESNTYLLGKDIIEHGLEKGVFYK
KPDGSVWIDLTEDGLDEKLVLRSDGTSVYMTQDIGTAVQRSKDFPDVGGMVYTVGNEQDY
HFKVLFLILKKLGYDWAQHLFHLSYGMVDLPSGKMKSREGTVVDADDLMEDMAETAKTIS
EELGKLDHYSEEEKAKLYKTIGLGALKYYILKVDPKKRILFNPEESVDFAGNTGPFIQYT
YARIQSIIRKADFDYSENVSVVLHEKEKELLKQMEAFPEVIQNAAQNYSPALIANYTYEL
VREYNSFYQAVPILGSENKTEKIFRVQLSKKVADIIASAFSLLGIDVPERM
>LONDMIMF_02251 hypothetical protein
MKTKSYFFQSFAIVLLATVAFIGFKQFLPKKIFSESAPDSKNVLIDSMLLDAVAKDVKAT
TKDTLVNKKIVFDPTFGVTFPAEKFEEYKGYQYLISFYEKLYQLETNPESENVRIAYFGD
SMTDGDMIVQDLRADYQAKFGGQGVGFVSITSESAASRGSITHQYSGNWKTQSYLNVKKP
RSPFGVNGHVFFANDTAHIEWVRFKANTTRFATMLDNPTLFYGKSSNLNGKVNVIIGKDT
IVKSLTPNNLVNTLKVSSNSIKGFKADFIKADSIPIFGFNFDDGKGVHVDNFSQRGNSGL
PISTFNPAVMQAFNNKLGYDLIVLHYGTNVLNYGTKDYTWYDRSMTKTVNHLKECFPGVA
ILIVSTADKGTKYDLEMKTDSAVVPLTVAQKRYALKTQSGFVNLYTLMGGDGSMVKWVEE
EPVKANKDYTHFNHRGAKKIAGLLYEQLNQGYEKYKALRQKRKPAAKKSPDSTGIKKDSV
NA
>LONDMIMF_02252 hypothetical protein
MHKLKLFLSLWFLLAVVGMRAQVTDSIFVEIDTVAAIDTTETIVIPDNHFHNTKALKPFF
EKLILNQQQKTGKINIVHIGDSHIQADLMTNVIRKKLQGEFGNGGRGFIFPYSLAKTNGS
YNERFSSNRTWESYRNIYPAIGHPVGLSGIGLWTKAKDFAIEINVKDSSYGFNTIKIITP
KNKDMFDVATASKTIVMESSVPKKITHKIKKGEAVSIIAEKYGISVAQLKKANNLKSNNI
RAGKTLRIPTNEMQQKSISRSEFIPLDIQSNQLTHYYTSDTPLSKIYLIPEPQASEFALN
GLVLENNNPGVIYSSIGVNGAKFSDYNKYPLFFEQLKALQPDMIVLSLGTNETFDKTVSS
EYMVQLNLFLENLKAQNINASVLVSTPPPSLFKRKFPNTFAADYSENILKSAEEKGFAVW
DLYSQFGGLYGVERNAARGLMSGDRVHYSKAGYEKQGNLLSEAFLKAYNNFKSGTEN
>LONDMIMF_02253 Peptidoglycan O-acetyltransferase
MTINSINDWFIQTFGAITLEQVKGWFIYNPKEPLLFNTGLFLGMFLIFYLVYAFLRKTFY
LRLVYVILFSLFFYYKSSGIYFLLLILSSVVDYNLSGVIYRENREGWRKFYIWLSVILNL
GLLGYFKYTNFLIGAYNDMFNGHFAFHDILLPVGISFYTFQSISYIIEIYRKEIVPTNNY
IEYLFFVSFFPQLVAGPIVRAKDFLPQIYQKLNLTKEDVNAALFLLIGGLIKKTVISDYI
SVNFVDRVFDAPTSYTAFENLMASYGYAIQIYCDFSGYSDMAIGVALLLGFKLPTNFRTP
YKSASITEFWRRWHISLSTWLKDFLYISIGGNRNGSFAGFLFPALFFFGLVVWGISYSTI
SHIPLIIAVSSLVLFSLTFILSKDRERTMFTNVNLLTTMLLGGLWHGASLRFIIWGALHG
IALAVHKIFLEFFPSKKDGEKNAFSYIWRFFSVLLTFHFVVFCWLFFRAKDFDTALQVIN
NIGQLTFDPKQWQIIIQGYKNVFLLMLIGYVWHFLPEGITRNMKLAFDKTPLVGKALILG
FVYWIVYATATAGPQPFIYFQF
>LONDMIMF_02254 hypothetical protein
MKYYLQLHDTIKNQASQLCNQFIIKVIAQKPLKDSKMKSSARITASSIVQFTNEVFLNTT
PTT
>LONDMIMF_02255 hypothetical protein
MPIGGQVATAIKIQRHHIIPKAVYKKSSKAIQEAFDLNGGFNLKKIPAPFHGNHPQYSIF
VTNQLNNLKEISPASIKNLQKELSSMINQAYDNYKSTGQNLNEYFRQLNAN
>LONDMIMF_02256 hypothetical protein
MKYYQIDRTGEPKIIGVTNGSAQVEVIEKAIDKNHNYLDFENHFSGYNLEFWQNQQRVYD
LTPPPIKGKILKKAKLTDIIEYGPNYHFLYKAYSEKYINIIRAFNIPRLKTFDFEIENIS
EKYHLLFFETVLLDEIDYEKSKVISGYKVLNNIKYHSVNNRDEYIAFNYNNPTGGFELIA
IPKKYLGKDIISIEASSLPFYSERLIDFLLDCKITGLQVAYNNSIQLEFV
>LONDMIMF_02257 hypothetical protein
MKYYQIFRSAEPKVIGIKDGTSQVELITKDILSDKSFIDFDNHFNSHNKDFWQSQDKIQF
LNPPTFTGVLRKKAKVTDIMQYGEMFAFLNYIYSERYYNIIKAFKIGQHKAFGFVIENVR
HPYYLLYFETVSLLEISHEKSLIYTGNSVLNNVQFHKVASYEAYVDLKKEFPLARFKSIA
IPEHYYGKDIIETQASGQPFYSEKLVDFLLDCKITGLEVNYNNSVQLEFV
>LONDMIMF_02258 hypothetical protein
MDLIGVLDPTGIVDGLNAIGYLARGQNTNAMIAAVGIVPYIGDLGKLTKYTKSSLKTGTG
LIDDVADVLSKGDYLRIQNAATRINKPITVVGSRASGTAKAYSDWDYVVPGLKSKNWSTI
KNSLPGSRSTLDNTPRNIDIFKGPLDPTKPHIIINPDLK
>LONDMIMF_02259 hypothetical protein
MKIEHEILVNKYGQELVNTEELSDLFRSFDISFQKVFLNEILFLILQSKPKEEDIEPAII
SSRLKSTHTPCVILKKGVANHNLEKLINLPENELTKAFVLLLSLFKIAYKRRFAIEKDNP
NKWWYWDLSDEANINRIQQNI
>LONDMIMF_02260 Penicillin-binding protein 1C
MIKRNPKKSVFFGLLFIAYYFCLPRTLFEQPYSTVIESEEGELLGAKIARDGQWRFPAQD
SIPEKFKKCIVYFEDEHFYQHPGFNPIAMVKAAKQNHDAGRVVRGGSTLTQQVIRLSRGE
KKRNYFEKLVELVLATRLEFRYSKEKILELYAAHAPYGGNVVGLEMASWRYFGVQPHQLS
WAETATLAVLPNAPSLIYPGKNQQKLLNKRNGLLKKLYQEKIIDKTTYQLSVLEELPQKP
YDLPQIAPHLLQNVARRQEGTRVKTTVKFALQNRVNQIATQYYNQYRQSEIYNLAIIVVD
VETRNILSYVGNSPTDKDHQKDVDIITAPRSTGSILKPLLYASMLDAGEILPNTLVPDIP
TQIAGYSPKNFDLTYDGAVPAHRALSRSLNIPSVLMLKDHGVYRFYDQLQQFKLRDINKH
PNHYGLSLILGGAESNLWDLTKTYAGLTSTLNYFTTHSAKYRTDEFKELNWLHGAKLDFG
KESYDKKNLGAASIWLTYNAMKEVNRPEGDEAWKFYDSSLEVAWKTGTSFGNRDGWAIGT
NSRYVVGVWVGNASGEGRPSLTGVGSAAPVLFDVFNLLPRKKWFTTPYDDLEEAEVCQLS
GHIAGEYCPKIKQWIPLKSKQTTVCPYHKLIHLDASGEYQVNSNCEEVDRMVAKPWFVLP
PVMELYYKTKHINYVPLPPFRPDCLGASSYSMDFIYPKENGKVYLTKNFNGEIQPFIIKV
AHSDQKAKLFWYLNDKFLGTTQTFHEMSVEAKTGKYYITVTDEAGNEISRRIEIVKE
>LONDMIMF_02261 putative lipoprotein YfhM
MRTGKLILLVSVFFLLNACRKSSPEDFDSDFSLFRDYVTSFSSGTISANSDIQVGLAFSK
AEWKPNQELDEDIFDISPSVDGKVVVLPNNILAFQPKKKLKQGEQYQVTLHLDKLIEVPK
ELSDFNFTVKTIEQDFKVEVQDLQSYTKDTQFLNMILKSADNMDLATAKKLVSATQNGKE
LPIKFNEKGSSPTEFSFVIDQIQRGEDDSKVLIKWDGDPADINQKGEKEFTIPGKNNFTI
VDVRIGDENNQSVRINFSDPLKKDQNFSGLVALETVGNLRYAVDGNVLKAFSDVALDGKL
LLEVFQGIENTDGYKMKKGYAAKITFEQIKPEVRFVKSGTILPSSHNLKVNFEAANLKKV
DVKVYRIFENNVLQFLQDNELNGNYDLRKVALPIAKKTLELTTNKLANYKKWNSYSLDLS
TLIKPEQGAIYRVEFTIKRSYSLYTCDTPAEEEPVAEEDEEPEDFSSYDSFDYDYYDYDY
NWNERDNPCHKSYYSNNKVATNILATDLGVIVKRGENGSYFFAVNNIVTTEPVSGATVEL
YNYQKQKLVSETTDGDGIVNFSTDKKAFFAIIKKDKNTTYVKLDDGNSQSVSNFNVDGEA
LQKGLKGFIYGERGVWRPGDTIYLSFILNDKSSRLPNTHPIKLKLSDPNGKVVYQKVQKY
TDKNHYKFAFKTQPNAPTGNYEAVVSVGGARFYKAVKIETIKPNRLKIKNGFDGKMLSAF
HKNDARVDVAWLHGAVAKDLKLEMQAKFTQQKTTFKNYSKYVFDDPARKFSTEEVNIYSG
KIDETGKANVSIQPRLQSQAPGMLKASFITKVYENGGDFSTDVISATYSPFQTYVGVKTP
EPNKYGMLETGKSNAFDVVTVDENGRPKAVRNLEVRVYKVDWRWWWDASDDLSNYSSSTT
NTPFYSQVLNTDGSGKARFQFKTTDDEWGRYLVRVTDPNGGHSSGETVMIDWPIWSGKTR
NTNGAEAKMLVFSADKEKYNVGEKAIVSFPSSEGGRALISLESGAQVVQTLWAESKKGET
QVEIPITSKMAPNVYIHITLLQPHASTKNDSPIRLYGIIPIEVVDKNTVLEPQIAMPEVL
KPEQKTTIKVSEKNGKAMTYTIAIVDEGLLDLTRFKTPNAWNSFYSREALGVKTWDIYDE
VIGAYGGKVNQIFSIGGDEDLGGGQAKKANRFKPVVIYLGPYSLSKGQTKSHEIKLPKYV
GSVRTMVVAGDAQTSAYGSVEKTTPVRNPLMILASLPRKVSPGEKVTLPVTVFAMEKHVK
NVTLQLKTNNGFRVIGNSKQTLSFAQPDEKIAYFDLNVGDLTGIGKVTVVATSGKEKASF
DVELDILNPNPVTQDYKELILEPNSAGTINWDAFGVAGTNTAKLEVSAFPSMDFNKRLDY
LIQYPHGCLEQTTSSVFPQLYLGDIADLDTARKSKIQKNITAGIQKLAQFQLANGGFAYW
QGNQTPDDWSTTYVGHFLIEAERKGYALPANLKKQWLAYQSKTAKQWRYNEGYRNDFAQS
YRLYVLALAGNPDLSSMNRLRETSGITNDTKLRLAATYALAGQKNVGMTLLGQSKIDEDS
MYGYYYYYGSSERNRAMALETLLLLGRKTEAFTMATKLAKEMSSNRWMSTQTTAYCLYAM
SKFAQQNGTKGIDVSFTSRGKSETIKTAKAFADRTLQVSGVGNTVTVKNNKNTTLYIKVI
TSGILPIGQEQTEQRGLSTDITFRDRKGNAINVASLAQGTEFVAEVTVSNTKGETVENVA
LTQIIPSGWEIVNTRFTDYGSFADNKVDYTDIRDDRTNFYFTLKSNETKTFRILLNASYL
GKYYLPGVQCEAMYDNSYYARTQGQWVNVVK
>LONDMIMF_02262 tRNA-specific adenosine deaminase
MENSNTDEYFMKKALQEAEAAFEKGEIPVGAVIVVENRIIARSHNLTEMLNDVTAHAEMQ
SITAAANFLGGKYLKNCTLYVTLEPCQMCAGALYWSQISRIVFGARDEQRGYMALGTKLH
PKTVVEYGVLEAEASSLMKRFFLEKRR
>LONDMIMF_02263 1-deoxy-D-xylulose-5-phosphate synthase
MSYTILQNINSPEDLRKLTEAELPVLAGELRDFIIDIVSVKEGHLGASLGVIELTIALHY
VFNTPDDLLVWDVGHQAYGHKILTGRKDNFDTNRQWGGISGFPKRSESPYDTFGTGHSST
AISAALGMAIASNLNGDFEKHHIAVVGDASIASGMAFEGLNHAGMTDANLLVILNDNAIG
IDPSVGALKNYLTAVKDGKNPRQNNMIKSLNFDYSGPIDGHDIGAVIKELKRLKSIKGPK
FLHITTTKGKGLEQAEKDQVKYHAPGKFDKLTGEIISKSEENLPPKFQDVFGLTLLELAE
KNEKIVGITPAMPTGSSLKFMMDAFPKRAFDVGIAEQHAVTLAAGMATQGMIVYCTIYST
FLQRAYDQVIHDVALQNLPVIFCLDRAGLVGEDGATHHGVFDLAYLRCIPNMIIYAPMNE
TAFRNMLYTAQLGLEHPIAIRYPRGRGVIVDWKKPFEKIEIGKARLLKEGNRIAILSTGF
IGNNVIPALANIDSPKDFSHYDFPFVKPLDEALLHTIFKKYDVIITLEDGAAKGGFGSAI
TEFAAQNNYTKRIKTLGIPDEFIEHGSIGELQRYSKIDAKNLQIIFETCRNY
>LONDMIMF_02264 hypothetical protein
MPVMRLSPLALGLFLFFSVSSFAQSVDTIQSKKLDSAIVKKVVTHWEKKNVVGFDLNEIA
FVNWSAGGNSAISGLLKGTFTRKYENGNLKWLNELIVRYGVSKQDGVELRKTDDAFQFNS
TFGYRKDTTSNWFHSAKFNFNTQFTSGYAYPNTEKAISKPFAPAYTFLGVGAEYNNKKYN
LQLYISPLTLKNTLVLDQRLADQGAFGVQKAVYDAVTGEKIEDGKNSRTELGFLFTSGYK
KELFKNINLENKLNLYTDYINNFGNIDVDWQVQLDFIVNKYVRANINTHLIYDHDIKAKE
EINGQQVTVGPKVQFKQMLGVGLIYSF
>LONDMIMF_02265 Deoxyguanosinetriphosphate triphosphohydrolase
MKYPKESLPKKPTSHISDKKYGFFQTDKEFFKEVAEELGMIPNKSGNDIGYERHPLAFLV
EAADDICYTIIDFEDGINLGLVSEDFALEYLINLVKDSIDTKKFNSLITKEDRISYLRAL
AIGSLISDVVKVFIENEELILQGKFHHALTEKSKYVAQMNDIIKLSIKNIYQSREVIEKE
LVGYQIIQTLLDKFITAFNNQFHGEASNYDRLLLKMLPEKFHDEKNDLYKRLLHICHYVS
LLTDGNALELFNTINGRKKL
>LONDMIMF_02266 Deoxyguanosinetriphosphate triphosphohydrolase
MMNWEQLLSLKKQGDKGKRLRKEQDDTRLGFEVDYDRIIFSSAFRSLQDKTQVIPLSKTD
FVHTRLTHSLEVSVVGRSIGRLVGKQIIEKYPHLREVHGYQPNDFGAIVAAASLAHDIGN
PPFGHSGEKAIGEYFKTGNGKQFQEQLSEKEWQDLIDFEGNANGFSLLTGSVSRFATGY
>LONDMIMF_02267 hypothetical protein
MLKDILKLDGVQELTKNEQTKVNGGGICPKTVEHFGVIGAAAHPNLFGLMCAKEIAANLA
LSKG
>LONDMIMF_02268 hypothetical protein
MSKQKKGVYTGIIEKDENGNYFCGPYLLDYQYTEANFKIGGEVNIKSVIENPSDKTHNQY
PKKSKNFFLANLKE
>LONDMIMF_02269 Proteasome-associated ATPase
MSTLYFRDRENVNLEDVVFEASVAGQVEQFLKEHRFSEILHQYELPVANKIFLYGKTGCG
KTMTAKAIAKELDKKIFIVNLSTIVSSKLGETAKNINNIFKEANYENSVLFFDEFDSLGQ
VRDYDNKDSSEMKRVVNALLQLIDNFPRNAILIAATNQIQMIDEALLRRFELKLEFISPS
EQVLDGYYDKLLARYPVKYQNVERKYGISFSEAKDFVFRQVKNNIILDEMAKLS
>LONDMIMF_02270 Ribonucleoside-diphosphate reductase 1 subunit alpha
MYVVKRDGHREPVMFDKITDRIKKLCYGLNDLVDPVKVAMRVIEGLYDGVTTSELDNLAA
ETAAAMTIAHPDYAQLAARIAISNLHKNTKKSFSETMKEMYFYVNPRTNQESPLLSEEVY
NVIQENAAFLDSHVIYNRDFNYDYFGFKTLERSYLLKINGKIVERPQHMLMRVAVGIHLN
DLDAVLETYDLMSKKFFTHATPTLFNAGTPKPQMSSCFLLAMQDDSIDGIYDTLKQTAKI
SQSAGGIGLSIHNVRATGSYIRGTNGTSNGIVPMLRVFNDTARYVDQGGGKRKGSFAIYI
ETWHADIFDFLDLKKNHGKEEMRARDLFFAMWTSDLFMKRVQEDSTWTLMCPNECPGLYD
VYGEEFEALYTSYEEQGRGRKTIKARELWEKILESQIETGTPYMLYKDAANRKSNQKNLG
TIRSSNLCTEIMEYTSKDEIAVCNLASISLPMFVENGQFNHELLFNVTKRVTRNLNKVID
RNYYPVPEAENSNMRHRPVGLGVQGLADAFILLRMPFTSDEAKKLNQEIFETLYFAAVTA
SMEMAKEEGPYSTFEGSPISQGEFQYNLWGLKDEDLSGRWDWASLRKEVMENGVRNSLLV
APMPTASTSQILGNNEAFEPYTSNIYTRRVLSGEFIVVNKHLLEDLVELGLWNEDLKQEI
MRHNGSIQNIDIIPQDLKELYKTVWEMSMKDIIDMSRQRGYFIDQSQSLNLFMQDANFAK
LTSMHFYAWQSGLKTGMYYLRTKSAVDAIKFTLNNDKKAEPVAVETVAEPAIAVDEFRAM
LERSKNAEPDDCEMCGS
>LONDMIMF_02271 Ribonucleoside-diphosphate reductase subunit beta
MAAIEPILQENKDRFVIFPIKHHDIWEWYKKMEASFWTAEEIDLHQDLSDWNNKLNNDEK
YFIKHILAFFAASDGIVNENLAENFVNEVQYPEAKFFYGFQIMMENIHSETYSLLIDTYV
KDEAEKDQLFHALEVFPAIKKKADWALKWIESDSFAERLIAFAAVEGIFFSGAFCSIYWL
KKRGLMPGLTFSNELISRDEGVHCDFAVHLHNHHLVNKVSKARITEILVQALDIEREFIT
ESLPVSLIGMNANLMTQYLEFVTDRLLVELGCARVYNSANPFDFMDMISLQGKTNFFEKR
VSEYQKAGVLNSGTGNDSESQKISFDADF
>LONDMIMF_02272 hypothetical protein
MFQLGKTIVSEDILEKEFVCNLSACKGACCVDGDAGAPLNEEETKILEAIYPKVKPFLRK
EGIDAIEALGTWIKGTDGDLETPLIDNKDCAYVIFDGKTALCGIEQAYNQGIVDWKKPVS
CHLYPIRIKDFTEFAAVNYDRWEICDDACSLGKELEVPVYKFVKEALIRRFGEDWYAELE
KVAQELKNQ
>LONDMIMF_02273 hypothetical protein
MGFDWREIFTASMVLFAVIDIVGSIPIIVDLRSKVGHIQSEKASIVACVIMIAFLFVGEE
ILKLIGINASSFAVAGSFVLFFLALEMILGIRLYKEDNPSTASIVPIAFPLIAGAGTMTT
ILSLRAEYEKINIIFAIIINIIVVFAVLKSSSKIEKLLGENGLSVIRKIFGVILLAIAVK
LFGANVKGLFI
>LONDMIMF_02274 hypothetical protein
MKIFTYILIFLALALIIFNITILDFDHLFEGDSVVGLIGIAASFCAIFILLIFRMSKMIE
EKTKDK
>LONDMIMF_02275 hypothetical protein
MFDVLIIGGGVSGMSCALVLGSAQNKAFAADKKIGIFTHQKASNLQDAVFNNAYGIPAGK
LGSELLEESKEQLASLYPHVQQIENEKVMKIEGAYPNFTVVTNKGSYQTKIIVVAINATN
TFAIEGLMEYVIPHKKAIAEKNRIQLKNEDHFVADGIYVAGTLAGLRSQLSIAAGSGASV
ATDILTLWNNGTHSQVHDSIRK
>LONDMIMF_02276 Carboxy-terminal processing protease CtpB
MKNNKIYLPLVIFAALAIGVVLGGMLNFPTQGVAFSKTSPKNKLNKLLDFIDREYVDNVN
TDSIVDLTVTGILDKLDPHSVYIAKNEFEQVSQSMKGDFVGIGVNFYMYNDTVAVIKPVE
GGPSEKAGIKSGDRILFADNYKLFGRKITNDTLFSKLKGSVGSDVELTIYRKNENKKLKV
KVRRDVIPIKSVDIAVMVNPGVGYIKINRFAETTYDEFESGLLSLKKQGAKTLIIDVRDN
GGGYLDKAIEIADDFLKDNALIVFTKNKKGRVDKTYATNDGSFETGKVYILINENSASAS
EILAGAIQDNDRGLIVGRRSFGKGLVQREMPLGDGSAVRLTVARYYTPTGRSIQKSYEKG
SEEYFKEFEKRFESGELYKSDSIKVADTLKFRTPKGRIVYGGGGIVPDIFVPLEVEHGEE
SIAYMMQSGLVGYFAFEELDKNRNDFKNLTFQQFLTKMQQTDSYFNTFQKYLIKNGVLLD
LKHTKNLVKRYLAAEFARQLYGDDKYYEIVLKEDAMIKAVLENKQEIN
>LONDMIMF_02277 Riboflavin biosynthesis protein RibD
MNLNKLNKYDKAYLRIAKEWSRLSYCKRKQVGAIIVKDRMIISDGYNGTPSGFENSCEGA
DGLTLWYVLHAEANAILKVAGSTQSCEGATLYITLSPCKECSKLIHQSGIKRVVYQEGYK
DDSGIQFLKDAGVEVVHISETEMNEKQ
>LONDMIMF_02278 hypothetical protein
MSKIRITKQFSFETGHALYGYDGKCKNVHGHSYKLSVTVIGTPISDTSNVKFGMVIDFSD
LKKIVREEVVDVFDHATVFNKNTPHVELAEELRNRGHHVILVGYQPTSENMVIDFAEKIK
SRLPENIALHSLRLQETETSYAEWFQSDN
>LONDMIMF_02279 Short-chain-enoyl-CoA hydratase
MTTERLNGSLYTVIENKIATVEFGHPASNSFPGELLQRLTDELNNLSSNPNVNLIILKSE
GDGAFCAGASFDELLAVSNLMEGTSFFSGFANVINAMRKCSKLIVGRIHGKAVGGGVGLA
AACDYAFATVDSAIKLSELAIGIGPFVIEPAVSRKIGKGALGEMTLAAHEWKNAYWAQEK
GLYAKVFETKEDLDKELEIFTSKLASYNPEALSEMKKVLWEGTENWDTLLYERASISGKL
VLSDFSRNALNQFKK
>LONDMIMF_02281 Regulatory protein AsnC
MNKFRLDEVDHQILDMLIDNTRVPFTDIAKKLLISAGTVHVRVKKMEEAGIIMGSSLTLN
YEKLGYSFIAYVGVFLHNTSQTKFVLERINEIPFVTVAHVTTGKFNIFCKIRAMDTKHAK
EVIFMIDDIEGVYRTETMISLDESINDKKRLMHTIFKDM
>LONDMIMF_02282 hypothetical protein
MDFEKVFRENKEKTLEGRYITLDKIEPLLRTINKNDNLDVIGKSVLGKPIYSYTIGTGKI
KILLWSQMHGNEGTTTKALFDLLNVLNSDTILGKELLSHFTFLAVPMLNPDGAERYTRIN
ANGIDLNRDFQDLSQPESRLLRELYNNFKPDFCYNLHDQRTIFAAGDVNKPATVSFLAPS
FNDAREVNEVRIKAMDVIVAMNTTLQSFIPGQVGRFDDGFNLNCVGDTFTYLGSPTILFE
AGHYQRDYEREMTRKFIFIALISGLEYIYENDIVLNETEKYFNIPQNKPVFYDFIYKNIK
IYYDNKQIITNFAIQFTEVLNEGKIEFIAFIVEIGELTQNFGHFEYDAKGASYSDDQDNI
PKLGQKAEFYLSEKVKIVNGLPNV
>LONDMIMF_02283 hypothetical protein
MVNTEDFIKRLEKILDYYNLTASSFADKIGVQRSSISHLLSGRNKPSLDFILKILDVFPE
IDLYWILNGKGSFPKNNEEDNAAPTLSDTDEKQPVNFKKEETIIKNDTIERIVIFYKNGA
FKEYRPQLTA
>LONDMIMF_02284 hypothetical protein
MRKKLLLAGLFCSILGFVSCSSDDDSNGNPGSAKLELFTSSNTSGTITYTDLLASMPMAK
TFTVGSLDADGIYYNNTRDEVIIASRTNNRLEVYGNFRNALSSSATSLTMTASSATGDFT
NAREIAVVGDRVVVVQDQAEINGNTNKLLVYQRTTSGFTLEKTFTVGFKLWGITVSNGNL
YAVVDLSSDIAVFNSFFSKPNGTLVADKRVSIEGLTRTHGIAYSEQDNVMVLTDVGLAAS
ATDGGIVVIENFNSVFSSTASGGSIALSKQKRIYGPNSLLGNPVDVSYDEQTNKIYVAER
LNGGGQVLSFAYPTSAQSDVMPLTARLEPGVTGIYLRRE
>LONDMIMF_02285 1-acyl-sn-glycerol-3-phosphate acyltransferase
MKRIIYKLIFFKIMGWSIKGTMNPEIKKSIIIVVPHTSWHDFYIGLFARGIINLEMNYVA
KKELFKFPFGAYFRWMGGAPLNRNSRQNTVEAIAEIFKKREVFRLAIAPEGTRKKVTDWK
TGFYYIALKAEVPIIPVAFDYAKKEVVLNEAFYPTGDIQKDFAELKSKYKGIVGRIPGYS
FEI
>LONDMIMF_02286 Polyamine aminopropyltransferase
MGKLSFVLKKILSYLLPINVYKQHSPVSKNLEVTWANGELVLDSKNTNYSYGSLQRILRI
GLENIGFETVLKAEHILVLGVAGGSVIKTLSEEIGFKGRITGVEIDSEVLQIANSYFGLD
KIPNLEIIVDDAFKYVLTDKNKYGLIIVDIFQDTTMPDFLFEDSFQKQLCELLDKKGIIL
FNTMCLTDNDRLRNKEYLSNINSEFYTLRTIPRIERYNELIIIEKK
>LONDMIMF_02287 hypothetical protein
MKRLSLIAIFAFAFAACDKDDGKSIVDCLGESLFLNAHHSISSENPMQVNYSVTYEGSHT
LNNTVKWDFGDGTQQTVTGTEVSHTYSQPGNYTATVSVKVSVNGSTCSSDLHEHVTIQ
>LONDMIMF_02288 3-deoxy-manno-octulosonate cytidylyltransferase
MKIIAVIPARYASTRFHAKLMQDLGGKTVISRTYEAAVSTQLFDDVFVATDSQLIFDEIV
SNGGKAIMSKKEHESGSDRIAEAVEDLDVDIVVNVQGDEPFINKEPLEKLLEVFRNDEAR
QIDLASLMREIKDREEIANPNNVKVIVDQSGLALYFSRSVIPYPRDENAGVRYFQHIGIY
AFRKPALMDFYSLPMKSLEASEKLEQLRYLEYGKKIKMVETTHVGIGIDTVEDLEKARKL
V
>LONDMIMF_02289 ATP-dependent RecD-like DNA helicase
MNAAFFYKTLKSKFPYQPTVKQDIFFQKIAEFLTNDKQDEIFVLKGYAGTGKTTVISTLV
NNLTEINKKYVLLAPTGRAAKVIANYSQKPAYTIHKKIYYPKTKSGGVTFTTQQNKHKNT
IFIVDESSMISDSGNETSMYENGSLLDDLIYYVYSGVNCKMILLGDTAQLPPVNLDISPA
LDINLLHRNYDMEVSHIEFDEVMRQEENSGILFNATELREQLEEDFFEDFKFDVTHFKDI
VRLTDGYDIQDAIHTAYSNYGLEDTAFIVRSNKRANAYNQQIRTRILDKESELSTGDFLM
VVKNNYFWLKDSTETDFIANGDIVEVMEIYKMQELYGFKFATVKIRMVDYPNQIPFETVL
ILDTLTSESASLTYEESNRLYQEVMLDYEEERTAYRKFQKVKENRYFNALQVKFSYAMTC
HKSQGGQWNTVFVEQPYLPNGIDRDYIRWLYTAITRAKDKLYLIGFKDENFIE
>LONDMIMF_02290 hypothetical protein
MSANTNITEKKYRKLSIQVSLNGFRFCCFDTLNQTVLFVKEVDFNDFEKSIKVEDHYWQA
FVNHKELTATYDEVVVLHENNLSSFVPKAMFDENYLGSYLQYSTKVFESDFFAFDVLEPF
DMVNTYIPYVNFNNYLLDQFDSFDYLHVNSILVQKLLENSKNVSETQLFVHVGKEHFEIV
VIENQKLLLFNSFEYQTKEDFIYYILFTAEQLKLNPETFKLQLLGEISEESDLFKIAYRY
IRNISLMNVFHTQKHNDFSTLENLKYFILFNS
>LONDMIMF_02291 Ribosomal RNA small subunit methyltransferase D
MRIISGKYKGRRISPPKGLPVRPTTDMSKEALFNVLNNYFNFNGLKVLDLFAGTGNISYE
FASRGCETITSVDGDFGCVKFIKQTADEFGFGIAGIKSDVFKFVEKSKAAYDIIFADPPY
DLDQATFEKLVELIFANELLEEDGMMIIEHSKYTKLDHMINFSFKKSYGGSVFSFFEINS
GEDEELKNEAEITEDDEG
>LONDMIMF_02292 hypothetical protein
MKIRLVVLTVLLARYPSFAQKTENDTLNQMEEVVIEGNTKTFIYKNGNVKIDIANSIHKT
VSNTLDLLSRLPKIQISPDREKITVIGKGTPLVYIDNQKVEMNDLNALSVEDIKTIEIID
NPSSKYEAEGRSVILITRKRNKKEGYQLTFLETAAFKKKFNNYLGLNSSFKLSKTEFKAN
FNYNGLNPWESNGSDYKIPANNIQSDYRVAGYTNRDKYVYGVGVYHKINEEEDFSFTANG
TSKNDDFDFSTKTNSKIGEEQNRIRTLGKSKEHENFINSFLNYNKKITSWEASLFAGLQY
SNYNSESFTSALNNYNETSYEPFQQTQDGFNVNVFSGRIDFEKKFKNEMKWETGAQYSSA
IAHTDLDIKNFEQDLASNSKYQLKEKNTVAYAQLSGTLMKISWMAGVRAENTKIFGRYEG
EPVSIDKNYTTLFPKAQLSIPIDSTKTLNLNYGRSISRPDYSSTSQGLTYINPYFAFATN
INLNPSITSEIAANLQYRDKSVKLSYYENSNVINYGFLYNESQNLLIYRPQNFEKETGYN
LEFMLPFSSNFWSSTNIVSFILNKIEDSSAVIGDTKPYAYYYSNHVFKLKNELQFSLTGW
GLTSRNEGVFQRNSYFQLDFAASKTFFKNLSCTVNYNNVFRNRTFTENFEVSKVRSNAIF
FVDNCEFSIAIRYTLGKIKDSIYKEKEVNENSGRIK
>LONDMIMF_02293 hypothetical protein
MQTKRVFIIMLLFSKIYSYSQKIPEDFGYRHIAMKYQDDPVDIIVISKKGEEKLAKPVFF
FCQGSLPQPVVKYDEKGLYGTLPFDENSFLETYHIVIVGKPFIPIISDVNKLGKDYMYLK
DIEKEIPPKGYTERNYLDYYVFRNNFIVKQLAKERWVKNKKLVVAGHSEGSSIAAKMASI
NKKITHLIYSGGNPYGRIMNILAQSRSFDTDSIDEGKNTIEHWKKVVAHSNDTSLTNGDT
YKTTYSFSLPQKDNLMGLKIPVLVSYGTKDWSGPFNDLFQIEAIREKKDNCIFKSYLNLE
HNYFPVNEDGTVNYEVYNWDKIAADWLNWLNNSDNEN
>LONDMIMF_02294 Sensor protein kinase WalK
MVLQSVSMKKKINLLIGFSALVLVVLSAIQYYLVKTTYEYKVEQFRSEIKAKIAKITNDY
SDIDSTIFSKKDLLYKQLAENYLRDKSTRFHIKNALLQNEFKSELTRKLQEEFENEIPNL
TIDFAIVLDKFVIYDATKEADTIFAEKPFIENKLYGDLASLDDAFLIRNYVGTTSGSFKK
QELNSDYKLLTEDTLYVSIKNWEYIVLKRMALILIFAVFSILTLITLFVIALKALIKQKK
ISDIKTDFINNITHELKTPLTTLSVSTKILERKEIRENEETYNTVLGTIIRQNNRLQNLI
DQVMTNSLGYEEIELHKEKVLMPDFLNSIINDFQIAYPDILIEKMLDSKKISINLDKFHL
TTAITNVLENAVKYGCTNIKVTSSLQEGQFAISISDDGIGISKNKHSLLFDKFYRVEQGN
LHDAKGLGLGLYYVDQIIKAHQGSIHVISDLGKGATFDLRLQVSNG
>LONDMIMF_02295 Alkaline phosphatase synthesis transcriptional regulatory protein PhoP
MAITIKKVLLAEDDFDFAMILKQYLDLHNFQVFWAKDGEEALNLFQNEEFSICIFDVMMP
KIDGFTLAEKIIKINPEVPFVFLTARKLKDDKIKGLKLGADDYIAKPFEADELVLRLNNI
VRRSEKTSLPVSEEIRIGDYVFNPQRLELKIGETIQRVTEKEGSLIFFLYKNKNQLLKRE
EILKAVWGNDDFFSGRSMDVFISRLRKYFGNDPKISIESIRNIGLEFKLKQ
>LONDMIMF_02296 hypothetical protein
MDHQMYHYATVSKALEELAEKGFTVDFNLEADRIKDCGDCFEIVHIYRYEGATDPGDEAT
VYGIKSDKGEKGVYVSGDLSFSEDEAAQTLHELVIKGRQPSE
>LONDMIMF_02297 hypothetical protein
MNRLEAKLQKIGSNPKVTAQSVGLRYAPQMHKGYYRIKDKNNAFVYKDENNTIIKDKSVI
ERIKKLVIPPAWENVWISPYENGHLQVTGIDARGRKQYRYHPNWNKIRNQSKFYRLRRFA
NALPMIRKQIEKDLNRKGLPYEKVVALVVKLIELTHIRVGNDAYKKLYGSFGLTTLRDKH
VKFSNSSVYFEFKGKKGVSHKISLQSRKLANLVKKCKEIPGQELFQYYDDQGKHHSIGSA
DINNYLKEITHEDFTAKDFRVWAGSVHALFTFQEIGQFITVTECKRNIVSVIDDVAKKLG
NTRAVCKKYYVHPTVIASYEKGSIWNYKVKANIKNNKLNPEEEALVRLLKKETIAEVLG
>LONDMIMF_02298 hypothetical protein
MKKTIWLFMGIGFISCSDKKAKTIETTPVSDTIAETILVKATDKKQLIVPGKSIGLTHLG
QNAETLAALGRPDFSDAAMGKAWSTWYSKDDKKNELNIYTTYKNSEMTEKVIRLIRITSP
EFKTEDGISTGSSINTIRNSYPKLVLCGKYKDAEGTVEIYDAVDLGIAFEIRKENCISII
VHETGKKVTDEYITFHPDMERF
>LONDMIMF_02299 DNA polymerase III subunit tau
MEHFVVSARKYRPQTFKDVVGQQAITNTLLNAIENNHLAQALLFTGPRGVGKTTCARILA
RKINQEGYDDPTEDFAFNVFELDAASNNSVDDIRNLIDQVRIPPQTGQYKVYIIDEVHML
SQAAFNAFLKTLEEPPKHAIFILATTEKHKIIPTILSRCQIFDFKRITVKDAKNHLADVA
NSEGITFEDDALHIIAQKADGAMRDALSIFDRVVSFSGNNLTRLAVTENLNVLDYETYIN
MTDLILENKIPELLIAYNEILSKGFDGHHFIAGLASHFRDLLVSKTPSTLALLEAGEQAQ
KMYGLQAQKASQDFLLKGIDLANDCDLKFKSSQNQRLLVELCLMQLASITFDGEKKKLTD
I
>LONDMIMF_02300 hypothetical protein
MEKVNSTIVRHEAELPKEPFTETDMLLQWNKYAQRLGDKGYKILEALLLINDPKLKGTTI
YHELPNEGSKIEFESEKHDLLGHLRGKLHNYDIQIEVVVNETVENKFAFTPQDKYNRLNE
INPSLDILRKTFDLDI
>LONDMIMF_02301 Guanosine-5'-triphosphate,3'-diphosphate pyrophosphatase
MITIRKYAAIDIGSNAMRLLIANIVEQKGKETQFSKSSLVRVPIRLGQDAFTVGEITEEN
IERMVDAMKAFKLLMKVHKVEKYMACATSAMREAYNGKEVVDLIKKKADVKIEIIDGKKE
AAIIASSDLHHLLKTDQTYLYVDVGGGSTEFSLFTEGKIVASKSFKIGTVRLLNNMVNDI
VWQEIEKWIKHVTEDYEHINMIGSGGNINKVFKMSGKLQEKPLSYMYLNSQFSFLNGLSY
EQRIAELGLNADRADVIIPALKVYLNAMKWSGARNIYVPKIGLSDGIVKAMYYNKI
>LONDMIMF_02302 Polyphosphate kinase
MIPPTDYRYIDREKSWLAFNARVLQEAADKNVPLLDRLRFLGIFSNNLDEFFRVRFAAIR
RLSHAGVSGEKLLGGISSQQLVKDITEIVIQQQSESLRILSNIESELENENIFIINENEI
SREQENFIKDFFIQKVSPALVTIILNDLAEFPVLKDTSGYLAVKLVMTKPKSTTKIVVKD
TVLKIKKPKKDVRYAVIEIPKTINRFVVLPSSNDKQYIILLDDVIRYNLGSIFNIFDYES
ISAHMIKITRDAQLDIDSDQSKSLMEKISTSVKDRRIGEPVRFVYDQSIEKDTLKFFLNK
MGIDSTDSIIPGGRYHNRRDYMDFPNLGRQDLLYQSNVPLPVDGLSLEGSMLEKIAKKDY
LVNAPYQSFSYLIKFLREAALDPKVISIKITLYRLAKNSQIISSLINAAKNGKKVTVQIE
LQARFDEASNISYAEQMQTEGIELIFGIKGLKVHSKICVIERVEEGKVKRYGLISTGNFN
ESTAKVYTDVTLFTSHSKILKDVAKIFDFFDINYRVHRYKHLIVSPHYTRTRFEKLIDRE
IANAQEGKEAHISLKMNSLSDYGMIDKLYDASRAGVKIRLIVRGICSLIPGVPGMSDNIE
AISIVDNYLEHSRVYIFNNDGDPEVYISSADFMTRNLDERVEVTCPIYDESIKQELIDTF
NIGWKGNVKARLHSEKLDNLYRVRKDAPVFRAQLETYNYYRNKLEVIAENLN
>LONDMIMF_02303 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase
MKNLILIRHGKSSWNAPLLDKDRPLASRGMQDAHLVSMEIGKHLPKTFTILSSTAKRASE
TAIIFAQNLSCPIESIIFKDELYTFDDRQLEKIIKSCNNDYDNVILFGHNDAITNFVNKF
GNVFIDNVPTTGFVSINFQSNDWQSIDKGKTQQVIFPRDLKKYDSTN
>LONDMIMF_02304 hypothetical protein
MLAKSGSLAALTISSVLPPVLFGPIADEAFPVVSNNPSSIGKVEVALLK
>LONDMIMF_02305 hypothetical protein
MLELTPLPPLPPPAGAAPPLKVVPLVPARAFPADEPPPPPYMVIKEDPSAPSPPERLKSP
ILAAAAPPLPPPVVLFATLSPPLASRVVFEPNHESPPAAVEVLPAPTVTV
>LONDMIMF_02306 hypothetical protein
MKDIALKFSVLIFFLFNSLSVLAQNPEEVPEEVDGPSAPISDHLWLLALIGLVYIFFKYS
PKTVKAKS
>LONDMIMF_02307 Carboxypeptidase T
MNKTTLLGVLCLFVMGITQGQVVFENKSPLEKAQHYLKEKGEVVFTFQAQSKEQFKELAR
FLSISHKRVDQNELKVEAYANPEQFEKFQTYGIPYEVSVSENEFIADEYLAYGTSAWDDT
WNAYPKYSEYVAKMQYWANTYPNLCKLQSIGTTPNGRTLYVLKISDNAQVDEAEPEFLYT
SSMHGDEITGYPTMLRLIDYLLTGYATNSEISDIVNNTEIFICPLANPDGSYKTAGNDTM
NSTGNTATRANSAGVDLNRNYPDPIDGLHPDGYAYQPETLAFMEFEKTRNFVLAANYHGG
AEVVNFPWDTSTTPSTSNFSIHPHDNYFKFVSKEYAQLCQTADGNANYMDDVYNTGQFAG
TTNGAAWYSVYGGRQDWNNFFNHNKEMTIEISATKFPSAANLPFYWQRNRQALLNYMKQA
NYGLKGTVKNSAGEAIDAKVYINGTDLMGSWVKTGPLGDYYKVMIEGTYNVIFEAPGYIS
QTQSVTVSNNAATVLNVTMVPSTTIPTANDKTICEGQTAALTATGTGTIRWYADNTTSTV
LATGTSYTTPALSANKSYFVERETPQTVGPATVSGGSAVNNTNSRNKYMIFSATAPSKLK
TVTINTSSAGEILVELQNSTGTMLESKMVKLTASGTQEIDLNFFVPAENNMRLVLRQISG
FNIYAANSGITYPYSNGIVSITANSGTGTFLPFFNWKFQTFKSVRDEVIVTVKPNPAITT
ITPNTKVRGEAGFTLTVNGTNFVNGESIINWNGTNKTTTFVSSTQLTASISASDIAASGT
VEVKVFNTCNNFSSTAANFTITAPTSTTWNGSSWSNGAPTASLDAIINGNYASGTNGSFT
TRSLTLNSGYTLTVNTGSSITISDAIVNNAGAANFIVESNANLIQTNNAVNTGLITVKRN
SAPLYRFDYTLWSSPVSGQNLRNFSPATLTNRFYVYNPASGNNGNYEAIFPAQNEGTYTF
AQAKGYLIRVPDNYVSYVNSSIPGISYNGVFVGVPYNGSFSFPLSNANNGFNLVGNPYPS
AISISGLFSSNSNAIDGTVWFWRKRNGVAGSGYATTTGLGITSAQPEVAGMNPNGIISSG
QGFFVKVKNGATQSSLNFNNAIRSAATNGVFFRNGNTNSDEPEKHRIWLNLSNETDIIGQ
TLLGYMAGATENVDYGIDGKYFNDSPIALTSYIDNSEYAIQGRSLPFSTNDVVPLSFKTN
VSGSYSISIDHLDGLFEANQDVFLKDNLTGQIHNLKIAAYNFVTESGNFTNRFEIVYRAA
LGMETPTINSNSIVVYKKNEMLYIDAGNYMMEKIEIYDVSGRLIYSKSEVNDTKTVISNL
SVANQVLLVKIVTSENGTATKKIVY
>LONDMIMF_02308 Inner membrane protein YedI
MASGIFAVLDDIALLMDDVAMTTKLATKKTAGILGDDLAVNAEKATGFLASREIPVLWAI
TKGSLLNKVIIVPIALLLNAFLPLAIIIILMFGGAFLAYEGVEKIVEYLFHRKTASHDAP
AVEEVRNDRDAEKTKVRSAITTDFILSVEIVIIALGSVLTEPLTVQIITVSAVALIATVG
VYGIVTLIVRMDDAGYNLIRRSKEKSFLFLIGTLLVKSLPLIIKGLAVVGTVALILVAGG
IFVHNVHFLHELFPSIPSIVKEFGIGLVVGIIVVVLVTVVKKIFGKKTSA
>LONDMIMF_02309 hypothetical protein
MKQEDFTTSFTVDATPRKVFDAINNVRGWWSENIEGPTDKLNGEFSYHYMDVHRCRIRVT
EMQPDTKIVWHVLDNHFKFTKDKSEWKDTYVIFEITEKNGRTEMKFTHQGLVPTYECYQV
CQDAWTYYIQESLKMLVETGKGQPTPKETESVAVTKQNNNPSDTKSIYHKLLIKSPLEKV
YQALTTQEGLAGWWTPDTIAKPEVGSILRFGFGPEYFKQMEVLELKPYSFIKWKCIKAFE
DWIGTTLTFELEAHQKGCTLLFHHDGWEAYTPEMASCSFDWALFFRSLKFLCETGKGFPY
PDFDK
>LONDMIMF_02310 HTH-type transcriptional regulator CdhR
MKHLTILVPDTQAGPNTLSCIIGAYHIFTEANNYYIRQHKDPVFTIEMAGVSEQSNFVNG
LLTVMPQKGINSIPKTDLIIIPAILAAFKKVEGGNVLLVDWILEQYKKGAEVASMCTGAY
ILASTGLLDKKSCSIHWNAAANFKQLFPKVNLKAEKLITDEQGIYTNGGGYSFLNLIIYL
VEKYYDRQTAIYCSKVFQIDIDRQAQSDFVIFNGQKTHGDEVVVKAQEYIEKNFTEKISI
EELSKKFTVGRRNFDRRFIKATGNTPVEYLQRVKIESAKKELETSRKTINEIMYEVGYAD
VKAFREVFRKITGLSPLEYKNKYNKTGVVAEL
>LONDMIMF_02311 hypothetical protein
MIKKSVPEYRLFCISNYGVAQGNKPLKTSKVDPRVELLSITFRLADAEEFKSTYLLQPNY
RDENVDYQPNYKYFSIPQ
>LONDMIMF_02312 Oxygen-insensitive NAD(P)H nitroreductase
MNFLDLAKSRYTTKSYNPNKRISEETIAELKEILSLSPSSINSQPWKFIFISDEKLKSEL
AGVSYFNQQKINDASHLVVFSVIDDIQLFENQIRQNLPEGSVNYYNQFLKPKPESEIKSW
LEHQVYLSLGFFLSACASMDIDSSPMEGIKNEEYDKILQLDGYRSLFAVAIGYRNPEDFN
QPSVKAKSRLSLEQTIQSF
>LONDMIMF_02313 putative HTH-type transcriptional regulator YybR
MYCIDDKKYPCTTSLTMKYIGGKWKAVILIHLIRKLRYSELRKELPMVTERTISLQLKEL
EEDGLIKRTVHTSKPPLKVEYELTEFGTTLIPLLQAISEWGRETAKSNKRIDIVA
>LONDMIMF_02314 Putative aminoacrylate hydrolase RutD
MKLSALLSFAVILFTQVVTAQQMFPYERDISNKENYILKEISFKAAEKKDSITIYGTLAM
PKSGFEKLVIIVPGSGADTQYSHYKLTDKLLQHNIAVYRYDDRGTGKSGGKNNSANYTID
QMSAELYNAFKVLKKTTELNGKKIGMLGHSQGGMVTMGAYKLGAKPDFLIQWATPVQKHG
AFLKYQLTKRPERFTDIFKYETLEEKLTVMESLHKVAEENPELDSWPLSKKLDKVSKKIG
YDEKRYTRFPYMTLTSEKAVVQKNLEPLYKNADFPLLYIVGSADDFVDANAETALLKNFA
NPNITVKVYDKLNHYLGNTLLTSESMYAINETPANEIANWIKNL
>LONDMIMF_02315 putative lipoprotein YiaD
MKKGILLLALTSMIFSCNKKSEGDQNTEVATEQVSEKNNHPETEKKFNIEDIAFSNASIG
DFPFFTLPQGLTQQNKPLEKKFDVCYFPVDGIMTPFEGRLYKANITSKPDEEFSQRYFEK
SLEDYLTSVGAVKVFDGKISSEEYDRYNKQDPNKGDEGDIGYADEQIKFYIIRTKDKGNI
YVQFSANNAAGKLNILQEEAFKQTITKVTADEIAKDLAEKGKSILYINFDVDKSTILPDG
KEIVKEIAGALKENSSLKIAIEGHTDNSGNAAHNKKLSDDRAKAVLSALTSQGIDQSRLS
AKGFGAERPLVPNDSESNKAKNRRVELVKIK
>LONDMIMF_02316 hypothetical protein
MDKVRNQTRTTLLDVCSIAFLILFPHLAPLPFYSYAVICLLLIWFLLRKKGMSFRDLGLS
KSRFTPKTILAGIISGLVWVVFMQFIYIPVIKSLFVVPDYTEYNFIQGSLSKLIMTISAA
WLIGGFYEEIVFRGYIQSLFEKWISKSSRIPWSIIITSLLFGLYHWQQNTFGIIAATLGG
LYWGFLYRKYNNNLWIVILSHALFDTITLLLIYTGVFGNLA
>LONDMIMF_02317 hypothetical protein
MYLTISGEVVTITINLIVFEMDNLFFISLNIKTASGFENYATYNLGSNKEKAKAIFDQLH
GSLDISDKTVLTMDFTEMKDGIPLPIAMLDCTFDQIICNTRIITREIFKNLNLEEE
>LONDMIMF_02318 Iron transporter MagA
MSSQLFSGIAVLSFVLLLLILLLRRLKQPYFIAYIASGLLLGPKVLNIIHSPEVVSELGE
IGIVLLMFSIGAHIDLRNLSKNFYKPLLIAFVQVALSFLFMYCIGKQVGWNINTIVLTSF
IISLSSSAIVFQYLARTGEIKSQLGIITCGVLLMQDILVVPMILTLNFMSGSNASMQDLV
KVCVGGILILLFLRAAITKKLFRIPMRREIIADHDLQVFIGFCICFGMAWISSWFGLSHA
FGAFAAGIIIGRDKATRWLEKSFIPFRVFFMAFFFLAVGLQLDIRFFVENMDTIIMVTVS
VLLINSLINSLLFKLTGNNWRDSIYGGALLSQIGEFSFMLATLGASLGLVTSYTYQITLA
VITFTMLLTTIWLTIIQQLIYRLPIAKNIKI
>LONDMIMF_02319 Spore protein SP21
MNLIKRNGNHTPGFHRSFFDDIFGRELFNWENNNFSTTSTTLPSVNIKETKDTYEVEVAA
PGLEKNDFKVTLDGNLLTISSEKENKQVSEQQNFTRREFSYQSFQRSFELPKNVVDEENI
SARYENGLLLLSIPKKEEAKQKPPRMIEIQ
>LONDMIMF_02320 hypothetical protein
MAKDHVGHNEIAQFAKDRVNLPPDWASDYRAQAARLREKLKIYLAEHPDFTLRKMLLSGS
LAKGTALRSLNDIDVAVYISGSDVPQDISALMDYLAEKLRAAFPNFSPDQVQPKTYCVTV
SFRGSGLDVDVVPILYSGDPDWYGDLVSQEDGSFLETCIPRHLEFIRTRKQKQETHFAQV
IRLIKFWVKKMKTENANFRFKSFMVELIMAKLLDEGKVFSDYPEGLQHFFTYLAKSDLSE
LVSFEDYYSKSKIPTFSNPVRIIDPVNPKNNAAKLYTRAQADLIIEAAIDAGDAIDAALA
ATTKEKTVYYWQKVFGSTFNV
>LONDMIMF_02321 hypothetical protein
MSSSFTNSTTGTFTVTHAKHLASKVAADLKRIQRFYNEPSDASIAQYESELIEFLKAGYL
EEVVYGFKKDGKWIVPTVRYKAKDLTNMMYADDDDPGKIVPNANISGASFSSFMSYKWEY
HMLDDVEKNKFKALLPFQRTTGTSPTYSGYMSQDKSYSSGSRGLDRSSLKNL
>LONDMIMF_02322 ATP-dependent zinc metalloprotease FtsH
MEQSKPQFSELFEQTILYPDPEMKSRLDLLVGLDEKKLRMSKILGLLVNPDGFLQWIKKH
HEGARGISNAVLRRPPLIILAGDVGAGKSELAVTIGDLVARQEKIDVELLPLSLASRGQG
RVGEMTQLISAAFGYTIEKAKKLQNGSSKSNGAIILLVDEADALAQSRENDQMHHEDKAG
VNAFIRGIDSLGNGRLPAAVIMCTNRPESLDPAVRRRAAEIFIFNRPDEQQRAAVLSNPL
TELGIDAPTIQKIVELTGASGGRNYGVTYSDIMQRILPSIVLDAYPDKSVTNESALKIAE
SIAPTPPFNEN
>LONDMIMF_02323 hypothetical protein
MAEWNLSTLLRSLHDDIHQKLETARKSIGHSVSKGDASEGVWLELFNEYLPQRYKAIKGF
IVDSKGNFSEQIDVIIIDRQYSPFIFTFKDLLVVPSESVYAVFEAKQSLTAETIQYANDK
IASVRALERTSLPIPHAGGTYAAKAPHHITGGILTFECDWKPAFGKSLNSALDKAPNIDM
GCVAAQGYFYQNDLDKTIYELVPDGKPATAFLFKLISDLQFKGTVPMIDVLAYSSWIID
>LONDMIMF_02324 hypothetical protein
MSFKQSEMLYDDGKHYKWVAKADHDNPYYTGGKDRTELNRTEGYEVLYFINHIGGKHWNV
VLGTTTYQKIEKMIRYSVPSPIRSHKGIADWIVSNWNNVNY
>LONDMIMF_02325 hypothetical protein
MGNLVWYLAYGSNLASSRFNCYITGGMPAGSGSDYKGCLDTTLPKETKNAVISHTLYFAK
NSKTWQQGGVAFITPSETDSKTYARLYLITKEQLADIAMQETNSNERPELDFDFAERNGR
HIFKSPSWYGLLLYLGEDSGMPIFTLTSTVQIEPKVKPSREYLATIMKGLIESHSLTLGQ
VYNYLSDKAGIGENYKHHELYDIVHNRYDPASE
>LONDMIMF_02327 hypothetical protein
MESKIRYELEFPLNSSPQLLYQYISTPSGLSEWFADNVNSRGELFTFIWDDAEEKARLAS
KKTGEKVKFRWIDENGQDGDYFFELRILVDEITKDVSLMVVDFAEKDEVAESTQLWENQI
SDLKHVIGSV
>LONDMIMF_02328 Aminodeoxychorismate lyase
MINFNGTITDDANLLAGNRAFLYGDSVFETVKILDGKVLFLEDHYFRLMSAMRIVRMEIP
MNFTMEYFEEQILSTAASENFSGSCRARISVYRKEGGFYLPKDNNVSFLITVLPLEDSVY
RIEKDQYEVELYKDFIVTKHLLSTIKSSNRMINVTGSIFADENGYDNCLLINDEKNVIEA
LNGNLFMLMGNKLVTPPISEGCLNGVMRKQILALAKKIETIEVEEAPISPFDLQKADELF
ITNVVRGIQPITKYRKKEYGMGLAKDLLLRLNAQIRLG
>LONDMIMF_02329 hypothetical protein
MISEKLKKGILLIAEPSIIGDLSFNRSVILLADHNEEGSVGFILNKPLEYTIQDLIPEIN
AKFKIYNGGPVEQDNLYFIHNIPEMIPNSIEISNGIYWGGDFESTKALINEGKIKKNNIR
FFLGYTGWDAQQLDREMQANSWIISKNIYENKIIGKSTTDFWKQKILELGGDYVIWSNAP
ENPILN
>LONDMIMF_02330 DNA-binding protein HU-beta
MNKSELIDAIAADAGISKAAAKLALESFLNNVGGTLKKGGRVSLVGFGSWSVSSRAAREG
RNPQTGKTIKIAAKNVVKFKAGAELEGSVNSK
>LONDMIMF_02331 Methionyl-tRNA formyltransferase
MEKLRIVFMGTPEFAVGILDTILNTNFEVVGVITAPDKPAGRGQKIKYSAVKEYALEKNL
KLLQPTNLKEEAFLAELKDLNANLQVVVAFRMLPKVVWDMPKFGTFNLHASLLPNYRGAA
PINWAIINGETKTGVTTFFIDDKIDTGAMILSKEVAITSDENAGQLHDTLMHLGSQAVAE
TLELIQNGKAETTLQVDSAEIKTAYKLNKDNCKIDWNRPGKEIHNQIRGLSPYPAAWSFF
SDNGQEWNVKIYEAKFIAQTHAETIGKIITTKKEMKIAVSDGYIEIIQLQFPGKKNLKTS
ELLNGISFGTNAKAF
>LONDMIMF_02332 ATP-dependent DNA helicase RecQ
MQEALSILQKYWKYDSFRTPQAEIIASVLDGQDTFALMPTGGGKSICFQVPALMQNGICL
VVSPLIALMKDQTANLQKRGIKAIALTGGISTDEISDLLDNCQFGNYKFLYLSPERLQAD
WIVERLKNLPINLIAIDEAHCVSQWGHDFRPAYLKIASLKTHFPKIPFLALTATATERVK
KDVIAQLGMENPAIFQKSFVRENLAYMVFEAEDKLYRIEQIVKKHPQPSIIYVRNRKGCL
DTASQLESLGIKATYYHGGLHITEKEKNMKLWMEEKVQVIVATNAFGMGIDKANVKTVIH
IQLPENLENYYQEAGRAGRNGEKAFAVLLNSPSDIQYSENQILNSLPDKKFLKEMYVKLC
NFFQIAYGEGIYEQFSFNINQFCVQYGFPALKTFNSLQFLDRQGIISLSQEFSEKVTVRF
VIESKEVIRYMSLNPQDEEIILTLLRTYPGIYEIVTAINIPLVAKKSGAKETQVMAVLLK
LQERQIIEYHAKNNDSTVTFNEIREDDRTINRVSKYLEEQNSLKKEQFEAVLEYATNNTT
CKSRQLLSYFGEKDSKDCGVCSYCIQKNKIAIPVTAGEKILHLLKTAPMSSREIQFHSKF
PDEALIFALRQLLETNKIELLPNNKYTLK
>LONDMIMF_02333 hypothetical protein
MEAKKQGIEQLFLENPLLFSELLLEGRKKQYHDALKEESPVVFIDRGIPDVLAYMHYIGD
AYPAFFDEACREHKYTKIFILPPWEDIYECDEARYENYEQATLIYKHLKETYESYGYSLI
EVPKDTVDNRILFILGHLSN
>LONDMIMF_02334 hypothetical protein
MKKFKSIISLVLLTILIGCSGDDTSLDSVTNAPAPTNLSALFTITQDNSGLVTIAPRGEG
LVKYDVYFGDATAEPAEVNVGGTVDHTYAEGQYNVKIVATAINGLTSEVELPLTVAFRAP
ENLDVTITPVVGDSFSIGVTASADYETFFAVTFGEDPQQEPVQFMQGDPAVTHTYANTGT
YTVTVTAYSGGVATTTYTENVVISNPILLPLTFENAALNYSFSDFGNVTTSKVNNPDVSG
INLSSKVGRTVKNNGAETWGGTTMVLDNPIDFSTLNKFRIKVWSPQVGAVVKLKIENLTD
AGINHEVDQVTTVANAWQYLTYDFSGVNTSQSYSKVILFFDFGNPGNGASYYFDDIYLTN
GDEPKTLPLTFESSTINYGFGDFGGAFATKVTNPNPSGINTTANVARVVKNAGAEVWAGT
AITLTEPIDFSVYHKIKIKVWSPQAGIPVLLKLENSTNTNINIELPVTTTVANGWEELTY
DFTGINTNNAYQNVVLFFDFGTNGTGATYYFDDVKLSN
>LONDMIMF_02335 SusD-like protein
MKKNIITAFMALTLLTTVSCGDDFIDREVPYSIGADNYFNNEQEYHNALIAAYDILQSTY
VNVLLGEIASDNTLSGGESANDVIGFQQVDEMIHTPVNANVKNVWDWMFAGVNRASYIME
FKDKTDFPNKPQIIAEARFLRAYFQFELVKWFGGIPLKQDARFKLGDEKTIPRSSKAEVY
ASIENDLILAIADLSPTAPQVGRVTKGAAQALLGKVYLYQDKFDLAAQTLENLITVTGGY
SLISNYDTIFEEAQENGVESVFEIQYTDVEGAGFECLQCSEGNVAVGFNGPRNYSGPRFS
SGYSFNVPTQEAVDIYEAGDLRKDVAILDIAAWATATGATYGVGYKHTGYFNKKYIPRTR
SANAAGDLNLTNPNNYRAIRYADVLLMAAEAFNRGGIDDTKARFYLNQVRRRAFGDTNHD
INGTGTTLTSLIWQERRRELMGEGHRFFDLVRTGRAAIEIDGFTADKNEVFPIPFEEIQF
SAGNWQQNPGY
>LONDMIMF_02336 TonB-dependent receptor SusC
MKSNFFLIAFLLISSFCYSQEYEISGKVTEAQTGLPLPGATVVVKNGTLQTIADLDGNFQ
ISGVPSGATLVFSYVGFTKYEFKVTKNETITVTLNPDAESLEEVVVIGYGSQTKREVTGA
VGVVSSKNLEDLRPVKIEQALQGTVSGVNVTTQSGRPGGNLDVRIRGIATNGENRPTFIV
DGNIIKDIGLLNPNDIESLTVLKDAQAAIYGTIGANGVILITTKTGKKNSKTRISYNTYM
GSQETSRKLPLLNATEYGLLLNESYANAGSPLPFPNVSALGKGTDWQDEVFDTGVPIVSH
DLSASGGSDKVTYNISGSHLDQGGIIGGYKSNFLRNTARLNLNADLTDKLRAKANVMYLY
TSSRTFNENALGSVLFNAINTPSIYKPYDQNGNLTLLPSGDVNIPGSNIGFEVINPLAQI
ENTFNSYNLKRVSGSFALEYDVIKDLTVTGRIGFETSNSEGKTFNKLINYGPGKVFNNPR
SSVDQSAVNDNSYTFDLFATYKKTLAENHNFALTAGTTVFKEYGNGLNATGFDVPNNSWQ
FADISLTTGYVDRKAAGSYAYDERRLSHFGRLQYDYKGKYLLSAMIRRDLSTKFGPSNRV
AYFPSFTAGWVISDESFFPESKTINFLKLRGSYGTLGNDQIKSNAYISLLGGEATYIFNG
QLVNGNAIGLLANPDVKWEEARKFDVGLDFRLFNNKVEIATDYFIDTRKDLLIVNVPISA
ITGIAAPGASSPVINAGSVRNKGFEFAINYREQVSDNFSFNINYNVTTLKNEVTEVNNGT
GFIEGGLFGTSTLTSRMQVGHEMGYFYGYKTNGIFQNQDEVDAHPSQLALGAEAKPGDLR
FVDVNGDNKIDANDRTDLGSPIPDVTMGLNFSLNYKGFDFTAYAFASIGNDMVRAYERTQ
NDVNRMNYTLGRWTGEGSTNSVPRVTTAATANNVFSDYFVEDASYLRIQNVQLGYTINSA
FTEKAGISKLRIYTGVNNLYTFTKYMGYDPGASNGNPIGGGVDNGFYPIPRTYLFGVNVN
F
>LONDMIMF_02337 hypothetical protein
MSKKLLLLVLFSYFLGFSQELPPILKYASNMYGAGNQNWMITQDSNQFIYFANNEGLLEF
NGANWTLYPSPNETIIRSAKSINNRIYTGCYMEFGYWERKKDGLLKYTSLSKPIIDKMLD
DEQIWNIIDYDQWVIFQSLNQIFLYDTKTSKFKIISPKGAISRAFKVNDAIYYQTYTEGL
FEIENGEGKLISNDPVLLKNKIVNIFSRNGGLLLQTQFNGFYTYSNARFEKWHTEADADL
SASSIYSSQILSDGSFALGSVSNGIFIISKEGKMLYHITQNKGLSNNTALSIFEDHDHNI
WIGLDNGINCININSPVRSFADDTGILGTVYTSILHDGKLYVGTNQGLFYKNYGSAEDFK
FINGTKGQVWTLYSYKGTLFCGHDSGTFIVNGNTANSIFITSGTWKFENVPGREDLLLQG
NYYGVSVIENKNGQWIFRNKIEGFDYSSKYFEITKNFEIYVSHEYKGVFRFQVDRDLRKT
KEFITYSYPTKGKNAGLTEFNGSIYYSYKSGIFKLDPKTKKFEKDTVLSRVFEKDGYTSG
KLMVDNSNRLWFFTKNYINYFSYGKLSSQLKHNIIPIPSSLTNSMLGYENITQISDSVYL
IGTTDGYYTINIDDLKFSKYKIFMSGIMVNKSNESPRHALIDGHSDFKFADNNITFSYTV
PEFNKYINAEYQFLLENYQDQWSEWSNKPTINFKNLPPGDYTFKVRAKIGSELSENTISY
TFTILKPWYRTTLAVIIYIIIFIVMAYFINRAYKNYYHRQKEKLIEENNRLLEIKELESQ
QELMKIKNQQLEQDFESKNRELAASTMSLIKKNELLSLIKEDLKRTSEEGNRNIKSVITT
INKNISEEDTWNIFKDAFNNADKDFLKKVKNLHPSLTPNDLRLCAYLRLNLSSKEIAPLL
NISVRSVEIKRYRLRKKMDLSHEDGLVEYILSI
>LONDMIMF_02338 hypothetical protein
MTAVTGLLFASCNSDDGGFERTIVGKWNYNKTIVTTGNGTPTDQSYVGHENGCEKDHVEF
KEGGIFRNVLMNKDQNNACVEDASQSTWAKNGNTLTIGTDTYQVTKLNGSELRYENTVDV
SGVPVKVVKVFTKN
>LONDMIMF_02339 hypothetical protein
MSSPTKLANRFREVILNGTWIANTNFKNELDDLDWEIATAKFQNLNTIAILAQHIHYYIN
GVKNVFLGGHLEISDKYSFDFPDINSQHEWKNFLVKFWNDSTEFAQLIENLDKEKLNEPF
VEEKYGTYLRNIDAMIEHSYYHLGQIVLIKKIIQNSRG
>LONDMIMF_02340 ATP-dependent Clp protease adapter protein ClpS
MSTKEKILEEVLVEELTSLNNEIILYNDDVNTFDHVIDTLIRVCNHTSEQAEQCSIIVHY
KGKCTVKTGSLDELKPQCTQLLEAGLSAEIV
>LONDMIMF_02341 Ribosomal protein L11 methyltransferase
MANTYLGYHFKVEPKELGSEILVAELGEKPFESFIETEFGVTAYIQKALWTEDVLEDIFI
LTSPEFTVSYTIEEIEQVNWNEEWEKNFEAIDVDGICHVRAPFHEKTDAQYDIVIEPKMS
FGTGHHETTHMMIQHLLETDVTGKKTLDMGCGTAILAILAEMKGAQPIDAIDIDNWCYLN
SIENAERNNCKHITVYEGDAALLAGRNYDVIIANINRNILLEDMQQYVDCLNPGGTLFLS
GFYEEDIPVIDASCTEKGLTYVKKHQKNNWVALKYVN
>LONDMIMF_02342 hypothetical protein
MKKIFPLFLLFLGLSAQAQDIKVTTKDNDLKLPTLPYYNFGRGLGLTSPDSLFQLNIRFR
MQNRVTYIQNEGEDAAYDGQIRRLRLRFDGYVGNPKFLYALQLSFAPGDVGEIEEGENIN
IIRDAVVYYRPNKSWSFSFGQTKLPGNRQRVNSSGGLQLTDRSINNAKFTIDRDFGFQAH
YLNDYAEKFSYNVKTAVSTGEGRNWTKSNDNGVALTGKVEILPFGAFSKDGVYFEGDIAR
EKKPKLMLSAAFQQNNHARRTQGQLGDDLFEQRTMKSVMLDAIVKYDGWAAMSSYMSRTA
NNPVTVNPEDIQDIKYVFVGSGMDYQLSYLFPTNYEIIGRFSTQKVHDDIRQYAPNAKQY
SIGLTKYIWEHAFKLQGELTLDDLNYFDGSTKQNWYLRFQIEIGI
>LONDMIMF_02343 hypothetical protein
MSHNYTSKTGKVLQMLLLLFAAQFMNGQTLIHYWNFNNNASVATITTPTQTLVTGASLTA
IAGGISTIDFAGGTGQNFDVQNLNARNNDASGTHLRFNDPIGGALQFALPTTGYENIIVK
FATRRSGSGAGNQKWSYTVDGTTFVPFATIAPNNGNPALETLDFSAIAAADNNANFKLKV
EFEVGAGGTVGNNRFDNFTAEGNSIGGGDTVAPTVTYVPANSSTNIAVDANITISFNEAI
RLVNDAAIDNTNVDALVELRLNNASGALVPFDATISGNTITINPTSNLANNQTYYVALLP
NTVEDLSGNAVTAVTSSSFTTIAVQTQFQAGDLAFVGYRMNASGTEDEVAFVTFVDILPG
TFLTFTDSKYTTNTQPQCPNGIVWTVGANECIPAGSVVKIQTSALIASKGTVTGSGFGLS
SGGDQVIVYSGTAAAPNYITALSSNGWVANNTSCSGSISMLPAGLIDGTSALNTSTAPGK
DAGNAVNAYYNGVQTGTTAALKTAILNPTNWVAIAGGTAPQTWPVWNFPSSLQVQNAVVI
NNTTLQITFNANLNVASASNVANYTGVANLNSVNVSNNIATLTFSVPFAPATNYALVISN
IQDASGTAMACPYTYNFSFNATLSLASNFITVNEDAGVLNFVVNLAAAATGSVDLVVKSA
PFSTADSNDFTFTTRTLNFTSASTLAQTIQIPIIDDTTPEQQAEYFVLSLENPVGYTITG
NPMATIYIKDNDRTAKVPSNDIQLNYIGSFDPSGSNNSTCEIVVHDPASQRLFTTSAVAG
YLDIIDFSNPTALTVVNSINMNPYGGVTSVAVKNGIVAVASPNANEALNGSVVFFNTDGV
FQKQVTVGALPDMITFTPDGTKVLTANEGQPNADYSVDPEGSVSVIDISAGIASLSQSNV
TTMLFTQFNSQESALMAGGIRKLKASSTLSQDLEPEYITISADSQKAWVALQENNAIAEI
NLTNNTYTSIWALGTKDMSVVGNGADISDNNGQILIANWPIKSFYQPDGIANYSAGGSNY
IVTANEGDEKEYTGFVERITIGASGYGLDAVAYPQAAMLKESYNAGRFRVSAFSGNTDAD
ADFEQIYALGGRSFSIFNTDTKQLVFDSGDDFEMYTAFTPSINPIFNADHEDNTPKGRSR
AKGPEPEGVTLAEIAGKTFAFIGLERIGGVMVYDVTNPNDVKFVDYKNSRSVSAYAGDHG
PEGITYIKAANSPTNKDYIVVANEISGTLTLFEINTENLSVPGFENEPKTFVLFPNPAVD
GIVYFNRIADIEVFDYTGKSIHQAKQALTIDTSSFASGIYLVKTSEGITKKLVVK
>LONDMIMF_02344 Triosephosphate isomerase
MRQKIVAGNWKMHKNAEETEDLLNDLIDKLPNDVEAHIIVAPTFVNLASAVDHLEFTNIG
VAAQNMHQAESGAFTGEISADMLRSIGVGIVILGHSERRAYFHETDALLAEKVNTALKHD
MQVIFCFGEELKDRQSGNHFNIVENQLRDGLFHLEAKDWENIILAYEPVWAIGTGETATP
EQAQEMHKFIRETITAKYSATLAEEVSILYGGSVKPDNAKEIFSKPDVDGGLIGGAALKA
SDFAAIVASI
>LONDMIMF_02345 Thiol:disulfide interchange protein TlpA
MKKIFLSLLVVLGTISCSKAQKSEFSPEALTEKLQTLDGKEISFKEILNKHKGKTLVIDV
WASWCGDCVKAMPKVKDMQEKSPTTDYIFISMDKTADKWKTGIEKHDLKGEHYLALDGMK
GKFGKAIDLDWIPRYIVIDKKGKIAIYRAIETDFDKINATLKKLK
>LONDMIMF_02346 Dipeptide transport system permease protein DppB
MIKYLLHKIGYALLTLFGVVTVIFFLFNVLPGDPARMMLDQNENSEQLAIVKKKYGFDKP
ISTQYLYYLNDLSPVSFHSKNQEDYTFLTEGKYNALRLFSIGNNEVVLKTPYLRESFQKS
GKKVSDVIGNTLPNTFLLALFAIIIAIVIGILLGIVSALYKDTWLDRLIALLSTLGMSIP
SFFSAILFAWLFGFLLHEYTGLNMTGSLYEVDDFGEGHYIQWKNIVLPAIVLGIRPLGVV
IQLMRNSLLETFGQDYIRTARAKGLSEFQIIRKHAVKNSLNPVVTAISGWFASMLAGAVF
VEFIFGWNGLGKEIVEALNNLDLPVIMGSVLVIATTFVVINILVDMVYAYLDPKIRLQ
>LONDMIMF_02347 hypothetical protein
MENLKKYLPWIIRILISFLFLISAVAKLYPSPYFAISTFEVKQLYPMGFSEDFSVFFSRI
LIGIELALGLLLLQPHYLKKWVIPATILMLVVFTTHLTIDTIQNGGNTGNCGCFGSLLPM
TPIEAIIKNVIAIILLAYLLYLLPKGATDKKNFWVLTTVTLACILAIFMMAPIQPKAVEG
NIDDATALPIESLETFPTQSADSLATATPAETKTTEAPVVEAEAKAADEPASQKSGYAQY
FSKADKGKKIICLFVPGCDHCRDVAKELAEMRAKNKNFPEVSVLFMNEEPEKIPDFFKFA
GTEYPYKVLEVIPFWKLLGTSKDTPGVIYLWNGNKIKEWDGINEKKFVGSELQNVLKKSY
SELKK
>LONDMIMF_02348 hypothetical protein
MNSTSQEFDRIIGICRSLYINKMQDYGSAWRILRLPSLTDQIFIKAQRIRSLQENDVRKV
DEDETGEFIGIINYSIMALIQLDLGVVDQPDLDTEKATQLYDEKVALTKALMEAKNHDYG
EAWRDMRVSSLTDLILQKLLRVKQIEDNKGKTIVSEGIDANYQDMINYSVFALILMGFAK
>LONDMIMF_02349 Dihydropteroate synthase
MNCKGTLIDLSTPKVMGILNITPDSFYDGGKNDNEQAIIDKVKQMLDEGATFIDIGAYSS
KPNAEFVSEAEELNRLIPIIDLLVKVFPEIIISVDTFRSGVAKAAIEHGAAIINDIAAGG
LDDKMMETVARYNVPYIMMHMRGNPKTMQSLTQYDDIIKDMLYYFSEKVNHARSLGINDI
IIDPGFGFAKTTEQNFEVMNKLELFQMLELPILSGISRKSMIYKTLGTTPQESLNGTTVL
NTISLLKGAKILRVHDVKEALETVMLCRAVDN
>LONDMIMF_02350 Ribosomal RNA large subunit methyltransferase H
MNIKLIAIGKTDNKSLQTLIDDYQKRLSFYIKFELEIIPDIKNVKNLSEAQQKEKEGELI
LSKLAATDQLVLLDENGKSFSSVGFSEELQKKMNSGIKTLVFVIGGPYGFSEAVYAKAQG
KISLSAMTFSHQMVRLFFIEQLYRGFTILRNEPYHHQ
>LONDMIMF_02351 Nicotinate-nucleotide pyrophosphorylase [carboxylating]
MISEAQFQNELRLIIENGIREDVGDGDHSSLACIPPTAQGKAKLLVKDEGIIAGVEFAKM
IFQYVDKDLKVETFIQDGTPVKYGDVVFHVSGSSQSILKSERLVLNAMQRMSAIATKTQS
FARLLEGTKTKVLDTRKTTPGIRAIEKWAVKIGGGENHRFALYDMVMLKDNHIDFAGGIT
KAIQKTNDYLKQNNLDLKIIVEARNLDEVREILQSDNVYRILLDNFDYDMTRTAVALIGD
QCQTESSGNINEKTIRNYADCGVNYISSGALTHSVYNMDLSLKAI
>LONDMIMF_02352 hypothetical protein
MTKIIEDKLEKIPVIRPLMHLTQRIKLPWLEGLSLYDLLELYFIGIAKGAFSYRASAIAF
SFFMALFPFALFILNLIPYIPIEGFQADFLKFVEESVPPNTYEAIYKIINDILNNSYRGL
LSSGFLLSIFLMANGVNAILGGFEISRHITVTRGFFRQYAVALGIAIILSFLLIVTVSSI
VVFEYIIQRMKSEGLFENINFVSIGRFVFVGLMILTATSILFKFGTKQTRRHSFFSIGSV
FTTILIILTSFIFGIYVVRFAKYNELYGSIGTLLILMIYIWLNCMILLLGFELNGAINRL
KRKNLFN
>LONDMIMF_02353 Efflux pump membrane transporter BepE
MGLLGLSKLPLQQFPDIAPPSVLVTAVYPGANAETVLRSVAPSLEESINGVENMTYMSST
ASNDGTLAITVFFKLGTDADQAAVNVQNRVAQATSQLPAEVVQQGIITAKQQNSFIMAIG
MYTEDEAKYDQTFVANYAQINIIPEIKRIPGVGSAAIFGGTKDYSMRVWLNPTQMATYNV
TPNEVMAAIQDKSLEAAPGKFGERSKEVFEYVIKYKGKLTKPEDYMNIAIRSNADGSILR
LKDVARVELGAYSYNSLTRLNGNKGVVIGIIQLAGSNSNDIQIAINKLMEKASKDFPKEI
KHNIFYSTKVSLDQSIAQVQHTLLEAFILVFIVVFLFLQDFRSTLIPAIAVPVAILGTFF
FMQLFGFSINLLTLFALILAIGIVVDDAIVVVEAVHAKMEHKHLSPKIATHEAMHEITGA
IISITLVMAAVFLPVGFMEGSTGVFYRQFAFTMAIAIVISAVNALTLSPALAALFLKDNH
EAHDKGKPYSKPGFKEKFFIGFNKSFTALTNRYVGGLKFLIRNKWASLGGLVVILVATIV
MVQRTPTGFIPTEDQGFIAIAVNTPSGTSLDGTQKVMTEAENTLKALESSRFVTAISGFN
LLTNSTSPSSAVVFVLLKPNEERGAIKNIDEIMNQVRGQLGAISGGNFFVFSFPTVPGFS
NVEALDLVLQDKTGGKLDKFSGVSQNFIGELMKRPEIAVAFTSFKADYPQLQLDINDEKA
DQLGVKVKDILQTMQAYFGSAQASDFNRFGKYYRVVVQADIADRADPTTIDRVFVKNKNG
EMVPINTLVKLTRIYGSETASRYNLFNSISINAIPKPGFSSGDAIKAIEEVAAQQLPAGY
SYEFSGQTREEISSGGQSTTIFLLCLVFIYFLLAAQYESYILPLAVILSIPTGIFGVFAA
IGLTGIQNNIYVQVALVMLIGLLAKNAILIVEFAAQKRRSGQALGKASIDAAKLRLRPII
MTSLAFVVGLIPMMSATGPSAQGNHSISIGAAGGMLSGVILGLFIIPVLFIIFQYLQEKV
SGKPIAVIHNEEK
>LONDMIMF_02354 Outer membrane protein OprM
MKRNINKYIAVLVLITTLTACKVSKDVETPKDALPENFRNVSSQDTTSIADQSWKEFFTE
PSLQKLIDSAIVRNNDLLIAQKKIEAAQWQLTQSKWGNVPKLNFEATATSTRLSDNSLNG
LSTSTFLKKKHIEDYNAALNLSWEADIWGKIRSRKKNALAEYLQSEEAKKALQTTIVANV
STGFYNLLMLDAQLEIARKNLALNDSTLFVINLQYESGQVTSLAKQQAEAQQSVAAQLIP
ELEQAIALQENALSIITGSFPGAKERKTTLGAIALKENVSAGIPSSLVSRRPDVKNAELA
LKAANAKVGIAKASLYPSLNITAAGGLTSFKSSNWFNTPASLFGTVAGSLAQPLLNGRSL
KAQYEISKIEREKAVLSFRQSVLVAVGEVADALVKVEKLKEQQAIAANRVTTLQNAVKNA
DMLFKSGMATYLEVIVAQGNLLQSELELATLKRTSLEADVELYRSLGGGWK
>LONDMIMF_02355 Glutathione-regulated potassium-efflux system protein KefC
MQDTFFFQAMIYLAGAVIMVPIAKRLGLGSVLGYLLAGIIIGPAFLGLIGTEGHDIMHFA
EFGVVMMLFVIGLELEPERLWRMRKKIAGMGGLQVAGTTLVLTAAALAFGLDWKTALVLG
MIISMSSTAIVMQTLNEKGWIKTVAGRNSFAVLLFQDIAIIPMLALLPLLASKELQQAAV
TAHPTLMDGFSKWTQALFVLSSITIVLLSGKYLLRPIFHAMAKTKLSEMFTAMALLVVVG
IAVLMTSVGLSPALGAFLAGVMLANSEYKHQLEIAIDPFKGLLLGLFFISVGSSIDFQLL
LSKPWLIMGLVVGIIIIKITVLYLLGKFFRIGHTQNFIFSFGLSQVGEFAFVLLSFSLQE
NILSKEITDLMMAVTALSMAFTPLLMMFNEKVLMKSKCSMSGSEEEEAESDVDSESNPVI
IAGYGHFGNTVGRFLRANNIQATVLDNNSDNVNMLRKLGFKVYYGDASRHDLLEIAGAGR
AQIIIIAIGNREKRMEMIEMVKKHFPNLYILVRSENRDDAYDQMNAGIMHIYRETLDTSL
RVGIDVMKLLGHNTYEATRSARTFFTHDEKTLKYLASIRNQDEYISAVREKIEELEQVIL
ADREAMSLENTEKSMIA
>LONDMIMF_02356 hypothetical protein
MKFIKYLLVGILFGIVLTKSEAVSWYRIYEMFQFESFHMFGIIMTAIAVGVVGIQIYKRN
KVVGLDGKQIQIADKDKGFKNYIIGGTIFGLGWGMIGTCPGPIFILIGAGFYSIGIVLLG
ALIGTFLYGLLKNKLPH
>LONDMIMF_02357 hypothetical protein
MYSFYGTWPWYVSGFLIGAVMLLLIYFGKTFGMSSNLRTLCSISGAGKFSDFFRFDWKAQ
RWNLVVVLGAMIGGFIAVHFLSDGSGVNLNPATVAKLQEMNIDAPNGKLIPELFTSAENV
FTPKIFGFLLFGGLLVGFGSRYAGGCTSGHAITGMSNLQLPSLIAVIGFFIGGLIAAHFL
LPLIF
>LONDMIMF_02358 hypothetical protein
MKKFAIEIKWGIRYIFCYLAWAILEKTLGIYGENMSFYMLSSLLFYIFAGLIYSLALREK
KTNYFNGHMDWKQGCATGLYMTIVIALLMPLAQASFHELIAPEFFENMINASKDKEAAAN
YFNLRSYIIQSIFFTLSIGMVISAIVAYFVQTKKQTK
>LONDMIMF_02359 hypothetical protein
MKIRSLILVLLTGILAVSCISTRSTIRNIDDNAPEPVITKNGWFLLTEYSKDKKYGYDKD
YPINVYYRSVADEDINPKRFLDALTGPKGETITYKKIESCCPFPTKRNEMGAGLLDVYEV
TWPGIAKPIRLYFNIFEKGYLYVPKGFGLKKNE
>LONDMIMF_02360 2-dehydro-3-deoxyphosphooctonate aldolase
MNLQDIPKIKHLDSNNFFLLAGPCAIEGEEMALKIAERLVEVTNKLQIPYVFKGSFKKAN
RSRIDSFSGIGDEKALKILRKVSETFDVPTVTDIHTNEDAAMAAEYVDVLQIPAFLVRQT
DLVVAAANTGKTVNLKKGQFMSPESMKHAVQKVLDCNNQKVMVTDRGTMFGYQDMIVDYR
GIPTMQQYATTVLDVTHSLQQPNQTAGVTGGRPDMIETIAKAGIAVGVDGIFIETHFDPA
NAKSDGANMLDLKYFEGLMTKLVAIRKTVNNF
>LONDMIMF_02361 hypothetical protein
MKHPLIVGVLTFFCAFSQYTFAQELATSPEKYTAHNKGKFFIYWGGNRESYTKSDITFKG
DGYNFTVNDVKAHDKPKGYHLDYLNPARMTIPQTNLRIGYFISDHYNVSIGVDHMKYVMT
QGQTANVTGEINLPASEAGAIHNGTYNNTPTVMSEDFLKFEHTDGLNYVHAQINRVDDIS
KLFRIWNTDKIQINLTEGIGGGLLYPKTNATLLSKKRHDDFHISGYGVSAQVGLNLTFFK
HFFIQGELKGGYIDMQDIKTTSSNADSASQHFGFFQRIITVGGIFRL
>LONDMIMF_02362 hypothetical protein
METNKYLNDISEIKNMMNRSSRFISLSGLSGVLAGVYSLIGAWMAYKTIYSDSSDLGSYK
NLVVSESSIKRLFAIAIIVILLSIATGISLSIKKAKKENENIWDASSKRLLINFAIPLAT
GGFFILFLIEKEIYGFVAPLTLIFYGLACVNASKYTLGDVRYLGITLIIIGLISSYFIGY
GLLFWALGFGVCHIFYGFKLYLKHDKN
>LONDMIMF_02363 hypothetical protein
MTRIKIIFKALQILSLAALFSCGGTWENDETVWKKTFNSEKPKEVTIVNSKIWVSSHWSY
EFQSFMEVKSNKKLLDAF
>LONDMIMF_02364 hypothetical protein
MKNIIQNINKAFDHRIRLGIMSVLMVNEAADFNMLKELLGVTDGNLASHTKALEAENYIS
IEKQFIGKKPNTRYIATKEGKKAFKEHIDALEKLIQKS
>LONDMIMF_02365 hypothetical protein
MRDLFIEKLYDISKKPYQKFLKKNEPWKITHKELLLMPEQTLGFHLGHFLSKHGFEIQSK
LEDHDVFHVLTNTGITVPEEIGMQYFLFGNGKRSLYLYMVIATGTLFYPDKIGYFENQYL
RGKNAFQFHNLDYFKMLSIPLKTIQTTFKIK
>LONDMIMF_02366 hypothetical protein
MKKQTTLKNWWKINYKWSLSLAAFIIACLILAYNISRGSFKDMAQAYADPTLFQNAITKA
NENMKVIQVFGTLEPIDNLAILEGNTKYTNDNKAIEATVRVIGKKAQGKMDISAQKIGSE
WTYGLIKLRVAKTGQEITVIKC
>LONDMIMF_02367 Inner membrane protein CreD
MKTEISFLQSTTARLILIGVLTIVLLIPLTFVQDLITERSFRKQEVISEITAKWGDNVLL
YGPIIKIPYTVHYPVKNTTETVSETEYAYFFPEQLNGHIDVNTTAKKRNNYEAVVFSSSM
KFDGTFTKPDFSSKGIATENIQWDKATLLIRANNLKSIKDGMKIKLGDKTMSFETATSDP
ATSVSTLETPNFTISEYFTDEKLNFNFNVAYDGSQELKIVPIGKTTSVSMKSNWTSPKLT
GYFLPGGNLKKSDDTGFEASWKILDFNRPFAQNYFGDFPELKNYSFGVDFIIPVDEYQKN
ERASKYGFLVIGLTFLIFFVIQSISKISIHIFNYTMIGLALVMFYTLLISITEHSSFLKA
YLIAGISVVLMISLYSVSILKSKKFAAFIGLSLTGLNSFIFVIIQLENYALLAGSIGLFV
ILGLVMYFSRKIDWNAIKEEV
>LONDMIMF_02368 hypothetical protein
MLVAAIAVSSCNSNKQATIKEDGTEVVKIRTPEEGKEEKNDTIAVQGKVNEINKGKDGYT
AILTAEDGKIYYATISIPNLKDPKQYRTVAIGETIKIKGNSWKMEDDNYITVRELEK
>LONDMIMF_02369 Alanine dehydrogenase 2
MKFGIIKERKNPPDRRVVFTPEEASRLLKEHPEVELKVESSDIRIFNDDEYRSQGLNVTD
DISDCDVFFGVKEVPVEALIPGKKYFFFSHTIKKQPHNRKLLQAILEKNIDLYDHETIVD
TDNRRLIGFGRYAGIVGAYNGIRAFGIKFELFNLPKAETLSGKSDLVARLKRQILPPIKI
VLTGHGKVGMGAKEILDGMKVKEVTPEDFLSKKYTQPVYTQIDVLDYNKRIDGKVIDKED
FYNNPQDYTSDFERFSKVADIFMAGHFYGNGAPVILTREMLNSKDNKIKIVADISCDVDG
PIASTIKASTIAEPLYGYLPSEHKEVEIYHPAAIVVMAVDNLPCELPKDASEGFGEMFME
HVIPAFFNGDKDGILQRAKITENGKLTKRFEYLQPFVDGK
>LONDMIMF_02370 hypothetical protein
MTKYPQYFMNKSFGGLAVNVIFGTNYNVVVTKL
>LONDMIMF_02371 Penicillin-binding protein 4*
MCLFFYICFPTIIITMTFSKYIYPLLASALLLTSCQEKNKQIASNEPVENNTDALSPYSI
KSKKLPASYVTPKQESLEKFYEKNWPNNSMNGGFLVAKNGQIIFEKYEGKSNFSKGEDIN
ATTPLHIASVSKVLTATAILRLIDREKLHLEDKVNAILPSFPYEEITIKMLLNHRSGLPN
YAYFADDTKVWNRSKMLHNQDILDLLAQHKFGLYFKPDRKFGYCNTNYAILALVIEKITG
KNYREAMKEMIFEPLGMKNTYVYDYSKDKETASLSYKGNKVLYELNHLDDVYGDKNIYST
PRDLLKFDMATYSDKFLNPVLVSEAFKGYSYEHRGTKNYGLGIRMLEWETGEQLFYHNGW
WHGNTSSYVKLKKDTVALFAISNKYTQKTYKIWKLAPLFGTYPIKLDKDDVIN
>LONDMIMF_02372 hypothetical protein
MKVVQNKISLFALFILIVFLLSDCPSNDKDFPIDAYCKIDRKDEVFTGPLVNMITCGHNS
SFTTVSDAKSEH
>LONDMIMF_02373 hypothetical protein
MTNGMKNLLKLEEVGQFLLSIALFSQLNYSW
>LONDMIMF_02374 hypothetical protein
MNAHTKMQNFKILILIKTIIFNGIFNSPCHSKDLNMKELDFLFRTYSQIQNQGLEMYFF
>LONDMIMF_02376 hypothetical protein
MKILVVGGTGLIGANVAGKLNNQGHEVVIGSPLHGINIITGEGLSEALRGTDIVIDLSNS
SSPEEENALNFFETAGKNLVAAEKLAGIRHHVVLSIVGIDRVQYIGYMRAKKNQEDIVKN
AGIPYTIIRSTQFHEHVSTIIAVQGKEDVVNVSTLDFQPIAAEDVANFVVKFALETAKNG
TIEIAGPELAPMDQFVSRYIKVTGQHKTVISDNEHKYMFYDFPKSGLVPEGDHQKGKIHF
DEWTQNLK
>LONDMIMF_02377 hypothetical protein
MEFVNAKLNHLHTRENTQTTVEGGQMALT
>LONDMIMF_02378 HTH-type transcriptional activator Btr
MANFSIEVNKSDKGVPIILRRLQGIEGFIVKAWDELSDDFTDALHPHRHDHYTCMLIEDG
ALEVLLDFEHFIMPAKTLFISPPWQVHQVLSVSKGSGWYISFENNLIEASVRATLDKCLE
EMISVGLTDLEFDWFKSVIQSIMALEEINSTTYKDVSHPLLSAFVAQAGLSYQSKPMGST
ANFASRSVMITKKFMNLVRHNYHHLKRPADYAEKLHISVSYLNDTIKKTTNSSASLLIQK
EILREAQRMLYYTDHSVKEISDLLGYEDEKYFMRLFRKKTGFSPTEYRKHNAPPSDFLL
>LONDMIMF_02379 hypothetical protein
MKNLNLIETAAHNRQAINKSFRNITVLILVCAIPAAICRLFFWEYTRRALVTSWRYKDLR
YVTDVGWPATIYTWGSRFAIAFMVIYLYLRFKQDLKKPSFGVAGNGIFINQQMLYNAFVP
WENIKKAELLGPVESPFMRLTFKDTTSLLKGQPFLLKMIAKPFIKNNPVLSVTKSETIGN
IRKMHEMINDKISQNI
>LONDMIMF_02380 hypothetical protein
MEIYYAKTQFGHPWIILGDAISEEAFLCEVEADEDFQSMELQWQPVKITVTYLTENDFPD
PVKIT
>LONDMIMF_02381 HTH-type transcriptional activator RhaR
MHHQLLPITPVLDRYIANASYFRQGADDYCEFKMVPRLFSVLFFVIEKKQSLEMSYGGGN
YTFSPNSLYAFGVGNLPAAFQVTSEIEVILVQMHPGISCLFHNDDAYISTNQRFDISDTD
QSIKDLNEKLAYANSIILKWQFIQEYLIKKFRSNFPEKYGAVAKAVDILRKKSGHFPVKS
LSEQVFTSHRNLNYLFMEYIGFSPKKYADIIRFNSFVNLYMQKPEFLSDIALQCGYHDLS
HLNKDFMRYMGTSPSDYFENFSSDVNNWCELDYLKP
>LONDMIMF_02382 hypothetical protein
MHLKVKSMKYKVFTHAIGTMKTKVHKVKLHLIIIFALLILYGKAFSQADGTLDTSFNIGT
GFNNAVVTIAVFPSGVLAGGWFTVYNGQNQSRIARLYTTGSLDNFFFNIGTGSNDEVSTI
VLQPDGKILAGGVFGYYNGQSRNSIARLNTDGTLDTSFNIGTGFSGAGYKVSTIAVQPDG
KIIVGGWFTNYNGHARNRIVRLNADGSLDTSFNIGTGFNDAIKEIALQPDGKILATGFFT
SYNGQTQNRIARLNTDGTLDASFNSGTAFSSPVSAIAVQPDGKILVGGGFLSYNGQAQNG
IVRLNINGSLDNSFTTGLGFDNGSVYTISIQPDGKILAGGSFTLYNGQTRNRIARLNTNG
TLDTSFNIGAGFNDIVNDIAIQPDGKILVGGFFTTYNGQTRNRIVRLNNSVLSTEEFAVS
NIKIYPNPVKDVLHFSKKIQKITVTDLSGKILYTKNNVNQTDMSEFPSGVYLVVMEQENG
SKESQKVIKK
>LONDMIMF_02383 Aconitate hydratase A
MAFDIEMIKKAYGTMAERVDKARQLVGRPLTLSEKILYSHLWEGMPSKAFTRGKDYVDFA
PDRVACQDATAQMALLQFMHAGKNKVAVPTTVHCDHLIQAKVDAATDLARAKTQSNEVFD
FLSSVSDKYGIGFWKPGAGIIHQVVLENYAFPGGMMIGTDSHTVNAGGLGMLAIGVGGAD
AVDVMSGMAWELKFPKLIGVKLTGKLSGWTAPKDVILKVAGILTVKGGTGAIVEYFGEGA
TAMSCTGKGTICNMGAEIGATTSTFGYDDSMRRYLISTGRPDVAEAADKVAPYLTGDAEV
YANPEQYFDQVIEINLSELEPHLNGPFTPDLATPISKMREEAIKNNWPLEIQVGLIGSCT
NSSYEDISRAASLAKQVADKNLKTKAQFTITPGSEVVRYTIERDGFIDTFDKIGATVFAN
ACGPCIGMWDREGAEKEERNTIVHSFNRNFSKRADGNPNTLAFVGSPELVTALAIAGDLG
FNPITDKLINEDGQEVMLDEPTGNELPPKGFDAEDPGFQAPSEDGSGVQVIVSPTSERLQ
LLAPFEPWNGENIMGAKLLIKAFGKCTTDHISMAGPWLRFRGHLDNISNNMLIGAVNAFN
QKTNSVKNQMNGKYDSVPAVQREYKAAGVPTIVVGDHNYGEGSSREHAAMEPRFLGVKAV
LVKSFARIHETNLKKQGMLALTFANEADYDKIQENDTFNFVDLKEFAPGKPLTIEIFHDN
GTTETILANHTYNEGQIGWFVAGSALNLIAAAGKA
>LONDMIMF_02384 hypothetical protein
MAKSKLSEQEQVTEYIQKLDPSISETITFLRQVILAINNEISEHIKWNSPSFYYSGEMKP
FDPKEYKRDILVMNIRHGKPILLVFPTGIKITDTSGLLEGNYSDGRKIATIKNLEEAKSR
QKDLENAIRNWMDQIEK
>LONDMIMF_02385 hypothetical protein
MHPEHNYKLTVRWTGNNGTGTSGYRAYERSHVILIDNKVEIKGSSDPVFHGDKTVHNPED
LLLASLSACHMMSYLHVCVNAGIVVTDYEDNATGKMTVNNDGSGHFTEVTLNPIVTVSDS
SMLEKANELHKMANKLCFIANSVNFPVKHIPQSKI
>LONDMIMF_02386 hypothetical protein
MKSILLHLMMLLPVLGFSQVGIGTTDPTAMLDVNGNFRLRSTTSNTRATAAKDSILVVDA
MGNAQRISSKSVIESHLKTFIKGGFASGSPALINISILANAYTTIPFNTIEFDTNNEYNT
TTNTFTAKQPGIYSVYAAIKASPGLVAAGDFGLAIFKNGVVNVRESYMNVQLLGININPP
NRSIQTLMQLNTGDTVTFRGFSGGVLTVGILSGGEESYFTIHQVR
>LONDMIMF_02387 hypothetical protein
MRMLIFNKFHFVNYVNKKKIRLIAMTDFLPKLKFKKLLIVRIPSYFRDVFR
>LONDMIMF_02388 Glyceraldehyde-3-phosphate dehydrogenase-like protein
MTKTALYEKELSFQADRRRAGVEFIKIISDLWYDKSIELVLFKNQLINTNVSDIINLHEY
AGEFVGKPINVFDSVEIARAILSLDLPPAKLDIGKLTYEYHLEDNKYNDAKAFVIDKLKN
AKDFPNNKPKDVVLYGFGRIGRLLARELMSKTGKGTQLRLRAIVVREKNDATSLEKRASL
LRYDSIHGDFQGSVAADPENNSLIINGTTVHVITAGSPEEIDYTTYGISDALVIDNTGAF
TTQEALARHLKSNGVDKVLLTAPGKGVPNIVHGVNHNEYNPDEVNIFSAASCTTNAITPI
LKAVEDTLGVVKGHLETIHAYTNDQNLVDNMHKKYRRGRAAALNMVITETGAGSAVAKAL
PSLAGKLTSNAIRVPVPNGSLVVLNLEVNKETSVEEINNIMKHYALEGELVEQIKYSLNN
ELVSSDIVGTSAPSIYDSNATIVSADGKNIVLYIWYDNEYGYSHQVIRLAKYISKVRRYS
YY
>LONDMIMF_02389 Periplasmic pH-dependent serine endoprotease DegQ
MKRFSGLFLVSLLSGATTLGAYKLFIENDGLFSDNQKSVVTTAPVNYTKNVGLGAEAVDF
TAAADNAVHTVVHVKNLSYRTISNPMLEYFYGYKGGQQQAQVGTGSGVIISEDGYIVTNN
HVIQDASELEVTLNSKETYKAKLVGTDSKMDIALLKIDTGKKLPYAIFGDSDNVKVGEWV
LAVGNPYNLTSTVTAGIISAKARNLDQRGIQSFIQTDAAVNPGNSGGALVNTRGELIGIN
TMISSMTGSYVGYSFAVPSNITRKIIEDIMEYGNVQRGVFGVEGYELNSTITKDMGLSTS
QGYYVKKVVKNSGAAKAGIQEGDILIKLDNTNISSYVDLSSYVNTKRPNDVVKATFIRNG
KAMQVPVTITKNEFVNAELNGIIFENLDASDKKRFNIDYGVKVKDITNKHFMRYYNALKG
NILIGINDAKAVDTETVANILNEKLSNESVVELTMINKQGVLVKFFVEVN
>LONDMIMF_02390 Diaminopimelate epimerase
MQLNFYKYQGTGNDFIMIDNRQGLFSKNNTKLVESLCDRRFGIGADGLILLENDNSTDFR
MVYYNSDGNESSMCGNGGRCLVAFAKSLGVIGDETTFVATDGLHHATVFEDGTVSLQMKD
VDEVKIEEGYVFLNTGSPHHVELVEDLKHFDVKGKGAAIRYGALYGQAGSNVNFVNQESA
DTFSVRTYERGVEDETLSCGTGATAVAIAMHALGKTNSDKIQLNVEGGKLEVSFVPEGGK
YTDVFLKGPATFVFGGNITI
>LONDMIMF_02391 Spermidine N(1)-acetyltransferase
MITLQGKTIYLRALEPEDLEFVFAVENDESIWEFSNTQTPYSRFLIRQYLENAHQDIYEA
KQLRLAICKNDTFEAVGLIDLFEYDPRNNRAGIGIVIKNEGNRNQGIGSQALELLIQYSF
RQLNLKQLFANINPENEASIALFTNFGFEKIGIKKQWNLIDGVYKDEAMFQLINQQS
>LONDMIMF_02392 Endolytic murein transglycosylase
MKIKKIVAIFSVLLVLALSVYGYMLYRKIFSANTNFSEKEVYVYIPTDANYETAEKIVAP
YVENLDNFRMVAEKKSYITNVKPGKFLLKKGMNNNDIINSLRISLPVKLAFNNQERLEDF
AGRIGSQIEADSTSLMKAFTDKAFLDENGFTEENVLSMFIPNSYEFFWNTSAEKFRDRMA
KEYRAFWNDERKAKAEAQNLTPLEVSTLASIVHKETVKTDERPRVAGVYLNRLKSGIKLE
ADPTVIYAVKKEANDFNRVIKRVLYKDLETVSPYNTYRNFGLPPGPIAMPDVSAIDAVLN
PEKHNYIYFCASVTNFGYHEFAVTPAQHEVNRQKYVAWVNKQGIKR
>LONDMIMF_02393 hypothetical protein
MKYHSALYFLFLLLFTDGLAQNQFQDFLRPSDSLNIPRRNAVVISEGVAITGALVGLSQL
WYNDYDKSGFHFKNDNASWLQMDKAGHVYSSYHIGRFGAELLNWSGVSKKDQLIYGATTG
FVFLTAVEVLDGYSSEWGFSWGDAAANASGTLLYVSQELLWNEQRIVPKFSFHRTPYAKA
RPEVLGASFSEEILKDYNGQTYWLSANIHSFFKESKIPKWLNVAVGYGGEGMITANDELV
NTIFLPEKERTRQFYLSLDVDLTKINTNSHFLKTLFSVFNSVKIPAPTIEFRELGGIKWH
FIYF
>LONDMIMF_02394 hypothetical protein
MLRKYYFFGGLILSVAFITLGFTSKESEKDSWFYVGDDEEIISTVPTLDESQYVNLELPY
TGKSYTGFKQAIAIRESQGQYKLVNPFGYMGKYQFGMSALRSIGIKSRSEFLNNPRLQEK
AFKALLSINKAQLSAEIEKFEGKIINGVKITESGILAAAHLGGAGSVKNYLHSNGKRKFK
DGFGTSMKSYFKLFGGYDTSHIIPNMNAKVKLN
>LONDMIMF_02395 Ribosomal RNA small subunit methyltransferase I
MKVLGKLYLIPTTLGESDPMDVLPQTVKRAIDFIDYYIVENEKTARKSIKAIHPEKKQPD
LKISLLNKHTDSREYEQMIKPCLQGINVGLMSEAGCPGVADPGAVIVKIAHERGIQVVPL
VGPSSILLALMGSGMNGQSFAFNGYLPIDKSEKKSALKSLEKLSYDKNQSQLFIETPYRN
NKLLEDLLQTLQGNTLLCIACDITLPTEYIKTLRVADWKKTKTDLHNRPCIFIIHKIN
>LONDMIMF_02396 Low molecular weight protein-tyrosine-phosphatase PtpA
MVCLGNICRSPLAEGILQSKLPRDRFVVDSAGTGDWHIGRQPDSRSIAVAKSNGLDISRQ
RGRLFTATDFETNDYIFVMDNSNYKDVMRLAPNAEAKSKVSLILNELFPGENVDVPDPYF
GLEDGFSNVYGMLDEVCEIIADKLKAKHQ
>LONDMIMF_02397 Chromosomal replication initiator protein DnaA
MNKTAQSVWENCLSFIKDNIQDQAYKTWFEPIKSVELTDNALYIQVPSKFFYEWLEEHYV
KLLKVALTKELGKNAKLLYKIKMENTYGNKQPFTEQLPSAHRQPVKAQDVDVPLQNKNPE
LKNPFVIPGIRNVKIESQLNANYSFDNFLEGDSNRLARSAGMAVANKPGGTSFNPLLIFG
GVGLGKTHLAHAIGVEIKDKYPEKTVLYISAEIFTQQYIDSVKKNTRNDFIHFYQLIDVL
IIDDVQFLSGKTGTQDVFFHIFNYLHQNGKQVILTSDKAPVDMQDIEQRLLSRFKWGLSA
ELHQPDYETRISILKNILYRDGVEVPEEIIEYVARNIKTNVRELEGAIISLIAQSSFNKK
EVTLDLAKQIVEKFVKNVKREISIDYIQKVVSDYFQLDLDMLQSKTRKRHVVQARQLAMF
FAKKYTKASLANIGSQIGDRDHATVLHACKTVDNLVSTDKQFKKFVDDINKKLSL
>LONDMIMF_02398 Acyl-CoA thioester hydrolase YbgC
MREYEFKVRVRYAETDQMGVVYHGNYAQYFEMGRVEWLRNLGVSYKWMEENGIMLPVVSL
SMNYKKPARYDDLIRVKTIFKSQTSVKIEFDYEIYNEKNELLTIGNSVLVFVDMKTGRPT
LPPDYIVEKLLALEEE
>LONDMIMF_02399 IMPACT family member YigZ
MEVKDTYRTLDFPSEEVLYKEKNSKFFGYAFPISSEEEAKEILDSLRKQHHSARHWCYAF
QIGTEKIHFRANDDGEPSNSAGMPIYGQIQSFEITNVLVVVVRYFGGIKLGVGGLIVAYR
AAAQMALEASEIVEKTIDIHYLISFDYKNMNKVMRVIKEKNLDIVSQKMEMSCEIEIKTR
KKNAEMVFDIFSNLYEIGIKLKE
>LONDMIMF_02400 D-ribitol-5-phosphate phosphatase
MINTIIFDFGDIFINLDFEAMQKALKSLGLKEWTEELDKLNYKFEKGNIKEEAFLKGIQS
HIPNASLEEIKNAWSKVLLDFPLYRLEFLQKLSHNYRLFLLSNTDSIHVEQFEHIVGESF
SRDFYQCFEKVYFSFEIGQRKPEPEAFNYIINKHELSPKRTLFVDDRKDNTDVAESLGFQ
VWNLKVGEEDVVDMFDKKIISL
>LONDMIMF_02401 Riboflavin biosynthesis protein RibD
MKIHEKYILRCIELAKNGLGTTYPNPLVGSVIVYDNKIIGEGWHKKAGEPHAEVNAVNSV
KDKSLLEKATIYVSLEPCSHFGKTPPCCDLIIQQKIPNIVIGTIDPFAKVSGNGIRKLEE
AGRNVTVGILEKECNELNKRFFTFHQKKRPYIILKWAESADGFLSPDTRDEQKPVWITNT
YSRQLVHKWRTEEQAILAGTQTVLDDNPKLNSRDWKGNNPIRIVLDRTGKIPNHYAVKDN
TSKTVIITEQEKTTNSENIIFENTIFDSSLPDSILKILYKNDIQSVIIEGGKMTLQTFID
AGLWDEARVFKGAISLVSGTAAPKFKGELIDRKNILNDELLIFKSHD
>LONDMIMF_02402 hypothetical protein
MKRILFPFFVFFILFSCKKAEVVEQEKTVDTVNVPVVEKETPVEMPADEADFKNDFDILR
ARSYRTWENENPATSLTKNWADLYEKNGRFYLGKADFKIENGYDECAGDSTRIINSATKT
LLFIDLPELKSGEIKSLKMDRNKIWPNEKITLTFNGTEYVLRGEGEVLASEKVINDDGKE
ELFQNVKNYKLYISTKNTPEKLLLQEASFNDTFVELLFAGDIDRDGKLDFIFGANRDYEE
ERVILFLSSKAEPGSNVKKVAEIAIQFDC
>LONDMIMF_02403 50S ribosomal protein L3 glutamine methyltransferase
MLAKDYRNRFIQKLAPLYDVLEAESFFYILLEDFYQMKRIDLALQPDFVFTDQEISRWNL
VLEKLEKEIPIQYILGKAHFYGLEFEVNENTLIPRPETEELVEWIVKKNEFKGKIKILDI
GTGSGCIAISLAKNLPDAEVFAIDVSEKALETAKKNAFTNEVNVVFMQRDILKTEDLEQN
FDLIVSNPPYVRNLEKDEIKKNVLEYEPHLALFVEDDDALLFYRKISELAQKNLKENGTL
YFEINQYLGTEMIDLLEAKNFNEIELRKDIYGNDRMIFGRK
>LONDMIMF_02404 Macrolide export ATP-binding/permease protein MacB
MFKLLKENVHIAMGSIRTQLLRTILTVLIIAIGITALVGILTLVSALENTISGNFSSMGS
NTFSMSQYDSSAQINRNNNTEKVNPIISYPQAKAFQEKYSYPFTTTSLSFTATSTAEIKF
ENKKTDPDISVLGVDENFLVNSGLETQTGRNFTGFDIQNNNYVCIVGSDFLKGILKDVNP
IDKVLSIRGAKFKVIGVLKEKGSTFGNSQDLRVLIPTQIARSLFTAPNINYDLKVLVGKK
ELLDSAVDDAIITMRRVRKLNPVEENNFGVTRSDELLEMLRSQTEIMGYAAWIIGIITIF
GSSIALMNIMIVSVTERTREIGVRKALGAKRSTIAFQFFTESLVIGQIGGFVGIFLGVLI
GYLISLGLNFEFVAPWMAIIAAVIISFIVALFSGLYPAIKAAYLDPIEALRYE
>LONDMIMF_02405 Histidine--tRNA ligase
MAKPGIPKGTRDFSPIEVSKRQYIIQIIKTNFERYGYQPIETPSFENSETLMGKYGEEGD
RLIFKILNSGDYFPQFRELIKSYFTVVYSEIFRNLFNEYREGISNNIEDFNNHVKVLLSK
NFVQHIVDFVNERNPEYKFTNFHSQYLIAEVRTEFLQIRKSEFAKKKFKEILQECIECDP
MENNKTKSLLRIFIDNTSARWMMSIDTKDLNKQISEKALRYDLTVPFARYVVQHQNEIEF
PFKRYQIQPVWRADRPQKGRFREFYQCDADVVGSTSLWQEVELVQLYDAVFTELGLEGVT
IKINNRKVLSGIAEVIGASDKLIDFTVALDKLDKIGEEGVKKEMLAKGISPEAIEKVQPL
FQFTGTIAEKIEKLSELLQSSEEGKKGVAELQFICDTVTKLGLKKSNLDLDVTLARGLNY
YTGAIFEVAAPKTVAMGSIGGGGRYDDLTGIFGLKNVSGVGISFGLDRIYLVLEELGLFP
QTVTATSKAIFFNYGETEAFYAMQAITRLRNEGIKVELYPDKAKLDKQFKYAEKRQISFA
VMAGSNEIATGSYSVKDLITGEKHTLDFEGLKKMLQ
>LONDMIMF_02406 hypothetical protein
MGSNASVYTSGQEPKFKNNPTDNVNFNAVVDFDNVSTEASGSYNYGLAGQQYLVGNSGYY
TQDQFIVVIPNVTVNNSFGSMDILCSDADTSTQENDGTGIGFGAYSQRFNNEVLSYAYGT
SSGLGNGYGVAETSTTKTYTNVGIINTRNNAGATAQELFYNGVSVVNTTSTGTFTNLSNG
KYWIGRSEGWKATLDGRVAEIITFSSRKNDASERIRIESYLAIKYGITMGVNGTSQNYTN
SDGTVIWNATSNAGFNWNIAGIGRDDLSKLNQKQSRSVNLATDVAIGLGEIAATNTQNAT
TFTTNKDYLVWGCNNGTFASSGTTTNVNLGGLTTSFTAGNRKWKIVETGTDVGQVVVSLP
KSSLTSNFTKTATQEYVLIVSSTSAFGSNDIVDIIPLTDAGSNYDVWYDFDGTKFFSFGV
SNQFDNKYRLDNQAGDFVLGEKNINLNSSFTVSGWIRHTSGGGTVVAKNGAYQFYINGSN
KFVGNWNGGDRITSTTSVNNGKWHYVAVAFNSGTASLYIDGVLDATATGQPTPVSNTANF
SIGAMWSNKSAISNVFSGDIDEIRIWNSALTAAQIRYIMNQEIEKNGTNTYGKAIPNTIT
KNDIASIPWNNLQAYYDLNTFYGTSIKDKSDNNRWARIKYLTVDKNIVATQTAPLPYVSA
TDGAWATTTTWTNGNVQELPNNVSIVNAGIPVDWNIVQTSHNVTSVGNKTLLGLNVSSNT
LSAQNDTKIEVSHYLKVNGKIDLVGKSQLIQTLNSDLDPTSSGTLERDQQGTSNKYNYNY
WCSPVSTQNATTNNIGYTINGVLRDGTTSTPQTIMWTSGTDGAPGSPITLSSKWLYKFQS
ASNNYANWIYVGHTGGLLAAQGFTMKGSGAATPTQNYTFVGKPNNGRIQYSIGPNLLNLT
GNPYPSALDATAFINDNLATTTGTLYFWDHFGGETHVLLSYLGGYAARNLIGGVVAMSQP
ELQDVGPGTKIPNRYIPVGQGFFVTSSNIGGDMVFNNNQRQFVKEDNASSNLMFRNQAGT
IPNASHFEKNSEDLEEEQDDFIRIRLGYNSRNNYHRQVLLGFMNELASSEIEPGYDAIHI
DNQVNDMYFVHNGTKLVIQGDGYFDVNNIYPVAVKADAAGNVKFMLDKVENLDENQGIYI
FDNMTGIYHNIRNNAFEINLDAGLHDRRFSLRFSPRENLGIENPTLEQGVDIAFTSNNNT
LHIKNKLLDTTVTSVTAYTILGQSLTTWNVENQTQQNIQVPISGLSAGAYIVKIITTDGE
LSKKIIVK
>LONDMIMF_02407 hypothetical protein
MKKTLPFLFFVLASGFANAQNVYNFGFSGTTTEMETAGWVRTNQSSPSTTTLWTVASYTP
VTVNLAATPAVQGNPFNDREYATGEVSPVPNGQAGGANSFALVNFTSTTGAGNISNWLIS
PVVTVENGDVVSFWSRKGTSGTTDYADRLELRMSTATTHTNPTGGSTNVGSFTTVGVTVN
PTLATGFVYPKVWTRYSFTVSGLTGPTAVKFGFRYFVTNGGPSGANSDIIGIDTFEVSRA
LSRDDFFANNFSMYPNPSTGIVNLSGKNNVAINTIQLTDLNGRVVRNINANGVSETQINI
SELTSGVYFLNIQTDSGTGSTKIVKN
>LONDMIMF_02408 S-adenosylmethionine synthase
MAYLFTSESVSEGHPDKIADQISDALIDNFLAFDADSKVACETLVTTGQVILAGEVKSKI
YLDVQQIARDVIKKIGYTKSEYMFEANSCGVLSAIHEQSQDINQGVDRASKEDQGAGDQG
MMFGYATNETEDFMPLALNLSHKLLQELAVLRRENNEIKYLRPDAKSQVTLEYDDNNKPV
RIDAIVISTQHDDFDNEVNMLAKIKKDLIEILIPRIIKNNPQYAHLFNDKIQYHINPTGK
FVIGGPHGDTGLTGRKIIVDTYGGKGAHGGGAFSGKDPSKVDRSAAYATRHIAKNLVAAG
VAEEILVQVSYAIGVAKPMGIYINTYGTSKVNLTDGEIAKKVEELFDMRPYFIEQRLKLR
NPIYSETAAYGHMGRKPETVTKTFKTPNGEEKTVTVELFTWEKLDFVDKVKAAFGL
>LONDMIMF_02409 hypothetical protein
MKNYSLGFLLFLSVISYAQNKTEKTVYVSNSLGQDIKLNLYDNKKYELVVFYGDYEVKND
TLFFNNNYSTESDFTVAFSPDANPAMGKIKVNLKGVSGYYSGIYIGTQSGKSEPDYKSVY
DLAGELNYDDTEVNFEINKAEYIYLAKEDYSGETSLYKYALPRNANKIQIEYTPNYLGKV
NLQGYYNEKNELVISENKKNPLTFIKENEKPKVVEIREKPIEIIKKKDWTFPGKTDMYGY
GVVDSAAVAPVSNFKLVVQDNLQKAIEATKKTPQKFLVVSYDPDNKNAKTAFDEFVQSQQ
YTIGNYSSYGSDTDYDKYNYYLATAKDKSWATKNVMFKSATIVMDADGNILSQTEKNLPE
NASLFDVYYSSIGEKLKYVKATVDLNKVLDSKKAKDSEIVKKLLPLSDENLYSWSIEPPI
KVAVGVADPSDVQSDTIQEYPNYENQTAYTKVNFDKKKLLSAWDRIVNSHAKDKTPDMDF
VKIALAEVQNRGFYYKIFNEERPLDETNFKAVDYLLKHYDAILEEQKKTSGQGDTIDYYG
DYTPTIESQLPLAISNGISQIGENTDEKYRNRIMDVYKKVIAKKPQDYTTNIEYLRILHG
IAEAQNKENPFVAEYDAFFKGVFKGGKNEIEILDDLYTSQNKIDYSYNDWASFKNSFSNI
SNDAAWFVVQKSKDSESIKKAIQWSESSLRIEKNNPYYLDTLAQLYYKNGEKQKAIATQE
QALKFSDIMEEESKADLEVVLEKMKNGTY
>LONDMIMF_02410 hypothetical protein
MKKILFLTFLFLSISGYSQNIRFSGIVADANAVGLEMANVMAVNQSTKAMDSYAITDDKG
RFQLSLKANTAYKIKVSYIGYQAKEVDVQTQAENMVQTLVLEQGVDLDQVEIVQEMPVSI
KGDTIVYNADSFKTGTERKLEDVLKKLPGVEVNADGQIEVEGKKVQKLMVEGKDFFDGDT
KLGVKNIPADAIDKVQVLRNYNEIGALKGLENNEENVAMNIKLKEGKKNFWFGDMSAGIG
VGHEDSRYIVNPKLFYYNPKYSINLISNFNNIGELPLTIQDYFKFTGGFRGMMQKGGSSF
NVSSNDLGIAMLRNNRAKEIETKFGATNFSYNVTKKWSLSGFAILSSSETDLETRSRSTI
LETGVRQKNEEIAHQKSNLGLFKFSSSYKPNTKLQFDYDVLMKQSKQDENNNLLREFIVN
DVTSAEDIYTKKKQNPTSINQNASLYYTANDKNVFAFEMQHLYQDEDPFYNANLMTQPFA
LSGYVENQNRNNLNQSRFVKTNKLDAKLDYYYMLTPKSNINVTLGNTNSHQNFNSSIFQI
LDNGDRNNLVAPENNNKVTYDFNDIFVGLHYKFLSGKFTFTPGFSAHYYNMDNAQLGTNY
KQNFSKILPDFYALYQIKKSETLTYTFALNNNFTDINNLVMGNVLSGYSSLYNGNRFLEN
STTQLHSLRYFKYSMYNLENIFANISYSKVTDAVKSRIVFDNVNQTLTPYNSNLADETIS
ANGAYGRSFLRFYKVSAGIGLNWSKFNNIQNGNVTTQESFMQNYTLRASTNYRALPNLEV
GYNFVVNDYAGSKFYTDKPFAKLDYYFLDSFSFVAEYEFYHYYNSSKTVENEYDFLNASL
IYQKKNSKFEYKIGAANLLNTRTLNDDSFNQFRTTTSQYRVQPRYIILTLKYNL
>LONDMIMF_02411 hypothetical protein
MIKSAITAAIAVALFSFQQMKAQEFTGRATYESKTIMNDIQISGSNMTPDMKASLEEKMK
KGLEKTYELSFNKTESVYEEPQKLEVPSGSGARVVMVNTSSSADGKSYKNIKDKTVMSEE
DFFGKEFLVSDSLRKWDWQLINETKKIGNYTCYKAIAVIPVTKEEMENYEKMKNKKSEGK
TQLFTPSEPKDRTITVWYTPEIPVSHGPAEYWGLPGLIMEVNDAKTVILCSKIVLNPKDK
VVIKMPKKGKKVTKKEYEALIEKHLESMKDSKGNIHINLGN
>LONDMIMF_02412 Sensor histidine kinase WalK
MKSKNYKYILFFISVTIIATISLQVYWNIKNYAENKQRLINDVQIALDNSIEHYYAEDVK
TDFMTFIGNDTIKDSNFVQNIVSDSIFINAITKRKGKVKASKKLVATSTFTEDNSPKTTT
VIKINNTGETSKQEINFIDSPKSQSSKATKGKTTEMHGKPFGLGPGKLSEVKVITGKRAM
DSISKIQNFTNKILISLTRDSIEFEKISKTLDKELARKDISIQYGMQLLKMDTVFQNYHV
NKNSHLPLSTTSNSTFLPPNQKMKLLFSNPVIVILKRSMVEIILSFLLSLSIIGCLFYLL
KTINKQKKVDEIKNDLISNITHEFKTPITTVATAIEGIRNFNAVNDTEKTNRYLDISNQQ
LKKLEIMVEKLLETATLDTDKLLLHKEPTNIISTIRNLVEKHKVIHPEKNISFHSNMEQL
IVEIDPFYFENTLSNLIDNALKYGGNIIDIYLKYTANILEIMVQDNGPGIEKDQREKIFD
KFYRIPKGNRHDVKGFGIGLYYSKKIIEKHGGTLELLSSQELTIFKIKLSDV
>LONDMIMF_02413 Response regulator MprA
MSSKIKIILAEDEPALAQIIKESLETRSFEVVLCKNGEEAFEAFSREKPELLVLDVMMPK
KDGFTLAKEIRKLDKKTPIIFLTAKSQTQDVVDGFQLGGNDYLKKPFSMEELIIRIHALL
GRIQLEKNDENISIGNYIFNQTKQTLDYSGNIQFLTHREASLLHLLIENKNDILDRSLVL
KKIWGDDDFFNGRSMDVFITKLRKKLSLDPNIQIINVRSQGYKLIT
>LONDMIMF_02414 hypothetical protein
MKKYLIFLMMLASVSNSYAQKQGTSAMGSQEFQGMAVYESKTSAPDMKSRFSANREITPE
MQKTIEERMKKMLEKTFILNFDKATSIYKEDERLDTPGQNNGGFRMMSSMMGGGGTYYKN
VKEKTFAVDKEFMGKEFLIKDTLPKLQWKLEGEIKKIGDYTCYKATAVKKVVQSDFRNFR
QKKQEETKDKKEEKTEEKKTNFMDDFEMPKEVNVIAWYTPEIPVNQGPEGYWGLPGLILE
VSDDKTVILCSKIVLNSKEKASIKAPTKGKVVTQKEYDEIVTTKMEEMKEQFRRGGGRPG
IRIGN
>LONDMIMF_02415 hypothetical protein
MRKIIFIALILIPLLAFSQQQSIIPFFSNSEKWETGQYIGKDNFGNFYSINQNEFKKTSP
NQVYFYKNVSLGKIHQVDLQNPLQLVLFYKQFTTAVLLDNQLNETARINFSELQTPLNPE
AVSLASQNRLWVYDMLTQKLGLFDIQKSTFQSITPSFKENVKFYQSDYNYFYWIDTKQNL
YVSNLFGKVNFLGHVPDYSQLQVISPKQILMKIDNGLFLYNLEDESLSPIQLNEKSFSHF
SFKDQILSIFTENEISQYKITLP
>LONDMIMF_02416 Deoxyadenosine/deoxycytidine kinase
MHIAVAGNIGAGKTTLTKLLAKHFKWEPHFEDVVDNPYLDDFYHQMERWSFNLQIYFLNS
RFRQVLQIRESGKNIIQDRTIYEDAHIFAPNLHAMGLMTNRDFNNYKSLFELMESLVEGP
DLLIYLRSSIPNLVNQIHKRGREYENSISIDYLSRLNERYEAWIQSYTNGKLLIIDVDNI
NFVDNPEDLGGIINRINAEINGLF
>LONDMIMF_02417 Putative K(+)-stimulated pyrophosphate-energized sodium pump
MLVSLHLHLLTKTNKLYMESIMIYVPAILAVVGLLFMAIKRSWVLKQDPGDGKMKEISEY
IYEGALAFLKAEYKLLTFFVIGASIALAAITFLPGATTHLSIVIAFIFGAVFSALAGNMG
MKIATKTNVRTTQAARTSLPQALKISFGGGTVMGLGVAGLAVLGLTAFFIFFFHFFMNGQ
WVEGIYDGETRTANELMTVLLETLAGFSLGAESIALFARVGGGIYTKAADVGADLVGKVE
AGIPEDDPRNPATIADNVGDNVGDVAGMGADLFGSYVATVLAAMVLGNYVIKDMGGSISD
AFGGIGPILLPMAIAGVGIIISIIGTMLVKIKNNDAKEAQVQGALNVGNWVSIGLIAVAC
YFLVTWMLPETMKMKFYGEGYHEISSMRVFYATLVGLFVGAVISSVTEYYTGLGKKPILA
IVQKSSTGAGTNIIAGLATGMVSTFPTVLLFASAIWASYAFAGFYGVALAASAMMATTAM
QLAIDAFGPISDNAGGIAEMSELPKEVRQRTDILDSVGNTTAATGKGFAIASAALTSLAL
FAAYVTFTGIDGINIFKAPVLAMLFVGGMIPVVFSALAMNSVGKAAMDMVYEVRRQFREI
PGIMEGTGKPEYAKCVDISTKAALREMMLPGILTIGFPILIVVIGKLVYADNNQLIAEML
GGYMAGVTVSGVLWAVFQNNAGGAWDNAKKSFEAGVMINGEMTYKGSDAHKAAVTGDTVG
DPFKDTSGPSMNILIKLTCLIGLVIAPILGGHEAKPVIDQLEGVEIVLDETTPAPEVKQS
TKEIRIESVKDADGKVKATVTTVTDSAEAVEVFEGTEAEVAAKLEAYKKK
>LONDMIMF_02418 Inorganic pyrophosphatase
MSAAKQKSFDVLIEIPKGSRNKYEYDFNLKKIRYDRMLFSSMMYPADYGFIPETLALDGD
PLDVLVLVTEPTFPGCVMEVKPIGVFHMADEKGPDEKIICVPVSDPIWNKLNDLSDMNPH
MLKEIEHFFQVYKDLEQKKVDVEGWGDVNEAKEIIEKCVDRFESLENRPEELFSIR
>LONDMIMF_02419 TonB-dependent receptor SusC
MTKKIFVSLSFFFLCINFLTAQTKVSGIVYDEFKQPLPYANVVFKGTTEGIITNEEGKFY
LESKSTQSAIVVTFVGMEPKEVPIEKAVTYNMEINLGAGKMLNEVVIYTGKTSKKNNPAI
DILRKIWARKKKNGLRQFKQYQYDKYEKVEFDLNTIDSALMKSKLFKGMEFVFEQVDTSD
VTGKSYLPIFINEALSQVYGDNTNGKLKEITKANKNSGFSNNQQLIAFIKDLYAEYDIYD
NYLKFFDKDFVSPLSRTGINVYNYVLHDSTYIDNKWCYNIVFYPRRKNELTFKGDFWVND
TTFAIKKINLTASRGANINWVKEIYIEQEFEVLNDSVFLLTRDHMMSDFAFSKKDKSRGV
YGKRTTLFRNHKFDIKKEDKFYKEDVNFYDPEIYTKSDDFWNENRFESLNKDEKGVYKML
DTLKTVKKFKRLYNLVSILGSGYIEMDNFDYGPIFSTFGYNDVEGIRVRTGGRTYFGPND
PWRIQAYTAYGFKDNQFKYGISGKILLDKKNRFIISGGNRRDIEQIGVSLTTSNDLLGRS
FASSSLFASGDNSKLTSVNLTNFSAEVEPLKNLVFQAGMSYRTLKSASPSTFSLDYYKVM
PDSQNPQGVIENEVNQYEFNASIDYMPGRRPIGYGVERTNVDSNFARLYLSFSQGIKGVF
GSDFDYEKVQLYYRQPLLVGGFGRLFTTFEAGKIFGTVPLGLMGVVPGNQSFFIIDNTYN
LMNYYEFMADEYVSLHFEHNFNGRLFARVPFLRKLNWREIIGIKGVYGTISDENRAINAQ
TAIPYRAPEDVYWEYHAGIGNIFKVLRIDFAWRGNYLDLPDANKFTVKASFGFYF
>LONDMIMF_02420 Pyruvate dehydrogenase E1 component subunit beta
MRTIQFREAICEAMSEEMRRDESIYLMGEEVAEYNGAYKASKGMLDEFGPKRVIDTPIAE
LGFAGIAVGSAMNGNRPIVEFMTFNFSLVGIDQIINNAAKMRQMSAGQFPMPMVFRGPTA
SAGQLAATHSQAFENWFANTPGLKVVVPSNPYDAKGLLKSAIRDNDPVIFMESEQMYGDK
GEVPEGEYTIPLGVADIKREGTDVTIVSFGKIIKEAYTAAEELQKDGISCEIIDLRTVRP
MDHDTILKSVKKTNRLVVLEEAWPFASVASEITYIVQERAFDYLDAPIQRITTADTPAPY
SPTLLKEWLPNAEDVVKAVKKVMYR
>LONDMIMF_02421 hypothetical protein
MKKTKWIILFAISFILCVLFYIKYDSKGYEYGLGCNYCNKKMPYHLTPYDERDGSRFSFT
LKDEDDFELVGTGFRYQTTNFEIKNLLAYGYNDTSVIVKCTDSLNTVRYLISFETGYTSK
KGNPEISFKDLSIDDFQKVKDKYNWFEIDKEKGYAIDRNKFLFVLGALLSLVFGLWGLFK
LKNK
>LONDMIMF_02422 hypothetical protein
MNNYSKIFIDISDKNPIFEIDKLIFIDKWNDFVSANGHSGIFAFTNDDELFLEFTNDYDF
QLYSNFII
>LONDMIMF_02423 hypothetical protein
MQYDNFYVSDEAISLDYLKSKNVTTKFVLINFASKSSLKIIPFFNTIKNEELTALLNLFT
EFAINLRLDDLLGKLHIVILKILSQDDNEQMIIIHDAGFTNSSIDFLVSNLNLLKHQLQN
KSVIVCPNLIY
>LONDMIMF_02424 hypothetical protein
MNLKFKNQINRKTKFLALIILLVSCDNKVEIVMRNKKKIYYNVLKETQHEAQSRTTYCFE
KNGYVYELRYDIKDELKKRYGYKISFDSPKKWFITGDSITIGKETFFIKLSKNDVLELYD
KWNEKLILTEEKDDKFPIEFVLRKEFIEFVNEKGDTIKTRNISI
>LONDMIMF_02425 hypothetical protein
MRKIFLLLISSFYLIGCKSQKTDIEKQIDLAGIYFVKDTSEKLEINTDGNYILYNPKGND
YYEIEKCVYASKGKWKLLNNDVFEITSEDYQVKQKGFEYELQKENKYSQDSLYINVKFPN
DLHPVKLNFYFNNSNNKSIHTESTVIKLLKSKYLLPKSTYSINRNHITFTLDANISGTNL
YNGRILFEIFEEDVDTEKTNYLTITLPNFDLCFYEFEPYNQEIIFIKNTKELFWKGYVWN
KLHN
>LONDMIMF_02426 hypothetical protein
MNHKLFRKTLLIIAFLGWLFYLYHTSATYLNISLSDNYNAFSQEDINSLLFTLKYGFILS
FFSIFFTFLLLRNKESR
>LONDMIMF_02427 hypothetical protein
MKHIVQNPKKVLLIKSLIYFLSLLLLSCNVENNKNTYEITDKHLIKILEEFIEVSKQHNR
QVEVISEKKIINTDIIMNFYVSNHKDTVLTFINTKPFTCENIKGLATINGYNVYLYSTLD
TNFLDKKFKITKPLDSCEKHIEKRIIDVNFQTSYYVKNNTFIKMAVIVEQMIK
>LONDMIMF_02428 hypothetical protein
MKKIIIISLTVFVIVLASLYFLFDFPIILNGNQKESLIESDTADNIFNPIKSIDFNTGNN
RVYLYFGNADIAELPKKMIKSKLFECSNNEILQDLKRDFIFKKSGGDMSTCESKLLVYKN
DKLVFCTSFVLTDNVIGLQNSLAGWADALNQENLKNNFLKFKPTRKIFIKL
>LONDMIMF_02429 hypothetical protein
MKASAVSTITKSLPIALSVLVNYSLLATLGYINLFI
>LONDMIMF_02430 hypothetical protein
MEIVLNKILSEIQRQEDMLSSQMMQTADEAYQMTLFLKEMLFTIKMKVLQTGFKDERQEI
NFFKNIKPQILGKLIYYNKVFRIETTCPVSAGRIHQSYFENQLKILKSEYKESISNEDFY
RYYRAGRTDRDHSYFRLGKVNYHDGLKSAVFEIDLSFSTYYDNKVAHIIANELLYTFLLT
KINPEKNPDTILMNGDASKDISWTNSQNALIELIYALYASNSIAYGKIGIRKLALIFQIL
FRTPLNDIHHSFHRMKTRAGSRTAFLDQLKISLEEYMDKDL
>LONDMIMF_02431 hypothetical protein
MNIITVDEEVWKHLNERLKAISEYILKLEDTSYDSLWLNNHEVCQYLHISEKTLWRMRTN
GQIAFSKMYGQYYYTIGAIKEMLNANAVQTTDEYVEQLMAKGKSYIEKGRKLKSGNN
>LONDMIMF_02432 hypothetical protein
MNIDKMEFVAWMERIMDRLDILGNHIDDLQKKRNSIDGEELLDNQDLLQMLKISNRSLQR
YRSIGKLPYYTISGKLYYKLSDVHQFIRESFNPPLPKLDANK
>LONDMIMF_02433 hypothetical protein
MSEETTNKQEMPEQLSDILLVLDKEKMKIQAVKSIGENGKMETVDPTKKNQNQFMRVDKS
GDFFSNFFSNFFSQLKNPTNFTFFKVPAPVAAEKAEELQKHVDKPTPQGEKVLKEHEVKA
EPQPDKKQENQNNMATAQTTTEASEYRYKPEQIDWDTMKNLGLSKEYLEKRNLLDPLLRG
YKTNELLPIGINLGGSILRTDARLSLQQGEDGNVIVAIHGIKKEPNLHFEFFGHKFTDED
KKNLLETGNMGRVVNLVNSKTGELMPSIISIDRLTNDVIALRTEFIKIPDEIKGVKLNDE
QKQTLMEGKPLYLEGMISTKGTEFSATVQFNADKRYVEFLFDRSNNNQQAQTNQQNTQQS
NQQSQPQEAPRTFRGKELDDEQYNKFKAGQTIYVELKDKKDQPYKGYITFDKDTGKTNFE
FPGQYKARVEPAETHKTQTAVNSEGKTNEATRNVQEPLKSGQQRPKNEKQQEQQDNKPAK
SKGRKM
>LONDMIMF_02434 DNA topoisomerase 3
MKTIIAEKPSVAREIAGLVGASDKKDGYLTGSGYFVTWAFGHLIGLGMPEDYGISGFDKA
SLPILPNPFLLTVRKVKKDKGYTADTGALKQLKVIEQLFKLSNSIIVATDAGRECELIFR
YIYEYLKCSKPFERLWISSLTEKAIKQGFDNLKDGAAFAGLYQAAQGRSRADWLVGINAT
QALSIAAGNGIYSLGRVQTPTLALICKRYLDNKNFTVKKYWQIQLSHNKAQVDFKSISAT
KWDEKQLADDTLKAIQRGATPTVSSVETKSVTEQPPLLFDLTGLQKEANKRLKLSAEATL
NIAQSLYEKKFITYPRTGSKYIPEDMWAEIPTLVRALQNREDCKQALTKIKWGRFNKRIV
NDLRVTDHHGLLITDKVPSVLNADENKIYNMIALRLLEAISQACVKEITDVSLQVLHYDF
TAKGCKIQEAGWRSIKGSFTDDGEDPVQELPELHKGDELAIKEAAVLEKQTKPPVLYTEA
GLLSAMETAGKEIENEEERKALKNIGIGTPATRAAIIETLFTRNYIERDKRSLIPTEKGL
QVYGLVKDRKIADVAMTAEWELALQKIENNEADAGTFQKEMEAYAKSITDELLQTSIAST
NQPRLTCPRCESQQLIIRDKIVKCPDEACNWVQFRTVCGVQISIENITSLVNKGKTSLIK
GMTSKAGKKFDAYIVLKENAESSFEFEKNKSTKRNGK
>LONDMIMF_02435 hypothetical protein
MENKPSIVPKEIRNLIYTIRGKQVMLDSDLAALYQVETKNLNKAVKRNIERFPVSFCFQL
TEEEVENLRFQFGTSSLSYGGRRYLPYVFTEQGVAMASAILRSDIAVKISVEIMEAFVEM
RKMLISNAALFHRLDNIELKQLEADQKFEEIFKALESDKLHSEKGIFYNGQVFDAYAFVS
DIIRSAKNSIILLDNYVDDTVLTLLGKRNDNVTATIYTKNIGNQLRLDMQRYNSQYPPIE
IEIFSDAHDRFLIIDHTELYHIGASLKDLGKKWFAFSRMDIEVGRMLHILNKP
>LONDMIMF_02436 hypothetical protein
MDVQQKDLSFFRLRLQELLNSSFPEKAHDQKFIDQRSSWAANAYEGAFRSGNAVEQCDEI
ANYILFEGLHFSKFDTVFKVVCNEFDTIMADEELRLFALKMFPVCEPVFAGYKLTDDFAY
GYEFDVLYTELTGTISIWIEENGLQ
>LONDMIMF_02437 hypothetical protein
MGFSKRFHLQQNIDALRIVFKLEKEKRQATVGERLLMMRYSGFGGLKFVLNPIENKIDIN
HWRKTEHDLFPLTQELHQLLKENSEDDKQYRRYVDSMKSSVLTAFYTPPKVIDAISSALR
DNGLHIDKFLEPSAGIGSFIQSFSENQTASVTAYEKDLLTGKILKQLYPDSNIRINGFEE
IPEREQNSYDIIASNIPFGDTSVFDLSYSRSRNSAKEQAARSIHNYFFLKGADMLREGGL
LAYITSQGILNSPKNEPIRRALMQDNNLVSVVRLPNNLFTEYAGTEVGSDLIILQKNTAK
KNLTDREDLFCQSKPTEYNTPGNALFQDSARIIHTDQKLDTDPYGQPALIYTHKDGVEGI
AEDLKQMLSEDFGKHLNLNLYRGERSDEPVIQIPIEPKVTPPVIDPVIIQQKPQSVSTPV
LRQESPQELKQLSIFDLFESAGEPIMVLAPPKRTTQAKRQSTKKRRGTTSRQPDLFSSAR
QQSYTPLKSNGAANGSHQVNDKKQEAIGDLFSQTNGNGQSDKTAIATTNINAIPEPAPYT
GELQSFHRNDCLVVDNGWVGYLQDVQRNDDKATATFHPLQLPSSQKARAEAYIAVRDSYI
NLYQKEAEKQTEHKEERETLNLLYDGFVKKYGNLNAADNAKLIKTDSAGKEIPYLERIIG
GVIHKADIFSRPVSFSTTTLATDNPEEALAASLNKYGNVDLDFMSEISSLPTDTLKEALH
GRLFFNPLQQEYEIAERWIAGNVVEKADDVRAYLENNPDDTEAKESLNALEEARPKRIDF
EELDFNLGERWIPTGIYARFASHLFDADVLVHYSESSDDFSVKCHQGNMHIWEKYAVKAE
SRTFDGIALLKHALVNTTPDITKKVMVGDQEVKVRDMEAIQMANTKIDEIRTAFTDWLHA
QNDEFKNRLTDQYNDTFNCFVRPNYDGSHQEFPGLDRKGAGIEDLYSSQKDTVWMIKLNN
GAICDHEVGAGKTLIMCTAAQEMKRLGLAHKPMIIGLKANIPAIAEDYRKAYPHAKILYP
GIDDFTPKKRLRIFGDIKNNDWDCVILTHDQFGMIPQSPEIQKEILEIELDSVERNLDAL
KSQGKEVTRGMLAGVIKRKENLEVKLKTLQHDIENRKDDIVDFKMMGIDHLFVDESHQFK
NLMFNTRHTRVAGLGNVDGSQKALNLLFAIRTIQERTNADMGATFLSGTTISNSLTELYL
LFKYLRPRALEKQGIHSFDAWAAIYARKTTDYEFSVANNIVAKERFRYFIKVPELAQFYS
EITDYRTAKDIGIDRPTKNEVLYNIPPTPDQDAFIQSLMQFAKTGDATLLGREPLSQREE
KAKMLIATDYARKMSLDMRMVSGIYDDHPDNKASHCAVNIAKYYNQFNAQKGTQFVFSDL
GTYKPGEWNVYSEIKRKLVEDHGIPAHEVRFIQEAKNDKQRKELINGMNEGKIRVLFGST
SMLGTGVNAQKRAVAVHHLDTPWRPSDLAQRDGRAIRKGNEIAKFFADNKVAVIIYAVEK
SLDSYKFNLLYNKQLFIDQLKTNNLTKRTIDEGSMDEKSGMNFSEYVAILSGNTDLLDKA
KLEKQIAGLESEKQAFNRSKSSAKFKVQDYMEMLQSTQSRLSRMSTDWENLQQRLQKRLD
GTIENPVLLDGLPPNANPKQIGAKLNEIANKARTAGDYREIGNLYGFQLLVKTELPKDNS
TLERVNRFFITGEGNIKYTYNNGLMAKDPETAAMNFLRALEKLPGFVKQEQEKIAEIQKD
LPILQEVVNGTWAKESRLSELKTELAAVERKIQLSITPETKQDASEQAEKQNEAPKVQES
IIRTKGVHSPRGVL
>LONDMIMF_02438 hypothetical protein
MKRMDKFYNETYLKLETAIQELEIETDCPIKRIEAVIHHIIQSLADLKDFVLKNDFKNME
EEIHFFKYQKPVIVSKLIYYNAIYKIETRRPYGNKRTKKYFTKELKKLKRFFENNLDFYK
YYRSNNSFLDEKLFLRGRHDIKLCLDTYYFQSDQTFSTSHDYKSAKIIANDLIQVYLEDR
LNNINVKRGSDNSLKWTASKTALTELIYALYSHGVFNNGNTDIKLIAKAFEDAFNIELGD
FYHTFMELKARKINRTKFLDSLCEALIKKMDEKDEK
>LONDMIMF_02439 Copper resistance protein A
MNRYNKIPIRILQTVLILLCTQTLFAQRVVHYELYVKDTLVNYAGKQKRAIAVNGQIPMP
TLTFTEGDTAEIVVHNQLKESTSLHWHGVFLPNKEDGVPWLTQKPIAPGTTYTYRFPIIQ
HGTHWYHSHSGLQEQIGMYGSFIMKKRSDDKTFRKGIDDLPTVPIILSEWTNLNPDNINR
MLHNANDWAAIKKGATQSYVEAIKEGKLGVKVKNEWKRMLAMDVSDVYYDKILINGSHST
DLKTIDGKKLKAGDKVRLRVSNGGASSYFWLRYAGGKITVVANDGNDVEPVEVDRLIIAV
SETYDIVVTIPQDGLAYEFLATTEDRTQSASYFIGDGVKQLISPLPRLKYFEGMKMMNDM
MKMNGDLNDMGMKMSLNQMDMNVVMYPEITGDATKKADHSKHEGMDMDNDANRYNANALG
DIKTLNYAMLQSPYNTSLPNDAPVKELKFTLTGNMNRYVWSMDNKILSETDKIPVKKGEI
LRITIYNNSMMRHPMHLHGFDFRVINGKGEKSPLKNVLDIMPMETDTIEFLANEEGDWFF
HCHILYHMMAGMNRVFEVGDYNNPYLPDKAKAYKELQRESNMPHFMAQNDFATNGNDGEA
MLMNARYQLGTEWRLGYNDMHGYEVETHLGRYLGRMQWFMPFIGFDWRYRRLGIDEHEKN
LFGQRNEKDTRRQFSLGFIYTLPMLVNFQAEVYHDGIVRLQLMREDIPISKRLRGGFMVN
TDLEYMGELRYIINKNIGIRTHYDSDMGFGVGLALTY
>LONDMIMF_02440 hypothetical protein
MTIKKKIILGLAVVLIAIQFFQPLRNQAVEVPATHIERVYAVPQNVKAILVQSCYDCHSN
NTHYPWYSRIQPGAWYMAEHIKKGKEELNFSEFGDYSVRRQRNKFRAMAGQVKDGEMPLS
SYTLIHRNAVLSPEDKQVLIAWFSTMEDSIK
>LONDMIMF_02441 hypothetical protein
MSKIIICFISSLTLLFTACGQTGSNKDEAAQHHSQATPASHEHDVQIGELVPSDEVCMVN
DAYMGKKQFEVKFDGKTYYGCCEMCKERIPKDATVRMAIDPYSHKQVDKANAVIAVTGNN
GEVSYFENKENYAKYVKKQ
>LONDMIMF_02442 hypothetical protein
MENMQNNHHTGHASGHGAHNSSHASAMYKRFAIMAVVMFGAMYFIMYAMIDGLRNLIPNI
NNLYMTLLMTSAMLLIELVVMKVMYPNRKMNWAIAIISVAVGIFSWFGIREQINVGDKQF
AKGMIPHHAAAILMSEKAHLTDPELIELQKNILKTQAEEIELMKRKLKEFEESK
>LONDMIMF_02443 hypothetical protein
MKNLTLSIIAVIMAFVTVSCNQASNKNEQSSSDTAVVSQEQSASQPKEDDTVAAPVVSET
PSGQEAKATGKEEAKNFSIAPIVTDYLSLKNALASDNDKAAANAGKKLLGTLNKVDMKTI
PADKHKEFMEIFESAKENAEHIGENAGKIDHQREHLASLSEDLKDLVSLFGTSQTLYQDH
CPMFNDGKGAVWFSESKEIKNPYYGSKMLTCGKVEKTINSK
>LONDMIMF_02444 Copper-exporting P-type ATPase B
MKKYTCPMHPQVLKDEPGKCPLCGMALVPVGGSSVSHVQKSGHGHSGHSHHNQARDSFNK
HEGHHTGDFLARFWISLVITIPILLLSHMIQQWLGFSLAFNGDKYVLLALGTVIYSYGGL
PFLKGMIGEVKAKAIGMMTLVAIAISVAYVYSVAVVFGLEGMDFFWELATLIDIMLLGHW
MEMRSQMAASRALQSLVALLPNDVTVERGGEAVKIKLEDLQSGETAIIKPGEKIPADGLV
LEGLSYINESMLTGESVPVKKEKDGKVIAGSINGDGALKVKVTAVGKDSYLNRVINLVQE
AQATKSNTQNLADKVAKWLTFIAIAVGIGTYAYWYASSGDIAFALERMVTVMVTACPHAL
GVAIPLVVAISTTLSATNGLLIRNRTAFETTRKLSTVIFDKTGTLTKGSHAVEKVIPLTD
EYNADEVIQYAAAVQQNSEHHIAKGIMATLKEKSLALWKSENFSYMQGIGVKGVVNGKNV
LAGGPNYFTENHLSLPEIPNEINQEAETVNFVLIDDRVIGIITLADSIREGSAQAIEELK
KMGIKSFLLTGDNDRIAAAVAGKLGMDGYLANVLPHNKQEKVKEFQAKGEIVAMTGDGVN
DAPALAQADVGIAVGSGTDVAAETADIILVDSDPRDVVKLIDFGKLTYKKMVQNLIWAVG
YNVVAIPLAAGVLYPNFVLSPAMGAVLMSVSTIVVAINASFLKIKK
>LONDMIMF_02445 hypothetical protein
MVQYNDMVQALKDLRQRGYSMDFSLLPDCLYCASRSLKLKPEDFTVTETHRFESLDSSPD
NNAVIYAISSNDGKNKGVLVDAYGAYAEEMTHEMAKKLSAT
>LONDMIMF_02446 hypothetical protein
MVIAVLLSSINGFAQIKNAKTETVKIYGNCGMCKTTIEKAGNVKKVASVDWNKDTKMATL
TYDGDKTNQDEILKRIALAGYDSEKFRAPDDVYAKLAGCCQYDRPVKTVAKNKEAGMDMN
AGHGNHDHSQMAAPANKDAAQNQSQLKAVFDNYFSVKDALIKTDAATASAKAAELAASLK
AVDMNKLSAEEHTAWMKVMQDLTANAESISKSKDVAKQRSAFAALSGSIYTLAKVSKQDT
PVYYQHCPMYNGGKGANWLSKENAVKNPYYGSQMLTCGSTVETIK
>LONDMIMF_02447 hypothetical protein
MENKQFQFKTNINCGGCIASVKPHLDKAEGICHWEVDTANKDKVLTVKSEGITEQEVIST
VQKAGFKIEPLDA
>LONDMIMF_02448 putative copper-transporting ATPase PacS
MATNRENIYIPLEDVESEHCALIVEKGLAQVKGVETHKVELNNRRAVITVDSNETVGEAV
KAIKDLGYGVPTVKSAFPVLGMTCASCAGSAESIVKYQPGVVNASVNFATGNLTVEYLPN
MTDASTLQKAVQGVGYDLLVEDETKQQETLEAIHEKKFRTLKNKTIWAIILSLPVVIIGM
FFMDMPYADPIMWLFSTPVVIWLGRDFFVNAWKQAKHRSANMDTLVALSTGIAYLFSVFN
MLFADFWHQRGLHAHVYFEAAAVIIAFILLGKLLEERAKGNTSSAIKKLMGLQPKTVIVV
QADGTEKQTAIEDVSAGDVILVKPGEKIAVDGMVISGNSYVDESMLSGEPVPVLKKEKEK
VFAGTINQKGSFRFRAVKVGKETMLAHIIKMVQDAQGSKAPVQKLVDRIAGIFVPTVIGI
AILTFTLWLILGGENGVVQGLLAAVTVLVIACPCALGLATPTAIMVGVGKGAENGILIKD
AESLELAKKVNAIVLDKTGTITEGRPQVTGIKWLNNEDTAKEILLSIEKQSEHPLAEAVV
KHLGDVATTSLSMFDSITGKGAKADHDNETYYVGNKKLLAENNIAIAGELQDQAEEWGKQ
SKTVIWFANSKKALAVIAIADEIKETSVQAIREMQEMGIDLYMLTGDNEATAKAIAEQTG
IKHYKAEVLPQHKADFVKELQSKGKVVAMVGDGINDSTALATADVSIAMGKGSDIAMDVA
KMTIISSDLTKIPQAIRLSKQTVATIKQNLFWAFIYNVIGIPVAAGILYPVNGFLLNPMI
AGAAMALSSVSVVSNSLRLKWKK
>LONDMIMF_02449 HTH-type transcriptional activator RhaR
MNTIFIKNMVCDRCIMVVQNELEKLGLDAKNIKLGEVILSKEITSLEKENLSKTLEPLGF
EVIDDKKGRIIEKIKNIIIDLVHHQDSDVKTNLSDVLSDKLHHDYNYLSNLFSEVEGTTI
EKYFIAQKVEKVKELLVYDELLLSEIANRLNYSSVAYLSNQFKKVTGLTPSHFKQIKEDK
RKPLDKV
>LONDMIMF_02450 hypothetical protein
MRRVYEIIKNKIREYQRHPPYPRSINTVMDLHDQLKKLFPDHQPSEEIEETESEPKELWV
QAEPMICKFEKRKGKPTTIIEGYTGSDDDFKILAKELKTKLSVGGTFKDDSIIIQGDYRD
KIMTILKEKGFKVKRVGG
>LONDMIMF_02451 Purine nucleoside phosphorylase DeoD-type
MIQSSELILNPDGSVYHLNLKPEHIANDIIFVGDQNRVEKITQFFDSIEFSTQKREFKTQ
TGIFKGKRITVMSTGIGPDNIDIVVNELDALVNINLETRQPKEELTSLNIIRIGTSGSLQ
KDIPVDSFVMSKYGLGLDNMLRSYKIDRITEEALGEAFLLHTNWDIRKGKPYVVRCSEKL
EKLIESDRIFKGITATAGGFYGPQGRVLRLEIQDPELNNKMDNFNFNDNRITNLEMETAA
IYGLSALLGHNALSLNAIIANRASGTFSEDPYKAVDELIAYTLDKLANNS
>LONDMIMF_02452 hypothetical protein
MLQEVILKFEELLVENLDYFKNTDKHVLEFKPENKWSKKEILGHLIDSAVHNLVRFTEIH
YAPKPYQYRTYNQEDLVSICQYQSADSNELIQLWLSLNKQILRIFKSVDSEALHYEIELN
DKSIINLRFLMSDYVAHLEHHIKQIQNNRYST
>LONDMIMF_02453 hypothetical protein
MKTIKIAGVPEHFNLPWHLCIENGEFEAQNIDLKWTDVPEGTGKLCQMLRNGETDIAVIL
TEGIIKDIVSGNPSKIVQVYVQSPLIWGIHVGAASNYRKLSDLKGTKAAISRIGSGSQLM
AYVNAHNQGWKTENLQFEIVNTIDGAVEALTSGTADYFMWERFMTKPLVDKGIFRRIADC
PTPWPCFVIAVRNEILETQPEIIKTVLEIINQTTEEFKDIPSIDKTLSSRYNQKIEDIQE
WLSLTEWSQKTLDDKTLNNVQNQLLELSIIDKKGTFADIAQI
>LONDMIMF_02454 hypothetical protein
MEKQGNIDFKKIKEKLQVKKPWDSIIIFLLNILIAIPVFIIIHQNIIDPNWYFHIDRILL
FILVVVIIQLVLRLMKTIIILCIALYLIALIYGSLFGNYGFNSVFEDYRSMVYSMSENPN
PQDIIISKLLPFPNKSKILNAIEYDNPKVRNFALLATTKYFRNVKGYSEYRRQIQSFAVF
KEIQRRWNYVSDPKGKEYIARATESLIHFSGDCDDHAILMAACVRAVGGTPRLIHTGGHI
YPEVLIGNKKADLEAINYLIKEVLFKEESKGKEIHYHIDERGQIWLNLDYTATYPGGPFM
SEEILGALTLN
>LONDMIMF_02455 hypothetical protein
MKKWLFAALLAFQFSNAQESSTIFARKQNEIKFDILSVIAFSKVHISYERFLNENFSVGI
SGSFQDSKDAKEDFDKGYDRTLPKYEVNPFVRYSLSHSQKSFYFAEIFVSANGGKYRELQ
RFVDESGNGYYDTFKGNYTDVAIGGALGYKLYIQEKFGLELFLGAGKNLFNTDKSPEVVP
RVGLNFGYRF
>LONDMIMF_02456 hypothetical protein
MKTIKILLLAIIGLAAVTGCGDDDEFYNSKYTSIPNLITIEHQNNYTVGDVLWLNTNFSR
YQPEPNQTTPLDIFKTTGGASFSFAYGLEKKTGTNTWTAIDIRSIIKDQGDAVANFYVIA
ESIYEPVSQNYKFRAGIPLSETGEYRLVFGLSEVSRLELSSNNNNSEDTFLTIQTTANNL
TAGYYNFTVQ
>LONDMIMF_02457 Uracil-DNA glycosylase
MQVKIHPSWKAVLSEEFEKPYFHHLIDFVKSEYTHHTCYPKGSQIFSAFDHCHFDDVKVV
IIGQDPYHGPNQANGLCFSVNDGIPFPPSLFNIFREIETDLGKPLPQTGNLERWADQGVL
LLNATLTVRKGEAGSHQKKGWETFTDAVIQKVSSEREQVVFLLWGGFAQNKRALIASKHL
ILTSGHPSPLSANRGLWFGNKHFSKTNEYLKSLGKKEIEW
>LONDMIMF_02458 hypothetical protein
MGIVLNQSAKNIAVTYFGFGIGAVNALFLYTSFLGKTHYGIVSFLLSAANIMMPLMAFGV
HSTLIRFYAKYKDEDKRERFLSFMLLMPFLLIIPITVITVFGYEQIASWIIKDNPTVEPY
LWLIPVVGLFMGYFEIFYAWVKVHMKSVFGNFISEVLVRIVTTILLCSIYMGWVDKDTFI
YCIAGAYGLQMLAMMVYAMYVKMPKFHVRLPENTRDIFGYSFFIILSGSVAVLLLDFDKV
MIPAYEEISKNAVYSVAIYIATVIAVPSRAMLQIIYPITARLMSEEKMEELNDLYKKSAI
SLQVFGGLVMLGIFLNIKQLYLVIPGNYEAGLWSVFLIGLGKFYDVILGNNNAIILNTKY
YRMVLIFGLLLVVMMIGLNMLFIPMYGITGSALATFISIFVYNTIKLLFVVRKMDLYPFT
ANTLKSFGIIALVFITFYFWDFPFNPFVNIILKSILITIVYVYLNYLFKISADINQVLEK
MVPIIKNSLKK
>LONDMIMF_02459 HTH-type transcriptional regulator CysL
MLDFRLKVFYIVAKRLNFTKAAEELFITQPAVSKHIHEIESFYQSKLFERNGTRIKLTPA
GEILLGYAEEILTIHRNIEFDLAALTKDIRGVLKIGASTTVAQYFLPKYLASFKRKFPDL
KITLFVNNTEQVENLLLENKVNLGIVEGQTKRKDIKYTPLVKDEIVLCTSAANPSSKKAT
FALKDLQQLPLVMRESGSGTREVIIAALKKAGLPFSALNIDMEFESTESIKSYLLNSNSY
AFLSVVSIFKELKSGELKIVDIRELEIERYFYCVIQQGDTHFLNEVFFKHLSLHNLKL
>LONDMIMF_02460 hypothetical protein
MEKNNHLLEQKRNFFGKNITVRQLLFILLILLCSSTYISPPFALFLGILTARTIGHPYLQ
FNHKITHYLLQISVVGLGFGMNVHTALQAGKSGFLFTVFSIFGVLTAGYIVGKILKINKE
ISFLISVGTAICGGSAIAAVSPVINAKEKQISVALGAIFILNSIALLLFPVIGHMLHLSQ
SQFGLWCAIAIQDTSSVVGAASKYGNEALQMATTVKLTRALWIIPIAFISSVIFKSKESK
IKIPYFIGLFVVAIILNTYVPFFHKIGGSLVSLSKIGMTVTLFLIGAGLSKTVLASVGFK
PILQGIILWILIAVPTVLIVFYL
>LONDMIMF_02461 UvrABC system protein A
MITDITKIEPKSNIIIKGAQIHNLKNLDVVIPRNKFVVITGLSGSGKSSLAFDTLYAEGQ
RRYVESLSSYARQFLGRLDKPKVEYIKGIAPAIAIEQKVNTTNARSTVGTSTEIYDYLKL
LFARIGKTFSPISGQEVRKDSVTDVINDVKSFDLDSRWLLLAPIHLEDGRALEDKLKVLL
QQGFARILVDNEMVRLDEIDGHSLDNKDILLIIDRIVVKEEEEFFNRLADAIQTAFYEGK
GVCYLQELNTDKRFTYSNNFELDGIQFFEPNVHLFSFNNPYGACPTCQGYGNVIGIDEDL
VIPNTALSIFENAIYPWRGESMSWYRDELVKNGYKFDFPIHKPYYELTEEQKALVWKGNK
EFVGLNDFFKELEVKNYKIQNRVMLSRYRGKTKCPDCRGKRLREEANYVKVGGKTISDLV
DLPIKRLVTFFKELELSEYDFKVAKRLLLEINNRLAFLSEVGLDYLTLNRNSATLSGGES
QRINLATSLGSSLVGSMYILDEPSIGLHPKDTERLIKVLLSLRDLGNTVIVVEHDEDIMK
AADMIIDIGPEAGTFGGELVAQGTFEEILKSSSLTAQYLNGQEEIKTPRIRRKHKNFIDI
IGARENNLKNIDVRFPLEVLTVITGVSGSGKSTLVKKILFPAMQKALEGVGEKAGQFSEM
TGSYQLIKHIEYVDQNPIGRSSRSNPVTYIKAYDDIRDLFAKQKLSQIRNYQPKHFSFNV
DGGRCETCKGEGTINVEMVFMADVQLVCDTCNGKRFKKEILEVTYEGKNIDDILTLTIDD
AVAFFSEHKQTKITQKLQPLQDVGLGYVQLGQSSSTLSGGEAQRIKLASFLVKGATKDKA
LFVFDEPTTGLHFHDIKKLLASFDALIDKGHSIIVIEHNLDLIKCADYIIDIGPEGGENG
GQLVASGTPEEIVQNKNSITGKYLKEKL
>LONDMIMF_02462 RNA polymerase sigma factor CarQ
MANVQTPDALLVKRYVAGDEVALASLIDRHQSKIYGFIYSKVSDRDITDDIFQDTFIKVI
KTLKSGSYNEEGKFLPWVMRIAHNLIVDHFRRGKKMPMSRETEEFSIFSVISDSCPNIES
RMITAQVEKDLKKLIEELPDDQKEVLLMRIYQDLSFKEISELTGVSINTALGRMRYALMN
LRKVIDKHQIILTN
>LONDMIMF_02463 hypothetical protein
MAKIYSKKSLATKPMQPKKETISFLLNYSKALSYIKVKGLKFESIAN
>LONDMIMF_02464 Endonuclease III
MTKKERATFVINTLKELYPTVPVPLDHKDAYTLLIAVLLSAQCTDVRVNQITPLLFARAD
NPYDMVKMSVEEIQDIIRPCGLSPMKSKGIYGLSQILIEKYNGEVPQSFEALEALPAVGH
KTASVVMSQAFGVPAFPVDTHIHRLMYRWGLSNGKNVVQTEKDAKAIFPRELWNDLHLQI
IWYGREYSPARGWNLEKDIITRTIGSKKVLAELAGK
>LONDMIMF_02465 Putative peroxiredoxin bcp
MTTLKAGDKAPDFSGFDQDGKFHQLADYKGKKLVVFFYPKANTPGCTAEACDLRDNFERF
KANNYELLGVSADSQKAQGRFRDKFKFPFPLMADEDKSIIEAFGVWGPKKFMGRTYDGIH
RTTFVIDEKGIIEEVITDVKTKAHANQILK
>LONDMIMF_02466 hypothetical protein
MLTLQSIITIMRNDENEIKLKGDKVIEQIPSIKDKALRINLNENIYGTFAEIGAGQETVR
HFFRTGGSSGTIAKAMSAYDKDFSDAIYGAEADGRYVTEARLKKMLSHEVKLVEQRLKRD
KHPSKMFFSYANTVATIDFAKQFKGHGWVGIKYQIEPDEDYNEIILHIRFKETDARLQQE
TLGILGVNLIYGAFYKYNDPKKLLRYLYDHLDKDQLEIDTINFSGPRFADVDNRLMSLQL
VKNGMTDAVMFDPEGNNVLPAAVLYKKNILALRGSFRPVTRVNMDMYEKSLQMFLEENKV
EKENTLVVFEITLSNLRSDGEIDERDFMDRAELLCSLGQTVMISNFQEYYKVVEYFSNYT
KARMGLAMGVSNLVDVFDEKYYRHLSGGILEAFGKLFYRDLKVFLYPMKDEHGVVINSEN
LKVHPRMKELYKFFKFNGKVVDITDFDEHDLEIFSREVLKMISKGKPGWESMLPKGIAEM
IKRDNLFGYDPKKLMEESTN
>LONDMIMF_02467 Phosphoribosyl 1,2-cyclic phosphate phosphodiesterase
MKVYFLGTGTSQGIPVIGSEHPVCKSTNAKDKRLRVSVWISWENHSFVIDCGPDFRQQML
VSQCPKIDGILFTHEHSDHTAGLDDIRPFNFRQGNIPIYLHKRVLESLKRRFDYVFETVD
KYPGAPSVEPIEVVNGQSFDIGNKKAIPINVMHGNLQVFGYRIDDFAYLTDVKTIEPSEV
EKLKGLKVLVVNALREEPHHSHFNLEEALEFINTVRPEKAYLTHISHRMGFHDEVEKMLP
ENVYLAYDNLQITI
>LONDMIMF_02468 hypothetical protein
MKKPLLYLFILSVLLNIFTYMYFTKKVKFEEDRIANFQKESKAKKDSIAALNNQVMEANY
FSLEYNDNAMDYFEQFDINQLSAEIRDEINSLNEKPEGNPLTKYDKINGDKAIINKIKIL
NNRWIIADFSIGKAWGEVMIKYYKQEGKPTEYETMDTFIYPATLK
>LONDMIMF_02469 hypothetical protein
MLAFITVSAFSCKDLGRNSDLSIQKDSLGTVVGNDKDDKGCVASAGYTWSELKRTCVRPF
EVGIRLNPAAEIKQGEAIYSAFAILEENGGNKAELFMPNEKTSMILERESEGKPYVKDDW
KLQTTNGYQLMKGDSLMYAGALINEEVITGSDKAED
>LONDMIMF_02470 Carboxylesterase 2
MKSNIEYLIREPKIKKEKNPLLLLLHGYGSNEEDLFSFASELPDEYYVVSARAPYNLQPY
GHAWYAINFDADENKFSDIDQAKESRDLIAKLINELISELPIDFQNVTLIGFSQGTILSY
AVALSYPEKVKNVIALSGHINTDLLVPGYEKNDFRHLNLFISHGTVDQVIPVEWARKAPD
LLKKLGIEATYKEYPIGHGVSPQNFYDFRNWLENHK
>LONDMIMF_02471 hypothetical protein
MENTVNEGKNIAIITHLTIIGTIIAAVLNGDKKNAFAGFYIRQTLGIFLLFFALGYPVGL
FDSWMISSALYIFIFILWAYSFVSALQGQMNKIPLLGGFFQKAFKNLT
>LONDMIMF_02472 Dihydroorotase
MNLIIRQAKVIDPKSPYHNEIADLKIEGGVITKIGKKLQNPDKLKEVTFKGLHISQGWFD
SSVSLGEPGFEDRETLANGLNTAGKSGFTAIALQPNAFPIPDSQSGISFSKRKAEGFATE
LFPIGALTKGSEGKDLAELFDMKNSGAVAFGDYNKSLSNANLLKIALQYVQDFDGLVIAY
PQDSDIKGAGVANEGIASTRLGLKGIPSLAEELQVSRNLFILEYTGGKLHIPTISTAKSV
QLIKEAKAKGLDVTCSVAVHNLVLTDEKLDGFDTRYKVTPPLRSETDRKALVKAVKDGII
DMITSDHNPMDIEHKKMEFDMAKNGTIGLESAFGALLTVLPLETVIEKLTQGKEIFSIDE
SVIKEGNKANLTLFNPEEKWTFGKESILSKSKNSAFLGESMKGKAYGIYNNQQLVLNE
>LONDMIMF_02473 hypothetical protein
MQFKHPEILYFLFLLVIPILVHLFQLRRFKKEYFTNVHFLKELAIQTRKSSRLKKWLLLL
TRLFLLACLIIAFAQPFFQAKDSKGITNEMFIVLDNSFSMQAKGKQGELMKRAVQELLEN
VPENQTFSLITNSETFWNTDIKSIQRELQNLKYSASPFVLDNLMAKIKSRKSPYNKDIVI
ITDAVGLQPKQLKNIDSTSNAYFIIPKAEQKNNVAIDSVFIQQALDNFYEIGIKLSSYGD
NEKDIPISLYNNKKLVAKTIVNFEGKEKSINFTIPKGNFNGYATIDDNALQYDNQLFFSI
SKPQKMNIVSIGQPEKSSFLKKIYSDNEFIFNNFDLKTLDYNILEKQDAIILNEVPEVPQ
ALQTTLKTFVEKGGNLIVIPSSESSISNLNSLMGNFGKIQFKSLENGEKLVTKIAFNHPL
YSTVFEKKIDNFQYPNVSSAYSISSAYPSILSFEDQNAFLTAIQNPVSSVYVFSAPLNKN
NSNFQNSPLIVPTFYNMALSSQKTGISALTIGENSPFLIDASLSKDEIVEIKSLSEETNE
KFIPMQQILNNKVKLTFNDFPQEAGNFGVYKQDNLLKEISFNYAQTESNIATSNESVLSD
YNVIGSIDEVFDTLQTNRTDNEIWKWFVFLTLLFLVTEILIQKFVK
>LONDMIMF_02474 6-phosphogluconolactonase
MKKINFFLLVFLFVMNAKAQDKIYNLIVGTYTNSCESKGIYVYDFSPDTGDFSLKKTQKT
DNPSYLTVSEDIKYIYSVNENGADSKISSFRFDSKSGQLQLLNSLDSKGADPCYIINDDK
NVIVANYSGGSIAVFEKKADGSLQEAKQVIQHTGKGINTSRQESAHVHMVYFSPDKKYIL
ANDLGTDMIYVYKYNKNAPEKILELKDKIAVKPGSGSRHLTFSKDGKFVYLLQELDGTLT
VFKYKNGSLKQLQETTVVAKDFKGENSAADIHISPDRHFLYATNRGDANTINVFAINKKG
TLDLVNQVSTKGKGPRNFAIDPSGKFLLVAHQYTNEVVIFRIDKTTGKLSDTGKRIELCS
PVCLVFTKF
>LONDMIMF_02475 ATP-dependent RNA helicase RhlE
MSTFEQFNLPKSLQKAIDDLGFTSPTPIQERSFSVIASGRDMMGIAQTGTGKTFAYLLPL
LKLYKFTPTHTPKIVILVPTRELVVQVVEEVEKLTKYMSVRTLGIYGGVNINTQKTSVYQ
GIDVLVGTPGRVMDLALDNVLRFDETQKLVIDEFDEMLNLGFRVQLTSILAMMRPKRQNI
LFSATMTDEVDAVLEDYFDFPEEVSLAPSGTPLEKIKQVKYAVPNFNTKINLLKHLLSTD
ESMSRILIFVNNKRFVDMIYDRIEEDFGEQFGVIHSNKSQNYRLTTMHDFQKGDLRGIIT
TDVMARGLDISDITHVLNFDVAEIPEQYIHRIGRTGRADKEGTAISFVGPKEEDAFIECE
MLMDMEVDMLPVPEGVEISTVLIESEKIKQPIKLLKKVKKEGGSAFHEKSDKNKKVNLGG
PGKTKPRKTKPRNRAVERNRDKKRKDKGK
>LONDMIMF_02476 hypothetical protein
MFLRWMLRQDKKGVDFGVWKTISPSALSCPVDVHSGNVARKLGLLHRKQNDAKALAELDL
QLRKLDPNDPVKYDFALFGLGVFEGF
>LONDMIMF_02477 hypothetical protein
MVSERVGEYMAKKGISYYAFENSIGASRGSISKAVKEGKSIGSQVLEKIISVYTDLNPTW
LLTGQGNIFVDNEEILNNKQIEMYRLKTDSFVENQQIPLYDIEAVAGLVPLFQDSKSQDP
IDHISIPHLPKCDGAVYVTGDSMYPLLKSGDIVLYKEIHDVANEIFWGEMYLLGIDMSGE
EYVTVKYIQKSENPGCVRLVSQNKHHQDKDVELSKIKALALVKASIRINAMN
>LONDMIMF_02478 hypothetical protein
MEGKSLPFLFCMLMKQLFLLSVFTVFCGSAVAQNGYWQQHVDYKMDVNMDVKTYQYKGKQ
ELVYTNNSPDTLKRVFFHLYNNAFQPGSEMDIRLQTIVDPDKRMVKTTKSGGVEKTESRI
SLLKPNQIGYLNVTNFMQDGVPATTTVVGTILEVDLAKPIAPKGKTKFTLDFDGQVPEQI
RRSGRNSSEGVALSMTQWYPKMAEYDFEGWHADPYIGREFHGVWGNFDVKITIDKKYILG
GSGYLQNKNEIGYGYQDQGVEVKIPRKVKTLTWHFNAPMVHDFSWAADKDYIHDVYPGPN
NVELHFLYKDKAKLKENWKKMQPKTAELMDFFNKNVGPYPYKQYSVIQGGDGGMEYAMCT
LITGERSYGSLVGVTAHEMAHSWFQHVLATNESKHGWMDEGFTSYISDLAMAKVLPSKDE
KNPFDSAYSNYFYMVKTGREQPQTTHGDRFEENMVYGISSYSKGELFLTQLGYIIGQENL
AKTLKKFYEDFKFKHPTPNDFKRTAEKISGMNLDWYLVDWTQTTNTIDYGIKEVRDAGGK
TEVVLQRIGRMPMPLDIMVTYVDGSKESFYAPLQMMRGIKENPYPGVKRTFLKGWDWAYP
SLKFTIDKGMGMISKIEIDPENLMADVKKDNNTYPAPIPDNSKILKN
>LONDMIMF_02479 Thermophilic serine proteinase
MKILKLSSLSLLSVLVLSGCGASKSMTPITSIENLPLKTSKIKENDLKRWSHLDIIKDTI
PGMSVDKAYAELIKNKKGTKVIVGVVDSGVDIEHPDLKSVIWTNPKEIPGNGIDDDKNGY
IDDIHGWNFLGDVTNETLEMTRIVRKGDDGSENFKKAKAAYEKEYQEALASKQQFDFINN
ADKTIQKELKKENYTLEDLKALESKDPTVSQYKRVMLSVIAQAGPEFKSELKEYQEHIYN
QLNYNLNLEHDGRKILGDNIDDLNDSKHGNNNVTGPKKEGASHGTHVSGIIAQVRNNGLG
GDGIANNVAIMAVRAVPDGDEYDKDIALGIRYAVDNGAKVINGSFGKGFSPHKEWVYDAI
KYAASKDVLIVLAAGNEGADLDVEERFPNDRIASGEIADNVIKVGALDTTYGTNLVADFS
NYGSKDVDVFAPGVKIYATYPNNEYKYEQGTSMAAPNVAGVAALIRSYYPSLTASQVKHI
LMDSGIPTNIDVVLNGEKANKRSFSKISTSGKMVNAYNALIMAEKMAKTKK
>LONDMIMF_02480 putative quorum-quenching lactonase YtnP
MKLYPIEAGNFKLDGGAMFGVVPKTIWNKTNPADENNLIDIAARCLLIEDGNRLILIDTG
MGDKQSEKFFGYYSLWGSHSIDKSLSRYGFHRDDVTDVFMTHLHFDHCGGSVQWNKNKTG
YEVAFKNAKFWSNDNHWEWATKPNPREKASFLTENIIPMQESGQLEFIKRPDGDLLKKSE
LGFDIFFADGHTEKMMIPKIQYQDKTICFMADLLPTAGHLPLPYVMGYDTRPLLTLPEKA
KFLTEAAENNYYLFLEHDAHNQIITVENTEKGVRLKDVFTCEEIL
>LONDMIMF_02481 Iron-sulfur cluster insertion protein ErpA
MIKVSDTASKRIIDMMNDDGFDATKDYVRVGVKSGGCSGLSYELKFDKELGENDKVFEDN
NVRIAVEKKSFLYLAGTTLEFSGGLNGKGFVFNNPNATRTCGCGESFSL
>LONDMIMF_02482 FeS cluster assembly protein SufB
MSKYTEDDLKIELENKEYEYGFYTDIESDTFPVGLNEDIVRAISKKKEEPEWMTNWRVEA
FRAWEQMVEPEWANVHYEKPKFQEISYYSAPLKKAKYESLDEVDPELLETFKKLGISIDE
QKVLAGVAVDIVMDSVSVATTFKKTLAEKGIIFCSISEAIKEHPELVQKYIGSVVPQKDN
FYAALNSAVFSDGSFCYIPKGVRCPMELSTYFRINQAGTGQFERTLVIADEGSYVSYLEG
CTAPSRDENQLHAAVVELIALDDAEIKYSTVQNWFPGNKEGKGGVYNFVTKRGLCEKNAK
ISWTQVETGSAVTWKYPSCVLKGDNSVGEFYSIAVTNNFQQADTGTKMIHLGKNTKSTII
SKGISAGKSQNSYRGLVQISSRADNARNFSQCDSLLMGNNCGAHTFPYIESKNPSAKIEH
EATTSKIGEDQVFYCNQRGIPTEKAIALIVNGFSKEVLNKLPMEFAVEAQKLLEISLEGS
VG
>LONDMIMF_02483 putative ATP-dependent transporter SufC
MLSIKNLHAGIEDKDILKGINLEVKAGEVHAIMGPNGSGKSTLSAVIAGNENYEVTEGSV
ELDGEDLSDLTPEERAHKGVFLSFQYPVEIPGVSVTNFMKTAINESRKAKGQEEMPANEM
LKLIREKSELLEIDRKFLSRSLNEGFSGGEKKRNEIFQMAMLEPKLAILDETDSGLDIDA
LRIVANGVNKLKSENNAIIVITHYQRLLDYIVPDFVHVLYNGKIVKSGGKELAYELEEKG
YDWIKAEN
>LONDMIMF_02484 hypothetical protein
MGKFNSFEEINSWQKSRIFNKKIYLITEGEFFKKDIDFVRQIRRASISISSNIAEGFERN
TDKEFIYFLYVAKASAGEVRSQLYLASDLNYIGEKDFDDLLFEIIEISKLISGFIKYLSR
KS
>LONDMIMF_02485 FeS cluster assembly protein SufD
MAFEERVDVDSALHDVRTEAFKNFENKGFPTKKEEAWKYTSLSSILKNDFSVFPKKENAV
EFSEVKKFFLHEIDTYKVVFVDGVFSSFLSSTTHDGLDVCLMSSALTKPKYKMVIDEYFN
KIASKDESLTSLNTAFAYEGAYINIPRSKVVEKPIEIINFSTGTEAALLVQPRNLIIVGE
NAHVQIIERHQSLNENPVLTNSVTEIFAQKRAIVDYYKIQNDNLEASLIDNTYIAQKTQS
NASVHTFSFGGNLTRNNLNFFHQGEHIDSTLKGITIIEGKQHVDHYTLVHHAAPNCESHQ
NYKGIFDDKATGVFNGKIYVEKEAQKTDAFQQNNNILLSDKASINAKPQLEIFADDVKCS
HGCTIGQLDEKAMFYMQSRGIPQKEAKALLMYAFSNEVIESIKIPAMKARVTKIIATKLG
VNMGFDL
>LONDMIMF_02486 hypothetical protein
MKKLVLALAFVSALFTSSCSSDDSNSSPSLGETTGNYWPMEVNNTWTFSSNSGSSELRMV
GVTTINGTPYYELSDDADNVFGVQNWVAKKGATYFQKIADTNINQDGVSINMQGYEIPLF
KDHLEANSSWNGTVTSRVNYSVNGQNSSTTATIKYTSTITEKNSTVVLNGATYPNVIKVK
TKVEIKILNQTTPIDLEYWLAKDVGPIREYTSSNGSIQERTLTNFMLY
>LONDMIMF_02487 hypothetical protein
MKKKLKIAGILLAIMIVYLGFTNYPKLDLISGFSAKSIASGYFIGHRTQQMIESGDNDIK
LINLASNTINEKEHYATTSVYGLKERKAIYREGLGVTLINNDFDLSKPYLVPKRIRLNSN
LPYPFGNNQPKDTVFATIDYSKLEKAVEGAFDKKGEKNKRTRSLLILYKDKLIAEKYDSG
FDKNSMILGWSMTKSLTATYFGILQKQGKIDINSPAPIAEWKNDKRSKITINDLLHMNSG
LEWEEKYDKICDATLMLFEAEDMSKVQREKPLVGQPNESWNYSSGTTNLLSGILRNQFKT
QQEYLDFWYSSLIDKIGMDSMLVETDMAGNYVGSSYAWATTRDWGKFGLLYLHKGNWNGE
QLFDENWAKYVATPTKTSNGRYGGHFWLNAGGKYPDAPKDLYYASGFQGQKIFIIPSKDL
VIVRFGLTEDEVFDFNKLLKNILDSISK
>LONDMIMF_02488 Colicin I receptor
MQIYTKAYISLSLFLSFSAFSQEKFQDTTSTSQLEEVVVTGQFEPQSLKKSVHNVRVITR
EDIKRLAANNLGDVLNQYLNISIRTSGSDGRSTVSMFGLDAQYFKILVDNVPLVSDTGLG
TNIDLTQVNLDDIEQIEIIEGSMGVTHGANAVTGILNIITKKSSKHKWEITATAQEETVS
NEFAFFDKGRHIQNAKISHNFNDNWFVSVGGSRNDFAGFFDNKEGKDYIQNNGKRGYSWL
PKEQLVGNGLVGYTKGDFRIFYKFDYFGENVDYYNPVVIPIDNYPFPNTNFSNDRRYISN
RYYHHLNSYGKLFSQLNYNVSVSHQKQNRDIEKFNYQLESQSETNNARETYQSKEVIYST
GALSNFFKDKRVDLQLGYEAVNERGFYDSTAGIFKDDQQQVKDVRKRLENYDIFTAAEIR
FTEKFSVRPGIRYSIQSKFEDQYASSLGLRYIFPHGIEARGSLGKSYRTPNFDELYTYFV
DSNHNLQGNENLIPETSTSYEVSVKKATYFDSGAQLSNNLAVTYMDVDDRISLVLTQVVP
SQSYKYMNIDKYKMWNISSTHQFAYKNWNAKVGLALVGISQKIDLAALNVTSDDKYLYSL
QVNSNLSYNVPKWNTLFSIYYKFNGKQQQYISSTDTAGNAEFILSELESYGWMDASIRKS
FFKNQFEVTVGARNLLDVTSVQLTQGTTGVHVSGSDLLLGYGRSYFLKLTYNLNFN
>LONDMIMF_02489 hypothetical protein
MKKNLIFILSLVMLAFTGCGDDDNKGPNPISVAFAVPSLNLIENATPIQVLFSSPTPTAG
NLTISYITTGVTYGTDFTTLPAQTENLIVVPFEANVSSVAITFNKLINALEGETKNVVFK
IEDVSLNNATISGNLTVKANFNETALSGQAMAAEVGGPNQPNQVYIDLSSGGHATAPRTS
WDLGFYGGTDFRVAINGSLKMAAKQLETTNIDEVQSPDESMIISQGQGVASQIDHPAGLI
TGTTIAAISANDADNKVYLINMGSNPSETAPSTGSEGSASGTSRGWKKVRILRSGTDYKI
QYADIDATTHEEKIISKNSAYNFTFFSLVSKNVVNVEPQKNQWDINFTTFTNLVGGTTPY
YYPDFVVTNLKGGARSYQVVNTETLNYDTFTLANVVSANFTEDQRNIGSNWRSTSVTGPG
GLPVSAFVLKTDRFFVIKDPAGNIYKLKFTGGANASGERGYPTFQYALLQ
>LONDMIMF_02490 hypothetical protein
MKKYLNFFLLSLLLFFASLSYGQTYTVTMSNVYVNNQWVNQGSAISFGANDIITVKLSVD
VYSSTGNSGTLNVYYQRGSSYEPIVPSGGYGGTITGSGSRNFTIELNGAQFDASGGFIFA
QFAVSGHNGAVPRSSNWPVIKPGAPPISNNSIVGTQTKFYGLSATITGTTPSGGNGSYFY
QWQKNTTGSWSNIVGAHEQNYITELLTQTTQFRRIVMSNGTSDHTSGAVVVTIVNSLPIT
NNSISGNQTINEGNTASFITGTSPSGGSGPESYRYVWQKKSGNSTWTIIPNASSQNYSPG
TPFVTTHYRRIVKSGNAVDITSNEVTITVIPAPPIQNNTIVLNNGTINGSQPTGGIGVYN
YSWILWGGEEPYTFPNTEQNLVITADIYNYLTAYPNLFIVRTVTSGSQISGSNSIVILPL
PAIQNNVISLNGSLVTGSQPTGGNGDYKYTWNLVGGEEPYVFPETSQNLVLSASVFQYLE
MYPNLFISRTVNSGNKISYSNNVTLVALPQIQNNTISANGLQIIGSQPTGGDNTYQYSWF
ISSPEDPIFFPDTTRDLDLNPYSNAIRILQTYPTAVLYRLVKSANRSSYSNSLSFYSGRQ
RQKEMSFAQGNENFDSEPKIYPNPTTKRVNFETGLAKTTTVEITATNELGINTVIFKGDV
NPGQVIEWNIPSNYPKGLYFYKILSGKEEIKTGKILYQ
>LONDMIMF_02491 Hemin transport protein HemS
MDTLTNNLKSQWDKLKAENPNLRIRNAAEKLGVSEAELLATQVGETVTRLRPEFAAILTD
VEKLGKVMALTRNEECVHERKGIYLNPDFSSPHAGLFVGEDIDLRIFLGHWAKAFAVEEK
SEHGDRKSLQFFGKDGLAIHKIYLTKDSNEAAFDELVAKYKSDDQAAEESAIEVPLNIDE
KADADIDVAGFQTAWENLKDTHEFFGMLRKFGVTRTQALRLAPNENFAKKVEKDVIVKML
EGAAESKLPIMVFTGNRGNIQIHTGLVRKTMWHGDWFNVMDPDFNLHLDMSKIAQTWIVR
KPTEDGEVTAIEVFNEMGDIIVQFFGKRKPGIPELKEWKDLVAAL
>LONDMIMF_02492 Hemin import ATP-binding protein HmuV
MLEACKISYAHKKFSILENIDVSVNYGELLVIVGPNGAGKSTLLSMLANEMKHGDEPIMF
KKKTFEEWDQKELPLHKAKFSQQNSNDIPLTVTDVVMMGRYPYFNSVPHQTDLDAVTKSM
EETDVLSMKDRDYNTLSGGERQRVHLARVLAQLENNIAHKLVFLDEPLNNLDVLHQHRIL
HTIKNFTELGNTAIVVLHDLNLAAQFADQVLLLKKGKIVSHDKPEKVFTKEIISKVYNFP
CTICLNPVNQNPLIIFGT
>LONDMIMF_02493 Hemin transport system permease protein HmuU
MQNKLPLYIVLSLLLLLILATAALYMGVYEFEKHSFFEIFKALINNDNSIPESDKFVLMD
LRLPRIVMAILIGSALSVSGTCLQGMFKNPLASPDLIGITSGAILFGAISIVLGSHIKPY
IPEVFHFSMLSIAAFLGALLTMTIVYRISTSNGKTNVVVMLLSGVAITAMAFATTGFLIY
LSKEEELRDLTFWNLGSLGGATWTKNAILAVVIIIAFSLLITKGKALNAMMLGERDAQHL
GIPVEKIKKRIIILTALMVGTCVAFSGNIGFVGLIVPYILRLIFKSNYHIILPMSAIFGS
ILLLTADTISRTIAAPSEIPIGILTAFMGAPIFIAILIRSKKSM
>LONDMIMF_02494 Hemin-binding periplasmic protein HmuT
MKKISVLVLAIVSLAVASCKKEEETKKEETPVEKTEALKIVSLNGAVTEIIAALGHEKEI
VGVDVTSTYPETVKTTAKDLGHVRSITIESIVALKPTVIIGTDKDMSPELAEKIKAAGIE
AHILTQDFSPEGTKKLIADVAGIIKNTDFKALTDKVDADLAKIQPIAKAPKVLFIYARGA
GTLMVAGKNTPVEKTIALAGGQNAVTEFDDFKPLTPESLIKGNPDVILLFTTGLQSLGGV
DGLLKIQGVEKTNAGKNKKIIALDGALISGFGPRVGEGAAALNAELIKATK
>LONDMIMF_02495 Cysteine desulfurase SufS
MLDIQSIRAEFPILSQKVNGKPLVYFDNAATSQKPKVVIDAISAYYEEINANIHRGVHKL
SQLATDAYEISRSKIQRHINARHNHEVIFTTGTTHGINLVSNGFSAILKAGDEVMVSNLE
HHSNIVPWQMLCERTGAKLTVIPMNNQGELVLEEFEKLLSEKTKIVAVNHISNALGTINP
IKEIIEKAHKAGAAVLIDGAQAAPHIKPDVQELDCDFYVFSGHKICGPTGSGILYGKEAW
LNKLPPYQGGGEMIKEVTFEKTTYAELPHKFEAGTPNIEGGIVLGTAIDYLNSIGFDNIA
AYEHELLEYGTQRLLEIEGLKIYGTSKNKTSVISFNIEDIHPYDIGAIVDKLGIAVRTGH
HCAQPIMSFFNIPGTVRASFAFYNTKEEIDALVEAVKKAKTMLS
>LONDMIMF_02496 hypothetical protein
MKILSAFVMVLVLAKGCNSSELRKESENISFEYEATTRGNYRKIIARQDTIFTIKSRNGE
AVEKKLSRSDWNSMLDLLAKVDRTNIQNLKAPSEKRFYDGAMIAGLTVIYKQDTYRSASF
DHGNPPKEIKKLVEKIISASDLNKE
>LONDMIMF_02497 Cysteine desulfuration protein SufE
MTIQEIQEEIKDEFSMFDEENWDERYQYVIDMGKTLPLIDEQYRTDDNIIKGCQSKVWLH
AEQRDGQIVFTADSDAILTKGIIAILIRTFSGQKASDILDADTKFIDEIGLKEHLSPTRA
NGLVSMIKQIKMYALAFESAS
>LONDMIMF_02498 hypothetical protein
MEQEIDTNQLGEDIVKILKTIYDPEIPVDIYELGLIYDVMVNTDYEVKILMTLTSPNCPV
AESLPKEVEEKINKIDNVKATEVEITFDPPWSKDLMSEEAKLELGML
>LONDMIMF_02499 ATP-dependent 6-phosphofructokinase 1
MSKTIKKIGVLTSGGDSPGMNAAIRSVVRTCAYHNIECIGIYRGYQGMIEGDFKEMGPRS
VNNIINKGGTILKSARSKEFMTEEGRKKAHSNLSAAGVEALVVIGGDGSFTGGLVFNKEY
GFPIIGIPGTIDNDIFGTTHTLGYDTALNTVVEAIDKIRDTASSHNRLFFVEVMGRDAGH
IALNAGIGAGAEEILIPEEDLGLDRLLESLRKSKLSGKSSSIVVIAEGDKIGKNVFELKD
YVEENMPEYDVRVSVLGHMQRGGAPSCFDRVLASRLGVKAVESILDGKSNYMVGLLNDKI
ELTPLEQAIKGHSQIDRELLRVSDIMTT
>LONDMIMF_02500 Glyceraldehyde-3-phosphate dehydrogenase A
MSKVKLGINGFGRIGRIVFRETINRDNVEVVAINDLLDVEHLAYLLKYDSVHGRFAGKVE
VKDGKLFVNDRLIRVTAEKDPSVLKWDEVGVDVVAECTGIFTTLEKANEHIKGGAKKVVI
SAPSADAPMFVMGVNHTKATAADTIVSNASCTTNCLAPLAKVINDNFGIVEGLMTTVHAT
TATQLTVDGPSRKDFRGGRAALLNIIPASTGAAKAVGKVIPELNGKLTGMSMRVPNADVS
VVDLTVKLQKETTYEDIMKVLKNASETDYKGIIGYTEDDVVSQDFISDSRTSIIDAKAGI
GLNSTFFKLVSWYDNEYGYSSKLIDLSVHIAQL
>LONDMIMF_02501 hypothetical protein
MKLLVDSGSTKADWIALDDNGNKLFTTQSLGLNPEVLDKKEVIERLEDRFDIYHNRKDVT
HLFFYGAGCGTDRMKNSLAETFREFFPHAEVSVKEDTYAAAYATNPTNEKAIISILGTGS
NCSYFDGEELHQKIQSLGYIAMDDCSGNRFGRDLIRAYYFGKMPKHLASLFEKEYDLDPD
VIKNHLYKQANPNAYLATFAKFLIQHKDDEFIQKLVFEAMQVFVDNYITQFEDCREVPVH
FVGSIAFYLKDELKQVLDKNGLRLGNVLRRPIDGLIEYHKIN
>LONDMIMF_02502 RutC family protein
MKKIIFTEKAPAPIGPYNQAVAFGNTLFTSGQIAINPQTGELVLEDIETETRQVMENMKA
VLEEAGMTFENVIKTSIFIMDMNNFAKINGVYGSYFDEKTAPARETVQVAGLPKGVNVEI
SMIAMK
>LONDMIMF_02503 LPS-assembly protein LptD
MARQKLSHIFTKIVFKPLRTNLFHIVLSAIFLTLGTAETYSQEGKNKSTSIAAEKQPNTK
KDSVSVSLSDITKSADTTAQDTIKPKKTFLESRVKRKAVDYEKMDQKKKQLTLYNKAELY
YQDFELKAGIIVMDYEKNEVYAGRIKDSAGNYTQRPVFKQGTNVIEPDSIRFNTITKKAL
VWNSRSAQGELNIKGEVTKKENDSVYFIKNARITTSKNIDDPEYYFLARKLKLVPGKKVV
VGLTNMVIADVPTPLGIPFAFFPMSNKGTSGLILPSPNNTNRQGFALQNGGLYLALSDNY
DLAILGDYYTNGSYAMRFESSYAKRYKFRGNVNVRFENQIQSERGFPDYTKATQYNIQWT
HSQDAKANPNSRFSASVNLGSSKYYQRSMNQANVGSALNNTLSSSVSYSRTFNSVPQVNM
SVTATHSQNTQTETINMTLPTFQGSVDRIFPFASENENKRGLIKNLNIQYNLNAQNQITT
KDSLFFKPQMFRDARVGFQHTIPVNTNFKVFKHFSVSAGGTYNEVWYMKTIEKRFNPVSQ
KVENFDVRGFDAFRTYNFSSSIGTTIYGTFNFGENKKIQAIRHVMRPSVSYSYTPSFAKY
YDTYDPDGTGTMLKEYSRFEGGIYGAPGRNISNNIGFSLSNTFEAKVTDKDSTKTEPKKI
MLLNNLNFSTSYDMTADSLKLAPLRVSGGTALFKEKMNINFAATLDPYALDNANRRIDRF
NIDNGGSLFRLSSANITINYSFSSTDGTNENDRSDPLKNQGLRNGGREDDLFGTARDLGD
NRQSQFNDEDTEKAEKKTRFYHALLPWNMTLAYSLTYSNSSRQNEITNNSVMISGNVDLT
PRWKVGISTGYDFVQKGVTFTQLRFERDLLSWRMDFNWIPIGDYTSWGFFIGIKSSVLSD
IKWDKRRQPDRRLR
>LONDMIMF_02504 N-acetylmuramoyl-L-alanine amidase AmiA
MYICNKFKRSLAVLTCIVSFAAFGQSGDKFKVVLDAGHGAKDFGAVKNGFVEKNIALAVA
LKVGRLLDKQPSVDVVYTRSTDVFIELVERANIANRANADLFVSIHCNSNPNSEAFGTET
YVMGLTKVKSNLEVAKNENEVITLEADYKVKYAGYDPKSPESLIGITLIQEEHLDQSIAV
ASKIQDNFTQQLSRKSRGVKQAPFMVLHKTSMPSILIEMGFLSNKTEGQYLNSEEGQNEI
AKAIADAIMGYKKEYYGGTSIENKIDKEALKVERPKEMASTAKKDSAKTPVTKAPEPKKT
EAKTPVAETKTDSKGVLFKVQISASGTKLDLVPSNFKGLENISMISEGNLYKYMYGETSD
YEKAKELVQEAKSRGFTSSYLIAFKNGKKVSIQEALK
>LONDMIMF_02505 hypothetical protein
MKISREVKTAILVISSILLFIWGYSFLKGRDLFNDYKTFYAVYDEVEGLAPSAPITINGL
AVGKVNSITLNENGKLLVELQVKTDFPISKSSVAKIYEPSFIGGKSIAIIPNFKDPVEAE
NGQMLLTDIKPGMLSSIGDKLSPLQEKVEKTVVSADSLLVNINNIFDKKTQQNLQASIAE
LAATMKEFSQAAKGVNSLIADNKSKIDNTFTNLDHTSTNFSKLSDSIAQANLGQAVKKLE
KSLANVDNIINDVQSGKGSLGKLLKDEGMYNNLEGASLELKQLLADLKNNPKRYVHFSVF
GKKATPYVEPKTETKKVKDTIKN
>LONDMIMF_02506 hypothetical protein
MGYIDNILFAVLLAVGFGFFISNVKKLIRNIKLGQDVDRSDNKGERWANMARVALGQSKM
VKRPIAAILHIIVYVGFIIINIELLEIIIDGLFGTHRVFAFMGTAYNVLIGAFEILAILV
LVAVITFLVRRNIIKLKRFIHNDLKGWPKSDANYILYFEIVLMALFLLMNAADFTLQQRG
APHFIQAGSFPVSQFVAPVFNSISTETLLILERVFWWMHIAGILIFMNYLYFSKHLHILL
AFPNTYFADLNPLGKFDNLESVTKEVKLMMDPNADPFAAPAADADAAPAKFGASDVQDLN
WVQLLNAYTCTECGRCTSSCPANITGKKLSPRKIMMDTRDRLEEVGKNIDANKGVFVADN
KTLLNDYITPEELWACTSCNACVEECPVNISPLSIIMDMRRYLVMEQSAAPMSLNAMMTN
VENNGAPWQYSQQDRLNWKNEN
>LONDMIMF_02507 hypothetical protein
MKTEDIDKNLVSATENGEQISPILPEGIKNYLIDIDGTICDDIPNEQPGRMLTAAVYPDA
LATLNRWYDEGHIIFFFTSRTEAHRQITEQWLKIHGFKYHGMVMGKPRGGNYHWIDNHLV
KATRYRGKFTDLVEKEVTIQVFDDGKHE
>LONDMIMF_02508 Lactate utilization protein A
MSEVLSVPTMAEMLAQGKQPEVLFWVGCAGSFDDRAKKITKAFVRILNRAGVSFAVLGTE
ESCTGDPAKRAGNEFLFQMQAMMNIEVLNAYEAKKIVTACPHCFNTLKNEYPELGGTYEV
VHHTQFLKSLLDEGRLTIEGGQFKGKRITFHDPCYLGRANKIYEAPRELIQKLDVELVEM
KRSRANGLCCGAGGAQMFKDAEPGNKEVNIERTEDALETVPQIIAAGCPFCNTMLTDGVK
NKEKEAEIKVMDVAELIANARDL
>LONDMIMF_02509 hypothetical protein
MKKSLFVFVLSLFCLNAKSQDILDVITKEVCSCANEKKDMLKDAASEKVQMQLGLCIISS
FSSHEKEVTAKYGNIMEAEGAMEKLGGDVGIKMASVCPDVLMMFADMESESGEEIEEIPA
LTLEGKIIEIKPEQFLTVIVKDNSGRNHTFLVLTFFEDSNLFIENKLKKNDKVSVQYWEQ
EFYDAKPGISDTTK
>LONDMIMF_02510 hypothetical protein
MYIPFENMPDESRIWIYQSNRKFTDDEMAEIESDLKAFVENWAAHGTGLEASYLLQYNRF
IILAVNQEVQSATGCSIDSSVQFIQELEKKYNVDLLDKMNVTFKLGEHIAHKPLIEFKKM
AKEKAVSANTIVFNNLVNTIGEWHEYWEVPARESWHSRFF
>LONDMIMF_02511 Beta-hexosaminidase
MRYFVIALLFISQIAFSQLREPKLVLDRTKETIWVDSIYNKMTLQERIGQLFMVAAYSNK
DSVHFNTIDKLIREQHIGGVIFFQGGPVRQARLTNRFQSKSKVPLFIGIDAEWGLAMRLD
SVIRYPWNMTLGAIQDMKLIEKVGEKYGQQSRRMGVQFNFAPVLDINTNPKNPIIGNRSF
GEDKMNVTERALALMKGIQNQGVFATGKHFPGHGDTETDSHHTLPMLNFTKQRINDIEFY
PYKKLFREGLASVMVAHLNVPSLEPKENYPTSLSYNVVTNVLQNELHFKGLIFTDALNMK
GATNFKQPGDIDLEAFKAGNDILLFAENVPLALEKICVAIQDTVISEKRLEQSVKKILRY
KYLAGLNNYKPVEIPYIYDDLNNADAQALQYQLYENAVTVLKNENEILPIKDVANEKIAY
VKLGDDTNTSFLNTLRQYTEVTEVSNDSLHLLIDDLKKYTTVIIGYHKADGAWKKHDFTV
DELVKIQEIAKNNKVILDIFTKPYSLIPINSFSDIEGLVVSYQNSDVAQNVSGQLIFGAI
DAKGKLPVSIGTTFKVNDGLKTKKLNRLGFTAAENVGMSSKALARIDLIANNAIERQMTP
GIQVLVARKGKVVFQKSYGYHDYKNEVKVKNSDIYDVASLTKIVSTLPDVMQLYDQKKIT
LDTRLGTMLPAFENTDKKNITFKELLSHYARLQPWIPFYQATLNADKKPSDKYYKNTLTP
EFSLQVAENLFLRNDYKDTIIKKIAESKLLPKKEYKYSDFTFIILKEYLEKETGKKLDVL
SEENFYKKLGANSTTYNPLRKFDMSVIPPTEEDKYFRYQTIQGYVHDMAAAMQDGVGGHA
GVFSNSIDLAKIMQMYLQKGNYGGIQFFSPATFDTFNTCYFCKEGNRRALGFDKPQLPGT
SGPTCGCTSKSSFGHTGFTGTMAWADPEEELVYIFLSNRTYPDSNAPNTLSKENVRENIQ
KVIYDAIEN
>LONDMIMF_02512 hypothetical protein
MQSTAKNPQEYLDSLPEERKEAMNKLRNSILEQLPKGFEENINYGMLCYCVPFSLYPGGY
HCNPEIPLPFLSLASQKNFIALYHMGIYADPKLLDWFVNEYPKHSKLKLDMGKSCIRFKK
MDQIPYELLGELFGKISPEKWIEMYEGAFRK
>LONDMIMF_02513 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MKIAIVCYPTFGGSGVVATELGLELARRGHEIHFITYSQPVRLALLNPNVHYHEVNVPEY
PLFHFQPYELALSSKLVDMVKLHKIELLHVHYAIPHAYAGYMAKQMLKHEGIKIPMVTTL
HGTDITLVGSHPFYKPAVTFSINKSDIVTSVSQSLKDETYKLFDIKKDIEVIPNFIEINK
PRLDENAPCQRALMASKEERIITHISNFRAIKRIPDVVKVFDKIQKKIPAKLMMVGEGPE
KEKAEILCEELGISDKVIFFGNSNDIDKILCYTDLFLLPSETESFGLAALEAMACGVPVI
SSNSGGLPEVNFNGISGYLSDVGDVDDMAKNALAILEDDEELSKFKQNALNVAKQFDILN
IMPLYEAIYEKALKNK
>LONDMIMF_02514 hypothetical protein
MKKLILMPLVCLLFCCGSTKKATEQKTENVNKKQQTALYQILSESAYQGKEVKSYEVIKD
KASLEKLYEAINDTQVPKVDFTKERIVALFMGQRNTGGYAIKVKNVTEKGEKIYVDVQET
SPGSGDIVTMALTNPFTIVKINSTKEIIFQ
>LONDMIMF_02515 hypothetical protein
MKKLFLSAFMLAGMAFSMQAQEISKNALGLRLGDNDGFGGEISYQRGLSSNNRLEVDLGW
RDSNHVDAIKLTGLYQWVWNIEGGFNWYAGVGGGLGTWSYDYRGADDSGTFFFAAGDIGI
EYKFDIPLMLSLDFRPEFYFNHDDFRDDSFGPDIALGIRYTF
>LONDMIMF_02516 UDP-2,3-diacylglucosamine hydrolase
MSGIFYLFVKLLKHNKLKKRVVDLVVISDVHLGTFGCHAKELHNYLCSIKPKTLILNGDI
IDIWQFRKSYFPKSHLKVIRKILDFTSKGTQVYYITGNHDEMLRKFSDSKVGNFSIIDKL
VLDLDGEKAWFFHGDVFDSSVHHAKWIAKLGGIGYDYLILLNRFINWCLTKIGKEPYSFS
KKIKSGVKSAVKFISDFESAAIDLAIENKYNYVVCGHIHEPKILNQTTKKGKTVYLNSGD
WVENLTALEYNKKRWKLYRHSENEEIIEEDYLEMETKLSEKLMSSFFVMK
>LONDMIMF_02517 Chorismate synthase
MAGNSFGNLFRLTTFGESHGEALGGIIDGCPPGITLDIEAIRFEMSRRKPGQSAIVTQRK
EDDEVQFLSGIFEGKTTGTPIGFIIPNTNQKSDDYSHIKESYRPSHADYVYEKKYGIRDY
RGGGRSSARETASRVVAGAIAKQVIPSIKINAFVSSVGDIFIDKPYQALDFSKTESNPVR
CPDEATAKKMEDYIKEIRKQGDTVGGTITCVIQNVPIGLGEPVFDKLHAELGKAMLSINA
VKGFEYGSGFCGARMKGSEHNDLYNPDGTTKSNLSGGIQGGISNGMDIYFRVAFKPVATI
MQKQETLDIYGNIVEMQGRGRHDPCVVPRAVPIVEAMAALVLADYYLLNKI
>LONDMIMF_02518 hypothetical protein
MKKILLFVGLIVSSFNANAQLSCAAATPITANGTFTVSSITGTYGAGCWAPGTAPKSNWY
SYTATANGEVTVSSDLAVNVGPTYSDDTRLSIFTGTCAALVCYDGNDDVSGTNYKSALTF
PVQSGTTYYIAWDNRWSAKGFQFTFAFNAVPCVRPSLLTINDATNVTTNSASLSWSAALG
NPSGYDVDYGAVGHTAGTGTIVNTTTTSVNLQSLPVSADLVYYLRSNCGGTQSAWVGPFN
LYLAKTMPYSNNFDDTADPTDGFDLGEWSLSTSSANAAYANTAPGFAFSNTSATAATNSF
MFFRPVSLSAGEQVTINFQTRFLGGATDIASLNVTVGNAPLAASQTTVVQAFPSIAGGST
TYTARTATWTAPAAGIYYFALNNVSGTTADTYSLIVDTITASSVLSTNEFSASNLSVYPN
PSNGIVNISSDSNILLNNLSITDLNGRTVKTAKLNGDSSAQVNISELAAGVYMMTINSDQ
GSVTKKIIKN
>LONDMIMF_02519 hypothetical protein
MNLPQDKKIILFDGVCNLCDSSIQFIIKHDKKDIFRFVALQSEIGLEIINHIGIDTSKID
SILLYEPGKAYYYKAQAALKIAKELGGIYTAISWFSILPNFLTNTVYDYIAKNRYKWYGK
KEACMIPTPELKAKFL
>LONDMIMF_02520 Endonuclease MutS2
MTNITDKTLQDLEFNTVLQAISEICNTEIGKEKALRISPFKHKKELMDALLQTSEYVSSF
TNNNAIPNHGFETISNEIKFLAIEDSFLEVGSFRKIAAISDTVNVLLLFLKKFNDYYPKL
SEKSSAVEYTKFITQKIDEIVDKYGEIKDNASPALVEIRRNMNMVRGKINQSFGMALSQY
NGLGYLDDIKESIVENRRVLAVLAMYRRKVKGSILGNSKTGSITYIEPEATLRFSRELSN
LEYEEKEEITRILKQLTNDIRPFLDLLKTYQEFLSDIDVIAGKAKYANRINGILPSITDE
KRLYFREAYHPILYLNNKKKNEVTFPQTIELTNESRIIVISGPNAGGKTISLKTVGLLQL
MLQSGMLIPVHERSETFLFDRILTDIGDNQSIENHLSTYSYRLKNMNYFLKKCNAKTLFL
IDEFGTGSDPELGGALAETFLEEFYHREAFGIITTHYSNLKMLANELPYASNANMLFDEK
SLEPMYKLILGQAGSSFTFEVAQKNGIPFGLINRAKKKIEGGKVRFDKTIATLQKERSKL
EKTSQNLKEEESKAREESKKMESINSKIQDKLERYQELYDANQRLIYMGQKLDDISEKYF
NNKNKKELIGEFLKMVEIENSKRKKLTAKEKKAKEIVQKEIIKEVTVKVEEIREEKKEKK
IKAIKQEANKPKPVLKLGDRVRLVDGKAVGTIDKIEKNKVTVNYGIFTSKVDLETLELVE
AKK
>LONDMIMF_02521 hypothetical protein
MKIKINIALILFCCLSLQTFAQIKIPKGYSELKESPANGRKIDKVTILFDNDAIKDVLML
IKNDTAFSSYKLLIYLSSFQKQFEVELFSTNDFSIYPVQLKSNKNTVQFGYFEDGTATFG
RFVTLRFNTTKNKIQVIGYDTSYKASPTEHIDKSYNLLTGKYIVKRTNINLNGTKKTQEF
SSKNDVFKNVVFIEDLKEKMYRNLDDVGSKYE
>LONDMIMF_02522 hypothetical protein
MTKKIKLIYLLTLLTLNFSCVEKKSTEKETNRPKLIVNQKTDTLKFTSGIRAIFQYSKGN
YWFGSHNEGVSFYNGKSFDYFTTTTSVRLLNKMRLKVSFWQKLIFNCKVI
>LONDMIMF_02523 hypothetical protein
MKLTTFLSCSILSILTSCNGQISNSKNQSVVPKEINVKGDTVKEPGSSIMVIYQDRKNNY
WFGSWKTGVYKYDGKTLINYTTKHGLYTDRVDDIKEDQSGNLYFTGMNPDAIVTKFDGKS
FTNIRATPSDEWKLEANDLWLLNPQQDKQKVYRFDGNRFYELTLPKPPQLNHTFDVYSIY
KDRKGNIWFGTNPVGVCRYDGKSFEWITEEDVTEFRDGGKNGVRSITEDKNGDFWFNTEN
RYSVYDSITLKCNKFYTRHESIGSLDGKNTTGLNEYLSTVRDNDNNLWFVTYRDGVWKYD
GTKITHYQVQEQSTNIKLFSIYKDNNGDLWLGTHENGIYKFNGKTFEKFKP
>LONDMIMF_02524 putative transport protein HsrA
MSKHMDTDSVKRFLPFILATAIFMQMLDSTILNTSLPAIARDLNESPLDMQNAIISYVLT
LALFMPVSGFLADKFGTKNVFITSLFIFSLGSLCCSLSQNLTQLVISRVIQGVGGSLMTP
VGKLALIKAFNKNELLKAINYAIIPALIGPVLGPLVGGYLVDYLSWHWIFLINIPIGVLG
IILGLKYMPNYKSPVFNFDLKGFLIFAMASLLLSISLELLGNANNITPVLLGFAFGFLML
FFYYKHARKNNNPIFPLNLFQVRTFRVGILGNLATRLGISSIPLLVPLMIQIAYDRSAFT
SGWIVAPMALTSIFAKSVVIKILDKFGYRLTLMVNTFVIGVLICCLAIPGIHHSIYWYVP
ILLLLGFFNSIQFTSMNTISIADLRTYQTSSGNSLVSVNQQFAIGFGIAFGLIILKFFEG
DTKLIHNEIHNAFRYTFLVVGFLTILSGLVFRRLNFRDGGNLNSV
>LONDMIMF_02525 hypothetical protein
MVIFNDENKKKFDLIWIETIPKKDTVSFVFDITEFYGKWN
>LONDMIMF_02526 HTH-type transcriptional activator HxlR
MYERKIPLNLNCGLDLIGEVLYGKWKMRLLWFINQGHKRPSELQRKIPDASRRVLTIQLK
ELEDHELISKVIYPVVPPKVEYSLTDFGKTLIPVIAAIGGWGDEHEERLRSLILKRLDSK
S
>LONDMIMF_02527 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MQFDFPLLPDSYIHPNFVQKYKTMEQTFNFNNELSGRIALITGGTKGAGKAIAERLLQAG
ATVIITARNAPEKENSRLHFIPSDLSKAEGTQKVIREVLSVYGKLDILVNNLGSSTTPAG
GFTALSDEDWESTLQANLLAPVRLDRGFLPQMISQKSGVIIHIASIQGRLPLYDSTLPYA
AAKAGLINYSKSLSNEVTPKGIRVLTVSPGWINTTASEAWLGEIARNANSTIEEAQQGVM
DALGGIPYGRPAQPEEVAELVGFLVSPRANYLTGTEFIIDGGTVPTI
>LONDMIMF_02528 hypothetical protein
MNLPKIITDLVNAQNSFDSIAYTNCFSETAVVFDEGKTHNGRVEIQHWIEESNEKYRSVM
KPLEYTENGNSCVLSAECSGTFPGSPICIKISF
>LONDMIMF_02529 hypothetical protein
MKTKITFLYLLALICFIQKVSAQCTYGSLTSSQAITPVYDNNERIIFNGIRPGEYLLIKT
FSTATRYTFKSTRATDYITIADANGAQVFVSGLSGSNGLNFTPPYPQTIRYYIHTGSQCE
SGDITDRQVYLKTTTIDNSCDSPNTLSVSNITSNSCKVSWNAQIIGQITSYDVYVNTTGI
SPVTNTIPTTEANGSREAQVSGLAPNTTHYYWVRTQCVSDRGVWVPGGSFTTTASGTGTA
GCNGAPFGLYPEATVNVTCNGSVQQIAADAHAGEYTNVYVTPNEQYTFTSSVSTDFITIT
DPTGATIYASGQTPLVWVNNSNWATIRYYLHTNSSCGTQNTARIKSIKCGGVVGGCTVGE
LHPQTTFTPACSGSLEMIVNDAYAGEYSNVNVTANKQYTFSSSNVNDYITIANPVGNAAI
ATGPSPLVWNSGSTSGVIRYYIHTNSSCGTQNINRQRYIKCTAAEPTCGVPTALSVSNIT
SNSSRLSWTAPATAPTSYDLYIVTANTAPTANTAATVTSTTAGVDVLSGLEGSTTYYYWI
RSNCGSTKSAWVSGGNFTTIAALNCNGAIYGLYPNATFTPACTGTNEPIATDCWAGEYSN
VNVVANKQYTFTSSVATDYITITNAAGTTVLASGVTPLNWTSGSTTGVVRYHLNTNASCG
TANTNRTRSVKCVDAPTGGCGVPSALSVTNITSNSIRLNWTAPATAPASYDIYIVTTNTA
PNANTAATVTSTTAGVGVLRGLDASTTYYYWIRSNCGGTKSAWVSGGSFTTIAALNCNGA
TNGLYPNATFTPACTGANEQIVADAWAGEYSNVNIMDNKQYTFTSSVATDYITITNANGT
VVLASGVTPLNWSSGSTSGVVRYHLNTNANCGTANTDRVRSIKCVDATPSCGAPSNLSVT
DVTSNSARIIWTAPTPAPMGYDLYVVQSNTAPTANSNPTHLSSTNSRLITGLSPATNYNY
WVRANCGSTRGNWVYGGSFDAIPAVGCNGAIYGSYPTETLQLACTGSPQIVAEGLAGQFT
KMYINFGQYYVFSSSIATDYITITDDNGMTVLASGTTPLSWSSGSNVGVIRFYVHSNANC
GAEDAIRIKSVNCSSTPIGGCGLPSNVSVSNVTSNSALIRWTAPSPTPSSGYDLYVVQSN
TAPTYNSTPTHTVSNNYTSMVVSGLSPATNYSYWIRANCGSTKGDWVYGGSFDAIPAVGC
NGATFGPNPAEAIQIACMGSAEVVSQGFAGEFTNIYINYGQQYTFSTSVATDYITITDDN
GMTVLASGPSPLNWSSGSNVGVIRYYVHTNANCGSQDAVRVKSVTCRNPLGIDQFAQNNV
TIYPNPSYGQFTVETGSVIADNITITDNLGRVITTFKPSLSKSDLSIDSFAEGIYYVKID
YQNKSVTKKLALKKN
>LONDMIMF_02530 Spermidine N(1)-acetyltransferase
MLIINFSDFPELETQRLKLRRADLNDVNELFALRSDPNIMKYIPRPVATSLEEATEHFKM
MDEKISNNEMINWAITLKDNPKMIGTIGYFRMKPEHYRAEIGYMLLPDFHGKGYVTEAIN
GVVDYGFTKMGLHSIEAMIDPENIASAKVLEKCSFVKEAHFKENEFYNGEFIDTVIYSKL
NSKNY
>LONDMIMF_02531 hypothetical protein
MKSYKLFIILFALLFSCESKKDKIKSDWKYYSGFDFGDFLSFKHQNLKIQNDTIYKDSTP
LAIIVELKTNYLPGTENKLTLKDIKSGALGIYTDKGK
>LONDMIMF_02532 putative HTH-type transcriptional regulator YtcD
MKKTAEINATPICQVRMQAISDTMSLLSGKWKFHILGTLIEGNTLGFMDLLREINGIGTK
MLSKELQDLEVNNLVNRRVMNTKPITVEYSITEYGKTLSPLIDEMAKWGIDYRKKVYFQE
V
>LONDMIMF_02533 hypothetical protein
MLANFGCQAQTDKKMKNNTNPLLCDPVEGICGIPDNAESGKVVTQNTQKPVKVIYFTDPI
CSSCWGIEPQIRKLKLEYGNSIEIEYRMGGLLPDWSYNSGGISKPSDVAHHWDEVSLYYD
MPIDGDVWLEDPLPSSYPPSIAFKAAEMQSKEKAIQFLREIREMVFLQKKNITKWENLEM
AAKKVGLDVKQFTTDFNGKAKTLFEEDLHFARQNGVRGFPTIFFIDATGQKETVYGSKPY
VFYESAILKLHSKATKSEYYKNWEVLFSKYPSLTAKEFSELSGTPRAESEKQLNELTTKG
KLEKLTTKNGSIWTVKN
>LONDMIMF_02534 hypothetical protein
MDFFRKNIIFISSILFILNEKQYKPLNYRIKPMLKIEFEEPHLELCECCGKETVNLTRFV
YEDDDAFAIYYIKFTKDHEDKVANGIISIGDWGTDEVPENRYSFPFRIWTKGKNYQVGLM
DREESPWTHQILGKILDRNDALKHPWIKEVFHITDHIVMEDKEVIEYFSE
>LONDMIMF_02535 hypothetical protein
MYRAFYCLGFLFSISLNAQTSNVVSWLNTNAIVIEDANPDTELVAFTQNEPQGFKEARIY
GFGEATHHAKEFFDLKAKFFKYLVEHNGVRVFIMEESYQGEQAINEWISGGPGDKASLIK
NFRHFLWRTTEVADLLEWIRNYNQGKPREAQIRFYGIDNQMGDDINKRLRSYVQKYNINI
DENLLAAADSCSVAEYGHVKIKEWAKKMQPKLQQLTQLLEQDSTRLKAANANEYIDMMRG
LGYLEDYTAYISWPAADVRDNAMYENVLKIMNIEVPDSKVFIWAHNEHINKKDLGMAVPS
LGSRLKEHFKDDYYAMGFDFGSGKMLGFIIKNKQVLGSEYRLLDKPYNKTYAETFFQAQP
DIYFVDIATAVKNPEMKKFFGTKMKQLFIGGPGFDPKDPKFFSRKYEETYDGIIFLKKIS
PSVRQKQT
>LONDMIMF_02536 hypothetical protein
MLLGTNTQTGVICTTTTILQPFISYIAGNDSFVFLICIMNSLYNYFCTLHPVFTPSDFEL
LTKDFQTKHFKKGDYIVREGETQRNIYFVEKGIQMYNFDTQGKTNILGFAYPPNLCVVME
SFIFQKPSTYNVTCITDSTLNYLHYSALQEIFEQSRQVERLFRKLSENLSIGLLNRQMEL
RSTTIEERFKIFCQRSPHLLQQVPQKYIAAYLAIDPTNFSKLMNTVRF
>LONDMIMF_02537 hypothetical protein
MTFQHLFYIPTIFLLGLIFGILLGNNTNTVSADGKVSVKKLGLVFLIFLIVFIITHAFTI
PAGSKQVSMLLDGLEIFDKKPIFGSDAVYHYMQSFTEIGIQVYKRFTYTIDVVFPLSMLA
FLHTFSKFTLQRIKLPKYFFKIAGLLPWIWFGFDMLENATVFYLLSEFPKQHPFIAGSLG
WITVIKFVLLFLSLFVPASLLLLARKLRYQY
>LONDMIMF_02538 Acetyltransferase YpeA
MNYQIKKASLEDLNETAVLFNLYRVFYRQESDLERGKTFLKERFLNSESDIFLAIVDGKA
VGFVQLYKLFHYTKLQKQWLLSDLFVHPDYRGKGLSVALIDRSKQWCEETGACGLMLETE
KTNDIGNQLYPRCGFEYDGLHNYYHWWK
>LONDMIMF_02539 HTH-type transcriptional regulator NorG
MFPFQNIITIDKESKTPLYRQIAISIINEIRTGTLKAGTPLPGTRELSKLLGVHRKTVIA
AYDELHAQDWIIVIPRKQVTVSQQIPVLKAKNWSQKEAASSYQNTFSLPFHKAEEKMSDK
KILTAPEILIDDGYPDIRLSPIEDLLKIYRSYTTRKYAVKNAIVGTTQGTLKLRNELVSY
LSKTRGLNITADNLLITHGAQMSIYLASQLLLDKDATIITGNPDYPIANKTFARTKATLI
EVAVDENGLDMAAVEKICKKKKITAVYVIPHHHYPTTVTLSVQRRMKLLELSHQYSFAII
EDDYDYDYHYASSPYLPIASGSHNGNIIYIGSFSKILGPSIRIGFMIAPKNFIEQCTMLR
EEIDFGGDGYMQNALAELIKNGDLSRCLKKTKKSYRQRRDYLDALLKKHLGDSVSYSLPD
GGMAIWIKINPMFSVNKLTSIHQLHIKRIHTQENAFRFGFASMNEPELEEAVSCLKAALK
N
>LONDMIMF_02540 hypothetical protein
MKKSYLTMLMLVFLGTVHAQIGIGTINPDASTALDVTATDKGILIPRVALTGSTDTSTIT
TGNVDGLLLFNTATVADITPGYYYWLAGKWQRMDGRGNGWQLAGNAGTDANADFLGTTDA
QDLTFRTDNMERLRITQRGRLDFSNTSSDPLFPNIFLEGGNETTSGAANIAIGESALKNI
DSGQLNIAIGRNALQATTSGSVNIAIGNQTLSSNTDSFSNIGIGFGVLPSLNNGGHNIGL
GDNTGLSLVSGNGNTFIGSFASSTLNSLENATAIGYMATVEADNSMVLGGIGSNAVNVGI
GNTIPNSTLQITGSFSAAIKSTNINYSLTDKDYTVLYTVSGITVTLPAADSSNVGRIYNI
ICDVTGGSVNLNATGTDITKDGTVITSATGSLVVQSTGTKWIVIP
>LONDMIMF_02541 hypothetical protein
MKTASHFLVWISILFTTSLFAQTHEIKGIAQANGEPAAFYDVLLIAKDTLRGKTAENGSF
ALQAQTGNYRLEVLYFDEIVYKQELSLKSNTDLGVIAFESKTKLDEVVIEAPKKLMERKA
DRFVYHVANATSSAGGTAIDALRTTPGVTVTQESISISGKNSVMVLIDDKPTYMEQAELM
NYLESISASNLSKIEVITTPPAKYQAEGNSGIINIVTKKVKKDSWNALLGGAYQRGQRNT
QQYNTAFNLQKNKLTLRSSASTGVRRSLIRWDNDIYYSDAFWQNESSSDGKNRYFNGQLA
LDYRLTKKWTIGTKVSAYTSKFTDAQPQLTTLFDQKGGAIQQFMKNNATSNDKTYQQIYN
LYSEYKLDTLGKKMMVDVDFVNYHTPTFNRYAYANYNPANELIANSQHAGINDVDIRIQN
LSAKVDFELPTKIADFTAGARFSNSKSDNLINAFKQDENGEMVYDTNLSNYFEYTEKNEA
LYISGNKKFNDKWNIQAGLRLEATQTDGYSREANNRHKNDYLKLFPTLYILHQFTEDKSL
GFNYSRRIRRPSYESLNPFRTINNEFSYNEGNPFLRPSFTHNFEVTFTYKTFDSRLSFSS
MRDGVNQASILNPDTKQNNYIWMNYVNEDMLSFTQSYTAKPTPWWTSVNNLSLSYSESDI
AVSDRRNKGASSSFFTTNDFTLNKNKTFFLSISYFQNFGETFQNSSLKPYAKFYATVKYQ
MLDKKLELGISGTDIFNGREYSKQNMYGVTQEFKNVWDTQRIRFSLTYRFGNRNLKTSER
QSGNSEELNRL
>LONDMIMF_02542 Sensor histidine kinase YehU
MKKKYVILLHLLFWLYYIMQDLTVFDFKQQKISFPILAFDFNKPEYLLMLSFTAIYIFVF
YLNYLVFMPKFFDVKNVKRIALSFLALFIIFIGMRYLIEEVLFDILFGFHNYYKGVTVTY
YIYDNLAYSSLPIMASSVLWFIVNMLRLQKEQLALLESKRETEINFLKSQINPHFIFNTL
NNIYYLIFEKSEKALPAVEQLSGLMRYMTYESQNETIALQREIAYIENFIALETMRISGD
AQVFFKKNIENPECRIPPLLLIPFVENGFKHGILNNPEQSFTIELTQNKNHLILQTQNSI
NNYKKDHQSGVGIENIKKRLQLYFPDRHSLEITRKENMYYVKLDITL
>LONDMIMF_02543 Transcriptional regulatory protein YpdB
MRTIRCAILDDEPMAVALLSKYVEKISSFELVKATTNPFEILELIAQTTIDVLFIDIQMP
ELTGIQMMEMLGNKTKFVITSAYSEYALKGYEHNVVDYLLKPISFDRFYKCIQKIESLAQ
EKPAPTVEIAAKTEEKPDEFLFIKTDGKLVKINLNDLLLVEGLKDYLYLHLKNEKLIVLD
TLKEFEAKLPASDFMRVHKSYIIRLDQIETIERNRVFIQKNIVPIGETYKIKFQDWVKSF
L
>LONDMIMF_02544 hypothetical protein
MKKTFLSLVVLASLYSCNMTVKTDTVAEEFSDIHFENYKEHFVDELWKLNPGWASSQGYH
KYDSVLLIPDDAYEQKQLQFSAIQLDSLKKYSLENLSDNNKTDYHMIKNLLESIVFNIKE
VKSDEWDPSAYNVSGSFAEMLNGNYDSLEARLKNISLKMDNIPAYYEAAKKNIKNPTLEH
TQLAIAQNLGGVSVFETDLKAAVAKSKLGKEEKEAILTKVKTSVKAIQDYAAWLQKLDNK
SPRSFRLGKELYAKKFDFDIQSGYNAEQIYQKAIEQKKELHDKMFVLADKLWSKYLGNAP
KPADKLELIKQVIDKISLQHTTPEKFQSEIEKQIPELTAYVKAKDLIYIDPSKPLVVRKE
PDYMAGVAGASISAPGPYDKNGNTYYNVGSLSGWSAADAESYLREYNDYILQILNIHEAI
PGHYTQLVYSNQSPSLIKAILGNGAMIEGWAVYTERMMLESGYKNSDEMWLMYYKWNLRT
ICNTILDNSVHSRNMSKEEGIHLLTKEAFQQDAEAEGKWKRVTLSQVQLCSYFTGYTEIY
DFREQLKKQQGKNFNLKHFHEKFLSYGSAPVKYIKELMKNEK
>LONDMIMF_02545 hypothetical protein
MKSKRLYLLLIFLVILFSCQKNNQKIVGIQPYGAFPKQQVTLMAEVIDSFYNVRTVILPH
KEIYKQAYVNIKSPRYRADSIIRIQKRNLPDSLDFVVGLTVKDISTTKRESSGEVIKPAS
KYTDWGVMGLGFCPGKSCIISTFRLHHKNPNVRLERLKKITIHELGHNLGLPHCKNKKCV
MTDAVESIATIDNESLSLCEDCRQEIGF
>LONDMIMF_02546 Mechanosensitive channel MscK
MRNKTLFKSFPHNPTLLLLFVLFLMTGMVTAQEKEKTATNQPTDSKNKPSVFAEDELAAS
DYLVSIERAGEMLDNAKSKGALDAGVLFLLGEMQQTEKALKLIDSNLGAKNNGNVRNQQM
YGKILLELQQKFENYWTRLNESDERIVKIRKGNKAIINDTVFRKLIRDSLLIKEFRPQLK
ELKNKWVTTDSLLRANIDSLNNWKKGIVEKRMLVSKDLILVNERLNKSGVSLLGNEHPHL
WDSNGDNQQQMQTYFQEKFKAEQKAFSYYFGYSFGSTFLLLVLGGLLLWWISFNLKYLKR
VHQMESLEIFQFRYLNQGAILPVIVLILNIAIAINLYAPALFIEFTHLILLIALTILFKK
VWSSKAFRNWLLLVALFVMFSFMDLFFEVSRIQRCIFILVNLASIRFGLAYLKTIQEEMY
IKGLLKYAKILFLTLNILAVIFNVFGRVSLAHTLSLAAVIALTQVIALSVFLKIILEMIT
LQIYAIRIRRGIVKIFDFRNLEKNLKKPFMLLIVYLWIIVIASNLNLSNIFYDSISSLLT
TQNKIGNFSFTVGNILLFLLIVWIAHIIQKYVAYFFGEIDDEDEETINKKQHSKLLITRL
LLLILGYLLAISAAGIPLDKITIVLGALGVGVGLGLQNIVNNFVSGVILIFDKPIQIGDV
IDVGSQSGRVKTIGLRTTKIDTSNGAEVIVPNGNILSQNIVNWTYTNNSKLVDMSFTLQG
EISQEQIKATIISSIKEIPTIYSEKEPRLFYNFISDTKYQLKIQFWCNIYRTEAAISEAR
IVLYEEFKKQGVSFE
>LONDMIMF_02547 hypothetical protein
MIQDVLELQQRHEDFIKNICQTEIVFGLENNVGFATLDSTNYENENGKSMPVMCFWSDRN
KALACAKDKWKQYRTAEIKLSEFIEEWCVGMYNEGLLAGTDFDENKQGNESDALELLLEI
TAELESLGKEPEFKKFENLADLEEQIREILE
>LONDMIMF_02548 hypothetical protein
MTSHEIDYQIYGEEMQYVEIELDPQEAVVAEAGSFMMMDNGIAMDTIFGDGSNQNQGVMG
KLFSAGKRLLTGESLFMTVFLNQYHAKRKVSFASPYPGKIVPIDLTEYGGRFICQKDAFL
CAAKGVTVGIEFSRKLGRGLFGGEGFIMQKLEGDGMAFVHAGGTLARKELAQGETLKVDT
GCIVGFTQNVDYDIQFVGGIKNTIFGGEGLFYATLTGPGIVYIQSLPFSRLAGRVWAAAP
QGGGKSRDEGSILGGIGNLLDGDNRF
>LONDMIMF_02549 Glucan 1,4-alpha-glucosidase SusB
MKRLLSAFLLMACCVINAQQITSPDQNLELKFGLSSKGEPTYELTYKKKAVIKTSKLGLE
LKNGTSFLDGFQIDKTEKNTFDETWSPVLGEQKNIRNHYNELLVTLSQKAANGRFIKIRF
RLFNDGLGFRYEFPEQKNLNHFVIKEEKTQFALAGDHKAFWLPGDYDTQEYSTVTSNLSE
VRGKMKAAVTPNASQTTFSPTGLQTPLMMKSKDGLYINIHEAALVDYSCMSLNLDDSNMI
LESWLTPDAIGDKGYLQAPTQSPWRTIVVSDKATDILASKLILNLNEPTKYKDVSWIKPV
KYVGVWWEMITGKSSWAYTDLESVQLGVTDYSKTKPNGKHAANTAHVKEYIDFASKHGFD
AVLVEGWNEGWEDWFGKSKDYVFDFVTPYPDFDVKELHRYAASKGVKMMMHHETSGSVTN
YERHMDKAYQFMVDNGYNSVKSGYVGDIIPRGEFHYSQTMIDHYLYAIKKAAEYKIMVNA
HEAVRPTGLSRTYPNLIGNESARGTEYESFGGNNPDHTTILPFTRLMGGPMDYTPGIFQT
KISAYNPENNSFVHTTLAKQLALYVTMYSPLQMAADLPETYNKFLDAFQFIKDVAVDWDD
TYILEAEPGDYITIARKAKGKNEWFVGGISDENPRTAEVTFDYLPKGKTFTAIIYADGKE
ASYDKNPQSYSIRTVKVNSKTKLKQPIAPGGGFAISIK
>LONDMIMF_02550 hypothetical protein
MKSLSKIMATFAMVFVFTACEAQIKNEKKENVKIYGNCNMCKSTIEKAGNINKIAKVEWN
KDTKMAAIAYDQKATNLDAVLKRIALAGYDSDSFRAPDDVYAKLPECCQYERAIKTTAET
EMAHTGHSGHDMKTTEQKNQSQLKAVFDNYFDVKDALVKTDGKLASEKAKGLVKAVTAVK
MNELNTEEHNVWMKVLNNLKEDAEHIVETTDAKHQRDHFITLSKSVYELLKVSKYEVPVY
YQFCPMANDGKGANWLSKENAVKNPYYGSQMLTCGKTVETIK
>LONDMIMF_02551 Copper resistance protein A
MDIKNYNPAKLLLLLVMLTAGSLHAQKVVRYDLYVKDTLVNYAGKEKRAIAVNGQIPMPT
LTFTEGDIAEIVVHNQLKESTSLHWHGIFLPNKEDGVPYLTQEPIAPGAVYTYRFPIIQN
GTHWYHSHSGLQEQIGMYGNFVMKKREDDKTFRKGIDDLPTVPIILSEWTNLNPDNIDRM
LHNANDWAAIKKGATQSYVEAIREGHFKTKLKNEWKRMLAMDVSDVYYDKILINGANSTD
LKSFDGKKLKAGDKVRLRISNGGASSYFWLRYAGGKMTVVASDGNDVEPIEVDRLIIAVS
ETYDVVVTIPEEGLSYEFLATTEDRTQSASYFIGNGVKQLISPLPRLKYFEGMKMMNDMM
KMNGDLDDMGMNMSLNQMDMNVVMYPEITGDAKQKDTKQKTDHSQHAMNMDNDPNRYNAN
ALADIVTLNYAMLKSPYNTVLPKEAPVKELKFTLTGNMNRYVWSMDNKILSETDKIPVKK
GEVLRITIYNNSMMRHPMHLHGFDFRIINGKGENAPLKNVMDIMPMETNTIEFLANEEGD
WFFHCHILYHMMAGMNRVFAVGDYENPYLPDKAKAYKMLQRESNMPHFMAQNDFATNGND
GEAMLQNARWSLGTEWRLGYNDMHGYEVETHLGRFIGKMQWFMPFIGFDWRYRRMGEDEH
EKNIFGQKNKKDSRSAVSLGFVYTLPMLVNFQAEVYHDGIARLQLMREDIPISKRLRAGF
MANTDLEYMVDLRYVLNKNMGVRTHYDSDMGFGVGFVLNY
>LONDMIMF_02552 hypothetical protein
MKLKSLLLCLLFIGAITQASAQESADKILEKAFTQAKKEKKNVFVMYHASWCKWCKKMEN
NMEAETVKPFFDKNYVTTFLVVQESKDKKHLENPGADDILKKSKADNSGIPFWQIYDANG
KLLADSFNAKGENLGCPATVEEVAEFTNKLKKTAKLSEKDRKKIEEVFVLKKK
>LONDMIMF_02553 Putative ketoacyl reductase
MEQLQGRKALITGGSRGLGKATALALAAEGVDIAITGRNEEALLETIAELQAYGVKAIYS
VFDVADFEAAKKGIAYIHEAFGAIDILINNAGTASFGSFLEMEPERWQEILNVNVMGIYN
VTHQVLPGMIARNTGDIINVSSTAGLRGNANTTAYTASKFAVAGFSEALMMEVRKHNIRV
SALMPSTIASEMSLSLNLTDGNPERVLQPEDFAELVVAQLKLNRRALLKSASLWSTNP
>LONDMIMF_02554 hypothetical protein
MNGFFKTLLAGWGAKKLGGGCLGTIILFFILYWLLGYL
>LONDMIMF_02555 Maleate isomerase
MKKYKIGQIVPSSNTTMETEIPALFRSRETIAPERFTFHSSRMRMKKVTKEELEAMDAMS
LKCAQELSDAQVDVMGYACLVAIMSMGRGYHCVSETNLHEETVKNGFPTPIVTSAGALIN
GLKVLGAKKIAVITPYMKPLTQLVVDYIEHQGFEVVDSIALEIPDNLEVAAQNPMNLLDI
YKRLNLKDVDVLVASACVQMPSLEAVDLIEKEIGIPVTTAAICTTYEMMKKLGLDTKVPI
GGELLSGKY
>LONDMIMF_02556 Ureidoglycolate lyase
MKLVTFTHKNSEPKLGIFNNDTILDLEAFAHKHNEEFPKNMLELIDLGLEEVNRIAEILK
TSSESAIAAASLPLNEIKLLAPITKPRKNIIGIGLNYTEHVAESARTLDTSKDLPQQPVI
FSKPPTAVIGTDEAILHNTKLTQQLDWEVELAVIISKKGKYIAKENAMDYVFGYTVINDI
SARDCRRAGQWIVSKGQDTFAPMGPVLVTKDEIEDPHNLNLSLTVNGVEKQNSNTKYMLF
RIPDLIEDLSTVFTLEAGDIIATGTPAGVGAGRNPQEWMWDGDVVEATVEGIGTLVNTIK
KIQ
>LONDMIMF_02557 Gentisate 1,2-dioxygenase
MESKFNDDVIGRARVKDTPELEAYYKELETLGAGALWTVANDIEPWEPRTSSVPMLWKYE
NLRELVLKSSELVTPEQAGRRVVYLVNDKRKDVSAAVGWLYTGIQVTRPGESTSAHRHKA
SALRFIMEGEGGYTVVDGNKITFEVNDFVITPNSTWHEHGVAEGGKTCIWQDGLDIPLVN
ALEANDYAVYDGKQELKYPVNFSPLTYGGSGLLPADKVWDKPYSPLFKYSWKNVYPSLLE
AAQVNDGSPYDGILMHYSNPVTGGHVMQTMGASMQLLRAGEHTKAHQHTGSFVYQCAKGK
GYSVINGKRYNWKERDIFCVPSWAVHEHVNLSETEDACLFSFNDLPVIESLGLYQERAYE
ENGGFQIVNS
>LONDMIMF_02558 hypothetical protein
MKMQPLEHEKFYHIFNRGNNGIDLFYDTDCYYHFLRLYEKYMEPVAETYAWCLLKNHFHL
LIYIKPRNEIDSSKLKYSTVEKPNVISASKQFSHLFNAYTQAINKRFKRTGSLFEKPFHR
KLVASNDYFQKLVFYIHNNPVHHGFCKNINDYPWSSYGSIISEKPTKIKRKEVIDAFYNL
DNFIAYHNQNQDLFDIDGLIIE
>LONDMIMF_02559 Aliphatic nitrilase
MEFPKFKAAAVQTAPVFLNAQATTDKAIAFIKEAAGKGASLVAFPEVFIAGYPYWNWIMT
PVQGSKWYEVLYKCSITTDGPEVQQLCQAAKEHNVHVVIGINERGNSYGEIYNTNLIIDN
NGILIGRHRKLVPTWAEKLTWTSGDGSSLKVYPTEIGPIGTLACGENTNTLARFTLLSQG
ELIHIANYISLPVAPPDYNMAEAIKIRAAAHSFEGKLFTIVSCSTISQEIMDALKEDVPN
VQELLTRKNSAFSGIIGPNGAVVGEPLIDEEGIVYADIDLSKCIQPKQMHDILGHYNRFD
IFDLRVNIAPTRKITFIDNHEEFSKK
>LONDMIMF_02560 1,4-dihydroxy-2-naphthoyl-CoA hydrolase
MSNYFIKEEKIRFQHVDYAGIVFYPRFLEMLNALVEDWFEEALERPFATIHETNGIPTVD
LKVQFRKAARLGEILTKYLWVKNLGSASMVCGFRFEDQQGKTCLEGEVTLVNVAISTNRE
NIKSEPFTEDMKQKITPFLSER
>LONDMIMF_02561 Glutamate synthase [NADPH] large chain
MRKAFVVLSITVLAIIGIMTYINWKASFLLLIFIPLIIMGLYDMFQSKKTIRRNFPLVGR
MRYLLESLGPGVRQYFIEKDLDGKPFNRLERSLVYQRSKKETDSNPFGTQLDIYEVGYQW
INHSIKAIPFSKVDSNPRIRIGSSQCEKPYDASLYNISAMSFGSLSRNAIQALNAGAKQG
GFYHNTGEGGLSPYHLEGGDVVWNIGTGYFSCRDDDGNFSYEQYAKRAVLDNVKMIEIKF
SQGAKPGHGGILPKEKVTDEIAAIRLVSKGKDIISPPTHSAFSTPLELMDFIKLLRKGSG
GKPIGMKICIGNKSEFIAICKAMVETETYFDFITVDGGEGGTGAAPQEYSDHVGMPLRDA
LAFVYDCLVGFGIKNQIKIICSGKIITGFDIIKTLATGADLCNSARGMMFALGCIQALEC
HANTCPTGVATQDPRLVKGLVPEEKSIRVARFQHETVKSAMELMASAGICHPDEVDRHVV
SMRVDRTKIQTFAETYPELENGCLLNENTVPENFRSFWKKATAASF
>LONDMIMF_02562 Benzoate--CoA ligase
MFQDNFAQKHLPSQKLQPDYIYNHPDFQLPEALNCVDRLLDSHVREGRGHHIAMRTFEKN
WTYQDLYEKANQIAHVLVDDLGLVSGNRVLIRSANNPMFVACWFAVLKAGGIVVATMPLL
REKELEVMIDSAEISHAFCDYRLEEALASVKSTFLKQVITFDGTEQSLSKLEILMHNKPK
EFENFPTKADSVALIGFTSGTTGNPKMTSHYHKDILLICEAFPKYSLQPVSEDIFTGSPP
LGFTFGLGGLVLFPFYFGASTFLIEKPSPELLLEAIQNHKVSIVFTAPTAWRVLATKVKD
YDISSLRKCVSAGETLPEKVWEDWYEATGLKIIDGIGATEMLHIFISSNEENMKKGATGL
PIRGYEARIVDRKGNELGINEPGRLAVRGITGCKYLNRTDKQKEYVQDGWNLTGDIFRKD
EDGYYWFVARGDDMIISSGYNIAAIEVESVLLKHEDISECAVVGLPDENRGMLVCAYVVL
ADKSKACDEYVRSLQDWFKENAAPYKYPREIRFLEQLPKTETGKIQRYKLKAFGKGN
>LONDMIMF_02563 Salicyloyl-CoA 5-hydroxylase
MKISVIGGGPGGLYFSILAKKANPEFQIDVYERNKADDAFGFGVVFSDETLSEFLSRDPK
SYELIRSRFAYWDDLDIARDGQKIRITGNGFCGCSRKTLLQLLQQRCREEGVVLHFEHAV
EDLAAFKDSDVIVASDGINSLFRDKQATDFGTTSSLQKNKFVWMGSTRPLDAFTYFFRNT
PHGPIVAHTYQYEEGKSTWIFETSPETWEKAGFVTEDEEGTIQKLTELFKEELDGHGLIS
NRSHWRNFPIITNTVWHKDNIVLLGDAKATAHYSIGSGTKLAMECAIALADAITAHPKDI
PQAFQMYEQSRRKRVEMIQHAAKVSLEWFEDMDRHIQQDFLPFAFGVMTRSKKVTLENLA
IRDASFTDAVLKDFNKSIGNAETKTPPAFTPYQLRQMQLQNRIVMAPMEQYAAKDGLVSD
WHLVHYGSRATGGVGLILTESVAVSEEGKITLGCPLISSQQQIDSWKKVTDFIHQNSKSK
IGIQLGHSGRRGAVKRPWEGHDEPIETPWKLLAPSAIPYNSKMPVPKEMDRQDMENVITQ
FRNAAKNAELAGFDMIELQANHGYLLGSFLSPLTNNRKDEYGGTVTNRLKFPLEVFKAVR
ENFDKNRPVSVRISANDWANGGITPEDVFEIAKAFQQAGADCIDVSSGYTVSHQKPAYGR
MYQTPFSDAVRNSTGIPVITAGTIQDIDQINTIILNRRADLVALGRPLLLDPGFVRNAQA
YEQYPAGDIPKAYEAGISHLYPYKLSERKAVEGMKKALKPESHKNS
>LONDMIMF_02564 Putative sialic acid transporter
MLQTAFKRYIDSFRGFSKEIWILALITFINRTGTMVLPFLSKYMKEDLHFDYDAIGTVMV
FFGLGSMIGSWIGGKLSDRIGFYKIMIFSLLTSGLLLIFVQFVTSFTGMCFAMFGIMLIA
DMFRPAMYVSLGAYAKPENRTRAFSLVRLAVNLGFAAGPALGGLIIMGIGYKGLFWVDGA
SCIISILIFATLVKEKKLATHQDHEDAEKAVVKSVFWDGPFWIFLFGSYLTALIFLQLFS
TLPLYHSEWYHITEFQTGLLMSLNGLLIFFLEMPMVTSLERKQVNRLKLILWGTFLLSVS
FFVLLFDNWAGILIVSMLFMTFGEILNFPFTNSFAMSRAPKGHEGRYMALFTMSFSLAHI
TSAKLGLGIISRYGYATNWLVMGVLGLLSCASILYLKRIVTQNK
>LONDMIMF_02565 hypothetical protein
MKSFFNLLFLLVSTVLLAQKSFDKEAVVAFQKELNAEYADSVKSPLLKKDLKTFKALDFY
PINGSFFVNAKFIRTPDEKPFEMPTTTSRKPMYVKYGEAHFSIDGKKFKVNLYQSLDLKK
IEEYKDALFLPFTDLTSGVDSYGGGRYIDLKIPQGDTISIDFNTAYNPYCAYNHKYSCPI
PPQENDLAIEIKAGVKKFKK
>LONDMIMF_02566 D-aminoacyl-tRNA deacylase
MLYNLHTHKFSNHPGCLELVNQYPQEFDASIPLYSIGIHPWYIVADRVEDDLAVIEEKIQ
TSNCLAVGECGLDKRIEIPFSLQEEVFRKQLALAQKYQKPVVIHCVASFQELIAIRNDVK
ITVPMIIHGFSKNEQLARQLLENGFYLSFGKYLLRNPELESVFKNVPDNRFFLETDTIEE
TIEEVYAVASKYKGKNTEDLQGIVEQNFKNVFKK
>LONDMIMF_02567 tRNA threonylcarbamoyladenosine dehydratase
MAQWTERAELLFKKEGLEKLKNSNVLIVGVGGVGSFAAEFIARAGVGKMTIVDGDVVDIT
NINRQLPALHSTVGKPKIDVVGDRLMDINPELQLTRIKEFLSPERAFEIVTDEFDYVMDC
IDSITPKLNLIIASKRKKIKIVSSMGAGGKMEAGKVKVTDISKTKNCYLAKAVKRRLREA
GIDKGVKAVYSYEIQDPNSLRMTDGSNFKKSFYGTNSYMPGLFGLHAAETVIRYLLKKE
>LONDMIMF_02568 Phosphorylated carbohydrates phosphatase
MDGVIVDTEPVHRYAYFQHFDELEISVTDDLFATFTGNSTRNVFQKLKHAFGLDHDVEDL
IQRKRNIFNDAFDTKKDLHLIEGVEDLIKDLYQNGIQLIVASSASKVTIERVFNRFKLHQ
YFSDIVSGEDFPKSKPHPAIFEYAASLAIGKKDECIVIEDSTNGVEASVAAGIFCIGYRS
ANTKLQDLSKADRIINHFNELNAEKIKNLK
>LONDMIMF_02569 Beta-phosphoglucomutase
MVRTVIFDMDGVLVDTEPVHYDVSLLQFKDLDITVPDEMYHTFTGNSNKMIYQKIKDNFQ
LVHEVEELIEAKNKLFIEAFDKKEDLYLMPGVKELIIDLYNNGIQLIVASSSEMAIINKV
FERFGLNPYFTHKVSGEDFPESKPNPAIFLKAASYSKAPINECIVIEDSTNGITAAKAAG
IFCIAYKGESGTGQDQSKADMVITDFRDLNFEKIKNINA
>LONDMIMF_02570 Deoxyribodipyrimidine photo-lyase
MNIFWFRRDLRLDDNRALFEALSNAATLPVFIFDKNILSELPKDDARVTFISALLDNIQD
ILKQNHKSLAVFHDDPIHVFKKLVAENAEINAVYTNHDYEPYAQKRDAEVGAFLKSKNIA
FHTFKDQVIFEKEEVIKEDGKPYVVFTPYSKKWKENFNEKLTESFPSEKKLAEIAQHSYP
YLSLKDIGFEASGIKVADYNISSALIENYAETRNFPGIEGTSHLSPHLRFGAVSIRKIVK
TALKHRKETFLNELIWREFFMQILWHFPNTVTESFRPKYDHIQWRNNKTEFQSWCEGTTG
YPIVDAGMRQLNATGTMHNRVRMIVASFLCKHLLIDWRWGEAYFAEKLLDYEQSSNIGNW
QWAAGSGVDAAPYFRIFNPSEQVRKFDKDLKYIRKWVPEFEQLDYRPIIDHKEARERCLV
VYKKAVG
>LONDMIMF_02571 hypothetical protein
MKLYTLHTKQQLPVSIETAWEFISNPKNLEIITPKSMQFKTLSGDEKEMFAGQIIHYKIT
PLFGISMQWVTEITHVQEQKFFVDEQRFGPYAFWHHKHFLKAIPGGVEMEDIVHYKLPMG
LLGQLAHPFIVKPKLDEIFAYRRKKLIEIFGEFKS
>LONDMIMF_02572 hypothetical protein
MKKIVIAAGLLLITLTANAQVKTPQASPKSDITQVVGLTDVHIEYSRPSAKGRAVFGDLV
PFGKTWRTGANGNTIITFSEDVKIGGKDLPKGSYSLFTVPRADSWDVIFYKDTNNWGLPA
EWNENKVALRTSVKPENLNRNVETFTIAVNGISNDSGSLEISWEKTLVAVKFDVPTQKTA
MASIESTLAGPKADDYFASAQYFYQSNGDMNKALTWVNAAIEKTKGEAPFWYLRQKSLIQ
SKLGDKKGAIETAKLSLAAAEKANNADYVKMNKDSINEWSKK
>LONDMIMF_02573 Sodium/glucose cotransporter
MQAIDWVVLIITLFFIVFYGAWKTRGSKNVQDYILGNNETPWYTVGISVMATQASAITFL
STPGQAFNDGMGFVQFYFGLPLAMIIICITFIPIYHKLKVYTVYEFLEQRFDLKTRSLAA
ILFLIQRGFSTGITIYAPAIVLSSILGWNLNLMNIIIGILIIIYTMTGGTKAVNVTQKQQ
MFIIMSGMFIAFFIILSLLPEEVSFNNALQVAGVNDKMNILDFSLDKEKRYTVWTGITGG
LFLALSYFGTDQSQAQRYLSGKSVKESQMGLVFNALLKVPMQFFILLVGVMVYVFFQFQS
VPINFNPNSKASIEKSVYAGDYKQLENQLVDIAAEKKEVTLAYVNQLNIETDNKVLKNRI
IALAEKEKTIREQAKVLISKANKKNKTTDSDYVFIHFIIHYLPKGFVGLLLAVIICAAMS
STAAGINSLASTTVIDIYKRNIKTEKSETHFVRASKGFTLLWGVIAILFACFGTLFENLI
QFVNIIGSIFYGTILGIFLVAFYIKYVRAQAVFWAAVFSQIAIFVIYYFAIYIFPPGKEK
LSYLWLNFIGVVITIIISVSFQYFKNSKEIKA
>LONDMIMF_02574 Mycothiol S-conjugate amidase
MIPKTAYHSLILFLLSFCTVNAQKPRKLSSGEIYEQVQKLNFLGSVLYVAAHPDDENTKL
ISYFSNEVKARTAYLSLTRGDGGQNLIGSELRELLGVLRTQELLAARRIDGGEQLFSRAN
DFGFSKEPNETFSIWDKNQVLSDVVLAIRKFQPDIIINRFDHRSPGTTHGHHTASAMLSM
EAFDLAGNKNSFPEQLSSLKTWQPKRIFFNTSWWFYGSEEKFAQADKSKMATINAGVYFG
IKGKSNGEIAALSRSQHKCQGFGTIGTRGDEMEYLEFLKGDLAKDKNNLFEGINTTWSRV
KGGEAIGKILNDIEAHFNFKDPSVHIPKLIEAYHLVSKLEDEHWRTIKKQELENIIMASA
GLFFEGVSSEQSTNPDSDFTLKLEAVNQGAQDVELVAVTFLNNPENGIIQGKKLDKNKPF
KTEKKLHTLGSTHYTSPYWLNEKGTLGMYTVKDRAMIGRPDSEKLKLKWSLKIAGQPLDI
YREIVYKISDPEKGEIYQPFEVLPEATATVIDEVTIFSDSKTKPISVRVKSGKANLKGNI
SLQVPQGWTVSPDKIDFDIAMKNDEKIVVFNVTPPSYENKGIIAPVITVDGQKYTQKLTT
IQYDHIPKQSVLMPSEASVVRLNIKKSGQVIGYIEGAGDEIPQSLKQIGYDVRIIKPAEI
TETALSGFDAIVMGIRAYNVITDLQFKQRYLLDYVKNGGTMVVQYNTSGRRGFNGFNVPD
FSPYELNISSDRVTDENAKVSFLNATHSVLNHPNKITEADFQGWVQERGLYFPDKWAPEF
TPILGMKDLGETEKQGSLLVANYGKGYYIYTGLSFFRELPAGVPGAFKLFTNLISIGKKD
KS
>LONDMIMF_02575 hypothetical protein
MRIKNWILYSGIGCLLLGSLILYFFDGEYLNSRQDINGAFLPILLFGIIIAPVFEEIAFR
GYFSKIKKLQILSLVILLLYVIIFFNIINLSLFLLFLLLLIINKGKENNFIFIVSIIFFG
VMHYKISDFTSLLAFNSIFFQIGFGAILLWIVINFNLKRAILLHSLINLTLFTFEYFYII
NETDFSQKRIENKEIYVEWKKEFNFLPKRQEITASETSFEAKNYDALELYRAIQPLDKKE
KQLFAKEPFISYTINFQLKDSINANSGLGLDLDELAEQYLKFSIEHNILAPK
>LONDMIMF_02576 hypothetical protein
MKTLKVLIAGLGLLMAGTLEAQVSVNVSIGSRPDWGPVGYTEANYYYLPDIEAYYDIRAS
NFIYINNGTWVRARYLPTRYRNYDLYNGYKVVLTDYHGSRPYAHFNTHKVKYYRGPRPRP
VVVREVHHYHDDHKHYKKHKKHHKHRHDD
>LONDMIMF_02577 hypothetical protein
MLKKIRFFLLLLTLCCCHYSHAQEKPVKRDSLKGYRDIERYSKKRGFTKFLHKLIFKPVD
SKKPKNRQKDKVVLKSYSQYEGKIIRNIYITTLDPFGFSEKDTTKKARNGFERFGNNVHI
KTRQLTIKNLLLIRKNRPLDSLLVKESERLIRSQRYIRSVDFTTRLVGTNADSVDIYIRA
LDSWSLIPNASGSTSKTTFELTERNFLGTGHELDNTYRQRFDNGRSAVSTRYTIPNILNT
YIRTSLAYRVDEHNNYSKSISVNRPFFSPFAKWGAGVYIGQDFTVDSLPDATGRYAAQNF
KVGTQDAWVGKSTQIFKGNSEEDRTTNFITSFRFVRKNYSEFPAPEYDSLKYFSDENFYL
VGFGITSRKFIQDKYLFNYGITEDVAIGKVYALTVGHQNKNHINRLYVGGRFSFGQYFKW
GYFSTNVEYGTFFRGPITQQTVFSVEANYFTNLIELGDWRLRQFVKPRLVIGNNRFPTVA
DRVDLNEENGIPGFSSYKLRGTKKALLTLQTQSYSPWNLGGFRFNPFFTYTIGLLSNENN
NLYKGKAYSQIGIGVIISNDFLVFNSFQFSFSYYPSVPIDGSGNMQTNSFKTTDFGMPNF
EFGKPQTVPYD
>LONDMIMF_02578 hypothetical protein
MSFFEENTPKIVSTIVLLVCVTIIRFIITTLIKRYAKHAEINEHRAILVSKYISIVIMAI
TLAGIFMIWGVRTNDIYLAFTSVITIIGVAFFAQWSILSNITAGGKLFFFFSFYLVKTIR
IHDKDFPLEGEIDDIKAFHTYLRTKEGELVTYPNNLLLQKGVSIVNTTREEREFMD
>LONDMIMF_02579 Maf-like protein YhdE
MLNPHLKNYTILLASGSPRRQQFFKNMHLDFEVRLKEVDEIYPEHLKASEITDFLAKLKA
DAFQGELAPNDILVTSDTIVWHNGKALGKPKDYDDAFQILRALSDSTHEVYTSVCFRHNG
KTDIINEVTKVTFAHLSDEAIAYYLDNFKPYDKAGAYGIQEWIGIIGISKIEGSYSNVVG
LPVQKVYEYFTTFGKNS
>LONDMIMF_02580 hypothetical protein
MSFLKLIRYQNLIMLAIMQLVFRYGFLESQSIPLALKDWQFALLVFSTVCIAAGGYLINN
IFDQATDEINKPDNVVIGKQISESMGYNIYIALNVIGVGIGFYLANAIHKPNFAAIFVII
AATLYVYANGLKQTLLIGNIIIALLLSLSILIIGIFDLLPMVVPETQAGMGIIFNILIDY
AVFAFIINFIREIVKDMEDVNGDYNQGMNTLPIALGLARTGKVVFGLSFIPLGLIVYYIN
ENLYSNNLFYASAYGFLFILAPLLYFTIKMFSAKKQKDFHHLSRVLKFVIFFGILSIAVI
NFNIKYA
>LONDMIMF_02581 3-deoxy-D-manno-octulosonate 8-phosphate phosphatase KdsC
MNDITTFIFDVDGVLTDSSVHITPTGEMLRVMNIRDGFAMKAAVESGYHVCIISGGSNEG
VRIRLRNLGITDIHLACPDKVEAFKEYTDIYNIKPEQVLYMGDDIPDYHVMKLVGLPTCP
LDSSPEIKEICTYVSHKNGGRGAVRDVIEQVMRVQGKWMQYFNGKHD
>LONDMIMF_02582 hypothetical protein
MIRATIIGSGNVAQHLIHAFKKSNGIELSQVFSRQKESLSHLVEDSKIINDHSQFLEADI
YIIAVSDSAIAEVSSSLPFENRLVVHTSGSVPLSELHPKNRRGVFYPLQTFTKNKEVDFS
TLPICMESEFDDDYTILENVAEAIGSKHYLISSDQRKSLHVAAVFVNNFTNHLYQIGKEI
CAEHQLPFEILKPLIAETANKVQHLSPLEAQTGPAKRNDLNTIQAHLALLTDNTQKEIYK
ILTHSIQQSNVKKL
>LONDMIMF_02583 Cytochrome c biogenesis protein CcsA
MDKIFSFLFSTRLMAVLFIVFAAAMGIGTFIEDAYNTDVARILIYNSWWFEAIMFLFLIN
FIGNIKKYQLHKKEKWATLLLHLSFIFILIGAFVTRHISYEGMMSIAEGASENQVYSEKT
FLNVFVDGEYKGEMKRRVEEKELLLSQVTDNDFSIKGKFADTPYEIEYKDFIMNAKEVIK
EDPNGTLYIKMVESGDGSRHEHYLKEGEVQSIHNVLFAFNKPTNGAVNVIKEGDKYTFKA
PFGGQFMRMADKFQGTVVKDSVQDLMFRSLYNVGGAQFVFPEAAIKGKVAYESNNDYKDK
ATDDALIVTIKAGGKTQDVTLIGSKGKMGEPQSFKVGGLDFTLFYGSKVYTLPFKIKLND
FIAEKYPGTLKSFSAFRSKITVEDEKPFDYEIFMNNVLDHGGYRFFQASYDYTDNHLRDT
YEPNITVLSANHDFWGTWITYIGYFLLYIGMMAILFDKNSRFGIVKKKLDKIKSRKAKLI
TVLLLFVSVGSFAQHDHNAPGHNHGTGNAAPLKRVMPTEKQIDSLLKIIEVKPEHAAKFG
RIVIQDDGGRMKPINTFSSELLRKVSKSDHYKGYNSDQVFLSMSQYPEVWFNVPFVYLKK
DNDSLHKILGVDLKAKHVPFISFFDEQGNYKLSPYLDEAYKAAIPNQFQKDFIDVDKKVV
LLNAALSGKILKIFPIPYNKANKWVSYLELNETGIKGVDSTYTKNVLPAYMGFLNEARKS
GGYKQADEILESITLFQKKYGKAVRPSDDKINSEILYNKYDIFKKLYYLYMMAGVFMLLF
TIVKIFNSRKAIRVIVKAFHILIGFFFILHTAGLIMRWYISGHAPWSDAYESMIYVGWAT
MFFGLAFGRKSELTVASTAFVASMILMIAHWNWMDPAIANLQPVLNSYWLMIHVAVIVAS
YGPFTLGMILGLVSLLLMIFANKKNSKKLELNIKEITYITELSLTVGLVMLTIGNFLGGQ
WANESWGRYWGWDPKETWALISIMVYAFVIHARLVPGLKGTWIFNVFSVFAFYSIMMTYF
GVNFYLTGLHSYASGDKVVTPNFVFVSIGIVTLISILAYFKQKKYLRS
>LONDMIMF_02584 hypothetical protein
MVSIQKEGRIETGKIKNNKKTGKWKYSYENGRLYQVGRFKNNLETGNWKVFHPNGFLRQT
GKFKNGKIDGFWKFYHENGILYGLGKAEEGNFQGFWKWFFPNGQIHTIRNYENGKLVSVD
FAKNFKGNDIDKGTIKNGNGTLIVYETQILKDSILEVLNYKDGQIK
>LONDMIMF_02585 hypothetical protein
MKKISAAILLIIFLGLTSCQEDPQTISENPTTASEHYQRKMSKDEMEMTVDPFNDKDKNY
TIVYEEIKDYEKELSFLTATVTTYNFTHVRVYEFPNIKDVTQKTAVITLIDKSYLLFYKE
EKNTLTVTNKKGIKIFTADLKSQDKNYIDSGLVYDLQNTFVGIPYSKCDCHGEESSCNHK
FDRMENCAKYKFSKCYACGNDVCTQDNRCDIARSLTGPAWTLGLIAACSVAQL
>LONDMIMF_02586 hypothetical protein
MPFREIEKAFLFETGKFLLGNKVSSHYFCTMKTSLKKIGIKVLKITGVTIASILLLMFLL
PMLFPGRIAEQVKAFANKKLDGELSFSESNLSFFKHFPSLTVTLDDFALKGSAPYKNDTL
VAAKDVSFGINLKNLIFDGNINIDEIYVSKGLINVKVNEKGQANYNVYISDKEETSKDTT
GTSIRLERIDIRNVALKYEDISAKVNLQARGFNYLGKGNLDKSIFDLYTEAKIESLDFTF
DGEKYLENKKIDADLITKINTNSLSFVFQQNDLKINKLPISFIGKMNFLKDGYDIDIKIE
SQDSRLNDLFTALPPKYVTWLEKTKVKGRTDLLLTFKGNYNASLNRKPDLAFGMNIREGN
ISYKDAPFETSNISLKFYTKLPSLETEQLEVKLDTLHFNVGNDYLSAKINSKGLKNIDLT
AKVKSKLDVGKAIGAMGISNLELKGVLLADINSKGQYNSEKRLFPITDGKINLQNGFLKT
EYYPNPITDIKFVAAVKNTTGQYKDLKIDVAPASFVFEQNPVYVKALLSNFDDVNYDVVA
KGTLDIAKIYKVFRQKGLDITGYAKADLSLKGKQSYATTGQYSKLNNKGSLLLRDIKTTS
ELFPKPFFIREGLFTFHQDKMNFDKFSANYGKSDFAMKGRLENVINFVFEKNATLKGNFE
VNSGLVVADEFMAQEPVAEKGKGVEKKTVQDTKTVAASGVILLPENLKVSLLANVKKLEY
DGLILDNVTGSTSLDRGKLLFQKIGFGIIGCRVGINGFYDDITAKKANFDIHFVAKNFNV
KKAYNEIEMFRNLATAAEKAEGIISLDYTVKGQLNEEMKPVYPSLEGKGVVSLSKVKVNG
LKLFNQLSSKTDFESIDNPDLSQVDIKSRIKNNIITIEQTKMKVALFRLRLQGETSFDGK
LNLRIRVGLPPFGLIGIPVVVAGTQDNPKIKVFSKTGEAIEETKPEGQ
>LONDMIMF_02587 Malto-oligosyltrehalose trehalohydrolase
MKKITLLFLLIASYAWSQQQTVTYSVTPATFEENQSITLTFNGSSINEATWGVAGNALYI
WAWSFDLNDQNNADCPTNGDWGNSNEANRLTYNSANDTYSISFVPTAFYNRTGIGRIGFL
IKAKNGNGDKKSQDILLRVGTFQVNLTAPAQNSSTMLASGSNFTITANNTGGNASYVLKS
NGSTINTNASTASYSYVHTGITSNQNYSLEVTQGATTITKNFAVVINPGVISAAMPAGMG
DGINYNPSDPTKATLVLNVPNKDFVYVAGSFNNWQPTGAYAMKKDPATGKFWLELSGLTS
GTAYTYQYWVCDQTNLPANSPALVKTADPFSTLVLSPYDDPEIASLGVYPNLPTYPAGQE
REVTVLQTGPNAFYNYNWSAATTNFVKPSKKDLVIYEVLVRDFDANRTYQNLIDRIDYFK
NLKINAIQLMPVMEFEGNESWGYNTVYHLALDKRYGTEAKLKEFIDLCHQNGIAVIFDIA
LNHVYGRSPLERMWMTDTDNDGWANGVTTENPYCNQNAMHSYSVGRDLNHFNEPNNLTGY
YVQRTIQRWMNDFKIDGFRWDLTKGFTQNCPYTGSSSAQESCTNNYQADRVAKLKYYADM
QWAIDPNFYVIFEHLGAGGSYNEEVEWANYRKTGDADGISKGIMQWRKMTDAYANFLKGN
SANLAGVADATDRFIGYAESHDEERVIYKALTESGQTNGNLPKALARMSAMGALHLLVPG
PKMIYHFGDLGYNSSIFTCNNGTVNTPNDATSGDCKLDTKPQPQWANNWLGDVARKKIYD
DWAKMIEFKKRENVFENGTHAWNFSQTGRPRLDIWTSTSQTAELSYVFVLTNATNTVYNA
TAGFPYTGTWYNLMDGTPITVTDANMTIPIEVDGFRVFGNKQALLERNDFNTTAIALYPN
PSKGIFNISKDTKQVSIYSITGQLVKEFKGEFSNEHQYSVENLNQGMYIVKVIDSEDKEA
TLKLMKQ
>LONDMIMF_02588 hypothetical protein
MKNIAKSLIALFAVLAVSCSSDDVEDRPIIRAIDGPALIAPDGGSYVLNIESANNLAERF
MWTSANFGQDVAINYEIQLDAADGVDEFAEPRSLGSVIGANQLAVSVVTLNTAAIALGGV
PLEEKQYVVRVKASVNDTFEPIYSNPVTISITPYQAFVPLQNLYLVGNATEYGYNNNAGN
SPLFRDPGNQYKFYYTGYFTGGNGEGIKILSALGNWHPQYGSAGAGILAVSGADGSNEPS
PISVPSSGYYELTIDIQEMTYSLEPFTYNPATMPTFGSVGIIGAATPGGWDADTDMTNST
ANPHLWKIDNIALTQDVLKFRANDSWDTPGNWGGGTPISGQMSINGGDFVGVAAEGNYSV
WFNDLDRRYIFIPR
>LONDMIMF_02589 Starch-binding protein SusD
MKKMLDILGKKALLLLVIMAIGVSCTDDLDVMPQDDDDFTAEKFYENPQAYRMFLAKLYL
GLAKAGNGEGDGGEDLQGIRNDFSPYLRAFYTLQQLPTDESVIAWQDGNLPSMNSHTWTS
NNEFIYVMYSRTFYQISLANEFLRQSTPDKVGSRNVDPAILNDMKSYRAEARFLRALSLY
HAMDLFGRVPIVTENDPVGFFYPQQREKIDVFNYIKDELIAIDADLKESRTNEYGRVDKI
AAKMLLSKLYLNAEVYIGQPKYAEAADALQAVLNSTYQIANVPYKYLFMADNDVNGAQNE
FIFPVRFDGQYTTSGGTNYLVHASILSSMNASDFGVDGGWKGLRARREFVNKFADVTGAS
DNRAMFHTTGQTLDIASIADETQGYAVTKWTNKRSDGSNGSNPTGAFVDTDFPLFRLADA
YLMYAELAVRGQGSLSQAVTYVNALRTRANAGTISQGDLNLDFILAERSRELYWECHRRQ
DLIRFGKFTGGSYLWQWKGNSANGAPISDHLKLFPIPDRAKAANPTLQQNTGY
>LONDMIMF_02590 TonB-dependent receptor SusC
MKTIYKKLLLLLLMLPFSVLAQNTLNGNVRDEVSGLPLPGVSVTVQGSTNGATTDFDGNF
SLSGVKSGDVITFSFLGYKPTTITYSSQNTISVILQEDASQLDEVVVVGYGSVKKKDATG
AVEVISQKDFNRGLNATAENLLNGRVAGLNITTSGAPGSGSTIRIRGGSSLNAKNDPLIV
IDGLPLDNEASGGSTSVLASINPNDIESFSILKDASATAIYGSRASNGVIIITTKKGSQG
DMQVSFNSVTTVNTLAKKVDVLSADQFRALVNQVGSPTQIGLLGNAKTDWQDEIFQTSMS
VDNNLSIRGNLFGVMPARLSVGYTQIPGLLKTGEFKRTTTSLALNPSFFDDHLKINLNAN
ISWQDNRFADEGAIGNALSFDPTQSVYDPSSYFGGYFEWLEPDGDRVVTGAQQNPVSLLN
QRRNITDNRKMYGNFQVDYKLHFFEDIRAVVNVGFDKQDGNGTNTLAPFSPAGFQTGSYS
GGTYQNYGAYSYFNENKENKLLDAYLVYSKEIGKFNLDVTGGYSYQNFKWVGFSTGNVYD
PNAQPDVFTRPTVNLQSYFGRMNLGFDDKYLLTLNYRRDGTSRFSKENRWGNFPGAAFAW
KISQEGFMKNVRFVSDLKLRLGWGITGQQDINDGFAYIERYTTGTTQAQYQFGNVFVPVG
RPEGYNKGLKWEETETRNIGIDYGFFDNRLRGSLDLYEKKSSDLLAIVPFPDGANLANQG
FRNYGNFTSKGVEFSVSYDIFRGEGFNWTTTFNATYNNQEITDIPSDNPVGDIDGGGGNK
IQINSVGYSPNAFYVYEQVYDANGKPVEGVYVDRNQDGVISTADQYRYKKPNADYTFGMM
NNMSYKQFDLSFAWRASLGNYMYNNVASNKGVLQAGVRYNDVISNINSDYLNSGFQLEGN
NRLFSDYYIQDASWFKLDNITLGYTIQNPFATKKSKFRVYGAVQNVFTITDYDGVDPEIY
GGIDKTIYPRPRMFMLGFNIDF
>LONDMIMF_02591 HTH-type transcriptional regulator DegA
MRKKVTLKQIAKELDVSISTVSKSLRDSPEISEDTRQKVQAFAKLYNYKPNLIALSLKNK
KTKTIGVIIPEIVHHFFATVISGIEHVANEHGYNVIVTLSDESFDKEVINMEMLANGSID
GFIMSLSKETQHKKDFHHITEVINQGMPVVMFDRVTNDILCDKVIIDDNLAAYEAVQDLI
DKGFKKIALITTVDYVSVGKLRTDGYIKALKTNNIPVDPKLILKIEDIDICEHQIEELIN
NNEIDAVFAVNELFAVTAIKAAKKINLKVPEDISVIGFTDGIISKYSSPSITTVSQNGIK
MGGKAAKMLIERLESEQEEDEHYRTEVIETHLVLRESTPSL
>LONDMIMF_02592 hypothetical protein
MKKRKLSFLDIWNMSFGYLGIQMGFALQNANASRILQIFGADVHSLSWFWIVAPLMGLIV
QPIIGHYSDRTWTRFGRRKPYFLIGSVLAALGLILMPQSALLTAFMPALWVGAGMLMIMD
ASFNIAMEPFRALVADLLPADQRTLGFSVQTALIGFGAVIGSWLPYALNKWFGVSSEAQP
GEVPYHLILSFIIGAAVLVGAVLWTISTTKEYSPEELEAFDKAEGIVHEEEEKGSLLNIF
SDFGNMPQTMRQLGWVQFFSWFALFGMWVFTTPAIAHHIYGLPLEDTNSKTYQEAGDWVG
IIFGVYNAVSAVFAFFLPAIAKKIGRKSTHAFSLIVGGIGLISVYFVPSPNWLIVSMIGV
GIAWASILAMPYAILSGSIPAKKMGVYMGIFNFFIVVPQIINAIIGGPIVKYIYGGNPIY
AIVTSGVAFIIASFFVLRVKDTDDTVKQ
>LONDMIMF_02593 Beta-phosphoglucomutase
MKTKAFIFDLDGVIVDTAKYHYLAWQKIANQLGIEFTPEHNEELKGVSRVRSLELILQLG
KIEASQEDKDKWLTQKNEDYLSYLVDMDDSELLAGVLPVLRYLKERKQLIALGSASKNAR
PILEKTGIIHYFDAIVDGNDVSNAKPDPEVFLRAAELLNTAPENAIVFEDSVAGIQAANI
ANMTSVGIGEAKILHEADYIFPDFTHIETNFIETLVNK
>LONDMIMF_02594 Maltose phosphorylase
MNQDYIVPNNWSIIEEGFDAERIKSSESLFSIGNGAMGQRANFEESYSGETFQGSYIAGI
YYPDKTKVGWWKNGYPEYFAKVLNAPNWIGIDIEINGENLDLNTCTEVRNFERELNMKEG
WYHRSFEATLKNGTQIKVDVRRFLSLNSDELGVINYEITPLNKDAKIVYKPYIDSGVKNE
DANWEEKFWEPLETKHSGNEAFVVARTFKTHFNVATYMSNSIFLNGQNLNTTPVNVEASA
EKILFAYETEAAKGEKSSIQKFGGYTVSLNHENSQLITAAQNVIAKANVKGYETLLQEQI
EAWAKIWEMSDITIDGDVKAQQGIRFNIFQLNQTYSGKDSRLNIGPKGFTGEKYGGSTYW
DTEAYCIPFYMATKDQQVARNLLTYRYNQLDKAIENAEKLGFTNGAALFPMVTMNGEECH
NEWEITFEEIHRNGAIAFAIYNYYRFTGDYSYIPEKGLEVLIAIARFWHQRATLSTVKDQ
FVILGVTGPNEYENNVNNNFYTNYLAKWCIDYAVEQIEKVQKEYAADYSRIVSKTKLEAG
EIINWKKVADKMYLPYSEEHDVYLQQDGFLDKELVKVHDLDKSQRPINQKWSWDRILRSP
YIKQADVLQGFYFFEDHFSKEQLERHFDFYEPFTVHESSLSPCVHSIQAATLGRMEQAYT
FYLRTSRLDLDDYNKEVEEGCHITSMAGTWMSIVEGFGGLRVKNDTLHFEPKIPEQWQGY
SFKINFRNQILQVFVNASETKFTLEGTQELTVYVNGKAVLVEPNTLVTV
>LONDMIMF_02595 Neopullulanase 2
MNFTKKLNLLVLLLSVSAFAQIDKIEPPFWYAGMHNPELQIMFYGKNIAQYEASVSNNVV
IKNVVKTENSNYIFITIDTKNIPASDFVFSFKNKNKVAFTKKYTLKARRKNSAQRKSFDS
SDLIYLIMPDRFANGNPNNDTDKSLNEKADRSLPGGRHGGDIDGIIKHLDYLEELGVTAI
WSTPLCEDNDKVHSYHTYGQSDVYKIDPRYGTNEEYVRLSAELKKRNMKLIKDYVTNHWG
AEHWMYKDLPTYDWIHQFPGFSQSNYRMTTQFDTNAAAIDAKNCMDGWFVPSMPDLNQSN
PLVLNYLIQNAIWWIEYADLDGFRVDTYSYNDKIGIAKWTKAITDEYPYFNIVGEVWMHD
QAQMSYWQKDSPISAIQSYNSYLPSVMDFTLHDAFGNVFNEDKATWNDGMIKVYDNFAND
FLYPNVNNLLTFVENHDTGRFNHIYKNDFRKYQMAMALIATVRGIPQIYYGSEIGMAGDK
GKGDADIRQDFPGGWTGDKNNAFIKAGRTEEQAKFFDFSSKLFQWRKGKSVIHSGKMTHY
IPEDNVYVYFRYNDNETVMVIINNAAQPKTFKTARFQENIKDFTSGKDVLTGKSINVKED
ITIEEKSVLILELK
>LONDMIMF_02596 hypothetical protein
MKENELSRIIVNLCFEIHTKLGPGLLESVYEAILVYELTEMGLKVERQKSLPVIWNDITM
SIGFRADIIVENLVLIEIKSVAEIAQVHLKQVLTYLKITGLKLGLLVNFNEPLIKNGIKR
IANKL
>LONDMIMF_02597 Alpha-amylase
MKKTILLAVALAAFISCKDDKKTENTTAAKTETIAPITDATAENAVIYEANIRQYSPEGT
FNAFAKDIPELKKLGVKIIWLMPIYPISMKNRKATGELSVEDIKDPKEKAKYLGSAYAIS
DYTAINPDYGTKEDFRNLVKTAHENGMYVILDWVANHTGWDHKWITEHPEYYHKNAKGEV
TDPLNPETGKSWGWTDVAHLNYANKELHKAMENEMLYWVKEENIDGFRCDVADNVPAEFW
QKAIPELRKVKPVFMLMESNKNYLLKDGLFDMGYGWEAHHVMNDINKGTKTVKDLDNVFD
KIAKEYEKNDIFMNFTSNHDENSWNGTEYERMGDGVEAFTALTYLMPGMPLIYTGQEYDL
KHRLKFFEKDSIPKTKAKMFPIYEKLGELKNNNIALNGGKNAASFKRLATSNDTNVLAFE
REKENQKVFFIGNLSKKDQQFTAPVEGTFTNYMTGEKITLAKDQKFSFKPWQYYILVK
>LONDMIMF_02598 hypothetical protein
MAFEYIEIERVERLTKKEFIENYYKPQKPVVITNQIEDWPAFSKWNFKFLREVAGDKTVP
LYDSRKTDYTKKVNEPDFKMTMSEYIDILEKGPTDLRIFLYNLMKDVPSLKADMRWPQLG
LRLIKSLPLVFFGGEDAKVFMHYDIDFPNIFHIHFEGKKQCVLVDPKETKYMYRLPYSWI
CNEDIDFDNPDFEKFPALKMVKPYITNLQHGEMLYMPEGWWHYMKYLTPGFSLSLRSLAG
RPTNLLKGLANVAVIRHYDNWMRKRKGQAWLDYKDAEAIRRTNELLKK
>LONDMIMF_02599 Glycerophosphodiester phosphodiesterase
MKKILNIGHRGAKGHEPENTLPSFQKAFDLHADGIELDVHSCKTGELVVIHDFTADRTTN
GSGAISELTLSEIKALRINGHIEVPTLEEVIELAGKNCLINIELKGRHTAKPVSHLVEKY
ILENDYSYENFIISSFQREELEMMHIINPKIHLGVLSQASVAQALEWATAFSAKAIHPHF
SLLTEENVQQAQKQGFKVYTWTVNETEDIERVKTYNVDGIITDFPEKI
>LONDMIMF_02600 hypothetical protein
MSTNFDIIIVGGGAGGFFTAINCVEKNPKLKIAILERGKEVLTKVRISGGGRCNVTHACF
VPNELVKFYPRGEKELRGPFHQFCSGDTIEWFEKHGVELKIEDDGRMFPVSNSSQTIIDC
FTAATKKLGIQVLTGQSVQSIYKSNADEGSFWKIETQNQQYFCEKLVLATGSNPKMWDML
QEFGHTIVSPVPSLFTFNIKDPRIKELPGVSAQVSVKVKDTKLTSTGPLLVTHWGMSGPA
ILKLSAWGARILFEKNYQFTIFVNWLNDVDTEEAESVLKELKLEHSKKAVAKKSPFDFPN
RLWESLVLASGISEETKWADLSKNQLQNLANQLTKAQFQVNGKSTFKEEFVTAGGIDLKE
INFKTMESKIHPNLFFAGEITNIDAITGGFNFQNAWTSGFIVANSISQ
>LONDMIMF_02601 Tryptophan-rich protein TspO
MMGIAGGLVWHEIDTPRKEEVKKGMLFFAIQLALNALWSYLFFGLKNPLLALFEIVLLWL
MIYETYAKFAKINRFAGYLFIPYLSWVGFAMVLNASIWWLNQ
>LONDMIMF_02602 hypothetical protein
MFEWINNTFGVSNEVSVPTFISIIVFIVGGVISYFYNLIRNYRANKNIRIIFRMILKEII
NDLRIKEGQMKRFYPTVNMSHKDAWILPFVTVGYLETMFELDYSNNFSAFKRKFYIRKKL
KYKAFHRIWAFLRDIKYLEDRLERTTGELMENFNLITEQYSDKIVAFSEFCRKHLESIDE
QISPPETKIDQDILRFSQELSDIFKRDSLSNQNEGTYMQRTYKNLVMPILVLTENNKHLK
VSFECNVMLQKIKVDYKAMDNLIIIYQRKFKNYYRTYRVSSRVLKVCLKILD
>LONDMIMF_02603 hypothetical protein
MDLLDKLRALDLETVSKDEIDALLHQIGALPIMKTDYGVGKLFLRAVRNSDPSSDFSTVS
RLSYCPPEYNKNFLRASTPDNTMFYGSVVKDNPTAEEVNHARITACCETSELLRDNEIPE
GERIITIGT
>LONDMIMF_02604 hypothetical protein
MEVGTIFDPNKNYDIEYLENIKNAYIKFLDDYPDLKEKGLAFLEYLSSEYSKDVKKGENH
KYLVSALFSRIVAQRSDGILYPSVRAAGIGLCLAIKPEAMENLELIMVHKCLLKKENGVV
RITFLKVCEVNKDAEAFELLDVAEYKERRKESE
>LONDMIMF_02605 hypothetical protein
MMNVKEHDFRANSLDKTISALYTTILEMEEFRKENYWYDGLFFLEDTEHIFGLAFIAFQN
YINASIKDLTNIGGKDLQTKYYKLGNKLKPSNYTLIELIVALANYIKHKEDDAEDFHRST
RNVLTNFKLNTNKDCDITESAIFKGLDKIDQDWNLKNIQSRVEEWRRDIALCIIANTQNA
KPFTDDLLF
>LONDMIMF_02606 Primosomal protein N'
MYFVEVILPLSLSKTFTYRVSEAEYNYIQKGMRIAVPFGKSKVYTALAIELHQNEPALYE
AKEIHQILDEIPVVTEIQITHWQWIASYYMCAIGDVYRGAMPSALLLESETIISQKKEIE
VDETQLSDDEFLIYEALQHQSSLKVLDIVALLGKKNVFPTIQKLIDKKILAVQEEVVELY
KPKLTKYIRLHTDYVDEQNLIALIDNLNKKAQKQKEILLSYFQLNASQQKPVSVKQLLEH
SQATSAVVKALVDKAIFEEYYIQEDRVSFDKNQKENNLQLSTAQQKAFDEISNAFEEKEV
CLLHGVTSSGKTEIYIRLIESYIASGKQVLYLLPEIALTTQLVGRLTAHFGNQVAVFHSK
YTNNERVEVWKQVLENSPKAKIVIGARSALFLPFRDLGLVIIDEEHEQTFKQYDPAPRYH
ARDAAIVLANYFKSKVLLGSATPSLETYFNASGGKYDLVEITERFGNVMLPEIELVDLKD
KYFRKRMKGHFSDTLLEYMAEALALGEQVILFQNRRGYSPVLECMTCGHVPECPQCDVSL
TYHKHKNQLRCHYCGYAMAKPTRCHNCSSVDLTTKGFGTEQIEMELAGLFPNKKTARMDQ
DTTRGKYGYEKILDSFKNREIDILVGTQMLAKGLDFDNVSLVGIMNADNMLYHPDFRAFE
RSYQMMTQVSGRAGRSGKRGKVIIQTYNPNHNTIQQVTNNDYMGMYKEQLYDRHIFKYPP
YFRLIKITLKHRDFEKLKDGSMWLYQVMSQNLDLPVLGPEEPAIGRIRNEYIRTILIKIP
QNQPLGSTKKTIQKILNSFETVSQYRPIKVAVNVDFY
>LONDMIMF_02607 Transcriptional regulatory protein YpdB
MKLNCVVVDDSAIQRMTVTKLVANHPNLNLVGDFSNAIETKNCLTNKEVDLIFLDIEMPV
INGFDLLDGLKVKPQIIFITSKAEYAVKAFDYDATDYLQKPISPQRFNAAVKRAMDLYLL
RKENIDEDSEHIFIKSNLKKLKIFTSKIKWIEAYGDYVKVVTEDENHLVLSTMKSFENDL
SKERFIRVHKSFIINIDKVDKFNSKFAEIGVTKIPLSRNKKEDLVKALASA
>LONDMIMF_02608 30S ribosomal protein S6
MNHYETVFILNPVLSEVQVKETVSKFEDFLTSRGAEMVSKEDWGLKKMAYEIQHKKSGFY
HLFEFKVAPEVLIAFETEFRRDERVMRFLTVSLDKHAISWAERRREKLKASKA
>LONDMIMF_02609 30S ribosomal protein S18
MSTIEQSAKGKKDGDIRYLTPLNIETNKTKKYCRFKKSGIKYVDYKDPDFLLKFVNEQGK
ILPRRLTGTSLKYQRKVSVAVKRARHLALMPYVADLLK
>LONDMIMF_02610 50S ribosomal protein L9
MELILKKDVQNLGFKDDIVTVKNGYGRNYLIPQGFAHMATPSAKKVLAENLRQKAHKEAK
IVEDAKKLAEALKALEIKISAKAGGEKLFGSITNIDIAEALEKQGQSIDRKFITSGIVKR
TGKYNATVRLHREVIVDLPYEIVAEK
>LONDMIMF_02611 hypothetical protein
MGAYSLKPIAYSKIMKYKRLTKEQFEALHMEFANFLATQSIDKKEWDAIKAEKPEVAEQE
LDVFSDLIWEGVLTGAHYLEHFSKSYIFLFHCQEKVIKSIVLKALIPEVDFMTREGLQWL
SDNMFTETVEIKIGQKEYEEERNDAIFNLIQQGAILSDGQLYLQVNGIIQSS
>LONDMIMF_02612 DNA ligase
MDIQSTIQSLREELNQHNYNYYVLDNPTISDYDFDTKLKELQELESKYPEFFDENSPTQR
VGGMITKNFETITHKNRMYSLDNSYSKEDVLDWEKRIQKILGDVPLEYTCELKYDGASIS
ITYEHGKLKRAVTRGDGFQGDDVTNNVKTIKSVPLQLKGDYPDSFEIRGEIILPLEGFAK
MNQELIEIGETPYSNPRNTASGSLKLQDSSEVAKRPLDCLLYTFIGNDVKFSTHFESLEK
ARSFGFKVPKEARLVKSIEEVFDFIDYWNIHRHELPYETDGVVVKVNNLHYQEELGYTSK
SPRWAIAYKFKAEQVSTRLNSISYQVGRTGAITPVANLEPVQLAGSLLKRGSP
>LONDMIMF_02613 DNA ligase
MLGGTIVKRASLHNADQIEKLDIRVGDEVFVEKGGEIIPKIIGVDFTKRSLDLLPTVYIT
NCPECQTELIRKEGEAQHYCPNFYGCPPQIIGRIQHYISRKAMDIEGLGGETVALLFNNN
LVQNYADLYDLTVEQVIPLERMAQKSAENLVNGIEKSKEVPFERVLFALGIRYVGETVAK
KLAKHYQNIDNLSNASLMDLILVDEIGERIAQSVIEFFENPENRIIIQRLRDYGVQLESK
TVFNPDATDKLAGKTFVVSGVFEKFSRDDLKKSIEDNGGKVGSSISAKTDYVVAGDNMGP
AKLEKANKLNIPIISEDDFIAMLG
>LONDMIMF_02614 Trifunctional nucleotide phosphoesterase protein YfkN
MKRRDFIQKTVAGSALLTVGGLSLSSFNTLNKKHITILHTNDVHSHIDPFPPTDAKNPNM
GGVSRRASLIESIRRENPNVLLLDAGDIFQGTPYFNYYGGELEFKLMSMMKYDLATMGNH
DFDNGIDGFYSQLHNAKFDFVSANYDFKNTVLDGIVKPYKIFIKDGIKIGVFGLGVELDG
LVDKKNYKETVYNDPVSVSQEMTRILKTQEKCDLIICLSHIGYAYKNDPDKISDLKLAAA
TRDIDLIIGGHTHTFLDKPTIVKNLDGIDTLVNQVGCYGINLGRIDFYFDTDKSKIHSGR
TIVV
>LONDMIMF_02615 Mannosylglucosyl-3-phosphoglycerate phosphatase
MLKQKNYNAALTQFVSILTLFLVISCATQKPYVSKIEGKQIGITNTNPQTPAIEEFIKPY
RENIDKDMNQILAYAPETLDKSKGEWQTTIGSLQADITLATANKLFLKRENKPVDICLLN
HGGIRSMISKGNVTTRTAFELMPFENELVVVALKGQQIVEMVNYLISEKKPHPLAGMEIV
LNKDASSYKSITIQGKPLDINKTYYVATNDYLYNGGDSMNFFKKGTMTSLDYKLRNVWID
YFKETDTIPVPRNKRIIVE
>LONDMIMF_02616 hypothetical protein
MFLNFFKNFSAKRTLKNSSLHVKGNPSDETITTVGLLIDKTYFEDKVNLIEELLANGIKR
ENIQILLYKDRFKKKETVNYPSFSHKDLSWKGTLDNKNVKEFTDKEFDMLISYYDTEKAP
LMITTFKSKANFKVGFSTIDKRLNHFMINTNAENYKVFVFELFKYLKILNKI
>LONDMIMF_02617 4-hydroxy-tetrahydrodipicolinate synthase
MQSLIGTGVALVTPFKKDFSVDVEALKRIVNYQIDNGIDYMVVLGTTGEPATMNKEEKEL
VIKTVKETNNGRLPLVLGVGGNNTAEVVEELKTRDFTGFTAVLSVSPYYNKPTQEGIYQH
FKAIAEASPIPVILYNVPGRTGSNMLPSTVIRLANDFKNVVAIKEAAGDIVQAMKLIQGK
PKDFLVISGDDMVTLPMVLAGGAGVISVIAEGFPKQFSKMVRLGLERKVDEAYELHYQIA
DSIDMIFEQGNPAGVKEIFKVLGLSENTVRLPLVNVNEDLAGRIEQFVKKTVL
>LONDMIMF_02618 putative bacterial non-heme ferritin
MLSKSIEEALNRQIKVEGDSSQVYLAMASWAEVQGFEGISTFMFAQSEEERMHMLKLVKY
INQRGGQAKISAIVEPVLDLSSYKVLFKQLLEHEIKVSESINDLVGIALDERDYATHNFL
QWYVAEQIEEEANARYILDKINLIGDDKGGLYLFDNEMKNFTSPITTGK
>LONDMIMF_02619 Outer membrane protein assembly factor BamD
MNRIFCLLIIAVAFASCSPYQKALKSEDIAVKYDIASKMYDAGKYTKAIRLFEQIAPSYR
GKPAAEKMFYMFGQSYYKTKQHYLAAYQFESFTSSYPKSEKAEEAAYLSAESYSRLSPRY
SLDQGDTDKAIDKLQAFINNYPNSEYLPKANEIVKALREKLEKKAFENAKQYHTIGGYTR
DYSAAIKALDNFIADYPGTPFKEDALYYRFDSAYILAINSVESKKKERLNLAKASYAMLM
KFNASTQYKKDADDKLARIEKELQQFSN
>LONDMIMF_02620 hypothetical protein
MDLKKTNAPVNTVTYNKTMIEEPTGNVYEAITIMAKRANQINSEIKKELTEKLEEFATYN
DSLEEIFENKEQIEVSKFYEKLPKPHALAVQEWLDGKIYHRDTTK
>LONDMIMF_02621 Coenzyme A biosynthesis bifunctional protein CoaBC
MSVLSGKKIVLGVSGGIAAYKTASLVRLFIKAGADVQVVMTPASKDFVTPLTLSTLSKNP
VHSTFYNDDEEAVWNNHVELGLWADLMLVAPATANTLSKMANGSCDNLLIATYLSAKCPV
YFAPAMDLDMYKHPSTLASFKLLRQFGNIMIPAESGELASGLSGEGRMAEPENIIAFLEA
DLESKLPLKGKKILVTAGPTYEAIDPVRFIGNHSSGKMGFDIAEHAAGLGAEVILISGPT
HLKPKSSGITLVNVTSAQEMYEAAHRYFGDVDVAISAAAVADYRPKFPATQKIKKTEDAF
TIELEKTQDILASLGKVKQKQFLIGFALETENEIENAKLKIQKKNLDLIVLNSLQDEGAG
FGKPTNKITFIDRNFEIEPMPLKTKEAVAEDILNKVIQHFYA
>LONDMIMF_02622 hypothetical protein
MRKILLFLLFVAGSVQAQELRCTVKINYDRITNANTQIFKTLERSLNEFVNKTRWTNQTF
AENERIESSMFINVSGYNSDQFSASIQVQSSRPGYNSMYASPVFNFNDKDFNFRYVEFEN
LIFNPNSYDSNLVSVMAFYSYIIMGLDADTFSPKGGTQYYELAQNVAILAQQGGSKGWNQ
ADGNVSRYFLITDLMSNTFAPFREALYQYHSTGIDLMSEDLKRGKENIKNSVKTLAQIYD
IRPNALLTRVFFDAKSDEIVSIYTGGPSIAIADLVENLNRISPLNSSKWGKIRF
>LONDMIMF_02623 DNA repair protein RecN
MLTSLSIKNFALIEKLDIDFSENFSIITGETGAGKSILLGALGLVLGKRADLSSLKNKEE
KCVIEAQFDIARYNLESFFEANDLDFEKETIIRREILSSGKSRAFVNDSPVNLQELQELG
EYLIDIHSQHQTQELSEENFQFDIIDSMAGNTSEIAAYKSLLKKYRSLKTTLTALQSRLQ
EASKEQDYNSFLLEELLAAKLKSGEQEELESVFEQLNNVELIKENLDRAVSIAEEEQFGV
LHNLKEIKASLQKIASFSADYNSLFERITSASIELDDIISELSQKSESLMSDPEQLELVN
QKLQTIYNLQQKHQVKTVDELLLIQEDLDKKVISVDSLQQEIGQAEKEIAESESGLDTIA
ATISEKRQNAIPVLIEKLVAILELLGMPNVRFKIEVTLSDSYHANGKDDLQFLFAANKGS
DFGLLKKTASGGEMSRIMLAVKSILAQYQKLPTIIFDEIDTGVSGEIAHKMGEIMKEMSK
TMQVFAITHLPQIAAKGNTHFKVFKSVVGDQTQSELKLLSADERVIEIAQMLSGKDISDS
AINHAKALLN
>LONDMIMF_02624 Enoyl-[acyl-carrier-protein] reductase [NADH]
MIIEPRMRGFICLTAHPKGAEQSVKNQIEYVKSKGKIDGAKKVLVIGASTGFGLASRITS
AFGSDAATIGVFFEKPPMEGKTASPGWYNSAAFEAEAHKAGLYAKSINGDAFSNEVKDQT
IELIKKDLGQVDLVIYSLASPVRTNPVTGITHRSVLKPIGDTFSNKTVDFHTGKVSEISI
EPSKEDDIENTVAVMGGEDWAMWMEAMKKAGVLAPGAMTIAYSYIGPSLTEPVYRKGTIG
RAKDHLEATAFSITDSLKDIGGKAYVSVNKALVTQASSAIPVIPLYISLLYKVMKEEGIH
EGTIEQIQRLYQQRLYTGGEVPTDEKGRIRIDDWEMRDDVQGKVAALWEKATTENLSEIG
DLEGYRKDFYNLFGFDIEGVDYKADTNEMVAVESIKE
>LONDMIMF_02625 hypothetical protein
MFPSAQLPATSTRDPGVPVYNTPTIVTPVAVPVNVNLARSTVGVNVYHTSSLNPAALQAG
AGSADWVAPIVVPVVVAVQVRAGLTVKLTAPLASLLAGTAGAAELPIQTSKVVEASVAVP
>LONDMIMF_02626 hypothetical protein
MLLSLETLKIFQGKISENGNLYFLGFRKNSWTIIYRDGSSLETKSFYQIINHFGDLIIHN
IYCFRYILEAMLFLQNKHCDYLRNSLIIITASKNKKEIKSFLFRRYIQKNLVVPKIHLFH
SLRNFELTVLYLELLDKGVVSETIQLKGQNYLKIKYKSIQIILDTEQQTKSKILFLLGIN
DKIFKIRNYDLSHLMSDRNLYW
>LONDMIMF_02627 hypothetical protein
MENTSTLLTDELRKFGIMNQQDHFSEKLSKKEIDDFLKGGILIAENDKNRLTFKINDDKL
DVNVYNKDIVNHKDLSTAELFEISSSNRNLYKVMADYGNITHIGTGYFNKNPENEMTTFV
EIENERGKTIFFGNKLEDSLKDFKVGDKIQIIQTGVEKTVLKIDDADEKELAKFDNVFII
NPFKEKNKQFQSRIFELDKKDNTIKDVDTTKYELKNVNGHNISEKQLQQLRKGKELKLDD
ETTIQISPASKNEAKLSASSKSLLILSLATDGGLSFLIIKGIQKLARMQEENQLQKESIR
YQVELQKLKAHLKSKSEQYPDNKNIITDLNIVSKEISASQSSLNENTNKEKEKSNINLQV
NDPDMYQDANQKKEEEKRDAEEASRSTSHSRGR
>LONDMIMF_02628 Murein DD-endopeptidase MepM
MKKTVILMHLLIFSNFLPQFNTASYKGKLNTIRLNSSLQNQFTTSFLSYHIAGKLNKKYF
EKRKDSLNNAANETEQTTTPQANSIKKDDDIQATSEDDSLSENHPSEKKYRNKKLSLLEY
EKYPTEELQIIYMPLEKMKITSNFGHRFHPIDKIEKFHAGVDLRANSDYVFAVLDGIISD
TGYSNGAGNYIKVQHGDFETIYLHLQKTFFSLGDFVYAGDIIAISGNSGKSTAPHLHFSV
KERGKYIDPVHFLNDLIKTNNAISDYNYGKY
>LONDMIMF_02629 hypothetical protein
MQESKEQQKIYGFFQKAVYMLVLIECSIIFFGGTQIPILPKLLKSFAKMPFLFPPYHAKL
AELLLIILIAIGTKPKKNQDINITKSILLPIVVGLLMMFGSLAFIDDTFRKDIPQFTPYF
NIYQAVYALLSFVGVLITLLGADNISKIMKIKLGKDRWNIEEESFDQNKELITNDFSINI
PYLFYYNKRMNHGWININPFRGTLVIGTPGSGKSFGIINPAIRQLIGKGFCLCIYDYKFP
DLGKIAYYHYQLKRQHDESYKHEFAVINLNEVERSKRVNPLRKEYLATLAEAQEMAEAMV
SSLQKGGGSGGGSDQFFTQSAINFLASCIAFLAKYEEGRFSTLPHLLSFMNRGYEEIFNT
LFTNIELHSLLSTFKSAFDNRAFDQLEGQIGTLKIFLSRLATKESFWVFSGDDVKLKISD
RKNPTIIVLASDPNTQDINSALYSTILNRLLKQINSKGNLPSGIIADELPTIYIHKIDNL
IATARSNKVAVLLGLQEIPQFRQFYKKEVADTITAIIGNILSGSARDKSTLDWLEKVFGK
VKQKSQSMSINNNQTTISIQEKMDNLIPAGKIAGLKTGEMVGIIAGDENNQTEEYKTSAI
HGRINLDMKSIEDEEANYIEMPVYYNFKDKSGKNDKEKILMSNFLRINREVELIIKDFNP
>LONDMIMF_02630 hypothetical protein
MKNFIIILMLMLVSTETSAQNTVLSRVYKNNLPEIYITGNVNLHFRSPQPIQFVDLSTKH
LIGDLPTENVVRIKIQQFEEESHSATDSIRIKEETPIYYYDNQELGIVTIVGQSFMAQYK
LIYKVDSSATIMTNIEILPEDMQALEYPDYQMSSAELRKYSVEIIRKKEANKIRRNRDLG
IESQLNNVYAFGDYVFLDISFKNNTNLIYDIDKLKFSIDDKKVYKATNVQSIEIEPVFRL
YDLKTFKKSYRNIFVFKKFTYPNNKVLNIRLIENQISGRTINLEIKYSDILQADTF
>LONDMIMF_02631 hypothetical protein
MKKLNLKQPKYVLPLIALPFVLMIGYFYVQFTENSGKDKNKLAESKDISTDFGKVGERSE
IKGKADAYADFFDKRTDGRTMIDGFGDEHESLEKFDDDLSERQKRHIDSMNYVREKERLN
NLSRQANRQSYYNAMDAKQSKEREDDQYDRSMKMLKMLNGDNNGVNNSGKADTRSAENSD
WKKDQMTLMREQMMLMDSIEKANNPELKNQAKAIEKMKKNEKEMDFFLNSTLDVTKASKS
TEFNSIFRQRENNFIKAVIDENIKGFAGSRIRIRLLEDVYVGNAKISKGTPLYALISGFS
LQRVNLNIVSVMHQNEILPISLNIYDVDGMEGLYVPSSAFREMTRSMGENIVQGQNLSSG
SADFFTTTLSSVYQSTSKTISDVIRKNKAKIKYNSFVYLIDNKELEKKKKNIYKKNTNP
>LONDMIMF_02632 hypothetical protein
MEQQNKIISKNPSTIWKSVEQFAERQPKRTFYLMFGLIFLSTLFSIGSLIYIQKVSIPEY
ETMKKQNVLKDAATSFNSPFTETEKILGIREALKELDYYRKKKILSSSDSSRIKYLLDKY
NINNSR
>LONDMIMF_02633 hypothetical protein
MAVVKNIEKKIKINKVTSIGCIILSVIVVIAGFVFSYKQIKDARKSIYILDNGVPVLVKQ
TDLLLNRPVEYKAQVDMFHSLFFTLSADDDYIKSQTRKALYLIDDSGMKEYMNLKEKGFY
NQIISSNSVMTIKADSIKLDEQNLKFIYYGKQTINRKTQLIVRKLITEGFLQDLPRSPNN
PHGVLIEKWKTLDNSDISVKEKFR
>LONDMIMF_02634 hypothetical protein
MKIMLLFIPCFAFSQDTHSDEYYQKAMDFLQGEGVLEGWFTEKFLPLYDSFMTAEYGQFI
LFGQAVAGLGALLYLGNIGWQMIGGDREWEIVPMLKPFAIGLVIVNWVSFVGILRTPLIK
LQDVSESSFVESQQELNSLRWVRFKKQQQVVDRIVEEQAKAQAEIQQQEAGDQSLIEEGL
DMVGDGLTSLMSPVYELYLRLQVGLQLAISSALELIGLWILRICVYGIFFIQLIFSTILI
IIGPIPVGLSVFPAFSSFLSQWVSRFINVNLYGFVAFIILKIGTLLQLFAFEAEIERYDQ
IINTDGSIKNMDLLLTYSSSGIMSFGLVIVCFLITAVGILCVPTLANYIIPSGGGNTGAM
SKMKKAGMAIATKGVSLLKG
>LONDMIMF_02635 hypothetical protein
MKNILLILSFLPLLSFVKGQTIKRVKDKHIVGQEKRQVFYQWGDWQPEPKYFLGIQTNYA
YAMVWGWLAPSRNRDYKGGNDIRPLGLAGLQNQRYATTLVQQDKTSDIQEEAKTTYEENL
KEFYHYSSATSGADPLYLLYYKDVLNSLDNFDTGSSALSQWGFTSSKAWERFNNYGIIGE
CRRKINVIQDKYKFAKSADMPRGKRILAYHDCLIEWRKMKKYLAYLNQQGENRFRAEVKL
ESYKTKNPGKITKERRDAEIFMDVMTGHL
>LONDMIMF_02636 hypothetical protein
MKTFLIVFFLLLLNNAKSQTYYQLYYNLELQAQVTANQAARVASEKLYQNSYEKQRKAYD
DIKEKAVQVVVIKNHIYNQLRNVNSALKQGKQLEAIYYDFTKLIGNMEKMLELSAQKPQY
AVLIMNYYSKLYLHAMNSYENISESVLNEENDFLMDSYDRQKILSKIQHEIKIMNGWTVH
IINYLRNAEKKPYFRHIGVFNSWYIRDKGLIQNIINNYNQNLNGW
>LONDMIMF_02637 hypothetical protein
MKTLSKTKVCFLILIFSNILKGQLTGGNYICYYLINSEIQKTMDENEKQKEMRNKQLTNL
SLESANKEQWSKYRDVTEKIRGRLNNLSFAVQAIPTSVNIVREIDKIYEIQSKIYTELSD
APIWIPVALNGQYEFINSLQLYIRLMAGIVLSYGTINEMEKAERKILLDFAQSEIKTLRQ
QSYSTLQKIINVKRKIKLRNNLLQNWVNRDKKIIQDIINNANLY
>LONDMIMF_02638 hypothetical protein
MKKYSIILMVFIMSFYKTQTPYIDVLTAPAMILYANQIKSEQEKTVDEMNKLQQAQAVVS
TQMVLANDLQNKLYKGLKEVNGTLKNGIQVQNIYNNLSKIITNVDGIYNEVQDAPEYSIF
ATKSIQLVTNKATDIYTDVADLLTSGELNLATSGDRKRLLYNIENNTRLLNVYLINVKMT
IRRAKRKGFWKSINPFQTYVNTDRHIFQQILNNAGTLGL
>LONDMIMF_02639 Chaperone protein DnaJ
MNNIIEQYLAYNYDVVIVDTGDSYSGTAKYKNGKYIQYTEEKPITMNPFVVSQSEFNIEK
IEFLGNLIFLIWQGADSSMTTTQKSIIDNLLLAYYHQFFKGGTNWYQQKTSRELILYLSK
YNIYEDDLYNEFESQYSENENYYQILGIPMDAESSDIKKAFRKLAVQYHPDKNLDKADFD
DSIFDKIHEAYETLVNTEKRKTYDESQLILSNTKIIERPKINSAEWENAFRKSLIKKLVE
LEEMLDVEELSFNTFYEYSEKFLPIYLSNKKFKISEAEFNLRTFLYVLADFYKGGRYGTT
LNEDADNSLFYEPFIVFEIDNVKDNPKLFPIVTLIIMDTFIQKMRLRKDRRKALIIEEAW
KAIASKLMGSYILYLYKTVRKFWGEAVVVTQELDDIIGNAVVKDSIINNSDTFILLDQTK
FIDNFDKIAKLLSLNEVEQSKIFTINNLNNKSGRSRFKEFYLKRGSKGEVYGNEVSLQQY
LTYTTEKPEKSALEYYVNEYRNYQDALEQFVLDIDHLKDGLPNLVSLVNIYQKPIDNGLI
EYYHSFKKQNPSKDFFKSIKRLLIDQDITLKEFIKSKNQTYEKI
>LONDMIMF_02640 hypothetical protein
MKKKSFSLPFIGYDYGSEFNVNYDVLIGEFGNPIIAIQIKNIVTQYSADRALYLKYHSIL
LNIISIIGEGYIVQKLDIFDKKIYQAEAHEEYLQQKYSEHFAGRIYKTIDSILVFTHRID
QSKKKNQYKYSDKKYKELRDKAEKIFMLLKENDFEPHFFFEKNFEYYISSILSMNFGRST
KAFDNIRSLDSNLQIGNSYVKTISLVDVENIELPNEIYPYTTLGGNGAIKDTAVDNFSFI
NDLELYNTIIYNQIIVIPDQTERVKFLANKKNRHEGFQNEPLNRICAEEIGILLDNIAKD
GQLIVDAHYSLVTSCPTIEDLEKIQSMIENQLFQKGVISSKNSFNQLELFRASLPGNANE
LKEYDLFTTTSEASLCFFF
>LONDMIMF_02641 hypothetical protein
MEEKSFFLYKGLKKPLVFKGLKGKYIYYAGGSFAGTMVLGIILSKVIGFFIGIVLALGIG
AGLIWNVFRLQKTKGLFNKTLNKNEIFMIPVKIKLKQKYKR
>LONDMIMF_02642 hypothetical protein
MKNNITSINKHHKIKKALFSAILVLCTNLLFAQTGGAGAISSATSDIEEYVEPVSNLVQM
IGAIVGIVGGVRIYNKWNNGDQDVNKELIGWGGACIFLLLVPTVIQAFFGI
>LONDMIMF_02643 hypothetical protein
MGKVLMITGLLYILYYTGIAVYDLFIKKQIVNRNENDGELISLENFIEETPGEIINIYED
DVENLNLPSSYDYEETELSSEENGEPFNHRRFEEEREIENFYGDNQQGKDEKEVRQSFLS
NLSSVIGSKNSEAIPHQKEIIPSVISDEMFRNFFEKASRHIVVGSESGQSFYKSSLVF
>LONDMIMF_02644 hypothetical protein
MGILDRYTTDEDKEELAKNLNILSDEAVLSKKGIKHKTADAAKNTRTKKKPTNLTELDDK
TLCIINEFVDSYKSNDKTSRMIRIQDHHYRKLVGLRADGISVSEFVSFAVHLALKSDDYE
NFLNILKK
>LONDMIMF_02645 hypothetical protein
MIITFANQKGGVGKTTLAIAFANYLSMFTDKKVNVIDFDFQRSFYRQWSEDKELKADYLY
EVEKISEENIHLTQNEKVLMQLKESQEVILFDTAGNIQNNYTQVLQYSDAIIIPYGYSSV
TMMSTVLFLNLLKLIKVKAKIYFIRNNMRKDDSYELKPVMDAEFNTIGKVIGGSVLTRKC
MLSINTKGLTYEQKLAVKETFDELIYHLWEF
>LONDMIMF_02646 hypothetical protein
MIVKILNKSSSEFNGVIYNDKKIEKGKGELLSIKNFPAHLNHSSGAPDIKNYLKAVSKNN
SRIKNPQFHATISAKGREYSKEQLALTADKFMDKMGYGEQPYIVVFHNDTANNHIHIVST
RVNKDSSKRIERDFEKYKSQTALQETIKELYGTDVHQNLEKLIDYNYSTLHQFKTLLELN
GYGYYEKNDKLNITKNGAFIKVLNVNDLNFSKKSFDEKRKKQIFALFKKYKEVFSNSVFR
VSDKNHASYQSELQYHLKKKFGIDVVLSFKDDKQPFGYSIIDHKTNTIYKGSDIMKMSDL
FIISSQVLDKKIFDILANSNLTIETKNVFKKHLEQEYKCEIQDYMLFLKQSKKTNYNIWK
DTRNSTIDHILNLRKVSNNSQDKIKIVSFSNEAFVINKIDNVVFTVKELVGDYYYNLYLS
QLLNPQNPGHQSIVNGVQAAEASSLEEMLKRTSLFDISAASPPSSEELENRRRKKKKKR
>LONDMIMF_02647 hypothetical protein
MKDLKTSGRSKTARITLRLHDEVKEKWLNHCNKYNLHLSDYIISGVEGKLLDNDRKEIMN
FIENQVNLFSKIENNINQIAKHINTNKHLPTTLLSDYNSKLEILNSLKIEQNRIIKKIYI
ELAK
>LONDMIMF_02648 hypothetical protein
MSEYEIIRKNYENLPKNDKRAIPYVKTYIQKSKNENDFEHLTQGYRDAVFFTKNEKQKLV
YSDSMIYAALKSRDKDLIGLAYLGKGIIYYFNYKKFDPALDEYLKAYNYLKNTKDEYLKY
KVVYHMGVVKSYLGYYSESKENFEECIKFFNNESVKQLHPNEVFNNKRGYFNSLHQLIIC
QRNLKNFAAADSLINVGLKEIEGIDEFSLEKSYFLKCKGISAYNRQNYKHAIDILNKSLP
KILKVDDFATASLIYSYLGKSYYHSDKEKALHYFEMVDSIFVHKNFVLPETRDSYEILIN
HFNNLNNTKKELYYTKQLLSVDSLLGKEFYYLTSRIHKEYDTKRLLDNKEALEKRNLLTS
LMVIFFICLSLLFITLYIFKYRKNKKIMLNYRILQIKLDNRQLEKMLHQHSPDTIYEDEK
TSIISKEIYQDLLLKIKSFEDRQEYTQIGLTLNQLAAQFNTNTTYLSTFINESKGVNFKN
YLNNLRIDYITNLMNTDKNYLKYTIEALAEKCGIASRQNFSDLFYEINGMRPTDFIKKKK
EEQKNNNGK
>LONDMIMF_02649 hypothetical protein
MKKVIPFLILIVGLCAQSCRQVDEQVDNDFALSRVAKESNKTSDSTRMKIELEKDPPVKD
GQDWKH
>LONDMIMF_02650 hypothetical protein
MKKSVFLQVPLITACFFILLFCYASASKIMDFGNFQVQIAQSPLLSAYAGFISYATIIVE
LLIVVTLIVPKFRLIGLYSSMGIMIAFTIYIYLILNFSDFVPCSCGGILEKMDWTEHLLF
NLGCILLSFISVILVEVINRQKFIIYFVKIFVVFVASTSLVVYLFYSSEYIIKKENNFVR
RFLIHPVLEDKSIDLKLDSYYIAGSDSKKIYLGNITAPLLFSEINYDLSNLSQQRIELDE
KDYSFKNLWLQTFKNDYFLYDGSVPIIYRGKIGDQYAETISYQNAYFTQLSVLDSARFAL
RTQSKSTQQYTLGSLDLNRNPKVVLNPDILQKQIDGVFDSDGKLLLNQNFKNLIYIYNYR
NEYMIMDEDLELKSRLKTIDTISRARFNVVKIPDGRHKMNVPSLKNNQNPTTNQNLLFVE
SKLIGKYESKKAWKKNSIIDIYRIDRQEYVGSFYIPKKDDKALTQMYATDMYLFVLIDKE
LKRYKFTRLILNLYEKGNAENLK
>LONDMIMF_02651 hypothetical protein
MIPVVTVLLGTGAAFATSAAKSNSAKAIVDAYRIDAVTGECLNAQQQCNTVGTAPCVWSG
DSSSSLHEKISDNPTMCGEELFRLQ
>LONDMIMF_02652 Dipeptidyl-peptidase 5
MIVRIYQIQNDSANQYDIIGYNNPASFDLRTLLDQGYFVYLPDIVFGPKGTGLSALDCVN
KALDTIQNRPYIDQSKIGLTGHSHGGYETNFIATHSNRFAAYLSGAGNSDIVRSYFSYNY
NFHSPFYWQYENGQYELKFPFSENKKLYFDNNPIYNVEKVNAPILLWAGKKDENIKWDQV
MEFYIGLKRNNKDVIALFYPNQGHNPSFNSEDRKDLYYRTLEWWDYFLKDKTNIDWINKQ
MKKDAL
>LONDMIMF_02653 Energy-dependent translational throttle protein EttA
MSDDKKVIFSMQKVSKTYQSSDKQVLKNIYLSFFYGAKIGILGLNGSGKSSLLRIIAGVD
KNYQGDVVFAPGYTVGYLEQEPQLDENKTVIEIVREGVAETMAVLDEFNKINDQFGLPEV
YEDADKMQKLMDRQAELQDKIDALGAWEIDTKLEIAMDALRTPEPDTPIKVLSGGERRRV
ALCRLLLQQPDVLLLDEPTNHLDAESVLWLEQHLAQYSGTVIAVTHDRYFLDNVAGWILE
LDRGEGIPWKGNYSSWLDQKSNRMAQEEKVASKRRKTLERELEWVRQGAKGRQTKQKARL
QNYDKLLNEDQKQLDENLEIYIPNGPRLGTNVIEAKGVAKGYGDKLLYEDLNFTLPQAGI
VGIIGPNGAGKTTIFRMIMGEETPDKGEFTIGETVKIAYVDQSHSNIDPNKSIWENFCDG
QELIMMGGKQVNSRAYLSRFNFGGSDQNKKVSTLSGGERNRLHLAMTLKEEGNVLLLDEP
TNDLDINTLRALEEGLENFAGCAVVISHDRWFLDRICTHILAFEGNSEVYFFEGSFSDYE
ENKKKRLGGDLTPKRIKYKKLIRN
>LONDMIMF_02654 Autoinducer 2 sensor kinase/phosphatase LuxQ
MPRSRIISYVLISLFFYNLSFSQEKDSLNKVRVKIYDLICKADGLLIDLKYMESLQVSKQ
ALNLAYKNKQYDYVAMSYNTIAGCHEELLNTKMALAYYNKALQYSLKTKNDTIKDWIYNN
IGNIYNFVIKDYDKGIYHYKKSLQYANKGKDTTEIIFTEMNLAWAYFNKKDFEQGYPYVK
DVEKQLDKYGDIESRVIVNNLLGMYYSNKGDARRAGFYFRTAIDYGIRYKQQNALADAYA
EYSKHLYQIKDYKNAYLNKVNYEKLKDDLHNHEKMKSAQIAGVQIELDESRRKIDKIELE
KYAQQENLKNSKIIVILFLAILIILLLLLYTFYKNSIYRKKVNQQLLESNAELKIAKDKA
EESSKLKSQFISTVTHELRTPLYGVIGVTNLILDEHKELENSPHINSLKFSARYLLSLVN
DLLQIHKIEDKKIVLEELPLNIMDEIEKVKEALQFIAIKNKNKVLIDVGIEIPEYLIGDK
LRLSQILVNLTSNALKFTQNGTIRLTAALVKKVGNIHHIKFEIVDNGCGIAIENQNKIFE
KFVQIDRKEGDYQGTGLGLSIVKRLLELLGSTIQLQSKEGEGTTVTFIIPFEYDANATKS
YIENIDVDTTNSSSYKILVVEDNKINQMVTKKIIEKNNYKCVVVDDGYAALEILDKENFD
AILMDINMPVINGFETTRMIRDKGIDIPVIALTAFDKDEITDEAKLSGMDDILIKPFEPL
RLFQIINSQIAKYLH
>LONDMIMF_02655 hypothetical protein
MKSVFLFLLLASQVTFSQDLKIMSYNIRLDTQSDGDNQWSKRKEFLTDQVKFYMPDFMGV
QEALPQQMSYIDSTLTGYGFIGKGRDDGKSKGEHSAIFYNSDKFKLLEENTFWLSETPEK
PSKGWDAAYNRVCTYGLFQNKKNKKKVWVFNTHFDHVGDIARAESSKLILEKIRKINRDN
LPVVLTGDFNLEADTRPLQLIKEQMDDAQKVCRGIVFGPEGTFNAFEFNKPVTTRIDYIF
INRNTMEVVKFATLSDSKDCRYPSDHLPIYAEINFR
>LONDMIMF_02656 ATP-dependent RNA helicase RhlE
MLFEDLSLSKSIQTAVHELGYIEATPIQEKSIPIILAGNDLVGCAQTGTGKTGAFAIPIV
HHLHRIVGSAKKTKQIRALVVTPTRELAVQIGQSFDAYAKYTNLVQLTIFGGVSQVPQVE
LLKKGVDILIVTPGRLLDLHKQGFINLDHLHTLVLDEADQMLDMGFIHDVKKIVKLTPKN
RQTLLFSATMPMAIRELAETFLNQPEYVSVSPPSTTAETVEQRIYFVHKTDKRKLLYHLI
RNEKISDVLVFARTKHGADNVVKALRKQGVAAEAIHGDKSQNARQRVLDSFKSKEVGVLV
ATDIAARGIDIDKLPYIINFDLPNVPETYVHRIGRTGRAGNGGIAISFCSKDEEVYWKDI
QRLIKVNVKTIGDHPYPWKDEEEPNPDAKPDFRHKNKSKGNNSRKSDASKKNKKRWY
>LONDMIMF_02657 Cobalt-zinc-cadmium resistance protein CzcA
MQKLVQSIVAFSLKNSLIVFFATVLLFAGGIISYMHTPIEAFPDVTNTRARIITQWPGRS
AEEVEKFITLPISKQMNTIPKKAEVRSISLFGLSVVTVLFNEDVDDFYAQQYASNRMASV
SLPEGADAEIDPPYGATGEIFRYVVKGNLPIKELTAIQDWVIERELVSVPGVANVVSFGG
EEKIYEIKINPTELVNYDLSPLDVYEAVSKSNINVGGDVIQRGDQAYVVRGVGLLDNIDD
IGNILIEVKGSTPILVKHVAEVKIGSKPRLGQVGLDNNDDLVEGIVVMLRGENPSEVIAN
LRTRIDELNERILPKGVTIEPFIDRTELVNTTVHTVTKNLIEGVLLVSLIVFIFMYNWRT
TVIVASVIPLSFLFAIIMLRIQGLPANLISMGALDFGLLLEGTLVIVEQVFVSLEKKAHK
VGMQRFNNMSKMGLIKKSVGSVATYIFFALIILIVALLPIFSFQKVEGKMFSPLAFTLGY
ALVGSLILSLTYVPAMCKVLLTKNIVEKENKISRFFRENLYKMFQWSEKHRRATVYGFII
LLAICFGRFMFYGSEFIPKLNEGAIYIRATLPNSINLDESVRLTKEMKTKLQKFDEVKFI
LSQTGRPNDGTDPTGFFNIEFHMELKHQNEWKRKISKEDLIAEIKEKLEEYPGINFGFSQ
PIQDNVEEYVAGVKSPLVIKIFGDDLFKLEEYANKVAKSIAPVKGIEDVNVYKNIGLPEL
RIQLHDSKMARYGVKTSDAQAVIAMTIGGQAATTFYENERMFDVRIRFEKEYRDSKEKIE
NILIPAMDGKKVPLREIATVSYQTGPTFIYREGNSRYIAIGFSIEGRDLGSTIAEAQKKV
AAEVKLPKENTMKWAGEFESKERASKQLAIIVPVVLLFILFLLYFNFGNMKDTLIATSTI
PYAFAGGFLSLWMTGTIFGISAGIGFIILFGVNTINGIILIAVMKDNLRAKMPLKQAISE
GVYSRIRPIVMIALMGSMGLLPAALSSGMGSEIQKPLAIMIVGGLLFCMIFSLTVLPQVF
YIAYRKKHE
>LONDMIMF_02658 Cobalt-zinc-cadmium resistance protein CzcB
MKYIYLMPLALLFSCNEKETVTEKNEKFCLNDDLKKKVTIEEIKREPVSETFTLTGNVTY
NSDNVIQFTSLINGVVTNTYFSLGDYVKKGQVLAEIKSTELNGLQSENKSVESQLAVAQR
QLASVKSMFEDGIASQKDLIQAESEVKVLKASLENIKSNLALYSASPEKSVFQIKAPSNG
FIVAKNMSSGMQISSGSEPLFTISDLNEVWVMVNIYATDMQNIKENMDVKIKTLAYPDEV
FSGKISALSQVFDAEEHVLKARIVMKNTDLKLKPGMSADIILNKSNASAESLLAVPVKAV
IFDDNQNYLVVYKDDCNLEIRQVDPVTKNREVVYFDKGIQENEKIISKNQLLIYESLK
>LONDMIMF_02659 Cobalt-zinc-cadmium resistance protein CzcC
MKRIFFTAIFTSFCLSGKAQNTTARDTVSVSRAEAETIFLKNNLRLLSEKLNIDQAEAQV
IQARLWPNPRLEVGEINLWSNAKSEQLPPIFGNWGKTSEVTVGLEQLIYTARKRKKQIEM
EKVGVEIAQEYFQDFLRILKVEFRNNLTQLQYTQEKQNLYKKQLTSIQKLLTAYSNQAKQ
GNISKSEFIRLKASELEFVKQLSDLQKENNQLQKELKTLMNLPPQSYLKISIDKFVPDLD
KVANINLAELASAALENRPDVKASVLEEKYNNRKYKYELSQRTPDVTLLASYDRGGNIMN
DFVGVGFAIDLPFFSRNQGNIKSAKIEIQKSQYMKEEKNNQAQNEVIQAYEDLVVSKRLY
ENIEASYEKDLDLLLESHQKNFTLRNTSMLEYLDFVNAYLENKTIILDSKKELNEHFEEL
QFVIGKEL
>LONDMIMF_02660 Sensor kinase CusS
MKIRNRLTLISSLTFGFVFIIASVLIYFAFYNSSEKVVFKELQKTCLLSAIYYLEKDELP
HYEHSAIKEQFEENIQNDIVRVYDLNNVIVYGEKEADRNINPTNLNFIRKNKKLSFKSNN
HFYYGIFYNDNQGDFVVFVKTKSEVFKSQTNRLLVIMIVVLFGGLFLIFLLSRLLSNIAY
RPITNVINQVNSMELSSLDDPILSSNTNDEVQELIATFNNLLSRLSDTFAIQKNFINYVS
HEFKTPLASISGNLEVFAQKDRTPEEYQKVTSEALENVYHIEEILNNLMMLSGLKTIHQE
NETFRIDETVWDINDQIFETHEKQEIGIDLDVKNEELLSVKGNEVQIRLALYNLIENAVK
YSEGNPIKISLSEVNNQLQIIIEDYGKGIQKEDLNYIQQTFYRGKNVGNIKGSGIGLSLA
TIIFKQNNIQFTIHSEENSGTRITLLFPKL
>LONDMIMF_02661 Transcriptional activator protein CzcR
MNILLIEDDKRISDFVIKGLEENGFSVTLAVTGEIAREMVSENEWDIILMDIMLPGIDGI
QLTKLIRFKKNHTPILVLSALDDADNKVAALDSGADDYLVKPFHFKELISRINALTRRTK
FNYKEKEQVYFCHNLTVNLDEHSVFQNDQPIDLSPREYKLLLFLLENKNKVVSRTQILNA
VWGIHYDNNTNVVDVYISYLRNKIDENQHKFIHTIKGTGYMLKE
>LONDMIMF_02662 Formimidoylglutamase
MEKLIPFTVHDLARVTNFRSGEVKFGEKMQTIPKGADASEYLKNSDAKFVLFGIPEDIGV
RANYGRPGAASAWESTIKSIANIQHNRFSKGNQILVLGHLDVAEEMKEVENLDFNIIEER
KQLSKVVEKIDKEVSHIIFNIVKAGKIPVIIGGGHNNAYGNIKGTALAKGKAINAVNFDA
HSDFRILEGRHSGNGFSYAYEEGFLKKYFVFGLHESYTSKSVLHEIKKLEDRVRINTYDE
INIRKEKDFRLEMERAYSFIRNDFYGIEIDLDSIPGIPSSAMTLSGFSVEEVRQFIHFFS
QDPNACYLHICEGAPDLGDSKNSHLVGKLIGYLVTDFMKAKSEIEK
>LONDMIMF_02663 hypothetical protein
MENQKSNSSLKAIIVVLAILLAGSLVYMYKMSSDAKSTETLLVKDKETAMNDLAALKTKL
DAAIAENTSISDELIAEREKVVKLMADLEKSKGDVASLKKYQSQYNALNAKFNALAKENG
LLKNQNSLLASKNDSISMALGEAKRFNDTLVIQNENLAKTVEKASKLTVMNLRTEAIKER
SSGKQVVTERARRADKLKVCFAIAQNEVAKSGNKLYYVQIIDSKNNVLGEKKTEAFGDMS
LTYSFTTTVAYENKAVDVCEFLDGNGVDFEKGTYFVNIFDKGTLVSKTSFTLK
>LONDMIMF_02664 Metallo-beta-lactamase type 2
MIKNILLSILFSFTFLSCNSQKKDNFKAKEIYKSDNLTITQISENSFIHTSFKQTNDFGN
VPCNGLIVRDNNETIVFDTPVNNTISEELIKWINDILHSKINAIIPTHFHDDCLGGLEAF
HNHNIPSYAYIKTVELAKENNFTIPKNSFNDSVILKVGDKETITKFFGEGHTKDNVVGYF
PSENILFGGCLLKELKASKGYLGDANISAWSNTAEKVKREYPDVKIIVPGHGKYGNYELL
DYTIKLFKTQ
>LONDMIMF_02665 hypothetical protein
MNHYLYKNFIVEVLNEPTYELGSTNKDFNYEKIFFSDDGQEYYPTSKHGIKIYRDNQVIT
GSLLIGSGGATGVYQNSSLIDDNELLICCCDTVFCIALPTLDLKWKTKADWATCFRIFKQ
DNDYIVHGETQISKLDKGGNIKWEFGGADIFVSLDNEEVFTIENDGISLIDFSKTKYKIN
FDGKLV
>LONDMIMF_02666 Imidazolonepropionase
MKTLLINIKELLQVRPTPIDKVSGTDMATLPAIQNAFLLIENNLISDFGKMEDLPKIPEA
QIIDATGKTVLPAWCDSHTHIVYAGNRVQEFVDRINGLSYEEIANRGGGILNSAKKLNET
SEEEIYQQSKERLEEVMKQGSGAVEIKSGYGLTVEGELKMLRVIKKLKENYPVAIKATFL
GAHAFPKEFKENHSGYIDVIVNEMLPKIAAENLADYIDAFLETGYFSVEETERIMEAGKK
YGLPAKIHVNQFTAINGIKACVKHNALSVDHLEIVTDEDIEILKNSDTMPVALPSCSYFI
SIPYTPARKMMEAGLPLALATDFNPGTTPSGNMNFVVATACIKMKMTPEEAINAATINGA
YAMGLSETHGSITKGKRANLIITKPITSFYQLPYAFGTNLIEQVIIEGKLV
>LONDMIMF_02667 Cobalt/magnesium transport protein CorA
MRRIRYKEVRKVQPNYFEYTGIHNTDTVEMQLFVYDDLGYEEYKKVSLDRVRKEIEDPLQ
AEDVKWLNVHGLHDVKLIQDIGELLNIQNFIIGDILNVSRRTKMDELDDVLFFSIKSILQ
EEESAVVRVEQISFLLKDNLLVSFQEKKSDFFTHIRERIKTHSGIVRKKKSDYLLYLLLD
AVMENFFITIESYENGIEALLVEAKNSYKSVFLENIEKERENLNFLKRSIIPLRDALFNL
KTHQNDDGFGSIEKSNYAFFERLYQKSLELLEQIDYDLKSLDSASNVFFSSQSQRMNQIM
KTLTIFSVIFMPLTFIVGVYGMNFENMPELKMENGYFIVLGVMFLTVLGMVYYFKRKHWF
>LONDMIMF_02668 hypothetical protein
MKKFKSDISGKEFPENERVTAKVVRKSILDFIKVEHPDFENDKCMSVDELRSFRERYIAE
MLLKETGDLSEMEQTVLRALNDNTILADKLDDEIQEFTLGQKIADKVATFGGSWTFILSF
MAFLFLWIGGNVFILLNKGFDPYPFILLNLILSCIAALQAPIIMMSQNRQEEKDRERAKK
DYMINLKSELEIRMLHEKIDHLLLHQEQSLVEIQKVQMDMMEDILKKIENKKHG
>LONDMIMF_02669 hypothetical protein
MTHPLTEKKWSDIRKFFTLLLIFYLFFYMFPFPFNQIYGVDILTGWYADGIDAVILWVGK
NILQIKNLQQILNTGSGDTTFDYVSLFTYMLLAFLASTIVFFTTRKRINYDRQYYWIIVY
ARYYLGLYLIVYGLFKLLEGQFVFHDFGRLEENFGDATPMGLLWTFMGHSKIYGGFTGII
EAGAGFLLLFHNTKTLGALLSVAVMSNVVLMNFCFDVPVKLFSSHLLLISIIILMPNLKK
LYNFFILNKTETLDHCKLVFENKWKARARGLGKALLILGFSAYIIFTGVQNMYTNGSWAP
EAPLKGSYHTTAFYISENDSLKKTEDKKTLWNRLHISGNYGSIRTESDSTNYYAIKIDTL
KNTIEFKSYRDTTDISVLHYEEKVPKTFVLKGKFGKQNIQAEFSKKSLDDYRLVNTGFHW
IQEYPNNR
>LONDMIMF_02670 Fumarate hydratase class II
MEYRIEKDTMGEVQVPADKYWGAQTERSRNNFKIGPSASMPKEIIEGFAYLKKAAAFANH
DLGVLPIEKRDAIAQVCDEILAGKLEGEFPLVIWQTGSGTQSNMNVNEVIANRAQVLAGG
KIGEGEQFIKANDDVNKSQSSNDTYPTGMHIAAYKAVVEVTIPGVEKLRDTLHAKAEAYK
NVVKIGRTHLMDATPLTLGQEISGYVAQLNYGLKAVKNTLAHLSEVALGGTAVGTGLNTP
EGYDVKVAEYIAKFTGHPFVTAPNKFEALASHDAIVETHGALKQLAVSLNKIANDVRMLA
SGPRSGIGEILIPENEPGSSIMPGKVNPTQCEALTMVCAQVMGNDVAITIGGTQGHYELN
VFKPLMASNFLQSARLLGDACVSFDEHCAQGIEPNYTRIKELVDNSLMLVTALNTKIGYY
KAAEIAQTAHKNGTTLKEEAVRLGYVSPEDFDAWVKPEDMVGSLK
>LONDMIMF_02671 hypothetical protein
MILALLGSFLFVILGIWMVIDHKEINSIFLKFPLAVLIAGILSILFFGFLAILIIKKLSS
QTDGLIISSEGITDNSSAISAGFIPWTEITAITETSYAGQASVIIVIKNPEEFIAAQKSS
FKRRAMTANHKSFGGAVSISANSLQTTHKNLKKILVEKLTEYNRMNTI
>LONDMIMF_02672 hypothetical protein
MYSKAEAQIIKKEFWVNFAEEYPRKWLLYDTKIKDFSFKFYVDNKKAQVLIDIESKDEEK
RKIYYEKIESLKQILVDEYIPDVIFERNFHLETGKVISKIWVEKTGISLFNKATWPAIFD
FFYENMDAFERFFYEYQDYITDLEINT
>LONDMIMF_02673 putative Nudix hydrolase NudL
MNHIAKFIMDFPVFLKYIPKIEKETLPAVEAHVKMASLDRISSLIDKSYDRDGLRNAAVM
MLVYPKNTKAYLALILRNASTGIHSSQVALPGGKVEPEDINLATTALRETFEEIGVLPER
IQVIKAFSEVYIPPSRFLVFPFLGVCLSELVFDPSPDEVAKMIELPLEDLMDETNLTNVQ
LKTTYADEIEVPAFDLQGHIVWGATAMILNELKETIKRVL
>LONDMIMF_02674 hypothetical protein
MGLFKRNPFGHILFLKKWLIRVFGILTHRRYRGFNELQIDGSEIIRALPDRNVLFISNHQ
TYFADVVAMFHVFNASLKGREDNIKNIGYIWNPKLNIYYVAAKETMKEGLLPRILAYAGA
ITVERTWRAKGKDIQREVNLNDTENIKIALEDGWVITFPQGTTKSFKPVRKGTAHIIKQH
KPIVVPIVIDGFRRSFDKKGLRLKKKGILQSFIIKEPLDIDYENDSIEEIVEKVEYAIEQ
HPSFLKVLQPEVLEEVLKVEEELNKKRRWDY
>LONDMIMF_02675 hypothetical protein
MKELDLLKKDWQKRADSFQQVSEKDIYKMIHKSSSSVVKLIMIIGIFEFLFWIGISIFSN
NDEYFNKLDINNIVVFLRVLSYAHYAVIIFFIYAFYKNYVLISTTDSTKVLMRNILKTRR
TVNIYVWYNLGMIIFCLIIGFCIAYFYNPDLALMKDKIEHDGIKTMAIFIGSMLIMIILF
TSVFWLFYKLLYGILMRKLYKNYEELKKIDL
>LONDMIMF_02676 ECF RNA polymerase sigma-E factor
MGQDLEKSFVKQLKENQNIIHKICRLYTSGEDAHNDLFQEITIQLWKAYPKFRGDSKFTT
WAYRVALNTAITLYRKSTRSISTTEFDNTKHFIKQEDYNYEEEEQIKLMYKAVYQLNDIE
KALIFMYLEDKDYEEISETLGISEVNARVKMNRIKGKLKKILNP
>LONDMIMF_02677 NADH dehydrogenase
MNIPQSDYPRIVIVGGGFAGIALAKKLKNKPVQVVLLDKHNYHTFQPLLYQVATGGLEAG
SIAYPIRKVVHEYKNFYFRLCHVNDINTKNNKIIADIGELRYDYLVIATGSKTNYFGNKE
IERNSIAMKTIPQSLNIRSLILENFEQALLTDDEHERNALINFVLVGGGPTGVELAGALA
EMKNAILQKDYPDLDISKMQINLIQSGDRILNTMSEKSSSAAEKYLKNLGVNVLKNIRVT
SYDGRTISTNTDVVLETATLIWTAGVQGAIVNGLPASSLMEKVERIKVNEYNQVIGFPNI
FAIGDIAMMATEEYPQGHPMVAQPALQQGRLLGENIIKLIQNQEMKPFHYNDKGSMATIG
RNKAVVDLPNYHFHGVFAWFVWMFVHLFSLIGFKNKAVVFLNWLYNYIRFDREGRLIVRP
YKKKSFTSFTFDEI
>LONDMIMF_02678 hypothetical protein
MKKSKIIWSIFLVIQVVLLKIVSFFPEVIEKYYSNGFYLSVSKISRTVFGSLPFSVGDVL
YLVLIIFLLYKLYKKRKEVLSWKSWKSDWKSKTLSILASISIFYFFFNCLWGLNYHRIPL
YAKMGIDKEYTLEELEAFTKKMIVKTNEIHSRIVKNDSSQVVSPYDIKTIYVMTLSGYGN
LEKKHPYFNYQIPSIKKSMVSLPLTYMGFGGYLNPFTNEAQVNYKIPKYNFPTTVCHEMA
HQIGYASESEANFIGYLASINNKDDYFRYSGYSYALKYCLSNLEKIQEGKSKEFLPLIHP
GILKDFQETKDFWKSYQTPVDTFFHYFYDHFLKINQQKDGLESYSKFVGLMIGYYKNHPL
>LONDMIMF_02679 Ferredoxin, 2Fe-2S
MKKKNDEKIIFFCNGKKCGKYNKEPKDYLKKKIVEFGLEDKVCVSKMDCQGMCKKAPVVC
IQPKDVWKKEVSVKKAKKIFEKHIL
>LONDMIMF_02680 Cytosol non-specific dipeptidase
MSQEIRNLEPKALWNKFADLNAVPRPSKKEERVIAFMKDFGKKLGLETIEDEVGNVIIKK
PATAGMENRKTIVMQSHLDMVHQKNNDTVFDFDTQGIEMYVDNGWVRAKGTTLGADNGLG
VATIMAILESTDIPHPAIEALFTIDEETGMTGAMGLKGGLLDGEILLNLDTEEDDEIDIG
CAGGIDVTATAEYDEEDTPEGSVGYSITVKGLQGGHSGMDIHKGLGNANKIMNRLLFDGF
DNFGLQISEIKGGSLRNAIPRESVAKVIIAKVYDEAFVFDMQEIVNEIKTEFKTMEPNLE
ILFEKLDTVPAKVMPSIAQFYFVRAMYTAHNGVYRMSADFDDLVETSNNIAKVIVGEGKL
SVQCLTRSSVESSKMDLANALRSAFELMGCEVEFTGSYPGWTPNAKSEILDILTGIYEKQ
NGSKPNVVACHAGLECGILGTNYPDMDMISFGPTIKGAHSPDERADIASAQKYWKFVLEI
LKNIPNKN
>LONDMIMF_02681 Nucleoside triphosphate pyrophosphohydrolase
MNSRQQKLDAFGRLLDIMDDLREKCPWDKKQTLQTLRHLTIEETYELGDAILDNDLQEIK
KELGDLLLHIVFYAKIGSETNDFDIADVCNEICEKLIYRHPHIYGDVTVADEEEVKQNWE
KLKLKEGKKSVLEGVPKSLPALVKASRIQDKVKGVGFDWEEPHQVWDKVEEEIQEFQEEI
KNGDQDQIESEFGDVLFSMINYARFLKINPEDALERTNKKFIKRFQYLENKANELGKQLS
EMTLAEMDVFWNEAKRL
>LONDMIMF_02682 hypothetical protein
MDTASLIIGLVLTLICAVPLIYIANNQAKNKKKVKEIFNHFRQGKYDFSTKETHYKKIYS
LDKTNKGFLFIDLNKENDRASFVDLSEVNSCRIEETSSGNNDDKIIFTFKLKNGNTTTIV
LYDLETDKLGKAYWQENEQIAKKWQLIVENTI
>LONDMIMF_02683 hypothetical protein
MKWIKNITVFFIFLVSLFFSQTEEAKAFGAISIPQNKKSIEQVDFLKASAFINQEISINS
ISNPRADLPTYAKWFEFYYDVSFSGFSTCKATAAFLKQDINRCLNVSILLFPFHFFW
>LONDMIMF_02684 hypothetical protein
MMLEEKNDNLHEADGSNENETQNVSQNENSQIEEPNENNADATEVSSDDANDVVSETADA
IEISPEELEETVVVSDNQKALDAIADSNAEESEDETLKERHEIPMQDYEAMDMESLVAEL
EKLVAVEKVMSVKDHVEELRSAFLSKYNHFIEEKREEFLAENPDTTEDFHYHLPLKVKFD
TLINQYRDKKNTHFKSLQNNLKANLDVRLAIVEELKELINPQENIKDTLKHFNELRERWK
NAGPIPRDKYNHVWNNYHFHVENFYDYLHLDREARDLDFKHNLEQKQRIISRVEELVNEP
DVNKAFRELQDLHKIWKEDIGPVSREHREAIWNTFSELTKKIHDKRELLFEKQRGTEQEN
LEKKKEIISKIAELAKEKVEAHSSWQAQIEKVEALRNEFFATGKVPADVNEETWSAFKNA
VRDFNALKNSFYKDIKKDQQENLNKKMALVERAKSLKDSEDFAATTPVMKQIQEEWKQIG
HVPRKYSDSIWKEFKEACNHYFDKLHAQRNEVNSEELEAFEKKKAYLETIRDFELTGEHK
ADLDAIKAHIETWKGFGKVPHARRHIEGKFNKILDALFDKLSLSKKDSEMARFNSRIDQL
SSSDDSRKLENEKIFLIRKIEEVQQEIFQLENNIQFFANAKKDNPMVLEVKKNIERHKES
LQMWKEKLKQVRNLKTE
>LONDMIMF_02685 Shikimate dehydrogenase (NADP(+))
MEITHLFGLLGKNIAYSFSKGYFTEKFKSLNLKNYDYVNFDIPSIEEFPNIIKENPNLKG
MNVTIPYKESVLPYLDKISRKAEKIGAVNTIKVTRKGNLKGYNTDYYGFRKSLEPLLEPH
HKKALILGTGGASKGIAYALEELGILYTFVSREATGESIGYNLVNATTFDNHQIVINCTP
LGTSPNTDAYPPIPYEYFTPKHIAHDLIYNPAETIFLKKAKKQGAKIKNGLEMLQYQAEK
SWKIWNR
>LONDMIMF_02686 TPR repeat-containing protein YrrB
MHLSHDEEDYNLSLSKFESMLKTNKVLFFDSEEFEEIILHYLDMGKASLAKKALKLALEQ
HPRSTGLKLVQVEMLVYDDKLETAEKLLNELYAIEPQNEEIFIQKANIYSKRDNHEKAVE
LLQEALKLTDDYADVYNLIGMEYLFMDNLELAKENFIKCLEEDVEDQAALYNVVYCFEFL
DQNKEAIAFLEKYIDRNPYSEIAWHQSGRLYYGLQDYENALRCFDYASMIDDEFMGAFME
KAKSLERLKRYEEAIESYNRTIELDDPTSYALLRIGKCYEKLGNKPLALKYFHKTVHEDP
LLDKGWIAITDFYVRQKNYQKALFYVNKAIGIDNENRLYWKRYATINRALDFLEEAEMGY
RKAVEFGDYELDTWLYWIDILQNLGEYDAAIHTLLQASEYFPEEFQLEYRLAGLYFAEGD
EAKGKFHLSNGLRVSFENHTILENLFPDVWAREDVQEMINKK
>LONDMIMF_02687 Putrescine aminotransferase
MNKDFQKYQAQTSPYPLGMEVSHAIGSYIYDTNNKKYLDFVAGVSACTLGHQNKRVNDAI
KNQLDKYSHVMVYGEYSQNPAVEFCKLLASLLPKPLEKTYLVNSGTEATEGALKLARRVT
GRSQLISCNNAYHGNTMGSMSVMGFEERKRAFRPLIPDVDFITFNNEEDLKKITTKTAGI
ILESIQGGAGFIQPENGFLKKVRERCTEVGAMMIIDEIQPGFGRTGKLFGFENYDVVPDI
IILGKGMGGGMPVGAFTASSEMMDLLSDNPKLGHITTFGGHPVIAAASLATLQEITETDL
IPQTLEKEKLFRLLLVHPLIKEIRGRGLMLAAMTEDAEITNQIILKCQDKGLILFWLLFE
GKAIRITPPLTISEEEIKEGCAIMLEVMDEVYSALKN
>LONDMIMF_02688 LPS-assembly protein LptD
MEILIKFEPKFHPLKKNFLFLASFFILLSFNTLLAQAPPKKIIVENSDFVDIQQEEIPGA
IRYRGNVRILHDGVRMTCNTAYLFQKENYIKAFGDVKMNQGDTVFMDSRYAEYQGNIKFA
FATGNVVMRDPKMTLTTDTINFDRRIQQAYYTTYGTIKDQENTLRSKSGRYYLNEKKFQF
LTAVTITNPKYVIKSNHLDYYSNSGHSYLFGPSTITSKENFIYTEKGFYDTKKNFAHFVK
NSYIKYDNRLIRGDSLYYDRNREFASATNNVKITDSINKGVVRGHYGEVYRNQDSLIMTK
RAVAATLIEKDTLYVHGKKLMVTGKPENRIVRAFNNVRFYKIDMSGKCDSLHSNQKNGLT
QLIGRPVIWNGENQLTGKVIHLISNPETEKLDSLKVLTDAFIASKDTLGTGYNQVKGVNL
YGKFRDNKLYEVDLVKNTEKLYYGYDKGQLVAIDKGISSRIHLELEDNKITTVTSFTNPE
SESYPEKDLPENARKLRGFLWRGDEIIKTKDDIFPPEENEIHEKILKQSKIDKAKEDTPM
EVRKETLDYDKKKPEKKLEKKAKTQ
>LONDMIMF_02689 Adenylosuccinate synthetase
MTVDLLLGLQWGDEGKGKIVDVLTSKYDIIARFQGGPNAGHTLEFDGIKHVLRTIPSGIF
HKNSINIIGNGVVIDPVVFQKELEGLAKFDIDIQSRLIISRKAHLILPTHRLLDAASEAS
KGKAKIGSTLKGIGPTYMDKTGRNGLRVGDIELADFKERYRALADKHEAMIAFYDVDLQY
DLKELEDEFFESIEVLKTLQFIDSEEYINKAMKEGKSILAEGAQGSLLDIDFGTYPFVTS
SNTTAAGACTGLGIAPNRVKEVFGIFKAYTTRVGSGPFPTELFDKDGETMAKVGNEFGSV
TGRARRCGWLDLVALKYAIQVNGVTALYMMKGDVLSGFDTLKICTAYNYKGTEIDHLPYN
IEPENVSPVYVEKKGWKADLTGMTTYNELPSELKEYVEFIENFVEVPIKVISVGPDRKQT
ILK
>LONDMIMF_02690 Ferric uptake regulation protein
MQDMTLISVDNNKNQEIVKNVFTKYLETKGHRKTPERYAILQEIYDNEEHFDIESLYIKM
KNKNYRVSRATLYNTIELLLDCALVRKHQFGQNQAHYEKSYFDKQHDHIIMTDSGEVIEF
CDPRIQSIKKTIEEIFDIEIHNHSLYLYGNKKTTPKE
>LONDMIMF_02691 GTP pyrophosphokinase
MVEIDLEQENKAIAREYKELLRISYQTLSEDDKKLIRKAFDVAVDAHKDQRRKSGEAYIF
HPIAVAKIVASEIGLGATSIAAALMHDVVEDTDITVEDIERMFNPKIAKIVEGLTKIAQV
KTDNEISMQAENFRKMLLTLNDDVRVILIKIADRLHNMQTMESMVDYKQAKIASETLYIY
APLAHRLGLYNIKNQLEDLGLKYTEPEIYNDIVSKIKETKEQQDEYIKSISDVLKESLDA
EGIDYIIKGRPKSIFSIRKKMLAQGVSFDEVYDKFALRIIYKATPSEEKFLAWKIYSIVT
DHYRPSPSRLRDWISSPKSTGYEALHITVMGPKGRWVEIQVRSERMDEIAEKGYAAHYKY
KQGGSEEHGLDTWLNLLKEALENASTNAVDFVEDFKLNLYSKEIYVFTPKGEIKSLPKGA
TSLDFAFSIHSEIGIRTRGTRVNGKLVPLNHVLNSGDQIEVITSPNQKPTSHWLDYVTTS
RAKTKIKNVLNENTKKIAEDGKELLTRKLRHLKVNMTETTVNELVNYFKLKTSLDLFYRV
GIGAIDNQQLKDFAAQKSNTFMNFFKNKIKRTPSSNPETINKPEISNNYDMLVFGKEQDK
LDYKLATCCNPIPGDEVFGFVTINEGIKVHKKDCPNAISLQSNYAYRIIKAKWIDSSQQE
FKAILNITGMDTLGLTNELTKVISNNMHVNIQSISLSGDAGIFNGQVVVIVQNNTILKKL
IENIKKIDGIDKVTRINKN
>LONDMIMF_02692 Putative penicillin-binding protein PbpX
MNFKLGFLATFLISTSVYAQITPTQIDEVVEKTIKTFDVPGIAVAVVKDGKIVHAKGYGV
KSIITKQKVDENTLFGIASNSKAFTSAALAMLVDEGKIKWDDKVVKYLPDFKMYNDYVTN
EFTVRDLLTHRSGLGLGAGDLMIWPDGSDFTAEDIIENIQYLKPVSGFRAKYDYDNLLYI
IAGELVHKVSGQTWNEFVENRIIKPLGMTNTASSWVRLKDTSNVIVPHVPIDGKLKVISR
YKNQLFDAAAGIYSSVNDMSKWAIMQLNKGKYGSGQKIFSEKEHAEMWTPQTLMPNKPVP
PYNSLFKAYGLGWQLNDVKGKMQVSHTGGLEGIVTQVTLIPELQLGIIVFTNQQSGAAFS
AITNTIKDSYLGMEPFDHVKYFSDREKASGEKADKVTDEVWQTVAKNKNQKIDTKKYIGT
YKDNWFGEVVITEKKGKMYFASKRSPQLKGEIFFYKDNNFVVKWDNRYFHADAHIFFEKD
NAGFTMKPISPATDFSYDFQDLNFFRIK
>LONDMIMF_02693 hypothetical protein
MLNPLNYKSLIEEIKHSHEETIEIPINVFGVLLVQDETDSVELGKIQIVKNENLNS
>LONDMIMF_02694 hypothetical protein
MGTFLISKRKNDEFQFVLKAGNGEVILTSEGYSSKAGCTNGIESVRKNSQDDSKFDKKEA
SNGKLYFNLKATNGQIIGSSQMYASASGRDNGIESVKKNAPDADVKEDL
>LONDMIMF_02695 Bacterial leucyl aminopeptidase
MKKMFVSGFMLSLFLVSCSSVKPTKYMEAISASDLKTNLYVIAGDEMEGRNTGEPGQKKA
GKYLISQYEKIGVSYPKGATDFYQKVPAAFMSRAFSPKLNDSENIWAFIEGSEKPDEILV
ISAHYDHVGMKNGQVYNGADDDGSGTVALLEIAKAFMLAKKDGHGPKRSILFLHVTGEEH
GLHGSRYYVEHPLFPLKNTIADLNIDMIGRRDDKHKDNGNYVYLIGSDRLSTDLHKISEN
ANKEYTKLELDYKYNDRNDPERIYYRSDHYNFAKNGIPSLFYFNGVHEDYHKATDTPDKI
EYDLLQKRAQLVFVTAWELANRKERPVIDRDGK
>LONDMIMF_02696 hypothetical protein
MGHQKLRENKTCLNCNYVVENKFCPNCGQENTETRQSFHYLFTHFIEDLTHYDGSFWKTI
KGLLFKPGYLTKTYLEGKRKKFVPPVKLYIFISFVTFFLPTLLPGPSLIKFNEKKDVEKQ
EVKTTKEEVNKESEKGLKEMNDEVEEELSGIDLPNRPRIKNLTQLDSIQKNSQKAEKLSD
FEYSATKKIIKILKSKNRAELWNKAMESFVHTLPKVLFLYMPIFAFFLWLMHDKKKWYYF
DSGVFTLHYFSFLLLVITIGMLFNWIMDLIPYGSIFSNLYNLAAMFYMFFYFFRAHSNFF
GEHKAISRLKGFVLFFINMLLISIFSTILFLYSLWNLH
>LONDMIMF_02697 hypothetical protein
MYSIFEWERLLINNHPFEFLFEVIFRSVIMFIVLLITLRFTGKRGVKQLSIFETVIIIAL
GSAAGDPMFYEDVGLIPAITVFIVIILLYRFVTMLTGKFKWFENLVEGKTECLIENGKFS
IASFEREGLAQDEFFSELRLRSIEHLGQVRNAYLETSGEVSIFFYEDKDVKYGLPILPQL
FEKKSQTIPGAGFYSCTFCGHTKEVEAGKAHCEVCHKTEWVEAINTIRKA
>LONDMIMF_02698 putative N-acetyltransferase
MITITKTTDYNAVRKIAEQTWPKTYGHILSPEQIDYMFAMMYSIDALKEQADSKGHHFIL
AEEDGIPLGFASYEFNYKGEPKTKIHKIYILPETQGKGIGKKLLDYIVEKAKENENTILS
LNVNRYNSAYEFYVKIGFEKKGEEDINIGNGYLMEDYIMEKQL
>LONDMIMF_02699 hypothetical protein
MIEQIHNLPQNMVGFRSSGEVTQDDFKLVNKKVSELVETTGKFNYLLFLDNSPADFTFGA
WIQDALLGIKNITKWNRAAIISDSETVDKFTSFFSKIMPGEFKVFRKDDMARAVDWTSEK
IDIKE
>LONDMIMF_02700 hypothetical protein
MGDYKNLSSEDAVSKLKKLAEDIRVCMFCTDLTHAPFSTRPMSVQEVDESGNIWFLSGAD
SDKNFEIKQDENVQLLFAKNSSSEYLNVYGKAFIYRDKSTIEDKWSPIAKAWFSKGKDDP
NVTVIRVQPDYVYYWDTKSGKMVSLLKIAVGAIIGKPLDDSIEGKLSV
>LONDMIMF_02701 hypothetical protein
MQIKAVISRFLEKISGLPRWVRISFRVLSGVFLLIIILYIGLAFYVNTHKEEILASINQK
INENINGKFTAESMEPTFLQGFPRVSLRIKNAVLKDSLWNSHKNTLLQAEDFDVSINVLA
FLRGTLEIKKVAINEAKIHLFVAEDGYSNTAIFKPKPEKEASGEGSSFAEIKAFELHNVV
FISENLKGKKLFKFSINDLKGRLDYNSEGWKAAVKLDASAQSLAFNTVHGSFIKGKTLNG
KFDIAYNEEAETIVFDPNDLEIGSDVFNIGGKFNVGKNNSGFSLHIRADNILWKNASNLL
SNNISRQLNRFDLEKPIDVNCDIIGDLNAEGDPLFLVKAVVKNNRLHIPDGIIDNCSFNG
MYTNELVKGKGFNDPNSVVKLMGFKGDYKEIPFVMDSAIINDFSKPIASGVFKAKFPLEK
LNNAVDRNLMVFSKGNADVEFQFKADIVDFEITKPFVSGLVTIKNGDMRYVPRNLAFKNT
NVALNFTDKDLFISNIRLQSGKSIVNMEGSIQNFLNLYYTEPEKLVLNWKVTSPQLYLGE
FLGFLDNRKTVKRAPVKTKKGNVNDKLDFLFEKSNVALNVQIDKFYYNKFTATNTKAAIL
LSDSGITIQNAVVHHAGGQVNLSGSVQQGKTKNNFSMKANVSNVAIEKFFYAFNDFDMQS
LKSKNLKGYLTTSATISGTISNEGKLVPNSMNGTVGFALKNGALISFQPIKSAGKFAFPF
RDLDNITFSNLKGNFDISGEKVTIHPMQINSSVLNMDIAGIYSFGKGTNIALDVPLRNPK
NDKDITDKEKLEERRNRGIVLHLLASDGDDGKIKIRLVSKKKRNEEVDLGDKQ
>LONDMIMF_02702 Outer membrane protein assembly factor BamA
MKPTMKTSLKYTLFFTLLFLYGCSNLKYLEEGEALYVGGKVKVEDSLLSRKERKNLEKEL
EPLLRPLPNKKFLGLRPKLYFYNIAGEPKKDKGFRYWLRNKVGEPPVLFSQVDLEYNESI
LQNYAENKGYFKVRTESDSTGTSRNRKVTAEYTVRPGKQYKIKSVTFPSDSSELSKNIAR
LQRRSRLKVGDAYSLDNIKDERERIDTRLKEKGYYYFSPDFILVQVDSTVGKQEVDLIVK
VKNETPERSKKIYKINETYIYPNYSLTADSISEDKSYAEKYKDLTIIDTTKTFNPRIYDR
TLYFKKGDVYNRTDHNLSLNRLVNLGTFKFVKNEFRVSDSIDDALDAYYYLTPLPKKSIR
VEVLGKTNSANYTGTELNVNWLNRNTFKGAELLTITAFGGMEVQVSGQNKGYNVFRFGGE
TSLIWPRFIAPFKFESGSGFVPKTRALIGYEHQERQRLYTLNTFKGSFGYLWKENARKEH
QLNLTEVTYVSSGNVSAEYQAQIDGTEETPGNPSLARVIEKQLIFGPTYSYTYTNTMRRR
RTNTFYYKGSIDLSATATGLIMGGNSDNPKQILGVPFSQFVKLENEFRHYLKLGSDSQLA
SRIIVGVGIPYGNSKELPFIKQFFIGGTNSIRAFRARSIGPGTYNPNVEESSFLPDQSGD
LKLELNTEYRAKLFSIVHGALFVDAGNIWLMNDNENKAGARFSSKFIDELAVGAGAGLRF
DLSFLVLRLDLAFPLRKPYLPEGDRWVIDKVRFGDPDWRKENLVFNLAIGYPF
>LONDMIMF_02703 hypothetical protein
MNKYVKKGLKIIGWTLGGILGLLLLIIILIQIPYFQNLIKDKAVSYLEEKIKTPVEIKRI
EIGFPKKVIVEGIYFESREGDTLLAGEKLKVDISLFKLLRNKVEINSIDLQGITTTIKRD
KDSVFNFDYIIKAFASEEPKKEDSEPMQFSIKKINLDKIRVRFDDQISKNDLTAYLQHFD
TKITKFDLEKMDFEVPKINLDGFKLMLKQGEIVEEVAQNTVEVADEAVRSPELNLKLGEI
NLANINIGFDNAGTRLNTGVNLKKLLVEFNAIDLKKQYIDLKNFEIDGIKGGLTFGKLDK
KIAVKTPDSLKATAPNWKVKLETTSLKNIAFRFDDENAVRAKKGIDYKHLNLDNVKLQGE
KLYYSADTISGNIQSFSMNDHSGVAIESFRTDFFYGTKRATLKKLYLKTPQTEIKDEINI
TYDNIATIADNLGNLGIKASLKDSRVGFKDILLFVPTLENTNPFKTNPNAVMYINSEVYG
KVSDITIPNLEISGIGTTVVAASGRITGLPDVEKTYFDLKIRELKTSSKDINTFVPEGTI
PSNIQLPAQLSLNGFFKGSVSNFNTDMALASSFGKTKIKATFDQRRKNHEKYNADATIDN
FDIGKLLKNDSLGKISLRAKVNGTGLNPKTANATVDGRLVKAEFNRYVYRDLKLKGAIQN
GQFNVKAGMDDANLTFVLDAEGNFKDKYPAVKLKLNTDIADLEKLNLHAGPLKIRGNVYA
DITSSDPAFLNGRIDIHNVLVADAKETYALDSIKIAAISTAESDTITLKSQFIDASLTGK
FQIDQVPTALINSIAKYYDTNPKGKKQATKPQQFDLKVGIKDDPILLKLVPELTSISPIQ
ITGRYNSEGDSITVNGKIPKIIYGANTITNGELDIETADSALVYSLVIDDIKNSQINLPY
TSLSGEVKNNRINYTLLVRDKKDEDHYLIAGNLMSAEGYTQISLEPDGLVLNYEPWDIER
DNIIRFGDKGIYADNFELSNDGSSIKLQSQSEKPNAPVDVTFNDFKIETITSAIQKDTLL
AGGKIDGNVLLKNLTGNATFTADLNIEDFSFKKDTIGNISIKVDNETANTLDAHVAITGD
GNQVNLDGIYKTDNSTFDMTLDIEKLNMKAIQGFTMGNLTESTGFLTGDFKITGSTKQPS
VIGELQFNEVGFKVKQLASKFKSINDKISFTNTGIGFNNFSISDAEDNLLTVNGRVLTTN
YSDFGFDLKIKADNFKALNSKEKDNDLYYGVLVLDTNLSVKGDLNKPVVDGTLKINKDTD
LTIVLPQSDPSLADREGIVEFIDQDEVQIDKRFTAPTEALTQTQFKGMDVSVNIEIVKEA
ELTMIIDKGNGDYLNLKGEAQLTGGIDESGKTTLTGRYEFNEGAYQMNYNLIKRKFDIKE
GSYILWTGEPTSADVNITAVYEIETAPIDLLDNQLGNAAPAVRNTYKQKIPFQTLLKMNG
ELLKPEITFDIVLPDGNYGVATEIISASKTKLAQLRQEPGELNKQVFALLLLGRFIGENP
FASDAGGTSAGAIARQSVSKILSQQLNNLASDLIQGVELDFDLQSREDYTTGSREDRTDL
NVGLSKRLLNDRLKVTVGSSFGIEGPQQSNEETTNIAGDISADYQLTKDGRYMVRAYRKN
QYQVALQGQVVETGVAFIITMDYNKFRELFHRTEEEKRMIRETRKREKELREKQKEKERL
AKEKEENETDNEN
>LONDMIMF_02704 Multifunctional non-homologous end joining protein LigD
MGLEKYNKKRDFSKTREPKGIKKTSKGKLSFVIQKHAASRLHYDFRLEIDGVLVSWAVPK
GPSANPSDKRLAVQTEDHPMDYFDFEGTIPKGEYGGGTVMVWDYGTYRPENPEKTISQDN
KIMKKQLAEGAIKIIIEGKKLSGAWHLVEMKGKDNLWLLMKSKDEFSGTNVKFDENSAIS
GLDFKGIEKNGAVYSSEKGKKLSKTEIEKEEKKDPEKKKPRQTLIRNEADFSAEDLVDAE
KIKSFPKDWRPQLATLAEEPFDNENWLFENKFDGYRALAQIQKNKVNLISRNGISFNTKY
VAVAKTLKNIKDDVILDGEVVVEDTKGKSHFQWLQHFDENPEKGKLKFYVFDLLYFNGYD
LRQLELQLRKKILKAILPKSDTIVFSSHTVGRGKETFEAIQKLGGEGIIAKKITSKYHQN
QRTKDWLKIKTIKQQEMVIGGFTEPQGSRNGLGALLCGYFDGNEFIYSGKVGTGFDDATL
KELRSKLDKMERKTSPFKTAPKFPATHWVTPELVAQLKFTEWTDSGSMRHPVFLGLREDK
KAHEVSREKETPTKEAVKELQSKAAKTNKPEKTKIMDIPESKTEFSNLDKIFWPKEKYTK
GDVIAYYDTVAEYILPYLKDRPESLRRTPNGITKDGFFQKNVEGQVPDWIKTRKLKSKST
DETITYLLCQDKDTLLFLANWGCIEINPWSSRVGTLNNPDYIIFDLDPNEAGMEKIIKTA
LTLKEILDSLQVPAYLKTSGGKGLHVFIPILPKYTYNQTRTFSHIVSQMVLKKLPDIVSL
ERSPSKRKGKVYLDYLQNGKGKTMASIYSLRPRENATVSTPLEWEEIDSKLDFSNFNIKT
VPVRLKEKGDLWKNFFKESIDLKSILDKI
>LONDMIMF_02705 Non-homologous end joining protein Ku
MKAIWKGGISFGLINIPVRLFSGSVTHRIDLDMIRKKDHCAIEFVRVCKKDGKEVPWEDI
AKGYKKENGDYIVLDQSDFAKAMPEKTQTIDVFEFVMEEEIPAQYLEKPYIVEPAKEAKK
TYVLLREALKKSGKVGLAKFVLRNTEHLGILKIEDNAILLIQIRFDQDLRNPSEAKIPDD
VKISKKELDMAINIIDQLTDKFEPEKYKDTYKDELLKIIRKKAKEKGKPAKKETETETKP
KAKKEAADDLLEQLKASLEAIKN
>LONDMIMF_02706 hypothetical protein
MKPVYDSLEEDVYPDQNSPDSNILKAENDKRDIDNPKLNRDNNNPHDKDRDFDDEDEDND
DFLDDGFEDDDDSLTDDEEYDDDPQETKRNQKRTGTDTNP
>LONDMIMF_02707 hypothetical protein
MKNSNSSATPKSRTTTTKTGNKNSQSKTASASRSQTVKPKSNAAEGLRELFIDQLKDIFW
AEKALSKALPKMAKNATAENLKTTIEDHLEVTLEQITRLEQVFESIGKKATAKKCDAMEG
LIKEGESILEETEPGAVRDAGIIAATQKIEHYEIASYGTLCTFAKILGEDEAAKLLEITL
NEEKEADVMLTQDANNTINFDAADDIDENEE
>LONDMIMF_02708 hypothetical protein
MKKVKILAMAILAISFGACSSDDDSSNNNMGSIAGRYNLTEFNTGAATDFNQDGTASTNQ
MDESSCYDARRIDFNSDNTFTYDMDYILIDTSTGVAVCADNTVSGTWTATNSVITATYEQ
ENGTEVTLNFVRSNNGRTLTQTTTLTTYPDRNSEGVAYNRVGSVTTVFTKQ
>LONDMIMF_02709 hypothetical protein
MKAQEVISRLSDLEVNVGNTERLLSVLSGSVLLYDALVKKPKNLPGALLAGFMIFRGTSG
HCFGYALLKDKPKVEKSKNILIKTQIIIDKPVSAVYDFWRNFENLPLFMKHLESVDVLDD
ETSEWRMKIPGNLGTIPWKAAIIKDEKDKEIRWRSFSDALIHNIGSVQFFDNGDGRTRLY
VIIAYYLPFGTIGETIGKVLAPILENTIEEDIKRCKLHFESGLA
>LONDMIMF_02710 hypothetical protein
MDKQKLLIIGMVFPEPNSSAAGRRMLQLIQLFKEAAYDITFASPAQDSEHEFNLGLLAIQ
KAKISLNDESFDTFIQNLKPDIVLFDRFVIEEQFGWRVSKYCPEAIKILDTEDLHFLRLA
RQDTFKKKKEFTIPDLFSDTAKREIASILRCDISLIISDFEMKLLVDEFKIDSSVLFYLP
IFADSDLDFVPLEERKDFVFIGNFLHEPNWDAVQYLKSTIWPLIHKQLPDAKMLIYGAYP
SQKVLELNHPKSNFHIMGRAESAAEVIKKAKIMLAPLRFGAGIKGKLIEAMEYGTPSVTT
SIGAEGMQMDGLWNGFIVDNPADFAHHAIELYKDENLWCNAQKNGVQLLKNKFAENLYKE
SFIAMVLDLKDNLTMHRNKNFIGQILQYHTIRSTEYMSRWIEAKNKKIPS
>LONDMIMF_02711 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MATKITMPRLSDTMTEGTVATWLKKVGDKVNEGDILAEIETDKATMEFESFNSGTLLHIG
IQEGESAPVDSLLAIIGKEGEDISGLLAGGGSSSDKKEEPKAEEKTAEAPKEEAKEAPKS
ETAALPKGVVVVTMPRLSDTMTDGTVATWLKKVGDKVSEGDILAEIETDKATMEFESFNS
GTLLHIGIQEGESAPVDSLLAIIGPEGTDISGVAENFKKGGAVSAPAQEEKAEESKSESA
ESKEETVETVSDGRRIFISPLAKKIAEEKNINISQVKGTGENGRIVKSDIENFKPAAATS
QAPASQETAAKPETTASAPAVKPFVPAGETYSEEIKNSQMRKVIAKRLSESKFTAPHYYL
TIEVAMDGAMASRSTINALPDTKVSFNDMVIKACAMALKKHPKVNSQWKDDVTVIHHHVH
IGVAVAVEDGLVVPVLKFADQLSLSQIGANVKDVAGRAKNKKLQPAEMEGSTFTVSNLGM
FGITEFTSIINQPNSAILSVGAIVEKPVVRNGQIVVGNTMKVTLACDHRTVDGATGAEFL
QTLRQYLENPVTMLA
>LONDMIMF_02712 Acetoin:2,6-dichlorophenolindophenol oxidoreductase subunit alpha
MKEITKEVYLKWYEDMLLWRKFEDKLAALYIQQKVRGFLHLYNGQEAVLAGALHAMDLSK
DKMITAYRNHVQPIGMGVDPKAVMAELLGKVTGTSKGMGGSMHIFSKEKGFYGGHGIVGA
QIPVGAGIAFADKYFNTGGVTLTYFGDGAARQGSLHEAFNMAMLWKLPVVFIVENNGYAM
GTSVERTANHTDIWKLGLGYEMPCGPVDGMNPVKVAEAMHEAIDRARRGDGPTFLEMKTY
RYRGHSMSDAQLYRSKEEVEEYKKIDPITQVLDIIKENNYATEAEIEAIDERVKNLVEEC
AQFAEDSPFPDTQQLYDVVYEQENYPFLPHKL
>LONDMIMF_02713 Cytidine deaminase
MKQINITTTFSVFDNKEELPEDVKNLMEQAIEIRKKAYAPYSRFRVGAAIFLDNGKIVLG
SNQESAAYPSGLCAERVAIFQAGAIYPDAKILRIAISATSDERPVTSPIPPCGACRQSIS
EYEFKQDYPIEIYFMGETGVVYKSDSLKNLLPFMFDKNFL
>LONDMIMF_02714 hypothetical protein
MFNSINTNLRMKKTILFIICILGLNIAKAQETNRVITTGVPFLLIAGDARSAGMGDIGVA
SSPDAYSQQWNPAKYAFSLDKQGFSLSYTPYLPELVNDISLSQLTYFNRISERSAFAGSL
RYFSLGVIEFRNDNPDDPAVEVNPSEFALDLSYALKLSERFSMSVAARYIRSNLRLAQLS
NDASAASSFAVDISGYYQSEEIAYEDFNGRWRGGFNFQNLGPKINYDLDESDEGSNFLPS
NLKLGGGFDFIFDEYNKVSINAEINKLLVPTPQDPDLNGDGEITDVERAQNNQDYRSIGW
VSGIFKSFGDAPGGLKEELKEVTWALGAEYWYQDSFAVRAGYFNESKEKGARKFLSLGAG
FKYNIVKLDVSYLFSTSKVRNPLENTLRFSLSFAFGDKYDEY
>LONDMIMF_02715 hypothetical protein
MKKITLLLLLISSYVSFAQQRDNVTIEWIDNSGIYSEQVQIKAPIFKSSRFQFDYEKKAV
LFNLKIPVSGFADEGSLQITNIVYETISREQLGDLRIASIPSSIEARIKNMNNSASQKAV
LSLSPIIKSGNTFQRVKSFTYSFSTTASRAGNAARNSNFVYNSVLSSGDWYRFYVVKSGV
YKISRSFLQSLGMNVGAADARNIKIYGNGGRMLPLLNGTYYPEDLIENAITLVGESDGSF
DSQDYILFYAEGMDNWNEESQTHNNLYADRSYYYVTSQGGPGKRITNMPVIADNPTLNVS
TFDDYQYHELDKTNIGRLGRKWFGERFNIENEQTFEFKFPNIATGTQIRLRTNAAAAAFS
QTSMSVSANGQDLGAMTFPPTSSDGDVAFERALTGSFPASENVAVKIQYNNGGVPSADAY
LDYIILEAKRNLQGYGKQFRFQYNDADLNTGVIQYQLSSAARITQVWDITDIYNVQKVEN
NGADAFSFKAYMGEDRNYIAVDASDFYSPLKDSRTRVVNQNLKGSILKNAQGSFQDLDYL
IVTPAFLSSQAERLANFHRTNSNLNVKVVNLENIYEEFSSGKQDIGAIRNFVKYIYNNGS
IPSKKLKYLNLFGDASFDFKNRISNNTNIVPVFQALNSFSLGGSIMSDDYFTMLDDNEGT
MLQTGSQDMELAVGRMLVSDLKQAEEMVTKVIEYHAIESYGKWRNNFVLISDDVDVAWEN
SIQTGIDALGDQISAQKPFVNVEKIHTDSYVQEASAGGFRYPKARKDFVDAINQGALVFN
YFGHGGEDGLAKERIFEKADAQNLNNRYKYPLFVTVTCEFTRFDNPYRPTAGEYTYWNPK
GGAISMVTTTRQISVTTGQDINDAFSSELYGYGTTNNVPISEALRVAKNNYNGSALMVSY
VGDPAIRLAIPKPTIVLTKINDQPVAASTFVFNALSPVKLSGEVRNVEGNTILSNYNGSL
SVNIFDKNVQRTTFGNDGVTDSSGNLILMDFILLGETIFRGNASVANGQFEFNFVVPRDI
AIPVGNGRISFYAKRNQGLEDQTGYNTDIKIGGINPNATADNIGPRVRLYMNDETFISGG
ITNESPIFLAFLEDENGINTASGIGHDIVAILDGDENNPYILNDYYETELDNHTKGKVRF
PFRNLAVGLHTITFKAWDVYNNPVTAEIQFIVVGDETVTLKNVLNYPNPFVSYTQFWFTH
NRPYEPLEVQVQIITITGKIVKTINQVVTTEGFLSREITWDGKDDFGDKIGKGVYVYKLT
VKSTLTNKKTEKYEKLVIL
>LONDMIMF_02716 Hercynine oxygenase
MVNYYIAARNLLPTESMKVNKIMALKLMLSLALVMGFTSCSKKSSSKNASSATGWKINDK
KGGFQYNSKFKKQETAPGLVLVEGGTFTMGKVQDDVMHDWNNTPNQQHVQSFYMDETEVT
NLMYMEYLDWLKRVFDPEDENYKNIYEGALPDTLVWRNRLGYNETMTNNYLRHPAYANYP
VVGVNWIQAVEFSKWRTDRVNEGVLEREGYLKRDAKVLDAKGDNTFSTETYLNAPTKTYG
GNEEIVLKGQRGRLAAKEDAKNVYAQRTSGIILPEYRLPTEAEWEYAAAADVGNREYNLY
RGQKKYPWKGNYTRSGKRQVRGDQLANFKQGKGDYGGIAGWSDDGADITNVVKYYPPNDF
GLYDMAGNVAEWVADVYRPIVDDEANDFNYYRGNIYMKNKIGEDGKAEIVTGDNIAYDTL
ANGKIIARNFPGQIAQVPVDEKETYLRQNFDKSDNRNYRDGDKQSTRYYDFGNSEEGEKI
DDSKRMYDSPKHNVTTDSLGNMVRRYDKSSKRTTLIDDNVRVYKGGSWRDRAYWLDPAQR
RYFPQDMATDYIGFRCAMSRVGPKSDKKKKARN
>LONDMIMF_02717 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase
MEIKEIHDLFLRCTSVSIDTRKIEEGSMFFAIRGEHFDANTFAQEALNKGALYVIIDNKD
YYIDEKTILVANTLETLQEVAKFHREYLGLPILALTGSNGKTTTKELINVVLSKRYHTRA
TVGNLNNHIGVPLTLLSLTSDTEIGIVEMGANHQKEIEFLCNIATPDFGYITNFGKAHLE
GFGGVEGVIKGKSEMYAFLSEHNKYVFVNLDDTIQKEKTAKNLRITFSHADKNASVFINK
IEANPFVAIEFDGIKIKSHLIGLYNANNINAAITIGRYFKISDDEIKEAIESYVPENNRS
QLLLKNSNEIILDAYNANPSSMEVAIKNFLQLDKENKVAVLGDMFELGEESLREHKHIVA
LLKHEKEVQTYFVGKDFYENKNDTENLHFFKTYDEFAQAFKAEKIENKTLLIKGSRGMAL
ERTLELL
>LONDMIMF_02718 Biopolymer transport protein ExbB
MIFSTILLQTDTIAKASTNTVIEGIAKNEEMNLFSFLMKGGAFLIPIVILLFYTIYLIFE
RYLSIKKATKQDSHLIKDIAIQLNSGNINAALSLAERSNTASGNVLREGILTIGRPISEI
ESNMERAANIEIGEMEKRMGHLGLIAGIAPTLGFVGTISGVIKIFYSISQTEDISIGNIS
GGLYEKMISSGAGLVVGIIAYAGYHLFNGMIDNFSLNVQKQILEFVSIIQRPNDGSKTK
>LONDMIMF_02719 hypothetical protein
MALKRNRRFHAEVATSSLSDIMFFLLLFFLIISTLANPNVIKMTLPKTQQNDKTNKQHIT
LSVSEEKQYYVDKQNVPFNELEAALLTKMGDARDQTVIVRIPYNLQVQDLVDLLQIGVKN
NLKFVIATDKK
>LONDMIMF_02720 hypothetical protein
MKIWQSNVKSDDKIIAFYNKTIYKGNPKPDEVEKIVRELTIGKQTSSLFGIPQKLLNEIN
FEVGKNHIEVLFGLDSIEYLKINDVDKKQEIFDFLRAEIPNSRYEVEKYSKFKAGKKPLF
AMAFILILFCWALYLANEIENGNQYEIVGSGRSITTIVLALASIGTVNVILLFGVLFCIA
LLGFIFKTKRPKVVHKIIVEPRL
>LONDMIMF_02721 hypothetical protein
MKKLLLLAMIFIWQNNFAQVLIYTAKKEFIPAEIRLANDEIISGYIKEFNVPNAIEFTDF
SLNFNLESELRLDRTKFNFKKTPDGASEKIELNNIKSITLKGEDTITYEKLKLKTINSKL
EVVDLKREIMAPLIKKGKINVYGLRVYECGHGCSLMWILAYIKKPNDEFAYIPVDYNRLN
LFNLGKIDDKFFKAFEEVGKDCPEFLSYLETRKAEFNDKAYKKELLAARKQFDKDKKEKL
KQADKRERRKMEDQMDTDYYLKFYLDEIDAYSSRCE
>LONDMIMF_02722 hypothetical protein
MKIFNTLFIIIITASVFFSCSRKHSQKTNVPISENIFKQDSLAFELCKMYGFDQGIRTNK
LNFNKRELMPKIDSVNFSNMVDFIIKNGYPTEELVGERNMKHECVEAAVAAILLHNPHRL
VNEKVYFDLFLKEVNKGNIDNAFFASVLDKYYWLNSPNKKQRRVFYGSQFGKPCIQTKEA
TNTARIEIGLKPLNDDEFIDCGQEELNMPKKRY
>LONDMIMF_02723 hypothetical protein
MEFFLLVLAGFIIGTCGTLIGAGGGFILVPLLLLFYPDLPPETVTAISMAVVAANAISGS
AAYAKSGKIDYKAGVIFALFTVPGSILGVFTVQYIPKESFNIIFGVLLLALSGFLFFKKQ
SEKRQVQEDDSQQKGLKHRKLVDKMGTVYQYSYNQRNGIIISIIVGYMSPLLGIGGGIIH
VPAMVNWLHFPVYIATATSHFILAVMSTVTVIVHAMNGTYNNPEVLKMVICLAGGVIPGA
QLGAYFSHRVKGTNIIKVLAICLALVGIRILLKN
>LONDMIMF_02724 hypothetical protein
MTKLNSLLITVISIIIVLIHIYIGHYYAPHGIDLLPITMILVTIMTFQFTNLKIYFKLLI
TAVLFLMLDVGIKLYAGGTHDLEGLEWMYAFYFIGLILCLPIILYKIFKNAGINTTAKIL
LVILFIAFLYFQKNIFGNLGLGRDFPIN
>LONDMIMF_02725 Protease HtpX
MKKEVQLSKEFKNQAAKSIFAICFFVLTYLIILLLALVLTGLSVAGGFSLIALKPNFLTI
ALGIGLASLGILIVAFLLKFIFKSHKADRSHLIEIKESQEPELFQMIRDLVLEVGTTFPK
KVYLSSEVNAAVFYDSSFWSMFLPIKKNLQIGLGLVNTVTKEELRAILAHEFGHFSQRTM
KVGSYVYNVNQVIFNMLYDNESYDNLIQKWASISGYFSIFVILAVKINQGIQWILRKLYG
VVNKSYMALSREMEFHADEIAASVTGYEPLKKSLLRMPLADNSFSNVLSYYNTKVSENIM
SENIYNDQSSVIHFLAETNNLPFTNGLPDIAIEEQSKFDKSKLGIKDQWASHPSTNDRIE
RLEKTGFLSPGHADMPANELFKDITALQKQLTNKLFENVSYPEDTMVMSSDQFIEEYKQQ
VQLNSFAKIYNGYYDNKNPIFDLNGNPAESKIDFNELYSDEKVDLVYSSIALQNDMETLK
NIANKSFPIKSFDYDGFRYERKDADSLIEKLKSELDIINARIEKNDSDIYHHFTEIETRL
NKPQLLKSIYNDFFTFDKIFDTKYDLYIKLLNGLQFVNVSTPFDQIASNLNCINPIEREL
KQEIHLLMSDPVLATEITQDIRHSLEEYTSKEWEYFNGANYLDGNLNILYTAMHNYAFLL
SRKYFLMKKALLTYQEELMKNHTTPVVTENFA
>LONDMIMF_02726 hypothetical protein
MRTTLLTLFLCVTCLTAKGQTAKELIGKWQLVRYTHNGQEKDIKDFFKTDQVYQVFYENG
KFESLIGDEVHKGKWKMSKDNQYLTLTSTLIPIKLHIDLFKDGKRITSYESIWTFEHKKI
ND
>LONDMIMF_02727 hypothetical protein
MTEKLNIDLSQTPEKFQDLGHEILDFLIGKLLLIDALEQEIYDRYQVLEEKRASPNQTHP
DEEDLWDEYAQRCKEIIAPISIKTYNDSRSFGKPTAYEYLSYSDTKISLIMKSENRAVVE
TYFEHGIAKKEQFVLKKDNNSWKIDTKKYGFPDEDKWWKDEI
>LONDMIMF_02728 hypothetical protein
MFDLEGRGKEIKLAKKGTSMILAGTVLIFIIDYSLWNLDFIADSLSDTSFETMTLLGSKF
IGKTVGLLSIGLFYLLIFGMMNRKNFFEQTLQEYEAMSLVEKEEVAQKGKYLIVIPFALA
LLLLFYIMLFRLD
>LONDMIMF_02729 hypothetical protein
MALPIINSVATWILKKRIHQIELFLKYPNEVQEELLLNLIRTAEQTVIGKQYDFSSVKSY
QEFTERVPVSTYEDLEPLIERTLKGEQNVFWSTPIKWFAKSSGTTNAKSKFIPVSTEALE
NCHYKAGKDLLSLYLNNNEESQLFTGKSLRLGGSKQLYEDNNTFFGDLSAILIDNMPIWA
EFSSTPSNKVSLMSEWETKIPAIINETIHENVTSFAGVPSWMLVLMNKTLEATGKSNLLE
IWPNLEVYFHGGVSFEPYREQYKKILPRSEFQYYEIYNASEGFFAIQDLNNSSDLLLMLD
YGIFYEFIPMDTFGTPEQKTIRLSEVELGKNYAIVITTNAGLWRYMVGDTVRFTSLNPYR
IRVSGRTKHHINVFGEELIVENTDKAIAKACKLTNTEVIDYTVAPVFMEGKEKGAHEWMI
EFKNAPENISDFRQILDDTLQSLNSDYEAKRHNNMTLNPLIINIARTNLFYDWLKEQDKL
GGQHKIPRLSNQRNYLEELKSMQHPVNT
>LONDMIMF_02730 ATP-dependent Clp protease ATP-binding subunit ClpX
MAKEVLECSFCGRKKPETNLLIAGIDAHICDRCIEQAHGIVIEELKQNKRNGAMASDLIL
QKPKEIRAFLDKYVIGQDQTKKVMSVAVYNHYKRLMQQQSDDEVEIEKSNIIMVGQTGTG
KTLVAKTIAKMLDVPLAIVDATVLTEAGYVGEDVESILTRLLQAADYDVAKAERGIVFID
EIDKIARKSDNPSITRDVSGEGVQQALLKLLEGTVVNVPPKGGRKHPDQKFVEVNTQNIL
FIAGGAFDGIERIISKRLNRQAVGYSSSKNTDNIDKDNLLQYVIPKDIKDFGLIPEIIGR
LPVLTHMDPLDRETLRAILTEPKNALIKQYQKLFAMDDVELSVSGEALDYVVDKALEYKL
GARGLRSLCEAILTDAMYDLPSSDDKTLVIDKSYAENALDKNLLQRLKAAS
>LONDMIMF_02731 ATP-dependent Clp protease proteolytic subunit
MDYGKEFKKFAIKHQGVNSMYYDKIVNSMTPYIIEERQLNVSQLDVFSRLMMDRIIFLGT
GVDDHVANIIQAQLLFLESVDSSKDVQIYINSPGGSVYAGLGIYDTMQYIKPDVATICTG
MAASMGAVLLCAGAAGKRSALPHSRVMIHQPSGGAQGVATDMEINLREMLKLKDELYEII
SKHSGQPFDRVHKDSERDYWMKADEAKEYGMIDEVLRRS
>LONDMIMF_02732 Trigger factor
MNITRNNVDALNAVVTVEVSKADYAPQVDKVLKNYSKNASVPGFRKGAVPMSLIQKQYGK
AVLLEEVNKVLQENLNNYLASEKLDILGNPLPKINEDFNWDADDYSFEFELGLAPEFTVD
LEAKNKITYYKITADDKMLDDQVKRIQKQYGKLISKDTVEEGFDVTGTFTNEENGINNTV
TISLDIFKDKKTAKKFIGKKVGDVVTLKTKGLFDDDHKLMDYLKVSHDNVHGLDIEVDFK
IEEINATELAELNQELFDKLFGEGNVTSVEQVKEKIKEDAEKQFASQADQKFINDVTTSL
LENTKFDLPAAFLKKWIQTVGETPLTAEQAEEEYARSENGLRYQLIEGKVMAQNNLQITF
DDLKAYTADVIKKQMAQFGQMNPTDEDVDGIVARVLSNQEEVKRLSEQVMNEKMLNLFKE
KVKAKTKEVSYEQFIKEMYGE
>LONDMIMF_02733 hypothetical protein
MNLIIRILITAVLVMIIAHFMPGVALKGTHGISSENFVTAIIVAVVLGLLNLFVKPLLVL
LTLPVTVITFGLFLLVINALIIMLCANLVDGFAVSSFWTALLFSLILSILQSVVFSLTGG
DN
>LONDMIMF_02734 Esterase YbfF
MLYSRIEGEGRPLLILHGFLGMSDNWKTFAGQIAAEGFQLHILDLRNHGRSFHSDVFTYE
AMVQDVFEYCEGHGLDKVSILGHSMGGKVAMFFATTYPEKVEKLIVADIGPKYYRPHHQD
IMAGLNAVDLSQKPDRAQVEEILKEYVSDFGTRQFLMKSLYWIEPGQLAFRFNLPVFNEY
IDNIGKALPDNAVFEKPTLFLRGGNSNYIKDEDFEMIRHHFPNSEIKTIPNAGHWLHAEN
PKDFYSESIQYLLK
>LONDMIMF_02735 Pyridoxine 5'-phosphate synthase
MTKLSVNINKIATLRNARGGNVPDLLQVAKDIQRFGGQGITIHPRPDERHIRYQDARDLK
PIVYTEYNIEGNPEQKFIDLVLEVKPTQVTLVPDAVDAITSNAGWDTVKHQDYLKEIIQE
FQRNGIRTSIFVDPVLEMIEGAKKTGTERIELYTEAFAHQYGLGNKEGILPYIEAAKLAN
ELDLGINAGHDLSLDNIQFFKQNIPNLLEVSIGHALISESIYLGLENVVNMYLQKLK
>LONDMIMF_02736 hypothetical protein
MTEITDYINNDIKAITVDDTIESVQDFFADLSFSHFPVLENGIYIGSISGDDVETFDAEK
KILDYRYTLEGFYARKNMIWLDLLEIFARNHTSIVPVLDEKNNYIGYYDITDIIKFFHET
PFLKEMGGIIIVEKNINDYSMSQISQIVESNNGKLLGMFVSSAEADKIQITVKIALGSLN
DIIQTFRRYNYEIISEHQEDNYLNALKERSDYLDKYLNI
>LONDMIMF_02737 NAD kinase
MKVAIYGQYYQNSTEPIIRDIFVFFNKNNVDLVIQDDFLAILHQKEIIKKEYNTFHDYND
LDRNIDILVSIGGDGTILRAATLVRDSGIPILGINAGRLGFLATVQKENIDELMQYIIDK
NYSLSPRTLLSLESTESIPEIERLNFAMNEISINRKDTTSMITVETYLNGEYLNAYWADG
LIISTPTGSTGYSLSCGGPILMPAVESFVITPIAPHNLNARPFVIPDNVEIKLKVSGREE
HYLVSLDSRVASMSNNAVLTIKKTPFQINMVELPEKSFLKTLRTKLLWGEDKRN
>LONDMIMF_02738 hypothetical protein
MFCIFSYAASNAQIHEIGIFAGGNNYIGDVGPTNYVKPNEFAFGLLYKWNKSPRHSWRIS
YMQGKVTSNDHDSDMPARKQRGLNFENSVKELSLGLEFNFFDFNLHESGFLLTPYVYSGI
SYFRYTELYHVNNQYEEDEDKNTFAIPMTVGIKTRIAEKLILGFEVGARYTFTDNLDGSN
PKNDSFKTLRFGNLNSNDWYVFTGFTLTYTFGNKPCYCAE
>LONDMIMF_02739 Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)
MDLLNTINKDNLPKHLAIIMDGNGRWAKQKGMLRAFGHENGTKAVRTTVETCAKLGIENL
TLYAFSTENWNRPKLEVDTLMKLLINSLKNELKTLTENNIKLNTIGNFEKLPASAQKELS
QVISKTKDNTRMTLTLALSYGSREEIVSAVKSISSIVKNNIISIDAIDESIINQHLYTQN
LPDVDLLIRTSGEHRISNFLLWQIAYAELYFTDVLWPDFREKDLYEAIISYQKRERRFGK
TSEQIK
>LONDMIMF_02740 Outer membrane protein assembly factor BamA
MLNKSIKLFLTVLVLGNIFQAKAQERVPFDQGREYILAGVSVIGKISYNEQTVVTFAGLE
KGQRITVPGEEISSAIKKLWKLGLFNEIDTYINRIDGDSIFIDMHISELPKLSEVKINGV
KKSKVDGLIKDNSLTKGKIVNENLITTTKNYIENKYKKDGFYNTKVVINTYPDTTSGNEV
KMLINIDKGKKVKVSSIVVDGNDKLSDGRIRKAMKNTKTRFPLRFWKGSKYIKEKYNEDL
ENIVSVYKEKGYRDARVVSDSISYNKDKNTVDIKLKVEEGNKYYFGNIKFLGNSVYSDQG
LTKMLGIKKGDVYNGVLLQKRIEDKTKPDANDIKNLYQNSGYLFSTVNAVEVKTANDTID
FEIRIMEGPMAYFNKITVVGNDKTNDKVIYRELRTLPGQKYSKELLMRTLRELGQLGFFD
PQALEPKFKNVDPAAGTVDIEYNVVEKGSSQIELQGGYGGGGFIGTLGLSFNNFSIRNIF
KKDAYTPLPMGDGQKLALRLQGSSYFQTYSLSFTEPWLGGKKPVQFSGSISHSKQFLYTG
RTSDVDRDKSFNITSISLGIAKKLNVPDDYFILSQGISFQYYDLNNYNTGLFTFGNGNSR
NLAYTIGLRRDSRGIDPIFPTFGSEFSISAKFTLPYSLFNGVDYANLKNDPNYQTTDSQG
NVVADQSKIDQKKFNWLEYYKIKFKADWYTKIYGKFVLRSLGEFGFLGAYNNDRGLVPFE
RFFLGGDGLANYSLDGREVIQLRGYPNQSLTPLDNKGNQNGATIYNKFSLELRYPITLKG
AASIYALTFLEAGAAYDNFRDYNPFVLQRSAGFGLRVFMPAFGLLGIDFGHGFDPVPGST
QKNGWETHFIIGQQF
>LONDMIMF_02741 hypothetical protein
MRKHFFILLLAATFSTAINAQTRGIRIGYIDMEYILEKVPDYAEAKNQLELKAQKWKQEA
EVKRNEINKLKENLKTERVLLTKELIEEREEEISFLENELLEFQQKRFGSTGDLITQKAV
LVKPIQDQVFTIVQDIAEAKKYDFIFDKSSDLTMLFGAQRHNISDQVVRQLTRAEKREQL
SKKQLKDEAEKERKQDMIDANPELAERQKVLEDKKAAREKMIEDRKLAAEEKRKAFEEKR
AQLLAEREEKRNAAKTKTEDTKKEEKPAAEKKTTSTENVTEEGKGKTEEKAGQTAEERKA
AMEQAKKEAAEERQRKLDERKKALEEKRKKLIEEREAAKREKEEKKNSEENNKGN
>LONDMIMF_02742 hypothetical protein
MKQLKTLLIAAALFIGASQTMNAQAKTAHVDVSEIMAKMPAMIEGQKQLEKLNQTYNADY
KTMVDEYQAKLKKYDAESSTVAEKVNQDRAVEIQDMQKRIRDYGENAQKELQQKEQDLFK
PIQEKIKAAIQKVGKAKGYQYVLDSAMVLLADGPNITADVKKELGF
>LONDMIMF_02743 Glutamate racemase
MINSNPIGLFDSGIGGTSIWKEIHQLMPNENTIYLADSKNAPYGQKTKDEIIALSIKNTE
YLLNQNAKIIVVACNTATTNAIKELRAKYDVPFIGIEPAIKPAANNSRTQTIGILATKGT
LNSELFNKTAEQFQDTNIIEQVGYNLVKLIEDGEMHSDEMTSLLKTYLTPMIEANIDYLV
LGCSHYPYLIPQIKEILPQHIKIIDSGEAVARQTYKVLEEKIGLNTAVGEHSTLFYTNSD
PKVLKSILENKYPVIQKDF
>LONDMIMF_02744 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase
MLYRDSFLYAMLIKTVNGKSPSIPEDCYVAENATIIGDVTFGAYCSVWFNAVVRGDVHYI
KIGNKVNIQDGAVIHCTYQKHPTEIGNNVSIGHNAIVHGCKVHDNVLIGMGAIVMDNCII
ESNSIIAAGAVVTQNTVVESGTIYAGVPARKVKDINKSDFAGEIERISNNYVMYSGWLKD
E
>LONDMIMF_02745 hypothetical protein
MNFKKRYLALLLLLSQISFSQEGIAVYSDYLSDNYYLIHPSMAGAANCAKLRLTARQQWF
GQDDAPALQTLSFNGRIGEQSGVGIILFNDRNGYHSQVGGKITYAHHIMFSRGDYDLNQL
SFGMSAGLVQSKLDESEFEGFDPIVVGGVYQKDSYFNVDFGASYNYLDFYAHFTVKNAVA
NIRREIYTDYESDNLRKYLFSAGYVFGDPDRLQWEPSFLFQYVDETKEKSIDVNLKVYKD
LDFGKLWGGLSYRRSFDGAQYLDGNSVSDQKLQYITPIVGLNYKNFMVAYTYSHLTGDVK
FDNGGFHQITLGLNLFCKREKWDCNCPAVN
>LONDMIMF_02746 Fe/S biogenesis protein NfuA
MINVTIKETQNPTILKFELPDFITQNENFEFKNIDEAKDSPLAQQLFYLPFVKAVYISGN
FIAIQRYNIVEWDDVKEAVAEQIENFVNKGGQILNVTEKKATKQPLTVYAESTPNPAVQK
FVGSRIMTKTAMEFKNIDEAAASPLALELFKFPYVKEVFIDENYISVTKYAVKEWQDITY
ELRSFIKEFIENGGIVIDESIAALNPKVEKQKIENFDNLDTTSQQIINILEEYVKPAVAA
DGGNILFDSYDENDKRVKVVLQGACSGCPSSTFTLKSGIENMLKDMLNDQDIKVEALNG
>LONDMIMF_02747 Dodecin
MSVLKVIEILSSSDTSWEDATRKAVSKASKTLKNIKSVYVQDQSATVENGSVKEFRVTLK
LTFELE
>LONDMIMF_02748 hypothetical protein
MNELQFETSPYLLQHANNPVHWKAWNPKSLELAKETNKLIIVSVGYSACHWCHVMEHETF
EDTAAAAVMNKSFINIKVDREERPDIDAVYMKAVQIMTGRGGWPMNVVCLPDGRPVWGGT
YFRKEEWMDTLEQLQQLYLSAPEKMLDYAEKLHQGINAISLVQQPDNNANFDADNLKALV
EKWKKSFDWEFGGYSRAPKFMMPGNYSFLLRYAYQEKDSELSEFVNLTLTRMAYGGLFDT
VDGGFSRYSVDMKWHVPHFEKMLYDNGQLVSLYSEAYRLTHNPVYKETIEKTLSFISKEF
TAPNGGFYSALDADSLTAQGHLEEGAFYVWTKEELKTIIGEDFELFAFIFNINDFGYWEN
GNYVLIQSESLETIAQRFNLEVNELQNKKENWEKLLYASREKRKKPRLDDKCLTSWNALM
LKGFVDAYKAIGTVEYLNIALKNADFIIGNFWTPEGNLLHNHKNGKNTINGYLEDYCFVI
EAFISLYETTLDEKWLHNSKQLTDYCFDHFYEPASGFFTFTSDIDTALITKHYELEDNVI
VASNSAMANNLYKLGIYFENSYYEVVAQKMLNHILPNIDYPSAFSNWLHAFLNFSYSNKE
LAVCGENALENIHLLQKEYLPDVVLAGTYKPSELPFLKARFEKGKDLFYLCQNKTCEQPL
EDIISILNAIKS
>LONDMIMF_02749 hypothetical protein
MTYTVTGFENGDDQSVITGALTRIAGENIGTYAIEQGTLATTANYDIAYTGADFNITKTT
LNIVADAKSKAYGSADPALTYTVTGFANGDDHTVITGALTRTAGENIGTYAINQGTLAVS
GNYDIAYTGADFNITKATLNIVADAKSKAYGTADPALTYTVTGLTNGDTGNIITGSLSRI
SGEATGTYPITQGTLSAGNNYDIAFTGADFTIIETLAITDSSQTNVTCYGGADGSATVSI
SGGTAPYTYSWSPIGGMAPTAAGLAAGTYTVTVTDANGSVITKVFTITQPQEVVPPVAEE
IQEFCSTANPTISNLEIQGTQVRWYASANATQELPANTPLVDGTTYYASQTVNGCESPER
TLVIVILNDRLPTPQGAPLQEFEEGATIADLVVTPANVIWYASYNDAVNNTNPLPPTTPL
VDGTTYYAVAVADGYCPSLPLAVAANAALGVGKPQKLTFKYYPNPVEDYLNIKCSETINS
IEVYNLMGQMVRKHDDHSAEVRLFLGDLPDGTYAVSVMSNGKKSTVKVVKK
>LONDMIMF_02750 hypothetical protein
MEKKELTIKVAIQILKPVSEVFEAIVDPEKMANYFIAKGSGRMEEGKEIEWKFPEFDMQF
PITVGKIEKDKYVSYYWDVNEKKNLVEITLAPFGKGTVVTVTEKGMENNEEGISWLMGNT
EGWANFLACLKAYLEYGINLRKGAFEFRRED
>LONDMIMF_02751 Uridine kinase
MLIIGIAGGTGSGKTTVVQQIMNELPQTEVGIISQDSYYRENHNLSFDERALINFDHPRA
IDFELLVAHLKDLKAGKNVEQPVYSFVTHNRTEDTINTHPRKVMIVEGILILANPELRDM
FDIKIFVHADPDERLIRRLKRDIAERGRDMEEVLNRYQTTLKPMHEQFIEPTKAFADIII
PNDKYNTVAIDVVRAVINQRIL
>LONDMIMF_02752 hypothetical protein
MKNPFKNIISRYPFLRFLGNRYVLVLALFIAWMVFLDNYSLLDHRILNKEIKELEDNKKY
YQDEIKLDEEKIKLLKNPDQIEKYAREKYYMKRDSEDIYIIEFEEDLPEEEQSKSL
>LONDMIMF_02753 Methylmalonyl-CoA mutase
MADHLFDDFNPVTSKQWKQQIQYELKGADYNETLIWESPEGIKVKPFYHIDEFENPLSFS
EKETAFKIVQNIFVHDLDKSVNRALETLSRGAESIRFTIEDENLDIAKLLEKLPLETITV
YFHLSFLSIDFVKKIDTIAKNRNANFFIQIDPIGKLAKEGNWHTNLDSDFNLLNTISISC
QNANFLSIDGSLYQNAGANIVQQLAYMLAHANEYFNRMATVSKPITFQVAVGTNYFFEIA
KLRALRLLFDLLAKEYDHNSGCHILAVPTKRNKTLYDYNVNMLRTTTECMSAILGGADAV
SNLAYDSLYHKDNEFGDRISRNQLLVLKHESYFDKVNNPADGSYYIETLTEQLAEKALAL
FKDIEANGGLITQLIEGTIQRKIQESAAKEQDLFDSGKEILLGTNKYPNKNDRMSHDLEL
FPFVKSKPRKTLVTPIIEKRLAEKMEQERLESEKENG
>LONDMIMF_02754 hypothetical protein
MKNFKNLLICIFFIGNLTYAQKSFKNTFSRNLMQIELANLKLYLNKYTETNLDSVSMLSI
HYIQPRKYCHYSKYVGNPKKVEEWFDNFYKEGNVVFPENSKIINSFYEEKGKEKYTPEYN
YYYDENHFLHNLINKINKMESCECFITLNSKGKLMIKYGEVSTDEIKHFIKETAILDKP
>LONDMIMF_02755 Methylmalonyl-CoA mutase large subunit
MKRKDIQHIKLDSQADGKKAKSENVENFLTAEGIELKNTYSEEDIQNLEHLNFGAGFAPN
LRGPYATMYVRRPWTIRQYAGFSTAEESNAFYRRNLAAGQKGLSIAFDLPTHRGYDSDHE
RVVGDVGKAGVAIDSVEDMKVLFDQIPLDEMSVSMTMNGAVLPIMAFYIVAAEEQGVKPE
LLSGTIQNDILKEFMVRNTYIYPPTPSMKIIADIFDFTSKKMPKFNSISISGYHMQEAGA
TADIELAYTLADGLEYIRTGLAAGMKIDEFAPRLSFFWAIGMNHFMEIAKMRAGRMLWAK
LLKQFNPQDEKSLALRTHCQTSGWSLTEQDPFNNVARTCIEAAAAAFGGTQSLHTNALDE
AIALPTDFSARIARNTQIFLQEETKITKTVDPWAGSYYVEKLTDEIVHKAWQLIQEVEEL
GGMTKAIEAGIPKLRIEEAAARKQARIDSSQDIIVGVNKYRLEKEDPLHILDVDNQMVRR
QQIERLEKIKSTRNTEKVKETLHKLTEAAKSGKGNLLEIAVDAARNRATLGEISDALETV
FGRYKAQIKSFSGVYSKEIKNDESFEKAKQKADEFAKSEGRRPRIMIAKMGQDGHDRGAK
VVATGYADVGFDVDIGPLFQTPAEAAKQAVENDVHILGVSSLAAGHKTLVPQVIEELKKY
GREDIMVIVGGVIPAQDYQYLFDSGAVAVFGPGTKISEAAITILDILMQE
>LONDMIMF_02756 hypothetical protein
MLVSCFKANSQTVNPNYDSKLAESLGADDYGMKMYVLAILKTGSNKIDDKEKLNELFKGH
MDNINRLAKDGKLIVAGPLKKNDKNYRGIFILNAKTIEEANELLLTDPAIKEKLFEVEVF
EWYGSAALPEYLKIHDKIEKTKH
>LONDMIMF_02757 putative 2,4-dienoyl-CoA reductase
MDFTKKMLRDNALEGKTIVVTGGGSGLGKAMTKYFLELGAKVAITSRDLEKLRTTADELE
KETGGECLPLACDVRNYEQVETMLASVLEKFGKVDVLLNNAAGNFISPTERLSANAFDTI
IDIVLKGSKNCTLAFGKHWIDTKQQNTTILNIVTTYAWTGSAYVVPSATAKAGVLAMTRS
LAVEWAKYGIRSNAIAPGPFPTKGAWDRLLPGDLKDKFDLAKKVPLKRVGDHQELANLAA
YLVSDFSAYVNGEVITIDGGEWLKGAGQFNLLEAVPDEMWDMLEAMIKAKKNN
>LONDMIMF_02758 Sporulation initiation inhibitor protein Soj
MGKIIAIANQKGGVGKTTTSVNLAASLGVLEKKVLLIDADPQANASSGLGIDVESVEIGT
YQILEHSNTPEEATIECSSPNVSVIPAHIDLVAIEIELVDKENREYMLKTALESVKDKYD
YILIDCAPSLGLLTLNALTAADSVVIPIQCEYFALEGLGKLLNTIKSVQKIHNPDLDIEG
LLLTMYDSRLRLSNQVVEEVQKHFHDMVFETVIQRNVKLSEAPSFGESIINYDATSKGAT
NYINLAEEIIKKNTK
>LONDMIMF_02759 putative chromosome-partitioning protein ParB
MTKAIKKQALGRGLSALLKDPENDIKSAEDKNADKVVGNIIELEIDAIEINPFQPRTNFN
EESLQELATSIRELGVIQPITVRKLDFNKFQLISGERRLRASKLAGLTVVPAYIRLANDN
ESLVMALVENIQRHDLDPIEIALSYQRLIDEIQLTQEQMSDRVGKKRSTIANYLRLLKLD
PIIQTGIRDGFISMGHGRAIINIEDHDIQADIYQKIVSQNLSVRETEALVKNYQDSLKPA
PPKAAKGNAFTIDESEKKAIGNYFGTKVDVKVAGNGKGKITIPFHSEEDFNRIIKLIKG
>LONDMIMF_02760 hypothetical protein
MNKLVSIFFLFFLIGTTSVSAQEELNIVVRDSIKGEEINPLAPSKAAFYSAILPGMGQAY
NKKYWKIPIVYAALGTGIGIYAYNNKNYHKYRDEYKRRLNGTEDPNGKLSNLTDNQLISA
QRQFQKNRDLSLIVTVGIYILNIVEANVDAHLLQFNVSDKLTLKPDIYQNDLNYKKNVGL
TLNYNF
>LONDMIMF_02761 4-hydroxy-tetrahydrodipicolinate reductase
MKIALLGYGKMGKVIEKIALERGHEIVLRKSAEDTFEGLEQADVAIDFSIPDAAVSNIST
CLDNNIPIISGTTGWLDSYDKMVALCQEKNGAFIYGSNFSLGVNIFFQLNDYLAKMMSNI
REYKVSMEEIHHTQKLDAPSGTAITLAKGIIENSDYSSWALENAKEDEILIDAKRIENVP
GTHSVFYNSAVDTIEIKHIAHSREGFALGAVVAAEWILGKKGVYTMKDVLNLT
>LONDMIMF_02762 Signal peptidase I
MTINQWFLFFLILQVVHFLGTWKLYKKAGRQAWEAAIPIYNAIILMKIINRPKWWVILLF
IPIVNLIMFPVVWVETLRSFGKNTTLDTALGVLTLGLYIYYINYTQDVKYIENRSLHPKD
KTADTVSSLLFAVVVATIVHTYVMQPFTIPTGSLEKTLLVGDFLFVSKNHYGARTPMTTV
AMPMVHDTIPGLKTKSYLNRPQLPYFRFPGFEPIEKNDIVVFNWPIDTIPHATEANFKPI
DKKTNYVKRCVATPGDNLSFIDGDAYINGKKLILSDRARVQYSYRVTTVNGSMLDPNYLT
KELRIYPDDIGFNQNDNSYFFISLTDENAAILKKNPTVESVTKLIAKAEEHPDPRIFPYT
KKWNQDNFGPIYIPQAGKTVKLDKESLPFYRTIIKEYEKNDLKVEGDKIIINGQVADSYT
FKQDYYYMVGDNRHNSLDSRYWGFVPADHIVGKPVFIWMSLDPYTPWSKAIDKIRWERLF
TTVGGSGEPVSYFSIFVLLMAGYFIANFFIRRKKKKLDRY
>LONDMIMF_02763 hypothetical protein
MNILLLPTYFPSISQFAAMVQADSITFEMEDNFQKQTNRNRMYIYSPNGIQMLNIPVKHS
KGDRHQKTKDVRIEDAFDWQKQHFKSLEAAYRTSPFFEYFEDDLAPVFQKKHDFLMDLNF
EAMEIVSDCLGFEFSYKKTEEYFHEAPQFTDFRPLANGKKDTLEFEPYTQVFGEKHGYLN
NLSILDLLFNEGRHALDYLKNQSL
>LONDMIMF_02764 hypothetical protein
MKNLSWFNKAMFFFNIVLTVLTFVAYILPFLAPKLFPILSVLTLILPFMLILNLLFFIYW
GIQMKRQILLSSVVLLMGITFINKFYKFSTTDLPPSDNDFTVMSYNVRLFNLYKWIERDD
VPELIANFINDKNPDILCIQEYSEGKINLRAYKHKYILMKGNKTKTGHAIFSKFPIVGRG
DIVFPNSNNNAIYADIKKGKDTIRVYNMHLQSIRITPDVHEINEDINGINEQKSKKIIKR
MSEAFKEQQEQAEIIMNHKKNSKLPEIICGDMNNSAFSFVYRSIRGNLNDAFEEAGSGFG
KSYNFKYYPARIDYIFVDKKMQVKNFENYPDFINSDHFPVMARLAFEN
>LONDMIMF_02765 hypothetical protein
MGIIDDLKMQYKTGGITLQLIFWNIGIAIPLFLLHAFSNDGFLSLMSWIQLTSDPSEFIV
KPWTLLTYSFLHVDVLHLLFNMIMLNFSGRLFLTFFTQKQFLGLYLLGAAFAGLVFLGTF
FLFGYKAPIIGASGAIMAVLIGSATYAPLYQIRLLLIGTVKLWHIAIVFLILDLIQIPTN
NMGGHIAHLGGAVFGFIYIKLLQNGTDLSLIVTRILDFFANLFKPKKGTPFKKVHRNVSQ
PKPKTAPASRIVVKDKTQQQIDEILDKISQSGYDSLTKEEKEFLFKAGK
>LONDMIMF_02766 Rhomboid protease AarA
MMNITPTVKQLLIINIIFFIGTQLIKNEVAYHYLSLYFFENPQFYAWQPLTHMFMHGGFM
HIFFNMFALYSFGSALEHFWGGKKFLFFYISCGLGAALLHTGVNYYFFHTGLTELVNAGF
SRDSILELLNKDMINQQWGQVLGQSGLENFARSYVTPAVGASGAIYGLLVAFAFMFPNAE
LMMLFLPIPIKAKYFVPVILLMDLFSGVTGISIFGGGNIAHFAHIGGAVVGFFMMWYWKK
NQFHNNRWN
>LONDMIMF_02767 DNA mismatch repair protein MutL
MSSIIQLLPDHVANQIAAGEVVQRPASVVKELLENAVDAKANDIKLIIKDAGKSLVQVID
NGVGMSVTDARLCFERHATSKIRAAEDLFSLHTKGFRGEALASIAAIAHVEMKTKQEQDE
LGTHLAIEGGKFVSQDVAVLPKGTSFAVKNLFFNIPARRNFLKSDTVEHRHIVDEFQRVA
LAHPNIHFTMYHNGSEMFNLPASNLRQRIVNIFSGKTNEKLVPIQESTEIVGIQGFVSKP
EFAKKNRGEQFFFVNDRFIKSGYLHHAIMAAYEGLLKDGCQPSYFIYLDVPPNTIDINIH
PTKTEIKFDDEHALYAILRSAIKHSLGQFNVAPVLDFDRDSNLDTPYEYEKKEASMPLIQ
VDANFNPFGDLDPIPAKSYSSGSNSSSYSGSGGSYRKPESSNWESLYVGLKQDTETITDI
QDIQFESEEVTGSLFNDKEIEEAIYKTYQIHKKYIVSPIKSGMVIIDQQRAHQRVLYEQF
LANMTVHQASSQQLLFPLNLYFSSQEILLISELELSLVNTGFVFEEIKEDSVVISGIPVN
VTESEVSILLEQLLSDLQDEIPESSFSQNDTIAKSMAKSLAVKTGTYLTEREQENLVNGL
FACKEPNVSPFHKPTFITMSVEDLDKKFAV
>LONDMIMF_02768 6,7-dimethyl-8-ribityllumazine synthase
MATANKNLSEYDKNTIPSAKDFRFGIVVSEWNDKITEGLFSGAEKALLDCDATPDNIIRW
NVPGSFELVYGAKRMIDTQQVDTVIVIGCVIQGETKHFDFVCEGVTQGIKDLNVQTDVPV
IFCVLTDNNEQQSIDRSGGVHGNKGTEAAIAAIKMAYLRQQSSK
>LONDMIMF_02769 hypothetical protein
MFQAQKYFQQATEGTASDSLYNLSLKGGEGKLGFTGIIENYSGTNAANLANYYAGIAYLN
TKKYKEAIEYLEKFSSDDLMLSVIAKGAIGDAFSQLNQPKEALEYYVKAAEMNQNDMTTP
RFLLKAGQTALALKQKETALKYFNEIKEKYDTAPEAMNIDAMIGLAQ
>LONDMIMF_02770 Voltage-gated ClC-type chloride channel ClcB
MSAKKAPKIKVFFRNIFRQIETLFFLFKNFLSERHFIYLSCVIVGISCAFAVIVLKGFAH
SVFVFATYVNGYLKLPYINSILPIIGILLTVFVVKNVLDGSLEKGSSRILYAVAKKGGIL
PKKQMYAQIITSSLTVGLGGSAGLESPITITGAAFGSNFAQKYRLSQKDRILLLACGVAS
GIAAAFNAPIAGVLFAIEVVLTDVAITAFIPIMISAATGALVSTIVLNEDVLLSFKQQQT
FDYHNIPFYVLLGILAGLVSVYHARKFQKIEGFFKKIKNGTYKKALFGASILAVLIFFFP
TLFGEGYESIKTLSNANPQMLLENTLLDEYKSNEWILLLFVGITMLLKVYATGLTLGSGG
NGGNFAPSLFVGSYLGFFVAKFFNILGIGKELPVGNFTIVGMAGILSGLFHAPLTAIFLI
GEITGGYNLMVPLMIVSSISFAVSKRFETHSMDVKHLADKGDVFTSDKDKNILSNIDILS
HINSEYKTVSPEDKLESLVEYLANSRQEVFPVVNAKNELIGIIDFEDLKPIVFNSFRLKY
TTIPEVMKPPLDVISYEDGMEVVMEKFENAHLEQLPVTKNGKYFGFISKVHVLETYRKKL
KEMVIE
>LONDMIMF_02771 Acyl carrier protein phosphodiesterase
MNFLAHIYLSGNNDFMKIGGFMADGVRGKDYEHFPDDIRKGILLHRAIDTFTDAHAVFRI
SKHRLHERYGHYSGVIIDVFYDHFLAKNWQDYSDEKLDVFVQNFYQSLEDNFDMLTPKVQ
NMLPHMERGNWLWNYQFVDGIGTILSQMDRRTKNTSKMGESVQELEQFYKEFEQEFTLFF
KELREFVAEKIKTL
>LONDMIMF_02772 Phosphomannomutase/phosphoglucomutase
MTLIKSISGIRGTIGGKVGDNLTPVDAVKFASAYGTWLKNYSKKEKLIVVIGRDARISGP
MIHNLVVNTLIGLGIDVIDLGLSTTPTVEVAVPLEKADGGIILTASHNPKQWNALKLLNE
KGEFLSGAEGAKILDIAEREAFDFSDVDSLGEIIPNDAYMDIHIDEVLELPLVDVEAVKE
AKFKVVVDGVNSSGGIIVPKLLELMGVEVVKLYCEPNGHFPHNPEPLKEHLTDISQLVVS
EKADFGIVVDPDVDRLAFISEDGEMFGEEYTLVAVADYVLSKTPGNTVSNMSSSRALSDV
TNNHGGTYEASAVGEVNVVELMKKNNAVIGGEGNGGIIYPELHYGRDSIVGIALFLTHLA
NKKMKVSELRASYPEYFMSKNKIELTPQIDVDAILTAMTDKYKSENISTIDGVKIDFPQN
WVHLRKSNTEPIIRIYTEAKSQAEADALALRIIEEIKVIAGI
>LONDMIMF_02773 hypothetical protein
MEDQSHGNFGPESHWPESGRPEPPRPEPLRAEPYRKLYYRKQLPNAVTVLILGIMSIIAA
FCYGFFGIVLGIIALVIARNDMQLHRENPGEYDGYPNLSAGRVCAIIGLSLGSLFFIGLF
FLFFLTTVFS
>LONDMIMF_02774 Peptide deformylase
MEKKIIVFAFLFLGLGVSAQHFTKSERSLIQSGDTKTMLKVIQITDEKELKILQSVSTDI
DPNDKLLPLLAERMFLAMRDPANPGIGIAAPQVGINRNVIWVQRFDKEGEPFELYLNPKI
VWRSAMLRKGMEGCLSIPDISGNVYRNYSIKLTYQDKTGKKHEEVIEGFTAVIFQHETDH
LNGILFTDRMKEQEKLEVSPVDDEMNDLFLEKKP
>LONDMIMF_02775 3-oxoacyl-[acyl-carrier-protein] synthase 2
MKRVVITGLGAITPLGNSIDEFWDNIVAGKSGAGLLTKFDTSKFKTQFGCEVKNFNPEEY
MDRKESRKYDLFTQYAVAASEQAIKDSGLDFESMSQKERSEIGVIWASGNGGISTFEEQL
KEFFTGDGTPHFNPFFIPKMIVDIAAGVISIRHKLHGPNYATVSACASSNTAIINAFDTI
RLGKAKIMIAGGSEAAITAASVGGFNASQALSKRNDEPEKASRPFDKNRDGFVIGEGAGA
LILEDLDYAIARGATIYAEIVGGGMAADAYHLTGTPENGFGAALGMQKALNEAGITAKEV
DYVNAHATSTPQGDSSELTAIREVFGNHPVAISATKSMTGHLLGAAGAVESIITVLALKN
DIIPPTINTTDIDETMTDLNIVLGNSVRKKVNYALNNTFGFGGHTASTVFKKYTDGITAG
>LONDMIMF_02776 hypothetical protein
MNKDAFNFLKQHIGKEVTQSPSPFMNWLKPKMIAVTEGSLSFEYTVRKEMTNPFGTLHGG
VIGAIIDDAIGATLISYGEPNFYVTINNVIDYFASGRENDIIIATTAINKKGKTIVNAQC
EIWNSDKTKMLAKGYTNLLKTEIK
>LONDMIMF_02777 putative oxidoreductase
MKTSKNTILITGGGSGIGFEFAKIFSENDNQVIITGRNEEKLNKAAALLKNTTAIVADIT
REEDIDKLVQTITKQYPSLNVLINNAGNASYYDVLVSGTDAFTKASDEINTNYLSIVRLT
ERLLSLLNSQEEAAIVNVSSIVALVPNKTLITYSASKAALHSYTQSLRIALDRSPYATQV
YEIMPPLVNTEFSKEIGGENGISPEVVAQDLLRAIGENQYEIHVGQTSYIYELSLTSPKD
ALLTMNSQS
>LONDMIMF_02778 HTH-type transcriptional regulator TtgR
MGKAEKTRSYIIEKTAPIFNIKGYAGTSMNDITEATGLTKGSIYGNFRNKDEVALEVFEY
NKKKMQDFFALEISRKKTYKDKLLTFPELYNHVFNGHFIDGGCPIMNTAIEADDTHPMLK
EAAKKALLNWKENLASLIQKGIDSKEFKPETNPEEAALLMLSIIEGTVMISKLTGKTNYL
KSLMHSLRKIINDL
>LONDMIMF_02779 hypothetical protein
MILFEFDKAKLLAKWNTVIAQSKAKIAKFKQFLISGGLY
>LONDMIMF_02780 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MENSNQKVWYITGASKGLGLALVKQLLNEGKKVAATSRSIEELKKAIGDADNFLPLQVNL
LSEESIEKSIQVTVAQFGRVDVIVNNAGYGLAGALEELTDVEARQNFDVNVFGSLNVIRK
VLPYLRKQQSGHIFNVSSIGGFTGAFPGFGIYCATKFAVQGFTESLAEEVKPFGIKATIV
SPGYFRTDFLKDSSLSVPKNQLQEYKTVRDVQSAHENEINGNQPGDPHKAALAFIRTAKM
QNPPVHLFLGQDAYAMAEVKIQSVKENMEAVREYAAATGFDN
>LONDMIMF_02781 putative oxidoreductase
MKTDKIWYVTGASKGLGLALVKKLLVTGYKVAATSRNAATLSEAVGAGNSENFLPLEVDL
VDEQSVAESIRRTQEVYGKIDVIVNNAGYGIGGTIEELSQEEISEAFNINVFGTINVIKY
AMPYLRAQRSGYIINISSIAGFAPATGWSIYAAAKHAIIGLSESLADDVRQLGTKVTAIA
PGAFRTQFLTKESLVFAENSIEDYEEVHVSHDKFHKMNGNQLGDPEKAAEVMINLAESDN
PPVRLYLGSDAYRRASAKLGTLTQMLEDWKDITLSTDFQE
>LONDMIMF_02782 HTH-type transcriptional activator RhaR
MPKTETIEDFYKQKLNYLPEDLQQGLGYFNVIRAEDCYKNDVYVPISYTRRDFYKISLAR
GRNVFHYADKSLEVNGSALIFFNPQVPYTVESLSDDRSGFFCIFKEAFFTESLRNSISSL
PMFKIGGKPAYILNEEQDKQISDIFQRMINEINSDYVYKYDLIRNYVTEMIHSAMKIEPS
EKLYQHPDANSRITSVFTELLERQFPIESPSQRFTLRSAKDFAEKLYVHVNHLNRAIKMT
TGKTTTDLISQRLVNEAQALLKHTDWNISEISYCLGFEEPAHFNNFFKKQMQVAPSVYRS
A
>LONDMIMF_02783 Stage 0 sporulation protein A
MRLFEEKINIVLADDDRDECELFKEAVSEINENYNLIFFSNGKELMDYLNDNEIHNPDII
FLDLNMPFMSGVDCLRQIRANEKYSDTVIAIYSTSSSDQDQEDTFTLGANVYIKKPSDYA
AMKKILQHIFKTYWQYHTSDMNRETFLISV
>LONDMIMF_02784 hypothetical protein
MVAMCQFKMPERLKIAGKNLDDETTRDIIDRIIDCLKSGKAELYKVESFCDIESQSDTPD
NIKEEPATFFEVILILDEHQVQDYKIYDALIIDKAIQCLEEDENYISRYWINGNQEYIGI
ETEF
>LONDMIMF_02785 Putative quercetin 2,3-dioxygenase
MTTKKIERIIAPPAPHMVGDGFRVHNFIPSAYGLSMQRMSPFIMMDYNSKFYFPPTQELR
GVGVHPHRGFETVTIAYKGKVAHHDSAGNSGVIGEGDVQWMTAASGILHKEYHEEQFSKE
GGEFQMVQLWVNLPAKDKMSAPKYQGITNDAINKFRLPNDEGLVEVIAGTYNGISGTAST
FTPVNLLNAKLNKGASASFDFPASYNTALLVLEGSIKVNGEDKVATDHFVLFANEGEEFM
IEALENAVVLVLGGEPINEPIAAHGPFVMNTQQEIIQAFNDFNIGRFGYLE
>LONDMIMF_02786 hypothetical protein
MILILSTFTVIKKHTIMDYTITHNESRKRFEISLDGKTAYVKYELFDGGIAYMHTIVPAE
LEGKGIASALAKYVLDYAKNNGLKVKPYCPFINAYIDRHPEYQENSLFHTKH
>LONDMIMF_02787 Fumarate and nitrate reduction regulatory protein
MTDLFKKYIIDTQCATESQYEEVEHLVHPVNIAKGQLLLQEGEICDKAYFVCKGILRSYT
LDESGKEHTIQFAPENWIIADRSSFYFHEPSEMYIDVLENTEAVYVQKEFFDIAEKKFEN
FTKVNTLALHNNIRHMEKRINYLLSASAEKRYLKFIETYRDLSLRVPQLLIASYLGITPE
GLSRVRKELANKNFNRD
>LONDMIMF_02788 Efflux pump periplasmic linker BepF
MKNNLYRTSALLLLLAVLNSCGPSEKAEAAPVEETVPAAIETFQISKEKLSTELRIPAEL
TGFQQVDIYAKVSSFVKELKVDIGSQVKKGQLLMVLEAPEISSQLAASESRLRSQEAVYM
ASNSTYKRILETSKVEGTISKNDLEQSEARKNSDYAQLQAAKASYKEIQNIQGYLQIRAP
FDGVVAARNVNLGAYVGPAGKGSELPLFTLQEQSKLRLSVYVPEMYTGYLKNGDEISFSV
KSMPGQTFKAKVSRMSGALDSRLRSERVEMDVINTTKKLLPGMVAEVLLPLKAQDSNYVI
PKTALVTSSEGTFVLEVVDNKTVRKQVQKGREVEDRVEIFGDIPENAQLVKLASEEIKDG
TPVK
>LONDMIMF_02789 Cobalt-zinc-cadmium resistance protein CzcA
MNLIRFALRKPISILVLVAGLFFFGIGAVRDVKVDILPKMNLPVIYLAHPFGGYTPNQME
SYFAKNYVNVMLFANGVKSIETKNIQGLTLMKVTYYEDTNMAQAAAELSALSNRIQAAFP
PGSQPPFIIRFDASSLPVGQLVLSSKTRSNNELQDLANVYVRASFTSIPGLLSPPPFGGS
PRTIEINVDPDLLRSHNLTPDQIVDAIRINNQTAPSGNVRIGDQNYITPTNNTIKEIKDF
EKIPLFKGGIQNLYLGDVATVKDGADITAGYALVNGKRSVYVSIAKAGDASTWDVVQKLK
ADLPKIQSTLPEDVKLSYEFDQSVYVINSVKSLITEGIIGAVLTGLMVLLFLGDRRAAII
VILTIPISIISGVLFLKLFGQTINLMSLSGLALAIGILVDESTVTIENIHQHLDMGKPKA
LAIWDACKEIALPKLLILLCILAVFAPAFTMKGIPGALFLPLALAIGFSMIISFLLSQTF
VPVMANWLMKSHPKQKHGPEMTDDEAEFIASGLTPESEDDTFNQKKILVERKDFNNDGKI
SRFERFRNRFMRMLERLFPLRKPVALFYLLGITGLAILLLNVIGQDVFPKVNSSQFQMRL
RAADGTRLERTEEKALKALKELENMVGKEHVSISSVYVGQHPSLFSVSPIYMFTAGPHEA
VFQIGLKDYHADMDEFKDQFRERIKKILPDVKISFEPIELTDKVLSQGSPTPIEIRIAGK
NKKLNEEYANKIIAKLNKISYFRDVQIAQPIKYPSLDINIDRTRAAQVGVDMNEISRSLI
ASTSSSRYTEKNTWIDEKAGLSYNVQVQVPLNKMKSVHDMGEIPLLKNSTRPVLSDVATI
TPSFTYGENDNLGAMPYISVTGNIHQTDLGTASKDVHKTIASLGELPRGLFIEPIGLSKV
LGETMSSLQGGLLVAVVVIFLMLSANFQSFRISLVILTTVPAVVLGSLLLLLITGSTLNL
QSYMGIIMSVGVSIANAVLLVTNAEQLRKHNGDALLSAREAASLRLRPILMTSVAMIAGM
LPMAIGHGEGGDQVSPLGRAVIGGLLFSTFTVLIILPLIFAWVQGKTSTQSVSLDPEDKE
SKHYISSLHPQNEK
>LONDMIMF_02790 hypothetical protein
MTTKRISLFLLTLFFFQGFSQTLSLKEAVETGMTNYGTLKAKNKYAEASKESVKQARRDY
LPNLNLAAQQDYGTVNGQNGPLYGFGGLGVASSGLPLPEQNWNAAFGALYLVNMNWDFFT
FGRAKQRINLAKADAERSEKDLEQEKFQHKIKISAAYLNLLASQRLLISQEKNLERSVVF
QKIAAARVKNGLLPGVDSTLASAEVSRAKIMLNQGKDQVKELNNKLVALMGTDIKDYVLD
STFVKKIPTSILRLETATDTLNPILQYYRSRIDLSKQQVRLFKREYYPTFSLFGVYQTRA
SGFNSNYAVDQTSYTRNYFDGISPDRQNYLLGVGVTWNLTSIARSSKKVSAQKLISEALQ
EEYNVIDQQLKTQSDAADAKIRYAMDNYAEAPKQVQAAEQAYLQKTTLYKNGLTNLVDVT
QTLYTLNRAEIDRDIIYTNVWQSLLMKAAATGDFELFINEF
>LONDMIMF_02791 hypothetical protein
MKNLLFPLTIVLFFTTIAVAQDLEYTVANIPAELKENANAVIRLDQKNIVISSRKSMIMT
NKRIVTVLNENGLSYMGLYEYFSGRERVKSIEAQFYNAFGKEIKKVKRKDFKENSVSEGS
IITDNKLLHYDYTPTEYPFTVVFSSETETSNTAFIPRWYPVPGFSVSVEKSTISIKAPSD
LGFKYKEFNMLDNHNIIKEVKTDGVSFTANNMQAYKTEDYSPSFDSYTPNVMMGLDYFHL
EGVDGNAKSWLEMGKWFTDKILIGTSELSDETKVKIKTLIGNEEDPLKKAKIVYGYVQEK
VRYVSIQEGIGGWKPMLAKDVDRLGYGDCKALTNYTKSLLDVVGVESYYVRLYGDRYKKS
VIPDIVSMQSNHVILAIPDKEKYVWLECTSQILPFGFQGDFTDDRNALVLKPEGGEIVRT
NVYATKDNTQITKGNYSISEDGMISGKLEIKSKGIQYDKKLNINGKSIDDLKKIYKNYFM
YMFWHSNK
>LONDMIMF_02792 D-aminoacyl-tRNA deacylase
MKAVIQRVSHASVTIEGEKVSEIQSGLLVLVGFEDSDTQEDIQWLSAKIANLRIFGDEDD
VMNLSIKDIGGDIIIVSQFTLHAATKKGNRPSYIKASKPDVAIPLYENFVSQMEADLGKK
VQTGRFGADMKVALLNDGPVTIVIDTKNKE
>LONDMIMF_02793 Small ribosomal subunit biogenesis GTPase RsgA
MTGTVYKSTGSWYTVKSESGDFIECRIKGKFRMKGIKSTNPIAVGDIVDYELDKSSDKIT
GTIHNIHDRKNYIVRKSVNLSKQVHIIASNIDRVFLLVTINNPPTTTSFIDRFLVTAEAY
GIETILVFNKIDTYDEAMLDEQLYLQYVYSNIGYQCLRVSSTEGKGVEKLKEMMIGKVSM
FSGHSGVGKSTLANALEPTLHLKTSVISEQSRQGQHTTTFAEMYDLSFGARIIDTPGIKG
FGIVDMEKSEVSGYFPEFFALQDQCKFNNCLHKEEPHCAVKEALEKDEIAWSRYRSYLQI
LEGDEEHYRTDDYADEKAGN
>LONDMIMF_02794 Phospho-2-dehydro-3-deoxyheptonate aldolase
MSRKTQDKMKNSKELRTWLDDFKLSHPLIIAGPCSAETEEQVLKIAHELKDSDVSIYRAG
IWKPRTRPGSFEGVGAVGLKWLQKAKAETGLLMATEVANVAHVQQALEHDIDVLWIGART
TVNPFAVQEIADALKNTDKIVLVKNPVNPDLALWLGGIERLYNAGIKKLGVIHRGFSTYE
KTKYRNIPEWQLAIELQNRFPDLPIICDPSHITGKREMIQEVSQQALDLNYDGLIIETHN
DPDNAWSDAEQQVTPEKLKEIFKNLKVRKETEDGSDYNQRLDRLRLDIDEYDAKILEILG
KRMKVADKIGALKKEKNVAVLQNKRWNEILGKMILEGEEKGLSEEFILKIFKAIHQESIS
HQEKIING
>LONDMIMF_02795 LL-diaminopimelate aminotransferase
MTEDILTVEKIENKGFAKRLETVEEYYFSTKLRQVRQMISEGKPVLNMGIGSPDLTPPPK
AIEAMVKALGDEKAHEYQSYQGLPELRKGIADFYKSQFDVALDPNTEILPLMGSKEGIMH
ISLAFLNEGDEVLIPDPGYPTYSSITNLVGAKSVFYDLKEQNNWMPDLEALESRDLSKVK
LMWINYPHMPTGTGGSLELFERLVAFAKRHQIVLGNDNPYSFVLNDNPISIFQIEEAKEV
ALELNSLSKTFNMSGWRIGMVSGKQEFIDAILKIKSNMDSGMFYGIQKGAIEALKLGSEW
FDSQNKIYKRRRKLIFQLAEKLGCTFNKEAVGMFVWAKLPFGNRSSETFIDTFLIEKNIF
LTPGTIFGKNGEGYIRFSLCIPEEKIQEAIDRLD
>LONDMIMF_02796 P-protein
METKIAIQGIRGSFHHQVAKEYFGENLELDECMSFDALVNSLVENKTQHAVMALENSIAG
SIIPNYALIDRNNLHIIGEHYLNINMNLMVLKGQKIEDIKEVHSHPIALLQCGEFFKKYP
HIKLVESGDTAETAHRIQENQLKKIAAVASPIAAEMFGLDILASGIHTIKSNKTRFVILK
TQNKVLPKSEINKASIKFELDDTPGSLATILNVMNNCKLNLTKIQSMPIIETPFQYSFFV
DVTFEKYKHYEKAKSIVELMTTHFKVLGEYRKGDTI
>LONDMIMF_02797 ABC transporter ATP-binding protein NatA
MSIEVTSISKNYGEQKALDTISFSIQKGEIVGFLGPNGAGKSTLMKILTTFITADEGQAS
VNGFDVSTAQKEVQKSVGYLPEHNPLYLDLYVREYLAFNADVYKVAKSRIEEVITMTGLT
PESHKKIGQLSKGYRQRVGLATALLHNPDVLILDEPTTGLDPNQLVEIRDLIKNIGKDKT
VFLSTHIMQEVEAICDRVIIINHGKIVTDKKLTNLKNEEEQVIEVEFDHTVEEQLLRSLP
NLVTLTNTHDMTWELTFSTSKDMRPAIFDFAHDNGLKTLQLNLKSKNLEAIFRDVTKK
>LONDMIMF_02798 hypothetical protein
MMKAKITTRIIVLFSIAFLSCDSENANDCFQTSGTPITREFVVNDFKKINIGEGIELIIK
QGPEKKVVVKTGENLLGGITAEVQNEELFLRNSNGCNWVRDYNTTQVYVTTPTLINVYSS
SQFGVKSDGVLGFPSLSLQSGMFSDTASGTFEVEVNCNQLTIEDNKDSYFAVSGTTQALY
IGFYNGNARFDGSDLTAKEVHVFHRSSNDIIVKPIDKISGTIYSTGNVVLKNVPPVIEVT
QLYQGRLVYP
>LONDMIMF_02799 hypothetical protein
MTHFYKHMTNNFFYLLYLVPLLCFSQQENSRYTLDINNFYGKILKHTEEISQFTDKRQEG
ILISLNRKTYGEKPWQSRYNYPDYGLSFQYQNMNYEALGHFYGLYGHYNFYFFQRNLMFR
IAQGVAYNTNPYDAVTNPENQAYGTHWMPATYFMLNYKKEKIWNGLGVQAGLSFFHHSNA
NLRTPNKSTNTLALNIGAVYDFESKEPLQYIEHKDSVRYTEPIRYNLVFRTGFNESDLVG
SGQFPFYVFSVYADKRLSRISAIHIGADLFIYKYLKETVKRIAADPNLNVSPDTDYRKGG
IFVGHELFVNRLSLETQFGYYAYAPLDYLPPIYQRLGLKYYLADEIFMGVALKTHAAKAE
ALEFALGVRL
>LONDMIMF_02800 hypothetical protein
MLKKLYIFIFSIPLAAFSQEINGKYSVDVNYFYGNILPHNSTIKHLITEHPEGVLISFNR
KTFGHKEWESEYNFPDYGASFHYENTKNPILGDLYGLYAHYNFYFLNRSLMFRVGEGISY
NTNPYDKDTNFRNMAYGTRWMTSTYMMLNYHKENLYKNIGLQAGISFFHHSNSNMASPNT
STNTLAVNLGVNYSFEKSENLKRTTIMYDTIQNFKEPVRFNISFRSGRNESDIIGSGKFP
FYVLSAYADKRLSRKSAIQFGADFFMMKYLEEYIRYKSAAYPDYHLDPDTDYRRVGVFVG
HELFINRLSIEAQAGYYVYAPFGYLGPFYQRIGLKYYFSDTIFAALTLKTHAAKAEAMEI
GVGIRL
>LONDMIMF_02801 hypothetical protein
MLQKYLSQEKIAWFSIVIAILGIFIPMLTIDYNTASKEMVYTIGFIKYIFQSIHLTIFNL
EDFYTFKLGTGDGMYMHYNLLNAFFYVLLILGAVFYLRSKAKETRLLRFVYSVIFITKVS
SFILGLFSIVLMENTTNSLGVFLYVLWFMDYVVMAFYAYLAFSILKYIEMGKTFEIIERT
YETHTSVTLVEAGRWRRFFHLIIDDFIMILVFSASFEFFIRTEKLQAFVSALQNGLGDRV
AFIIIFAFFRVFYYAIFESVLGVTAAKMLTETRVTDEEGNKPPVSSILKRTFLRLVPFEA
LTFFTPSGLHDKWSETYVIKEQRTGVSGAWYLLIVPVTIVVGLLIAFGIYKYESLQAEKK
EQAIIQQNKEVFAHKLKNLSTNDFIKLESLDYANSDIYLKTEEIKPDGIVFLILDAQKDY
SEAKGPNFNEYSVPDFLEKIYVIEKESAKKVTISKGQLEKAIELNAGYSYSNQDTENALN
IGDGKKYSIKSIETYFMPRLTLIDNYSNDKIKNVIVTNEGWKAELIKISNAQLYSGQPPI
PLYKQSQAVITIPQAENYKFQITIKDTLGRIFSYEISKEKELEAVIKRTK
>LONDMIMF_02802 5,10-methylenetetrahydrofolate reductase
MKVTEHIEKANGKSLFSFEILPPLKGQNIQSIFDSIDPLMEFNPPFIDVTYHREEYEYKE
LPSGLLEKKIVKKRPGTVGICSAIQNKYQVDAIPHILCGGFTKEDTENFLIDLDFLGIQN
VVALRGDAVKNETYFKPEKEGNHYASELVTQIANLNNGIYLDDELQNSSATNFCIGVAGY
PEKHMEAPSLDSDIYFLKQKIKNGASYIITQMFFDNKKFFDFVAKCRKEGITVPIIPGLK
PISTKKQLNLVPHRFKVDIPDELIMSIVRAKDADAVKQIGIEWCISQSKELIKEGIPVLH
YYSMGKSENIKAIAREVF
>LONDMIMF_02803 Methionine synthase
MADVDCKKYLRLSGLEPLIITPESIFVNVGERTNVTGSRKFLRLIKEEKYEEALDIARAQ
VEGGAQIIDINMDEGMLDGVRAMTIFLNLIASEPDISRVPIMIDSSKWEIIEAGLKIAQG
KSVVNSISLKEGEENFIRQAKLIKKYGAAVIVMAFDETGQADTYERRIEICKRSYDVLVN
KVGFPAEDIIFDPNIFPVATGMEEHRRNAVDFFRATRWIKENLPYASVSGGVSNVSFSFR
GNDRVREAMHSAFLYHAVNHGMTMGIVNPEMLEIYDQIPEDLLEYVEDVLLDRRDDATER
LLAFAENIKGDTKEVSEKQSQEWRSLPLQERLTHALVRGVDEFIDADIEEARQLATRPIE
VIEINLMTGMNVVGDLFGSGKMFLPQVVKSARVMKKAVAYLLPYIEAEKDGSSSSAGKVL
MATVKGDVHDIGKNIVAVVLACNNYEIIDLGVMVPPEKIIQTAIEEKVDIIGLSGLITPS
LDEMVYLAKQMDRQNVKIPIMIGGATTSRAHTAVKIAPEYRETVVHVNDASRAVTVAGNL
INKNTNQEYFKSLRMEYDELREGYLSRSRDKNFLSIEEARKNKLQLDWTNFTPVKPNTIG
TKVIDVKLGELVDYIDWTPFFRTWDLHGKFPEILKDEIVGEQAKVLFADAQEMLRQIIQE
NWLEAKGVYGIFPANQINDDDIELRDENGKLLQTFLTLRQQSAKTKGAPNIALSDFIAPK
DSGITDYMGAFCVTTGFGVDEKAAEFEKNLDDYNSIMVKALGDRFAEAFAEYLHEKIRKE
IWGYASDETLNNEALIKEEYKGIRPAPGYPACPDHLEKPTIWKLLKVEQNIGVTLTESMA
MWPASSVSGYYFGHPESKYFGLGKIKKDQVEDYAKRRNVSYEYAEKWLNPNIAD
>LONDMIMF_02804 Methionine synthase
MSGIHKAIKERILILDGAMGTMLQRYNFSEEDFRGERFKEFPHPLKGNNDLLSLTQPKAI
QEVHRQYFEAGADIVETNTFSGTTIGMADYHLEDLVYELNYESARLAREIADEFTAKNPD
KPRFVAGSIGPTNRTASMSPDVNDPGFRAVTFDELRIAYKQQVEALIDGGSDILLVETIF
DTLNAKAALFAIEEVKEERNIDIPVMVSGTITDASGRTLSGQTVEAFLISISHIPLLSVG
FNCALGADQLKPYLQRLSHNTTFNVSAHPNAGLPNAFGQYDQTPEDMQVLIREYLEDNLI
NIIGGCCGTTPEHIRLIAEVAKEYSPRIVEPV
>LONDMIMF_02805 Bifunctional aspartokinase/homoserine dehydrogenase 1
MSVKKINIILFGIEETGSSLITEVLSNQESLLENNNLDLRLPVITNSTVAFFEKPTVRNS
WEANFIQCAVPFKIADIINFVQENELENLIAVDTSDTEDILPDYFDLLQNDFDIISANPL
VQTFSADFKMALNNSIKKTEKDFVFVNPNEKYLSPKLLEQILKIAAKQNFRIAV
>LONDMIMF_02806 hypothetical protein
MKAINVLGYSRNNEQFVVKTQNSDVRISRNEKFPELEGPSPFEYILAGFAGCVNAVSQQV
ASELGINLKSLQVEITGVISQEERVGFSKIEIVLKPTTDTSLQVLQKWLKLVQQKSPVYD
NLVNSTPVELILYKEYNYAA
>LONDMIMF_02807 hypothetical protein
MKKTLLISFLVSVSGIANAQNIYNFGFSGTTTEMETAGWVRTNQSSPSTTTLWSVASYTP
VTVNTTVTPPVQGNPFNDREYATGEVSPVPNGQAGGANSFALVNFTSTTGAGNISNWLIS
PVVTVENGDVVSFWSRKGTSGNLDFADRLELRMSTATAHTNPTGGPTDVGSFTTLGVSVN
PNLATGFVYPKVWTKYSFTVSGLTGPTAVKFAFRYFVTNGGPTGANSDIIGIDTFEVSRT
LSRDDFFTNNFSIYPNPTTGVVNLTGKNNIAINTIQVTDLNGRVVRNINAGGVSETQINI
SELTSGVYFLNIQTDSGTGTTKVVKN
>LONDMIMF_02808 hypothetical protein
MSSLLLTEQKILEIENQLREAMKKSDVEVLEQLLHDDLLFVLPSGEVITKKTDLETHQSG
NLILEEITSSIDSIKQIDENVVVTLSSKLKGKMLEQNFEGNFRYLRVWKMFDGQLKVIAG
SCVSV
>LONDMIMF_02810 Thioredoxin reductase
MSDTIEKIKCLIIGSGPAGYTAAIYAARADMKPVMYTGMEPGGQLTTTTEVDNFPGYPEG
IDGPTMMIQLQQQAERFGTEVRIGMVTAVEFSKEKGGWHKITVDGNKEVLAQTVIISTGA
TAKYLGLPSEQKLRGGGVSACAVCDGFFYRNQDVAIVGAGDTAAEEATYLANICKSVTML
VRKDVMRASKAMQHRVENTPNLKVLFNTEVEEVVGDQVVEGLKMINNATGEKSEIAITGL
FIAIGHKPNTDIFKGQLDMDETGYLITSGKTTKTNLPGVFASGDVQDKEYRQAITAAGSG
CMAALDAERYLATLH
>LONDMIMF_02811 hypothetical protein
MRRLILFAVILTTAVSFAQSKERIKGTKVVTIAPREIQSFENLEVEDNIEIFLVKGDNNA
LEIEADENLHEIIESSLNGGTLRLTTTKNVTSYKKLSVKVTYTDDFKMVTAKNEATINAL
SDIELDNITFKTFDYTKLFLNVKSRWFTIFANDKSKIELNVKAETAAVELSKSANMKALI
SSESLKFDMYQKSTAVIEGDIVDLKLRLDNNANFTGKNLNAKNAEIITEAYANGSIQVSV
KAIIEAGGKSELQLYGDQKIEIKNFTDSAVLMKKPIK
>LONDMIMF_02812 hypothetical protein
MIRIIIYFMKLIIALLFALFFSSCRYTNERTITGSGNVRVETRNVTGFKGINVSNALEVE
VEQGDAYQVVVEADENLLSHIITRVENGILHIEADSNTFRNIDARKIKVKLPVIVSLEAS
SASKITSIGTLITDKLLVDASSAAGIDIAVEADELTCNSSSASSVDLKGKALKFKADSSS
ASEIDADQLLANDVIAVASSAATISTHPILTLDAEASSGGNISYNNTPRNSLKQNADSGG
GISKNE
>LONDMIMF_02813 hypothetical protein
MNKTVNINLGGMFFHIDEDAYQKLNRYFEAVKRSLSNSTGKDEIMKDIEMRIAELLTEKN
RGEKQVVGLKDVEEIITVMGQPEDYRIDDEEAAEPAYNFSRRRTKKLYRDKDNSMVGGVL
AGFGHYLGIDPLWLRIIMVILLLGFGTGFLIYIILWILMPAAITTTEKLEMTGEPVTISN
IEKKVRQEFDTISEKFKNVDYDKFGNQARNAGERIGSSLSDVLLKIFSIFGKLIGAFLVV
VASATLASLVIGFITAGSFSMVDFPWQSYIDNFTDVPLWIVGMLILIAIGIPFFFLLILG
LKLLITNMKSIGNPAKYTLLALWIISIGTLVALGLQQATEVAFDAKVVQKQKFDLNPKDT
LQIKFTYNDYFAKSIYDREDFLFAQDSAKTMVIYSNNVTLRILKTDEKTPYIQIEKKAEG
KSFAAARERAEKINYGYKFKGNQLLLDNYLLTDSKNKYRHQKVEIFLYLPEGTYFKPDMT
VQNYDHTDNGFFDLWFDSDIYIYQMQSSQVKCLNCADVHGEGEGEVWVDEEQIAREAEQE
ARLEVEREMQRQNIQNGQNSSTTVTINDKGVQIKKEGTEGPQGNKPKGLKMDKNGVIIKN
N
>LONDMIMF_02814 hypothetical protein
MNIENTKAQMRKGVLEFCILSVLKEKDAYTSEILDTLKNAKLLVVEGTVYPLLTRLKNDG
LLNYRWEESTSGPPRKYYGLTELGKQFLKELNGTWTELSDAVNIITSQK
>LONDMIMF_02815 hypothetical protein
MLKFIITTAMAMAALTGYAQVSENRKVNDFSKIEVESGIELFYMESDENSIRVEGDSKDG
LDSVITETDGKTLRIYHVKRNKKQSESISKVFVAAKNVNSFKASSKSKLFFENPVTSDDI
RIEILSDSYFRGTVLPNSRVSVKVSSGSLFSGRFETESFTGIFKSGATVSLTGKAKKATI
NTSSGAYCNAKNFFVDKMTATADTKSSALLNAKEKIAKATDASSITFFGNPENLKTGYDS
FAIVNKSGAITWNTPE
>LONDMIMF_02816 hypothetical protein
METSSNQKTTSAFVHLSTLTQYFIPFGNYIFPIIIWGASKKDSDYIDHHGRQTINFQLSL
LLYSLLLSLIAIPIFIVTIFKNIPINAIVYNDDFIIDNFHLEHITGIVIIGITAAVLFFT
LKVAEFFLIIYASIKAANGELYKYPLTINFLKTEKKEENKTEISEENESSINHQSESETV
>LONDMIMF_02817 hypothetical protein
MMEFTAGKLNKFLFFKLPSAFLCGVRVQKIDLERCVVTVKHRWINQNPFNSMYFAVQAMA
AELSTGALVMYHIKRSNRKISMLVANNKGNFTKKATGRIVFTCQDGHLIEDAVKRTIQTG
EGQTFWMKSIGINEKGEQVSEMDFEWSIRVK
>LONDMIMF_02818 Epimerase family protein
MKILITGATGLIGTELVSLLLQNGITIHYLTTSKKEIKNEPNYQGFYWNPEQGVIDEKAI
VGVDTIVHLAGASISMRWTSKNKQEIIESRTLTTNLLYRILKSHPHQVRHFVSASAIGIY
PDSLTAFYTEDNKSVDNSFLGQVVVKWEEAVDNFKRLNIKVCKIRTGLVLSNRGGMLKEL
LKPIKVGMGSAYGSGKQWQSWIHIHDLVHLYHFAIQHEWEGVYNATAPNPVDNHELVKKT
AAILEKPFFMPNIPEFLLKLLLGEMYILLVSSQNVSSQKAQDNGFVFKYRTLDKALENLL
G
>LONDMIMF_02819 Protein YceI
MKNRIASLLILSALTLTVSCKNDKAAEAETTEAGAVKEASGEAVSYTVDKGNSKIDWTGS
KPTGKHTGTINLSDGTVSIKDNVLDSGKFTIDMNTITVTDLKAGDGKEDLEGHLKGTGGT
EEDFDHFFNVKKYPQSTFEITKAVTENGKTAVEGNLTMKGITKNVKFPATVTVDGNTVTL
VSDPFTINRTLWNVNYGSKSVFDNLGDKFINDDIELKVSITAKK
>LONDMIMF_02820 Protein GrpE
MNAENQDKEQEIDDATLEANANGEQLIVEELSVEEQLTQDLAAEKDKFIRLFAEFENYKR
RTAKERIDLFKTANQEVLLALLPVLDDFDRAQVEISKSGDENLLKGVELIHEKLRTTLAS
KGLEGVEVKAGDSFDPDFAEAITQIPAPSADLKGKIVDVVEKGYKLGDKIIRFPKVVIGQ
>LONDMIMF_02821 Chaperone protein DnaJ
MKQDFYEILGISKSADAAAIKKAYRKKAIEFHPDKNPGNKEAEENFKKAAEAYEVLSDPQ
KKAKYDQYGHQAFDGAGGFGGGGMNMDDIFSQFGDIFGSAFGAGFGGFGGGNSGPRRVKG
SNLRIKVKLTLEEIANGVEKKVKVKRKVQAKDAHYKTCPTCNGQGQVMRVTNTILGRMQS
ATTCHTCGGSGQVLESKPKDADAQGMIMVDETVSIKIPAGVVDGMQLKVSNKGNDAPGSN
SIPGDLIVAIEEVEHEFLKREGENLHLDLYISFPEAVLGVTRDIEAVNGKVRIKLEEGIQ
SGKILRLKGKGIPSINGYGNGDLLVHVNVWTPKNLNKEQKQFFEKSITEENFIPKPEKSE
KSFFEKVKDMFS
>LONDMIMF_02822 ABC transporter ATP-binding protein NatA
MSNILEVKNVVKQYGDYTALNNVSLQVPKGSIYGLLGPNGAGKTSLIRIINQITMPDSGT
VFLDGEQLKPEHVQHIGYMPEERGLYKTMKVGEQALYLAQLKGLSKAEAKKQLDYWFDRL
EIQGWWNKKIQELSKGMAQKIQFVVTVLHKPKLLIFDEPFSGFDPVNANLIKDEILELKK
QGSTIIFSTHRMESVEELCDDIALIHRSNKLIEGKLHDVKKEYRTNSFQVGIMTSNVEGL
MYQLTQKFTVGQTSFKTLNDDLKLEVQIGDSSPNELLNILTQMGQVTHFVEKIPSVNDIF
IQTVSDK
>LONDMIMF_02823 hypothetical protein
MSVLSLIIKREFVAKVRNKSFIVMTFLSPLLMVGLVAFVAYLSTMKSDVKEIAIHDESNL
FVKEFKNSDEYHYLDRSNVDLKVLKDSIMAEKYEAVLYIPKVDDNKELSKKIQYISNDSP
SLSYIDDLESIIAQKLTKSNFEKANLDTLAIRNAEAQVDISLAKASGEETVKGLNEIKIF
IGAAFGYLIMMFIIIYGNMVMRSVIEEKTNRIIEIIISSVKPFKLMLGKIIGTSLAGVLQ
FVIWALLGGILLFVASVFLGINIGTSPSMSPEMMATANEGISGNMQLYVNEFRNLPIVTL
LVSFIVYFIGGYFLYSSIYAAIGAAVDNETDSQQFLLPIILPLMLGVYVGFFSVLNDPHG
TVATVFSFIPLTSPIVMLMRIPFGVPWWQIVVSLVLLFGTFFLVVWFASKIYRIGILMYG
KKPTWKELYKWLKY
>LONDMIMF_02824 Transcriptional regulatory protein ZraR
MPKILIIEDEAAIRRVLVKILSEENDSYVVEEAEDGQQGLEKIKNDDYDLVLCDIKMPKM
DGVEVLEAVKKIKPEIPMVMISGHGDLETAINTMRLGAFDYISKPPDLNRLLNTVRNALD
KKKLVVENKILKKKVSKNYEMIGDSEAINHIKQIIEKVAQTDARVLITGPNGTGKELVAH
QLHERSERSAAPLIEVNCAAIPSELIESELFGHVKGAFTSAVKDRAGKFEAADKGTIFLD
EIGDMSLSAQAKVLRALQENMITRVGADKDIKVDVRVVAATNKDLKKEIEEGRFREDLYH
RLAVILIKVPALNDRRDDIPLLIHHFTEKIAAEQGNAPKQFSDEAIALLKEYDWTGNIRE
LRNVVERLIILGGNEISETDVKLFASK
>LONDMIMF_02825 ATP-dependent RNA helicase DbpA
MKLKKINEKLQRALVENGLVEANEMQQETFSTIKSGADCVIIAPEKSGKTTTLVINVIQR
LEKAFEESPRALIVVESKEKMLEMKQLFEKLGNYTDLRVYGVHDKGDIDFDKNQISLGID
VLIGTPNRLSDMFSSAGFDVNRLKMFIIEDTDDLLRLRFDTKLARMSESMGKTQRIYFSE
NITERVDSFADRTMVEPLFFEMDDWEEEEETE
>LONDMIMF_02826 hypothetical protein
MGLMKVFSGDEILAIALKTKLEEAGIETLMRNNNQSAIVLGTGGSIAVEIFIDESKYGKA
DPIITDFKMNL
>LONDMIMF_02827 hypothetical protein
MRTSIETERLLMRELQPSDDVGMFELDSNPAVHTYLGKNPVTDIEQVREAIANIRQQYLE
NGIGRWAVILKETGEFIGWSGLKFNKNVNGHDTYYDLGYRFIEKHWGKGYACETAKAFVD
FGFNEMKLEKINAYADFDNFASRKVLEKAGLHFVNFFDEDGISQAWYEIKNPNS
>LONDMIMF_02828 AI-2 transport protein TqsA
MSKTTPFYTRLAHVLVSIICLFYLAIIGETLLAPLIFAFLFSLLLLPFANFLEKRWKFPR
SLSSATVLLALVLAITSIAYLLLNQLSDLTNDLPAFKEQLLATSTTLQDWISDTFNIDNH
EQISYINSATTEALSKGTSILGQTLLSVSSVMLFLVFIFLYTFFILLHRRLLLTFLVSLF
KEKHSAVVYDVVFNIQYIVKKYIVGLFLQMLIVSVLACTAFEIIGIKYAFLLGLITGIFN
VIPYIGILTSLILTVLLTFSTMNSTSVLLVIFSVFLIHLIDSNYVMPKIVGSKVKINTLT
ALLGLVLGELIWGIKGMFLSIPIIAIFKVIFDRVDGLKPWGYVLGEDDSAPKIPVTETEQ
AIIEKMEEPE
>LONDMIMF_02829 putative ABC transporter ATP-binding protein YbiT
MITVNDISVQFGGTTLFSDVTFSINENDKIALMGKNGAGKSTLLKIIAGQNKPSGGNISA
PKDAVIAYLPQHLLTKDETTVMEETSKAFSGIFKMKAEIDELNEQLTIRTDYESDDYMKL
IERVSDLSEKYYAIEEINYEAEVEKILMGLGFVREDFTRLTSEFSGGWRMRIELAKILLQ
KPDLILLDEPTNHMDIESIQWLEDFLINSAKAVVVISHDRAFVDNITNRTIEVTMGRIYD
YKAKYSQYLELRKDRRAHQLKAYEEQQKMIAENMEFIERFKGTYSKTLQVQSRVKMLEKL
VPVEVDEVDNSALRLKFPPSVRSGQYPVVVKDLSKSYGDHVVFKDANIVIERGEKVAFVG
KNGEGKSTMIKAIMKEIGIDSGAVEIGHNAQIGYFAQNQASLLDENATIFETIDSIAVGE
IRTQIKNILGAFMFSGDDTTKKVKVLSGGEKTRLAMIKLLLEPVNLLILDEPSNHLDMKT
KDIIKDALRDFDGTLILVSHDRDFLDGLATKVFEFGNKRVKEHFEDITGFLAHKKMESLR
EIEK
>LONDMIMF_02830 hypothetical protein
MLFINGHQNLAGNLYIVFIVQFVLFIGYVVYFVLKKK
>LONDMIMF_02831 Glutathione peroxidase  BsaA
MKKLAFAFALLGCLACQQNQAQEKNTKTATPKNKTMSKETIYQFKVKDLEGNDFDFASLK
GKKVLIVNTASKCGLTPQYKDLQAIYDQYKDKGFVIVGFPANNFASQEPGTNEEIGAFCE
RNYGVTFPMMSKISVKGDDMDAVYKFLTQKSKNGLQDSEVEWNFQKYLINEKGELVKVIS
PKTLPTDPEIVNWIKA
>LONDMIMF_02832 L-methionine sulfoximine/L-methionine sulfone acetyltransferase
MEIHIRTARIEDTEAILEIVNDAILNTTAIYDYDVRTLNEQLDWFREKGQQNFPVIVATD
ENDKILGFGTYGSFRLKAGYKFTVEHSVYVREGFSGKGIGKLILSELIEVAKKQKLHTLI
GLIDTDNAGSIAFHEKFGFEKAGVLKEAGYKFEKWLDVQLMQLLLK
>LONDMIMF_02833 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase
MIYPKIPLAQSIIEICRTKGLIDIVISPGSRNAPLTIGFASNPDFKCYSIADERCAAFFA
LGMAQQTKKAVALVCTSGSALLNYYPAIAEAFYSQIPLVVISADRPLSKIDIGDGQTIRQ
QNVYANHIIYSANLTEEASQENDLKIADAITLAFVKKGPVHINAPFEEPLYETVSEPEVT
PVISETTFENPNSDEDLTPYISQWNTAKKKLVLVGVNDPDTIDEAVINHLAQDSSVVVMT
ETTSNLHHPNFINNIDTIITPFTNEDFKDFQPEILLTFGGMVVSKRIKAFLRKYRPKAHW
HIDTLRAYDTFGALTKHFIAEPNDFLKQFLSETVVVSDYNKKAQELKAARKEKHDLYVSK
IPFSDFTVFDKIIPGLPKNSQLQISNSSAIRYAQLIDIDPSIAVFCNRGTSGIDGSTSTA
VGAALASGKETILITGDVSFFYDSNALWNNYIPKNFKIILLNNGGGGIFRILPGHQETPV
FNTYFETSHCLTGEQLAKMYHFDYFSASNETALEDGLKAFYASKKPVILEIFTPTLENDK
ILLQYFKELV
>LONDMIMF_02834 Conserved virulence factor B
MIEIGKYNTLTIDRDTQVGLFLTDGKEDVLLPNKYVPKVFEIGEEIEVFVYLDHEERPVA
TTLRPYIQLNEFALLRVNYTNRIGAFMDWGLEKDILVPFKEQARPMEKGKRYLVFLYMDE
KTNRLVASSKTNQFLNNEELTVEVGEEVDLIVSHITDLGINVIINEQHKGLIYKDEVYDD
RIRTGDRLRGYIKAIRPGNKIDVALQKQGFDAVEPNAEKIMDELRASRGFLRLNDNSHPE
DIKTVLKMSKKTFKKAIGVLYKQKLIEIKEDGIYLVK
>LONDMIMF_02835 hypothetical protein
MKKIYILFLLSAHTIFAQDYSVEKSTFSFQTGFFGFWLNNESRLSDKVTLKTEIGLDVFT
QKNNDNEGSVDFDALVPVITFEPRWYYNLEKRGAKGKNIHNNAANFIALTVSYHPDWFVI
TGVENAYLNHQVAVVPKWAMKRNIGKSDFTYELGAGLGYNFIFNKKYPFDDSGEVWLDLH
ARIGYIFKSSRKK
>LONDMIMF_02836 4,5-DOPA dioxygenase extradiol
MASLQPFYNWTQDLNEEDIKHPVLFIGHGSPMNGIEDNEFSQNWAKMGKEIPKPKAVLVI
SAHWLTRGTHITAMNNPKTIHDFGGFPQALFDVQYPAKGSPELAAETAKLIHSTNVGLDH
DWGLDHGTWTVVRHMYPDADIPVLQLSIDYSKPAQYHYDLAKQIALLRKKGVLIIGSGNM
VHNLRMIDWKKLREPEYGFDWAIEMNDIFKQKIENRDHKALIDYENLSKASKLAIPTPDH
YYPMLYSLALQDNQEDTVFFNDKLVGGSLNMTSVKIG
>LONDMIMF_02837 hypothetical protein
MENINFLAFAMPAFFLFVYLEYKLAQRKKRPEIFNYESSVSNISIGLAERLINLFIAASF
YQLFYYIYEHYRIFDIPGNFWIWIGLILATDFVWYWYHRLGHEVNFFWAAHIVHHHSEEF
NFTAAARITTFQAIIRTGFWCILPFLGFHPKMVITMLLVHGAYSFFTHTQVIGRIKWLEY
VFVTPSVHGVHHASDEKYLDKNYGDMFTFWDRMFGTFQEEEEKPKYGLTHPLKSYSFLWQ
HFHYYFEIYELWKRSKGFKARWDAVFGSPAAMDQDIRPMLEKRFLQDKTDRSHRLKFRNY
LYIQLAVSTIILTVFTYYFGSLGFYDKIFGLSFIIITLINCGALLEQRKWIYYLEYSRLF
ILSTYLLYIENLAEYFLVPVIIMIAAEKMFSLSRKYQNLVLQMESAKR
>LONDMIMF_02838 hypothetical protein
MKKFYSDHHIPTVTMLWLIVLFLIATPFFTPNQIWGEMFIPIIIVSLCALLILWILLDTK
YVIKNSFLHYTSGPIRGKIDIYKINAIVHQKKWFVQSTLKPALGSKGLIIKYGKFDDIYI
SPKRKQEFIDALLEINPHIEIE
>LONDMIMF_02839 hypothetical protein
MRQTFLPIALLAFAFSAYSQKYEFQTIKDIEATPVISQDITGTCWSFSSTSFLEAEIIRT
TGRKIDLSEMYNVRNTYPKKAWNYVMRQGKAQFGEGGLNHDVINSAMQFGLVPLTAYSGL
VGNATKHDHSKMAKELEDLLKKYADPSKKLDPKWKTEVEAILDKYMGANVTEFTYDGKKY
TPKSFLEMTKLNLKDYVTITSFTNEPYYKTFILDIPDNFSNGSFYNMPLDEFVQNVDNAL
DKGYTLALDADVSEKTFSGKNGIAVIPENEADEKTILTEIKPEKNITPEFRQQEFENFNT
TDDHLMHIVGKVKDQKGNIYYKVKNSWGSKNLGNDGYIYMSVPYLRLKAISVLLHKDGLL
KKTKKELGV
>LONDMIMF_02840 1,4-dihydroxy-2-naphthoyl-CoA synthase
MSSINWETVKDFEDITYKKSNGVARIAFNRPDVRNAFRPKTTSELYQAFYDAQEDTSIGV
VLLSAEGPSSKDGIYSFCSGGDQKARGHQGYVGDDGMHRLNILEVQRLIRFMPKVVIAVV
PGWAVGGGHSLHVVCDLTLASKEHAIFKQTDADVTSFDGGYGSAYLAKMVGQKKAREIFF
LGRNYSAQEAFDMGMVNAVIPHAELEDTAYEWAQEILAKSPTSIKMLKFAMNLTDDGMVG
QQVFAGEATRLAYMTDEAKEGRNAFLEKRKPNFEKKYLP
>LONDMIMF_02841 hypothetical protein
MEFTNETIDINQLPKFEEVHFSPLNKNYIKVVYINIAIVLLIIAIGIGVLIYFNEDFQNT
QTYLVFGISYAVFALILYFSSVMAVKRRAFALRDKDILYKRGLLSTTTTIMPFNRIQHVA
MHEGAFSRIYKLAQIQIFTAGGNTSDVKISGIEKEKAESIKELLMQKIQNHI
>LONDMIMF_02842 hypothetical protein
MRLDFTTPQRQSVTGIIVMFADTFQSIVRQFWVLLLVILFKLKEDQYLVVGLGFLGLVLL
TLVIGYLKYRNFTFYLDEEKQEFILRKGVINKSKISIQLSKIQQVDINQSIIQKIIGVYS
LDIDTAGTDKKEISIRAIDQRLALLLKEKLLDYGNKDEEALDDNQEVIKESKTFLKISYN
TLFKVGITSNYGRTIALLVTFVITLYQSFKDAINAFEIDEKEVDTVFERGAGFFSAGILI
FGLLVLVLLINIVRIFIKHFDFVMIKQKQSLVITSGLFAKKNTLLNPDKVQITSYSQNYF
QKKFRILDMNMKQASSDEVKEQKKKSNAIEVPGCNTEERDEILRIILGKIPQKGNQYRSN
FRYLIFRTFSAVAFMAVILTLLHYAEIGNMDLYIPLVFVYLCLISSLIYFGYRNHALYVN
QDFVIKRHGAWDVEHEIIEPHKIQAITAKQYFWHKSADVGHLILHTAAGDVDFRFGDFTH
IKQLVNYWLYQVETSEKNWM
>LONDMIMF_02843 1,4-dihydroxy-2-naphthoate octaprenyltransferase
MKHWVEAARLRTLPLSVSGIIVGSMYALAYPTANVLTPTEVFNWQLFGFAILTTLGLQVL
SNFANDYGDGIKGTDNEDRIGPKRAIQSGVISPQAMKRAIIITSVLTFISAVLLIYFAFG
KTNIGYSIFFLVLGLLAIASAIRYTIGNTAYGYRGYGDLFVFVFFGLVSTLGVNFLYSKE
LDYKLILPAIAIGFLSVGVLNLNNMRDEESDRKSGKNTIVVKIGGAKAKKYHYFLVISAM
ILVLVFAVLNNFQFDQYIFVVAYFPLISHLITVYKNKDPKKLDPELKKLAISTFLLSVLL
SLCLIFFLSDIIVNN
>LONDMIMF_02844 Hydroxyacylglutathione hydrolase
MKITFYGHASLGIEVGGKNIIVDPYITANELASHINIEELKADYILVTHAHGDHVLDVEA
IARRTGATIVSNAEIAWYFEAKGLKSHPMNHGGSWKFDFGTVKYVNAIHSSSFNDGKYGG
NPGGFVIEGEHKNIYIAGDTALTFDMKLIPLRTKLDLAIFPIGNNFTMDVEDAIIASDFV
ECDKILGCHYDTFGYIKIDKEEAKKKFFDRGKDLMLLEIGDSIDI
>LONDMIMF_02845 hypothetical protein
MLTRKITFLLFLVLAQSAFSQQDGYWDKERATTKEIIVSAGEKITVKTEDLPMGTTEIVY
RITILDENQQMANSLSSLLKAIPDPSGISQGAAGAVFLTSKISGDDKCKYGIFSSNAFAK
EYKEKGKTDNACLFQNSPVNKEARRLSIDKSSCLKTGQEYLWFGFESMNWIMKQKIVLEI
VPWVDNKLSRGWTLENRQTIIRQIKASDLAKKMLNADDFSLCILEKMQKRYKFQEFQNLL
AIEKNKAFKDFGNACLLEKPANKSILTAIRLDAMQYFKNRKYEQAIDLLQTGIMENGNAS
VLDYNALGQYYLYSRQLDKALKALKEGESKDESELLIQLNMAHVYLLKGDYKKAKEIHKK
YRGQNVTPTLSWKARTQFDFDDLRKAGFVSDDFDRILKLLEE
>LONDMIMF_02846 L-Ala-D/L-Glu epimerase
MLKASYKKYILDFKRPSGTSRGIMTHKETWFLILEENGKRGIGECGILRTLSADDRPDYE
EKLKWVCENIHLGKEKLWEMLLEFPSLQFGVEMAFLSLESETSFLLFPSDFTTGKKNIPI
NGLVWMGEPAFMKSQIEEKLAEGFHCIKLKIGAIDFEKELRLLRFIRENYDDSTIEIRVD
ANGGFTSSEALLKLNQLSEFKIHSIEQPIQKNQHDSMSELCKNAPFPIALDEELIGVFDY
AQKEALLQKIRPQYIILKPSLIGGFRGSEEWIALAEKYNIGWWATSALESNIGLNAIAQW
TFQKQNPMPQGLGTGSLYTNNFDCPLEVKKGELVYNPDLDWNIDLLLKA
>LONDMIMF_02847 Caffeyl-CoA reductase-Etf complex subunit CarC
MTNPILNSFLPLFYIAWSDDVLTEKEATLLQESINSQDWLTKADKKELLSKINIDNPPTR
TELLEWKESIKKAVNEDNEEESLTDVALKLALLDDPKISNEKLKPLYFYLQNLEKSLGII
SNEAVYAFKETHDTITSKYSTEATFSVEKLTEILDGNQAEIINTVKKVISRPTFKYETST
DIEVYREKVLKWCKILAKEGLGATAYPKKHGGQDDIEAYFSIMETLSYHDLSLVIKFGVQ
FGLWGMSIQSLGTEKHYAKYLKDIGSLKLPGCFAMTETNHGSNVKSLETTAIYDHRTKTF
TINTPHKLARKEYIGNAARDGQMATVFAKLIIDGKDHGVNAFIVPIRDSKNNVLEGITIE
DCGHKMGLNGVDNGIIYFDNVIIPKENMLDRFASINSKGQFVSPIASDNRRFFTMLGTLV
GGRIGVPRSALAAAKSALTIAISYGDQRRQFGPQGGSEVPILNYRIHQRRLMPYLAKSYA
VHFALQYVTQRFVKRQESEMQEIEALAAGMKAYSTWNTRDTIQECREACGGKGYLSENRF
DALKNDTEVYTTFEGDNTVLMNLVAKNRLTEFRNQFGEMNVLSLFNYVVDQAKTSITYKN
PFATRNTDENHLIDSEFHIHAFTFREKETQASAAKRIKKLLDSGLDSFDAFNIAQHHLIS
VSQAYLERIVLEQFQLQVENTKDEGCKAILKKLCQLYALSTLEKNASWYLEQGYMEGVKT
KAIRKSVNQLCWEIRQNAVPLVNAFNIPESCLSAPIVTKQ
>LONDMIMF_02848 hypothetical protein
MNTNEQIIEEFYAAFAAQNAETMSSCYHPDIVFEDPAFGKLHGKDVSDMWHMLIERAKGN
LNIEFADIKADGQKGTATWIATYHFTKTNRKVINKINASFEFKDGLIIKHTDSFDFWNWA
KQALGTTGLLLGWSSFLHKKVQRQALESLRKYQQKNNIDN
>LONDMIMF_02849 hypothetical protein
MKKIFLLLFGIAILGACKSKPSTPKMAKLELSQVSPSQKNKAYELGKRVLNACNTSKFKP
FTKEEATDKVIQNTTIERLSSTCRKFSIKYGKFEDLRLVEVIRNNTDESLIFRYKADYQR
KFAQKELQVTLDKDNKVAAIRSTDWTDIYTP
>LONDMIMF_02850 hypothetical protein
MYWYTPKDSVDLAFQNAKSKIITDLNVFEFHKIIAPLVALSREDHTDIFLPKEVKEETNK
NENIRFLPLTVVFLGEKLYCTHNASNSPEKIENLEIERINGEKPKEIVAKIGNLFASDGY
IKTVKYSDLSGFNFSKYYYYYYGIIEKYEVKFKEIAEPITINSLPVSQINTNLKKNISIV
REKIENEPLLFKIINPKTAYLDIQTFSDDIIKKDSKYRTLKNFLKHSFFEIKDKNIENVI
IDVSRNGGGTEGNEGLLYSYFGDNYQKYFKVRAKAQKVILNNGIDKPIKLKVFGLLERTF
ANKKMNDGSFERKNNIGPGLMAYKKSPKNKFKGDVYVIISPITYSGGSEFSNMMYSKGLA
TFIGQETGGGYFGNTSGYSQNLTLPNSKITIEIPALQFVMNVEPKLSFGSGVKPNYEVIP
TINQYISNENICLEYTLKLINEKK
>LONDMIMF_02851 hypothetical protein
MKNKKTLVLGASSNPARYSYMAIRNLTAKGHSVVAIGLKEEEVLGVKIQTKQIPFTKVDT
VTLYLNPQRQRDYYNYVVSLSPKRVIFNPGTENPEFYQLLKLNNIQVEVACTLVLLSTNQ
F
>LONDMIMF_02852 hypothetical protein
MNFFKNFFTIMVLLISFQGAYSQVLEGHVYDMQNNALQAATVYLDGSTVATTTDAEGYFR
INGNVNSRATLIVSYMGYKTIRLENPFQHKKIKVLMEEDAITMPEVVLQKGPFTRKEMMK
AFKEQFLGNTNAGSSCKILNEDDINLYYDIATNTLNATSHKPIKIKNSYLGYEVFFELAD
FNVVYRRRSLSSFSIDKSYFSGTTFYKELSQSKKTDKRRLNSYLGSTSHFVNTIANESWD
KERLALFVDGFKVDPKKYFAVSDTLGVKKITVLKEPMKQVPIYKKETPEVSRKGQTIIIG
SQAEITGYNETEVPFNVLFNDKHQSLADFTEKVIFVDENGNYSPVYGVMVGGYMSSLKVG
DMLPIDYYQSVKGKY
>LONDMIMF_02853 hypothetical protein
MEIFIYVFAALFSVINPLGAIPIFVGLTQQDTKEERSRISLWTAINVFIILIISFFVGQY
VLNFFGISIDALRIAGGLIILNSGFALLSGRFNKTRGVNKKVENDAQNRNDIALTPLAIP
MLAGPGSISLLIALYQDYQHLNEQIIVCLSIAAVAIVIFLVMRSAHYLSRILGASGIVAI
SRIIGFIVIAIGVQYISSSVVNILKTI
>LONDMIMF_02854 hypothetical protein
MACQKYPYLKKVIELIMTKLFNIHYMRYFLLPILFFFSSCSVKQYVPNNNLLDKKLVIAY
INDGGYKLEIDKTEFIKQINEKLYKGESIIDNLEIKKDYTVGDKKIEYHYINLSSRSRHL
NIVRFLFNDNGKLYIDKSYNEETFTYVDFYIACEGYEGCLPKLFIYDSVFSWSCRDFVGC
VTYETAETYKCKQSTIVF
>LONDMIMF_02855 hypothetical protein
MIKNINCLALCCIFIILLSFNSCDSESDTITIKDTVNNITIGYKTIAPKNIIEVGDNGDV
KFLIKKSILLSNWNHNLKLLEKIDANLTDIRVFREYDNYYIQAVGKEWTSTILLRINEKV
GIGEGISCTSNICSNSSTECVPKPDKKSCTGCGFKVGDCTKTVTAIALMDEEFTLQKP
>LONDMIMF_02856 hypothetical protein
MIRPVAFRMNEQTAVNNYYQKVLDGLHPETVNAKAQQEFDAFVEKLRAAGIDVIVVEDTK
SPDTPDSIFPNNWISFHENGDVALYPMFAENRREERREDILDLLEDQGYRIDNIVDYTSA
EEDNIFLEGTGSLLLDRANGKAYCALSPRADEELLIEFCEDFDYAPVIFEAFQTVNGERK
LIYHTNVMMCLGETFAVICADSIDDKKERKMVLDNLKADGKEVILITEDQVNNFAGNMLE
VRGKDDKRYLVMSAAAYKSLKPVQIEKLEYHCEIISSSLDTIEACGGGSARCMMAEVFLP
KG
>LONDMIMF_02857 Arginine deiminase
MLQLNVKNETSRLRAVVLGSAVNNGPTPTADEAYDPKSLEHILAGTYPVEKDMVEEMEAF
NKVFQKYDVKVYRPEMIENYNQIFTRDIGFVIDDVFVKANILPDRERELDAIQYVIDQID
PKKVVRPPDEVHIEGGDVMLWNDYIFIGTYKGSDYKDYITARTNMEGVKYIKELFPHKKV
REFDLVKSKLEARDNALHLDCCFQPVGKDKGIIYKSGFRQESDYIFLVNLFGKDNLFHID
RDEMYHMNSNVFSIAENVVVSERNFTRLNNWLRSQGFTVEEIPYAEIAKQEGLLRCSTLP
LIRD
>LONDMIMF_02858 hypothetical protein
MKTKKAIIIGGGPAGLTAAYEFIQNTDIQPVVLEQSEFWGGISRTVNYKGNRIDIGGHRF
FSKSDVIMDWWCKILPIISEEKAIRISYQNKSKELNTIEFPSDVKNLDNVMLVRSRKSRI
YYQKQFFDYPIALTPETVWKLGLFNTFLIGLSYLKSVAFPIRNEKNLEDFFINRFGKKLY
KTFFKDYTEKVWGIKCTEISSEWGAQRIKGLSIRKSVAHFLKKKFSKKTDKNISQKDTET
SLIEYFLYPKFGPGQMWEEVARKITDNKGELHQNLKVIKIQAENDRITAVTVQNLLTKEE
KVLEGDYFISTMPVQELIASLEVEVPEKIKDIAEGLVYRDFITVGLLLKKMTKEEITDNW
IYIQEPYVKVGRLQIFNNWSPFMVQDPNTTWVGLEYFCYEGDALWNKSEAEMKELAIKEM
VKIGMINREDVLDSVVIKMPKTYPAYFGTYEKFNAIIDYTARFENLYLIGRNGMHKYNNQ
DHSMLTAIQAVQNIKNGISGKENIWAINTEQEYHEEK
>LONDMIMF_02859 hypothetical protein
MSKFVCLKTLKKAQLTTFFNNLNDSEFRKHFLFLSFFMLFFLALRIIQGDFRLADSEDYF
ATAELLKSGEYFSSSTDFGMATLLTKRPFLYPILILFPGFSNDLVIVLLQTLLGFLNIYL
TLELFKKLGGKSFRLVTALVLLTPSIFIYTHLVMTEALVMTLSLLMALQLTGKLDSKKTF
RIQLIGIALVFLKPAFYLFPIVSLLFFLFYFVRTKTFHFSVFLPLLLTIGYMGFNKERTG
YFHFSSMQNINLIDYNLYLFKAQKEGAEAANQWRDSVYLQVEKLPTFEKQSEFLATEGKK
AIQENLIPYSVFHFYGAVRGSIDPGRFDLMTLVEKYDPNQGFLNMLSTAGLKKTISNFFE
YKYFWIILILIPIFFATLFKWALLFRHLWQRKKRIDFAGTFLVIFIAYAILITGPVNASR
YMMPLQGILIAYAVISWESYRAKKSSTKQ
>LONDMIMF_02860 Citrate synthase 1
MSKTAILEIDGNRHEFPVLVGTENEVAIDIDKLRSATGAITLDPGYKNSGSCKSEITFLD
GEEGILRYRGYSIEELAEKADFLEVSYLLIFGELPTAKQLEQFETDIRKYTLVNEEMKNI
IDGFPKNAHPMGVLSCLTSALTAFNPKSVNVESEKDMYEAVCKTMGKFLVIATWTYRKSM
GYPLNYYDNTKGYVENFMRLMFELPTGPYTADPTIVAALDKLFILHADHEQNCSTSTVRM
VGSSHAGLFASISAGVSALWGPLHGGANQAVLEMLEEIQKNGGDADKYLAKAKDKNDPFR
LMGFGHRVYKNFDPRAKIIKKAADEVLATLGVNDPILNIAKKLEEAALEDEYFKSRNLYP
NVDFYSGIIYRALGIPTDMFTVLFAIGRLPGWIAQWKEMRVNKEPIGRPRQVYVGSPLRD
FVPFEKR
>LONDMIMF_02861 Internalin-J
MKRLLLYGLLFLYGFSYAQNVDILDPSFKSKLLAADVSNRIAKDGNGTPIRIDLNNDGEI
QLSEAVRVVELNVSASDISSLQGINHFSNLKILECYHNSINELNLSNNPYLEYVDCSENQ
ISSLNLNGLVNLKHLDCRVMGSGNLTSLNLTGLTALRVLRCGRNSLTTLDLSPVTNLIEL
DCSVTGLTSLNLNGLVNLKSLDCSLSQLSTLNLASLGNLERLDYSYNPGLASLNISSLTS
LKELSCNAMGLTSLNLSSFPELVSLSCHSNILTNLDFSANSHLERIECSANQLTALNVAG
LPSLTTLMCSYNQFSILNLSGLENLSHLDCRNNNIVIIETAGLNGLISVFCNNNSLTKLD
LSHSPYVSVVSCADNPQLISVNLKNGFSLPQIFDGFDFANTPNLEYVCADEDELALFQSF
FTGQGMNVSVTPYCTFTPGGDYNTIAGMLRLDENGNGCDTNDRTQPFIKVKINDGIEESS
VFTDLETGYAFYTQSGAFTLTPATENTSFFSFSPASTVVNFPNNNNNTQTQNFCITPNGV
HSDIEIAIAPVVPARPGFDAVYKVVYKNNGNQTVSQNAGITLRYNQDLMSFVSSTPVAGS
QTPGRITWGYTDLHPFESRSFTVTMNINRPTDGHPVNINDILSFNASITAPGDENTNDNT
FTLRQKVVGSFDPNDISCLEGDIVPPTEIGEYLHYLVRFENTGNAPAQNIVIRNEIDEEE
YDVSSLQILDSSHKLRARVKGNRAEFIFQNVYLDSGGHGNILLKLKSTENLVAESTVSSR
VGIYFDYNTPVLTNRVTTVFKMLSVGEKDLDQTIKIYPNPVNKMLNIKAAGLIRTVYLYD
AQGRILMTQLLGKNEVSFDLSNYAAGVYFVKIITDEGAKTEKIINRKN
>LONDMIMF_02862 Transcriptional regulatory protein YehT
MITAVLIDDDSNLRKGMKSLLSRYAPEIKILGEADSVKTGIKVMDSLKPQVVFLDIQLTD
GTGFDILENLAQKNGKSSSHIVFITAHEEYAIKAFRFSALDFLLKPVDPEELEKVIEKIK
STLEKNDNYAHIDLLLENIRKKVDNFKRIALSTSDGIHLLEVSDIIRCESEDNYTKFYIK
NGKPILISKTLKEYEELLAEHGFERIHQSHLINLSCLKSYIKKDGGYVIMADNSKLPISQ
RKKERLHELLKMI
>LONDMIMF_02863 Sensor histidine kinase YpdA
MNMKSFVICFFMLFCVLSYSQEKTIDSLKNVLNHTKNDIDKAELLNAIASEYMSSDPKQM
REYANKALELSKKIKYRIEEGNACLNLGNVNVILGNYSLALDNFSNAQEIFEADLVTDLK
NSTKIKNGLARAYGSIGIVFSEQSNYAKALQYHLKAVRIYEEMKDGARTARIYNNIGIVY
QALKEDFKALDYFTRAQKLQEKAGDMTVGITTTNIGNIYLRQKNYSKAFEYYTKSKNTFD
KSSDARGLGELYNNLGSYYWQTGNLPKATESWEKAIAQFKSIDDKFGISDTYSHLGNFYY
NQKQYNEAMANAVSALKLAKELDVLEQIMNSEKLISSIYEKQNKPDLALEHYKYYNIARD
SLVSHENIRKSVQAEMNFDFEKKQTMQQEAHEKRELLFKEQNKRYQLQAIFGALFVILIF
GIIFLIYNRMQLKKTLTLQKELAEYEQKALHLQMNPHFVFNCLGSISSFIVQNGTDSAIK
YLSKFSKLMRLTLEYSKESLIPIDKEIESLQNYLELEQLRSDKMFNFSITKSDLIEDDMA
LPPLLLQPFVENAIIHGLIPKKEVGKIDIDFSLKEESLICTIVDNGIGFEKSQELKAASV
SIHKSMALDITRKRLEMMEAVTSKTSKVEIKELKDENGNPVGTEVVLHLPIQYIK
>LONDMIMF_02864 Enolase
MSRIIKIHARQILDSRGNPTIEVDVVTEHGILGRAAVPSGASTGEHEAVELRDGGKAFMG
KGVMKAVENVNIKIAEELLGNSVFEQNLIDQRMIELDGTPNKSNLGANAILGVSLAVAKA
AANELGLPLYRYVGGVSGNTLPVPMMNIINGGSHSDAPIAFQEFMIMPVKAKTFTQAMQM
GTEVFHHLKKVLHDRGLSTAVGDEGGFAPNLAGGTEDALDSIKKAVENAGYVFGEDIKIA
LDCAASEFYVNGNYDYKKFEGETGKVRSSKEQAEYLAELASKYPIISIEDGMQENDWDGW
KYLTELIGDKVQLVGDDLFVTNVERLKKGIDKGIANSILVKVNQIGTLTETIAAVNMAHN
AGYTSVMSHRSGETEDNTIADLAVALNCGQIKTGSASRSDRMAKYNQLLRIEEELGSTAY
FPGEKAFKIK
>LONDMIMF_02865 hypothetical protein
MLSLLKTVRKFFGEAIVVTQEVDDIIQSPIVKESIINNSDCKILLDQRKYMNKFDDIQAM
LGLTDKEKGQVLSINMNNDASRLYKEVWIGLGGTHSAVYATEVSLEEYLAYTTEETEKME
VMQLAAELDGNVELAIKHIAMQRRDNSNQ
>LONDMIMF_02866 hypothetical protein
MKKVLYLVCTALMLAVAPSAKAQWVVTDPANLASGIINSANEIVQTSSTVSNVIKNFNEV
KKVYDQGKEYYDKLKAINNLVKDARKVQQTVLLVGDVSEMYVQNFGKMMNDPNFTPQELT
AIGNGYSALLNESTELLKELKQIITSSSLSLNDKERMDVIDRVYKEVKDYHSLVRYYTNK
NISVSYLRAKKKNDAQRVLELYGTANQKYW
>LONDMIMF_02867 hypothetical protein
MEWDNLHELLRSLYDDMMPLAGDMAAVAKGLAGLGALFYVALKVWQALSRAEPIDMFPLL
RPFALGLCIMFFPTIVLGTINAVLSPVVVGTHQILEDQVLDLNKLQQQKDQLEYEAMVRN
PETAYMVSDEEFDKKLDELGWSPSDSGTMAGMYMDRQAYKIEKAIKDWFRNLLEILFQAA
ALVIDTIRTFFLIVLSILGPIAFAISVWDGFQSTLTQWLTRYVSVYLWLPVSDLFSSMLA
RIQSLILERDIAMLADPTYIPDTSNTVYIIFMIIGIIGYFTIPTVTGWVIQAGGAGNFTR
NVNSTAMKAGNIAGAGAGSTVGNIGGKLMNK
>LONDMIMF_02868 hypothetical protein
MEFKTLRNIENSFRQIRLYAIVFAVLCISVVGYAVWRSYRFAEEQRQKIYVLDNGKSLML
ALSQDASINRPVEAREHVRRFHELFFTLAPDKNAIESNMKRAFNLADKSAFDYYKDLSEK
GYYSRIISGNVQQRIEVDSVVCNFDNYPYAVRTYAKQFIIRSSNVTRRNLITSCYLVNSV
RSDNNPQGFNIEKFAVVENKDIEVIER
>LONDMIMF_02869 hypothetical protein
MEALSDLSTFAKILTDKGYNGYFHTQGSYAGKLKDSISEYLESCQKGADTLPKQDLLLTG
YLQWSGDDKPRVECSMWVKYLNGKFSLSRMEVAKKDGFGQLLKKSELANLSVMSAPKLTE
AVALVNDAPKQQAGKSPKRFKL
>LONDMIMF_02870 hypothetical protein
MKKLRANMDRYFDKQDERWRALPLRKQHQYTLYFFVGYLLLTVAVIGKVMYDTSKSGNGM
VIEHIENPVLKSKNPARLQDSVSTILKNQIYERK
>LONDMIMF_02871 hypothetical protein
MKENEKRVSFLVEGEDQNGASNLPDNKKSNKDKLKKPIIFLLMGVVFLGCMYLIFKPSKD
KKAVENIGLNDAVPQATGAGMPDDKSKAYEQEMLERKEQEKRNALTTLSDYWNTEDTASA
DNEESLPEEDEESNGFGGGGRKSGRNGNSVLNSYRNAQSTLGSFYQDNNSETMELRKQVD
ELKAKLSEKDVPPVATVDDQLKLMEKSYEMAAKYLPQNANTGNAAPANGATTGAAGANQK
EQFVSFTPTRKNIVSALYREPSDSAFAADWSQTKNRGFYTAGSIEQAVQPKNSIKACVHE
AQTVVGETGVRLRLLEPAKTPQRTIPKGTIVTANAKFQNGRLQLKVTSVELEGNIIPVDI
TIYDLDGQQGLYVPYSPEMNALTEMAGNMSQTGGTSVMLTQNAGQQVAADLSRGVVQGIS
GYFAKKVRTPKVTLKAGYQVFLVSKK
>LONDMIMF_02872 hypothetical protein
MKNHLKTFWAIALILGFAVTTYAQDSATAKTPLALGKIEPYRMEVTYDKTSHLIFPTAIR
YVDLGSEYLIAGKAEDAENVLRVKASVRDFEPETNFSVITNDGRFYSFNVYYSSYPEALS
YDLLTMQKAVDKANGNDVLFEELGNNSPSLAGLLLETIYKKDKRIVKHIGAKSFGIQFIL
KGIYIHNGKYYFHTELRNRTNVPFEIDFINFKVVDKKVAKRTVVQERPLTPLRTYKPLDG
IAGKSTEQNVFLLDQFTIADDKVLLIEIFEKNGGRHQTLQVENSDLIKARLIDDMHLKF
>LONDMIMF_02873 hypothetical protein
MKKYIYTVLFVLIGITAAQAQRMLPKQKGLEISAGVLSNDKIGNDYYISAAMTINGKNGN
YQLWALEYTHQYHDYKDLRIPQETYSTEGGYSFFLLGDARKNITLNFAVTGVVGYEAINR
GEAMLYDGAKILSEDNFIYGAGGRLIFETYLSDRFVLVLQGRTKVLWGTDLEQFRPSAGV
GLKFNF
>LONDMIMF_02874 hypothetical protein
MIAIFNKFRIGLLPIYVLLAILTASVSLVSCSKDDELEIQNDFPFEVNVMPVPKDVANGQ
TVEIRITIQRTGNYSNTQYFLRYFQFDGQGTLQYYNEPPYQPNDLYQLPTEQFRLYYTST
SAVSQSFDVWISDSFGNEKQITFQFNSSD
>LONDMIMF_02875 hypothetical protein
MVASLVIGIIFLVAGLGLRYWINRRKFYRRSPMGAEGFSSYESSVFIKLIERVGKWIAYA
LIIFGLLSLWVYSREKKEKSSPNTEIQNPR
>LONDMIMF_02876 hypothetical protein
MNTIFLTPYTLIENTDYPTDTKIVIRASDFENVLFQDGRITFSFINCRFKKLEIENSDTI
EFKDISIQFIGCYIEEITVENIITTNLSIFFGSSILQGRIKNSNLLSVTVNNCFLNNSLF
LLDLKIAVVSFTEENIYPVRWKRLLKSVNTTLENLLLEKQSFYIYDCKEIVFNFNENSTD
KIGLYKRPHSNNIENKIGYFPSEAEKKNFKVSLNIQYSADKEHKLTKVINAKLLALSMSG
YSTGEVLVENCKIDSWYIRNFSAQLGSNFYDIKPFRKETEETKLEIHKSNLDKVWFDNVS
FDGYSTISLYRNKFGQTTLTACDFPTTYKGFDKIQTIENIHYPDKKDNNYFKTRYEIFVQ
FKKQLEASGNFYEAQKFQAISNEALKNIENLPYWDRLILKVNSLSNNHGLSIKEPFIATI
AISVVFYVLYLWSLGRIFNCSDVDWNLVGYYFSFLDITHRSDFLVNKTELNGFSLTIDYF
NKILVGFLIYQFIAAFRKYGKSKV
>LONDMIMF_02877 hypothetical protein
MEVIAIQKSALDGMNNGLRELLELTENATRKYTPIFKEEKWLDNQEVCLMMNITKRTLQI
YKDKGLLPYSRLNRKNYYKRSDVQALLEAGQPYNTTENGFIHE
>LONDMIMF_02878 hypothetical protein
MDLFTNDNEEIIVHQEMITQLRNRIESILKNYRPVMNGEIYLSGEDVCKLLHISKRTLQQ
YRDDNILPYIQIGGKIIYKESDILTILEQNYISHKAVLP
>LONDMIMF_02879 hypothetical protein
METGTAQQRITLAFINDNSPILDLTCDNLVASGLEVLFRSENIEDGLSQLSALKELPKVC
IIDLDFYNKNVLEQLQKLRTQYPTIKLIAHSDIDTEKTVKSLLEIGFAGYLLIGSDADDF
RKAIEVATK
>LONDMIMF_02880 hypothetical protein
MIETEISITVNRKPDINLIEQKIIENKFQFPIYIREYEFSYQINFTSDYEEWELDTAILN
SFPGYEFTKNLEKGRKEIRIQIMRYQSELSTDGWGRQIENPLNETKYLVKTSASKPEKFS
PKIKVLFEDKEEYYFINIVDGINKTTDEKGFLLLDDFKTKNEDGNAEILKDKLYKSPQEA
FQWGFYKISDVVENDFNIYLENKKKEIREIQKLPRKIIRDFINACNSSDESNILKHLDEQ
IIFEKRKNWKTIFEVEGISKFKEYLSSSEQELCGKDFKIRSSWNFNLPNVTIGVKYFPSS
VDKGSKFNLKYEQMTITLDNNKIFGIIYEI
>LONDMIMF_02881 hypothetical protein
MKIRDKNGNWIEVTDLKKGIWQTGWYKEYQHNPPVESDKERQAYWADIHEKLLALKVGLN
NPKN
>LONDMIMF_02882 hypothetical protein
MKLSDKATAHILVKANTNSEWDNCGFAIIHLSEEWKKEQEKRLALVKPLEGNSYFCSMNY
YDTAVDFYSTGEDDNPNIEEMLNGKEWVFVELDEQEQETFTVPENRLDCFRLVLRANGTG
YYTAYGKHTSEEFWTEEFSLIKLIA
>LONDMIMF_02883 hypothetical protein
MANWCNNWVVFEGTAEAIEQITQLFKSMAEQEQKDNCGHLPHFVQDTHGDYFYNISQDNE
SAGVFQYETKWSPNTDAVKQIAEHFKVNFTQDYEELGCLVYGQAIFEDGILTNTCLDSQD
FCSYELDEDTDTYHFEGKEYDSEWEILDTLLERKSENQLNTIKI
>LONDMIMF_02884 hypothetical protein
MKALDKMDNLDKAGLLCKLFPAELENLQNAIKTQCDYFLQNETAFREGWYQKGFFTAEFW
YRLVQNAQKGIDKNEPLWKRPNWFTDHFFDGHNSIFAIHCLIEYTEDAQCDPQLKQAIHL
LFGNDKFLQITLNDK
>LONDMIMF_02885 hypothetical protein
MAHNINFNEQTGRHSFFSVQQKAWHGLGQIVEQYPTSEEAIVHAGLDYEVIKSPLFTQGR
TMNIGDSGELIEANDILVPNSFATLRTDTNRPLGVVGKDYHIVQNREAFNFFDAIVGGGD
GILYETAGALGNGERIFITAKLPDYIRVGKGDDVTEKYIFLTTSHDGSGSITAAFTPIRI
VCQNTLNASLRSMTNVVRIKHTSGAKQRIENAHKIMGLANTLSNQLEGIFNQWTKVRVTD
REVRKLIQLALCPNKETLDLLKKGAEDEVSTVFRNTVDDAFQYAMISDTQQMETTKGTLF
GAYNAVTGYFQNVRNYRDGEAKLQSIVMGGTAQLKTQKAFELCTDFAYSGAEIFNFN
>LONDMIMF_02886 Tyrosine recombinase XerC
MEQTKKSTFKLLFYLKKNELKKNGNAPIMARITIDGTPKTFGTKLEIDPNNWDLKHGRVQ
GKSAQALSINKKLDNIRGRIDKIYEDMLKHEGFATAQKVKLSFLGVGVMDDAILKVFNDQ
NEDFKKLVEKEERSQSTYNKYITVYNHLTTFIKERYHRDDMAFRELTADFIREFDFYLRY
DLQSSHNTVWVYTMPLLAVVELAIKKGLIRDNPFQDYEINMEETDRGYILKEDVEKLIMC
VPSHPRYELVKDLFIFSCFTGLAYADIKKLTRNNIQSFFDGHQWIISRRKKSDIASNVRL
MEIPKRIIEKYQGTTRNEFIFPVPTNATCNTHIGKLVEKAEIITEQKVTFHTARHTFGTM
FLTEGVPLESLSKMMGHKNISTTQIYAKITSQKISKDMDLVTPKFKAMEEAFMMAI
>LONDMIMF_02887 Altronate dehydratase
MQKKILKVNPKDNVIVALLDLSAGESVHLDGAEYTLVKDIKAKHKFAAVDFKEGDQIIMY
GVIVGKANQFIEKGEVITTKNVKHQSAKVEGKTETLGWTPPNVDQWKDRTFMGYHREDGQ
VGTENIWLFFPLVFCENKNIETLKDIFEKELLHEKASKHQLLLRSLLNGGETSHTAVEEE
EDTRVFKNIDVRFITHQGGCGGIRQDAEALGRLFAGYVNNPNVAGATVLSLGCQNLQVQI
FMDALHALAPDNKKPIVVYEQQKSGTIDEMLTGVIKDSYEGIKQANNIERKPAPITKLNI
GLECGGSDGFSGISANPVLGEVSDIMAAVGGTTMLAEFPELCGVEQELVNRCINDEDGVK
FLQLMKDFEKSVVAAGSGFDMNPSPGNIKDGLITDAMKSAGAAKKGGSAPIVEVLDFTEY
ATKPGLNLLCTPGNDAECTTALVGSGATVVLFTTGLGTPMGNPIAPVIKISSNTVLAEKM
SDIIDFNAGTVISGDKTIPEAADELLEYIIKVASGEMKTKADLLNQNDFIPWRRGVSL
>LONDMIMF_02888 Altronate oxidoreductase
MPVNLTFSLAGLIRFYQGSFGEKALLLNDEEGIVAKFKEIWANEEYEKVAELALSEKSFW
DTDLTQIEGLKTAVSKALYEIDHNDMETAYNNFVEFNS
>LONDMIMF_02889 ATP-dependent DNA helicase RecQ
MNSNEIDIHKELKKYFGFSQFKGLQEQVVKSIINRNNTFVIMPTGGGKSLCYQLPALIKE
GTAIVVSPLIALMKNQVDAIRSLSSENGIAHVLNSSLTKTEIAQVKKDIVSGITKLLYVA
PESLTKEEYIQFLKSVPLSFVAIDEAHCISEWGHDFRPEYRNLRTIIKQLGDIPVIGLTA
TATPKVQEDILKNLDMVNAKTFKASFNRPNLFYEVRTKTKNIESDIIRFIKQHKGKSGII
YCLSRKKVEEIAQVLQVNGISAVPYHAGLDAKTRAKHQDMFLMEDVDVVVATIAFGMGID
KPDVRFVIHHDIPKSLESYYQETGRAGRDGGEGHCLAYYSYKDVEKLEKFMAGKPVAEQE
IGFALLQEVVAYAETSMSRRKFLLHYFGEEFDSETGEGADMDDNVRNPKKKVEAKDQVVK
LLKIVRDTKHLYKSKEIIFTLIGKINATIKAHKTDAQSFFGSGADFDERYWMALIRQVLV
DGYLSKDIETYGILKLTEKGADFIKNPASFMMSEDHDYNESEDEAIVTAAKSSGTADEVL
MGMLRDLRKKVAKKLGVPPFVVFQDPSLEDMALKYPVSIEELGSVHGVGEGKAKKYGKDF
VELIGRYVEDNDIIRPDDLVVKSTGANSALKLYIIQNVDRKLSLNDIAKAKGLDMDVLLK
EMEQIVYSGTKLNIKYWIDDILDEDQQEEIHEYFMESDSDNIKDALKEFDGDYDIEELRL
MRIKFISEVAN
>LONDMIMF_02890 Arabinose 5-phosphate isomerase KdsD
MIEKEAILASAKKTILAESKAIANLSELLTNDFAEAVEIIFKSKGRLIVTGIGKSAIIAQ
KIVATLNSTGTPSMFLHASEAIHGDLGMVQQDDVVICISKSGNSPEIKVLVPLLKRFGNI
LIAITGNLTSFLGKESDYVLNAYVESECDPINLAPTNSTTAQLVIGDALAVALMELRDFK
SEDFAKYHPGGALGKKLLLRVKDMLDTTHRPVVAPDSSIKKVIVEISEKRLGVTAVVEND
KVIGIITDGDIRRMLNDRDTFNDLTAKDIMTKNPKMIKSSDMVVDALNILEDFSITQLVV
VDEGNYLGVIHLHDILKEGIV
>LONDMIMF_02891 Sec-independent protein translocase protein TatC
MAKKKNVNEMSFLDHLEELRWLLIRSTLAIVVASTVAFFFSDFIFDKIIFGPKDPNFITY
RWFCEVSKFFGSTGEGFCDYKINFDVQSRVMSGQFNAHIWTSITAGFILAFPFILWECWK
FISPALYDKEKKNAKLFLAVASFLFFLGVLFGYFIITPLSINFLAGYQVSTQIHNDIDLD
SYISLIRSTTLSCGLVFELPIVMFFLSKLGLITPTFLRKYRKYAIVIILIIAAIVTPPDV
VSQIIVTIPLLILYELSIFISGWVLKNKLKNEQSS
>LONDMIMF_02892 Alkyl hydroperoxide reductase AhpD
MSNLVKEFNDYRQAMNEKLLNDDNKVIKRIFNLDTNAYMEGALNVKTKELLGLVASAVLR
CDDCVKYHLETCYKEGITKAEMMEAMSIATLVGGTIVIPHLRRAYEFWEALEENK
>LONDMIMF_02893 Lipopolysaccharide export system ATP-binding protein LptB
MILRADNLVKTYKGRSVVKGISVEVNQGEIVGLLGPNGAGKTTSFYMIVGLVKPNSGKIY
LDNTEITDYPMYKRAQNGIGYLAQEASVFRKLSIEDNIMSVLQLTNLSKQEQEAKMESLI
AEFSLGHIRTNRGDLLSGGERRRTEIARALATDPKFILLDEPFAGVDPVAVEDIQRIVAQ
LKNKNIGILITDHNVQETLAITDKTYLMFEGGILKAGVPEELVQDEMVRRVYLGQNFELR
KKKLEF
>LONDMIMF_02894 Lysozyme M1
MKKQAPRRKPAVRKPKKKKSFFSGNVLKFSLWAFFILLIAGTAYHYREGLAYYFSFKTDK
RLAEEKRIADVRIYQVLSKHENKVYGFDVSEYQGDVDWEKANAIEEKFPLGFVFIRATAG
KNRVDATFKDNWKEAKKHKLIRGAYHYYRPNENSIEQADNFIKTVKLHKGDLPPVLDIEK
LPEEQSIDSLKVGLKRWLKKVEKHYNVKPIIYSGESYYNDFLKEEFKGYTFWIANYNFFE
ETIKDEWLFWQFTEKATVPGIKGTVDVNIYNGTPKQLQYFTIN
>LONDMIMF_02895 hypothetical protein
MGIKAQVPNTITLLNLFSGCIALIFAFHQDFKLAFLFVCLGIFLDFFDGFFARLFKVSSP
LGLQLDSLADMVTSGVVPGVAMYYLMNQALGFPSSGWQLFFPYLGFIITLGSCYRLANFN
IDTRQTDSFIGLPTPANALFILSLPLILLDNQYGFISQALSNPWVLLVISLFSAFMLNAE
IPLFSLKVKSASFAKNKLQIIFLVVSALLLVFFKALGIPLLILFYIALSVLTNKKSI
>LONDMIMF_02896 hypothetical protein
MKKPLIASFLLVCSFAYSQAVRKYSNEFMNIGVDAAALGMSNAVTASTNDVNSGYWNPAG
LIYLEDKQAALMHASYFANIAQYDYAGFAMPIDNESAWGLSVIRFGVDDILNTTELIDSE
GNIDYNRISLFSTADYGVTFSYARKLKIPGFQYGVNAKVIRRVIGDFANSWGFGFDIGVQ
FERNDWKFGLMVRDVTTTYNIWNIDEEAYNKIKDAIPGENQELPEDSEITLPKAQLGIAK
KFIIRYDYSILAAANLNMSFARTNDIISTDVVSIDPAVGFEFGYTDLVFLRAGVGNFQNV
KQLDGSEKVGFQPNIGLGFKYKGIQVDYALTDIGDQSVALYSNIFSVKVDLGIFRR
>LONDMIMF_02897 hypothetical protein
MSRFRLLLLLLLLAFPLSKSFSQSAILSDSSKVSILTIGTANESHTLYGHTGLRILDEQR
GLDVVYNFGYFDFNTPYFLAKFVKGDLQYFVATNQYADFEYNYREENRSIYEQELNLSKI
QKQKLLDELNKNLYSDERFYTYKFIDKNCTTMVIDKVNDVLGGKIITTKKPVTVTYREIL
NPYLSSNFFQKLGINIIFGPKTDKKAEVLFLPLELMDVLKTTVYNGKPLVTETKTIFEAK
PVKTVSYWNNIYVFSALVLLVIVLKNNTVYLTYFTILGLLGLFLSSVGFYSLHEEVRWNY
NVLLFNPSLLFLVYFFKKKNRKWISNLALFNLACIAVYLIVIFNKAQLLLFMPILITSTV
ILAKLARKNKKTKIAKA
>LONDMIMF_02898 UDP-N-acetylgalactosamine-undecaprenyl-phosphate N-acetylgalactosaminephosphotransferase
MFSFKKIHFEISERKLLLRLFDVLTVILALYIVGLLFKFDYFSISKANFYWTIVLGIYLN
ILGTVFEMYNLQTASNQYQIIKSILLTSSTTVLFFLLTPIFTPVLPSNRLQIIYFFLAIT
LALFAWRIFYQAFLASHRFLKRVVMVCDKNQLEELVASLEKVDPHYKILGFINTDSKGDT
VSNHAGVANIEIADLNGFIRKNGVSEIVIASQKTDGITVDLYNRLLVLLEQGFVIREYTQ
VYENITQRIPVQYVDRDFYRYFPFSRSNHNKLYLLLARLIEILISLVGIAIGLYLLPFIY
VANFIGNKGPLFYVQERVGKNGKIFRIYKFRTMVKNAETDKAVFATQNDNRITFFGKFLR
KSRIDEFPQFINVLKGDMAVIGPRPERPFFVEQIANQMPFYQTRHVIKPGLTGWAQVNYS
YGDSIKDSLIKLQYDLYYIKHRSIFLDINITIKTISTILFYRGQ
>LONDMIMF_02899 Spore coat protein SA
MKNLLYIGNKLSQHGFSVTSIETLGPLLEGEGYTLFYASSKKNKALRLLDMVWSILRLRN
KIDYLLIDTYSTSNFWYALLVSQLARLLKIKYIPMLRGGDLPGRLSKNPALCAMIFNHAY
KNSAPSGYLLEHFQKKGIQNMTYIPNTLDMSNYNFLKREIIQPKLLWVRSFAAIYNPFMA
VEVFREIKKQFPEASLCMVGPEKDGMLAKTKELALKYNLDVNFTGKLSKTDWIRLSENYN
IFINTTHFDNTPVSVMEAMALGLPVVSTNVGGIPFLLDDKKTALLVDDGNTEAMIKAVKE
ITENKNLAEDLAQNARAKAESFDWQQVKSLWNKILC
>LONDMIMF_02900 hypothetical protein
MQNKSRQITYIGLVLLHIAIGFAIYLFPLLSKVYGLLTLLIGVGIVMKTSNKHNEVLYIS
AYIAGSEVLLRMTGGNFLNEFSKYGVMLFMLMGIFYSSFSKNSIPYWIYLLLLVPGVVIS
TVTLDISTDVRKAITFNIVGPVCLGLCSIYAYRRKISFAELSNVLLAAVLPILSTACYLF
IYSPDVKDVVTGTSSNFETSGGFGPNQVSTILGLGFFIFFSRMLLNSSNKRYLLINLFFA
LVLTFRAIVTFSRGGVITGLVMIVVLFGALYTMANLQTKMKLNVVVILTVLAGIGVWGYS
SLQTSGLIEKRYANQDAAGREKEDRLGGREQIASTELQMFLENPILGIGVGKNKEYREEI
TGIRAASHNELTRMLAEHGTLGIFSILILFFTPLVLYVDNRHHFYLLSFFVFWFLTINHA
AMRLVAPAFIYSLTLLKVYSIEKPAVHRE
>LONDMIMF_02901 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MRVLQLIDSLEAGGAERMAVNYANGLANRIAFSALAVTRKQGILKEQLDKAVSYTFLERK
RTVDFKAVSRLKRFVKDNSIDIIHAHGTSYFIAVMLKIAYPKIKIVWHDHHGGRNTQKGY
KNAVLKIASRFFDTVMVVNQELKAWAERNLAMAKVIYLPNFAVRDKVEEKQTTLKGTDGK
RIVCLSNLRYPKNHALLLEAFRDSGLHKKEWSLHLIGKDSQDDYSSFLKRFISDNRLDDS
IFIYGSCSDISNVLEQGTIGVLASVFEGFPVTLLEYGMAGLAVVSTNVGYCGEIIQNEKT
GLSFTPSDVEMLTAQLKRMADDEQLRKSVSEALKTTIRESYSEEIVMNALILQYQNILNA
KQK
>LONDMIMF_02902 Alpha-D-kanosaminyltransferase
MKFAIITHVPHIKENGRLYAYAPYVREMNLWIDNVDEVLLVAPTADLQPNAIHLPYEKEV
RLMEIPVFNAIGLKAKISALFKMPKLIAVIYKAMREADHIHLRCPGNIGLLGCFVQILFP
KKPKTAKYAGNWDSESQQPFSYKFQRWILSNTFLTRNMQVLVYGNWPNQTKNIRPFFTAT
YSEQDKKDVSLRTLDGKIKLLFAGTLAQGKRPLYAIQLAENLINKGFAIQLELFGDGPER
DKLQEYIIKNNLQNPVLLKGNQTKESLQQAYEESHFLVLPSKSEGWPKVVAEAMFWGCVP
VSSRVSCVPDILDYGTRGVLLEMNLEQDSENIAALLKAPEEYKNKAEKAMLWSRRYTLDY
FESEIKSFLKNK
>LONDMIMF_02903 Putative glycosyltransferase EpsH
MKFSLIICTYKRATPLRTLLESVQLQTVYPDEILVVDGSLDDFTKAVLEEKHFKGLSYFK
VDPKDRGLTRQRNFGINRVMPEAEIVCFLDDDTVLEPAYFAEILSVYKLYPQALGVGGYI
TNETTWQPIPVGYKANTNEFVYDGWKRKDGSRFAARKKLGLDSNVAPGFAPEYSHGRSIS
FLPPSGKIYEVQQLMGGVSSFRKEVFDRLRFSTYFEGYGLYEDADFTLRLSNLGKLYINT
NARLAHYHDASGRPNKYAYGKMVVRNGWYVWRSKYPKPSGKAKLKWHSITLLLTLIRYGN
VFTSSQKKQAFTEAIGRTVGWWSLFFSKPKQKLS
>LONDMIMF_02904 hypothetical protein
MGMDLYDYGARNYDPALGRFLQVDPITHHNQSPYVAFDNNPIVFVDPDGADSKDPIKESI
TVITSIIDKSNVTHITQTTTHTTTIINDDGSVSVSYSTSSITNTVDAYGNVTNGKTVTTT
SGTITRETGGDISSTTGETITRNANNGELTSGFREWTSTVSNYNKNNDGIYNIDMINKTA
DYTIKAGKAGFAILGNFAGFNKLFNNLDSKTKSAIGILGSYTSAEGLVGQSGAALKDMVG
KNNSYAILYGVEHIQNGTMIKAMKTPSGSGAGERKRVGPTSFQQLWKGIKSIFD
>LONDMIMF_02905 hypothetical protein
MGIIDKYPNLFVFIFKLVFILLFYFLLRFLLNLFNIKISDKRIASLVILLIILYYIISIL
LGIFFDINI
>LONDMIMF_02906 Modification methylase HaeIII
MKQLNYIDLFAGASGMSEGFTKAGFSPIAHIEMNEEACFTIKTRAAYHYLKSKKKLDLYY
SYLKKEINRDEFYNNIPEKILNSVINIEINDNTIKDLFKKINAENKKIDLIIGGPPCQAY
SLLGRHQENIEKDPRNKLYIQYGRFLKEFNPKAFVFENVPGMLSANKGQHFKNLKTYFKK
LGYEVHYDTLDASDYGVVQARKRIIIVGWKKENDFGFPEILKIKEKYTVNEAFEDLPTLK
PGEGYQYTSYKEEKNSYLEKFDLRNGIDFVTQHISRPHNERDLAIYKTAIRKWNNEQIRL
KYPDLPENLKTHKNESSFIDRFKVVDGTGVSHTVVAHIAKDGHYYIHPDEEQCRSISVRE
AARLQSFSDDFYFEGSRSAAFKQIGNAVPPLMAFAIAQKMKKLL
>LONDMIMF_02907 hypothetical protein
MRFMIHTDMPNKKIHQGRNIKRFREMLGIKQDALAYELGEDWNQKKISLLEQKESVEKDI
LEQVAKILKVPTEAIENFDEEQAVNIISNTASFDNCQQPAFFNNQPSFNPIDKVVELYDE
KIALYERMLKEKDEMMARLINK
>LONDMIMF_02908 hypothetical protein
MKFLNYAFLGIKHPETEFIIPQTFPYFTTSLHNDIKNTDGNKYKPIQIRQITGNRIY
>LONDMIMF_02909 hypothetical protein
MCNVRFLTEEEENQIVLDTRYITVNRIPIKGHYNPHECCSKVQLQGRWIDKCGFKPNDKL
TVSVYRNRLVIEKQKPNTINPKVLAREQKANEKYVRERVKQLVSPDIFNRLSFKNGEIKW
IK
>LONDMIMF_02910 hypothetical protein
MSTKNTKNTEKKPENQSKDQLIEMRRLTVSAIYMNSEGYNKNDYASRIMLLGKWVRKCGF
NEGDKLTISIYQNRIVVEKEDPNTLDTKLLARIQDESSRLLRKKIKAMVHPEVFEQLRFV
NGQIKIK
>LONDMIMF_02911 hypothetical protein
MSNYIVNAVAKVTFHRVLKNGTNSCWLKIKKASFSYTQRYWLAKPDFYYLKIYEKLENGT
IGRQIGFITRSTSQFTP
>LONDMIMF_02912 hypothetical protein
MNQILYLTENRALKTVQFDVDNFWATFPEKAFILAVIWDNNVLTSSLDGLTALEKYAKDA
NGFDYLILSDGDYRHENTRFYLPANWDVALPPSGSNGGNNGGGGSSSVSGISPLFPVYRN
GIDINKCISLLYTSFGEIFYANIGDFDTVGYIYNTEFEVTTVQVFGCIYFMSAYKMPENV
YIYINPKTGEFMFSDFTEWTEVHLPQFTTWSANKGYIRVFRHSAGNHIFLSTTPFDNSIG
TVLPT
>LONDMIMF_02913 hypothetical protein
MAVRRKSQNFLQDKLIPFLKKYGIFILVFFLVAPMLYRWIMKLITSVKETNMDMATKQNT
AENSQNNPNIVKQKTETIKKKYPNISTQRMEELKDITARVAYALGTNIEDNHQLFGGVVE
LFNVKAWVEDEKEVIKQLKKTPGTFPIVEDLYYSVYTKSKNLKSDLLKYLSKKDLDVLSK
HYRAYGYKFI
>LONDMIMF_02914 hypothetical protein
MEKIKEFFTNHKKTLMAVGGIILAIIVWRKLSK
>LONDMIMF_02915 hypothetical protein
MNSFLNNHNVRGLRNNNPGNLIRTNIAWQGKIPHAQNPDAKFEQFVNLTYGLRAMLKDLI
NDISKGKNTVRKLISEYAPPSENNTLAYVNSVAKTLGVSIDEKLTQINGKFLLGLVRAII
MVELGKAHTQVTDRHILEAIKMLGDVSTANLKVDTDNGFTLIDVLKPYLLPTLLTVGLFF
YTCVTLTL
>LONDMIMF_02916 hypothetical protein
MKKVSGVLGILKLVIKYGAYIAVAVKVVQFAFDEFSKIDAEKGETNEQLPE
>LONDMIMF_02917 hypothetical protein
MFLRGLAKLLPLIVHEVAGLISDKIRERRQRKELEKSKNQTNEKS
>LONDMIMF_02918 hypothetical protein
MANYNNNYGNNNGGYNRGYNGNNGGYNRGYNNGGYNRNNGGNQQQFKKSGATYTRMKNGK
FEGLICVNAWRKTKQGLMRASAFPVDGVIHVGKEKGNEFMRYVVNVVNSSTGQTSTFWCL
MRLDTKIINIKELSLCISPNGSGTTASGKRVSGYFGRNFKS
>LONDMIMF_02919 hypothetical protein
MGFFKNIGKAIKKGVKQISFKNAVKVVSSLDPSGIIGGISQAHELEKQAKAEANAQKAYE
AQILAQEAAAKVGTVTGTLAGQVGKTILEETYNGMNAGFKQGAGVVAANVADEGIKAWFK
KHWKKLAIGVGALVAVILAWRYFKKPKRRGRRPY
>LONDMIMF_02920 hypothetical protein
MEIINTKDRNIANTGTLLVTKSIGSLIVASTLPFAQLTTEKIKIEIERANGSNFEITKGN
MSLKDFILLTTYNDDAITADQNYALTAECEICEGGSIQLNEKDVIRIELTGLKTAETYVL
NGIEEPATSHAVLSFEQKSMSSDDTNKIFQVHGHDLAILDKHSSIEEVAYTFDNGQVVKY
TLFELSVLSRAIDPVAYVKADGTVQSGFTDKLQLPLFGVDAIEIRKSQGALINLILRKEA
>LONDMIMF_02921 hypothetical protein
MIDTNNYKDFQKLSYKDIESLLVTISETTAKRYLSDIKQHFNIDTVLYCHFKAYFKV
>LONDMIMF_02922 hypothetical protein
MAFIKTTLKYADKRTLYVNSAQILHIEEEEETGKTLIILVDGTVCICDMPIIKFMAIYND
>LONDMIMF_02923 hypothetical protein
MSSKKEKPTCETCHYFDNSHHVKDERTKHAGLCKKWCEITFCRDSCKEYFNQENDPIWLN
LIKPKEEKSEFDNQLTFFNHCI
>LONDMIMF_02924 hypothetical protein
MKKQRKKVEEINVIFEVVGNAKIPTNDSRDFHNKNVNQDCTKKRRNYE
>LONDMIMF_02925 hypothetical protein
MTTVLFVHARSNYKKLPFFDCYDENRNALTYTGLEPVICHPPCRTFSRLKGWSTADVEEK
KLAFWAVDLVRKNGGIVEHPYDSDLWKEINAPKPGTYDDFGGFTIVFDQKDFGYYTRKRT
RLYIVGCKLRDLPAMPISFDCTVRKFENLTKKQRSETTIDLCSFLHEIINIIKSTGALKI
AC
>LONDMIMF_02926 hypothetical protein
MFNQGLTDSLKIRIKLDKIKVLDKRLISDYIEYYPNIEQLDNDLEQQLLGDNLQKAKPLV
KIINGITYRFYVKAFIDKRKTAQEYLVLQVSAKMLKQRYFEGITKDNIGLILADINSFKI
IRIEKKDLLDGLVSDIDICINQLIDEKSLKIAFSLIHNFPRPSKKPLMHFISQKNHKGEK
NLGVDFNKREKATNGAPYCKIYHKGHELLSKSKDFYKAYLEPMKRSILDNLVRYEFTIKA
SKHKQYLCKQGYKADFKTLGELLEMSPKDLADIAKSGLKHYVEKPTKSKVNTDLSPTDIM
LQYYIEQLIKVGFDSEKLLGFQYSIDCPVAKSRSKTKAKNLIKGLGTLDGLLNVKLLEND
RAGEFLNNIGLSI
>LONDMIMF_02927 Chaperone modulatory protein CbpM
MKIERIIISDYCNHYKIERTFIDILDEMGIIPFEKKNNEKFMDSEKLEDLDRCRQLYYEL
HINPEGIDAILNLLQKQKKLQQEIQDLKNRLRLHE
>LONDMIMF_02928 Curved DNA-binding protein
MAFIDYYSVLEVDKKASTDEIKKAYRKLARKYHPDLNPNDTEANKKFQQINEANEVLSDP
EKRKKYDAYGENWQHAEEYEKARQSQSQSQYSGSSYSNFGDDASFGNADFSDFFESMFGG
RRSSGRQAGFKGQDYNAELHLKLRDIAQTHKQTITVNGKNLRITVPAGVADGQVIKLKGH
GGPGANNGPAGDLYITFRIEEDAEYKRLNNDLYKTVSLDLFTAILGGEITVETLDGKVKL
KVPPETQNGTKVRLKNKGMAVYKKEGSFGDLIITYDIKIPTNLTEKQKEAFRELSKL
>LONDMIMF_02929 hypothetical protein
MKLQKRIGIFLMTLVMTAFANAQDKKASPAETVTGKINGATITINYGSPSVKGRAIWGEL
VPFGEVWRAGANEATTFETDKEITVEGKKLPAGKYAFFVIPEKDAATIIFNKEWKQWGAY
KMDAKQDQLRVKVTPKKSASMTEKLVYKINKDNITLSWENWDIPVKIK
>LONDMIMF_02930 hypothetical protein
MFYIVLSIICSVSVGALLKFSKRYSFDIIQVIAVNYILALGLCYITFRPDVSVVNSSSPW
KIYIGLAILLPSVFLLLASSIKHIGIVKTDIAQRLSLFIPILAAYFIFKENFSTLKLMGL
IVGFPAIFLTLSKKQSGTQENRWIFPVLVLLGFGIIDILFKQIALEKSIPYTTSLFIVFC
GALVLALCFTIYSLFIKKNPIQWKNIIIGAFLGILNFGNILFYLKAHKAFSENPSTVFAA
MNLGVIVLGSLVGILAFKEKVTLKNYIGIVLALGSIVLITLSQIQAK
>LONDMIMF_02931 Inosine-5'-monophosphate dehydrogenase
MKNPIAEKVVDFLKNYPPFNSLNYQELLHIASEVKVLYLEKGKILFQIGDACHDSFYIVA
SGAIGLSVTSDAEETLIDKCDEGDILGLRPFFAKNNYLMTAKAREESIVYAIPIQIFQPY
VFANHDVMSFMLESFASNTRNPYDKEHRGKLISENIIYKEQQADIQYFQSIQYSKEPITA
SPEAIVRDIAQMMTDKLIGSVIITKDDFPIGIVTDKDLRSKIATGHFQITTTAAKIMTSP
VVTVPEDLSLAEAQVYMLKYNVDYLCVTEDGSDKSPVRGIISENDLVVAQANNPGVLIKE
VKRAQSAKDLKRIREKLSELIQTSITKDIPVSHIMNISGEINTAITRRAIDLAILEMGSP
PARFAWLSIGSQGRKEQLLLTDQDSFLVFEDVPQDKYRDVKDYFLRLARRTTSTLEKVGY
FLSPDGFVSSNMMWCKSLTDWIKQYGNWINTPGENSEVINTIFFDYEIAFGETSIEEALT
EIIFKNAKGNKLFFDYLGNDALRKPPPLGFFRQFLVEEEGENKDMFDIKTRALTPLIDAG
RLLVLHQNIKGINNTYMRFKQLAIADPRNSELFLNCAEAFLTLSEFRTVEGLKNDSSGQF
INLEELSKTDKVKLKNCFIPIKEVQELIKSRFKLTYFS
>LONDMIMF_02932 DNA polymerase III PolC-type
MLDWLKINKDYPQFWKDYLGKFENKSRRFVAFSTETTGLDAEKDVILSIGAVAIENNTIV
VKDSFEALIFQEKFTPETALKTGVIKGVPEEKHSESEAIEAFINYLGNAVLIGHRIHFDI
AMINTALEKLHCGKLKNEALDIEVMFKKWKQLPEEKQFSLDELGAYFKISKSDRHTASND
AFTISLLFQRLKQRLGL
>LONDMIMF_02933 Sensor protein ZraS
MLEISTEEKLKERIKELSCLYDISKTTSMNANCSESALREICTIVKIAWRFSDVSIVELQ
CNDFYFTTSKLPEDTRFQVSSISIFEKEAGFIKVHYPISSGAFFLVEEEQQLLDKVALEI
GNYIEKNHIREREKQLQRSVERIDRLSILGEITAGIAHELNTPLGNILGFAELINEQNID
RQVTQDVSKIINAAIYSREIVKKLMFFSCEMPQNMEVVPIKPIVVEALSLLGPNFKKAQV
SYELIFDNPELKAQIDNIQLTQVLFNILINSIYVAPENSSITVKVTDDSNNFYIEIADEG
SGIPEEIKSRIFEPFFTTKPIGEGSGLGLSVVHGIVKSHKGDIIALDNQPKGTIFQVRLP
LNS
>LONDMIMF_02934 hypothetical protein
MFSRLLIAELKWILLALAISFFLVNSIDGGVFKSDAEIGVPQTFLGLNLFLEILVFFVFS
TFVVFGIKGFFEMYSRKFANVIIFISGVLMAALIFILSYQILSIE
>LONDMIMF_02935 Demethylmenaquinone methyltransferase
MLFVINYNSLSLRKLLKMSENVTPYKGSSLGKKEQVEQMFDTISGKYDGLNRVISFGIDI
KWRKKVLKIVASKQPETILDIATGTGDLAILMSQTKASKIIGLDISAGMLEVGRKKIEAK
NLSDRIEMIQADSENMPFEDNSFDAITVAFGVRNFEHLEKGLSEILRVLKPGGIFVILET
SNPTKSPYKQFYSFYTKNILPLIGKLFSKDNAAYGYLSESASVFPFGEALNNILRKIGFI
EVADQPQTFGVATIYSASKK
>LONDMIMF_02936 hypothetical protein
MKKIFAILLLSLSLNSQAQFGTNLFSKDPIINLENWDKQRVHWGYFLGFNAYDFKFDYKQ
PGKDIQVKGTTGFNVGLIGNLRLHEYIDLRFEPGLYYTQRDLQFTGFEDESDALRQVKST
YIHFPLLLKFSSMRTGNIRPFLVGGVSTSLNLGSNSKSKEDNLNDRFRMKQWTNNYELGF
GVDLYLEYFKFSPSIRGIFGLDDELIRDNDPNSPWTSNVGSMKTRGVFVNFTFQ
>LONDMIMF_02937 tRNA (guanosine(18)-2'-O)-methyltransferase
MVSKNQIKLITGLQQKKFRKEHQLFFAEGKKVIQELIHSDFFLEYLFTTTAVFPDVNPKK
ITNISESELKKISALTTPNDCLAVFRKPEPKKITETGLIVALDDIRDPGNLGTIIRLCDW
FGISELVCSEETVDIYNPKVVQATMGSIARVNVSYVNLEKFLSETNLPVFGTFMDGDNIY
KTELPKEGIIVMGNEANGISSQIEQTVNHRLAIPRFGNLQLTESLNVATATAIILSEFKR
S
>LONDMIMF_02938 hypothetical protein
MKKISTKISLFLLIGIIFTACNTVKRVPEGKRLLTKNEIVVNDQITKDEAIGNLLYQKPN
STILGYNLRLNLYNLAKQNPDSSFKAKMNANPKKYERLSKLLSKKQVERLGKSFFYSGFH
NFLKRTGEPPVIIDEARAKKSTARLRAYYFNNGFFNAKTSYKIDTLPNKKGQIQYTVTTG
EPYIIDSLYREIATPALDSLYEKNKNKTLIIPGQQFKSVNFEAERERITTNFRNNGAYYF
QPTNINFVCDSIDTNHKTHVNLKISDRNVRVGDTTITKPFKLYKISEVNIFTDSPSNSNR
VKVADSAIYNNFNIYSKDKLRYRPKALTDAIFISKGSTYADFRRTATSRSLNNLRVFNYP
NIQFVEDSTDVNESSLIANIYLTPRKKFSFGASADVTHSNIQNFGISGSMTGTFRNLFRG
AETLELSLRGNIGSSTDLGIANPNNVFFNLSEYGADVKLNIPRFFSPFNTDKLIAKNMIP
NTVFSLGFAKQQNIGLDKENLTASMYYTWSPKRNTTSRFDLFNIQYVKNINKANYFNVYR
SSYGRLNDVARDYASQVNPDYFNANGDLIIESGTNGFLQDVTGPNPTIVTSPEDLRVIES
ISERKDRLTENNLIFASSYTYTKNTKTDLLDNNFWIFKTKIESAGNFLGLISDIAKQPKN
SLGNKTILQVEYSQYVKGELDFIKHWGLSGNRVLAMRAFFGIAIPYGNSNNIPFSRSYFA
GGSNDNRAWQSYGLGPGSSGSINDFNEANLKILYSAELRFKMLGKLNGAIFGDAGNIWNV
LDDVKDPKSTFTGIRSLENIAIGSGFGFRYDFNFFVIRLDIGFKTYDPAKEVGGRWFKDY
NLGHSVLNIGINYPF
>LONDMIMF_02939 Fructose-bisphosphate aldolase class 2
MAHNIKPGVATGDQVQEIFKYAKEKGFALPAVNVTGSSTINGVLETAAKLKAPVIIQFSN
GGAIFNAGKGLSNENEKAAIAGAIAGAKHIHTLAEAYGATVILHTDHCAKKLLPWIDGLL
DASEKHFAETGKPLFSSHMIDLSEEPIEENIEICKEYLKRMSKLGMTLEIELGITGGEED
GVDNSDVDSSKLYTQPEEVAYAYEELLKISPRFTVAAAFGNVHGVYKPGNVKLTPKILRN
SQEYVQNKFNTEHNPVDFVFHGGSGSTLEEIREAIGYGVIKMNIDTDLQFAFTEGIRDYI
VKNIDYLKTQIGNPEGPEAPNKKYYDPRKWIREGEVTFNTRLEQAFKDLNNVNTL
>LONDMIMF_02940 Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta
MAWFKRTEKGITTATEDKKDVPKGLWYKSPTGKIVDADELARNLYVSPEDGFHVRIGSKE
YFEILFDNNEFKELDAKMTSKDPLHFVDTKKYSDRLKDAMEKTKLKDAVRTAVGKSKGKD
LVVCCMDFAFIGGSMGAVVGEKIARGIDYSIKNNIPFLMISKSGGARMMEAAYSLMQLAK
TSAKLAQLAEAKIPYISLCTDPTTGGTTASYAMLGDVNISEPGALIGFAGPRVVKDTTGK
DLPEGFQTAEFVLEHGFLDFITPRKELKNKINLYLDLILNNPIR
>LONDMIMF_02941 Macrolide export ATP-binding/permease protein MacB
MVVYLRLLRESFGFALNALRNNKLRTILSLLGVTIGIFSIIAVLTAVDSLDRKIKSDMST
LDKNTMYLKRFPFGPSEVPRWKRDQYPNVTYEEYDYLKNAVNGMDKSTYQLFTKREIVKY
DTKSVSDVNIVPATYEFVEIQPQKIKEGRFFNESESNSGTPVAIIGYEVANSLFGNMDPI
GKKIRLYGQRFTVIGVLEKQGQGMFGENNDISAFIPVNFLRNKFGDHNDSMTPIIIIKPD
PGVDVDAFKGEIIQKLRNKRGLKVGSEDNFFIDVLSGFTDFIDEIVGRMNLIGWIISFFS
LLVGGFGVANIMFVSVKERTNLIGIQKSLGAKNKFILLQFLFEAIILCLIGGVVGLLMVW
GIAAILTNTLDFEFVLGFKNIVIGTTLAALIGLVSGILPAVSASRLDPVEAIRTGM
>LONDMIMF_02942 Bifunctional purine biosynthesis protein PurH
MSTSKTIKSALISVFSKDGLEPIVRKLHEQNVTFYSTGGTEDFIKNLGIPVVPVEDVTSY
PSILGGRVKTLHPKIFGGILNRQDHEGDVQQMEEYQIPQIDLVIVDLYPFEKTVASGASE
AEIIEKIDIGGISLIRAAAKNFKDTVIVASVDQYADFLEVITKQNGALTLEDRKLFATKA
FHVSSHYDTAIFNYFNTDDTVYKASVAEGQILRYGENPHQKGFFFGDFDAMFKKLHGKEL
SYNNLLDVDAAVNLILEFKNDDPTFAILKHNNACGLATRSTMRAAYLDALAGDPTSAFGG
VLIANGKIDTETAKEINQLFCEVVIAPGYDETAIEILSEKKNRIILVQNDIELPQKQVRT
CLNGLLVQDKDNVTDNKEHLKTVTTTPPSSGETEDLLFASKICKNTKSNTIVLAKNKQLI
ASGTGQTSRVDALKQAIEKANSFNFDLKGAVMASDAFFPFPDCVEIAHNAGITAVIQPGG
SIKDELSINYCNENKVAMVFTGTRHFKH
>LONDMIMF_02943 Rod shape-determining protein MreB
MGFFDFMTEDIAIDLGTANTLIIHNDKVVIDSPSIVARDRVSGKIIAVGKEASMMQGKTH
ENIKTIRPLKDGVIADFDASEKMISMFIKSIPALKKRLFTPALRMVICIPSGITEVEMRA
VKESAERVNGKEVYLIHEPMAAAIGIGVDIMQPKGNMIVDIGGGTTEIAVIALGGIVCDK
SVKIAGDVFTNDIVYYMRTQHNLFVGESTAEKIKIEIGAAIEDLESPPDDMSVQGRDLLT
GKPKQVEVSFREIAKALDKSIQRIEDAVMETLSQTPPELAADIYNTGIYLAGGGSMLRGL
DKRISQKTDLPVYIAEDPLRAVVRGTGMALKNIPKFRSILIK
>LONDMIMF_02944 Cell shape-determining protein MreC
MQQIFNFILKNSNRLLFLLLLGISLVLTIQSHSYHRSKAVTSANFISGGVYEKIHSVQEY
LNLKTQNEQLAKENAILKKMLFNAKDSTGIVVRDSLKGYGKINIVQAKVIKNSYNVKENY
LTLDEGSKAGIKPDMGVVNSLGIIGIVEHTSKNYATVISILNVKSEINARIKKSNHFGTL
RWDGKSTGFVQLIDVPRLANVRKGDTIVTGNESVTFPPNINIGVIDKIYTDKETNYFTLN
IRLFNDMTNLGHVYVLENYERKEIEELEAKTEEKNE
>LONDMIMF_02945 hypothetical protein
MNSTLLLNIARFILLLAAQVLIFNEIDFWGYVNPYPYILFILLYPVNGNRAGLLLASFFL
GIIMDMFCDSGGVHATACVILAYVRPTFFRFSFGVSYEYQTVKINDKLTPERFSFLLISV
FTHHIILFLLEIFKLSFILNILLRTLFSSIFTLILCIVIIYIFKPTAKR
>LONDMIMF_02946 Peptidoglycan D,D-transpeptidase MrdA
MRKLLLPSLIIVAAIVIVARLFYLQIIDDSFIKKSDNNAIKIKYDYPERGYMFDRNGVLL
VANQPSYDVMVIPKDVKQIDTLEFCKLLKITKEEFITKMNKAAVYSPRLPSVFLPQLNKK
EYAGFQEKIRKYQGFYIQKRSLRDYQVNAAANVFGYIAQVNDAIIKKNPYYKSGDLIGKQ
GVEEVYEEFLRGTKGVKYIQKDRFNRDIGSYKEGIYDTIAVQGEDVTLTLDIELQKYGES
LMINKRGGIVALEPKSGEILALVSAPSYDPAILVGRDRSKNYLKLSQDSLAKPLFDRGLL
AEYPPGSPFKIMTGLIGLQEEVIDENMTFHCSHGFSYGRGAFMKCHDSGNNNLHTGIAHS
CNTYFANVFMRTINKYPKPTYGVDAWSNHLKSFGLGNFMGYDLPAGRKGLIPDSRYYKRW
YPNGGWRSTTIVSNAIGQGEVSTTPIQLANMMAAVANEGYYYTPHIIKKIKNHTIDKKYT
TKHVTTVDKQYFKPVIEGLFAVYNEGTARSLRVEGIDICGKTGTAENKTKINGVTTQLTD
HSIFVAFAPKDNPKIAVAVFVENGYWGARWAGPIASLMLEKYLRGKITRTDLEKRMLEGS
LESEYAKVTSGKPFKINQ
>LONDMIMF_02947 Peptidoglycan glycosyltransferase MrdB
MKNQSVTSNIDWITILLFILLVIMGWLNIYSASLPLEQTSIFDISQIYGKQILFICLTVP
LVLVVLTVDAKIYEKYAFVFYIAGLISLLGLFVFGKTIKGQTNWYSIGGFTLQPSEFVKT
STALLLAKYLSDVQVNLKNFNDQLKAFAIMGVPLLLILVHDTGTAMIFVALVFVLYREGL
PAWYLWTGFLAVLLFFMSLLIEPHFVLLIALVVILIQFLLSKRINRNPLASAIIFVLIAG
FTYSVDFVYDNVLEAHQKDRINVLFGQNVDLKNEGYNLNQSMIAIGSGGWFGKGFLEGTQ
TKGGFVPEQHTDYIFTTVGEEWGFVGAVIVIALFVALFLRIIYLAENQKTKFSRVYGYCV
ATFLFAHFFVNITMLIRLFPTIGVPLPFFSYGGSSLFAFSILLFIFIKMDANKVNEW
>LONDMIMF_02948 Nuclease
MNKKTVLYALLSVIVAIAYFLKNNKKEVSSNKLPAEISSTETKKDTVGLETLIVKDKYLP
TSTTNQLVMHQNFTLSYHEKYEQAEWVFYEAKASGGRSYDFKRPFFIQDPLVKTGSADWK
NYKNSGYDKGHLCPAGDMKFSKQAFDDTFYTSNISPQKKDFNSGVWNRLEQKIRYWADKY
DGIYVVTGGVLSDGLKTIGHEEVAVPKYFYKVLLDVDKGQYRMIGFLVPHENSQKPLYEF
VVPVDEIERMTGIDFFPVLPDAIENKLEKSSDYKAWSF
>LONDMIMF_02949 hypothetical protein
MKAKIILTSILCTALQTVSAQEKQETPLVAKDSVAVMASAQTALLTQTQLEEKAKADAKA
LKEAEKKAKEFEKEQRKLEKAQKEMEREKKDFEKRQKKILSAEKSVLKAKTKLADEKKSL
EKNKSKLDKKKAKGKLTPIEIQEEEIKISKQEVKIKELELKVQNEESSLIKVRS
>LONDMIMF_02950 hypothetical protein
MKASNFILFSDCIPVKGISRSIICDTMNNKYFYIPNGLYEILEKYNGKTIQSVKEKFNHE
YDEIIDEYFTFLFDNRLVFFNSNPELFPKINLEWTSSSAITNSIIDFGTEIHDYKNIISQ
IEALKCSYIQLRFYQITNIYLIKEIIEHLNYKKSRIISIDFIFPYYENLDMVEVNSLLDQ
NTRIHSIIIYNSPSDQNFEAVNKKMGYLSLLKRNILNEKHCGIISTEYFYSNINLFTESL
NHNSCLNRKISIDKDGNIKNCPSMVQSFGNIKDTTLEEALNHPDFKKYWNITKDQIEVCK
DCEFRYVCTDCRAYIEEPDNKYSKPLKCGYNPYTNVWEEWSTNPLKQRAFEYYRMQDLVK
KNV
>LONDMIMF_02951 hypothetical protein
MKKKLIFGVFAMALFFTTACSSDDDSNSSSTNATIQQVTNIARSGSWRITSYIDSGTIKT
DNFTNYNFTFGAGDILIANNGTNNYQGVWSVTRDDDSANDIDFNISFTAPATFADLSDDW
DILETTPTKIRLVDVSGGGSGTDYLTFEKNVE
>LONDMIMF_02952 hypothetical protein
MRKIISRLLLFLVLLFAGQSMLAQEESPVVPLKEILANLSKQYKIQFNFLEEEVKYISVI
PPSPELSLSEKLHYLSNRTALTFENINNRYIVITSQKQVITIIDSVKGIPIPLEETVIEK
YLTKGIAKTAEGNLVIKPKKFGILPGLTEADVLQTMQQVPGIYSADETVSNINVRSGTHD
QNLFLWNGIRMFQTGHFFGLISAFNPSLPQKITISKNGTSAFYGESVSSTIAISSFPEPI
ENTASSISTNLIAAQFNSNIKISDNSSFQISGRRSFTDWVNSPTYQSFYNRVFQNTIVTN
IENNEISDYHTDEKFYFYDFTAQYQQKIGSKSEATAAFIGINNSLDLDQNMISEGIQKSR
SSDLSQQNFGGMLALKTAWNDNISSKISGYLSYYNLNSKNEAVENNQTLVQQNTVIDMGF
RLENRHILNPNMVLNTGYQYNETGIRNFENIDNPGFSKSIKEVLRSHSLISEAEMHYLNR
HLFIKPGFRFNYIEELEKYIFEPRLQFNYRLTQEISIEVLGELKSQTASQVIDQQQDFLG
IEKRRWVLANDRSIPIQKSRQASVGFTYNTSDWLISLDNFYKKVTGITTPSQAFQNQLEF
IKLNGDYTVWGSEFLIQKNFDRFYSWISYNLSSSEYNFGTLIPSQFSNNFQIIHNINWAV
IYDWNNLKVALGTKWHSGRPETTPATNLLDLSNPAKPEIYYNFPNNKNLSDYFQVNFSAA
YCWKWNSKNQLELGISVLNLLNKKNTISRYYRVNDNNAIESVNTYSLERTPNIALKFNF
>LONDMIMF_02953 hypothetical protein
MENNVDLAKWLAGEMTGSELEAFEKSPEFATYQKIKNYSGSMEAPAFDTDESYQNVIKQV
KKEPVRKQNYWFIKLVAATLVISLGTVFYSKNKTTTQYAEAGQKTTFSLPDNSEIVLNSD
SKIQYKKWKWKTNRSLKLEGEAFFKVAKGETFDVNTSLGKVTVVGTQFNVKSRNRNFEVE
CYEGKVKVAFGNKNFLLEKGSSITVRNGNITATVPLNTEKPSWLLNEIKFSQNNLKEVMD
EIQRQYGIEIEYPQIHSGQYFTGTVPADNIDTAMKIIGKVYHLNYIKASDKKIILKKE
>LONDMIMF_02954 RNA polymerase sigma factor CarQ
MEEIKKIGSICEEIVFSDFFRSHAKTLRNYLLYKFGNEEQANDMCQEAFVKLWENCANVP
VGKARSFLYTVANNATLNQIAHQKVVLNYVKKESSSQHTNESPEFILEEEQFKKKLERAI
QNLSESQRTAFLLNRIDGKKYSEIAILLDISVKAVEKRIHGALVFLRQEIENIK
>LONDMIMF_02955 hypothetical protein
MKKVLQSILVLSCIAVFAISCQDEENETRQNEETLSKTAPLTGLMKRVSMNATADDNVID
STSCFSVKLPVNLIVNSQSVTINTENDYHLVNDIFEVTDTDQDYVDFVFPITIIYPDYSE
VVVQNQTQFDALKDACQEPEPEQRNIGCVTIHYPIRVFGYNSNYQLAHTYTIRNDMEFFL
LLFNLNATEFYAVDYPITITNREGNQVTIRNNIEMTGAIQDCINNQCPNPNILTNNLIIY
MPFANEVRDLVSGDYAVPAAAPTFVTDRNGNANSAISFTRTNFLRLNTIAARNIQVGNSL
TVSVWFRMQNTEEGDLERIFEKSNGTSSHLQPRFGVAIYDGNAPLFYGNTLGVWDDSWLM
DPNLRYDTTNWHHVVITVERAAAGNVDNVKIYRDGILRNSDQGSDLFSNTQAFDYYIGKD
FQGFVDDLRVYRKALTPQQVTTLFQLEGDNNNCLDN
>LONDMIMF_02956 Signal recognition particle protein
MFDNLSDKLDKAFHILKGHGKITEVNVADTLKEVRRALLDADVNFKIAKEFTTKVKEKAI
GQDVLTTLQPGQLLVKLVKDELTELMGGDAAGVNLSGNPTVILMSGLQGSGKTTFSGKLA
NYLKTKKNKKPLLVACDIYRPAAINQLHVVGEQIGVEVYSEPENKNPVEIAQNAIKHAKS
NGFNVVIVDTAGRLAVDEEMMTEIANVHKAIQPQETLFVVDSMTGQDAVNTAKAFNDRLN
FDGVILTKLDGDTRGGAAISIKSVVNKPIKFIGTGEKMDAIDVFYPNRMAERILGMGDVV
SLVERAQEQFDEEEARKLQKKIAKNEFGFDDFLTQIQQVKKMGNMKDLVGMIPGAGKALK
DVEIEDDAFKHIEAIIHSMTPGERSKPAIIDLKRKNRIAKGSGTDIQQVNQLMKQFDQMS
KMMKMMQGGGGKNLMRMMGGMKGMR
>LONDMIMF_02957 Bifunctional protein FolD protein
MQLLDGKKVSDDIKNEITAEVQKMKEKGEKVPHLAAVIVGNDGASLTYVGSKVKACERVG
FESTLVKMPSTTSETELLKKIQQLNEDDNIDGFIVQLPLPDQIDTQKVLMAIDPKKDVDG
FHPENFGKMALDMSTFIPATPFGILELLERYGVETKGKHTVVIGRSHIVGRPMSILMGRK
GFPGNSTVTLTHSYTKNIAQITTQADIIITALGVPNYLKAEMVKDDAVVIDVGITRVNDD
SEKGYRITGDVDFEFVSKKASFITPVPGGVGPMTIAMLLKNTLLAREQKLLRD
>LONDMIMF_02958 23S rRNA pseudouridine(2604) synthase
MEENIKRLNKFIGETGYCSRREADKLIEEGRVTVNGSVAEMGTKVSQNDEVRIDGRLIVE
KKEKPIYLAFNKPVGIECTTNQEVRNNIVDYINYPTRIFPIGRLDKASEGLIFMTNDGDI
VNKILRARNNHEKEYIVTVNRPITDRFIERMSNGVPILDTVTRKCKVEQVSKYIFKIILT
QGLNRQIRRMCEYLGYEVTALKRIRIINISLDVPVGRYRELTDKEIKDMNQLIEPSSKTE
EASLPKPEPRQPQQRVIRKIPPRNKDNRNFRKDR
>LONDMIMF_02959 Minor extracellular protease Epr
MKKITLVISCALFSLSVSFGQDRKGSFVLEKGSASHELYVSFQPTLHFEGEAYHAVALEK
IPDFKTLQEEYNIVLEKGILISDEKLEEMEQKAIELTGKGNSVAKLRNILKVRIDNPTNE
RLLELAKKLEGLQEVEYCSLNSLEPVQPPYDIAPTTPNFEVNQTYIRPNPGVNMTYAWGL
NLTGAGIRVRDVEYGFNASHEDLNERNVSIAPGMTISASASVSFTEHGTAVFGIVYGDKG
AYGISGMAYGAAEMMLAPEWQQSGYNRVNAVTQAIANSTAGDVLIYEMQATGAQGNYGPA
EYTGTIWDLTKAATDAGMVIVAAAGNGAENLDDAVYQSYRNRGNSGAIIVGAGDNTINHN
KLSFSTYGDRVDVQGWGTGVFSSGYGDAQQIGGDFNQYYTNFSGTSSATPIVASCAIVLQ
SYYHSLTGNYMTSVQMRNLLKNTGLPQGTATTGNIGQFPDMEAAILYIQDEFLSREKWTG
LEFIAYPNPVQDRLTIKTKDLSANAKVEISNSLGQFVHKGAIAEENTIDLSSFSQGLYFV
KVTDGNKTQTKKIVKK
>LONDMIMF_02960 Arylesterase
MKKISNFLLAKSVGLYINLLSYVFPKKASQLAYKFFSEPRTGKLFSNQMPDVLKNAKTEI
LNLHEHQFPVYIWEGNDTYVLLVHGWESNASRWENFLPYLKESGSTIIALDAPAHGLSSG
REFNVPRYAEFVNVVVEKYKPQFLVGHSMGGATSLYYQHLYQNKAVEKLVLLGAPSDLQT
LVLNYAKLLSLNLKAISMIENHFMEHFKIKIEEFSGKVFGSKIKIKGLIAHDIDDDVVSF
EEAKKIVSSWKEAVFIETKGLGHSMHDDMLYQKICSFLFEKDNYRDKKRAS
>LONDMIMF_02961 Chromosome partition protein Smc
MATTKELSVEDKLRAIYDLQLIDSRIDEIRNVRGELPLEVEDLEDEVAGLSTRLDKLKND
LEVIEEQIKGKKNAIDEHKEAIKKYTKQQETVRNNREFNSLTKEVEFQELEIQLAEKQIK
EMKASIEHKKQVIADSKEKLEAKSAHLKHKKSELEAIMSETEKEEIFLTEKSAEYEALIE
ERLLQAYKRIRGSVRNGLAVVSIERGASAGSFFTIPPQTQMEIASRKKVITDEHSGRILV
DAALADEEKEKMEKLFSQF
>LONDMIMF_02962 GTP cyclohydrolase 1 type 2 
MKIKEVISVIETMAPLAYAEDFDNVGLLVGNPEDETTGILVCHDALENVIDEAISKKCNM
VVCFHPILFSGLKKITGKNYVERAVLKAIKNDIAIYAVHTALDNHQNGVNKIFCDALGLQ
NTKILVPKENFIQKLVTYTIPENHQKLRNALFDAGAGNIGNYENCSFNTQGIGSYQGNEN
SNPEIGERGEFVENTEIKIEVTFEKHLQSKILKALFSNHVYEEVAYEIYDLKNSHQNIGL
GMIGELETEMPEKDFLLFVKNKMKADGIRHSEYLGKPIKKVAVLGGSGSFAIKKAIQAGA
DAFLTADLKYHQFYEAENQLLLADIGHYESERYTKNYIVDYLTKKIPNFAIILSEENTNP
VKYL
>LONDMIMF_02963 Tetraacyldisaccharide 4'-kinase
MMLLRKILLPFSVLYGLITSIRNFLFDKGILKSYSFDLPVIAVGNLSVGGTGKTPLIEYL
IRLLSPEYQVATLSRGYKRKSEGFVLADENSDAALLGDEPFQFYKKFPNINVAVDADRKN
GIERLLEITRPEIILLDDAYQHRKVRAGFYILLTAYGDLYVNDFILPAGNLREGRSGAER
AGIIVVTKCPPNLSAKEQYDIKRKLKIDLDQKLCFTTIAYDTFVFSEESQLAVSEIKDVD
KLLLAGIAKPEPFFAYLQSDNDVVMTFPDHHHFTEKDIAEIKNKAQDKKIITTEKDFVRL
KGKLPDSQLFYLPIKSDFISGGDDFDKTILNYVGKSSRNR
>LONDMIMF_02964 Purine nucleoside phosphorylase 1
MWEKVQETVNYIKSKTNFSPEYGVILGSGLGGFTEDIQIEFTLPYSEIPNFPVSTVQGHK
GALVFGTIGSKKVVAMQGRFHFYEGYDMKEVTFPVRVMKYLGVQRLVVSNASGGVNPFYK
VGDIVVIYDHINMMPEHPLRGHNDERFGPRFVNMSEPYSRDLINKAKAIAIELNIEVKDG
IYYGLQGPTFETLSEYRMVKILGADCVGMSTVPEVIVARHMDMECFGISVITDMGDEHNI
DSVSHSEVLEAAKKAEPKVRTLIRELISRN
>LONDMIMF_02965 hypothetical protein
MGATSDTSCGDSSDFASGNILSFNAANTTTINVATPGSTQSIPAGSYAPTAGASTFPTDI
PLCNLSTFLNGVVVNGNWTMTLYDNGEEDTGSLNSWQIIFSTGFDLDTQDFLFTKRISVL
GNPFTENLNLKLNEPGDTVLRIYSIDGREVFTKSYAANDVSQNINIDSSSWQQGIYLLVP
EVEGRKLNAIKLAKK
>LONDMIMF_02966 D-alanyl-D-alanine carboxypeptidase
MNKSGYFTFFLLFALLQGKAQVEKTSELYKTIMSKDSLLFNIGFNTCDVSQFENLISEKL
EFFHDIDGISDKKKFLKDFKGGLCRYPKNYQARRELLPGSTEIYALYEKSNGGELYGALQ
TGIHQFFEKETGQPEKFGSSARFSHLWLLENGEWKLVKSYSYEHVTKQLESAATPVFDDD
IAVEKWLKENKVPVLGLGIIKNGELQQLKVFGEIKPGVPAPYNTIFNVASLTKPVTAMVA
LKLVSLGKWDLDKPIYNYWTDPDITKDPRSKKITTRHVLSHQTGFPNWRWMNADKKLSFL
FEPGNGYQYSGEGFEYLRRALENKFHKSLQQLASELIFQPLKMDETSYVWNENTDESRYA
LGYDKELKPYAIEKHNSPNAADDLLTTVEDYGKFLAGVMNGELVKESVFNEMVTPQTASE
RSKHFGLGFEIYDLENGEYALAHGGADLGVRTMAFILPKTKQALLIFTNSDVGGNLYEVL
VKHYLGKNGEKIIDIETK
>LONDMIMF_02967 hypothetical protein
MPNLKLLREQQNLTQEELSEKSGISVRTIQRIEAGTQPKGYTLKTLAKVLDVRESDLSDK
SIKTETTVESEKTISSQEPAIDYSKIKLINLSSLLFAVLPPLNIIAPLILAAVLKQKNQL
VKQIVSVQILWAILAPVVFMLGIFLKLGRKFTLVLMIAIVLSNVFIILRNVAEIDKKKKL
YYRLKFNII
>LONDMIMF_02968 hypothetical protein
MLTRINIFGIIKDHFGTLKNFDTHKTSFGDILLFFIIPIIIAFILTYKEYTFENQLSNLI
AGISIFGGFLFNLLAIIYSQLESIEKKTENMHDDHLQNLKVRYIKEIHANISFCIILSIA
IVLGLFLTTIDFPKPFKIVFKIIIGIDYFMMMLFALTMLMVINRIYILLKR
>LONDMIMF_02969 hypothetical protein
MEKILLSTYLVKITKDKNDLVLSQFAGEEDFFNFCDGFFKKIFSVIQKSMDAKDSTTIHL
SLDEMPIVDEKKRCIYGFLSSGVGGENYKIKDTDTNIEMFAVKSNHAAFRDVFFYLQIPK
NKTVGALILQRKSRFGIKTAFLKGINLYSRNLGYQGFHIQINNVIHGQVYRKMINEGNLK
KIEFIKRKIPKYIEQYYRKNGEVDKIPGTLKTTMSASKLPDNFKEFVDRLFSTKRNDRIE
LKDIGDDFEEIEFELELNGKKKTFYVAHRSRIQPDIDVSNEIERDSNGNPTIDSLVEQCD
SLIKEVIYQ
>LONDMIMF_02970 hypothetical protein
MFVVENELFMEIGIVIFFIIVFFIAFIKKDRKSFEISSEPKRGTRAERNLVSILKHSGIP
EQTIFHDLYVKKHNGNFSQIDLVVATKVGIIVFEVRDYNGWIFGTGYQSQWLQILANVQK
KYKFDNPIMQNNKHISDLRKTLKQFDNIPFYSIIVFYGDCILKDVSFVPKGTFLVKPERV
IEAMRIIIANNEPAQYTNKHEVVKVLQEAVNNGESPEVQWQHIENVRDMMGKDRIFG
>LONDMIMF_02971 hypothetical protein
MKQIFSLKTLLLLLGFALLSTQAKADKIRMTIKEELASCTGVAPQNCYQVKYKKSKDWEF
FYDQIEGFEYTPGYRYVIDVKRTKRKNIPADASAYTYKLKKIIKKERITNEAATELAFIT
KHKWNLIQINGTMPPTSSAYLIFQADGKRMGGSAGCNRISGGFELTKDKISFSKIASTLM
ACPDENKNKLEGTLLKMLTDTTFRYDIADQTLNLYQGDKLVLMFGMSPLE
>LONDMIMF_02972 hypothetical protein
MKIETSQLLQQLTAQVKNHMQYAESLEKQSEKSLNARLTPDSWSVLECIEHLNRYGKFYL
PEIEKRINASHSGPELQFKSGLLGNHFAESMLPKAKLNRMKTFKNMNPIHSKLDRNVLLT
FINQQNKLLTLLADAEKVSLNKTKTSISISNLIKLKLGDTFRFLIYHNERHIQQSQKVLQ
TTGL
>LONDMIMF_02973 hypothetical protein
MSKAIIIDKFDIGSLFEKTVTIERNQFLKKGGSTDTHIYFIASGSLRIFITDGEEERIVR
FGYQNNIIVALDSFFTQKPSDFYIQAIKKTTVKVISKEKFMTFINSNPENLKIWLEILED
LVLQQIEREKDLLVQSPRERYERVLKRSPRLFQEIPNKHIANYLRMTPETLSRLKKS
>LONDMIMF_02974 hypothetical protein
MEIIENNIPIEIYRELRVKSGLSGKDIEAAIIGLQNSIYSVMIKKEETIVGMGRIIGDGG
CFCQVVDICVLPECQGQGIGKIIMEQISNFIQTQLPKSCYVSLLADGNANHLYEKFGFKD
TLPHSRGMALKVV
>LONDMIMF_02975 hypothetical protein
MKQDIKIAVIGGTGKSGKYLVRALINQGFTFKLLVRNPKNFQSDYPNVEVIIGDASDYSS
IAKLVKGCHAVISTLGLGIPPSEPTLFSKATTNILQAMQQWNVQRYIVTTGLNVNTPQDQ
KGPKVIFATNWMYENFPISTANQQLEHDILTQSTADWTLVRLPLIELVDEKCPIAISLED
CPGDKINAASLACFLIEQLNDQEFVKKAPFIANLP
>LONDMIMF_02976 N(1)-aminopropylagmatine ureohydrolase
MTKEQIIKNFDPSQPGLADASIFGLPFSAEDSEIIIIPVPWEVTVSYGAGASEGPDAILD
ASFQVDLHHQEFPELWKLGIYLDQTEQTEKWAKESEKYKSLAQPIIEALESGEVIESLPG
LQSDLDKINKVCKNLKEEVKERVLYWTKKGKKVALLGGDHSTPLGYYEALATQHNDFGLL
HLDAHMDLRIAYEGFTYSHASIMYNALQIPQITKIVQVGIRDFCQQEVETAFEQGNRVLV
HTDMDLKAETFTGKTWEQQCEAIIAALPQKVAISFDIDGMYPWYCPNTGTPVPGGFSFEQ
AAYLLSKLGESDKEIIGFDLVEVAPGDNDWDGNVGARMLFHMCGVLAKNNGLPVGEKIKF
NR
>LONDMIMF_02977 Kynureninase
MTFQNTREFAQELDSQDKLHHYRNEFLFPQVNGRKVIYFTGNSLGLQPKRTKAYVDEVMD
DWAKLAVEGHFYAEKPWWDYHERFAAPLSKIVGALPSEVSVMNTLTVNLHLLMVSFYRPT
EKKYKILCEAKAFPSDQYMLQSQVRFHGYNPDDAIVELQRREGEHNIRLEDILAKIEELG
EEIALVLIGGVNYYTGQVFDIKTITEAGHKVGAYVGWDLAHAAGNIKLELHDWDVDFAAW
CSYKYMNSGPGNASGCFVHEMHHDNYELNRFAGWWGHNKERRFLMEPKFSPETGANGWQI
SNLPILSLAPYLASVEMFAEVGMDALIEKRNKITSYLEFILHEIDKEVDSTFEIITPENP
EERASQLSVFLHGEGRTLFDYLMKNGVITDWREPNVIRLAPVPLYCSFEDMYEFGQILKQ
GILSHK
>LONDMIMF_02978 S-adenosylmethionine:tRNA ribosyltransferase-isomerase
MKLSHFNFNLPKELLAEYPAENRDESRLMVVNRKTKTIEHKMFKDIIDYFEEGDVMVLNN
TKVFPARLYGNKEKTGARIEVFLLRELNAEQRLWDVLVDPARKIRIGNKLYFGDDDSLVA
EVIDNTTSRGRTLRFLYDGSYEEFRNKLTELGETPIPKYINREVTPEDAERYQTIYAKEE
GAVAAPTAGLHFSKHLLKRLEIKGIDFAEVTLHVGLGTFNPVEVEDLSKHKMDSEELKIT
QEACDIVNKAKANKKKVCAVGTTSMRAIESSVSSAKTLNPYDGWTNKFIFPPHDFSIADC
MITNFHTPKSTLLMMISAFTGHDLMKKAYEEAIKEGYRFYSYGDAMLIL
>LONDMIMF_02979 3-phosphoshikimate 1-carboxyvinyltransferase
MNLSLKPATCTVKSEISITGSKSETNRLLLLQALYPAIVLKNTSNSDDSEVMTKALNTKD
SVIDVHHAGTAMRFLTAYFATQENREVILTGSSRMKERPIKILVDALNQLGASITYEEKE
GFPPIKIKGQQLSKNKVSLPANISSQYISALLLIAPKLENGLELQLEGKITSVPYIKMTL
ALLEEIGVETNFKENTITIQSKKEIQARQLTVESDWSSASYFYAIAALSETGTEIKLSSY
KKHSLQGDSVLAEIYRKLGVDTIYEGNSIILKKSTARIAETLKLNLNDSPDIAQTIAVTC
FGLGITCHLSGLHTLKIKETDRLEALKTELEKLGAVIKVTQDTLELGKSEEIKSGVSITT
YDDHRMAMAFAPLALKVPIIIKDAGVVSKSYPHFWEDIKSIGFQMSEI
>LONDMIMF_02980 hypothetical protein
MEIKNAQLQVDNWIKEHGVRYFNELTNMAQLTEEVGEVARIIARRYGEQSEKESDKHKDL
GEELADVVFVVLCLANQTGINLQEAFDKKMDLKSNRDKDRHKNNEKLK
>LONDMIMF_02981 hypothetical protein
MKKNIFTICFVLFALNLFAQKKCELGKVTVEELKEKVHPKDTSAVAAILFKKGNTYLDYD
MDGNWVAVTEVATKIKIYKKEGYEFANEQIPYYTGGKQIRLFFDDAVTYNLVGDKVEKTK
LKSDGEFTERVNEIFSVKKITMPNVKEGSVIEYKYTIRTPYLTSLNDWYFQYPIPADYVE
YRIAIPQYFNYSVFMKGYLKVNKKPSVVASAAAQKFNELVTVYNIENVKALKEESYVNNV
DNYRSMLQFELASTDFPNQGLKNYAADWASVTKNIYEHKDFGDELNYKSYFEKDIEPIIK
GVTSREEKIKLIFDYVKTRMNWNEKNSYYCNVGVKKAYAEKVGNVAEINLMLVAMLRYAE
LKANPVLISTRSNGIAVYPAPSAYNYVIAGVELDNNQQILLDATSKNALPNILPFRALNW
LGRMIRNDKTSIEVDLAPKSNSKEIVNVIAAIDEEGKVEGKIRAQYFDYNAYGFREIHLK
TSKDKYLEEMEKRYGGVEVGEYTTTNDNDLSKPIIETFSFVNNNLADRIGNKIYFSPMLH
YARHENPFKDEVREFPVDFMFPYQDKYSYTITIPKGYEVESMPEPIAIYMESNIGSFKYN
IIKTANQVQVTTILDMNYSNIPPDYYHTLRDFYKKMLEKQNEKVVLKKV
>LONDMIMF_02982 hypothetical protein
MVFALNAYNPSFSVPQRYRNRTNPFEISRGYYDYDEVTIDLPKSFVIEAKPEDVEIKSVF
GEYKTEYVILNESQLIYKRIYQINPGLYDKKDYENFRKFREQIAKNDNAKIVLVKN
>LONDMIMF_02983 ABC transporter ATP-binding protein NatA
MKSIVGALKIDEGEIIFNGKNITENEIESKKKIGFLPENNPLYLEMYVKEYLQFVANVHK
IPASRVDEVIELVGITPEKSKKIGQLSKGYKQRVGLAQAIIHQPDLLILDEPTNGLDPNQ
IIEIRNVVKEIGQQKTVLLSTHIMQEVEALCSRVILIHKGNILQDCPIDEFKGKFESLEE
AFANYTA
>LONDMIMF_02984 hypothetical protein
MELSFHGWMIPVVIALLCVIFYKFILRIFFGLVIVPQDRIGLVTKKFVLVGKQELPEGRI
IATNGEAGFQAQTLAPGVYFGKWIWQYSIDFQPFTVIPTGKIGLLLAKDGMELETGRILG
RKVDCDSFQDAEAFLKNGGRKGRQTAIIAPGSYRINTLLFEIELTDMTQIPDNAVGIITT
MEGSPLEEGQIAGKIINGHNKFQDVDTFLNSGGYKGLQEQVILAGSYFLNPWFTKVEMVK
MTEIPIGHVGVIISYVGEEGQDLSGVDFKHGNIVEKGHKGVWAEPIGPGKYPINPYIMKV
ELVPTTNLVLNWAYERSESHQLDKNLSTITVRSKDGFPFNLDVSQIIHIPTYEAPKVIAR
FGNMINLVSQVLEPTIGNYFRNSAQDSDVIAFLGTRKERQQSAKDHISSVLEQYNVNAVD
TLIGAIVPPESLMKTLTDRKLAEEQKITYETEMLAQETRQALEKETAVADMQKEIVKADQ
GVLIAERIADASVKKATGDANSVRLQATAEGDRLKLLATGEAEKTRLLAKAEAEKIELLA
KASAGQISLTGNAEAEKILAIGKSNAESYKLSVEAMGGNNFTQLKIMENIASQNVRIMPE
VLIGGNGDSANGGISGLLGLQLLEQVQKKNLETVNIIEEKSDNNS
>LONDMIMF_02985 hypothetical protein
MIRKILLGAFCIAQFSLVQAGAFNENPVSKISYQQEKVPKSFIIKTKKFKIKIDKQPNGN
YLYQSWAANGKVTSKPSMIISDGELIPDGTGGNYYYEFNNNGYTYQIWRNYLTSSAKKAP
YTLTVTDRNGKTIVNQDGYVVKN
>LONDMIMF_02986 Cys-loop ligand-gated ion channel
MKTILSLVLLLFSLFPKAQASESAKQKDAPLEVAVSIHLNKIYDINSVNQTYMIDGYLVL
SWHDPKLEKKYCRKYGNKLVYENKEFPKDILVPSFEFINILGDREIINRRLIVNSDQNLI
YNERFHGRFTTPMDFHKYPNDKQCFTIQLESFSMEKEDLLFVNPQLFPKVLDASYMEEWN
ILDKKDYVNEMMYNHLSANKKGESFSRCNFEIFAQRKIEYYLWKVFLPIGLLVVASWLVF
WVKDFANQLNISFTLMLTMVTFNFFTSSLLPTLPYNTFIEIVIISGYISIFLTLIAIIFT
YAYSKNKRTTVKINNFFQVFFPLLYILFIVLCIIIIFV
>LONDMIMF_02987 Glutamate decarboxylase
MKEKPTSKPYQFPKKGEGAFRAYQKISNELTLDGNVQLDLGSFSTTSMNPLADKLITEQL
GKNFIDYNEYGQTKKIHDRIIGMLSGLLHAAAPHNPTGTSTLGSSEAIHLALLSHKWNWK
KRRESFGLSASKPNIVYSGNAHVCWDKFALYFDVEPRKIPQTSHDSYPIEEILKSIDQNT
ICVGAIAGNTYTGSIDPIEKLNDEIIRLNKKHNWDVGIHVDAAIGGFVFPFIKREVKTWD
FRLPLVRSINLSGHKYGLVYPGIGWLIFREAAVLPKELIFTSHYLEKPIETYTLNFSKGA
SMILAQYFSILQHGKQGYEKTIRDYCKTADVIRKRLRRSGHFEIIDEGILPVIVFRLKDV
KEDMLTSLLLQLRSKNWMLPAYQIPGISKQETLLRIVVKENISPELAQLFCDDLIHSYET
LKND
>LONDMIMF_02988 Extracellular phospholipase C
MKKLFLWYSGTGTTAEHMRNFFNITASDTIKIAYVDGLGTENNRTESQTLSNNQTGSWTE
WLMGFFRKTELLHDQAYGYKEKHQLAQLEHYFKLLEEIDPEKDNHVELIIGGHSRGAAAG
VLGFITALYSCCKEGNTLEGSPIKKIRILGVDPVPGTKGNDLLGLESETAEFKKNPILNM
LNFIESSSKKENLFSVIYYAARFDARNEFKADDYWLNFYKSQLLNKQIDTEFYIGGFRHS
AMVFEDDEISSLYNGNARPTALMKELVKRELGLPCANIVTLYNGLTATELTALSNLANDT
GNTTLINRTNKSSYGSASVVYTGSSLQEIVKKITANGTKKSELNKANLINNRYLTL
>LONDMIMF_02989 hypothetical protein
MNAIVEKIKNRSYFHETDSIASEDVEIIPSEWEKEKRRLVLAQKKQNKTVMERHIDDEIK
LMLDHIHRKSNDTLEVATDDLKLSQKIEWHGQLQKVIAPASLKSIKYATRFCGNFPTGRS
FFKFPLAKYFFGLIILMAIVMAVGFCTKETRLFTGYYSFELTDTAVLYFIKSYGISTACL
GNLLYLTAKLSRQIHDVTLTAERIPFYRNNFLFGLMASSSIAFKIPELLLMELTPIGYLF
IGIITGLLIDILNLIFKE
>LONDMIMF_02990 hypothetical protein
MKKYILLYLGLFYLGQTATAQNIWSLKECIAYGRANSFEASEIKILNASYKEDRKSIRAS
YLPQYNLFANGAFTANNNAVAWNPNAGLEVNALLYSGFRKKHELQKADLIIAQSQYNIAI
AENNVEMQVLYAYTEALTKKGQYQVCIDFYEKTRQLYDECSASKLLSPADGYFFEVLLQQ
DCQEIESLEQQYAIALLKIRQTINLYDAPDFEIAEIPSFTPAHTTLDVAYPLALLADPGI
SSNQLDIDVARESSRIAKTLLLPTVSLRYTPYYELHKSGLQHYAGLQISLPVFNRTVQKT
AIEKATIQGLFQEKQLDNQKEMLWNAVVLIISELKNRQSLYEISLTTLKKSTRLLNDGEE
KLKNKNTYPEAYLVVRNWNKQCALDSVALKYQTITQAKLLDFYTGTTL
>LONDMIMF_02991 hypothetical protein
MGSLLTVKGKHHEMLYVTSVNRLALDDELCIFAIADFSQKNGVPYPNCEIRQKVDISKYE
AVNLDELAKN
>LONDMIMF_02992 hypothetical protein
MALIFKKGWNEARKDYVKKYGKYQAFLDTLTESLIVGAFRNARNHFSDHWVLEFIDIATN
PGRVEQVSIEQGSHQPEDLTGGGFCLHFTGRDNSGYAFHFYIIQNLDGTPRIIEISYREN
GQTVSDYRR
>LONDMIMF_02993 hypothetical protein
MSQQRFDHLLQAIHNAALKAQEITEEQHIMQIAKYFDEDGKPITQEIQVPTLDPDDDPET
MTTLKVPLLSLLPPSAIKIKELKLSFKVGLGKIKIDPSDNKNGPSLDIDMGGGGGIFGKK
QATAKVDITFEAGDPSESFLRINDYLVKSVI
>LONDMIMF_02994 hypothetical protein
MIPDNSKKTTIAEIRYIKKVTIGTVNPSAPFTDDMREDQLALLNKCLSQHPKGIIIGKDI
SIGSFKLGEHELNMQSTTYHVGFARKPYWLDEK
>LONDMIMF_02995 hypothetical protein
MNIGDQFRGLPMEDLIGGPLSAAVKSNTDLAKSTAAFINDIGFEKVKDADGSIMPGPARM
VDFVFERPGQDKEGNATVEEVKMKVPMLAIVPIPNLQVDLVDITFDMEVKSSTKSVESSA
SKGEFSASMSAKIAFFSVNASVSGSISSSKENTRSTDHSAKYHVAVKATNHGMPEGLARV
LDIMNDAAKPRQIVAYKPNANGEIERGEDGKPTEQGKLVNADGTEVIPTSDTN
>LONDMIMF_02996 hypothetical protein
MKPSIAEIQKVLTKKGYAFFDQNKPYNVNIIGIRSKNTVANSFDDTLCLVYRDESLSPQI
FTFSVTTDPGLYWLKNPTNVNGTAILVPGQYKGSHQIGLHKGQYEALVQKAPVKVWRDAN
KDGKLDFSGPQHQGIFGINIHRSNPVSESLAVEKWSAGCTVFQKVADFHFFMSICNKSKG
LYGNSFTYTLLEESDFTTS
>LONDMIMF_02997 hypothetical protein
MSGKTGGTNGRIKGIKFICLFLLLLNPLKNYVMTKIKFKRPVLLVAPDLKQNLEIDSPLL
NAKFRESDTGNEKWTLEIFCLLKVSPDSIERSIDIFMDEGIHMMGILPIKKIFMNRIGDI
KDDVENLWYIETEEFELEEFYNIIELTIDDNLGGCGKKRGGKTVGIYTSLSKF
>LONDMIMF_02998 Histidine protein kinase DivJ
MKGTKDGRKQPDFVPFHNMHIQLYERQYSEVLPSILASIAVYSETSKNDTLLYLSYYARG
SFYRKKGLKDEALASMLQAEKISKNIKNPPGNVGFYSDIANLFFELQQYEDALQYYLDLL
HKNDFSANKKLQGAVYNNIARCYANIDKHDYEKAESYYKKSLAFYGKFQDSLNLAAVHLN
LGDLYFEQYKDRLAVDHLKKALLYSEVSEAVDIKDDIYFNLSLAMESAGQTKKALEFYKK
YVEQLEGIWNRDRIWGLAEQEKKFIVDKKQTEIQLLEKEAKLQKMQLDTKRMQSNTFFSI
AAVLLLLLLVGLYSYNQRIKKNRVIALQNIQLDELNATKDRLFSIIAHDLRTPVYLLKES
NLRLKKALIKNELTDLEKQLDLNINMTENTYSMLDNLLYWSLEQKNGSFYKKEQLPLHSI
VEQVLVNYGNALKIKDIRLDKNIPEGIQVYADSNAIKIVLRNIIDNAIKFTQDGGSIKID
AGIYENQAELVVKDNGIGINKAMLDTIKSGKAVRQKDTSGRTSTGLGLELCRIMTEKNGG
WLMIESEEGKGTSVKIVLELVKK
>LONDMIMF_02999 putative transcriptional regulatory protein pdtaR
MEKIRILIIEDDSFQAVSLQEALEEKGYEVTATASNLKDALGYFYAQKPDIVIIDVYLGN
DPDGILFAQRINENPATLKPFVFLTSAVDRETFESARLTNPYSYLIKPFNVLELQFAIEL
AIERFLEMPGMFSAHQTGTAIMEAFLLIKKKEALTKVLFSSIECVRVEGKYVSIATHEES
FLIEMSLKLLQQKLPEKQFIQVHRNYVVNMNLVKKLHLSDNQIELLSGNRIPMSRRFKEK
FMERYSILK
>LONDMIMF_03000 Threonine/homoserine exporter RhtA
MRFRNINIPPIPAVLLAIISVQSGAAIAKTLFPSIGAAGTASLRIGISALILMAVYRPKL
TKLTKEQWKFVIPYGLCLGAMNLVFYFAIERIPIGLAVTLEFIGPLMVAVLGSKRAVDFL
WVLLAAAGIVLIAPWTTNGVDILGAALATLAGAFWAAYIVLGGKISQKMDGNEAVATGML
LAACLVVPFGIFGGGLEGLTPKFLGMGIALALLSSAIPFTLEMKALGRLPARTFSILMSL
EPAAAAICAFIFLQEYLSFNEILAVVFVVAASAGSTITSRR
>LONDMIMF_03001 Lipoprotein-releasing system ATP-binding protein LolD
MIQAKNLHKYYDKLHVLKGVDLHIEKGEIVSIVGASGAGKTTLLQILGTLDKPNIENGTE
LQIDGENILHLNDKALSRFRNLKLGFIFQFHQLLPEFTALENVCIPAFIAGKSKSETEAE
AKRLLDYLGLSHRIDHKPGELSGGEQQRVAVARSLINKPAVIFADEPSGNLDTVSAENLH
QLFFKLRDEFGQTFVIVTHNEELANMADRKLVMSDGLIP
>LONDMIMF_03002 Peptide methionine sulfoxide reductase MsrA
MKKMIGLLTLITISCQSKEKEQEQLISEIKEPIKMEVEKGLEIATFGGGCFWCTEAIFLE
LDGVKKVESGYTGGKTENPTYEEVSTGTTGHAEATQITFDPNKISFGELLEIFFATHDPT
TLNRQGADIGTQYRSEIFYHNEEQKKLAEDYIKLLDRENTFGKPVVTKVSPAGKFYVAEN
YHQNYYARNKEKSYCSYVITPKVEKVRKQFAGKLKK
>LONDMIMF_03003 hypothetical protein
MTEQVQIKVASDKKQKQLLLSILFDVIGMTTYALPFIGEFADIAWAPISGFILARMYKGT
VGTVGGIISFLEELFPLTDILPTFTLTWIYTYYFSNEKK
>LONDMIMF_03004 hypothetical protein
MSNFIQILSNMKNLIYIIALFFLIFGCTTTKDTKTKTFQQTDKAVQNDTIKIANEELEYE
VIIIDPGFNSWFYSYARPRNYYSQQYMETRNRVWVMEWNSRFNQGDRRFDMSIDYRNNIN
YGYEVNYMLYNYLTYFQLTHNIKLGGFVPRI
>LONDMIMF_03005 hypothetical protein
MLEQLSDLVRQYGNDAVVNNNSVPNELNEGVMDEASTSIFSGLQKIISDGGADQIGQLFQ
GDNAGSASNPVVKQLTEQLSGNLGEKFGLSSDAASGVAGGLIPKVLGSLIGKAKNPNDKS
FEISDIVNSLSGGQGGSSIMDAIQKYGGQFGLDQNNDGKIDMSDAMAAVNKKGGIGGFLG
KLFGR
>LONDMIMF_03006 Hydroxypyruvate reductase
MKVLANDGISKSGIIALEKGGFEVITTKVAQEQVANYINKNAISVLLVRSATKVRQDIID
NCPTLKVIGRGGVGMDNIDVDYAREKGIHVINTPASSSESVAELVFAHLFSGVRFLHDAN
RNMPLEGDSNFEGLKKAYANGIELKGKTLGIIGFGKIGKAVAKIGLGLGMRVIASDKFVG
NAEIKVDFYNGQFINVDIVTEPMEDILRHSDFISLHVPAQDGYVIGKEEFEQMKDGVGII
NASRGGIINEVDLIEALDNGKVLFAGLDVFEEEPTPAVQVLMHPKISLTPHIGAATLEAQ
DRIGIELAEQIISLLKSDI
>LONDMIMF_03007 Phosphoserine aminotransferase
MKKHNYSAGPCILPQEVFEKSAQAILNFNDSGLSILEISHRSKDFVAVMEEARALVLELL
GLQGKGYQALFLQGGASMEFLRVPYNLLRDGGKASYLDTGTWAAGAIKEAKAFGETIVVA
SSKEDKYNHIPKHYAIPADADYFHCTSNNTIYGTQMKEFPETKIPVVCDMSSDIFSRQLD
FSKFDLIYAGAQKNMGPAGVTLVVVKEAILGKTGRNIPNILNYQQHIEKESMYNTPAVFA
VYTSLLTLQWLKRQGGIPAIEKINEAKAQLLYAEIDRNPLFTGTAVTEDRSNMNATFLLK
DETQAQAFDRYWKEAGISGLTGHRSVGGYRASMYNALPLESVQVLVDVMKEFEKTNA
>LONDMIMF_03008 hypothetical protein
MRKACLLPRKGLFLCKITSKTIHKQINMTLEYKKNIFAELGKFLSQFSENESIKKENVLH
NDLFFNDFLDLIELSQSHNGWYTPEQVYFAIRSWAEALTKENLDQWLSKYNLENVGGKTV
GLVLAGNIPLVGFHDFLSVLISGHKVLVKTSSNDQHLLPFLAKYIMAVEPKMAEYITFTE
GKLENFDAVIATGSNNTARYFEYYFKDKPSIIRKNRNSVAVLDGTESKEDFIQLGEDIFR
YFGLGCRNVSKLFVPKNYKFEAFFEGIFEYQDVIHYEKYANNYDYNKAVFLMSNFKLLDN
GFLTIKEDTSYSSPISSVFYEFYENTEELKKRLATDNEQIQCIVSKGIIENSIPFGKTQK
PELWDYADNVDTIAFLSSI
>LONDMIMF_03009 Ferredoxin
MAIIITDECINCGACEPECPNTAIYEGADDWRYKDGTKLNGKIVLPNGEEVDADAPHTPL
SDDIYYIVPGKCTECKGFHEEPQCAAVCPVDCCVPDDNHVESEETLLNRQAFLHGE
>LONDMIMF_03010 hypothetical protein
MKTILLSSITLLAALSLQAQNKNVTDVSKTTVTTVKDSDGEKTYLKTQEVKEVQNIEFQN
ADSKALNKDLKETPVEVISKTQVINPDGSTRTVDIDRSSYYTSNGKTYQLRLDPAGYVIT
TQDNKRLGLLRATTTNSYIYRGKNQTSIGYFDTNGNLVVETYDDKSDKVSIETYVRSPK
>LONDMIMF_03011 Ribosome-binding ATPase YchF
MKAGIVGLPNVGKSTLFNCLSNAKAQSANFPFCTIEPNIGVVNVPDPRINKLEELVKPER
VQMATVDIVDIAGLVKGASKGEGLGNQFLGNIRECNAIIHVLRCFDNDNIVHVDGNVNPI
RDKETIDIELQLKDLETVEKRLEKVNRAAKTGNKEAQVEQALLNRIREALLQAKSARTIT
PQNNDEEALLESFQLITAKPVLYVCNVDEASAVNGNKYVDQVRELVQDEDAEVIVLSVGA
EADITELESYEERQVFLEDMGLTEPGSSVLIRAAYKLLKQQTYFTAGVKEVRAWTINIGA
TAPQAAGVIHTDFEKGFIRAEVIAYDDFVTYGSESKVKEAGKLRVEGKEYIVKDGDVMHF
RFNV
>LONDMIMF_03012 hypothetical protein
MKAKGLFSKTWYLLKNTISEFNDDNAIKLSASLSYYTIFAIPPLMIIIITLCGFFFGKDA
VTGELYGQINRLVGNDAAIQIQNAIKNVELSDSNAFAAIFGGVMLLIGASGVFAEIQSSI
NFIWGLKAKPNKGFKKFIQNRLMSFSMIVSVGFLLLVSLLVNSIMDLLSAKLRSYFQEGT
IYIFYVLNLLLVFAIITLLFTIIFRTLPDGKIRWKDAFIGSSFTAVLFMVGKFAIGLYLG
NSTVASVYGAAGSIIIILVWVYYSAIILYFGAEFTKVYAKAYGGSISPNEYSVEIQKEIF
EITDAETNTKTRI
>LONDMIMF_03013 FMN-dependent NADPH-azoreductase
MKIIAFGGSNSSKSINKMLATYASGLFEDAEVEILDLNDFEMPLFSVDREKEVGQHETAK
KFLAKLASADILVVSLAENNGIYSTAFKNIYDWSSRIDNEVFQQKPMLLMATSPGGRGGK
GVLDFASSNLPRHGANIKALFSLPSFYTNFDVENKKISNAELDNELKEIVTNFEA
>LONDMIMF_03014 hypothetical protein
MKKIFRILLKIILGILGFFIVYILLALAIPYIGVNTEDKDKQEDVAIYIKTNGVHTDIVV
PIKTEYKDWSEKIKYEHIASKDSTMQFIGFGWGDKGFYLNTPEWSDLKFSTAFNAAFYLG
TSAMHATFFKRLKENESCVRIAISKEEYAKLIAYIEDSFQYDSQGNPILIHATTYGQNDS
FYEANRKYSLFYTCNTWANNALKAADQKAALWTPSDKGIFCHYK
>LONDMIMF_03015 DNA topoisomerase 4 subunit B
MSEQNQYTEDNIRSLDWKEHIRMRPGMYIGKLGDGSSPDDGIYILLKEVLDNCIDEFVMG
AGKTIEVSIKEKTVTVRDYGRGIPLGKVVDVVSKMNTGGKYDSLAFKKSVGLNGVGTKAV
NALSTYFRVESVREEKQKAAEFSAGNLVLEEDIIETTKRKGTKVTFTPDEAIFKNYKFRN
EYVLKMLKNYCYLNTGLTIIYNGEKFYSDNGLKDLLEENIAEEDMVYPIIHLSGDDIEIA
LTHSKSQYSEEYHSFVNGQNTTQGGTHLVAFREAVVKTIREFYNKGFEPSDIRKSIVSAI
SVKVMEPVFESQTKTKLGSTEMGPDLPSVRTFINDFIKNKLDNFLHKNPETADLLLRKIL
QAERERKELSGIRKLAKDRAKKASLHNKKLRDCRVHLTDSKNPRSLESTLFITEGDSASG
SITKSRDVNTQAVFSLRGKPLNSYGMSKKIVYENEEFNLLQAALNIEEDMGDLRYNNIVI
ATDADVDGMHIRLLLITFFLQFFPELIKEGHLYILQTPLFRVRNRKETIYCYSEEERVNA
IEKLKPKPEITRFKGLGEISPDEFKHFIGDDIRLDPVMLDKLTSIEQLLSFYMGKNTPDR
QEFIINNLKVELDVVEK
>LONDMIMF_03016 Ribosomal RNA small subunit methyltransferase C
MKDLFGKAILDYQTNNSPENLITETSISEADEMSVAYLFRNYSTMPKIEKKAMNLAKGKV
LDVGCGAGSHSLYLRDIKKLEVLPIDISANAIQACRLRGLDNAKVQDVMQLDSNNSENKF
DTILLLMNGTGICGRLNNMSDFLQQLKSLLTPTGQILIDSSDIIYMFDEDEDGGKWIPTE
RDYYGEITFTVYYKKEEEKPFDWLYVDYNTLQNAALANGLQCELVLEGDHYDYLARLTL
>LONDMIMF_03017 Isopenicillin N epimerase
MKQLFLLDPSITFLNHGSFGACPKPIFEEYQRLQLELENEPVYFIQKKAETYLKKAKEKL
SGYIGCQPEDFFFTSNPTVAINTVMRSLNLQPGDEILATNHEYGAMDKTWAYFCKKTGAK
YVRQPISLPIVSKEQLLEDFWKGYNSNTKVVFINQISSATALIFPVREICKKAQELGLIT
IVDGAHVPGHIPLNIEEIDADFYTGTLHKWMLAPKGSSFLYVKKEFQDDLDPLVVSWGYD
NETIAGTQFLDYHEYQGTRDISSFLCTPAVVDFLERNNWNEVAENCKEIVLNNYQRFCDL
LNTTPICPITKEFLGQMASIPVSTDEPQKLKELLFEKYQIEIPVMPLNGDFYIRYSINAY
NSQEDLDRLYEVLQEIIETTNLVKT
>LONDMIMF_03018 hypothetical protein
MKKLIVTFAFVLAAQVGFAQDAAFKNDVKKVIEMTGASAQIDVAKKQILGMIPEAKQAAF
LKDFDATMPSYFDKVADVYMKEYTHAEIKEMIKFYETPLGKKITSKAGVLTEKTMEAAQA
WGVELQSIMMKYMQ
>LONDMIMF_03019 7-carboxy-7-deazaguanine synthase
MLKKELQIAVEKGVMLPLMEEFYTIQGEGYHTGTAAYFIRVGGCDVGCHWCDVKESWNAE
LHPPTAIEAIVENAKKYANTVVVTGGEPLTWDMGPLTQKLKEKDLKVHIETSGAYPLSGT
WDWITLSPKKNKLPTQTVYDNASELKVIVHNKHDFIFAEEQAEKVNKDAILFLQPEWSKK
EAMTPLIVDYVMNNPKWRVSLQTHKYLNIP
>LONDMIMF_03020 Lipopolysaccharide assembly protein B
MKKIKFISLSLLFFGTAVFAQDLEQAKKAIDAEQYQKAKTILKSLIASSPDKGKNYFHLG
EVYLALDNADSAKIYFDKGIVAKDNGNFNYIGLGEISLDNGNVSEAEANFNKATANMKKK
DAEEFLYIGRAYINSEKHDYKKAITSLKKAIAVDPKYAQAFLSLGDAQFGDSDVNSAYSS
YRTAYDLDNSLLRAKMQLGVITKNAKAFPEAIAAFNEVIKLNANYGPVYRELAETYYFWS
TSDTSKRAEYIKKALEYYEKYMSLTDYSLDSRMRHADFLILAKDYEALQKEAQAMQQLDK
VNPRIYRYLGYAAYENKNYDESIKALNDFLAKVDPKRISARDYLFLAKAKLGKAISAEGA
ITDKAQFDSAMADLTKATDIDPAIGSEFSDLGVSLYKQKLYLESTKVFEAATKAPNSKNA
LLDNFYLGNAVLFYVANDLKTDAERNKPEVQELLKKADTAYAAVVAGSPTTQDAHLNKAK
INRFILGPEAKEAAVAAYQKYIEVVHAKGEAELAKENVKSGLIGAYSYIGSHYAISDKVK
AREYFEKALALDPNSQYIKESLDVLKK
>LONDMIMF_03021 hypothetical protein
MPKYLRFLFYSFGFIMTIFFIDSCADKKKKEDQTATFYVDETVMPMMDDQLAVFHSERTE
KINLVPKTEGAILDLLKNDTTKLVVMSRVLSKSEEKRFTDKGIVPRITQIAIDGVALIAN
NKAKDSVIDLQNVIDFMNGKPVASIKGLVFDNANSSTIDFLSRKASVTKVDSKNIFALKS
NNDVIKYISENDGYIGVIGVNWMTQPMPDMLNSTTNVKVLAVKNVKSEPNSSAYYKPSQT
NLAEGLYPLTRKIYMLNYEGSVGLGMGFATFVAGDVGQRIVLKSGLAPVRLALREVKVRK
DIENK
>LONDMIMF_03022 hypothetical protein
MDGSKYRTNKDQKSLLGRFLLILGMLFFLMYFVMGMAIIFWKDIPIEMPKPYRIAFGLLL
IVYSFFRFIRFIKKDQQ
>LONDMIMF_03023 hypothetical protein
MSNSKLDLFEQSWIENVFEGRNKSYGAYELRTNSGKRTLKALAIGAVIFLFMVCIPIISK
FISENMTKEEEVLDEQVVLVNVQEPIKKEEIIVEPVVQKQTQSNVDIQKYVPPVVVDKQV
VREEVAVVEELKKTGSETVKAKEGGEVVLDGTQSEIKVDAEVIEEDPNKIYTSVQVLPEF
PGGIAGFYAYVKKNYRIPEVDDDVSGNVIVNFVVEKDGSLTDIKVVRDLGYGTGKEAIRM
LKSAPKWKPGIQNGKAVRVSYNLPIKLVIKSN
>LONDMIMF_03024 hypothetical protein
MAELNTGDGGGKKGGGKVRSKKANPSVDLTAMVDLAFLLITFFILTTTLSKPQSMNLAMP
DDIKDQAPPPETPAWRTLTLVLGSNDKLVWYSGRTDGPPLDGPVATGYGKTGVRDLILNK
KAAVDAKNKAEGADIEKSGITIIIKPSKKSNYKNLVDILDEMAITKVKKYAIVDITDADI
KFLEDNKIY
>LONDMIMF_03025 hypothetical protein
MAKIKLSKKSSRIDMTAMCDMAFLLLSFFIMTATAKVPEALPVDTPASTVQTKLPEENLA
TLTIGKEKVFFGVTGRATREETLKRMGEKYNIQFSDTDKKKFALIDGFGVDIRQMKQLID
MKNEQRMKEGVQPGIPFDSLNNQLADWVKTAREVAKDMDGKDLDIAIKGDAKEEYPTVKK
VLDILQKQNKNNFFLVTGLRSDDF
>LONDMIMF_03026 Biopolymer transport protein ExbB
MAQASNAKVQNNGGSKSSNLFAGLTILFCIVIGFLVWQFIMGDGSHFQGGVNTGQPLQGD
YLGMVYKGGYIVPVLMGLLLMTIVFSFERFFVISKAAGKGDVEKFVKSVQGQISSGDIQG
ALDACDKQQGSVANVVKAGLIKYQEVKRENFDTEKASEVIQKEIEQATSLEMPMLEKNLT
ILSTLVSLGTLLGLMGTVSGMIKAFAGLATSGTPDQAELANGISEALINTLTGITTSALA
VVVYNYFTSKIDTLTYFIDEAGFTITQAYRRATNRD
>LONDMIMF_03027 hypothetical protein
MASKEDFISHINTGYATKGESITLGGAIFNGEALPDAHIKIPLKTLNRHGLIAGATGTGK
TKTIQVFSEQLSLLGIPVLMMDIKGDFSGIAKPGVEQPFITERHSKINIPYQVSGFPVEL
LTLSKQNGVRLRATVSEFGPVLFSRILDLNDTQAGVVAVIFKYCDDNQMPLLDLKDIKKV
INYITEEGKAEIEEHYGKISTSTTGTILRKIIELEQQGADIFFGEVSFDVNDLMRIDENG
KGYVNIIRLTDIQDKPKLFSTFMLSLLAEIYNVMPEQGDSGQPELVIFIDEAHLIFNQAS
KALLDQIETIVKLIRSKGIGIYFVTQNPMDVPSSVLAQLGLKIQHALRAFTANDRKAIKM
TSENYPISEYYKTDELLTSLGTGEALVTALNEKGIPTPLAATMMRAPMSRMDVLTDAEIG
EINNSSKLTRKYNEVIDRESAYEMLTKKIQDIQQQAAETAQKEQEAKQEKKAANEPMSQT
TKSIIKVVTSATFIRGFFGVLTKIFKK
>LONDMIMF_03028 hypothetical protein
MKSFITIGLLVLSNFFMTLAWYGHLKFKELKWFENAGLITIVLISWGLALFEYCFQVPAN
KIGFNGNGGPFSLMQLKVIQEVITLVIFVIFSLLFFKNETFRWNHAVGFVFLILAVYFIF
KK
>LONDMIMF_03029 hypothetical protein
MKKYTLQKSPFVVPTNDGKLIEEHFGNATNNNSDVSIAHMVAPPKWSEPFQVPEFDEYTY
IIKGKKQFIIEGETLILEAGQSIKIEKNARVQYSNPFDEPCEYLSVCLPAFSLEKVNRED
>LONDMIMF_03030 NADH dehydrogenase-like protein YjlD
MVTLHTNETCMETQKRIIIVGAGFAGLTLAEDLENTGYEVYLIDRNNYHQFQPLLYQVAT
ARLEPASISFPLRKVFQRSKNVKIRIADVLSVEADKKCLKTSIGDFSYDYLVLAYGCRTN
YFGNKDLEHCAFPMKSVPEAIQLRNRILQTFEDAVITKSPEELQYILNFVIVGGGPTGVE
LAGALAEMKKNILPKDYPDKDFSKLTVYLLEGSPNVLNAMSDDSKKASRKYLEQLGVIVK
TGTVVENYDGRTVRLKNGETIEAKNVIWAAGVTGNQIEGIPETAITRGNRLVVNRFNEIE
TLKDVFAIGDIAYMTTPKYVNGHPQLAAVANEQAKVLAKNFKLLAKNKPLKEYEYHDKGS
MATIGKRKAVVDLPSFSFQGRFAWFTWMFVHLMLILSVKNKLTIFVNWAFSYFSNDSTLR
VLIKPVTKKVDN
>LONDMIMF_03031 Kynurenine 3-monooxygenase
MQNPLNIAIVGSGLVGSLLAIYLRKAGHSVHVYDRSPDIRKIQFSGRSINLAMSHRGWKA
LDGVGVGDAVRAISIPMDKRAIHLKDKLNFQPYGKEGESIYSISRGTLNRKMIDLAEEVG
TKFFFEKKIWDVTLADATLHIGETERGEWEAVKYDVVFGADGAFSRIRHRMQRQSMFDYS
QEFLQTGYKELNIPPNPDGTHRLDKNSFHIWPRGDYMLIALPNLDGSFTCTLFMPFEGEN
SFASLTDREKVESFFEKNLPDTVDVIPNLAEDFFKNPTSTLVTMKCYPWTYGDKVALIGD
ACHAIVPFYGQGMNAGFEDITVLNDFMEQFGNDWERIFKEYEQSRKPNADAIAELSYRNF
MEMSSKTADEKFLLQKKIEKRFSDKYPDKWLPLYSRVTFSLDPYSQALEVGDFQNQLMEE
VLKMDDIEAKWDSPEVEERILELLNRKTK
>LONDMIMF_03032 DNA replication and repair protein RecF
MSKTTRVLTISWRLQMYLKKIALFNYKNFSEANFEFDSKINCFVGKNGIGKTNVLDAIYH
LSYGKSYFNPLAVQNIKHNEEFFVIDGEFEKDDRNEQIVCSLKKGQKKILKRNGKQYEKF
SDHIGFIPLVIISPADRDLIIEGSETRRKFIDSVISQLDSHYLQQLIQYQKVISQRNALL
KYFAINHVFENTTLLIYNEQLHSLGHAIFEKRKQFLEDFVPIFNRHHQAITGNAETVQLV
YESQLHEKELMALLEESLAKDRIMHYTTAGIHKDDLSFEIDHHPIKKFGSQGQQKSFLIA
LKLAQFEFVKKQSHQNPILLFDDIFDKLDETRVGKIIEMVNNDNFGQLFISDTHPERTES
VIKSMHQSYKIFNL
>LONDMIMF_03033 Autoinducer 2 sensor kinase/phosphatase LuxQ
MLASLKHRKTIHSGLFIFVILLQVLIFSLWYNQNTNENELADSFRKASRQSLIMSYSGEV
TKNYFDAEDSFMEYLYSYDRSALHKYRNSLSLMTSYLDSLNRLLNKDEKTLPNIQSKKEK
EKKIIVLRKELDSLIKYRVDPVSESNPEIFTLKPYNHKKVMKSISYDTIRSSEGVEKKGF
FKRIGNAIAGKYDVEKEEFRYYMTMTFGAVEKTGTPEEQMANIFNSTRQYYEKEFGRLRN
TYSNLREIDRELMAINKKILKNSQDIILLYDKSVQESNKQQFEKALENLKNKRSLIATLM
IIMSICTGLLLLYSIFAYHFEKKLAAAKIEAEKNLEFKNRIIGMLSHEMRSPLSIISNLT
NKLISTKMDGAQNDMAKSLNFTSNSLHITVNQILDFFKNENGKLQLYNSKTVLKNEITSI
VESLKSLADAKKIELVSRVDDSLQNEVWADSGKIHQLFYNMIGNAIKFTSKGNITVDCRF
TEVNDKFKLDVKIKDTGAGIPKEDLDKIFDKYYQSKFHKDQASFGAGLGLSLCKEIIELY
DGEIRVESEPGTGTEISFHLFLEKSDSSQETNQARLIRSYGNSGIRVAVIDDDRIITTLL
KKLLSDINFEMIGFNSDIAAKEYLQKENVNIILTDLQIANASGIDLIKDIKSIPNHNATV
PIIAITGDTYMNSIELSSIQADELLIKPINKEELYSKLLKVLSK
>LONDMIMF_03034 hypothetical protein
MLSPKTLQFLEDLKENNNRDWFQANKPYYEEYKKEYHRLIAEFLEEMAPHDESLRTLEPK
KCAFRINRDIRFSKDKSPYKTHMGIWMTTDQNCGNAPGYYVHIEKGGSFIAAGLHVPEAP
DLKKIRKEIAYFYEDLEEIFADKDFKKIYSGFDRNESNSLKTAPKDYEKDHPAIEFLKLK
SFTVTQKLDDKSLLEKDFVKKTAKKLIVAKPLNDFLTRGLNTE
>LONDMIMF_03035 UDP-N-acetylenolpyruvoylglucosamine reductase
MEIIDNFSLKNYNTFGIEAKAKQFVSVHSVEELQTVLKENPAQKKFILGGGSNMLLTKDI
EALTIHVDIKGKTIIDQTEDAVWVEAKAGENWHEFVLWTIDQDFGGLENMSLIPGNVGTT
PIQNIGAYGTEIKNTFVYCDAVNIQTLEIRRFNKEECKFGYRESIFKNEVKDQYIIVSVV
FKLTRQNHKINISYGDIAAELAKKDISAPTLKEVSNAIITIRQSKLPDPKELGNSGSFFK
NPIIPRSDFERIHLLHPEMPSYTVSETEVKVPAGWLIEKAGFKGKRFGDAGIHKNQALVL
VNYGNATGQEILNVSKEIQKTVKELFDIEIEAEVNVI
>LONDMIMF_03036 hypothetical protein
MNNIFDNKAEFQKRGFTTINSVYSQEEIDSIIKFIEEQDTNSPIFRKSENLFAIRQFIKE
LPEIKPLIFNDKLKSIINIIGENAFIVKSIYFDKPEESNWFVAYHQDLTISVNKKEDVEG
FGPWTSKHNQFAVQPPIEILENIFTIRIHLDDTNENNGALKVIDGSHHKNIYRPENIDWK
NEKESCCNVDAGGIMLMKPLLLHSSSRTLNHKRRRVIHIEFSNIGLPKPLKWSEYSQISY
>LONDMIMF_03037 Poly-beta-1,6-N-acetyl-D-glucosamine synthase
MLTITFYAFIGVVALQLFYYIVVFGKFSFAKPQKSTPKRIPISVIVCAKNEEENVKKFVP
LLAEQNYPDYEIILIDDASSDNTLDVFEEFEKQYSNIRLVKVQNNEAFWGNKKFALTLGI
KAAKNEYLLFTDADCYPSSKEWIKEMSSQFTMSKTIVLGYGAYEKIAGSFLNKIIRFETM
LTAVQYFSWAKIKHPYMGVGRNLAYKKEEFFNVNGFIDHMKIRSGDDDLFINQASTKKNT
TICFTPESFTFSEPKKTFKDWFDQKRRHVSTASFYKAFDRMQLAVFFLSQFLFIVLAVVL
LAFQFNWMIIVPIVAGRYLFSWISLGYSAGKLKEKDVIYWYPVIEIMLIFTQLNIFITNL
FSKPVHWK
>LONDMIMF_03038 ECF RNA polymerase sigma factor SigW
MEIKKQIEKAKVGDQVAFTTLLDYYWNEVYGFMLQRTQNETDAEDITIETFAKAFDKIAT
YNPDFQFNTWLISIAKNVHIDMLRKKKSTLFIDITDEEDSQAYNIADSSPSAEDKLITEQ
NLSRLLQCIKELKPHYQEVIQLRYFQELSYQEISEELEEPLSNVKIKLLRAKKLLAEIIK
NKR
>LONDMIMF_03039 hypothetical protein
MLAVFLSMTAAKAQYTTPNTGVTWSLDDLVANSSGALTLSAGIYTLSQNLTIAANDAIVI
NTDATLKINADIGILVNGDFTSDAGAITITATNTATPYNAITFETGSSGYFRNTTISYGK
GIRVATPDFEMQSCVMSYHMNGSTTSSAINFSTGGNALINNSRFLFNYYPAFSSGANQSV
APTLTNNYLEGNNQSNGNRPQINMGPSGADTLRIVGNTIKGDRTKIRTGGIGASNLLGGG
QLKVIIDNNIVTDNRYGITVVGAASSGYIRGNIIEDNNSQNIPAEGGSGISLSASGASTM
NIIASRNQIRRNLWGITVIGTARINLGDTNEATFNEGGNIFSENGNTGAAYALYNNTAFP
IMAKNNCWIEGQTPTEAQVEAVISHQVDDNTLGLVTFTPFGCDALSNPDFTVVKPIIYPN
PSKGNIAIDTPENGTLKIFSINGMFISSFDLNAGTNTIKLDLPAGIYVTKTETKDKNFSN
KLVIQ
>LONDMIMF_03040 hypothetical protein
MSNLNIFSQSWNENVFEGRNKEYGAYQLRQENPKTTLKALFFGTLACASLVSIPIISNLL
TNKGQGEIICAIPAELPPVTYVNLGIKPEIKLENTVAAKPEKSSAKQTKYVTPIITDNQT
TPQDVATIDPAKNIKTGDSDNPGDNMGAVALGNSSIDGTGTEPAFGNTGTATDPGDGIFT
NIGLQASPEFPGGIKNFLALVGKNFRLPEIGEKATMKVFVYFVVEKDGTLTNIKVVRDPG
YGLGAEAIRVLKSIKTKWKPGIQNDKPVRTAYNLPITVEIKN
>LONDMIMF_03041 Lipoyl synthase
MDTVLDNAILPTGKPKWLKVKLPIGQKYTELRGLVDKYKLNTICTSGSCPNMGECWGEGT
ATFMILGNVCTRSCGFCGVKTGRPETVDWDEPEKVARSIKIMNIKHAVVTSVDRDDLKDG
GSIIWMETVKAIRRMNPNTTLETLIPDFQGIERNIDRIVEANPEVVSHNMETVRRLTREV
RIQAKYDRSLAVLKYLKEKGINRTKSGIMLGLGETEEEVIQTLHDLREANVDVVTIGQYL
QPSKKHLPVKEFITPDQFAKYEKIGLELGFRHVESGALVRSSYKAQKHIL
>LONDMIMF_03042 Glyceraldehyde-3-phosphate dehydrogenase
MTKTRIAINGFGRIGRNLFRLLLNHPTIEVAAINDIADNRTMSHLIKYDSIHGVLPFECS
FDQDNIIIDGKPYPFFHERSISNLDWKSLDIDVVIEATGKYKTFEDINLHILVGAKKVIL
SAPSETDKIKTVVLGVNEHILDGTEKIISNASCTTNNAAPMIKVINDLCGIEQAYITTVH
SYTTDQSLHDQPHKDLRRARGAAQSIVPTTTGAAKALTKIFPELDGKIGGSGIRVPVPDG
SLTDITCYVKREVTIEEINKAFQQTCQNQFNGIMAYTEDPIVSVDILGNRNSCLFDSQLT
SVIDKMVKVVGWYDNEIGYSSRLVDLILLTNKK
>LONDMIMF_03043 Sensory/regulatory protein RpfC
MKHLPLFFILLFSTLLPAQHDKLMPEKIDSVDYYIQLANFNLKINNYQNALESSQNAIEV
SQKKGNKEQEANAYTFLGSIYFELKKYDDAIETYVRSISLYNDLEPSTEQAYCYYNLGLC
YMEKGKYGVAEIYFDKANVIYETIDIPDAKELLNLQKGILYKAKDKTQLAATIFNSIIAK
PDNNDSFKTKAEALYQMGAIEFEAGRNNLALNYLRRALDLNAKSDNFEQKSKILKLISET
YEKMMDIDNSFIYLKKHLALKDSILRLNSQKIGAEAFEKFKESEQMKTIKQKDKENREQK
KLIKVSKLTSVLSIALITILSLLSLSLYKNNIIRNRTNKQLQEKNTELEIAKDKAEKASQ
ARAEFLSTVSHELRTPLNAINGITHLLIEENPKKSQIEYLKSLKFSGNYLLTFINEILEI
NRIESNNIEIENICFNLRQLLTDIQNSLKEIASQNNIDFGLEIDPEINTSFSGDPTKLSQ
IFMNLINNALKFTENGTVIVRAKLLGETETRQNIYFEIVDTGIGIPAEKQEVIFESFSQG
SVEINRKYGGTGLGLAIVKRLVSLLGGTIKLESTISKGSNFNFSLELEKGIENKESLKLF
TNDSDFVDKKVLLVEDNKINQMVTRKMLEKKQIQCEIVDNGEDAIEAVRENKYDLVLMDV
HLPGINGTIATQSIRKFDKKTPIIALTAISLNENREMLLSFGMTDVITKPFNPDVFYRVI
AESMS
>LONDMIMF_03044 hypothetical protein
MKKSILIVGMTVLFAFASCREDKKVPDPAPKTPPVDNPTPPPSPTTGVPATSQDEDGTNI
SVSKDGAAVETKDGKNKTGISVSKNDASVEIKKSKN
>LONDMIMF_03045 hypothetical protein
MAQITNFMKILGIVVTLARVGYILFFSKNSNVKFLLQVKT
>LONDMIMF_03046 hypothetical protein
MSQISETNSGNTPEKSQDAPKATPAAAKPASPKTAAIAKTTRPAGTTAKTTTAKPATARA
TAPGTTAAKPTTTKPASRTSNASKTIASKPATAKTAAVSKTTTASKTVSAKAAPKENAEV
VSQEAEKSVVAQVAQENTEVAKKDKKKSKKAKKEKEKIKKAKKKKKEKAKAKKKKEKEKK
KKARKKAKAKKAAKAKAKAKKKKKSKK
>LONDMIMF_03047 Thioredoxin reductase
MADSNTFEVIIIGGSYSGLSAAMSLGRSLRKVLIVDSGKPCNRQTPHSHNFLTQDGETPA
AISQKAKKQVMDYPTVSFHEGLAIKAHKTGNDFEVITETGEKFTSKKLIFATGLKDIMPE
IDGFADCWGISILHCPYCHGYEARDTKTAILANEDSGFHYAQLLSNWTKDLALFTDGISI
LTAEQAEIVKKNEVKIIEEAISHIEHDKGKVRHIVFKDGTRFPVETIYCRPNYIQHCPIP
EELGCELTEQGLIKTDAFQKTNIDGVFACGDSTSGRSVAVSVSTGSIAGVFANNELTGEA
FNS
>LONDMIMF_03048 Ferric uptake regulation protein
MSTRNTKTKSIILDSLKKSRQALSHENLLNTLGGQADRATIYRVLNRFCEEGIAHRIVGD
DGKQYFAICINCEKKQHHHNHFHFRCLRCDKVECMPNEASLNLPAGYSVANFNGFISGYC
PNCS
>LONDMIMF_03049 hypothetical protein
MRLKATLLFSLFLFCSCKEETKIQNTVKEEEPTETIETAVIPSEEGFRFKDFQIRKGGLG
NINVGMSLEESEKYLRGLTRKRCDPFDFGFDGGGDAYIYYWKDQPVLALIPEMDTNILLA
IAAIHKELKTDSGLHPNATIKDIQRHYGNLPLYQNLMMSWEFMYDEKANWDFVFMKDPEH
QVGNYETPDAPGKVIDFNAKTDWITIH
>LONDMIMF_03050 Fatty acyl-CoA reductase
MTFQNNTILITGGSSGLGLEMAKQFISLGNKVIVCSRTSEKLRQAQKTVPEIITYVCDIS
IEEERRKLSKWIEEHYPEINILINNAAIVHRIEFADDTESYEKSAREIATNLQAPIHLCQ
LFLPLLAVNPNAKIINITTGLVYVPRTDYPFYNATKAALHSFTQVLRNQLKNNSVKVTEV
LFPVVDTPWHEGNAPKIAITPHKAVNEMIKGLTNGKNEIRVGKVRILYYLSRLAPKFAFK
KINSLR
>LONDMIMF_03051 hypothetical protein
MESKFYAMDSPKDVLKRLGIPEKQAAELLSISRTKPISSGEDYISAGQTPKTFAIVINGL
FRYYYIDEKGNEFTKGFIPAATVLSAYSAMRYETSSFFYIQALEDSEILEIDYKKWLLLQ
QEDSFWDKFLIQALEKGYFIKEKRERELLLLDAEARYKIFTTEFPDLEKRIKLQIVASYL
GIQPESLSRIRKNKPA
>LONDMIMF_03052 hypothetical protein
MINEAELAQRLGINADRLKEFLSVSETREFKKNSILFEGNAVCDWLGYIVNGAVRTYCVN
DLGEEISFLLQVNGDFFGDYESYITNQKSGFIIKTTLDTEILVFQKKHLDILIDSDIFWT
RFSKTMSDICFLEAKRRIEDLLFYSPEERYQNLLQKSPEIIRKIPQKYISSYLGITAQSL
SRIRKRSN
>LONDMIMF_03053 2-heptyl-3-hydroxy-4(1H)-quinolone synthase
MEIAIIGAGIGGLTTALALKKAGISFKVYESADELKPLGAGIILAMNAMQVYRHLGLADT
IARHGNRITAMNLTKPNFSKLSSNDLRFFEKQLNVSTIAIHRADLHKILAEEVGLEHIIL
GKRLKDIIPGENYHHIEFEDGTSVKAEYMIGADGIRSAIRTLLFPKSELRDAGQWCWRGV
VDKVELLGTYRNEANEAWGKGTRFGFVQLNERQLYWYFLADKDLAEADSDIVPFLKDYHP
SVAQIIKATPKENWFVSPIMDLKPIQQWNLDKVCLIGDAAHATTPNLGQGACQAIEDAYV
LGELFKKHSMQEAFRVYPQLRKEKAHAVVAVSWKIGKLSHLRNPFGIILRNLVMKATPTC
LNRRQLTKLFALESKS
>LONDMIMF_03054 hypothetical protein
MLKKLFFLFFGFQAIYAQEKTPHLNGNVKISITEGTFECDFTLSDIPNLKDYYIRINSGM
NILNFKSLQPDEFLIGYSFSPDDKAYESRGYYFSANNRKNKFLPKAVQVKYVGKFPVIKD
TINDYSRKDWKGNIAFNSFSVRADGTQSAWYPILYDVTNDKIYDQMTYDVTIECADCNTL
YVNGNIPVKTSKNRFVSDTPKELMLFCGNYDYKQINSTYILNPDIGIGIDKLKELEAFTD
TFKKYYEKKLSIPFGQPITFIQTTPTSKKDGWLFVAYPTIVNVGYGNNSLSGLLDKWFKP
FIAHELGHYYFGTYKVFNSELGDMLSEGFAEYLSLKLSLDLLGKDVYQKEINEKFEFLSD
FKAIPFQKIKTPADYVDRQTYVYDYAPVVFLAIEKEIGEKQMWQWIRTLLQSKTEMTNYD
FMIKTLDSVLKDKAKLENIISKYLDSDDSVENAIKKLKS
>LONDMIMF_03055 hypothetical protein
MSTEIKNTLFRFVTMRSPELPEETNKDKRFVYRIANESGFDNAVTNRPIGTSKWAAMKNF
SETFNPVKEEGISDYFNHDLQQFAIWITRNKYSYTASELANKVTGLGNVLNTVDRTVLWD
NFFYQVITQKDFYLKEIFMQLLVAVHVLENFDANNTKLVKHLMNAKVVLPKKLFVEDVPA
LPNTPLAARSVEEEEEQTITLPGEEMKRVQAISQSNANIERHRKLKKELQKVEKIYNRDY
KIAYDLALEQYEEDIKPILATYEAALEAERQNWCTVRDPQVPYNPNDPCDNPVSVPKPEL
PKFEFRFKDQLDLAYFQSVLSAPSYETLLELLEIETEIASRSGIIENFSLDPVMPSFEGL
NLLIDDGINHNTGVIIGNTPGQGNTSISIGGVLIPATGTLEILAAPFAYQICPKSYKSPT
LAGTYVNFDLSFSTPDLSWQIIGVTTITESLSGVKTYGTDFTQSWTGNKVTLPNLHTNGL
TEDEFYSTLKTLTVEIAFSNGAKKSLAVNFFQSLNCVSRRSMVTIADPKQEVPEIPTIPS
VPQTGSEGTFIPSGFGVRQLGIADYKKVEQSIQGYVEGEVAAIENVMAREYKEKATRRLR
RSENTTTTSSESEREQLTDTTSTTRHEMQNEVAKIIQDNKDFTAGTFFNADLGKYNIGGN
VNMATHSSKEESTRQAVTQAKEITERAMERIVAKVKEERIEKIIDEFEENNKHGFDNTKG
DKHVVGVYRWVDKVFKNQVVNYGKRLMFEFMIPEPAKLHFLGMAENQAITKLVEPVDPRT
YKDPTNAAVKFNLENYASVNDNTVRYWAGKYNVEIPNKPEDIIHCGASFGVAYDGTSASR
HEGAAGSGKIEIPEGYITTQGFVNFTAAKDNDRQVYSGMHVTLGRVNKSISSHDGGIWLN
DSFPLTGYVQSVPVSYTMANFFHGNVNVSVECKLTNEVKDRWKKETFKAIIDAYEDAVAE
YEQKLAEEKAKEVTIKEANSGFYRQIENLILRKNCISYIIDQNATAKRTYGKDMSKPLGA
GVVKNFGNHEIQVDANLDDYTAFVKFIEQAFEWDIMSYNFYPYYWGARQSWNKLYQHENN
DPLFRSFIQAGMARVIVTVKPGFEEAVSYYMQTGQIWNGGEVPVIEDKLFLSIVDELNQT
EGQKEGKAWATRIPTSLTILQADSIGLKVEKALPFDEDLSDFEDPTSVPQSENFYVSDSL
LRGEDENLAEQVEEIASKMIGKIAIEDGYLKLKTNSEPSQTISQITIETLKESMNF
>LONDMIMF_03056 hypothetical protein
MATNIFEDFDEKILKFLENTRNSIVNNLKNKNNASSYRFIEINERLK
>LONDMIMF_03057 hypothetical protein
MPAVTDLSKLMKDLSNWESDSSLWFDIDNYETYEQDFPSAGTSPVVNFPIEIPFKVKNSL
TGKEIKIPINVEFSSEKGYISINPNNKINWDVNINVSNKEIRYSLKYPFNDTRKKKDKYA
IVIELKSTLHFNLTLSYLKMAIKSERNFQYARSRFNNAFTEAQSRPDKLDWMYENALDFI
IKERGDDTLWADMFILSKYDESKWFVDTGSAITNLLQGFSSTQKTFEYFNMFPETTFEIY
NNISSYDYKLMFCQFLIGLNYLFPPKTLGDMPIFTQGGGHELIKGKPIQNANKQFMITDR
VQTGTKNERVIVNRYAINQKRVIYKIIEERQLSPLDWVIVVDNNIKRNSGNALQSLPVPA
LYAYYLADRKAHEELMKTLRISLDILVIIMAVGSLGTASGLSLAIAAVEIGVATTDLALM
DEDVKTFLMQYEEGQWFVENWDVIYAMLGAGMLTTSLVRGILQNGPQLLQQLKNLKNIGT
KNQTFVKELELFIVKIEASNVGRNLKPQLLEEVIIVSNPTNVSTIKKILKLAFSSTDDFI
EFVSKNLANKGISARKIEEGIFEVLYKGVVVESGNEKKVGVFLKKMYYKGPKKTIRILDD
LINVAKRLNFKLKKMEAKYIGEETGRGWSSPMKVRYLDETERLEYKLVIKEGKLYDGSGN
LFDTLGTKTIFDKEKAIFVLSPDGSIYASKFHFPKKFHHSSFLSGNPVASAGEIKVSKGV
IQEISAKSGHYKPNKEINKQIIQHLANNGVDIKTIKIIDGF
>LONDMIMF_03058 hypothetical protein
MEKTYLQIPIFPLYDVVSIISIKLTDDDAEFLKSGYTLAERKHIHEALVWAKDNPDFEFE
SIMDRAPIVGKLPFSNEEIYAYLMRFKTFMEESKSLLIEESSPKY
>LONDMIMF_03059 hypothetical protein
MKRVLFSILVYVSVSAFCVAQTLEDYNRQLNVFKEDFKIKSDGELLKADSKRPINLPTYL
EQMGLEKDIINNVTHVEVYSKSDLNLINVYAVQYSKDDYSKYLMVIEDAKALENYILING
SFDFKNNTVSVYKTAKGKSKWSDCFGSCVEKGLSAHTTIGRVIIGMGVAAGFGCVACGAV
AATYTSVILLGCAGGCNK
>LONDMIMF_03060 hypothetical protein
MGKVSSYTILFLLLLYISLLVYSLILIFRREVKLRFLFSVLIVLFLPFIGSLSYIIFCHG
KKVG
>LONDMIMF_03061 Ribonuclease 3
MNIIRKIFPNSRSHEDGIFFSDIYKILGFKPINLECYRRAFTHRSSNKLDADGNQINYER
LEFLGDAMLSSVIAAHLFNQVPSGDEGYLTKMRSKIVSREHLNELGRDLNLIRFIESKVP
AQHFGENIHGNIFEALIGAIYLDKGYTYCEKFIKKRVITPYVDIAKLEGKVISYKSLLIE
WCQKEKRAFHYDVYEDNGIDGQRFFGVKLSIDHKVVAKARATSKKKAEEKASQRAYFAFQ
GKINGK
>LONDMIMF_03062 3-oxoacyl-[acyl-carrier-protein] synthase 2
MKLRRVVVTGLGALTPIGNNVQEYWNGLINGVSGAAPITYFDTTHFKTKFACELKNFNAE
DFIDRKEARKMDRYAQYAIVSSDEAVKDANFDFDKLDKDRVGVIWGSGIGGLETFQQEVM
DFTKGNGTPKFNPFFIPKMIADIAGGHISIKYGFRGPNFTTVSACASSTNALIDAFNYIR
LNHADVMVTGGSEAAVTIAGMGGFNAMHALSTRNDDPKTASRPMDKDREGFVLGEGAGAL
VLEEYEHAIARGATIYCEIGGGGMSADAHHITAPHPEGLGAKNVMLNCLRDAGLKPEDVD
GVNMHGTSTPLGDIAESKAIQHVFGEHAYTLNLNATKSMTGHLLGAAGAIEAIAAILSIK
HGIVPPTINHFTDDENIDPKLNFTFNKAQKRDMKVVMSNTFGFGGHNACVLVKKLEL
>LONDMIMF_03063 Acyl carrier protein AcpP
MSDIASRVKAIIVDKLGVDENEVVTEASFTNDLGADSLDTVELIMEFEKEFDIQIPDDQA
ENIATVGQAISYIEEAKK
>LONDMIMF_03064 Phosphoribosylglycinamide formyltransferase
MKKIILFASGSGSNAENIIRYFQDKKTAETVAVFSNNPNAKVLEKAEKLGVPCYVFTKEE
LNTGKVLEQVMTLNPDLIVLAGFLWKFPTDIVTQYPNKIINIHPALLPKYGGKGMYGMNV
HRAILENKESHSGISIHYVNENYDEGAMIFQAEVAVDSCTTPEEIAVKVQELEHAHFPEV
IDKILN
>LONDMIMF_03065 hypothetical protein
MKSLLFLFLFPFFSVFGQERFEVKNINFSVQVPESWTILEEKEILENVKKFDFNTKQLKE
LISSDSDGVNLVTYTKYNPKTYAGIIPTIKIRMVKTNAKNIGSFLKSIEMSNTEAEKVFG
SFTFTKKPSVVKVSKDNAVSFAVNFKLKKGSNEYKINSDSYYILRKGYYISINFIEQLGK
EDNSELFKTLIGSIISGN
>LONDMIMF_03066 Ribonuclease HI
MSHQVHIYTDGAAKGNPGPGGYGVVMEWVGRPYRKEFYEGFRLTTNNRMELLAVIVGLEK
LKLPNTKVLVISDSKYVVDSVTKGWVFGWEKKGYKDKKNPDLWRRFLIVYRKHQVDFKWI
KGHNNHPQNERCDQLAVMASGLPNLSVDTFYEREEKGLL
>LONDMIMF_03067 hypothetical protein
MDKMNGPIKYTCECCGDIHENWPALTFISPDNYDLLSADDKKNIAELKSDTCIINHPNQT
DRFIRCTLTQLVNDHCEGLEYGLWVSLSEKSFQDYMENFDNDNHEVQYFGWLCNDIPEYK
FPESIPTTVVTKKGNQRPEIFPHESFDHPFVRDYYNGISKKEAESRIKMMLQKTKDNKLA
LTSKKAWWKFW
>LONDMIMF_03068 hypothetical protein
MKRIMLIFTIIFVVSCLSQKTVKKDNKCKVLETENEIAFDSLFKNIDTTDLFKNKIKDFE
IHRTGVLLCQFLPNMKYGKYTLVKKVDDKFFCYNSNSSHNNEVDLKNPDIQLISNNINSI
RKKYYYEECDEYISNDAFYLMFVKKDGEIIAKYFSHGNISLKKTDENVNLNMLKSVLEVM
YRNSFR
>LONDMIMF_03069 hypothetical protein
MHQKNSLSSIILFLIIIAVSSCQKKDNSQIEIYTITSAKETKEPAYDSLRKEFLYAPQFE
ATEEMLDSVPLIINDDIICLDTISGQIKFSANAINKIVSLKPSMKEGIKFAICKNKKPLF
TGYFWSSLSSYGNMWNSIEYNHTEKVSQPTKWSIYKGNGIDASKREKISFANYKELVQIL
TESDRIGCKSN
>LONDMIMF_03070 hypothetical protein
MLNIIKKMKTNRTYLFLIFLLIACKKEGNINAEVYENNEVAQYKGLLYTTKYGGLNYYIP
EQKERDKIFESKNIDSIIFTINDKKFIAKSLKRKKYSRERNNSDFSFFVDKETNKIVADT
VSGLKTILLFSERTDMEVLKENGSIKFEFIEK
>LONDMIMF_03071 hypothetical protein
MATNGEEINPANAEKYKQFPNPMAVDSTPGFSQVDNFDNVGFNQGIASIGGQHTVSFYGK
SKDGTVYVLTKDGRQAKPQILPLKEVISGFNSDQGTNFTMKDVKYYKKNEDK
>LONDMIMF_03072 hypothetical protein
MNQKQKTINFLFLIFTLFNFSCQKRDKKMELYEQYANKNIDSSYIEMFYIGPNISTPFSY
PCSMISKEVLKDDINYKKIDDKQKIKKFMDLYSKYETAVDSGGMNIRIKVLIHNKTKTDT
LCLGEHFNTYKNGTKMKDNKQLLNYVKDIIDYENTVSSFVKKHPERYKSKQ
>LONDMIMF_03073 hypothetical protein
MKFFSPFIVLICLISCLKKTSQDQYLEVFFLKEGLRSPMAINCNALQGSILDVNYKKIED
KKVFETFKEELKKLVNAKEQRDIDVRIQVVYHDKKIVDTICMGAYFDIKVNGINKEDSKK
LLKTIKDEIYKY
>LONDMIMF_03074 hypothetical protein
MSYAMDKEKGKIYIMEENHYYPFGLKHEKYNSDKYEYVEISKEDGGYLIGIEPLGPQQRR
SYQYKYNGKEFQDELGLNFYDYGARNYDPAIGRWMNIDPLAETSRRFSPYTYALNNPVYF
IDPDGMKAVAGGDWRINYVDKQGNNQEFIFNGGQTALPDNQFVRDFVNAYNYNVENGGGD
SMKAIAENPNIMVDVEQTNGLTITDQPSLAAGSGDYNVVKWNPSLGLETTNGAILSPATL
LDHEAGHALKYAKDGKVAANLQLETKDAKYDNKAEKSVIIGTEQKTARANGEIGMVGTTR
NDHKGLPVVTTSPTSTKVNKSKTVQFNQQLNKSGFYSPISYEKYKQN
>LONDMIMF_03075 hypothetical protein
MKKIYIVGLTVLVGLTVLFFYLKDEKVYTYKEYSPSGKLIGTNEYIIRNGNTIQHGKFVN
YNENGVKIAEGNFVNNEPNGLCSYYFDNGKIESVYYRKNSKIDLEASYYSQDGKIRKYVM
CNDLGEPKFIIEFDKKAVKKYDGYATYPIKQYKLYNKKQIEIKTGDVLKVGDIIKYDYLL
ANIPYAKRTFKIEMEGIDNSKVKRTITKEEPTRIVVEEVLTKKGLNRVKAITQYTFDDNV
TPVKNDTVSFDIYVK
>LONDMIMF_03076 hypothetical protein
MVKIKNQKVRKKGDNIDADAFLTAAPGAEKTGNNLKNIKELLEAGNDIKGIFEKGMQVGD
GVNGVIDENKGKKDKSSEYVIVVHDPNNSNNDVQVRRDVYESQQKKKEEK
>LONDMIMF_03077 hypothetical protein
MNGGVGARVMEYLDGFHYQDGTLRFFPTAEGYVEVTQTKDGESYSYVFNYTDHLGNIRLS
YAEDPQSPWSLRILEENHYYPFGLKHTNYNSDMLAFREGGQGLALLAPQASPVPQFPYNY
KYNGKELQDEMGMNIYDYGTRNYDPAIGRWMNIDPLAEQGRRWSPYAYAFDNPVYFIDPD
GRWPWPVIKALASVANDKWDKAWKKSYNRKTYNHDIAKAPIYFVADILENANTYKRKKIE
ISNKDINSTATSKNGGGENQKSKGKKKRR
>LONDMIMF_03078 hypothetical protein
MGSGHEVKMGYDTNTAADAVRLYKAESQWQELQGYYASSLTLGASYAAGELYKTVTKDEN
WTSGSLHTTEEFTDKEGRILLKRNYIVEAVEGVSRIVTANTYYVYDQYGNLSFVLPPNAA
GLVHQTILNNWCYQYRYDKRNRLVEKKLPGKQWEFIIYDNLDRVIATGPAKSPFADLSPA
IGWLITKYDALNRVCYTAWMASTTVNSTDRKNLQNARNAELKNISEAKLTDTSDTNINGV
TFRYTSSVWPTSGYHLLTVSYYDNYNFPNAPTQSDFVDFEQHPIFYGVSEKPKGMPTGSW
IRVLEASTATDAEKGYVMYDKKGRTIKENSQNHMGGYTLRYTKPDFTGKATYTVTKHRRT
ASDAELTLREDFTYDNQNRPDSHMHKINNNPLQLMSKNEYDQLGRLIRKSVGSGDETGAA
ALQKVDYSYNIRGWLKSINDIGSLNNTTGDHSDLFAFNIWYNTPIAAQPLFNGNIAETGW
RTSSDDKTRRYAYTYDAINRLTNAAYIKEDQMTGSYNESLQYDLMGNIIGLQRNGGLDSD
SGAYIQIDDLSYYYDSKNRLESVEDFSTDPQGFRDGSDDPLEFLYDDDGNMTQDLNKGIT
SITYNHLNLPTRILFGGGNRGKLSIFIPQTAGKCAKQPHTWTAT
>LONDMIMF_03079 hypothetical protein
MSRRIKLIWDFRGPAGTKTAEHHEIHLKEFIEAEKLPLNITGFETLHEMHAIAFMVVEEE
NMIAVRDALKPHRGEIWEE
>LONDMIMF_03080 hypothetical protein
MKISHYLFLFCFQFSFSQELTLEKANHLATLPIKCLQQEYPNKLGQLLQDATELQSPKKL
HPAFYGCFDWHSSVHGHWSLVYLLKRFPDLDKRDEIIQKLKVNLSKENIQQEVAYLSKEH
EKSFERTYGWAWLLKLQLELETSNEPYAKELADNLKPLSDIIITRYIEFLPKLLYPVRAG
THANTAFGLNFAWDYAVHSNNQALQKSIWVNAMRLFQNDKDCPFAWEPSGTDFLSPCLEE
MGIMQRILPREEFLKWMKSFAPSLFNKRFTWDVAKVSDRTDGHLVHLDGLNFSRAWNLYS
LINQYPKEFWYLKDAADKHLDFSLPSVVDGNYEGEHWLASFALRAYEEKNNDK
>LONDMIMF_03081 hypothetical protein
MINNYLTKKLFGVLLPLLFLSAKGNAQYTVSAIPHQAYTLVSPTPLFNVDDRNSPVITLP
FNFTFYGNTYNQLVVSSNGYIDFRTNLANQNGPWQITTPIPNAGFGIKNAILACYHDLNN
SGGTGTISYSIVGAAPYRKFILMFINQPQYGPCSTNKSTFQAILYETLNTIDVQIVSKPS
CTAWNNGMAVTGIVNETGTIALTPPGRNSGSWSATQEGWRFSLPSEVNTYKYTKCDANSD
GLETFNLQVVKDDLAAPNMEFYETLADLYNQVNPIMLTYSNLYPDQTIYAENNGQITKII
LRALDCNVDYDLDTIPTALEDLNGDGNLENDDTDGDGIPNFLDNDDDGDMVLTSFEYVFT
SGRSSDAANSALDTDNDGIPNYLDNDDDGDGVLTINEDYNRNNNPADDDTNNNGLPDFLE
RAVALGVNEHALNNLISLYPNPASNLLNIDNRTNEVISNIAIYSINGMLVKQVPNAANVT
SIPVSELQTGMYFVKMEVGNQVMNYKFIKK
>LONDMIMF_03082 Putative thiazole biosynthetic enzyme
MPREFQIQVAPEVAANSQLLTEHVARLMQVNPVEIRHIAILKRSIDARQKAIKINLKIQA
YWKEDFQETKIALPEYKDVSGKQEVIVIGAGPAGLFAALQLIELGLKPIVLERGKDVQER
RRDLKAINRDHIVNEDSNYCYGEGGAGTYSDGKLYTRSKKRGDVDRILELFVGFGASEEI
LVEAHPHIGTNKLPKIIKAMREKIIEFGGVALFDTRVTDILVKNNQVEGVATQKGDIIKA
SKIILATGHSARDIFELLDRKKIFIEAKPFALGVRAEHPQTLIDSIQYSCDFRGDYLPPA
PYSIVKQVNGRGMYSFCMCPGGVIAPCATSPGEVVTNGWSPSKRDQETANSGIVVELKLE
DFKPFAKFGALAGMEFQKSIEQRAWHLAGETQRVPAQRMVDFTQSKVSADIPKTSYVPGT
TPVELGQVFPGFLTQIMREGFVQFGKSMRGYMTNEAILHAPESRTSSPVRIPRDNFSLEH
VQIKGLYPCGEGAGYAGGIISAAIDGEKCALKIGESLGIATT
>LONDMIMF_03083 hypothetical protein
MKKLLLLAIPLLLFGFTSLSSSPKKEAATHKKMLANSLCVASCTSTHIRVKIAGDPLPPG
DINWYVNGIHAGAGGRIFNVPKTAINVYVTVGGVLLTGDTVAALNLQCAAPPCP
>LONDMIMF_03084 hypothetical protein
MQTSKGQGDELNPSADTAGNTRNVSKVKVWLTPSQSEFIEFVLFYGASELSKSLKLVHDM
ALYHSDISINADEKRALFGVKCLWEGVEEI
>LONDMIMF_03085 hypothetical protein
MARINNEKEHYRSLIDLFKFALSLLSVFGIIIGYIVYSDGKEMRQDQKERRIELESNFKD
MKQDLEKQKAEHKNELLLQKSEMESDRERLTKRFEDEINWTKAQAIYEIANVKTTSKEIA
QTEAKKKINEVFDNKNFDDYVAKIAEERMKPQINDLVDKKLTANINVLIEDAIQNLYSPD
MNKFMEGIAYLQINRHIKLTELQIQKIIKATNNINKDYRPGVIAILLFKESQSSTNFFIK
ELQSENNMSQLFSLQYFAYNNIYAPLSDALYSIISKHSDLYGLYFNAIEASSGINQQHTM
SLLNSKQLVDLIYPNIPKEQLQYHKENTLRILKDKDFKEERIISSYFFKK
>LONDMIMF_03086 hypothetical protein
MEIKKKYIEKYLYSIALDQITDEYQKKGYKIFKGEKIANFNVDLIAKNDFETIVFEIKTN
KLTKEKKKSIIKIGNYIRKQKDYRFLIIIATAPKNKKLEIENIESELFNCFIEDIPDEVD
MLSTHTFIEEITDVDIDEIIIDNQYLFIKGDGVVSIQLQYGSDGDQKRDNGYKMYDNFPF
DFDVTMEYIKNQGFKIIEVNDISVDISSF
>LONDMIMF_03087 hypothetical protein
MHCFIFKRQPKSYNSGFKSDLSKQLYTDALILALNQFNTISSPFEEDLYGIVYHFYKKNV
GIDADNLSKPLWDLLKGIMFKDDKQIKLRIAGSIDISSGDFSVFDFSNLKGEVTAELIEA
FDTQDHFLYVECGKLKNGMFKFNIEDYGN
>LONDMIMF_03088 hypothetical protein
MEPITKQELELINSLYSRSYSNNTIISNASNAERDSLLLIRRKLKSYANYFSNKYQLDFG
PFETEMSTGNPVGQSTTLNNVWAGLFKGNTNKQYAAQISFVINRFEACLDVGFYFGRASA
RSITADEKRVLETQFLQLGKNLSFSLNQNKNLEERYNSLFDFGFKASIDGNPVSPLEWRT
GIAQNPQSSQITAKIYPNDFNIIESSTIDSFVAQVIFLMGFVNRNATASEIPPPINPEQY
IKKAERYAEIGSKGELFILEKERKRLEELGFLDSEYPRHVALESSHFGYDILSKNDNGEE
IFIEVKSTTRTSDDVYSRQFFLTNHEYETYNKNKKQYKLIRVYDVENLATIEYIDMETAI
KKTNGYIIEY
>LONDMIMF_03089 hypothetical protein
MDPKYTNDYTFLNKNKIAEIMKSVFLRQDFKTDEYTLVTEAVKVEKMKIGDKEFDKPKYE
TIREK
>LONDMIMF_03090 hypothetical protein
MVSIPTFSQQKSEKEILGYSCGYSGEPTSVIIKFGGLLYEKKYKSIKALLYSKIPVENFL
AVVISKKLADKKNITLTKSEMERIDELYKSAEKVPICGGCTYYKEIELKELLNSKKEVNG
VTSYFFD
>LONDMIMF_03091 hypothetical protein
MKKTLLPILILISFLSNAQTIEEKIAKKACECEEQKTKIGEEAYRSCIADIVKEAIATEE
DPKTREEVNTVEGLMGLLPKVKSLLPEICDKAKGQKTDEKRKLFYSDSKIESAQNAYIIA
KEFMSKNQYKPAIENFLTAIKNDEKFVLAYDDLAVCYRQLEKYNDAIKYYKKSLEIYPEG
DFALMNIAVVYSLKSDFKTAIQYYEKLIQFYPENAEGYFGAGKNYLLVKNYEKALNNIFT
AHRIYTEENSKYTKDSEVVIGAIYQKLQEENKEDLFKKIAKEHNIQLN
>LONDMIMF_03092 hypothetical protein
MKTIRIVIIGIVIALIAFLIFYKTEKINIGGIWTSKEIVLDGKTLYPVKSDSLMQANAFD
IIIDDWTNSLYICNQDTIRANFTIKKDSDNKLRMKLTSSESSLNGNFSLEMDTLSLGPTA
YDVYAKLESGETLLYIQRTVYYQSQKPLLPRRGTP
>LONDMIMF_03093 hypothetical protein
MVSNNYEPPNNYKMKHLLTLLIAISTSGIFAQEKLNFDKRYVQSEDQWVVFPADTLGSYP
FGFIYIDSEAGLTFNYESSFTIDSNGKFIPEEKVPTRIMKYRLDPKQNVLVAFIPESKFS
ELQIKKIPDWLSIYKEGENSVEQLYKKGYRYNAWGECEKALEFLEKAKKTDIEYKGLRVE
LAYSYNCLERYSDAIEILKKAVKDAPLDAYTNKELIYAYAKSGNLKEAKNICRKMVRDCP
DKTFNAEITFNILQAYFMKKDIANFNDWLAESGSYLLNDKNLKVYVEAMKEELKK
>LONDMIMF_03094 hypothetical protein
MKLTLQKISLFSFFLFAAFTAKAQTTCDCFETFKWVKETFEKNDAGFDYAIQQKGMDMYE
KHNAVFLAKVKTITESHECAEVLNEWLKFFRKGHFGVTALATATTQQSANVKQWPILAVK
EKELRSKPTKDAKDLVGIWKVGAYKIGIVKKDKGYKGVILESGNAAWKPQQVKMEINEDG
SGAFYMGDFSPLKFKKIDWIGKNAIKLAPAIQLQREYPTFPENADIQLYAKTMSTGKPFM
EKLSEETLYLRIPSFGGEQKKVIDSVLSAHEKEIKSTKNLIIDIRNGTGGDDDSYANIIP
YLYTNPIRIVGMELLSTPLNNKRMESYLSMPDLSEKSRMQVNAALTLLNDNLGKFVNLNG
GDKVHIQKMDAVLPFPQQVAIIANEANGSTDEQFLMAAKQSKKVKLFGTSTFGVLDISNM
NFVKSPDEKFQLGYCLSKSYRIPGMAIDGIGIQPDYFIDSTIPNELWIKYATSVLEDKEF
QP
>LONDMIMF_03095 hypothetical protein
MQIANTAKANSGCISRKVGAVILDKNLSIRSIGWNDVAKGHTPCNLRNVEDFLGEHPLNV
EHYSDFELGNHSDISEYKYKTSNPNNFRDALKDFYKQSYDKDKLKGKNCSFCFKTVHNHY
EGDGNQVHTRSLHAEENAMLQLTKYGGQGVENGILFTTASPCELCSKKAYQLGIKVIYYI
DPYPGISQDQILKGGNISNRPKMMAFSGAMGTTYHKLYESFLSYKDELSLVLDIKPKNKL
GIQFKNILESISSEKEFLSYIREKNGVITNEEVIGIIKKGLRK
>LONDMIMF_03096 hypothetical protein
MAIGKKVMLNNQCFYFEAKVEFYKTYLERYLRILYLLPYT
>LONDMIMF_03097 hypothetical protein
MNQNILELVQKNDVQGIAKALENGANVNTADNHKNSLLLIATRNGQTEMAKLLVQHGADV
NQQSDNLDSAFLYAGASGQTELVKLYLDNGARFDVFNRYNGTALIPACERGHVETVRLLA
NTKKFPIDHVNRLGWTALMEAIVLGDGSKKYQEIVQILKDAGSRLDIPDNDGIGPLQHAK
KRGFKEIVKILQT
>LONDMIMF_03098 hypothetical protein
MKKLFFLMTLVFLSSCVKNEQKEDFSTIIINLGHSQYPTQIIIDIQKSQIGYQNLNVVLA
SADADKTIPHNQIVSLDKTSLSKIMDLFYAIDRTPQERNKSAEGMYSSIEAHSDNGKVLN
IDQLNDRHADEIAFFEAALKTIAKKSKAPNAQHQMDKLIKEL
>LONDMIMF_03099 hypothetical protein
MKNYILLSFVIVFFVSCKTGKLSTQDTLSQSETVIIGEIRIMNGDKEVTKNSKIYFDENT
KGVLFYKLAADGLVMMKLPKGNHFIKYIYTPYGSVNLPIGYANFSVPETGKVYYIGTILI
DTEKKLRKKSRGIIYDTDPKGLKEEKVQITISDTPQKVSKAYHDAFGTDKKIENALLTVA
P
>LONDMIMF_03100 hypothetical protein
MGLFSALLGNAGAVSQDELQKKYGQLLTEGESIELGFKLLRDTFIFTNKRLILIDVQGLT
GSKTEYKSIAYKAISRFSIETAGTFELDAELKIWVSSEANPSIKKQFNKSVNVYEVQKVL
AHHVLK
>LONDMIMF_03101 hypothetical protein
MKKYYLNRGDENLGPFSLEDLREHRISPETMVWFIGLEGWTPARNVRELRPLFESIPGHE
LTSSQGVEKYYISKMEKESFFLKHIDKFLLLFLFALAVGIIMFLLELNL
>LONDMIMF_03102 hypothetical protein
MSEKQKPPEGGLVRIASLLWLDPRVPTVNQNILNSKFICIENYFLTAIRKTMLFLKKYSH
YENLEPVIVCKNFHLQI
>LONDMIMF_03103 hypothetical protein
MIVDRMITNTIYEYYKKLMLFFLKKSMFYGNP
>LONDMIMF_03104 hypothetical protein
MKKYYINSGEQNLGPFDLNDLKSKGIGRDTLIWFFGISRGSRVRNMSELKELFRANREKR
KEGFRKSMNDETASFLKDRLLLFVALGLILGFGILFYSFYITSSISKDEQRSYNELQLSR
ELFWRERSADNDEAIGIALSGQESLLTSDENGAAAKRMTQIEIELDMATQNLEAAKQELL
GAKSFQFLRMTDDRKEEIEEANKKIQVWKEEIRTLEVEMEQLQKVPHLASLAE
>LONDMIMF_03105 Putative pyridoxal phosphate-dependent acyltransferase
MVKDLFERIQQNKGPLGKWASQAEGYYVFPKLEGDLGPRMKFHGKDILNWSLNDYLGLAN
HPEVRKVDTEAAAQFGAAYPMGARMMSGHTKYHEQLENELAAFVMKEAAYLLNFGYQGMV
SIIDALVTKNDIIVYDVDSHACIIDGVRLHMGKRFTYKHNDLESMEKNLQRATKMAMETG
GGILFITEGVFGMRGQQGKLKEIVAMKEKYNFRLLVDDAHGFGTLGKTGAGAGEEQGCQD
GIDVYFSTFAKSMANIGAFVAADKDIIDYLKYNLRSQMFAKALPMIQTIGSLKRLELLRN
SSEIKDKLWENVNALQNGLKNRGFNIGDTNTCITPVYLEGSIPEAMVMVNDLRENYGIFL
SIVVYPVIPKGIILLRMIPTASHTMEDIEETLAAFEAIREKLVNGTYKEIAARTTVDVSD
ER
>LONDMIMF_03106 hypothetical protein
MHMKIRFLVMGLVISLTACNKKEESKVVTEPEMEQPEMTAPAKECYEYTNGKDTIHLSMA
ITNGNNVAGDLKYAWFEKDSNTGMFSGMFKGDTLYADYTFQSEGMTSIREIVLIRKGDNL
LQGYGDITEKGNKQLFKDRKSIKFDEKMMLKKVACK
>LONDMIMF_03107 hypothetical protein
MITIKEANTKALLLDYVKFPFSLYKGNKYWVPPIINDELETFDKDKNPAFASAEAKFYLA
YRNNTIVGRIAAIINWNEVNDQDKKKVRFGWFDVIDDIEVTKALMEKVYEFGREHQLEYV
EGPVGFSNLDKVGVLTEGFDQISTMITWYNLPYYKEHFEKLGMKVEKEYVESKFSFTNIN
PETFIKANELIKQRYQLKPLNFTKTKDIMPYVDKMFDLFNKSYANLSSFVAITDIQKEYF
KKKYISFINPELIKFIVDKDDNIIAFSIVMPSFSEALQKAKGKIFPFGIFHLLKARKQSK
DMIFYLIGIDPEYQNKGVTAIVFNEYYKTFKEKNVQTCYRTPELVDNVAIHNIWKHFDPI
IHKRRCTYVQNL
>LONDMIMF_03108 hypothetical protein
MSKSRFASLLLFAFCSSASYAQFTDVINSNRPGESMSGFSVGKTVFQTEAGIYALAEDHD
ILNTKAKGFGLDLALRYGAFLEQLEFIMNLQYQTDQYETALGSENRNAIKKLTLGAKYLI
YDPFKNYEEKVNIYSWKANHRFKWRQLIPAVGVYAGANINFSNNPYTFPTDPKISPKLMV
ITQNHFGSRYVYVMNIIADRITTDYPSYGIIATLTRGFNEKWSGFIELQGYQSDFYSDAI
GRIGAAYLLQPNLQVDASISKNIKDTPSIFYGGVGVSWRFDGFYKDIMIQGPDKSDKKDK
KKDKKKEDEKKRIDEVGGEKE
>LONDMIMF_03109 hypothetical protein
MQFASFNGVLRTLFILVCIYYAVRLLARIFFPIMVRTVVQKAEQSFQQQQQNYQRQNSQD
DFVNINTNANRRSDRPRETKKVGEYIDYEEID
>LONDMIMF_03110 hypothetical protein
MKIISKYYPHLLAILGFVLVSLIYFYPVMQGKQIYQSDIAQYTGMAKEQNDFRAKEKEEP
FWTNSAFGGMPTYQLGAKYPNDFVGDLDDVLRFLPRPADYLFLYFLGFYGLLLALRIDPL
KAFFGALAFGFSTYLIIILGVGHNAKAHAIAYMPLVVAGVILVFRRKYVLGGLLTMIAGA
LEINANHFQMTYYLLFLLLIIGIYFLYKYIKQKDYKGILYAVGVFAVAGILAVGANATSL
MATSEYTDFSMRGKSELTYNPDGSKNTTTSSMSYDYITEYSYGIAESLNLFAPRLFGGSN
SEHLGNKSKVYEFISAQGANPEEAQGFTEAYAKTYWGDQPIVAAPAYIGAVVFFLCILAL
FNDKRKIKYAFLGGAIFSLLLSWGKNFPLMTDFFINYVPMYDKFRAVSSIQVVLELCIPV
LAIMGLQSFFKSEKEEQWKSLKLAGGVSLGIIVLLFFAKGMFDFTGPYDAQMQQMFSQAQ
GSHSFGLEFIEALREDRKNMYNADLLRSGFLILVTAGLLWLHIKNKLSHTFAVVLVGLFM
IGDLFFIDKNYVDSTGFVSAREVNEPFQPTVSDQQILRDTTQYRVYEIEGRLQARTSYFH
KSLSGYSAVRPRRIEQLFDYQIAKNNLNVLNMLNTKYVIQVDEKGQEYPIINPDANGNAW
FVSEVKFVNTPDEEMKALDKLDTKNQAVFNQKEFKNAISKTYQKDSTATIVLNSYKPNHL
KYTSNNSQKGLAVFSEIYYPKGWKATIDGKPADHFRVDYTLRAMEIPAGKHTIEFKFEPQ
VVKTGSTIALISSIVMILLLIGGIYWENRRNKKENSLEK
>LONDMIMF_03111 hypothetical protein
MKKVLIITYYWPPAGGPGVQRWLKFVKYLPDFGIQPVVYIPENPTYPILDEELVSEVSDK
AIILKKKIFEPYGFASIFSRKKTKKISSGIIPNQKKQSLLEKLFLWIRGNVFIPDARVFW
VKPSVLSLEKYIRENEIDTIITSGPPHSLHLIGLALKERTKAHWIADFRDPWTTIGYHNK
LKLSASAAKKHKELESIVLNEADQILVTSQTTKKEFEVLTTKPIEIITNGFDVEKVAPQP
LDEKFSIAHIGSFLSERNPRILWKCLKEIIKENPDFKKDFELKLIGAVSQEVLDALAEFR
LNSYVNNLGYVPHKTAVEHQKKSQVLLLVEINSEDTKSIIPGKLFEYMASERPILAIGPE
GSDFASIIKETNTGAFFHYDEFDALKERILAYYAAYKEGNLKTYAVGLQQYSRKSLTEKL
SKIIRK
>LONDMIMF_03112 Aspartate aminotransferase
MPKISTKGQHMPESPIRKLVPYSEIAKKKGHKVYHLNIGQPDIKTPEVALNAVKNSNITV
LEYSHSAGFESYRNKLSQYYQTHGLPINTADIIITTGGSEALLFAMGSTMDQGDEIIIPE
PFYANYNGFSTASGVTVVPVISTIDEGFALPPIAAFEKLITPKTKAILICNPGNPTGYLY
SKEEILQLAEIVKKHDLFLIADEVYREFIYDGEEHFSIMNVPGLEENAIMIDSVSKRYSM
CGARIGCIVSKNKEVMATAMKFAQARLSPPTLAQIASEAALDTPQSYFDDVITEYKDRRD
TLIAGLQKIEGVKVATPKGAFYCIAKLPVKNADDFAQWLLESYDLNGETIMVAPAAGFYS
TPNVGLDEVRIAYVLKKEDLIRSVEILEDALKKYNNK
>LONDMIMF_03113 hypothetical protein
MKLRILVLFLLVVSSSLFAQKGFQWNSHKDKIEIPFQHIYNLIIIPVEINNVKLNMLLDT
GADNSMIFSLPENDTIQFKNYKKVKVRGIGSEEIIEALLSVDNKIKISSYEDNKFPILIV
LDQDVNFSSRLGIPVNGVIGYSFFKEYPIEINYQKKIVTIHRTRKFLAKKKFKKYLKHPI
KVIDKRPYIDVVAKIEEDTLDLKLLIDIGLGDGLWLFQNKKIRAGNNYFEDILGSGLNGL
IIGKKSRVRTVRIADFTLDEALVSYPEEVYFPKIGIIEGRNGSVGGEILHRFNVVLDYQE
QFIYLKKNSKFKKPFNYNMSGIVVQHKGVEFVQEAIRLETKSNYGVKVDGGLDNFNDNNF
RYKFSLKPVFEIASVRTGSPADLAGIQPGDKIVRINKKMTHGYTIQKISDLLQSEEGKWI
YIDVERESKIIAFKFQLKKIL
>LONDMIMF_03114 hypothetical protein
MMKKILSLFAVMMFAVSAMAQTGPKIEFKEETIDYGTVTKGEDNGLRVFEFKNIGDAPLI
INDVKSSCGCTVPTKPQEPIMPGKTGKIEVQYNMNPGPISKTITVQSNAVNKDSGIIPLR
IKGNVIVKEEVNLMEKKKTLPSS
>LONDMIMF_03115 Valine--tRNA ligase
MTIPAQFDAKSVEQKWYSYWMENNYFHSEPDHRTPYTITIPPPNVTGVLHMGHMLNNTIQ
DVLIRRARLKGFNACWVPGTDHASIATEAKVVAKLKSEGINKNDLSREEFLEHAWDWTHK
YGGVILDQLKKLGASCDWERTKFTMDPDMSASVIRSFVDLYNKGMIYRGYRMVNWDPEAK
TTLSDEEVIFEERQGKLYFLKYQIEGSNDFLTIATTRPETIFGDTAICINPNDERFTHLK
GKKAIVPIAGRVIPIIEDEYVDVEFGTGCLKVTPAHDMNDKTLGDKHNLEVIDIFNEDAT
LNSFGLHYAGKDRFVVREEIEKELEANGSLAKTEIHLNKVGTSERTKAVIEPRLSDQWFL
KMDELVKPAIKAVLETEEIKLYPKRFENTYRHWLENIRDWNISRQLWWGHRIPAFFYGDG
KEDFVVAETIEDAVVLAQKATGKADLKAEDLRQDVDALDTWFSAWLWPMSVFGGIMEPEN
KDFKYYYPTNDLVTGPDILFFWVARMIIAGYEYTGEKPFTNVYLTGLVRDKQRRKMSKSL
GNSPDPLDLIDNFSADGVRVGLLLSASAGNDILFDEEMCNQGKAFTNKVWNAFRLIKGWE
VSDTIPQPESSKVAVEWFEAKLQQTLVEIEDHFEKYRISDALMAIYKLVWDDFCSWFLEM
IKPAYQSPIDRKTLTKAIEMLESNLKLLHPFMPFLTEEIWQHITERTPEQALIISTWPES
KSFDAKLITDFDFAAEVISGIRTIRKEKNIPFKDAIELKAINNDNSSTYFDAVITKLGNL
SSLEYVSEAVTGALTFRAKSNEYFVPISGSVDVEEEIAKLTEELKYTQGFLKSVQAKLSN
EKFVNNAPEKVLEIERKKEADALAKIATIEQSLASLK
>LONDMIMF_03116 Superoxide dismutase [Mn]
MKKTQLFLSSLVLAFVLQSCNKEKKLEEVEVPLPVTEEKAPMGNPDDVAAEPGAFKMMKL
PYAYDALEPHIDAKTVEIHYSKHHVGYVNNLNKAIAGTALEKQTIEEILSKLDLENKAVR
NNAGGYYNHNLYWEIMGPKKGGEPTGALAEAINKDLGSFENFKTQLTEAATKQFGSGWAW
LVVDKTGKLVIGSTPNQDNPLMPNMSVSGTPILGLDVWEHAYYLKYQNKRPDYITAFFNL
INWDAVAKKYEAAKAASAPKA
>LONDMIMF_03117 hypothetical protein
MSEKDLDTLFEEAYELASNMTEPLPQDVMLRIYAYYKQATQGTAKSKRVTSVDLRDAFKT
NAWIQISHLSSDEAKRLYIETIHSLIKK
>LONDMIMF_03118 Phosphatidylserine decarboxylase proenzyme
MFKFHKEGAKIILITCAVVVAIVLLTDSLIPNFWVLKTIQVISLLFLILVLQFFRNPKRY
TQINDNQIIAPVDGKVVVIEEVYEGEYFKDKRLMVSIFMSPINVHVTRYAMNGVIKYSKY
HPGKYLVAWHPKASEENERTTVVIENTTFGEILYRQIAGALARRIVNYAKEGMQVIQGED
AGFIKFGSRVDLYLPIGTEINVKLNQKAVGGITVIATKS
>LONDMIMF_03119 Phosphatidate cytidylyltransferase
MRETLTRSLSGLVYILLLIGATLYSHDSFLLLFGMFLAVCTAEFCDLVNLQKPIPILLAI
GAYALFAYFNTFNKTNDWLLTGAALFVSVRLILFLFSEKRQKVDRQSKYVYLIGYIILPV
IILTKIPYEGTVFNPKILIGIFILIWTNDTFAYIVGKSIGKRKLYEKISPKKTIEGFLGG
LVFTIIASILIAIYFINQPVILWIIFALIAGIFGTIGDLVESKFKRIAGVKDSGKIMPGH
GGILDRLDSIIFVSPFIFLFYQILDYV
>LONDMIMF_03120 hypothetical protein
MSLFKKLFGASESSDDDKDGNLSPFNPETVIPADELFTLNFKKNGGKFLYCENLEEAKDH
FEHILEENDWFESEALCFEPKLFSLLEENKLSYTKPTNPRFLLASCENLIADEGSVLFSS
NQIKQYKPNELPGNIVILATTSQILGSKSDGLREIKRKYEKDYPTNITTIKYFEKAKDED
FLQYGSVAKNLYLLLLEDL
>LONDMIMF_03121 ATP-dependent zinc metalloprotease FtsH 3
MAKDNNTNPNPKKFRLSPWWIYGGLILFFFILNWASGGSSWGETSKASASDFNKLLEKGQ
IEKVVVYNKNEAEIFLNKEGLADPANKKVTKDIFDKPNPGPHYILDNIGNDELFQKKLET
AQLEGKLKDYNFLPKSNWSEIFIALLPILIIVGIWLFIMRRMSGGGAAGGGGQIFNIGKS
KAKLFDEKTDVKVTFKDVAGLEGAKEEVQEIVEFLKNPEKYTNLGGKIPKGALLVGPPGT
GKTLLAKAVAGEAKVPFFSLSGSDFVEMFVGVGASRVRDLFKQAKEKSPAIIFIDEIDAV
GRARGKNNISGSNDERENTLNQLLTEMDGFGTNTNVIVLAATNRADVLDKALMRAGRFDR
QIYVDLPDIRERKEIFEVHLGPLKKVEGLDTDFLAKQTPGFSGADIANVCNEAALIAARK
DKKAVDKQDFLDAVDRIIGGLEKKNKIITPEEKRAIAIHEAGHATVSWMLEHAAPLIKVT
IVPRGQSLGAAWYLPEERQIVRTDQMLDEMCATMGGRAAEKVTFNRISTGALSDLEKVTK
QARAMITVYGLNDKLGNVTYYDSSGQSEYNFSKPYSEDTAKIIDKEISDLIEGQYQRAIQ
ILEENKDKLNQLADILIEKEVIFKDDLETIFGKRAFGEAVEEVFEE
>LONDMIMF_03122 Ribosomal silencing factor RsfS
MAKKNISNDDLLAHIIKGIEEVKGNDIDILDLRAIDNTVCDYFVICNGTSNTQVNSIVNS
VQKTVSKELKDKPWHVEGTENGEWVLMDYVNIVVHVFQKHIREYYNIESLWGDAKITTIQ
NKY
>LONDMIMF_03123 Bifunctional ligase/repressor BirA
MNIIKLDAINSTNDYLKGLLQQQFVENFTIVTAENQTDGKGQMGSKWNVESGKNLTFSVL
VKDLLLEVNQIFHLNVATAVSIIEALSFLEIKDLAIKWPNDILAEGKKIGGILIENSIKS
NGEIFSIIGIGLNVNQRDFENLPKASSLSLLLRRELDKEAILIPIIECLTRNVSLILNKN
TQSIWEKYHACLYKKGIPMPFENIKGNKFMGIINGVDQSGKLHLTLEDDFVKSYEIKEIR
MLY
>LONDMIMF_03124 hypothetical protein
MNLESPKTSVQKPAQYMFDQLTDVKNFEKLMPDNIAKFEVTGEDSFIFGLKGMPEIKLKM
KDKVAPTKVVLGAASDKLPFSLTANITPVSDDSSDVQLFFEGEFNAMMAMMVKGPISKFI
ETLSGNMHKL
>LONDMIMF_03125 Orotate phosphoribosyltransferase
MIFNKDTAQKTAELLLQINAIKLNPKNPFTWASGWKSPIYCDNRITLSFPPIRNYIREEF
SKNLEKQFGKPDVIAGVATGAIGIGMLVAEYMGLPFVYVRPEPKKHGRQNQIEGFLQKGQ
NVVVIEDLISTGNSSLLAVEALREAGANVKGMAAIFTYGFDVSVENFKKANIDLFTLSNY
ENLLELAVAKKYITEEEQETLKIWSKSPSTWNVENDNASVK
>LONDMIMF_03126 Transcriptional regulatory protein YehT
MIRAVVIDDIERIRKENIAIIKSNCPNISIIGQADSVESGVKLIKLTSPDLVFLDVEMSD
GTGFDLLQKLKPIQFKVIFITGYEDFAIRAFRFSAIDYLLKPLDATELVDAVKKAQESFN
KEIFDTKLNNLFSNIERPKNLQKLILKTADKIYSVNIQDIVSCEADKNYTTFNFINAPKL
IVSTNLKEYETMLVPYNFFRTHKSHLVNMAYFDHFIKSDGGNTIVMQNKLTIPLSVRKKE
EFLLLLENM
>LONDMIMF_03127 hypothetical protein
MKTTVRILGVFIILLILFASAASIWRAERDKTELRESQAAIAEAQQSLALLKEEAKNMTG
ESKVQIESQIAEAESDIKKLPAESTFTIVQVLFGASMLLSIVFGVFLFRPNLKSSKTLLV
ASILLLLATYFISPDIDGGKYSGFSRRTLALITGIPLIVVALFAFWIAKKKNAESLRSGR
>LONDMIMF_03128 hypothetical protein
MKLRNVMFGLVIALAVSCGSKETKENDTVATDSTATEAVETKAPASVKETLTKVWVVDDI
NYNVGLNAAKDKEAYKAQLEKVLADMKGKSELNLGADGKVTVEMMDHTNTIKNYTGTWSL
TDEDKTLNVMPEGALDPFQWTIWEISPESLSLLINNTTMKFVPKK
>LONDMIMF_03129 hypothetical protein
MKKILFVLFLAMSATSYAQLSAYINGKAIKEGASVSKKDLASLQVGFKNQKKVTIISGIS
ALYVQLLDANKKDIQSFFLQKDGYVAIEDFFKSNTPTTKYKVFGEGGFLSNGNTLDWILS
AAVGQEAQKTIQVKIGLYVAEETGYRQYGQSVRLLEPMTFNVPIWDAKNVTMPFLDLTID
KTNIAGDMDTKQNGMLGRKETEIGYRLIEKDKIWYTAFALDSDKYPGLNAKEVADDFIHA
GTFYANYNQMNDKKPFKDYDIQKYTLPWDHINDLLDSKNRLSKLSYRVNKEAKNSNLMNL
FETVTINGMKGYAFKSSTDEREHINATKWTPKGNFVIYILEHPTNPKLTLIISSSVKNNG
NTLEETDALLQTFINSIKK
>LONDMIMF_03130 hypothetical protein
MKLLTTLFLAAFFAFSSFAQSSSPTWNKFLSDLQKAQVEYNKHYPAKEYQQAATVLNTVA
TSLDNLKLTEKEKQEFQPTIKDVYANIYYNLACLQSLLNEKKQAITNFEKAIAWGYKDYQ
NALNDADLANIRKEKKFIKAFSQLKQYDKLFLLQQSGNYISENKNSLPAFNYQAANDRNL
TEVKRYFKLDSIAGTGDEVSKIINIMLFVTNSIKYDGTNWALCEFDAIDFYNYHKATGKG
INCRHKAMTLNEMYLAMGFKSRYVTCMPKDDTDTDCHVINSVYSETLKKWLWMDASHGAY
VMDENNNLLSIEEVRERLRNNQSMKLNSETKVTKIWYLDNYMTKNLYWIQCTNKSQFNTE
SRYRQADADLQYISLIPTGFDKDSNKYLKNNVITHDPAYFWKSPEIKTLQ
>LONDMIMF_03131 Dihydrofolate reductase
MRKISLFIAMSLDGYIAKPNDDLSFLKLVEKEGEDYGYSEFVSTIDTIIIGRKTYDYVLK
EIGPSHYDNGQRDVYVITRTERPQLGRTIFYTGSITDLVKQLKSEQGKNIYCDGGAEIIN
ELMKHTLIDEFKISVIPVLLGTGTRLFKDGRPEQILEFVKAKTFDTGLTQLHYKSKNNNE
S
>LONDMIMF_03132 HTH-type transcriptional activator RhaS
MEYKIIKPYKDLNPFIHFYWELKGNEAELQRERVFPDGCAGILINLGDTCLTDNGSVSME
FGKTYIVGAMNSFKDSFININTHLLGVCLKPATFANFYNYADQNELTNDTVEFEKHNSFD
IDKIVDNPFRYFDHFYSERVKSQHIQLQPVINDIHLTNGQISISELSKKNFTTVRQLERN
FKKYIGLTPKEYSNIIRFQNALRVIKNPKQDRSLLDIAFECGYYDHSHLSNEIRRNTGLW
PSHL
>LONDMIMF_03133 hypothetical protein
MKRIITILLVSLSLQLSAQCVQKAGAGSSCTFVIKADGTLWAWGRNNYGQLGIGNTTNTP
VKTQVGTASNWQNIEGGQFHTVAIKADGTLWTWGFNSSGQLGLGNTTNRTTPTQVSSSNV
WSSVAAGYDHTVAITNDGTMYAWGLNDHGQLGDGTTTNRTTPRLIGTGWKSVSAGNNVTI
AVKTDGTLWGWGEGSQVGDGTTADKRSPVQLGTATNWKSVSRGVSHALALKADGTLWAWG
TGGRGQMGNGTTSGYSVPTQVGTDTNWESVKAGFFFSIGRKTDGTIWAWGQNTYYQLGLG
ASTADVLVPTQIGTENDWRTISVGTSSLFSGAIKNDGSFWAWGYNNYSQLGDGLTGRLQV
PTLIACPGSVIVTETACDSYTWAATGITYTTSGIYIDSVTSNELHLTINNSTTSSITETA
CNSYTWAENGTTYTTSGTYTHVTTNASGCTNTATLNLTINNSTTSSLTETACDSYTWTAN
GTTYTTSGTYTHVTTNASGCTNTAILNLTINNSESPVGESSQTITVDVSGDATISDIVIS
PSTVVWYASESDAISHTNPLNSTTTLVNGATYYAVYTTSQGCSSAPYPVTVSVALGTNSF
NDTKLSFYPNPTSDVLYIKYSHTINTISVNNVLGQEVYAKSINANDGVVEFSNLPSGNYF
VKVTSGDSAKIIKIIKR
>LONDMIMF_03134 hypothetical protein
MDDKNVKILFRFFSDVLDEWTVETLWSETVDAEKGLYKLMSIPFLAYVSCEDIVFAEYDQ
DEEMLTYRRTIEHSGNSTIQVFVRDKEIVTNDLREIFSSLGCESEKFREGYFVIKVPKSL
NYKPIREKLMDLEEQGKIGYAEPNLDENHFY
>LONDMIMF_03135 hypothetical protein
MNKTKKLLYLLAMQYGCACLAQNIPDIVIPQAAEIPNYPIQINNPTIKRGMPLQPAQNDP
DFSRKQRQNQTIMQEANRDIKQSALQRQAMHDAQADISALRSNINYSLPSWASRPGVEYY
YKAFDNLIMSDSLYSLKDNIFLIENAYFDNKLDKHAFDETIKNCRTFLIDIMEERGYDLN
SNTAKNYMLFQFFSETLQLKKTKAKHLPFTYDFEDYAGIKDHSKMFITKLQNTATGQCHS
MPLLYLILADEIGAEAYLALSPNHSYIRFPDDNGKWYNIELTNGMFSTTSYILQSGYIKS
EALLNKIYMQNLSRKELMAQQLADLAQGYVRKFGYDEFVGKVIHRALELYPNSINANMIK
ANLDTARFEYVMRQLNINPYDGKQLQAIGQFPKAVELLNGVNRQYDLIDNLGFEPMPQEA
YQQWLQAMKGEEQKRESIKAQEMLKGLKTGLKTVRD
>LONDMIMF_03136 hypothetical protein
MKQLFTLFFISISAIGLAQSQQQIYDNSFALLDGMLKDEKAYSFKKAVFAVENAYYNGKL
DTIAVNREIRLLTNLCETLIKDRFLAYVENDKKDVNKWAAAYQVMCDSIPIVMNDQEYRY
IPFKYDFNDVYGNRDIANMFVSKLLYTRKGNCHSMPYLYKILCEEQGTTAHLALAPSHVY
IKHQNKKNGWYNTELTSGIFPNDAWLMASGFIHVDAITNGVYMKALNNKESIALVMIDLA
HAYERSFPDNDGTFLLKCAESAIKAYPNFATALILKAEIHKKQVEQENDPSKAKKNFKAL
EKEYAHIHQIGYRFMPEQMYLNWLVSLKTERDKYENKKLNTFNKQ
>LONDMIMF_03137 hypothetical protein
MKQFYFIMICLLVSSAVIAQEKLSKEEKERREKNIQAANPFAKFGYKAKVATLSKGKYLE
VHDLDSIVTIGSVRFHVDKKEIVGFVEPDTINGEYARPVGDIASRWLSPDPLAEEFMSWS
PYNFVYNSPLSYVDPDGRSGEPVIDKKNKTITIYSNMIFYGGSASKDIATSTARDIQNVW
NSAGGKVTVGGTEYSVQFSITGIYNPGLKKSDVENNTDIKNNFIRVEETVAGGISFMDDA
GSNTGYFLLKNIANDGSTTEGHEYGHGLGLNHPTQTDVRGFGPPGIMYPRGTIVDPEYQY
NKNAPAGTYGGTVNPEKRKVTQQDINNLGLDKIQYDSNGKGKLGNVTNQYHEKTQ
>LONDMIMF_03138 hypothetical protein
MKKLNKISIVVISLIVILSCVSVNKIDDQNENIIGAWALNKRQINYPELIFKKDNTCIFT
SMGDTIYRFKYELEKDKLILEDIRGTIKKNHILKLTKSELVFEALWENKTKQEYIKK
>LONDMIMF_03139 Ferric-pseudobactin 358 receptor
MNKLIITLTIVLFSAITFAQNGTLNGRVVSTDNTPLESVTVTVNGTRFGTQTGTDGKFEI
QNIKPGDYTLKIAFVGYTSKEVAFTITENATTTLENISLNSKNETLAEVVITGNINRYTK
AESNYVSKMPIKNLENAQVYSVVTKELMKDQLVVNQDEALKNIPGLYQLWASTGRVGDGG
SYFSSRGFITQSLLRNGIAGKITNNVDASNLERLESIKGPSATLFGSLLTSYGGLINRVT
KKPYDNFGGEISYQAGSFGLNRITADVNTPINDDNTALLRVNAAYNNANTFQDYGHTRSY
FFAPSFSYQVNEKLSISIDAELSNVDASSMPLIYIPFDKTPNSLGLHSATDIKMNWKRSF
VGDEFMMNTKTANIFAEANYQMSDNWKSQSVFSTSSNQSVGPQTWFYLLGNNEMSRNVWN
IDGRDNIIEFQQNFNGEFDLFGMKHRFLLGGDIYRMESKVGYGYLPTFFYFDTVNYAGPN
DNYYNFTPQATEALFAQGTHYKTHNSLTTYSAYISDVINVTDRLILSAALRFDHYNNDGN
FDPAANTTSGAFSQNALSPKFGAVYQIVKDQVSVFGNYQNSFKNIGYQLADVNGTPQLKA
FDPEQANQFEAGVKINTFQNKLSASFSYYNIEVKDILRAGQLANTSVQDGNQTSKGFEAE
ITANPIPGLNFIIGYAFNNSKINNAAPNVNGLRPETAGPENMINYWISYSLQTTKMKGLG
FGFGGNYADKTFIYNRNPTGSGNSADVQTFSLPSYAVINAALYYDQPKYRLSLKINNLTD
ELYFNGYTTINVQAPRTFMGSVSYKF
>LONDMIMF_03140 Ycf48-like protein
MKKVLCIFLLSVAFTQCKHEIKPEKNHYFSDVIIDTLWQDNFSIRAILIENDKLWYAADK
GKYGYYDLTSKEKFQKTISKDTVNPEFRSIAKNSSAIFVMSVGTPGLLYKIAKDGSETKL
VYKDDNEKAFYDSMQFWNDKEGIAVGDPIGGCFSVIITRDSGNTWQKISCEKLPKIAEGE
AAFAASNTNLIVRNNAAWIVSGGKRARIFYTSDKGNSWEVSTTPIVQGEAMTGIFSADFY
DENIGFIVGGNYEKPELNSKNKALTINGGKTWTLIGDNTGFGYASCVQFVPESGGKQLVT
VGFSGLQYSSDNGATWKQFSKDKDLYTIRFIDNNMAIAAGKNKIVRIKFKK
>LONDMIMF_03141 hypothetical protein
MKNLFLILLVFGLTASAQDDKREQIKSLKTAFITTELSLTSDEAAKFWPVYNAFDEKQFE
LKHQKMRALGKKLDAMDAMTDKEALALINQMEDYENELFQNRRKLVSSLKTILSPVKILK
LKKAEDDFNRKLLRQYKDKGPRK
>LONDMIMF_03142 hypothetical protein
MNSFNLENGPKIKPGFKTPDNYFENFSEQMLARIDSNEKPVSSIFQRRKNWFMAAAAVLI
IGFAIPFLNKPANNAAIDGESLENYLAYQSTISQYDLINLLDKEDIEALESDLKIDDAVV
ESALSDNTNLENYLTE
>LONDMIMF_03143 ECF RNA polymerase sigma-E factor
MLLLDEQAFIKELLDPKTQNKAFQTLLSSYQKPLYSHIRNIVLNHDDADDVLQNTFLKVF
QHLKNFKGESKLFSWLYRIATNEAITFLNAKARRNGMTSENFQQKQIESLKADDYFEGDE
IQLKLQKAIATLPEKQQLVFKMRYFEELKYEELSEILDTSVGALKASYHHAVKKVEEYML
KH
>LONDMIMF_03144 hypothetical protein
MKILKYILLLILLAVIGLTVYIATQPGEYESEQSRIIKAQKSVVFSYVNDYKNWEDFGSW
KDDDPNMQFTYSDTTIGKGAFYTWKGSSGEGKTETVFEKENDSIAQKTTFSGNEGKAYLT
FKDTVGGTKVTWHSQGKLSFMDKAYAIFKGGAKKMVGDMQERTLAKLDKVISYEINTYSI
QVDGIVQKSGGYYFQQKVTCKISEVQKNVGIILPSMLRFFKDNNIALTGSPFILYNTYDV
PNNKASFSVCLPMREEIFTAEGSDYTSGKLEPFQALKTTLKGDYSHGKEAWDKALAHIKK
NNLTENKSGSYIEVYVTSAAQVKNPSKWVTEIYVPVGQSAPTEAVTPSAVSGTSVKTTTP
ATNTTKTVTPAKPVVKENQVIE
>LONDMIMF_03145 hypothetical protein
MKLKTIAGMFLASAFLVSCGKDKEEPKEVAANTGDFQYEVEQFADIKVLRYQVPGWEKLT
LKEQKLVYYLTQAGMAGRDIHWDQNYKHNLKIRKALENIYENYKGDKASEDWKNFEIYLK
RVWFSNGIHHHYSSDKIKPAFTKEYFQKLLSETKTTLAPEIVEILFNNQDAKKVNLDESK
GLLAGSAVNFYDKGITDKEAEEYYKTKKSPDAKRPYSFGLNSKLVRNASGQIEEKVWKSG
GMYGPAIDKIIYWLEKAQGVAENKKQGDAIGLLIKYYKTGDLKTWDDYNIAWTEATEGNI
DYINGFIEVYNDPLGYRGSYESVVQIKDFDMSKKMEVISSNAQWFEDNSTLMPEHKKKNV
VGVSYKVVVVAGESGDSSPSTPIGVNLPNADWIRAEHGSKSVSLGNIVDSYNHAGGSDRL
KEFANDKEEIELEEKYGEVADKLHTALHEVVGHASGQINPGVGTPKETLKSYASTLEEGR
ADLVGLYYLYNPKLQELGLVDDWKKVGMAAYDGYIRNGLMTQLIRLEPGADIEEAHMRNR
QWVSAWVFEKGKKDNVIEKITRDGKTYFNITNYEKLHELFGQLLRETQRIKSEGDFAAGK
ALVENYGVKVDQKLHKEVLERNKKFKSAPYSGFVNPVLVPKTDAKGEIISFEIQQPKTFA
EQMLYYSKTYGFLPEEN
>LONDMIMF_03146 hypothetical protein
MKQLKRTPYFLVLGIFLFLSCQTEEIPVTENRQKQTRQVTKVSFSTFKKQTGLVDFKTTF
EIPKSSNGAILQRKNNGYTPADFIIDTKEITQTIAGEKTSYVFSITPVKGEIEDKRFYLV
VYNKDGKWLEMIIQADYSVDKDGDASQSGFKEIYASSGRGLGCIIIYSWVLKCNGRGECA
GGVCDKCSICLRGFADRLCPPINKQDYLDGGFTKPGGGGAGGGGGGGSSNPNPNPDPELI
IELPLPLLPDPRNNDPCKELKKMMQNTKIEESYTGPNGLKSKVNENIEYGFAFKRTPGYD
DVEPITRNYANPTTLNMTNFIGGKYYGASHTHINYVTSENVPMFPAPDIDYLFKVAAKYD
WEGVTPRNRDYSIFVFTLTVPQGTYAIKIKDWLKFTYVMNNSVRYGEFKQKIEREYNKID
NSNIDKLIKTLLKIMNDSNLGVGLYEAEQDFSNWKELTLSNPTDVNSQIKETPCN
>LONDMIMF_03147 hypothetical protein
MRYIIIFIILLFASNCKAQSPIIPLNNSEYEDIRGAYYKDTENFLQQFEGTWLYSNNGTI
LKIILKKKEMFYVNGSILNFYTDYIVGEYQYIKNNLEMQNTLGNINMNHQEISDYNIYGN
IMTKGTKFPAACPECQPGELRLKTFYTEPTRRNVEGLDAQMVFRRFTENGVAKLKIWFYS
TSGSYGFTRDGQPTDIVSYLLPYGEYVLTKQ
>LONDMIMF_03148 hypothetical protein
MKRIIQLSTILLTVIVCKAQTPVINIHGSKKEIENAYYKDIENFYGQFVGTWIYSDNVKT
IRYRFAKKDMFYYRSPTNYYVDFLVGEMQYIENGVEKINTVNRVDLNFDNIFKYSMSSIA
KIGYDFAPLCPECPPDVKRLAMSYDEPTNDDFGLDATFVMRRVVEDGIEKLKVQYRSISG
ASGESKRDMSQPSTTTDFTIPYGDYTLVREN
>LONDMIMF_03149 hypothetical protein
MKTIAFILFILFNSFASMAQTPVLERYGNLSYGEIRGAYYKDTRNFLGQFEGTWLYSNNG
TILKIVLKKKEMFHENGNIRNFYTDYIVGEYQYIKNGIEMQNTLSNINIDYQNISDYNIE
GNLQKRGNKIPTLCPECQPGEKKLMVYYTEPSRRNVEGLNAQMVFRWFTENGITKLKMWF
YSTSGSYGFTRDGQPTDIVSYLLPYGEYVLTKQ
>LONDMIMF_03150 hypothetical protein
MFTQGQWTFAGFFVVAFIIAMIYAYRKDLKLHKLFYKRSYLVLLGFLAFIGLLFVIKVYL
KH
>LONDMIMF_03151 hypothetical protein
MQKQLNAVKEFHQAFGLGVSETPKGDLGESKNRLRYNLMKEENEEYLEAVQNDDKIEIAD
ALGDMLYILCGTIIEHGLQHKIEEVFDEIQRSNMSKLGEDGKPIYREDGKVMKGPNYFKP
DFSLILK
>LONDMIMF_03152 hypothetical protein
MLYPFMTIGFLIVFIVYVLYLALTKKLKQNISTVVYPGLFFISVWAGLYFLVFR
>LONDMIMF_03153 Branched-chain-amino-acid aminotransferase 2
MANKDGFQQIIWTDDATHTKLEEAGTMNVFFRINDTLFTAPASERILDGVTRKSLITLAE
KEGIDIQVRSVLVWELVEAAKNGTLKEIFGAGTAAVVNPIVGFSYKGEYFELPKVEDSIA
LQLKEKLTNIQYKLAEDPFDWTVKI
>LONDMIMF_03154 Cobalt-zinc-cadmium resistance protein CzcA
MLDKIIRFSIKNKIVIGIMTLLLIIWGVWSATKLPIDATPDITNNQVQIITVCPTLAGQE
VEQLVTFPIEQSIANVPDIEETRSISRFGLSVITVVFKEEVDIYFARQLVTEKLKQAEEE
IPQGVGTPELAPVSTGLGEVYQYILHPKKGSEKKYDAKELRTMQDWIVRRQLNGTPGVAE
INSFGGQLKQYEVAVNPDRLRAMGVSISDIFTALEKNNQNTGGAYIDKKPNAYFIRGIGL
VTSLEDAGNIVVKNNTGSVPIFIKDVAEVRLGSAVRYGAMTFNGQVDAVGGVVMMLKGAN
SNEVVNRIKEKIPVIQKSLPADVVIEPYLDRTDLVGRAIDTVEKNLIEGALIVIFVLVIF
LGNLRAGLIVASAIPLSLLFALGMMNVFGVSANLMSLGAIDFGLIVDGAVIIVEATLHHL
GLNKSKKMLTQAEMDEEVFLSASKIRSSAAFGEIIILIVYIPILTLVGVEGKMFTPMAKT
VGFAILGALILSLTYIPMMSALFLSKKMSHKENFSDKMMNRIQKVYQPLLEKALKIKYWL
VGGTVALFAVAIFVFGRMGGEFIPQLQEGDFAFHCILPQGSSLNQSIETSMQASRIIKQF
DEVKMVVGKTGAAEVPTDPMPPEATDMMVILKPQKEWKTKKTYDELADEISEKLEVIPGV
FFEKNQPIQMRFNELMTGIRQDVAVKIFGENLDSLAIYADKTAKVIQSVKGSTSPQIERV
SGLPQINVEYDRTRMANYGLNIEDVNNAVSTAFAGKSAGQVFENERRFDLVVRLDSLHRT
NIDDVSNLMISTASGTQIPLAQVANISYKLGPAQISREAGKRRIVIGFNVKDRDVESVVK
DIQSKLDKEVKLPAGYYFTYGGQFENLQAASKRLMIAVPVSLFLIFMLLYFTFNSFKQAT
LIFTAIPMSAIGGVFALLLRDMPFSISAGIGFIALFGVAVLNGIVLIGTFNQLEKEGETN
ILKRVMEGTKTRLRPVLMTATVASLGFLPMAISTGAGAEVQKPLATVVIGGLVTATFLTL
FVLPMLYIIFNTKINLKKINNKSVTAIVVLGFLFLGQTFSAQQGRTITVEEATRTAIENN
QSIRSRDLDIKATQALIPTSKELPKMNVDAQLGQYNSKKFDQSFSISQTIPFPTLFKARK
ELIAEQIKGKQINREVSMNELAKQVRTYYYQIEYLQFNKSKLSNLDSLYNDFIRVATVRF
KAGDIKKIEINTAETQRGEINLLLKQNEVYLTNAYKNLKTLLNIEEDISVPFDQNYHPLQ
AQYVLDSSAIAQHPTVKAFYQEMQIAEKNKKVEKSLGLPDFTIGYTNQSLIGFQTINGMD
QYFNGGNRFHSATIGVSIPLTFGATKARIQSYEYQRQMAESNAKFQQKQLEAQLQNAFNQ
YQQNVNQYDYYVNQAIPNAEKIAKAGQLGYKTGEISYVEYLFALQTSTNIQLKYLESIQQ
VNESVVIINSIINK
>LONDMIMF_03155 Cobalt-zinc-cadmium resistance protein CzcB
MKIKYSIVSLALISILAVSCGKKDAPAEGEEKPKTEQAEESHEEAPQTIAELTEEQMKSV
GISLGTLEMKDLASTIKANGVLRVPNNRKATVTSLYGGVIKTLTVQIGDYVRQGQVIATI
SNPEYIQLQEQYLTINSRITYAEQEFRRQKELFDNDAGAKKNLQSSDAELKSLRTQRSSL
QRQLQLMGISPGKVSNGNLRSGLVITSPISGTVSTINAQIGSYVDVSSPVLEIIDNSSIH
LDLQVFERDLPKMKVGQIVQFKLTNNPEETFNAKVYSIGSSFENESKTISVHAMVTGNKA
GLIDGMNITGNVSLGNSQTPAVPNEAIVEADGKFYVFVQTSKKVEEHAEEKGDDDHGHGH
DEGEAEHGHKNETEAGNHAKEQAKKMNFEKIEVVKGTSDMGYTAITPVSAIAPDAKIVVK
GAFFVNAKLSNAGDHGH
>LONDMIMF_03156 hypothetical protein
MPLKQELETQGNWLFRYRSFLPIIVLALGLGVFIQNVLLKNDNDCSLFFEMLCLAVSILG
LIIRVYTVGFTPHNTSGRNTKAGQVADELNTTGIYSTTRNPLYLGNFFMWLGLAMFTENL
WFVISFVFFYWVYYERIVFAEEQFLERKFGEQYTKWADKVPVFIPNLYLFRNTHLSFSLK
KVLLKEKNGLFAMFLIFTVFEITGEIILRHTHYNMIFIVGCILTMILYIILKVIKKRKTM
LQNKFSQ
>LONDMIMF_03157 hypothetical protein
MLLNKRISVWYFVKQIKFQIVLIVSFAFLIGFLDDIDFLKKITIPLSIPALLGTAVSLLL
AFRTAQSYERWWEARTVWGAIVNDSRSFMRLIKQFFPNSENDTSEFAERHIIWLNALGES
LRKVPFSIRVREYLESQNINALNIPNALLDKHSDHLRKLAEQENLSEYKLVQMNDMVIRF
CDSMGKCERLKNTVFPRAYSILLHTLIYVFAFLLPFGLEDSQLGVEIATTIIVPVIFIAI
EKTAIIMQDPFENTPVDTPMTSLAKTIEINLLQMIGEKNVPVKEVSTSYYEM
>LONDMIMF_03158 Metal cation efflux system protein CzcD
MNDQNKNISASAKHKRNLLIVLCLSGTYMIAEVIGGLATKSLALLADAAHMLTDVVGLFL
AFIAIKIGERKADAQKTFGYYRTEILAAVINAVVLLGISVYVLFEAWQRFKNPPEVQSTA
MMIVAGIGLLVNIIGIMIIRKDSGESLNMKGAYFEVLSDALTSVGVMIAGVIMLTTGWYY
ADPLISAVIGLLIFPRTWKLLKEAVNVLLEGTPKDVNIEELRNSLESVKGVIKLHDLHVW
SLTSGVNAMSSHVVADHQEDLNKLLKNLSDKATSEFKISHTTFQIETEGHQEGEVHL
>LONDMIMF_03159 Lipoteichoic acid synthase 1
MKLKQNYWGNYTLLVYSFLFYLVSSLLLRFGFLAVSFQKADLSLLPIMKIFLLGFLFDFG
VGLFFLLPYSFYLLIFPQKYIRSLFNKIITYSTFIIFLLIHLFSFFAEVTFWQEFESRFN
FIAVDYLVYTYEVINNINESYPLPVLISSILLLMTLIFILFYKSKIFFFSFNGQHKFSVR
LIVFLGFFCLTIIYSLFISNSLADKSVNRYQNEISKAGIYSFFSAYKNNEINYDHFYKLI
DNESAFKIVRTDLNDNQRFFSNNLSIERKISSKQNLIKPNVIMITMESFSADFMGTFGNK
QGLTPNLDSLAGGGILFSQMYATGTRTVRGMEALSLAVPPTPGNSIVRREDNDHLTTIGS
IFSAQGYDNTFIYGGDGYFDNMNKYFGNNGYDIIDKKRNPLAKENYQALRTPINQKEITF
ENAWGICDEDLYNQVIKQADQKYKQGKSFYDFVMTTSNHRPFTYPDGKIDIPSGSGREGA
IKYTDYAIGQFFKKARSKPWFKNTVFVIVADHCASSAGKNEIDISKYHIPAMIINLPNQN
SLKIEKMCSQIDLYPTLFDLMGWNYRSNLYGKNVLSDNYIPRIFVSTYQKLGYMENDKLV
ILSPQQKVEAYLYNKTQNQQIPKIFSDQYINKAVANYQTAYYLYKNQGLKQK
>LONDMIMF_03160 hypothetical protein
MDIKFELILSGKLLLSILFGSIIGYEREAAHKDAGIRTFAILCLASCLFVAVASHLTDDK
SAIARMLAAIPAGLGFISAGLALKDKSSNMQGLTTSTALWAASAIGAALALNMFLLSFLA
TVLTLFVLSLNKFKWYKNWIAKKEQSKNLK
>LONDMIMF_03161 Zinc-transporting ATPase
MKHQHTYDEQGNQLCCTPQEGKIYKDAGAKKLIVEDNGCCSTNVKKEVQHHSDDDGHNHD
HDNSDKSTFQMFLPAIVSLLLLLLGIALDNYFKPDWFKDWIRIVWYAAAYAPVGLPVLKE
AFESIKDGDVFSEFFLMSIATIGAFIIGEYPEGVAVMLFYAVGEVFQTLAVTRAKSNIKA
LLDQRPDEVTIIENNETKTIKASNAEIGQTIQLKPGEKLALDGELISDSASFNTAALTGE
SKPDTKNKGETVLAGMINMNSVALVKINTAYEDSKLSKILELVQNATAQKAPTELFIRRF
ARVYTPIVVVLAVLICLIPYFFVDNYIFRDWLYRALIFLVISCPCALVISIPLGYFGGIG
AASRNGILFKGSNFLDKIAEIKNVVMDKTGTMTEGVFKVQEVDIKSEFDKNEILKMVNVV
ESKSTHPVATAIHEYVGDLDTSINVENSEEIAGHGLKAVINGKDILVGNFKLMDKFNIQY
DVDPSKIVYTVIAIAYDKKFAGYITIADSIKDDAKKTLELLHNLNVKATMLSGDKTSVVK
YVAEQIGIDNAFGDLLPEDKVNKVKEIKSKNESVAFVGDGVNDAPVVALSDVGIAMGGLG
SDATIETADVVIQDDKPSKIPMAINIGKKTKRIVWQNIILAFVVKAIVLILGAGGLATMW
EAVFADVGVALIAILNAVRIQRMNFK
>LONDMIMF_03162 hypothetical protein
MQKFKLELLFQIIGIGSASGLVFRDNSLFIISDNSSVLYEYNMDSKSLESHKIIEMPTGT
PAENIPKAQKPDFESITGFGEDCYIFGSGSTENRNRMIHFDVDKKEKIKETDLTDLYLVM
QSFGNTKPEDFNIEGAVYNGENWFLFNRGNGASGKNGIFTIGGNNLTDDFSVLYNSYKLP
KIKSIQSSFTDAVRVDGKIYFLATVENTKSTYDDGDVLGTFIGRLDIEKMKIDFTQKITD
THKFEGLTVYKENDKTIEFLLCEDKDNDDLKSDIYKLTLDK
>LONDMIMF_03163 hypothetical protein
MRTINTDDFKITGPIKLSQLPTFIDLKATKDKIKDALDETREALSDLQDKMYAHNRYSVL
VCLQGMDTSGKDSLIREVFREFNARGVVVHSFKTPTSAELEHDYLWRHYIALPEKGKFAV
FNRTHYENVLVTRVHPEYILNENLPGIENVEDIPKDFWKKRMKQIAHFENHIAENGTIVL
KFFLHLSKEEQRQRLLRRLEKEKHNWKFSPGDLKERSFWDDYQRYYEEAINETSKEKAPW
YVIPADDKDTCRLLLAKVIWDVLSQHKDIKYPELEDKVKDNMSFYKNELTNER
>LONDMIMF_03164 hypothetical protein
MKILKSITGLFLLCSTVLTTATMSAQETTSAIGATENYDQGFRLGFGINGGFIFDDPYDF
SLGADARIQYDLNQRYSITFTTGFTNLFIGDDIPDLGFIPAKAGFKAFVWENRFYVLGEL
GAAIPVTNDYDKTSLLLSPGIGYANKYFDASIRYEYYNDFPRENGEGVGQLALRLAYGFR
L
>LONDMIMF_03165 Multidrug resistance protein NorM
MWNCRIWCYLCHTIFYTIVNLQQYTKEFSYNLKLAYPIILGMLGHTLIGIVDNIMVGKLG
AAELAAVSLGNSFIFIAISLGIGFSTAITPIIAQADAEKDNIKIRSAFHHGLFLCGILGL
TLFGVIVLAKPLMYYMGQPDEVIALAKPYIDWVAFSLIPMVIYQGYKQFADGLSMTKYSM
YAIIMANVVHVVLNYLLIYGIWFFPRMGIIGAALGTVISRIMMVVFMHIILSKNEKLTAY
FQNFSFQELKKSMLKKIIGLGLPSAMQMFFEVALFTAAIWLSGSLGKISQAANQIALSLA
SATFMFAMGLSVTAMIRVSNQKGLKDYKKLLVVARSIFLLAIIIEVVFAIGFVLFHQFLP
HLFLNMENSALLVDNEEVIAIAAKLLLVAAVFQISDGIQVVVLGALRGLQDVKVPMYITF
AAYWVVGFPVSYYLGKHTDLKATGIWIGLLAGLTVAAVFLYIRFNYLTKKMIKEATVETA
I
>LONDMIMF_03166 hypothetical protein
MELPKFLLGDNTDFPDDIFVIHMDYPRFIINLKDDEVEFLEEAEDLDEGELNQVMEGLIT
EANEFYDREVGRYEE
>LONDMIMF_03167 hypothetical protein
MRFQDLLAYKKSFEVAMAIFEVSKSFPSEERYSLTDQARRSSRSVSANIAEATRKRMYER
HFISKLTDSDAENSETQVWLEYAYACNYIDVVSFNRLTEKSLEVGRLLNYMIKNPNKFL
>LONDMIMF_03168 putative GTPase
MSKSGPHKSALKEKEGISQPESVGKNSVAQIIQFRKKQPSAQELIDGILKGDKISLSRAI
TLVESTQPKHLEKANEIIQACLPHANNSVRIGITGVPGVGKSTFIEAFGRYLTATGKKVA
VLAVDPSSTISHGSILGDKTRMEELVKDENAYIRPSASGETLGGVARKTRETIILCEACG
FDTIIIETVGVGQSETAVHSMVDFFLLLKIAGAGDELQGIKRGIMEMADAIVINKADGDN
IKKAKMAKTEFNRALHLFPAKSSGWQPKVTTCSAITHDGIAEIWEMISEYLTLTKGNDYF
NERRKDQNQHWLMETINEQLKTHFFEHPEIKSLLEENKKAVHDNEISPFAAASVLLEKYF
R
>LONDMIMF_03169 hypothetical protein
MKIAIIGATGFVGSKITAELANRHHEITAISRNGKNSDIQNVKYVAADIFNIQELAQILK
GHDAVVSAYNSGWTNPNIYDDFIAGSKAIQEAVKLSGVKRFITIGGAGSLFVAPGLQAVD
TTDFPKEYHAGASAARDYLNILKEEKELDWAFFSPAFEMHQGITTGRTGNYRLGLDNPVF
DDNQRSILSAEDLAVVIADEIENPKHHQVRFTAAY
>LONDMIMF_03170 Putative HTH-type transcriptional regulator YwnA
MISGKFAITLHILTLLSKFPDEYLSSEFLAGSMNLHPVLIRKEIANLKKHNIVESKEGKN
GGTKLLKPAAKINLDDIFRMTFEKVTLGYSKNDPNPDCPVGKNINKKLDELYEDINDKII
KQLGTISLNEFSDKF
>LONDMIMF_03171 hypothetical protein
MDSIILLFLCLLVGFVLQRAKNFPANSHQVLNQFVIYISLPALALFYIPKIEISSKLLFP
LGIAWLGFLFSFLFFSVLGSYFKWSRKLVGCLILMGGLGNTAFVGFPVIEALYGKEGMET
AIIVDQPGTFVVMATLGIIVASLYSRGTPNPKEIVSKILLFPPFLAFFAALLMNVLDADF
NENLQLVFQRLGSTVTPIALVAVGLQIKIQEKSRHWNFLVLGLFFKLMITPAFFYVLYKI
IFNGNGIETDVAILESAMAPMITASIIASNYGLKPKLSSMMIGIGIPLSFITLAFWYWVL
ITF
>LONDMIMF_03172 Fosmidomycin resistance protein
MKATDLNFQAQDNKEVAQKTVYSILFSIAFAHMLNDLLQAVIPSVYPILKESYKLSFTQI
GLITFAYQMAASILQPFVGFYTDKKPQPYSQIYGMLFTLSGIILLSYASNFYVIILSVIL
VGIGSSIFHPEASRISFLASGGKRGLAQSVFQLGGNAGTAIGPLLVALLVVPNSQRYILF
FVIIATLALLVLGRIARWYDNHLTLRAKKKIEVVLPDLSKNRIVLTVIILLVLIFSKFFY
MASMSSYFTFYLIEKFNVSVQDAQFHLFLFLASCALGTLLGGPLGDKFGRKYVIWFSVLG
AAPFALFLPYADLFWTGILSVVIGIIISSAFPAILVYAQELLPKKLGMVSGLFYGFAFGM
GGLGSALLGYTADHIGIEAVYKICAYLPLIGIIALFLPNLKKKK
>LONDMIMF_03173 hypothetical protein
MMKIFSTAQNKNLSNIMLFVVRATVSSFMLVHGVEKFDTLYAGGPFEFPDPLGVGPAASL
SLAVFAEVLCSGLLLVGFATRLVTIPLIITMYFAVFVIHGSHGFEKQELGGLYLLIYVLL
LVTGSGKYSVDHFIYKRTRPEKP
>LONDMIMF_03174 putative FAD-linked oxidoreductase
MKTELLSKEVISRLQQIVGPSFLFLDEETRNNYGRDETEDYVFPPGVVLKPASAEEISAI
LKLANEYKIPVTPIGGKTGLSGGALSIHQGIGLSMERFNKILHIDEQNLQVMVEPGVVTQ
TLQEAVLEKGLFYPPDPSSRGSCFIGGNVAENAGGARAVKYGVTKDYVLNLEVVLPTGEI
VWTGANTLKNSTGYNLTQLMVGSEGTLGVITKIVMKLLPKNAHNVLMLVPFFNSSQACEA
VAQIFKAGITPSALEFMERDAIDWTLRFIDGVSLNIKDEVEAHLLIEVDGNYPDVLFSEA
EKITEVLEQFAIDEILFADSEDQKNALWKLRRAVAEAVKSNSVYKEEDTVVPRYELPRLL
EGIKSIGNKYGFKSVCYGHAGDGNLHVNIVKGDMSDEDWKTEIPKGIREIFELTVSLKGT
LSGEHGIGYVQKNYMDIAFSPTQLLLMKNIKNCFDPNNILNPGKVLPDSI
>LONDMIMF_03175 Na(+)/H(+) antiporter NhaP
MELYYSFSVLIVLASFFAYLNIRFLKLPATIGIMIIAMISSIILVVTGNIFPETFTNFSK
LFSEFDFTEVLMGAMLNFLLFAGAIHVNLKDLREQRGPVMVFSTISVLISALAIGLILDF
VTDLLHIDLPFIYCLLFGALISPTDPIAVLSILKDAKVPKSLETKIAGESLFNDGVAVVV
FAVILKLAQDPASDFSLPHVSWLLIREALGGFILGTILGIQSSKAMRKVDDYKVSVLITL
SVVMGGYLIAQAMHISGPLTMVAAGIIIGNYGKKTAMSATTKDYLNKFWELIDEILNAIL
FLFIGFELLLIPNILSFWSIGLICIFIVLLCRLISIWIPTKIIPFKKKFESSTIKIMVWG
GLRGGVSIALALSIAEGPHKKIIVAITYFVVVFSIIVQGLTIGKLANRLLPKAKSANI
>LONDMIMF_03176 hypothetical protein
MAKSHDAKKNVKKEPAKTAKEKKAEKRDKKNNPKRD
>LONDMIMF_03177 D-alanyl-D-alanine carboxypeptidase
MIKKVKTITLIFLCFIGQTADAQNKLDAYFNHLQANNKMMGSVAISLNDSIVYKKAIGYS
NADAKTSNTTDTKFRVGSITKTYTAVLALKAVEEELLTLDTKLSHYYPEVKNAEKITIEH
LLKQRTGIYNFTEIAGEVEWGQQFHTQQEFINYFVNQKSNFEPGSEYEYSNTNYALLGFI
LEKIYGKTYAEILDEKIVRPLHLHNTYYSFETDETKNEALSYNIQDKYVRNEKTNFSNHP
ASGGIVSTPTELNKFLFALFNGKLISPESLKIMLPEEKGAYGMGIIKLSFKNPEGYTHSG
RVENYISDYYYFPDENIGIVSLTNAVNINTDEVMNTMLMYLYRKTPELANFNATAEVSEK
DFMPIKGTYYLKETNATVTISSDGQNVIFQDSRAGQMYVPLTYKAKNEFEYEDLKLSFVP
KKEEMIFEQGGVKVVYKKK
>LONDMIMF_03178 HTH-type transcriptional regulator BetI
MERKAVAGNIRNKERSKEKFLEAVGKILETKGYSGLKVNDIAATAGVDKKMIYNYFGGTD
QLIDEYISSLDFWSNVDGNTAPEIADGGQEFSKQLLTQQFDYVASNKNLQKILLWGVAEK
RNSLRNIADERERNGEQLFNQIADPYFAENALQYRAIMAILISGIYYLNLYKGVNAETFC
GIDLTKNEGSQQIKGALGKIIDLVYEDHNKEN
>LONDMIMF_03179 hypothetical protein
MTTRHFVFIVLFALQYTGLNAQTDLQTPLRNEINSKLINNEQYTMDWYTMREDKKIMIAK
IFTEIKKSKSEVLITTKVKMVNSTSDWIDSTRAKLPNLLPIAHSSFNRQRDMVLQFGKTI
TGYYLRKPANEKTEINEIAEGSYFDSNLYPQLIRWLPLKENYKTSISIFDYNPQAGKGIM
KAHIKNTRKAIYKDKDVWAVEVTDDITDNQSTVIFYIDSKTRKLLGQEINMGARKMFMEL
SAD
>LONDMIMF_03180 Penicillin-binding protein 4*
MKQFTLFFMLLIISKFAYAQKKQSERLDSLFTVLYQQNQFNGTALIAEKGKIIFKKSYGI
ANEDTKAPINEKTIFELASCSKQFTATAIVLLKREGKLQYTDKISKYLPELGFWENVTIY
DLLRHTSGIPDFLKYMPDNWDHNKIADNNDLIKVLAAKKDSLEFTPKSRHSYSNSNYILL
GSIVEKVSGKKFPDFLSDRVFKPLKMKNTFVYCRHKYPKKIDNFAYGYVWEDGGFKKILE
ENSQREISEVYYLDAILGTSKVHSNAEDLYTWMTSLKNNTLLTKKEFDEMTEITKTSNGR
DVAYGFGLDLRKGENKFTFGHTGSWDGYSTFMLHDVVKDRTFIILQNFHFGAVPYTNMFQ
IMEDKPLQLQYPKKIALSDDEIAQYTGTYTNEEGETHIITSKEKHLLYNTPTVSWNMRFF
PYSDHEFRGIRQAGADAVLNFTKLDNGDIKLEMFQDKQIVGTGVRKGK
>LONDMIMF_03181 hypothetical protein
MRFTHLIVSLLLQIPYRMTSFTPDELIEAKKSLDSILNKCEKAFAKLKENSPQHTLMVRR
INALRVSLNLIEKELQNL
>LONDMIMF_03182 Exoenzyme S synthesis regulatory protein ExsA
MVNDYKKHDLFGKTLLQKIALTAPFKFDFPVTEQACFLYVLQGEFQYQVDTEQINIPANY
SLLLNCITSGKQLRNPEPSSTCEIVIVTFYPDILKKIYDRELPTLLHAPKNIVSNKSNEK
INNDFLIQKYIEGLLFYFENPSLINEDILVLKLKEIILLLSQTQNAEAVQIILSQLFSPT
TYTFKQVIEANLFSQLTIEQLAEQNNLSVSSFKREFAKLYNDSPANYIKNKRLEKAAQLL
RVSDQRITDIAFDCGFNDLANFTKSFSDKYNVTPTNYRNGTKDN
>LONDMIMF_03183 hypothetical protein
MGLSGLGIFHTIIGITAIVAAVIGFIRYGKINLNELSGNMYFYTTIVTSATALGISKHGG
FNAGHVFSIFIILLVVVAYFLFSKKKTSKRARYFENFLLSFSFFLSLVPTVNETFTRIPI
GHPLAKDISDPIIGQTLLALFLLFIAGSVYQYIRQKKVNVSVIKKD
>LONDMIMF_03184 hypothetical protein
MDTNDLLKQVAFIKEIDKLKYIQRRTRLFQSDRHENDAEHSWHLAMMALVLAGHSDKPVN
ILKVVQMVLIHDLVEIDAGDTFIYDTSKNHTNTDEELLAAKRIFGLLPEKQAQEFIAIWE
EFEAGNTDEAKFARAMDRFEPLLQNTSNNGGTWAEYDVEYHTVYNKKKAIKDGSASIWSY
AERLLNESVEKGILRKNQDAED
>LONDMIMF_03185 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MNKIALVTGGSRGLGKDMALNLAKKGIDVILTYNSNKDAADKVVSEIESMGQKALAVQLD
VSQPNTFDTFFGELEKALNPKFGTSKFDFLINNAGTGVAAGFTETSEEQFDEMINVQFKG
PFFFTQKALNHMNDGGGIVNVSSGLTRIIIPYYPVYASVKAAMENLTKYLAKDLGVARKI
RVNIVAPGAIETDFGGGVVRDNQEMNTFIASQTALGRVGQPTDIGSVVAFLCTDEAKWIT
AQRIEISGGQSL
>LONDMIMF_03186 hypothetical protein
MTKLVCVVISFFVINKGIIVKIKQLMQMKVF
>LONDMIMF_03187 putative HTH-type transcriptional regulator YtcD
MECTTRIEEQHKKEMMAVQDSMDVLNGKWKIAILSSICYYNKRRFSDILNDVKGISNKML
SKELKELEINKLVRRTVLDTQPVSVLYELTEHGLTLKTLITHLVEWGIQHRKEITRK
>LONDMIMF_03188 Glucose 1-dehydrogenase 4
MSKLKDKVAIVTGASKGIGASIAKFFAAEGAKVVVNYASSKEGADKVVRAITEQGGTAIA
VQGDVSKEADVARIFEETRNTFGSLDILVNNAGVYLYEPIEQISAETFHKSFNTNVLGSI
LAIQESLKLFGDKGGNIINISSGASNSPLPTGSVYSATKTALDAITIALSKEFSGRNIRI
NSILPGIVETEGSHSAGFIGSEAEANFVSKTPLGRTGQPDDIAKVAVFLASDDAAWITGE
KITVGGGIYGF
>LONDMIMF_03189 Peptide methionine sulfoxide reductase MsrA
MLKWIDIIRFAGTGNPVPDKKVVKTNDEWQKLLTPEQFRITRLKGTERAHSSEMCSLFEP
GKYACVCCGTLLFDANEKFESGTGWPSFTQPVTENAIAYHKDISYGMVRVETTCNTCDAH
LGHVFPDGPGPGGLRYCMNAVALKKVESNERKATFGGGCFWCTEAVFNQLKGVTKVESGY
SGGKIANPTYREVCSGLTGHAEVIEVTYNPDEITYGDLLRIHLSTHNPTTLNRQGADVGT
QYRSAIFYRNEAEKKEAEQVIAEIQAVYDEPIVTEVAPLEYFYKAEEYHQDYYSNNSQEG
YCQAVINPKLRKFRELFKNRLKDTKEGELK
>LONDMIMF_03190 Peptide methionine sulfoxide reductase MsrA 1
MVRQAGFGGGCHWCTEAVFSSLKGIVSVQQGWIASTGSDMSFSEGVIVEYNDDIISFDTL
IAIHLHTHSSTSQHSMRGKYRSAIYTFNVQDAESAKEAIETLQPEFDSTIITKVLPYGAF
TSSREELLDYYFNDPQKPFCELYINPKLKLIMERFSKLADTDKLRHLKQLDA
>LONDMIMF_03191 Alkanal monooxygenase alpha chain
METTNKKTAYSILELAIVSSGVTIEQTFKNSVDLAQKTEEMGYKRFWLAEHHNMIHVASV
ATSVLIGHIAGNTKSIRVGSGGIMLPNHSPLIVAEQFGTLGRLYPNRIDLGLGRAPGTDQ
ITAHAIRSDRMQSVHNFPGEIGQIQKYFSNENEWSQVRAVVAEGVNVPLYILGSSLDSAH
LAAKMGLPYAFASHFATGLLQEALDIYRKEFQPSEWLDKPYTIAGVNVIAANTDDEAERN
FTSLIRMFLGILTGKREALQPPMEMTDELMMIQHNPAVREMLKYSFVGRKEAVAKQLDKF
LLDTGVDELMVVSNMHAHKDRVVSYQILSEIMDERNNKENN
>LONDMIMF_03192 UvrABC system protein A
MLDTENTIEVLGARVHNLKNIDVTIPREKLVVITGLSGSGKSSLAFDTIYAEGQRRYIET
FSAYARQFLGGLERPDVDKIDGLSPVIAIEQKTTSKSPRSTVGTITEIYDFLRLLYARAG
DAYSYVTGEKMVSYSDEQIKELIFEQFKGRRINILAPIIRSRKGHYRELFEQITKQGFLK
VRINGEIKDITAGMKLDRYKTHDIETVIDRMLIENTPENDKRLTESIKTAMYHGDDILMI
IDQDSQEIRYFSRNLMCPTSGISYPNPEPNNFSFNSPKGACDHCNGLGTVNEINMKKIIP
NPKLSIKQGGFAPLGEYKSSWIFKQLEIIGEKFGFKLTDPIEKISDEAMEIIMHGGKEKF
EVSSKTLGVTKDYKIDFEGISNFIKNQFDESGSTTIRRWAKEFMDEVKCPVCEGSRLKKE
SLYFKVNGKNIAELTDMDISDLAVWFEQLDNDLTEKQKKIASEVVKEIKSRLSFLVNVGL
NYLALSRSSKSLSGGEAQRIRLATQIGSQLVGVLYILDEPSIGLHQRDNEKLIHSLEQLR
DIGNSVVVVEHDKDMIERADYVIDIGPKAGRFGGQIISKGTPKELLKEHTLTASYLNGEM
EIAVPKKRREGNGKFLKLTGATGNNLKNVSIELPLGKLICVTGVSGSGKSTLINETLYPI
LNAHFFNGVKKPQPYKKIEGLENIDKIIDIDQSPIGRTPRSNPATYTEVFSEIRSLFTQT
PEAMIRGYKPGRFSFNVSGGRCETCEGSGVRTIEMSFLPDVYVECETCQGKRFNRETLEI
RYKGKSISDVLNMTVDEGVEFFENIPKIYRKVKALQDVGLGYITLGQQSTTLSGGEAQRI
KLAGELSKKDTGNTFYILDEPTTGLHFEDIRVLMEVIDKLVDKGNTVLIIEHNMDVIKLA
DYIIDIGPEGGKGGGQLIAKGTPEEVAKNKNSYTAQFLKKELS
>LONDMIMF_03193 Cytokinin riboside 5'-monophosphate phosphoribohydrolase
MKKETFENEDDKIQEVFKQKTWNEIRSNDSWAIFKIMSEFVNGYENMGRIGPCVSIFGSA
RTKPEDKYYLLAEKIAYKISKAGYGVITGGGPGIMEAGNKGAHLGGGTSVGLNIELPFEQ
HFNPYIDKDKNLNFDYFFVRKVMFVKYSQGFVVMPGGFGTLDELFEAITLIQTKKIGKFP
IILVGRDFWAGLIEWVKTVLIEKYSNVSPGDMDLIKIVDNEDEVLDVLDNFYKKYNLSPN
F
>LONDMIMF_03194 hypothetical protein
MKTFAKIAIACLSLFFSTRGNAQHHSKVNVEINSEEKSAYVQQEITFYNQTGDTLTSIVV
NDWNQAYSDKNTPLAKRFSDEFVRNFHLAHDEDRGKTENITIIDQDNLFLKWHRFEKHPD
VIEINLREKLAPNERIILKLTYQVKFPNDRFTKYGWNDKGEFNLKNWCLAPARYENHRFI
MYSNNNLDDITNAATDFDVTLKLPPGLIATSDLDEVNHIKDISFSTYELTGKNRLDFNLF
VEPKTTFYSYKNNNVTVETNLKENRLNDIQKAIVIDRIVNFVHENIGSYPFEKITVSQTD
YERNPFYGLNQLPSFMSPFPDEFMFEIKFLKTYLNNFLKTSLHLNARDDNWIYDGIQIYT
MMKYIDENHPNSKMMGNLSQWWLLRGYNLTTIDFNEQYSYFYMLMARKNLDQPLGDPKNT
FIKFNEQIASKYRAGLSLKYLDNYLGNDIVENSIKEFYNLNSEHITSRTDFENILKSNAN
QNIDWFFNTIIDSRDIVDYRFTDVSKTKDSVTFTVRNKTKTVVPIPVYGIKKNEVVFKKW
LNNIKTDSTFTVPRNDADKIVLNYKNEVPEYNLRNNWKSLKGFFSQNRPIKFNFMKDLED
PYYNQILYIPTISYNLYDGLSPGIRFNNKTILDKPFIYEINPIYSPNTQTLTGSFSFLVN
QHNRNTNSPFNVRYQLSGSYFHYAPDAAYTKLTPTVTMLFRENNFRDNRKQGIQFREVLV
NRDKSAYSVERTENYSVFNAKYYNIKTEVTNHFNFLTDLQLSGKFGKLSTEIEYRRLFED
NRQLNLRLYAGTFLYNKTNTDYFSFALDRPTDYLFDYNYYGRSESTGFFSQQLILAEGGF
KSKLDTPFANHWMATLNGSFNIWQWIEIYGDAGFVKNRHNDPNFVYDSGIRLNLVTDYFE
LYFPVYSSNGWEVGQPHYNEKVRFIITFSPRTLINLFTRKWF
>LONDMIMF_03195 2-oxoisovalerate dehydrogenase subunit beta
MTQIASKKELSFEDFKTEVLNDYRIAVISRECSLLGRREVLTGKAKFGIFGDGKEVPQLA
MAKAFKNGDFRSGYYRDQTFMMAIGQMTIQQFFAGLYGHADIDHDPMSAGRQMGGHFATH
SLNEDGSWKNLTLQKNSSADISPTAGQMPRLLGLAQASKIYRNVSGINNKTNFSINGNEI
AWGTIGNASTSEGLFFETINAAGVLQVPMVMSVWDDEYGISVHAKYQTTKENISEILKGF
QRDNENKGYEIIRVKGWDYPALVTAYEQAAQIAREEHVPVLIHVQELTQPQGHSTSGSHE
RYKNADRLTWEADYDCIRQMKLWMIAINIATQEELDEIDNAVKKEVLEGKKAAWSAFVDP
IKTEQKELVALLENIAASSENKVFIQKFSSDLAGIKEPIRKDIIVTARKVLRLIAKENGK
NQLAQWITAYIEKIQPKFSSNLFSESTQNVLSVEEVRPQYAENAEEVDGRIIIRDNFDAI
FSKYPETLVFGEDAGNIGDVNQGLEGMQEKYGELRVADAGIREATILGQGIGMAMRGLRP
IAEIQYLDYLLYAIQIMSDDLATLQYRTKGKQKAPLIIRTRGHRLEGIWHSGSPMGMIIN
AIRGIHVLVPRNMTKAAGFYNTLLETDEPALVVECLNGYRLKEAMPVNMGEFKTPIGVVE
TLKEGKDITLVSYGSTLRLVEQAAKELLEIGIDAEIIDVQSLLPFDINHDIVKSLAKTNR
LLVIDEDVPGGASAYILQQILDEQNGYKYLDSKPETLAAKAHRPAYGTDGDYFSKPSVED
IYEKVYAIMNEVNPEKFPNLY
>LONDMIMF_03196 hypothetical protein
MNKQEILQKVQNVLDNKKINYIKNSLKYLKYEENGMARDGVKKNMHLICYYLDIQSDNLI
LHTVFVDAETDDLMYIITPHGYIEIEK
>LONDMIMF_03197 Bifunctional (p)ppGpp synthase/hydrolase RelA
MLLSDVVQKYWNFASIAHLNQFYTNHKDEKLPYINHIGSVVQELYIFLLQTENIYNIELA
IGCAILHDTIEDTPFTHHDIENQFGKKIADGVLALTKNETIENKKERMADSLRRINQQPK
EISLVKIADRIVNLQPPPKHWSLEKKEKYYEESKLIHKELSPSNTLLSNRLLEKIKNYTI
YLNEVNPEKFPGLY
>LONDMIMF_03198 hypothetical protein
MNYTEKQIDTIALQVMKDIDWPYNIKKGPSSFETTIEEQYEKYKKIDGFEENKHKIFAFW
VTSFEFPEEEGWNGRNMMFILTRDDNGEPYEVGHRQSKFKILKNEDGKYYTEPLKR
>LONDMIMF_03199 hypothetical protein
MITLEEIKEYFGEECKTFPEVTEVNDRLSEKTKYILYEIGLPSYSGYGGDYIMLDRLQVI
NNRYLKYGTRRGDLAHYSECIDMFTSEIVFNLNYEGDNDEYHVLNTDLESSLKYVYVYVR
FRAEIKIPQKFGEYYKNHSQYAKELKRQLLQINDDVKNETWANLIEEMDLGVI
>LONDMIMF_03200 hypothetical protein
MITLEEIKEYFGEECRTFPEVTEVNDKLSEKTKQILYKIGLPNYSGYGGEYIMLDKLQII
HNRYLKYGTRKRDSEFYSECIDMFTGEIVFNLNYKGDNNEYHFWNSNLEAYLKYVYTYTK
YVNEFEIPQKLGDYYKNHSKYAKELKRQFLQINKDVENGCWANLIEEMDLGVI
>LONDMIMF_03201 hypothetical protein
MKKVFLFLAFFIFLISCSDSEISSTSDQTSTLKVYKKISQDDLKKEYEALQKSLSHKIFI
EASNNFISKMKFNDDIKLIESEVTLLKWISDNISITEFSNIEEATEEWKIIIELKANEIA
ENKNFYNLIKDATEEQLINVFTPEFEQVTLGECEKTCNYGRNRCLLGAAVRYAKEWMDNG
AFSVAGQAYATLSYLLNQSTCAKSYSLCLEGCEFN
>LONDMIMF_03202 N-acetylmuramoyl-L-alanine amidase LytC
MKNTFRFLGAAVLVSILSFTTPESKKRIVIDAGHGGQDIGATHGFYSEKQIVSNIAKQIA
SQNRNTEIEIILTRDNDEFSSLQERTEKINKLQPDLVISLHINKNTNEEANGIEAYVSDQ
NERFEASKAHAEELVSVLSDNKLRSRGVKIAPMYLLKNTKSPAVVLELGFLSNANDRNYL
SSDSGQKEIAQKISGYLTR
>LONDMIMF_03203 hypothetical protein
MKRFREAKPEDIRQIQKVRNSVKENTLSDPSLVTDQDCNNFLFSRGKGWVCEIDGKIVGF
AIADLKGNNIWALFLHPDYEKQGIGKKLHDDMLDWYFSMTSQTVWLSTSPDTRAEAFYRK
CGWKETGLFGKGEIKFEMTAEKWKKSKEEPFSSKLIRYLVDIFLNSR
>LONDMIMF_03204 putative N-acetyltransferase YjaB
MPLVNYTLDNVTEPEYGKILSVWESSVKATHDFLKEEDFEFYKNLVPQYFSAVTLIGLKD
ENGQILGFMGTADGNLEMLFVCAEARGQGIGKILLTHALENLSITKVDVNQDNEQAVGFY
EKFGFRTVASSEVDGCGKPYPILHMLLKK
>LONDMIMF_03205 hypothetical protein
MKKIKELINLLLADFDIENENEIWENLQLAIDNPEQYLTENEAEWLLEADPDGVIQFAVS
NEIGEFMIVGDKIDEIHELIVDELDGALPSYPYEKKLNAADYIEWVSSELQKEFPELELI
EIGDSYADTIQLMLVYGEDVPRIKELCEELNIRCKKADEILKL
>LONDMIMF_03206 hypothetical protein
MLRINFLSSLTLILCTYITVVPCFTGNKSPFTPKQNPTLIRKTDVKTKTEILLENFAKVD
DSIIIQPKEIDNPESDSKKTVYTSIFADNGAAL
>LONDMIMF_03207 hypothetical protein
MKTTDQSHIHLFEFTTPNSLQKSLNYILFNYLNQKNLILPDNFQTIIEDFYFLLTYLQEI
EENSSK
>LONDMIMF_03208 hypothetical protein
MKLKKPIIIAIITINILAFLNIFYVFYYKKASFDTSVKAEVPTEKITKVYSDVGTWYLNN
QTFDFYKKHSIKLNKNEISEFCNIINASHAKYIDNVRPDYWIDINIETIDKKDILITLNQ
NKSDGFFFTIDYDDNFEGKDLADFIVKHIHSNQ
>LONDMIMF_03209 hypothetical protein
MEHCNFKVSFIIIAKHLSFAVLLCFILSGCTSNNSEPTALYNEKANEIIAHIIKKGECDC
LLQIPKESLIEIANIERSPYDIRDIAIKKLNLLNNAELDTVINWSRKFELDSLALKKEGI
KIITLQRVMEEKAKKDGKLFKLCPQGILAIKKPIFNRQFKKAIVDFSWVFTCVRTEPNIF
EFKDNDWVIVAN
>LONDMIMF_03210 hypothetical protein
MKSILIMGIFASILSLLGLGKKESNSQNYIQTPTQIKISQLAEVLQLLQDGKTEYDLFGI
TSNGIDCIYFVREGKNFQVEFEAMTKDQIPFIEKLKTFATQNGFGIEMISYGNKPHYGAN
PAPVIRIITHSNLKRTTEIGQKIQKEVFNNNAETVYDVVP
>LONDMIMF_03211 hypothetical protein
MKVLFSLLSILTVSIALSQNSENKLINLSDIKFCDLKVSDLKKQDPNLQEIAILEMSLCP
DGFVTDSRFENRKGYVSKLYPGVIFQKYNNRDLISKVRLTKEFKGNLPDGTYINLAKLSA
KNVLDKYPTFNSWTSRDCSDFLALTNNETYFYVKIDKAKKPRYPINEKYYLTKPIEGIDI
IMNCYKTP
>LONDMIMF_03212 Glutaredoxin arsenate reductase
MTKKILVLCTGNSCRSQMAEGYLRYFAGNKAEIYSAGIETHGVNPNAIAIMKEDGIDISA
HTSNHIDEYSHINFDFIITVCDNANESCPIFLSKAKKFHHNFPDPAKAVGTDHEIKAQFR
TVRQSIKEYSRNFVAENL
>LONDMIMF_03213 hypothetical protein
MKLSEVKQILPTLENVEFQLEDGTFVPEHFHVTEVGMITKNFIDCGGTIRTEKVVNFQLW
NADDYEHRLKPGKLLTIIKLSEEKLGIGDFEIEVEYQSTTIGKYDLEFNQKTFVLKNKTT
ACLAQDACGIPSEKQTLNLSDLRANSSGCSPNSGCC
>LONDMIMF_03214 HTH-type transcriptional repressor CzrA
MGATKTEHFTDKQNQIATIAKALGHPARIAIIEYLAKVNECICGDIVNELPLAQPTVSQH
LKELKNAGIIKGSIEGNTICYCIDEKTIEILNTYFSQIVQTVTKSKCC
>LONDMIMF_03215 putative chromate transport protein
MKKEHRLKELTQVFLKLGFTAFGGPAAHIAMMQQEVVTKRRWMSEQHFLDLIGATNLIPG
PNSTEMAIHIGQDRAGWKGLLIAGLCFILPAVSITLFFAWLYQQYGQLPEVQPFIYGIKP
AIIAVILAAIYPLAKKSLKNLQLWAIGFSVLLLSLYGINEVFLLFGAGILAMAIHFINQQ
RTAGLFIPITLLQISDSEVVSAKNLNLFLIFLKIGAILYGSGYVLFAFLDAELVATGLLS
RQQLIDAIAVGQFTPGPVFSSVTFIGYQINGLSGALISTLAIFMPSFIFVALLHPLMKKM
RSSKLLSVFLDAVNVASVAIIITVCYEMAKDSIADWRTVVIGIISSLIVFKFRKINSAFV
VIGGGILGYLLYIV
>LONDMIMF_03216 hypothetical protein
MANETLIREFMQRIWNEKKLEDIPKYLAPEYTIHLDNADPWEGKTLNHDEFATRLHHTFG
PFPDIHFDIRTAISDGNIVAITWIMTGTNTGQIGEWPATNRKIEAQGMTFYHILDGKIAG
HTQAYDRTSIMKQLGFI
>LONDMIMF_03217 hypothetical protein
MKTKITAFATLFLFVLLMGCSGGDDGGSNCGKVESVTFSTTPVAVTLYFTGGTNANSFKV
EYGPTGFRQGTGTSVVTSNTQIEVNGLVPSTTYDFYITGICSDTENSTPYKLSSVTTQAS
QCTGTTSVQFGQLYPNEIDLQFTYSGGYAEYHEVEYGPVGFTLGTGTKATTSFGTSSKTL
TGIQASTTYDFYVRSYCASGEKTPFVKFSYTTMNGCPKPTNLSSWIVSGSCNSGTATRAF
SWSYLAGTPQSYTISIVQGATDNPAEGNTFVTSTTGISISNMFCNWRAFYVRANCTGNDS
SEWAGPYYF
>LONDMIMF_03218 hypothetical protein
MENNCLNCSRPITENFCSNCGQKKYKRIDRKYLIDEVQYLAVHTNKGFFYSLKNVARNPG
KTAKKFIDGDRVNHYKPILLAFVLSGISAFLSFKVIKTDAIMEKYMQQIYGEQKLPMLGM
HDAMSILSSYSSIIMLLLIPLASIVTALVFKKWGENYYEHVIMNTYTLVYYTILSIVVFF
PILYLLKDMPTMFVTFTSLSTFLAYPFIMVWFYKEYYTQKSIGDIILKVLLALGIGIVIY
MMIIFGMAIWMVMNNPEMFIPKK
>LONDMIMF_03219 hypothetical protein
MKTNKLSELPLEELHKQKNTLKSVLIAFSIVMLIACAGLLFVAIKSKNFALIAIIPGCML
TMLPNYIRFGQLNTEIKSRNSK
>LONDMIMF_03220 hypothetical protein
MKNLITKKSLLLFVSGIALVLTTLFASNKVNKISDTKYLTPAQYEQKYGK
>LONDMIMF_03221 hypothetical protein
MIGGLVSISLSCEQDSTNNQENSVNFKKLSEDDNYLKFKNDNRIIEFGNKIEDFIVKYKE
LRVDDRPVALANSLVKDFGKDNTLLYLDQIIIEYPEASIVIPNGTHDGDKCTRNLDGTTY
WDKCTR
>LONDMIMF_03222 hypothetical protein
MKKNKYLPLFIFFLSLGKSFGQSFNQPQIDSLLLVAEQLEIKDAAYGVTLSLKAYDDSKK
IGYKKGMAQGLLIASRKQHELAKYEDVLKNATAAEKLAVEISDAKLISDALRLKGIGFTG
TGDYGKGLAQFRKALHFAQNLTDKEVKSSRLGVLYNDIAFNLDENGGETDSVAFYYRKGY
QEFQKMVLNNPLRNKTLSLACSNVGSSFLRAKQLDSAEFYLDRALQLANSVNHEAVKANT
LCDLGSLNYSRKKYKQSIDYFEKGIGVAKAINDVYALKSLYLGISKSYEAVRDTKKAENY
LLLYNELNDSVKKNQKEDVQMQTASMEDGNIIADVDGNSKRTLIFSAIFVLLLIMILIHI
YRKFQKEKANNARLQAEVEDSITMFTLLQKDEAHLKKIRHLASSNDPSFLMLFKETYPDF
YKKLNKINPGLIAGEQKLCAFLKLDLSTKEIAQFTNSSIRAVEAKKYRLRKKLSIPSEED
INVWMMNL
>LONDMIMF_03223 hypothetical protein
MPDLSPIKPESHYRWEDQLALGLWAAVAAVHYLQNNLQLKTKQPQDLSLGLGQSS
>LONDMIMF_03224 Riboflavin synthase
MFTGIIETLGTIKDLRKEGENIHITLSSSVTHELKIDQSVSHNGVCLTVVGISNDQYTVT
AIKESIDKTNIGEWKIGDQVNLERAMRLGDRLDGHIVQGHVDQTGTCISIEEADGSWYYT
FEYDPKLSNITIEKGSITVNGVSLTVVNSQKNAFSVAIIPYTYEHTNFKNFEVGTKINLE
FDVIGKYVSRLHQLA
>LONDMIMF_03225 4-hydroxythreonine-4-phosphate dehydrogenase
MKKAENIIVGISVGDLNGIGSEIILKTFEDTRMLELCTPVIFANVKIMSFAKKNLDATIA
LHGIDKIEQLLPGKINVLNVWKESVTIEYGVNDENVGKYAIKSFVAATNALKDGQIDVLV
TAPINKYNIQSEEFKFPGHTDYLNQELEGDALMLMVQDDLRVGLITDHVPVNEVASHLTE
ALIKSKIETIKKSLIQDFSISKPKIAVLGLNPHAGDGGVIGKEDDEILRPAIKKLFESGT
LAFGPYAADGFFGSGQYEKFDAVIATYHDQGLIPFKTLSFGKGVNYTAGLNKIRTSPDHG
TAYDIAGKGIADYNSFKEAVYLAIDIFHSRNEYAAMTEKPLKIKEKHL
>LONDMIMF_03226 hypothetical protein
MHSRSLGQIVVKMRVSNEFLIPFIGLKLGKHQFEYQINKKFFEDFGYDEFESCDIKVNVV
LEKKSTMLELHFKHKGTIHVPCDLTNEMFDLPVKGKINLIVQFGEAFNNDNEELLILPHG
EHQVDISQYIYEMIALSIPLKRIHPGVKDGTLKTDILDKLDELKVNAKEQKADAKQEDTD
PRWDQLKKLLTDK
>LONDMIMF_03227 50S ribosomal protein L32
MAHPKRKTSKTRRDKRRTHYKASVPQIATCPVTGEAHLYHRAYWHEGKMYYRGQVVIDKQ
EAVA
>LONDMIMF_03228 3-oxoacyl-[acyl-carrier-protein] synthase 3
MNTITAAITAVGAYVPDFVLSNKVLETLVDTNDEWITSRTGIKERRILKDDTKGTSYLAI
KAAEDLIAKNNINPAEIDLVLLGTTTPDMPVAATAVYVASQIGAVNAFAYDLQAACSSFL
YGMSTAAAYIESGRYKKVLLIGADKMSSIIDYTDRATCIIFGDGAGAVLFEPNYEGLGFQ
DQYLRSDGIGREFLKIEAGGSLLPASKETVENRQHYVFQDGKTVFKYAVSGMADVSEKIM
ERNNLTKDDVDWLVAHQANKRIIDATAHRMGLDESKVLVNIQKYGNTTSGTLPLLLNDFE
KQFKKGDNLIFAAFGGGFTWGSIYMKWAYDKQ
>LONDMIMF_03229 Biotin carboxyl carrier protein of acetyl-CoA carboxylase
MDIREIQNLIKFVAKSGATEVKLEMDDFKITIKTTEGGSSETTTYIQQAPISHALPQAAM
PQPVAPAAPSAPAAPSSDEDTSKYVTVKSPIIGTLYRKPSPDKAPFVEVGSTISKGDVVC
VIEAMKLFNEIESEVSGKIVKVLVDDASPVEFDQPLFLVDPS
>LONDMIMF_03230 Biotin carboxylase
MFKKILIANRGEIALRVIRTCREMGIKTVAVYSTADAESLHVRFADEAVCIGPPPSNLSY
LKMSNIIAAAEITNADAIHPGYGFLSENAKFSKICQEHGIKFIGASPEMIEKMGDKATAK
ATMKAAGVPTIPGSDGLLESYEQTKKLAKEFGYPVMLKATAGGGGKGMRAVWKEEDLLKA
WEGARQEAAASFGNDGMYMEKLIEEPRHIEIQVVGDAYGKACHLSERDCSVQRRHQKLTE
ETPSPFMTDELRQKMGEAAVKAAEYIKYEGAGTVEFLVDKHRNFYFMEMNTRIQVEHPIT
EQVIDYDLIREQILVAAGVPISGKNYLPQLHAIECRINAEDPYNDFRPSPGKITTLHTPG
GHGVRLDTHVYSGYTIPPNYDSMIAKLITTAQTREEAISKMKRALDEFVIEGIKTTIPFH
RQLMDDPAYVEGNYTTKFMETFKMEEPK
>LONDMIMF_03231 Lipopolysaccharide assembly protein B
MFTQWAFAQKNATREEKLYAALDQFIANPTVTGIKNLEITERQFWDDPKPKSKNEILALV
ILDCNKGFYEKQFGLYFDAIRSYEKALSLFQSHQLTNYDIVEYCLKPLGNLYTLTGDYTS
AENTIKQYLFLAIKNNNTEQKTSAVINLAAVYKSIGKSEEAIDLLESQPVDKLSPEKKSL
LLSLLGENYLLLGEYENSKKALEKAESILPDFVVYKNLALVYRKQRNYPKAEEYIKKAKS
SLIGTSRRDISQVYLEEAKLFLDQKKIMASQNAVRAIFKELIPGYNPKNILPKEKNLYPE
TLLIDALEILAQTYTEQKNYFKAIDCYQLTFTIDSRFSTVFFYEETSLLHTSNIRNRVEK
AIGIYEQLFHKTNDRQYLEQAFKLQETTKSKALKNYIALTKKSGSKKQKEILYKIHELSA
IITKEQEKGENANLEVINNTLSFQNEKIAELKKTFGKNGMELTSEFDMDRLYVKLKNDDI
TLTSYFYGKDTIYIFDIASNGIRLKSFPNSPKNKKTITDYLDYFTEASAISDHVSGYQKQ
SFALYKLLALEKIKTGKHLIIPDGLLCFVSFESLLTKASQSTDFSKLPYLMKDEIISYET
SADFYLNHENHHIKEASVLGVFPVFENSSRSLVFSLEEMKAIKELFPGAYLEKSEATYAH
FIKESKKHPILHLSTHASSGTVDVPATISFYNQDIVYSDLYSLDIHPDLVVLSACETGIG
KLYRGEGAISIARGFQNAGAENLLFSLWKVNDFTTSLLMKNFYTHYKKGNSYPIANHKAK
MKFLNDKAIPNGKKSPYYWSAFVFYGEVSEDTSCNYWYLFGGALIILSCLIVLQRQKKS
>LONDMIMF_03232 hypothetical protein
MSYQNLKDYSTNGKLYLFYNDKQFKDDNFGIPEARAYENEKEKLEENYAFVDDYDKHETY
LASNANAFFRNPKNIEDLENLEETLEQSKALYRNSKVFEFDSLAPKQTRNLFFTFRTTPE
MIKDTSATLTIRGVFVPDRNYKNHKVKNLEMEIVTSHDPNKMSSNGFFMNYRLVRFKTLN
FKTRFQNDGEGPARKIKLETDVPDIFDKSTLKIVDMYPKCEICPKNEEVNYSCLDTIVLK
NQIHFTFKNIYLPGSNQKNVMEKDSTKGFVKYSLKFGKDFHKVKTKSRTAIIFDKNEPII
TNYAVTRFSPGISIGVRTGYNYFPDQENPKSYFLGATISPYKSYRWYLQAELYYNYMESS
SSSASDPVLTQISPPLVLSNGTVLDVAYVQKENSQKTVRNLAEVVPVSLRYNLNNYIGFG
LGPQFSVALDETMENNSITRYFQPLFNNPDGPRRGEEVARDTKTEKTKTKAFEKMQSNVF
ADVTFGFSRIGPSLGARYVWSFENDFSHWQFYAIWKF
>LONDMIMF_03233 hypothetical protein
MVLLLPLQSTAVDAVNVGTVGFVQLMHVTEGVGKLEGCIGIAVVVELSCIQLIGLLIAAR
SAIEVPVKVPLYFEFNCSGPGAGNNEIQFTPFSKPVGMAESEVAQLVLVDGGFQVVTGSY
FVEL
>LONDMIMF_03234 hypothetical protein
MGESLPPFILLFMKIGILLPQSKQYPSLDRDFMRGMKLNDLDVKFFIESIGIGADEKIII
EKMQKLSLQEDISIFIGFLGHRNIQSVYDYASNHNLFLLATDMGSTLPYALPKKQGVYIN
SFGIAESSYHLGAYFASQNYKNIATSSSYYDSGYGINQAIEMALYQNDSQFSGHYITPLN
PRENEADCMQETLAPLKPDAIFAFHSGIYAEEHASYLTKNKLTQDYPFYFTSFSISDKIK
EENREALQNTMIVSSWSDSLRSKKNLSFVEKHKAIFHQAPNIFGLLGYETGMILENLLKD
NDSIPSLEQLIDKMEEALEGPRGKIQFHPETNRTSFDNYIFKITDDGIQIETVLKNDGQF
IQNIMSDQRPQSMGGWHNAYLCH
>LONDMIMF_03235 hypothetical protein
MYEPFLGQIQTFGFNFPPRGWTFCDGQIMSIAQNTALFSLLGTTYGGNGQTTFGLPDLRG
RSVVHPGNGPGLTPVVWGEVGGIQNVTLTTSNMPMHAHPLVDGQAHVATTILATNNNNGS
NTTDGGSNGFGDSGNMPEIYRESPTGTNVVGGVKSVISGTTGIAGGSIPFGIRNPYLGIY
TSIALEGIFPSRN
>LONDMIMF_03236 hypothetical protein
MHTTTIQKVDCLFQAKNSSVTLTFRKEKLSHNARTFFYGILLLILHLPIRINKFDNSTIN
LNL
>LONDMIMF_03237 hypothetical protein
MSDVRYIKEPFLARIISVVFIFASIILLSEEQKGFGIVTLIMALACLSATLSVRESKSTQ
NKNTIVSYIPFWVLYLANGNLFQKRNTFLSINHGKH
>LONDMIMF_03238 hypothetical protein
MDGKILKKKLQSLDIQMTEVAKRLNISPQNLQNRFKSKEITLDFLIEVSKAVNASVYYFI
KGTAYENEFLQPDNVILKEPDGEFIPNVVDAKNQTIEILQREVQDLRSDKDFLKKIIDSN
LVKRNPEEGTEQI
>LONDMIMF_03239 Polyphosphate kinase
MILETKTKEVSLKPDFFDRDISWLSFNQRVLLEAEGNDVPLFEKIKFLSIYSSNLDEFYR
VRIPSLMALKKISKNQKENSFAYQHILDKIQHIVDDQQRVFGTIMTQKILPALEKEKYHL
LYNEPIPENIHNEITHYFFKEVLAFLQIVEITKETDFFPENNKLYKLVVVEENTDTHQLF
LLNIPSDDLPRFFAVKKGAKTYILFLDDIIKFGLKFIFKDQKLPADYNFKITRDAALELD
DEYDEAIAEKMEKKIAKRDYSFATRFLFDYRMPPPFLQSLIDTFKLKDATIVLGGSYHNL
KDLASLPLKKQSLSYTEMVPVSLDAPVAKSIFDTVAEKDLMLHVPYQSYDSVLRFFNEAS
IHPNAEEIYVTLYRVASDSRIANALISAARNGKKVTVVVELKARFDEANNIKWSKQLKKA
GVKIVHSIPSLKVHAKIALVKFKKQSKLPSIGLLATGNLNENTARFYTDHILMTAHKEML
KDLEKTFLLLATIKKNPKRYKMDFKHLLVAKFNLREKFIKLIDNEIQNKRKGLAAGITIK
LNNLEEKSLIEKLYEASNAGVKIQLIVRGICCLVPGIPGRNENITVRRIVDRYLEHGRIF
VFENNGNPLLFMGSADWMNRNIYHRIEVCFPVYEPILKEEMLDILKIQLEDNVKASLLGA
SLENIPLRNEKEPTRSQEKIHEYLKRKS
>LONDMIMF_03240 C4-dicarboxylate transport protein
MGESIAKNNGLLFKIVTNLTFWVLIAIISGVLVGHYLPETGTKMKVIGDTFIQIVKLFIA
PIIFLTIVLGISGMGDLRKVGRIGIKALIYFEIVTTFALAIGIIAAYIIQPGKIDKSGLD
IQDASKYTSNPRTEFDWWQFFMDNFTLQVLVVAIVCGILLNYYSKRESVVATLYKASKIV
FKALKFVMFLAPLGAFGGMAYTVGKFGLHTLIPLGKLMFTVYLTMAVFIFLILGGIMRYY
KMRIWDLIKYLKAELLIVLGTSSSEPALPNLMDKLERLGCSKSVVGLVVPTGYSFNLDGT
SIYLSMCVIFLAQLYNVHLSFGEILTIIGLLMITSKGAAGVTGSGFIVLASTLTAIHKIP
LEGLAFLLGVDKFMSEARAITNFIGNGVATIVISKNENEFVDIENPMELN
>LONDMIMF_03241 hypothetical protein
MSSDFIRKLENSTAHRQSRESISDSISANPELLPVLMGVLLDTKNKNHYKACWTSELVFE
KHIEWLIPYLDVFSKTLSCYSHDGALRSVSKICLFSATYHLKKKKSGAIFLTDEQLELMV
ESCFDWLISNQKVATKAYAMRALYAFGKINDWIYPELKTILTQDYPNHSAAYKLASKEIL
KKLK
>LONDMIMF_03242 hypothetical protein
MNPICKNCEHEVNGNFCSECGQSTHTHPINFHYLWHDIQHGIFHFDKGLLFTAKELFTRP
GHSIREFIQGKRVSHFKPTSLVFLLGSFYGLLYHFFHIEIPANVTSEDTGQTFNVMGDWI
TAHYALATLFTIPLLSIASFLAFRKTGYNLVEHLVLNGFIAGQKLMLQFIFFPLLYIYSG
TQTILLLSVISVFIDILLAFWTYNQFFDTQSTIKNILKTILTYIYLFIMFTVLTIAIGLV
LELVIKKA
>LONDMIMF_03243 Aldose sugar dehydrogenase YliI
MKTRILPLLSCIAFSFLSCNGQEKKPPVKNSTTIIKTAVGDLELPAPYATESARKISRMK
EWPEGVTPKAPEGFVVTKFADGLKNPRWTYIAPNNDIFVVESNTFKSANQITIFRDKDGD
GVFETREIFKDGLNMPFGMLILDNYFYIANTDGLFRFPYSAGDLKLRGNGTKILELPAGG
YNNHWTRNLLANADGSKIYVSVGSASNNAEHGMEVEKRRANILEINPDGTGEQIYASGLR
NPVGMDWNPANNELWTAVNERDDLGDELVPDYITSVKRGGFYGWPYSYYGQIADPRMKGE
GKELVAKAIIPDVSVGAHTASLGFAFYNQDVFPAKYRNGAFVGQHGSWNRSKLSGYKVLF
VPFKNGKPSGKPEDFLTGFIANEEKAEVYGRPVAVTVMKDGSLLVNDDSGNTIWRVAVKK
>LONDMIMF_03244 Chitinase A1
MKQILLSVALLAFTGFSFAQNGKSPWKKTDLKSSVTIFENRTPLPTKNLFELDITSLKNE
LSKAPLRNKSKSDVIVSIPNAEGISEQYRIFDVQTMEAELAARYPEIKSYIGIGITDPTA
TIYFSVSPLGFQGMKLAADKPAEFIEPFSKDLKTYAVFKRADKRMGFTKFECQVIDHAKN
EMDSNLAQRPNADDSTLRTYRLAMSVTGEYTAYHGGTKALALAAINNTMTRVNGVFEKDF
GVRMVLISNTDAVIYTNASTDPYGSTDANYNSQLQSTLTSVIGNANYDIGHLMSAIGNNG
NAGCIGCVCASGKGSGFTTSTVPVGDNFDIDFVAHEMGHQFGANHTFTFSNEGTGVQNEP
GSGTTIMGYAGITGATDVQPHSDPFFHAVSIQQVTNYVKTTTCQTNTATGNAVPTANAGA
DYTIPKGTPFLLTGSGTDANGDTLTYCWEQMNSGTSSTTYPSATATSGPAFRSFVPSTSG
IRYFPRLETIKTGATTWKWEAVPNVARTLNFRLTVRDNKAGGPANNSDDTVITVNGTAGP
FVVTAPNTAVSWTAGTSQTVTWNVAGTTANGVNAANVDILLSTDGGDTYPITLLAGTPND
GSQAITVPNNPGTQNRIMVKGSNHIFFDISNTNFTITAGSGDTTAPTAPTSLAASGTTQT
ATNLSWTASTDNIAVTGYEVYQNGVLKTTVTTTTYPVTGLTPSTAYSFYVKAKDAAGNLS
ASSNTVNITTLAGTASYCASKGNSVADEYIGRVQLGTINNTSTGGTGYTDFTSISTNLNK
GTAYTITVTPTWTGTSYSEGIAAWIDYNGDGDFDDAGELVWSRAASTATPASGSFTVPTT
AATGATRMRVSLKYNAIPTACETFSYGEVEDYTVNIQAGTADTTPPTAPTSLTATGTTQT
TTNLSWTASTDNVAVAGYEVYQDGVLKTTVTTTSYAVTGLTAATAYTFSVKAKDAAGNLS
ASSNNANVTTLSNSVSYCASQGNSVADEKIGRVQFGTIDNTSTGGTGYTNFTSISTNATR
GATYTITITPSWTSTVYSEGYAVWIDYNGDGDFTDSGEQVWTKAASTTTPVSGSFTIPAG
ATLGATRMRVSMKYDGIPTACEAFSYGQVEDYTVNIVATARGENNIQNEIKLYPNPASSV
INLTSVSEKASFRILNMLGQEVLKGKIQDGTISVASLNDGNYIVEINDNEIVSVKRFIKK
>LONDMIMF_03245 Dipeptidyl-peptidase 5
MKKILFLTISMIGLTATAQNVMTPELLWQLGRVSPLGISKDGKNIIYKVSIPSVEENKSN
SKFYSIPISGGNPTEVADYTTLVQDKNISPDGKLLLASKEVKIGKVLGKDYYPNLEKSDA
QVYDGLNYRHWDTWNDGTHNHVVFSNVNDKENFTDIMKDEPYDSPQKPFGGDEDYIWSRD
GKSIVYVSKKLEGTAYALSTNTDLYQYDLATKTTKNLTEKNLGYDTAPQFSPNGDLTWLQ
MKRDGYEADKNDIIVRFKGMDINLTSGWDGTVESFTWSADGKKVYFLAPINGTKQLFEVN
FPGLTRIAITVRQLTDGDFDVTDIVGFSGDKAIVARTDFNHAAEIYSYDLKKKTWAQITK
VNDAAYSKIALSKFERRYVTTTDGKKMLVWVILPPNFDKNKKYPTLLYCQGGPQSALTQF
YSFRWNFQVMAAQGYIVVAPNRRGMQGHGVEWNEQISKDWGGQVMDDYLSAIDDVAKENY
VDKTRLGAIGASYGGYSVFYLAGIHQKRFKTFIAHCGVFNLQSMYGTTEEVFFTNWDSGG
PYWEAGNAAAQKTYSQFNPINNVSKWDTPILIFQGGKDYRVPIGQGQEAFQAAQLQGIKS
RFVLFPDENHWVLKPQNAQVWQKEFFRWLKETL
>LONDMIMF_03246 hypothetical protein
MKQNYHQKLFFAPIKRQSFLTVVLFVLAFGANAQISTFPWMETFEDNSPSRGAWTQIYEV
NNMSWTFATSPSTGGGGVTAYEGVKFANYPGTSHDFDKTKLVSPVLDLSAVSNPSVSFYF
RNPFWNPDQNWLRIFYRTSESAAWVQIAEFHSDVRTWTSSGDIALPSPSATYQIAVEVET
DYGYSTTVDALEVKGNALGLHEFSKSLVKYYPNPTGGLLNLSSGETISDVTVFNLLGQKV
LESTINSNQGQLDISSLTSGNYVIHANTEKGKEIFKIVKK
>LONDMIMF_03247 hypothetical protein
MNEEAYIRFENYLNNEMSEEERLDFESELRDNSQFKESFELYKETTAFVKQKFSPETMAF
KKNLESISDGYFAEGKKKAKVISIKPWHYAAAASVLLLLGTWIFNKDSMPEYSDYSQHEN
AAFVERSTNDENLKNAQDFFNQKKYAEAVASFEEIRNADNPEYQYFYAIALIETNHFKKA
EMLLESIRNGNSVYKNKATWYLALSELKQLDYEQCKELLRQIPEDAEDYENAQKLLQQLE
>LONDMIMF_03248 hypothetical protein
MTEKSIHSDQFYIEGLLQNDSAVIKSIYKNFVPKVKNYIRTNSGDDDNAADVVQEVIVTI
YHQAKTKGLQLTCPFEAYFFLLCKRKWLNELKKPSNKGVTINDNIVSTDESAYELVLQSE
SFDERQSLFDEMFRKLGEKCQEVLKLSFVLKTMEEVARQLNVTYGYVRKKKSLCTGQLTE
MIQQSNRYKSLKK
>LONDMIMF_03249 hypothetical protein
MKKSILTLVMIALSISANATEKRTAVNNENTTEITADKIIIVYDWSVKTDQGSYSGTARS
LEKAESRIAMAAAGEIILDKKIESYYQLADEASNPMLRLYFWEVETVNGTAKGFSGSENH
ALKMIQLISTNDILTYKIIRSAEFER
>LONDMIMF_03250 hypothetical protein
MKSFFKKIGILSIASFSLLSCDMNDDNNQNLNPFPTSNELNALFSEAINSRKQVFTIDAS
TTNYITTTQGAIIQFNAGAITLNSTPVAGPVTVEVIEIYQRGDMLVTNKPTVAKLPGNNF
EILTSGGEIYVNAKQNGQQLATSGYVIQIPAALTGGLDTDMDVFTGEFLPDGNLVWVQQN
QWDLGFGNSAAPAYTTFSANFGWTNVDKFYTHPNPKTTINVIPPAGYTNANSEVFLSLDG
DDNSLVNLFGDPLTQTFTFNSYPAFPIGLECHIIFISEENGMWKYGIKPVTIQENGTYTF
SAGELNTASEANLVQIINNLP
>LONDMIMF_03251 hypothetical protein
MKTSFTKIGLVFLGLFATISCNNDDNQNQPVPAGCNTANSEFSQLYATTLASDPSFTDVT
TMDLQTHEYTFVLSSNKTVCSIGYQGNANLYTANIPYLIEIVDNSTNTVIYSGNHVFDSA
LTDYVSITPTALTAGTSYTLKRTVTNYLGNIGNTVGRLLRFNGPSPYPVSNTLMTITASD
FYGTGGPVPDFGIPYIDIVFQ
>LONDMIMF_03252 hypothetical protein
MKTSFKKIGQFLLLGILVAGCSKNDDGDSPDYVPSASAFAALRQDALGVQTFTFNAEDGV
TTFTSAKGVQFTINGNCLTQNGNPVSGEVVVKYSEVFDPGTMLATDKTTMGRMSNGDMAL
LISGGEFFINATKNGQQLQISCPMQVIIPTNLTGGPDSGMSLWDGTFDEDGNLEWDQQDR
GANGQNGVFVEGANYYAYFSSFGWTNVDRFYNDPRPKTTILAEAPEGYNFENSAIYLHYD
GEGSSLAKLDTYNPVTNQFSEHYGQIPIGLQCHIIFVTEDNGQWRYAIKPATIAANDVHV
FTLAQTTLGTEAQLIAAINALP
>LONDMIMF_03253 hypothetical protein
MASTIITAPSTINPKSIAPKLIKLALTPNTFIKAKANSIAKGIADATINPALKFPKKRTK
TKMTINAPSIKFFSTVLIARPTNSVRSK
>LONDMIMF_03254 hypothetical protein
MTELEKILQQKAIKPTAMRLLVVEKLLKQQYAVSHKELAEQFEKADNITLFRTLKVFLEY
KLVHTIDDGSGVIKYALCQSGCNCNLSELHTHFYCTDCKHTFCLTETEIPNIEVPQNFKL
DGANLVLKGKCDKCNK
>LONDMIMF_03255 hypothetical protein
MLSTEKTLSEVIEVLRQRGYTEDFNLLEENISYKIDGEKVNLRDIVIDKIYRFTGLNDLE
DEAILYAMRNQKDGAKGVFVNGYGTYSDSAANSIIEQISVDEDDNDDWTIEN
>LONDMIMF_03256 Mercuric transport protein periplasmic component
MVTDGKLIGTGLLTAIAASLCCITPVLALIAGTSGLASTFSWLEPFRPYFIGLTILVLAF
AWYQKLKPQKKIDCNCETTEKSNFMKTKSFLGIITVMAALLLSFPLYAHIFFPKTESKAI
ITQTSKIQKVEFTIKGMTCSGCEHHVKTEVSKLKGIVEVVVSYEKGNAIVKFDNKQTSII
EIEKAINSTGYKSLKSKIIS
>LONDMIMF_03257 Cadmium resistance transcriptional regulatory protein CadC
MDNTSCTRQQADIKQINRCKERVSELHSSFDYLSNALELTGNNVRLKILFLLYEEKRLCV
CDVSEILGMTISAISQHLRKLKDRKLIETEREAQTIFYSLTKEYEKMLDPFFKILDDKKN
LETIW
>LONDMIMF_03258 hypothetical protein
MQGEDDLRGLAKIMAFMRAVSILLVLMHLYWFCYGFFLERGWTLEVINKILGNFDRTAGL
FSHTLYTKVFALVLLALSCLGTKGVKNEKITWTKIYVALGVGFVLFFLNTPLLKLSPATG
TFLYMLTISLGYIALLMAGVWMSRLLRTNLMDDVFNNENESFQQETKLMENEYSVNLPTK
FYYKGKWNNGWINIVNPFRASIVLGTPGSGKSYAIVNNYIKQQIEKGFSMYIYDFKFDDL
STIAYNHLLKHRDKYKVQPKFYVINFDDPRKSHRCNPLNPDFMTDISDAYEAAYTIMLNL
NRSWIQKQGDFFVESPIILLAAIIWYLKIYEDGKYCTFPHAIELLNKKYSDVFTILTSYP
DLENYLSPFMDAWQGGAQDQLQGQIASAKIPLSRMISPQLYWVMTGDDFTLDINNPKEPK
ILCVGNNPDRQNIYSAALGLYNSRIVKLINKKGQLKSSVIIDELPTIYFRGLDNLIATAR
SNKVAVCLGFQDFSQLTRDYGDKESKVIQNTVGNIFSGQVVGETAKSLSERFGKVLQKRQ
SMTINRNDKSTSISTQLDSLIPASKISTLTQGMFVGSVSDNFDERIEQKIFHAEIVVDNE
KVAAESKAYQQIPQILSFVNEQGEDKMKQEIENNYKQIKSDILNIVVSEMERIKNDPNLQ
HLVQKE
>LONDMIMF_03259 hypothetical protein
MIAKIGRSANLYGALAYNQLKVENENGQNLFANKMIETASGHYSVAQLAQSFAPYLIANR
NTEKHTLHISLNPDPNDKVSDDKFREMAEQYMREMGYGEQPFVVFKHTDIDRSHIHIVSV
CVDEQGKKISDKFEKMRSMNVCRELERKHGLIPATDKERNQNDKVFRPVDYRAGDVKSQI
ASVVRHLPNYYQYQTLGEYNALLSLFNITAEKIEGELQGEMKQGLIYIPLNEKGERAGHP
FKASLFGKSAGLPALELHFAKCKTALKDSPTKQTLKSAVTIALKTTSDEQAFKKQLAEQG
INVVVRRNDTGRIYGITFIDHNSKAVWNGSRLATELSANTFNDYWNNNIKPNIKEPAVLQ
PKLSTSNDADLPAEEPHHLFDFLHTEKHEDGLIEALGGLLPEAQGEDYEEQDFANKMKKK
RKRQRGQK
>LONDMIMF_03260 hypothetical protein
MNDNNKKQLKKTGRRPKEDPATIRYTISFNEQEHARFLALFDKSGMQVKAHFITSCIFDK
TIKTIQIDKGTVDFYMRLTSLNSQFRSIGVNYNQIVKLLYKNFSEKKAAAFLYKLEKQTA
EMAMLCQKIIQISEEFEAKYLKK
>LONDMIMF_03261 Iron-sulfur cluster carrier protein
MDTKKKPLFVAFSSQKGGVGKSTFTTLVASTMHYRLGYNVAVFDADFPQHSLMKMKTRDL
AMVMENEALKKLAYKQFTTINKKAYPITQHKADSVLDAAHEFVTASAVPIDVVFFDLPGT
VNTPGILKALAGMHHIFTPITADRVVMESTLIFTQLLQDVIMKKGETSIQTINLFWNQVD
GRESTPLYDVYNQLIEQLGLSLMQSQIKNSTRFRKESEADSKTVFRSTVMPPDERLMKAC
QLDLFISEFLNIIQL
>LONDMIMF_03262 hypothetical protein
MEKDNKRKVTPDINEEMMMNLMVDGVKKDGLQLPPEPAEEQVKEAAKDEVQQEELPQSKP
AQRERNRTKKNLDGSYGEHFLKTHSMTKRGDKSIYIRQEYHERLSRIVQVIGKDAIPLYA
YLDNILEHHFELFEKAITDDFNEKFKPIF
>LONDMIMF_03263 hypothetical protein
MEIVIVICLLVVIVLVLQDKIFIHKRSEQKPTQEKVNPNLPDIMGQPKPVKSHSLPNTAN
ESQITEPEINPDNLDIEYDENENVSIQIPQEELDEVFSNMPDLEEEEEEWNRYGISGGDN
GFAQGVTYDELSSVGALLQKENLEQAQKETAVAIVQKLQGTELFSLLENSIEGASRKIAE
LLDSKLSSESDDGSSTLRKSDLDDFDIGEFV
>LONDMIMF_03264 hypothetical protein
MKEVLFPELEETTDFEGYNLQQLRQFFALSFLSFYFIRWIEGYLDSGMGENNLSYGSNPL
SMSADKFKKLMCQITGLNVELVSSIIKDLTFNPSSFHTSVTIQPFIYSQGEYYILPNLFV
QVEPSRMMLGALNKGEKKRVYDKLINSIEKTNLDLIGRKVKQLPNIVCYLEKTLKNNGQR
ICPDIILIDPTRKFLLVADYKHFIGPISGSEVEYKIKELEKAINQVQKYIDNLNQLSKVE
LISIQDFTVSGLIITHKPLPVPIPIKNNIPIVDMETFNQLVEDAIFKKMGIYGVTKSINH
WYHSEPKNVFSEFESEIIVEDWKVKRTQHKFA
>LONDMIMF_03265 Outer membrane porin F
MKKITLVMTAWLSVFFTLSVVAQERKVAKADKLYDDFAYIDAITVYENIVAKGYSSPDLL
KKLANAYYFNAEFQKANKWYTELFALGEEPEPEYFYRYSQTLKSIGDYEKSAQMMDRFSK
KNVIDGRGKLYEEDKDYLSAILDNSGRYSIESAGINSEGQDYGTTFYKGSLIFASSREEK
GAAKRIDRWTELPFTNLYASKVRSDGTLEAPERFANEISSGFHEATPAFTQDGKTIYFTR
NNYNNGKNGRSKDRRIVLKIYKATFEDEKWRNVTELPFNNDEFNTAHPALSPDDKTLYFA
SDRPGSIGQSDIYKVSINADGTFGKPENLGKEINTEGKETFPFLSDENELYFASDGHPGL
GGLDIFRSKMGENGFEKPQNVGTPVNGGQDDFAFMIDTKSQGGFFSSNRNGGMGYDDIYR
LKENRKLENEQFAEGQVRDSINDKGLENVKLGLYDDKFKLLEEAVTDRKGNYIFKTKLQK
GKRYHIRAEKKDYLTDEKNIEADGSNGFVEVDIALQKRITEIREKGNIADAFGIRDIYFD
FDEANIRPDAALDLEKIIDVMRQYPGMTVAIRCHTDSRGTREYNLKLSQRRANAVKQYMI
EHGIDSSRLSAKGYGETLLRNGCSDGVECTEREHEINRRSEFVILKIK
>LONDMIMF_03266 hypothetical protein
MKTSYKLALLALFIGVVGFAQQDSQYTQYMYNTANINPAYAGSRDVLSIFGLYRAQWIGL
KGAPKTGAFALHSPISNSNVGLGLSFVNDKIGPSSENNISVDFSYMIRLSEEFNLAFGLK
TTANLLNVDYTKLDIYDPNDPRFQSNIEDSFTPNIGAGAFLYSKDTYVGLSVPAFLETKH
YQDNGNYSTARQNMHFYLMGGHVFELNPDLKFKPSLLFKIAEGAPLQADFSANFLFNEKI
TAGVAYRWSAAVSAMVGFQLTDGLFAGYAYDAETTRLATYNSGSHEIFLRFELFKKYDKV
MTPRFF
>LONDMIMF_03267 hypothetical protein
MRTTTIGNLFLALLFWGSLRAQMANTGEMSVLPGTTLSTYLDFDNTSTATFTNDGEFHVF
RNFNNDGIIGFTSGQRGYTLFEGNRLQSISGNAPSDYFKFYDVLFNNSSPQPPFKLSGTI
SISGNSDLLNGIVKGEGDGLAVYENKATHSNTDNDSHIDGYVQKNGDEEFWFPIGNGGYH
RPAKIAPTSPNTPTDAFMGKYFLENSNTLYPHASKAGNIEVIDNTEYWTIDKLDGETEIM
LSLTWDELTTPEFIWRGLEGSGVEEEKVTIVRWNEEQNLWVDEGGIVDRGNRGTGTVTSF
FTTSGFGVFTLAKVKRRVEPEGNIVIYNGVTPNGDGKNDYFFIDGITHYPNNRVTIYNRW
GVKVFETTNYDSDGNVFNGISHGRATIQPDSKLPSGTYFYVLTYEFSSPSGNKRNIEKAG
YLYLNDN
>LONDMIMF_03268 1,4-beta-mannosyl-N-acetylglucosamine phosphorylase
MRDIANRFPENPLLSPKDLLASNSQFQVICLLNPGVFIYENKIWLIVRVAENISQKEGSI
FFPVVDESGEIEILEILLDDPHLIANDARVINYKGNDYLTTLSHLRLLCSDDGIRFKEPE
GYPILSGIGYQEKFGVEDCRVSKIDNTYYLTYTAVSNNGVGVGLRTTINWKDFEQKGMIF
PPHNKDCAIFEERINGKYYALHRPSSKEIGGNYIWIAESPDGLHWGNHQCILKTRENHWD
SARVGAGAAPIKTERGWLEIYHGANAENFYCLGAFLMELDNPSKVISRTVEPIMVPTETY
EINGFFGGVVFTNGHIIEGDRLTIYYGAADEFVCGAHFSIREILSLLE
>LONDMIMF_03269 Peptidoglycan-N-acetylglucosamine deacetylase
MTITQKHTFILLFFLLHTGLYAQKEIAITIDDPNTTVTPKLEWQERNNALLKTLKKHHIK
AALFVCGMRVADSNGRDLLKQWDDQGHMICNHSYSHLYFNSKSNSFKKFSADFNKGDSII
KPYRNYTKYFRFPYLKEGNTVEKRDSMRIFMSQTNYKNGAVTIDASDWYIDAEIAKALKE
NPDADLTPYKNYYIQHILDRAAYYDALAVQLFNRPVKHTLLLHHSLLNALFLDDLLTALK
KKGWKLIDAQMAFKDPVFEKTPDIVPCGESIIWQCAKTTATLSQSLRYPGEDAEYEKIPL
EEAVKAYKNSRN
>LONDMIMF_03270 hypothetical protein
MKKLMMLAALVLGTSAMVNAQQKAPAKAEVKVEAKATNKEMKKAEGKTKKAEVAKVKKEE
APKAKA
>LONDMIMF_03271 Sensor histidine kinase ResE
MKLKNKISIFSAVIRLLLLIIMWFTLSFVIKKVAYKNIENSMVEKRDKFVKNLNTSEINA
FIERNDSTELYVSFSNLHSEFLQLYRSNNAVRSKDCFVDETRIVENESNEYRVLYHHFTY
KNTNYVLEIGERLSEVNELLDKFHLVILLLLTATLIVSHFAQSVFIDYLLKPFQKIIDTK
INLINEPELFDHSKVHTTTSDFIVLDDGLNQMMDRIQEQFKKEKQFIANVSHELLTPVSV
LQNRLENLLNNESINDEGVDKIVVSLRNLDTLKRIINNLLLISRIENHQYSNFEPIDFQS
LISELLADLEDRIEMKQLRVSNTVKEHFVFEGNKTLMHILIYNIVFNAIKFTPNGGSVSV
SDSFEEGLYSISISDTGKGMTETQLSQIFNRFMKINLEDEGQGLGLSIVSSIANLHKIAI
KVSSELNVGTTFRLIFQEVKK
>LONDMIMF_03272 Sensory transduction protein regX3
MNVLIVEDTKELAVELIDYLDKSGYVCKWVATCEEALEEVSVNQYDALLLDLGLPDGSGF
DVLKSVRNAKSKMAVIVITARGELDDKINGLDLGADDYLTKPFALTELGARLYAVIRRIH
GFTVNELDIHGFKIRLQDYKVSYQENAVALTKKEFDIFQYLVLNKNRVITRLQLTEHVWG
DVLEVSSDSNFIDVHVRNLRKKLDKHASIEWFETVRNVGYRIIS
>LONDMIMF_03273 hypothetical protein
MKNTFLAALLLITAGFYGQTDKKQPYSPPDEARFAFEKEFPKTNAVWRSEFDGDDGNEEL
YVADFTVQGTRVSAYYNLRGELQVLEHAVKPNKLPQTIQSYLKKNYPTYKIVEAARIRKT
PNYYTYEVGLTSDSKFYDAVFSDAGDFLQMVEKDR
>LONDMIMF_03274 hypothetical protein
MLSLLKTVRKFFGEAIVVTQEVDDIIQSPIVKESIINNSDCKILLDQRKYMNKFDDIQAM
LGLTDKEKGQVLSINMNNDISRLYKEVWIGLGGTHSAVYATEVSLEEYLAYTTEETEKLE
VMQLASELDDNVELAIKHIAMQRRDKVNQ
>LONDMIMF_03275 hypothetical protein
MKKLMYLVCTALMLAVAPSAKAQFVVTDPANLASGILNSANEIVQTSSTVSNVIKNFNEV
KKVYEQGKEYYDKLKAVNNLVKDARKVQQTVLLVGDVSEMYVQNFGKMMNDPNFTPQELV
AIGNGYSALLNESTELLKELKQIVSASSLSLNDKERMEVIDRVYKEVKDYHSLVRYYTNK
NISVSYLRAKKKNDAKRVLDLYGTPNQKYW
>LONDMIMF_03276 hypothetical protein
MEWNNLHEVLRSLYDDMMPLAADMAAVAKGLAGLGALFYVALKVWQALSRAEPIDVFPLL
RPFALGLCIMFFPTIVLGTINAVLSPVVTGTHSILENQVLDLNKLQQQKDQLEYEAMVRN
PETAFMVSDEEFDKKLDELGWSPSDIGTMAGMYMDRQAYQIEKAIKDWFRNLLEVLFQAA
ALVIDTIRTFFLIVLSILGPIAFAISVWDGFQSTLTQWITRYVSVYLWLPVSDLFSSMLA
RIQSLILERDIEMLSDPTFIPDTSNTVYIIFMIIGIVGYFTIPTVTGWIIQAGGAGNFTR
NVNQTAMKAGNLAGAGAGSTVGNISGQLLK
>LONDMIMF_03277 hypothetical protein
MEFKTLRNIENSFRQIRLYAIMFAVLCIGVVGFAVWQSYRFAEEQRQKIYVLDKGKSLML
ALSQDASINRPVEAREHVRRFHELFFTLAPDKNAIESNMKRAFNLADKSAFDYYNDLSEK
GYYNRIISGNVQQRIEVDSVVCNFDRHPYAVQTYAKQFIIRSSNVTRRNLITSCFLVNSV
RSDNNPQGFNIEKFAVIENKDVEVIEK
>LONDMIMF_03278 hypothetical protein
MKKIRANLDRYFDKVDERWQKLPMRKQHQYTLYFFIGYLVLTAFVIGKVWYDTSKSENGM
VIEHIENPVLKKDESPAKLRDTVSTILKNQFYERK
>LONDMIMF_03279 hypothetical protein
MKENDNKKSVVRVTEGNPKDNADLLHEGNQNKMDKLKKPLIFVLMGIVFIGCMYLIFKPS
SDKDEIENLGLNDAVPQATDAGMQSDKQKAYEQEMLEKQEQAKRNALTTLADYWNTDSTQ
SSEESLSQEEESNVLGKDKSANPALNSYQNAQNTLGSFYQNDNSETMQLRRQVDELRDRL
AERDVPRATTVDDQLALMEKSYQMAAKYLPQNTNTGNAAPDNASNQTTSASEKEHFVAFA
PARKNTVSALYREPSDSAFSADWSEIKNRGFFTAGSKEQVVQPKNSIKACVHDAQTVTGE
TGVRLRLLETAQTPQRTIPKGTIVTANAKFQNGRLQLKVTSIELEGNIIPVEITIYDLDG
QQGLNVPNSPERSAITDIVANMGNATGSSFSMNSSTGQQIASDLSKSAVQGISGYFAKKV
RAPKVTLKAGHQVFLVSKK
>LONDMIMF_03280 hypothetical protein
MKKYIKTFWAIALILGLAVHSYAQDSIRTPLELGKIEPYKMEVTYDKTSHLIFPSAIRYV
DLGSEYLIAGKAEDAENVLRVKASVRAFEPETNFSVITNDGRFYSFNVYYSSYPEVLSYD
LLTMQKAVDKANGNDVLFEELGNNSPSLAGLLLETIYNMDKRIVKHIGAKSFGIQFILKG
IYIHNGKYYFHTELRNRTNVPFQIDFVNFKVVDKKIAKRTVVQERPMIPLRTYKPLDEIG
GKAIEQNVFLLDQFTIDDDKILLIEIFEKNGGRHQTLQIENSDLIKARLINDMHLKF
>LONDMIMF_03281 hypothetical protein
MKKYIYTVMLVLVGITVAQAQRMLPKQKGIELNAGILSKDKIGNDYYLNIGMTVNGKNGN
YQLWALEYTHQYHDYKNVRIPQETFTAEGGYSLFLLGDARKNITINLGITGVVGYESINR
GEAILYDGAKILSEDNFIYGAGGRITFETYLSDRFVLVLQGRTKVFWGTDLEQFRPSAGV
GLRFNF
>LONDMIMF_03282 hypothetical protein
MITIFNKFRIGLLPVYLMLAILTASVSLVSCRKDDDLEIQNNFPFEVKVMPVPKDVANGQ
TVEIRVTIQRTGNYSNTQYYLRYFQFDGQGSLRYYDETPYLPNDLYLLPTEQFRLYYTSA
SAVSQSFDVWISDSFGNEKQLTFQFNSSD
>LONDMIMF_03283 hypothetical protein
MDAVTAQLVLGIIPLVIGIGLVYWISRRKFYRRNAVGAEGFSSFEASVFTRFIERIGKWL
AYALIIIGILSIWSHWQMKKEKKQTEVKTEQPVER
>LONDMIMF_03284 hypothetical protein
MNRKLTTNSRLVNELFANYISTFAAFCELLNNSIQAKSKNIWIEIDYTLETEIHPLLIKK
ISVKDDGNGVHMSDIERKLLDIGTANKDGGKGIGRFASFQIGQEIEIETIGYSQEDKTFT
ETYIPLSFNSFGKNINVSEIELATKENILEGNNHNTFYKVTISSLYPHSTTENEPKKKII
DKFLKDNLSDAIFERYPLKIFNKEVTFHINGKALNPTDFVIDNPIKIAKTYTDTKGKEHK
VLFDFMQIKKMDKIKVFLTAQNAGLNTIAGSLEYDASWLSPKIGGWFIYVSSSTLSSDIY
RNIDLDDLDPDWRKVREFIKDKLNTFFKDRNFEFDNFSDNLKNDDFYPYKERASSKSKVI
LFDKLAYLVEDKYHILKDNNQLREIIYPLIDRTISNGELNNILRSVLKLNNKMISKFSDL
LEKTDLDNIVEFSDKVASKIEDIEFLEKLVYSEISKNVKERKELHKFLEKMLWVFGEEYS
ESTKLLSDKNLEKNLTQLRQDCLMFKPSKDGDNINVIDEKPVKSITDLFMYNERVLDAKR
REVLVVELKAPKVKISPKEIEQVMKYAREIEKLDASSSNIHYKILLISSKINSDAEFQIK
GNQRNEDNPYFYFRNENKNIEIWIMKWSDLLENVKRKLKYMSAILNTKDIDVQEKAEKDF
ADIEFNKVSSSLKRVAM
>LONDMIMF_03285 hypothetical protein
MEVIAIQKSALDRINNELKSLLELTENATTKYIQIFKAEKWLDNQEVCLMMNITKRTLQT
YKDKGLLPYSKLNRKNYYKLSDVQALLEARQSYNTNENGFTNE
>LONDMIMF_03286 hypothetical protein
MIMQLRSYIEVILKNYRPVMNGEIYLSGDDLCRILHISKRTLQQYRDDNILPFIQIGGKI
IYKESDILTVLEQNYIAKGKHCL
>LONDMIMF_03287 hypothetical protein
MKTGTAQQKTSLAFINDKSPILDLICNELLSSGIEILFRSETFPNALNELSALKKLPQVC
IVDLNFYDKNVLEQLQYLTSLHPTIKLIAHSDIDAEKVAKSLLGIGFVSYLLIGSDADIF
KKAIKNATE
>LONDMIMF_03288 hypothetical protein
MIGVKYFPASTELEKQPFQKFEQMNFVLENNKITSIIYEI
>LONDMIMF_03289 Type I restriction enzyme EcoR124II R protein
MATSLVSTKYATTNTKEEFWAIWKEKDPNFLEELDVLVNTALPEAVEEKLFADPDLRTSN
DLTLFREKYSQYIAPSQQDIFIHGLLNPNRLMSIVKDFILFEGGVVKKIARFQQFFSINK
IMDRIKPIRNGKRRGGVIWHTQGSGKSLTMAMLARKIQDTIQNPQIILVTDRIDLDRQIT
ATLKKVEIEVINANSGKQLVSLLKGNGDMVITTIINKFDAAVKSLSDNQLLSPNIFVLID
EAHRTQHGIFNVNMERVLPNACFIVFTGTPLMKKQKNTANKFGGIIDTYPISEAVIDGAI
VPILYEGRLAVQDVNKKALDNTVNMVIEDLSEKHRGDLKSKMSREKLISKTEQNIYQIAF
DISKHFQSNWGEDKSKGHSGFRGMIVCPDKLTAVKYKKNFDLIGKVKTEVVMSASDTREN
NEDIHSSEAPEVTQHYELLKAKYGPDIDSNIIQHYEKGEDIELLIVIDKLLTGFDVPQTI
VMYLCRKLKEHTLLQAIARVNRVYPGKDYGFIIDYAGIMEDLKEALESYSGDDSFDPEDL
VSSLTNISEEVGKLPQAYKDVVNIFKDVINKLNIDEYVVFLSDQAIREEFYSKFNVFARI
LKVALSSIDFHNSISEAEINHYKEELKKYAGIRVAANSVYMDTISFAQYEKQIQKLLDQH
VVTEEIIRLVDPLNIMDVDAFAEEVEKLAGPRAKAEKIAAATSRYLSINLELNPALFKRL
SEMINDTIAEMRANRLSELEALKKLTVFKEQALDGHTSTIPEEIRDKKRNVSIYNLLKAN
GDLDGKEIEITRMFDQIVSNFEVVDWYKRTDIINKIELDFGDYLMDVFDLSIEKADELTK
KLIEIAVANR
>LONDMIMF_03290 hypothetical protein
MQIGSVMLDSIQYGRQIIEFELQYSKRKSIGIKVLPTSSVEVTAPMGLCVDKIKEELLKK
ASWIIKQKSLMLNLDSNLVDYEVKSGYSVYYLGRKYKILVEKSDRVEVFYKGNLFLIKVK
SKDKARSVFDKWLRERAMIKITEIAKPIIDRFSERFEEPEDIFFQNMATRWGSCTISNKL
IFNPKLIHTPKRCIEYVVMHELCHIVYKNHNQDFFNLLTMMMPDWEKRKEKLDCFA
>LONDMIMF_03291 hypothetical protein
MKILKSSFFRPRKCQHGNFELSPDKGREILQTFIDFESGLLVVSTVKGKEDSSKSGVQCE
VKQYLINLQSLQILSSDDYKEYFDYGLKESYSLDGKLRLISQRIHDKQRNNDFFAEKLYD
TEMGTLISSGESLALTADRRENLLERHYSTLKLQKESQRKETEKLSLSDLESIHKAVLKK
EVPIISFFDEFYRYKLIYTGIHFEILRYSLNGKEPKSIPAKLSTFLNTEDFWKEITTDSN
WFRALSINQQESLQPFVLSRKVIESLNSLKKENELSYGQHEKIYGWEKVFIHPDLKAGEV
KQFCSNCTKEVKYNPRYPKYICSICSSKDKYSQDGMLLEFYNTDLSGGLKIVYKDIDGNV
LREDDSKAECLCLIDGKEFTAQEARFGGIVIHKK
>LONDMIMF_03292 hypothetical protein
MNLFIKKPWAGNPRLSTILTYFMKSNTKTVITDFSFPLIFFDSRDTVKSTFRVKQANIF
>LONDMIMF_03293 Major NAD(P)H-flavin oxidoreductase
MELLKDLNWRYAVKKYSTEKVDEQKIDLILNAINLSASSCGLQPYRLFVISNEELKLKLK
ADLFNGQIAESSHLLVFAAYNKITTQNVQDLVSLKAEVKNVSIESLDGLFVSIDSFFRSR
TDEQNRHWAE
>LONDMIMF_03294 putative HTH-type transcriptional regulator YtcD
MVTFCNFVTKSNGDIWVTILVNCIIMENIAGENIDSPVKECSYNILCIHDAMDVIGGRWK
VSIIACLCYQPMRYSELLREVKGISGKMLSRELKDMEINQLISRTVTNTQPLSVVYELTD
YGQTLRELTLTISNWGRNHRKKIMEK
>LONDMIMF_03295 HTH-type transcriptional regulator BetI
MDKKEERLHQILSTTINILTEKGAEKLSMRMVAKSANISLSNLQYYYKDKDLLFIATVEF
YFESCKKELTHAIKMITEDRTPDKDIFLEKVLSMLLIDSKSSHQTLMFQEIWTLAARNKE
LQKAVETYYKTYCIWMIDLISKFCSKPDEIVSFLIPFVEGYTIVHNVIPLTKEKVIEMML
KLISIVER
>LONDMIMF_03296 hypothetical protein
MESNKKRILIVGGYGQVGSNIARLIRNEHRTAELILAGRNPQSGEMLIKELTNAETAYIN
LDESFDLSDFGKIDLIISALDDHRNVLRETALSNGISCISVSELADQISPMVFLSLHKRI
SAPIVFSGHWQGGLLTLVVKHLSARFSRVDKVEIAGLYDPKDPVGPLVTEEVKGFVGKAL
IRQDGSWLSVESRDHARLIDLHDHSQVLGYPMGTLDVPSIAAFTDASNIRFDFIVGESIG
SSKGLGASHDLYIEIEGTLLSGERTKLRTIVSGPRGNSHLTAVGIYLIAESILGLKGQSV
QKAGGLYLPENIVSSDDIISRLSGFGINVVEEIGIS
>LONDMIMF_03297 hypothetical protein
MLVACNISAQKKNNHLKQQKKMKNATILHKANEFVSEGDYESFLAYCTPGTKWVFVGERT
LNGKEEVRAYMKEFYYEPPVFSVEKTIEDGDFVMVTGEIRLKNKDGQYEHFDYCDLWRFE
DGKIAELKAFVIEKK
>LONDMIMF_03298 hypothetical protein
MNEYLKEIATICDLSGELNTHKARRTFGSTVTLKNGVPIHVVKEMMGHYSVKQTEEYAIT
EQESISVEMQQLKEKLGKKDNVIDDPLNLLLKLQQDIQVVSNTTAHKENVNKVQRLKEIT
QQLDFIKEILLGPNL
>LONDMIMF_03299 hypothetical protein
MLEKSLGVTFFLKTPEKKENLRVFYLRVTVDGIPKEISTKRKWDVTRWSQKAERANGSKE
DAKSLNYFLDSLFNRVLNYRTELINSDQTITSQKIIDFVKGKNVSKVKVLEEFQAHNDEM
SALVKKGEYAYGTFERYTTARSHVAEFIKYKYSREDLEFRELNYEFVKDYELYLKTVRNC
SNNTALKYIANLKRLFLEPSQKISFLRTPLKCLKAKKLNAIKSRFLQKSFNGWKTKYFLL
SDFLS
>LONDMIMF_03300 hypothetical protein
MFDAQPTPDYGFILAGSSLSKNTGNKTDDNNGNLDYFIWKMDEKGDLDWQKGFGGSGADL
LQSIKLTPDGGFILAGTSNSPKGLHKKDECKGLEDFWIIKLNAKGAEQWQRTIGGTGQEL
LQSIASTSDGGYIIGGTSGSSRSEKLKNGKEDAFGKKEDSQGGLDYWIIKLDNEGQIEWQ
KTIGGQYHDELRSIIQTADGGYMLAGSSNSTATGNKTEKRYGESDYWVIKTDKFGTIEWQ
RVYGGEGDEQLKTILHTSDGNYILAGNSASETNGNKTVSNKNGIDFWLLKIDPSGEILWQ
ETYDVGKTDLLASLVENEDGSFLIGGHAMSETATDKKKDKEDINDYVAIKINAKGEEEWR
KTVGSNGQDILRKAVRVRDGGYLLAGTSKGSNSRDRYSSQGRNDFWVVKLKNEKKKKEEK
SPIEAFPNPTAQFTNVIVGYEFEKGTATVFDLSGRQLQHFDIQNRTVPVDLGGLPIGIYL
VQIRTNVQNDAIKVAKTIIKN
>LONDMIMF_03301 hypothetical protein
MKKYYYILLFAINFNANAQLDKTIPELTKPNPEVASLGKYGELPMNYYSGTANIDVPLHE
IDFDGLKIPIAVSYSTGGISARQEASWVGLGWGLSVEPFITKNTRGLDDITQVGANVGFP
YTRYALPEFSYNFSYASPLWEELGVHEDPDNVVNTYDTEPDIFTVNLFGESAKFILTQKS
LNGGVIGTVMINADSRIRVVYNESAKTFTVTNDRGFVFYFTNPEYSVTAVERQIANDFAV
LSGFDNPMITGWKIEKIVSPKGNALYYNYYERATIKDQPLASEKGHNVVCPSMDNFAPWG
GYISSYIRPSRSLNCHAALYLASIVYDDFRVDFVGSDRLDLMDGNNGRYPIVTSIANYRN
EKPKKLDHIYVKDLKNQTVKDFQFGYSYFNANATFNSQFTQEYLRLKLDNIFENGEMLRR
FEYLNPDQLPNKLTKSTDYWGYYNGKTNEHLYPSYKALKNCLSTPTMVSIIAADKSPDFN
FGKNGLLAKIYYPTKGYSEITYEPHSILLNSQTKNTNVPFEDVEVFQAESYDESSPGNSA
VFTLNGTPVDYAWKKESGVGAPPSSIFGHIVLEISCGSGFVPGGGTESYRKCTVLDVDAW
KPALQIINASNNQVVLTRRFSSDVVCNLLCPPLSINNGVAVINIPLSDLPAGSYYFRVTA
LKHISNLLDAEEGFQPGNPDYMKQYYFPVRAKVKIPKSSIYANYNKEIGGGRVKKITNYN
YDASITDKKEYKYVTALSSSSELYSSGILMNVLDFANDYSYGTDDYLCPNGGCSGICSTR
NVTVYSENRRNQYAPSQAHVGYSRIEEIYSANTGIETNGKAVYHYSANRNESVFYSSVSS
HMIYRPNNPIYDNLNLALSPKRTYEESNGDLLKTEHFDALGNLKRREENTYIFHDYYPPR
KVGIGIHIKFHLNYRFACIGSNPIVTGTIENMQIYEIKDEVTPILQKKTTEYFSNGQLEK
IISYEYNNKYQPSVITETTSESGANKIIKNYYPGDAEIASFPYTSELVSKNIIGSPLRSK
QYSGTELLEQVDKEYGLFNGSLLAEASVKTLKGGNTTIPQTEFNLERYDEKGNLLQYKKA
NSIPISLIWGYKKTLPIAKIENLAYNTIPASTITNLQQKSDTGTEADLLLALDALRTAFP
DALVTAFTYKPGIGISTKTDSKGNKASYHYDNKGRLRQVRDRDNNILSENEYHYKP
>LONDMIMF_03302 hypothetical protein
MKKLTYLVLLLPFIAFGQSQDKNYIKTTTYKIPSTSSILTPSLNQAVESTSYFDGMGRLL
QMVTKGQSGNGKSITKVTQYDAFGRQLKEYLPYVSQRTDLDYIDGALTEVLNYPEYQGKV
PYEEKILENSPLSKMLKKSAPGLAWSMGSGKEIKIDYLTNTSQDGVKLYKATATWNSAQG
VYDVSLSSAIYNEGQLYKTITKNENWTSGLNNTIEEYMDKDGRLVLKRTYNAGVRHDTYY
VYDQYGNLSYVFPPLVDNPAIQLNDLCYQYKYDNRNRLIEKKLPGKQWEYMVYDKLDRVV
ATGPAVSPFNGNGSGCLITKYDLFNRPVYTGWLSTNETRSVLQSQLNNINNNFSEKRLSG
GTVDNINIGYTSVAFPISGIKLLSVNYYDDYNYPNAPATFDPIEGQTVYYNNTVKPKGLQ
TGTWLRIPDLSASATGELSYSLYDSKDRTIRSKTINYLGGYTTIDSKFDFSGKVIYSVTR
HSRAGVGEIYIKDSYTYSDQDRMIKHTHQVGENGIPQLLAKNEYDELGRLIVKRTGGTDL
SGNIPLQKIDYTYNIKGWLREINKIDNLIQAGNPDDLFAFKINYETVENTVYGEIKPLYN
GNISETFWRTSSNDIIRSYGYKYDDLNRLNRALYQKSGTVLNSYDEEISYDKNGNITDLS
RNGGYDGDFMALEMDRLTYSYHPQKKNQLMKVLDYAFNPDGFTDDSPDGITDPDDDYAYD
ANGNMISDQNKGITQILYNHLNLPIKIVFGSESNKIEYLYDAAGKKVQKLVTEAGTPRSF
IYLQGFQYKGKTLLFFPTAEGYVNYTPAVYGGSLGNQTVITPESYNYVFNYKDHLGNIRL
SYGLDPVTNALKIIEENHYYPFGLKHTNYSSGWNSFQRIDEKVSLRPGRPSAPLEYKYKF
LGQERQDELGLNWDSFRHRNYDSSIGRFMSIDPISEDYMSISTYQFAHNNPIWKIEIEGL
EGQETTGHDIINDELIKVATYETKGPDGLKRTVTMSVSRNLYERGYVNQNEEPSNGDDNY
GGTVSYVPIFEPPKGLMSINANDELLIAHDVYQLADLASSMGVAGAGKKMIQETLEKVAK
NGPEAVSNLSGVLKSAQKSIKGIDGQIASHTKKLEDFIKNPLAGDNKGFLKNASPELREK
IISARIKSLQSQIDNFKNQKEEITTGVQQLLESINRLQ
>LONDMIMF_03303 hypothetical protein
MVIKKRELIKIIERLSREIELNCNEEMSFDENYYWETKPNDLFNLNVTPELVMGELNDDW
DDLRRLLDKENVSLSYDLKRLSSILHLLEFKLGSDWILQDNKDL
>LONDMIMF_03304 hypothetical protein
MGNKNIILLLILSLLLFNCKEFKAEKIELNYKEGYVKILSDNYVIDSLVIHNHLNKYYII
GLSEKDKGTNIIYFQKENFGYKIYSDSLKYYCSKSPEVISPGIDIHIRKKGFLGRNDNDD
FTNIEYFNYNQIPCNKTITDTIEASNPYK
>LONDMIMF_03305 hypothetical protein
MEGVILFADDHIFEAGRIENALFQKFNSEGNFSILAINNLNNLEKTVTSISTYKALILDW
NFERNIEGNEEDGLVIPDETPLEFLKSNKVYSLVYVYSQANISQEIKDELQALYPGKIFF
ETKNAGNEANTEYEKIIAGISQFENNNKHLNVPFIWSQAINKSSQEIFSELEQADPNWIE
EIYTTAQNDGTEPNTEVISVFHHLLNESIIQNKPLLNAIDANAVEEDIVVGDKEESLAKL
YNRIYYTKLKDDAPLMTGDIFKFSEEEYAILFTPECDVNTKKEKALEFLVFQKTNYIEFL
KSKREYEKGNYEDIKSKGYKNDAQGNPTKELKGKLRELIKDFNNGDIKNHLLPSFPFDNG
IYNLSALIDFETAFIVKIKADFDGKRSGYKLNSPYIYQLRQRYLAYIGRVGVPAIPQSLR
LYNLK
>LONDMIMF_03306 Sensor protein ZraS
MDFTEFNPEKVDLFNQPTNIDFKLLEQVDNTWYENPTPEVIKKEKGTLIRISHLREHWKE
SDFEELYKSIQRLIPPVDENAKKLGIDFKQDFDIEIYKDDDIYSSEDATTFKDVIERAQY
KMIGTVSEKGILSFEYESKAPQRAIQKTINLFDLEELDRNGYDLYAIKKGFKNSKGLSCG
EFKFSFYAFDLNKPDKLLITPAIKSFVKDNFVFVLRDGVRVYPYGEKGIDWLNLDKLRST
VRAGQFISYNDLTGFVYISQKDNPKLKDASNRQGIMNVDGALDDFQNLVTAVTEILNIES
KIDKQKLEIKKRTYRESNDVVSKSFNSLKTSLEKINDREVLEKANSFLKTVENHNNLIKE
RMLTVEDLAGLGMAVEKASHDALTILSKMRGNIRDFKVKAQKSNYRNEELIDLLSELDEN
LNFVYDEMQVIQPLFKNQRKAIQDISIYESIEKVLKYFRRDINGKINVRVIKDNDIKVKT
NTGLVLQILINLLDNAIYWVNRNETKGKEIILKLNTKENTLIIADSGSGIREDAAPFVFD
EFFSLKSDGRGLGLYIVKEILLRINGEIFVLEQEKDKLLSGANFIIKFNQEL
>LONDMIMF_03307 hypothetical protein
MSERKKYSQPFKPYARLMNIIGDQLITDKKVAVIEVVKNSYDADAENVQVRFFNLKNYGL
GYLPENEQPYIEIEDDGDGMTLEIIEKVWLRPATPSKYEKKVRKQNETKKGRIIQGEKGI
GRFAIHKLGEKIELFKIIMRLSLKWILPSLIPKK
>LONDMIMF_03308 hypothetical protein
MNSKVQNISFDNIPVSPEWTFKNVRSVENWTHGYHRYPAKFLPNIVKKIIEEHTEVGDTV
ADVFAGCGTTLVEAKIHGRKSVGVDINPVAQLITSVKTNPIDPAKLNETYSLILEKFDDF
ILEDYINVATHERIDYWFFPENKGKIAFLYGVILNLQENQRIKDFFLVALSNILKNCSKW
LQSSTKPQIDPDKIPTDPFIAFKRQIKSMLRKNAEFYKELANLNFLDTECNIYLEDARAT
GIDSESVNAVITSPPYVTSYEYADLHQLTGYWFEYVENLLEFRKQFIGTFYSYGEVVETV
SDLANQTVKKISEKHLRTAKEMSNYFSDMAAVSNEMFRILKVGGKAFIVIGNTTYKNVKI
NSAEIFVEMLRSSGFEIDEVIKRSIPHKLIPTIRDNVSGKFTTLSNKNSKEVYPEEYIII
AKK
>LONDMIMF_03309 hypothetical protein
MKINRLKAVLAEKSKTSKWLANQLGRSESTISRWCTNEIQPSMDTFVEIAQLLNIDVKEL
INSTKN
>LONDMIMF_03310 hypothetical protein
MGLIEGCEMMNISILFCFDMKNIYFKFAYNAD
>LONDMIMF_03311 hypothetical protein
MEKQRKKVLLAAVAMLSGIGVFAQGNGSAGINEATQMVTSYFDPATQLIYAIGAVVGLIG
GVKVYNKFSSGDPDTSKTAASWFGACIFLIVAATILRSFFL
>LONDMIMF_03312 hypothetical protein
MSNYNINKGIGRTVEFKGLKAQYLFIFAGGLLGTLIFVMILYMAGVNSYICLFLGAGGAS
LIVWQTFSLNRKYGEHGLMKIAANKRHPRYIICRKPVHRYLKFTPKQNAV
>LONDMIMF_03313 hypothetical protein
MRNVAKTTTLENKFPLLAVENNCILSKDADITACFEVRLPELFTVASAEYEAIHSAWHKA
IKTLPDFTVIHKQDWYIKESYAPDLSIEDQSFLSKSYQRHFNERPFLNHYCYLFLTKTTK
ERMRMQSNFSSLCKGTLIPKEIRNKETIHRFMEAVAQFERIVNDSGFVSLKCLTEDEIIG
TEDTQGLLEQYLTLSRGAGTPMQDIALGNEEVRIGNKRLSLHTLSDTDDLPGTVSADTRF
EKLSTDRSDCRLSFAAPVGLLLSCNHIYNQYIFLDNSEDNLQKFEKSARNMHSLARYSRA
NQINKEWIEKYLNEAHSFGLSSIRAHFNIMAWSEDPAELKQLKNDCGSALALMECKPRHN
TTDVATLYWAGMPGNAGDFPSEESFYTFIEPALCFFTEETNYHNSPSPFGIKMADRLTGK
PIHLDISDLPMKRGIITNRNKFILGPSGSGKSFFTNHMVRQYYEQGAHVLLVDTGNSYQG
LCELIKGKTKGEDGVYFTYTEDNPIAFNPFYTDDGVFDIEKRESIKTLILTLWKRDDEPP
TRSEEVALSNAVSGYIERIKHQDVYPSFNGFYEYVKGDYRKVLEEKQVREKDFDIANFLN
VLEPYYKGGEYDYLLNSNKQLDLLSKRFIVFEIDAIKDHKILFPIVTIIIMEVFINKMRR
LKGIRKLILIEEAWKAIAKEGMAEYIKYLCAPVKAA
>LONDMIMF_03314 CTP synthase
MNQTKYIFVTGGVTSSLGKGIIAASLAKLLQARGYRTTIQKFDPYINVDPGTLNPYEHGE
CYVTDDGAETDLDLGHYERFLNVPTSQANNVTTGRVYLSVIEKERRGEFLGKTVQVVPHI
TNEIKERMQLLGKTGEFDIVITEIGGTVGDIESLPYIESVRQLVWELGENNGIVIHLTLV
PYWAAAGELKTKPTQHSVKALMESGIKADILVCRTEHELSDELRQKLALFCNVKREAVIQ
SIDASTIYDVPNLMLEEGLDKVALKKLDLPEKATPDLKQWNEFLQKLKNPKHIVNIGLVG
KYVELQDSYKSILEAFIHAGAANETKVNVVSIHSEYVDEKNIADKLRDLDGILVAPGFGE
RGIEGKIDTVRYARENNIPFFGICLGMQMAVIEYSRNVLGYSDANSTEMNAGTAHPVINL
MEEQKTITDKGGTMRLGAWKCEIKPDTLASKIYGKNQIQERHRHRYEFNGEYLEELENAG
LKASGINPDTKLVEIIEIEKHPFFIGVQYHPEYKSTVAQPHPLFVSFVKAAVTHKNK
>LONDMIMF_03315 Membrane protein insertase YidC
MEEKKFDRNSIIGFLLIFMLLLGVMYINKPSQKEIDAKAKIEAEKQKAAAKTSEKEATLT
AVDTTAKDSLQLEKLKSSLGSFAYAATLPSAKQEIQTLENDVVKLTFSNKGGYIVGAEMK
NFEAVSKGSGELVKIIKDNNAKLNIELKTQGNLVLNTKDLYFEPTLTKEGENQVLTMRLK
AGPEQYLEYRYVLKPKEYMLDFSIRTQGLSKVLQTSNPLPLEWTMKTYRSEKSISYENRY
TELVYEYENGKDDYLGQSSSNTEAKDVTYIAFKQHFFTSILLTDTPFKVAELKSDNLVKD
IEKDTIFTKSFKATVPLAFKGGEVNYNMNWYYGPADYKILNKYDKNLDEVISLGWGIFGW
INRWIFIPVYDFLSLFLSHGIAIIVFTILVRLVMSPVTYKSYLSQAKMKVLRPEIMELNE
KFKKDPMKKQQETMKLYNKAGVNPMAGCLPALMQIPVFYALFQFFPSAIELRQKSFLWAE
DLSSFDAIFSWKQHIPVISGFYGNHISLFPILAAIAIFFYMKMTTGDQTMSAPPQEGMPD
MSKIMKMMIYLSPLMMMIFFNNNASGLSLYYFVSNTITIGIMLVIKNYIINDEKIHARIQ
ENKTKEKPKSKFQQKMQEMMEQAQEQQKQKNKALEDKKKSLDERKKK
>LONDMIMF_03316 hypothetical protein
MKLPVITFILFLSIFQAAFAQETNKFDEKGLRHGLWKGTYAESQRPRYEGIFEHGKETGV
FKFFDDTKELKVIATRDFTAKDGSAYTTFFDQKGNKVSEGKEVNKLYEGEWKYYHLESKE
IMTVENYSKGKLNGIRKVFYKSGKIAEEANYKDGIKNGPYKKYSERGVVLEDAIYKNGEF
DGAVTYNDDAGKTIKGQFKNGKKSGIWKYYENGKLVKEENPNKPVKEKFKINSKNKGARK
LPQNAPANR
>LONDMIMF_03317 tRNA-specific 2-thiouridylase MnmA
MKRVVVGLSGGVDSSVAAYLLKEQGYEVIGLFMKNWHDDSVTISNECPWLEDSNDALLVA
EKLGIPFQTIDLSEQYQEKIVDYMFREYEKGRTPNPDVLCNREIKFDVFMKIALSLGADY
VATGHYCRKGEIEVDGKPVYQLLAGVDGNKDQSYFLCQLSQEQLAKSLFPIGELTKPEVR
EIAAKMELVTAEKKDSQGLCFIGKVRLPEFLQQKLQPKDGLIFEIGADQEIYKKEKTEFN
SLQEELAHEAASIPYAPEMGKVVGKHQGAHYFTKGQRKGLNVGGTVEPLFIIETDVENNI
IYTGQGNHHPGLYKKALFVERSEVHWIREDLALKDGETMEVMARIRYRQPLQKATLHQFE
NGLYVAFEEAQSAITEGQFVSWHLGEELIGSGVIA
>LONDMIMF_03318 Homoserine dehydrogenase
MSRKKLNIGLFGFGCVGFGLYEVLQKTPGLKADIRKICVKDKNKPREIAAENFTFDKNDI
FNDPEINVIVELIDDADAAYEIVTTALKSGKAVVSANKKMIAEHFEELLELQKKHNVPLL
YEAACCASMPIIRNLEEYYDNDLLESIQGIVNGSTNYILTKTFKENLSYEEALKEAQEKG
FAESNPILDTGGFDAKYKLLILLAHSFGYIARPENLLNIGIDNIGGLELKYAREKGLKIK
LVAQAFKNTDGNITAFVIPKFVDSADRLFNVDDVFNGVITKTSFADEQFFVGKGAGAHPT
ASAVLSDISALSYDYQYEYKKIAQQEDYSLSDDVNLKVFLRHQIEDAVTLKKHFSAIDES
YLNHESGYITGTISLEKLRNIHFDESIDKSFVLLDIA
>LONDMIMF_03319 Cystathionine gamma-lyase
MKEQTQILNYIPVDKLTGSISVPIYQTSTFVQDAPGVHKGFDYARSNNPTRKVLEDLVAK
LENGTNGYAFSSGLAAIDAVVKLLSAGDEIIAVDDIYGGAFRLFTHVYEKFGIQVTYVDA
TDAKNVADAISDKTALIWIESPTNPTLKISDLRAIGKIAKENNILFCVDNTFASPIAQKP
IDFGADLIVHSATKYISGHSDLIAGLVITATEELGAKIKFIQNASGAILGPFDSWLVIRG
IETLNLRIRQHAENAQKIAEFLTTEKLVRNVYYPGLKTHRNHEIAKSQQKYFGGVVTFDL
VIDDKELASRIVSGTKLFQLAESLGGVKSLCCLPCEMTHKSIPAEKRYQSGVTDSLIRLS
VGLEDADDLIADIKQALENAVKENATVEFHKN
>LONDMIMF_03320 hypothetical protein
MIKLNLQPIFKMKGITKPVKYLIERGHSGSYANAVVNDKPLSIPFKKLEKFCIDFNCTPN
DLFDFVPEKNQKLPGNHALYTISKGDAIGEIHKILNELPVSKIQELYGILKNTE
>LONDMIMF_03321 30S ribosomal protein S1
MTNLEFISKQVTAPVKNIENTLQLLSEDCTIPFISRYRKDKTGNLDEVIIEQIAKLNKEF
ETIVKRKEAILKSIEEQNSLTPELEKKIRQTFDLNDLEDLYLPFKKKKKTRADVAREKGL
EPLAKIIMAQNNDDIDFVASKYINDKVENEDEALQGARDIIAEWINENIYIRKNLRRIYQ
RKSAIVTKAVKLKFENESSPEAEQIKQKAKKFEQYFDWSENLMKAPSHRLLAMLRAENEG
FIKLKIEIENEEAIEMMEESIIKNKKETAVHLKKAIEDSYKRLLSPAISNETLQEAKAKA
DITAIQVFAGNLGQLLLAPPLGEKRILAIDPGFRSGCKVVCLDEKGDLLYNETIFPHAPQ
NETAIAMKKIRSMVNAYKIDAISIGNGTASRETEFFIKKIAFDKPIQVFVVSEAGASVYS
ASKIARDEFPNYDVTVRGAVSIGRRLSDPLAELVKIEPKSIGVGQYQHDVDQSQLKEELD
TVVMRCVNSVGININTASKSLLSYVSGIGEKMAENIVAYRSENGAFEERKQLKKVPRLGE
KAYQQAAAFIRISNAKNPLDNSAVHPEAYGIVEKMAKDLKISLNELIANKEKIGQIPLEK
YVTEDVGLLGLKDIVKELEKPGLDPRKAAKVFEFDPNVKTIDNLRTGMVLPGIVNNITNF
GCFVDIGIKESGLVHISQLKEGYVSDVNEVVKLHQQVQVKVMEVDESRKRIQLTMIL
>LONDMIMF_03322 Ribose-5-phosphate isomerase B
MKISIGNDHAGPEYKKAIVDMLKAKGYEVTNYGTDTTDSVDYPDFGHPVALDVENGKADF
GIVICGSGNGINMTVNKHQGIRSALCWTKEIAALARQHNNANIISIPARFTAIHQAVEMV
ETFLNTDFEGGRHQNRVNKIACS
>LONDMIMF_03323 hypothetical protein
MENFITLAIFNYPHEITILKHRLDLEDIRYFFENETMMNIVPMYSQALGGIKLKVHPEDA
EEAKEILDEFNRNQNLKIV
>LONDMIMF_03324 Ribonuclease R
MSKKPRKPVKKTKDFTAKILKILSQDANKTFNYKQIGAKLGVDDTKSRNEIIKDLKLLAS
QKKIVEIEPGKYLVVATSQDYYEGIIDMTSRKTAYFVSEEFEDDIFIPTNNLNKALDGDR
VKIYLYNRRKGKKPEGEVIEIIERKKTDFVGVIDIQKNFAFVSTANPKMYTDIFIPKEKI
GEAQNGDVVLVHIEDWPKKADSPFGAVIKVLGKPGEHNTEIHAILAEYGLPYDFPVDVEA
YAQKLDTSIQESEIARRRDMRDVLTFTIDPKDAKDFDDALSFQILENGNYEIGVHIADVS
YYLEEGTILDNEAYQRATSVYLVDRVVPMLPEVLSNFACSLRPHEEKYTFSAIFELKENA
EIVNQWFGRTVIYSDQRFAYEEAQHIIETKGNTIPAEISLTGSEYIVPEAIQKATLKMDE
LAKILRKKRMRDGAISFDKVEVKFNLNEAAEPVGVYFKVSKDANHLIEEFMLLANRKVAE
FIGKQRPKKTFVYRIHDEPDENKLISLQTVISKFGYSINFKSKKDISKSLNQLLEDVNGK
KEQNMVDTLTIRSMSKAKYSTENIGHYGLAFDYYSHFTSPIRRYPDVMAHRLLQHYLDGG
KSVDEESYEEKCQHSSNMEVLATNAERDSIKYMQVKYMQDHQDEEFLGVISGVTEWGIYV
EIVSNKCEGMCRIREIRDDYYTFDEKQYALVGEISKNILQLGDEVYVKVKSADLVKKQLD
FTFLRKNE
>LONDMIMF_03325 hypothetical protein
MKKIIFVAFLMLSQLNFAQEKITKNLGDFDQVKVFDRISLQLVPANENKIEITGDRREDV
EIVNKNGELKVRMKLKKLLKGEDITAILYYKNEIETIEASEGSYVSSEKTFKAIDFHVNA
KEGAEIKISLDAQKLDVKATSGGIVKLKGNANSQDIVINSGGIVDAKDLETSQTTVAVNA
GGEADVRASELVDAKTRAGGDITIYGSPKKINKKTFAGGNITESQR
>LONDMIMF_03326 DNA repair protein RecN
MLIENIRRTFKNYNPFLMIQDILTGIPLGLFLCFMIGPVFFILLETAAVKGIRAALVFDF
GVIVADVLFICIAYFSSYRLINSLKDEPALFIFGGLIMLTYGIISYLKLNKASKNISEEA
EVELIKKNYGSLFIKGFLLNFINVGVLGFWLLIIITFGPQLDLKTSRLIVFFASVIGTYL
MVDLAKMFLAKRLKSKMTSSNILKIKKITSILLIIFGFSIMLQGWFPSDQKLVKSALEKI
ENYGEIYKGKLVDLKNIYYEIQELARDFENMREDVCFDEYERNEIEKRLDIIFSLKRKYG
NSIEEILKYKENVSKQIYEIENVDEHNEKLRKSIAELEEKMKAQSKLMEEIRKKYAIVLS
EKINKELKDLEMFNSVFEINVETIQEFNLNGLNKVEFFICTNIGDESKPLVKIASGGEMS
RLMLAIKSVLASTDEVPVLVFDEIDTGISGKAAKAVGEKLKAISKTHQVICITHLAPIAA
KGDYNYYITKNIKNEKTVTNIKQLNEEETINEIARIATGEVTEISKKQAIELRKVS
>LONDMIMF_03327 Isoleucine--tRNA ligase
MSTKFTEYKGLDLPTVASEVLDFWKKQEIFEKSVTTREGNSPYVFFEGPPSANGLPGIHH
VMARAIKDIFCRYKTQKGFQVKRKAGWDTHGLPVELGTEKELGITKEDIGKTISIEEYNE
ACKKTVMRYTDVWNDLTEKMGYWVDMQDPYVTYKSKYMETVWWLLKQIYDKGLLYKGYTI
QPYSPKAGTGLSSHEVNQPGAYRDVTDTTIVAQFKALSETLPSFLQGFGDIHFLAWTTTP
WTLPSNTALTVGPKIDYVLVKTFNQYTFEPVNVILAKNLVGKQFGKGYFESTEEADFDKI
KSGDKQLPYKIVAEALGADLVGIRYEQLLPFVLPYQNPENAFRVISGDFVTTEDGTGIVH
TAPTFGADDAKAAKEATPEVPPMLVLDENGTPVPLVDLQGKFTSHMGEFAGKYVKNEYYN
TGEAPEKSVDVEIAIRLKEENKAFKVEKYVHSYPHSWRTDEPLLYYPLDSWFIKVTDIKD
RMFDLNETINWKPKSTGEGRFGNWLKNANDWNLSRSRYWGIPLPIWRTEDKREEVIIGSV
EELYNAIEKSIEAGFQKENPFKGFEIGNMSEANYDLVDLHKNVVDEIILVSPSGKPMKRE
TDLIDVWFDSGAMPYAQWHYPFENKDKIDGNKDFPADFIAEGVDQTRGWFYTLHAIAALV
FDKVAYKNVVSNGLVLDKNGQKMSKRLGNAVDPFTTLAEYGPDATRWYMISNANPWDNLK
FDIEGVAEVRRKFFGTLYNTYSFFALYANIDGFSYSEAEVPLQERPEIDRWILSELNTLV
KNVDSYYADYEPTKAARAVSDFVQENLSNWYVRLCRRRFWKGEYAQDKIAAYQTLYTCLL
TVAKLSAPIAPFFMDRLYRDLTQATHKETFDSVHLADFPEYADNFVDKSLESRMEKAQTI
SSLVLSLRKKEMIKVRQPLQKVMIPVLDAKQKAEIEAVSDLIKAEVNVKEIELLDDASGV
LVKQIKPNFKALGPRFGKDMGLISKEIQNFSQEQINELDKNGSLDIVISGKSINLTSEDV
EISSQDIEGWLVANANGITVALDITISDELRKEGVARELVNRIQNIRKDSGFEVTDKIKV
QVQKDGIIEEALQANQDYIKAETLTEELIILDKVENGIEIEFDDIKTSILISK
>LONDMIMF_03328 General stress protein 16O
MVDEVARYSDADLAEFKEIILKKIQKAQADLDLIKSAYMNDLNNGTDDTSPTFKAFEEGS
ETMSKEANSQLAIRQEKFIRDLKNALFRVENKTYGVCKVTGKLISKERLKIVPHATMSIE
AKNLQR
>LONDMIMF_03329 Lipoprotein signal peptidase
MSLKKAYLLVILILIVDQISKIYIKTNFIYGEEGQINVASWFKILLIENEGMAWGTQIPG
DYGKLILTLFRLVAVTGIGWWLWDSVRKNSSRYLIVAISLILAGAFGNIIDSVFYGVIFD
HSTGQTATLFSDQPYGTWFHGKVVDMLYFPIWEGNLPTWLPIWGGKHFTFFNAIFNIADM
AISTGVGILIVFNKKAFSGSNKRSELA
>LONDMIMF_03330 hypothetical protein
MKTTLKLSIGLLMLCFAFSISGCSASVSTGTSSRSSKSKPLPPGQAKKVTGEKSAKKYAP
GQN
>LONDMIMF_03331 5-formyltetrahydrofolate cyclo-ligase
MHKKELRLKYKALRAELSHEDMEERSLSIANQVVRMDIWDKLYYHTFLPISEHKEVDTEF
LLQVLAGRDKEIVVSKSDFETRKMTHFLLTDNTRFQKNEYNIPEPVDGIEVPADKIDVVF
VPLLAFDKKGHRVGYGKGFYDLFLSGCKKDVLKIGLSFFEAEEEITDVFENDVRLDFCVT
PDTIYKF
>LONDMIMF_03332 N-alpha-acetyl-L-2,4-diaminobutyric acid deacetylase
MAQPTYKSLTILGETILPGESRTLNMEIAKLHTMTKLKIPVIIERSEIEGPTVLFSAGLH
GDEINGIEIVRQLIVQKINRPKTGTIICIPVINVFGFLNRSREFPDGRDMNRVFPGSKNG
SLASRFAYYLLKEIIPNVDYCIDFHAGGASRFNAPQIRIVPNNHELKALADVFHAPFALY
SKNISGSFRNSCDRLGVKMLLFEGGKSLDINESITQQGVEGTKRFLDYFGMLNPKRKATN
AEQKIIYIEKSAWVRAKASGLFHGLTTIGSYVEKSQVLATISDPYGKVEYKVKAPNSGYI
INVNDAPIVYQGDAIFHITTALENQG
>LONDMIMF_03333 UvrABC system protein C
MRTPLELQIQTLPDGPGVYQYYDKDDKILYVGKAKNLRKRVSSYFNKLHDNGKTNVLVRK
IVSIRHIVVPTETDALLLENNLIKKLQPRYNVLLKDDKTYPWICIKKEPFSRIFTTRNMI
KDGSEYFGPYTSFKTVHTLLDLIKELYPLRTCNYDLSRENINSGKYKVCLEYHIGNCKGP
CEGYQSLEEYQGNVEAVREILKGNFKESLKDFKTLMKNLAAEMKFEEAQKIKDKIETLEN
YQSRSTIVNPRISNVDVFSIVSDESMAYINFLQISHGAIIRSHTMELKKKLDESDEELLE
LAIVELRERFRLLSKEVIVPFEVDLGENIKVTVPQLGDKKQVLELSIRNAKFYRMDQLKQ
LQIVDPDRHTNRIMAQMKKDLRLSVEPRHIECFDNSNIQGTNPVAACVVFKDGKPSKKDY
RHFNIKTVEGPNDFASMEEVVYRRYKRLLDENQPLPQLIIIDGGKGQLSSALKSLEELDL
RGKIAIIGIAKRLEELFYPGDSVPLYLDKKSETLKVIQQLRNEAHRFGITHHRDKRSKGA
LKTSIETIPGIGEKTMITLIKHFKSVKRLSQATEKEISDVVGVSKAKKITDFYNSTK
>LONDMIMF_03334 Transcriptional regulatory protein ZraR
MDYLVKPFTSEELKKAVQNSFEGKIGSKKKSSPTLPDSDKKITNYAGIVGDSEQFENLVD
VIERVKNNKATVLIQGESGTGKELIARAIHFKGSFASNPFVAVNCGGIPENLMESELFGY
EKGAFTGANESKIGLFQAANGGTIFLDEIGTAPLAVQTRLLRVLQEKEVTRIGSQKAHKI
DVRVISATNNDLYEMVQKGSFREDLYYRLNVVSIETKPLRERKNDIRPLITTFIKKYGIE
YGKPNCTISDKAIEILLRHSWPGNVRELENIIQRMIIMCDYAIDIVDIPDYLKYQQPTEG
ETLKPLKDIEKDHILKVLHAVGDNKTKAAEILQIDRKTLRQKLL
>LONDMIMF_03335 Glutamate dehydrogenase
MITAKEPAKKSMYENVMEQFNKTADIMNLNPDIRKILSITNNEILVHFPVKMDNGQVEVF
TGYRVQHNNALGPYKGGLRFHPTMDGDDAKALAMWMTWKTSLAGLPYGGAKGGIQINPRD
YSLSELERITRRFTFALGDNIGPELDIPAPDVNTNEQTMAWIADTYMSTKSPSERSNNKH
VVTGKPVGSGGLEGRDRATGFGVYLTLKLFFENKNETLAGKKYIVQGFGNVGYWVSYFME
KDGAKLLAVQDAHATIINENGISVNDLYEHSKPRKGSIQGFTGAKEMEPKDFFALDCDFV
IPAALGNQITAANAYDIKAKVVAEGANGPTDNEGERILLERGITIIPDILCNSGGVIGSY
FEWLQNRNGELWPLDEVMAKIEKKLTENYKKVQNIVNEKQVDWRTAAYILAISRIETAYI
QRGIFP
>LONDMIMF_03336 Regulator of nucleoside diphosphate kinase
MKEIIIEKREYEMLRQIISNAGHNVDKTYKASIEKLANELKSATIMDKESMPEEIVRFNS
IVTVQMPFGDPKSFQIVTPEKSDISQNRLSILAPMGLALFGYAVSDEIMWQFPSGMNAIK
ILNVEQPDALQK
>LONDMIMF_03337 hypothetical protein
MKKEVIKIHQDQDDLQKFFINRDVDRWKDEVAIIEEEIILFSNLLGAKNDKSYSNILEKM
TVFKVQNSEIQEELINYDRKLEVLKECEDLQCETFFLNSHNDFKEKIEVHFYQYRNFKKN
VFSVINNK
>LONDMIMF_03338 hypothetical protein
MVLESISGFYCKLIEVGTEKYTQKMEVEHIKLWNKSFLSLSLLFFAISVYDFIYISSLIS
YCFFLLSILFFYTIFTDLKFNALAQTFTYLLLSFIFFYISSHIGLGSGIYFYYIPLILSL
PVFFKISRNKKAIVLICFFLFFMMFLDIKTNSVKHPVNDMIFFESLLGSIGLVFWLVCFI
IRKQAISIKYYKKRVGIWKREAEIDIDKLKEVIDMAVQNSSHFFPKFKELYPYFCERLIE
IQPNVVASEQEFCAYIKLGFTTKEIAKFTNSSIRSIEGKKYRIRRKYNISEKVDIYVWAA
NL
>LONDMIMF_03339 HTH-type transcriptional activator RhaR
MNRIFSALLLLCLFSSLLNAQSNKEDIDKLLKDAGYTLDFVDNQKGLKIILKAREASKRI
GYKEGLLKSGSMLTVFYMREDNYKKVIENSREMEPLALELKNYIALTDLYRMMALAHGQL
GLSKPSYEKYQAALKASKKIQQKNTRHYKTSLIYGNMITYFDRMDDNYSQDSILHYLKKS
LDEIKQIDDNSPDTKLNDKYDILAGTNSNIGMFYINQHKPPRVDLAEKYFMDAIAIYDNK
KYKLMAINRVLLSNSFGRFFQAKKDYNNTIKYATNALELERKANSPYMRKESYEMLADSY
LELDNKALSKKYMQLYTSINDSITAAQNASIEAPVNQIVSQEKKKHTTIIVIISGCILVI
MAFVVRLFWKRKNRILHENYESLIEKLKSEKKPGRLTEEENYGKISSDKSFTITEETTDA
LLLKLEKFEKSKNVIKKEVSLTWLANHLNTNTRYLSEVIKKYKGKSFNNYINGLRINYIV
ELLYEEPKHREYKISYLAELCGFSSREVFTTIFKKETGISPSYFIDNLKNKDISSGTENK
E
>LONDMIMF_03340 Adaptive-response sensory-kinase SasA
MNNKFLILLFTMGACGAYGEVGIGTKMPDNSIRLEVVANNKSILFSQVPHAGAKAIAKKN
STNTLSVPDKVIISDNTGGYGIDYNQLLENNRNLQLSQKASRQTVMILIFFLISCTILLL
LLLRAYKKIRNDYKKKVVLCELLKNKNSSLSEADTIKSNLVSILAHDFRSPLISMLYMMR
LLERNSELLTKSEKESFYLAVSNDISLTLENFDATLQWIKHQLGEFKINFETVNIRSLLN
EAISGYKAQLNEKSITVINNVPEGILTTSDREMLQFVNRNLLSNALKFSPNGKTIAIDAL
KTGKEIIISVKDEGPGLSDNQMKKLFSISSKGGSTRDGAGIALSFSKDFIVKLGGRIWAE
NRNTGGTIFSYGVPSGSINRERTTAKIVA
>LONDMIMF_03341 hypothetical protein
MGHNLAVDEHRILKSFIKQFLIEKNDSLIQNHAIELTYITKLLNSVFDTCFDFKVSVTDV
YRIFEEYGYVHSITGPKLSIWTETSHIQANSCAIYITISPITILELKAVAASRKMGYTTA
EMFQIEEALVKLRAFWATAI
>LONDMIMF_03342 hypothetical protein
MLYPTPYFMDNDKFIFCLEAVPDIDSESTTATFKSLEKLALQTGIDSIYKTCDTIEGLEE
SLNALLYEDHNFKNYEIIYLVVPGEGNTICLNNYYYSLEEIAELFEGKMKGKILHFANTK
SLDLDQEEAQYFLDVSGAKAVSGFGLRSGKANSNPLDNVFFSFCQDEDNVIEIVELLHEK
YYAACKLLDFRLYY
>LONDMIMF_03343 Poly-beta-1,6-N-acetyl-D-glucosamine synthase
MKSETITSKEFYSSKKEVCQEEQSLTNFIFQINSLVLEKMLFFRSPKKINLMILAGTFLL
MIIGTYLVYELQPEFYQFNVERLNSAIGFPFLVLASVLLLFKAGFIVYSIYLYFRYKPVK
SVTDELLPTCTVIVPAYNEGKLVWDTLLSIAESDYPQEKLQLLAIDDGSQDDTWYWMQQA
KKRLGDRLSIYQQPENKGKRHALYRGFNMGTGEIFVTIDSDSIVKTDTLRNLVSPFVTNE
NCGAVAGNVRVLNNEKAILPKMLNVSFVMSFEFIRSAESKVGTVLCTPGALAAYRSSAVF
ACLPEWINQTFMGQASDIGEDRAMTNMILKQGYHVLFQRNAYVLTNVPEKYEGLSKMFIR
WGRSNVRENLMMSKFVFKNFRKESKAGARLMFLNQFLTLAMAYPFLLFMLYFILIHPVLF
FSSTLLGILIFSSFPVFFYAKRHNFSESLWAYSYSILYTFGLFWITPYAIATAGKRGWLT
R
>LONDMIMF_03344 hypothetical protein
MVVYGDFFSVYKIFFLWKTVEYYKKELTTTRLASAMPFGKAPIIRDI
>LONDMIMF_03345 hypothetical protein
MNEEYKNKWISQLKKGTLSFIVLSILNKDKEYYGYDLISEIKRITDIDIAEGTLYPLLIR
LKNENLVEHNWVEQPSGIPRKYYRITKEGKATIAQMKAYWDNLNQTINSI
>LONDMIMF_03346 hypothetical protein
MGQSKPNYQFNLIMKFQEITFTDTNAQRLYKDYIGRVKHAVKDLNKENQHETLLEINSHI
YEAFTVSKTNEVESLLDIFDKLGRPEIFLKELVAEKRLEEATKTFNPIKIIKALFLNITN
GIKYIIFLLLYLSLFSFLFLIFAKIIDPENVGFFYRNNDIFVLGKISSSSVNYQQYEQLG
NWFIPIMAASAFILYIIITFLLKLSKRLKNK
>LONDMIMF_03347 Penicillin-binding protein 4*
MKFSLLATCFSLCIATATFSQSFDSKKLDRYLETLENHHKFMGSVAISKNNEIIYTKTVG
FQNIKDKTKADNNTVYSIGSISKTFTAALVLKAVEQKKVSLNTTIDKFFPSVTNAKKITV
ENLLNHSSGIGSFTDNADYLSWHTQPKSEKEMLEIITKTGSYFEPDTKSAYSNSNYVLLS
YILEHIYKKKYSEILTTYIIKPLQLKNTYFEHSLNTAHEAISYTFSTDWDLQPNTDASIP
MGAGAIQSNAADLVKFSDALFNGKIISKESIAKMKTLKNDYGLGLFDYSFEKHTGIGHDG
AIDGYKSIFTNFENDKMSYAITSNATNYKLDLIANIITSAAFGMAYEIPEFKAIHITPEE
LEAYTGVYSAEGLPFKITITRQENTINAQATGQAPLPLEATDKNVFTFDKAGIQLTFRSD
AKMILKQSGREIEFKKE
>LONDMIMF_03348 2-oxoisovalerate dehydrogenase subunit beta
MLITLLGVKPCYHKCIDYFENLISKVINNRKFCNIKSLCCYFFILLGELKNCANLFVTIM
NFDRKNLTNEQLLDLYKRILKPRLIEEKMLILIRQGKVSKWFSGIGQEAIACGVTAVLDK
DEYILPMHRNLGVFTGRDIPLYRLFSQWQGKANGFTKGRDRSFHFGTQEYKIIGMISHLG
PQMGIADGIALANKLKKNGKVTAVFTGEGATSEGDFHEALNIASVWELPVMFVIENNGYG
LSTPTNEQYRCENLADRGIGYGMESHIIDGNNILEVFTKLSELKVSMIENPRPVLLEFKT
FRMRGHEEASGTKYVPQELMDMWAIKDPVDNYRKFLSEAGVLTQEQDDEIRSEIKKEIDE
NWAMVQAEPEITATYEEELNDVYKPYDFEEVTPSDKKINIRLIDAISNSLKQSMERHENL
VIMGQDIAEYGGAFKITDGFVAQFGKERIINTPICESAVVSAGMGLSINGYKAIVEMQFA
DFVSTGFNPIVNLLAKSHYRWLEKADVVVRMPCGGGTQAGPFHSQTNEAWFTKTPGLKVV
YPAFPYDAKGLLNTSINDPNPVLFFEHKLLYRSIYQDVPKDYYTLPLGKASLLKEGKDVT
IIAFGAAVHWALETLAKNPEISADLLDLRTLQPLDTEAIYASVKKTGKAIILQEDTMFGG
VASDISAMIMENCFEYLDGPVKRVSSLDSPIPFTKALEDQFLSKGRFEEALKELMAY
>LONDMIMF_03349 hypothetical protein
MQNIPSVDLRDFLSDDPKRKQKFVNEIGKAFEDIGFVALKGHFLDDKLVDELYGEIRNFF
ALPLETKSSYEIPGIGGQRGYVSFGKEHAKGKKEGDLKEFWHFGQYVDKNSRWAEEYPDN
VEVKELPRFNEVGKEAYQMLEKTGIYVLRALALHLGLDEFYFDKYAEEGNSILRPIHYPP
ITQEPENAIRAAAHGDINLITLLMGAQGRGLQVQNHNGDWIDAIAEPDELVINVGDMLSR
HTNNKLKSTIHQVVNPPRELWGTSRYSIPFFMHPVSDMRLDCLENCIDEENPKLYEDISA
GEFLHERLVDLGLIKK
>LONDMIMF_03350 hypothetical protein
METNELLHKELTGDILKLYYEVYNELGYGFLERVYQNALFYELKSNGFKVEAQKRIPVYY
KNMIVGDYFADLIVNDSVILELKAVESLTKEHHYQIINYLRGTECEVGLVLNFGRKVQFM
RRVYENYKK
>LONDMIMF_03351 hypothetical protein
MMVSKVDDKKFVGKDIIHVAIFDKNDKRTIYNMIYRDGKSGPSYIKRFNVSGITRDKAYD
LTQEKPGSQVLYFSHNPNGEAEVITVLLRQVGSVKKLKFDIDFAAMAIKGRASKGNLVTK
YPIKKIELKEKGISTLKPRRIWFDDTVQKLNVDGRGELLGEFRPNDRLLIINQSGRLKTI
IPELTTHFDEDMVVLEKWLPKKPISAIYYDGEKERYFVKRFLVENENKEEIFITEHPKSQ
LEIVATDYRPVAEIVFAKVKGVQKENQTVDLESFIAVKGIKALGNQLTTDKLKQVNLLEP
LPYEEPEEEIPEEIEVSGSTEISDDVQLDDDGQITLSLD
>LONDMIMF_03352 Cytochrome c551 peroxidase
MKLKYFIFSLTLFTFFFSGCQDRAFEKNIKQELLIDLTKLKNEIILLQQKIAADGSQKEV
LEQFKKTRLQYKRIEWAVEYFVPETARFMNGPALDEMELEENKFFVPNGFQVIEEHIYPE
YDFKNKKEIIRELDILLSNTKQVETTFGAITISDDYVLDALQQNVHRILTLGITGFDSPI
LNSSIPEARQSLSVIPELLLIIQPNSKILDDVKQIAAKAKEYCDSNPNFNTFNRVVFITE
YLNPLSQKLNLFQKEEKIPAVERNRPLKATAATLFDENAFDVNGFVASNEYRYSDEKAIL
GEKLFYDKSLSKDGNRSCASCHNPEKAFTDGLKTNVSLKGKNLNRNTPTLTYASFQNAQF
WDMRQLDLEKQSVDVIENKDEMHGSLVAIHSKVSSDREYIQLFQKAYPKSDKTEAWQIQN
AISSYVRSLNSFDSRFDSYMRGNKNSINAEEIQGMNLFMGKAKCATCHFTPLFNGTVPPN
FAKTEHEVVGTPEDASGKRLSKDEGRYIFNQLPQLKGAFKTPTLRNVAVTAPYMHNGAYA
TLEEVVEFYDLGGGTGLGLTVENQTLPTDKLNLTVAEKKALVAFMKTLTDKRYN
>LONDMIMF_03353 hypothetical protein
MRQLTTKTFAILATASILLASCQNDDSSNGTPVNREIDFTSHSSIPAFVFAMPGFESMEI
STLITSADQLSQSPAFVYGAQPDGAGLMKNPSGEGYILISNHEILQSVSRVYLDKTFKPV
KGEYIVDGVGGMTRLCSATLATPEIHGFGPIFLTAGESGEESMVHGIDPMGLANDRSRTD
RILPALGKASMENAVPLPKDAYPGKTVILIGEDQSYTTSHASAGQMIMYMSNTVGDLSNG
KLYALKRTDGNQVETAMTMNNSYNVSFVEIPNAKNLTGAVINTTVNNLGAIRFSRVEDVD
YRKGSASNNREVYFTATGQATSNAPVDGYTMWGRVYRLKMDANNPLAATLEVIAEGDSTP
GTGLINPDNLCVTENFVYIQEDGDSYYTAAQHDSYIWQYNIATKQNKPWLNMNHKRNDAA
WNSLYNQTGEMRFGSWEFGAMTDISDIIGVPGTFLVNIHPHTWQKDAFLNADGSGRSTNK
EGGQTVIIRNVQR
>LONDMIMF_03354 hypothetical protein
MEVFLNPDAWIALLTLTFLEIILGIDNIIFISIVTGKLPVEDRKRATRIGLFLAMFMRIG
LLFGITLLIAMKAPLFSFDFGWFSGHVTGQALILLLGGLFLIYKSTKEIHEKVDHKGEEE
KSLGDVAKKSFSSVILQILLIDLIFSVDSILTAVGMTNGLEGALYIMITAVVISVGVMML
FAVPVGNFVNANPSIQILGLAFLILIGFMLITESMHLSEAQLAGQHVGAVPKGYLYFAIA
FSLAVEFLNMKMRKKSSN
>LONDMIMF_03355 hypothetical protein
MKKILPLALLTLGLLTSCYNVERNCKDFKTGEFQFEYEVNGVKKTSHFVRNDTLEIDTFE
GKTDTSKVRWINDCEYILEKMNPKNMAEKQAIHMKILSTTENSYTFEFSKLGNTNKQKGT
VTKIK
>LONDMIMF_03356 hypothetical protein
MDANSHFLDSVKKQFLYYKTLGEKAMAQLADEQLFISLNEDTNSIAVIVKHMHGNMLSRW
TDFLTSDGEKEWRKRDGEFVDTYQSREELMAKWNEGWECLFNAINPLHPEQLTEIIYIRN
EGHTVIEAINRQLAHYPYHIGQIVFYAKLLKKTEWDSLSIPKNKSGDYNAAKFAREKSIK
NFTDDELNKLK
>LONDMIMF_03357 Pentapeptide repeat protein MfpA
MKETVHIGKTFTKVTYTEESIQKREFENCTFIDCDLYGSDFSQSQFIDCSFKGCNLSMIK
LNATGLKNVVFDACKMMGIGFDYSDDFLFEVQFNDCTLDFSSFVRKKMQKTKFINSSMQE
VNFSETDLTKAVFEDINLNRALFNRTILVEADLSKAYNFSIDPELNFLKKAKFSLKDAGG
LLEKYNIKLV
>LONDMIMF_03358 hypothetical protein
MNTDKKILQKGILYLSIAMPLLFLGPVIIHSAFKNQSHPLYLIVLGIGILTCLGAMLMLF
LGIRKIMNSLFKKR
>LONDMIMF_03359 N-acetylmuramic acid 6-phosphate etherase
MTFTKTTEQSSKYEHLEKMPVADLLRNINNEDKTVPLAVEKALPQIEKLVEKIVEKMKEG
GRLFYIGAGTSGRLGIVDASECPPTFGVPFDLVIGIIAGGDTAIRKAVEFAEDDREQAWK
DLQEWDINEKDVVIGIAASGTTPYVIGGLQKCIENQITTGSISCNAESPLSKTSDFPIDV
VVGPEFVTGSSRMKAGTAQKLVLNMISTSTMIQLGRVKGNKMVDMQLSNHKLVGRAVRMI
MEELSVSETEATSLLEKYKNVRNSIENYKR
>LONDMIMF_03360 putative type I restriction enzymeP M protein
MNHAVHNKLVSFIWSIADDCLRDVYVRGKYRDVILPMVVLRRLDALLEPTKQHVLEEVEF
QKNTMKFTEWDDKGMTAASKYVFYNTSEWTLQSLYASATNSRQILLGNFEDYLNGFSSNV
QEIIEKFNLRAQIKHMANKDVLLDVLEKFTSPDINLTPFEKLDSSGRKLPALTNLGMGYV
FEELIRKFNEENNEEAGEHYTPREVIDLMTHLVFEPIKDKIPSVITIYDPACGTGGMLTE
SEHFITDEEGEIKATHTSVYLFGKEVNDETYAICKSDMMIKGKDPERIKVGSTLSTDEFA
GTKFDFMLSNPPYGKSWASEQKYIKDGKDVIDSRFLIKLKNYWGEEEDADAVPRSSDGQL
LFLMEMVDKMKAITSKNTIGSRIASVHNGSSLFTGDAGGGESNIRRYIIENDLLDVIIQL
PNNIFYNTGITTYIWILSNNKQADRKGKVQLIDASEMYQKLRKNLGNKNCELTKTHIQEI
LNCYLKLEELDKKKTGNIGSKVFDNADFGYYKVNIERPKRLKSQLTEEKIEALKWDKAQP
DFSKVLFEKYGMEVFAGLEKHKKEIEDLAEKQELNINAKQLSGFLKKENWEKQEALYQTA
VRLMEVLGTEVYTNFNTFSAKVDEVLKGDKTKLSASEKKQILDAVSWYDEEADKVVKKTE
KLSGQKLTDLLNYLGCTEKDLPYYGYFPCHPELAEGSAKGLYTLYETESDLRDSESIPLK
ENIQDYFLREVQPYSEESWIALESVKIGYELSFNKYFYQPSPLRSLEEVTQDILALEQEG
DGLLAEILNF
>LONDMIMF_03361 Type-1 restriction enzyme EcoKI specificity protein
MQRYEKYKNSGVDWIGEIPESWEILPGLSFIYENKAKNKGMIRNTVLSLSYGKIRVKAEN
ELTGLVPESFETYQLVNVGDLIFRPTDLQNDTVSLRSSISEYEGIITSAYLNLRFKENAN
PKFFHYFFRGIDNNKIIYGLGSGLRQNISYLDFRRFNFPFPPIEEQQTIANFLDDKTAKI
DLTIAIKEKEIELLKERRQILIQKAVTKGLDDTVTLKDSGVDWIGEIPEHWEVRKLKYCL
TIKNGQDYKHVETESGYPVIGSGGQFAHASKYLYDGEAILLGRKGTIDKPQHIIGKFWTV
DTMFYSIPKKKFLGKFLFYCCQCIPFSFYSTATALPSMTQKDLNNHLISIPQLEEQIRIV
SHLEEIEEKIAKAILLKQQEIEKLKEYKTVLIDNVVTGKVRVS
>LONDMIMF_03362 hypothetical protein
MTNVLEPRSIGELTLTSKNYRFFIPSYQRGYRWGKDEVSALLNDLLEFLIFSENKKEKYC
LQPIVVKEMPDSRYEVLDGQQRLTTLYILLSYLRQSDDEVSLFSLQYETRTNSETFLQNL
TTEINSDNPDYFYISQAYGIISNWFTDNGTRVPRLKRKITDIVLEQVDIIWYEIKDESNP
IDVFTRINIGKIPLTNSELVKAIFLSKNNLQLGLDEEDQKIAETILNNKQSVIALEWDVM
QKQLQDDKFWAFIYNKKENNYQTRIDYILDLVTESPINKKDSLESFNTYYDKIKEVRSNP
ETVKELEVSNTSFIEKEWSELKAYFDILLEWYSNKWYNHIIGFLISRNENVIELLKKYKD
LNRDGFKASLLNRIKDRFLAKKLSALSYESNDKKTIEGILLLHNVVSSLLQPDTSIQFPF
DQIRTNKWSLEHIYAQNSEDLKEKDIPLWIDEHLQYFQKNLKENDTELVAIIESLKILSE
FDISNGFSEEYKELFTNIFSDIDRYNSKKDEQDMKAEALIDEADDYHWITDDQSIANLTL
LDVGSNSYLSNSIFGVKREKIKELDKIMAFIPNETRKVFFKYYSDTVWHDAYWTLDDRKA
YVQDIESKVYHLNNLLEN
>LONDMIMF_03363 Bifunctional oligoribonuclease and PAP phosphatase NrnA
MKEEDIKGIQELLVSPKKIAIIPHRSPDGDAMGSTLGLCHLLKKLGHDAVVIAPNEFPEF
LAWLPGSEAVLIYEKDKTNVTAVLQKAELVFTLDFNALHRTGEMESVLSKLTVPFIMIDH
HQKPDNYAIYTYSDTNFGSTCEMIYNFILFLGHKNLIDKTIASCLYTGIVTDSGSFRFPS
TTSMTHRVVAELLDIGVENGDIHNSLFDNNSYHRLQLLGRALQNMKVLPEYKTSYIKLTQ
QELDEFHYVKGDTEGIVNYGLTIRGIIFTAIFIENKEEGIIKISFRSQGNFDVNQFARDY
FNGGGHINAAGGKSTLSLDETVKQFESILPKQNFNV
>LONDMIMF_03364 Chloride/fluoride channel protein
MNMESTGIQNHLSSFFKWIVICLLTGILSGLASALFLFLLEWATSYRENNYWIISLLPVG
GLMIGLLYYYYGKEAVKGNNLILEEYDNPKKTIPFIMAPLVLAGTIITHLFGGSAGREGT
AVQMGGALSDQFTLLFKLQPEERKTILIIGISAGFASIFGTPLAGALFALEVLYFSKIRI
NSIVPSFMTAYIAYYTVELLPVKHTHYSIPFVPELTAMNLFWIVPAGILFGLAAMLFSRT
THFWGHLFSKYIPYPPLRPFAGGIILAIVIFSSHTTKFIGLGIPAIVDSFQNQSDNFDFL
LKILFTGFTLGAGFKGGEVTPLFFVGATLGSALSGLIPLPVALLAGMGFVAVFSGATHTP
VACSIMGMELFGVDCGIYVALACLVAYFCSGSVGIYHSQIVKGPKHIVYQKIRRKDLKDL
>LONDMIMF_03365 GMP synthase [glutamine-hydrolyzing]
MQHNVLILDFGSQYTQLIARRVRELNIFCEIFPYNHFPSDLSSYKAVILSGSPFSVRAED
APHPDLSQIRGKMPMLAVCYGAQYLAHFSGGEVAPSNIREYGRANLTFIKDDEDFFDDVH
LNSQVWMSHSDTIKKMPENGVRLASTKDVENAAYRIEGETTYAIQFHPEVYHSTDGKQIL
ENFLVKIAKVPQNFTPNAFVEEIVAELQEKIKNDKVVLGLSGGVDSTVAAVLLNKAIGEN
LYCIFVNNGLLRKNEFENVLEQYKGMGLNVKGVDASARFLGELAGIEDPETKRKTIGRVF
IEVFDDESHQLEDVKWLAQGTIYPDVIESVSVKGPSATIKSHHNVGGLPDFMKLKVVEPL
RMLFKDEVRRVGATLGISPELLGRHPFPGPGLSIRILGDITPEKVRILQEVDSIFIEGLK
SHGLYDKVWQAGAILLPVNSVGVMGDERTYEKVVALRAVESTDGMTADWVHLPYEFLMTI
SNEIINKVKGVNRVVYDISSKPPATIEWE
>LONDMIMF_03366 Muramidase-2
MKQFFYVLVLMFLVSFTAKAQQNVKHTVLSGETVTQIAQKYKVTPLDIYTLNPDARNGLK
ENSVLLIPSKGTVKIPVKEQKVTDTPSQKKNGTHTVAPKETVYGLAKQYNISVSDLEKAN
PEIKNGLKIGQVLTIPKKEQQAPPQETKPTKKEERKAEKAEKKAEKEEKKELKNTVQDFT
HEVQPKETKYSIAKKYGITLEELEKRNPETKEGLKIGQVLIIKGNPSKVETADKKSETRQ
EAPKQETADSNFDKYEVKPKETLYSLSRQFGLSQNELIDLNPELKDGVKVGMMLKVPNTL
PVSGASTKNFTDLTKTLSKKDRKELVLLLPFNLTKISGDSTSTVQTRLKKDGFLNMTLDF
YSGALMAIDSAKTLGLNIDVKIFDSQENKNTSNISSTFVQNNLTKADVVIGPFYQAHAEK
TAEMLNQSNVPVISPLSKDSAKLYSNLYQSMPTPEYLRNAMFDYMNSKNGNIVAVVDPKK
ATTRKYISDNYGNVRFATFTDKGGLSAESLKSLLKPNQMNYVVMETASIWMIKSTITALL
AAQSEYQLQLVILESNEALDSDEILVSNLAKLKMMYPAVTRENDTPEALIFAKMYKKKNN
ILPNQYATRGFDVTFDAMLRLSQEKSFEETIYDVATEQVENKFNYNRNPAGGYSNKGVYI
LYYDEDLSVKEAK
>LONDMIMF_03367 hypothetical protein
MTSKVTYLGDLRTSSVHLQSGTEILSDAPTDNHGKGEAFSPTDLLANALGSCMISIMAIK
SKDMDINLVGSTVEVTKIMQAEPRKIAKIEIVMNMSVAADDKTRTILERTAMNCPVILSL
NPDIEKVITFNWK
>LONDMIMF_03368 hypothetical protein
MENSQFITFQKFNLKEDAVELANFLKESKIEYRIEDVSSGLDGNFGGSELTKDYLIKLQK
EDFEKADVLLLQLSSNLVETIGSDHYLHDFTDEELKEIIVKKDEWSHLDYLLAQKILKER
GHEIAPEEIERHRKQRLEDLAKPEERQTIWIIIGYIMAFLGGFMGIFIGWYLKTHRKTLP
NGDRVYNYIESDRKQGGRILTLSTISLVFWIGVRIYFSK
>LONDMIMF_03369 hypothetical protein
MPFGKYEGRYLIDLPEYYVVWFSNKGFPKGELGQQLQLVYELKLNGLEELVRNIKKQYAK
P
>LONDMIMF_03370 hypothetical protein
MKYAAVKQDGSSLEGDYATSATRNVTLFIPLLDLILVLIDKPRLGDDLAKTKVVNK
>LONDMIMF_03371 hypothetical protein
MYIKAKRHRAKNIPKSIIKSEGLFFFFDKLTFEGLEAPYLLYGGTF
>LONDMIMF_03372 Zinc-transporting ATPase
MEHKHKYDAQGKQLCCTPQEEKIYTDANAKKLLEKHHDNDGHNHEHSDDDGHNHGSTDKS
TIQMFLPAIISFVLLMIAIAFDNWFPQSWFTGWVRIVWYIVAYAPVGFPVIKEAFESIRK
SDVFSEFLLMSIATIGAFAIGEYPEGVAVMLFYAVGEVFQTLAVTRAKANIKTLLDQRPD
EVTILENNQPKTVKAETVNIGNIIQLKPGEKLGLDGELLSETASFNTAALTGESKPDTKT
KGETVLAGMINLKTVAQVKVTTAYTDSKLSKILELVQNATAQKAPTELFIRKFAKIYTPI
VVLLAVLITVVPYFFVDDYLFSQWLYRALVFLVISCPCALVISIPLGYFGGIGAASKNGI
LFKGSNFLDAIADIKNVVMDKTGTMTEGVFKVQEVVLKSEFNKDEILKMVNALESQSTHP
VATAIHQYVGEIDNSIRLDNTEEIAGHGLKANVNGRELLVGNFKLMDKFNISYDLDPTTI
VYTLIAIAYDGKFAGYITIADSIKEDAQLTIDKLKALGVKTTMLSGDKSTVVKFVADKLG
INNAFGDLLPEDKVNKVKEIKAQNETVAFVGDGVNDAPVVALSDVGIAMGGLGSDATIET
ADVVIQDDKPSKIPMAINIGKQTKKIVWQNIILAFAVKAIVLVLGAGGLATMWEAVFADV
GVALLAILNAVRIQRMKF
>LONDMIMF_03373 hypothetical protein
MIWLKFYLPVYLVLYMMVAFVLPSYRTYKQTGINPVTFGKTDNAHDYIGFVMKVLIALLF
VAVFIYSFSDKIYQYLVPISYLMKDVFLIIGLILIHFSLLWISVAQYQMSNSWRIGIDEN
NKTELITKGLFSYSRNPIFLGMIISVAGIFFILPNALTFFLMLTTYIVIQIQIRLEEEFL
EKQHGEQYLIYKKTTKRLL
>LONDMIMF_03374 Cobalt-zinc-cadmium resistance protein CzcB
MKFNIKKITLMTAIAVLLFAFSACKNDKKAEDKSAETKTAGKEEAPHEEETPTIATLTEE
QIKTVGIQLGTIEHKELTATIKANGNLKVPNNNKANATSLYGGVIRTLKVQIGDYVRKGQ
VIATIANPQFIQLQEEYLSTASRITFAEQELARQKELNEGNAGAKKNLQSATAELSSLRT
RRASLQQQIQLMGINPGSVSNGNLKSALVVTSPLNGTVSNVFAKIGSYVDVSSPVIEIVD
NSSLHLDLQVFEKDLPQVKVGQTIHFTLTNNPTAEYDATVFSIGSSFENESKTIAVHCRV
NGNKSGLIDGMNITGIVSLSNVTTPAVPNDAIVNADGKYYIFVQTDKEAEAHHEEGEKEG
NHKEGEEKDHKEDKTAKNFEKVEVLKGVSDMGYTAVTFVNEIPANAKIVVKGAFFVNAKL
SNAGGHEH
>LONDMIMF_03375 Nickel and cobalt resistance protein CnrA
MGGEFIPQLQEGNFAFHCILPQGSSLSQSIETSMQASRIIKEFDEVKMVVGKTGAAEVPT
DPMPPEATDLMVILKPQSEWKSGRSYDELADAINEKLEAIPGVFFEKNQPIQMRFNELMT
GIRQDVAVKIFGENLDTLALNADKVSKVIQTVEGATSPQVERVSGLPQINVEYDRTRLAN
YGITVEDVNNVVSTAFAGKSAGVVFENERRFDLVVRLDSTYRSSIEDVNNLMIPTSTGNQ
IPLSQVANIDYKLGPAQISREAGKRRIVIGFNVADRDVQSVVEEIQQKLNAQVKLPPGYY
FTYGGQFENLQEASNRLMIAVPISLLLIFVLLYFTFRSFKQAGLIFTAIPMSAIGGVLAL
MLRGMPFSISAGIGFIALFGVAVLNGIVLIGTFNQLEKEGIKDVFKRVIEGTKIRLRPVL
MTATVASLGFLPMALSSSAGAEVQKPLATVVIGGLVTATFLTLFVLPLLYIIFNSKINLK
RKPKVKPIATIIVLLLSLTGFTANAQTQHLSSVDDAINIALQNNQAIKASDLEIDASKAL
KKTARELPKLDFNAQLGQYNSTKFDQSFQVSQTIPFPSLFGAKKQLINAEIKGKELQKNL
TVLELKNQVRTYYYQILYLQHNEKQLQQLDSLYNDFIKIAQVRYKTGDTKKVDISTAEAK
KGEINLLLKQNGVFLSNAVANLKTLMNTKDDFTIVENGIFQPLQISNLLDNEAVANHPAI
QSLYQDAIIAEQTKKVERSQGLPDFTIGYVNQSLIGFQNVNGSEQFFNGGNRFSSVNIGI
AIPITYGATKARIKSLDYRKQAAEANAQQQQRTLATQMQNALLQYQQDMKQFNYFQQEAL
PNAKEIVSAAQLGYKTGDIGYVEYLFALQTATDIQLNYLKSIQQVNQSVINIYSFINQ
>LONDMIMF_03376 hypothetical protein
MRGFFVFNYFGFYMGAFVISKKDEDHYKFVYTSRKGKIVFTSMTYELKMDCESDIEIIKA
KAETALCLKFKASSGKYFYKLIIDSKIYAVSRKFNTELRLAKGIAEVALYVPKAEVLDFT
GADIFADLP
>LONDMIMF_03379 DNA mismatch repair protein MutS
MATKDKAPKETPLMKQYNEIKAKYPDACLLFRVGDFYETFGEDAIRASKILGIVLTKRGA
GSDTETALAGFPHHSLNTYLPKLVKAGLRVAICDQLEDPKMTKTIVKRGVTELVTPGVSM
NDEVLQSKSNNFLASIYFGKRIIGISFLDVSTGEFLAAQGNEEYIDKLLQNFSPSEVLVP
KQNKANFKEVFGEDYHNFYLEDWVYKEDYAFETLTGHFQTNSLKGFGIEELPEGIIASGA
ILYYLSETQHNKVQHITSIQRIAEDAYVWMDRFTIRNLELYHSYNPNAVTLLDVIDRTLS
PMGGRLLKRWLALPLKDADKVKGRHEVVSYLKENNEVLKSIQYQIKQISDLERLISKIAT
GKVSPREVVNLKESLDAIIPIKTLALDSKNTAVKTIGDSLHSCDLLREKIKETLNPDAPV
SINKGNAIAKGVHAELDELRSISTSGKEYLEGIETRESERTGISSLKISFNNVFGYYIEV
RNTHKDKVPAEWIRKQTLVNAERYITEELKEYETKILGAEEKIHQLESQLFEQLVVWIST
YIKPVQLNANLIAQLDCLSSFTQLAIENNYVCPVLDDTFELEIKNGRHPVIEKQLPVGVP
YIANDVYLDRETQQIIMITGPNMSGKSAILRQTALIVLLAQMGSFVPAESVRMGIIDKIF
TRVGASDNISMGESTFMVEMNETASILNNLSDRSLVLLDEIGRGTSTYDGISIAWAIAEY
LHEHPGRPKTLFATHYHELNEMTEILERIQNYNVSVKELKDTVLFIRKLIKGGSAHSFGI
HVAKMAGMPQTVIQKAQKLLKKLEKDHSGEALNGTKASNDEMQLSIFNLDDPLLEEIKDE
ILNLDINTLTPVEALMKLNEIKRMLGKK
>LONDMIMF_03380 Putative TrmH family tRNA/rRNA methyltransferase
MRKLANSELERKSIEDFKQAEKTPITIILDDIRSLHNIGSVFRTADAFLIEKIYLCGITA
TPPNKEIHKTALGATETVAWEYAKDVLEVIDTLQKENVSVMAIEQVENSISLQEFEPKSG
QKYALVFGNEVKGVSQEAIKKCEGTIEIPQLGTKHSLNISVSAGIVVWDLFQKLNY
>LONDMIMF_03381 Deoxyguanosine kinase
MKMQHQAILSIGSNQGDRLRNIQEAIDLIHSEVATVVKVSRLYETPAWGFEGDAFYNCVL
LVHTFKESAVLLDEILNAELRLGRIRNKAMGYQSRTIDIDVISFDEEIIDTENLKVPHPR
MADRKFVLLPMDDLKSDFAHPVLQKNVTELLRECHDDSDCNVVSNLKSPVTDYHFDRFNY
IAIEGNIGAGKTTLAHKIAEDFNAKTVLEGFADNPFLPKFYKDQARYAFPLEMSFLADRY
QQLSQDLAQFDLFKDFIVADYHIFKSLIFAKVTLGEDEYRLYKTLFDIIYKEMKKPDLYV
YLYQNTERLLENIKKRGRSYEQEIPAEYLDKISRGYLDYIKSQKDLNVLIIDVSDKDFVK
NQSDYLQILNEIESQALAV
>LONDMIMF_03382 Protease 4
MNFLKNVFSTVLGLFVFLFILFFGFIIIAALFGNNEKTVTVKDNSVIELNLEEVTNDYAG
KFLYEDFEFLNEEKTNGLSDVINAIDAAKTDSKIKGISILNNISLLGMAQSKALRDKLED
FKKSGKFVVAYANSYSQKEYYLNSVADTIYLNPVGEMDFKGLSSEVMFYKDFQEKTGIKM
EVIRHGKYKSAVEPYLANEMSEANREQISVLLNSVWNSVVADISKSRKISVDRLNEIANG
LLARTPEMAKAEKLIDKIAYEDEYHDGIRKALKVKKDEEYNTVSIIDYAHKNSTTGKKPA
TDNTIAIIYAQGTILSGEGDVNIIGEGSMRRSLQKARKDKNVKAIVLRIDSPGGSALTSD
LIWREIELTKKVKPVVVSMGNVAASGGYYIACNASKIFAEETTITGSIGVFGTLPNITKL
TNNIGIHTEQVKTHQNAAGYSIFLPLDEGTKVTLQESVENIYKVFVGRVAQGRNMNFEAV
DSIAQGRVWTGTDALKIGLVDKIGGMDDALKEAAKLANIKEYKTADFPSYEKKFGDLFGG
MPFMKSKESFIKEEVGEENYQMIEQIRRMSAQKGMQALLPYEINIK
>LONDMIMF_03383 hypothetical protein
MQNIIIFFIFYDNFVSFFLIFADKGSFRFTIYIGSIIHIEFVKVFYSNSFRQYDSYFACI
SMWIVDFYRHHSLIFLIEFHLFSNSLTSRKQVIFPCLTNQVFSFKYYIHYKWFFTNVVNS
VIFGCKCFEFGFDCIVLGNAFEHIFILLR
>LONDMIMF_03384 hypothetical protein
MRWLRLLNKNCFFISLIFLSLQVEAQEKTPVFLEYKKKYGDINEVVISNKSSYDIFIENK
KLRILQDSYYESMILSENGIQNNQENFSYSELVKLNKYEAYSIINDKGKDRKIKVTQTNE
KQAKQNSVFYNDVKERQLIFSNLEAGAKKVYSVQTEFLDPFLLHSFIFGDNFPIVNSTLE
VRTDKDINIGYRIFNDPTNSIEFSKSEKKGKYIYNWTLKDVKAVKMEPNNPGFRYFIPHI
NIYVKDYTIDKNTTKVLDNTEELYNYYKSFIKNLNKTDDTELKELSVELTEGLSSDTEKI
KKIFYWVKDNIKYIAFENGYEGFIPREASLVFKRKFGDCKDMSSIITSMANYAGIKNVTV
SWIGTREIPYSYEQLPTPSVDNHMIAVYNDNGNYIFLDATDRESRYGIPTSFIQGKEALI
SNGDTYKIITVPVVDAENNETVEVLKLSFDKEKIIGSGTVDYKGFARSSILSQIGDASNK
RRFDMIKSLVLKGNNKFNLKGFSEKNVSDRDKPYQIDFNFELSDYALQVDKELYVNLFLD
RLYEKLSLEPDRVTAFDLEYLAAYNGSYELELPKNYSVKYLPENVSFDNALMKFESQYTN
IAGKVILALKIQLKKILLEQPDFALWNETVKKLKNTYTQTLILTEK
>LONDMIMF_03385 Beta-barrel assembly-enhancing protease
MKNIFIAFVFGFSSISYAQTDYSFVYDSESFLSDGIRLYEEGKYQDALKTFDKIVKDDPN
FYSAQYEKAITLAVGDDKEAARAFYENAYNKGYMKENPLFYMAYGNFLSDQKDYDKAEKM
FQESLKIYPNSSSLFYNLALLYLRKEERQKSVDYLKKAITINPNHAGSHYMLGLIALEDG
RVTEGSMALLAYLSLVNEGKGCENAILKLNAKFSENYLDKSKLTFSKSGDNFEEIDVILR
NSLPLKSAYKVNSTIDDVIIRQVQAIAEYATEHKVEGGFFETIYVPWLADIVKKKQFEGF
SYHILLGMKEHLGKKITSQNKKITAFNETYLSRDFWQVFARRTVDLFGKQEQVVVYLKNN
KPYLLGKEENGKKVGKYKVLNEDGNMVGELNLVNDELDGLQKYYDAKGRLTEEKNYSKGK
AEGKRTKYYENGNVEFVENYKNDLLEGISTSYYYNGGKSCEVNFVNNERDGAFTCFYENG
SKKSEINYSKGKFNGNYILYDTAGNISNSYSYVMGEIDGKVYEYYDGKIVKSEIEYKTGK
ISSPYKVYYPNGILKEETTYQNNNPVNQISNFANGKKSYETLYDKDGYVASYNYFNGNDD
LYFQETYKKGEIKTALQYETGKSKPTEVPVSKGTYIMKNLDGLVLTKGNYEKGSKKGEWN
YFYNTGSLSTKESYANGKLTGIANTFGTDERPSSVFNYVNDTISGVYESYERGHLSNVYH
YKSGKLNGPHKSFYPDGSISKENFYINGELYKGIDYWQNGNANLVTWYINDVAIKLETYS
PDGKKQNEINYANKNEKMSIAFFGGAEIHENTLKNGAFDGKYIVKDKNGRMISDNNYMNG
FRHGKQVVYGPTGAPTTEKNYYSGKPNGISKYYDIVGNLRMSDNELFGNDTGTFTRYYHN
KGKYLEYNQYNNNIEGEAKYYNQKGDNILIVGYQNNELLYYIKLDKNGKLSEKTPVVGQT
AKIISSYPNGKTAIEINFVKGNIDGKLVVNSQEGRTEYEANYDMNLLSGPRIEYYANGKV
YKKENFKNSSFEGLQQFFKEDGKPWVTAEYKNDELHGLCKIYTNGIVSQTQRYDSDALVE
IIK
>LONDMIMF_03386 hypothetical protein
MIFSLRLCVFASNYFRVKTQSRKTFVVKFPAIHYFYRMTEENLKILSFFENIEKYYGCKT
EITEGLYSLQESFDNHSTTWNLSEFTLIRSGYRKSGGRMMMEGEKMYFEISAALIVSFKQ
TGRNSFEFIEKYGESVFRITKIRFHYRY
>LONDMIMF_03387 Threonylcarbamoyladenosine tRNA methylthiotransferase MtaB
MTENRKKVAFYTLGCKLNFSETSTIARNFQDEGFDRVEFEEVADIYVINTCSVTENADKQ
FKQVVKKAMKLNEKAFVAAVGCYAQLKPEELAAVDGVDLVLGATEKFKITDYINDLSKND
FGEVHSCEIAEADFYVGSYSIGDRTRAFLKVQDGCDYKCTYCTIPLARGISRSDTMENVL
KNAKEISQQNIKEIVLTGVNIGDYGKGEFGNKKHEHTFYELVQELDKVEGIERLRISSIE
PNLLRDETIEFVSKSRTFVPHFHVPLQSGSNDILKKMKRRYLREVYTNRVNKIREVMPHA
CIGVDVIVGFPGETDEHFLETYHFLNDLEISYLHVFTYSERDNTEAAAMPNPVPANIRAK
RSKMLRGLSVKKRRAFYESQLGTNRTVLFEGENKEGYIHGFTENYVKVKTPWNPELVNTL
HEINLTKIDEDGLVRMEFLNVEA
>LONDMIMF_03388 Oligopeptide-binding protein OppA
MKSIIYYISIFWITLTLCSCGKRAEENRDHEVFRFNQDANVSSLDPAFAKSQDNIWMCNQ
LYNGLIQLDDSLNIKPDLAKSWTISEDGKTYNFNLRKDVFFHKSGVFANSKDSTRTVNAH
DFEYSFNRLLDEKIASPGGWIMQNVENFEAKNDTVFEIRLKKPFPAFLGLLSMKYASVVP
KEAFAVPGYDFRTKPIGTGPFQFKLWEENVKLVLRKNPLYFEKDENGNQLPYLEAVAVTF
LPDKQSGFLLFAQGKIDFVSGLHPSYKDEILTQSGELQEKYKKDVTMITGPYLNTEYLGF
RMDGNDKVLLDKRIRQAMNYGFDRQKLITYLRNGMGTPAINGMIPAGLPSFDASKIGYDY
DIQKARDLVAAYKKATGDKNPKITLSTNATYLDISEYLQREWKKIGLDVAIDVNPPATLR
QAISTGKVSFFRASWIADYPDAENYLSLFYSKNFAPNGPNYTHFKRDEFDRLYENAFLET
DNAKRFELYQKMDDLIIKEAPVIPLFYDKVARFTRKNVTGLGINPLNMLDLRRVKKSKI
>LONDMIMF_03389 Response regulator MprA
MKILIIEDEAGLREVIQQSLEKEKYIVETAHDFISGLDKLGSYDYDCVLIDIMLPNGSGL
DLLAEIKKQRKQEAIIIISAKDAVDDKVKGLDLGADDYLSKPFHLAELHARIKSAIRRKS
HNGDNHIVWKNLTLSPEQRSVTVNNENLVLNRKEFDLLYYFVINPNRLINKTALAEYVWG
DHTDQADNLDFVYSQIKNLRKKLKDADAEMDIQAVYGIGYKMS
>LONDMIMF_03390 Swarming motility regulation sensor protein RssA
MKLQNYTLRYLAITLLAVIPIWAGLFYMLILDEVYDNIDDDLKNSKIIIIRQAFADEKLL
NTPEFGINKFTIKPLPKGNYSYKDEFSSSSEFMEYDDDDEPIRTLTTVFNDKEGNPHELI
IKASIVEEDELLEDLALALLGLYVMLVISILVVNHFLLKRIWKSFHAILDNLKKFRLGTG
MQPKPINSPINEFKTLAKEVEEMLQRNEIIYSSQKQFIENASHELQTPLAISINKLELFA
ENNTLPEEQMSEIGKITDTLNRLVRLNKSLLMLSKIENQQFAEEEQVHFNELIHQLADDF
SDLATYKEITISVTENTSLSFSMNKGLATALISNLLKNALVHNHQGGKVTFEIDENSITI
SNSGATTPLNPEIIFNRFYRHTNTNESTGLGLAIVKSIANTYSLSIKYSFVDSHQFKIIF
PKK
>LONDMIMF_03391 hypothetical protein
MKVQFILGLIASTFFSLSVSAQKTTITTAELPANAQTFLKKHFPNETPTYIVKEKEIFST
EYKVQFSNATEIEFDGKGNWEEIDGNHNAIPVTAIPAKIAAYVKANYKDANVTKIDKSRW
GYEVDLSNGLELEFDSNEKFLRIDY
>LONDMIMF_03392 hypothetical protein
MKSIRNLLATAFLASITAILLASCSNDDNNDGNTSTVIEFSALPENARTFLTTHFPGVES
RMIKQNAIADDDGSIYDVYLNNGFEIDFDSNGNWTDVDGNTQAVPTAIVPEAITTYVTAN
YAGQTINTIEIERIGYDIELSNGLDLVFDSQGQFIRIDS
>LONDMIMF_03393 1,4-beta-mannosyl-N-acetylglucosamine phosphorylase
MRLSVERKPIKVYPDSGRVIARYFFNGEERAVELLKKLLLLDNETVFGLISPLLQDFSKR
HRNITKKLLKHCDRVKAYIEKAGGNYEKLDDYTKLLIGSYFTHEYSIESAAFFNPSIVPD
PDQTNLEEGQLRVLISFRAVGEGHVSSVVFRRAMIDKHGNITVIPAGNYIDEAEKVHNMV
YNKKLFLKKAQEADINDDFLKAVDEKLGERFDYDSLKKVVIEAKEKTKDEKIITQYNMIL
ALSDSYRKISFSKDTDISDRVIFPISDFESNGIEDARFVRFVKENGKVIYYCTYTAYDGN
HIMPKLLQTYDFYDFKTSPLNGSGAKNKNLALFPRKINGKYAMLSRIDGWNNYLMYSDHI
NIWEKPIKIQSPEYPWELVQIGNCGSPIETKYGWLIITHAVGPMRRYCIGASLLDIDNPE
IEIGRLKEPLIMPNPDEREGYVPNVVYSCGSIIHNNDLIIPYGLSDHSSGFASVNLDLLL
EKLVQGG
>LONDMIMF_03394 hypothetical protein
MNFAETVYQKVSMKSVALLFIVFFTAQMYAQVDYNKSISIPSANTNSTMSIPSTESNTTV
DPNFGFTIPKSLPKSDKYKVGGTDTVNFGQGSEQFANPGDKYTKELNKKSGGESQVAVKG
NQYFGDFKNNGEYVNIVFRDHGAPDGDMIKISVNDVVVVASVTLTTDFRTLKLPLKPGFN
RVDFEALNQGTSGPNTAEFHVFDDKGNLVVANRWNLATGFKATAIIVKE
>LONDMIMF_03395 Spermidine N(1)-acetyltransferase
METLSIHTERLHIRHLTQNDLDDFHIYRSNPEVTKYQGFDVMTREQASEFIAKQENKLFG
KKGEWVQYAIESKETGRLIGDCAIKLDAFDERIAEVGMTISHLHQQKGYAKEAFSGIMDF
LFAVKNIHRIVETVDAENIASISLLESLKFRREGHFIENIFFKGNWGSEFQYAMLKREWL
ANS
>LONDMIMF_03396 Bifunctional NAD(P)H-hydrate repair enzyme Nnr
MKALLINKHEILKRYKPVSVQAHKGTQGHALIIGGSYGKIGSIILASKASLKSGCGLVTA
LIPKCGYTSIQTSFPEAMVITDKEEAYISEIEFEIIPNAIAIGMGIGQHETTQKAFIKFL
KDNNKRLLIDADGINILSKNKELFDFVSEQTILTPHRKELQRLIGDWSSEEEMIEKAARL
TESKKWIIVIKGAPTQIISGNAIYTNSTGNQALATAGSGDTLSGIIAGLLAQGYTPEDAA
ILGVYIHGLTADIGSKSLGYQAFIASDIIENLGKAFLSLDENF
>LONDMIMF_03400 hypothetical protein
MKTHKVNYKLISFIVGFLVWLSATVLFRVAGHYFFIVDNALVMAVLYVILIPALGLISTS
VFNKLNLNNLESIKSAAIMVLPGMLLDTACIQFFENLFPNMPETYSKTFASWLMFAYSIV
LIFGLLRKKQKKEIE
>LONDMIMF_03401 Acetyl-CoA acetyltransferase
MNKKVVIVSAARTPIGSFMGALSTVSAPQLGAVAIKGALDKINLDPKLVDEVLMGNVVQA
GVGQAPARQAALYAGLPDSVIATTVNKVCASGMKAVMMGAQSIISGDAEIIVAGGMENMS
MIPHYLHLRNGHKFGPASMIDGMQKDGLTDAYDNNAMGVCADLCATEYKISREEQDQFAI
QSYERSAKAWDAGKFDNEVVPVAVPQRKGDPIMVTKDEEYTNVKLDKIPSLNPAFTKEGT
VTAANASTINDGAGAVVLMSEEKAKALGLKPLAYIKSYADAAQEPKWFTTSPAKALPKAL
EKAGIAINDVDFFEFNEAFSVVGLANAKILGLDNNKVNVNGGAVSLGHPLGCSGVRIIIT
LLNVLEQNNAKIGAAAICNGGGGASAIVIERA
>LONDMIMF_03402 hypothetical protein
MTYKKILKLLSILLFLWFCIHIIYTIIDGNKDEGKSADIAVILGTTVNTDGTLSERLEKR
MESGLKLYKDGRVKKIIVSGGLGKEGFLEGDKMKEYLIGKGMPDSLVIVDNKGNNTTATV
ANTLQMRDSLHYNSVIVVSQYFHLTRTKMLFKKEGFENISSVSPDYSEYRDFYSLFREFF
AYYYDRLK
>LONDMIMF_03403 Trans-aconitate 2-methyltransferase
MTRLVGMHKEMSLANNQTFALWNTFMPRRKEITNNLNTDLFSMQIYDTAYFENFRLDKKF
TKWAAVAVGNFESIPDGMESYTLEGGEYAVFTHKGGPETGAEVFVYIFNTWLPNSDYVLD
SREHFELLGGKYKHGDPESEEEIWIPIKLKVTDKTKIAVALFDKLADRYQDKFMDVGLYA
DSLNLFCDNITKPNASILELACGPGNVTKYLLGKRPDFKILGTDLATKMIELAKANNPSA
TFRLMDCRDLGKVSKTYDGIVCAFCLPYLSKEETQKIIADAYNVLEKNGLLFISTMENDY
EKSGWEKASSGDSIYMHYYPAEFLLTTLKTNGFTIIDERHKKYDGPGNTPVTDLLLIARK
>LONDMIMF_03404 hypothetical protein
MNKNTILGWATFVMVLMGLLLIGLGIFRYDDVAGWGFGAVGIGFFAIAWVFSSLKGRV
>LONDMIMF_03405 Regulatory protein PchR
MSAILAYFSYARRMLFYAKRIRMRITINDSDLDEIIFEKDFHAAYDGLTDIVEQETQLFD
NKIGYTDISEIWFDGVHTLRRRSQLNQEVCLIAKSDLSVFEMHFSLTGSAEVESLNSKFD
YSFGPQQHNFFYSSNFEGKFRGGKQEKPNEVFEIHFTENYFNRFIDSESKTIDKFLKQID
KQEISNCLSPHHMPITAQMNLILSQINQCQRKGVLKRLYLESKILELFMLQIEQFESIQL
TPTSEKLKKEDVEKIYYAKKLLEQNISEPYSLLELAHKVGLNDFKLKKGFKILFGTTVFG
YLHEIRMQQSKRMLLEENKPVKEVAAYCGYQYVQHFTTAFKNKFGITPGKLAHS
>LONDMIMF_03406 Vibriobactin utilization protein ViuB
MTKVPKWLGDTMEVVYQRFMYETVITNVEYLDEKLKRVRFEGDFRKIKFMPGNVVKVRVN
DMEYRHYTLSAFDAKTGFCEIVFYLHGLGPGSNWAEGLKMGDRAKLLGPGGKLYYSENRV
NHFLFGDETSLGWMKCMEEEAERRGEFFFGFVELDEPHQDWAERLGSSVKIVGKSSEFPA
QPVIDIVKEWEEDFWLTAVDTVFYLTGRTKSIQAFRKFLLSKGISSKKIKTEPYWADGKS
GL
>LONDMIMF_03407 Quaternary ammonium compound-resistance protein SugE
MEFLKKKFMNWIILIIAGLFEVAFTFCLGKAKEATGNEAYAWYSGFLVACIISMSLLIKA
TQNLPLGTAYAVWTGIGAVGTVLLGIFVFKDPANFWRIFFIVTLIASIVGLKAVSAH
>LONDMIMF_03408 hypothetical protein
MKLHEILNQIYPLSQEAAQKILRYSSEIQLSKGHTLLEADKNETSIYFIKKGMVRAFAPK
EEKDITFWFGKEGDPIVSMKSYVANLPGYECVELLEDCELYEIQNKDLQLLFLEDIQIAN
WGRKFAERLLVQTEERLISKLFKSAKERYLELLEENPDFVQRIQLGYIASYLGITQVSLS
RIRAEIK
>LONDMIMF_03409 hypothetical protein
MKITSLIALFLFAVQLAFSQSENPVHGKVTTEGFPTAGIEVINQTSGSVVVTDASGKFSI
KAKVGDVLIFAGKNYTSRRITLNQKDFGKTGVETNMNQEAIQLVEVEIKKEVDDVKPEPP
AVAPLRSVDNILNSPTNMMVYNGAIIHGLDFVAIGKMVGNLFKGKKKDKVISNIEMKEYI
SDNFNKDFFLNTLQLKEDEIEIFLEFCYADAKTSTLINNNNVLEITDFLISKKEEFKKLK
N
>LONDMIMF_03410 hypothetical protein
MNEQLSNHTLEANKLQAEARSISQEQLQHEVDYVRAQHILQSLFHKGLLSANEFSKITAV
NRKTFSPVLAAILPSIP
>LONDMIMF_03411 hypothetical protein
MKTVTKIGGQLVFPTQKHKLRVAAYCRVSTDSEEQLVSLATQRKHYEAYITANPDWEFAG
IYYDEGITGTKKEKRPALLRLIDDCEHKKIDFIVTKSISRFARNTTDCLELVRKLLELTV
YIYFEKENLNTGSMESELMLSILSGLAENESVSIAENSTWSIQRRFQNGTFKLAYAPYGY
DVIEGKLVLQPEQAPIVKAMFDQTLAGIGTDAIAKELNAKKIPAKRGTHWTATTVRGILK
NENYTGDAIFQKTYTDSHFNRHHNHGEKDKYRVEHHHEAIITKDMFEATQQVIRQRGKEK
GALPQDKKYQNRYPFSGIIRCHQCGATFKRRIQGGHNSYVAWCCATHVADTTKCSLKYIK
EAALEYAFVTMMNKLIFGHAFVLKPLLASLRTLHSNDSITVIQDLDTKLAENAEHQKTLA
YLLTKKYLEPAMYQKGNNELLQEAEQWQHQKDSLVDFLNDDNKTVHETRELLQYTCKAKM
LTGFDEAVFQQFVEQILAYSRTNIGFKLKCGITLRERLV
>LONDMIMF_03412 hypothetical protein
MDVEEAKKIQVLFQAYLSGAALTTAAKEAAIHAFHRSIRHILQTTHYIGDDYYPAIIDAD
TFTAVQKEITRRAKKLGRIREPKKASPVLYPTTFSLAEKTQTYTDPFQQAEYAYSLIESE
ESIHGITDAECHDHSGTNLSTPKPY
>LONDMIMF_03413 hypothetical protein
MAAYCRVSTDSDEQATSYETQIEHYTTYIHNHPDWKLAGIYADDGISGTNTKKRNEFNRM
IEDCMAGTIDMIITKSISRFARNTLDCLKYIRQLKDKHIPVFFEKENINTMDSKGEVLLT
IMASLAQQESQSLSQNVKLGLQYRYQRGEVQINCNHFLGYAKDENKHMVVVPEEAEIVKR
IYREYLEGASMLKIARNLTADGLKNGAGHTKWRDSNIRQILQNEKYMGDALLQKTYTVDF
LTKKRVKNTGIMPQYYVKDNHEAIIPRDIFLQVQEEMVRRSSIHLKNGRKLTYSSNHCFS
QRIRCGKCGEIFRRIHWNNRGKKSIVWRCVNRVDHTGKCDARTISEPALEQVCLTAINQV
LCEKKDFLAMLQHNIETVLSHSNDETLVAIDTRLEELQTQLVKLASSKAGYDDVAEEIYH
LREQKQQALAKNANQDEIRSRIENMATFLKTTSTAITQFDDYLVRQLIKTITVFEDSCTV
EFKSGVTVDVEK
>LONDMIMF_03414 hypothetical protein
MPKYYVFRINYEESWQPLVRSAIDKGELRQGWGMQQGTDSLRVDPDESAFLKAWDKIWPG
SEISYCKRKYSSLSKMLDFNNGDIIVVPKAPDWRQFLILTVNGSYRFDDDLNSKFNNGDD
FRHIIPVEYKKTVGYDYSDDSRKIVKKFGAYRSPINSVYDKKFQNAINTLLQDSNKNLTT
SQDELAALGLEDSQPFKDLKKWIPNTINNWGADKLEKLIQSLFEKNGFTLIKRNRHNNKG
GDIDLVFAMPSVPLLDGILEDTPFPQVWIQAKNKRGHDANAIDGIKQLIEQKRTDNLSAI
CILINTTDCFDKEAKMMAESHDIILINGTQFARLILKYGIEDCLA
>LONDMIMF_03415 hypothetical protein
MPDYSIYEFNELVTDQELGNATLILGNGASMAVSSSFSYTNLFGKACNDSILNQTSKNLF
ETLQTTDFELVMNKLRQAYIINEVLQLDTDNVALHTYDNIRQSLIKTIKEIHVQYADAIF
QIDNIRKFLEKFKTVISLNYDLLIYWAIMASNDRKPYKMKDCFTNHIDGNLGFEYDIEKL
REPYNGGPDPTLVFYPHGNLILASNENNDELKIRINNNTNLFDAIGEKWKQKYVPLFVSE
GSSEQKLKAIRRSTYLNFVYENVLSHLEPTVIIYGWKLAEQEQHLIKKIFSNNKISNVYI
SMYLGSNPEPIDEQKRIASMLKRENRTMNIKFFDAASKNCWCNF
>LONDMIMF_03416 hypothetical protein
MEEQKNIYRLCIVVNCLDKPMLYIFSYSTEANTWLSENGESLIIDQVISAKCYV
>LONDMIMF_03417 Esterase YbfF
MTQNNGRWIPINGKKLYIEFQSTYENRPTLVFLHDSLGCTSLWRDFPQKLAEAIQCNVLV
YDRLGYGKSDPMPTHERPINYLEAEAHSLDSLLNALAIDNAILFGHSDGGSIALITASRY
GKKIKAVICEAAHIFVEELTLKGIREAMETYQSTDLPERLQKYHADKVETLFKAWTGTWT
RADFRSWNIEHFFPAISCPLLFIQGESDEYGTMEQAEKTVSQVNGTASVFSIPGIGHTPH
KEAPDVTIEAVKSFLKK
>LONDMIMF_03418 2-hydroxy-6-oxononadienedioate/2-hydroxy-6-oxononatrienedioate hydrolase
MIKTIFYLAFLIVQQCAYSQLKYTTTNTALVKLLPVKKYTGKQYRLSIDIKNEPSDDISG
GTVMVLQTKKQDWEFLENTRKTFFAPKDSQTWKTYTITGSIDSEAYKLWFTLATYGNGDF
YYDNMKFEIKEGENWVDVPVEGGDFEKLSAGNPLKGFKNGESAKKEGLSVSLVNQEGRGQ
SLRIHAEGGTIDKRFFYGNNSATGKYINSKGVKIYYETYGEGEPLLLLHGNGGSISSFAG
QIEEFARNYKVIAVDTRGQGKSIDMQTEHFSYDLFADDMKTLLDSLGLKQVNVVGWSDGG
NTGLLLASKYPDYVKKLVTMGANLNPSDNAIDKKMLKTIAKDIKQLKDQKNAEIVTIRLL
EMLLQEPNIQPESLGAIKAKTLVVAGEHDLILENHTRLIGASIPGAKVSILKGQTHEVVA
DNPKVFNQQVLDFLKEH
>LONDMIMF_03419 hypothetical protein
MKNKLLIAAFCCFLKSYGQKTEKVFLDKNDPSHECYTAILPDKSPVVGYLVLIPGFGETA
ERVMQQTDLPLRCAEKGILTIIPTLTDGVMSFGVDNSSQKSLTAIIADASKKFNLAARQF
YIGGFSIGGSAAVKYAEIALSGNFKNKPAAIFAIDPPLDFERFYNSAQRDLRLSAGSQPN
QENVYMVGRIKQVMGGTPVDALKSYHAISPYSYSDTEQKAIKSLVNIPIRLYSEPDVNWW
IENRNADFSAMNVLDGSAMVNELRRLGNRQAELVLTENKGYRKPDNKRHPHSWSIVDSEG
LIGWLLGNKG
>LONDMIMF_03420 hypothetical protein
MQRIAEIFTMSKLFNPGVYFEIPVTNLERAEQFYTSVFGFEFEKASIHDNEMALFPLDEN
ASGISGALAKGEIYKPTKDGTLIYLKSKKIDETLKRVINNGGTILFPKTSNGEWGFVAEF
EDSEGNRIGLLEALES
>LONDMIMF_03421 hypothetical protein
MASTIMTAPSTIIPKSIAPRLIRLPLTPKRRIIVMAKSNAKGITEATTNPARQFPSNNTS
IKITISAPSIRLVCTVFIALSTNFVRSINGSMATPSGSDFLICSIFSFTLFTTSPLFSPL
SIMTIPLTSSPLPSLVTAP
>LONDMIMF_03422 Type I restriction enzyme EcoKI M protein
MSAQEIANKLWNLCNVLRDDGVTYHQYLNELTFILFLKLSEVKGFSDQIPEEYRWNKFVD
ETDNVKAFDLYRKFLATVSNETSSPSIKDIYTNASTTLTKPVNFNTLVQAIDKLDWYEES
DRDVMGDIYESLLEKNAGEKKSGAGQYFTPRPLINVMVKLAAPKLGEKWNDPACGTFGFM
ISADHYLKEKYDYRYVLSSEKIKFQEEEAFSGVELVADAHRLALMNARLHQMESNIILGD
TLTSLGETLKGYNGVLANPPFGTKKGGEKPTRTDLKYISSNKQLNFLQHIYRSLIADGTG
RAAVVLPDNVLFEDGDGQRIRKDLMEKCNLHTILRLPIGIFYAVGVKTNVLFFTRGKKEE
GNTKNVWFYDMRTNMPNFGKRTPFTEKAFDDFITAYTGGLTAENVVKDYNGAIDEEKRKL
IKNERWQCISREEIAKKNDSLDLGLIADESLTTSSDIGEPLDIANDALKELNAIQKELEN
LIKELK
>LONDMIMF_03423 hypothetical protein
MDSKFYFLQDLYPELFNCARLAETLYYIDASSSISKSRLFCEKLAGLIAGFESEDISNLS
QYEAIQYLNQHEILPDTIADIFHTVRKSGNKASHNGSNTPDEALFILKKIFSLGKWFFET
YDNDIIEDLSYELPPNKSEQEITSLTGKVDELTIQLKKYELKIQSLNASENDIKQRREKA
QFYADKISLNEYDTRIQLIDVQLRAAGWECDTENINYKNKKTLPEKGKNKAIAEWPCGTK
YADYALFIGTELYGLVEAKKYNTDISTNLRQSKVYSENILPQDEIVLLGQWDTYKVPFLY
STNGKKYLEQLKTKSGIWFQDIRKSTNRPYALKGWYSPEGLKELYNRDLDTASEKLLESD
YEYLTSPSGLNLRDYQIEAIQSVENKITESPFDKRALLVMATGTGKTRTINGLIYRLIKA
NRFKRILFLTDRKLLATQARDSIKENKVEAQQSFGGIYHFDDLGTTIPDSESRLHFATVQ
SMVKRLFYNEGEPLTVDTYDCIIVDEAHRGYQLDKEMNEDDFGIRNEDDYVAQYRKVLDY
FDAFKIGMTATPALHTTEIFGESVYNYSYRKAVIDGNLVDHEPPYNIATILNTEGIAWEK
GEKPQVYDAETGEITDLDELEDELKFDVEHFNKQVLNDNFNRVVVQELVKNLDPEGNEKT
IIFAARDSHADTIINMLGEEFEKIGVDVHEKAIQKITGSVYDNAQLTRDFKNERYPNIVV
TVDLLTTGIDVPSICNVVFMRRVRSRILYEQMMGRATRLCPEIGKESFKIFDAVRLYEAL
KDYTQIQTVGNPSYTFQQLVEETQRISDEQRLYKQIEQIIAKLQRKSRNLTDENKEHISY
HTNGNSIEGLIQSLKNTTGSDIKNTVEQLSSLWNYLDTKVYKKYSQFVSTHVDAVREVSR
GYGNAEKPEDYIDGFKKFLQENINTIAAINIICNKPQELDRKSLKELKLLLDEKGFNETS
LNTAWKSTKNVEIAADIIAYIRTLSMGIDLITPHERVQRAIGKLKSKHQWNAVQLKWIDR
FEKQLMAETVLTKQDLDLRPFVDEGGFNRLNRIFNNELEELITELNSELYSA
>LONDMIMF_03424 hypothetical protein
MKTKSLLLIGIVGLSLVTIIKTVWNRMEIFEEEEEDQELEGQDEEYGFPLFI
>LONDMIMF_03425 hypothetical protein
MTNKKLILGIAAGVAALAVVGIICNKKGYINFGSMLDKAGDMAGKVKDTLGKIKDSAVAE
ADSVIQESKNIAGKAINAATGVNDKASNAVS
>LONDMIMF_03426 hypothetical protein
MRLIITIAFMACSYLASAQKTPPTPPTPPTPPTPATSTKVSSNTTSVVTINGKTYVSSSS
STPVKTEAKSSSKKSKSSSSSSSSSSSTSVSVNNSDFTYSIRASFDDYKTEKIRKILMDN
LEKDYLSTKGDTYTWKKLEDGEAAYSYVLSEGRLKGTVNKELNSNNAVDKFIILGEKISE
ALSND
>LONDMIMF_03427 Response regulator SaeR
MKKHILLAEDDFDYASILKQYLEFSGFDVTWAKDGKEALKLFPATQPDICVFDVMMPQMD
GFTLAEKVVDTYPETPFIFLTAKSMKEDKIKGLRLGADDYIVKPFEVEELILRITNILKR
VQKTAPQHTADKKFKIGQYLFDNENYLLTHENVTHRITEKEAHLIQFLYASKNKLVKRED
ILKEIWGNDDFFSGRSMDVFISRLRKYFSEDPAISIPSVRGLGFEFNIKE
>LONDMIMF_03428 Sensor protein kinase WalK
MKRKIMLLIASCIFTVAALATIQGYFIYNTYKLTEKEVSAKIKKQLVDMEDTDEWYDLNN
AWMRLTGQFIKDYAYKRVKKDEFVAFMTKKSDSLSSLMSDYMAKKKKPGDYDIGYSVYIN
SATILENKKMENLYKGKLFVSGNRIRNKDEISASTGRWESDLELNVEDSLLDPIKKDLKF
LIKSETYYSVANWQMTVISQMAGLLIFSVLLMAFVVYLYYLSLKNLISQKRIADIKTDFV
NNITHEFQTPLATMDIAIKTLQRKEKDMTEEHYRHTLSLLERQNERLQKLFRQVTDASLL
PSTRSENVKEISCSEIRDIIDDFKLSHPDTVINCHQEQKSLHAKIDPFHLNTIIVNLLEN
AVKYGATKIDIEMKSQKNSFVMSIQDNGQGIATKEQFAIFDKFYRIEKGNIHETKGLGLG
LFYVKQLIESYKGTIKVESEEDKGALFLITLPL
>LONDMIMF_03429 hypothetical protein
MKQLVIFLLLFPLWSSAQHSLSGSVTETGGKAVPFTDVTLLKAQDSTAYRNVLADEEGRF
TIGSVDNGQYILKASAIGMSSAYRNINVTGDLQLEPLVLSQAAEMLEGVEIVSKRPIVKR
LVDRMEFNVENSSLSSNNAWEILSKTPGVTATGSGSISVRGSQSILVTINDKKIYMSGDE
LKQYLENTSGDDVKSIEVITNPPAKYDAQGAAVINIKLKKVVALGYKGSVNTAYVQSIYP
KAVTSTGHFYKGKKLSLMGRYTFGMGEYVNESRDKTRYYDENGGTASEWDSFLRRKSKSL
EQHSYRLQASYELDSLNTFSIGTTGFQAPEQRGRYSAPTSIYGSDGLLDSLYVTTNNRKN
PARNAAYNFLYERLLSHKAKLVFNTDFTNYLSKDYQDIMTAFSLPDGTPYRDNRFINNSR
QAIKLFSMQADYSNETNGTFEAGLKYGNVSADSNLDYRDDVDGILVPNPGRTSKFLYDES
IFAGYMSYSKEFGKWNLKAGLRGEYTSLEGNSVTTSEVNDQNYFKLFPTFYTMYKPNENH
EIGFSYGKRISRPRYSQLNPFRIYNNNYSYGMGDPKLLPTIVHNLNFLYTLKGKYNFDLY
YRLEKDPSMEIVYQDYETNTVVYQFTNIDKNYAFGLEFNTNLTFFDWWDAGIQGALSYVE
DRFQGVDGKLYSNGRPTYNFNVNNRFALNKKKDFNGEINFDYNSSSVQGTFVFTPTSNLT
LALRKKVLKGNGEVYGIFSDVYRGETLGLRTDYGNQYNKSRFYADSQNFRLGFRYNFGNQ
KLKEKTREQTEEQRRI
>LONDMIMF_03430 Prophage integrase IntA
MAKIAKKLTDTEIKSTKPADKEINLFDGDGLILRIAPLAKGGKKNWYFRYAVPVSKKRTK
MSLGTYPHLTLARARALRDEYLSFLANGVDPQIHNNDKAKALKSATEHTLQAVARKWLDE
KVKTSGISQDHAADIWRSLERNVFPGLGNVPINEIRPKLLKQHLDPIEQRGVLETLRRII
SRLNEIFRWAATEELIEFNPADNLGQRFSKPKKQNMPALPPSELPRFMESLTNASIRLET
RMLIEWQLLTWVRPGEAVRARWSDIDTTNSIWNIPADFMKMKKLHKVPLSKEALRILELM
KSISGHREWVFPSIKAPLNHMHEQTANAAIIRMGFGGELVAHGMRSIARTAAEESGKFRA
EVLEAALAHSKKDEIIAAYNRAEYLIERQSLMQWWSDYVQAQRSNALVA
>LONDMIMF_03431 hypothetical protein
METLFKVFEKFSSRPLFFIFFGLSLCEFFQKQSVLMNPSADNIAKLFAAMILVVFFTWGF
EWLIFKFNVNLEPHDQGDIGPTIGTATLAVYLVYAFHFLSENPEALNLKLLTNSGFIYST
TLLLFSLECMKLRRLKQK
>LONDMIMF_03432 hypothetical protein
MEWSSNMTVANYNSLVQKTFCENAIRSVVMIDDDFLTYSESIRALNNEVDLDYNKIDSSK
RAATLESFFQSKNMICDVDNGSVNFDVDRIRKSDLIIVDYHLDNNAPDKTLKLLQDLKDS
DHLNMIVIYTRENLETVWMQISSTLKGALDINSLIIDYDNEDVQSYWEDVVLPNLNDNGN
KALTRDETIAYIKDSKPCRRIKRLIHDDAVLEDQKDKNFIAKMIAEYAVSRNAIISSNTS
GNVIRGDESGVKWIQCGNIFVSLFHKVQDDHENDGDRIWQTLNDSLIEWKPSYYQLIKSE
IQNAIEAEALSFVNHLANDHYGQAAWLNEILKSDSPDIRCRNINFVFGNLSEELYQRLKN
NNTLDEFIKSVFDSYSNEYANSGVAALLQYCSSKMDLPSNNDTYHEMYHALNMNLSSKNF
EDGHISTGTIFFDTESNKWYLCVSAACDLVPTQGNDPHHVRLSPHRLIKVLELFNASQSK
ALPFAEHSKYIYVMHKNQRKYLSIFEGDKTLPVVDYMVVLNHGTTVDGEEKNIISAVFLS
NMDGNVQNVPVRLKLKSQLRTGYAERYQAIASQYSSRIGVDYVSMMLP
>LONDMIMF_03433 Adaptive-response sensory-kinase SasA
MIFRDSLRVLPYGRVDNDFFQIEERRSWNAGRYYWSNRRIFGYIGITQSSNKELKDKSGR
EGFIRNQAARELKTIISNLLTELADRFFGSRSDDRKELLEQVKREKELRKSAQQQARKST
QKSFSEALKNQTPVLDASLEAVKRLKTKLDKTDGSLDLNYLKIIDSDLTNLDALRSEIKT
PIKPPKLGMYEEKYRDYRDKFNEFSAYILQMKLAINKLDSELNKLEPSLSAKNHLEKNQG
IINSKLTKFNNTIEEKIHSLLKKWADEIKVDRSDYYAKTISVVDSIDNDSQIENVFNLLD
SLYVESVDTLTFKYQSIIKGLDRLFEGINLDSAFSLSEEERSYFEEKAKSLNALAQLGIS
VEIISHELEEMDSMVTRGLNSLPTSVKEHPGFSLALNAHRSLTQQIRFLSPLKISGYQSR
QRITGKNIMDYVLKFFGERFERQRITIEFSEEFKQIAITDIPSRIYPVFTNIINNAMYWV
SLSNNRLIKIGFVNSLVIIANSGPAIDTDDIPRLFELFYSKRANGHGVGLYLCRENLAVA
HHKIWYSEPDEGDNYLIKDGANFVIQFNGVEF
>LONDMIMF_03434 hypothetical protein
MKQRAKLLKSLLFIWSMVLLSCQTDETQELPGENNSVSPIVSKPFTDFKKLPDLLSEALP
GELLLAARNGNSNADSNYQFEIDSTSVTQITNNGIEYYTMAVTRETTEEGTFENLVVFNI
GNEKKAVLIKYKPDDSYLSRYKADTQTQFTGKFNMTEISRTPFLSRSATATKCFISTQLY
CTNNNPPTLAGQGCYKNKDGGAHVKSVISINCFEVVMNNPEPYLENKFVLEPVTDAGGGN
PDIAIPIATQPIFLGNIQFNFIRRLTPEQKDWWDSPVNNKAVVSILNHLNQNTFDGTINP
EAIAFAKKLIDYSIANGLSFEFDGRIEPSGTRTINSLEELAESLNQLEINSVEMEQQPNI
SNTFLGSYKFKINLFTGLRLNVKFSVSRQQRHTVTNVTSEEYGASLGEWSQSDYFVDILP
NGNIKVEVIGSMKYDYSIEGWGIKVFKGIRLTLILNPMDATIVSSSWRYN
>LONDMIMF_03435 Putative ribosomal N-acetyltransferase YdaF
MTLKKEFDFSQNLVLEDDTVLLRPLQHSDFENLLYFALNEPEIWTFSSIAASGSENLKNY
INLAIQARENKTEFPFIVIDKKTGRYAGSTRFYDINFPFSSLQLGYTWYGKDFQGTGLNK
HCKFLMLQFAFEVLKMERVEFRADSNNAKSIAAMKSIGCQVEGILRSHMPKLNSHDRRDS
IILSILKNEWEEGARQRLLDKINNK
>LONDMIMF_03436 hypothetical protein
MKINPKTGIDKLVFGMLQKDVEEVYGKPDKTSPDEDGNRILQYNKQKIRLTFYKDEDFRL
GYLITSNPEVLLFDKKIIGRPMAEVQKELETAGWAKWEKEEFDTLENFFNEANWTILQAE
FDEVVKVEIGAIINDKDEFEWKFKK
>LONDMIMF_03437 putative peptidyl-prolyl cis-trans isomerase
MKLKFICLLFLAMTTGLSAQTKSAAPKKAATTKKAGATAQDPGIYAQIETNKGRIVVKLE
YQKTPITVANFISLAEGTNNAVSAKYKGKPFYTGIKFHRVIKDFMIQAGDPDGNGSGGPG
YRFADEIVPELKHDSGGVLSMANAGVGTNGSQFFITHKDTPWLDGKHTVFGKVISGMDIV
NAIEQNDVIMEVKIIRNGADAKKFDAAKVFNDYFANKDEIEKKQLAAEAEKKRALEAEYA
PVKAKKVAEFAAMKATAKKTESGLQYAITHKGTGAKPTSGTVYVGYAGYLEDGSLFDSSN
AEISKAFGKYDANREAQGGYQPFPFDITNKGGLIPGFLEGINLMSFGDKATFFIPSNLGY
GERGAGNVIPPNSNIIFEVELLEAPKQ
>LONDMIMF_03438 putative peptidyl-prolyl cis-trans isomerase
MKKITSLLLSLSVLFLSCDKSNSNLPDGMYAEIETDKGTIMVELEYKKTPVTVANFVSLA
EGKNPVVNEKYKGKPFYDGLKFHRVIPNFMIQGGDPDGNGSGGPGYRFQDEIVPELKHDK
GGVLSMANGGKATNGSQFFITHQATPWLDGIHTIFGHVMGNGMEVVNAIQQDDVIKKITI
IRKGQDAKKFDAPKIFKDGFDKQTEELKKLEEEQLKMREKYSAVIKEKEAQFQQLKAQST
KTQSGLQYKIITKGKGKKPVAGTPVSINYAGYFENGDLFDTNIESIATIFGKLDPNRAAA
KAYSPIPFTIGMKEGMIPGFIEGIEQLSPGDKAVIFIPSYLAYGERGAGGVIPPNANIIF
EIEMLGATPAN
>LONDMIMF_03439 hypothetical protein
MIYTELELRPQVYRVDKQNIMMGMRDGIKLMKKGEKLTFLFPSHMGYGYHGDNRRIGHNQ
PLMVTITLKDIKPEKDAKATAKDAKTTVPLTTETPKTTETIKQ
>LONDMIMF_03440 hypothetical protein
MLRIDCWEAEKDLKTTYGSECALTSLAVDEPLEYARLYLEGNLQMWVDAEDSLELY
>LONDMIMF_03441 Bacitracin export permease protein BceB
MYAKLVFRNAKRSVKDYLVYIVTMTICVTLFYAFLSISSSYYSPDIGSEYDFTLLSDGMK
IAICMITLLLLFLIRFVNHYMLRRKQKEFAVQSIMGMEQKTIGRIFFAETLIMGMFSILI
GIFCGVFCSQFITAMLLTAYGEPYEISWTLFPDTVLLTVIFFVVSFFVVGVFNTRTIKKT
KIIDMLSAEKENEPELKKSRFIPVVVILFLMFTLWELFSGIQTVRFYYDSRFVFPVKIMY
WGNILLPVVTLGWAALWMLKKKKIAFQKLIDGLLICSVLHAFLAASVPALTNQYYLPLHG
GILNQYLVFVLIDLLFFICALIYLASSLIVAWKVKSPEHRYKGENLFFFGQIISKLNTTS
KTMTLICITLVLAIFMFIAAPILTGWASGYLDMRSMYDVQVYSRYNDVYEEENLPQDSYE
IITEFLTEHKIDTVYDCTFNLYLPEKDDFHNRQKYDFPIVAISLSDYNTIREMLGYEQIS
LEEDEFTTQWKAIATEEERDSFLKEHTSIMTDAGELTLSGQSYYEDPIGETAYNSYTNVL
YVLPDNICEKLLPVIKNRYITTTENISYENARKLEKLFTEKYPEQAETGAIYGVRFSTLQ
INSSIANNFILQTSMIYGAVVLMVICLTVLSLQQLLDAGQYKYRFSVLRKLGAEEKHIGK
LILQQLSVWFGLPIITAIIVAAVVIAYFIQTISAEISAYIGFSTLMLQIGATMGILAILL
ICYFISTWIIFRRSVNP
>LONDMIMF_03442 ABC transporter ATP-binding protein YxdL
MNTILKLEHIQKYYGNEGNITKAIKDISFSVEAGEFLGIMGASGSGKTTLLNCISTIDTV
SAGHIFLEGTDITEINPKSLARFRRENLGFVFQDFNLLDTLTISENIALALAINKVPAGS
VEPRILDIAGKLNISDILNKYPYQVSGGQKQRCACARAIINNPKLLLADEPTGALDSHSS
QMLLSTIQSINEQLRATILMVTHDAFTASYANRILFLKDGEIFMELRKGNDSRSDFFDKI
LNVLTMIGGGQSHVC
>LONDMIMF_03443 Sensor histidine kinase GraS
MSGKQYLKNQLPVILINLLGMLVLALFLIASDNPIQTVLFIFAVWSIVLVLSLLAFYFSR
KKYLNKLLNMTEQLEERYLLPEIMQVPERADEQVFYQIMKMAEKSMLERIGEVQRERREY
KEYIEQWIHEVKTPITAMKLLCENNRSPFSREVLAELENINQYTEQALYYARSEHAEKDY
SVREVNLCDVVHSAIADNKYLLRQSNMSIQIDDIETKVYTDEKWVRFILNQIIGNAIKYH
AEQPILHFRATKTNDKIVLSISDNGIGIPKSDLPRIFEKGFTGQNGRTGKNSTGIGLYLC
KRLCDKLGIGLTAYSENRGTTISLIFQMNDFIIGVQG
>LONDMIMF_03444 Response regulator protein GraR
MKEKILIIEDDFTIQTQLKTLLSGNGYEVFAVTDFSKTIEQLKEAAPHLVILDIKLPGNN
GFEICSGIRTFSDIPIVFVTSSNTDMDELNSIMLGGDAFITKPYNPAILLAKIAALLKKA
YRSPQTEIYMWREATLHLESSMIEYKGQKAELTKNELKILYYLFKNSGKICSRNDIVDFL
WDNQLYVDDNALSVNITRIRDKLAAIGLVDFIKTKHRQGYTL
>LONDMIMF_03445 hypothetical protein
MRTIFAEYNPHRNSIDVYTSAGYMLRIDCWEAEKNLKTTPGSDCALNALAIDEPLEYARL
YLDGTMQMWVDAEDSLEI
>LONDMIMF_03446 hypothetical protein
MLVGIKNVSKLIGISIIACCAVLVCTMFLNFYFDIRLIESEITSELSMFFYNAQVSTAKV
VCLVSGGCLLLTAIVMLLFYIKHYIDTHKKELGILKALGYSNIKIAKSFWVFGISIFIGT
VTGYAGAFLIMPWFYALQNEDKMLPEITINFHPSILFYFVVLPTVCFSALSVYYAWYKFK
KTVLLLLKDNMQTASKTPNHRIEKSSELSFVEYLKRNTLKSKKALVFFIIFASFCFSAMT
QMSFSMKDLSSEMMGVMMLVIGLVLAFTTLFLAITTVINGNTKTIAMMRVFGYSQKECCR
AILGGYRPLSYIGFIIGTVYQYGLLRLMVDIVFKDVEGVPTYKFDFPTMLISLACFITIY
EIMMYIYSEKIKKISIKEIMIE
>LONDMIMF_03447 putative ABC transporter ATP-binding protein YknY
MIKARNIIKSYQNGESRFQVLKDISLDIEDNDFVVILGASGSGKSTFLNVISGLERPDSG
KVFYDGKDITALSDNELTSFRKENVGFIFQQYYLLPNMSVDKNVKMGADLANNKDYKNVI
RAVGLGEKLHKYPSELSGGEQQRVSIARALAKRPRVLFLDEPTGALDEQTGRQVLDYICK
LQKEYGFTIVMVTHNLNIAEMANTVIKMNSGKISEIYTNEAQKTAYEIGW
>LONDMIMF_03448 hypothetical protein
MPPKAKFTKAEIIEAALNIVRADGYEALTSRALGTYLGSSARPIFTVFKNMEEVQQDMIK
SAKALYKEYVNKGLTTEHPFKGVGTQYILFAVNEPKLFQLLFMTEQKQIPDLSGVLPLID
ESYEQILLSIQDDYKICKAAGKKLYHHLWIYTHGIATLCATKMCRFTDEEISTMITEVCM
SILKKLKEGENND
>LONDMIMF_03449 hypothetical protein
MSLQGTLNFGHGFDEPLHFGQNRFLTPIQIDITIIMNWRKLWQTESLQNRKCSH
>LONDMIMF_03450 hypothetical protein
MANRKFTEQEMLTLRNSKYVLDVSPSIVHFSAEFKKLFWEELSKGRLPREIISTLGIDPN
ILGDSRINGLKTMIGNEVKKGNGFRDLNTYAQGCNGYLSAENRIKYLEMQLAYKDQEIEF
LKKIVSLNPEAPE
>LONDMIMF_03451 hypothetical protein
MKIPAHAKYQIIYDTMQKNDNLLNVAAMCEIAGVSRSGYYHYLSTEDQRMEREEQDRQDF
LLILKAYQYRGYHKGARSIYIPGSK
>LONDMIMF_03452 Thermostable beta-glucosidase B
MANDKTSPLGSWRIGADDNTAVSFLEGMANYKGNQIIYEKGADVALGEPRFMLETKINTT
DKSGFEKAIAAAKQADVVIMVLGEHGLQSGEGRSRSDITLPGVQQELLEAVYKANPNIVL
VLQNGRPLAIPWAAKNIPAIVEAWHLGTQSGHAIAQVLYGDYNPSGKLPMTFPRNVGQLP
IYYNYKNTGRPSTDNPESVFWSHYTDIENTPLYPFGYGLSYSKFEYSNLKLDTKTLHKNG
KIKVSVDVKNNSTVDGKEVVQLYIRDLIASATRPVRELKGFELTEIKAGQTKTVTFTINE
KTIEFYSARKIWEAEPGDFQLFVGGSSMATLQADFNYSN
>LONDMIMF_03453 Beta-glucanase
MKKTAILLLLTGCSVFGQVKKGKLIWEENFNGNKLNEKVWNYELGDGCPNICGWGNNERQ
IYTKENHKIVDGKLIITAKKDGNQYTSTRITTAGKKEFKYGYMETRAKIPVGQGIWPAFW
MLGSNIKQVGWPKSGEIDILEYVGKEPHMVYTTLHTKANHGDNASSHKTRFDNIEEGFHT
FGVDWTKDKMDFYVDDTLVFTFNPSDKNEDVWPFNQPFYFILNVAVGGNFGGPEVDDTIF
PQEFIIDYIRVYSNK
>LONDMIMF_03454 hypothetical protein
MNNVKTLREAKNLTQTELAEKSGLSLRTIQRIEAGSILKGFTLKAIAQSLETQPENLMGD
TDENTGIDRAKLINLSALFGLIFPYGNVILPLILTYKTKDAKNKELGKNIVSIQIVLSAI
ASLLMMVSPFLQKAFSLRFPLFLIFLIAIIGIKLIVIIQNGINLNRKSELYFKLKTSFL
>LONDMIMF_03455 HTH-type transcriptional regulator BetI
MASKDRILRQKEETRNNILDAAYYIVKEEGWQGLSMRKIADRIEYTAPIIYEYFSNKEAI
LQELTKKGFLCLTKDLEKAKAVSADPAEQLEAMWMAYWNFAFADKELYQVMFGVEMTCCM
QRVPEAEGPFQLFTQAIAEIMKGQKPSDDVIKQKYFTFFSVIHGLISINIVGNGLASNIN
NQILKDAIGGIIKSIQVVEV
>LONDMIMF_03456 Multidrug export protein AcrE
MQSKKQKSIKMSNKFKNHKTMRNTILTSLLLAAILIGCSDKNQGQAAPPPPTLPVYAIQS
ATTTTDSEYPASIQGTVDVEIRPQVSGNLEKIYVDEGAFVTKGQPLFKINEQPFREQLNN
ALASLHGAEAALINAQLEIDKLTPLVQNKVVSEYQLKTAKASHRIASANLDQAKAMVGSA
KINLGYTTITAPVSGYIGRLPKKQGSLVSATDIEPLTKLSDVHEVYAYFSLGETDFINFK
AQYSGNTIDDKIKKLPPVSLVLADNNVYAQTGKIDMVDGQFDKNTGAITLRATFPNANGT
LRSGNTGRIRLGIQHDDAILVPQSATMEMQDKVFVFTVNKENKVTKAPITIIGKSGSNYL
IKDGVKSGDQIVLSGIDKLQEGQAIQPEKSNKIAQVINKK
>LONDMIMF_03457 hypothetical protein
METRVNILKTAPEAYKAMLGLEKFLASTSLNPIHKELIKIRASQINGCAYCINMHTRDAR
KMGETEQRIYLLNAWRETQLYTEEEQAILAMTEEITLIQNHLSKATYDNARRLFDEEYIA
AIIMMITTINAWNRIAISTEMA
>LONDMIMF_03458 hypothetical protein
MNPLLQHIRKFIALDNWEAETVLSYFETESFRKKQIMLEEGQICNKQYFITKGCVRFYIN
NRKGVEQTLQFGIENWWIADYLSFQEQIPSHFYIQAIEPIETLSIDRKSFEALLLELPKL
ERYFRLIIQKSFGASQTRIKYLFTMSAEERYHHMNSRFPEFIQRVPQYMLASYLDFSPEF
LSKIRAGKV
>LONDMIMF_03459 50S ribosomal protein L20
MPRSVNSVAKRARRKKIMKQAKGFFGRRKNVWTVAKNAVEKAMAYAYRDRKQNKRNFRAL
WIQRINAGARLEGMSYSQFMGKVKANGIELNRKVLADLAMNHPEAFKAILNKVK
>LONDMIMF_03460 50S ribosomal protein L35
MKTKSSAKKRFKVTGSGKIKRKHAFKSHILTKKSKKRKLALTHSALVHQSDVKSVKEQLR
II
>LONDMIMF_03461 Translation initiation factor IF-3
MAEEQELDLVEISPNAEPPVCKIMDYKKFLYMQKKREKELKAKSTQITVKEIRFGPQTDE
HDYEFKRKNAEKFLKEGSKLKAFVFFKGRSIIYKDQGQILLLRLAQDLEEFGKVEALPIL
EGKRMIMFIAPKKKK
>LONDMIMF_03462 Threonine--tRNA ligase
MIKITLPDGSVKEFAQGVTPMDVAKSISEGLARNVISASFNGTTVETTTSLTTDGSLILY
TWNDIEGKKAFWHSTSHVMAQALEELFPGIKLTLGPAIDNGFYYDVDFGDQKITDADFKR
IEDRVLEISREKHEFKMRSVSKAEALAIYKDNEYKTELIQNLEDGTITFCDHATFSDLCR
GGHIPNTGIIKAMKIMSIAGAYWRGDEKNKQLTRVYGISFPKQKDLTDYLELLEEAKRRD
HRKLGKELELFAFSQKVGQGLPLWLPKGAALRDRLEQFLKKAQKKAGYEQVVTPHIGQKE
LYVTSGHYEKYGADSFQPIHTPAEGEEFLLKPMNCPHHCEIFNARPWSYKDLPKRYAEFG
TVYRYEQSGELHGLTRVRGFTQDDAHIFCTPEQLDEEFKKVIDLVLYVFGSLGFENFTAQ
ISLRDKENRSKYIGTEENWEKAENAIINAARDKGLNTVVEYGEAAFYGPKLDFMVKDALG
RQWQLGTIQVDYNLPERFDLTYKGSDNELHRPVMIHRAPFGSMERFIAILLEHTAGNFPI
WLMPEQAIILSLSEKYENYAKKVLDLLENHEIRALIDNRNETIGKKIREAEVQKYPFMLI
VGEEEEKNGTVSVRRHGQEGKGNISVTIEEFAAIVDEEIKKTLKTFGV
>LONDMIMF_03463 hypothetical protein
MKTILESIQARLSTISELNYIGEDYGQLNTEPLVTMDWPCCIFNISRGNYSNLGKDLIQT
PKNRQRGMFRLKINIVNPRRENNVDSWMEHDLMEKLHKSLHGFIPKENCSILKRGNYKRL
KRNDGLIVYKVIYTFEVVNI
>LONDMIMF_03464 hypothetical protein
MKSTKQSLGAQRNKLLRYKQVMDEFNKHDCRYTPITVIWREFIYPKFHISRDTLYRILNT
PIEEELERTNTPQSFS
>LONDMIMF_03465 hypothetical protein
MENIVSYESSTLALDSIYNVLSWYDRVSLHYYLQNGSLLTANAIKLLDIVKKHEWYPPKM
RYNQNNLLEYYEPKQESWLHVNQYIANYSKLTTQIQKYFN
>LONDMIMF_03466 Peptidoglycan L-alanyl-D-glutamate endopeptidase CwlK
MDKVSLQRIEKLHPYVREEVKQIVKECNEALTGKAKIRITQGLRSFEEQEKLYAIGRITS
GKKVTNAKAGQSIHNYGLAVDICLMIDGKTASWDTVKDWDNDKVADWYECVKIFAKYGWD
WGGNWKTFKDLPHFEKKNIVTKKGLVKTSWRTLYKMPRDKENYPVF
>LONDMIMF_03467 hypothetical protein
MKKTTILSLDGGGIRGIITCIILRYIEEQLQFYDKPGARLGDYFDFVAGSSTGGLIASII
LCPDEHRKAKYSIQKGLELYAEKGGDIFQVSFWERLVNPFGLLNEKISQEALEKNLNDFF
GNLELKELIKPCLITSYDIENRRAKLFNSWKANLSTDNFYVKDVCRATSAAPTYFSPVQI
KSMYGQIFSLIDGGMFANNPALCAYAEARKIPFAEVLKNHQKANHPSVNDMIVVSIGTGI
EARSYSFKKLEKSGKIGWVNPIIDILMSANAETVDYQLSQMFQTLGLRNQKNYYRLNPSL
KNASPAMDNVKRSNIENLIQAGLCYIDENRETLNQIVQKLIKNKI
>LONDMIMF_03468 hypothetical protein
MQKTKTLLGTALCIAIWERFAGARTSLGEILRCGVGDVVQDRLLQNVLTKTWVRYLFKFG
>LONDMIMF_03470 Adenine phosphoribosyltransferase
MSIEKYIRDIQDFPKPGIVFKDITPLLAEPEASKMCLELLLNGLPDVKIDKVVGVESRGF
FFATLLAYKLNAGFVPVRKPKKLPFTTISATYDLEYGQDTLEIHTDAIQKGDKVLIHDDV
LATGGTAKTVCELVEKLGGEIVQCNFLMELTFLNGREKIKQYDIFSPLKY
>LONDMIMF_03471 hypothetical protein
MFKILAKLNKWLLPNYTKQGLDLAKATKFQKAIIAWKYYVTIHALD
>LONDMIMF_03472 hypothetical protein
MENFILYFAKASALLAVFFLAYYFLLRKETFFTANRWFLLAGIITSLLLPKIIFVKTIWI
EPAATVNYAPIETAKEPIVFDAISNAEAGLSSPLHTVSENSVITTEPLMVEEPAFEINWL
YVIVGIYLIGMFFFLVKFIQDFWGLRKIFRNQTVELHGRFKFVDTDRIQSPFSFFNYIVY
NSNHFKKEELENILEHEKVHSSQMHSADMILSQLFCIAFWFNPFAWLHKKAIVQNLEFIA
DSTALKAVPDRIIYQKTLLKVSAPHHCIPITNHFFQSLIKKRIVMLNTNQSKKRNSWKYA
IVLPLLTVFMLQFQVETIAQEKEDGKIQKQQTSNYEVRVDKNSTDDYLKAQSKIFKNNHG
IDLKFSKIKRNSDKEIVAIKTTYKDKNGNSGDSYLKGKEPIQPFLLSREDNKVVVSNVPA
VYGSFNTPTVYGKFKNNSSPVALTYKTGMPTMPIPPVPPTMPNVPALPNAPTFPQLPAPP
TPPTSEYDENSAEWKKFEEQIAKFEAEMDAKEGDIAKFEQAMEKFAAQVEATYTKDVEKQ
MAEFEKKMKVYEKEMEVYAKQIETLMEKEERNR
>LONDMIMF_03473 Methicillin resistance regulatory protein MecI
MQKLTNKEEEVMQILWKLEKAFVKEIMAEIKEDQPHYNTLSTIVRILEEKGFVGHTAFGN
SHQYYPIVALEDYRKRFMTTAIDNYFDSSYKNLVSFFAKEEKISADELREILDMIEKKK
>LONDMIMF_03474 hypothetical protein
MRNVAKTTTLENKFPLLAVENNCILSKDADITACFEVRLPELFTVAAAEYEAIHSAWHKA
IKTLPDFTVVHKQDWYIKENYAPDLTEENQSFLAKSYQRHFNERPFLNHYCYLFLTKTSK
ERMRMQSNFSSLCKGSLIPKEIRDKEAIHRFMEAVSQFERIVNDSGFVSLQRLTEDDIIG
TDEKQGLLEQYLTLSREVGTPMQDIALGSEEVRIGNKRLSLHTLSDTDDLPGAVSTDTRY
EKLSTDRSDCRLSFAAPVGLMLSCNHIYNQYLFLDNSEDNLQKFEKSARNMHSLARYSRA
NQINKEWIEKYLNEAHSFGLASIRAHFNIMAWSDDPAELKQLKNDCGSALALMECKPRHN
TTDVATLYWAGMPGNAADFPSEESFYTFIEPALCFFTEETNYHNSPSPFGIKMADRLTGK
PIHLDISDLPMKRGIITNRNKFILGPSGSGKSFFTNHMVRQYYEQGAHVLLVDTGNSYQG
LCELIKGKTKGEDGVYFTYTEDNPIAFNPFYTDDGVFDIEKRESIKTLILTLWKRDDEPP
TRSEEVALSNAVSGYIERIKTTDDFPSFNGFYEYVKGDYRKVLERKEVREKDFDIANFLN
VLEPYYKGGEYDYLLNSDKQLDLLTKRFIVFEIDAIKDHKILFPVVTIIIMEVFINKMRR
LKGIRKLILIEEAWKAIAKEGMAEYIKYLCAPVKAA
>LONDMIMF_03475 hypothetical protein
MNYNINKGIGRTVEFKGLKAQYLFIFAGGLLGTLILVMILYMAGVNSYFCLFLGAGGSSL
IVWQTFSLNRKYGEHGLMKIGAKKRHPKYIICRKLVHRYLKFNPKQNIV
>LONDMIMF_03476 hypothetical protein
MEKQRKKVLLAAVAMLSGIGAFAQGNGVGGINEATQMVTSYFDPATQLIYAIGAVVGLIG
GVKVYNKFSSGDPDTSKTAASWFGACIFLIVAATILRSFFL
>LONDMIMF_03477 DNA replication and repair protein RecF
MYISKVSLVNYRNFVNAYFNFNKGINTVIGENGSGKTNVFKAIRLLLEDASLQFAYKLTE
GDFNRTLDKGRWKGHWIIISIEFDELNDEEAIQSLFIHGTGIAEADYVEKATYNLFFRPK
ADIRQKLSELAEGDKAGLQAILDDINILDNYETFFTGKSTADFNDPDVYKELVGDFENVI
FPSAIDASKFGSKIPHQLSVAKEVSFTFIQALRDVVSDFHNNRTNPLLTLLKNKSGEIKD
ADYQPISDLVKELNESIEALPDVQTIRDDIKTTIQDAVGLTYSPSSLSIKSSVPDEAEKL
LQSLKLFIGEPGEEYEGGIHELSLGGANLIFLTLKLLEFKYRKSKNTKI
>LONDMIMF_03478 Prophage integrase IntA
MMGIGAFPALSLADARRLRADYLALLANGIDPQVQAEFIEEQQQIALDSIFSTVATNWFQ
IKSKSVSPDYAKDIWRSLEKDIFPAIGEIPVQQIKARTLVETLEPIKARGALETVRRLVQ
RINEIMIYAVNTGLIDANPASGVGMAFEKPKKQNMPTLRPEELPALMRSLIMSNLSVPTR
CLIEWQLLTLVRPSEASGTRWSEIDLDAKLWVIPAERMKAKREHIVPLSPQALDILEVMK
PISAHREHVFPSRNNPRQSMNSQTANAALKRIGYGGKLVAHGLRSIASTAMNEAGFNADV
IEAALAHSDKNEVRKAYNRSTYLQQRIELMNWWGNEIHP
>LONDMIMF_03479 hypothetical protein
MSSCAYTIDSYITLLTMSSKKRLLVEGRHDRSHLYQLIYKFNPASKVKIDTAQDIKASDK
AMSKNNRLKIETIHSKVKGKDNISFLCDREFREFAFNDQIEDLLNSHYCDDSLYWTLGHS
LENYFFNPSIIIDAFQFLSPSEYKYKAIELFSELISSSFAVLAAISLAAKDIDKAGLPAA
LIDWKDIVINDGTIKLIRRDSYDIDSACVDSFFNAFDAVLPRVIASDVGICSRVVRGHTG
ILLLQKLFSACLYYVGREDDALQADSSANYFCNLSELSLTTALAESWVRKIGVLEDVYFP
DSLLKNIE
>LONDMIMF_03480 hypothetical protein
MAIRTISKIELSKIHNRYNLTVDFFNDLNVIHGKNGAGKSTLIHVIANIVNGDFIRFAFL
IFEEIKATYSDGLKIVIRRDKIDEQSFISVTLSNGKYIKFAVGEAMATVREIESERHLRE
RDVKSMLAMDIDKFVKENELQKVRASYFPAFRTMLEAWSSSSDVGYERRVIRSSFYNRKA
STFARELFGQFLPSINYPSPMEIEDRLREEIRRAQLGIAAYESRTFSESFVKVFSALFDN
SSVEGEITGELLKEIEGLAIAQDSSIKNGYYAEYSKVYEEIRSLINRNLKGKVENSVSGA
LVVYRDALRDRQDYQEKAFSEIDNYMSSVNSFLEDKEMAYDFDLRRKYPKVGLKFPDGSW
SPIRVLSSGERQLLTMLYAASKMGDDAIVLIDEPEISLHIDWQEDLLKRMLSQLSGRQII
VCTHSPSIATGYEDFMINISPEFISSRDNDNHKDSEEMEEDESL
>LONDMIMF_03481 hypothetical protein
MKRTNTSPRKSTDFQLFKLLKEGNPVALNHLHLRYKRLLFWLGWQVLKDDFVVDTIVQDT
FLKLWTHRDTIETPDHITGFLRFVMKRDCIAYVSAPRNKFTRLMASLDSFENYQEYLAGY
DPLKDKEFLLSQESDQNKFDEITKVLPVLNPKRKHLIELCLEYGFQYKPIAEAMGSSVTG
ISTEVSKAINDLRKILNVTSFEQPQDRVFNNEVPSEKLSSQQLEIIKRRFEQKSSFAVIA
KELQLPEKEVHREFLYAYQHLQNQNRPEITL
>LONDMIMF_03482 hypothetical protein
MEKSTITLTRKIQLVIDVPADNKSEMWEKLYRYQNRCFRAANLIVSHLYVQEMIKDFFYL
TEDIQYKLADASKDEMGIFNRSKTNTTARLVFDRFKGEIPTDILGCLNNSIQSTFSKNKA
DYWQGSKSLMNFKRDIPIPLPVKCISKMKYDPDKKAFTFNMFAIPVKTYLGRDFSDKHLI
LERLLREEIKLCNSQVQLKDGKIFWLAVFEFQKDDHGLKPEIIAEASLSLEHPIVVKANN
VRMTIGSKEEFLYRRLAIQASNKRIRAGVAYSRSGHGNKRKQKALQKTENLENRFVSHHL
HLYSRMLIDFCIRQQAGTLILKDQEDKIGIAKEQEFVLRNWSYYELQTKIKYKAEKAGIE
LIIG
>LONDMIMF_03483 hypothetical protein
MKPRKIRKENLRSKSSLRLAAVARFREKDYSEPSTDVKKLVVIRGFGSSRKYVKAVSRIY
SREINDIDRFIDFAESLVKND
>LONDMIMF_03484 hypothetical protein
MKLHPYLRKLDNIDLIEHFLETVINYEDSSNNTILHKIKSGEAELKNYIDSKSTLASTEN
RNRQYKNNRDRWELRKQIVTELITLKREDDDDNISLGVGGTLPNCGLLTEKKAVIIIGLP
ASGKSTIANTIADSYGAIILDSDFAKRKIPEYVDNPAGASLVHEESDYLVFGANISDKPN
DFKCLFEKCIEKNFNIVIPKIGHDHKKINDLSIALTKLAYEVHLVCVSLDRRLATQRAIG
RFIKTNRYVPLSLVFDGYGNDCILTFYRLKDRIGIDDDVPIKSFGKLSTNVPHGSNPIIL
YSEEDSPVEIFR
>LONDMIMF_03485 hypothetical protein
MVKHYHQVDNNPEELLAENTYNDLSQLVNKKVGNNLQSIDYTYNIRGWMTKINDPANLNG
KLFGYEMKYTNPQDTDYGVGRYNGNISEIDWKTSGAGDENYRRYVYRYDNLNRLTDGIYL
TPLLASNSQNHYYDEKMTYDINGNIKTLNRFRNPSAGLNVPQHIDELTYEYDKSENSNRL
AKVKDNKFNSFGYPVGGNIISYDANGNMTNHVDKGISLIQYNYLNLPRQISSSQGNTSYI
YRADGVKVRKIFGTITTDYISGFQYENNSLKFLPTSEGFYNFERNEYVYNYTDHLGNIRL
SYSAADGGGIAVLEENNYYPFGLKHQGYMKDRC
>LONDMIMF_03486 hypothetical protein
MNDFGTKYNYKYNGKELQESGMYDYGARFYMPDIGRWGVVDPLAEKMTRHSPYNYAFNNP
IRFTDPDGMEPYDPIITITNQIVGWTQQKLVGNYTKGKNDYLTIGVPLYKAVVTDDEDAN
FKMEFMVTRDSWVVNQDKGNSMTLDNIAFEPKVGGSNEYDTEFIDVYPHSNDTAAFELRQ
EGSKILDSEPRKNDKGQDATSASSVMIHVEGVYKNEEENKIRHSGSLACFGIVNNNNSMK
NTSDSEAKRVIGGIRKQADKDSMFGYSNIKVIIQPRTNVQRTQEVKKPSNTN
>LONDMIMF_03487 hypothetical protein
MYREHKKLKSLVILISIAFTILSCNKYKGDFSIISTYYSKNPLCPKYIYYEGKKLTIENI
RKYRNGKLSEYIGCGSEGLYTDDFAKGGKYSKEDEAVKQLSISKKGKKIFFFDKEYEAIK
ENHDTIFVKSKVENEYFVFVGIIPEN
>LONDMIMF_03488 hypothetical protein
MSIIFYVNKFCRNNQYIYQYKDHLGNTRVSFGKNSAGVLEIVDANDYYPFGMNHLKSGNS
FFGSSSYKNYKYNGKELQETGMYDYGARFYMPDIGRWGVVDPLAEKMRRWSPYTYAFDNP
IRFIDPDGRLPWEGPGGPKKMTITYAQQSQNIRKVVYQASVSTLGQNGKKTVNETNITTY
LTSEGAVGNTYINKRTVVLTPYESSYTDAMGNKATSTEYTSQVKNNTTRLATNNEIEKAD
GGHYKAKVDDIAGKVNGDADFIKNEAREQFHGQSDYDNADDIASAFNNIGLPLSKLLDFL
PDVTVGEVTSTASKVIDKATSSHSGENRKLIITKPQTR
>LONDMIMF_03489 hypothetical protein
MEQVIKNLPKLAKDKHNENKKYFDKLKKKAPKNIDYIMQELHDQEFKKTDCLKCANCCKT
TGPLFTLADIERISKHFRQKPQQFIDQYLRIDEENDYVLQSVPCTFLDAENYCMIYDVRP
KACREYPHTDRKKFQQISNLTLQNVAICPAAYNIVEEMKKRMPL
>LONDMIMF_03490 hypothetical protein
MKHKRNLFYIFLASAIISVLLVFVNQDVVVRGLFDKIMEAVIMTALIYIVLIVLYFLMFI
AKSGANRIARKQKKDLTK
>LONDMIMF_03491 hypothetical protein
MNTSQLLLDYMDKLQEFFEWIDSYVDKAIELFHNAKEWVEKILEYIKRGIDYVVDAIGGR
FDESIELPEDYIFV
>LONDMIMF_03492 hypothetical protein
MISNMVFKNTALFLVLSILSCGNSFNTKARSEKPKAQDTIKSSKSSTAIAEIKTGADDWI
TYLPVLKKHKNIGIVANQTSIVNYNPNAKNRDEFRTEPATKSMHLVDWLVENKINVTKIY
APEHGFRGTADAGELIKDGKDTKTGIPIISLYGDNKKPKPEQLAGIDILVFDLQDVGARF
YTYISSLHYIMEACAENKIKLLILDRPNPNGNTVDGPVLEKENSSFIGMHTIPVLHGMTI
GEYGKMINGEKWLKNGIQCELSVVPCVNYTKDMSYSLPVRPSPNLPNDQSINLYASLCFF
EGTNVSLGRGTEKQFQIYGSPFLPKTDFSFIPKPNLGSKDPLHNGKVCYGEDLSNAPKVK
GIELKWLLKAYATTADKSKFFIPFFTKLAGTKKLQEQIEAGMTEADIKKSWEKGIEDFKK
IRKKYEIY
>LONDMIMF_03493 Lipoprotein-releasing system transmembrane protein LolE
MNLEYFIAKRLIAAKNHKSSISAPIIKIAIAAIAIGMIMMIVSVATGIGLQQKIREKVAA
FNGHIIITNYDDNQSQVSISPISTHQDFYPKFKSVDGINHIQAVATKAGIIRTETSFEGI
IYKGVGKDYQWKNLEEYLVQGKLPDVMHKLTPDVLISKYLADRLNLKVGDKFNTFFMKEN
SNQLPNLRVFVVAGIYNSGFQEFDATYIIGDIRHLQRINKWKPDQVGAFEVFIDDFNKIE
QKGQQVYDNTQNKEDASKTLDTQTISEKYYNIFEWLQLFDFNIIVIIVIMIIVATINMVV
ALLVLILERTQMIGILKAIGANNWSVRKIFLYNAFYLIVRGLLWGNCIGIGLIIIQQQFG
IIKLNPDSYYVNVAPAHLDWLYILLLNVGTLIICLAVLLIPSYIITKISPVKAIRFE
>LONDMIMF_03494 hypothetical protein
MTTFRPIQTSDIDTIVPMMQKFYSIDNYPIDIAISKALFLEFIENPHLGKAWLIYSDEEI
VGYIILTFVFSFEYKGTIAFLDELYISDKARGKGIGKKALDFIHQEALSLSLKIIYLEIE
NHNEIAQKLYLSKDFVVHNRSLMKLTLK
>LONDMIMF_03495 Asp/Glu-specific dipeptidyl-peptidase
MKFLRLIVLLLVLPAYSQQGGMWIPSLLKGMNETEMKNLGMKMSASDIYDVNKSSLKDAV
PQFNGGCTSEVISPKGLLLTNHHCGFGEIQSHSTVDHDYLTDGFWAMSLEEELPNPDLEV
TFIVKIEDVTAKILDGVAAISSEADKQKKIQENIASLTKSSPKEAWQENRIRTFYEGNQY
ILFVVESYKDVRLVGAPPSSIGKFGSDTDNWVWPRHTGDFSLFRIYADKNNRPAAYSKDN
VPYTPKHYLPVSIKGVEENDFTLVFGYPGRTTEYLPSVAVEQIVNELNPAKIEIRDKALK
VADGFMRKDKAIKIQYASKYASIANYWKKWIGETQGLKKSNAIEAKKKFEKDFLEKVNKA
GKQAEYGNLFADFEKNYAEIAPYALSRDYFTEVVLRNTELLTIGYRLYQLEQVYNARGEQ
SFKDRKEATIKALEETYKDFNATVDEKVFEQLIELYATKVPKQFLPASMKNSDYKKLTDK
IYDQSKLTTYKGLKELLSGDTKSVLAKINADKGYQFVKSMADVYLKEVAPKYDEINLRIA
ALQRTYMKGILELSPKEARIFPDANSTLRVTYGKVKGYSPSDAVTYNHTTYLDGVMEKYI
PGDYEFDVPAKLIDLYNKKDYGQYGKNGKMPVCFIGTNHTTGGNSGSPAIDAKGNLIGLN
FDRVWEGTMSDIYYDPAICRNIMVDMRYVLFIIDKFAGAKHLINEMKVVGGKK
>LONDMIMF_03496 hypothetical protein
MKKVVLSLALVATMAFVSCKETEKPAEEAAVEATEVEATQAVENAEVNAEATVDSTKVAE
EAKVEEAKAEAAAPAKQ
>LONDMIMF_03497 Dipeptidyl-peptidase 5
MKLKYSLLALAAPLLMNAQQLMTPEILWTLKKVGVQAVSPDQTSLIYKIGQTDLKTEKTK
SENYFLNVLNNQSVKVDLGKKALIQWDKNGLYAQEGDKIFLSKDNGKTWTEFYTIGEADN
IVISPDGKKIAFSKQVLVEKVMGKDKYSDTPKTTAQVYTDLNHRHWDYFNEGKYNHVFVV
NVSDKADSAKDLLEGKMWDSPQRPFGGAEDFIWSPDSAQLLYVTKPKSGKEYSTSTNTDI
FAYDLASGTTKNLTESNKGYDVNPKFSPDGKSLLWQSMARDGYEADKNDVKIMDWKSGKT
TNLTQSWDESVSGDVFWSGDSKMIYFTAAFRGTKQLFSLDPKNAKVQQITKGDFDVNEIF
ADQKTSLLVGRTDINHATDIFSVNLKNGEMKQVTEANKEMYAQLAQGKSELKMVKTSDGK
EMGVWFHYPPNFDPNKKYPTLVYCQGGPQSALTQFFSTRWNFALMAANGYIVVAPNRRGM
PGWGTKWNEEISRDWGGQPMRDYLAATDYAKTLPYVDGSRVAAVGASYGGYSVFMLAGIH
ENRFKTFIAHDGLFDMKSWYLTTEELWFANWDLGSPWEKPQPKAYTEFNPSNFVDKWNKP
IMIVQGGIDYRVPYEQGQEAFQAAKLRGLKSKLVYFPNENHWVLHPQNGLVWQREFFDWL
KETL
>LONDMIMF_03498 hypothetical protein
MNLIIRLLVTAIVAYLLTWILPGVHFTGFGGAIIFAIVLGLLNLIVKPVLNILGLPLTII
TLGLFTLVINAIIILIADYFIDSMEVGGFLWALIFSILLSIVSSLANSMFSDGD
>LONDMIMF_03499 hypothetical protein
MTPHKKQLITDSFNRSETLKFYKAELLEVETDFISMKIPKMELMTRKAGMFNGAMIASLV
DVSSGYAAVSHYEEDCYVVTVELKVNYLRPAIGDALVSKSYVIKGGSKISVIRTEIYVVD
EDGASESHVATSLVTMMKIR
>LONDMIMF_03500 Oxygen sensor histidine kinase NreB
MKNKLLFPFIFLISQALYSQRVYMLDDDQSYTDSLVQVIKTTRIDSIKCITSFRLADLYR
RSKKNELADEYLAIANKIAPRYPFLKDVGIFYNSTSYLIKGDIENLGKQLNLANTTLKKY
QTKEAYALRAYIVRVLSIIQQIKNNEKEAMRMLIEEAMPLAKKSGDYEALSGLYKSVGII
FMNNTEREKAEEYLNSAKEYIEKASKSSNTYKETKAEIYIIDAENLCHLENLTGAKKSLD
KAYAIIKDYPKSNMNASYCLSEGYYFYKMKQYENALKSYDKGIANSMLFNDIYSANRLKL
VKYHPLKAMNRYEDIKNMLSDLIESGSLLAVDEKRYSLELAYAFEKLGDIKNAYKYKSRY
IVLSDSLNEQYSKDKITALEAKFNKVENERKIAQLEAQRERDKLIAENNKLYYGLLVALS
VLLLLLVIFLWINSKNHKKIAVQHAKNYAQNLKSLKDQKEIEVMQAMIKGEEGERKRIAR
DLHDGIGSMLSSLKMRFMKVNSASETVDLNEIESMNTLLNNSITELRQISYNLIPESLLK
LGLEHALNDLCHMLQTDEVQIDFHANNISKDIPESIQITIYRIVQELLNNALKHSKGTDI
LVDCNQNRSTFFITVEDNGIGFDSKNMDGFNGQGLKNLKSRVELLNGKMEIDSSAEKGTA
FNIELSI
>LONDMIMF_03501 hypothetical protein
MRKSILKTAGIIAIALFGLASCSSDDSNNGPGGGGGIDAAVGTYKGTLDPLGGDAPTYFD
AILIVTKVDGNHLKITPKSGEPYSNYTSKTMKVFNNSNQAIFGDGNIPEGTFSYTISSKA
LLVQTREQSATDLTYTFQGTKQ
>LONDMIMF_03502 ECF RNA polymerase sigma factor SigW
MQRDAQRQVYELLAPKLYRTCKRYLKKEEEIEEALADAFYTIFTKIDQLKEVRAFEAWAR
KIAVNQCLLSLKKNINFNMYLDDVKIISQPITNHMTDLEEEDLLNLLNFIPEGCRTIFNL
FAIEGYSHKEIAKTLDISEGTSKSQLNVAKTKLKELVNNLYYQKAK
>LONDMIMF_03503 TonB-dependent receptor SusC
MENQDKIFEQFKDASKKAETKDFPAMEKVWNRVEEKLDKKDDKKTIALWKKIGIAASLLL
FFSLGYQFLKTDETTIDTPKNPIVTQEKENTISNSEKEAVVDNSDITVKHEKTEIKTSKI
IKSKAVSIKTDDAVAVAEDTKETEEVYSKAAEIAGVEITQAEPKAEILKEAKIIVAETKT
DPVTNEKTVIGTVVDGQNLPLPGVNVVVKGTTRGTQTDFDGKYSIAVNPNEQLAFSFVGY
KSTTVPVKDQSRLDIALSESSGMLSEVIVTGYTSTKRTKSSAAVKLNESRRRSKKEVELA
PTASFANGYIAQNNSTDNKLYRDGDKNSNPTIQSLQGAVAGLNIGTGSGQPGGDTSIVIR
GNGSVNDNNEPLYIVDGMPVDEEGLRKLAQNNIEEITVLKDASATAIYGNRGINGVIVIK
TKNGTNQKLSKRELRKKLRELKQKKNTEVYRTDEHTEDYNPFVENPFENPKSEPLSTFSI
DVDNASYTNIRRFINNGPEVPKNAVRVEEMVNFFKYSYEQPKGEDPFSIQTEYSDAPWNP
KHKLLKIGLQGKTIPTEKLPASNLVFLIDVSGSMDEENKLPLLKQSLKILVNELRKEDKV
SIVVYAGAAGMVLPPTSGDDKKTIIDALEKLNAGGSTAGGEGIELAYKTAQENFIKNGNN
RVILATDGDFNVGKSSNADMETLIEEKRKSGVFLTCLGYGMGNYKDSKMQTLANKGNGNH
AYIDNIQEANRFLGKEFKGTLFAIAKDVKIQIEFNPKHVQSYRLIGYEKRKLKTEDFTND
TIDAGELGSGHTVTALYEIIPVGVNSEFAGKTSDLKYTNAQENNTSYNDELATIKFRYKK
PDGEKSIELTNVVGNKSIPLNAASKDFKFSAAVAWFGLKLRDSNLIPNKSLNDIKKLAKE
GLSNDEEGYKSEFIRLVDSIK
>LONDMIMF_03504 hypothetical protein
MKKLNLFFIFIILFSLGSCHSDPSSPTEATVDNTVKTGKITGKVMSQNGAKAIGGASVFT
FDDKYKIYYTTSDADGNFTLDAPVGNHTIHIQTGNGSNFRTEVAATVKNNETLTLDLSQT
KLNQVAKIAYVKGSYDKIEDIILSLGYTATEITNNDLTNLNTIAQYDIIFLNCGSRKYST
NQALFPAIDANLAIFVANGGSIYASDWDVSYLVGGTDNTSSCAPAGGFVPDSKLCSTNTG
NSGIVPAVVSNAGLSSALGFNNLNIDFDLGSWQKITNYDPSYWEVLVKDGANQALMLRTN
HFTATGIPVTPIGNAPNTTFVTVCITIPGSSIQITISVPQTLVPYLVALGATVGPCSGSS
NSGYIYYTSFHNHAAGNIGNAAVILQYVILNL
>LONDMIMF_03505 hypothetical protein
MDSTLINILCLILLFLGILGTFLPVLPGLLLSICGLLIYKFGTDADLPMIYVWAFGILTV
ASVVLNYVIPAKTNQKYGGTRWGSIGSIIGTIVGIFLPIPLGFLVGMFAGVFIGELLHDS
KDVNKALKSTKGAFIGFIYGTGFSLVVGVAMFLVVLLDMLNII
>LONDMIMF_03506 hypothetical protein
MLHKMLILSLGSLFLMNCNAQKENKLKVNTDKTGVTKVTSKDGGMIYFNEGENKFLEEYQ
MNVTFKGISEDSRCPKDVNCIWAGVAVAQVEVMGTATRPVVLNLASMDNEGRNYHQSAVF
NGYTISLTDVQPYPASADGAKALNGKYKIGITIKKGGENPTMK
>LONDMIMF_03507 Uracil-DNA glycosylase
MTWTEILAPIKNTEYFTNLWEKVKQEYATTKVFPPKNQIFRALEITPFEDIEVVIIGQDP
YHNDYQANGLCFSVSEQVAAPPSLKNIFIELKDDLGVERTSKELDDWGKQGVLLLNATLT
VRAHSPNSHKDLGWEKFTDFIIKEISDKKENVVFVLWGAFAQKKAELIDPAKHFILKSAH
PSPFSVYRGFFGSKPFSKINEYLVSKGKKPISW
>LONDMIMF_03508 Alpha-amylase 2
MKKLILIAVTGLGILSCTSQKAVKNMTDLPKDWKHTTNIYEVNVRQYTKEGTFRAFEKEM
PRLKSMGVKTLWFMPITPIAQQNKKGSLGSPYAASDYTSINPEFGTLNDFKHMVNEAHRL
GFKVIIDWVANHTGWDHIWTKTHPDFYLKDPDGKFHIASGMDDIIELDYKNQEMRLAMID
AMKYWVKETNIDGFRCDLASWVEVDFWQQARPEVEKVKPLFWLGEFDELESPEYGKVFDA
SYSWKWMHKSADYYKKNEPLSELTDLLRKYSAIGDSSMRAWFTTNHDENSWNGTEYEKYG
VITKPMAVFSATWNGVPLLYSGQELPNMKRLEFFEKDVIKWSNVYQNADFYKILLNLKSS
NPALRGGDSNVTTYLLNTTANDKILAYIRKNGNDEVLVVLNMSKDPVNFSIEDEHLSGSF
KNVFEKTKRDFSSGKDFNFKPGDYAVFEK
>LONDMIMF_03509 hypothetical protein
MTKKLFAIALISNYCLFFSQVGINTPNPHPSSALEISSDTKGLLLPRLTTASINNLSSSA
NEGLIVFDKELKSFVGWDGTKWINLGYEEINTVPTATNLVIGGNLSVGASLTGNYTFSDA
QSNPDNASTFIWKRADDNSGTNVMIIPAASAQNYTLVAADLGKFIQFCVTPGSTIGASPG
LQKCSAWAGSVIANQAPTVSNVSISGTTNTGQTLTGNYTYTDIEGNTEGTSIFRWTRSDD
ASGTNETTISDATAKTYVLGNADATKYIKFYVTPVATAGTTTGNETGSGYVGSVVLTPVA
LGSWDTSSIAGGTGNFGPSPWNGTLATGIQSAKIIRDSGATQSGSGSAGAWGSDGLNSTS
QALAEAANDTWTFEFVPQTGKSLSITSIEAYSFRKSASGPKNGQYQYKIGTSGTWTDISG
AVISGISGASQTTANQSAIDLSGITALQNITVDTPVSIRLVLWGATATTGTAYMGYTNQT
ISIKGFAQ
>LONDMIMF_03510 hypothetical protein
MELPKLNFQETFDFKFKKDKDKFFIYDLVRKTYLLLTPEEWVRQHWIHYYLTVQSYSASA
LITEKKIVLNGLTKRVDLLITEKAQPKILIECKAPQIKLTEKTFEQTARYNSVIGAKEIV
LTNGLQHIHAYYENEQYQFYKPE
>LONDMIMF_03511 hypothetical protein
MKELDLILKNIKNKEVLPIYFFHGEEPYFIDLAVKALEHDFLTEDEKAFNQTVVYGKDTT
YQEVLSLARQFPMMGDKQVIIVKEAQDLRLAESESNALEMYVQNPVPSTVLVFAHKHKKL
DSRKKVTKSLEKAKALFLSESIRENNLPKWIADECAALKIKPAPNISHLLAEYLGNDLSR
IANELNKLKIILKEGEILDGTIIENHIGISKEYNVFELQKALGTKNANAAFKIAHFMGKN
PKNNPFVMMLASLYNYFSNVIIYNTMIGQPPQTIAAQMGVNPYFIKDYAESARLYPLKHA
TRVISILREFDMKGKGLGAVNMSEAELIKELVYRIINVDKIKMKV
>LONDMIMF_03512 Thioredoxin reductase
MEQNILDCVIVGSGPSGFTAAIYAARADLKPELYTGLEPGGQLTTTTEVDNFPGYPNGIT
GPEMMMDLQKQAERFETKVHYEMITKVEFSKEVGGVHKLYAGNKEIFAKTVIISTGATAK
YLGLDDEKKYNGGGVSACATCDGFFYRGKDVVVVGAGDTAAEEATYLAKLVNKVTMLVRK
DEFRASKAMVHRVNNTPNIEVKFHHELIGIEGENNLVERAVVINNQTQEKSTIDVHGIFI
AIGHKPNTDIFVGQIDLDENGYIVTEKGSSRTNLPGVFAAGDVQDHIYRQAITAAGSGCM
AAMDAEKYLAELH
>LONDMIMF_03514 Bleomycin resistance protein
MNSKITQIISQLPSLDFEKSKQFYQEILGGKLVGEYEDLLIFLWDDNEIHLWKCNEKIVP
ENSSCYIRVNDIEAVFERYKKILGDKIALKNQPWGMREFYIIDDSGNLFKFGQPIQ
>LONDMIMF_03515 Subtilisin NAT
MKKITFLIVLLSGFWAVAQEDAWVYFTDKPDAAHYMANPLEMLSQRALDRRTRQNIALDE
KDVPISVSYINQVTASAGITVKAKSKWMNALHIRGTVEAIQNLETLTFVDHIQFANPTLN
TAGRAMRQSQLANGNKNLETQVSFGYGTSANQIQMLKGNQLHQQDFTGNGKIIAVMDAGF
PNVNTAQPFQRLITNNKILGGYDFVNRNTNFYTGGTHGTLVLATMGGYVENQLVGTGPDA
SYYLFITEDISDENPVEESYWVEAAEMADSLGVDIINTSLGYFIYNNPVYSYEYADMNGT
TAFISRGADIAFSKGMICVVSAGNSGAGANPNISAPADAVNALAVGAVAPDSSYAGFSSI
GPSFDGRVKPDIMAQGQQAVVSDTFGNIVTANGTSFSSPIISGMVACLWQAFPDKTNVEI
IQLIKQSAHLYNTPNNQFGYGIPDFSRALANALDTPVFSENSFLVYPNPANSVVNLVIPE
SYEEVRIFIYNQLGQEIMNSKIKRENPVFSVENLQSGIYWYKIKAGNNYKTGKLAVK
>LONDMIMF_03516 Nitronate monooxygenase
MNKITQLFNIQYPIVQGGMIWNSGYKLASAVSNAGGLGLIGAGSMYPDVLREHIQKCKKA
TDKPFGVNVPMLYPNIEEIMNIIVEEGVKIVFTSAGNPKTWTAFLKEKGITVVHVVSSSK
FALKAQEAGVDAVVAEGFEAGGHNGREETTTLTLIPMVREKIQIPLIAAGGIATGRGMLA
AMVLGADGVQVGSRFAASIESSSHADFKQTIVDLEEGGTQVTLKELAPVRLIKNKFYQDI
QELYAKCPTTDDLKVLLGRARAKRGMFEGDLVEGELEIGQISGLIHDIKPVKEIVENMVS
EFEKAKQEAVSL
>LONDMIMF_03517 Tyrosine recombinase XerC
MASIKKRKSTFSVIYWYLDNAGERKQKWDTLETKKEAKQRKAFIEYYQEKYGYVIVPLEE
QFARQIDESKKELDSTDEDITLCDFLKIFVNLYGTSKWSPSTFSSKVGTIENYINPLIGD
WKLNEITTKKLSAYYNDLLSVPEVPRANRKATGRCVQPANIKKIHDIIRCALNQAIRWEY
IDTNKRNPASLATLPKVPKVKRKVWSVDTFREAIQKSDDDLLTICMHLAFSCSMRIGEIT
GLTWEDVIIDEQSIATNNARVIINKELSRVNAQAMQKLKEKDIIKIFPTQKPHCTTRLVL
KTPKTETSNRTVWLPKTVAELLVQYKKDQQKLQEFLGDAYNNYNLVIALENGNPVESRIV
RDRFQKLCEQNGYEKVVFHSLRHLSTGYKLKMTNGDVKSVQGDTGHAEAEMVTDVYSEII
DEDRRYNAQKMDEQFYSTLNHDSEMQPQNEKVQPENNGLSDSDMELLQLLKSLTPEMKAM
LLKQSASK
>LONDMIMF_03518 hypothetical protein
MTLLNVCILLLSHGKELLLLVISDTSNTETPKKEKKTYTVEEIAEQLCVSKKVAYALVKS
GQFAYVRAGRAIRVSKDSFDKWLNQN
>LONDMIMF_03519 hypothetical protein
MLGIKKRDTKQVFKAIAHQQGVSVSEVKERIQSTIDEMYYSDDPDVQAEFSSYFGKKRPT
PEEYVYTMATKIKY
>LONDMIMF_03520 Very short patch repair protein
MDVHSPEQRSKNMRAIKATGSKDEIRLAKALWHSGYRYRKNDKTVFGKPDLVFKKHKIAI
FVDSEFFHGKDWNTEKFRIKSNQEFWHKKIERNIERDKEVNQYLTDSGWKIIRFWSTEVK
KHLQDCIDKIISIIEK
>LONDMIMF_03521 hypothetical protein
MMSSGFHRKWGAGIDGNAKDGVAAIVISGGYEDDLDSGDEIIYTGAGGNDGKGKQIENQR
WDKSDNKGLLISMDRGLPVRVIRGYKHRSEFSPKTGYTYAGLYSVVDAWEETGKSGFIIC
RVRLEYSGQNPERNTPERIELKYSNKRTERKESTVLRIVRDTRIADDVKKLYNYECQVCG
ETIPTKSGGYAEGAHIKPLGRPHDGDDSSDNLICLCPNHHVMFDKGTFSITDDLKLVGAA
RGELMVHETHILNKLNLQYHRKSHGYD
>LONDMIMF_03522 CTP pyrophosphohydrolase
MGTIRVVCGVIFNEGRILLCRRKPEKPLGGYWEFPGGKIEVGETEEESLYRELQEELGIR
VEIERYFMSVVHDYDAFTIELIAYICRSEQSVCVLTDHDEYEWVDKSELLNWKLAPADIP
IANELCFIEQKMREG
>LONDMIMF_03523 hypothetical protein
MEKDITVITANGKRCLIFIDKITHICEDENGKAIICFGSEKVVCNESYSEVMHEIKFL
>LONDMIMF_03524 hypothetical protein
MIENKSQIYYVSKQNEKIISEIFYRLQLKRPI
>LONDMIMF_03525 hypothetical protein
MTSFQLKKGLFLCIVFFTVNINAQTSDSADSKKNQDDVKYPVLQVKGLFQARYLVGTTKN
VDVNGLHHEDGSGTDNSFIVKYMRVQMRAQISKRTEVVALANLADFKNDPKSRVLENAYL
KYTFNPKLAFTVGQFRPLFGIEETYPIDIIKSLDWSNQYTEFGKLGWTSFQIGLAATGQL
KLGKIPFQYAVSLVNGNGKNQISDNDNGKQYSTRLVFGLAEKYKLNLGLNGGIGEVFSKK
IYAAGIDLSSLIRFNPKWSLDMQLEAKQATNHLLYFAVAPELRPSNPDEYLTRGVYFLPN
IRYEINHRNLSAFELSCRYEYLDSNFRLNSNPRQTITPMLGLEFLKNYGARIQLGMQFDR
YKHQIDNTTQHNNNLFIVQVQSRF
>LONDMIMF_03526 hypothetical protein
MDFPASPGAATCVSAVNATAIIHIVPIGAALRMIPKIVAAKIANRCHAFSLTPCGAGINQ
IINAMAKVMITALTLISFIRLCFLMV
>LONDMIMF_03527 hypothetical protein
MNAVVVASMDNAPPKIQSPSKMKKARSISHSFFVIGPISFNFSAAILGASPVFFNSGGYN
L
>LONDMIMF_03528 hypothetical protein
MKKNILSGCVALFFSLPFYAQVGINTKNPAATLHIEPSSSASPTGKDGIIVPKVQNLPSV
NPSRLGQFIFLENNATLADGFYYWDGSSWISFPESIDRNADNTIYSFDGQGYTGTALSRN
INFSRYIKATTDGFTLNNNTITVGKGGLYLISFTGNSKKPSGAEEHANFTFSVLVNGVQA
SSVQTSMAAESTASVSTAFSFLRRLNVGDNLTATVTKSNEGPNNYQAFGINNLTLFFIQN
>LONDMIMF_03529 hypothetical protein
MKKTLLQSLFLFAGIFIKSQIGINNTNPKASLHLDAKNKILPESTVGLGVPVVDKFPTAS
PSSNQDGMLIYLRNTTDSNLEGFYYWDHAKSNWEYIMDLKAAGLDVSKTIASGSSFSPNN
MSGNGVQSRTIPLTTINSLDPSFSLSNGGLKIGKTASYYIFLTGGVYKDAVNNVNEYITE
ILINGVSNTQLTSTNTAPGGDTVGRSSTFYIATIFSLNKDDVLTVKTTRTTTAANTVSVD
TPYTLTIINLN
>LONDMIMF_03530 hypothetical protein
MNKLSIFFFALAFLCTGKVTAQIGINNPAPKSTLDVKPDNQANPSGISGVIIPRVNALNT
TDVKEKGLMVFLNSADTAQKGFYWWNGTEWKRFLSLSRVSSNKSILYATTKNIFKEGNMN
ELGSSNDRTLDFEDFTTNDASNFEINTSGELVVKKAGYYHIQAASFIKKNNGNDLKREQL
DMKIYVNGVTASANNPVNFDLEGTKSFPIGLYSIAINATGVLKLNANDRLSMKIIRTYRD
TDQTGNLVIIPDQNTKSNVTLRYMGNF
>LONDMIMF_03531 hypothetical protein
MLKKILKGIGIFLLVVIIALAAAPFLFKDKIQQLVLKSINEKVDAKVAFADVHLSLFKSF
PRANVTIDKLAIINKAPFEGDTLLYAGEVNLKMSVRELFKGDGEPMNIESFSSTNGVVNI
LFDKNGVGNFDIAIKDDKEKKDDSESKPFAMNIQNYEIENLRFTYFDERSKVKMVIDSLN
HTGKGNFAASKLDLTTKTTAKVSLDMDKTNYMKNVKLDLDAILGIDLENSKYTFKDNKAL
INQLPLEFDGFIQIVDAGQEYDLTFKTPTSSFKNFLGVIPEAYAGNLNTVKTTGDFKVSG
FAKGLYSDKTIPKFNLAIASNNASFKYPDLPKSVENIVIDTKIINESGNLNDTYINLDKL
SFRIDQDVFNVQANVKNIVENPLVDAKLKGTINLGNVSKAYPVKLDTPLSGILKADVETK
FDMKSVEANQYQNIQAMGNASITGFKYVDADKKTYTINTAAAQFSNQKINLQQLDMTTGK
TDLKVNGTLENFLGYAFKNQELRGNFTMKSNQFLVSDFMSKTETTVNNKTVTTEAVKIPK
LLNVTLNASANTVVYDNLNLKDVSGKIVVKDEAVSLQNLKTSIFNGLITATGDVSTKGKV
PTFDMNLGLTTVDINQTFTQLDMMKKIAPIAEAINGKLNSTIKLSGNLDAKTMSPDLNTL
SGDLFGQLLSTTVNAKNSAVLNKLDEKVKFIDLQKLNLNDLKANLTFKDGKVNVKPFDIK
YQDIKINVGGQHGFDQSMNYNLKFDVPAKYLGNDANKLIAKLTPAEANKLENIPVTAILT
GNFKNPKVSTDIEQAVTKLANQLVKAEKDKLVTKGTSALENLLGGNKKDTTKTQTSTPKE
DVKTKVSEGIKGLFNKKKKE
>LONDMIMF_03532 hypothetical protein
MEMLFLLKNLYRDPLALSRFSQFRYLHIGKGEIIQNLNENHEFQVCFVLKGSLCLFRDQM
ESMPLIAVQNEFFFISSLHKCKIKTMDDVQLVIHACNIVAPYLHSRIIEYLQDISIEEVK
PVEVLPIYPLIRSYLDLLVDYMKNGTEIPDLHRAKEYELFSLFKICYSKNEIASIFRYAL
SNDLQFFVSVMTHYKACRTAKELAILCGYNDLIFTQLFKKNFHGDTPYQWLQKQTSYEIE
FKLKESTLPIKQIMLDYHFKTFSHFTTYCKRNIGATPNEIRKKGEESKGTPPLETYSVSA
ND
>LONDMIMF_03533 hypothetical protein
MTLRSFGPLQKIQKPIFGIFLAEETDNHLILVKMEIGISAIKTQKSKLSAKMERMELMEK
TDFPLMNYGNNLLLTAI
>LONDMIMF_03534 hypothetical protein
MVKMVLLHMLVKMVIGTLAIMIQIFPLKVKKEKMVKTEHPLILVLMETGGSIHPIQK
>LONDMIMF_03535 hypothetical protein
MNVTLSDEQKKSLAITTALFALLLLLLFLIKFATEERIQELAGGGGGGVTVNFGDSEFGS
GADYTSEVLKVTQTTKSAPQPTTSSQEDILTQDSDEDAVSVTETKKPVKTEVKKPTTTPV
EVKKPSKSTNDALSSILGGANKGGDGDDGISGNKGKLNGDKNSNNYYGDGGSGGGTGGGN
GPGNGPGNGPGSGPGSGGGSGGGYSLGNRKALSKPMPNSDCSNETGVVVVEVSVDKNGNT
ISATAGIKGTTITAKCLRDQAKQAAMRTKWQASSDAPDRQVGKIIYNFGLN
>LONDMIMF_03536 Dihydrofolate synthase/folylpolyglutamate synthase
MTYTETLDWMFSQLPMYQKQGASAYKEDLTNTVLLANHLHHPEKNIKTIHVAGTNGKGST
SHFLASILQEAGYKTGLYTSPHLKDFRERIKIDGKEISEDFVIQFIAANKSFFEQNQLSF
FEMTVGLAFDYFRQEKVDIAIIEVGMGGRLDSTNIISPLLSVITNIGMDHVQFLGNTMEK
IAFEKAGIIKPKTPVVIGEYTTETRPVFEKRATEMQSEIYFASDLINTTFPSTLTGDYQE
QNKKTVLQAIRVLQAQGNFIISEENIKDGFWNVIKNTGLQGRWQQLKEAPMVICDTAHNK
HGLEIVMKQVARQKFDILHIVLGVVNDKDLDDVLPLFPKNAKYYFCRPNIPRGLDATALQ
EKAATFGLNGKVYSSVAEAYKIALENASQTDFIYIGGSTFVVAEIL
>LONDMIMF_03537 hypothetical protein
MNLKTKLLFSFLIIGSLLLVNCQVEDLQESASKRNPYVPIVSKEFKEFEKLPGLLSEIIP
NHGLSVRNKNTDPHYRFEIDSTAVIQITNNGIAYYTMSITRENQEDGVFENLVVFDDGNE
KKAIIVKYKPDASFLSRFELNPDAQFSGKFNMTELGHSTLASRLTSATKCFISTHLYCTN
NNPPTLAGKGCYTNKDGGAHVKSITSVNCFEIIINEPEPYLNNTFVLNPINDAGGGNPDI
ATSIATHPVFMGIIDFRFIRRLTPEQKAWWNNANNNAAVAVILNYLKDNTSNHSYVNNQL
ILDGDINSEARIFGRWAIDYLRTHPSITIGKFQNWFMVPDEGRDFLYDENFWENPNLNFP
QQDLPSWDDFENAYPSESSSQLYGVVGGEVAKAQIDYPEATVNGCALKVSRALNYSGVII
PRIITSNGYPGTLKGADGKYYFLNAKSLNKWMRETFGTNPATNSTPLNENHYHFTADDGG
SNGENFPTLVDGKKGIFSMVSTNPQWSSGHADIINDDGTCKSGCHFQDNPPAPIDYIDIW
VLE
>LONDMIMF_03538 hypothetical protein
MKRKSILIILCISFLLSCKTSSKFNRNDIPRDKEKKEWIFAFKAQVFYECLKNNNVMIEK
DASPSLNFQVLGDFNVLSKTNAIGKNYSKIINDRATWLKGGDLEGYKAITNGCLSFFESK
ELDSIANSEYLNFKNLNSKKS
>LONDMIMF_03539 Ribonuclease G
MNKELIIRSGSDAVDFALLKDGKLIELHKEEEKSNFQVGDIFIAKIRKPVAGLNAAFVNV
GFEKDAFLHYHDLGPNLTSQLKFIKLVSAGKLKDFSLKSFPFEKEIDKDGVITDVISANQ
SILVQVVKEPISTKGPRISSELSLAGRFIVLVPFSDRVSISQKIESKEEKDRLKRLVQSI
RPKGFGVIVRTVAEGKKVAELDKDLQNLLSRWTAMCKKLPTAHHPSKVLGELNRASSILR
DVFNDTFTGIHIDDEELYNETKDYLQEIAPSKQSIVKFYQSKDTPIFEKYNIERQIKTSF
GKTVSMSKGAYLIIEHTEALHVIDVNSGNRSNKASNQEDTALEVNLIAAAEVARQLRLRD
MGGIIVVDFIDMSNPENRKVLFDFLREEMSDDKAKHKILPPSKFGLIQITRQRVRPEVNI
KTREEDPNNEHGEIDAPISIVDKITSDVERLLKAHKKIVLNAHPFVAAYLTKGFPSLRSK
WFFEHKKWVKIIPRDAYTFLEYHFYDKNGNEITD
>LONDMIMF_03540 hypothetical protein
MGFFTKKEKKEETAKSNLLLAMPMFNNGERFDIDKVIAYLQSDWGIDVTDIDKSTEAASF
SVQGETVVLATVAAQIPMGDIQGAAQYAYNWPTAVKDLENHNVHGLVTILSSNTTAKERF
GILTKVLTAILATSNCIGVYQGTQSLLIPKAQYLDSAEALKSNQIPLDLWIYIGIRRGEQ
TNSAYSYGLTAFDKLEMEFVNAPLGLRELHTFLSQICAYVINSNVTFKSGETLGYTAEQK
IKITQSKGKFVEGESFKLEL
>LONDMIMF_03541 hypothetical protein
MADLKREELKKLLSPINKELRIHGGNENTVKITKLKAAQIDFLLELLNVHLDDYKTFART
KLEEFHAEDIKTLVNYKMPVSIHKITLPENDDEDCIWELIIGRLRFGSTEIILDLKKWEI
IDDTVVG
>LONDMIMF_03542 Mannosyl-D-glycerate transport/metabolism system repressor MngR
MKKNLLTLDVALSKEIKYMLKEEHYLPGDKLPSERKLAELFHVQRLTVRGALNLLLQDKT
IISKPRSGYYVAPKRILQSIRNFSLHSEEDSGQLTYELYDFKKIEADNYLASEMLLPEKS
KIYKIVWLYSDGTQLICINTTYIPEYIYPDLTQQIAASAPAIDLITNNCQIPLAKSNQKV
TLLYADTKTAQILNIPVDSPLMKYKGLMYDKQGHLAVFFENNMLIDRFGFIKEVVL
>LONDMIMF_03543 HTH-type transcriptional repressor YvoA
MSNDDVLAAQIKSSIITKIKTQEYLPGELLPSERDFATMYSVSRYLIHDIFDELISQHYL
IRVHGKGTFVRKPEQNRVALGVLNESKNASFTSLVRNFGIEISNKCLGTGIIKNRKYFAD
KLGLSEEDEIYGIHRIRLGNKEPLAIEFTYVPIHFFSDIDNYNFEHISLYDYMKSKNHLP
VKFNETMVMVEAGEKLQKHLHLPSATSIVNYIEFIGYDENGNLVEYTESYSRPDKLEVRF
VTNDI
>LONDMIMF_03544 hypothetical protein
MYANASVEITMEEKHNDLTEIIAHHFTIFTFL
>LONDMIMF_03545 hypothetical protein
MRIGELLALTYNDINLEEKTISINKSYQRLKGKDMITQPKTPKSIRVITMPDFLAEEFRE
YCSHLYGIMKKERLFRFTKSHMEHCMAILVVYNMLLTGFKEM
>LONDMIMF_03546 hypothetical protein
MRPASKLAVGTLQAYLDDYLKAHKDVKIDYIHGEDSLKKLAETRNALGFLFDGMKKEELF
DAVRQDGSLPRKTFSMGEADDKRFYLECRKL
>LONDMIMF_03547 hypothetical protein
MKNNIRTIKRKLDNSISQLCDVSWMFSSNPEKDFSRNRKLPLKKVISILLSMQGGTLTTE
LLKYFNCSLDTSSSSAFIQQRCKLNSFAFPTLFDLFVKKTDSAKLYKGFRLFAADGSDFK
IPHNPDHPASHYDGTNGQSPYNLFHLDAMYDLLQHTYQDVALGGDREMNERKSLCSMVDR
SDIKNAIVIADRGYENYNLMAHIQEKGWHYLIRIKDIQSLNGISSGLTLPSSDEFDTFIN
LSLTTKQTKEIKYLCKNSNEYRFIPSAVTFDFLPKTNRKFAPTVFYKLPFRIVRFKITDT
TYETVVTNLGSIQFPVTELKKLYAMRWGIETSFRKLKYTVGLLHFHSKKVELIYQEIYAK
LIMYNFTELITSHVIVHKLDTKYVYKANFTVAVHLCRQLFLGNISPPDLEALIRKNVSPV
RPGRSRPRTLTAKYAVSFLYRVA
>LONDMIMF_03548 putative HTH-type transcriptional regulator YybR
MGKNIEVEGKHYPCTISLAMDLVGGKWKAVILYHLKDGDKRFNELRKEIEVITEMTLSLQ
LKNLESDGLISRTVDGDKAPVKVFYSLTQFGRTFIPALDVINKWGHYVAEKKTNHR
>LONDMIMF_03549 hypothetical protein
MKNTIVGLFCFISLFSCAQERKAGSGLNFNPDKYEIQILTYNGKEIRVRAFEKIVYVEKP
VDTTYQVLNFYVPEEYYRNKSINGYNAQNAPIFFPNQVGGYMPAEPGSTKLNNFRPPING
GVVKDNNQQRPQGGLEDKKENTILKALSHGYVVASAGARGRTNKNKDGKYYGKAPAGLVD
LKAAIRYLKLNDREMPGNADKIISNGTSAGGAMSALLGATGDNPDYLPYLKEIGAAETSD
AIYASSDYCPITNLDHADAAYEWQFFGVNDYKKGGLFGPQADTATETLNERQQKVSLELK
NTFPAYINSLKLKDEKGNLLTLDNSGNGSFKEFLKAKVIVSANVALKAGTDLSERPFLII
KNGIVTDINWDEYIRYMQRQKTPPAFDALDLSAAENTEFGTESFDAKHFTEYSLKNTTVS
NAVIADKQIVKMMNPMNYIGDAHTKTAKYWRIRHGSKDKDTGLAISAILAVRLANQCYHV
DYALPWDKHHSGDYDLDELFHWIDQISK
>LONDMIMF_03550 hypothetical protein
MAHNINFNERTGRYSFFSVQQKAWHGLGQIVEQFPTSEEAIKYAGLDYEVVKSPIFTKNS
GIIETASGIEIGSSELEVPNYFANIRTDNNAVLGVVGKDYHIVQNREAFNFFDAIVGGGE
GILYETAGALGNGERIFITAKLPDYIRVGNGDDVTEKYIFLTTSHDGSGSITAAFTPIRI
VCQNTLNASLRNMTNVVRIKHTSGAKQRIENAHKIMGLANTLSNQLERIFNDWAKVKVTD
QEVKKLIQLALCPNKETFDLLKKGAEDEISTLFKNTVDDAFAYAMISDTQQMETTKGTLF
GAYNAVTGYYQNVRNYKNDEAKLQSIVLSGTAQLKSQKAFELCTAFALDGAEILNLN
>LONDMIMF_03551 Single-stranded DNA-binding protein
MNIIGRLTKDAEVRTLSNEKQVVNFSVATNESYKNKQGDRIEQTTYFDCAYWISAKVATL
LTKGKLVELTGRVSTRAWIGKDGEAHSGLNFHTSQIKLHGGGRKTETVQVTGEGKTDDLP
F
>LONDMIMF_03552 hypothetical protein
MQKYQERKRSGRNAKTGVKTDTMEYVLECLRNNTTKVRNIRSYMLTTLYNAPVTCSNYYK
AEVNHDFYGK
>LONDMIMF_03553 hypothetical protein
MENLHSMEFEKYKKYLISTWLPEYEAEHTERDLMVEGWNMLLDEVFSPLIAKELGMRYLG
NRIWADDYCNHRRRVLSLFQQTDLGGSFKWGWNYDFIPKMSAKKAVYVRTDKSIFTHFFE
NIWENHNKIVEGKCQKADMTFNRCYIDSADFENSMRQRVKAYEAAFYYTLPLIRSFYEET
KTYEQSIKMINTLLESSYYRLIQGNYLYLTKIFLQQYVSLGEENEKELRELFVNDNTRES
FLKKFAQIPKDYR
>LONDMIMF_03554 hypothetical protein
MNGLIIKVLSISIAVVTVVYLIIYKGNTMITKIFSVCIIAAMVIYWIVYERNTRKRKKQE
LQRDDYLFAKENDLPLQINWNEINDFLSDSGYGVNMPMENWFMMDWARQPCVENGIKEGK
FSMKGFRVLQALSNDMKHIFYDVRFNYDRGPDIEDKNRKYEAVKKVLDTKYAGLSEEVRK
NIYDQFVKIYERKI
>LONDMIMF_03555 hypothetical protein
MKEKSNYNTKEEAVEFLMNETNLTYEECSKANDFHIRLNKKN
>LONDMIMF_03556 hypothetical protein
MLSSQLKLSLSYYSDLYDMIVPKDHILRKIRELVDFSFIYDELKNKYCLDNGRNAKNPIL
LFKYLLLKYLYNLSDNGVVERSRYDMSFKYFLELTPEEEVIHPSLLTKFRKQRLKDENIL
DLLINKSVELAINQGVLKSNTIIVDSTHTEARYHKTTQREMLKKASTSLKVALKDSDKDI
YLPDEPEKRASLDEYNEYCHELLNTVQESPYSELPTIKEESSMLSEILDNQIDCYDQSID
PDARIGHKTVNSSFYGYKTHLAMTDERIITAATITSGEAFDGQELPVLVQKSKAAGATVN
EVIADTAYSTLENLKDAQSNDYKLISKLNPSIIKGTRSEDGFIFNKDADTMQCPAGHLAI
KYRIDKRSNQKKNTRIKYFFDINKCHVCPYRNGCYKENAKTKTYSITIKSDYHKNQEAFQ
KTQYFKERFKTRYMIEAKNSELKNIHGYSRCDAAGLSNMQLQGAVSIFAVNLKRILKLKG
EVCPNEKK
>LONDMIMF_03557 hypothetical protein
MYASIENLWSVLFTTGYLTQTGRKDANTFMLTIPNMEIRNIFLTQIMEYFNNRSKNSLTS
IGTPLKKWS
